PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Apperley, JF				Apperley, Jane F.			Chronic myeloid leukaemia	LANCET			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; DIAGNOSED CHRONIC-PHASE; TYROSINE KINASE INHIBITORS; CHROMOSOME-POSITIVE LEUKEMIAS; CHRONIC GRANULOCYTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; DASATINIB 100 MG; COMPLETE MOLECULAR REMISSION; STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE	In less than 10 years, the prognosis of chronic myeloid leukaemia has changed from that of a fatal disease to a disorder amenable simply to lifelong oral medication and compatible with a normal lifespan. This change has been made possible by a deep understanding of the molecular pathogenesis and a determination to develop targeted and selective drugs. This Seminar summarises the presentation, pathophysiology, diagnosis and monitoring technology, treatment options, side-effects, and outcomes of chronic myeloid leukaemia, and discusses the possibility of cure-ie, stable undetectable or low level disease in the absence of medication. Chronic myeloid leukaemia continues to instruct us in the mechanisms of leukaemogenesis and provides hope not only for similar developments in management of other malignancies, but also for the remarkable speed with which these can move from bench to bedside.	[Apperley, Jane F.] Univ London Imperial Coll Sci Technol & Med, Dept Haematol, London W12 0NN, England	Imperial College London	Apperley, JF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, Cane Rd, London W12 0NN, England.	j.apperley@imperial.ac.uk			NIHR Biomedical Research Centre funding scheme; National Institute for Health Research [NF-SI-0611-10275] Funding Source: researchfish	NIHR Biomedical Research Centre funding scheme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	JFA acknowledges support from the NIHR Biomedical Research Centre funding scheme.	Agostino Nicole M, 2011, J Oncol Pharm Pract, V17, P197, DOI 10.1177/1078155210378913; Aichberger KJ, 2011, AM J HEMATOL, V86, P533, DOI 10.1002/ajh.22037; ALLAN NC, 1995, LANCET, V345, P1392, DOI 10.1016/S0140-6736(95)92596-1; [Anonymous], 1968, Br Med J, V1, P201; Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Apperley JF, 2009, J CLIN ONCOL, V27, P3472, DOI 10.1200/JCO.2007.14.3339; APPERLEY JF, 1986, BONE MARROW TRANSPL, V1, P53; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Bonifazi F, 2001, BLOOD, V98, P3074, DOI 10.1182/blood.V98.10.3074; Branford S, 2008, BLOOD, V112, P3330, DOI 10.1182/blood-2008-04-150680; Branford S, 2013, BLOOD, V121, P3818, DOI 10.1182/blood-2012-10-462291; Branford S, 2012, J CLIN ONCOL, V30, P4323, DOI 10.1200/JCO.2011.40.5217; Brummendorf TH, 2011, ONKOLOGIE, V34, P263; Conan Doyle A., 1882, LANCET, P490, DOI [10.1016/S0140-6736(02)21638-4, DOI 10.1016/S0140-6736(02)21638-4]; Cortes J, 2008, LEUKEMIA, V22, P2176, DOI 10.1038/leu.2008.221; Cortes JE, 2013, NEW ENGL J MED, V369, P1783, DOI 10.1056/NEJMoa1306494; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Cortes JE, 2012, J CLIN ONCOL, V30, P3486, DOI 10.1200/JCO.2011.38.7522; Cortes JE, 2010, J CLIN ONCOL, V28, P424, DOI 10.1200/JCO.2009.25.3724; Crawley C, 2005, BLOOD, V106, P2969, DOI 10.1182/blood-2004-09-3544; Cross NCP, 2012, LEUKEMIA, V26, P2172, DOI 10.1038/leu.2012.104; CROSS NCP, 1993, BLOOD, V82, P1929; Dazzi F, 2000, BLOOD, V95, P67, DOI 10.1182/blood.V95.1.67.001k07_67_71; de Lavallade H, 2008, BRIT J HAEMATOL, V141, P745, DOI 10.1111/j.1365-2141.2008.07108.x; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Deininger M, 2009, BLOOD, V114, P462; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; FEFER A, 1979, NEW ENGL J MED, V300, P333, DOI 10.1056/NEJM197902153000702; Fullmer A, 2011, EXPERT REV HEMATOL, V4, P253, DOI [10.1586/EHM.11.20, 10.1586/ehm.11.20]; Gambacorti-Passerini C, 2014, AM J HEMATOL, V89, P732, DOI 10.1002/ajh.23728; Giles FJ, 2013, LEUKEMIA, V27, P107, DOI 10.1038/leu.2012.181; Giles FJ, 2012, LEUKEMIA, V26, P959, DOI 10.1038/leu.2011.355; GOLDMAN JM, 1982, LANCET, V2, P623; Goldman JM, 2001, NEW ENGL J MED, V344, P1084, DOI 10.1056/NEJM200104053441409; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gratwohl A, 1998, LANCET, V352, P1087, DOI 10.1016/S0140-6736(98)03030-X; Guilhot F, 1997, NEW ENGL J MED, V337, P223, DOI 10.1056/NEJM199707243370402; Hanfstein B, 2012, LEUKEMIA, V26, P2096, DOI 10.1038/leu.2012.85; Hansen JA, 1998, NEW ENGL J MED, V338, P962, DOI 10.1056/NEJM199804023381405; Hasford J, 1998, JNCI-J NATL CANCER I, V90, P850, DOI 10.1093/jnci/90.11.850; Hasford J, 2011, BLOOD, V118, P686, DOI 10.1182/blood-2010-12-319038; HEHLMANN R, 1994, BLOOD, V84, P4064, DOI 10.1182/blood.V84.12.4064.bloodjournal84124064; Hehlmann R, 2014, J CLIN ONCOL, V32, P415, DOI 10.1200/JCO.2013.49.9020; Hehlmann R, 2011, J CLIN ONCOL, V29, P1634, DOI 10.1200/JCO.2010.32.0598; Hochhaus A, 2008, LEUKEMIA, V22, P1200, DOI 10.1038/leu.2008.84; Hochhaus A, 2012, J CLIN ONCOL, V30, P232; Hoffmann VS, 2013, LEUKEMIA, V27, P2016, DOI 10.1038/leu.2013.171; Huang XL, 2012, CANCER-AM CANCER SOC, V118, P3123, DOI 10.1002/cncr.26679; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Hughes T, 2009, J CLIN ONCOL, V27, P4204, DOI 10.1200/JCO.2009.21.8230; Hughes TP, 2010, BLOOD, V116, P3758, DOI 10.1182/blood-2010-03-273979; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Jabbour E, 2013, LEUKEMIA, V27, P907, DOI 10.1038/leu.2012.305; Jabbour E, 2014, BLOOD, V123, P494, DOI 10.1182/blood-2013-06-511592; Jabbour E, 2012, AM J HEMATOL, V87, P1038, DOI 10.1002/ajh.23282; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Kantarjian HM, 2011, LANCET ONCOL, V12, P841, DOI 10.1016/S1470-2045(11)70201-7; Kantarjian HM, 2003, CANCER-AM CANCER SOC, V98, P2636, DOI 10.1002/cncr.11831; Khouri IF, 1998, J CLIN ONCOL, V16, P2817, DOI 10.1200/JCO.1998.16.8.2817; Khoury HJ, 2012, BONE MARROW TRANSPL, V47, P810, DOI 10.1038/bmt.2011.194; Khoury HJ, 2012, BLOOD, V119, P3403, DOI 10.1182/blood-2011-11-390120; Kim TD, 2013, LEUKEMIA, V27, P1316, DOI 10.1038/leu.2013.70; KOLB HJ, 1990, BLOOD, V76, P2462, DOI 10.1182/blood.V76.12.2462.2462; Larson RA, 2012, LEUKEMIA, V26, P2197, DOI 10.1038/leu.2012.134; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; le Coutre PD, 2012, LEUKEMIA, V26, P1189, DOI 10.1038/leu.2011.323; Steegmann JL, 2012, LEUKEMIA LYMPHOMA, V53, P2351, DOI 10.3109/10428194.2012.695779; MACKINNON S, 1995, BLOOD, V86, P1261, DOI 10.1182/blood.V86.4.1261.bloodjournal8641261; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Marin D, 2012, J CLIN ONCOL, V30, P232, DOI 10.1200/JCO.2011.38.6565; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Milojkovic D, 2011, BLOOD, V118, P605; Milojkovic D, 2012, HAEMATOL-HEMATOL J, V97, P473, DOI 10.3324/haematol.2011.057513; Milojkovic D, 2012, BLOOD, V119, P1838, DOI 10.1182/blood-2011-10-383000; Milojkovic D, 2010, HAEMATOL-HEMATOL J, V95, P224, DOI 10.3324/haematol.2009.012781; Montani D, 2012, CIRCULATION, V125, P2128, DOI 10.1161/CIRCULATIONAHA.111.079921; Muller MC, 2009, BLOOD, V114, P4944, DOI 10.1182/blood-2009-04-214221; Neelakantan P, 2012, HAEMATOL-HEMATOL J, V97, P1444, DOI 10.3324/haematol.2012.064618; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Pavlu J, 2011, BLOOD, V117, P755, DOI 10.1182/blood-2010-08-301341; Preudhomme C, 2010, NEW ENGL J MED, V363, P2511, DOI 10.1056/NEJMoa1004095; Pye SM, 2008, BLOOD, V111, P5505, DOI 10.1182/blood-2007-10-114900; Quintas-Cardama A, 2007, J CLIN ONCOL, V25, P3908, DOI 10.1200/JCO.2007.12.0329; Quintas-Cardama A, 2009, BLOOD, V114, P261, DOI 10.1182/blood-2008-09-180604; Radich JP, 2012, BLOOD, V120, P3898, DOI 10.1182/blood-2012-02-410688; Ross DM, 2010, LEUKEMIA, V24, P1719, DOI 10.1038/leu.2010.185; Ross DM, 2013, BLOOD, V122, P515, DOI 10.1182/blood-2013-02-483750; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Saglio G, 2012, BLOOD, V120; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Saussele S, 2010, BLOOD, V115, P1880, DOI 10.1182/blood-2009-08-237115; Shah NP, 2008, J CLIN ONCOL, V26, P3204, DOI 10.1200/JCO.2007.14.9260; Sobrinho-Simoes M, 2010, BLOOD, V116, P1329, DOI 10.1182/blood-2009-11-255109; SOKAL JE, 1984, BLOOD, V63, P789, DOI 10.1182/blood.V63.4.789.789; Soverini S, 2011, BLOOD, V118, P1208, DOI 10.1182/blood-2010-12-326405; TALPAZ M, 1986, NEW ENGL J MED, V314, P1065, DOI 10.1056/NEJM198604243141701; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; TURA S, 1994, NEW ENGL J MED, V330, P820; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; White DL, 2012, HAEMATOL-HEMATOL J, V97, P907, DOI 10.3324/haematol.2011.056457; White HE, 2010, BLOOD, V116, pE111, DOI 10.1182/blood-2010-06-291641	110	242	264	15	132	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1447	1459		10.1016/S0140-6736(13)62120-0	http://dx.doi.org/10.1016/S0140-6736(13)62120-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25484026				2022-12-28	WOS:000352719800033
J	Belvisi, MG				Belvisi, Maria G.			Therapeutic advances for treatment-resistant cough	LANCET			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, Resp Pharmacol Grp, London SW7 2AZ, England	Imperial College London	Belvisi, MG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, Resp Pharmacol Grp, London SW7 2AZ, England.	m.belvisi@imperial.ac.uk			MRC [MR/K020293/1] Funding Source: UKRI; Medical Research Council [MR/K020293/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdulqawi R, 2014, LANCET; Basoglu OK, 2005, CHEST, V128, P1905, DOI 10.1378/chest.128.4.1905; Canning B. J., 2009, V187, P23, DOI 10.1007/978-3-540-79842-2_2; Everett Caroline F, 2007, Cough, V3, P5, DOI 10.1186/1745-9974-3-5; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; Ford AP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00267; French CT, 2002, CHEST, V121, P1123, DOI 10.1378/chest.121.4.1123; Haque RA, 2005, CHEST, V127, P1710, DOI 10.1378/chest.127.5.1710; Kamei J, 2005, EUR J PHARMACOL, V528, P158, DOI 10.1016/j.ejphar.2005.10.030; Khalid S, 2014, J ALLERGY CLIN IMMUN, V134, P56, DOI 10.1016/j.jaci.2014.01.038; Kwong K, 2008, AM J PHYSIOL-LUNG C, V295, pL858, DOI 10.1152/ajplung.90360.2008; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Morell DC, 1972, J R COLL GEN PRACT, V22, P297; Schroeder K, 2002, BRIT MED J, V324, P329, DOI 10.1136/bmj.324.7333.329	14	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1160	1162		10.1016/S0140-6736(14)61740-2	http://dx.doi.org/10.1016/S0140-6736(14)61740-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25467587				2022-12-28	WOS:000351715100009
J	Costello, A; Azad, K				Costello, Anthony; Azad, Kishwar			Scaling up antenatal corticosteroids in low-resource settings?	LANCET			English	Editorial Material									[Costello, Anthony] UCL, UCL Inst Global Hlth, London WC1N 1EH, England; [Azad, Kishwar] Diabet Assoc Bangladesh, Perinatal Care Project, Dhaka, Bangladesh	University of London; University College London	Costello, A (corresponding author), UCL, UCL Inst Global Hlth, London WC1N 1EH, England.	anthony.costello@ucl.ac.uk						Althabe F, 2014, LANCET; Azad K, 2014, LANCET GLOB HEALTH, V2, pE191, DOI 10.1016/S2214-109X(14)70020-8; Crowther C, 2014, LANCET GLOB HEALTH, V2, pE447, DOI 10.1016/S2214-109X(14)70260-8; Kaliti S, 2014, LANCET GLOB HEALTH, V2, pE445, DOI 10.1016/S2214-109X(14)70262-1; Lawn J, 2012, CASE STUDY ANTENATAL; Lawn JE, 2014, LANCET GLOB HEALTH, V2, pE446, DOI 10.1016/S2214-109X(14)70263-3; MacGregor SN, 2008, GLOB LIB WOMENS MED, DOI [10.3843/GLOWM.10206, DOI 10.3843/GLOWM.10206]; March of Dimes PMNCH Save the Children WHO, 2012, BORN TOO SOON GLOBAL, DOI DOI 10.1016/S0140-6736(12)61970-9; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Save the Children, 2013, SURV 1 DAY STAT WORL; United Nations Commission on Life-Saving Commodities for Women's and Children's Health, COMM REP	11	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					585	587		10.1016/S0140-6736(14)61699-8	http://dx.doi.org/10.1016/S0140-6736(14)61699-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AZ	25458729				2022-12-28	WOS:000349214000009
J	Holmes, D				Holmes, David			Richard Suzman: helping the world to grow old more gracefully	LANCET			English	Biographical-Item																			0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					499	499		10.1016/S0140-6736(14)61778	http://dx.doi.org/10.1016/S0140-6736(14)61778			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AV	25468157				2022-12-28	WOS:000349213600014
J	Mathers, CD; Stevens, GA; Boerma, T; White, RA; Tobias, MI				Mathers, Colin D.; Stevens, Gretchen A.; Boerma, Ties; White, Richard A.; Tobias, Martin I.			Causes of international increases in older age life expectancy	LANCET			English	Article							MORTALITY-RATES; VERBAL AUTOPSY; SOUTH-AFRICA; HEALTH; DEATH; TRENDS; ADULTS; SMOKING; POPULATION; DEMOGRAPHY	In high-income countries, life expectancy at age 60 years has increased in recent decades. Falling tobacco use (for men only) and cardiovascular disease mortality (for both men and women) are the main factors contributing to this rise. In high-income countries, avoidable male mortality has fallen since 1980 because of decreases in avoidable cardiovascular deaths. For men in Latin America, the Caribbean, Europe, and central Asia, and for women in all regions, avoidable mortality has changed little or increased since 1980. As yet, no evidence exists that the rate of improvement in older age mortality (60 years and older) is slowing down or that older age deaths are being compressed into a narrow age band as they approach a hypothesised upper limit to longevity.	[Mathers, Colin D.; Stevens, Gretchen A.; Boerma, Ties] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [White, Richard A.] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Div Infect Dis Control, Oslo, Norway; [White, Richard A.] Norwegian Inst Publ Hlth, Dept Hlth Stat, Div Epidemiol, Oslo, Norway; [Tobias, Martin I.] Minist Hlth, Wellington, New Zealand	World Health Organization; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH)	Mathers, CD (corresponding author), WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland.	mathersc@who.int		Mathers, Colin/0000-0002-0617-6731; White, Richard Aubrey/0000-0002-6747-1726	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Alam N, 2010, J HEALTH POPUL NUTR, V28, P520; [Anonymous], 2002, INT NETW CONT DEM EV; Becher H, 2008, AM J TROP MED HYG, V78, P106, DOI 10.4269/ajtmh.2008.78.106; Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323, DOI 10.4054/DemRes.2008.19.35; Brenner H, 2002, LANCET, V360, P1131, DOI 10.1016/S0140-6736(02)11199-8; COALE AJ, 1991, DEMOGRAPHY, V28, P293, DOI 10.2307/2061281; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Dechter A R, 1991, Popul Bull UN, P1; Di Cesare M, 2013, INT J EPIDEMIOL, V42, P838, DOI 10.1093/ije/dyt063; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Ezzati M, 2005, INT J CANCER, V116, P963, DOI 10.1002/ijc.21100; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Gavrilova NS, 2000, POPUL RES POLICY REV, V19, P397, DOI 10.1023/A:1010621601409; Gay J, 2011, MORTALITY AMENABLE H; Ghana Statistical Service Ghana Health Service Macro International, 2009, GHAN MAT HLTH SURV 2; Glei DA, 2011, INT DIFFERENCES MORT; Herbst AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-47; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; Kannisto V., 2000, DEMOGR RES, V3, P6, DOI [10.4054/demres.2000.3.6, DOI 10.4054/DEMRES.2000.3.6]; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; McKee M, 2001, BRIT MED J, V323, P1051, DOI 10.1136/bmj.323.7320.1051; Mostafa G, 2000, SOC SCI MED, V50, P763, DOI 10.1016/S0277-9536(99)00295-6; *NAT I POP RES TRA, 2003, BANGL MAT HLTH SERV; Negin J, 2010, JAIDS-J ACQ IMM DEF, V55, P239, DOI 10.1097/QAI.0b013e3181e9b3f2; Nolte E, 2008, HEALTH AFFAIR, V27, P58, DOI 10.1377/hlthaff.27.1.58; Nolte Ellen., 2004, DOES HLTH CARE SAVE; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Office of the Registrar General of India, 2009, REP CAUS DEATH IND 2; Page A., 2006, AUSTR NZ ATLAS AVOID; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Sun E, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.6616; Tang KK, 2008, J HEALTH ECON, V27, P624, DOI 10.1016/j.jhealeco.2007.08.003; Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706; Tobias M, 2008, AUST NZ J PSYCHIAT, V42, P828, DOI 10.1080/00048670802277297; UK Department for International Development and Government of the United Republic of Tanzania, 1997, POL IMPL AD MORB MOR; United Nations, 2011, HIGH LEV M GEN ASS P; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; Wilmoth JR, 1999, DEMOGRAPHY, V36, P475, DOI 10.2307/2648085; Wilmoth JR, 2000, EXP GERONTOL, V35, P1111, DOI 10.1016/S0531-5565(00)00194-7; World Health Organization, 2012, WORLD HLTH STAT 2012; World Health Organization, 2014, WORLD HLTH STAT 2014; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, WHO MORT DAT; World Health Organization (WHO), 2014, WHO METH LIF EXP HLT	55	198	205	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					540	548		10.1016/S0140-6736(14)60569-9	http://dx.doi.org/10.1016/S0140-6736(14)60569-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AV	25468166				2022-12-28	WOS:000349213600033
J	Karnik, RN				Karnik, Rohit N.			MATERIALS SCIENCE Breakthrough for protons	NATURE			English	Editorial Material							FUEL-CELLS; GRAPHENE; OXIDATION; MEMBRANES		MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Karnik, RN (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	karnik@mit.edu						Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Chen Y, 2004, APPL PHYS LETT, V84, P2430, DOI 10.1063/1.1667278; Devanathan R, 2008, ENERG ENVIRON SCI, V1, P101, DOI 10.1039/b808149m; Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Hu S, 2014, NATURE, V516, P227, DOI 10.1038/nature14015; Liu L, 2008, NANO LETT, V8, P1965, DOI 10.1021/nl0808684; Paneri A, 2014, J MEMBRANE SCI, V467, P217, DOI 10.1016/j.memsci.2014.05.002; U.S. Department of Energy Fuel Cell Technologies Office. Multi-Year Research Development Demonstration Plan, 2012, MULT RES DEV DEM PLA	9	21	21	1	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					173	175		10.1038/nature14074	http://dx.doi.org/10.1038/nature14074			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25470064				2022-12-28	WOS:000346383500028
J	Bliem, R; McDermott, E; Ferstl, P; Setvin, M; Gamba, O; Pavelec, J; Schneider, MA; Schmid, M; Diebold, U; Blaha, P; Hammer, L; Parkinson, GS				Bliem, R.; McDermott, E.; Ferstl, P.; Setvin, M.; Gamba, O.; Pavelec, J.; Schneider, M. A.; Schmid, M.; Diebold, U.; Blaha, P.; Hammer, L.; Parkinson, G. S.			Subsurface cation vacancy stabilization of the magnetite (001) surface	SCIENCE			English	Article							TUNNEL-JUNCTIONS; OXIDE SURFACES; FE3O4(001); RECONSTRUCTION; TERMINATION; FABRICATION; FE3O4(111); FILMS	Iron oxides play an increasingly prominent role in heterogeneous catalysis, hydrogen production, spintronics, and drug delivery. The surface or material interface can be performance-limiting in these applications, so it is vital to determine accurate atomic-scale structures for iron oxides and understand why they form. Using a combination of quantitative low-energy electron diffraction, scanning tunneling microscopy, and density functional theory calculations, we show that an ordered array of subsurface iron vacancies and interstitials underlies the well-known (root 2 x root 2)R45 degrees reconstruction of Fe3O4(001). This hitherto unobserved stabilization mechanism occurs because the iron oxides prefer to redistribute cations in the lattice in response to oxidizing or reducing environments. Many other metal oxides also achieve stoichiometry variation in this way, so such surface structures are likely commonplace.	[Bliem, R.; Setvin, M.; Gamba, O.; Pavelec, J.; Schmid, M.; Diebold, U.; Parkinson, G. S.] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria; [McDermott, E.; Blaha, P.] Vienna Univ Technol, Inst Mat Chem, A-1060 Vienna, Austria; [Ferstl, P.; Schneider, M. A.; Hammer, L.] Univ Erlangen Nurnberg, Chair Solid State Phys, D-91058 Erlangen, Germany	Technische Universitat Wien; Technische Universitat Wien; University of Erlangen Nuremberg	Parkinson, GS (corresponding author), Vienna Univ Technol, Inst Appl Phys, Wiedner Hauptstr 8-10, A-1040 Vienna, Austria.	parkinson@iap.tuwien.ac.at	Diebold, Ulrike/A-3681-2010; Blaha, Peter/F-2847-2010; Schneider, M. Alexander/ABD-3301-2020; Hammer, Lutz/D-9863-2013; Schneider, M. Alexander/C-6241-2013; Parkinson, Gareth S/L-3866-2018; Setvin, Martin/G-4879-2016; Parkinson, Gareth/X-7314-2019	Diebold, Ulrike/0000-0003-0319-5256; Blaha, Peter/0000-0001-5849-5788; Schneider, M. Alexander/0000-0002-8607-3301; Hammer, Lutz/0000-0003-3529-1779; Schneider, M. Alexander/0000-0002-8607-3301; Parkinson, Gareth S/0000-0003-2457-8977; Setvin, Martin/0000-0002-1210-7740; Parkinson, Gareth/0000-0003-2457-8977; Bliem, Roland/0000-0002-8714-8942; McDermott, Eamon/0000-0002-5311-1500; Pavelec, Jiri/0000-0001-8899-5652; Gamba Vasquez, Oscar Alberto/0000-0002-3177-1620; Schmid, Michael/0000-0003-3373-9357	Austrian Science Fund [P24925-N20, SFB-F41 ViCoM]; Austrian Science Fund doctoral college SOLIDS4FUN [W1243]; Vienna University of Technology; European Research Council advanced grant "OxideSurfaces"; Austrian Science Fund (FWF) [P 24925] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund doctoral college SOLIDS4FUN; Vienna University of Technology; European Research Council advanced grant "OxideSurfaces"; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	G.S.P. and O.G. acknowledge support from the Austrian Science Fund project number P24925-N20. R.B. and E.M. acknowledge a stipend from the Vienna University of Technology and Austrian Science Fund doctoral college SOLIDS4FUN, project number W1243. U.D. and J.P. acknowledge support by the European Research Council advanced grant "OxideSurfaces." P.B. was supported by the Austrian Science Fund project SFB-F41 ViCoM. The computational results were achieved (in part) using the Vienna Scientific Cluster (VSC). All authors acknowledge Z. Mao and T. J. Liu (Tulane University) for the synthetic sample used in this work. We thank W. Moritz for sharing experimental LEED IV spectra.	Bartelt NC, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.235436; Bliem R, 2014, ACS NANO, V8, P7531, DOI 10.1021/nn502895s; Chambers SA, 1999, SURF SCI, V420, P111, DOI 10.1016/S0039-6028(98)00657-8; Condon NG, 1997, PHYS REV B, V55, P15885, DOI 10.1103/PhysRevB.55.15885; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; Dohnalek Z, 2010, PROG SURF SCI, V85, P161, DOI 10.1016/j.progsurf.2010.03.001; Kim W, 2003, J APPL PHYS, V93, P8032, DOI 10.1063/1.1557337; Lanier CH, 2009, SURF SCI, V603, P2574, DOI 10.1016/j.susc.2009.06.006; Li XW, 1998, APPL PHYS LETT, V73, P3282, DOI 10.1063/1.122745; Lindsay R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246102; Lodziana Z, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.206402; Nascimento VB, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.035408; Nie S, 2013, J AM CHEM SOC, V135, P10091, DOI 10.1021/ja402599t; Noguera C, 2000, J PHYS-CONDENS MAT, V12, pR367, DOI 10.1088/0953-8984/12/31/201; Novotny Z, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195410; Novotny Z, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.216103; Pacchioni G, 2013, CHEM REV, V113, P4035, DOI 10.1021/cr3002017; Parkinson GS, 2013, NAT MATER, V12, P724, DOI [10.1038/nmat3667, 10.1038/NMAT3667]; Parkinson GS, 2011, SURF SCI, V605, pL42, DOI 10.1016/j.susc.2011.05.018; PENDRY JB, 1980, J PHYS C SOLID STATE, V13, P937, DOI 10.1088/0022-3719/13/5/024; Pentcheva R, 2008, SURF SCI, V602, P1299, DOI 10.1016/j.susc.2008.01.006; Pentcheva R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.126101; Pussi K, 2012, SURF SCI, V606, P1, DOI 10.1016/j.susc.2011.07.014; Reuter K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.035406; Shaikhutdinov SK, 1999, PHYS REV B, V60, P11062, DOI 10.1103/PhysRevB.60.11062; Stanka B, 2000, SURF SCI, V448, P49, DOI 10.1016/S0039-6028(99)01182-6; TASKER PW, 1979, J PHYS C SOLID STATE, V12, P4977, DOI 10.1088/0022-3719/12/22/036; Tobin JG, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/31/315218; WIESENDANGER R, 1992, SCIENCE, V255, P583, DOI 10.1126/science.255.5044.583; Woll C, 2007, PROG SURF SCI, V82, P55, DOI 10.1016/j.progsurf.2006.12.002; Yang XF, 2013, ACCOUNTS CHEM RES, V46, P1740, DOI 10.1021/ar300361m	31	181	181	15	335	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1215	1218		10.1126/science.1260556	http://dx.doi.org/10.1126/science.1260556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477458	Green Submitted			2022-12-28	WOS:000346189000054
J	Coate, KC; Kliewer, SA; Mangelsdorf, DJ				Coate, Katie C.; Kliewer, Steven A.; Mangelsdorf, David J.			SnapShot: Hormones of the Gastrointestinal Tract	CELL			English	Editorial Material									[Coate, Katie C.; Kliewer, Steven A.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75235 USA; [Coate, Katie C.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75235 USA; [Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Coate, KC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75235 USA.			Coate, Katie/0000-0002-6604-3906; Mangelsdorf, David/0000-0002-4355-0796	Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [P01 AG051459] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Furtell L., 2013, HDB BIOL ACTIVE PEPT, P1307; Holst J.J., 2013, HDB BIOL ACT PEPT, P1241, DOI [10.1016/B978-0-12-385095-9.00168-8, DOI 10.1016/B978-0-12-385095-9.00168-8]; Kastin AJ, 2013, HDB BIOL ACTIVE PEPT, V2nd, P1251; Martinez V., 2013, HDB BIOL ACTIVE PEPT, P1320, DOI DOI 10.1016/B978-0-12-385095-9.00180-9; Miller L.J., 2013, HDB BIOL ACTIVE PEPT, P1314; Peeters T.L., 2013, HDB BIOL ACTIVE PEPT, P1236; Poitras P., 2013, HDB BIOL ACTIVE PEPT, P1257; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Shulkes A., 2013, HDB BIOL ACTIVE PEPT, P1219	10	8	9	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1478	+		10.1016/j.cell.2014.11.026	http://dx.doi.org/10.1016/j.cell.2014.11.026			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480303	Bronze			2022-12-28	WOS:000346652900024
J	Deng, LQ; Song, JM; Gao, X; Wang, JW; Yu, H; Chen, X; Varki, N; Naito-Matsui, Y; Galan, JE; Varki, A				Deng, Lingquan; Song, Jeongmin; Gao, Xiang; Wang, Jiawei; Yu, Hai; Chen, Xi; Varki, Nissi; Naito-Matsui, Yuko; Galan, Jorge E.; Varki, Ajit			Host Adaptation of a Bacterial Toxin from the Human Pathogen Salmonella Typhi	CELL			English	Article							III SECRETION; TYPHIMURIUM; EXPRESSION; RESISTANCE; SURVIVAL; SEROVARS; MURINE; CELLS; MODEL	Salmonella Typhi is an exclusive human pathogen that causes typhoid fever. Typhoid toxin is a S. Typhi virulence factor that can reproduce most of the typhoid fever symptoms in experimental animals. Toxicity depends on toxin binding to terminally sialylated glycans on surface glycoproteins. Human glycans are unusual because of the lack of CMAH, which in other mammals converts N-acetylneuraminic acid (Neu5Ac) to N-glycolylneuraminic acid (Neu5Gc). Here, we report that typhoid toxin binds to and is toxic toward cells expressing glycans terminated in Neu5Ac (expressed by humans) over glycans terminated in Neu5Gc (expressed by other mammals). Mice constitutively expressing CMAH thus displaying Neu5Gc in all tissues are resistant to typhoid toxin. The atomic structure of typhoid toxin bound to Neu5Ac reveals the structural bases for its binding specificity. These findings provide insight into the molecular bases for Salmonella Typhi's host specificity and may help the development of therapies for typhoid fever.	[Deng, Lingquan; Varki, Nissi; Naito-Matsui, Yuko; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Deng, Lingquan; Naito-Matsui, Yuko; Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Deng, Lingquan; Naito-Matsui, Yuko; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Song, Jeongmin; Gao, Xiang; Galan, Jorge E.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06536 USA; [Wang, Jiawei] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Yale University; Tsinghua University; University of California System; University of California Davis	Galan, JE (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu; a1varki@ucsd.edu	Wang, Jiawei/D-1144-2010; Chen, Xi/H-1811-2018	Wang, Jiawei/0000-0001-9893-8539; Chen, Xi/0000-0002-3160-614X; Song, Jeongmin/0000-0002-6777-3505; gao, xiang/0000-0001-6397-5639	National Cancer Institute (NCI) [CA38701]; National Institute of Allergy and Infectious Diseases (NIAID) [AI079022]; NATIONAL CANCER INSTITUTE [R01CA038701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI079022, R01AI114618, R01AI079022] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Jonathon Okerblom for help with sialic acid analysis, Ana Lazic for assistance in the microscale thermophoresis studies, and members of the Galan laboratory for critical review of the manuscript. This work was supported by the National Cancer Institute (NCI) grant CA38701 to A.V. and National Institute of Allergy and Infectious Diseases (NIAID) grant AI079022 to J.E.G.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; DeLano W.L, PYMOL MOL GRAPHICS S; EDSALL G, 1960, J EXP MED, V112, P143, DOI 10.1084/jem.112.1.143; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metchnikoff E., 1911, ANN I PASTEUR, V25, P865; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padler-Karavani V, 2014, FASEB J, V28, P1280, DOI 10.1096/fj.13-241497; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2008, CURR OPIN INFECT DIS, V21, P531, DOI 10.1097/QCO.0b013e32830f453a; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Raffatellu M, 2008, J INFECT DEV COUNTR, V2, P260; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Schwan WR, 2000, INFECT IMMUN, V68, P1005, DOI 10.1128/IAI.68.3.1005-1013.2000; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Spano S, 2008, CELL HOST MICROBE, V3, P30, DOI 10.1016/j.chom.2007.11.001; Spano S, 2012, SCIENCE, V338, P960, DOI 10.1126/science.1229224; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; VLADOIANU IR, 1990, MICROB PATHOGENESIS, V8, P83, DOI 10.1016/0882-4010(90)90072-X; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093	35	76	77	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1290	1299		10.1016/j.cell.2014.10.057	http://dx.doi.org/10.1016/j.cell.2014.10.057			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480294	Green Accepted, Bronze			2022-12-28	WOS:000346652900009
J	Gravitz, L				Gravitz, Lauren			Untitled	NATURE			English	Editorial Material																			0	61	66	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S1	S1		10.1038/516S1a	http://dx.doi.org/10.1038/516S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3PT	25470192	Bronze			2022-12-28	WOS:000349541400001
J	Simonds, SE; Pryor, JT; Ravussin, E; Greenway, FL; Dileone, R; Allen, AM; Bassi, J; Elmquist, JK; Keogh, JM; Henning, E; Myers, MG; Licinio, J; Brown, RD; Enriori, PJ; O'Rahilly, S; Sternson, SM; Grove, KL; Spanswick, DC; Farooqi, IS; Cowley, MA				Simonds, Stephanie E.; Pryor, Jack T.; Ravussin, Eric; Greenway, Frank L.; Dileone, Ralph; Allen, Andrew M.; Bassi, Jaspreet; Elmquist, Joel K.; Keogh, Julia M.; Henning, Elana; Myers, Martin G., Jr.; Licinio, Julio; Brown, Russell D.; Enriori, Pablo J.; O'Rahilly, Stephen; Sternson, Scott M.; Grove, Kevin L.; Spanswick, David C.; Farooqi, I. Sadaf; Cowley, Michael A.			Leptin Mediates the Increase in Blood Pressure Associated with Obesity	CELL			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; CENTRAL MELANOCORTIN SYSTEM; BROWN ADIPOSE-TISSUE; EARLY-ONSET OBESITY; WEIGHT-LOSS; SYMPATHETIC ACTIVATION; POMC NEURONS; KAPPA-B; MICE; HYPERTENSION	Obesity is associated with increased blood pressure (BP), which in turn increases the risk of cardiovascular diseases. We found that the increase in leptin levels seen in diet-induced obesity (DIO) drives an increase in BP in rodents, an effect that was not seen in animals deficient in leptin or leptin receptors (LepR). Furthermore, humans with loss-of-function mutations in leptin and the LepR have low BP despite severe obesity. Leptin's effects on BP are mediated by neuronal circuits in the dorsomedial hypothalamus (DMH), as blocking leptin with a specific antibody, antagonist, or inhibition of the activity of LepR-expressing neurons in the DMH caused a rapid reduction of BP in DIO mice, independent of changes in weight. Re-expression of LepRs in the DMH of DIO LepR-deficient mice caused an increase in BP. These studies demonstrate that leptin couples changes in weight to changes in BP in mammalian species.	[Simonds, Stephanie E.; Brown, Russell D.; Enriori, Pablo J.; Spanswick, David C.; Cowley, Michael A.] Monash Univ, Dept Physiol, Monash Obes & Diabet Inst, Clayton, Vic 3800, Australia; [Pryor, Jack T.; Spanswick, David C.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Pryor, Jack T.] Neurosolut Ltd, Coventry CV4 7ZS, W Midlands, England; [Ravussin, Eric; Greenway, Frank L.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Dileone, Ralph] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA; [Allen, Andrew M.; Bassi, Jaspreet] Univ Melbourne, Dept Physiol, Melbourne, Vic 3010, Australia; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Div Endocrinol & Metab, Dept Internal Med, Dallas, TX 75390 USA; [Keogh, Julia M.; Henning, Elana; O'Rahilly, Stephen] Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, Metab Res Labs, Cambridge CB2 0QQ, England; [Myers, Martin G., Jr.] Univ Michigan, Div Metab Endocrinol & Diabet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Licinio, Julio] Flinders Univ S Australia, South Australian Hlth & Med Res Inst, Sch Med, Adelaide, SA 5001, Australia; [Keogh, Julia M.] Flinders Univ S Australia, Dept Psychiat, Sch Med, Adelaide, SA 5001, Australia; [Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Grove, Kevin L.] Oregon Natl Primate Res Ctr, Div Diabet Obes & Metab, Portland, OR 97239 USA	Monash University; University of Warwick; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Yale University; University of Melbourne; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Michigan System; University of Michigan; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); Flinders University South Australia; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon National Primate Research Center	Farooqi, IS (corresponding author), Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, Metab Res Labs, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk; michael.cowley@monash.edu	Greenway, Frank/N-1966-2017; Cowley, Michael A/B-9428-2008; O'Rahilly, Stephen/ABF-6509-2020; Licinio, Julio/L-4244-2013; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Ravussin, Eric/N-1985-2017; Allen, Andrew Mark/B-3663-2015	Greenway, Frank/0000-0002-1766-6111; Cowley, Michael A/0000-0001-7811-134X; O'Rahilly, Stephen/0000-0003-2199-4449; Licinio, Julio/0000-0001-6905-5884; Ravussin, Eric/0000-0003-2129-547X; Pryor, Jack/0000-0002-3962-4596; Farooqi, Sadaf/0000-0001-7609-3504; Allen, Andrew Mark/0000-0002-2183-5360; SIMONDS, STEPHANIE/0000-0003-1590-6190; Spanswick, David/0000-0002-8129-8173; DiLeone, Ralph/0000-0002-4770-2590	Heart Foundation of Australia; National Health and Medical Research Council of Australia [1029188, 1063955]; Monash University; Pfizer Australia; NORC Center grant at the Pennington Biomedical Research Center [P30DK072476]; Leverhulme Trust; Wellcome Trust [082390/Z/07/Z]; Medical Research Council; NIHR Cambridge Biomedical Research Centre; Bernard Wolfe Health Neuroscience Fund; Medical Research Council [G0600717, MC_UU_12012/1, MC_UU_12012/5/B, G0600717B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10380, NF-SI-0513-10109] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P30DK072476, R37DK056731] Funding Source: NIH RePORTER; MRC [MC_UU_12012/1, G0600717] Funding Source: UKRI	Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Pfizer Australia(PfizerPfizer Australia); NORC Center grant at the Pennington Biomedical Research Center; Leverhulme Trust(Leverhulme Trust); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Bernard Wolfe Health Neuroscience Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Heart Foundation of Australia (M.A.C. and S.E.S.), the National Health and Medical Research Council of Australia (1029188 to M.A.C. and 1063955 to D.C.S.), Monash University (S.E.S.), Pfizer Australia (M.A.C.), a NORC Center grant (P30DK072476) at the Pennington Biomedical Research Center (E.R., F.L.G., and J.L.), the Leverhulme Trust (J.T.P.), the Wellcome Trust (082390/Z/07/Z) (I.S.F.), Medical Research Council (I.S.F.), NIHR Cambridge Biomedical Research Centre (I.S.F. and S.O.R.), and the Bernard Wolfe Health Neuroscience Fund (I.S.F.). We thank Professor Streamson Chua for the LepR flox mice. J.L. and I.S.F. treat patients with recombinant human leptin which is provided by BMS/AstraZeneca.	Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Cao WH, 2003, BRAIN RES, V980, P1, DOI 10.1016/S0006-8993(03)02981-0; Carlyle M, 2002, HYPERTENSION, V39, P496, DOI 10.1161/hy0202.104398; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; DUSTAN HP, 1983, ANN INTERN MED, V98, P860, DOI 10.7326/0003-4819-98-5-860; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Enriori PJ, 2011, J NEUROSCI, V31, P12189, DOI 10.1523/JNEUROSCI.2336-11.2011; Esler M, 2006, HYPERTENSION, V48, P787, DOI 10.1161/01.HYP.0000242642.42177.49; Fan W, 2005, PEPTIDES, V26, P1800, DOI 10.1016/j.peptides.2004.11.033; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fontes MAP, 2001, AM J PHYSIOL-HEART C, V280, pH2891, DOI 10.1152/ajpheart.2001.280.6.H2891; Galgani JE, 2010, J CLIN ENDOCR METAB, V95, P851, DOI 10.1210/jc.2009-1739; Gautron L, 2010, J COMP NEUROL, V518, P2090, DOI 10.1002/cne.22323; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Harlan SM, 2011, CIRC RES, V108, P808, DOI 10.1161/CIRCRESAHA.111.240226; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Haynes W G, 2000, Curr Hypertens Rep, V2, P311, DOI 10.1007/s11906-000-0015-1; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Horiuchi J, 2006, CLIN EXP PHARMACOL P, V33, P1265, DOI 10.1111/j.1440-1681.2006.04522.x; Horiuchi J, 2004, AM J PHYSIOL-REG I, V287, pR824, DOI 10.1152/ajpregu.00221.2004; KASSAB S, 1995, HYPERTENSION, V25, P893, DOI 10.1161/01.HYP.25.4.893; Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376; Knudson JD, 2005, AM J PHYSIOL-HEART C, V289, pH48, DOI 10.1152/ajpheart.01159.2004; Konstantinides S, 2004, ARTERIOSCL THROM VAS, V24, P2196, DOI 10.1161/01.ATV.0000146531.79402.9a; Kuo JJ, 2003, HYPERTENSION, V41, P768, DOI 10.1161/01.HYP.0000048194.97428.1A; Lee S, 2012, J COMP NEUROL, V520, P3617, DOI 10.1002/cne.23116; LeGal CS, 1997, FEBS LETT, V404, P185, DOI 10.1016/S0014-5793(97)00125-7; Leshan RL, 2012, NAT MED, V18, P820, DOI 10.1038/nm.2724; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Mark AL, 1999, J HYPERTENS, V17, P1949, DOI 10.1097/00004872-199917121-00026; Marsh AJ, 2003, HYPERTENSION, V42, P488, DOI 10.1161/01.HYP.0000090097.22678.0A; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morgan DA, 2008, AM J PHYSIOL-REG I, V295, pR1730, DOI 10.1152/ajpregu.90324.2008; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Patterson CM, 2011, BRAIN RES, V1378, P18, DOI 10.1016/j.brainres.2011.01.010; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Purdham DM, 2004, AM J PHYSIOL-HEART C, V287, pH2877, DOI 10.1152/ajpheart.00499.2004; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Rezai-Zadeh K, 2014, MOL METAB, V3, P681, DOI 10.1016/j.molmet.2014.07.008; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Sayk F, 2010, J CLIN ENDOCR METAB, V95, P1998, DOI 10.1210/jc.2009-2297; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Simonds SE, 2013, TRENDS NEUROSCI, V36, P121, DOI 10.1016/j.tins.2013.01.004; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang Y, 2011, J NEUROSCI, V31, P1873, DOI 10.1523/JNEUROSCI.3223-10.2011; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	60	224	231	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1404	1416		10.1016/j.cell.2014.10.058	http://dx.doi.org/10.1016/j.cell.2014.10.058			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480301	Green Published, hybrid			2022-12-28	WOS:000346652900018
J	Nunes, VD; Gholitabar, M; Sims, JM; Bewley, S				Nunes, Vanessa Delgado; Gholitabar, Maryam; Sims, Jessica Mai; Bewley, Susan		Guideline Dev Grp	GUIDELINES Intrapartum care of healthy women and their babies: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nunes, Vanessa Delgado; Gholitabar, Maryam; Sims, Jessica Mai] Royal Coll Obstetricians & Gynaecologists, Natl Collaborating Ctr Womens & Childrens Hlth, London NW1 4RG, England; [Bewley, Susan] Kings Coll London, Womens Hlth Acad Dept, London WC2R 2LS, England	University of London; King's College London	Nunes, VD (corresponding author), Royal Coll Obstetricians & Gynaecologists, Natl Collaborating Ctr Womens & Childrens Hlth, London NW1 4RG, England.	vnunes@rcog.org.uk		Sims, Jessica/0000-0003-1565-7315				Blix E, 2012, SEX REPROD HEALTHC, V3, P147, DOI 10.1016/j.srhc.2012.10.001; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; National Institute for Clinical Excellence (NICE), 2014, INTR CAR CAR HLTH WO; National Institute for Health and Care Excellence, 2007, INTR CAR CAR HLTH WO	4	31	31	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2014	349								g6886	10.1136/bmj.g6886	http://dx.doi.org/10.1136/bmj.g6886			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KN	25472418	Green Published			2022-12-28	WOS:000346116600002
J	Crous-Bou, M; Fung, TT; Prescott, J; Julin, B; Du, M; Sun, Q; Rexrode, KM; Hu, FB; De Vivo, I				Crous-Bou, Marta; Fung, Teresa T.; Prescott, Jennifer; Julin, Bettina; Du, Mengmeng; Sun, Qi; Rexrode, Kathryn M.; Hu, Frank B.; De Vivo, Immaculata			Mediterranean diet and telomere length in Nurses' Health Study: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; CIGARETTE-SMOKING; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; OXIDATIVE STRESS; RISK-FACTORS; ASSOCIATION; MORTALITY; ADHERENCE; PATTERNS	Objective To examine whether adherence to the Mediterranean diet was associated with longer telomere length, a biomarker of aging. Design Population based cohort study. Setting Nurses' Health Study, an ongoing prospective cohort study of 121 700 nurses enrolled in 1976; in 1989-90 a subset of 32 825 women provided blood samples. Participants 4676 disease-free women from nested case-control studies within the Nurses' Health Study with telomere length measured who also completed food frequency questionnaires. Main outcome measure Association between relative telomere lengths in peripheral blood leukocytes measured by quantitative real time polymerase chain reaction and Alternate Mediterranean Diet score calculated from self reported dietary data. Results Greater adherence to the Mediterranean diet was associated with longer telomeres after adjustment for potential confounders. Least squares mean telomere length z scores were -0.038 (SE 0.035) for the lowest Mediterranean diet score groups and 0.072 (0.030) for the highest group (P for trend=0.004). Conclusion In this large study, greater adherence to the Mediterranean diet was associated with longer telomeres. These results further support the benefits of adherence to the Mediterranean diet for promoting health and longevity.	[Crous-Bou, Marta; Prescott, Jennifer; Julin, Bettina; Du, Mengmeng; Sun, Qi; Hu, Frank B.; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Crous-Bou, Marta; Prescott, Jennifer; Julin, Bettina; Du, Mengmeng; Sun, Qi; Rexrode, Kathryn M.; Hu, Frank B.; De Vivo, Immaculata] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Crous-Bou, Marta; Julin, Bettina; Hu, Frank B.; De Vivo, Immaculata] Harvard Univ, Sch Med, Program Genet Epidemiol & Stat Genet, Dept Epidemiol, Boston, MA 02115 USA; [Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA; [Fung, Teresa T.; Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Du, Mengmeng] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Rexrode, Kathryn M.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Simmons University; Harvard University; Harvard T.H. Chan School of Public Health; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital	De Vivo, I (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	nhidv@channing.harvard.edu	Crous-Bou, Marta/A-9499-2019; Rexrode, Kathryn M/I-1177-2018	Crous-Bou, Marta/0000-0003-1493-4288; De Vivo, Immaculata/0000-0002-7185-7402; Rexrode, Kathryn/0000-0003-3387-8429	National Cancer Institute, National Institutes of Health [1R01 CA134958, 2R01 CA082838, P01 CA087969, R01 CA49449, CA065725, CA132190, CA139586, CA140790, CA133914, CA132175, CA163451, HL088521, HL60712, U54 CA155626, R01 AR059073, HL34594]; Sara Borrell postdoctoral fellowship from the Spanish Ministry of Health, Carlos III Health Institute; National Cancer Institute [R25 CA94880]; NHLBI [R00HL098459]; NATIONAL CANCER INSTITUTE [R01CA065725, K07CA140790, R01CA134958, R03CA133914, R25CA094880, P01CA087969, R03CA132175, R01CA049449, U54CA155626, R01CA163451, R03CA139586, R01CA082838, R03CA132190] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R00HL098459, R01HL088521, R01HL060712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059073] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sara Borrell postdoctoral fellowship from the Spanish Ministry of Health, Carlos III Health Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The Nurses' Health Study is supported by the National Cancer Institute, National Institutes of Health (1R01 CA134958, 2R01 CA082838, P01 CA087969, R01 CA49449, CA065725, CA132190, CA139586, CA140790, CA133914, CA132175, CA163451, HL088521, HL60712, U54 CA155626, R01 AR059073, HL34594). MC-B is also supported by a Sara Borrell postdoctoral fellowship from the Spanish Ministry of Health, Carlos III Health Institute. MD is supported by grant R25 CA94880 from the National Cancer Institute. QS is supported by an NHLBI sponsored career development award (R00HL098459). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2009, NATURE, V461, P706, DOI 10.1038/461706a; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, P43, DOI DOI 10.1126/SAGEKE.2004.51.PE43; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Benetou V, 2008, BRIT J CANCER, V99, P191, DOI 10.1038/sj.bjc.6604418; Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Boccardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062781; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Colditz G A, 1995, J Am Med Womens Assoc (1972), V50, P40; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Devore EE, 2011, NEUROSCI LETT, V492, P15, DOI 10.1016/j.neulet.2011.01.041; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Du MM, 2012, AM J EPIDEMIOL, V175, P414, DOI 10.1093/aje/kwr330; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Farzaneh-Far R, 2010, JAMA-J AM MED ASSOC, V303, P250, DOI 10.1001/jama.2009.2008; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Garcia-Calzon S, 2014, INT J OBESITY, V38, P177, DOI 10.1038/ijo.2013.68; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; Krauss J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026983; Liang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023462; Lopez-Garcia E, 2014, AM J CLIN NUTR, V99, P172, DOI 10.3945/ajcn.113.068106; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Okereke OI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040516; Ornish D, 2013, LANCET ONCOL, V14, P1112, DOI 10.1016/S1470-2045(13)70366-8; Page JH, 2008, CLIN CHEM, V54, P1190, DOI 10.1373/clinchem.2007.099291; Prescott J, 2012, HUM REPROD, V27, P3622, DOI 10.1093/humrep/des314; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Samieri C, 2013, ANN INTERN MED, V159, P584, DOI 10.7326/0003-4819-159-9-201311050-00004; Scarmeas N, 2006, ARCH NEUROL-CHICAGO, V63, P1709, DOI 10.1001/archneur.63.12.noc60109; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038374; TRICHOPOULOU A, 1995, AM J CLIN NUTR, V61, p1346S, DOI 10.1093/ajcn/61.6.1346S; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Trichopoulou Antonia, 2009, BMJ, V338, pb2337, DOI 10.1136/bmj.b2337; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vallabhaneni H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003639; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; von Zglinicki T, 2003, NAT BIOTECHNOL, V21, P229, DOI 10.1038/nbt0303-229b; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wang H, 2008, MOVEMENT DISORD, V23, P302, DOI 10.1002/mds.21867; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	69	148	150	0	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2014	349								g6674	10.1136/bmj.g6674	http://dx.doi.org/10.1136/bmj.g6674			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KK	25467028	hybrid, Green Published			2022-12-28	WOS:000346116300002
J	Kim, IN; Lee, K; Gruber, N; Karl, DM; Bullister, JL; Yang, S; Kim, TW				Kim, Il-Nam; Lee, Kitack; Gruber, Nicolas; Karl, David M.; Bullister, John L.; Yang, Simon; Kim, Tae-Wook			Increasing anthropogenic nitrogen in the North Pacific Ocean	SCIENCE			English	Article							ATMOSPHERIC DEPOSITION; ATLANTIC OCEAN; FIXATION; ASIA; EMISSIONS; PATTERNS; NITRATE; CARBON	The recent increase in anthropogenic emissions of reactive nitrogen from northeastern Asia and the subsequent enhanced deposition over the extensive regions of the North Pacific Ocean (NPO) have led to a detectable increase in the nitrate (N) concentration of the upper ocean. The rate of increase of excess N relative to phosphate (P) was found to be highest (similar to 0.24 micromoles per kilogram per year) in the vicinity of the Asian source continent, with rates decreasing eastward across the NPO, consistent with the magnitude and distribution of atmospheric nitrogen deposition. This anthropogenically driven increase in the N content of the upper NPO may enhance primary production in this N-limited region, potentially leading to a long-term change of the NPO from being N-limited to P-limited.	[Kim, Il-Nam; Lee, Kitack] Pohang Univ Sci & Technol POSTECH, Sch Environm Sci & Engn, Pohang 790784, South Korea; [Gruber, Nicolas; Yang, Simon] ETH, Inst Biogeochem & Pollutant Dynam, Environm Phys Grp, Zurich, Switzerland; [Karl, David M.] Univ Hawaii Manoa, Daniel K Inouye Ctr Microbial Oceanog, Honolulu, HI 96822 USA; [Bullister, John L.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Kim, Tae-Wook] Korea Inst Ocean Sci & Technol, Ocean Circulat & Climate Res Div, Ansan 426744, South Korea	Pohang University of Science & Technology (POSTECH); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; Korea Institute of Ocean Science & Technology (KIOST)	Lee, K (corresponding author), Pohang Univ Sci & Technol POSTECH, Sch Environm Sci & Engn, Pohang 790784, South Korea.	ktl@postech.ac.kr	Gruber, Nicolas/B-7013-2009; Karl, David/AFP-3837-2022; Kim, Tae-Wook/E-9611-2011; Lee, Kitack/G-7184-2015	Gruber, Nicolas/0000-0002-2085-2310; Kim, Tae-Wook/0000-0002-4236-0720; Lee, Kitack/0000-0002-4226-2303; Karl, David/0000-0002-6660-6721	Mid-Career Researcher Program [2012R1A2A1A01004631]; National Research Foundation (NRF) of Ministry of Science, Information Communication Technology, and Future Planning, Science and Technology [2013K1A1A2A02078278]; "Management of marine organisms causing ecological disturbance and harmful effects" program - Ministry of Oceans and Fisheries; Basic Science Research Program through NRF [2012R1A6A3A0403883]; NSF [OCE09-26766, EF04-24599]; Gordon and Betty Moore Foundation; NOAA's Climate Program Office; ETH Zurich	Mid-Career Researcher Program; National Research Foundation (NRF) of Ministry of Science, Information Communication Technology, and Future Planning, Science and Technology; "Management of marine organisms causing ecological disturbance and harmful effects" program - Ministry of Oceans and Fisheries; Basic Science Research Program through NRF(National Research Foundation of Korea); NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NOAA's Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); ETH Zurich(ETH Zurich)	We thank all scientists responsible for the CFC-12 and nutrient measurements in the GLODAP (http://cdiac.ornl.gov/oceans/glodap/) and PACIFICA (http://cdiac.ornl.gov/oceans/PACIFICA/) databases and the CREAMS II (http://sam.ucsd.edu) and HOT (http://hahana.soest.hawaii.edu/hot/) programs. This research was supported by the Mid-Career Researcher Program (no. 2012R1A2A1A01004631) and the Global Research Project funded by the National Research Foundation (NRF) of Ministry of Science, Information Communication Technology, and Future Planning, Science and Technology (no. 2013K1A1A2A02078278). Partial support was provided by the "Management of marine organisms causing ecological disturbance and harmful effects" program funded by the Ministry of Oceans and Fisheries. T.-W.K. was supported by the Basic Science Research Program through NRF (no. 2012R1A6A3A0403883). D. M. K was funded by the NSF (nos. OCE09-26766 and EF04-24599) and the Gordon and Betty Moore Foundation. J.L.B. was funded by NOAA's Climate Program Office. N.G. and S.Y. acknowledge the financial support from ETH Zurich. Author contributions: I.-N.K. and K. L. designed the study and wrote the manuscript with support from N.G., D. M. K., and J. L. B. I.-N.K. analyzed the data. N.G., D. M. K., J. L. B., S.Y., and T.-W.K. contributed to the manuscript with discussions and comments. S.Y. and N.G. performed NCAR Community Earth System Model simulations. The authors declare no competing financial interests.	AKIMOTO H, 1994, ATMOS ENVIRON, V28, P213, DOI 10.1016/1352-2310(94)90096-5; Carrillo JH, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001892; Ciais P., 2013, CLIMATE CHANGE 2013, P465, DOI [10.1017/CBO9781107415324.015, DOI 10.1017/CBO9781107415324.015]; Dentener F.J, 2006, GLOBAL MAPS ATMOSPHE; DONEY SC, 1992, DEEP-SEA RES, V39, P1857, DOI 10.1016/0198-0149(92)90003-C; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Fine RA, 2011, ANNU REV MAR SCI, V3, P173, DOI 10.1146/annurev.marine.010908.163933; Galloway JN, 2000, NUTR CYCL AGROECOSYS, V57, P1, DOI 10.1023/A:1009832221034; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Gruber N, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1, DOI 10.1016/B978-0-12-372522-6.00001-3; Jung JY, 2011, J ATMOS CHEM, V68, P157, DOI 10.1007/s10874-012-9218-5; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Kim TW, 2011, SCIENCE, V334, P505, DOI 10.1126/science.1206583; Lee K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014198; Lee K, 2001, LIMNOL OCEANOGR, V46, P1287, DOI 10.4319/lo.2001.46.6.1287; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/NGEO1757, 10.1038/ngeo1757]; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Moore JK, 2013, J CLIMATE, V26, P9291, DOI 10.1175/JCLI-D-12-00566.1; Okin GS, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003858; Prospero JM, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001524; Singh A, 2013, DEEP-SEA RES PT II, V93, P148, DOI 10.1016/j.dsr2.2013.04.008; Suntharalingam P, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050778	22	131	137	10	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1102	1106		10.1126/science.1258396	http://dx.doi.org/10.1126/science.1258396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430767				2022-12-28	WOS:000345763400040
J	Baker, DN; Jaynes, AN; Hoxie, VC; Thorne, RM; Foster, JC; Li, X; Fennell, JF; Wygant, JR; Kanekal, SG; Erickson, PJ; Kurth, W; Li, W; Ma, Q; Schiller, Q; Blum, L; Malaspina, DM; Gerrard, A; Lanzerotti, LJ				Baker, D. N.; Jaynes, A. N.; Hoxie, V. C.; Thorne, R. M.; Foster, J. C.; Li, X.; Fennell, J. F.; Wygant, J. R.; Kanekal, S. G.; Erickson, P. J.; Kurth, W.; Li, W.; Ma, Q.; Schiller, Q.; Blum, L.; Malaspina, D. M.; Gerrard, A.; Lanzerotti, L. J.			An impenetrable barrier to ultrarelativistic electrons in the Van Allen radiation belts	NATURE			English	Article							INNER ZONE ELECTRONS; RELATIVISTIC ELECTRONS; SOLAR-WIND; PRECIPITATION; EVOLUTION; DIFFUSION; STORM; EARTH; RING	Early observations(1,2) indicated that the Earth's Van Allen radiation belts could be separated into an inner zone dominated by high-energy protons and an outer zone dominated by high-energy electrons. Subsequent studies(3,4) showed that electrons of moderate energy (less than about one megaelectronvolt) often populate both zones, with a deep 'slot' region largely devoid of particles between them. There is a region of dense cold plasma around the Earth known as the plasmasphere, the outer boundary of which is called the plasmapause. The two-belt radiation structure was explained as arising from strong electron interactions with plasmaspheric hiss just inside the plasmapause boundary(5), with the inner edge of the outer radiation zone corresponding to the minimum plasmapause location(6). Recent observations have revealed unexpected radiation belt morphology(7,8), especially at ultrarelativistic kinetic energies(9,10) (more than five megaelectronvolts). Here we analyse an extended data set that reveals an exceedingly sharp inner boundary for the ultrarelativistic electrons. Additional, concurrently measured data(11) reveal that this barrier to inward electron radial transport does not arise because of a physical boundary within the Earth's intrinsic magnetic field, and that inward radial diffusion is unlikely to be inhibited by scattering by electromagnetic transmitter wave fields. Rather, we suggest that exceptionally slow natural inward radial diffusion combined with weak, but persistent, wave-particle pitch angle scattering deep inside the Earth's plasmasphere can combine to create an almost impenetrable barrier through which the most energetic Van Allen belt electrons cannot migrate.	[Baker, D. N.; Jaynes, A. N.; Hoxie, V. C.; Li, X.; Schiller, Q.; Blum, L.; Malaspina, D. M.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Thorne, R. M.; Li, W.; Ma, Q.] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Foster, J. C.; Erickson, P. J.] MIT, Haystack Observ, Westford, MA 01886 USA; [Fennell, J. F.] Aerosp Corp, Space Sci Lab, Los Angeles, CA 90009 USA; [Wygant, J. R.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Kanekal, S. G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Kurth, W.] Univ Iowa, Dept Phys, Iowa City, IA 52242 USA; [Gerrard, A.; Lanzerotti, L. J.] New Jersey Inst Technol, Ctr Solar Terr Res, Newark, NJ 07102 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Aerospace Corporation - USA; University of Minnesota System; University of Minnesota Twin Cities; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Iowa; New Jersey Institute of Technology	Baker, DN (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA.	daniel.baker@lasp.colorado.edu	Erickson, Philip J/N-6853-2018; Kurth, William/AAA-7334-2019; Blum, Lauren/I-2164-2017; JAYNES, ALLISON N/F-7876-2018; Li, Wen/F-3722-2011	Erickson, Philip J/0000-0002-0031-9324; Kurth, William/0000-0002-5471-6202; Blum, Lauren/0000-0002-4797-5476; JAYNES, ALLISON N/0000-0002-1470-4266; Foster, John/0000-0002-1993-241X	JHU/APL [967399]; JHU/APL under NASA [NAS5-01072]; Div Atmospheric & Geospace Sciences [1242204] Funding Source: National Science Foundation	JHU/APL; JHU/APL under NASA; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the entire Van Allen Probes mission team for suggestions about this work. Data access was provided through the Johns Hopkins University/Applied Physics Lab Mission Operations Center and the Los Alamos National Laboratory Science Operations Center. This work was supported by JHU/APL contract 967399 under NASA's prime contract NAS5-01072. All Van Allen Probes data used are publicly available at http://www.rbsp-ect.lanl.gov.	Abel B, 1998, J GEOPHYS RES-SPACE, V103, P2385, DOI 10.1029/97JA02919; Baker DN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031007; Baker DN, 2014, GEOPHYS RES LETT, V41, P1351, DOI 10.1002/2013GL058942; Baker DN, 2013, SPACE SCI REV, V179, P337, DOI 10.1007/s11214-012-9950-9; Baker DN, 2013, SCIENCE, V340, P186, DOI [10.1126/science.1233518, 10.1126/science.1231518]; Baker DN, 2004, NATURE, V432, P878, DOI 10.1038/nature03116; BLAKE JB, 1992, GEOPHYS RES LETT, V19, P821, DOI 10.1029/92GL00624; Blake JB, 1997, GEOPHYS RES LETT, V24, P927, DOI 10.1029/97GL00859; Brautigam DH, 2000, J GEOPHYS RES-SPACE, V105, P291, DOI 10.1029/1999JA900344; Eastlund BJ, 1997, ASTROPHYS J, V483, P857, DOI 10.1086/304292; Goldsten JO, 2013, SPACE SCI REV, V179, P485, DOI 10.1007/s11214-012-9917-x; JOHNSON MH, 1992, J SPACECRAFT ROCKETS, V29, P556, DOI 10.2514/3.55641; Kletzing CA, 2013, SPACE SCI REV, V179, P127, DOI 10.1007/s11214-013-9993-6; KOONS HC, 1981, J GEOPHYS RES-SPACE, V86, P640, DOI 10.1029/JA086iA02p00640; Li X, 2013, J GEOPHYS RES-SPACE, V118, P6489, DOI 10.1002/2013JA019342; Li XL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026294; LI XL, 1993, GEOPHYS RES LETT, V20, P2423, DOI 10.1029/93GL02701; LYONS LR, 1973, J GEOPHYS RES, V78, P2142, DOI 10.1029/JA078i013p02142; Mauk BH, 2013, SPACE SCI REV, V179, P3, DOI 10.1007/s11214-012-9908-y; NASA Goddard Space Flight Center, 2014, COORD DAT AN WEB; Ni BB, 2013, J GEOPHYS RES-SPACE, V118, P7740, DOI 10.1002/2013JA019260; Roederer J. G., 1970, DYNAMICS GEOMAGNETIC; Spence HE, 2013, SPACE SCI REV, V179, P311, DOI 10.1007/s11214-013-0007-5; Thorne RM, 2013, NATURE, V504, P411, DOI 10.1038/nature12889; Thorne RM, 2013, GEOPHYS RES LETT, V40, P3507, DOI 10.1002/grl.50627; VAMPOLA AL, 1978, J GEOPHYS RES-SPACE, V83, P2543, DOI 10.1029/JA083iA06p02543; VANALLEN JA, 1958, JET PROPULSION, V28, P588, DOI 10.2514/8.7396; VANALLEN JA, 1959, NATURE, V183, P430, DOI 10.1038/183430a0; Zhao H, 2013, J GEOPHYS RES-SPACE, V118, P756, DOI 10.1029/2012JA018179	29	140	144	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					531	+		10.1038/nature13956	http://dx.doi.org/10.1038/nature13956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428500				2022-12-28	WOS:000346247600048
J	Chen, CY; Chen, CJ				Chen, Chih-Yen; Chen, Chi-Jen			Emphysematous Pyelonephritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chen, Chih-Yen] Taipei Med Univ, New Taipei City, Taiwan; [Chen, Chi-Jen] Shuang Ho Hosp, New Taipei City, Taiwan	Taipei Medical University	Chen, CY (corresponding author), Taipei Med Univ, New Taipei City, Taiwan.	08889@s.tmu.edu.tw							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					E34	E34		10.1056/NEJMicm1314314	http://dx.doi.org/10.1056/NEJMicm1314314			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25427126				2022-12-28	WOS:000345580000012
J	Liu, ZY; Lu, ZY; Wen, XY; Otto-Bliesner, BL; Timmermann, A; Cobb, KM				Liu, Zhengyu; Lu, Zhengyao; Wen, Xinyu; Otto-Bliesner, B. L.; Timmermann, A.; Cobb, K. M.			Evolution and forcing mechanisms of El Nino over the past 21,000 years	NATURE			English	Article							TROPICAL PACIFIC; SOUTHERN-OSCILLATION; ANNUAL CYCLE; CLIMATE; VARIABILITY; HOLOCENE; MODEL; CIRCULATION; SUPPRESSION; VARIANCE	The El Nino Southern Oscillation (ENSO) is Earth's dominant source of interannual climate variability, but its response to global warming remains highly uncertain(1). To improve our understanding of ENSO's sensitivity to external climate forcing, it is paramount to determine its past behaviour by using palaeoclimate data and model simulations. Palaeoclimate records show that ENSO has varied considerably since the Last Glacial Maximum (21,000 years ago)(2-9), and some data sets suggest a gradual intensification of ENS 0 over the past 6,000 years(2'5'7'8). Previous attempts to simulate the transient evolution of ENSO have relied on simplified models(10) or snapshot(11-13) experiments. Here we analyse a series of transient Coupled General Circulation Model simulations forced by changes in greenhouse gasses, orbital forcing, the meltwater discharge and the ice-sheet history throughout the past 21,000 years. Consistent with most palaeo-ENSO reconstructions, our model simulates an orbitally induced strengthening of ENSO during the Holocene epoch, which is caused by increasing positive ocean-atmosphere feedbacks. During the early deglaciation, ENSO characteristics change drastically in response to meltwater discharges and the resulting changes in the Atlantic Meridional Overturning Circulation and equatorial annual cycle. Increasing deglacial atmospheric CO2 concentrations tend to weaken ENSO, whereas retreating glacial ice sheets intensify ENSO. The complex evolution of forcings and ENSO feedbacks and the uncertainties in the reconstruction further highlight the challenge and opportunity for constraining future ENSO responses.	[Liu, Zhengyu] Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI 53706 USA; [Liu, Zhengyu] Univ Wisconsin, Nelson Ctr Climat Res, Madison, WI 53706 USA; [Liu, Zhengyu; Lu, Zhengyao; Wen, Xinyu] Peking Univ, Sch Phys, Lab Climate Ocean & Atmosphere Studies, Beijing 100871, Peoples R China; [Otto-Bliesner, B. L.] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80307 USA; [Timmermann, A.] Univ Hawaii Manoa, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Timmermann, A.] Univ Hawaii Manoa, Dept Oceanog, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Cobb, K. M.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Peking University; National Center Atmospheric Research (NCAR) - USA; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University System of Georgia; Georgia Institute of Technology	Liu, ZY (corresponding author), Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI 53706 USA.	zliu3@wisc.edu	Timmermann, Axel/F-4977-2011; Timmermann, Axel/Y-2799-2019; Otto-Bliesner, Bette/AAY-7691-2020	Timmermann, Axel/0000-0003-0657-2969; Timmermann, Axel/0000-0003-0657-2969; Cobb, Kim/0000-0002-2125-9164; , Zhengyao/0000-0002-5911-7110	US National Science Foundation (NSF)/P2C2 Program, Chinese [NSFC41130105]; US Department of Energy/Office of Science (BER), Chinese [MOST2012CB955200, NSF1049219, 1204011]; Directorate For Geosciences [1049219, 1049238] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1010869] Funding Source: National Science Foundation	US National Science Foundation (NSF)/P2C2 Program, Chinese(National Science Foundation (NSF)); US Department of Energy/Office of Science (BER), Chinese(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is supported by the US National Science Foundation (NSF)/P2C2 Program, Chinese NSFC41130105, the US Department of Energy/Office of Science (BER), Chinese MOST2012CB955200, NSF1049219 and 1204011. The computation is carried out at Oak Ridge National Laboratory of the Department of Energy and the National Center for Atmospheric Research supercomputing facility.	BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Brown J, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001512; Carre M, 2014, SCIENCE, V345, P1045, DOI 10.1126/science.1252220; Chiang JCH, 2009, J CLIMATE, V22, P923, DOI 10.1175/2008JCLI2644.1; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; Cobb KM, 2013, SCIENCE, V339, P67, DOI 10.1126/science.1228246; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Deser C, 2006, J CLIMATE, V19, P2451, DOI 10.1175/JCLI3759.1; Felis T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1973; He F., 2011, SIMULATING TRANSIENT; He F, 2013, NATURE, V494, P81, DOI 10.1038/nature11822; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Kim ST, 2011, CLIM DYNAM, V36, P1609, DOI [10.1007/s00382-010-0872-5, 10.1007/s00382-010-0796-0]; Koutavas A, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002378; Liu Z, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000819; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Liu ZG, 2002, J CLIMATE, V15, P1088, DOI 10.1175/1520-0442(2002)015<1088:ASMSOE>2.0.CO;2; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; LIU ZY, 1994, J ATMOS SCI, V51, P3807, DOI 10.1175/1520-0469(1994)051<3807:EPOCAD>2.0.CO;2; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; McGregor S, 2013, CLIM PAST, V9, P2269, DOI 10.5194/cp-9-2269-2013; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Meehl GA, 2006, CLIM DYNAM, V26, P549, DOI 10.1007/s00382-005-0098-0; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Otto-Bliesner B., 2003, GEOPHYS RES LETT, V30, DOI [10.1029/2003GL08553, DOI 10.1029/2003GL08553]; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; PENLAND C, 1995, J CLIMATE, V8, P1999, DOI 10.1175/1520-0442(1995)008<1999:TOGOTS>2.0.CO;2; Rein B, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001099; Riedinger MA, 2002, J PALEOLIMNOL, V27, P1, DOI 10.1023/A:1013514408468; Rittenour TM, 2000, SCIENCE, V288, P1039, DOI 10.1126/science.288.5468.1039; Roberts W. H., 2007, THESIS U WASHINGTON; Sadekov AY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3692; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Timmermann A, 2007, J CLIMATE, V20, P4899, DOI 10.1175/JCLI4283.1; Timmermann A, 2007, J CLIMATE, V20, P4147, DOI 10.1175/JCLI4240.1; Timmermann A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019442; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724	41	179	192	12	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					550	553		10.1038/nature13963	http://dx.doi.org/10.1038/nature13963			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428502	Green Submitted			2022-12-28	WOS:000346247600051
J	Long, H; Su, YW; Lu, QJ				Long, Hai; Su, Yuwen; Lu, Qianjin			Rapidly Progressing Leg Ulcer With Fever in a Woman With Chronic Diarrhea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PYODERMA-GANGRENOSUM; THERAPY		[Long, Hai; Su, Yuwen; Lu, Qianjin] Cent S Univ, Xiangya Hosp 2, Dept Dermatol, Changsha 410011, Hunan, Peoples R China	Central South University	Lu, QJ (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Dermatol, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China.	qianlu5860@gmail.com						Agarwal A, 2013, ALIMENT PHARM THER, V38, P563, DOI 10.1111/apt.12431; Brooklyn T, 2006, BRIT MED J, V333, P181, DOI 10.1136/bmj.333.7560.181; Cabalag MS, 2015, ANN PLAS SURG, V74, P354, DOI 10.1097/SAP.0b013e31829565f3; Callen JP, 2007, RHEUM DIS CLIN N AM, V33, P787, DOI 10.1016/j.rdc.2007.07.016; Cummins DL, 2007, BRIT J DERMATOL, V157, P1235, DOI 10.1111/j.1365-2133.2007.08217.x; Li J, 2013, J AM ACAD DERMATOL, V69, P565, DOI 10.1016/j.jaad.2013.05.028; Marzano AV, 2014, INFLAMM BOWEL DIS, V20, P213, DOI 10.1097/01.MIB.0000436959.62286.f9; Ruocco E, 2009, J EUR ACAD DERMATOL, V23, P1008, DOI 10.1111/j.1468-3083.2009.03199.x; Weenig RH, 2002, NEW ENGL J MED, V347, P1412, DOI 10.1056/NEJMoa013383	9	2	3	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2158	2159		10.1001/jama.2014.13007	http://dx.doi.org/10.1001/jama.2014.13007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25423221				2022-12-28	WOS:000345626800020
J	Mohammadi, D				Mohammadi, Dara			Adrian Hill: accelerating the pace of Ebola vaccine research	LANCET			English	Biographical-Item																			0	0	0	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1660	1660		10.1016/S0140-6736(14)61738-4	http://dx.doi.org/10.1016/S0140-6736(14)61738-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KU	25441187				2022-12-28	WOS:000345116200015
J	Hawley, JA; Hargreaves, M; Joyner, MJ; Zierath, JR				Hawley, John A.; Hargreaves, Mark; Joyner, Michael J.; Zierath, Juleen R.			Integrative Biology of Exercise	CELL			English	Review							HUMAN SKELETAL-MUSCLE; ACTIVATED PROTEIN-KINASE; MODERN CHRONIC DISEASES; FATTY-ACID OXIDATION; MITOCHONDRIAL BIOGENESIS; SIGNALING PATHWAYS; OXYGEN-UPTAKE; MOLECULAR-MECHANISMS; RESISTANCE EXERCISE; ADAPTIVE RESPONSES	Exercise represents a major challenge to whole-body homeostasis provoking widespread perturbations in numerous cells, tissues, and organs that are caused by or are a response to the increased metabolic activity of contracting skeletal muscles. To meet this challenge, multiple integrated and often redundant responses operate to blunt the homeostatic threats generated by exercise-induced increases in muscle energy and oxygen demand. The application of molecular techniques to exercise biology has provided greater understanding of the multiplicity and complexity of cellular networks involved in exercise responses, and recent discoveries offer perspectives on the mechanisms by which muscle "communicates" with other organs and mediates the beneficial effects of exercise on health and performance.	[Hawley, John A.] Australian Catholic Univ, Sch Exercise Sci, Exercise & Nutr Res Grp, Fitzroy, Vic 3065, Australia; [Hawley, John A.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UA, Merseyside, England; [Hargreaves, Mark] Univ Melbourne, Dept Physiol, Parkville, Vic 3010, Australia; [Joyner, Michael J.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Zierath, Juleen R.] Karolinska Inst, Dept Mol Med, S-17177 Stockholm, Sweden; [Zierath, Juleen R.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	Australian Catholic University; Liverpool John Moores University; University of Melbourne; Mayo Clinic; Karolinska Institutet; Novo Nordisk Foundation; University of Copenhagen	Hawley, JA (corresponding author), Australian Catholic Univ, Sch Exercise Sci, Exercise & Nutr Res Grp, Fitzroy, Vic 3065, Australia.	john.hawley@acu.edu.au; juleen.zierath@ki.se	Hawley, John A/U-3814-2018	Hawley, John A/0000-0002-0886-9881; Zierath, Juleen/0000-0001-6891-7497				Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Bartlett JD, 2014, SPORTS MED, V44, P303, DOI 10.1007/s40279-013-0127-9; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bassett DR, 2002, J APPL PHYSIOL, V93, P1567, DOI 10.1152/japplphysiol.01246.2001; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; BERGSTROM J, 1966, NATURE, V210, P309, DOI 10.1038/210309a0; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002; Booth FW, 2000, J APPL PHYSIOL, V88, P774, DOI 10.1152/jappl.2000.88.2.774; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Bouchard C, 2011, COMPR PHYSIOL, V1, P1603, DOI 10.1002/cphy.c100059; Boushel R, 2011, MITOCHONDRION, V11, P303, DOI 10.1016/j.mito.2010.12.006; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Brooks GA, 2012, COMPR PHYSIOL, V2, P537, DOI 10.1002/cphy.c110007; Calbet JAL, 2004, J PHYSIOL-LONDON, V558, P319, DOI 10.1113/jphysiol.2003.059287; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chakravarthy MV, 2004, J APPL PHYSIOL, V96, P3, DOI 10.1152/japplphysiol.00757.2003; Chin ER, 2005, J APPL PHYSIOL, V99, P414, DOI 10.1152/japplphysiol.00015.2005; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Coffey VG, 2005, FASEB J, V19, P190, DOI 10.1096/fj.05-4809fje; COYLE EF, 1991, MED SCI SPORT EXER, V23, P93; Dempsey JA, 2002, RESP PHYSIOL NEUROBI, V130, P3, DOI 10.1016/S0034-5687(01)00327-9; Dempsey JA, 2014, J PHYSIOL-LONDON, V592, P463, DOI 10.1113/jphysiol.2013.261925; Drummond MJ, 2009, J PHYSIOL-LONDON, V587, P1535, DOI 10.1113/jphysiol.2008.163816; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639; FITTS RH, 1978, J APPL PHYSIOL, V45, P899, DOI 10.1152/jappl.1978.45.6.899; Fiuza-Luces C, 2013, PHYSIOLOGY, V28, P330, DOI 10.1152/physiol.00019.2013; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; GOLDSTEIN M, 1961, DIABETES, V10, P232, DOI 10.2337/diab.10.3.232; Gonzalez-Alonso J, 2003, CIRCULATION, V107, P824, DOI 10.1161/01.CIR.0000049746.29175.3F; Gonzalez-Alonso J, 2008, J PHYSIOL-LONDON, V586, P45, DOI 10.1113/jphysiol.2007.142158; Green DJ, 2012, EXP PHYSIOL, V97, P295, DOI 10.1113/expphysiol.2011.058826; HAGERMAN FC, 1984, SPORTS MED, V1, P303, DOI 10.2165/00007256-198401040-00005; Hawley JA, 2002, CLIN EXP PHARMACOL P, V29, P218, DOI 10.1046/j.1440-1681.2002.03623.x; Hawley JA, 2006, ESSAYS BIOCHEM, V42, P1, DOI 10.1042/bse0420001; Hawley JA, 2011, J APPL PHYSIOL, V110, P834, DOI 10.1152/japplphysiol.00949.2010; Hellsten Y, 2012, J PHYSIOL-LONDON, V590, P6297, DOI 10.1113/jphysiol.2012.240762; HICKSON RC, 1980, EUR J APPL PHYSIOL O, V45, P255, DOI 10.1007/BF00421333; Hill AV, 1925, NATURE, V116, P544, DOI 10.1038/116544a0; Hochachka PW, 1999, COMP BIOCHEM PHYS A, V124, P1, DOI 10.1016/S1095-6433(99)00079-3; Hoier B, 2014, MICROCIRCULATION, V21, P301, DOI 10.1111/micc.12117; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182; Hoppeler H, 2011, COMPR PHYSIOL, V1, P1383, DOI 10.1002/cphy.c100042; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jensen TE, 2012, J PHYSIOL-LONDON, V590, P1069, DOI 10.1113/jphysiol.2011.224972; Jeppesen J, 2012, J PHYSIOL-LONDON, V590, P1059, DOI 10.1113/jphysiol.2011.225011; Jeukendrup AE, 2003, BIOCHEM SOC T, V31, P1270, DOI 10.1042/BST0311270; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Joyner MJ, 2009, J PHYSIOL-LONDON, V587, P5551, DOI 10.1113/jphysiol.2009.179432; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu ZQ, 2002, J CLIN ENDOCR METAB, V87, P5553, DOI 10.1210/jc.2002-020424; MACDOUGALL JD, 1985, J APPL PHYSIOL, V58, P785, DOI 10.1152/jappl.1985.58.3.785; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; McGee SL, 2014, FASEB J, V28, P3384, DOI 10.1096/fj.14-249359; Mcgee SL, 2011, J APPL PHYSIOL, V110, P258, DOI 10.1152/japplphysiol.00979.2010; McGee SL, 2010, CLIN SCI, V118, P507, DOI 10.1042/CS20090533; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; NEEL JV, 1962, AM J HUM GENET, V14, P353; NEUFER PD, 1993, AM J PHYSIOL, V265, pC1597; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Parolin ML, 1999, AM J PHYSIOL-ENDOC M, V277, pE890, DOI 10.1152/ajpendo.1999.277.5.E890; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Pedersen L, 2012, AM J PHYSIOL-ENDOC M, V302, pE831, DOI 10.1152/ajpendo.00339.2011; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Phillips SM, 2014, SPORTS MED, V44, P71, DOI 10.1007/s40279-014-0152-3; Philp A, 2011, J APPL PHYSIOL, V110, P561, DOI 10.1152/japplphysiol.00941.2010; Poole DC, 2011, COMPR PHYSIOL, V1, P1, DOI 10.1002/cphy.c091001; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Rose AJ, 2003, J PHYSIOL-LONDON, V553, P303, DOI 10.1113/jphysiol.2003.054171; Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Saltin B, 1977, Ann N Y Acad Sci, V301, P3, DOI 10.1111/j.1749-6632.1977.tb38182.x; SALTIN B, 1967, J APPL PHYSIOL, V23, P353, DOI 10.1152/jappl.1967.23.3.353; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Sharp NCC, 1997, J ZOOL, V241, P493, DOI 10.1111/j.1469-7998.1997.tb04840.x; Spriet LL, 2014, SPORTS MED, V44, P87, DOI 10.1007/s40279-014-0154-1; Tavi P, 2011, J PHYSIOL-LONDON, V589, P5021, DOI 10.1113/jphysiol.2011.212860; van Loon LJC, 2005, AM J PHYSIOL-ENDOC M, V289, pE482, DOI 10.1152/ajpendo.00092.2005; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379; Willis BL, 2012, ARCH INTERN MED, V172, P1333, DOI 10.1001/archinternmed.2012.3400; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Yang YF, 2005, J APPL PHYSIOL, V98, P1745, DOI 10.1152/japplphysiol.01185.2004; Zacharewicz E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00266; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	110	534	555	11	158	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					738	749		10.1016/j.cell.2014.10.029	http://dx.doi.org/10.1016/j.cell.2014.10.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417152	Bronze			2022-12-28	WOS:000344522000008
J	Hubener, M; Bonhoeffer, T				Huebener, Mark; Bonhoeffer, Tobias			Neuronal Plasticity: Beyond the Critical Period	CELL			English	Review							OCULAR-DOMINANCE PLASTICITY; ADULT VISUAL-CORTEX; CHONDROITIN SULFATE PROTEOGLYCANS; EXPERIENCE-DEPENDENT PLASTICITY; SPINAL-CORD-INJURY; MONOCULAR DEPRIVATION; FUNCTIONAL REORGANIZATION; SYNAPTIC PLASTICITY; CORTICAL PLASTICITY; STRIATE CORTEX	Neuronal plasticity in the brain is greatly enhanced during critical periods early in life and was long thought to be rather limited thereafter. Studies in primary sensory areas of the neocortex have revealed a substantial degree of plasticity in the mature brain, too. Often, plasticity in the adult neocortex lies dormant but can be reactivated by modifications of sensory input or sensory-motor interactions, which alter the level and pattern of activity in cortical circuits. Such interventions, potentially in combination with drugs targeting molecular brakes on plasticity present in the adult brain, might help recovery of function in the injured or diseased brain.	[Huebener, Mark; Bonhoeffer, Tobias] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Hubener, M (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	mark@neuro.mpg.de; tobias.bonhoeffer@neuro.mpg.de	Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634				Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; Akbik FV, 2013, NEURON, V77, P859, DOI 10.1016/j.neuron.2012.12.027; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Asher R A, 2001, Prog Brain Res, V132, P611; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Balog J., 2014, NEUROIMAGE IN PRESS; Baroncelli L, 2010, EXP NEUROL, V226, P100, DOI 10.1016/j.expneurol.2010.08.009; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Bergan JF, 2005, J NEUROSCI, V25, P9816, DOI 10.1523/JNEUROSCI.2533-05.2005; Beurdeley M, 2012, J NEUROSCI, V32, P9429, DOI 10.1523/JNEUROSCI.0394-12.2012; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Calford MB, 2005, NATURE, V438, pE3, DOI 10.1038/nature04359; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Djurisic M, 2013, P NATL ACAD SCI USA, V110, P20771, DOI 10.1073/pnas.1321092110; Duffy KR, 2013, CURR BIOL, V23, P382, DOI 10.1016/j.cub.2013.01.017; Ebbinghaus H., 1880, GEDACHTNIS; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Geryain J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00102; Gherardini L., 2013, CEREB CORTE IN PRESS; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Gordon JA, 1996, J NEUROSCI, V16, P3274; Greifzu F, 2014, P NATL ACAD SCI USA, V111, P1150, DOI 10.1073/pnas.1313385111; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; He HY, 2007, NAT NEUROSCI, V10, P1134, DOI 10.1038/nn1965; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Heimel JA, 2008, GENES BRAIN BEHAV, V7, P915, DOI 10.1111/j.1601-183X.2008.00431.x; Heimel JA, 2007, EUR J NEUROSCI, V25, P795, DOI 10.1111/j.1460-9568.2007.05333.x; Hengen KB, 2013, NEURON, V80, P335, DOI 10.1016/j.neuron.2013.08.038; Hertle RW, 2007, ARCH OPHTHALMOL-CHIC, V125, P655; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hussain Z, 2012, J NEUROSCI, V32, P474, DOI 10.1523/JNEUROSCI.3845-11.2012; Iny K, 2006, J NEUROSCI, V26, P7368, DOI 10.1523/JNEUROSCI.0124-06.2006; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kaneko M, 2014, ELIFE, V3, DOI 10.7554/eLife.02798; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Keck T, 2013, NEURON, V80, P327, DOI 10.1016/j.neuron.2013.08.018; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Laing R. J., 2014, CEREB CORTE IN PRESS; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; Lehmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003120; Levelt CN, 2012, ANNU REV NEUROSCI, V35, P309, DOI 10.1146/annurev-neuro-061010-113813; Li RW, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001135; Li RW, 2008, J NEUROSCI, V28, P14223, DOI 10.1523/JNEUROSCI.4271-08.2008; Li RW, 2004, J VISION, V4, P476, DOI 10.1167/4.6.7; Lickey ME, 2004, VISION RES, V44, P3381, DOI 10.1016/j.visres.2004.09.018; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; LORENZ K., 1935, Journal fur Ornithologie, V83, P137, DOI 10.1007/BF01905355; Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085; Matthies U, 2013, J NEUROSCI, V33, P11774, DOI 10.1523/JNEUROSCI.4262-12.2013; Maya-Vetencourt JF, 2011, EUR J NEUROSCI, V33, P49, DOI 10.1111/j.1460-9568.2010.07488.x; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; OOHIRA A, 1991, J NEUROSCI, V11, P822; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Ranson A, 2013, J NEUROSCI, V33, P15220, DOI 10.1523/JNEUROSCI.2078-13.2013; RECANZONE GH, 1993, J NEUROSCI, V13, P87; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Sengpiel F, 2014, CURR BIOL, V24, pR936, DOI 10.1016/j.cub.2014.05.063; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Takesian AE, 2013, PROG BRAIN RES, V207, P3, DOI 10.1016/B978-0-444-63327-9.00001-1; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; VAEGAN, 1979, T OPHTHAL SOC UK, V99, P432; Vorobyov V, 2013, J NEUROSCI, V33, P234, DOI 10.1523/JNEUROSCI.2283-12.2013; Wahl AS, 2014, SCIENCE, V344, P1250, DOI 10.1126/science.1253050; WIESEL TN, 1974, BRAIN RES, V79, P273, DOI 10.1016/0006-8993(74)90416-8; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yamahachi H, 2009, NEURON, V64, P719, DOI 10.1016/j.neuron.2009.11.026; Yoon BJ, 2009, P NATL ACAD SCI USA, V106, P9860, DOI 10.1073/pnas.0901305106; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010; Zhao RR, 2013, NEUROSCI BULL, V29, P477, DOI 10.1007/s12264-013-1359-2	110	128	136	4	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					727	737		10.1016/j.cell.2014.10.035	http://dx.doi.org/10.1016/j.cell.2014.10.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417151	Bronze			2022-12-28	WOS:000344522000007
J	Lopatkin, AJ; You, LC				Lopatkin, Allison J.; You, Lingchong			Synthetic Biology Looks Good on Paper	CELL			English	Editorial Material								Tremendous progress has been made in the design and implementation of synthetic gene circuits, but real-world applications of such circuits have been limited. Cell-free circuits embedded on paper developed by Pardee et al. promise to deliver specific and rapid diagnostics on a low-cost, highly scalable platform.	[Lopatkin, Allison J.; You, Lingchong] Duke Univ, Ctr Syst Biol, Ctr Genom & Computat Biol, Dept Biomed Engn, Durham, NC 27708 USA	Duke University	You, LC (corresponding author), Duke Univ, Ctr Syst Biol, Ctr Genom & Computat Biol, Dept Biomed Engn, Durham, NC 27708 USA.	you@duke.edu						Cheng AA, 2012, ANNU REV BIOMED ENG, V14, P155, DOI [10.1146/annurev-bioeng-071811-150118, 10.1146/annurev.bioeng-071811-150118]; Church GM, 2014, NAT REV MOL CELL BIO, V15, P289, DOI 10.1038/nrm3767; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Hockenberry AJ, 2012, CURR OPIN CHEM BIOL, V16, P253, DOI 10.1016/j.cbpa.2012.05.179; Lentini R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5012; Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004; Riccione KA, 2012, ACS SYNTH BIOL, V1, P389, DOI 10.1021/sb300044r; Struss A, 2010, ANAL CHEM, V82, P4457, DOI 10.1021/ac100231a; Sun ZZ, 2014, ACS SYNTH BIOL, V3, P387, DOI 10.1021/sb400131a; Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h	10	5	5	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					717	720		10.1016/j.cell.2014.10.003	http://dx.doi.org/10.1016/j.cell.2014.10.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417149	Bronze			2022-12-28	WOS:000344522000005
J	Zhou, CK; Slaughter, BD; Unruh, JR; Guo, FL; Yu, ZL; Mickey, K; Narkar, A; Ross, RT; McClain, M; Li, R				Zhou, Chuankai; Slaughter, Brian D.; Unruh, Jay R.; Guo, Fengli; Yu, Zulin; Mickey, Kristen; Narkar, Akshay; Ross, Rhonda Trimble; McClain, Melainia; Li, Rong			Organelle-Based Aggregation and Retention of Damaged Proteins in Asymmetrically Dividing Cells	CELL			English	Article							BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; MISFOLDED PROTEINS; QUALITY-CONTROL; AGGRESOME FORMATION; HEAT-SHOCK; LIFE-SPAN; MITOCHONDRIA; STRESS; ER	Aggregation of damaged or misfolded proteins is a protective mechanism against proteotoxic stress, abnormalities of which underlie many aging-related diseases. Here, we show that in asymmetrically dividing yeast cells, aggregation of cytosolic misfolded proteins does not occur spontaneously but requires new polypeptide synthesis and is restricted to the surface of ER, which harbors the majority of active translation sites. Protein aggregates formed on ER are frequently also associated with or are later captured by mitochondria, greatly constraining aggregate mobility. During mitosis, aggregates are tethered to well-anchored maternal mitochondria, whereas mitochondria acquired by the bud are largely free of aggregates. Disruption of aggregate-mitochondria association resulted in increased mobility and leakage of mother-accumulated aggregates into the bud. Cells with advanced replicative age exhibit gradual decline of aggregates-mitochondria association, likely contributing to their diminished ability to rejuvenate through asymmetric cell division.	[Zhou, Chuankai; Slaughter, Brian D.; Unruh, Jay R.; Guo, Fengli; Yu, Zulin; Narkar, Akshay; Ross, Rhonda Trimble; McClain, Melainia; Li, Rong] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Zhou, Chuankai; Narkar, Akshay; Li, Rong] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Mickey, Kristen] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Li, R (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	rli@stowers.org	Narkar, Akshay/AAD-2925-2022	Unruh, Jay/0000-0003-3077-4990	American Heart Association predoctoral fellowship [13PRE16750001]; NIH grant [RO1-GM057063]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057063] Funding Source: NIH RePORTER	American Heart Association predoctoral fellowship(American Heart Association); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Parnell and B. Rubinstein for assistance with data analysis, J. Lange for assistance in microscopy, D. Bradford and S. McCroskey for assistance in strain construction, R. Parker, Y. Ohsumi, K. Weiss, J. Nunnari, D. Kaganovich, D. Gottschling, S. Jaspersen, and L. Pon for providing plasmids and strains, and R. Halfmann for comments on the manuscript. This work was supported by an American Heart Association predoctoral fellowship (13PRE16750001) (to C.Z.) and an NIH grant (RO1-GM057063) (to R.L.).	Altmann K, 2008, J CELL BIOL, V181, P119, DOI 10.1083/jcb.200709099; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Bockler S, 2014, DEV CELL, V28, P450, DOI 10.1016/j.devcel.2014.01.012; Boldogh IR, 2004, MOL BIOL CELL, V15, P3994, DOI 10.1091/mbc.E04-01-0053; Bufalino MR, 2013, J CELL BIOL, V201, P523, DOI 10.1083/jcb.201207052; Camilleri A, 2013, BBA-BIOMEMBRANES, V1828, P2532, DOI 10.1016/j.bbamem.2013.06.026; Carpenter JF, 1999, METHOD ENZYMOL, V309, P236; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; KAWAI S, 1992, J BACTERIOL, V174, P254, DOI 10.1128/jb.174.1.254-262.1992; Kornmann B, 2013, CURR OPIN CELL BIOL, V25, P443, DOI 10.1016/j.ceb.2013.02.010; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kummer E, 2013, FEBS LETT, V587, P810, DOI 10.1016/j.febslet.2013.02.011; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; PESTKA S, 1972, J BIOL CHEM, V247, P6895; Rafelski SM, 2012, SCIENCE, V338, P822, DOI 10.1126/science.1225720; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Rikhvanov EG, 2005, CURR GENET, V48, P44, DOI 10.1007/s00294-005-0587-z; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; SERRANO R, 1977, EUR J BIOCHEM, V80, P97, DOI 10.1111/j.1432-1033.1977.tb11861.x; Slaughter BD, 2010, MOL BIOL CELL, V21, P4306, DOI 10.1091/mbc.E10-05-0451; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Unruh JR, 2013, CURR BIOL, V23, pR74, DOI 10.1016/j.cub.2012.12.005; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Youngman MJ, 2004, J CELL BIOL, V164, P677, DOI 10.1083/jcb.200308012; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002	50	141	141	1	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					530	542		10.1016/j.cell.2014.09.026	http://dx.doi.org/10.1016/j.cell.2014.09.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417105	Green Accepted, Bronze			2022-12-28	WOS:000344521700010
J	Allemani, C; Weir, HK; Carreira, H; Harewood, R; Spika, D; Wang, XS; Bannon, F; Ahn, JV; Johnson, CJ; Bonaventure, A; Marcos-Gragera, R; Stiller, C; Silva, GAE; Chen, WQ; Ogunbiyi, OJ; Rachet, B; Soeberg, MJ; You, H; Matsuda, T; Bielska-Lasota, M; Storm, H; Tucker, TC; Coleman, MP				Allemani, Claudia; Weir, Hannah K.; Carreira, Helena; Harewood, Rhea; Spika, Devon; Wang, Xiao-Si; Bannon, Finian; Ahn, Jane V.; Johnson, Christopher J.; Bonaventure, Audrey; Marcos-Gragera, Rafael; Stiller, Charles; Azevedo e Silva, Gulnar; Chen, Wan-Qing; Ogunbiyi, Olufemi J.; Rachet, Bernard; Soeberg, Matthew J.; You, Hui; Matsuda, Tomohiro; Bielska-Lasota, Magdalena; Storm, Hans; Tucker, Thomas C.; Coleman, Michel P.		CONCORD Working Grp	Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)	LANCET			English	Article							BREAST-CANCER; CHILDHOOD-CANCER; RECTAL-CANCER; NORDIC COUNTRIES; EUROPE 1999-2007; OVARIAN-CANCER; NET SURVIVAL; DATA QUALITY; CARE; STAGE	Background Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. Methods Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25.7 million adults (age 15-99 years) and 75 000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. Findings 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. Interpretation International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems.	[Allemani, Claudia; Carreira, Helena; Harewood, Rhea; Spika, Devon; Wang, Xiao-Si; Ahn, Jane V.; Bonaventure, Audrey; Rachet, Bernard; Coleman, Michel P.] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England; [Weir, Hannah K.] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Atlanta, GA USA; [Bannon, Finian] Queens Univ Belfast, Ctr Publ Hlth, Northern Ireland Canc Registry, Belfast, Antrim, North Ireland; [Johnson, Christopher J.] Canc Data Registry Idaho, Boise, ID USA; [Marcos-Gragera, Rafael] Inst Invest Biomed Girona, Dept Salut, Unitat Epidemiol & Registre Canc Girona, Girona, Spain; [Stiller, Charles] Publ Hlth England, South East Knowledge & Intelligence Team, Oxford, England; [Azevedo e Silva, Gulnar] Univ Estado Rio de Janeiro, Dept Epidemiol, Rio De Janeiro, RJ, Brazil; [Chen, Wan-Qing] Natl Canc Ctr, Natl Off Canc Prevent & Control, Beijing, Peoples R China; [Chen, Wan-Qing] Natl Canc Ctr, Natl Cent Canc Registry, Beijing, Peoples R China; [Ogunbiyi, Olufemi J.] Univ City Coll Hosp, Ibadan Canc Registry, Ibadan, Nigeria; [Soeberg, Matthew J.] Australian Technol Pk, New South Wales Cent Canc Registry, Sydney, NSW, Australia; [You, Hui] Canc Inst NSW, Sydney, NSW, Australia; [Matsuda, Tomohiro] Natl Canc Ctr, Populat Based Canc Registry Sect, Div Surveillance, Ctr Canc Control & Informat Serv, Tokyo 104, Japan; [Bielska-Lasota, Magdalena] Natl Inst Publ Hlth, Dept Hlth Promot & Postgrad Educ, Warsaw, Poland; [Bielska-Lasota, Magdalena] Natl Inst Hyg, PL-00791 Warsaw, Poland; [Storm, Hans] Danish Canc Soc, Canc Prevent & Documentat, Copenhagen, Denmark; [Tucker, Thomas C.] Univ Kentucky, Kentucky Canc Registry, Lexington, KY USA	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; Queens University Belfast; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Public Health England; Universidade do Estado do Rio de Janeiro; University of Ibadan; University College Hospital, Ibadan; National Cancer Center - Japan; National Institute of Public Health (NIPH); National Institute of Hygiene (NIH); Danish Cancer Society; University of Kentucky	Coleman, MP (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England.	concord@lshtm.ac.uk	Alexandre, Tiago/ABI-3506-2020; Curado, Maria Paula/M-6200-2013; Serraino, Diego/J-3915-2018; Cornet, Edouard/M-5625-2019; Sánchez, Maria-José/D-1087-2011; Berrino, Franco/AAC-2364-2020; MOLINA PORTILLO, ELENA/ABA-3364-2021; Katalinic, Alexander/D-2512-2010; Abdel-Rahman, Manar/R-4652-2016; Pathy, Nirmala Bhoo/C-1228-2010; Marcos-Gragera, Rafael/A-1437-2017; Coleman, Michel/AAA-9543-2020; Belot, Aurelien/N-9287-2016; Ogunbiyi, Olufemi/ABE-4224-2020; Didkowska, Joanna Aleksandra/ABG-8672-2020; Tagliabue, Giovanna/D-4194-2017; Herrmann, Christian/J-1094-2019; Clavel, Jacqueline/Q-2750-2016; Yépez, Maria Clara/N-7710-2017; falcini, fabio/W-4345-2018; Contiero, Paolo/F-6721-2016; Sekerija, Mario/W-8550-2019; Ochir, Chimedsuren/AAW-7743-2020; Sant, Milena/D-2362-2017; Alexandre, Tiago/GRJ-3364-2022; Calleja, Neville/E-3895-2019; Matsuda, Tomohiro/H-7078-2019; BOUVIER, Anne-Marie/R-6600-2017; Cornet, Edouard/A-9757-2010; Valkov, Mikhail Yurievich/L-4441-2018; SALAZAR, ANTONIO/A-5806-2013; Baili, Paolo/J-7422-2016; Zucchetto, Antonella/ABC-8649-2020; BOUVIER, Véronique/L-7799-2015; Monnereau, Alain/L-1249-2014; Mangone, Lucia/J-4701-2016; Gatta, Gemma/B-8627-2017; Bastos, Joana/M-6918-2015; Antunes, Luis/A-8572-2014; Bravo, Luis Eduardo/K-9882-2014; JURADO, DANIEL/G-3254-2014; Lima, Carlos Anselmo/A-4225-2013; De Angelis, Roberta/N-3970-2017; Gozdz, Stanislaw/D-3300-2013; Ferretti, Stefano/K-8636-2015	Alexandre, Tiago/0000-0003-3791-9793; Curado, Maria Paula/0000-0001-8172-2483; Serraino, Diego/0000-0003-0565-8920; Cornet, Edouard/0000-0003-1667-3421; Sánchez, Maria-José/0000-0003-4817-0757; Berrino, Franco/0000-0002-4858-1866; MOLINA PORTILLO, ELENA/0000-0002-9955-3080; Katalinic, Alexander/0000-0003-0490-1554; Abdel-Rahman, Manar/0000-0001-9968-9853; Pathy, Nirmala Bhoo/0000-0003-0568-8863; Marcos-Gragera, Rafael/0000-0001-9824-3657; Coleman, Michel/0000-0001-8940-3807; Belot, Aurelien/0000-0003-1410-5172; Didkowska, Joanna Aleksandra/0000-0001-9160-9118; Tagliabue, Giovanna/0000-0001-8165-5524; Herrmann, Christian/0000-0001-9349-8917; Clavel, Jacqueline/0000-0002-3616-7676; Yépez, Maria Clara/0000-0002-3482-5786; falcini, fabio/0000-0002-0864-6266; Contiero, Paolo/0000-0001-6760-3605; Sekerija, Mario/0000-0001-7508-1501; Ochir, Chimedsuren/0000-0002-7134-5255; Sant, Milena/0000-0002-4148-8597; Alexandre, Tiago/0000-0003-3791-9793; Calleja, Neville/0000-0003-1800-2103; Cornet, Edouard/0000-0003-1667-3421; Valkov, Mikhail Yurievich/0000-0003-3230-9638; SALAZAR, ANTONIO/0000-0003-2639-2340; Baili, Paolo/0000-0003-0335-2418; Zucchetto, Antonella/0000-0003-2812-6345; BOUVIER, Véronique/0000-0002-2016-0779; Monnereau, Alain/0000-0002-5056-1397; Mangone, Lucia/0000-0002-5089-5178; Gatta, Gemma/0000-0003-4160-6458; Bastos, Joana/0000-0002-9815-5603; Eisemann, Nora/0000-0002-8521-6497; tumino, rosario/0000-0003-2666-414X; molinie, florence/0000-0002-0645-4017; Zborovskaya, Anna/0000-0001-5684-9634; Mitter, Vera/0000-0002-1483-5020; Woods, Ryan/0000-0002-9520-2128; grosclaude, pascale/0000-0002-6755-5970; Bento, Maria Jose/0000-0002-7690-9830; Sciacca, Salvatore/0000-0002-8613-6296; Antunes, Luis/0000-0002-3098-0711; Dimitrova, Nadya/0000-0002-5958-6320; Spika, Devon/0000-0001-9738-7755; Crocetti, Emanuele/0000-0002-4649-2034; Bravo, Luis Eduardo/0000-0002-9708-0312; Vercelli, Marina/0000-0002-9757-2616; JURADO, DANIEL/0000-0003-0628-0253; Tryggvadottir, Laufey/0000-0001-8067-9030; Bielska-Lasota, Magdalena/0000-0003-0960-8672; Lima, Carlos Anselmo/0000-0003-4269-7320; De Angelis, Roberta/0000-0001-7787-3043; CHIANG, CHUN-JU/0000-0002-1330-5319; Gozdz, Stanislaw/0000-0001-6902-3807; Currow, David/0000-0003-1988-1250; Sassi, Franco/0000-0001-9773-2117; ZAIDI, ZOUBIDA/0000-0003-3378-4799; Ferretti, Stefano/0000-0001-5241-2101; Sacerdote, Carlotta/0000-0002-8008-5096; Bonaventure, Audrey/0000-0001-6665-8145; Brewster, David/0000-0002-5346-5608; Chiolero, Arnaud/0000-0002-5544-8510; Trojanowski, Maciej/0000-0002-9124-1509; Carreira, Helena/0000-0003-1538-2526; Larranaga, Nerea/0000-0002-9993-9880; Storm, Hans/0000-0001-7223-8198; Vitale, Francesco/0000-0002-6354-8060; Rachet, Bernard/0000-0001-5837-7773; Lillini, Roberto/0000-0001-9872-8670	Canadian Partnership Against Cancer (Toronto, Canada); Cancer Focus Northern Ireland (Belfast, UK); Cancer Institute New South Wales (Sydney, Australia); Cancer Research UK (London, UK); Centers for Disease Control and Prevention (Atlanta, GA, USA); Swiss Re (London, UK); Swiss Cancer Research foundation (Bern, Switzerland); Swiss Cancer League (Bern, Switzerland); University of Kentucky (Lexington, KY, USA); NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; Cancer Research UK [16148, 18525] Funding Source: researchfish	Canadian Partnership Against Cancer (Toronto, Canada); Cancer Focus Northern Ireland (Belfast, UK); Cancer Institute New South Wales (Sydney, Australia); Cancer Research UK (London, UK)(Cancer Research UK); Centers for Disease Control and Prevention (Atlanta, GA, USA)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Swiss Re (London, UK); Swiss Cancer Research foundation (Bern, Switzerland); Swiss Cancer League (Bern, Switzerland); University of Kentucky (Lexington, KY, USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	Canadian Partnership Against Cancer (Toronto, Canada), Cancer Focus Northern Ireland (Belfast, UK), Cancer Institute New South Wales (Sydney, Australia), Cancer Research UK (London, UK), Centers for Disease Control and Prevention (Atlanta, GA, USA), Swiss Re (London, UK), Swiss Cancer Research foundation (Bern, Switzerland), Swiss Cancer League (Bern, Switzerland), and University of Kentucky (Lexington, KY, USA).	Aareleid T, 2002, INT J CANCER, V102, P45, DOI 10.1002/ijc.10663; Allemani C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003055; Allemani C, 2013, INT J CANCER, V132, P1170, DOI 10.1002/ijc.27725; Allemani C, 2010, EUR J CANCER, V46, P1528, DOI 10.1016/j.ejca.2010.02.016; Andersen MR, 2013, EUR J CANC; [Anonymous], 2012, RES AD GEN ASS POL D; [Anonymous], 2013, COMP MACR CONT REG G; [Anonymous], 2013, WORLD POP PROSP 2012, V1; [Anonymous], HUM MORT DAT; Beniaiche K., 2012, DEFICIENCE NOTRE SYS; Berrino F, 1995, IARC SCI PUBL, V132, P1; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Bossard N, 2007, EUR J CANCER, V43, P149, DOI 10.1016/j.ejca.2006.07.021; Brasso Klaus, 2006, Ugeskr Laeger, V168, P1243; Bray F., 2014, IARC TECHNICAL PUBLI, V43; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Brenner H, 2004, EUR J CANCER, V40, P326, DOI 10.1016/j.ejca.2003.10.013; Brenner H, 1996, CANCER-AM CANCER SOC, V78, P2004, DOI 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#; Brenner H, 2007, INT J CANCER, V121, P2274, DOI 10.1002/ijc.22932; Brenner H, 2012, INT J CANCER, V131, P1649, DOI 10.1002/ijc.26192; Capocaccia R, 2003, ANN ONCOL, V14, pV14, DOI 10.1093/annonc/mdg751; Casali PG, 2014, ANN ONCOL, V25, P1458, DOI 10.1093/annonc/mdu218; Cavalli F, 2013, LANCET, V381, P425, DOI 10.1016/S0140-6736(13)60059-8; Chawla Neetu, 2013, Journal of the National Cancer Institute Monographs, P36, DOI 10.1093/jncimonographs/lgt009; Chen XC, 2014, LANCET ONCOL, V15, pE471, DOI 10.1016/S1470-2045(14)70441-3; Clerc-Urmes I, 2014, STATA J, V14, P87, DOI 10.1177/1536867X1401400107; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Coleman MP, 2014, LANCET, V383, P564, DOI 10.1016/S0140-6736(13)62225-4; Corazziari I, 2004, EUR J CANCER, V40, P2307, DOI 10.1016/j.ejca.2004.07.002; Curado MP, 2007, CANC INCIDENCE 5 CON, VIx, p[160, 961]; Curtis RE, 2006, NIH PUBLICATION, V05-5302; Cutler SJ, 1964, NCI MONOGRAPH, V15; Danieli C, 2012, STAT MED, V31, P775, DOI 10.1002/sim.4464; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; De Angelis R, 2009, EUR J CANCER, V45, P909, DOI 10.1016/j.ejca.2008.11.003; Department of Health, 2011, IMPR OUTC STRAT CANC; Dickman PW, 1997, J EPIDEMIOL BIOSTAT, V2, P87; Elandt-Johnson R C, 1980, SURVIVAL MODELS DATA; Elferink MAG, 2010, EUR J CANCER, V46, P1421, DOI 10.1016/j.ejca.2010.01.025; Ellis L, 2014, INT J CANCER, V135, P1774, DOI 10.1002/ijc.28990; Ellison LF, 2010, CANCER EPIDEMIOL, V34, P550, DOI 10.1016/j.canep.2010.06.015; European Network of Cancer Registries, 2011, REC COD MULT PRIM; EWBANK DC, 1983, POP STUD-J DEMOG, V37, P105, DOI 10.1080/00324728.1983.10405927; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Ferlay J, 2005, CHECK CONVERSIONS PR; Folkesson J, 2009, INT J CANCER, V125, P2406, DOI 10.1002/ijc.24562; Fritz APC., 2013, INT CLASSIFICATION D; Gatta G, 1999, CANCER CAUSE CONTROL, V10, P575, DOI 10.1023/A:1008959211777; Gatta G, 2014, LANCET ONCOL, V15, P35, DOI 10.1016/S1470-2045(13)70548-5; Gatta Gemma, 2013, Journal of the National Cancer Institute Monographs, P79, DOI 10.1093/jncimonographs/lgt004; Gondos A, 2005, BRIT J CANCER, V92, P1808, DOI 10.1038/sj.bjc.6602540; Gondos A, 2004, INT J CANCER, V112, P860, DOI 10.1002/ijc.20471; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Greenwood M., 1926, NATURAL DURATION CAN; Hijmans R., 2012, GADM DATABASE GLOBAL; Horton R, 2014, LANCET, V383, P1620, DOI 10.1016/S0140-6736(14)60769-8; IARC, 2010, C15 CANC INC 5 CONT; Innos K, 2012, ACTA ONCOL, V51, P521, DOI 10.3109/0284186X.2011.633928; Jansen L, 2012, EUR J EPIDEMIOL, V27, P689, DOI 10.1007/s10654-012-9723-5; Johnson CJ, 2013, CANCER EPIDEMIOL, V37, P20, DOI 10.1016/j.canep.2012.08.007; Johnson Christopher J, 2010, J Registry Manag, V37, P86; Jonsson B, 2007, ANN ONCOL, V18, P1, DOI 10.1093/annonc/mdm095; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Karanikolos Marina, 2013, Journal of the National Cancer Institute Monographs, P7, DOI 10.1093/jncimonographs/lgt003; Kelly RJ, 2014, LANCET ONCOL, V15, pE112, DOI 10.1016/S1470-2045(13)70578-3; Klint A, 2010, ACTA ONCOL, V49, P632, DOI 10.3109/02841861003691945; Krilaviciute A, 2014, ACTA ONCOL, V53, P1238, DOI 10.3109/0284186X.2014.888495; Kurman R.J., 2014, WHO CLASSIFICATION T, V4th; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lakhani SR, 2012, WHO CLASSIFICATION T; LANGMUIR AD, 1963, NEW ENGL J MED, V268, P182, DOI 10.1056/NEJM196301242680405; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Li RR, 2014, CANCER EPIDEMIOL, V38, P314, DOI 10.1016/j.canep.2014.02.013; Maringe C, 2013, ACTA ONCOL, V52, P919, DOI 10.3109/0284186X.2013.764008; Maringe C, 2012, GYNECOL ONCOL, V127, P75, DOI 10.1016/j.ygyno.2012.06.033; Mariotto AB, 2007, CANCER EPIDEM BIOMAR, V16, P566, DOI 10.1158/1055-9965.EPI-06-0782; Matsuda T, 2011, JPN J CLIN ONCOL, V41, P40, DOI 10.1093/jjco/hyq167; Micheli A, 2003, ANN ONCOL, V14, pV28, DOI 10.1093/annonc/mdg752; Minicozzi P, 2014, DIGEST LIVER DIS, V46, P645, DOI 10.1016/j.dld.2014.03.009; Ministerio da Saude (BR), 2011, PLAN AC ESTR ENFR DO; Mitenbergs U, 2012, HLTH SYSTEMS TRANSIT, V14, P1; Mitry E, 2005, EUR J CANCER, V41, P2297, DOI 10.1016/j.ejca.2005.01.028; Mitry E, 2002, BRIT J SURG, V89, P1557, DOI 10.1046/j.1365-2168.2002.02276.x; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; National Audit Office, 2010, DEL CANC REF STRAT; National Cancer Center, 2010, CANC FACTS FIG 2010; OECD, 2013, CANC CAR ASS QUAL IM; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Parkin DM, 2006, NAT REV CANCER, V6, P603, DOI 10.1038/nrc1948; Perez-Cuevas R, 2013, PEDIATR BLOOD CANCER, V60, P196, DOI 10.1002/pbc.24265; Perme MP, 2009, BIOSTATISTICS, V10, P136, DOI 10.1093/biostatistics/kxn021; Pui CH, 2013, SEMIN HEMATOL, V50, P185, DOI 10.1053/j.seminhematol.2013.06.007; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Rosso S, 2009, EUR J CANCER, V45, P1080, DOI 10.1016/j.ejca.2008.11.030; Rutherford MJ, 2013, BRIT J CANCER, V108, P691, DOI 10.1038/bjc.2013.12; Samiei M., 2013, CANC CARE EMERGING H, P87; Sankaranarayanan R, 1998, IARC SCI PUBLICATION, V145; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; SANKILA R, 2003, EVALUATION CLIN CARE; Sant M, 2010, TUMORI, V96, pi; Sant M, 2010, BLOOD, V116, P3724, DOI 10.1182/blood-2010-05-282632; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Shimakawa Y, 2013, INT J CANCER, V132, P658, DOI 10.1002/ijc.27646; Shulman L., 2011, CLOSING CANC DIVIDE; Sobin L, 2009, TNM CLASSIFICATION M; StataCorp, 2013, STATA STAT SOFTW VER; STILLER CA, 1990, BRIT J CANCER, V62, P806, DOI 10.1038/bjc.1990.383; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Surveillance Epidemiology and End Results program, 2007, MULT PRIM HIST COD R; Swaminathan R, 2008, B WORLD HEALTH ORGAN, V86, P509, DOI 10.2471/BLT.07.046979; Tomatis L, 1997, TUMORI, V83, P505, DOI 10.1177/030089169708300113; Tretli S, 1996, J NATL CANCER I, V88, P128, DOI 10.1093/jnci/88.2.128; Umoh NJ, 2011, LIVER INT, V31, P215, DOI 10.1111/j.1478-3231.2010.02418.x; United Nations Population Division, 2005, WORLD POP PROSP 2004, P54; Vineis P, 2014, LANCET, V383, P549, DOI 10.1016/S0140-6736(13)62224-2; Viviani S, 2008, CANCER EPIDEM BIOMAR, V17, P3216, DOI 10.1158/1055-9965.EPI-08-0303; Walters S, 2013, BRIT J CANCER, V108, P1195, DOI 10.1038/bjc.2013.6; Walters S, 2013, THORAX, V68, P551, DOI 10.1136/thoraxjnl-2012-202297; Walters S, 2013, INT J CANCER, V132, P676, DOI 10.1002/ijc.27651; Wang Chia-Siu, 2002, Chang Gung Med J, V25, P216; Weir HK, 2013, CANCER CAUSE CONTROL, V24, P1231, DOI 10.1007/s10552-013-0203-3; WHO, 2012, DEC LIST RES 65 WORL; Woods LM, 2012, INT J CANCER, V131, pE1120, DOI 10.1002/ijc.27545; Wu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062930; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007; Zeng H, 2014, INT J CANC	133	1533	1673	9	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					977	1010		10.1016/S0140-6736(14)62038-9	http://dx.doi.org/10.1016/S0140-6736(14)62038-9			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD2EK	25467588	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000350886900032
J	Bernard, L; Dinh, A; Ghout, I; Simo, D; Zeller, V; Issartel, B; Le Moing, V; Belmatoug, N; Lesprit, P; Bru, JP; Therby, A; Bouhour, D; Denes, E; Debard, A; Chirouze, C; Fevre, K; Dupon, M; Aegerter, P; Mulleman, D				Bernard, Louis; Dinh, Aurelien; Ghout, Idir; Simo, David; Zeller, Valerie; Issartel, Bertrand; Le Moing, Vincent; Belmatoug, Nadia; Lesprit, Philippe; Bru, Jean-Pierre; Therby, Audrey; Bouhour, Damien; Denes, Eric; Debard, Alexa; Chirouze, Catherine; Fevre, Karine; Dupon, Michel; Aegerter, Philippe; Mulleman, Denis		Duration Treatment	Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial	LANCET			English	Article							METHICILLIN-RESISTANT; DURATION; OUTCOMES; FRANCE	Background Duration of treatment for patients with vertebral osteomyelitis is mainly based on expert recommendation rather than evidence. We aimed to establish whether 6 weeks of antibiotic treatment is non-inferior to 12 weeks in patients with pyogenic vertebral osteomyelitis. Methods In this open-label, non-inferiority, randomised controlled trial, we enrolled patients aged 18 years or older with microbiologically confirmed pyogenic vertebral osteomyelitis and typical radiological features from 71 medical care centres across France. Patients were randomly assigned to either 6 weeks or 12 weeks of antibiotic treatment (physician's choice in accordance with French guidelines) by a computer-generated randomisation list of permuted blocks, stratified by centre. The primary endpoint was the proportion of patients who were classified as cured at 1 year by a masked independent validation committee, analysed by intention to treat. Non-inferiority would be declared if the proportion of cured patients assigned to 6 weeks of treatment was not less than the proportion of cured patients assigned to 12 weeks of treatment, within statistical variability, by an absolute margin of 10%. This trial is registered with EudraCT, number 2006-000951-18, and Clinical Trials.gov, number NCT00764114. Findings Between Nov 15, 2006, and March 15, 2011, 359 patients were randomly assigned, of whom six in the 6-week group and two in the 12-week group were excluded after randomisation. 176 patients assigned to the 6-week treatment regimen and 175 to the 12-week treatment regimen were analysed by intention to treat. 160 (90.9%) of 176 patients in the 6-week group and 159 (90.9%) of 175 of those in the 12-week group met the criteria for clinical cure. The difference between the groups (0.05%, 95% CI -6.2 to 6.3) showed the non-inferiority of the 6-week regimen when compared with the 12-week regimen. 50 patients in the 6-week group and 51 in the 12-week group had adverse events, the most common being death (14 [8%] in the 6-week group vs 12 [7%] in the 12-week group), antibiotic intolerance (12 [7%] vs 9 [5%]), cardiorespiratory failure (7 [4%] vs 12 [7%]), and neurological complications (7 [4%] vs 3 [2%]). Interpretation 6 weeks of antibiotic treatment is not inferior to 12 weeks of antibiotic treatment with respect to the proportion of patients with pyogenic vertebral osteomyelitis cured at 1 year, which suggests that the standard antibiotic treatment duration for patients with this disease could be reduced to 6 weeks.	[Bernard, Louis] Univ Hosp Bretonneau, Div Infect Dis, Tours, France; [Dinh, Aurelien] Univ Hosp Raymond Poincare, Div Infect Dis, Garches, France; [Ghout, Idir] Univ Hosp Ambroise Pare, Clin Res Unit, Boulogne, France; [Zeller, Valerie] Hosp Diaconesses Croix St Simon, Referral Ctr Bone & Joint Infect, Paris, France; [Issartel, Bertrand] Unite Mobile Referents Infectiol, Villeurbanne, France; [Le Moing, Vincent] Univ Hosp, Montpellier, France; [Belmatoug, Nadia] Univ Hosp, Div Internal Med, Beaujon Clichy, France; [Lesprit, Philippe] Univ Hosp, Mobile Infect Dis Unit, Creteil, France; [Bru, Jean-Pierre] Reg Hosp, Div Infect Dis, Annecy, France; [Therby, Audrey] Gen Hosp Versailles, Div Infect Dis, Le Chesnay, France; [Bouhour, Damien] Gen Hosp, Div Infect Dis, Bourg En Bresse, France; [Denes, Eric] Limoges Univ Hosp, Div Infect Dis, Limoges, France; [Debard, Alexa] Univ Hosp, Div Infect Dis, Toulouse, France; [Chirouze, Catherine] Univ Hosp, Div Infect Dis, Besancon, France; [Bernard, Louis; Fevre, Karine] Bretonneau Univ Hosp, Div Infect Dis, Tours, France; [Dupon, Michel] Bordeaux Univ Hosp, Div Infect Dis, Bordeaux, France; [Aegerter, Philippe] Ambroise Pare Univ Hosp, AP HP, Clin Res Unit, Boulogne, France; [Mulleman, Denis] Univ Hosp Tours, Div Rheumatol, Tours, France	CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre Hospitalier Annecy Genevois; Centre Hospitalier de Versailles; CHU Limoges; CHU de Toulouse; Universite de Franche-Comte; CHU Besancon; CHU Tours; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU Tours	Bernard, L (corresponding author), Univ Hosp Tours, Bretonneau Hosp, Div Infect Dis, F-37044 Tours, France.	lbernard@univ-tours.fr	AEGERTER, Philippe/AAY-6003-2021; Mulleman, Denis/O-3221-2019; Mulleman, Denis/K-5822-2012; Dinh, Aurélien/AAI-5355-2021; DENES, Eric/ABI-2443-2020; Revest, Matthieu/L-9533-2015	AEGERTER, Philippe/0000-0002-9156-5028; Mulleman, Denis/0000-0003-4089-7513; DENES, Eric/0000-0001-5321-3171; MARCHOU, Bruno/0000-0002-0673-2945; Stahl, Jean Paul/0000-0002-0086-3557; ORCEL, Philippe/0000-0001-7028-1133; Roblot, France/0000-0003-4325-023X; Gandjbakhch, frederique/0000-0002-3181-4598; Cottier, Jean-Philippe/0000-0001-9166-212X; Sotto, Albert/0000-0002-6463-9386; Le Moing, Vincent/0000-0002-9529-2792; Wyplosz, Benjamin/0000-0002-9779-9044	French Ministry of Health [PHRC 2005AOM05031]; Assistance Publique-Hopitaux de Paris [PO50607]	French Ministry of Health; Assistance Publique-Hopitaux de Paris	We thank all patients and their relatives for participating in this study. We thank the staff (physicians, nurses, medical microbiologists, secretaries, and assistants) at all participating sites for their cooperation. We thank Celine Vichot, Layide Meaude, Frederic Barbot for monitoring and planning the study, members of the independent monitoring committee for their precise evaluation work, and Cecile Kedzia from the Delegation Regionale a la Recherche Clinique for her help with this study. We thank Cristina Cherrier and Marie-Charlotte Bernard for their technical assistance and Jacques Ropers for critical review. This study was supported by a grant from the French Ministry of Health (PHRC 2005AOM05031) and sponsored by Assistance Publique-Hopitaux de Paris (PO50607). We also thank the Centres de References pour les infections Osteo-articulaires du Grand-Ouest de la France (CRIOGO) for their contribution to this study.	Akiyama T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002412; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Chen IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065621; Cheung WY, 2012, INT ORTHOP, V36, P397, DOI 10.1007/s00264-011-1384-6; Clinical and Laboratory Standards Institute:, M100S17 CLIN LAB STA; Colmenero JD, 1997, ANN RHEUM DIS, V56, P709, DOI 10.1136/ard.56.12.709; Cottle L, 2008, J INFECTION, V56, P401, DOI 10.1016/j.jinf.2008.02.005; Grammatico L, 2008, EPIDEMIOL INFECT, V136, P653, DOI 10.1017/S0950268807008850; Grammatico-Guillon L, 2012, J HOSP INFECT, V82, P40, DOI 10.1016/j.jhin.2012.04.025; Gras G, 2014, EUR J CLIN MICROBIOL, V33, P371, DOI 10.1007/s10096-013-1965-y; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Hopkinson N, 2001, QJM-MON J ASSOC PHYS, V94, P465, DOI 10.1093/qjmed/94.9.465; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Inoue S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-283; Kaier K, 2012, VALUE HEALTH, V15, P87, DOI 10.1016/j.jval.2011.09.005; Kapeller P, 1997, EUR NEUROL, V38, P94, DOI 10.1159/000113167; Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017; Locke T, 2014, J INFECT PUBLIC HEAL, V7, P44, DOI 10.1016/j.jiph.2013.08.001; McHenry MC, 2002, CLIN INFECT DIS, V34, P1342, DOI 10.1086/340102; Meropol SB, 2008, PHARMACOEPIDEM DR S, V17, P523, DOI 10.1002/pds.1547; Mylona E, 2009, SEMIN ARTHRITIS RHEU, V39, P10, DOI 10.1016/j.semarthrit.2008.03.002; Park KH, 2013, J INFECTION, V67, P556, DOI 10.1016/j.jinf.2013.07.026; Rice LB, 2008, CLIN INFECT DIS, V46, P491, DOI 10.1086/526535; Roblot F, 2007, SEMIN ARTHRITIS RHEU, V36, P269, DOI 10.1016/j.semarthrit.2006.09.004; Sandberg T, 2012, LANCET, V380, P484, DOI 10.1016/S0140-6736(12)60608-4; Spilf, 2007, MED MALADIES INFECT, V37, P573, DOI 10.1016/j.medmal.2007.03.007; Team RDCR, 2007, LANG ENV STAT COMP; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zimmerli W, 2010, NEW ENGL J MED, V362, P1022, DOI 10.1056/NEJMcp0910753	29	212	226	1	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					875	882		10.1016/S0140-6736(14)61233-2	http://dx.doi.org/10.1016/S0140-6736(14)61233-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25468170				2022-12-28	WOS:000350451100035
J	Siemieniuk, RAC; MacFadden, DR; Matukas, LM				Siemieniuk, Reed A. C.; MacFadden, Derek R.; Matukas, Larissa M.			Disseminated blastomycosis with cutaneous involvement in a Canadian railroad worker	LANCET			English	Editorial Material									[Siemieniuk, Reed A. C.; MacFadden, Derek R.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Matukas, Larissa M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Matukas, Larissa M.] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Matukas, LM (corresponding author), St Michaels Hosp, Dept Lab Med, Div Microbiol, 30 Bond St, Toronto, ON M5B 1W8, Canada.	matukasl@smh.ca	GALIOTIS, Costas/O-7013-2016	GALIOTIS, Costas/0000-0001-8079-5488					0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					883	883		10.1016/S0140-6736(14)61641-X	http://dx.doi.org/10.1016/S0140-6736(14)61641-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25467582				2022-12-28	WOS:000350451100036
J	Chou, S; Daugherty, MD; Peterson, SB; Biboy, J; Yang, YY; Jutras, BL; Fritz-Laylin, LK; Ferrin, MA; Harding, BN; Jacobs-Wagner, C; Yang, XF; Vollmer, W; Malik, HS; Mougous, JD				Chou, Seemay; Daugherty, Matthew D.; Peterson, S. Brook; Biboy, Jacob; Yang, Youyun; Jutras, Brandon L.; Fritz-Laylin, Lillian K.; Ferrin, Michael A.; Harding, Brittany N.; Jacobs-Wagner, Christine; Yang, X. Frank; Vollmer, Waldemar; Malik, Harmit S.; Mougous, Joseph D.			Transferred interbacterial antagonism genes augment eukaryotic innate immune function	NATURE			English	Article							LYME-DISEASE SPIROCHETE; VI SECRETION SYSTEM; BORRELIA-BURGDORFERI; BACTERIA; PEPTIDOGLYCAN; EVOLUTION; SEQUENCE; PROTEIN; HOST; PERFORMANCE	Horizontal gene transfer allows organisms to rapidly acquire adaptive traits(1). Although documented instances of horizontal gene transfer from bacteria to eukaryotes remain rare, bacteria represent a rich source of new functions potentially available for co-option(2). One benefit that genes of bacterial origin could provide to eukaryotes is the capacity to produce antibacterials, which have evolved in prokaryotes as the result of eons of interbacterial competition. The type VI secretion amidase effector (Tae) proteins are potent bacteriocidal enzymes that degrade the cell wall when delivered into competing bacterial cells by the type VI secretion system(3). Here we show that tae genes have been transferred to eukaryotes on at least six occasions, and that the resulting domesticated amidase effector (dae) genes have been preserved for hundreds of millions of years through purifying selection. We show that the dae genes acquired eukaryotic secretion signals, are expressed within recipient organisms, and encode active antibacterial toxins that possess substrate specificity matching extant Tae proteins of the same lineage. Finally, we show that a dae gene in the deer tick Ixodes scapularis limits proliferation of Borrelia burgdorferi, the aetiologic agent of Lyme disease. Our work demonstrates that a family of horizontally acquired toxins honed to mediate interbacterial antagonism confers previously undescribed antibacterial capacity to eukaryotes. We speculate that the selective pressure imposed by competition between bacteria has produced a reservoir of genes encoding diverse antimicrobial functions that are tailored for co-option by eukaryotic innate immune systems.	[Chou, Seemay; Peterson, S. Brook; Ferrin, Michael A.; Harding, Brittany N.; Mougous, Joseph D.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Daugherty, Matthew D.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Daugherty, Matthew D.; Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Biboy, Jacob; Vollmer, Waldemar] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Yang, Youyun; Yang, X. Frank] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Jutras, Brandon L.; Jacobs-Wagner, Christine] Yale Univ, Microbial Sci Inst, New Haven, CT 06516 USA; [Jutras, Brandon L.; Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06516 USA; [Fritz-Laylin, Lillian K.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Jacobs-Wagner, Christine] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT 06516 USA; [Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06516 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Newcastle University - UK; Indiana University System; Indiana University Bloomington; Yale University; Howard Hughes Medical Institute; Yale University; University of California System; University of California San Francisco; Yale University; Yale University	Mougous, JD (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	mougous@u.washington.edu	Daugherty, Matthew/AAT-4418-2020; Malik, Harmit S/I-5591-2019	Malik, Harmit S/0000-0001-6005-0016; Ferrin, Michael/0000-0002-9899-1169; Jacobs-Wagner, Christine/0000-0003-0980-5334; Jutras, Brandon/0000-0002-7989-1031; Biboy, jacob/0000-0002-1286-6851; Fritz-Laylin, Lillian/0000-0002-9237-9403	National Institutes of Health [AI080609, AI083640]; Defense Threat Reduction Agency [HDTRA-1-13-014]; BBSRC [BB/I020012/1]; Howard Hughes Medical Institute (HHMI); American Society for Microbiology Undergraduate Research Fellowship; Irvington Institute Fellowship from the Cancer Research Institute; Burroughs Wellcome Fund; Biotechnology and Biological Sciences Research Council [BB/I020012/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083640, R01AI080609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); American Society for Microbiology Undergraduate Research Fellowship; Irvington Institute Fellowship from the Cancer Research Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Holland for assistance with transcriptome analysis, D. Vollmer and C. Aldridge for PG preparation, J. Parrish for microinjection assistance, J. Young for assistance with phylogenetic analyses, H. Merrikh for sharing equipment, and T. Alber, C. Fuqua, K. Clay, E. Rynkiewicz, U. Pal, C. Grundner, G. Nester, P. Singh and members of the Malik and Mougous laboratories for helpful discussions. This work was funded by the National Institutes of Health (AI080609 to J.D.M. and AI083640 to X.F.Y.), the Defense Threat Reduction Agency (HDTRA-1-13-014 to J.D.M.) and the BBSRC (BB/I020012/1 to W.V.). S.C. was supported by a Howard Hughes Medical Institute (HHMI)-sponsored Life Sciences Research Foundation fellowship, M.A.F. by the American Society for Microbiology Undergraduate Research Fellowship, and M.D.D. by an Irvington Institute Fellowship from the Cancer Research Institute. C.J.-W. and H.S.M. are investigators of the HHMI. J.D.M. holds an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; BECK G, 1990, BIOCHEM BIOPH RES CO, V167, P89, DOI 10.1016/0006-291X(90)91734-A; Boto L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2450; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards D. H., 1993, BACTERIAL GROWTH LYS; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fulton C., 1970, Methods Cell Physiol., V4, P341; FULTON C, 1967, DEV BIOL, V15, P165, DOI 10.1016/0012-1606(67)90012-7; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hajdusek O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00026; Hawlena H, 2013, ISME J, V7, P221, DOI 10.1038/ismej.2012.71; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; Jutras BL, 2013, J BACTERIOL, V195, P757, DOI 10.1128/JB.01956-12; Kashyap DR, 2011, NAT MED, V17, P676, DOI 10.1038/nm.2357; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Moran Y, 2012, MOL BIOL EVOL, V29, P2223, DOI 10.1093/molbev/mss089; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Narasimhan S, 2014, CELL HOST MICROBE, V15, P58, DOI 10.1016/j.chom.2013.12.001; Nikoh N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-12; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Sonenshine DE, 2013, BIOL TICKS, V2nd; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Warnke KM, 2011, MOL PHYLOGENET EVOL, V58, P390, DOI 10.1016/j.ympev.2010.11.024; Wybouw N, 2014, ELIFE, V3, DOI 10.7554/eLife.02365; Yu JK, 2008, DEV GENES EVOL, V218, P723, DOI 10.1007/s00427-008-0228-x; Zhang LL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002079	47	52	54	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					98	+		10.1038/nature13965	http://dx.doi.org/10.1038/nature13965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25470067	Green Accepted			2022-12-28	WOS:000349098000039
J	Mischiati, M; Lin, HT; Herold, P; Imler, E; Olberg, R; Leonardo, A				Mischiati, Matteo; Lin, Huai-Ti; Herold, Paul; Imler, Elliot; Olberg, Robert; Leonardo, Anthony			Internal models direct dragonfly interception steering	NATURE			English	Article							SENSORIMOTOR INTEGRATION; PREY; INSECTS; MECHANISMS; PREDICTION; SYSTEM; MOTION; EYE	Sensorimotor control in vertebrates relies on internal models. When extending an arm to reach for an object, the brain uses predictive models of both limb dynamics and target properties. Whether invertebrates use such models remains unclear. Here we examine to what extent prey interception by dragonflies (Plathemis lydia), a behaviour analogous to targeted reaching, requires internal models. By simultaneously tracking the position and orientation of a dragonfly's head and body during flight, we provide evidence that interception steering is driven by forward and inverse models of dragonfly body dynamics and by models of prey motion. Predictive rotations of the dragonfly's head continuously track the prey's angular position. The head-body angles established by prey tracking appear to guide systematic rotations of the dragonfly's body to align it with the prey's flight path. Model-driven control thus underlies the bulk of interception steering manoeuvres, while vision is used for reactions to unexpected prey movements. These findings illuminate the computational sophistication with which insects construct behaviour.	[Mischiati, Matteo; Lin, Huai-Ti; Herold, Paul; Leonardo, Anthony] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Imler, Elliot] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Olberg, Robert] Union Coll, Schenectady, NY 12308 USA	Howard Hughes Medical Institute; University of Arizona; Union College	Leonardo, A (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	leonardoa@janelia.hhmi.org		Mischiati, Matteo/0000-0002-8448-9143	Howard Hughes Medical Institute; AFOSR [FA9550-10-1-0472]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	We thank I. Siwanowicz for advice on neck joint anatomy, and J. Melfi for assistance on kinematic computations. J. Osborne and J. Jordan provided assistance with the retroreflector assembly and artificial prey delivery systems. M. Barbic provided guidance on retroreflector mirroring. D. Parks and the Janelia vivarium provided dragonfly husbandry. We are grateful to V. Jayaraman, A. Karpova, W. Denk and J. Wang for discussions and comments on the manuscript. This work was supported by the Howard Hughes Medical Institute. Additional support to R.O. from AFOSR FA9550-10-1-0472.	Adelman TL, 2003, NEURON, V40, P823, DOI 10.1016/S0896-6273(03)00680-9; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Chang LY, 2007, J BIOMECH, V40, P1392, DOI 10.1016/j.jbiomech.2006.05.010; COLLETT TS, 1978, J COMP PHYSIOL, V125, P191, DOI 10.1007/BF00656597; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; Flanagan JR, 2001, CAN J EXP PSYCHOL, V55, P87, DOI 10.1037/h0087355; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Ghose K, 2006, PLOS BIOL, V4, P865, DOI 10.1371/journal.pbio.0040108; Gonzalez-Bellido PT, 2013, P NATL ACAD SCI USA, V110, P696, DOI 10.1073/pnas.1210489109; Gorb SN, 1999, P ROY SOC B-BIOL SCI, V266, P525, DOI 10.1098/rspb.1999.0668; Haselsteiner AF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0216; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Huston SJ, 2011, CURR OPIN NEUROBIOL, V21, P527, DOI 10.1016/j.conb.2011.05.030; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Justh EW, 2006, P ROY SOC A-MATH PHY, V462, P3629, DOI 10.1098/rspa.2006.1742; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; LABHART T, 1995, J COMP PHYSIOL A, V176, P437, DOI 10.1007/BF00196410; Mehta B, 2002, J NEUROPHYSIOL, V88, P942, DOI 10.1152/jn.2002.88.2.942; Olberg RM, 2007, J COMP PHYSIOL A, V193, P685, DOI 10.1007/s00359-007-0223-0; Olberg RM, 2000, J COMP PHYSIOL A, V186, P155, DOI 10.1007/s003590050015; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Shneydor N.A., 1998, MISSILE GUIDANCE PUR; Thomas SJ, 2012, IEEE T BIOMED CIRC S, V6, P424, DOI 10.1109/TBCAS.2012.2222881; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; TU MS, 1994, J EXP BIOL, V192, P207; Tucker VA, 2000, J EXP BIOL, V203, P3755; von Reyn CR, 2014, NAT NEUROSCI, V17, P962, DOI 10.1038/nn.3741; Wang ZH, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.136804; Webb B, 2004, TRENDS NEUROSCI, V27, P278, DOI 10.1016/j.tins.2004.03.004; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003	32	152	155	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					333	U410		10.1038/nature14045	http://dx.doi.org/10.1038/nature14045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25487153				2022-12-28	WOS:000347810300038
J	Anderson, DL; King, SD				Anderson, Don L.; King, Scott D.			Driving the Earth machine?	SCIENCE			English	Editorial Material							MANTLE; ASTHENOSPHERE; VISCOSITY; BOUNDARY; FLOW		[Anderson, Don L.] CALTECH, Seismol Lab, Pasadena, CA 91125 USA; [King, Scott D.] Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24060 USA	California Institute of Technology; Virginia Polytechnic Institute & State University	Anderson, DL (corresponding author), CALTECH, Seismol Lab, Pasadena, CA 91125 USA.	sdk@vt.edu	King, Scott D/B-1220-2008	King, Scott D/0000-0002-9564-5164				Anderson DL, 2014, P NATL ACAD SCI USA, V111, pE4298, DOI 10.1073/pnas.1410229111; Anderson DL, 2011, J PETROL, V52, P1547, DOI 10.1093/petrology/egq068; Barrell J, 1914, J GEOL, V22, P28, DOI 10.1086/622131; Crepisson C, 2014, EARTH PLANET SC LETT, V393, P105, DOI 10.1016/j.epsl.2014.02.048; Crowley JW, 2012, GEOPHYS J INT, V188, P61, DOI 10.1111/j.1365-246X.2011.05254.x; Dasgupta R, 2013, NATURE, V493, P211, DOI 10.1038/nature11731; French S, 2013, SCIENCE, V342, P227, DOI 10.1126/science.1241514; HAGER BH, 1978, TECTONOPHYSICS, V50, P111, DOI 10.1016/0040-1951(78)90130-0; Hoink T, 2012, GEOPHYS J INT, V191, P30, DOI 10.1111/j.1365-246X.2012.05621.x; Julian B. R, 2014, AM GEOPHYSICAL UNION; Li L, 2013, PHYS EARTH PLANET IN, V222, P1, DOI 10.1016/j.pepi.2013.06.009; Moore WB, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004778; Ritsema J, 2009, EARTH PLANET SC LETT, V277, P244, DOI 10.1016/j.epsl.2008.10.024; Samuel H, 2014, NAT GEOSCI, V7, P603, DOI 10.1038/NGEO2208; Zhang N, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006896	15	10	10	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1184	1185		10.1126/science.1261831	http://dx.doi.org/10.1126/science.1261831			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477443				2022-12-28	WOS:000346189000043
J	Muoio, DM				Muoio, Deborah M.			Metabolic Inflexibility: When Mitochondrial Indecision Leads to Metabolic Gridlock	CELL			English	Review							FATTY-ACID OXIDATION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; LYSINE ACETYLATION; INDUCED OBESITY; GLUCOSE; PROTEINS; FLEXIBILITY; MECHANISMS; EXERCISE	Normal energy metabolism is characterized by periodic shifts in glucose and fat oxidation, as the mitochondrial machinery responsible for carbon combustion switches freely between alternative fuels according to physiological and nutritional circumstances. These transitions in fuel choice are orchestrated by an intricate network of metabolic and cell signaling events that enable exquisite crosstalk and cooperation between competing substrates to maintain energy and glucose homeo-stasis. By contrast, obesity-related cardiometabolic diseases are increasingly recognized as disorders of metabolic inflexibility, in which nutrient overload and heightened substrate competition result in mitochondrial indecision, impaired fuel switching, and energy dysregulation. This Perspective offers a speculative view on the molecular origins and pathophysiological consequences of metabolic inflexibility.	Duke Univ, Med Ctr, Duke Mol Physiol Inst, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Duke University	Muoio, DM (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA.	muoio@duke.edu	Muoio, Debbie Marie/E-1147-2012	Muoio, Deborah/0000-0003-3760-9277	United States Public Health Service [R01DK089312, P01DK058398, R01HL101189]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089312, P01DK058398] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The author is supported by grants from the United States Public Health Service: R01DK089312, P01DK058398, and R01HL101189.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Asterholm IW, 2012, J LIPID RES, V53, P1254, DOI 10.1194/jlr.M021725; Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; Bergouignan A, 2013, J APPL PHYSIOL, V114, P371, DOI 10.1152/japplphysiol.00458.2012; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Chambers Kari T, 2011, J Biol Chem, V286, P11155, DOI 10.1074/jbc.M110.217349; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; de Azevedo FR, 2013, REV ASSOC MED BRAS, V59, P167, DOI [10.1016/j.ramb.2012.09.003, 10.1016/S2255-4823(13)70451-X]; Di Sarra D, 2013, J CLIN ENDOCR METAB, V98, P2581, DOI 10.1210/jc.2013-1161; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Fisher-Wellman KH, 2013, FREE RADICAL BIO MED, V65, P1201, DOI 10.1016/j.freeradbiomed.2013.09.008; Frohnert BI, 2013, ADV NUTR, V4, P157, DOI 10.3945/an.112.003319; Fuse Yuta, 2012, J Circadian Rhythms, V10, P4, DOI 10.1186/1740-3391-10-4; Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782; Ghanta S, 2013, CRIT REV BIOCHEM MOL, V48, P561, DOI 10.3109/10409238.2013.838204; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hu T, 2012, AM J EPIDEMIOL, V176, pS44, DOI 10.1093/aje/kws264; Jans A, 2011, OBESITY, V19, P2158, DOI 10.1038/oby.2011.149; Jessen N, 2005, J APPL PHYSIOL, V99, P330, DOI 10.1152/japplphysiol.00175.2005; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2013, J LIPID RES, V54, P522, DOI 10.1194/jlr.P028910; Lee S., 2014, PEDIAT DIABETES; Li LO, 2014, DIABETES; Lindeboom L, 2014, J CLIN INVEST, V124, P4915, DOI 10.1172/JCI74830; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Prior SJ, 2014, OBESITY, V22, P451, DOI 10.1002/oby.20609; Ramsay Rona R., 2004, Molecular Aspects of Medicine, V25, P475, DOI 10.1016/j.mam.2004.06.002; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Shimomura Y, 2001, CURR OPIN CLIN NUTR, V4, P419, DOI 10.1097/00075197-200109000-00013; Sparks LM, 2009, DIABETES RES CLIN PR, V83, P32, DOI 10.1016/j.diabres.2008.09.052; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Thyfault JP, 2008, AM J PHYSIOL-REG I, V294, pR1103, DOI [10.1152/ajpregu.00542.2007, 10.1152/ajpregu.00924.2007]; Trepanowski JF, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-107; Turer AT, 2010, CURR OPIN CLIN NUTR, V13, P458, DOI 10.1097/MCO.0b013e32833a55a5; Ukropcova B, 2007, DIABETES, V56, P720, DOI 10.2337/db06-0521; Vadvalkar SS, 2013, BIOCHEM J, V449, P253, DOI 10.1042/BJ20121038; van Dijk JW, 2013, DIABETES CARE, V36, P3448, DOI 10.2337/dc12-2620; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wasserman DH, 2011, J EXP BIOL, V214, P254, DOI 10.1242/jeb.048041	53	208	210	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1253	1262		10.1016/j.cell.2014.11.034	http://dx.doi.org/10.1016/j.cell.2014.11.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480291	Bronze, Green Accepted			2022-12-28	WOS:000346652900006
J	Lutz, W; Muttarak, R; Striessnig, E				Lutz, Wolfgang; Muttarak, Raya; Striessnig, Erich			Universal education is key to enhanced climate adaptation	SCIENCE			English	Editorial Material									[Lutz, Wolfgang; Muttarak, Raya; Striessnig, Erich] WU, VID OAW, Wittgenstein Ctr Demog & Global Human Capital IIA, Vienna, Austria		Striessnig, E (corresponding author), WU, VID OAW, Wittgenstein Ctr Demog & Global Human Capital IIA, Vienna, Austria.	striess@iiasa.ac.at		Lutz, Wolfgang/0000-0001-7975-8145; Striessnig, Erich/0000-0001-5419-9498; Muttarak, Raya/0000-0003-0627-4451				Baker DP, 2012, DEV COGN NEUROS-NETH, V2, pS6, DOI 10.1016/j.dcn.2011.12.001; Center for Research on the Epidemiology of Disasters (CRED), 2010, EM DAT; Frankenberg E, 2013, ECOL SOC, V18, DOI 10.5751/ES-05377-180216; Helgeson JF, 2013, ECOL SOC, V18, DOI 10.5751/ES-05390-180202; Keyfitz N, 1985, APPL MATH DEMOGRAPHY; Lutz W, 2008, SCIENCE, V319, P1047, DOI 10.1126/science.1151753; Muttarak R, 2014, ECOL SOC, V19, DOI 10.5751/ES-06476-190142; Muttarak R, 2013, ECOL SOC, V18, DOI 10.5751/ES-06101-180451; Nakhooda S., 2013, MOBILISING INT CLIMA; Nakicenovic N, 2014, CLIMATIC CHANGE, V122, P351, DOI 10.1007/s10584-013-0982-2; Niederdeppe J, 2007, CANCER EPIDEM BIOMAR, V16, P998, DOI 10.1158/1055-9965.EPI-06-0608; O'Neill BC, 2014, CLIMATIC CHANGE, V122, P387, DOI 10.1007/s10584-013-0905-2; Pamuk ER, 2011, POPUL DEV REV, V37, P637, DOI 10.1111/j.1728-4457.2011.00451.x; Samir KC, 2017, GLOBAL ENVIRON CHANG, V42, P181, DOI 10.1016/j.gloenvcha.2014.06.004; Walker B., 2006, RESILIENCE THINKING	15	83	83	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1061	1062		10.1126/science.1257975	http://dx.doi.org/10.1126/science.1257975			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU7EK	25430758				2022-12-28	WOS:000345763400024
J	Elvis, M				Elvis, Martin			ASTRONOMY Cosmic triangles and black-hole masses	NATURE			English	Editorial Material									Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Elvis, M (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	melvis@cfa.harvard.edu						Buscher DF, 2013, J ASTRON INSTRUM, V2, DOI 10.1142/S2251171713400011; Elvis M, 2002, ASTROPHYS J, V581, pL67, DOI 10.1086/346015; Honig SF, 2014, NATURE, V515, P528, DOI 10.1038/nature13914; Onken CA, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/37; Pedretti E, 2009, NEW ASTRON REV, V53, P353, DOI 10.1016/j.newar.2010.07.008; Peterson B. M., 2011, BLACK HOLES, P100; Suganuma M, 2006, ASTROPHYS J, V639, P46, DOI 10.1086/499326	7	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					498	499		10.1038/515498a	http://dx.doi.org/10.1038/515498a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25428496				2022-12-28	WOS:000346247600039
J	Stefanov-Kiuri, S; Fernandez-Heredero, A				Stefanov-Kiuri, Stefan; Fernandez-Heredero, Alvaro			Parkes Weber Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Stefanov-Kiuri, Stefan; Fernandez-Heredero, Alvaro] Hosp Univ La Paz, Madrid, Spain	Hospital Universitario La Paz	Stefanov-Kiuri, S (corresponding author), Hosp Univ La Paz, Madrid, Spain.	stefanovkiuri@hotmail.com							0	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2114	2114		10.1056/NEJMicm1312948	http://dx.doi.org/10.1056/NEJMicm1312948			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25427114				2022-12-28	WOS:000345580000011
J	Lane, R				Lane, Richard			Tina Musuya: leading the fight on gender-based violence in Uganda	LANCET			English	Biographical-Item																			0	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1501	1501		10.1016/S0140-6736(14)62015-8	http://dx.doi.org/10.1016/S0140-6736(14)62015-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG3ZT	25467584				2022-12-28	WOS:000353220000016
J	Nallamothu, BK; Normand, SLT; Wang, YF; Hofer, TP; Brush, JE; Messenger, JC; Bradley, EH; Rumsfeld, JS; Krumholz, HM				Nallamothu, Brahmajee K.; Normand, Sharon-Lise T.; Wang, Yongfei; Hofer, Timothy P.; Brush, John E., Jr.; Messenger, John C.; Bradley, Elizabeth H.; Rumsfeld, John S.; Krumholz, Harlan M.			Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR DATA REGISTRY; ST-ELEVATION; CARDIAC-CATHETERIZATION; PERFORMANCE-MEASURES; PRIMARY ANGIOPLASTY; PRIMARY PCI; REPERFUSION; OUTCOMES; TRENDS	Background Recent reductions in average door-to-balloon (D2B) times have not been associated with decreases in mortality at the population level. We investigated this seemingly paradoxical finding by assessing components of this association at the individual and population levels simultaneously. We postulated that the changing population of patients undergoing primary percutaneous coronary intervention (pPCI) contributed to secular trends toward an increasing mortality risk, despite consistently decreased mortality in individual patients with shorter D2B times. Methods This was a retrospective study of ST-elevation myocardial infarction (STEMI) patients who underwent pPCI between Jan 1, 2005, and Dec 31, 2011, in the National Cardiovascular Data Registry (NCDR) CathPCI Registry. We looked for catheterisation laboratory visits associated with STEMI. We excluded patients not undergoing pPCI, transfer patients for pPCI, patients with D2B times less than 15 min or more than 3 h, and patients at hospitals that did not consistently report data across the study period. We assessed in-hospital mortality in the entire cohort and 6-month mortality in elderly patients aged 65 years or older matched to data from the Centers for Medicare and Medicaid Services. We built multilevel models to assess the relation between D2B time and in-hospital and 6-month mortality, including both individual and population-level components of this association after adjusting for patient and procedural factors. Findings 423 hospitals reported data on 150 116 procedures with a 55% increase in the number of patients undergoing pPCI at these facilities over time, as well as many changes in patient and procedural factors. Annual D2B times decreased significantly from a median of 86 min (IQR 65-109) in 2005 to 63 min (IQR 47-80) in 2011 (p<0.0001) with a concurrent rise in risk-adjusted in-hospital mortality (from 4.7% to 5.3%; p=0.06) and risk-adjusted 6-month mortality (from 12.9% to 14.4%; p=0.001). In multilevel models, shorter patient-specific D2B times were consistently associated at the individual level with lower in-hospital mortality (adjusted OR for each 10 min decrease 0.92; 95% CI 0.91-0.93; p<0.0001) and 6-month mortality (adjusted OR for each 10 min decrease, 0.94; 95% CI 0.93-0.95; p<0.0001). By contrast, risk-adjusted in-hospital and 6-month mortality at the population level, independent of patient-specific D2B times, rose in the growing and changing population of patients undergoing pPCI during the study period. Interpretation Shorter patient-specific D2B times were consistently associated with lower mortality over time, whereas secular trends suggest increased mortality risk in the growing and changing pPCI population. The absence of association of annual D2B time and changes in mortality at the population level should not be interpreted as an indication of its individual-level relation in patients with STEMI undergoing primary PCI.	[Nallamothu, Brahmajee K.; Hofer, Timothy P.] Univ Michigan, Sch Med, Ann Arbor VA Med Ctr, Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.; Hofer, Timothy P.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Wang, Yongfei] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Wang, Yongfei] Yale New Haven Med Ctr, Ctr Outcome Res & Evaluat, New Haven, CT 06504 USA; [Brush, John E., Jr.] Eastern Virginia Med Sch, Div Cardiol, Norfolk, VA 23501 USA; [Brush, John E., Jr.] Sentara Cardiovasc Res Inst, Norfolk, VA USA; [Messenger, John C.; Rumsfeld, John S.] Univ Colorado, Dept Med, Aurora, CO USA; [Bradley, Elizabeth H.; Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med & Robert Wood Johnson Fdn, Dept Internal Med,Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Yale University; Yale University; Eastern Virginia Medical School; Sentara Healthcare; University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University; Yale University; Yale University	Nallamothu, BK (corresponding author), Univ Michigan, Ctr Cardiovasc, SPC 5869, Ann Arbor, MI 48109 USA.	bnallamo@umich.edu	, Harlan/AAI-2875-2020; Hofer, Timothy Philip/AAC-9238-2022	Hofer, Timothy/0000-0003-0434-8787; Normand, Sharon-Lise/0000-0001-7027-4769	National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.	Antoniucci D, 2002, AM J CARDIOL, V89, P1248, DOI 10.1016/S0002-9149(02)02320-2; Bates ER, 2013, NEW ENGL J MED, V369, P889, DOI 10.1056/NEJMp1308772; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Boulton G, 2011, LANCET, V377, P1633, DOI 10.1016/S0140-6736(11)60647-8; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Brennan JM, 2012, CIRC-CARDIOVASC QUAL, V5, P134, DOI 10.1161/CIRCOUTCOMES.111.963280; Brodie BR, 2006, J AM COLL CARDIOL, V47, P289, DOI 10.1016/j.jacc.2005.08.065; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brodie BR, 2003, AM HEART J, V145, P708, DOI 10.1067/mhj.2003.9; Byrne RA, 2013, NEW ENGL J MED, V369, P1649, DOI 10.1056/NEJMe1310361; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; CHRISTIAN TF, 1992, CIRCULATION, V86, P81, DOI 10.1161/01.CIR.86.1.81; Dehmer GJ, 2012, J AM COLL CARDIOL, V60, P2017, DOI 10.1016/j.jacc.2012.08.966; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Finney JW, 2011, AM J PUBLIC HEALTH, V101, P1635, DOI 10.2105/AJPH.2011.300153; Flynn A, 2010, ARCH INTERN MED, V170, P1842, DOI 10.1001/archinternmed.2010.381; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Jauhar S, 2014, NEW YORK TIMES  0320; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Krumholz HM, 2008, J AM COLL CARDIOL, V52, P2046, DOI 10.1016/j.jacc.2008.10.012; Levine GN, 2011, CIRCULATION, V124, P2574, DOI 10.1161/CIR.0b013e31823a5596; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Mehta SR, 2013, NEW ENGL J MED, V369, P2263, DOI 10.1056/NEJMe1312702; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Nallamothu BK, 2007, NEW ENGL J MED, V357, P1631, DOI 10.1056/NEJMra065985; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; REIMER KA, 1993, AM J CARDIOL, V72, pG13, DOI 10.1016/0002-9149(93)90102-I; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Ross JS, 2013, JAMA-J AM MED ASSOC, V309, P1355, DOI 10.1001/jama.2013.1299; Szabo L, 2013, USATODAYCOM     0409; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Wang TY, 2009, ARCH INTERN MED, V169, P1411, DOI 10.1001/archinternmed.2009.223; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	37	206	215	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1114	1122		10.1016/S0140-6736(14)61932-2	http://dx.doi.org/10.1016/S0140-6736(14)61932-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25467573	Green Accepted			2022-12-28	WOS:000351270400029
J	Perkins, GD; Lall, R; Quinn, T; Deakin, CD; Cooke, MW; Horton, J; Lamb, SE; Slowther, AM; Woollard, M; Carson, A; Smyth, M; Whitfield, R; Williams, A; Pocock, H; Black, JJM; Wright, J; Han, K; Gates, S				Perkins, Gavin D.; Lall, Ranjit; Quinn, Tom; Deakin, Charles D.; Cooke, Matthew W.; Horton, Jessica; Lamb, Sarah E.; Slowther, Anne-Marie; Woollard, Malcolm; Carson, Andy; Smyth, Mike; Whitfield, Richard; Williams, Amanda; Pocock, Helen; Black, John J. M.; Wright, John; Han, Kyee; Gates, Simon		PARAMEDIC Trial Collaborators	Mechanical versus manual chest compression for out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised controlled trial	LANCET			English	Article							EUROPEAN RESUSCITATION COUNCIL; CARDIOPULMONARY-RESUSCITATION; SURVIVAL; DEVICE; NONCOMPLIANCE; GUIDELINES; CPR	Background Mechanical chest compression devices have the potential to help maintain high-quality cardiopulmonary resuscitation (CPR), but despite their increasing use, little evidence exists for their effectiveness. We aimed to study whether the introduction of LUCAS-2 mechanical CPR into front-line emergency response vehicles would improve survival from out-of-hospital cardiac arrest. Methods The pre-hospital randomised assessment of a mechanical compression device in cardiac arrest (PARAMEDIC) trial was a pragmatic, cluster-randomised open-label trial including adults with non-traumatic, out-of-hospital cardiac arrest from four UK Ambulance Services (West Midlands, North East England, Wales, South Central). 91 urban and semi-urban ambulance stations were selected for participation. Clusters were ambulance service vehicles, which were randomly assigned (1: 2) to LUCAS-2 or manual CPR. Patients received LUCAS-2 mechanical chest compression or manual chest compressions according to the first trial vehicle to arrive on scene. The primary outcome was survival at 30 days following cardiac arrest and was analysed by intention to treat. Ambulance dispatch staff and those collecting the primary outcome were masked to treatment allocation. Masking of the ambulance staff who delivered the interventions and reported initial response to treatment was not possible. The study is registered with Current Controlled Trials, number ISRCTN08233942. Findings We enrolled 4471 eligible patients (1652 assigned to the LUCAS-2 group, 2819 assigned to the control group) between April 15, 2010 and June 10, 2013. 985 (60%) patients in the LUCAS-2 group received mechanical chest compression, and 11 (<1%) patients in the control group received LUCAS-2. In the intention-to-treat analysis, 30 day survival was similar in the LUCAS-2 group (104 [6%] of 1652 patients) and in the manual CPR group (193 [7%] of 2819 patients; adjusted odds ratio [OR] 0 . 86, 95% CI 0 . 64-1 . 15). No serious adverse events were noted. Seven clinical adverse events were reported in the LUCAS-2 group (three patients with chest bruising, two with chest lacerations, and two with blood in mouth). 15 device incidents occurred during operational use. No adverse or serious adverse events were reported in the manual group. Interpretation We noted no evidence of improvement in 30 day survival with LUCAS-2 compared with manual compressions. On the basis of ours and other recent randomised trials, widespread adoption of mechanical CPR devices for routine use does not improve survival.	[Perkins, Gavin D.; Lall, Ranjit; Cooke, Matthew W.; Horton, Jessica; Lamb, Sarah E.; Slowther, Anne-Marie; Smyth, Mike] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Perkins, Gavin D.] Heart England NHS Fdn Trust, Birmingham, W Midlands, England; [Quinn, Tom; Deakin, Charles D.; Woollard, Malcolm] Univ Surrey, Fac Hlth & Med Sci, Surrey Peri Operat Anaesthesia Crit Care Collabor, Res Grp, Guildford GU2 5XH, Surrey, England; [Deakin, Charles D.; Pocock, Helen; Black, John J. M.] NHS Fdn Trust, South Cent Ambulance Serv, Otterbourne, England; [Deakin, Charles D.] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Resp Biomed Res Unit, Southampton, Hants, England; [Lamb, Sarah E.] Univ Oxford, Oxford, England; [Carson, Andy; Smyth, Mike] NHS Fdn Trust, West Midlands Ambulance Serv, Brierley Hill, England; [Whitfield, Richard; Williams, Amanda] Welsh Ambulance Serv NHS Trust, St Asaph, Denbighshire, Wales; [Wright, John; Han, Kyee] NHS Fdn Trust, North East Ambulance Serv, Newcastle Upon Tyne, Tyne & Wear, England; [Wright, John] Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England	University of Warwick; Heart of England NHS Foundation Trust; University of Surrey; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Oxford; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Perkins, GD (corresponding author), Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England.	g.d.perkins@warwick.ac.uk	Perkins, Gavin/E-7613-2010	Quinn, Tom/0000-0002-5116-0034; McClelland, Graham/0000-0002-4502-5821; Pocock, Helen/0000-0001-7648-5313; Lall, Ranjit/0000-0003-1737-2866; Blair, Laura/0000-0001-9846-9429; Perkins, Gavin/0000-0003-3027-7548; Lamb, Sarah/0000-0003-4349-7195; Hulme, Claire/0000-0003-2077-0419	National Institute for Health Research's (NIHR) Health Technology Assessment Programme [HTA-07/37/69]; Director of Research for the Intensive Care Foundation; National Institute for Health Research [07/37/69] Funding Source: researchfish	National Institute for Health Research's (NIHR) Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Director of Research for the Intensive Care Foundation; National Institute for Health Research(National Institute for Health Research (NIHR))	This is a summary of independent research funded by the National Institute for Health Research's (NIHR) Health Technology Assessment Programme (Grant Reference Number HTA-07/37/69). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. GDP is supported as a Director of Research for the Intensive Care Foundation. We thank the independent members of the Trial Steering Committee (Jon Nicholl, Helen Snooks, Fionna Moore, Alasdair Gray, Martyn Box, Father Neil Bayliss, and John Long) and the Data Monitoring Committee (Marion Campbell, Jerry Nolan, and Kathy Rowan).	Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Brooks SC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007260.pub3; Christenson J, 2009, CIRCULATION, V120, P1241, DOI 10.1161/CIRCULATIONAHA.109.852202; Deakin CD, 2009, EMERG MED J, V26, P888, DOI 10.1136/emj.2008.064642; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; Dunn G, 2003, BRIT J PSYCHIAT, V183, P323, DOI 10.1192/bjp.183.4.323; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hallstrom A, 2006, JAMA-J AM MED ASSOC, V295, P2620, DOI 10.1001/jama.295.22.2620; Hewitt CE, 2006, CAN MED ASSOC J, V175, P347, DOI 10.1503/cmaj.051625; Idris AH, 2012, CIRCULATION, V125, P3004, DOI 10.1161/CIRCULATIONAHA.111.059535; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Koster RW, 2010, RESUSCITATION, V81, P1277, DOI 10.1016/j.resuscitation.2010.08.009; Krarup NH, 2011, RESUSCITATION, V82, P263, DOI 10.1016/j.resuscitation.2010.11.003; Nolan JP, 2010, RESUSCITATION, V81, pE1, DOI 10.1016/j.resuscitation.2010.08.002; Ong MEH, 2010, ANN EMERG MED, V56, P233, DOI 10.1016/j.annemergmed.2010.01.004; Perkins GD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2435; Perkins GD, 2012, EMERG MED J, V29, P3, DOI 10.1136/emermed-2011-200758; Perkins GD, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-58; Rubertsson S, 2014, JAMA-J AM MED ASSOC, V311, P53, DOI 10.1001/jama.2013.282538; Smekal D, 2011, RESUSCITATION, V82, P702, DOI 10.1016/j.resuscitation.2011.01.032; Stiell IG, 2011, NEW ENGL J MED, V365, P787, DOI 10.1056/NEJMoa1010076; Vadeboncoeur T, 2014, RESUSCITATION, V85, P182, DOI 10.1016/j.resuscitation.2013.10.002; Wang HE, 2012, RESUSCITATION, V83, P1343, DOI 10.1016/j.resuscitation.2012.07.013; Wik L, 2014, RESUSCITATION, V85, P741, DOI 10.1016/j.resuscitation.2014.03.005; Yeung J, 2009, RESUSCITATION, V80, P743, DOI 10.1016/j.resuscitation.2009.04.012; Zuercher M, 2010, CRIT CARE MED, V38, P1141, DOI 10.1097/CCM.0b013e3181ce1fe2	26	271	291	2	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					947	955		10.1016/S0140-6736(14)61886-9	http://dx.doi.org/10.1016/S0140-6736(14)61886-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD2EK	25467566	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000350886900029
J	Althabe, F; Belizan, JM; McClure, EM; Hemingway-Foday, J; Berrueta, M; Mazzoni, A; Ciganda, A; Goudar, SS; Kodkany, BS; Mahantshetti, NS; Dhaded, SM; Katageri, GM; Metgud, MC; Joshi, AM; Bellad, MB; Honnungar, NV; Derman, RJ; Saleem, S; Pasha, O; Ali, S; Hasnain, F; Goldenberg, RL; Esamai, F; Nyongesa, P; Ayunga, S; Liechty, EA; Garces, AL; Figueroa, L; Hambidge, KM; Krebs, NF; Patel, A; Bhandarkar, A; Waikar, M; Hibberd, PL; Chomba, E; Carlo, WA; Mwiche, A; Chiwila, M; Manasyan, A; Pineda, S; Meleth, S; Thorsten, V; Stolka, K; Wallace, DD; Koso-Thomas, M; Jobe, AH; Buekens, PM				Althabe, Fernando; Belizan, Jose M.; McClure, Elizabeth M.; Hemingway-Foday, Jennifer; Berrueta, Mabel; Mazzoni, Agustina; Ciganda, Alvaro; Goudar, Shivaprasad S.; Kodkany, Bhalachandra S.; Mahantshetti, Niranjana S.; Dhaded, Sangappa M.; Katageri, Geetanjali M.; Metgud, Mrityunjay C.; Joshi, Anjali M.; Bellad, Mrutyunjaya B.; Honnungar, Narayan V.; Derman, Richard J.; Saleem, Sarah; Pasha, Omrana; Ali, Sumera; Hasnain, Farid; Goldenberg, Robert L.; Esamai, Fabian; Nyongesa, Paul; Ayunga, Silas; Liechty, Edward A.; Garces, Ana L.; Figueroa, Lester; Hambidge, K. Michael; Krebs, Nancy F.; Patel, Archana; Bhandarkar, Anjali; Waikar, Manjushri; Hibberd, Patricia L.; Chomba, Elwyn; Carlo, Waldemar A.; Mwiche, Angel; Chiwila, Melody; Manasyan, Albert; Pineda, Sayury; Meleth, Sreelatha; Thorsten, Vanessa; Stolka, Kristen; Wallace, Dennis D.; Koso-Thomas, Marion; Jobe, Alan H.; Buekens, Pierre M.			A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial	LANCET			English	Article							GESTATIONAL-AGE; NEWBORN BABIES; SCALE-UP; INTERVENTIONS; ATTENDANTS; EXTENSION; INFANTS; DEATHS; RISK	Background Antenatal corticosteroids for pregnant women at risk of preterm birth are among the most effective hospital-based interventions to reduce neonatal mortality. We aimed to assess the feasibility, effectiveness, and safety of a multifaceted intervention designed to increase the use of antenatal corticosteroids at all levels of health care in low-income and middle-income countries. Methods In this 18-month, cluster-randomised trial, we randomly assigned (1:1) rural and semi-urban clusters within six countries (Argentina, Guatemala, India, Kenya, Pakistan, and Zambia) to standard care or a multifaceted intervention including components to improve identification of women at risk of preterm birth and to facilitate appropriate use of antenatal corticosteroids. The primary outcome was 28-day neonatal mortality among infants less than the 5th percentile for birthweight (a proxy for preterm birth) across the clusters. Use of antenatal corticosteroids and suspected maternal infection were additional main outcomes. This trial is registered with ClinicalTrials.gov, number NCT01084096. Findings The ACT trial took place between October, 2011, and March, 2014 (start dates varied by site). 51 intervention clusters with 47 394 livebirths (2520 [5%] less than 5th percentile for birthweight) and 50 control clusters with 50 743 livebirths (2258 [4%] less than 5th percentile) completed follow-up. 1052 (45%) of 2327 women in intervention clusters who delivered less-than-5th-percentile infants received antenatal corticosteroids, compared with 215 (10%) of 2062 in control clusters (p<0.0001). Among the less-than-5th-percentile infants, 28-day neonatal mortality was 225 per 1000 livebirths for the intervention group and 232 per 1000 livebirths for the control group (relative risk [RR] 0.96, 95% CI 0.87-1.06, p=0.65)and suspected maternal infection was reported in 236 (10%) of 2361 women in the intervention group and 133 (6%) of 2094 in the control group (odds ratio [OR] 1.67, 1.33-2.09, p<0.0001). Among the whole population, 28-day neonatal mortality was 27.4 per 1000 livebirths for the intervention group and 23.9 per 1000 livebirths for the control group (RR 1.12, 1.02-1.22, p=0.0127) and suspected maternal infection was reported in 1207 (3%) of 48 219 women in the intervention group and 867 (2%) of 51 523 in the control group (OR 1.45, 1.33-1.58, p<0.0001). Interpretation Despite increased use of antenatal corticosteroids in low-birthweight infants in the intervention groups, neonatal mortality did not decrease in this group, and increased in the population overall. For every 1000 women exposed to this strategy, an excess of 3.5 neonatal deaths occurred, and the risk of maternal infection seems to have been increased.	[Althabe, Fernando; Belizan, Jose M.; Berrueta, Mabel; Mazzoni, Agustina; Ciganda, Alvaro] Inst Clin Effectiveness & Hlth Policy IECS, Buenos Aires, DF, Argentina; [Ciganda, Alvaro] UNICEM, Montevideo, Uruguay; [McClure, Elizabeth M.; Hemingway-Foday, Jennifer; Meleth, Sreelatha; Thorsten, Vanessa; Stolka, Kristen; Wallace, Dennis D.] RTI Int, Durham, NC USA; [Goudar, Shivaprasad S.; Kodkany, Bhalachandra S.; Mahantshetti, Niranjana S.; Dhaded, Sangappa M.; Metgud, Mrityunjay C.; Joshi, Anjali M.; Bellad, Mrutyunjaya B.; Honnungar, Narayan V.] KLE Univ, Jawaharlal Nehru Med Coll, Womens & Childrens Hlth Res Unit, Belgaum, Karnataka, India; [Katageri, Geetanjali M.] S Nijalingappa Med Coll, Bagalkot, Karnataka, India; [Derman, Richard J.] Christiana Care Hlth Syst, Dept Obstet & Gynecol, Newark, DE USA; [Saleem, Sarah; Hasnain, Farid] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Goldenberg, Robert L.] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA; [Esamai, Fabian; Nyongesa, Paul; Ayunga, Silas] Moi Univ, Sch Med, Eldoret, Kenya; [Liechty, Edward A.] Indiana Univ Sch Med, Indianapolis, IN USA; [Garces, Ana L.; Figueroa, Lester; Pineda, Sayury] Fdn Alimentac Nutr, Ctr Amer & Panama, Guatemala City, Guatemala; [Garces, Ana L.] Francisco Marroquin Univ, Guatemala City, Guatemala; [Hambidge, K. Michael; Krebs, Nancy F.] Univ Colorado, Sch Med, Denver, CO USA; [Patel, Archana; Bhandarkar, Anjali; Waikar, Manjushri] Lata Med Res Fdn, Nagpur, Maharashtra, India; [Patel, Archana] Indira Gandhi Govt Med Coll, Nagpur, Maharashtra, India; [Hibberd, Patricia L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Chomba, Elwyn; Mwiche, Angel] Univ Teaching Hosp, Lusaka, Zambia; [Carlo, Waldemar A.; Manasyan, Albert] Univ Alabama Birmingham, Birmingham, AL USA; [Chiwila, Melody] Ctr Infect Dis Zambia, Lusaka, Zambia; [Koso-Thomas, Marion] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Jobe, Alan H.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Buekens, Pierre M.] Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA	Research Triangle Institute; K.L.E. Academy of Higher Education & Research; Jawaharlal Nehru Medical College, Belgaum; Christiana Care Health System; Aga Khan University; Columbia University; Moi University; Indiana University System; Indiana University Bloomington; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Harvard University; Massachusetts General Hospital; University of Zambia; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cincinnati Children's Hospital Medical Center; Tulane University	Althabe, F (corresponding author), Inst Clin Effectiveness & Hlth Policy IECS, C1414CPV, Buenos Aires, DF, Argentina.	falthabe@iecs.org.ar	Wallace, Dennis/AAR-7005-2021; Bellad, Mrutyunjaya/R-6494-2019; Figueroa, Lester/GYD-4468-2022; GOUDAR, SHIVAPRASAD S/S-1217-2019; Liechty, Edward A/AGN-4710-2022; Hemingway-Foday, Jennifer/HHN-4777-2022; Metgud, Mrityunjay/R-6612-2019; ESAMAI, FABIAN/AAI-3268-2020	Bellad, Mrutyunjaya/0000-0003-0460-1439; Figueroa, Lester/0000-0003-1732-0361; GOUDAR, SHIVAPRASAD S/0000-0002-8680-7053; Metgud, Mrityunjay/0000-0002-0844-8569; Derman, Richard/0000-0003-1148-1594; Stolka, Kristen/0000-0002-9029-0288; Thorsten, Vanessa/0000-0003-4430-1473; Katageri, Geetanjali/0000-0001-6893-1504; McClure, Elizabeth/0000-0001-8659-5444; Hibberd, Patricia/0000-0002-7455-8117; Manasyan, Albert/0000-0001-6275-245X; Hemingway-Foday, Jennifer/0000-0001-9776-5306; Pasha, Omrana/0000-0003-4046-3918; Dhaded, Sangappa/0000-0001-9575-5251; Belizan, Jose/0000-0002-8412-3010	Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD076461, U10HD078439, U10HD076474, U01HD040657, U01HD058326, U10HD078437, U01HD043464, U10HD076457, U01HD058322, U01HD040636, U01HD040607, U01HD040477, U01HD042372] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009083] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT003683] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Riganti AA, 2010, INT J GYNECOL OBSTET, V108, P52, DOI 10.1016/j.ijgo.2009.08.022; Althabe F, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-22; Azad K, 2014, LANCET GLOB HEALTH, V2, pE191, DOI 10.1016/S2214-109X(14)70020-8; Belizan JM, 2012, AM J PERINAT, V29, P649, DOI 10.1055/s-0032-1314885; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Darmstadt GL, 2014, LANCET, V384, P174, DOI 10.1016/S0140-6736(14)60458-X; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Porto AMF, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1696; Gail MH, 1996, STAT MED, V15, P1069, DOI 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.3.CO;2-H; Garces A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-34; Goudar SS, 2012, INT J GYNECOL OBSTET, V118, P190, DOI 10.1016/j.ijgo.2012.04.022; Hofmeyr GJ, 2009, ANTENATAL CORTICOSTE; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jehan I, 2010, INT J GYNECOL OBSTET, V110, P231, DOI 10.1016/j.ijgo.2010.03.030; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McClure EM, 2011, INT J GYNECOL OBSTET, V115, P215, DOI 10.1016/j.ijgo.2011.07.017; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Myles TD, 2011, OBSTET GYNECOL, V117, P429, DOI 10.1097/AOG.0b013e31820711f0; National Institutes of Health, 1994, CONS DEV C STAT FEB; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Onland W, 2011, AM J PERINAT, V28, P33, DOI 10.1055/s-0030-1262509; Pasha O, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-82; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Silva L K, 1999, Cad Saude Publica, V15, P817, DOI 10.1590/S0102-311X1999000400016; UN Commission on Life-Saving Commodities for Women and Children, 2012, COMM REP SEPT 2012; Vargas-Origel A, 2000, Ginecol Obstet Mex, V68, P291; Vermillion ST, 2000, AM J OBSTET GYNECOL, V183, P810, DOI 10.1067/mob.2000.108838; Weijer C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001346; WHO Department of Reproductive Health and Research, 2003, INT MAN PREGN CHILDB; WHO Expert Committee, 2013, SEL US ESS MED REP W; World Health Organization (WHO), 2003, INT MAN PREGN CHILDB	37	188	195	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					629	639		10.1016/S0140-6736(14)61651-2	http://dx.doi.org/10.1016/S0140-6736(14)61651-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AZ	25458726	Green Accepted			2022-12-28	WOS:000349214000031
J	Banerjee, S				Banerjee, Sube			Multimorbidity-older adults need health care that can count past one	LANCET			English	Editorial Material							DEMENTIA; COMORBIDITY; DEPRESSION; SERTRALINE; DISEASE		[Banerjee, Sube] Ctr Dementia Studies, Brighton, E Sussex, England; [Banerjee, Sube] Univ Sussex, Sussex Med Sch, Brighton BN1 9RY, E Sussex, England	University of Brighton; University of Sussex	Banerjee, S (corresponding author), Ctr Dementia Studies, Brighton, E Sussex, England.	s.banerjee@bsms.ac.uk		Banerjee, Sube/0000-0002-8083-7649				Alzheimer's Disease International, 2013, GLOB IMP DEM 2013 20; Banerjee S., 2009, USE ANTIPSYCHOTIC ME; Banerjee S, 2011, LANCET, V378, P403, DOI 10.1016/S0140-6736(11)60830-1; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; House of Commons Health Committee, 2011, WRITT EV BRIT GER SO; Imison C, 2012, OLDER PEOPLE EMERGEN; LARSON EB, 1984, ANN INTERN MED, V100, P417, DOI 10.7326/0003-4819-100-3-417; Mason B, 2014, BMJ SUPPORT PALLIAT; MCCORMICK WC, 1994, J AM GERIATR SOC, V42, P517, DOI 10.1111/j.1532-5415.1994.tb04974.x; Rosenberg PB, 2010, AM J GERIAT PSYCHIAT, V18, P136, DOI 10.1097/JGP.0b013e3181c796eb; Schubert CC, 2006, J AM GERIATR SOC, V54, P104, DOI 10.1111/j.1532-5415.2005.00543.x; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; United Nations, 2014, INTR PROP OP WORK GR; WHO, 2014, WHO STRAT PEOPL CTR; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; World Health Organization, 2014, MON PROGR UN HLTH CO	17	140	141	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					587	589		10.1016/S0140-6736(14)61596-8	http://dx.doi.org/10.1016/S0140-6736(14)61596-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AZ	25468155				2022-12-28	WOS:000349214000010
J	Rothwell, PM				Rothwell, Peter M.			Blood pressure in acute stroke: which questions remain?	LANCET			English	Editorial Material									Univ Oxford, John Radcliffe Hosp, Stroke Prevent Res Unit, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England	University of Oxford	Rothwell, PM (corresponding author), Univ Oxford, John Radcliffe Hosp, Stroke Prevent Res Unit, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	Wellcome Trust [095626] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Ankolekar S, 2013, STROKE, V44, P3120, DOI 10.1161/STROKEAHA.113.001301; CARLBERG B, 1991, STROKE, V22, P527, DOI 10.1161/01.STR.22.4.527; Fischer U, 2014, LANCET NEUROL, V13, P374, DOI 10.1016/S1474-4422(14)70031-6; He J, 2014, JAMA-J AM MED ASSOC, V311, P479, DOI 10.1001/jama.2013.282543; Manning L, 2014, LANCET NEUROL, V13, P364, DOI 10.1016/S1474-4422(14)70018-3; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Qureshi AI, 2008, CIRCULATION, V118, P176, DOI 10.1161/CIRCULATIONAHA.107.723874; Robinson TG, 2010, LANCET NEUROL, V9, P767, DOI 10.1016/S1474-4422(10)70163-0; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2003, STROKE, V34, P2583, DOI 10.1161/01.STR.0000094424.38761.56; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; The ENOS Trial Investigators, 2014, LANCET; Wang HJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085484, 10.1371/journal.pone.0097917]; Willmot M, 2004, HYPERTENSION, V43, P18, DOI 10.1161/01.HYP.0000105052.65787.35	15	8	8	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					582	585		10.1016/S0140-6736(14)61898-5	http://dx.doi.org/10.1016/S0140-6736(14)61898-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AZ	25465109	hybrid			2022-12-28	WOS:000349214000008
J	Efremov, RG; Leitner, A; Aebersold, R; Raunser, S				Efremov, Rouslan G.; Leitner, Alexander; Aebersold, Ruedi; Raunser, Stefan			Architecture and conformational switch mechanism of the ryanodine receptor	NATURE			English	Article							PROTEIN-STRUCTURE PREDICTION; CALCIUM-RELEASE CHANNEL; CROSS-LINKED PEPTIDES; SKELETAL-MUSCLE; TOPOLOGY; RESOLUTION; CALMODULIN; SYSTEM; MODEL; FORMS	Muscle contraction is initiated by the release of calcium (Ca2+) from the sarcoplasmic reticulum into the cytoplasm of myocytes through ryanodine receptors (RyRs). RyRs are homotetrameric channels with a molecular mass of more than 2.2 megadaltons that are regulated by several factors, including ions, small molecules and proteins. Numerous mutations in RyRs have been associated with human diseases. The molecular mechanism underlying the complex regulation of RyRs is poorly understood. Using electron cryomicroscopy, here we determine the architecture of rabbit RyR1 at a resolutionof 6.1 angstrom. We show that the cytoplasmic moiety of RyR1 contains two large alpha-solenoid domains and several smaller domains, with folds suggestive of participation in protein-protein interactions. The transmembrane domain represents a chimaera of voltage-gated sodium and pH-activated ion channels. We identify the calcium-binding EF-hand domain and show that it functions as a conformational switch allosterically gating the channel.	[Efremov, Rouslan G.; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany; [Efremov, Rouslan G.] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Efremov, Rouslan G.] VUB, Struct Biol Brussels, B-1050 Brussels, Belgium; [Leitner, Alexander; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Max Planck Society; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Efremov, RG (corresponding author), Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany.	rouslan.efremov@vib-vub.be; stefan.raunser@mpi-dortmund.mpg.de	Raunser, Stefan/AHE-1573-2022; Efremov, Rouslan/P-9085-2015; Leitner, Alexander/U-1601-2019	Efremov, Rouslan/0000-0001-7516-8658; Leitner, Alexander/0000-0003-4126-0725; Raunser, Stefan/0000-0001-9373-3016				Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AHERN GP, 1994, FEBS LETT, V352, P369, DOI 10.1016/0014-5793(94)01001-3; Baylor SM, 2003, J PHYSIOL-LONDON, V551, P125, DOI 10.1113/jphysiol.2003.041608; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON DG, 1984, J CELL BIOL, V99, P1735, DOI 10.1083/jcb.99.5.1735; Fessenden JD, 2004, J BIOL CHEM, V279, P53028, DOI 10.1074/jbc.M411136200; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Gulbis JM, 2004, CURR OPIN STRUC BIOL, V14, P440, DOI 10.1016/j.sbi.2004.06.008; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; HAWKES MJ, 1989, MEMBRANE BIOCHEM, V8, P133, DOI 10.3109/09687688909025827; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huang XJ, 2012, J BIOL CHEM, V287, P30328, DOI 10.1074/jbc.M112.383109; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kimlicka L, 2011, SCI CHINA LIFE SCI, V54, P712, DOI 10.1007/s11427-011-4198-2; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu Z, 2004, J MOL BIOL, V338, P533, DOI 10.1016/j.jmb.2004.03.011; Ludtke SJ, 2011, STRUCTURE, V19, P1192, DOI 10.1016/j.str.2011.05.003; Mackrill JJ, 2010, BIOCHEM PHARMACOL, V79, P1535, DOI 10.1016/j.bcp.2010.01.014; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Parys JB, 2012, ADV EXP MED BIOL, V740, P255, DOI 10.1007/978-94-007-2888-2_11; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Penczek PA, 2011, STRUCTURE, V19, P1582, DOI 10.1016/j.str.2011.10.003; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie G, 2012, BIOPOLYMERS, V97, P742, DOI 10.1002/bip.22074; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schwaller B, 2012, ADV EXP MED BIOL, V740, P1, DOI 10.1007/978-94-007-2888-2_1; Sharma P, 2012, FEBS J, V279, P3952, DOI 10.1111/j.1742-4658.2012.08755.x; SITSAPESAN R, 1994, BIOPHYS J, V67, P1484, DOI 10.1016/S0006-3495(94)80622-8; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Uysal S, 2011, P NATL ACAD SCI USA, V108, P11896, DOI 10.1073/pnas.1105112108; Van Petegem F., 2014, J MOL BIOL; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Yin CC, 2005, J MOL BIOL, V349, P538, DOI 10.1016/j.jmb.2005.04.002; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	69	224	228	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					39	U72		10.1038/nature13916	http://dx.doi.org/10.1038/nature13916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25470059				2022-12-28	WOS:000347178400030
J	Watts, G				Watts, Geoff			Pascal Diethelm: tireless opponent of the tobacco industry	LANCET			English	Biographical-Item																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2016	2018		10.1016/S0140-6736(14)62326-6	http://dx.doi.org/10.1016/S0140-6736(14)62326-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BD	25483159				2022-12-28	WOS:000346353600031
J	Burgers, P; Dawson, I				Burgers, Paul; Dawson, Imro			Enteroenteric Intussusception	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Burgers, Paul; Dawson, Imro] IJsselland Ziekenhuis, Capelle Aan Den Ijssel, Netherlands		Burgers, P (corresponding author), IJsselland Ziekenhuis, Capelle Aan Den Ijssel, Netherlands.	pburgers@ysl.nl							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2217	2217		10.1056/NEJMicm1313388	http://dx.doi.org/10.1056/NEJMicm1313388			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW0IY	25470697				2022-12-28	WOS:000345976700010
J	Scudellari, M				Scudellari, Megan			DRUG DEVELOPMENT: Try and try again	NATURE			English	Editorial Material																		Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Finn RS, 2014, J HEPATOL, V60, P243, DOI 10.1016/j.jhep.2013.10.031; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089	3	33	35	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S4	S6		10.1038/516S4a	http://dx.doi.org/10.1038/516S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW5JD	25470198	Bronze			2022-12-28	WOS:000346310800001
J	Wardle, DA; Lindahl, BD				Wardle, David A.; Lindahl, Bjorn D.			Disentangling global soil fungal diversity	SCIENCE			English	Editorial Material									[Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden; [Lindahl, Bjorn D.] Swedish Univ Agr Sci, Dept Soil & Environm, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Wardle, DA (corresponding author), Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden.	david.wardle@slu.se	Wardle, David A./F-6031-2011; Lindahl, Björn D./AAH-4538-2019	Wardle, David A./0000-0002-0476-7335; 				Averill C, 2014, NATURE, V505, P543, DOI 10.1038/nature12901; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Decaens T, 2010, GLOBAL ECOL BIOGEOGR, V19, P287, DOI 10.1111/j.1466-8238.2009.00517.x; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Huston M. A., 1994, BIOL DIVERSITY; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P926, DOI 10.1016/j.soilbio.2010.02.009; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Taylor PH, 1999, ECOLOGY, V80, P2474, DOI 10.1890/0012-9658(1999)080[2474:CRSRBR]2.0.CO;2; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Wardle D., 2002, COMMUNITIES ECOSYSTE	12	28	30	7	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1052	1053		10.1126/science.aaa1185	http://dx.doi.org/10.1126/science.aaa1185			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430752				2022-12-28	WOS:000345763400018
J	De Strooper, B				De Strooper, Bart			Lessons from a Failed gamma-Secretase Alzheimer Trial	CELL			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; BETA-PEPTIDE; SYNAPTIC PLASTICITY; ASPARTIC PROTEASE; DISEASE; PRESENILIN; INHIBITOR; MICE; SEMAGACESTAT	gamma-Secretase proteases have been associated with pathology in Alzheimer disease (AD), but we are just beginning to understand their basic mechanisms and physiological roles. A negative drug trial with a broad spectrum gamma-secretase inhibitor in AD patients has severely dampened enthusiasm for the potential of pursuing gamma-secretase research therapeutically. This pessimism is unwarranted: analysis of available information presented here demonstrates significant confounds for interpreting the outcome of the trial and argues that the major lessons pertain to broad knowledge gaps that are imperative to fill.	[De Strooper, Bart] VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [De Strooper, Bart] Univ Leuven, KU Leuven Ctr Human Genet, B-3000 Louvain, Belgium; [De Strooper, Bart] Univ Leuven, Leuven Inst Neurodegenerat disorders, B-3000 Louvain, Belgium; [De Strooper, Bart] UCL, UCL Inst Neurol, London WC1N 1PJ, England	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University of London; University College London	De Strooper, B (corresponding author), VIB Ctr Biol Dis, B-3000 Louvain, Belgium.	bart.destrooper@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019		European Research Council (ERC); Stichting Alzheimer Onderzoek (SAO); Fonds voor Wetenschappelijk Onderzoek (FWO); KU Leuven and Leuven University fund; Vlaams Instituut voor Biotechnologie (VIB); KU Leuven/Flemish Government; IUAP P7/16 NEUROBRAINNET network; Vlaams initiatief voor dementia (VIND); Janssen Pharmaceutica	European Research Council (ERC)(European Research Council (ERC)); Stichting Alzheimer Onderzoek (SAO); Fonds voor Wetenschappelijk Onderzoek (FWO)(FWO); KU Leuven and Leuven University fund; Vlaams Instituut voor Biotechnologie (VIB); KU Leuven/Flemish Government(KU Leuven); IUAP P7/16 NEUROBRAINNET network; Vlaams initiatief voor dementia (VIND); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	The author thanks Profs Lucia Chavez-Gutierrez and Eric Karran for critical discussion and input and Gwen Aerts for help with the figure. Research is supported by the European Research Council (ERC), the Stichting Alzheimer Onderzoek (SAO), the Fonds voor Wetenschappelijk Onderzoek (FWO), KU Leuven and Leuven University fund, the Vlaams Instituut voor Biotechnologie (VIB), a Methusalem grant of the KU Leuven/Flemish Government, the IUAP P7/16 NEUROBRAINNET network, Vlaams initiatief voor dementia (VIND) and Janssen Pharmaceutica. B.D.S. is the Arthur Bax and Anna Vanluffelen Chair for Alzheimer Disease.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Bammens L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216978; Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Borgegard T, 2012, J NEUROSCI, V32, P17297, DOI 10.1523/JNEUROSCI.1451-12.2012; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Crump CJ, 2012, BIOCHEMISTRY-US, V51, P7209, DOI 10.1021/bi301137h; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dolev I, 2013, NAT NEUROSCI, V16, P587, DOI 10.1038/nn.3376; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Grigorenko AP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P826, DOI 10.1023/A:1016365227942; Groth C, 2012, SEMIN CELL DEV BIOL, V23, P465, DOI 10.1016/j.semcdb.2012.01.016; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Haass C, 1998, NATURE, V391, P339, DOI 10.1038/34800; Henley DB, 2014, CURR MED RES OPIN, V30, P2021, DOI 10.1185/03007995.2014.939167; Jurisch-Yaksi N, 2013, BBA-BIOMEMBRANES, V1828, P2815, DOI 10.1016/j.bbamem.2013.04.016; Kageyama R, 2010, CURR TOP DEV BIOL, V92, P311, DOI 10.1016/S0070-2153(10)92010-3; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Karran E, 2014, ANN NEUROL, V76, P185, DOI 10.1002/ana.24188; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Li T, 2003, J NEUROSCI, V23, P3272; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Miyashita H, 2011, J BIOL CHEM, V286, P26188, DOI 10.1074/jbc.M111.260273; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Portelius E, 2012, J ALZHEIMERS DIS, V31, P335, DOI 10.3233/JAD-2012-120508; Probst G, 2013, J MED CHEM, V56, P5261, DOI 10.1021/jm301741t; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Yi P, 2010, DRUG METAB DISPOS, V38, P554, DOI 10.1124/dmd.109.030841; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang JB, 2013, J NEUROSCI, V33, P12825, DOI 10.1523/JNEUROSCI.0783-13.2013	46	201	201	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					721	726		10.1016/j.cell.2014.10.016	http://dx.doi.org/10.1016/j.cell.2014.10.016			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417150	Bronze			2022-12-28	WOS:000344522000006
J	Hussain, T; Llacer, JL; Fernandez, IS; Munoz, A; Martin-Marcos, P; Savva, CG; Lorsch, JR; Hinnebusch, AG; Ramakrishnan, V				Hussain, Tanweer; Llacer, Jose L.; Fernandez, Israel S.; Munoz, Antonio; Martin-Marcos, Pilar; Savva, Christos G.; Lorsch, Jon R.; Hinnebusch, Alan G.; Ramakrishnan, V.			Structural Changes Enable Start Codon Recognition by the Eukaryotic Translation Initiation Complex	CELL			English	Article							40S RIBOSOMAL-SUBUNIT; C-TERMINAL DOMAIN; PREINITIATION COMPLEX; CRYSTAL-STRUCTURE; FUNCTIONAL INTERACTIONS; MESSENGER-RNA; FACTORS EIF1; SELECTION; BINDING; TRNA(MET)	During eukaryotic translation initiation, initiator tRNA does not insert fully into the P decoding site on the 40S ribosomal subunit. This conformation (POUT) is compatible with scanning mRNA for the AUG start codon. Base pairing with AUG is thought to promote isomerization to a more stable conformation (PIN) that arrests scanning and promotes dissociation of eIF1 from the 40S subunit. Here, we present a cryoEM reconstruction of a yeast preinitiation complex at 4.0 angstrom resolution with initiator tRNA in the PIN state, prior to eIF1 release. The structure reveals stabilization of the codon-anticodon duplex by the N-terminal tail of eIF1A, changes in the structure of eIF1 likely instrumental in its subsequent release, and changes in the conformation of eIF2. The mRNA traverses the entire mRNA cleft and makes connections to the regulatory domain of eIF2 alpha, eIF1A, and ribosomal elements that allow recognition of context nucleotides surrounding the AUG codon.	[Hussain, Tanweer; Llacer, Jose L.; Fernandez, Israel S.; Savva, Christos G.; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Munoz, Antonio; Lorsch, Jon R.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Martin-Marcos, Pilar; Hinnebusch, Alan G.] Eunice K Shriver Natl Inst Child Hlth & Human Dev, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Munoz, Antonio; Lorsch, Jon R.] Eunice K Shriver Natl Inst Child Hlth & Human Dev, Lab Mech & Regulat Prot Synth, NIH, Bethesda, MD 20892 USA	MRC Laboratory Molecular Biology; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk	Llácer, José Luis/AAB-8711-2022; Llacer, José Luis/K-4299-2017	Llácer, José Luis/0000-0001-5304-1795; Llacer, José Luis/0000-0001-5304-1795; Ramakrishnan, V/0000-0002-4699-2194; Lorsch, Jon/0000-0002-4521-4999; Hussain, Tanweer/0000-0003-4735-2380; Fernandez, Israel/0000-0001-7218-1603	UK Medical Research Council [MC_U105184332]; Wellcome Trust Senior Investigator award [WT096570]; Agouron Institute; Jeantet Foundation; NIH [GM62128]; Human Frontiers in Science Program [RGP-0028/2009]; Intramural Research Program of the NIH; EMBO; FEBS; Medical Research Council [MC_U105184332] Funding Source: researchfish; Wellcome Trust [096570/Z/11/Z] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008940, ZIAHD001004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062128] Funding Source: NIH RePORTER; MRC [MC_U105184332] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Senior Investigator award(Wellcome Trust); Agouron Institute(Pfizer); Jeantet Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers in Science Program(Human Frontier Science Program); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); FEBS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Shaoxia Chen and Greg McMullan for technical support with cryo-EM, Toby Darling and Jake Grimmett for help with computing, Xiao-Chen Bai and Sjors H.W. Scheres for help and advice with EM data processing, and Garib Murshudov and Alan Brown for help with refinement of the atomic coordinates. We also thank Fan Zhang for providing the purified Sui3-2 mutant of eIF2, Jinsheng Dong for sharing his genetic findings on the U31:A39 tRNA<INF>i</INF> variant prior to publication, Ann Kelley and Sarah Walker for providing reagents and advice, and Thomas Dever for his insightful suggestion to employ Sui<SUP>-</SUP> variants. T.H. and J.L.L. were, respectively, supported by postdoctoral fellowships from EMBO and FEBS. This work was funded by grants to V.R. from the UK Medical Research Council (MC_U105184332), Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute and the Jeantet Foundation, from the NIH (GM62128) previously to J.R.L., and from the Human Frontiers in Science Program (RGP-0028/2009) to A.G.H., J.R.L., and V.R., and by the Intramural Research Program of the NIH (A.G.H., P.M.-M., J.R.L., and A.M.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Dong J, 2008, GENE DEV, V22, P2242, DOI 10.1101/gad.1696608; Dong JS, 2014, GENE DEV, V28, P502, DOI 10.1101/gad.236547.113; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fekete CA, 2005, EMBO J, V24, P3588, DOI 10.1038/sj.emboj.7600821; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Julian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001095; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lancaster L, 2005, MOL CELL, V20, P623, DOI 10.1016/j.molcel.2005.10.006; Lomakin IB, 2013, NATURE, V500, P307, DOI 10.1038/nature12355; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Martin-Marcos P, 2014, RNA, V20, P150, DOI 10.1261/rna.042069.113; Martin-Marcos P, 2013, J BIOL CHEM, V288, P27546, DOI 10.1074/jbc.M113.498642; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nanda JS, 2013, J BIOL CHEM, V288, P5316, DOI 10.1074/jbc.M112.440693; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Qin D, 2007, RNA, V13, P2348, DOI 10.1261/rna.715307; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schmitt E, 2012, NAT STRUCT MOL BIOL, V19, P450, DOI 10.1038/nsmb.2259; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharifulin D, 2013, CHEMBIOCHEM, V14, P2136, DOI 10.1002/cbic.201300318; Shin BS, 2011, NAT STRUCT MOL BIOL, V18, P1227, DOI 10.1038/nsmb.2133; Stolboushkina E, 2008, J MOL BIOL, V382, P680, DOI 10.1016/j.jmb.2008.07.039; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Weisser M, 2013, NAT STRUCT MOL BIOL, V20, P1015, DOI 10.1038/nsmb.2622; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	54	133	133	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					597	607		10.1016/j.cell.2014.10.001	http://dx.doi.org/10.1016/j.cell.2014.10.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417110	hybrid, Green Published			2022-12-28	WOS:000344521700015
J	Lipton, SA; Stevens, CF				Lipton, Stuart A.; Stevens, Charles F.			Stephen F. Heinemann 1939-2014 Obituary	CELL			English	Biographical-Item									[Lipton, Stuart A.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Lipton, Stuart A.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Stevens, Charles F.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Salk Institute	Lipton, SA (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	slipton@ucsd.edu		Lipton, Stuart/0000-0002-3490-1259				HEINEMANN SF, PUBLICATION LIST	1	0	0	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					231	232		10.1016/j.cell.2014.09.042	http://dx.doi.org/10.1016/j.cell.2014.09.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25436266	Bronze			2022-12-28	WOS:000343095600003
J	Barcena, A				Barcena, Alicia			Health protection as a citizen's right	LANCET			English	Editorial Material									Comis Econ Amer Latina & Carib, Santiago 7630412, Chile		Barcena, A (corresponding author), Comis Econ Amer Latina & Carib, Santiago 7630412, Chile.	alicia.barcena@eclac.cl						Economic Commission for Latin America and the Caribbean, 2010, 33 SESS ECLAC; Economic Commission for Latin America and the Caribbean (ECLAC), 2014, COMP EQ SUST FUT; Economic Commission for Latin America and the Caribbean (ECLAC), 2013, SOC PAN LAT AM; Evans DB, 2012, LANCET, V380, P864, DOI 10.1016/S0140-6736(12)61483-4; UN, 2000, GEN COMM 14 RIGHT HI	5	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					E29	E30		10.1016/S0140-6736(14)61771-2	http://dx.doi.org/10.1016/S0140-6736(14)61771-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF0ZD	25458717				2022-12-28	WOS:000352272400003
J	Lawitz, E; Gane, E; Pearlman, B; Tam, E; Ghesquiere, W; Guyader, D; Alric, L; Bronowicki, JP; Lester, L; Sievert, W; Ghalib, R; Balart, L; Sund, F; Lagging, M; Dutko, F; Shaughnessy, M; Hwang, P; Howe, AYM; Wahl, J; Robertson, M; Barr, E; Haber, B				Lawitz, Eric; Gane, Edward; Pearlman, Brian; Tam, Edward; Ghesquiere, Wayne; Guyader, Dominique; Alric, Laurent; Bronowicki, Jean-Pierre; Lester, Laura; Sievert, William; Ghalib, Reem; Balart, Luis; Sund, Fredrik; Lagging, Martin; Dutko, Frank; Shaughnessy, Melissa; Hwang, Peggy; Howe, Anita Y. M.; Wahl, Janice; Robertson, Michael; Barr, Eliav; Haber, Barbara			Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial	LANCET			English	Article							SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-EXPERIENCED PATIENTS; TREATMENT-NAIVE PATIENTS; INTERFERON-ALPHA 2A; HCV NS5A INHIBITOR; DISEASE BURDEN; PLUS RIBAVIRIN; DOUBLE-BLIND; SOFOSBUVIR; SIMEPREVIR	Background There is a high medical need for an interferon-free, all-oral, short-duration therapy for hepatitis C virus (HCV) that is highly effective across diverse patient populations, including patients with cirrhosis or previous null response to pegylated interferon (peginterferon) plus ribavirin (PR-null responders). We aimed to assess the efficacy, safety, and effective treatment duration of grazoprevir (an HCV NS3/4A protease inhibitor) combined with elbasvir (an HCV NS5A inhibitor) with or without ribavirin in patients with HCV genotype 1 infection with baseline characteristics of poor response. Methods The C-WORTHY trial is a randomised, open-label phase 2 trial of grazoprevir plus elbasvir with or without ribavirin; here we report findings for two cohorts of previously untreated patients with cirrhosis (cohort 1) and those with previous PR-null response with or without cirrhosis (cohort 2) enrolled in part B of the study. Eligible patients were adults aged 18 years or older with chronic HCV genotype 1 infection and HCV RNA concentrations of 10 000 IU/mL or higher in peripheral blood. We randomly assigned patients to receive grazoprevir (100 mg daily) and elbasvir (50 mg daily) with or without ribavirin for 12 or 18 weeks. Randomisation was done centrally with an interactive voice response system; patients and study investigators were masked to treatment duration up to week 12 but not to treatment allocation. The primary endpoint was the proportion of patients achieving HCV RNA less than 25 IU/mL at 12 weeks after end of treatment (SVR12), assessed by COBAS TaqMan version 2.0. This study is registered with ClinicalTrials.gov, number NCT01717326. Findings We describe findings for 253 patients enrolled in cohort 1 (n=123) or cohort 2 (n=130). In cohort 1, we randomly assigned 60 patients to the 12-week regimen (31 with ribavirin and 29 with no ribavirin) and 63 to the 18-week regimen (32 with ribavirin and 31 with no ribavirin); in cohort 2, we randomly assigned 65 patients to the 12-week regimen (32 with ribavirin and 33 with no ribavirin) and 65 to the 18-week regimen (33 with ribavirin and 32 with no ribavirin. High SVR12 rates were achieved irrespective of the use of ribavirin or extension of the treatment duration from 12 to 18 weeks; SVR12 rates ranged from 90% (95% CI 74-98; 28/31; cohort 1, 12 weeks, ribavirin-containing) to 100% (95% CI 89-100; 33/33; cohort 2, 18 weeks, ribavirin-containing). Among patients treated for 12 weeks with grazoprevir plus elbasvir without ribavirin, 97% (95% CI 82-100, 28/29) of patients in cohort 1 and 91% (76-98, 30/33) of patients in cohort 2 achieved SVR12. Adverse events reported in more than 10% of patients were fatigue (66 patients, 26% [95% CI 21-32]), headache (58 patients, 23% [95% CI 18-29]), and asthenia (35 patients, 14% [95% CI 10-19]). Interpretation Treatment with grazoprevir plus elbasvir, both with and without ribavirin and for both 12 and 18 weeks' treatment duration, showed high rates of efficacy in previously untreated patients with cirrhosis and previous PR-null responders with and without cirrhosis. These results support the phase 3 development of grazoprevir plus elbasvir.	[Lawitz, Eric] Univ Texas San Antonio, Hlth Sci Ctr, Texas Liver Inst, 7703 Floyd Curl Dr, San Antonio, TX 78249 USA; [Gane, Edward] Auckland Clin Studies, Grafton, Auckland, New Zealand; [Pearlman, Brian] Atlanta Med Ctr, Emory Sch Med, Atlanta, GA USA; [Pearlman, Brian] Med Coll Georgia, Atlanta, GA USA; [Tam, Edward] LAIR Ctr, Vancouver, BC, Canada; [Ghesquiere, Wayne] Vancouver Isl Hlth Author, Victoria, BC, Canada; [Ghesquiere, Wayne] Univ British Columbia, Victoria, BC, Canada; [Guyader, Dominique] Univ Rennes 1, Rennes Univ Hosp, Dept Hepatol, Rennes, France; [Alric, Laurent] IRD Toulouse 3 Univ, Digest Dept, CHU Purpan, UMR 152, Toulouse, France; [Bronowicki, Jean-Pierre] Univ Lorraine, Ctr Hosp Univ Nancy, INSERM U954, Vandoeuvre Les Nancy, France; [Lester, Laura] Univ Calif, Davis Med Ctr, Sacramento, CA USA; [Sievert, William] Monash Univ, Melbourne, Australia; [Sievert, William] Monash Hlth, Melbourne, Australia; [Ghalib, Reem] Clin Res Inst, Arlington, TX USA; [Balart, Luis] Univ Sch Med, New Orleans, LA USA; [Sund, Fredrik] Uppsala Univ, Infect Dis, S-75105 Uppsala, Sweden; [Lagging, Martin] Gothenburg Univ, Inst Biomed, S-41124 Gothenburg, Sweden; [Dutko, Frank; Shaughnessy, Melissa; Hwang, Peggy; Howe, Anita Y. M.; Wahl, Janice; Robertson, Michael; Barr, Eliav; Haber, Barbara] Merck & Co Inc, Whitehouse Stn, NJ USA	University of Texas System; University of Texas Health San Antonio; Emory University; WellStar Atlanta Medical Center; University System of Georgia; Augusta University; Vancouver Island Health Authority; University of British Columbia; CHU Rennes; Universite de Rennes; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Monash University; Uppsala University; University of Gothenburg; Merck & Company	Lawitz, E (corresponding author), Univ Texas San Antonio, Hlth Sci Ctr, Texas Liver Inst, 7703 Floyd Curl Dr, San Antonio, TX 78249 USA.	lawitz@txliver.com	Lagging, Martin/D-7734-2015	Lagging, Martin/0000-0002-7995-3626; TAM, EDWARD/0000-0002-8306-3968	Merck Co, Inc.	Merck Co, Inc.(Merck & Company)	Merck & Co, Inc.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Coburn CA, 2013, CHEMMEDCHEM, V8, P1930, DOI 10.1002/cmdc.201300343; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Kim AY, 2013, J INFECT DIS, V207, pS1, DOI 10.1093/infdis/jis927; Lahser F, 2012, HEPATOLOGY, V56, p236A; Lawitz E, 2014, LANCET; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Naggie S, 2014, TOP ANTIVIR MED, V22, P14; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Sulkowski M., 2014, LANCET; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; Summa V, 2012, ANTIMICROB AGENTS CH, V56, P4161, DOI 10.1128/AAC.00324-12; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; WHO, 2014, GUID SCREEN CAR TREA; Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058	30	223	225	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1075	1086		10.1016/S0140-6736(14)61795-5	http://dx.doi.org/10.1016/S0140-6736(14)61795-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25467591				2022-12-28	WOS:000351270400025
J	Sulkowski, M; Hezode, C; Gerstoft, J; Vierling, JM; Mallolas, J; Pol, S; Kugelmas, M; Murillo, A; Weis, N; Nahass, R; Shibolet, O; Serfaty, L; Bourliere, M; Dejesus, E; Zuckerman, E; Dutko, F; Shaughnessy, M; Hwang, P; Howe, AYM; Wahl, J; Robertson, M; Barr, E; Haber, B				Sulkowski, Mark; Hezode, Christophe; Gerstoft, Jan; Vierling, John M.; Mallolas, Josep; Pol, Stanislas; Kugelmas, Marcelo; Murillo, Abel; Weis, Nina; Nahass, Ronald; Shibolet, Oren; Serfaty, Lawrence; Bourliere, Marc; Dejesus, Edwin; Zuckerman, Eli; Dutko, Frank; Shaughnessy, Melissa; Hwang, Peggy; Howe, Anita Y. M.; Wahl, Janice; Robertson, Michael; Barr, Eliav; Haber, Barbara			Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial	LANCET			English	Article							ALPHA-2A PLUS RIBAVIRIN; TREATMENT-NAIVE PATIENTS; HCV NS5A INHIBITOR; PROTEASE INHIBITOR; DOUBLE-BLIND; THERAPY; ABT-450/R-OMBITASVIR; COMBINATION; SIMEPREVIR; SOFOSBUVIR	Background Both hepatitis C virus (HCV) mono-infected and HIV/HCV co-infected patients are in need of safe, eff ective, all-oral HCV regimens. In a phase 2 study we aimed to assess the efficacy and safety of grazoprevir (MK-5172; HCV NS3/4A protease inhibitor) and two doses of elbasvir (MK-8742; HCV NS5A inhibitor) in patients with HCV mono-infection and HIV/HCV co-infection. Methods The C-WORTHY study is a phase 2, multicentre, randomised controlled trial of grazoprevir plus elbasvir with or without ribavirin in patients with HCV; here, we report findings for previously untreated (genotype 1) patients without cirrhosis who were HCV mono-infected or HIV/HCV co-infected. Eligible patients were previously untreated adults aged 18 years or older with chronic HCV genoype 1 infection and HCV RNA at least 10 000 IU/mL in peripheral blood without evidence of cirrhosis, hepatocellular carcinoma, or decompensated liver disease. In part A of the study we randomly assigned HCV-mono-infected patients to receive 12 weeks of grazoprevir (100 mg) plus elbasvir (20 mg or 50 mg) with or without ribavirin (arms A1-3); in part B we assigned HCV-mono-infected patients to 8 or 12 weeks of grazoprevir (100 mg) plus elbasvir (50 mg) with or without ribavirin (arms B1-3) and HIV/HCV co-infected patients to 12 weeks of therapy with or without ribavirin. The primary endpoint was the proportion of patients achieving HCV RNA less than 25 IU/mL 12 weeks after end of treatment (SVR12). Randomisation was by presence or absence of ribavirin, 8 or 12 weeks of treatment, and dosage of elbasvir. Patients were stratified by gentoype 1a versus 1b. The patients, investigators, and study site personnel were masked to treatment group assignements but the funder was not. Analysis was by intention to treat. This trial is registered at ClinicalTrials.gov, number NCT01717326. Findings 218 patients with HCV mono-infection (n=159) and HIV/HCV co-infection (n=59) were enrolled. SVR12 for patients treated for 12 weeks with or without ribavirin ranged from 93-98% in mono-infected and 87-97% in co-infected patients. SVR12 rates in mono-infected and co-infected patients treated for 12 weeks without ribavirin were 98% (95% CI 88-100; 43/44) and 87% (95% CI 69-96; 26/30), respectively, and with ribavirin were 93% (95% CI 85-97; 79/85) and 97% (95% CI 82-100; 28/29), respectively. Among mono-infected patients with genotype 1a infection treated for 8 weeks, SVR12 was 80% (95% CI 61-92; 24/30). Five of six patients who discontinued early for reasons other than virological failure had HCV RNA less than 25 IU/mL at their last study visit. Virological failure among patients treated for 12 weeks occurred in seven patients (7/188, 4%) and was associated with emergence of resistance-associated variants to one or both drugs. The safety profi le of grazoprevir plus elbasvir with or without ribavirin was similar in mono-infected and co-infected patients. No patient discontinued due to an adverse event or laboratory ab normality. The most common adverse events were fatigue (51 patients, 23%), headache (44, 20%), nausea (32, 15%), and diarrhoea (21, 10%). Interpretation Once-daily grazoprevir plus elbasvir with or without ribavirin for 12 weeks in previously untreated HCV-mono-infected and HIV/HCV-co-infected patients without cirrhosis achieved SVR12 rates of 87-98%. These results support the ongoing phase 3 development of grazoprevir plus elbasvir.	[Sulkowski, Mark] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; [Hezode, Christophe] Univ Paris Est, Hop Henri Mondor, AP HP, Dept Gastroenterol & Hepatol,INSERM U955, Creteil, France; [Gerstoft, Jan] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Vierling, John M.] Baylor Coll Med, Houston, TX 77030 USA; [Mallolas, Josep] Hosp Clin Barcelona, Infect Dis Serv, Barcelona, Spain; [Pol, Stanislas] Univ Paris 05, Hosp Cochin, AP HP, Paris, France; [Pol, Stanislas] INSERM, Paris, France; [Kugelmas, Marcelo] South Denver Gastroenterol, Englewood, CO USA; [Murillo, Abel] Adv Med & Pain Management Res Clin, Miami, FL USA; [Weis, Nina] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Nahass, Ronald] ID Care, Hillsborough, NJ USA; [Shibolet, Oren] Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol, Liver Unit, Tel Aviv, Israel; [Serfaty, Lawrence] Univ Paris 06, Hop St Antoine, AP HP, Paris, France; [Serfaty, Lawrence] Univ Paris 06, INSERM, UMR 938, Paris, France; [Bourliere, Marc] Hop St Joseph, Serv Hepatogastroenterol, Marseille, France; [Dejesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Zuckerman, Eli] Carmel Hosp, Techn Fac Med, Liver Unit, Haifa, Israel; [Dutko, Frank; Shaughnessy, Melissa; Hwang, Peggy; Howe, Anita Y. M.; Wahl, Janice; Robertson, Michael; Barr, Eliav; Haber, Barbara] Merck & Co Inc, Whitehouse Stn, NJ USA	Johns Hopkins University; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Rigshospitalet; University of Copenhagen; Baylor College of Medicine; University of Barcelona; Hospital Clinic de Barcelona; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Copenhagen; Tel Aviv University; Sackler Faculty of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Orlando Immunology Center; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Merck & Company	Sulkowski, M (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA.	msulkowski@jhmi.edu	Weis, Nina/GLT-4232-2022; Hezode, Christophe/U-4659-2018	Mallolas Masferrer, Josep/0000-0002-8365-141X; Weis, Nina/0000-0002-3133-2724	Merck Co, Inc.	Merck Co, Inc.(Merck & Company)	Merck & Co, Inc.	American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society, 2014, REC TEST MAN TREAT H; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Coburn CA, 2013, CHEMMEDCHEM, V8, P1930, DOI 10.1002/cmdc.201300343; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hulskotte EGJ, 2013, CLIN INFECT DIS, V56, P718, DOI 10.1093/cid/cis968; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Kramer JR, 2012, J HEPATOL, V56, P320, DOI 10.1016/j.jhep.2011.05.032; Lahser F, 2012, HEPATOLOGY, V56, p236A; Lawitz E, 2014, LANCET; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; McGowan CE, 2013, HEPATOLOGY, V57, P1325, DOI 10.1002/hep.26246; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Molina JM, 2014, 20 INT AIDS C MELB V, DOI MOAB0105LB; Pawlotsky JM, 2014, J HEPATOL, V61, P373, DOI 10.1016/j.jhep.2014.05.001; Rodriguez-Torres M, 2012, HIV CLIN TRIALS, V13, P142, DOI 10.1310/hct1303-142; Sulkowski M, 2014, 20 INT AIDS C MELB V; Sulkowski M, 2014, TOP ANTIVIR MED, V22, P324; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; Summa V, 2012, ANTIMICROB AGENTS CH, V56, P4161, DOI 10.1128/AAC.00324-12; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; von Schoen-Angerer T, 2013, LANCET, V381, P628, DOI 10.1016/S0140-6736(13)60346-3; Yeh W, 2014, TOP ANTIVIR MED, V22, P238	33	226	231	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1087	1097		10.1016/S0140-6736(14)61793-1	http://dx.doi.org/10.1016/S0140-6736(14)61793-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25467560				2022-12-28	WOS:000351270400026
J	Perdiguero, EG; Klapproth, K; Schulz, C; Busch, K; Azzoni, E; Crozet, L; Garner, H; Trouillet, C; de Bruijn, MF; Geissmann, F; Rodewald, HR				Perdiguero, Elisa Gomez; Klapproth, Kay; Schulz, Christian; Busch, Katrin; Azzoni, Emanuele; Crozet, Lucile; Garner, Hannah; Trouillet, Celine; de Bruijn, Marella F.; Geissmann, Frederic; Rodewald, Hans-Reimer			Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors	NATURE			English	Article							STEM-CELL DIFFERENTIATION; MICROGLIA DERIVE; MONOCYTES; ONTOGENY; HEMATOPOIESIS; MATURATION; REVEALS; EMBRYO; LIFE; MYB	Most haematopoietic cells renew from adult haematopoietic stem cells (HSCs)(1-3), however, macrophages in adult tissues can self-maintain independently of HSCO4-7. Progenitors with macrophage potential in vitro have been described in the yolk sac before emergence of HSCO8-3, and fetal macrophages(13-15) can develop independently of Myb(4), a transcription factor required for HSC16, and can persist in adult tissues(4.17,18). Nevertheless, the origin of adult macrophages and the qualitative and quantitative contributions of HSC and putative non-HSC-derived progenitors are still unclear'. Here we show in mice that the vast majority of adult tissue-resident macrophages in liver (Kupffer cells), brain '(microglia), epidermis (Langerhans cells) and lung (alveolar macrophages) originate from a Tie2(+) (also known as Tek) cellular pathway generating Csf1r(+) erythro-myeloid progenitors (EMPs) distinct from HSCs. EMPs develop in the yolk sac at embryonic day (E) 8.5, migrate and colonize the nascent fetal liver before E10.5, and give rise to fetal erythrocytes, macrophages, granulocytes and monocytes until at least E16.5. Subsequently, HSC-derived cells replace erythrocytes, granulocytes and monocytes. Kupffer cells, microglia and Langerhans cells are only marginally replaced in oneyear-old mice, whereas alveolar macrophages may be progressively replaced in ageing mice. Our fate-mapping experiments identify, in the fetal liver, a sequence of yolk sac EMP-derived and HSC-derived haematopoiesis, and identify yolk sac EMPs as a common origin for tissue macrophages.	[Perdiguero, Elisa Gomez; Schulz, Christian; Crozet, Lucile; Garner, Hannah; Trouillet, Celine; Geissmann, Frederic] Kings Coll London, CMCBI, London SE1 1UL, England; [Klapproth, Kay; Busch, Katrin; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, D-69120 Heidelberg, Germany; [Azzoni, Emanuele; de Bruijn, Marella F.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Mol Haematol Unit, Oxford OX3 9DS, England	University of London; King's College London; Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford	Geissmann, F (corresponding author), Kings Coll London, CMCBI, London SE1 1UL, England.	frederic.geissmann@kcl.ac.uk	Azzoni, Emanuele/AAE-8064-2022; Perdiguero, Elisa Gomez/U-2120-2018; Schulz, Christian/J-8545-2012	Azzoni, Emanuele/0000-0002-4572-5692; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Schulz, Christian/0000-0003-3878-7833; geissmann, frederic/0000-0001-5029-2468	Wellcome Trust [WT101853MA]; ERC from European Research Council [2010-StG-261299]; ERC [233074, SFB 938, SFB 873]; MRC [MC_UU_12009/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1168004] Funding Source: researchfish; Medical Research Council [MC_UU_12009/2] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); ERC from European Research Council; ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are indebted to J. Pollard, University of Edinburgh for the Csf1r reporter strains, J. Frampton, University of Birmingham for the MA-deficient animals, and T. Boehm, Max Planck Institute, Freiburg for the Flt3<SUP>Cre</SUP> strain. The authors also thank A. McGuigan and the staff of the Biological Service Unit at King's College London, S. Heck and the Biomedical Research Centre at King's Health Partners, S. Woodcock and the staff of the Viapath haematology laboratory in Guy's hospital and S. Schafer and T. Arnsperger for technical assistance at the German Cancer Research Center. This work was supported by a Wellcome Trust Senior Investigator award (WT101853MA) and ERC Investigator award (2010-StG-261299) from the European Research Council to F.G. and an ERC Investigator award (Advanced Grant 233074), SFB 938 project L, and SFB 873 project B11 to H.-R.R.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; DZIERZAK E, 1995, TRENDS GENET, V11, P359, DOI 10.1016/S0168-9525(00)89107-6; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Frame JM, 2013, BLOOD CELL MOL DIS, V51, P220, DOI 10.1016/j.bcmd.2013.09.006; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kieusseian A, 2012, DEVELOPMENT, V139, P3521, DOI 10.1242/dev.079210; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palis J, 1999, DEVELOPMENT, V126, P5073; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87, DOI 10.1002/jlb.45.2.87; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/nmeth.1309, 10.1038/NMETH.1309]; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	27	1242	1263	9	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					547	551		10.1038/nature13989	http://dx.doi.org/10.1038/nature13989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25470051	Green Accepted			2022-12-28	WOS:000350097300049
J	Zalk, R; Clarke, OB; des Georges, A; Grassucci, RA; Reiken, S; Mancia, F; Hendrickson, WA; Frank, J; Marks, AR				Zalk, Ran; Clarke, Oliver B.; des Georges, Amedee; Grassucci, Robert A.; Reiken, Steven; Mancia, Filippo; Hendrickson, Wayne A.; Frank, Joachim; Marks, Andrew R.			Structure of a mammalian ryanodine receptor	NATURE			English	Article							CALCIUM-RELEASE CHANNEL; PARTICLE ELECTRON CRYOMICROSCOPY; EM STRUCTURE DETERMINATION; SKELETAL-MUSCLE; CRYO-EM; INTRACELLULAR CALCIUM; DEFECTIVE REGULATION; HEART-FAILURE; MICROSCOPY; DOMAIN	Ryanodine receptors (RyRs) mediate the rapid release of calcium (Ca2+) from intracellular stores into the cytosol, which is essential for numerous cellular functions including excitation-contraction coupling in muscle. Lack of sufficient structural detail has impeded understanding of RyR gating and regulation. Here we report the closed-state structure of the 2.3-megadalton complex of the rabbit skeletal muscle type 1 RyR (RyR1), solved by single-particle electron cryomicroscopy at an overall resolution of 4.8 angstrom. We fitted a polyalanine-level model to all 3,757 ordered residues in each protomer, defining the transmembrane pore in unprecedented detail and placing all cytosolic domains as tertiary folds. The cytosolic assembly is built on an extended alpha-solenoid scaffold connecting key regulatory domains to the pore. The RyR1 pore architecture places it in the six-transmembrane ion channel superfamily. A unique domain inserted between the second and third transmembrane helices interacts intimately with paired EF-hands originating from the alpha-solenoid scaffold, suggesting a mechanism for channel gating by Ca2+.	[Zalk, Ran; Reiken, Steven; Mancia, Filippo; Hendrickson, Wayne A.; Marks, Andrew R.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Clarke, Oliver B.; des Georges, Amedee; Grassucci, Robert A.; Hendrickson, Wayne A.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Grassucci, Robert A.; Frank, Joachim] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Frank, Joachim] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Marks, Andrew R.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Marks, Andrew R.] Columbia Univ, Wu Ctr Mol Cardiol, Coll Phys & Surg, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University	Marks, AR (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	wayne@xtl.cumc.columbia.edu; jf2192@columbia.edu; arm42@columbia.edu	Georges, Amédée des/C-3588-2014	Georges, Amédée des/0000-0002-9704-3781; Mancia, Filippo/0000-0003-3293-2200	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL061503, P01 HL081172, R01HL061503, R01 HL083418] Funding Source: Medline; NIAMS NIH HHS [R01AR060037, R01 AR060037] Funding Source: Medline; NIGMS NIH HHS [R01 GM029169, U54GM095315, R01GM29169, U54 GM095315] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081172, R01HL083418, R01HL061503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, R01GM029169] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Andersson Daniel C, 2010, Drug Discov Today Dis Mech, V7, pe151, DOI 10.1016/j.ddmec.2010.09.009; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez IS, 2013, SCIENCE, V342, P824, DOI 10.1126/science.1240585; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langlois R, 2014, J STRUCT BIOL, V186, P1, DOI 10.1016/j.jsb.2014.03.001; Lau K., 2014, NATURE COMM, V5, P5937; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu XP, 2012, CELL, V150, P1055, DOI 10.1016/j.cell.2012.06.052; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; MARKS AR, 1990, J BIOL CHEM, V265, P13143; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meissner G, 1995, BIOSCIENCE REP, V15, P399, DOI 10.1007/BF01788371; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Paolini C, 2004, J MOL BIOL, V342, P145, DOI 10.1016/j.jmb.2004.07.035; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Serysheva II, 2008, P NATL ACAD SCI USA, V105, P9610, DOI 10.1073/pnas.0803189105; Sharma P, 2012, FEBS J, V279, P3952, DOI 10.1111/j.1742-4658.2012.08755.x; Stern MD, 1997, J GEN PHYSIOL, V110, P415, DOI 10.1085/jgp.110.4.415; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Volkov AG, 1997, BIOELECTROCH BIOENER, V42, P153, DOI 10.1016/S0302-4598(96)05097-0; WAGENKNECHT T, 1988, J MOL BIOL, V203, P753, DOI 10.1016/0022-2836(88)90207-0; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; XIN HB, 1995, BIOCHEM BIOPH RES CO, V214, P263, DOI 10.1006/bbrc.1995.2283; Xiong LW, 2006, BIOPHYS J, V90, P173, DOI 10.1529/biophysj.105.066092; Yin CC, 2005, J STRUCT BIOL, V149, P219, DOI 10.1016/j.jsb.2004.10.008; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237	54	276	280	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					44	U90		10.1038/nature13950	http://dx.doi.org/10.1038/nature13950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25470061	Green Accepted			2022-12-28	WOS:000347178400031
J	Jaiswal, S; Fontanillas, P; Flannick, J; Manning, A; Grauman, PV; Mar, BG; Lindsley, RC; Mermel, CH; Burtt, N; Chavez, A; Higgins, JM; Moltchanov, V; Kuo, FC; Kluk, MJ; Henderson, B; Kinnunen, L; Koistinen, HA; Ladenvall, C; Getz, G; Correa, A; Banahan, BF; Gabriel, S; Kathiresan, S; Stringham, HM; McCarthy, MI; Boehnke, M; Tuomilehto, J; Haiman, C; Groop, L; Atzmon, G; Wilson, JG; Neuberg, D; Altshuler, D; Ebert, BL				Jaiswal, Siddhartha; Fontanillas, Pierre; Flannick, Jason; Manning, Alisa; Grauman, Peter V.; Mar, Brenton G.; Lindsley, R. Coleman; Mermel, Craig H.; Burtt, Noel; Chavez, Alejandro; Higgins, John M.; Moltchanov, Vladislav; Kuo, Frank C.; Kluk, Michael J.; Henderson, Brian; Kinnunen, Leena; Koistinen, Heikki A.; Ladenvall, Claes; Getz, Gad; Correa, Adolfo; Banahan, Benjamin F.; Gabriel, Stacey; Kathiresan, Sekar; Stringham, Heather M.; McCarthy, Mark I.; Boehnke, Michael; Tuomilehto, Jaakko; Haiman, Christopher; Groop, Leif; Atzmon, Gil; Wilson, James G.; Neuberg, Donna; Altshuler, David; Ebert, Benjamin L.			Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL DISTRIBUTION WIDTH; MYELOPROLIFERATIVE DISORDERS; DNMT3A MUTATIONS; POINT MUTATIONS; TET2 MUTATIONS; MOSAICISM; DISCOVERY; GENES; INFLAMMATION; MORTALITY	Background The incidence of hematologic cancers increases with age. These cancers are associated with recurrent somatic mutations in specific genes. We hypothesized that such mutations would be detectable in the blood of some persons who are not known to have hematologic disorders. Methods We analyzed whole-exome sequencing data from DNA in the peripheral-blood cells of 17,182 persons who were unselected for hematologic phenotypes. We looked for somatic mutations by identifying previously characterized single-nucleotide variants and small insertions or deletions in 160 genes that are recurrently mutated in hematologic cancers. The presence of mutations was analyzed for an association with hematologic phenotypes, survival, and cardiovascular events. Results Detectable somatic mutations were rare in persons younger than 40 years of age but rose appreciably in frequency with age. Among persons 70 to 79 years of age, 80 to 89 years of age, and 90 to 108 years of age, these clonal mutations were observed in 9.5% (219 of 2300 persons), 11.7% (37 of 317), and 18.4% (19 of 103), respectively. The majority of the variants occurred in three genes: DNMT3A, TET2, and ASXL1. The presence of a somatic mutation was associated with an increase in the risk of hematologic cancer (hazard ratio, 11.1; 95% confidence interval [CI], 3.9 to 32.6), an increase in all-cause mortality (hazard ratio, 1.4; 95% CI, 1.1 to 1.8), and increases in the risks of incident coronary heart disease (hazard ratio, 2.0; 95% CI, 1.2 to 3.4) and ischemic stroke (hazard ratio, 2.6; 95% CI, 1.4 to 4.8). Conclusions Age-related clonal hematopoiesis is a common condition that is associated with increases in the risk of hematologic cancer and in all-cause mortality, with the latter possibly due to an increased risk of cardiovascular disease.	[Jaiswal, Siddhartha; Grauman, Peter V.; Mar, Brenton G.; Ebert, Benjamin L.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Lindsley, R. Coleman] Brigham & Womens Hosp, Dept Med Oncol, Div Hematol Malignancies, Boston, MA 02115 USA; [Kuo, Frank C.; Kluk, Michael J.] Brigham & Womens Hosp, Ctr Adv Mol Diagnost, Boston, MA 02115 USA; [Kuo, Frank C.; Kluk, Michael J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Jaiswal, Siddhartha; Mermel, Craig H.; Chavez, Alejandro; Higgins, John M.; Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Flannick, Jason; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Higgins, John M.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Gabriel, Stacey; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David] Massachusetts Gen Hosp, Dept Med, Div Endocrinol, Boston, MA 02114 USA; [Jaiswal, Siddhartha] Brigham & Womens Hosp, Boston Childrens Hosp, Joint Program Transfus Med, Boston, MA 02115 USA; [Jaiswal, Siddhartha] Dana Farber Canc Inst, Boston, MA 02115 USA; [Mar, Brenton G.] Dept Pediat Oncol, Boston, MA USA; [Neuberg, Donna] Dept Biostat & Computat Biol, Boston, MA USA; [Higgins, John M.] Massachusetts Gen Hosp, Dana Farber Canc Inst, Boston, MA 02114 USA; [Higgins, John M.] Dept Syst Biol, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Dept Med, Boston, MA USA; [Ebert, Benjamin L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ebert, Benjamin L.] Harvard Stem Cell Inst, Boston, MA USA; [Fontanillas, Pierre; Flannick, Jason; Manning, Alisa; Burtt, Noel; Gabriel, Stacey; Kathiresan, Sekar; Altshuler, David] Broad Inst Massachusetts Inst Technol & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Altshuler, David] MIT, Dept Biol, Cambridge, MA USA; [Moltchanov, Vladislav] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Moltchanov, Vladislav] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Cent Hosp, Minerva Fdn Inst Med Res, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Cent Hosp, Dept Med, Div Endocrinol, Helsinki, Finland; [Kinnunen, Leena; Koistinen, Heikki A.; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Henderson, Brian; Haiman, Christopher] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Ladenvall, Claes; Groop, Leif] Lund Univ, Ctr Diabet, Dept Clin Sci, Clin Res Ctr,Skane Univ Hosp, Lund, Sweden; [Correa, Adolfo] Univ Mississippi, Med Ctr, Dept Med, Oxford, MS USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Oxford, MS USA; [Banahan, Benjamin F.] Univ Mississippi, Ctr Pharmaceut Mkt & Management, Oxford, MS USA; [Stringham, Heather M.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McCarthy, Mark I.] Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford, England; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah 21413, Saudi Arabia; [Atzmon, Gil] Albert Einstein Coll Med, Dept Med & Genet, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Southern California; Lund University; Skane University Hospital; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Michigan System; University of Michigan; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Danube University Krems; King Abdulaziz University; Yeshiva University	Ebert, BL (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Hematol, 1 Blackfan Cir,Karp 5-210, Boston, MA 02115 USA.	bebert@partners.org	Altshuler, David M/A-4476-2009; Manning, Alisa Knodle/ABC-7711-2021; Kinnunen, Leena/B-7059-2012; Mermel, Craig/AAZ-7322-2020; Lindsley, Coleman/AAA-3040-2021; McCarthy, Mark/M-3763-2015; Koistinen, Heikki/J-7313-2016	Altshuler, David M/0000-0002-7250-4107; Kinnunen, Leena/0000-0001-8739-4812; Mermel, Craig/0000-0002-0816-3395; Mar, Brenton/0000-0002-3857-9324; Lindsley, Coleman/0000-0001-9822-806X; McCarthy, Mark/0000-0002-4393-0510; Koistinen, Heikki/0000-0001-7870-070X	National Institutes of Health (NIH) [R01HL082945]; Gabrielle's Angel Foundation; Leukemia and Lymphoma Society Scholar and Specialized Center of Research (SCOR); NIH [5T32HL066987, U01 DK085526, U01 DK085501, U01 DK085524, U01 DK085545, U01 DK085584, DK088389, P01AG021654, 1R01AG042188, P30AG038072]; Medical Research Council [G0601261]; Medical Research Council (High Throughput Genomics Hub) [G0900747 91070]; Wellcome Trust [090367, 090532, 098381, 083948, 085475]; Paul Glenn Foundation; National Heart, Lung, and Blood Institute [HSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C]; National Institute on Minority Health and Health Disparities; National Human Genome Research Institute (NHGRI) of the NIH [U54 HG003067]; NATIONAL CANCER INSTITUTE [P01CA066996, T32CA009216, T32CA009172] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987, R01HL082945] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085524, U01DK085526, P30DK020572, U01DK085584, U01DK085501, RC2DK088389, DP2DK098087, U01DK085545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038072, R01AG042188, P01AG021654] Funding Source: NIH RePORTER; MRC [G0601261] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation; Leukemia and Lymphoma Society Scholar and Specialized Center of Research (SCOR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (High Throughput Genomics Hub)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Paul Glenn Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Human Genome Research Institute (NHGRI) of the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the National Institutes of Health (NIH) (R01HL082945) and the Gabrielle's Angel Foundation, by Leukemia and Lymphoma Society Scholar and Specialized Center of Research (SCOR) Awards (to Dr. Ebert), and by an NIH Training Grant (5T32HL066987, to Dr. Jaiswal). The T2D-GENES (Type 2 Diabetes Genetic Exploration by Next-Generation Sequencing in Multi-Ethnic Samples) consortium was supported by grants from the NIH (U01s DK085526, DK085501, DK085524, DK085545, and DK085584). The GoT2D (Genetics of Type 2 Diabetes) consortium is supported by grants from the Medical Research Council (G0601261 and High Throughput Genomics Hub grant G0900747 91070), the Wellcome Trust (090367, 090532, 098381, 083948, 085475), and the NIH (DK088389). The Longevity Genes Project is supported by grants from the NIH (P01AG021654, 1R01AG042188, P30AG038072), and by a Paul Glenn Foundation Grant. The Jackson Heart Study is supported by contracts (HSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C) from the National Heart, Lung, and Blood Institute and the National Institute on Minority Health and Health Disparities. Dr. McCarthy is a Wellcome Trust Senior Investigator and an NIH Research Senior Investigator. Exome sequencing in the Jackson Heart Study was funded by an award from the National Human Genome Research Institute (NHGRI) of the NIH (U54 HG003067, to Dr. Gabriel).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Asmar F, 2013, HAEMATOLOGICA, V98, P1912, DOI 10.3324/haematol.2013.088740; Bazick HS, 2011, CRIT CARE MED, V39, P1913, DOI 10.1097/CCM.0b013e31821b85c6; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Bonnefond A, 2013, NAT GENET, V45, P1040, DOI 10.1038/ng.2700; Busque L, 1996, BLOOD, V88, P59; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Champion KM, 1997, BRIT J HAEMATOL, V97, P920, DOI 10.1046/j.1365-2141.1997.1933010.x; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Ley TJ, 2013, NEW ENGL J MED, V369, P98; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Neumann M, 2013, BLOOD, V121, P4749, DOI 10.1182/blood-2012-11-465138; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Odejide O, 2014, BLOOD, V123, P1293, DOI 10.1182/blood-2013-10-531509; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Rollison DE, 2008, BLOOD, V112, P45, DOI 10.1182/blood-2008-01-134858; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Surveillance Epidemiology and End Results Program, 2014, US POP DAT 1969 2012; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	45	2371	2420	5	113	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2488	2498		10.1056/NEJMoa1408617	http://dx.doi.org/10.1056/NEJMoa1408617			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX4RZ	25426837	Green Accepted, Green Published			2022-12-28	WOS:000346920300008
J	Besansky, NJ				Besansky, Nora J.			MALARIA How vector mosquitoes beat the heat	NATURE			English	Editorial Material									[Besansky, Nora J.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Besansky, NJ (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.	nbesansk@nd.edu						Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; COLUZZI M, 1984, B WORLD HEALTH ORGAN, V62, P107; Dao A, 2014, NATURE, V516, P387, DOI 10.1038/nature13987; Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023; Powell JR, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P101; Sohn E, 2014, NATURE, V511, P144, DOI 10.1038/511144a	6	4	4	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					334	336		10.1038/nature14073	http://dx.doi.org/10.1038/nature14073			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25470053				2022-12-28	WOS:000346484800032
J	Fleurie, A; Lesterlin, C; Manuse, S; Zhao, C; Cluze, C; Lavergne, JP; Franz-Wachtel, M; Macek, B; Combet, C; Kuru, E; Van Nieuwenhze, MS; Bruns, YV; Sherratt, D; Grangeasse, C				Fleurie, Aurore; Lesterlin, Christian; Manuse, Sylvie; Zhao, Chao; Cluze, Caroline; Lavergne, Jean-Pierre; Franz-Wachtel, Mirita; Macek, Boris; Combet, Christophe; Kuru, Erkin; Van Nieuwenhze, Michael S.; Bruns, Yves V.; Sherratt, David; Grangeasse, Christophe			MapZ marks the division sites and positions FtsZ rings in Streptococcus pneumoniae	NATURE			English	Article							SER/THR PROTEIN-KINASE; CELL-DIVISION; MEMBRANE-PROTEIN; BINDING; GROWTH; STKP; IDENTIFICATION; MORPHOGENESIS; PEPTIDOGLYCAN; MAINTENANCE	In every living organism, cell division requires accurate identification of the division site and placement of the division machinery. In bacteria, this process is traditionally considered to begin with the polymerization of the highly conserved tubulin-like protein FtsZinto a ring that locates precisely at mid-cell(1). Over the past decades, several systems have been reported to regulate the spatiotemporal assembly and placement of the FtsZ ring(2-5). However, the human pathogen Streptococcus pneumoniae, in common with many other organisms, is devoid of these canonical systems and the mechanisms of positioning the division machinery remain unknown(4,6). Here we characterize a novel factor that locates at the division site before FtsZ and guides septum positioning in pneumococcus. Mid-cell-anchored protein Z (MapZ) forms ring structures at the cell equator and moves apart as the cell elongates, therefore behaving as a permanent beacon of division sites. MapZ then positions the FtsZ ring through direct protein-protein interactions. MapZ-mediated control differs from previously described systems mostly on the basis of negative regulation of FtsZ assembly. Furthermore, MapZ is an endogenous target of the Ser/Thr kinase StkP, which was recently shown to have a central role in cytokinesis and morphogenesis of S. pneumoniae(7-9). We show that both phosphorylated and non-phosphorylated forms of MapZ are required for proper Z-ring formation and dynamics. Altogether, this work uncovers a new mechanism for bacterial cell division that is regulated by phosphorylation and illustrates that nature has evolved a diversity of cell division mechanisms adapted to the different bacterial clades.	[Fleurie, Aurore; Manuse, Sylvie; Zhao, Chao; Lavergne, Jean-Pierre; Combet, Christophe; Grangeasse, Christophe] Univ Lyon 1, CNRS, UMR 5086, IBCP, F-69007 Lyon, France; [Lesterlin, Christian; Sherratt, David] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Cluze, Caroline] Univ Lyon 1, CNRS, UMR 5305, Lab Biol Tissulaire & Ingn Threrapeut,IBCP, F-69007 Lyon, France; [Franz-Wachtel, Mirita; Macek, Boris] Univ Tubingen, Proteome Ctr Tubingen, D-72076 Tubingen, Germany; [Kuru, Erkin; Van Nieuwenhze, Michael S.; Bruns, Yves V.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Kuru, Erkin; Van Nieuwenhze, Michael S.; Bruns, Yves V.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Eberhard Karls University of Tubingen; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Grangeasse, C (corresponding author), Univ Lyon 1, CNRS, UMR 5086, IBCP, F-69007 Lyon, France.	christian.lesterlin@bioch.ox.ac.uk; c.grangeasse@ibcp.fr	VanNieuwenhze, Michael/B-5120-2018; Zhao, Chao/AAG-4497-2020; Macek, Boris/N-1442-2015	VanNieuwenhze, Michael/0000-0001-6093-5949; Zhao, Chao/0000-0001-7349-306X; Macek, Boris/0000-0002-1206-2458; Lesterlin, Christian/0000-0002-9108-0848; Cluzel, Caroline/0000-0001-8946-3439; Brun, Yves/0000-0002-9289-1909; Grangeasse, Christophe/0000-0002-5484-4589; Sherratt, David/0000-0002-2104-5430; COMBET, Christophe/0000-0002-7348-3520	CNRS; Universite Claude Bernard Lyon 1; FINOVI foundation; Agence National de la Recherche [ANR-12-BSV3-0008-01]; Region Rhone-Alpes [ARC1]; Wellcome Trust [WT083469MA, 091911]; National Institutes of Health [GM051986]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051986] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1; FINOVI foundation; Agence National de la Recherche(French National Research Agency (ANR)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the CNRS, the Universite Claude Bernard Lyon 1, the FINOVI foundation, the Agence National de la Recherche (ANR-12-BSV3-0008-01) and the Region Rhone-Alpes (ARC1 and financial support for A.F. (Cluster 10) and C.Z. (CMIRA)). C.L. was supported by a Wellcome Trust Programme Grant to D.S. (WT083469MA), advanced microscopy at Micron Oxford was supported by a Wellcome Trust Strategic Award (091911), and Y.V.B. was supported by a National Institutes of Health grant (GM051986). We acknowledge the contribution of the PLATIM and the Protein Science facilities of the SFR Biosciences Gerland-Lyon Sud (UMS344/US8) and the Centre Technologique des Microstructures de l'Universite Lyon 1. We thank C. Chamot for technical assistance in microscopy, S. Uphoff and J. Wiktor for providing help with Matlab and A.-M. Di Guilmi for providing us with the antibody against pneumococcal FtsZ. We thank N. Campo, N. Dubarry and J.-P. Claverys for stimulating discussions and critical reading of the manuscript. N. Campo is also thanked for her help with time-lapse microscopy.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Beilharz K, 2012, P NATL ACAD SCI USA, V109, pE905, DOI 10.1073/pnas.1119172109; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CORTAY JC, 1994, J BIOL CHEM, V269, P14885; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Fleurie A, 2012, MOL MICROBIOL, V83, P746, DOI 10.1111/j.1365-2958.2011.07962.x; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Franz-Wachtel M, 2012, MOL CELL PROTEOMICS, V11, P160, DOI 10.1074/mcp.M111.016014; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HIGGINS ML, 1970, J BACTERIOL, V101, P643, DOI 10.1128/JB.101.2.643-648.1970; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Krol E, 2013, JOVE-J VIS EXP, DOI 10.3791/50844; Krol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043293; Krzywinski M, 2013, NAT METHODS, V10, P1041, DOI 10.1038/nmeth.2698; Krzywinski M, 2013, NAT METHODS, V10, P809, DOI 10.1038/nmeth.2613; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; Lesterlin C, 2014, NATURE, V506, P249, DOI 10.1038/nature12868; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Martin B, 2000, MOL MICROBIOL, V38, P867, DOI 10.1046/j.1365-2958.2000.02187.x; Martin B, 2010, MOL MICROBIOL, V75, P1513, DOI 10.1111/j.1365-2958.2010.07071.x; Monahan LG, 2013, MOL MICROBIOL, V87, P231, DOI 10.1111/mmi.12114; Monahan LG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00019; Morlot C, 2003, MOL MICROBIOL, V50, P845, DOI 10.1046/j.1365-2958.2003.03767.x; Morlot C, 2013, MOL MICROBIOL, V90, P88, DOI 10.1111/mmi.12348; Novakova L, 2010, J BACTERIOL, V192, P3629, DOI 10.1128/JB.01564-09; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; TOMASZ A, 1964, J CELL BIOL, V22, P453, DOI 10.1083/jcb.22.2.453; Wheeler R, 2011, MOL MICROBIOL, V82, P1096, DOI 10.1111/j.1365-2958.2011.07871.x; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671	50	131	134	3	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					259	+		10.1038/nature13966	http://dx.doi.org/10.1038/nature13966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25470041	Green Accepted			2022-12-28	WOS:000346383500048
J	Pilling, MJ				Pilling, Michael J.			Calculating the pressure dependence of chemical reactions	SCIENCE			English	Editorial Material							KINETICS		Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Pilling, MJ (corresponding author), Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England.	m.j.pilling@leeds.ac.uk						BROUARD M, 1989, J PHYS CHEM-US, V93, P4047, DOI 10.1021/j100347a037; Jasper AW, 2014, SCIENCE, V346, P1212, DOI 10.1126/science.1260856; Klippenstein SJ, 2006, PHYS CHEM CHEM PHYS, V8, P1133, DOI 10.1039/b515914h; Klippenstein SJ, 1999, J PHYS CHEM A, V103, P9388, DOI 10.1021/jp991574x; Miller JA, 2006, J PHYS CHEM A, V110, P10528, DOI 10.1021/jp062693x; Nguyen TL, 2011, J PHYS CHEM A, V115, P5118, DOI 10.1021/jp2022743; Zador J, 2011, PROG ENERG COMBUST, V37, P371, DOI 10.1016/j.pecs.2010.06.006	7	6	6	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1183	1184		10.1126/science.aaa1257	http://dx.doi.org/10.1126/science.aaa1257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477442				2022-12-28	WOS:000346189000042
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN Don't forget the relatives	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Sokol, DK (corresponding author), 12 Kings Bench Walk, Temple, London, England.	daniel.sokol@talk21.com						General Medical Council, TREATMENT AND CARE T; Osler W., 1928, COMMUNICATION, P153	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2014	349								g7351	10.1136/bmj.g7351	http://dx.doi.org/10.1136/bmj.g7351			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KN	25471549				2022-12-28	WOS:000346116600003
J	Lee, N				Lee, Naomi			The Lancet Technology: November, 2014	LANCET			English	Editorial Material												naomi.lee@lancet.com							0	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1917	1917		10.1016/S0140-6736(14)62267-4	http://dx.doi.org/10.1016/S0140-6736(14)62267-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25478615				2022-12-28	WOS:000345450100015
J	Shang, Y; Ma, YS; Zhou, Y; Zhang, HM; Duan, LX; Chen, HM; Zeng, JG; Zhou, Q; Wang, SH; Gu, WJ; Liu, M; Ren, JW; Gu, XF; Zhang, SP; Wang, Y; Yasukawa, K; Bouwmeester, HJ; Qi, XQ; Zhang, ZH; Lucas, WJ; Huang, SW				Shang, Yi; Ma, Yongshuo; Zhou, Yuan; Zhang, Huimin; Duan, Lixin; Chen, Huiming; Zeng, Jianguo; Zhou, Qian; Wang, Shenhao; Gu, Wenjia; Liu, Min; Ren, Jinwei; Gu, Xingfang; Zhang, Shengping; Wang, Ye; Yasukawa, Ken; Bouwmeester, Harro J.; Qi, Xiaoquan; Zhang, Zhonghua; Lucas, William J.; Huang, Sanwen			Biosynthesis, regulation, and domestication of bitterness in cucumber	SCIENCE			English	Article							SPECIALIZED METABOLISM; BIOLOGICAL-ACTIVITIES; CUCURBITACIN-C; CANCER-CELLS; SATIVUS L; PLANTS; GENE; RESISTANCE; PATHWAY	Cucurbitacins are triterpenoids that confer a bitter taste in cucurbits such as cucumber, melon, watermelon, squash, and pumpkin. These compounds discourage most pests on the plant and have also been shown to have antitumor properties. With genomics and biochemistry, we identified nine cucumber genes in the pathway for biosynthesis of cucurbitacin C and elucidated four catalytic steps. We discovered transcription factors Bl (Bitter leaf) and Bt (Bitter fruit) that regulate this pathway in leaves and fruits, respectively. Traces in genomic signatures indicated that selection imposed on Bt during domestication led to derivation of nonbitter cucurbits from their bitter ancestors.	[Shang, Yi; Ma, Yongshuo; Zhou, Yuan; Zhang, Huimin; Zhou, Qian; Wang, Shenhao; Gu, Wenjia; Liu, Min; Gu, Xingfang; Zhang, Shengping; Wang, Ye; Zhang, Zhonghua; Huang, Sanwen] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom, Inst Vegetables & Flowers,Minist Agr, Beijing 100081, Peoples R China; [Shang, Yi; Huang, Sanwen] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen 518124, Peoples R China; [Ma, Yongshuo; Zhang, Huimin; Liu, Min] Nanjing Agr Univ, Coll Life Sci, Nanjing 210095, Jiangsu, Peoples R China; [Zhou, Yuan; Zeng, Jianguo] Hunan Agr Univ, Hort & Landscape Coll, Natl Chinese Med Herbs Technol Ctr, Changsha 410128, Hunan, Peoples R China; [Duan, Lixin; Qi, Xiaoquan] Chinese Acad Sci, Inst Bot, Beijing 100093, Peoples R China; [Chen, Huiming] Hunan Acad Agr Sci, Hunan Vegetable Res Inst, Changsha 410125, Hunan, Peoples R China; [Gu, Wenjia] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Ren, Jinwei] Chinese Acad Sci, Inst Microbiol, Beijing 100190, Peoples R China; [Yasukawa, Ken] Nihon Univ, Sch Pharm, Tokyo 1018308, Japan; [Bouwmeester, Harro J.] Wageningen Univ, Lab Plant Physiol, NL-6700 Wageningen, Netherlands; [Lucas, William J.] Univ Calif Davis, Coll Biol Sci, Dept Plant Biol, Davis, CA 95616 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Nanjing Agricultural University; Hunan Agricultural University; Chinese Academy of Sciences; Institute of Botany, CAS; Hunan Academy of Agricultural Sciences; Wuhan University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Nihon University; Wageningen University & Research; University of California System; University of California Davis	Huang, SW (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom, Inst Vegetables & Flowers,Minist Agr, Beijing 100081, Peoples R China.	huangsanwen@caas.cn	Bouwmeester, Harro J/C-1414-2008; Huang, Sanwen/ABE-9053-2020; Qi, Xiaoquan/G-1545-2010; Zhou, Yuan/J-6908-2017	Huang, Sanwen/0000-0002-8547-5309; Qi, Xiaoquan/0000-0001-7175-115X; Zhou, Yuan/0000-0003-2892-0100; Ma, Yongshuo/0000-0002-0748-2810; Bouwmeester, Harro/0000-0003-0907-2732; Lucas, William/0000-0003-4714-7491; zhang, zhonghua/0000-0002-1034-227X; Zhou, Qian/0000-0002-5269-8178; Shang, Yi/0000-0001-5795-1198	Spanish Consolider-Ingenio program [CPAN CSD2007-00042, MultiDark CSD2009-00064]; Academy of Finland [127740]; DFG Cluster of Excellence; Croatian Science Foundation (HrZZ) [09/176]; University of Rijeka [13.12.1.3.02]; DFG Collaborative Research Centers [SFB823/C4, SFB876/C3]; Polish MNiSzW grant [745/N-HESS-MAGIC/2010/0]; DFG [WI 1860/10-1]; ERDF; Spanish MINECO [FPA2012-39502, JCI-2011-10019, AYA2009-13036-C02-02, AYA2012-38491-C02-01]; Generalitat Valenciana [PROMETEO/2009/104]; COST [MP0905]; national research councils; European Commission [283393]	Spanish Consolider-Ingenio program(Spanish Government); Academy of Finland(Academy of Finland); DFG Cluster of Excellence(German Research Foundation (DFG)); Croatian Science Foundation (HrZZ); University of Rijeka; DFG Collaborative Research Centers(German Research Foundation (DFG)); Polish MNiSzW grant; DFG(German Research Foundation (DFG)); ERDF(European Commission); Spanish MINECO(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); COST(European Cooperation in Science and Technology (COST)); national research councils; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank the Instituto de Astrofisica de Canarias for the excellent working conditions at the Observatorio del Roque de los Muchachos in La Palma. The support of the German BMBF and MPG, the Italian INFN, the Swiss National Fund SNF, and the Spanish MICINN is gratefully acknowledged. This work was also supported by the CPAN CSD2007-00042 and MultiDark CSD2009-00064 projects of the Spanish Consolider-Ingenio 2010 program, by grant 127740 of the Academy of Finland, by the DFG Cluster of Excellence "Origin and Structure of the Universe", by the Croatian Science Foundation (HrZZ) Projects 09/176, by the University of Rijeka Project 13.12.1.3.02, by the DFG Collaborative Research Centers SFB823/C4 and SFB876/C3, and by the Polish MNiSzW grant 745/N-HESS-MAGIC/2010/0. We thank also the support by DFG WI 1860/10-1. J. S. was supported by ERDF and the Spanish MINECO through FPA2012-39502 and JCI-2011-10019 grants. E. R. was partially supported by the Spanish MINECO projects AYA2009-13036-C02-02 and AYA2012-38491-C02-01 and by the Generalitat Valenciana project PROMETEO/2009/104, as well as by the COST MP0905 action 'Black Holes in a Violent Universe.' The European VLBI Network is a joint facility of European, Chinese, South African and other radio astronomy institutes funded by their national research councils. The research leading to these results has received funding from the European Commission Seventh Framework Programme (FP/2007-2013) under grant agreement No. 283393 (RadioNet3). The MAGIC data are archived in the data center at the Port dInformacio Cientfica (PIC) in Barcelona. The EVN data are available at the Data Archive at the Joint Institute for VLBI in Europe (JIVE).	Balkema-Boomstra AG, 2003, J CHEM ECOL, V29, P225, DOI 10.1023/A:1021945101308; Blaskovich MA, 2003, CANCER RES, V63, P1270; Chae L, 2014, SCIENCE, V344, P510, DOI 10.1126/science.1252076; Chen JC, 2005, NAT PROD REP, V22, P386, DOI 10.1039/b418841c; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; DACOSTA CP, 1971, SCIENCE, V172, P1145, DOI 10.1126/science.172.3988.1145; De Luca V, 2012, SCIENCE, V336, P1658, DOI 10.1126/science.1217410; Dwivedi NK, 2010, GENET RESOUR CROP EV, V57, P443, DOI 10.1007/s10722-009-9484-5; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Horie H, 2007, JARQ-JPN AGR RES Q, V41, P65, DOI 10.6090/jarq.41.65; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; METCALF RL, 1980, P NATL ACAD SCI-BIOL, V77, P3769, DOI 10.1073/pnas.77.7.3769; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Shibuya M, 2004, TETRAHEDRON, V60, P6995, DOI 10.1016/j.tet.2004.04.088; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839	19	258	308	36	506	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1084	1088		10.1126/science.1259215	http://dx.doi.org/10.1126/science.1259215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430763				2022-12-28	WOS:000345763400035
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Stop playing politics with illegal drug use	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Home Office, 2014, DRUGS INT COMP; Hughes CE, 2010, BRIT J CRIMINOL, V50, P999, DOI 10.1093/bjc/azq038; Johnson A., 2009, GUARDIAN; Light M, 2013, MINISTRY JUSTICE ANA; Nordt C, 2006, LANCET, V367, P1830, DOI 10.1016/S0140-6736(06)68804-1; Nutt DJ, 2009, J PSYCHOPHARMACOL, V23, P3, DOI 10.1177/0269881108099672; Parliament.uk, 2013, 9 PARL UK	7	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2014	349								g7273	10.1136/bmj.g7273	http://dx.doi.org/10.1136/bmj.g7273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KG	25430933	Green Published, hybrid			2022-12-28	WOS:000346115800010
J	Davies, P				Davies, Peter			NHS Exposing the myth that reconfiguration of clinical services improves quality and saves money	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												petergdavies@ntlworld.com						Gulland A., 2001, BMJ-BRIT MED J, V332, P1143; Iacobucci G., 2013, BMJ-BRIT MED J, V347, pf4884; King's Fund, 2014, REC CLIN SERV WHAT I; Torjesen I, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4905	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2014	349								g7172	10.1136/bmj.g7172	http://dx.doi.org/10.1136/bmj.g7172			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KF	25428345				2022-12-28	WOS:000346115700017
J	Webb, S; Sherburn, M; Ismail, KMK				Webb, Sara; Sherburn, Margaret; Ismail, Khaled M. K.			Managing perineal trauma after childbirth	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MORBIDITY; REPAIR		[Webb, Sara; Ismail, Khaled M. K.] Birmingham Womens NHS Fdn Trust, Birmingham B15 2TG, W Midlands, England; [Sherburn, Margaret] Univ Melbourne, Dept Physiotherapy, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia; [Sherburn, Margaret] Royal Womens Hosp, Melbourne, Vic, Australia; [Ismail, Khaled M. K.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham Ctr Womens & Childrens Hlth, Birmingham B15 2TT, W Midlands, England	University of Melbourne; University of Birmingham	Ismail, KMK (corresponding author), Birmingham Womens NHS Fdn Trust, Acad Unit, Birmingham B15 2TG, W Midlands, England.	K.Ismail@bham.ac.uk	Ismail, Khaled/Z-5530-2019	Ismail, Khaled/0000-0001-9449-0706	Keele University, Office of Research and Enterprise; National Institute for Health Research; National Institute for Health Research [CDRF-2012-03-064] Funding Source: researchfish	Keele University, Office of Research and Enterprise; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	We have read and understood the BMJ policy on declaration of interests and declare the following interests: KMKI receives royalty fees for sales relating to the Keele and Staffs episiotomy trainer, managed through Keele University, Office of Research and Enterprise. Money generated from this funds academic activities related to women's health. SW is partly funded by a clinical doctoral fellowship from the National Institute for Health Research. The authors had no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Abbott D, 2010, BMJ-BRIT MED J, V341, P140; Abrams P, 2017, INCONTINENCE 6 INT C; AlMufti R, 1997, EUR J OBSTET GYN R B, V73, P1, DOI 10.1016/S0301-2115(96)02692-9; Bick DE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-57; Boyle R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007471.pub2; Byrd LM, 2005, COLORECTAL DIS, V7, P311, DOI 10.1111/j.1463-1318.2005.00801.x; Chandru S, 2010, GYNECOL SURG, V7, P245, DOI 10.1007/s10397-009-0501-7; Dudley L, 2013, COCHRANE DB SYST REV, V9; Dudley L., 2013, BR J MIDWIF, V21, P160, DOI [DOI 10.12968/BJOM.2013.21.3.160, 10.12968/bjom.2013.21.3.160]; Dudley L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001458; East CE, 2007, COCHRANE DB SYST REV, V4; East CE, 2012, MIDWIFERY, V28, P93, DOI 10.1016/j.midw.2010.11.009; Elharmeel SMA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008534.pub2; Glazener CMA, 1997, BRIT J OBSTET GYNAEC, V104, P330, DOI 10.1111/j.1471-0528.1997.tb11463.x; GLAZENER CMA, 1995, BRIT J OBSTET GYNAEC, V102, P282, DOI 10.1111/j.1471-0528.1995.tb09132.x; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Ismail KMK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-209; KALTREIDER D F, 1948, South Med J, V41, P814; Kettle C, 2002, LANCET, V359, P2217, DOI 10.1016/S0140-6736(02)09312-1; Kettle C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000947.pub3; Kettle C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000006.pub2; Mahmud A, 2013, BRIT J OBSTET GYNAEC, P120; National Institute for Health and Care Excellence, 2006, POSTN CAR ROUT POSTN; National Institute for Health and Care Excellence, 2007, INTR CAR; Olsson A, 2005, SCAND J CARING SCI, V19, P381, DOI 10.1111/j.1471-6712.2005.00357.x; Radestad I, 2008, BIRTH-ISS PERINAT C, V35, P98, DOI 10.1111/j.1523-536X.2008.00222.x; Rogers RG, 2009, J MIDWIFERY WOM HEAL, V54, P98, DOI 10.1016/j.jmwh.2008.09.001; Royal College of Obstetricians and Gynaecologists, 2007, 3 4 DEGR PER TEARS M; SLEEP J, 1987, BRIT MED J, V295, P749, DOI 10.1136/bmj.295.6601.749; Sultan A. H., 1995, Journal of Obstetrics and Gynaecology (Abingdon), V15, P19, DOI 10.3109/01443619509007724	30	9	9	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2014	349								g6829	10.1136/bmj.g6829	http://dx.doi.org/10.1136/bmj.g6829			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KF	25425212				2022-12-28	WOS:000346115700005
J	Subramaniam, AR; Zid, BM; O'Shea, EK				Subramaniam, Arvind R.; Zid, Brian M.; O'Shea, Erin K.			An Integrated Approach Reveals Regulatory Controls on Bacterial Translation Elongation	CELL			English	Article							AMINO-ACID STARVATION; TRANSFER-RNA ISOACCEPTORS; ESCHERICHIA-COLI; RIBOSOME-RESCUE; MESSENGER-RNA; GENE-EXPRESSION; CODON USAGE; PROTEIN TRANSLATION; QUALITY-CONTROL; TMRNA SYSTEM	Ribosomes elongate at a nonuniform rate during translation. Theoretical models and experiments disagree on the in vivo determinants of elongation rate and the mechanism by which elongation rate affects protein levels. To resolve this conflict, we measured transcriptome-wide ribosome occupancy under multiple conditions and used it to formulate a whole-cell model of translation in E. coli. Our model predicts that elongation rates at most codons during nutrient-rich growth are not limited by the intracellular concentrations of aminoacyl-tRNAs. However, elongation pausing during starvation for single amino acids is highly sensitive to the kinetics of tRNA aminoacylation. We further show that translation abortion upon pausing accounts for the observed ribosome occupancy along mRNAs during starvation. Abortion reduces global protein synthesis, but it enhances the translation of a subset of mRNAs. These results suggest a regulatory role for aminoacylation and abortion during stress, and our study provides an experimentally constrained framework for modeling translation.	[Subramaniam, Arvind R.; Zid, Brian M.; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Subramaniam, Arvind R.; Zid, Brian M.; O'Shea, Erin K.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Subramaniam, AR (corresponding author), Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.	asubram@fas.harvard.edu; erin_oshea@harvard.edu		Subramaniam, Arvind Rasi/0000-0001-6145-4303; Zid, Brian/0000-0003-1876-2479	NIH [GM107113]; Howard Hughes Medical Institute; FAS Division of Science, Research Computing Group at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM107113, K99GM107113] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); FAS Division of Science, Research Computing Group at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Calarco, P. Cluzel, V. Denic, A. Murray, and C. Shoemaker for discussions; G.W. Li and E. Oh for advice on ribosome profiling; G.L. Chew and A. Gutu for advice on northern blotting; H. Aiba for the XL001 strain; P. Shah for clarifications on the yeast model; and K. Amarnath, A. Buskirk, S. Chandrasekaran, A. Darnell, G. W. Li, W. Moebius, J. Moffitt, P. Shah, and E. Wallace for comments on the manuscript. The computations in this paper were run on the Odyssey cluster supported by the FAS Division of Science, Research Computing Group at Harvard University. This research was supported by an NIH K99 Pathway to Independence Award GM107113 (A.R.S.) and by the Howard Hughes Medical Institute (E.K.O.).	Abo T, 2002, GENES CELLS, V7, P629, DOI 10.1046/j.1365-2443.2002.00549.x; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; [Anonymous], [No title captured]; BILGIN N, 1994, J MOL BIOL, V235, P813, DOI 10.1006/jmbi.1994.1041; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Brewster RC, 2014, CELL, V156, P1312, DOI 10.1016/j.cell.2014.02.022; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Fender A, 2004, BIOCHIMIE, V86, P21, DOI 10.1016/j.biochi.2003.11.011; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; HARRIS CL, 1980, NUCLEIC ACIDS RES, V8, P2023, DOI 10.1093/nar/8.9.2023; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ivanova N, 2005, J MOL BIOL, V350, P897, DOI 10.1016/j.jmb.2005.05.033; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; JACQUES N, 1990, MOL MICROBIOL, V4, P1063, DOI 10.1111/j.1365-2958.1990.tb00679.x; Keiler K.C., 2014, J BACTERIOL JB; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Li X, 2008, MOL MICROBIOL, V68, P462, DOI 10.1111/j.1365-2958.2008.06167.x; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; MYERS G, 1971, J BIOL CHEM, V246, P4955; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Pavlov MY, 1996, ARCH BIOCHEM BIOPHYS, V328, P9, DOI 10.1006/abbi.1996.0136; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Sorensen MA, 2005, J MOL BIOL, V354, P16, DOI 10.1016/j.jmb.2005.08.076; Sorensen MA, 2001, J MOL BIOL, V307, P785, DOI 10.1006/jmbi.2001.4525; Subramaniam AR, 2013, ELIFE, V2, DOI 10.7554/eLife.01501; Subramaniam AR, 2013, P NATL ACAD SCI USA, V110, P2419, DOI 10.1073/pnas.1211077110; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; VIND J, 1993, J MOL BIOL, V231, P678, DOI 10.1006/jmbi.1993.1319; Wallace EWJ, 2013, MOL BIOL EVOL, V30, P1438, DOI 10.1093/molbev/mst051; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Wintermeyer W, 2004, BIOCHEM SOC T, V32, P733, DOI 10.1042/BST0320733; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; YEGIAN CD, 1966, P NATL ACAD SCI USA, V55, P839, DOI 10.1073/pnas.55.4.839; Zaher HS, 2011, CELL, V147, P396, DOI 10.1016/j.cell.2011.08.045; ZHANG SP, 1994, J THEOR BIOL, V170, P339, DOI 10.1006/jtbi.1994.1196	58	92	93	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1200	1211		10.1016/j.cell.2014.10.043	http://dx.doi.org/10.1016/j.cell.2014.10.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416955	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000345506300028
J	Pang, T; Panisset, U; Becerra-Posada, F; Horton, R; Frenk, J				Pang, Tikki; Panisset, Ulysses; Becerra-Posada, Francisco; Horton, Richard; Frenk, Julio			The spirit of Mexico: a decade on	LANCET			English	Editorial Material							HEALTH; SYSTEMS; POLICY		[Pang, Tikki] Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore 25972, Singapore; [Panisset, Ulysses] WHO, CH-1211 Geneva, Switzerland; [Becerra-Posada, Francisco] Pan Amer Hlth Org, Washington, DC USA; [Horton, Richard] The Lancet, London, England; [Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	National University of Singapore; World Health Organization; Pan American Health Organization; Harvard University; Harvard T.H. Chan School of Public Health	Pang, T (corresponding author), Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore 25972, Singapore.	spptep@nus.edu.sg			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2004, LANCET, V364, P1911; Becerra-Posada F, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-13; Bennett S, 2008, LANCET, V372, P1571, DOI 10.1016/S0140-6736(08)61658-X; De Angelis C, 2004, LANCET, V364, P911, DOI 10.1016/S0140-6736(04)17034-7; El-Jardali F, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-2; Hamid M, 2005, LANCET, V366, P1758, DOI 10.1016/S0140-6736(05)67709-4; Horton R, 2006, LANCET, V367, P1633, DOI 10.1016/S0140-6736(06)68709-6; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; Rottingen JA, 2009, LANCET, V373, P193, DOI 10.1016/S0140-6736(09)60054-4; Terry RF, 2014, SCIENCE, V345, P1302, DOI 10.1126/science.1258737; Viergever RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084727; WHO, 2004, REP MIN SUMM HLTH RE; World Health Organization, 2004, WORLD REP KNOWL BETT; World Health Organization, 2005, MIN SUMM HLTH RES RE	14	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2028	2029		10.1016/S0140-6736(14)61893-6	http://dx.doi.org/10.1016/S0140-6736(14)61893-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI7XK	25467567				2022-12-28	WOS:000354979100010
J	Carter, J				Carter, Jimmy			Patriarchy and violence against women and girls	LANCET			English	Editorial Material									Carter Ctr, Atlanta, GA 30307 USA		Carter, J (corresponding author), Carter Ctr, Atlanta, GA 30307 USA.	lauren.gay@emory.edu						[Anonymous], 2008, PEW INTERNET AM LIFE; Beijing Platform for Action, 1995, 4 WORLD C WOM BEIJ C; Black M.C., 2011, NATL INTIMATE PARTNE; Brown G., 2013, WEDLOCK SCH COMBATTI; Carter J., 2014, CALL ACTION RELIG WO; Ellsberg M, 2014, LANCET; Garcia-Moreno C, 2014, LANCET; Hegewisch A, 2014, GENDER WAGE GAP 2013; Hvistendahl Mara., 2012, UNNATURAL SELECTION; Jewkes R, 2014, LANCET; Krebs C.P, 2007, CAMPUS SEXUAL ASSAUL; Michau L, 2014, LANCET; Sarkeesian A, 2013, TROPES VS WOMEN VIDE; Wingfield N., 2014, NY TIMES	14	24	26	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					E40	E41		10.1016/S0140-6736(14)62217-0	http://dx.doi.org/10.1016/S0140-6736(14)62217-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG6NG	25467580				2022-12-28	WOS:000353418000002
J	Garcia-Moreno, C; Zimmerman, C; Morris-Gehring, A; Heise, L; Amin, A; Abrahams, N; Montoya, O; Bhate-Deosthali, P; Kilonzo, N; Watts, C				Garcia-Moreno, Claudia; Zimmerman, Cathy; Morris-Gehring, Alison; Heise, Lori; Amin, Avni; Abrahams, Naeemah; Montoya, Oswaldo; Bhate-Deosthali, Padma; Kilonzo, Nduku; Watts, Charlotte			Violence against women and girls 5 Addressing violence against women: a call to action	LANCET			English	Article							INTIMATE PARTNER VIOLENCE; RANDOMIZED CONTROLLED-TRIAL; HEALTH; PREVALENCE; IMPACT; INTERVENTION; MULTICOUNTRY; EXPERIENCES; COSTS; ABUSE	Violence against women and girls is prevalent worldwide but historically has been overlooked and condoned. Growing international recognition of these violations creates opportunities for elimination, although solutions will not be quick or easy. Governments need to address the political, social, and economic structures that subordinate women, and implement national plans and make budget commitments to invest in actions by multiple sectors to prevent and respond to abuse. Emphasis on prevention is crucial. Community and group interventions involving women and men can shift discriminatory social norms to reduce the risk of violence. Education and empowerment of women are fundamental. Health workers should be trained to identify and support survivors and strategies to address violence should be integrated into services for child health, maternal, sexual, and reproductive health, mental health, HIV, and alcohol or substance abuse. Research to learn how to respond to violence must be strengthened. The elimination of violence against women and girls is central to equitable and sustainable social and economic development and must be prioritised in the agenda for development after 2015.	[Garcia-Moreno, Claudia; Amin, Avni] WHO, Dept Reprod Hlth & Res, CH-1121 Geneva 27, Switzerland; [Zimmerman, Cathy; Morris-Gehring, Alison; Heise, Lori; Watts, Charlotte] London Sch Hyg & Trop Med, London WC1, England; [Abrahams, Naeemah] MRC, Cape Town, South Africa; [Montoya, Oswaldo] MenEngage, Washington, DC USA; [Bhate-Deosthali, Padma] Ctr Enquiry Hlth & Allied Themes, Bombay, Maharashtra, India; [Kilonzo, Nduku] Natl AIDS Control Council, Nairobi, Kenya	World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Garcia-Moreno, C (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1121 Geneva 27, Switzerland.	garciamorenoc@who.int	Heise, LORI/AAI-6251-2020; Abrahams, Naeemah/AAF-1144-2020	Abrahams, Naeemah/0000-0002-6138-6256	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Abrahams N, 2014, LANCET, V383, P1648, DOI 10.1016/S0140-6736(13)62243-6; Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; [Anonymous], 2011, WORKING PAPER; [Anonymous], 2010, REPROD HEALTH MATTER, V18, P226; [Anonymous], 2012, ILO GLOB EST FORC LA; Ansara DL, 2010, SOC SCI MED, V70, P1011, DOI 10.1016/j.socscimed.2009.12.009; BERG RC, 2013, OBSTET GYNECOL INT, V2013, DOI DOI 10.1155/2013/496564; Black CM, 2001, AM J LIFESTYLE MED, V5, P428; Bonomi AE, 2009, HEALTH SERV RES, V44, P1052, DOI 10.1111/j.1475-6773.2009.00955.x; Clark KA, 2002, VIOLENCE AGAINST WOM, V8, P417, DOI 10.1177/10778010222183143; Colombini M, 2008, B WORLD HEALTH ORGAN, V86, P635, DOI 10.2471/BLT.07.045906; Department of Health and Human Services Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2003, COSTS INT PARTN VIOL; Department of Social Services, 2004, COST DOM VIOL AUST 1; Diop NJ, 2009, STUD FAMILY PLANN, V40, P307, DOI 10.1111/j.1728-4465.2009.00213.x; Domino ME, 2005, PSYCHIAT SERV, V56, P1223, DOI 10.1176/appi.ps.56.10.1223; Ellsberg M, 2014, LANCET; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Garcia-Moreno C, 2002, LANCET, V359, P1509, DOI 10.1016/S0140-6736(02)08417-9; Garcia-Moreno C, 2014, LANCET; Garcia-Moreno C, 2011, B WORLD HEALTH ORGAN, V89, P2, DOI 10.2471/BLT.10.085217; Gracia E, 2014, B WORLD HEALTH ORGAN, V92, P380, DOI 10.2471/BLT.13.131391; Hallward-Driemeier Mary, 2013, WOMENS LEGAL RIGHTS; Heise L., 2002, WORLD REPORT VIOLENC, V1, P87, DOI DOI 10.1503/CMAJ.1150071; Heise L, LANCET GLOB IN PRESS; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Hossain M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-339; Htun M, 2012, AM POLIT SCI REV, V106, P548, DOI 10.1017/S0003055412000226; Humphreys J, 2012, BIOL RES NURS, V14, P115, DOI 10.1177/1099800411398479; International Rescue Committee, 2012, LET ME NOT DIE MY TI; Jewkes R., 2002, WORLD REPORT VIOLENC, P149; Jewkes R, 2014, LANCET; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Khumalo B., 2014, TOO COSTLY IGNORE EC; Kim JC, 2007, AM J PUBLIC HEALTH, V97, P1794, DOI 10.2105/AJPH.2006.095521; Koenig MA, 2003, DEMOGRAPHY, V40, P269, DOI 10.1353/dem.2003.0014; MacMillan HL, 2009, LANCET, V373, P250, DOI 10.1016/S0140-6736(08)61708-0; Michau L, 2014, LANCET; Morrison A, 1999, SOCIAL EC COSTS DOME, P51; Nasrullah M, 2009, EUR J PUBLIC HEALTH, V19, P193, DOI 10.1093/eurpub/ckp021; National Council to Reduce Violence Against Women and Their Children, 2009, COST VIOL WOM THEIR; National Institute for Health and Care Excellence (NICE), 2013, REV INT ID PREV RED; Putnam FW, 2003, J AM ACAD CHILD PSY, V42, P269, DOI 10.1097/00004583-200303000-00006; Schuler SR, 1996, SOC SCI MED, V43, P1729, DOI 10.1016/S0277-9536(96)00068-8; Stockl H, 2013, LANCET, V382, P859, DOI 10.1016/S0140-6736(13)61030-2; The Organisation for Economic Co-operation and Development, 2012, SOC I GEND IND; Towers J., 2012, MEASURING IMPACT CUT; UN Women, UN TRUST FUND END VI; United Nations Children's Fund, 2014, ENV FINANCE BLO 0116; United Nations Children's Fund, 2013, FEM GEN MUT CUTT STA; United Nations Development Fund for Women, UN TRUST FUND ENG VI; United Nations Office on Drugs and Crime, 2004, UN CONV TRANSN ORG C, P41; Wagman J, 2014, IMPACT INEGRATED INT; Walby S., 2004, COST DOMESTIC VIOLEN; Warshaw C, 1997, ACAD MED, V72, pS26; WHO, 2007, MAN EST EC COSTS INJ; WHO, 2012, 65 WORLD HLTH ASS PR; WHO, 2006, PREV CHILD MALTR GUI; World Bank, 2013, WOM BUS LAW 2014 REM; World Bank, 2014, VOIC AG EMP WOM GIRL; World Health Organization, 2013, RESP IN PARTN VIOL S; World Health Organization, 2008, EL FEM GEN MUT INT S; World Health Organization, 2005, WHO MULT STUD WOM HL; World Health Organization, 2021, VIOL WOM PREV EST 20; World Health Organization/London School of Hygiene and Tropical Medicine, 2010, PREV INT PARTN SEX V; Zimmerman C, 2008, AM J PUBLIC HEALTH, V98, P55, DOI 10.2105/AJPH.2006.108357	67	184	194	0	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1685	1695		10.1016/S0140-6736(14)61830-4	http://dx.doi.org/10.1016/S0140-6736(14)61830-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG6NG	25467579				2022-12-28	WOS:000353418000041
J	Dayer, MJ; Jones, S; Prendergast, B; Baddour, LM; Lockhart, PB; Thornhill, MH				Dayer, Mark J.; Jones, Simon; Prendergast, Bernard; Baddour, Larry M.; Lockhart, Peter B.; Thornhill, Martin H.			Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis	LANCET			English	Article							ANTIBIOTIC-PROPHYLAXIS; TEMPORAL TRENDS; NICE GUIDANCE; PREVENTION; IMPACT; GUIDELINES; RISK; BACTEREMIA; DIAGNOSIS; ADULTS	Background Antibiotic prophylaxis given before invasive dental procedures in patients at risk of developing infective endocarditis has historically been the focus of infective endocarditis prevention. Recent changes in antibiotic prophylaxis guidelines in the USA and Europe have substantially reduced the number of patients for whom antibiotic prophylaxis is recommended. In the UK, guidelines from the National Institute for Health and Clinical Excellence (NICE) recommended complete cessation of antibiotic prophylaxis for prevention of infective endocarditis in March, 2008. We aimed to investigate changes in the prescribing of antibiotic prophylaxis and the incidence of infective endocarditis since the introduction of these guidelines. Methods We did a retrospective secular trend study, analysed as an interrupted time series, to investigate the effect of antibiotic prophylaxis versus no prophylaxis on the incidence of infective endocarditis in England. We analysed data for the prescription of antibiotic prophylaxis from Jan 1, 2004, to March 31, 2013, and hospital discharge episode statistics for patients with a primary diagnosis of infective endocarditis from Jan 1, 2000, to March 31, 2013. We compared the incidence of infective endocarditis before and after the introduction of the NICE guidelines using segmented regression analysis of the interrupted time series. Findings Prescriptions of antibiotic prophylaxis for the prevention of infective endocarditis fell substantially after introduction of the NICE guidance (mean 10 900 prescriptions per month [Jan 1, 2004, to March 31, 2008] vs 2236 prescriptions per month [April 1, 2008, to March 31, 2013], p<0. 0001). Starting in March, 2008, the number of cases of infective endocarditis increased significantly above the projected historical trend, by 0.11 cases per 10 million people per month (95% CI 0.05-0.16, p<0.0001). By March, 2013, 35 more cases per month were reported than would have been expected had the previous trend continued. This increase in the incidence of infective endocarditis was significant for both individuals at high risk of infective endocarditis and those at lower risk. Interpretation Although our data do not establish a causal association, prescriptions of antibiotic prophylaxis have fallen substantially and the incidence of infective endocarditis has increased significantly in England since introduction of the 2008 NICE guidelines.	[Dayer, Mark J.] Taunton & Somerset NHS Trust, Dept Cardiol, Taunton, Somerset, England; [Jones, Simon] Univ Surrey, Integrated Care Res, Guildford GU2 5XH, Surrey, England; [Prendergast, Bernard] John Radcliffe Hosp, Cardiothorac Serv, Dept Cardiol, Oxford OX3 9DU, England; [Baddour, Larry M.] Mayo Clin, Div Infect Dis, Coll Med, Rochester, MN USA; [Lockhart, Peter B.; Thornhill, Martin H.] Carolinas Med Ctr, Dept Oral Med, Charlotte, NC 28203 USA; [Thornhill, Martin H.] Univ Sheffield, Unit Oral & Maxillofacial Surg & Med, Sch Clin Dent, Sheffield S10 2TA, S Yorkshire, England	University of Surrey; University of Oxford; Mayo Clinic; Carolinas Medical Center; University of Sheffield	Thornhill, MH (corresponding author), Univ Sheffield, Unit Oral & Maxillofacial Surg & Med, Sch Clin Dent, Sheffield S10 2TA, S Yorkshire, England.	m.thornhill@sheffield.ac.uk	Dayer, Mark/AAE-4654-2020	Jones, Simon/0000-0002-8267-5647; Thornhill, Martin/0000-0003-0681-4083	Heart Research UK; Simplyhealth; US National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE023092] Funding Source: NIH RePORTER	Heart Research UK; Simplyhealth; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Heart Research UK, Simplyhealth, and US National Institutes of Health.	Aylin P, 2007, EUR J VASC ENDOVASC, V33, P461, DOI 10.1016/j.ejvs.2006.10.033; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Bikdeli B, 2013, J AM COLL CARDIOL, V62, P2217, DOI 10.1016/j.jacc.2013.07.071; Chambers JB, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3531; Connaughton M, 2008, BRIT MED J, V336, P771, DOI 10.1136/bmj.39512.666412.AD; Dayer MJ, 2013, QJM-INT J MED, V106, P237, DOI 10.1093/qjmed/hcs235; DeSimone DC, 2012, CIRCULATION, V126, P60, DOI 10.1161/CIRCULATIONAHA.112.095281; DURACK DT, 1995, NEW ENGL J MED, V332, P38, DOI 10.1056/NEJM199501053320107; Duval X, 2006, CLIN INFECT DIS, V42, pE102, DOI 10.1086/504385; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; FOX J, 2002, TIME SERIES REGRESSI; Gilg J, 2013, NEPHRON CLIN PRACT, V123, P1, DOI 10.1159/000353320; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Health & Social Care Information Centre, 2014, DIAB PREV; HINKLEY DV, 1970, BIOMETRIKA, V57, P1; HSCIC, 2014, NHS DENT STAT ENGL; HSCIC, HOSP EP STAT; HSCIC, 2014, METH CREAT CIP SPELL; Lacassin F, 1995, EUR HEART J, V16, P1968, DOI 10.1093/oxfordjournals.eurheartj.a060855; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lockhart PB, 2004, CIRCULATION, V109, P2878, DOI 10.1161/01.CIR.0000129303.90488.29; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Lockhart PB, 2007, J AM DENT ASSOC, V138, P458, DOI 10.14219/jada.archive.2007.0198; Lockhart PB, 2009, J AM DENT ASSOC, V140, P1238, DOI 10.14219/jada.archive.2009.0046; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; NICE, 2008, PROPH INF END; Office for National Statistics, 2012, CHANG OLD RES CAR HO; Pallasch Thomas J, 2003, Dent Clin North Am, V47, P665, DOI 10.1016/S0011-8532(03)00037-5; Pasquali SK, 2012, AM HEART J, V163, P894, DOI 10.1016/j.ahj.2012.03.002; Prendergast BD, 2006, HEART, V92, P879, DOI 10.1136/hrt.2005.067256; R Core Development Team, 2008, R LANG ENV STAT COMP; Richey R, 2008, BMJ-BRIT MED J, V336, P770, DOI 10.1136/bmj.39510.423148.AD; Rogers AM, 2008, J AM SOC ECHOCARDIOG, V21, P775, DOI 10.1016/j.echo.2008.04.001; Strom BL, 1998, ANN INTERN MED, V129, P761, DOI 10.7326/0003-4819-129-10-199811150-00002; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392; Tleyjeh IM, 2005, JAMA-J AM MED ASSOC, V293, P3022, DOI 10.1001/jama.293.24.3022; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095	38	332	346	8	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1219	1228		10.1016/S0140-6736(14)62007-9	http://dx.doi.org/10.1016/S0140-6736(14)62007-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25467569	Green Accepted, Green Submitted			2022-12-28	WOS:000351715100035
J	Franklin, SS; Weber, MA				Franklin, Stanley S.; Weber, Michael A.			Optimum antihypertensive therapy: does adiposity matter?	LANCET			English	Editorial Material							SERUM ALDOSTERONE; HYPERTENSION; RISK; OBESE		[Franklin, Stanley S.] Univ Calif Irvine, Div Cardiol, Heart Dis Prevent Program, Irvine, CA 92697 USA; [Weber, Michael A.] SUNY, Downstate Coll Med, Div Cardiovasc Med, Brooklyn, NY USA	University of California System; University of California Irvine; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College	Franklin, SS (corresponding author), Univ Calif Irvine, Div Cardiol, Heart Dis Prevent Program, Irvine, CA 92697 USA.	ssfranklinmd@earthlink.net						Blood Pressure Lowering Treatment Trialists' Collaboration, 2014, LANCET; Bomback AS, 2007, NAT CLIN PRACT NEPHR, V3, P486, DOI 10.1038/ncpneph0575; Calhoun DA, 2002, HYPERTENSION, V40, P892, DOI 10.1161/01.HYP.0000040261.30455.B6; Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; Cooper JN, 2013, HYPERTENS RES, V36, P895, DOI 10.1038/hr.2013.45; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Krug AW, 2008, HYPERTENSION, V51, P1252, DOI 10.1161/HYPERTENSIONAHA.107.109439; Landsberg L, 2013, J CLIN HYPERTENS, V15, P14, DOI 10.1111/jch.12049; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; Wassertheil-Smoller S, 2000, ARCH INTERN MED, V160, P494, DOI 10.1001/archinte.160.4.494; Weber MA, 2001, J AM COLL CARDIOL, V37, P169, DOI 10.1016/S0735-1097(00)01103-7; Weber MA, 2013, LANCET, V381, P537, DOI 10.1016/S0140-6736(12)61343-9	13	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					834	836		10.1016/S0140-6736(14)61336-2	http://dx.doi.org/10.1016/S0140-6736(14)61336-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25468165				2022-12-28	WOS:000350451100010
J	Stewart, S; Ball, J; Horowitz, JD; Marwick, TH; Mahadevan, G; Wong, C; Abhayaratna, WP; Chan, YK; Esterman, A; Thompson, DR; Scuffham, PA; Carrington, MJ				Stewart, Simon; Ball, Jocasta; Horowitz, John D.; Marwick, Thomas H.; Mahadevan, Gnanadevan; Wong, Chiew; Abhayaratna, Walter P.; Chan, Yih K.; Esterman, Adrian; Thompson, David R.; Scuffham, Paul A.; Carrington, Melinda J.			Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial	LANCET			English	Article							HOME-BASED INTERVENTION; HEART-FAILURE; CARE; HEALTH; RISK; PREVENTION; EPIDEMIC; WARFARIN	Background Patients are increasingly being admitted with chronic atrial fibrillation, and disease-specific management might reduce recurrent admissions and prolong survival. However, evidence is scant to support the application of this therapeutic approach. We aimed to assess SAFETY-a management strategy that is specific to atrial fibrillation. Methods We did a pragmatic, multicentre, randomised controlled trial in patients admitted with chronic, non-valvular atrial fibrillation (but not heart failure). Patients were recruited from three tertiary referral hospitals in Australia. 335 participants were randomly assigned by computer-generated schedule (stratified for rhythm or rate control) to either standard management (n=167) or the SAFETY intervention (n=168). Standard management consisted of routine primary care and hospital outpatient follow-up. The SAFETY intervention comprised a home visit and Holter monitoring 7-14 days after discharge by a cardiac nurse with prolonged follow-up and multidisciplinary support as needed. Clinical reviews were undertaken at 12 and 24 months (minimum follow-up). Coprimary outcomes were death or unplanned readmission (both all-cause), measured as event-free survival and the proportion of actual versus maximum days alive and out of hospital. Analyses were done on an intention-to-treat basis. The trial is registered with the Australian New Zealand Clinical Trials Registry (ANZCTRN 12610000221055). Findings During median follow-up of 905 days (IQR 773-1050), 49 people died and 987 unplanned admissions were recorded (totalling 5530 days in hospital). 127 (76%) patients assigned to the SAFETY intervention died or had an unplanned readmission (median event-free survival 183 days [IQR 116-409]) and 137 (82%) people allocated standard management achieved a coprimary outcome (199 days [116-249]; hazard ratio 0.97, 95% CI 0.76-1.23; p=0.851). Patients assigned to the SAFETY intervention had 99.5% maximum event-free days (95% CI 99.3-99.7), equating to a median of 900 (IQR 767-1025) of 937 maximum days alive and out of hospital. By comparison, those allocated to standard management had 99.2% (95% CI 98.8-99.4) maximum event-free days, equating to a median of 860 (IQR 752-1047) of 937 maximum days alive and out of hospital (effect size 0.22, 95% CI 0.21-0.23; p=0.039). Interpretation A post-discharge management programme specific to atrial fibrillation was associated with proportionately more days alive and out of hospital (but not prolonged event-free survival) relative to standard management. Disease-specific management is a possible strategy to improve poor health outcomes in patients admitted with chronic atrial fibrillation.	[Stewart, Simon; Ball, Jocasta; Chan, Yih K.; Thompson, David R.; Carrington, Melinda J.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic 3000, Australia; [Stewart, Simon; Chan, Yih K.; Carrington, Melinda J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Horowitz, John D.; Mahadevan, Gnanadevan] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Horowitz, John D.; Mahadevan, Gnanadevan] Univ Adelaide, Adelaide, SA, Australia; [Marwick, Thomas H.] Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Wong, Chiew] Footscray Hosp, Dept Cardiol, Melbourne, Vic, Australia; [Abhayaratna, Walter P.] Canberra Hosp, Div Med, Canberra, ACT, Australia; [Abhayaratna, Walter P.] Australian Natl Univ, Canberra, ACT, Australia; [Esterman, Adrian] Univ S Australia, Div Hlth Sci, Adelaide, SA 5001, Australia; [Scuffham, Paul A.] Griffith Univ, Ctr Appl Hlth Econ, Brisbane, Qld 4111, Australia	Australian Catholic University; Baker Heart and Diabetes Institute; University of Adelaide; University of Tasmania; Australian National University; Canberra Hospital; Australian National University; University of South Australia; Griffith University	Stewart, S (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic 3000, Australia.	simon.stewart@acu.edu.au	Scuffham, Paul/AAS-8084-2021; Scuffham, Paul/B-3066-2014; Esterman, Adrian J/D-1042-2009; Stewart, Simon/M-3316-2016; Thompson, David R/E-2431-2018; Marwick, Thomas/AAK-3869-2021	Scuffham, Paul/0000-0001-5931-642X; Scuffham, Paul/0000-0001-5931-642X; Stewart, Simon/0000-0001-9032-8998; Thompson, David R/0000-0001-8518-6307; Marwick, Thomas/0000-0001-9065-0899; Horowitz, John/0000-0001-6883-0703; Carrington, Melinda J/0000-0003-3865-1645; Chan, Yih-Kai/0000-0003-3836-8145; Esterman, Adrian/0000-0001-7324-9171; Abhayaratna, Walter/0000-0002-4908-0641	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	National Health and Medical Research Council of Australia.	Ariti CA, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.003; Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; Ball J, 2014, EUR J CARDIOVASC NUR; Ball J, 2013, INT J CARDIOL, V167, P1807, DOI 10.1016/j.ijcard.2012.12.093; Ball J, 2013, HEART, V99, P542, DOI 10.1136/heartjnl-2012-303182; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Carrington MJ, 2013, EUR J CARDIOVASC NUR, V12, P337, DOI 10.1177/1474515112451702; Carrington MJ, 2013, CIRC-CARDIOVASC QUAL, V6, P379, DOI 10.1161/CIRCOUTCOMES.111.000006; Carrington MJ, 2013, INT J CARDIOL, V166, P359, DOI 10.1016/j.ijcard.2011.10.065; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Feltner C, 2014, ANN INTERN MED, V160, P774, DOI 10.7326/M14-0083; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hendriks JML, 2012, EUR HEART J, V33, P2692, DOI 10.1093/eurheartj/ehs071; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Inglis Sally, 2004, J Cardiovasc Nurs, V19, P118; Krumholz HM, 2006, CIRCULATION, V114, P1432, DOI 10.1161/CIRCULATIONAHA.106.177322; Ledwidge M, 2013, JAMA-J AM MED ASSOC, V310, P66, DOI 10.1001/jama.2013.7588; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Page K, 2014, MED J AUSTRALIA, V201, P146, DOI 10.5694/mja14.00032; Patel NJ, 2014, CIRCULATION, V129, P2371, DOI 10.1161/CIRCULATIONAHA.114.008201; Pearson S, 2006, ARCH INTERN MED, V166, P645, DOI 10.1001/archinte.166.6.645; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748; Stewart S, 2014, INT J CARDIOL, V174, P600, DOI 10.1016/j.ijcard.2014.04.164; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	31	91	95	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					775	784		10.1016/S0140-6736(14)61992-9	http://dx.doi.org/10.1016/S0140-6736(14)61992-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC0UD	25467562				2022-12-28	WOS:000350051700031
J	Rao, JK				Rao, Jaya K.			Engaging Public Health in End-of-Life Issues: It Is Time to Step Up to the Plate	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE		Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Rao, JK (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	jrao@acponline.org						[Anonymous], 2014, AM IMPR QUAL HON IND; Committee on Care at the End of Life; Institute of Medicine, 1997, APPROACHING DEATH IM; D'Onofrio C, 2003, HASTINGS CENT REP, V33, pS30; Morhaim DK, 2013, AM J PUBLIC HEALTH, V103, pE8, DOI 10.2105/AJPH.2013.301316; Rao JK, 2014, AM J PREV MED, V46, P65, DOI 10.1016/j.amepre.2013.09.008; Rao JK, 2009, PREV CHRONIC DIS, V6; Rao JK, 2005, AM J PREV MED, V29, P453, DOI 10.1016/j.amepre.2005.08.014; Rao JK, 2002, AM J PREV MED, V23, P215, DOI 10.1016/S0749-3797(02)00500-7; Seaman JB, 2014, AM J HOSP PALLIAT CA	9	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					230	U142		10.7326/M14-2479	http://dx.doi.org/10.7326/M14-2479			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC1NP	25486456				2022-12-28	WOS:000350108100011
J	Monte, AA; Zane, RD; Heard, KJ				Monte, Andrew A.; Zane, Richard D.; Heard, Kennon J.			The Implications of Marijuana Legalization in Colorado	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL MARIJUANA; CANNABINOIDS		[Monte, Andrew A.; Zane, Richard D.; Heard, Kennon J.] Univ Colorado, Dept Emergency Med, Aurora, CO 80045 USA; [Monte, Andrew A.; Heard, Kennon J.] Rocky Mt Poison & Drug Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Monte, AA (corresponding author), Univ Colorado, Dept Emergency Med, Leprino Bldg,Seventh Floor,Campus Box B-215, Aurora, CO 80045 USA.	andrew.monte@ucdenver.edu			NCATS NIH HHS [UL1 TR001082] Funding Source: Medline; NIDA NIH HHS [R56 DA038366, 1R56DA038366-01] Funding Source: Medline; NIGMS NIH HHS [1K23GM110516-01, K23 GM110516] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM110516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA038366] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baca R, 2014, DENVER POST; Enforcement Division, MED LIC FAC; Esposito G, 2013, PHYTOTHER RES, V27, P633, DOI 10.1002/ptr.4781; Grotenhermen F, 2003, CLIN PHARMACOKINET, V42, P327, DOI 10.2165/00003088-200342040-00003; Hayes MJ, 2014, JAMA INTERN MED, V174, P1673, DOI 10.1001/jamainternmed.2014.2716; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; Wang GS, 2013, JAMA PEDIATR, V167, P630, DOI 10.1001/jamapediatrics.2013.140	7	118	118	1	78	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2015	313	3					241	242		10.1001/jama.2014.17057	http://dx.doi.org/10.1001/jama.2014.17057			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3RS	25486283	Green Accepted			2022-12-28	WOS:000348145000010
J	Pulla, P				Pulla, Priyanka			FAMILY PLANNING Why are women dying in India's sterilisation camps?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												priyanka@gmail.com						[Anonymous], 2014, TIMES INDIA; [Anonymous], 2013, LIVEMINT        0207; Centre for Health and Social Justice, 2009, REACH UNR; Das A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7282; Date Shilpa Vishwas, 2014, Int J Appl Basic Med Res, V4, P81, DOI 10.4103/2229-516X.136781; Mehrotra Kartikay, 2014, BLOOMBERG; Multiorganisational Team, 2014, ROBB CHOIC DIGN IND; National Health Mission, STAT PROGR IMPL PLAN	8	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2014	349								g7509	10.1136/bmj.g7509	http://dx.doi.org/10.1136/bmj.g7509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY5RE	25487114	Green Published, hybrid			2022-12-28	WOS:000347628600002
J	Makino, T; Mori, N; Sugiyama, H; Mizawa, M; Seki, Y; Kagoyama, K; Shimizu, T				Makino, Teruhiko; Mori, Naoya; Sugiyama, Hiromu; Mizawa, Megumi; Seki, Yuri; Kagoyama, Ko; Shimizu, Tadamichi			Creeping eruption due to Spirurina type X larva	LANCET			English	Editorial Material									[Makino, Teruhiko; Mori, Naoya; Mizawa, Megumi; Seki, Yuri; Kagoyama, Ko; Shimizu, Tadamichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Dermatol, Toyama 9300194, Japan; [Sugiyama, Hiromu] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo, Japan	University of Toyama; National Institute of Infectious Diseases (NIID)	Makino, T (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Dermatol, 2630 Sugitani, Toyama 9300194, Japan.	tmakino@med.u-toyama.ac.jp		Shimizu, Tadamichi/0000-0002-3231-0279				CHUANG CK, 1993, INT J PARASITOL, V23, P647, DOI 10.1016/0020-7519(93)90171-T; HASEGAWA H, 1978, Acta Medica et Biologica, V26, P79; Miyake T, 2004, PATHOL INT, V54, P730, DOI 10.1111/j.1440-1827.2004.01687.x; Otaki N, 1995, JPN J CLIN DERMATOL, V44, P88; Sugiyama H, 2007, JAPANESE SOC SYSTEMA, V25, P4	5	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2082	2082		10.1016/S0140-6736(14)61644-5	http://dx.doi.org/10.1016/S0140-6736(14)61644-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BD	25483168				2022-12-28	WOS:000346353600030
J	Otto-Bliesner, BL; Russell, JM; Clark, PU; Liu, ZY; Overpeck, JT; Konecky, B; deMenocal, P; Nicholson, SE; He, F; Lu, ZY				Otto-Bliesner, Bette L.; Russell, James M.; Clark, Peter U.; Liu, Zhengyu; Overpeck, Jonathan T.; Konecky, Bronwen; deMenocal, Peter; Nicholson, Sharon E.; He, Feng; Lu, Zhengyao			Coherent changes of southeastern equatorial and northern African rainfall during the last deglaciation	SCIENCE			English	Article							LATE PLEISTOCENE; ATLANTIC-OCEAN; HUMID PERIOD; CLIMATE; CIRCULATION; EVOLUTION; MONSOON; FLUCTUATIONS; SIMULATION; ONSET	During the last deglaciation, wetter conditions developed abruptly similar to 14,700 years ago in southeastern equatorial and northern Africa and continued into the Holocene. Explaining the abrupt onset and hemispheric coherence of this early African Humid Period is challenging due to opposing seasonal insolation patterns. In this work, we use a transient simulation with a climate model that provides a mechanistic understanding of deglacial tropical African precipitation changes. Our results show that meltwater-induced reduction in the Atlantic meridional overturning circulation (AMOC) during the early deglaciation suppressed precipitation in both regions. Once the AMOC reestablished, wetter conditions developed north of the equator in response to high summer insolation and increasing greenhouse gas (GHG) concentrations, whereas wetter conditions south of the equator were a response primarily to the GHG increase.	[Otto-Bliesner, Bette L.] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80307 USA; [Russell, James M.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Clark, Peter U.; Konecky, Bronwen] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Liu, Zhengyu; He, Feng] Univ Wisconsin, Ctr Climat Res, Madison, WI 53706 USA; [Liu, Zhengyu; He, Feng] Univ Wisconsin, Dept Atmospher & Ocean Sci, Madison, WI 53706 USA; [Liu, Zhengyu; Lu, Zhengyao] Peking Univ, Sch Phys, Lab Climate Ocean & Atmosphere Studies, Beijing 100871, Peoples R China; [Overpeck, Jonathan T.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Overpeck, Jonathan T.] Univ Arizona, Inst Environm, Tucson, AZ 85721 USA; [Konecky, Bronwen] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [deMenocal, Peter] Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA; [Nicholson, Sharon E.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA	National Center Atmospheric Research (NCAR) - USA; Brown University; Oregon State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Peking University; University of Arizona; University of Arizona; University of Colorado System; University of Colorado Boulder; Columbia University; State University System of Florida; Florida State University	Otto-Bliesner, BL (corresponding author), Natl Ctr Atmospher Res, Climate & Global Dynam Div, POB 3000, Boulder, CO 80307 USA.	ottobli@ucar.edu	Otto-Bliesner, Bette/AAY-7691-2020; He, Feng/B-3583-2008; deMenocal, Peter/B-1386-2013	He, Feng/0000-0002-3355-6406; Konecky, Bronwen/0000-0003-1647-2865; deMenocal, Peter/0000-0002-7191-717X; , Zhengyao/0000-0002-5911-7110	NSF; Office of Science (Biological and Environmental Research), U.S. Department of Energy (DOE); NSF Paleo Perspectives on Climate Change (P2C2) program; NSF [AGS 1160750]; DOE Office of Science; Div Atmospheric & Geospace Sciences [1158984] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Office of Science (Biological and Environmental Research), U.S. Department of Energy (DOE); NSF Paleo Perspectives on Climate Change (P2C2) program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NSF(National Science Foundation (NSF)); DOE Office of Science(United States Department of Energy (DOE)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the reviewers for comments that improved the manuscript. The National Center for Atmospheric Research (NCAR) is sponsored by the NSF. This research was also supported by the Office of Science (Biological and Environmental Research), U.S. Department of Energy (DOE), the NSF Paleo Perspectives on Climate Change (P2C2) program, and NSF grant AGS 1160750. This research used resources of the Oak Ridge Leadership Computing Facility, located in the National Center for Computational Sciences at Oak Ridge National Laboratory, which is supported by the DOE Office of Science. The observed data are downloadable from the National Oceanic and Atmospheric Administration Paleoclimatology (www.ncdc.noaa.gov/data-access/paleoclimatology-data) and/or Pangaea (www.pangaea.de/). The model data are downloadable from the Earth System Gateway at NCAR (www.earthsystemgrid.org/home.htm).	Bonnefille R, 2000, GLOBAL PLANET CHANGE, V26, P25, DOI 10.1016/S0921-8181(00)00032-1; Braconnot P, 2012, NAT CLIM CHANGE, V2, P417, DOI 10.1038/NCLIMATE1456; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Cole JM, 2009, EARTH PLANET SC LETT, V278, P257, DOI 10.1016/j.epsl.2008.12.011; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Dong BW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015229; Gasse F, 2008, QUATERNARY SCI REV, V27, P2316, DOI 10.1016/j.quascirev.2008.08.027; Giannini A, 2008, CLIMATIC CHANGE, V90, P359, DOI [10.1007/s10584-008-9396-y, 10.1007/s10584-008-9396-v]; Johnson TC, 1996, SCIENCE, V273, P1091, DOI 10.1126/science.273.5278.1091; Kageyama M, 2013, CLIM PAST, V9, P935, DOI 10.5194/cp-9-935-2013; KUTZBACH JE, 1982, J ATMOS SCI, V39, P1177, DOI 10.1175/1520-0469(1982)039<1177:TSOTAA>2.0.CO;2; Kutzbach JE, 1997, SCIENCE, V278, P440, DOI 10.1126/science.278.5337.440; Liu Z, 2003, J CLIMATE, V16, P2472, DOI 10.1175/1520-0442(2003)016<2472:CCSOTE>2.0.CO;2; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Liu ZY, 2012, P NATL ACAD SCI USA, V109, P11101, DOI 10.1073/pnas.1202183109; McGlue MM, 2008, J PALEOLIMNOL, V40, P635, DOI 10.1007/s10933-007-9187-x; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mulitza S, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001637; Niang I, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1199; Nicholson SE, 2014, HOLOCENE, V24, P1840, DOI 10.1177/0959683614551230; Schefuss E, 2011, NATURE, V480, P509, DOI 10.1038/nature10685; Shanahan TM, 2006, PALAEOGEOGR PALAEOCL, V242, P287, DOI 10.1016/j.palaeo.2006.06.007; Stouffer RJ, 2006, J CLIMATE, V19, P1365, DOI 10.1175/JCLI3689.1; STREET FA, 1979, QUATERNARY RES, V12, P83, DOI 10.1016/0033-5894(79)90092-9; STREETPERROTT FA, 1990, NATURE, V343, P607, DOI 10.1038/343607a0; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Timm O, 2010, J CLIMATE, V23, P2612, DOI 10.1175/2010JCLI3217.1; Tjallingii R, 2008, NAT GEOSCI, V1, P670, DOI 10.1038/ngeo289; Verschuren D, 2009, NATURE, V462, P637, DOI 10.1038/nature08520; Weijers JWH, 2007, SCIENCE, V315, P1701, DOI 10.1126/science.1138131; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461	32	114	115	4	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1223	1227		10.1126/science.1259531	http://dx.doi.org/10.1126/science.1259531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477460				2022-12-28	WOS:000346189000056
J	Chiu, HY; Yeh, NL				Chiu, Hsien-Yi; Yeh, Nai-Lun			Sudden Onset of Generalized Blisters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FIXED-DRUG ERUPTION; TOXIC EPIDERMAL NECROLYSIS		[Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Dept Dermatol, Hsin Chu Branch, Hsinchu 300, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Yeh, Nai-Lun] Natl Taiwan Univ Hosp, Dept Community & Family Med, Hsin Chu Branch, Hsinchu 300, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Yeh, NL (corresponding author), Natl Taiwan Univ Hosp, Dept Community & Family Med, Hsin Chu Branch, 25,Lane 442,Sect 1,Jingguo Rd, Hsinchu 300, Taiwan.	yehnailun@gmail.com		Yeh, Nai-Lun/0000-0002-0122-0959; Chiu, Hsien-Yi/0000-0002-0493-9707				Andrade P, 2011, CONTACT DERMATITIS, V65, P195, DOI 10.1111/j.1600-0536.2011.01946.x; Blum L, 1996, J AM ACAD DERMATOL, V34, P1088, DOI 10.1016/S0190-9622(96)90297-2; Hermida MD, 2011, ARCH DERMATOL, V147, P250, DOI 10.1001/archdermatol.2010.419; KAUPPINEN K, 1985, BRIT J DERMATOL, V112, P575; Lee CH, 2012, DERMATOL SIN, V30, P11, DOI 10.1016/j.dsi.2012.02.002; Lipowicz S, 2013, BRIT J DERMATOL, V168, P726, DOI 10.1111/bjd.12133; Mahboob A, 1998, INT J DERMATOL, V37, P833, DOI 10.1046/j.1365-4362.1998.00451.x; Paquet P, 2010, DRUG SAFETY, V33, P189, DOI 10.2165/11532540-000000000-00000; Shiohara T, 2007, EUR J DERMATOL, V17, P201; Weyers Wolfgang, 2011, Dermatol Pract Concept, V1, P33, DOI 10.5826/dpc.0101a09	10	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2281	2282		10.1001/jama.2014.13029	http://dx.doi.org/10.1001/jama.2014.13029			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25461999				2022-12-28	WOS:000345684800024
J	Gould, J				Gould, Julie			Genie in a vector	NATURE			English	Editorial Material							HEMOPHILIA; HEMOSTASIS											Du LM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3773; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707	4	5	6	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S160	S161		10.1038/515S160a	http://dx.doi.org/10.1038/515S160a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427205				2022-12-28	WOS:000346247600007
J	Woloshin, S; Schwartz, LM; Frankel, B; Faerber, A				Woloshin, Steven; Schwartz, Lisa M.; Frankel, Brittney; Faerber, Adrienne			US Food and Drug Administration and Design of Drug Approval Studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Woloshin, Steven; Schwartz, Lisa M.; Faerber, Adrienne] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Med & Media, Lebanon, NH 03756 USA; [Frankel, Brittney] Cornell Weill Med Sch, New York, NY USA	Dartmouth College; Cornell University	Schwartz, LM (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Ctr Med & Media, 35 Centerra Pkwy, Lebanon, NH 03756 USA.	lisa.schwartz@dartmouth.edu						[Anonymous], 1998, FED REGISTER, V63, P66631; Darrow JJ, 2014, NEW ENGL J MED, V370, P1252, DOI 10.1056/NEJMhle1311493; Sacks LV, 2014, JAMA-J AM MED ASSOC, V311, P378, DOI 10.1001/jama.2013.282542; US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), GUIDANCE FOR INDUSTR; US Food and Drug Administration, DRUGS FDA FDA APPROV; US Food and Drug Administration, INDEPENDENT EVALUATI	6	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2163	2165		10.1001/jama.2014.13329	http://dx.doi.org/10.1001/jama.2014.13329			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25423223	Bronze			2022-12-28	WOS:000345626800022
J	Fang, B; Everett, LJ; Jager, J; Briggs, E; Armour, SM; Feng, D; Roy, A; Gerhart-Hines, Z; Sun, Z; Lazar, MA				Fang, Bin; Everett, Logan J.; Jager, Jennifer; Briggs, Erika; Armour, Sean M.; Feng, Dan; Roy, Ankur; Gerhart-Hines, Zachary; Sun, Zheng; Lazar, Mitchell A.			Circadian Enhancers Coordinate Multiple Phases of Rhythmic Gene Transcription In Vivo	CELL			English	Article							REV-ERB-ALPHA; NUCLEAR RECEPTORS; CLOCK; BINDING; EXPRESSION; MOUSE; LIVER; DBP; METABOLISM; ACTIVATION	Mammalian transcriptomes display complex circadian rhythms with multiple phases of gene expression that cannot be accounted for by current models of the molecular clock. We have determined the underlying mechanisms by measuring nascent RNA transcription around the clock in mouse liver. Unbiased examination of enhancer RNAs (eRNAs) that cluster in specific circadian phases identified functional enhancers driven by distinct transcription factors (TFs). We further identify on a global scale the components of the TF cistromes that function to orchestrate circadian gene expression. Integrated genomic analyses also revealed mechanisms by which a single circadian factor controls opposing transcriptional phases. These findings shed light on the diversity and specificity of TF function in the generation of multiple phases of circadian gene transcription in a mammalian organ.	[Fang, Bin; Everett, Logan J.; Jager, Jennifer; Briggs, Erika; Armour, Sean M.; Feng, Dan; Roy, Ankur; Gerhart-Hines, Zachary; Sun, Zheng; Lazar, Mitchell A.] Univ Penn, Div Endocrinol Diabet & Metab, Dept Med, Dept Genet, Philadelphia, PA 19104 USA; [Fang, Bin; Everett, Logan J.; Jager, Jennifer; Briggs, Erika; Armour, Sean M.; Feng, Dan; Roy, Ankur; Gerhart-Hines, Zachary; Sun, Zheng; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lazar, MA (corresponding author), Univ Penn, Div Endocrinol Diabet & Metab, Dept Med, Dept Genet, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Everett, Logan/AAK-1523-2021; Lazar, Mitchell A/AAF-3738-2019	Feng, Dan/0000-0001-5926-8894; Jager, Jennifer/0000-0003-3740-9742	NIH [R01 DK45586, F32 DK095526, K99 DK099443, F32 DK095563]; JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045586, F32DK095563, R00DK099443, K99DK099443, F32DK095526, P30DK019525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Functional Genomics Core (J. Schug and K. Kaestner) and Viral Vector Core (J. Johnston and A. Sandhu) of the Penn Diabetes Research Center (P30 DK19525) for next-generation sequencing and AAV production, respectively. We also thank the Penn Microarray Core for microarray analysis. We thank Dr. Ken Zaret for critical reading of the manuscript. This work was supported by NIH grants R01 DK45586 (M. A. L.), F32 DK095526 (L. J. E.), K99 DK099443 (Z.S.), and F32 DK095563 (Z.G.H.), and the JPB Foundation.	Adamovich Y, 2014, CELL METAB, V19, P319, DOI 10.1016/j.cmet.2013.12.016; Anafi RC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001840; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bell P, 2011, HUM GENE THER, V22, P985, DOI 10.1089/hum.2010.194; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Ciarleglio CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097412; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Everett LJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-337; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gilardi F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004155; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Li SB, 2001, GENE, V263, P239, DOI 10.1016/S0378-1119(00)00565-5; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Peek CB, 2012, TRENDS ENDOCRIN MET, V23, P312, DOI 10.1016/j.tem.2012.02.003; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JA, 2001, CURR OPIN CELL BIOL, V13, P357, DOI 10.1016/S0955-0674(00)00220-9; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Step SE, 2014, GENE DEV, V28, P1018, DOI 10.1101/gad.237628.114; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Yoshitane H, 2014, MOL CELL BIOL, V34, P1776, DOI 10.1128/MCB.01465-13; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; Zhao X, 2014, EMBO REP, V15, P518, DOI 10.1002/embr.201338271	49	149	154	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1140	1152		10.1016/j.cell.2014.10.022	http://dx.doi.org/10.1016/j.cell.2014.10.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416951	Green Accepted, Bronze			2022-12-28	WOS:000345506300024
J	Adachi, K; Arima, D; Hosaka, A; Kiriu, T; Sakashita, K; Kojima, A; Kozai, Y				Adachi, Kensuke; Arima, Daisuke; Hosaka, Akihiro; Kiriu, Takahiro; Sakashita, Kentaro; Kojima, Akira; Kozai, Yasuji			A non-traumatic splenic rupture leads to diagnosis of underlying abnormality	LANCET			English	Editorial Material									[Adachi, Kensuke; Arima, Daisuke; Hosaka, Akihiro] Tokyo Metropolitan Tama Med Ctr, Dept Surg, Tokyo 1838524, Japan; [Kiriu, Takahiro] Tokyo Metropolitan Tama Med Ctr, Dept Pathol, Tokyo 1838524, Japan; [Sakashita, Kentaro] Tokyo Metropolitan Tama Med Ctr, Dept Resp Med, Tokyo 1838524, Japan; [Kojima, Akira; Kozai, Yasuji] Tokyo Metropolitan Tama Med Ctr, Dept Haematol, Tokyo 1838524, Japan		Adachi, K (corresponding author), Tokyo Metropolitan Tama Med Ctr, Dept Surg, Tokyo 1838524, Japan.	kensuke_adachi@tmhp.jp	Arima, Daisuke/GYQ-7850-2022	Arima, Daisuke/0000-0001-5920-2895; Sakashita, Kentaro/0000-0002-3948-5557				Aubrey-Bassler FK, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-11; Goddard SL, 2007, AM J HEMATOL, V82, P405, DOI 10.1002/ajh.20812; Renzulli P, 2009, BRIT J SURG, V96, P1114, DOI 10.1002/bjs.6737; Roberts JA, 2014, JAMA-J AM MED ASSOC, V311, P2227, DOI 10.1001/jama.2014.117	4	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1820	1820		10.1016/S0140-6736(14)61398-2	http://dx.doi.org/10.1016/S0140-6736(14)61398-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KX	25455251				2022-12-28	WOS:000345116400032
J	Kett, M; van Bergen, L				Kett, Maria; van Bergen, Leo			Disability and socioeconomic inclusion after World War 1	LANCET			English	Editorial Material									[Kett, Maria] UCL, Leonard Cheshire Disabil & Inclus Dev Ctr, London WC1E 6BT, England; [van Bergen, Leo] KITLV Royal Netherlands Inst Southeast Asian & Ca, Leiden, Netherlands	University of London; University College London; Royal Netherlands Academy of Arts & Sciences; Royal Netherlands Institute of Southeast Asian & Caribbean Studies (KITLV-KNAW)	Kett, M (corresponding author), UCL, Leonard Cheshire Disabil & Inclus Dev Ctr, Mortimer St, London WC1E 6BT, England.	m.kett@ucl.ac.uk	Kett, Maria/AAA-3421-2022	Kett, Maria/0000-0002-1975-7674				Cohen Deborah, 2001, WAR COME HOME DISABL; Collinson M., 2013, UK CONTEMPLATES GOVT; HARRISON M, 1999, MED MODERN WARFARE; Hopkins Nick, 2012, GUARDIAN; JONES E, 2005, MILITARY PSYCHIAT 19; Ministry of Defence, 2014, CAR TRANS PARTN Q ST; Ministry of Defence, 2013, ARM FORC COV; van Bergen Leo, 2007, Med Confl Surviv, V23, P189, DOI 10.1080/13623690701417337	8	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1646	1647		10.1016/S0140-6736(14)61927-9	http://dx.doi.org/10.1016/S0140-6736(14)61927-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KU	25441184				2022-12-28	WOS:000345116200007
J	Frenk, J				Frenk, Julio			Leading the way towards universal health coverage: a call to action	LANCET			English	Article							COUNTRIES; MEXICO; REFORM; CARE; TRANSITION; DISEASES; SYSTEMS; BRAZIL	Policy innovations and lessons associated with the quest for universal health coverage in Latin America are the result of a complex epidemiological transition, an extended process of democratisation, and high economic growth in recent times that has facilitated additional investments in health. The goal of universal health coverage is part of a third generation of health-system reforms, which implies a comprehensive scope of policy interventions, including the introduction of explicit ethical frameworks, the enhanced attention to financial arrangements, and the transformation of major dimensions of the organisation of health systems. The call for action emphasises the next steps that could help reach the goal of universal health coverage both in the Latin American region and the rest of the developing world.	[Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Frenk, Julio] Harvard Univ, Kennedy Sch Govt, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Frenk, J (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	jfrenk@hsph.harvard.edu						[Anonymous], 2008, LANCET, V372, P2001; [Anonymous], 2013, INT BUSINESS TI 0524; [Anonymous], 1980, EXPLORATIONS QUALITY; Atun R., 2014, LANCET; Averill C., 2013, UNIVERSAL HLTH COVER; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; BOBADILLA JL, 1993, DIS CONTROL PRIORITI, P51; Brachet-Marquez V, 2001, REFLEXIONES ACERCA S, P43; Cecchini S, 2014, LANCET; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cotlear D, 2014, LANCET; de Andrade LOM, 2014, LANCET; Dourado I, 2011, MED CARE, V49, P577, DOI 10.1097/MLR.0b013e31820fc39f; Economic Commission for Latin America and the Caribbean (ECLAC), 2007, LATIN AM CARIBBEAN D, V2, P27; Fiszbein A., 2009, TRANSFERENCIAS MONET; Frenk J, 1991, Health Transit Rev, V1, P21; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Frenk J, 2011, HARVARD INT REV, V33, P36; Frenk J, 1994, EC SALUD PROPUESTAS; Frenk J, 2009, LANCET, V374, P170, DOI 10.1016/S0140-6736(09)60693-0; Frenk J, 2009, LANCET, V373, P1406, DOI 10.1016/S0140-6736(09)60800-X; Hunter DJ, 2013, NEW ENGL J MED, V369, P1336, DOI 10.1056/NEJMra1109345; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Londono JL, 1997, HEALTH POLICY, V41, P1, DOI 10.1016/S0168-8510(97)00010-9; Lopez-Calva LF, 2010, DECLINING INEQUALITY IN LATIN AMERICA: A DECADE OF PROGRESS, P1; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; May E, 2006, P WORLD BANK; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; Parker SW, 1999, DESIGN METHODOLOGY I; Rasella D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4014; Rodin J, 2012, LANCET, V380, P861, DOI 10.1016/S0140-6736(12)61340-3; Titelman D, 2014, LANCET; UNESCO, 2009, RIGHT INF LAT AM COM; United Nations Development Program, HUM DEV IND; Victora CG, 2009, LANCET, V373, P1404, DOI 10.1016/S0140-6736(09)60564-X; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World_ Bank, COND CASH TRANSF; World Health Organization, 2012, MEX CIT POL DECL UN; Yamin AE, 2014, LANCET	41	44	48	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1352	1358		10.1016/S0140-6736(14)61467-7	http://dx.doi.org/10.1016/S0140-6736(14)61467-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25458718				2022-12-28	WOS:000352272400041
J	Abdulqawi, R; Dockry, R; Holt, K; Layton, G; McCarthy, BG; Ford, AP; Smith, JA				Abdulqawi, Rayid; Dockry, Rachel; Holt, Kimberley; Layton, Gary; McCarthy, Bruce G.; Ford, Anthony P.; Smith, Jaclyn A.			P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study	LANCET			English	Article							REFLEX SENSITIVITY; INDUCED ENHANCEMENT; TASTE-BUDS; ATP; NERVES; BRONCHOCONSTRICTION; INVOLVEMENT; VALIDATION; ACTIVATION; ASTHMA	Background Preclinical studies suggest that P2X3 receptors are expressed by airway vagal afferent nerves and contribute to the hypersensitisation of sensory neurons. P2X3 receptors could mediate sensitisation of the cough reflex, leading to chronic cough. We aimed to investigate the efficacy of a first-in-class oral P2X3 antagonist, AF-219, to reduce cough frequency in patients with refractory chronic cough. Methods We did a double-blind, placebo-controlled, two-period, crossover study at one UK centre. With a computer-generated sequence, we randomly assigned patients with refractory chronic cough to AF-219, 600 mg twice a day, or to placebo (1:1), and then, after a 2 week washout, assigned patients to receive the other treatment. Patients, health-care providers, and investigators were masked to sequence assignment. We assessed daytime cough frequency (primary endpoint) at baseline and after 2 weeks of treatment using 24 h ambulatory cough recordings. The primary analysis used a mixed effects model with the intention-to-treat population. This study was registered at ClinicalTrials.gov, number NCT01432730. Findings Of 34 individuals assessed between Sept 22, 2011, and Nov 29, 2012, we randomly assigned 24 patients (mean age 54.5 years; SD 11.1). In the observed case analysis, cough frequency was reduced by 75% when patients were allocated to AF-219 compared when allocated to placebo (p=0.0003). Daytime cough frequency fell from a mean 37 coughs per h (SD 32) to 11 (8) coughs per h after AF-219 treatment versus 65 (163) coughs per h to 44 (51) coughs per h after placebo. Six patients withdrew before the end of the study because of taste disturbances, which were reported by all patients taking AF-219. Interpretation P2X3 receptors seem to have a key role in mediation of cough neuronal hypersensitivity. Antagonists of P2X3 receptors such as AF-219 are a promising new group of antitussives.	[Abdulqawi, Rayid; Dockry, Rachel; Holt, Kimberley; Smith, Jaclyn A.] Univ Manchester, Ctr Resp Med & Allergy, Inst Inflammat & Repair, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Abdulqawi, Rayid; Dockry, Rachel; Holt, Kimberley; Smith, Jaclyn A.] Univ S Manchester Hosp, Educ & Res Ctr, Manchester M23 9LT, Lancs, England; [Layton, Gary] ParamStat Ltd, Ash, Kent, England; [McCarthy, Bruce G.] Afferent Pharmaceut, San Mateo, CA USA	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Smith, JA (corresponding author), Univ S Manchester Hosp, Educ & Res Ctr, Manchester M23 9LT, Lancs, England.	jacky.smith@manchester.ac.uk	Abdulqawi, Rayid/GYA-2055-2022	Abdulqawi, Rayid/0000-0002-0805-5714; Dockry, Rachel/0000-0002-0908-3362; Smith, Jaclyn/0000-0001-8837-4928; Holt, Kimberley/0000-0003-0413-8085	Afferent Pharmaceuticals; Medical Research Council [G0701918] Funding Source: researchfish; MRC [G0701918] Funding Source: UKRI	Afferent Pharmaceuticals; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Afferent Pharmaceuticals.	Abdulqawi R, 2011, EFF LID ITS DEV CHRO, pP2171; Basoglu OK, 2005, CHEST, V128, P1905, DOI 10.1378/chest.128.4.1905; Bo XN, 1999, NEUROREPORT, V10, P1107, DOI 10.1097/00001756-199904060-00037; Burnstock G, 2012, PHARMACOL REV, V64, P834, DOI 10.1124/pr.111.005389; Canning B. J., 2009, V187, P23, DOI 10.1007/978-3-540-79842-2_2; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Decalmer SC, 2007, THORAX, V62, P329, DOI 10.1136/thx.2006.067413; Dicpinigaitis PV, 2014, PHARMACOL REV, V66, P468, DOI 10.1124/pr.111.005116; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; Ford AP, 2013, FASEB J S, V27, P8875; French CT, 2002, CHEST, V121, P1123, DOI 10.1378/chest.121.4.1123; Haque RA, 2005, CHEST, V127, P1710, DOI 10.1378/chest.127.5.1710; Hilton ECY, 2013, J ALLERGY CLIN IMMUN, V132, P847, DOI 10.1016/j.jaci.2013.04.042; Horton MR, 2012, ANN INTERN MED, V157, P398, DOI 10.7326/0003-4819-157-6-201209180-00003; Irwin RS, 2006, CHEST, V129, P1, DOI 10.1378/chest.129.1.1; Kamei J, 2005, EUR J PHARMACOL, V528, P158, DOI 10.1016/j.ejphar.2005.10.030; Kamei J, 2006, EUR J PHARMACOL, V547, P160, DOI 10.1016/j.ejphar.2006.07.034; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Koskela HO, 2008, CLIN EXP ALLERGY, V38, P1100, DOI 10.1111/j.1365-2222.2008.02996.x; Kwong K, 2008, AM J PHYSIOL-LUNG C, V295, pL858, DOI 10.1152/ajplung.90360.2008; McGarvey L, 2009, PULM PHARMACOL THER, V22, P59, DOI 10.1016/j.pupt.2008.11.003; McGuinness K, 2012, THORAX, V67, pA131, DOI 10.1136/thoraxjnl-2012-202678.220; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; Morice AH, 2007, AM J RESP CRIT CARE, V175, P312, DOI 10.1164/rccm.200607-892OC; Pavesi L, 2001, CHEST, V120, P1121, DOI 10.1378/chest.120.4.1121; Pellegrino R, 1996, J APPL PHYSIOL, V81, P964, DOI 10.1152/jappl.1996.81.2.964; Prado FC, 2013, NEUROPHARMACOLOGY, V67, P252, DOI 10.1016/j.neuropharm.2012.11.011; Ryan NM, 2012, LANCET, V380, P1583, DOI 10.1016/S0140-6736(12)60776-4; Schappert SM, 2006, VITAL HLTH STAT, V159, P1; Singapuri Amisha, 2008, Cough, V4, P10, DOI 10.1186/1745-9974-4-10; Vulchanova L, 1997, NEUROPHARMACOLOGY, V36, P1229, DOI 10.1016/S0028-3908(97)00126-3; Weigand LA, 2012, J PHYSIOL-LONDON, V590, P4109, DOI 10.1113/jphysiol.2012.233460; Young EC, 2009, THORAX, V64, P993, DOI 10.1136/thx.2009.116723	35	314	340	2	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1198	1205		10.1016/S0140-6736(14)61255-1	http://dx.doi.org/10.1016/S0140-6736(14)61255-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25467586				2022-12-28	WOS:000351715100033
J	Hickey, M; Moore, P				Hickey, Martha; Moore, Paddy			Follow-up after medical abortion: does simple equal safe?	LANCET			English	Editorial Material							PREGNANCY		[Hickey, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Moore, Paddy] Royal Womens Hosp, Early Pregnancy Serv, Parkville, Vic 3052, Australia	University of Melbourne	Hickey, M (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia.	hickeym@unimelb.edu.au		Hickey, Martha/0000-0002-3941-082X				Cameron ST, 2012, BJOG-INT J OBSTET GY, V119, P1074, DOI 10.1111/j.1471-0528.2012.03407.x; Cameron ST, 2012, CONTRACEPTION, V86, P67, DOI 10.1016/j.contraception.2011.11.010; Goldstone P, 2012, MED J AUSTRALIA, V197, P282, DOI 10.5694/mja12.10297; Grossman D, 2011, CONTRACEPTION, V83, P504, DOI 10.1016/j.contraception.2010.08.023; Kapp N, 2013, CONTRACEPTION, V88, P350, DOI 10.1016/j.contraception.2012.10.027; Langston AM, 2014, CONTRACEPTION, V89, P103, DOI 10.1016/j.contraception.2013.10.014; Lynd K, 2013, INT J GYNECOL OBSTET, V121, P144, DOI 10.1016/j.ijgo.2012.11.022; Oppegaard KS, 2014, LANCET; Perriera LK, 2010, CONTRACEPTION, V81, P143, DOI 10.1016/j.contraception.2009.08.008; Rose SB, 2012, AM J OBSTET GYNECOL, V1, pe1; Royal College of Obstetricians and Gynaecologists, 2011, CAR WOM REQ IND AB; Saav I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048948; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.	13	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					669	670		10.1016/S0140-6736(14)61337-4	http://dx.doi.org/10.1016/S0140-6736(14)61337-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7ED	25468163				2022-12-28	WOS:000349788300006
J	Tannock, IF				Tannock, Ian F.			CANCER Resistance through repopulation	NATURE			English	Editorial Material							DRUG-RESISTANCE		Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Tannock, IF (corresponding author), Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON M5G 2M9, Canada.	ian.tannock@uhn.ca						Chen J, 2014, CLIN THER, V36, P1253, DOI 10.1016/j.clinthera.2014.06.015; Fenwick JD, 2012, INT J RADIAT ONCOL, V82, P1021, DOI 10.1016/j.ijrobp.2010.12.048; Gakis G, 2014, ADV EXP MED BIOL, V816, P183, DOI 10.1007/978-3-0348-0837-8_8; Green SK, 1999, ANTI-CANCER DRUG DES, V14, P153; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; TEICHER BA, 1990, SCIENCE, V247, P1457, DOI 10.1126/science.2108497; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135	8	21	21	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					152	153		10.1038/nature14075	http://dx.doi.org/10.1038/nature14075			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY3IM	25470047				2022-12-28	WOS:000347477600023
J	Genovese, G; Kahler, AK; Handsaker, RE; Lindberg, J; Rose, SA; Bakhoum, SF; Chambert, K; Mick, E; Neale, BM; Fromer, M; Purcell, SM; Svantesson, O; Landen, M; Hoglund, M; Lehmann, S; Gabriel, SB; Moran, JL; Lander, ES; Sullivan, PF; Sklar, P; Gronberg, H; Hultman, CM; McCarroll, SA				Genovese, Giulio; Kaehler, Anna K.; Handsaker, Robert E.; Lindberg, Johan; Rose, Samuel A.; Bakhoum, Samuel F.; Chambert, Kimberly; Mick, Eran; Neale, Benjamin M.; Fromer, Menachem; Purcell, Shaun M.; Svantesson, Oscar; Landen, Mikael; Hoeglund, Martin; Lehmann, Soeren; Gabriel, Stacey B.; Moran, Jennifer L.; Lander, Eric S.; Sullivan, Patrick F.; Sklar, Pamela; Groenberg, Henrik; Hultman, Christina M.; McCarroll, Steven A.			Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELLS; EPIGENETIC REGULATORS; PPM1D MUTATIONS; MOSAICISM; GENOME; EVOLUTION; DNMT3A; ASXL1; JAK2; TET2	Background Cancers arise from multiple acquired mutations, which presumably occur over many years. Early stages in cancer development might be present years before cancers become clinically apparent. Methods We analyzed data from whole-exome sequencing of DNA in peripheral-blood cells from 12,380 persons, unselected for cancer or hematologic phenotypes. We identified somatic mutations on the basis of unusual allelic fractions. We used data from Swedish national patient registers to follow health outcomes for 2 to 7 years after DNA sampling. Results Clonal hematopoiesis with somatic mutations was observed in 10% of persons older than 65 years of age but in only 1% of those younger than 50 years of age. Detectable clonal expansions most frequently involved somatic mutations in three genes (DNMT3A, ASXL1, and TET2) that have previously been implicated in hematologic cancers. Clonal hematopoiesis was a strong risk factor for subsequent hematologic cancer (hazard ratio, 12.9; 95% confidence interval, 5.8 to 28.7). Approximately 42% of hematologic cancers in this cohort arose in persons who had clonality at the time of DNA sampling, more than 6 months before a first diagnosis of cancer. Analysis of bone marrow-biopsy specimens obtained from two patients at the time of diagnosis of acute myeloid leukemia revealed that their cancers arose from the earlier clones. Conclusions Clonal hematopoiesis with somatic mutations is readily detected by means of DNA sequencing, is increasingly common as people age, and is associated with increased risks of hematologic cancer and death. A subset of the genes that are mutated in patients with myeloid cancers is frequently mutated in apparently healthy persons; these mutations may represent characteristic early events in the development of hematologic cancers.	[Genovese, Giulio; Handsaker, Robert E.; Rose, Samuel A.; Chambert, Kimberly; Neale, Benjamin M.; Moran, Jennifer L.; McCarroll, Steven A.] Stanley Ctr Psychiat Res, Cambridge, MA USA; [Genovese, Giulio; Handsaker, Robert E.; McCarroll, Steven A.] Program Med & Populat Genet, Cambridge, MA USA; [Gabriel, Stacey B.; Lander, Eric S.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Genovese, Giulio; Handsaker, Robert E.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Mick, Eran] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Neale, Benjamin M.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Kaehler, Anna K.; Lindberg, Johan; Svantesson, Oscar; Sullivan, Patrick F.; Groenberg, Henrik; Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lindberg, Johan] Karolinska Inst, Sci Life Lab, Stockholm, Sweden; [Lehmann, Soeren] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden; [Lehmann, Soeren] Karolinska Univ Hosp, Ctr Hematol & Regenerat Med, Stockholm, Sweden; [Landen, Mikael] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Gothenburg, Sweden; [Hoeglund, Martin] Univ Hosp, Dept Med Sci, Uppsala, Sweden; [Hoeglund, Martin] Univ Hosp, Div Hematol, Uppsala, Sweden; [Bakhoum, Samuel F.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Fromer, Menachem; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA; [Fromer, Menachem; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	giulio.genovese@gmail.com; mccarroll@genetics.med.harvard.edu	Handsaker, Bob/AAX-9095-2021; Landen, Mikael/AAD-7917-2020	Handsaker, Bob/0000-0002-3128-3547; Hoglund, Martin/0000-0003-2468-0226; Lindberg, Johan/0000-0003-3610-6774; Bakhoum, Samuel/0000-0002-4779-8422; Moran, Jennifer/0000-0002-5664-4716; McCarroll, Steven/0000-0002-6954-8184; Rose, Samuel/0000-0001-9701-0050; Genovese, Giulio/0000-0003-3066-5575	National Human Genome Research Institute [U54 HG003067, R01 HG006855]; Stanley Center for Psychiatric Research; Alexander and Margaret Stewart Trust; National Institute of Mental Health [R01 MH077139, RC2 MH089905]; Sylvan C. Herman Foundation; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006855, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139, RC2MH089905] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Stanley Center for Psychiatric Research; Alexander and Margaret Stewart Trust; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sylvan C. Herman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the National Human Genome Research Institute (U54 HG003067 and R01 HG006855), the Stanley Center for Psychiatric Research, the Alexander and Margaret Stewart Trust, the National Institute of Mental Health (R01 MH077139 and RC2 MH089905), and the Sylvan C. Herman Foundation.	Akbari MR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt323; Busque L, 1996, BLOOD, V88, P59; Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chen TC, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2013.74; Chuman Y, 2009, J BIOCHEM, V145, P1, DOI 10.1093/jb/mvn135; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Damm F, 2014, CANCER DISCOV, V4, P1088, DOI 10.1158/2159-8290.CD-14-0104; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Fasan A, 2014, LEUKEMIA, V28, P794, DOI 10.1038/leu.2013.273; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jaiswal S, 2014, CANCER CELL, V25, P713, DOI 10.1016/j.ccr.2014.06.001; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kulasekararaj AG, 2013, BRIT J HAEMATOL, V160, P660, DOI 10.1111/bjh.12203; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Ley TJ, 2013, NEW ENGL J MED, V369, P98; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Martelli MP, 2013, BLOOD REV, V27, P13, DOI 10.1016/j.blre.2012.11.001; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Potter NE, 2014, NATURE, V506, P300, DOI 10.1038/nature13056; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Schick UM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059823; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Vasanthakumar A, 2014, CELL STEM CELL, V14, P421, DOI 10.1016/j.stem.2014.03.008; Zhang LW, 2014, NAT GENET, V46, P726, DOI 10.1038/ng.2995	41	1859	1900	5	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 25	2014	371	26					2477	2487		10.1056/NEJMoa1409405	http://dx.doi.org/10.1056/NEJMoa1409405			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX4RZ	25426838	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000346920300007
J	Trivellin, G; Daly, AF; Faucz, FR; Yuan, B; Rostomyan, L; Larco, DO; Schernthaner-Reiter, MH; Szarek, E; Leal, LF; Caberg, JH; Castermans, E; Villa, C; Dimopoulos, A; Chittiboina, P; Xekouki, P; Shah, N; Metzger, D; Lysy, PA; Ferrante, E; Strebkova, N; Mazerkina, N; Zatelli, MC; Lodish, M; Horvath, A; de Alexandre, RB; Manning, AD; Levy, I; Keil, MF; Sierra, MD; Palmeira, L; Coppieters, W; Georges, M; Naves, LA; Jamar, M; Bours, V; Wu, TJ; Choong, CS; Bertherat, J; Chanson, P; Kamenicky, P; Farrell, WE; Barlier, A; Quezado, M; Bjelobaba, I; Stojilkovic, SS; Wess, J; Costanzi, S; Liu, P; Lupski, JR; Beckers, A; Stratakis, CA				Trivellin, G.; Daly, A. F.; Faucz, F. R.; Yuan, B.; Rostomyan, L.; Larco, D. O.; Schernthaner-Reiter, M. H.; Szarek, E.; Leal, L. F.; Caberg, J. -H.; Castermans, E.; Villa, C.; Dimopoulos, A.; Chittiboina, P.; Xekouki, P.; Shah, N.; Metzger, D.; Lysy, P. A.; Ferrante, E.; Strebkova, N.; Mazerkina, N.; Zatelli, M. C.; Lodish, M.; Horvath, A.; de Alexandre, R. Bertollo; Manning, A. D.; Levy, I.; Keil, M. F.; Sierra, M. de la Luz; Palmeira, L.; Coppieters, W.; Georges, M.; Naves, L. A.; Jamar, M.; Bours, V.; Wu, T. J.; Choong, C. S.; Bertherat, J.; Chanson, P.; Kamenicky, P.; Farrell, W. E.; Barlier, A.; Quezado, M.; Bjelobaba, I.; Stojilkovic, S. S.; Wess, J.; Costanzi, S.; Liu, P.; Lupski, J. R.; Beckers, A.; Stratakis, C. A.			Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTEIN-COUPLED RECEPTOR; ISOLATED PITUITARY-ADENOMAS; SHORT STATURE; EXPRESSION; GENE; DUPLICATION; MESSENGER; AIP	BACKGROUND Increased secretion of growth hormone leads to gigantism in children and acromegaly in adults; the genetic causes of gigantism and acromegaly are poorly understood. METHODS We performed clinical and genetic studies of samples obtained from 43 patients with gigantism and then sequenced an implicated gene in samples from 248 patients with acromegaly. RESULTS We observed microduplication on chromosome Xq26.3 in samples from 13 patients with gigantism; of these samples, 4 were obtained from members of two unrelated kindreds, and 9 were from patients with sporadic cases. All the patients had disease onset during early childhood. Of the patients with gigantism who did not carry an Xq26.3 microduplication, none presented before the age of 5 years. Genomic characterization of the Xq26.3 region suggests that the microduplications are generated during chromosome replication and that they contain four protein-coding genes. Only one of these genes, GPR101, which encodes a G-protein-coupled receptor, was overexpressed in patients' pituitary lesions. We identified a recurrent GPR101 mutation (p.E308D) in 11 of 248 patients with acromegaly, with the mutation found mostly in tumors. When the mutation was transfected into rat GH3 cells, it led to increased release of growth hormone and proliferation of growth hormone-producing cells. CONCLUSIONS We describe a pediatric disorder (which we have termed X-linked acrogigantism [X-LAG]) that is caused by an Xq26.3 genomic duplication and is characterized by early-onset gigantism resulting from an excess of growth hormone. Duplication of GPR101 probably causes X-LAG. We also found a recurrent mutation in GPR101 in some adults with acromegaly.	[Trivellin, G.; Faucz, F. R.; Schernthaner-Reiter, M. H.; Szarek, E.; Leal, L. F.; Dimopoulos, A.; Xekouki, P.; Lodish, M.; Horvath, A.; de Alexandre, R. Bertollo; Manning, A. D.; Levy, I.; Keil, M. F.; Sierra, M. de la Luz; Stratakis, C. A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Trivellin, G.; Faucz, F. R.; Schernthaner-Reiter, M. H.; Szarek, E.; Leal, L. F.; Dimopoulos, A.; Xekouki, P.; Lodish, M.; Horvath, A.; de Alexandre, R. Bertollo; Manning, A. D.; Levy, I.; Keil, M. F.; Sierra, M. de la Luz; Stratakis, C. A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Endocrinol Interinst Training Program, NIH, Bethesda, MD USA; [Bjelobaba, I.; Stojilkovic, S. S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cellular Signaling, Program Dev Neurosci, NIH, Bethesda, MD USA; [Chittiboina, P.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Quezado, M.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Wess, J.] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bethesda, MD USA; [Larco, D. O.; Wu, T. J.] Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, Bethesda, MD 20814 USA; [Daly, A. F.; Rostomyan, L.; Villa, C.; Beckers, A.] Univ Liege, Ctr Hosp Univ Liege, Dept Endocrinol, Liege, Belgium; [Caberg, J. -H.; Castermans, E.; Jamar, M.; Bours, V.] Univ Liege, Ctr Hosp Univ Liege, Dept Clin Genet, Liege, Belgium; [Palmeira, L.; Coppieters, W.; Georges, M.] Domaine Univ Sart Tilman, Grp Interdisciplinaire Genoprote Appl GIGA Genom, Liege, Belgium; [Lysy, P. A.] Catholic Univ Louvain, Clin Univ St Luc, Dept Pediat, Pediat Endocrinol Unit, Louvain, Belgium; [Faucz, F. R.; de Alexandre, R. Bertollo] Pontificia Univ Catolica Parana, Sch Hlth & Biosci, Curitiba, Parana, Brazil; [Naves, L. A.] Univ Brasilia, Fac Med, Dept Endocrinol, Brasilia, DF, Brazil; [Yuan, B.; Liu, P.; Lupski, J. R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, J. R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, J. R.] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Villa, C.] Hop Foch, Dept Anat & Cytol Pathol, Suresnes, France; [Villa, C.; Bertherat, J.] Univ Paris 05, Inst Cochin, Hop Cochin, INSERM,U1016,Serv Endocrinol, Paris, France; [Chanson, P.; Kamenicky, P.] Hop Univ Paris Sud, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Chanson, P.; Kamenicky, P.] Ctr Reference Malad Endocriniennes Rares Croissan, Le Kremlin Bicetre, France; [Chanson, P.; Kamenicky, P.] Univ Paris 11, Fac Med, UMR S693, Le Kremlin Bicetre, France; [Barlier, A.] Aix Marseille Univ, CNRS, UMR 7286, Ctr Rech Neurobiol & Neurophysiol Marseille, Marseille, France; [Shah, N.] King Edward Mem Hosp, Dept Endocrinol, Mumbai, Maharashtra, India; [Metzger, D.] BC Childrens Hosp, Endocrinol & Diabet Unit, Vancouver, BC, Canada; [Levy, I.] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada; [Ferrante, E.] Fdn Ist Ricovero & Cura Carattere Sci Ca Granda O, Endocrinol & Diabetol Unit, Milan, Italy; [Zatelli, M. C.] Univ Ferrara, Dept Med Sci, Endocrinol Sect, I-44100 Ferrara, Italy; [Strebkova, N.] Inst Pediat Endocrinol, Endocrinol Res Ctr, Moscow, Russia; [Mazerkina, N.] NN Burdenko Inst Neurosurg, Moscow, Russia; [Horvath, A.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC USA; [Costanzi, S.] Amer Univ, Dept Chem, Washington, DC 20016 USA; [Costanzi, S.] Amer Univ, Ctr Behav Neurosci, Washington, DC 20016 USA; [Choong, C. S.] Princess Margaret Hosp Children, Dept Paediat Endocrinol, Perth, WA, Australia; [Choong, C. S.] Univ Western Australia, Sch Pediat & Child Hlth, Perth, WA 6009, Australia; [Farrell, W. E.] Keele Univ, Guy Hilton Res Ctr, Inst Sci & Technol Med, Stoke On Trent, Staffs, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Uniformed Services University of the Health Sciences - USA; University of Liege; University of Liege; University of Liege; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Pontificia Universidade Catolica do Parana; Universidade de Brasilia; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; BC Childrens Hospital; University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Ferrara; Russian Academy of Medical Sciences; Endocrinology Research Centre; Russian Academy of Medical Sciences; N.N.Burdenko National Medical Research Center of Neurosurgery; George Washington University; American University; American University; University of Western Australia; Keele University	Stratakis, CA (corresponding author), NIH, Clin Res Ctr, 10 Ctr Dr,Bldg 10,Rm 1-3330,MSC1103, Bethesda, MD 20892 USA.	albert.beckers@chu.ulg.ac.be; stratakc@mail.nih.gov	Sierra, Maria/GYU-1134-2022; Xekouki, Paraskevi/AAM-2485-2021; Ferrante, Emanuele/O-2500-2015; Wu, John/ABI-3578-2020; Liu, Pengfei/U-9743-2019; Choong, Catherine/J-4646-2014; Zatelli, Maria Chiara/Y-1160-2019; Stratakis, Constantine/AAP-4745-2020; Daly, Adrian F/E-2178-2011; Naves, Luciana A/I-1111-2012; Kamenicky, Peter/S-4554-2018; Trivellin, Giampaolo/J-6583-2016; Bjelobaba, Ivana/ABA-1538-2020; Leal, Leticia Ferro/F-1053-2015; Faucz, Fabio R/C-1607-2009; Chittiboina, Prashant/AAE-3799-2020; Lodish, Maya/HCH-4078-2022; Rostomyan, Liliya/ABB-1961-2021; choong, catherine S/D-4051-2012; Chittiboina, Prashant/T-7177-2017; Barlier, Anne/G-2398-2015; Chanson, Philippe/F-8511-2013; Zatelli, Maria Chiara/U-2649-2018; de Alexandre, Rodrigo/H-9489-2013	Ferrante, Emanuele/0000-0002-0556-7650; Liu, Pengfei/0000-0002-4177-709X; Choong, Catherine/0000-0002-3982-271X; Daly, Adrian F/0000-0001-6130-2975; Naves, Luciana A/0000-0002-3363-3803; Trivellin, Giampaolo/0000-0003-2384-4153; Bjelobaba, Ivana/0000-0002-7649-0304; Chittiboina, Prashant/0000-0001-9349-4756; Rostomyan, Liliya/0000-0003-3784-2132; choong, catherine S/0000-0002-3982-271X; Chittiboina, Prashant/0000-0001-9349-4756; Wu, Tao-Yiao/0000-0002-8274-0226; Faucz, Fabio/0000-0001-7959-9842; Schernthaner-Reiter, Marie Helene/0000-0002-7972-7610; Beckers, Albert/0000-0001-6351-1367; Costanzi, Stefano/0000-0003-3183-7332; Metzger, Daniel/0000-0002-1715-4319; BERTHERAT, Jerome/0000-0003-2551-3008; Savateev, Aleksandr/0000-0001-6433-1202; Mazerkina, Nadia/0000-0002-0428-0498; Chanson, Philippe/0000-0001-5096-5722; Barlier, Anne/0000-0002-3740-6173; KAMENICKY, Peter/0000-0002-1994-4226; Georges, Michel/0000-0003-4124-2375; Zatelli, Maria Chiara/0000-0001-8408-7796; Lodish, Maya/0000-0002-7701-9290; de Alexandre, Rodrigo/0000-0002-1253-7716	Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920, U54HD083092, ZIAHD000195] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others.	Bates B, 2006, BRAIN RES, V1087, P1, DOI 10.1016/j.brainres.2006.02.123; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; Behrens LH, 1932, ENDOCRINOLOGY, V16, P120, DOI 10.1210/endo-16-2-120; Bergamaschi S, 2010, HORM RES PAEDIAT, V73, P74, DOI 10.1159/000271919; Cho-Clark M, 2014, MOL ENDOCRINOL, V28, P80, DOI 10.1210/me.2013-1203; Daly AF, 2006, J CLIN ENDOCR METAB, V91, P3316, DOI 10.1210/jc.2005-2671; de Herder WW, 2009, PITUITARY, V12, P236, DOI 10.1007/s11102-008-0138-y; ESPINER EA, 1981, J ENDOCRINOL INVEST, V4, P445, DOI 10.1007/BF03348309; Glasker S, 2011, J CLIN ENDOCR METAB, V96, pE2078, DOI 10.1210/jc.2011-1401; Gurrieri F, 2011, AM J MED GENET A, V155A, P145, DOI 10.1002/ajmg.a.33586; Kurth I, 2009, NAT GENET, V41, P862, DOI 10.1038/ng0809-862; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Lowell BB, 2011, Patents: novel gpr101 transgenic mice and methods of use thereof, Patent No. 20110173706; Madrigal I, 2010, J HUM GENET, V55, P822, DOI 10.1038/jhg.2010.119; Moller RS, 2014, HUM GENET, V133, P625, DOI 10.1007/s00439-013-1403-3; Nilaweera KN, 2007, J NEUROENDOCRINOL, V19, P34, DOI 10.1111/j.1365-2826.2006.01502.x; Nord KH, 2014, NAT GENET, V46, P474, DOI 10.1038/ng.2927; Peverelli E, 2014, J MOL ENDOCRINOL, V52, pR67, DOI 10.1530/JME-13-0172; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Stankiewicz P, 2005, AM J MED GENET A, V138A, P11, DOI 10.1002/ajmg.a.30910; Stratakis CA, 2010, CLIN GENET, V78, P457, DOI 10.1111/j.1399-0004.2010.01406.x; Tatton-Brown K, 2007, EUR J HUM GENET, V15, P264, DOI 10.1038/sj.ejhg.5201686; Veldhuis JD, 2012, HANDBOOK OF NEUROENDOCRINOLOGY, P237, DOI 10.1016/B978-0-12-375097-6.10010-1; Vissers LELM, 2012, METHODS MOL BIOL, V838, P29, DOI 10.1007/978-1-61779-507-7_2; Xekouki P, 2010, EXPERT REV ENDOCRINO, V5, P697, DOI 10.1586/EEM.10.47; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	28	187	195	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2363	2374		10.1056/NEJMoa1408028	http://dx.doi.org/10.1056/NEJMoa1408028			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25470569	Green Accepted, Green Published			2022-12-28	WOS:000346425800005
J	McKay, DJ; Lieb, JD				McKay, Daniel J.; Lieb, Jason D.			A Split Personality for Nucleosomes	CELL			English	Editorial Material							RESOLUTION		[McKay, Daniel J.] Univ N Carolina, Dept Genet, Dept Biol, Integrat Program Biol & Genome Sci, Chapel Hill, NC 27599 USA; [Lieb, Jason D.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Chicago	Lieb, JD (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	jdlieb@uchicago.edu		Lieb, Jason/0000-0001-7601-8061				Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Henikoff JG, 2011, P NATL ACAD SCI USA, V108, P18318, DOI 10.1073/pnas.1110731108; Kent NA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1183; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Rhee HS, 2014, CELL, V159, P1377, DOI 10.1016/j.cell.2014.10.054; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; WEINTRAUB H, 1976, CELL, V9, P409, DOI 10.1016/0092-8674(76)90085-4; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036	9	0	1	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1249	1251		10.1016/j.cell.2014.11.030	http://dx.doi.org/10.1016/j.cell.2014.11.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480289	Bronze			2022-12-28	WOS:000346652900004
J	Weintraub, K				Weintraub, Karen			VACCINES: Taking a shot at protection	NATURE			English	Editorial Material							VACCINATION; PROGRAM											Bian T, 2013, J VIROL, V87, P12196, DOI 10.1128/JVI.02127-13; Chiang CJ, 2013, JAMA-J AM MED ASSOC, V310, P974, DOI 10.1001/jama.2013.276701; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Wu TW, 2013, HEPATOLOGY, V57, P38, DOI 10.1002/hep.25988	4	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S12	S13		10.1038/516S12a	http://dx.doi.org/10.1038/516S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470194	Bronze			2022-12-28	WOS:000346310800005
J	Volerman, A; Cifu, AS				Volerman, Anna; Cifu, Adam S.			Cervical Cancer Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; LIQUID-BASED CYTOLOGY; SERVICES TASK-FORCE; CONVENTIONAL CYTOLOGY; HUMAN-PAPILLOMAVIRUS		[Volerman, Anna; Cifu, Adam S.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						American Cancer Society, CERV CANC; American College of Obstetricians and Gynecologists (ACOG), 2012, OBSTET GYNECOL, V120, P1222, DOI DOI 10.1097/AOG.0B013E318277C92A; [Anonymous], SCREEN CERV CANC WOM; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Kulasingam SL, 2011, 1105157EF1 AHRQ; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Siebers AG, 2009, JAMA-J AM MED ASSOC, V302, P1757, DOI 10.1001/jama.2009.1569; Whitlock EP, 2011, ANN INTERN MED, V155, P687; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376	11	5	7	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2279	2280		10.1001/jama.2014.14992	http://dx.doi.org/10.1001/jama.2014.14992			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25461998				2022-12-28	WOS:000345684800023
J	Kind, AJH; Jencks, S; Brock, J; Yu, MG; Bartels, C; Ehlenbach, W; Greenberg, C; Smith, M				Kind, Amy J. H.; Jencks, Steve; Brock, Jane; Yu, Menggang; Bartels, Christie; Ehlenbach, William; Greenberg, Caprice; Smith, Maureen			Neighborhood Socioeconomic Disadvantage and 30-Day Rehospitalization	ANNALS OF INTERNAL MEDICINE			English	Article							HOSPITAL READMISSION; ALL-CAUSE; MORTALITY; DISPARITIES; HEALTH; RISK; CARE; INEQUALITIES; COMMUNITIES; COMORBIDITY	Background: Measures of socioeconomic disadvantage may enable improved targeting of programs to prevent rehospitalizations, but obtaining such information directly from patients can be difficult. Measures of U.S. neighborhood socioeconomic disadvantage are more readily available but are rarely used clinically. Objective: To evaluate the association between neighborhood socioeconomic disadvantage at the census block group level, as measured by the Singh validated area deprivation index (ADI), and 30-day rehospitalization. Design: Retrospective cohort study. Setting: United States. Patients: Random 5% national sample of Medicare patients discharged with congestive heart failure, pneumonia, or myocardial infarction between 2004 and 2009 (n = 255 744). Measurements: Medicare data were linked to 2000 census data to construct an ADI for each patient's census block group, which were then sorted into percentiles by increasing ADI. Relationships between neighborhood ADI grouping and 30-day rehospitalization were evaluated using multivariate logistic regression models, controlling for patient sociodemographic characteristics, comorbid conditions and severity, and index hospital characteristics. Results: The 30-day rehospitalization rate did not vary significantly across the least disadvantaged 85% of neighborhoods, which had an average rehospitalization rate of 21%. However, within the most disadvantaged 15% of neighborhoods, rehospitalization rates increased from 22% to 27% with worsening ADI. This relationship persisted after full adjustment, with the most disadvantaged neighborhoods having a rehospitalization risk (adjusted risk ratio, 1.09 [95% CI, 1.05 to 1.12]) similar to that of chronic pulmonary disease (adjusted risk ratio, 1.06 [CI, 1.04 to 1.08]) and greater than that of uncomplicated diabetes (adjusted risk ratio, 0.95 [CI, 0.94 to 0.97]). Limitation: No direct markers of care quality or access. Conclusion: Residence within a disadvantaged U.S. neighborhood is a rehospitalization predictor of magnitude similar to chronic pulmonary disease. Measures of neighborhood disadvantage, such as the ADI, could potentially be used to inform policy and care after hospital discharge.	Univ Wisconsin, Sch Med & Publ Hlth, Geriatr Res Educ & Clin Ctr, William S Middleton Vet Affairs Hosp, Madison, WI 53706 USA; Univ Wisconsin, Sch Nursing, Madison, WI USA; Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; Telligen, Englewood, CO USA	Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kind, AJH (corresponding author), William S Middleton Vet Affairs Hosp, Geriatr Res Educ & Clin Ctr, 2500 Overlook Terrace, Madison, WI 53705 USA.	ajk@medicine.wisc.edu	Ehlenbach, William J./R-5784-2019; Bartels, Christie Michels/ABG-4072-2020	Ehlenbach, William J./0000-0002-2864-5543; Bartels, Christie Michels/0000-0001-6523-0374; Kind, Amy/0000-0002-7183-610X	National Institute on Aging; University of Wisconsin School of Medicine and Public Health's Institute for Clinical and Translational Research and Health Innovation Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG038352, K23AG034551] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Wisconsin School of Medicine and Public Health's Institute for Clinical and Translational Research and Health Innovation Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging and University of Wisconsin School of Medicine and Public Health's Institute for Clinical and Translational Research and Health Innovation Program.	Acevedo-Garcia D, 2008, HEALTH AFFAIR, V27, P321, DOI 10.1377/hlthaff.27.2.321; Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; Begg MD, 2003, STAT MED, V22, P2591, DOI 10.1002/sim.1524; Berenson Julia, 2012, Issue Brief (Commonw Fund), V34, P1; Berlin JA, 1999, BIOMETRICS, V55, P470, DOI 10.1111/j.0006-341X.1999.00470.x; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Breslow NE, 1980, IARC SCI PUBL, P5; Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Bureau U.S. Census, 2012, CART BOUND FIL DESCR; Cederberg M., 2009, THEMATIC REPORT SOCI; Centers for Medicare & Medicaid Services, 2009, CHRON COND DAT WAR; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Federal Reserve System Brookings Institution, 2008, END CHALL CONC POV A; Fleegler EW, 2007, PEDIATRICS, V119, pE1332, DOI 10.1542/peds.2006-1505; Foraker RE, 2011, CIRC-HEART FAIL, V4, P308, DOI 10.1161/CIRCHEARTFAILURE.110.959031; Franco M, 2008, AM J PREV MED, V35, P561, DOI 10.1016/j.amepre.2008.07.003; Gordon D., 1997, BREADLINE BRITAIN 19; HOUSE JS, 1994, J HEALTH SOC BEHAV, V35, P213, DOI 10.2307/2137277; HOUSE JS, 1990, MILBANK Q, V68, P383, DOI 10.2307/3350111; Hsieh C.-C., 1993, CRIMINAL JUSTICE REV, V18, P182, DOI [10.1177/073401689301800203, DOI 10.1177/073401689301800203]; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Kangovi S, 2011, JAMA-J AM MED ASSOC, V306, P1796, DOI 10.1001/jama.2011.1562; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kleinman LC, 2009, HEALTH SERV RES, V44, P288, DOI 10.1111/j.1475-6773.2008.00900.x; Kneebone Elizabeth, 2011, METROPOLITAN OPPORTU; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Krumholz HM, 2008, HOSP 30 DAY ACUTE MY; Krumholz HM., 2008, HOSP 30 DAY PNEUMONI; Krumholz HNS, 2008, HOSP 30 DAY HEART FA; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Ludwig J, 2012, SCIENCE, V337, P1505, DOI 10.1126/science.1224648; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040; National Quality Forum, 2012, PAT OUTC ALL CAUS RE; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; Philbin EF, 2001, AM J CARDIOL, V87, P1367, DOI 10.1016/S0002-9149(01)01554-5; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Rau J., 2012, KAISER HLTH NEW 0813; Robert SA, 1999, ANNU REV SOCIOL, V25, P489, DOI 10.1146/annurev.soc.25.1.489; Ross JS, 2012, HEALTH AFFAIR, V31, P1739, DOI 10.1377/hlthaff.2011.1028; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Singh GK, 2004, CANCER, V101, P1051, DOI 10.1002/cncr.20467; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Singh GK, 2002, JNCI-J NATL CANCER I, V94, P916, DOI 10.1093/jnci/94.12.916; Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600; Singh GK, 2013, J URBAN HEALTH, V90, P388, DOI 10.1007/s11524-012-9744-0; Singh GK, 2011, J CANCER EPIDEMIOL, V2011, DOI 10.1155/2011/107497; Spicker P., 2000, WELFARE STATE GEN TH; Sundquist K, 2003, J EPIDEMIOL COMMUN H, V57, P347, DOI 10.1136/jech.57.5.347; U.S. Census Bureau, POV DEF; U.S. Department of Agriculture Economic Research Service, RUR CLASS OV; US Department of Housing & Urban Development, 1996, 1 BIENNIAL REPORT C; van Walraven C, 2013, J HOSP MED, V8, P261, DOI 10.1002/jhm.2025; Washington State Department of Health, 2009, GUID US RUR URB CLAS	59	506	506	1	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					765	U36		10.7326/M13-2946	http://dx.doi.org/10.7326/M13-2946			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX9UJ	25437404	Green Accepted			2022-12-28	WOS:000347247200005
J	Arns, M				Arns, Martijn			Open access is tiring out peer reviewers	NATURE			English	Editorial Material									Res Inst Brainclin, Nijmegen, Netherlands		Arns, M (corresponding author), Res Inst Brainclin, Nijmegen, Netherlands.	martijn@brainclinics.com		Arns, Martijn/0000-0002-0610-7613					0	32	32	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					467	467		10.1038/515467a	http://dx.doi.org/10.1038/515467a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25428463	Bronze			2022-12-28	WOS:000346247600017
J	Brown, JR				Brown, Josephine R.			CLIMATE SCIENCE El Nio's variable history	NATURE			English	Editorial Material							NINO-SOUTHERN OSCILLATION; VARIABILITY		Bur Meteorol, Ctr Australian Weather & Climate Res, Melbourne, Vic 3001, Australia	Bureau of Meteorology - Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Brown, JR (corresponding author), Bur Meteorol, Ctr Australian Weather & Climate Res, Melbourne, Vic 3001, Australia.	j.brown@bom.gov.au		Brown, Josephine/0000-0002-1100-7457				Brown J, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001512; Carre M, 2014, SCIENCE, V345, P1045, DOI 10.1126/science.1252220; Cobb KM, 2013, SCIENCE, V339, P67, DOI 10.1126/science.1228246; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Liu ZY, 2014, NATURE, V515, P550, DOI 10.1038/nature13963; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Sadekov AY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3692; Timmermann A, 2007, J CLIMATE, V20, P4899, DOI 10.1175/JCLI4283.1; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710	11	4	4	0	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					494	495		10.1038/515494a	http://dx.doi.org/10.1038/515494a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25428494				2022-12-28	WOS:000346247600036
J	Kent, KC				Kent, K. Craig			Abdominal Aortic Aneurysms	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; REPAIR; RUPTURE; TERM; MEN; SURVEILLANCE; ULTRASOUND; GUIDELINES; MORTALITY; SURGERY	A 76-year-old woman presents with a 2-day history of left-lower-quadrant pain. A computed tomographic (CT) scan reveals diverticulitis and an incidental 5.6-cm infrarenal abdominal aortic aneurysm. Her medical history is notable for hypertension, hypercholesterolemia, and obesity. She is a current smoker, with an 80 pack-year history. How should her case be managed?	[Kent, K. Craig] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kent, KC (corresponding author), 600 Highland Ave,H4-710 CSC, Madison, WI 53792 USA.				Medtronic	Medtronic(Medtronic)	Dr. Kent reports receiving consulting fees from Medtronic and holding a patent on methods for treating aneurysms. No other potential conflict of interest relevant to this article was reported.	Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; [Anonymous], 2014, ABD AORT AN SCREEN; [Anonymous], 2014, SCREEN ABD AORT AN; [Anonymous], 2013, NHS ABD AORT AN SCRE; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; BENGTSSON H, 1992, EUR J SURG, V158, P19; Blanchard JF, 1999, EPIDEMIOL REV, V21, P207, DOI 10.1093/oxfordjournals.epirev.a017997; Bown MJ, 2013, JAMA-J AM MED ASSOC, V309, P806, DOI 10.1001/jama.2013.950; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Brewster DC, 2003, J VASC SURG, V37, P1106, DOI 10.1067/mva.2003.363; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Cao P, 2011, EUR J VASC ENDOVASC, V41, P13, DOI 10.1016/j.ejvs.2010.08.026; Chaikof EL, 2009, J VASC SURG, V50, P880, DOI 10.1016/j.jvs.2009.07.001; De Bruin JL, 2010, NEW ENGL J MED, V362, P1881, DOI 10.1056/NEJMoa0909499; Dillavou ED, 2006, J VASC SURG, V43, P230, DOI 10.1016/j.jvs.2005.09.043; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Forbes TL, 2006, ANN VASC SURG, V20, P564, DOI 10.1007/s10016-006-9079-y; Forsdahl SH, 2009, CIRCULATION, V119, P2202, DOI 10.1161/CIRCULATIONAHA.108.817619; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Golledge J, 2011, ATHEROSCLEROSIS, V217, P57, DOI 10.1016/j.atherosclerosis.2011.03.006; Greenhalgh RM, 2005, LANCET, V365, P2187, DOI 10.1016/S0140-6736(05)66628-7; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Guirguis-Blake JM, 2014, ANN INTERN MED, V160, P321, DOI 10.7326/M13-1844; Heart Protection Study Collaborati, 2007, J VASC SURG, V45, P645, DOI 10.1016/j.jvs.2006.12.054; Hirsch AT, 2006, CIRCULATION, V113; Jongkind V, 2010, J VASC SURG, V52, P760, DOI 10.1016/j.jvs.2010.01.049; Kent KC, 2010, J VASC SURG, V52, P539, DOI 10.1016/j.jvs.2010.05.090; Lederle FA, 2002, JAMA-J AM MED ASSOC, V287, P2968, DOI 10.1001/jama.287.22.2968; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lederle FA, 2013, ANN INTERN MED, V159, P852, DOI 10.7326/0003-4819-159-12-201312170-00012; Lederle FA, 2012, NEW ENGL J MED, V367, P1988, DOI 10.1056/NEJMoa1207481; Lederle FA, 2011, CIRCULATION, V124, P1097, DOI 10.1161/CIRCULATIONAHA.111.052365; Lindholt JS, 2008, EUR J VASC ENDOVASC, V36, P167, DOI 10.1016/j.ejvs.2008.03.006; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; Meijer CA, 2013, ANN INTERN MED, V159, P815, DOI 10.7326/0003-4819-159-12-201312170-00007; National Center for Injury Prevention and Control, WISQARS LEAD CAUS DE; Norman PE, 2007, CIRCULATION, V115, P2865, DOI 10.1161/CIRCULATIONAHA.106.671859; Norman PE, 2005, BRIT MED J, V330, P596; OSullivan JP, 1996, J CLIN PATHOL, V49, P737, DOI 10.1136/jcp.49.9.737; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Powell JT, 2007, BRIT J SURG, V94, P702, DOI 10.1002/bjs.5778; Powell JT, 2003, NEW ENGL J MED, V348, P1895, DOI 10.1056/NEJMcp012641; Reddy HK, 2006, J CARDIOVASC PHARM T, V11, P65, DOI 10.1177/107424840601100106; Shreibati JB, 2012, ARCH INTERN MED, V172, P1456, DOI 10.1001/archinternmed.2012.4268; Svensjo S, 2011, CIRCULATION, V124, P1118, DOI 10.1161/CIRCULATIONAHA.111.030379; SZILAGYI DE, 1966, ANN SURG, V164, P678, DOI 10.1097/00000658-196610000-00014; Volodos' N L, 1988, Grudn Khir, P84; Wyss TR, 2010, ANN SURG, V252, P805, DOI 10.1097/SLA.0b013e3181fcb44a	49	294	311	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2101	2108		10.1056/NEJMcp1401430	http://dx.doi.org/10.1056/NEJMcp1401430			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25427112				2022-12-28	WOS:000345580000009
J	Powles, T; Eder, JP; Fine, GD; Braiteh, FS; Loriot, Y; Cruz, C; Bellmunt, J; Burris, HA; Petrylak, DP; Teng, SL; Shen, XD; Boyd, Z; Hegde, PS; Chen, DS; Vogelzang, NJ				Powles, Thomas; Eder, Joseph Paul; Fine, Gregg D.; Braiteh, Fadi S.; Loriot, Yohann; Cruz, Cristina; Bellmunt, Joaquim; Burris, Howard A.; Petrylak, Daniel P.; Teng, Siew-Leng; Shen, Xiaodong; Boyd, Zachary; Hegde, Priti S.; Chen, Daniel S.; Vogelzang, Nicholas J.			MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer	NATURE			English	Article							TRANSITIONAL-CELL CARCINOMA; ADVANCED UROTHELIAL CARCINOMA; PHASE-II; 2ND-LINE TREATMENT; SINGLE GROUP; VINFLUNINE; TRIAL; PACLITAXEL; CLONING; PLUS	There have been no major advances for the treatment of metastatic urothelial bladder cancer (UBC) in the last 30 years. Chemotherapy is still the standard of care. Patient outcomes, especially for those in whom chemotherapy is not effective or is poorly tolerated, remain poor(1,2). One hallmark of UBC is the presence of high rates of somatic mutations(3,5). These alterations may enhance the ability of the host immune system to recognize tumour cells as foreign owing to an increased number of antigens(6). However, these cancers may also elude immune surveillance and eradication through the expression of programmed death-ligand 1 (PD-Li; also called CD274 or B7-H1) in the tumour microenvironment(7,8). Therefore, we examined the anti-PDLi antibody MPDL3280A, a systemic cancer immunotherapy, for the treatment of metastatic UBC. MPDL3280A is a high-affinity engineered human anti-PD-L1 monoclonal immunoglobulin-Gl antibody that inhibits the interaction of PD-L1 with PD-1 (PDCD1) and B7.1 (CD80)9. Because PD-L1 is expressed on activated T cells, MPDL3280A was engineered with a modification in the Fc domain that eliminates antibody-dependent cellular cytotoxicity at clinically relevant doses to prevent the depletion of T cells expressing PD-Li. Here we show that MPDL3280A has noteworthy activity in metastatic UBC. Responses were often rapid, with many occurring at the time of the first response assessment (6 weeks) and nearly all were ongoing at the data cutoff. This phase I expansion study, with an adaptive design that allowed for biomarker-positive enriched cohorts, demonstrated that tumours expressing PD-L1 -positive tumour-infiltrating immune cells had particularly high response rates. Moreover, owing to the favourable toxicity profile, including a lack of renal toxicity, patients with UBC, who are often older and have a higher incidence of renal impairment, may be better able to tolerate MPDL3280A versus chemotherapy. These results suggest that MPDL3280A may have an important role in treating UBC-the drug received breakthrough designation status by the US Food and Drug Administration (FDA) in June 2014.	[Powles, Thomas] Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London EC1M 6BQ, England; [Eder, Joseph Paul; Petrylak, Daniel P.] Yale Canc Ctr, New Haven, CT 06520 USA; [Fine, Gregg D.; Teng, Siew-Leng; Shen, Xiaodong; Boyd, Zachary; Hegde, Priti S.; Chen, Daniel S.] Genentech Inc, San Francisco, CA 94080 USA; [Braiteh, Fadi S.] Comprehens Canc Ctr Nevada, Las Vegas, NV 89169 USA; [Loriot, Yohann] Gustave Roussy, F-94805 Villejuif, France; [Cruz, Cristina] VHIO, Barcelona 08035, Spain; [Cruz, Cristina] Vall dHebron Univ Hosp, Barcelona 08035, Spain; [Bellmunt, Joaquim] Harvard Univ, Sch Med, Bladder Canc Ctr, Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02215 USA; [Burris, Howard A.] Sarah Cannon Res Inst, Nashville, TN 37203 USA; [Vogelzang, Nicholas J.] Univ Nevada, Sch Med, Las Vegas, NV 89169 USA; [Vogelzang, Nicholas J.] Univ Nevada, US Oncol Comprehens Canc Ctr Nevada, Las Vegas, NV 89169 USA	University of London; Queen Mary University London; Yale University; Roche Holding; Genentech; Comprehensive Cancer Centers of Nevada; UNICANCER; Gustave Roussy; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitari Vall d'Hebron; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Sarah Cannon Research Institute; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Comprehensive Cancer Centers of Nevada; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Powles, T (corresponding author), Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London EC1M 6BQ, England.	Thomas.Powles@bartshealth.nhs.uk	Ge, Leeyuan/O-4508-2014; Cruz, Cristina/GLR-3029-2022; Loriot, Yohann/W-5572-2019; Chen, Daniel Shin-Yu/AGD-8923-2022; Bellmunt, Joaquim/B-8151-2019	Cruz, Cristina/0000-0002-6474-7504; Chen, Daniel Shin-Yu/0000-0001-5085-3579; Bellmunt, Joaquim/0000-0003-2328-3421				Bellmunt J, 2010, J CLIN ONCOL, V28, P1850, DOI 10.1200/JCO.2009.25.4599; Bellmunt J, 2009, J CLIN ONCOL, V27, P4454, DOI 10.1200/JCO.2008.20.5534; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen DS, 2012, CLIN CANCER RES, V18, P6580, DOI 10.1158/1078-0432.CCR-12-1362; Chen G. J., 2013, J CLIN ONCOL S; Choueiri TK, 2012, J CLIN ONCOL, V30, P507, DOI 10.1200/JCO.2011.37.7002; Culine S, 2006, BRIT J CANCER, V94, P1395, DOI 10.1038/sj.bjc.6603118; Dahlberg SE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju163; De Santis M, 2012, J CLIN ONCOL, V30, P191, DOI 10.1200/JCO.2011.37.3571; Dreicer R, 1996, J UROLOGY, V156, P1606, DOI 10.1016/S0022-5347(01)65459-4; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gallagher DJ, 2010, J CLIN ONCOL, V28, P1373, DOI 10.1200/JCO.2009.25.3922; Iwai Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002404; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Ko YJ, 2013, LANCET ONCOL, V14, P769, DOI 10.1016/S1470-2045(13)70162-1; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Necchi A, 2012, LANCET ONCOL, V13, P810, DOI 10.1016/S1470-2045(12)70294-2; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Seront E, 2012, ANN ONCOL, V23, P2663, DOI 10.1093/annonc/mds057; Sonpavde G, 2013, EUR UROL, V63, P717, DOI 10.1016/j.eururo.2012.11.042; Sweeney CJ, 2006, J CLIN ONCOL, V24, P3451, DOI 10.1200/JCO.2005.03.6699; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vaughn DJ, 2009, CANCER, V115, P4110, DOI 10.1002/cncr.24460; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890	27	1748	1868	13	328	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					558	+		10.1038/nature13904	http://dx.doi.org/10.1038/nature13904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428503				2022-12-28	WOS:000346247600052
J	Sarma, K; Cifuentes-Rojas, C; Ergun, A; del Rosario, A; Jeon, Y; White, F; Sadreyev, R; Lee, JT				Sarma, Kavitha; Cifuentes-Rojas, Catherine; Ergun, Ayla; del Rosario, Amanda; Jeon, Yesu; White, Forest; Sadreyev, Ruslan; Lee, Jeannie T.			ATRX Directs Binding of PRC2 to Xist RNA and Polycomb Targets	CELL			English	Article							X-CHROMOSOME INACTIVATION; REPRESSIVE COMPLEX 2; LONG NONCODING RNAS; SYNDROME PROTEIN; STEM-CELLS; CHROMATIN; GENE; DOMAIN; REPEAT; LOCALIZATION	X chromosome inactivation (XCI) depends on the long noncoding RNA Xist and its recruitment of Polycomb Repressive Complex 2 (PRC2). PRC2 is also targeted to other sites throughout the genome to effect transcriptional repression. Using XCI as a model, we apply an unbiased proteomics approach to isolate Xist and PRC2 regulators and identified ATRX. ATRX unexpectedly functions as a high-affinity RNA-binding protein that directly interacts with RepA/Xist RNA to promote loading of PRC2 in vivo. Without ATRX, PRC2 cannot load onto Xist RNA nor spread in cis along the X chromosome. Moreover, epigenomic profiling reveals that genomewide targeting of PRC2 depends on ATRX, as loss of ATRX leads to spatial redistribution of PRC2 and derepression of Polycomb responsive genes. Thus, ATRX is a required specificity determinant for PRC2 targeting and function.	[Sarma, Kavitha; Cifuentes-Rojas, Catherine; Jeon, Yesu; Lee, Jeannie T.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Sarma, Kavitha; Cifuentes-Rojas, Catherine; Ergun, Ayla; Jeon, Yesu; Sadreyev, Ruslan; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Sarma, Kavitha; Cifuentes-Rojas, Catherine; Ergun, Ayla; Jeon, Yesu; Sadreyev, Ruslan; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Sadreyev, Ruslan; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sadreyev, Ruslan; Lee, Jeannie T.] Harvard Univ, Sch Med, Boston, MA USA; [del Rosario, Amanda] MIT, Dept Bioengn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Lee, JT (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu		White, Forest/0000-0002-1545-1651	National Institutes of Health Grants [F32-GM090765, F32-GM101828, RO1-GM090278]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090765, F32GM101828, R01GM090278] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ulandt Kim for next generation sequencing, all lab members for helpful advice, and Drs.David Picketts (Ottawa Hospital Research Institute) and Xiaolu Yang (University of Pennsylvania) for the kind gift of ATRX plasmids. This work was supported by National Institutes of Health Grants F32-GM090765 (to K.S.), F32-GM101828 (to CCR), and RO1-GM090278 (to J.T.L.).J.T.L.is an Investigator of the Howard Hughes Medical Institute.	Baumann C, 2009, CHROMOSOMA, V118, P209, DOI 10.1007/s00412-008-0189-x; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; Cifuentes-Rojas C, 2014, MOL CELL, V55, P171, DOI 10.1016/j.molcel.2014.05.009; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Clynes D, 2013, TRENDS BIOCHEM SCI, V38, P461, DOI 10.1016/j.tibs.2013.06.011; Curran TG, 2013, METHODS, V61, P219, DOI 10.1016/j.ymeth.2013.03.004; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Davidovich C, 2013, NAT STRUCT MOL BIOL, V20, P1250, DOI 10.1038/nsmb.2679; Dhayalan A, 2011, HUM MOL GENET, V20, P2195, DOI 10.1093/hmg/ddr107; Dupont C, 2013, CURR OPIN CELL BIOL, V25, P314, DOI 10.1016/j.ceb.2013.03.001; Duszczyk MM, 2011, RNA, V17, P1973, DOI 10.1261/rna.2747411; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Hernandez A, 2008, J MOL BIOL, V381, P35, DOI 10.1016/j.jmb.2008.05.003; Hoki Y, 2009, DEVELOPMENT, V136, P139, DOI 10.1242/dev.026427; Ilik IA, 2013, MOL CELL, V51, P156, DOI 10.1016/j.molcel.2013.07.001; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Johnson H, 2012, MOL CELL PROTEOMICS, V11, P1724, DOI 10.1074/mcp.M112.019984; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kaneko S, 2013, NAT STRUCT MOL BIOL, V20, P1258, DOI 10.1038/nsmb.2700; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Maenner S, 2013, MOL CELL, V51, P174, DOI 10.1016/j.molcel.2013.06.011; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Mitson M, 2011, HUM MOL GENET, V20, P2603, DOI 10.1093/hmg/ddr163; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Nusinow DA, 2007, J BIOL CHEM, V282, P12851, DOI 10.1074/jbc.M610502200; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; Ratnakumar K, 2013, EPIGENETICS-US, V8, P3, DOI 10.4161/epi.23271; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Starmer J, 2009, DEVELOPMENT, V136, P1, DOI 10.1242/dev.025908; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yildirim E, 2012, NAT STRUCT MOL BIOL, V19, P56, DOI 10.1038/nsmb.2195; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	57	144	153	2	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					869	883		10.1016/j.cell.2014.10.019	http://dx.doi.org/10.1016/j.cell.2014.10.019			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417162	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000344522000018
J	Thome, JJC; Yudanin, N; Ohmura, Y; Kubota, M; Grinshpun, B; Sathaliyawala, T; Kato, T; Lerner, H; Shen, YF; Farber, DL				Thome, Joseph J. C.; Yudanin, Naomi; Ohmura, Yoshiaki; Kubota, Masaru; Grinshpun, Boris; Sathaliyawala, Taheri; Kato, Tomoaki; Lerner, Harvey; Shen, Yufeng; Farber, Donna L.			Spatial Map of Human T Cell Compartmentalization and Maintenance over Decades of Life	CELL			English	Article							EFFECTOR-MEMORY; RHEUMATOID-ARTHRITIS; LYMPHOID ORGANS; DOWN-REGULATION; EXPRESSION; RESIDENT; CD4(+); SUBSETS; CCR7; DIFFERENTIATION	Mechanisms for human memory T cell differentiation and maintenance have largely been inferred from studies of peripheral blood, though the majority of T cells are found in lymphoid and mucosal sites. We present here a multidimensional, quantitative analysis of human T cell compartmentalization and maintenance over six decades of life in blood, lymphoid, and mucosal tissues obtained from 56 individual organ donors. Our results reveal that the distribution and tissue residence of naive, central, and effector memory, and terminal effector subsets is contingent on both their differentiation state and tissue localization. Moreover, T cell homeostasis driven by cytokine or TCR-mediated signals is different in CD4+ or CD8+ T cell lineages, varies with their differentiation stage and tissue localization, and cannot be inferred from blood. Our data provide an unprecedented spatial and temporal map of human T cell compartmentalization and maintenance, supporting distinct pathways for human T cell fate determination and homeostasis.	[Thome, Joseph J. C.; Yudanin, Naomi; Sathaliyawala, Taheri; Farber, Donna L.] Columbia Univ, Columbia Ctr Translat Immunol, Med Ctr, New York, NY 10032 USA; [Ohmura, Yoshiaki; Kubota, Masaru; Kato, Tomoaki; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA; [Thome, Joseph J. C.; Yudanin, Naomi; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Grinshpun, Boris; Shen, Yufeng] Columbia Univ, Dept Syst Biol & Biomed Informat, New York, NY 10032 USA; [Grinshpun, Boris; Shen, Yufeng] Columbia Univ, JP Sulzberger Columbia Genome Ctr, New York, NY 10032 USA; [Lerner, Harvey] New York Organ Donor Network, New York, NY 10001 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Farber, DL (corresponding author), Columbia Univ, Columbia Ctr Translat Immunol, Med Ctr, New York, NY 10032 USA.	df2396@cumc.columbia.edu	Yudanin, Naomi/U-2757-2019	Yudanin, Naomi/0000-0002-5019-2851; Farber, Donna/0000-0001-8236-9183; Grinshpun, Boris/0000-0001-7699-7554	NIH [P01AI06697, F31AG047003]; BD Bioscience Immunology Research Grant; S10 Shared Instrumentation Grant [1S10RR027050]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086164, P01AI106697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG047003] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BD Bioscience Immunology Research Grant; S10 Shared Instrumentation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH P01AI06697 awarded to D.L.F. J.J.T is supported by NIH F31AG047003 and a BD Bioscience Immunology Research Grant. These studies were performed in the CCTI Flow Cytometry Core funded in part through an S10 Shared Instrumentation Grant, 1S10RR027050. We wish to gratefully acknowledge the generosity of the donor families and the outstanding efforts of the NYODN transplant coordinators and staff for making this study possible. We also wish to thank Dr. Claire Gordon and Mr. Sam Mickel for assistance with tissue processing, and Drs. Uri Hershberg and Claire Gordon for critical reading of this manuscript.	Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Campbell JJ, 2001, J IMMUNOL, V166, P877, DOI 10.4049/jimmunol.166.2.877; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; De Boer RJ, 2013, J THEOR BIOL, V327, P45, DOI 10.1016/j.jtbi.2012.12.025; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Kiazyk SAK, 2008, TRENDS MICROBIOL, V16, P567, DOI 10.1016/j.tim.2008.08.011; Lo DJ, 2011, AM J TRANSPLANT, V11, P22, DOI 10.1111/j.1600-6143.2010.03317.x; Macallan DC, 2004, J EXP MED, V200, P255, DOI 10.1084/jem.20040341; Martens PB, 1997, ARTHRITIS RHEUM, V40, P1106, DOI 10.1002/art.1780400615; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Robins H, 2013, CURR OPIN IMMUNOL, V25, P646, DOI 10.1016/j.coi.2013.09.017; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Saule P, 2006, MECH AGEING DEV, V127, P274, DOI 10.1016/j.mad.2005.11.001; Schmidt D, 1996, J CLIN INVEST, V97, P2027, DOI 10.1172/JCI118638; Schon MP, 1999, J IMMUNOL, V162, P6641; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Strauch UG, 2001, J IMMUNOL, V166, P3506, DOI 10.4049/jimmunol.166.5.3506; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Turner DL, 2014, MUCOSAL IMMUNOL, V7, P501, DOI 10.1038/mi.2013.67; Turner DL, 2014, IMMUNOL REV, V258, P150, DOI 10.1111/imr.12149; Vallejo AN, 1999, J IMMUNOL, V162, P6572; Vander Lugt B, 2013, J IMMUNOL, V191, P3119, DOI 10.4049/jimmunol.1200938; Walch JM, 2013, J CLIN INVEST, V123, P2663, DOI 10.1172/JCI66722; Wang DH, 2004, J IMMUNOL, V172, P214, DOI 10.4049/jimmunol.172.1.214; Wang XTZ, 2003, IMMUNITY, V18, P631, DOI 10.1016/S1074-7613(03)00116-X; Warrington KJ, 2003, BLOOD, V101, P3543, DOI 10.1182/blood-2002-08-2574	42	351	358	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					814	828		10.1016/j.cell.2014.10.026	http://dx.doi.org/10.1016/j.cell.2014.10.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417158	Bronze, Green Accepted			2022-12-28	WOS:000344522000014
J	Markenscoff-Papadimitriou, E; Allen, WE; Colquitt, BM; Goh, T; Murphy, KK; Monahan, K; Mosley, CP; Ahituv, N; Lomvardas, S				Markenscoff-Papadimitriou, Eirene; Allen, William E.; Colquitt, Bradley M.; Goh, Tracie; Murphy, Karl K.; Monahan, Kevin; Mosley, Colleen P.; Ahituv, Nadav; Lomvardas, Stavros			Enhancer Interaction Networks as a Means for Singular Olfactory Receptor Expression	CELL			English	Article							ODORANT RECEPTOR; GENE-EXPRESSION; HIGH-RESOLUTION; HUMAN GENOME; MOUSE; PROTEIN; CHOICE; TRANSCRIPTION; PROMOTER; FEEDBACK	The transcriptional activation of one out of similar to 2800 olfactory receptor (OR) alleles is a poorly understood process. Here, we identify a plethora of putative OR enhancers and study their in vivo activity in olfactory neurons. Distinguished by an unusual epigenetic signature, candidate OR enhancers are characterized by extensive interchromosomal interactions associated with OR transcription and share a similar pattern of transcription factor footprints. In particular, we establish the role of the transcription factor Bptf as a facilitator of both enhancer interactions and OR transcription. Our observations agree with the model whereby OR transcription occurs in the context of multiple interacting enhancers. Disruption of these interchromosomal interactions results in weak and multigenic OR expression, suggesting that the rare coincidence of numerous enhancers over a stochastically chosen OR may account for the singularity and robustness in OR transcription.	[Markenscoff-Papadimitriou, Eirene; Colquitt, Bradley M.; Lomvardas, Stavros] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Allen, William E.] Stanford Univ, Grad Program Neurosci, Sch Med, Stanford, CA 94305 USA; [Goh, Tracie; Monahan, Kevin; Mosley, Colleen P.; Lomvardas, Stavros] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Murphy, Karl K.; Ahituv, Nadav] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Murphy, Karl K.; Ahituv, Nadav] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lomvardas, S (corresponding author), Columbia Univ, Mortimer B Zuckerman Mind Brain & Behav Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	sl682@columbia.edu	Colquitt, Bradley/AAR-7838-2021	Colquitt, Bradley/0000-0001-5819-7924; Monahan, Kevin/0000-0001-8922-5801; Ahituv, Nadav/0000-0002-7434-8144; Lomvardas, Stavros/0000-0002-7668-3026	NIH [5R01DA030320, 5R01DA036894, 5R01DC013560, R01HD059862, 1R01NS079231, 1R01DK090382]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030320, R01DA036894] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank members of the Ahituv lab for their help and expertise with the zebrafish expression assay. We warmly thank Christos Papadimitriou for consultations about modeling and critical reading of the manuscript. We would like to thank Jessica Tollkuhn and members of the Lomvardas lab for critical reading of the manuscript. This project was supported by NIH grants 5R01DA030320, 5R01DA036894, 5R01DC013560 (for S.L.), R01HD059862, 1R01NS079231, and 1R01DK090382 (for N.A.). None of the authors of this manuscript have financial interests related to this work.	Andrey G, 2014, CELL, V156, DOI 10.1016/j.cell.2014.01.060; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Ariza-Cosano A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-713; Armelin-Correa LM, 2014, P NATL ACAD SCI USA, V111, P2782, DOI 10.1073/pnas.1317036111; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Booker BM, 2013, DEV GENES EVOL, V223, P395, DOI 10.1007/s00427-013-0453-9; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; Dalton RP, 2013, CELL, V155, P321, DOI 10.1016/j.cell.2013.09.033; Delpretti S, 2013, CELL REP, V5, P137, DOI 10.1016/j.celrep.2013.09.002; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ferreira T, 2014, NEURON, V81, P847, DOI 10.1016/j.neuron.2014.01.001; Guo Y, 2012, P NATL ACAD SCI USA, V109, P21081, DOI 10.1073/pnas.1219280110; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Johnston RJ, 2014, SCIENCE, V343, P661, DOI 10.1126/science.1243039; Jordan-Sciutto KL, 1999, J BIOL CHEM, V274, P35262, DOI 10.1074/jbc.274.49.35262; Khan M, 2011, CELL, V147, P907, DOI 10.1016/j.cell.2011.09.049; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Landry JW, 2011, GENE DEV, V25, P275, DOI 10.1101/gad.2007311; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lyons DB, 2013, CELL, V154, P325, DOI 10.1016/j.cell.2013.06.039; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Noordermeer D, 2014, ELIFE, V3, DOI 10.7554/eLife.02557; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Smith RP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r72; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Vassalli A, 2011, MOL CELL NEUROSCI, V46, P381, DOI 10.1016/j.mcn.2010.11.001; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Williams A, 2010, TRENDS GENET, V26, P188, DOI 10.1016/j.tig.2010.01.007; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang XM, 2004, GENOMICS, V83, P802, DOI 10.1016/j.ygeno.2003.10.009; Zhou ZS, 2012, CELL REP, V2, P1143, DOI 10.1016/j.celrep.2012.09.035	56	110	113	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					543	557		10.1016/j.cell.2014.09.033	http://dx.doi.org/10.1016/j.cell.2014.09.033			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417106	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000344521700011
J	Chokshi, DA; Sommers, BD				Chokshi, Dave A.; Sommers, Benjamin D.			Universal health coverage for US veterans: a goal within reach	LANCET			English	Editorial Material									[Chokshi, Dave A.] NYU, Dept Populat Hlth, Langone Med Ctr, New York, NY USA; [Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	New York University; NYU Langone Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Chokshi, DA (corresponding author), New York City Hlth & Hosp Corp, New York, NY 10013 USA.	dave.chokshi@nychhc.org		Chokshi, Dave/0000-0001-7467-4591				[Anonymous], WASHINGTON POST; [Anonymous], 2012, AM COMM SURV; Department of Veterans Affairs, 2012, HLTH CAR BEN OV; Haley JM, 2013, UNINSURED VETERANS F; Kaiser Commission on Medicaid and the uninsured, 2009, AR STAT TOD MED STAT; Kizer KW, 2012, JAMA-J AM MED ASSOC, V307, P789, DOI 10.1001/jama.2012.196; Sommers BD, 2014, HEALTH AFFAIR, V33, P700, DOI 10.1377/hlthaff.2013.1023; Tsai J, 2014, AM J PUBLIC HEALTH, V104, pE57, DOI 10.2105/AJPH.2013.301791	8	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 6	2015	385	9984					2320	2321		10.1016/S0140-6736(14)61254-X	http://dx.doi.org/10.1016/S0140-6736(14)61254-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1CR	25467585				2022-12-28	WOS:000355943500035
J	Mcnab, S; Duke, T; South, M; Babl, FE; Lee, KJ; Arnup, SJ; Young, S; Turner, H; Davidson, A				McNab, Sarah; Duke, Trevor; South, Mike; Babl, Franz E.; Lee, Katherine J.; Arnup, Sarah J.; Young, Simon; Turner, Hannah; Davidson, Andrew			140 mmol/L of sodium versus 77 mmol/L of sodium in maintenance intravenous fluid therapy for children in hospital (PIMS): a randomised controlled double-blind trial	LANCET			English	Article							SERIOUSLY ILL CHILDREN; ANTI-DIURETIC HORMONE; ANTIDIURETIC-HORMONE; INAPPROPRIATE SECRETION; IATROGENIC HYPONATREMIA; ACQUIRED HYPONATREMIA; SALINE; SURGERY; MENINGITIS; PREVENTION	Background Use of hypotonic intravenous fluid to maintain hydration in children in hospital has been associated with hyponatraemia, leading to neurological morbidity and mortality. We aimed to assess whether use of fluid solutions with a higher sodium concentration reduced the risk of hyponatraemia compared with use of hypotonic solutions. Methods We did a randomised controlled double-blind trial of children admitted to The Royal Children's Hospital (Melbourne, VIC, Australia) who needed intravenous maintenance hydration for 6 h or longer. With an online randomisation system that used unequal block sizes, we randomly assigned patients (1:1) to receive either isotonic intravenous fluid containing 140 mmol/L of sodium (Na140) or hypotonic fluid containing 77 mmol/L of sodium (Na77) for 72 h or until their intravenous fluid rate decreased to lower than 50% of the standard maintenance rate. We stratified assignment by baseline sodium concentrations. Study investigators, treating clinicians, nurses, and patients were masked to treatment assignment. The primary outcome was occurrence of hyponatraemia (serum sodium concentration <135 mmol/L with a decrease of at least 3 mmol/L from baseline) during the treatment period, analysed by intention to treat. The trial was registered with the Australian New Zealand Clinical Trials Registry, number ACTRN1260900924257. Findings Between Feb 2, 2010, and Jan 29, 2013, we randomly assigned 690 patients. Of these patients, primary outcome data were available for 319 who received Na140 and 322 who received Na77. Fewer patients given Na140 than those given Na77 developed hyponatraemia (12 patients [4%] vs 35 [11%]; odds ratio [OR] 0.31, 95% CI 0.16-0.61; p=0.001). No clinically apparent cerebral oedema occurred in either group. Eight patients in the Na140 group (two potentially related to intravenous fluid) and four in the Na77 group (none related to intravenous fluid) developed serious adverse events during the treatment period. One patient in the Na140 had seizures during the treatment period compared with seven who received Na77. Interpretation Use of isotonic intravenous fluid with a sodium concentration of 140 mmol/L had a lower risk of hyponatraemia without an increase in adverse effects than did fluid containing 77 mmol/L of sodium. An isotonic fluid should be used as intravenous fluid for maintenance hydration in children.	[McNab, Sarah; South, Mike] Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic 3052, Australia; [Duke, Trevor] Royal Childrens Hosp, Paediat Intens Care Unit, Melbourne, Vic 3052, Australia; [Davidson, Andrew] Royal Childrens Hosp, Dept Anaesthesia, Melbourne, Vic 3052, Australia; [Babl, Franz E.; Young, Simon] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic 3052, Australia; [McNab, Sarah; Duke, Trevor; South, Mike; Babl, Franz E.; Lee, Katherine J.; Arnup, Sarah J.; Young, Simon; Turner, Hannah; Davidson, Andrew] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [McNab, Sarah; Duke, Trevor; South, Mike; Lee, Katherine J.; Young, Simon; Davidson, Andrew] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne	Mcnab, S (corresponding author), Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic 3052, Australia.	sarah.mcnab@rch.org.au	Lee, Katherine J/A-2519-2016	Arnup, Sarah/0000-0002-9497-1902; South, Mike/0000-0002-5530-2722	National Health and Medical Research Council; Murdoch Childrens Research Institute; Royal Children's Hospital; Australian and New Zealand College of Anaesthetists	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Childrens Research Institute; Royal Children's Hospital; Australian and New Zealand College of Anaesthetists	National Health and Medical Research Council, Murdoch Childrens Research Institute, The Royal Children's Hospital, and the Australian and New Zealand College of Anaesthetists.	Arieff AI, 1998, PAEDIATR ANAESTH, V8, P1, DOI 10.1046/j.1460-9592.1998.00730.x; ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; Brazel PW, 1996, SPINE, V21, P724, DOI 10.1097/00007632-199603150-00013; BURROWS FA, 1983, CRIT CARE MED, V11, P527, DOI 10.1097/00003246-198307000-00009; Choong K, 2011, PEDIATRICS, V128, P857, DOI 10.1542/peds.2011-0415; Coulthard MG, 2008, ARCH DIS CHILD, V93, P335, DOI 10.1136/adc.2007.124461; Coulthard MG, 2012, ARCH DIS CHILD, V97, P491, DOI 10.1136/archdischild-2011-300221; DHAWAN A, 1992, ANN TROP PAEDIATR, V12, P455, DOI 10.1080/02724936.1992.11747614; Duke T, 2003, LANCET, V362, P1320, DOI 10.1016/S0140-6736(03)14577-1; FAJARDO JE, 1989, PEDIATR NEUROL, V5, P37, DOI 10.1016/0887-8994(89)90007-6; Foster BA, 2014, J PEDIATR-US, V165, P163, DOI 10.1016/j.jpeds.2014.01.040; Halberthal M, 2001, BRIT MED J, V322, P780, DOI 10.1136/bmj.322.7289.780; Hasegawa H, 2009, PEDIATR NEPHROL, V24, P507, DOI 10.1007/s00467-008-1053-1; HOLLIDAY MA, 1957, PEDIATRICS, V19, P823; Holliday MA, 2005, PEDIATRICS, V115, P193, DOI 10.1542/peds.2004-1769; Holliday MA, 2004, J PEDIATR-US, V145, P584, DOI 10.1016/j.jpeds.2004.06.077; Holliday MA, 2004, LANCET, V363, P241, DOI 10.1016/S0140-6736(03)15333-0; Holliday MA, 2007, ARCH DIS CHILD, V92, P546, DOI 10.1136/adc.2006.106377; Hughes PD, 2003, LANCET, V362, P1320; JUDD BA, 1990, ACTA PAEDIATR SCAND, V79, P461, DOI 10.1111/j.1651-2227.1990.tb11494.x; Kannan L, 2010, PEDIATR NEPHROL, V25, P2303, DOI 10.1007/s00467-010-1600-4; Kellum JA, 2002, CRIT CARE MED, V30, P259, DOI 10.1097/00003246-200201000-00046; Koczmara Christine, 2010, Dynamics, V21, P21; Liamis G, 2008, AM J KIDNEY DIS, V52, P144, DOI 10.1053/j.ajkd.2008.03.004; Luu R, 2013, J PEDIATR-US, V163, P1652, DOI 10.1016/j.jpeds.2013.06.041; Mohan S, 2013, AM J MED, V126, P1127, DOI 10.1016/j.amjmed.2013.07.021; Montanana PA, 2008, PEDIATR CRIT CARE ME, V9, P589, DOI 10.1097/PCC.0b013e31818d3192; Mori J, 2011, PEDIATR INT, V53, P354, DOI 10.1111/j.1442-200X.2010.03264.x; Moritz ML, 2007, NAT CLIN PRACT NEPHR, V3, P374, DOI 10.1038/ncpneph0526; Moritz ML, 2011, PEDIATRICS, V128, P980, DOI 10.1542/peds.2011-2015; National Patient Safety Agency, 2007, PAT SAF AL 22 NPSA 2; Neville KA, 2010, J PEDIATR-US, V156, P313, DOI 10.1016/j.jpeds.2009.07.059; PATWARI AK, 1995, ANN TROP PAEDIATR, V15, P179, DOI 10.1080/02724936.1995.11747769; Playfor S, 2003, ARCH DIS CHILD, V88, P646, DOI 10.1136/adc.88.7.646-a; Rey C, 2011, ACTA PAEDIATR, V100, P1138, DOI 10.1111/j.1651-2227.2011.02209.x; Saba TG, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-82; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Stewart PC, 2007, BRIT J ANAESTH, V98, P406, DOI 10.1093/bja/ael381; Sutherland A, 2013, ARCH DIS CHILD, V98, pe1; Wilkes NJ, 2001, ANESTH ANALG, V93, P811, DOI 10.1097/00000539-200110000-00003; Yung M, 2009, J PAEDIATR CHILD H, V45, P9, DOI 10.1111/j.1440-1754.2007.01254.x	41	104	105	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1190	1197		10.1016/S0140-6736(14)61459-8	http://dx.doi.org/10.1016/S0140-6736(14)61459-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25472864				2022-12-28	WOS:000351715100032
J	Lora-Tamayo, J; Murillo, O				Lora-Tamayo, Jaime; Murillo, Oscar			Shorter treatments for vertebral osteomyelitis	LANCET			English	Editorial Material							OFLOXACIN; RIFAMPIN		[Lora-Tamayo, Jaime] Hosp Univ 12 Octubre, Infect Dis Unit, Madrid 28041, Spain; [Murillo, Oscar] Hosp Univ Bellvitge, Dept Infect Dis, Barcelona, Spain	Hospital Universitario 12 de Octubre; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Lora-Tamayo, J (corresponding author), Hosp Univ 12 Octubre, Infect Dis Unit, Ave Cordoba, Madrid 28041, Spain.	jaime@lora-tamayo.es		Murillo Rubio, Oscar/0000-0001-5776-8422				Bernard L, 2014, LANCET; DRANCOURT M, 1993, ANTIMICROB AGENTS CH, V37, P1214, DOI 10.1128/AAC.37.6.1214; Euba G, 2008, SEMIN ARTHRITIS RHEU, V38, P28, DOI 10.1016/j.semarthrit.2007.08.007; GENTRY LO, 1991, ANTIMICROB AGENTS CH, V35, P538, DOI 10.1128/AAC.35.3.538; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; MacDougall C, 2005, CLIN INFECT DIS, V41, P435, DOI 10.1086/432056; Murillo O, 2014, CLIN MICROBIOL INFEC, V20, pO33, DOI 10.1111/1469-0691.12302; Mylona E, 2009, SEMIN ARTHRITIS RHEU, V39, P10, DOI 10.1016/j.semarthrit.2008.03.002; Pigrau C, 2005, AM J MED, V118, DOI 10.1016/j.amjmed.2005.02.027; Stengel D, 2001, Lancet Infect Dis, V1, P175, DOI 10.1016/S1473-3099(01)00094-9; Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537; Zimmerli W, 2010, NEW ENGL J MED, V362, P1022, DOI 10.1056/NEJMcp0910753	12	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					836	837		10.1016/S0140-6736(14)61936-x	http://dx.doi.org/10.1016/S0140-6736(14)61936-x			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25468169				2022-12-28	WOS:000350451100011
J	Molyneux, AJ; Birks, J; Clarke, A; Sneade, M; Kerr, RSC				Molyneux, Andrew J.; Birks, Jacqueline; Clarke, Alison; Sneade, Mary; Kerr, Richard S. C.			The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT)	LANCET			English	Article							BARE PLATINUM COILS; INTRACRANIAL ANEURYSMS; RANDOMIZED-TRIAL	Background Previous analyses of the International Subarachnoid Aneurysm Trial (ISAT) cohort have reported on the risks of recurrent subarachnoid haemorrhage and death or dependency for a minimum of 5 years and up to a maximum of 14 years after treatment of a ruptured intracranial aneurysm with either neurosurgical clipping or endovascular coiling. At 1 year there was a 7% absolute and a 24% relative risk reduction of death and dependency in the coiling group compared with the clipping group, but the medium-term results showed the increased need for retreatment of the target aneurysm in the patients given coiling. We report the long-term follow-up of patients in this UK cohort. Methods In ISAT, patients were randomly allocated to either neurosurgical clipping or endovascular coiling after a subarachnoid haemorrhage, assuming treatment equipoise, between Sept 12, 1994, and May 1, 2002. We followed up 1644 patients in 22 UK neurosurgical centres for death and clinical outcomes for 10.0-18.5 years. We assessed dependency as self-reported modified Rankin scale score obtained through yearly questionnaires. Data for recurrent aneurysms and rebleeding events were collected from questionnaires and from hospital and general practitioner records. The Office for National Statistics supplied data on deaths. This study is registered, number ISRCTN49866681. Findings At 10 years, 674 (83%) of 809 patients allocated endovascular coiling and 657 (79%) of 835 patients allocated neurosurgical clipping were alive (odds ratio [OR] 1.35, 95% CI 1.06-1.73). Of 1003 individuals who returned a questionnaire at 10 years, 435 (82%) patients treated with endovascular coiling and 370 (78%) patients treated with neurosurgical clipping were independent (modified Rankin scale score 0-2; OR 1.25; 95% CI 0.92- 1.71). Patients in the endovascular treatment group were more likely to be alive and independent at 10 years than were patients in the neurosurgery group (OR 1.34, 95% CI 1.07-1.67). 33 patients had a recurrent subarachnoid haemorrhage more than 1 year after their initial haemorrhage (17 from the target aneurysm). Interpretation Although rates of increased dependency alone did not differ between groups, the probability of death or dependency was significantly greater in the neurosurgical group than in the endovascular group. Rebleeding was more likely after endovascular coiling than after neurosurgical clipping, but the risk was small and the probability of disability-free survival was significantly greater in the endovascular group than in the neurosurgical group at 10 years.	[Molyneux, Andrew J.; Clarke, Alison; Sneade, Mary] Univ Oxford, Oxford Neurovasc & Neuroradiol Res Unit, Nuffield Dept Surg Sci, Oxford OX3 9DU, England; [Birks, Jacqueline] Ctr Stat Med, Oxford, England; [Kerr, Richard S. C.] John Radcliff Hosp, Dept Neurosurg, Oxford, England	University of Oxford; University of Oxford	Molyneux, AJ (corresponding author), Univ Oxford, Oxford Neurovasc & Neuroradiol Res Unit, Nuffield Dept Surg Sci, Oxford OX3 9DU, England.	andy.molyneux@nds.ox.ac.uk			UK Medical Research Council; MRC [G0700479, G9401611] Funding Source: UKRI; Medical Research Council [G0700479, G9401611] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council.	Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Campi A, 2007, STROKE, V38, P1538, DOI 10.1161/STROKEAHA.106.466987; Kerr R, 2013, J NEUROSURG, V118, P478, DOI 10.3171/2012.2.JNS12190; Kunz R, 2008, INTERNIST BERL, V49, P673; Langham J, 2009, STROKE, V40, P111, DOI 10.1161/STROKEAHA.108.517805; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Molyneux AJ, 2012, STROKE, V43, P2544, DOI 10.1161/STROKEAHA.112.657254; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Shultz F, 2011, INT J SURG, V9, P672; White PM, 2011, LANCET, V377, P1655, DOI 10.1016/S0140-6736(11)60408-X	11	316	361	1	46	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					691	697		10.1016/S0140-6736(14)60975-2	http://dx.doi.org/10.1016/S0140-6736(14)60975-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7ED	25465111	Green Published			2022-12-28	WOS:000349788300025
J	Do, R; Stitziel, NO; Won, HH; Jorgensen, AB; Duga, S; Merlini, PA; Kiezun, A; Farrall, M; Goel, A; Zuk, O; Guella, I; Asselta, R; Lange, LA; Peloso, GM; Auer, PL; Girelli, D; Martinelli, N; Farlow, DN; DePristo, MA; Roberts, R; Stewart, AFR; Saleheen, D; Danesh, J; Epstein, SE; Sivapalaratnam, S; Hovingh, GK; Kastelein, JJ; Samani, NJ; Schunkert, H; Erdmann, J; Shah, SH; Kraus, WE; Davies, R; Nikpay, M; Johansen, CT; Wang, J; Hegele, RA; Hechter, E; Marz, W; Kleber, ME; Huang, J; Johnson, AD; Li, MY; Burke, GL; Gross, M; Liu, YM; Assimes, TL; Heiss, G; Lange, EM; Folsom, AR; Taylor, HA; Olivieri, O; Hamsten, A; Clarke, R; Reilly, DF; Yin, W; Rivas, MA; Donnelly, P; Rossouw, JE; Psaty, BM; Herrington, DM; Wilson, JG; Rich, SS; Bamshad, MJ; Tracy, RP; Cupples, LA; Rader, DJ; Reilly, MP; Spertus, JA; Cresci, S; Hartiala, J; Tang, WHW; Hazen, SL; Allayee, H; Reiner, AP; Carlson, CS; Kooperberg, C; Jackson, RD; Boerwinkle, E; Lander, ES; Schwartz, SM; Siscovick, DS; McPherson, R; Tybjaerg-Hansen, A; Abecasis, GR; Watkins, H; Nickerson, DA; Ardissino, D; Sunyaev, SR; O'Donnell, CJ; Altshuler, D; Gabriel, S; Kathiresan, S				Do, Ron; Stitziel, Nathan O.; Won, Hong-Hee; Jorgensen, Anders Berg; Duga, Stefano; Merlini, Pier Angelica; Kiezun, Adam; Farrall, Martin; Goel, Anuj; Zuk, Or; Guella, Illaria; Asselta, Rosanna; Lange, Leslie A.; Peloso, Gina M.; Auer, Paul L.; Girelli, Domenico; Martinelli, Nicola; Farlow, Deborah N.; DePristo, Mark A.; Roberts, Robert; Stewart, Alexander F. R.; Saleheen, Danish; Danesh, John; Epstein, Stephen E.; Sivapalaratnam, Suthesh; Hovingh, G. Kees; Kastelein, John J.; Samani, Nilesh J.; Schunkert, Heribert; Erdmann, Jeanette; Shah, Svati H.; Kraus, William E.; Davies, Robert; Nikpay, Majid; Johansen, Christopher T.; Wang, Jian; Hegele, Robert A.; Hechter, Eliana; Marz, Winfried; Kleber, Marcus E.; Huang, Jie; Johnson, Andrew D.; Li, Mingyao; Burke, Greg L.; Gross, Myron; Liu, Yongmei; Assimes, Themistocles L.; Heiss, Gerardo; Lange, Ethan M.; Folsom, Aaron R.; Taylor, Herman A.; Olivieri, Oliviero; Hamsten, Anders; Clarke, Robert; Reilly, Dermot F.; Yin, Wu; Rivas, Manuel A.; Donnelly, Peter; Rossouw, Jacques E.; Psaty, Bruce M.; Herrington, David M.; Wilson, James G.; Rich, Stephen S.; Bamshad, Michael J.; Tracy, Russell P.; Cupples, L. Adrienne; Rader, Daniel J.; Reilly, Muredach P.; Spertus, John A.; Cresci, Sharon; Hartiala, Jaana; Tang, W. H. Wilson; Hazen, Stanley L.; Allayee, Hooman; Reiner, Alex P.; Carlson, Christopher S.; Kooperberg, Charles; Jackson, Rebecca D.; Boerwinkle, Eric; Lander, Eric S.; Schwartz, Stephen M.; Siscovick, David S.; McPherson, Ruth; Tybjaerg-Hansen, Anne; Abecasis, Goncalo R.; Watkins, Hugh; Nickerson, Deborah A.; Ardissino, Diego; Sunyaev, Shamil R.; O'Donnell, Christopher J.; Altshuler, David; Gabriel, Stacey; Kathiresan, Sekar		NHLBI Exome Sequencing Project	Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; SINGLE NUCLEOTIDE POLYMORPHISMS; OF-FUNCTION MUTATIONS; HEART-DISEASE; RECEPTOR; VARIANTS; HYPERCHOLESTEROLEMIA; TRIGLYCERIDES; CHOLESTEROL	Myocardial infarction (MI), a leading cause of death around the world, displays a complex pattern of inheritance(1,2). When MI occurs early in life, genetic inheritance is a major component to risk(1). Previously, rare mutations in low-density lipoprotein (LDL) genes have been shown to contribute to MI risk inindividual families(3-8), whereas common variants at more than 45 loci have been associated with MI risk in the population(9-15). Here we evaluate how rare mutations contribute to early-onset MI risk in the population. We sequenced the protein-coding regions of 9,793 genomes from patients with MI at an early age (<= 50 years inmales and <= 60 years in females) along with MI-free controls. We identified two genes in which rare coding-sequence mutations were more frequent in MI cases versus controls at exome-wide significance. At low-density lipoprotein receptor (LDLR), carriers of rare non-synonymous mutations were at 4.2-fold increased risk for MI; carriers of null alleles at LDLR were at even higher risk (13-fold difference). Approximately 2% of early MI cases harbour a rare, damaging mutation in LDLR; this estimate is similar to one made more than 40 years ago using an analysis of total cholesterol(16). Among controls, about 1 in 217 carried an LDLR coding-sequence mutation and had plasma LDL cholesterol > 190 mg dl(-1). At apolipoprotein A-V (APOA5), carriers of rare non-synonymous mutations were at 2.2-fold increased risk for MI. When compared with non-carriers, LDLR mutation carriers had higher plasma LDL cholesterol, whereas APOA5 mutation carriers had higher plasma triglycerides. Recent evidence has connected MI risk with coding-sequence mutations at two genes functionally related to APOA5, namely lipoprotein lipase(15,17) and apolipoprotein C-III (refs 18, 19). Combined, these observations suggest that, as well as LDL cholesterol, disordered metabolism of triglyceride-rich lipoproteins contributes to MI risk.	[Do, Ron; Won, Hong-Hee; Peloso, Gina M.; Altshuler, David; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Do, Ron; Won, Hong-Hee; Peloso, Gina M.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Do, Ron; Won, Hong-Hee; Peloso, Gina M.; Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Do, Ron; Won, Hong-Hee; Kiezun, Adam; Zuk, Or; Peloso, Gina M.; Farlow, Deborah N.; DePristo, Mark A.; Hechter, Eliana; Folsom, Aaron R.; Lander, Eric S.; Sunyaev, Shamil R.; Altshuler, David; Gabriel, Stacey; Kathiresan, Sekar] Broad Inst, Cambridge Ctr 7, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Stitziel, Nathan O.; Cresci, Sharon] Washington Univ, Div Cardiovasc, Dept Med, Sch Med, St Louis, MO 63110 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO 63110 USA; [Jorgensen, Anders Berg; Tybjaerg-Hansen, Anne] Copenhagen Univ Hosp, Rigshosp, Mol Genet Sect, Dept Clin Biochem KB3011, DK-1165 Copenhagen, Denmark; [Jorgensen, Anders Berg; Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth Sci, DK-1165 Copenhagen, Denmark; [Duga, Stefano; Guella, Illaria; Asselta, Rosanna] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, I-20122 Milan, Italy; [Merlini, Pier Angelica] Osped Niguarda Ca Granda, Div Cardiol, I-20162 Milan, Italy; [Farrall, Martin; Goel, Anuj; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX1 2J, England; [Lange, Leslie A.; Lange, Ethan M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Auer, Paul L.; Folsom, Aaron R.; Reiner, Alex P.; Carlson, Christopher S.; Kooperberg, Charles; Schwartz, Stephen M.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Girelli, Domenico; Martinelli, Nicola; Olivieri, Oliviero] Univ Verona, Dept Med, Sch Med, I-37129 Verona, Italy; [Roberts, Robert; Stewart, Alexander F. R.] Univ Ottawa, Inst Heart, John & Jennifer Ruddy Canadian Cardiovasc Genet C, Ottawa, ON K1Y 4W7, Canada; [Saleheen, Danish; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; [Epstein, Stephen E.] MedStar Hlth Res Inst, Cardiovasc Res Inst, Hyattsville, MD 20782 USA; [Sivapalaratnam, Suthesh; Hovingh, G. Kees; Kastelein, John J.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Samani, Nilesh J.] Glenfield Gen Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Schunkert, Heribert] Tech Univ Munich, DZHK German Res Ctr Cardiovasc Res, Munich Heart Alliance, Deutsch Herzzentrum Munchen, D-13347 Berlin, Germany; [Erdmann, Jeanette] Med Univ Lubeck, Med Klin 2, D-23562 Lubeck, Germany; [Shah, Svati H.] Duke Univ, Ctr Human Genet, Durham, NC 27708 USA; [Shah, Svati H.; Kraus, William E.] Duke Univ, Sch Med, Dept Cardiol, Durham, NC 27708 USA; [Shah, Svati H.; Kraus, William E.] Duke Univ, Sch Med, Ctr Genom Med, Durham, NC 27708 USA; [Davies, Robert; Nikpay, Majid; McPherson, Ruth] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1Y 4W7, Canada; [Johansen, Christopher T.; Wang, Jian; Hegele, Robert A.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, Robarts Res Inst, London, ON N6A 3K7, Canada; [Hegele, Robert A.] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, Robarts Res Inst, London, ON N6A 3K7, Canada; [Marz, Winfried; Kleber, Marcus E.] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Publ Hlth Social & Prevent Med, D-68167 Mannheim, Germany; [Marz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Marz, Winfried] Synlab Acad, D-68259 Mannheim, Germany; [Huang, Jie; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Johnson, Andrew D.] NHLBI, Ctr Populat Studies, Framingham Heart Study, Framingham, MA 01702 USA; [Li, Mingyao] Univ Penn, Dept Biostat & Epidemiol, Sch Med, Philadelphia, PA 19104 USA; [Burke, Greg L.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35233 USA; [Gross, Myron] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Liu, Yongmei] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27106 USA; [Assimes, Themistocles L.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Heiss, Gerardo] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Lange, Ethan M.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Taylor, Herman A.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Hamsten, Anders] Karolinska Inst, Dept Med, Atherosclerosis Res Unit, S-17177 Stockholm, Sweden; [Hamsten, Anders] Karolinska Inst, Ctr Mol Med, S-17177 Stockholm, Sweden; [Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, Oxford OX1 2JD, England; [Clarke, Robert] Univ Oxford, Epidemiol Studies Unit, Oxford OX1 2JD, England; [Reilly, Dermot F.; Yin, Wu] Merck Sharp & Dohme Corp, Rahway, NJ 08889 USA; [Rivas, Manuel A.; Donnelly, Peter; Watkins, Hugh] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 2JD, England; [Rossouw, Jacques E.] NHLBI, Bethesda, MD 20824 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; [Herrington, David M.] Wake Forest Sch Med, Sect Cardiol & Publ Hlth Sci, Winston Salem, NC 27106 USA; [Wilson, James G.] Jackson State Univ, Med Ctr, Univ Mississippi, Jackson Heart Study, Jackson, MS 39217 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22904 USA; [Bamshad, Michael J.] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Bamshad, Michael J.] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Bamshad, Michael J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Tracy, Russell P.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA; [Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Reilly, Muredach P.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Spertus, John A.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Cresci, Sharon] Washington Univ, Dept Genet, St Louis, MO 63130 USA; [Hartiala, Jaana; Allayee, Hooman] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Hartiala, Jaana; Allayee, Hooman] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; [Tang, W. H. Wilson; Hazen, Stanley L.] Cleveland Clin, Cleveland, OH 44195 USA; [Reiner, Alex P.; Schwartz, Stephen M.; Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Jackson, Rebecca D.] Ohio State Univ, Columbus, OH 43210 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Siscovick, David S.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Tybjaerg-Hansen, Anne] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen N, Denmark; [Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MO 48109 USA; [Ardissino, Diego] Parma Hosp, Dept Cardiol, I-43100 Parma, Italy; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); Washington University (WUSTL); Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Oxford; Wellcome Centre for Human Genetics; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; University of Verona; University of Ottawa; University of Ottawa Heart Institute; University of Cambridge; MedStar Health Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; German Centre for Cardiovascular Research; German Heart Centre Munich; Munich Heart Alliance; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Duke University; Duke University; Duke University; University of Ottawa; University of Ottawa Heart Institute; Western University (University of Western Ontario); Western University (University of Western Ontario); Ruprecht Karls University Heidelberg; Medical University of Graz; SYNLAB Group; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Pennsylvania; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; Wake Forest Baptist Medical Center; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Mississippi Medical Center; Karolinska Institutet; Karolinska Institutet; University of Oxford; University of Oxford; Merck & Company; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Wake Forest University; Jackson State University; University of Mississippi; University of Mississippi Medical Center; University of Virginia; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Vermont; Boston University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Washington University (WUSTL); University of Southern California; University of Southern California; Cleveland Clinic Foundation; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health Science Center Houston; University of Washington; University of Washington Seattle; University of Copenhagen; University of Parma; University Hospital of Parma; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	skathiresan@partners.org	Erdmann, Jeanette/A-4417-2009; Hazen, Stanley L/ABD-5845-2021; Won, Hong-Hee/D-2672-2011; Stewart, Alexandre F.R./A-5677-2011; Erdmann, Jeanette/P-7513-2014; Hegele, Robert/AAF-6482-2020; Hartiala, Jaana A/GLR-1825-2022; Auer, Paul/AAC-5060-2019; Stitziel, Nathan/AAL-8413-2021; Tang, Wai Hong Wilson/I-1238-2013; Singleton, Andrew B/C-3010-2009; Martinelli, Nicola/J-5622-2016; Hardy, John/C-2451-2009; Kastelein, John/AAF-7950-2020; Hegele, Robert/G-3301-2011; Johnson, Andrew D/G-6520-2013; Altshuler, David M/A-4476-2009; Spertus, John/ABD-3075-2021; Duga, Stefano/F-8173-2014; Girelli, Domenico/B-1183-2008; Rivas, Manuel/ABE-8173-2020; Asselta, Rosanna/AAC-2367-2019; de Bakker, Paul IW/B-8730-2009; Olivieri, Oliviero/A-9126-2008; Ardissino, Diego/AAC-4041-2022; Assimes, Themistocles Leonard/D-9696-2015	Won, Hong-Hee/0000-0001-5719-0552; Erdmann, Jeanette/0000-0002-4486-6231; Hegele, Robert/0000-0003-2861-5325; Hartiala, Jaana A/0000-0003-4883-9318; Stitziel, Nathan/0000-0002-4963-8211; Martinelli, Nicola/0000-0001-6465-5119; Hardy, John/0000-0002-3122-0423; Johnson, Andrew D/0000-0001-6369-5178; Altshuler, David M/0000-0002-7250-4107; Duga, Stefano/0000-0003-3457-1410; Girelli, Domenico/0000-0001-9684-1899; Rivas, Manuel/0000-0003-1457-9925; Asselta, Rosanna/0000-0001-5351-0619; de Bakker, Paul IW/0000-0001-7735-7858; Olivieri, Oliviero/0000-0001-8209-9056; Assimes, Themistocles Leonard/0000-0003-2349-0009; Wulff, Anders Berg/0000-0002-2175-8342; Seshadri, Sudha/0000-0001-6135-2622; Rich, Stephen/0000-0003-3872-7793; Watkins, Hugh/0000-0002-5287-9016; O'Connor, Timothy/0000-0002-0276-1896; Turner, Emily/0000-0001-9040-9229; Kleber, Marcus/0000-0003-0663-7275; Tang, W. H. Wilson/0000-0002-8335-735X; Bustamante, Carlos D./0000-0002-4187-7920; Stewart, Alexandre/0000-0003-2673-9164; Akey, Joshua/0000-0002-4411-1330; Donnelly, Peter/0000-0001-9495-3408; Reilly, Muredach/0000-0002-3035-9386; Goel, Anuj/0000-0003-2307-4021; Caan, Bette/0000-0002-5803-310X; Ballantyne, Christie/0000-0002-6432-1730; solinas, emilia/0000-0003-3532-1317; Cupples, L. Adrienne/0000-0003-0273-7965	National Heart, Lung, and Blood Institute (NHLBI); National Human Genome Research Institute (NHGRI) of the US National Institutes of Health (NIH); NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926, T32HL007604, T32HL007208]; NHGRI [5U54HG003067-11]; NIH [P01 HL076491, P01 HL098055]; Massachusetts General Hospital (MGH); Howard Goodman Fellowship from MGH; Donovan Family Foundation [R01HL107816]; Fondation Leducq; Canadian Institutes of Health Research; NIH/NHLBI [K08HL114642]; Foundation for Barnes-Jewish Hospital;  [RFPS-2007-3-644382]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, T32HL007604, RC2HL102923, ZIAHL006175, RC2HL103010, P01HL098055, K08HL114642, K08HL000720, T32HL007208, RC2HL102924, RC2HL102926, RC2HL102925, R01HL107816, ZIAHL006002, ZIAHL006173, ZIAHL006170] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033193] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10170, NF-SI-0508-10235, NF-SI-0512-10165] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; MRC [MR/L003120/1] Funding Source: UKRI	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute (NHGRI) of the US National Institutes of Health (NIH); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital (MGH); Howard Goodman Fellowship from MGH; Donovan Family Foundation; Fondation Leducq(Leducq Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Foundation for Barnes-Jewish Hospital; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors wish to acknowledge the support of the National Heart, Lung, and Blood Institute (NHLBI) and the National Human Genome Research Institute (NHGRI) of the US National Institutes of Health (NIH) and the contributions of the research institutions, study investigators, field staff and study participants in creating this resource for biomedical research. Funding for the exome sequencing project (ESP) was provided by NHLBI grants RC2 HL-103010 (HeartGO), RC2 HL-102923 (LungGO) and RC2 HL-102924 (WHISP). Exome sequencing was performed through NHLBI grants RC2 HL-102925 (BroadGO) and RC2 HL-102926 (SeattleGO). Exome sequencing in the ATVB, PROCARDIS, and Ottawa studies was supported by NHGRI 5U54HG003067-11 to E.S.L. and S.G. Cleveland Clinic GeneBank was supported by NIH grants P01 HL076491 and P01 HL098055. S.K. is supported by a Research Scholar award from the Massachusetts General Hospital (MGH), the Howard Goodman Fellowship from MGH, the Donovan Family Foundation, R01HL107816, and a grant from Fondation Leducq. R.D. is supported by a Banting Fellowship from the Canadian Institutes of Health Research. N.O.S. is supported, in part, by a career development award from the NIH/NHLBI K08HL114642 and by The Foundation for Barnes-Jewish Hospital. N.O.S. was supported by award number T32HL007604 from the NHLBI. G.M.P was supported by award number T32HL007208 from the NHLBI. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHLBI, NHGRI, or NIH. The Italian ATVB Study was supported by a grant from RFPS-2007-3-644382. A full listing of acknowledgements is provided in the Supplementary Information.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	48	454	493	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 5	2015	518	7537					102	+		10.1038/nature13917	http://dx.doi.org/10.1038/nature13917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7LE	25487149	Green Accepted, Green Submitted			2022-12-28	WOS:000349098000040
J	Riedel, C; Gabizon, R; Wilson, CAM; Hamadani, K; Tsekouras, K; Marqusee, S; Presse, S; Bustamante, C				Riedel, Clement; Gabizon, Ronen; Wilson, Christian A. M.; Hamadani, Kambiz; Tsekouras, Konstantinos; Marqusee, Susan; Presse, Steve; Bustamante, Carlos			The heat released during catalytic turnover enhances the diffusion of an enzyme	NATURE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CALORIMETRY; CATALASE; PROPULSION; DRIVEN	Recent studies have shown that the diffusivity of enzymes increases in a substrate-dependent manner during catalysis(1,2). Although this observation has been reported and characterized for several different systems(3-10), the precise origin of this phenomenon is unknown. Calorimetric methods are often used to determine enthalpies from enzyme-catalysed reactions and can therefore provide important insight into their reaction mechanisms(11,12). The ensemble averages involved in traditional bulk calorimetry cannot probe the transient effects that the energy exchanged in a reaction may have on the catalyst. Here we obtain single-molecule fluorescence correlation spectroscopy data and analyse them within the framework of a stochastic theory to demonstrate a mechanistic link between the enhanced diffusion of a single enzyme molecule and the heat released in the reaction. We propose that the heat released during catalysis generates an asymmetric pressure wave that results in a differential stress at the protein-solvent interface that transiently displaces the centre-of-mass of the enzyme (chemoacoustic effect). This novel perspective on how enzymes respond to the energy released during catalysis suggests a possible effect of the heat of reaction on the structural integrity and internal degrees of freedom of the enzyme.	[Riedel, Clement; Gabizon, Ronen; Wilson, Christian A. M.; Hamadani, Kambiz; Marqusee, Susan; Bustamante, Carlos] Univ Calif Berkeley, Calif Inst Quantitat Biosci, QB3, Berkeley, CA 94720 USA; [Wilson, Christian A. M.] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago 1058, Chile; [Tsekouras, Konstantinos; Presse, Steve] Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46202 USA; [Marqusee, Susan; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Presse, Steve] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Kavli Energy Nano Sci Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Universidad de Chile; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Berkeley; Indiana University System; Indiana University Bloomington; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Presse, S (corresponding author), Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46202 USA.	stevenpresse@gmail.com; carlosjbustamante@gmail.com	Hamadani, Kambiz/AAM-4138-2020	Gabizon, Ronen/0000-0002-3626-5073; Hamadani, Kambiz/0000-0002-2768-3361; Bustamante, Carlos/0000-0002-2970-0073; Tsekouras, Konstantinos/0000-0002-4936-5620; Presse, Steve/0000-0002-5408-0718	NIH [R01-GM0325543, R01-GM05945]; US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-05CH11231]; NSF [MCB-1412259, MCB-1122225]; grant NIGMS [R01-GM65050]; Human Frontier Science Program; Burroughs-Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065050, R01GM050945] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); grant NIGMS; Human Frontier Science Program(Human Frontier Science Program); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Sen for discussions of his experiments. We thank J. Kirsch, R. Golestanian, D. Leitner, J. Kirsdu, P. Geissler, P. Nelson and A. Szabo for their feedbackonthiswork, J. Liphardt for the 405-nm laser line, P. Harbury for the TIM plasmid and B. Maguire for the TIM expression. This research was supported in part by NIH grants R01-GM0325543 (C.B.) and R01-GM05945 (S.M.), the US Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under contract no. DE-AC02-05CH11231 (C.B.), and the NSF grants MCB-1412259 (S.P.) and MCB-1122225 (S.M.). K.M.H. was supported in part by grant NIGMS, R01-GM65050. C.R. acknowledges the support of the Human Frontier Science Program. S.P. further acknowledges support from the Burroughs-Wellcome Fund.	BEERS RF, 1952, J BIOL CHEM, V195, P133; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; Diaz A, 2012, ARCH BIOCHEM BIOPHYS, V525, P102, DOI 10.1016/j.abb.2011.12.011; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Go MK, 2010, BIOCHEMISTRY-US, V49, P5377, DOI 10.1021/bi100538b; Goldberg RN, 2004, BIOINFORMATICS, V20, P2874, DOI 10.1093/bioinformatics/bth314; Golestanian R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.018103; Gouet P, 1996, NAT STRUCT BIOL, V3, P951, DOI 10.1038/nsb1196-951; HABER J, 1993, EUR J BIOCHEM, V217, P567, DOI 10.1111/j.1432-1033.1993.tb18278.x; Howse JR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.048102; Krajewska B, 2009, J MOL CATAL B-ENZYM, V59, P9, DOI 10.1016/j.molcatb.2009.01.003; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Kurtuldu H, 2011, P NATL ACAD SCI USA, V108, P10391, DOI 10.1073/pnas.1107046108; Marzzacco CJ, 1999, J CHEM EDUC, V76, P1517, DOI 10.1021/ed076p1517; Muddana HS, 2010, J AM CHEM SOC, V132, P2110, DOI 10.1021/ja908773a; Pavlick RA, 2013, NANOSCALE, V5, P1301, DOI 10.1039/c2nr32518g; PETERS KS, 1988, SCIENCE, V241, P1053, DOI 10.1126/science.3045967; RADMACHER M, 1994, SCIENCE, V265, P1577, DOI 10.1126/science.8079171; Sakaue T, 2010, EUR PHYS J B, V75, P381, DOI 10.1140/epjb/e2010-00138-x; Sanchez S, 2009, CHEM-ASIAN J, V4, P1402, DOI 10.1002/asia.200900143; Sekiguchi S, 2011, ENZYME MICROB TECH, V49, P171, DOI 10.1016/j.enzmictec.2011.04.019; Sengupta S, 2013, J AM CHEM SOC, V135, P1406, DOI 10.1021/ja3091615; Sijia L., 2009, APPL PHYS LETT, V96; SMITH PT, 1993, J GEN MICROBIOL, V139, P957, DOI 10.1099/00221287-139-5-957; Steel BC, 2006, BIOPHYS J, V91, pL66, DOI 10.1529/biophysj.106.090944; Stern KG, 1937, J BIOL CHEM, V121, P561; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Wang J, 2009, ACS NANO, V3, P4, DOI 10.1021/nn800829k; Whitford PC, 2007, J MOL BIOL, V366, P1661, DOI 10.1016/j.jmb.2006.11.085; WILLIAMS BA, 1993, J ORG CHEM, V58, P3507, DOI 10.1021/jo00065a010; Wong FHC, 2007, J AM CHEM SOC, V129, P10302, DOI 10.1021/ja0715905; Wong FHC, 2011, J FLUORESC, V21, P299, DOI 10.1007/s10895-010-0717-y; Yu H, 2009, J AM CHEM SOC, V131, P5722, DOI 10.1021/ja900372m	34	147	149	3	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					227	U288		10.1038/nature14043	http://dx.doi.org/10.1038/nature14043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25487146	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000347477600042
J	Blair, RJR; Leibenluft, E; Pine, DS				Blair, R. James R.; Leibenluft, Ellen; Pine, Daniel S.			Conduct Disorder and Callous-Unemotional Traits in Youth	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DISRUPTIVE BEHAVIOR DISORDERS; OPPOSITIONAL DEFIANT DISORDER; ANTISOCIAL-BEHAVIOR; AMYGDALA RESPONSE; PSYCHOPATHIC TRAITS; DEVELOPMENTAL PATHWAYS; REWARD ANTICIPATION; PREFRONTAL CORTEX; MODERATING ROLE; FOLLOW-UP		[Blair, R. James R.; Leibenluft, Ellen; Pine, Daniel S.] NIMH, Hlth Intramural Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Blair, RJR (corresponding author), NIMH, NIH, 10 Ctr Dr,Rm 4C104, Bethesda, MD 20892 USA.	jamesblair@mail.nih.gov	Blair, Robert James/ABH-7982-2020; Pine, Daniel/Z-1601-2019		Intramural NIH HHS [Z99 MH999999] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002781] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aharoni E, 2013, P NATL ACAD SCI USA, V110, P6223, DOI 10.1073/pnas.1219302110; Batson C.D., 2011, ALTRUISM HUMANS; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Blackford JU, 2012, CHILD ADOL PSYCH CL, V21, P501, DOI 10.1016/j.chc.2012.05.002; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Blair RJR, 1999, PERS INDIV DIFFER, V27, P135, DOI 10.1016/S0191-8869(98)00231-1; BLAIR RJR, 1995, COGNITION, V57, P1, DOI 10.1016/0010-0277(95)00676-P; BLANCHARD RJ, 1977, ANIM BEHAV, V25, P622, DOI 10.1016/0003-3472(77)90113-0; Brotman LM, 2007, ARCH GEN PSYCHIAT, V64, P1172, DOI 10.1001/archpsyc.64.10.1172; Burke JD, 2005, J CHILD PSYCHOL PSYC, V46, P1200, DOI 10.1111/j.1469-7610.2005.00422.x; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Chamberlain P., 2003, ANTISOCIAL BEHAV CHI; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Connor DF, 2002, J AM ACAD CHILD PSY, V41, P253, DOI 10.1097/00004583-200203000-00004; Crowe SL, 2008, DEV PSYCHOPATHOL, V20, P1145, DOI 10.1017/S0954579408000540; Crowley TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012835; Dandreaux DM, 2009, J ABNORM CHILD PSYCH, V37, P375, DOI 10.1007/s10802-008-9261-5; Dawel A, 2012, NEUROSCI BIOBEHAV R, V36, P2288, DOI 10.1016/j.neubiorev.2012.08.006; de Wied M, 2012, J ABNORM CHILD PSYCH, V40, P211, DOI 10.1007/s10802-011-9557-8; DODGE KA, 1995, J ABNORM PSYCHOL, V104, P632, DOI 10.1037/0021-843X.104.4.632; Eyberg SM, 2008, J CLIN CHILD ADOLESC, V37, P215, DOI 10.1080/15374410701820117; Findling RL, 2008, J CLIN PSYCHIAT, V69, P9; Finger EC, 2008, ARCH GEN PSYCHIAT, V65, P586, DOI 10.1001/archpsyc.65.5.586; Frick PJ, 2014, J CHILD PSYCHOL PSYC, V55, P532, DOI 10.1111/jcpp.12152; Frick PJ, 2014, PSYCHOL BULL, V140, P1, DOI 10.1037/a0033076; Gao Y, 2010, AM J PSYCHIAT, V167, P56, DOI 10.1176/appi.ajp.2009.09040499; Gregg TR, 2001, PROG NEURO-PSYCHOPH, V25, P91, DOI 10.1016/S0278-5846(00)00150-0; Guyer AE, 2007, J CHILD PSYCHOL PSYC, V48, P863, DOI 10.1111/j.1469-7610.2007.01758.x; Hawes DJ, 2005, J CONSULT CLIN PSYCH, V73, P737, DOI 10.1037/0022-006X.73.4.737; Heinz AJ, 2011, NAT REV NEUROSCI, V12, P400, DOI 10.1038/nrn3042; Isaacs EB, 2008, PEDIATR RES, V63, P308, DOI 10.1203/PDR.0b013e318163a271; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Lau JYF, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-12; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Lozier LM, 2014, JAMA PSYCHIAT, V71, P627, DOI 10.1001/jamapsychiatry.2013.4540; MANNUZZA S, 1991, ARCH GEN PSYCHIAT, V48, P77; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; McCrory EJ, 2011, CURR BIOL, V21, pR947, DOI 10.1016/j.cub.2011.10.015; McCubbin JA, 2011, PSYCHOSOM MED, V73, P743, DOI 10.1097/PSY.0b013e318235ed55; McLaughlin KA, 2012, ARCH GEN PSYCHIAT, V69, P1151, DOI 10.1001/archgenpsychiatry.2011.2277; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; New AS, 2009, BIOL PSYCHIAT, V66, P1107, DOI 10.1016/j.biopsych.2009.07.015; NUCCI LP, 1982, CHILD DEV, V53, P403, DOI 10.1111/j.1467-8624.1982.tb01330.x; O'Doherty JP, 2012, EUR J NEUROSCI, V35, P987, DOI 10.1111/j.1460-9568.2012.08074.x; Odgers CL, 2008, DEV PSYCHOPATHOL, V20, P673, DOI 10.1017/S0954579408000333; Pardini DA, 2014, BIOL PSYCHIAT, V75, P73, DOI 10.1016/j.biopsych.2013.04.003; Pardini DA, 2010, J ABNORM PSYCHOL, V119, P683, DOI 10.1037/a0021441; Park G, 2013, EMOTION, V13, P645, DOI 10.1037/a0032971; Passamonti L, 2010, ARCH GEN PSYCHIAT, V67, P729, DOI 10.1001/archgenpsychiatry.2010.75; Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008; Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490; ROBINS LN, 1991, PSYCHIATRY, V54, P116; Rowe R, 2010, J ABNORM PSYCHOL, V119, P726, DOI 10.1037/a0020798; Rowe R, 2010, J CHILD PSYCHOL PSYC, V51, P688, DOI 10.1111/j.1469-7610.2009.02199.x; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; Scott S, 2014, AM J PSYCHIAT, V171, P649, DOI 10.1176/appi.ajp.2014.13050697; Seidel K, 2011, J NEUROENDOCRINOL, V23, P1166, DOI 10.1111/j.1365-2826.2011.02208.x; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Taylor DM, 2003, INT J CLIN PRACT, V57, P49; Tottenham N, 2011, DEVELOPMENTAL SCI, V14, P190, DOI 10.1111/j.1467-7687.2010.00971.x; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Viding E, 2012, AM J PSYCHIAT, V169, P1109, DOI 10.1176/appi.ajp.2012.12020191; Waller R, 2013, CLIN PSYCHOL REV, V33, P593, DOI 10.1016/j.cpr.2013.03.001; Waller R, 2012, J CHILD PSYCHOL PSYC, V53, P946, DOI 10.1111/j.1469-7610.2012.02550.x; Waschbusch DA, 2007, J CLIN CHILD ADOLESC, V36, P629, DOI 10.1080/15374410701662766; Webster-Stratton C, 2001, J CLIN CHILD PSYCHOL, V30, P283, DOI 10.1207/S15374424JCCP3003_2; White SF, 2013, AM J PSYCHIAT, V170, P315, DOI 10.1176/appi.ajp.2012.12060840; White SF, 2012, AM J PSYCHIAT, V169, P750, DOI 10.1176/appi.ajp.2012.11081270; Wootton JM, 1997, J CONSULT CLIN PSYCH, V65, P301, DOI 10.1037/0022-006X.65.2.292.b; Workman JL, 2011, PHARMACOL BIOCHEM BE, V100, P25, DOI 10.1016/j.pbb.2011.07.008; Yau WYW, 2012, J NEUROSCI, V32, P2544, DOI 10.1523/JNEUROSCI.1390-11.2012	73	205	208	3	118	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2207	2216		10.1056/NEJMra1315612	http://dx.doi.org/10.1056/NEJMra1315612			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW0IY	25470696	Green Accepted			2022-12-28	WOS:000345976700009
J	Morgan, B				Morgan, Branwen			FATTY LIVER DISEASE: The liver labyrinth	NATURE			English	Editorial Material													Morgan, Branwen/ABG-1328-2021	Morgan, Branwen/0000-0001-5318-1675				Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P645, DOI 10.1038/nrgastro.2013.182; Bakiri L, 2013, MOL ONCOL, V7, P206, DOI 10.1016/j.molonc.2013.01.005; Griffett K, 2013, ACS CHEM BIOL, V8, P559, DOI 10.1021/cb300541g; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001	4	6	6	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S8	S9		10.1038/516S8a	http://dx.doi.org/10.1038/516S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470200	Bronze			2022-12-28	WOS:000346310800003
J	Pogue, BW				Pogue, Brian W.			TECHNOLOGY Ultrafast imaging takes on a new design	NATURE			English	Editorial Material									Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA	Dartmouth College	Pogue, BW (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.	brian.w.pogue@dartmouth.edu	Pogue, Brian/AAD-8114-2020	Pogue, Brian/0000-0002-9887-670X				Cai WS, 2007, NAT PHOTONICS, V1, P224, DOI 10.1038/nphoton.2007.28; Gao L, 2014, NATURE, V516, P74, DOI 10.1038/nature14005; Goda K, 2009, NATURE, V458, P1145, DOI 10.1038/nature07980	3	0	0	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					46	47		10.1038/516046a	http://dx.doi.org/10.1038/516046a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471878				2022-12-28	WOS:000346310800033
J	Sanchez-Garcia, F; Villagrasa, P; Matsui, J; Kotliar, D; Castro, V; Akavia, UD; Chen, BJ; Saucedo-Cuevas, L; Barrueco, RR; Llobet-Navas, D; Silva, JM; Pe'er, D				Sanchez-Garcia, Felix; Villagrasa, Patricia; Matsui, Junji; Kotliar, Dylan; Castro, Veronica; Akavia, Uri-David; Chen, Bo-Juen; Saucedo-Cuevas, Laura; Barrueco, Ruth Rodriguez; Llobet-Navas, David; Silva, Jose M.; Pe'er, Dana			Integration of Genomic Data Enables Selective Discovery of Breast Cancer Drivers	CELL			English	Article							COPY-NUMBER ALTERATION; ABERRATIONS; EXPRESSION; MUTATIONS; LANDSCAPE; RSF-1; RNAI; OVEREXPRESSION; RSF-1/HBXAP; SURVIVAL	Identifying driver genes in cancer remains a crucial bottleneck in therapeutic development and basic understanding of the disease. We developed Helios, an algorithm that integrates genomic data from primary tumors with data from functional RNAi screens to pinpoint driver genes within large recurrently amplified regions of DNA. Applying Helios to breast cancer data identified a set of candidate drivers highly enriched with known drivers (p < 10(-14)). Nine of ten top-scoring Helios genes are known drivers of breast cancer, and in vitro validation of 12 candidates predicted by Helios found ten conferred enhanced anchorage-independent growth, demonstrating Helios's exquisite sensitivity and specificity. We extensively characterized RSF-1, a driver identified by Helios whose amplification correlates with poor prognosis, and found increased tumorigenesis and metastasis in mouse models. We have demonstrated a powerful approach for identifying driver genes and how it can yield important insights into cancer.	[Sanchez-Garcia, Felix; Kotliar, Dylan; Akavia, Uri-David; Chen, Bo-Juen; Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Sanchez-Garcia, Felix; Kotliar, Dylan; Akavia, Uri-David; Chen, Bo-Juen; Pe'er, Dana] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Sanchez-Garcia, Felix] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Villagrasa, Patricia; Matsui, Junji; Castro, Veronica; Saucedo-Cuevas, Laura; Barrueco, Ruth Rodriguez; Llobet-Navas, David; Silva, Jose M.] Mt Sinai Hosp, Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Columbia University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai	Silva, JM (corresponding author), Mt Sinai Hosp, Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	jose.silva@mssm.edu; dpeer@biology.columbia.edu	Llobet-Navas, David/B-5660-2009; Akavia, Uri David/P-8437-2019; Llobet-Navas, David/AAT-4676-2021; Rodriguez-Barrueco, Ruth/F-6810-2010	Llobet-Navas, David/0000-0003-1443-7003; Rodriguez-Barrueco, Ruth/0000-0003-4925-8865; Pe'er, Dana/0000-0002-9259-8817; Saucedo-Cuevas, Laura/0000-0001-5904-5041; Villagrasa-Gonzalez, Patricia/0000-0002-8662-3641	NIH [R01CA164729, DP2OD002414]; National Centers for Biomedical Computing grant [1U54CA121852-01A1]; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA164729] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414] Funding Source: NIH RePORTER; Cancer Research UK [19556] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers for Biomedical Computing grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK)	The authors would like to thank Sourav Bandyopadhyay, Oren Litvin, Richard Marcotte, Ben Neel, Ramon Parsons, and Sagi Shapira for valuable comments. This research was supported by the NIH (grants R01CA164729 and DP2OD002414) and a National Centers for Biomedical Computing grant (1U54CA121852-01A1). D. P. holds a Packard Fellowship for Science and Engineering.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; BRUNK HD, 1955, ANN MATH STAT, V26, P607, DOI 10.1214/aoms/1177728420; CAMPBELL SM, 1988, EXP CELL RES, V177, P109, DOI 10.1016/0014-4827(88)90029-8; Chen TJ, 2011, APMIS, V119, P808, DOI 10.1111/j.1600-0463.2011.02808.x; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Danussi C., 2013, CANC RES; Davison CA, 2013, CANCER RES, V73, P3704, DOI 10.1158/0008-5472.CAN-12-2482; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Fang FM, 2011, AM J PATHOL, V178, P2407, DOI 10.1016/j.ajpath.2011.01.043; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu BS, 2012, INT J CLIN EXP PATHO, V5, P668; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li QC, 2012, BIOCHEM BIOPH RES CO, V420, P6, DOI 10.1016/j.bbrc.2012.02.095; Liu SL, 2012, TUMOR BIOL, V33, P1485, DOI 10.1007/s13277-012-0399-y; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Morganella S, 2011, BIOINFORMATICS, V27, P2949, DOI 10.1093/bioinformatics/btr488; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Pires MM, 2013, CANCER BIOL THER, V14, P246, DOI 10.4161/cbt.23297; Pletscher-Frankild S., 2014, DIS TEXT MINING DATA; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Sheu JJC, 2013, J PATHOL, V229, P559, DOI 10.1002/path.4147; Shih LM, 2005, P NATL ACAD SCI USA, V102, P14004, DOI 10.1073/pnas.0504195102; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walter V, 2011, BIOINFORMATICS, V27, P678, DOI 10.1093/bioinformatics/btq717; Widmer C., 2011, JMLR WORKSH C P, V27, P207; Wong WC, 2011, BIOINFORMATICS, V27, P2147, DOI 10.1093/bioinformatics/btr357; Yang Shengyu, 2012, Methods Mol Biol, V928, P221, DOI 10.1007/978-1-62703-008-3_17; Yuan XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052516; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	49	63	65	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1461	1475		10.1016/j.cell.2014.10.048	http://dx.doi.org/10.1016/j.cell.2014.10.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25433701	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000346652900022
J	Roediger, HL; DeSoto, KA				Roediger, H. L., III; DeSoto, K. A.			Forgetting the presidents	SCIENCE			English	Article							SIMILAR PRINCIPLES; SEMANTIC MEMORY; POSITION; RECALL	Two studies examined how U. S. presidents are forgotten. A total of 415 undergraduates in 1974, 1991, and 2009 recalled as many presidents as possible and attempted to place them in their correct ordinal positions. All showed roughly linear forgetting of the eight or nine presidents prior to the president holding office at the time, and recall of presidents without respect to ordinal position also showed a regular pattern of forgetting. Similar outcomes occurred with 497 adults (ages 18 to 69) tested in 2014. We fit forgetting functions to the data to predict when six relatively recent presidents will recede in memory to the level of most middle presidents (e.g., we predict that Truman will be forgotten to the same extent as McKinley by about 2040). These studies show that forgetting from collective memory can be studied empirically, as with forgetting in other forms of memory.	[Roediger, H. L., III; DeSoto, K. A.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Washington University (WUSTL)	Roediger, HL (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	roediger@wustl.edu		DeSoto, K. Andrew/0000-0001-9061-0301	James S. McDonnell Foundation	James S. McDonnell Foundation	H.L.R. devised the concept and design of this research with the assistance of K. A. D.; H. L. R. and colleagues collected and analyzed the 1974 and 1991 data; K. A. D. programmed, collected, and analyzed the 2009 and 2014 data; both authors analyzed and interpreted the aggregate data and contributed to writing and revising this manuscript. Data necessary to understand, assess, and extend the conclusions of the manuscript are available in the supplementary materials. A collaborative activity grant from the James S. McDonnell Foundation provided funding for the Internet research. We thank E. Tulving for his comments and A. M. Obenhaus, M. K. Bissell, C. D. Gordon, and M. E. McDoniel for their help with data collection and transcription. M. A. Wheeler collected the data reported in (7).	ANDERSON JR, 1991, PSYCHOL SCI, V2, P396, DOI 10.1111/j.1467-9280.1991.tb00174.x; Atkinson R. C., 1968, PSYCHOL LEARNING MOT, V2, P89, DOI [DOI 10.1016/S0079-7421(08)60422-3, 10.1016/S0079-7421(08)60422-3]; CROWDER RG, 1993, MEM COGNITION, V21, P142, DOI 10.3758/BF03202725; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Healy A. F., 2007, FDN REMEMBERING ESSA; Healy A. F., 2001, NATURE REMEMBERING E; Healy AF, 2000, J MEM LANG, V42, P147, DOI 10.1006/jmla.1999.2671; HUNT RR, 1995, PSYCHON B REV, V2, P105, DOI 10.3758/BF03214414; Hunt RR, 2001, J EXP PSYCHOL LEARN, V27, P1359, DOI 10.1037//0278-7393.27.6.1359; Kelley MR, 2013, MEM COGNITION, V41, P600, DOI 10.3758/s13421-012-0286-1; Neath I, 2011, CAN J EXP PSYCHOL, V65, P77, DOI 10.1037/a0021998; Neath I, 2010, MEM COGNITION, V38, P659, DOI 10.3758/MC.38.5.659; Overstreet MF, 2011, MEM COGNITION, V39, P251, DOI 10.3758/s13421-010-0018-3; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Roediger HL, 2009, MEMORY IN MIND AND CULTURE, P138, DOI 10.1017/CBO9780511626999.009; ROEDIGER HL, 1976, B PSYCHONOMIC SOC, V8, P275, DOI 10.3758/BF03335138; ROEDIGER HL, 1982, J VERB LEARN VERB BE, V21, P635, DOI 10.1016/S0022-5371(82)90810-6; Rubin DC, 1996, PSYCHOL REV, V103, P734, DOI 10.1037/0033-295X.103.4.734; Rubin DC, 1998, PSYCHON B REV, V5, P397, DOI 10.3758/BF03208816; Silver N., 2013, NY TIMES; Tulving E., 1972, ORG MEMORY; von Restorff H, 1933, PSYCHOL FORSCH, V18, P299, DOI 10.1007/BF02409636; Wertsch J.V., 2002, VOICES COLLECTIVE RE; Wertsch JV, 2008, MEMORY, V16, P318, DOI 10.1080/09658210701801434; Wixted JT, 1997, MEM COGNITION, V25, P731, DOI 10.3758/BF03211316; Zaromb F, 2014, MEM COGNITION, V42, P383, DOI 10.3758/s13421-013-0369-7	26	39	40	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1106	1109		10.1126/science.1259627	http://dx.doi.org/10.1126/science.1259627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU7EK	25430768				2022-12-28	WOS:000345763400041
J	Savage, N				Savage, Neil			BORN IN THE BLOOD	NATURE			English	Editorial Material																			0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S158	S159		10.1038/515S158a	http://dx.doi.org/10.1038/515S158a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427204	Bronze			2022-12-28	WOS:000346247600006
J	Ying, A; Arima, H; Czernichow, S; Woodward, M; Huxley, R; Turnbull, F; Perkovic, V; Neal, B; Agodoa, L; Estacio, R; Schrier, R; Lubsen, J; Chalmers, J; Cutler, J; Davis, B; Wing, L; Poulter, NR; Sever, P; Remuzzi, G; Ruggenenti, P; Nissen, S; Lindholm, LH; Fukui, T; Ogihara, T; Saruta, T; Black, H; Sleight, P; Lievre, M; Suzuki, H; Fox, K; Lisheng, L; Ohkubo, T; Imai, Y; Yusuf, S; Bulpitt, CJ; Lewis, E; Brown, M; Palmer, C; Wang, J; Pepine, C; Ishii, M; Yui, Y; Kuramoto, K; Pfeff, M; Asselbergs, FW; van Gilst, WH; Byington, B; Pitt, B; Brenner, B; Remme, WJ; de Zeeuw, D; Rahman, M; Viberti, G; Teo, K; Zanchetti, A; Malacco, E; Mancia, G; Staessen, J; Fagard, R; Holman, R				Ying, A.; Arima, H.; Czernichow, S.; Woodward, M.; Huxley, R.; Turnbull, F.; Perkovic, V.; Neal, B.; Agodoa, L.; Estacio, R.; Schrier, R.; Lubsen, J.; Chalmers, J.; Cutler, J.; Davis, B.; Wing, L.; Poulter, N. R.; Sever, P.; Remuzzi, G.; Ruggenenti, P.; Nissen, S.; Lindholm, L. H.; Fukui, T.; Ogihara, T.; Saruta, T.; Black, H.; Sleight, P.; Lievre, M.; Suzuki, H.; Fox, K.; Lisheng, L.; Ohkubo, T.; Imai, Y.; Yusuf, S.; Bulpitt, C. J.; Lewis, E.; Brown, M.; Palmer, C.; Wang, J.; Pepine, C.; Ishii, M.; Yui, Y.; Kuramoto, K.; Pfeff, M.; Asselbergs, F. W.; van Gilst, W. H.; Byington, B.; Pitt, B.; Brenner, B.; Remme, W. J.; de Zeeuw, D.; Rahman, M.; Viberti, G.; Teo, K.; Zanchetti, A.; Malacco, E.; Mancia, G.; Staessen, J.; Fagard, R.; Holman, R.		Blood Pressure Lowering Treatment	Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials	LANCET			English	Article							PROSPECTIVELY-DESIGNED OVERVIEWS; METABOLIC SYNDROME; HYPERTENSION; OBESITY; EVENTS; REDUCTION; REGIMENS; OUTCOMES; STROKE; IMPACT	Background The cardiovascular benefits of blood pressure lowering in obese people compared with people of normal weight might depend on choice of drug. We compared the effects of blood pressure-lowering regimens on cardiovascular risk in groups of patients categorised by baseline body-mass index (BMI). Methods We used individual patient data from trials included in the Blood Pressure Lowering Treatment Trialists' Collaboration to compare the effects of different classes of blood pressure-lowering regimens for the primary outcome of total major cardiovascular events (stroke, coronary heart disease, heart failure, and cardiovascular death). We used meta-analyses and meta-regressions to assess interactions between treatment and BMI when fitted as either a categorical variable (<25 kg/m(2), 25 to <30 kg/m(2), and >= 30 kg/m(2)) or a continuous variable. Findings Analyses were based on 135 715 individuals from 22 trials who had 14 353 major cardiovascular events. None of the six primary comparisons showed evidence that protection varied by drug class across the three BMI groups (all p for trend >0.20). When analysed as a continuous variable, angiotensin-converting-enzyme inhibitors gave slightly greater protection for each 5 kg/m(2) higher BMI than did calcium antagonists (hazard ratio 0.93, 95% CI 0.89-0.98; p=0.004) or diuretics (0.93, 0.89-0.98; p=0.002). The meta-regressions showed no relation between BMI category and the risk reduction for a given fall in systolic blood pressure. By contrast with a previous report, we noted no relation between BMI and the efficacy of calcium antagonists compared with diuretics. Interpretation We found little evidence that selection of a particular class of blood pressure-lowering drug will lead to substantially different outcomes for individuals who are obese compared with those who are lean.	[Ying, A.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia	George Institute for Global Health; University of Sydney	Ying, A (corresponding author), Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia.	aying@georgeinstitute.org.au	Staessen, Jan A/A-1065-2011; Huxley, Rachel R/C-7032-2013; Woodward, Mark/D-8492-2015; Woodward, Mark/L-6817-2017; Rahimi, Kazem/Q-1279-2015; van Gilst, Wiek/R-1806-2019; Asselbergs, Folkert W./ABD-6752-2021; de Zeeuw, Dick/E-9080-2014; Remuzzi, Giuseppe/V-9766-2017	Staessen, Jan A/0000-0002-3026-1637; Huxley, Rachel R/0000-0002-2705-6616; Rahimi, Kazem/0000-0002-4807-4610; van Gilst, Wiek/0000-0003-2968-8585; Asselbergs, Folkert W./0000-0002-1692-8669; de Zeeuw, Dick/0000-0003-3434-7777; MacMahon, Stephen/0000-0003-2064-7699; Remuzzi, Giuseppe/0000-0002-6194-3446; Rodgers, Anthony/0000-0003-1282-1896; Teo, Koon/0000-0002-3731-0956; Ohkubo, Takayoshi/0000-0002-3283-8196; zanchetti, alberto/0000-0003-4796-7959; Neal, Bruce/0000-0002-0490-7465; Pepine, Carl/0000-0002-6011-681X; Woodward, Mark/0000-0001-9800-5296; Anderson, Craig/0000-0002-7248-4863; Yusuf, Salim/0000-0003-4776-5601	Australian Research Council (ARC); National Health and Medical Research Council of Australia (NHMRC); Heart Foundation of Australia; National Institute for Health Research [CDF-2013-06-012] Funding Source: researchfish	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation of Australia(National Heart Foundation of Australia); National Institute for Health Research(National Institute for Health Research (NIHR))	HA is supported by an Australian Research Council Fellowship. BN is supported by an Australian Research Council (ARC) Future Fellowship. BN and MW are supported by National Health and Medical Research Council of Australia (NHMRC) Senior Research Fellowships. VP has received grants from The Heart Foundation of Australia. BN, MW, and VP have received grants from the NHMRC. This work received no specific funding support.	[Anonymous], 1985, Prev Med, V14, P312; Barzilay JI, 2012, DIABETES CARE, V35, P1401, DOI 10.2337/dc11-1827; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Charlon V, 1998, INT J CLIN PRACT, V52, P257; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chrostowska M, 2006, CURR OPIN NEPHROL HY, V15, P487, DOI 10.1097/01.mnh.0000242173.14082.dc; Czernichow S, 2012, J HYPERTENS, V30, P2338, DOI 10.1097/HJH.0b013e3283593010; Czernichow S, 2011, J HYPERTENS, V29, P4, DOI 10.1097/HJH.0b013e32834000be; Czernichow S, 2010, HYPERTENSION, V55, P1193, DOI 10.1161/HYPERTENSIONAHA.109.140624; de Simone G, 2005, CIRCULATION, V111, P1924, DOI 10.1161/01.CIR.0000161799.91577.0A; Domanski MJ, 2006, EUR HEART J, V27, P1416, DOI 10.1093/eurheartj/ehl022; Dorresteijn JAN, 2012, OBES REV, V13, P17, DOI 10.1111/j.1467-789X.2011.00914.x; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Haass M, 2011, CIRC-HEART FAIL, V4, P324, DOI 10.1161/CIRCHEARTFAILURE.110.959890; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Irie Hidekazu, 2012, Int J Cardiol, DOI 10.1016/j.ijcard.2012.06.103; Jordan J, 2007, J HYPERTENS, V25, P897, DOI 10.1097/HJH.0b013e328051b510; Kalil GZ, 2012, HYPERTENS RES, V35, P4, DOI 10.1038/hr.2011.173; Kawano Y, 2011, AM J HYPERTENS, V24, P1250, DOI 10.1038/ajh.2011.138; Kenchaiah S, 2007, CIRCULATION, V116, P627, DOI 10.1161/CIRCULATIONAHA.106.679779; Kennedy LMA, 2007, INT J CARDIOL, V119, P33, DOI 10.1016/j.ijcard.2006.06.064; Kragelund C, 2005, INT J CARDIOL, V98, P123, DOI 10.1016/j.ijcard.2004.03.042; Krug AW, 2008, HYPERTENSION, V51, P1252, DOI 10.1161/HYPERTENSIONAHA.107.109439; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mallamaci F, 2011, J AM SOC NEPHROL, V22, P1122, DOI 10.1681/ASN.2010090969; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Nakao K, 2010, HYPERTENS RES, V33, P600, DOI 10.1038/hr.2010.38; Neal B, 2000, LANCET, V356, P1955; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Shihab HM, 2012, CIRCULATION, V126, P2983, DOI 10.1161/CIRCULATIONAHA.112.117333; Silventoinen K, 2008, CIRCULATION, V118, P1637, DOI 10.1161/CIRCULATIONAHA.108.772707; Tsukinoki R, 2012, STROKE, V43, P1478, DOI 10.1161/STROKEAHA.112.650317; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Turnbull F, 2003, LANCET, V362, P1527; Turnbull F, 2008, EUR HEART J, V29, P2669, DOI 10.1093/eurheartj/ehn427; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wassertheil-Smoller S, 2000, ARCH INTERN MED, V160, P494, DOI 10.1001/archinte.160.4.494; Weber MA, 2013, LANCET, V381, P537, DOI 10.1016/S0140-6736(12)61343-9; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO Int Soc Hyperten Blood Press Lower, 1998, J HYPERTENS, V16, P127	42	26	27	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					867	874		10.1016/S0140-6736(14)61171-5	http://dx.doi.org/10.1016/S0140-6736(14)61171-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25468168				2022-12-28	WOS:000350451100034
J	von der Ecken, J; Muller, M; Lehman, W; Manstein, DJ; Penczek, PA; Raunser, S				von der Ecken, Julian; Mueller, Mirco; Lehman, William; Manstein, Dietmar J.; Penczek, Pawel A.; Raunser, Stefan			Structure of the F-actin-tropomyosin complex	NATURE			English	Article							NEMALINE MYOPATHY; GENE ACTA1; ELECTRON-MICROSCOPY; MUSCLE ACTIN; CRYO-EM; CRYSTAL-STRUCTURE; GESTALT-BINDING; ATOMIC MODEL; MUTATIONS; FILAMENT	Filamentous actin (F-actin) is the major protein of muscle thin filaments, and actin microfilaments are the main component of the eukaryotic cytoskeleton. Mutations in different actin isoforms lead to early-onset autosomal dominant non-syndromic hearing loss(1), familial thoracic aortic aneurysms and dissections(2), and multiple variations of myopathies(3). In striated muscle fibres, the binding of myosin motors to actin filaments is mainly regulated by tropomyosin and troponin(4,5). Tropomyosin also binds to F-actin in smooth muscle and in non-muscle cells and stabilizes and regulates the filaments there in the absence of troponin(6). Although crystal structures for monomeric actin (G-actin) are available(7), a high-resolution structure of F-actin is still missing, hampering our understanding of how disease-causing mutations affect the function of thin muscle filaments and microfilaments. Here we report the three-dimensional structure of F-actin at a resolution of 3.7 angstrom in complex with tropomyo sin at a resolution of 6.5 angstrom, determined by electron cryomicroscopy. The structure reveals that the D-loop is ordered and acts as a central region for hydrophobic and electrostatic interactions that stabilize the F-actin filament. We clearly identify map density corresponding to ADP and Mg2+ and explain the possible effect of prominent disease-causing mutants. A comparison of F-actin with G-actin reveals the conformational changes during filament formation and identifies the D-loop as their key mediator. We also confirm that negatively charged tropomyosin interacts with a positively charged groove on F-actin. Comparison of the position of tropomyosin in F-actin-tropomyosin with its position in our previously determined F-actin-tropomyosin-myosin structure(8) reveals a myosin-induced transition of tropomyosin. Our results allow us to understand the role of individual mutations in the genesis of actin- and tropomyosin-related diseases and will serve as a strong foundation for the targeted development of drugs.	[von der Ecken, Julian; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany; [Mueller, Mirco; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Lehman, William] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Penczek, Pawel A.] Univ Texas Houston, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Max Planck Society; Hannover Medical School; Boston University; University of Texas System; University of Texas Health Science Center Houston	Raunser, S (corresponding author), Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany.	stefan.raunser@mpi-dortmund.mpg.de	Manstein, Dietmar J./AAG-2640-2019; Raunser, Stefan/AHE-1573-2022; Manstein, Dietmar J. J/M-1034-2013	Manstein, Dietmar J./0000-0003-0763-0147; Manstein, Dietmar J. J/0000-0003-0763-0147; von der Ecken, Julian/0000-0001-8526-2656; Raunser, Stefan/0000-0001-9373-3016	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [175.010.2009.001]; European Union's Regional Development Fund through 'Kansen voor West' [21Z.014]; Behrens-Weise foundation; NIH [U54 094598, R01 60635]; DFG [MA1081/19-1, R37HL036153]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060635, U54GM094598] Funding Source: NIH RePORTER	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); European Union's Regional Development Fund through 'Kansen voor West'; Behrens-Weise foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Hofnagel for excellent assistance in cryo sample preparation and electron microscopy, R. S. Goody for continuous support and for comments on the manuscript and I. Vetter for assistance in data processing. We gratefully acknowledge R. Matadeen and S. de Carlo (FEI Company) for image acquisition at the National Center for Electron Nanoscopy in Leiden (NeCEN), which is co-financed by grants from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (project 175.010.2009.001) and by the European Union's Regional Development Fund through 'Kansen voor West' (project 21Z.014). J.v.d.E. is a fellow of Studienstiftung des deutschen Volkes. This work was supported by the Behrens-Weise foundation (to S.R.), NIH U54 094598 and R01 60635 (to P.A.P.), DFG MA1081/19-1 (to D.J.M.) and R37HL036153 (to W.L.).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Agrawal PB, 2004, ANN NEUROL, V56, P86, DOI 10.1002/ana.20157; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Bathe FS, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-2; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Costa CF, 2004, J CELL SCI, V117, P3367, DOI 10.1242/jcs.01172; Coulton A, 2006, BIOCHEMISTRY-US, V45, P12853, DOI 10.1021/bi0613224; CROSBIE RH, 1994, BIOPHYS J, V67, P1957, DOI 10.1016/S0006-3495(94)80678-2; D'Amico A, 2006, NEUROMUSCULAR DISORD, V16, P548, DOI 10.1016/j.nmd.2006.07.005; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Durer ZAO, 2010, J MOL BIOL, V395, P544, DOI 10.1016/j.jmb.2009.11.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Graziano C, 2004, INT J MOL MED, V13, P805; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Ilkovski B, 2004, HUM MOL GENET, V13, P1727, DOI 10.1093/hmg/ddh185; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; Jain RK, 2012, NEUROLOGY, V78, P1100, DOI 10.1212/WNL.0b013e31824e8ebe; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Koy A, 2007, NEUROPEDIATRICS, V38, P282, DOI 10.1055/s-2008-1065356; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lehman W, 2014, ARCH BIOCHEM BIOPHYS, V552, P68, DOI 10.1016/j.abb.2013.09.011; Lehman W, 2013, J MUSCLE RES CELL M, V34, P155, DOI 10.1007/s10974-013-9342-0; Li XE, 2014, BIOCHEM BIOPH RES CO, V446, P304, DOI 10.1016/j.bbrc.2014.02.097; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Nair UB, 2008, J MOL BIOL, V384, P848, DOI 10.1016/j.jmb.2008.09.082; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Ohlsson M, 2004, NEUROMUSCULAR DISORD, V14, P471, DOI 10.1016/j.nmd.2004.05.016; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Penczek PA, 2014, ULTRAMICROSCOPY, V140, P9, DOI 10.1016/j.ultramic.2014.01.009; Penczek PA, 2010, METHOD ENZYMOL, V482, P73, DOI 10.1016/S0076-6879(10)82003-8; Perkins KZ, 2011, NEUROMUSCULAR DISORD, V21, P696, DOI 10.1016/j.nmd.2011.06.942; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; PITTENGER MF, 1994, CURR OPIN CELL BIOL, V6, P96, DOI 10.1016/0955-0674(94)90122-8; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sousa DR, 2013, J MOL BIOL, V425, P4544, DOI 10.1016/j.jmb.2013.08.020; Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stenzel W, 2010, NEUROMUSCULAR DISORD, V20, P531, DOI 10.1016/j.nmd.2010.06.008; STRZELECKAGOLASZEWSKA H, 1995, BIOCHEM J, V307, P527, DOI 10.1042/bj3070527; Sudo Akira, 2013, No To Hattatsu, V45, P452; van Wijk E, 2003, J MED GENET, V40, P879, DOI 10.1136/jmg.40.12.879; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wang Z, 2012, BIOPOLYMERS, V97, P687, DOI 10.1002/bip.22046; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443	66	241	242	4	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 5	2015	519	7541					114	U272		10.1038/nature14033	http://dx.doi.org/10.1038/nature14033			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC4EQ	25470062	Green Accepted			2022-12-28	WOS:000350304000047
J	Rutz, S; Kayagaki, N; Phung, QT; Eidenschenk, C; Noubade, R; Wang, XT; Lesch, J; Lu, RZ; Newton, K; Huang, OW; Cochran, AG; Vasser, M; Fauber, BP; DeVoss, J; Webster, J; Diehl, L; Modrusan, Z; Kirkpatrick, DS; Lill, JR; Ouyang, WJ; Dixit, VM				Rutz, Sascha; Kayagaki, Nobuhiko; Phung, Qui T.; Eidenschenk, Celine; Noubade, Rajkumar; Wang, Xiaoting; Lesch, Justin; Lu, Rongze; Newton, Kim; Huang, Oscar W.; Cochran, Andrea G.; Vasser, Mark; Fauber, Benjamin P.; DeVoss, Jason; Webster, Joshua; Diehl, Lauri; Modrusan, Zora; Kirkpatrick, Donald S.; Lill, Jennie R.; Ouyang, Wenjun; Dixit, Vishva M.			Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells	NATURE			English	Article							T(H)17 CELLS; MULTIPLE-SCLEROSIS; REGULATORY NETWORK; EXPRESSION; IDENTIFICATION; INFLAMMATION; CYTOKINE; PROTEIN; IL-17; MICE	helper type 17 (T(H)17) cells that produce the cytokines interleukin-17A (IL-17A) and IL-17F are implicated in the pathogenesis of several autoimmune diseases(1,2). The differentiation of T(H)17 cells is regulated by transcription factors such as ROR gamma t(3,4), but post-translational mechanisms preventing the rampant production of pro-inflammatory IL-17A have received less attention. Here we show that the deubiquitylating enzyme DUBA is a negative regulator of IL-17A production in T cells. Mice with DUBA-deficient T cells developed exacerbated inflammation in the small intestine after challenge with anti-CD3 antibodies. DUBA interacted with the ubiquitin ligase UBR5, which suppressed DUBA abundance in naive T cells. DUBA accumulated in activated T cells and stabilized UBR5, which then ubiquitylated ROR gamma t inresponse toTGF-beta signalling. Our data identify DUBA as a cell-intrinsic suppressor of IL-17 production.	[Rutz, Sascha; Eidenschenk, Celine; Noubade, Rajkumar; Wang, Xiaoting; Lesch, Justin; Lu, Rongze; DeVoss, Jason; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Kayagaki, Nobuhiko; Newton, Kim; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Phung, Qui T.; Vasser, Mark; Kirkpatrick, Donald S.; Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Huang, Oscar W.; Cochran, Andrea G.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Fauber, Benjamin P.] Genentech Inc, Discovery Chem, San Francisco, CA 94080 USA; [Webster, Joshua; Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	ouyang@gene.com; dixit@gene.com	dixit, vishva m/A-4496-2012; Lu, Rongze/R-2149-2016; Ouyang, Wenjun/ABA-8763-2020	dixit, vishva m/0000-0001-6983-0326; Kirkpatrick, Donald/0000-0003-3091-2804; Cochran, Andrea/0000-0001-6469-795X; Ouyang, Wenjun/0000-0002-1811-5864				Anania VG, 2014, MOL CELL PROTEOMICS, V13, P145, DOI 10.1074/mcp.M113.031062; [Anonymous], 2008, EUR J IMMUNOL, V38, P2616; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chabaud M, 1998, J IMMUNOL, V161, P409; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Collison LW, 2011, METHODS MOL BIOL, V707, P21, DOI 10.1007/978-1-61737-979-6_2; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hemdan NY, 2010, AUTOIMMUN REV, V9, P785, DOI 10.1016/j.autrev.2010.07.003; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirkpatrick DS, 2013, P NATL ACAD SCI USA, V110, P19426, DOI 10.1073/pnas.1309473110; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kryczek I, 2011, J IMMUNOL, V186, P4388, DOI 10.4049/jimmunol.1003251; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Ma C, 2011, SCAND J IMMUNOL, V74, P47, DOI 10.1111/j.1365-3083.2011.02539.x; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sterling JA, 2006, ANTICANCER RES, V26, P1893; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang P, 2013, BLOOD, V122, P2224, DOI 10.1182/blood-2013-05-503250; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	37	77	78	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					417	421		10.1038/nature13979	http://dx.doi.org/10.1038/nature13979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470037				2022-12-28	WOS:000349547400046
J	Baldridge, MT; Nice, TJ; McCune, BT; Yokoyama, CC; Kambal, A; Wheadon, M; Diamond, MS; Ivanova, Y; Artyomov, M; Virgin, HW				Baldridge, Megan T.; Nice, Timothy J.; McCune, Broc T.; Yokoyama, Christine C.; Kambal, Amal; Wheadon, Michael; Diamond, Michael S.; Ivanova, Yulia; Artyomov, Maxim; Virgin, Herbert W.			Commensal microbes and interferon-lambda determine persistence of enteric murine norovirus infection	SCIENCE			English	Article							III INTERFERON; REPLICATION; SUSCEPTIBILITY; TRANSMISSION; SUFFICIENT; AUTOPHAGY; IMMUNITY; ATG16L1	The capacity of human norovirus (NoV), which causes >90% of global epidemic nonbacterial gastroenteritis, to infect a subset of people persistently may contribute to its spread. How such enteric viruses establish persistent infections is not well understood. We found that antibiotics prevented persistent murine norovirus (MNoV) infection, an effect that was reversed by replenishment of the bacterial microbiota. Antibiotics did not prevent tissue infection or affect systemic viral replication but acted specifically in the intestine. The receptor for the antiviral cytokine interferon-lambda, Ifnlr1, as well as the transcription factors Stat1 and Irf3, were required for antibiotics to prevent viral persistence. Thus, the bacterial microbiome fosters enteric viral persistence in a manner counteracted by specific	[Baldridge, Megan T.; Nice, Timothy J.; McCune, Broc T.; Yokoyama, Christine C.; Kambal, Amal; Wheadon, Michael; Diamond, Michael S.; Ivanova, Yulia; Artyomov, Maxim; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu	Nice, Timothy/X-9114-2019; Baldridge, Megan/T-7274-2019; Diamond, Michael/AAH-1733-2019	Nice, Timothy/0000-0002-4471-7666; Baldridge, Megan/0000-0002-7030-6131; Diamond, Michael/0000-0002-8791-3165; Virgin, Herbert/0000-0001-8580-7628; Wheadon, Michael/0000-0002-2579-3786	NIH [R01 AI084887, U19 AI109725, 5T32CA009547, 5T32AI007163, 1F31CA177194, U19 AI083019, U19 AI106772]; Crohn's and Colitis Foundation Genetics Initiative [274415]; Broad Foundation [IBD-0357]; W. M. Keck Fellowship from Washington University; Cancer Research Institute; American Cancer Society; NATIONAL CANCER INSTITUTE [F31CA177194, T32CA113275, T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, U19AI109725, U19AI083019, R01AI084887, U19AI106772] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation Genetics Initiative; Broad Foundation; W. M. Keck Fellowship from Washington University; Cancer Research Institute; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Liu for technical assistance, H. Lazear for discussions, D. Kreamalmeyer for animal care and breeding, members of the Virgin laboratory for manuscript review and discussion, and S. Doyle and Bristol-Myers Squibb for providing Ifnlr1<SUP>-/-</SUP> mice. The mouse norovirus strains used in this paper are available from Washington University under a material transfer agreement. Ifnlr1<SUP>-/-</SUP> mice were made available from ZymoGenetics Inc. (Bristol-Myers Squibb) under a material transfer agreement with Washington University School of Medicine. H.W.V. is a co-inventor on a patent filed by Washington University School of Medicine related to the use of murine norovirus. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Sequencing data have been uploaded to the European Nucleotide Archive (accession no. PRJEB7745). Supported by NIH grants R01 AI084887 and U19 AI109725, Crohn's and Colitis Foundation Genetics Initiative grant 274415, and Broad Foundation grant IBD-0357 (H.W.V.); NIH training grant 5T32CA009547 and the W. M. Keck Fellowship from Washington University (M.T.B.); NIH training grant 5T32AI007163 and postdoctoral fellowships from the Cancer Research Institute and American Cancer Society (T.J.N.); NIH grant 1F31CA177194 (B.T.M.); NIH training grant 5T32AI007163 (C.C.Y.); and NIH grants U19 AI083019 and U19 AI106772 (M. S. D.). Washington University and H.W.V. receive income based on licenses for MNoV technology.	Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Basic M, 2014, INFLAMM BOWEL DIS, V20, P431, DOI 10.1097/01.MIB.0000441346.86827.ed; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chachu KA, 2008, J VIROL, V82, P6610, DOI 10.1128/JVI.00141-08; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; Gonzalez-Hernandez MB, 2014, J VIROL, V88, P6934, DOI 10.1128/JVI.00204-14; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kim YG, 2011, CELL HOST MICROBE, V9, P496, DOI 10.1016/j.chom.2011.05.006; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Norman JM, 2014, GASTROENTEROLOGY, V146, P1459, DOI 10.1053/j.gastro.2014.02.001; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Rodriguez MR, 2014, J VIROL, V88, P9277, DOI 10.1128/JVI.01422-14; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Sukhrie FHA, 2010, J CLIN MICROBIOL, V48, P4303, DOI 10.1128/JCM.01308-10; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432	34	278	291	4	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					266	269		10.1126/science.1258025	http://dx.doi.org/10.1126/science.1258025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25431490	Green Accepted			2022-12-28	WOS:000347915300034
J	Rowland, DC; Moser, MB				Rowland, David C.; Moser, May-Britt			NEUROSCIENCE A three-dimensional neural compass	NATURE			English	Editorial Material							GRID CELLS		[Rowland, David C.; Moser, May-Britt] Kavli Inst Syst Neurosci, N-7491 Trondheim, Norway; [Rowland, David C.; Moser, May-Britt] Ctr Neural Computat, N-7491 Trondheim, Norway		Rowland, DC (corresponding author), Kavli Inst Syst Neurosci, N-7491 Trondheim, Norway.	daverowland22@gmail.com; may-britt.moser@ntnu.no						Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Calton JL, 2005, J NEUROSCI, V25, P2420, DOI 10.1523/JNEUROSCI.3511-04.2005; Finkelstein A, 2015, NATURE, V517, P159, DOI 10.1038/nature14031; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Jeffery KJ, 2013, BEHAV BRAIN SCI, V36, P523, DOI 10.1017/S0140525X12002476; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; TAUBE JS, 1990, J NEUROSCI, V10, P420; Yartsev MM, 2013, SCIENCE, V340, P367, DOI 10.1126/science.1235338	10	2	2	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					156	157		10.1038/nature14076	http://dx.doi.org/10.1038/nature14076			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25470063				2022-12-28	WOS:000347477600026
J	Suga, M; Akita, F; Hirata, K; Ueno, G; Murakami, H; Nakajima, Y; Shimizu, T; Yamashita, K; Yamamoto, M; Ago, H; Shen, JR				Suga, Michihiro; Akita, Fusamichi; Hirata, Kunio; Ueno, Go; Murakami, Hironori; Nakajima, Yoshiki; Shimizu, Tetsuya; Yamashita, Keitaro; Yamamoto, Masaki; Ago, Hideo; Shen, Jian-Ren			Native structure of photosystem II at 1.95 angstrom resolution viewed by femtosecond X-ray pulses	NATURE			English	Article							OXYGEN-EVOLVING COMPLEX; CRYSTAL-STRUCTURE; MANGANESE COMPLEX; WATER; DIFFRACTION; MODELS; DAMAGE; CLUSTER; STATES; EXAFS	Photosynthesis converts light energy into biologically useful chemical energy vital to life on Earth. The initial reaction of photosynthesis takes place in photosystem II (PSII), a 700-kilodalton homodimeric membrane protein complex that catalyses photo-oxidation of water into dioxygen through an S-state cycle of the oxygen evolving complex (OEC). The structure of PSII has been solved by X-ray diffraction (XRD) at 1.9 angstrom resolution, which revealed that the OEC is a Mn4CaO5-cluster coordinated by a well defined protein environment(1). However, extended X-ray absorption fine structure (EXAFS) studies showed that the manganese cations in the OEC are easily reduced by X-ray irradiation(2), and slight differences were found in the Mn-Mn distances determined by XRD1, EXAFS(3-7) and theoretical studies(8-14). Here we report a 'radiation-damage-free' structure of PSII from Thermosynechococcus vulcanus in the S-1 state at a resolution of 1.95 angstroms using femtosecond X-ray pulses of the SPring-8 angstrom compact free-electron laser (SACLA) and hundreds of large, highly isomorphous PSII crystals. Compared with the structure from XRD, the OEC in the X-ray free electron laser structure has Mn-Mn distances that are shorter by 0.1-0.2 angstroms. The valences of each manganese atom were tentatively assigned as Mn1D(III), Mn2C(IV), Mn3B(IV) and Mn4A(III), based on the average Mn-ligand distances and analysis of the Jahn-Teller axis on Mn(III). One of the oxo-bridged oxygens, O5, has significantly longer distances to Mn than do the other oxo-oxygen atoms, suggesting that O5 is a hydroxide ion instead of a normal oxygen dianion and therefore may serve as one of the substrate oxygen atoms. These findings provide a structural basis for the mechanism of oxygen evolution, and we expect that this structure will provide a blueprint for the design of artificial catalysts for water oxidation.	[Suga, Michihiro; Akita, Fusamichi; Nakajima, Yoshiki; Shimizu, Tetsuya; Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, Photosynth Res Ctr, Okayama 7008530, Japan; [Hirata, Kunio; Ueno, Go; Murakami, Hironori; Yamashita, Keitaro; Yamamoto, Masaki; Ago, Hideo] RIKEN, SPring Ctr 8, Mikazuki, Hyogo 6795148, Japan; [Hirata, Kunio] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan	Okayama University; RIKEN; Japan Science & Technology Agency (JST)	Ago, H (corresponding author), RIKEN, SPring Ctr 8, 1-1-1 Kouto Sayo, Mikazuki, Hyogo 6795148, Japan.	yamamoto@riken.jp; ago@spring8.or.jp; shen@cc.okayama-u.ac.jp	Akita, Fusamichi/C-2034-2015; Yamamoto, Masaki/B-7844-2015; Shen, Jian-Ren/B-2558-2011; Suga, Michi/C-2870-2015	Akita, Fusamichi/0000-0003-0537-6157; Yamamoto, Masaki/0000-0002-1311-1768; Yamashita, Keitaro/0000-0002-5442-7582; Ago, Hideo/0000-0002-9040-488X; Nakajima, Yoshiki/0000-0002-0529-8075	The Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT; JST/CREST; Japan Synchrotron Radiation Research Institute (JASRI) [2012A8011, 2012B8040, 2013A8047, 2013B8052, 2014A8036]	The Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST/CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Synchrotron Radiation Research Institute (JASRI)	We thank T. Ishikawa, M. Yabashi, K. Tono and Y. Inubushi for help in using the SACLA beamline, T. Tsukihara and S. Yoshikawa for suggestions and comments on the experiments, F. Seno for assistance with sample preparation, and K. Kawakami and Y. Umena for suggestions in the initial stage of the project. F. H. M. Koua participated in the initial stage of this work. This work was supported by an X-ray Free Electron Laser Priority Strategy Program (The Ministry of Education, Culture, Sports, Science and Technology of Japan, MEXT) (H. A. and J.-R. S.), a JST/CREST grant (K. H.), a grant-in-aid for Specially Promoted Research no. 24000018 (J.-R. S.) and KAKENHI grant no. 26840023 (M. S.) from JSPS, MEXT, Japan. The XFEL experiments were performed at beamline 3 of SACLA with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal nos 2012A8011, 2012B8040, 2013A8047, 2013B8052 and 2014A8036), and we thank staff at SACLA for their help.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blomberg MRA, 2014, CHEM REV, V114, P3601, DOI 10.1021/cr400388t; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2008, PHILOS T R SOC B, V363, P1237, DOI 10.1098/rstb.2007.2220; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Galstyan A, 2012, J AM CHEM SOC, V134, P7442, DOI 10.1021/ja300254n; Glockner C, 2013, J BIOL CHEM, V288, P22607, DOI 10.1074/jbc.M113.476622; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/NMETH.2962, 10.1038/nmeth.2962]; Holton JM, 2010, ACTA CRYSTALLOGR D, V66, P393, DOI 10.1107/S0907444910007262; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kern J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5371; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; Luber S, 2011, BIOCHEMISTRY-US, V50, P6308, DOI 10.1021/bi200681q; Murray JW, 2004, J APPL CRYSTALLOGR, V37, P513, DOI 10.1107/S0021889804010660; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Shoji M., MOL PHYS; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	35	834	847	28	759	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					99	U265		10.1038/nature13991	http://dx.doi.org/10.1038/nature13991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25470056	Green Submitted			2022-12-28	WOS:000347178400043
J	Gorbunova, V; Boeke, JD; Helfand, SL; Sedivy, JM				Gorbunova, Vera; Boeke, Jef D.; Helfand, Stephen L.; Sedivy, John M.			Sleeping dogs of the genome	SCIENCE			English	Editorial Material							TRANSPOSABLE ELEMENTS; RETROTRANSPOSITION; MOBILE		[Gorbunova, Vera] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Boeke, Jef D.] NYU, Langone Med Ctr, Inst Syst Genet, New York, NY 10016 USA; [Helfand, Stephen L.; Sedivy, John M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	University of Rochester; New York University; NYU Langone Medical Center; Brown University	Gorbunova, V (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	john_sedivy@brown.edu		Gorbunova, Vera/0000-0001-8979-0333	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107632, P30GM103410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG016694, P01AG047200, R01AG027237, R37AG016667, T32AG041688, R01AG024353] Funding Source: NIH RePORTER; NIA NIH HHS [T32 AG041688, R37AG016667, R01AG027237, P01AG047200, R37 AG016694, R37 AG016667, T32AG041688, R01AG024353, RF1 AG024353, P01 AG047200, R37AG016694, R01 AG027237, R01 AG024353] Funding Source: Medline; NIGMS NIH HHS [P50GM107632, P30 GM103410, P30GM103410, P50 GM107632] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047; Dawkins Richard, 1976, SELFISH GENE; De Cecco M, 2013, AGING-US, V5, P867, DOI 10.18632/aging.100621; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Faulkner GJ, 2011, FEBS LETT, V585, P1589, DOI 10.1016/j.febslet.2011.03.061; Guo H, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms5986, 10.1038/ncomms6276]; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Li WH, 2013, NAT NEUROSCI, V16, P529, DOI 10.1038/nn.3368; Maxwell PH, 2011, P NATL ACAD SCI USA, V108, P20376, DOI 10.1073/pnas.1100271108; Savva YA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3745; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Solyom S, 2012, GENOME MED, V4, DOI 10.1186/gm311; Van Meter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6011	14	29	31	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1187	1188		10.1126/science.aaa3177	http://dx.doi.org/10.1126/science.aaa3177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477445	Green Accepted			2022-12-28	WOS:000346189000045
J	Schmidtko, S; Heywood, KJ; Thompson, AF; Aoki, S				Schmidtko, Sunke; Heywood, Karen J.; Thompson, Andrew F.; Aoki, Shigeru			Multidecadal warming of Antarctic waters	SCIENCE			English	Article							SEA-LEVEL RISE; GLOBAL HEAT; PINE ISLAND; SENSITIVITY; WIDESPREAD; THWAITES; DRIVEN; TRENDS; MELT	Decadal trends in the properties of seawater adjacent to Antarctica are poorly known, and the mechanisms responsible for such changes are uncertain. Antarctic ice sheet mass loss is largely driven by ice shelf basal melt, which is influenced by ocean-ice interactions and has been correlated with Antarctic Continental Shelf Bottom Water (ASBW) temperature. We document the spatial distribution of long-term large-scale trends in temperature, salinity, and core depth over the Antarctic continental shelf and slope. Warming at the seabed in the Bellingshausen and Amundsen seas is linked to increased heat content and to a shoaling of themid-depth temperature maximum over the continental slope, allowing warmer, saltier water greater access to the shelf in recent years. Regions of ASBW warming are those exhibiting increased ice shelf melt.	[Schmidtko, Sunke; Heywood, Karen J.] Univ E Anglia, Sch Environm Sci, Ctr Ocean & Atmospher Sci, Norwich NR4 7TJ, Norfolk, England; [Schmidtko, Sunke] GEOMAR Helmholtz Ctr Ocean Res Kiel, D-24105 Kiel, Germany; [Thompson, Andrew F.] CALTECH, Pasadena, CA 91125 USA; [Aoki, Shigeru] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan	University of East Anglia; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; California Institute of Technology; Hokkaido University	Schmidtko, S (corresponding author), Univ E Anglia, Sch Environm Sci, Ctr Ocean & Atmospher Sci, Norwich NR4 7TJ, Norfolk, England.	sschmidtko@geomar.de	Heywood, Karen J/L-1757-2016; Aoki, Shigeru/D-9105-2012; Schmidtko, Sunke/F-3355-2011	Heywood, Karen J/0000-0001-9859-0026; Schmidtko, Sunke/0000-0003-3272-7055	German Federal Ministry for Education and Research (BMBF) project MiKlip; NERC Antarctic Funding Initiative research grant GENTOO [NE/H01439X/1]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Daiwa Foundation; NSF [OPP-1246460]; NERC [NE/H01439X/1] Funding Source: UKRI; Natural Environment Research Council [NE/H01439X/1] Funding Source: researchfish	German Federal Ministry for Education and Research (BMBF) project MiKlip; NERC Antarctic Funding Initiative research grant GENTOO; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiwa Foundation; NSF(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	All data used in this manuscript are publicly available; data sources are detailed in the supplementary materials. We thank all officers, crews, and scientists involved in collecting and calibrating the data in the often harsh Southern Ocean environment, as well as everyone involved in making the data publicly available. We thank three anonymous reviewers for helpful discussions and feedback. Supported by the German Federal Ministry for Education and Research (BMBF) project MiKlip (S.S.); NERC Antarctic Funding Initiative research grant GENTOO NE/H01439X/1 (S.S. and K.J.H.); a Grant-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a Daiwa Foundation Small Grant (S.A.); and NSF award OPP-1246460 (A.F.T.).	Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Azaneu M, 2013, J GEOPHYS RES-OCEANS, V118, P4213, DOI 10.1002/jgrc.20303; Bintanja R, 2013, NAT GEOSCI, V6, P376, DOI [10.1038/NGEO1767, 10.1038/ngeo1767]; De Angelis H, 2003, SCIENCE, V299, P1560, DOI 10.1126/science.1077987; Dinniman MS, 2012, J CLIMATE, V25, P4799, DOI 10.1175/JCLI-D-11-00307.1; Dutrieux P, 2014, SCIENCE, V343, P174, DOI 10.1126/science.1244341; Gille ST, 2008, J CLIMATE, V21, P4749, DOI 10.1175/2008JCLI2131.1; Grange LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077917, 10.1371/journal.pone.0084448]; Hellmer HH, 2011, OCEAN SCI, V7, P305, DOI 10.5194/os-7-305-2011; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; Heuze C, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50287; Holland PR, 2012, NAT GEOSCI, V5, P872, DOI [10.1038/ngeo1627, 10.1038/NGEO1627]; Jacobs SS, 2010, J CLIMATE, V23, P4508, DOI 10.1175/2010JCLI3284.1; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Petty AA, 2013, J PHYS OCEANOGR, V43, P920, DOI 10.1175/JPO-D-12-0172.1; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Purkey SG, 2013, J CLIMATE, V26, P6105, DOI 10.1175/JCLI-D-12-00834.1; Purkey SG, 2010, J CLIMATE, V23, P6336, DOI 10.1175/2010JCLI3682.1; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Rintoul SR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028550; Schmidtko S, 2013, J GEOPHYS RES-OCEANS, V118, P1658, DOI 10.1002/jgrc.20122; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Spence P, 2014, GEOPHYS RES LETT, V41, P4601, DOI 10.1002/2014GL060613; Stewart AL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053099; Zenk W, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030340	28	269	277	12	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1227	1231		10.1126/science.1256117	http://dx.doi.org/10.1126/science.1256117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477461	Green Accepted			2022-12-28	WOS:000346189000057
J	Cho, H; Uehara, T; Bernhardt, TG				Cho, Hongbaek; Uehara, Tsuyoshi; Bernhardt, Thomas G.			Beta-Lactam Antibiotics Induce a Lethal Malfunctioning of the Bacterial Cell Wall Synthesis Machinery	CELL			English	Article							PENICILLIN-BINDING-PROTEINS; SOLUBLE LYTIC TRANSGLYCOSYLASE; ESCHERICHIA-COLI; INDUCED LYSIS; MUREIN; DIVISION; MECHANISM; GROWTH; RESISTANCE; ELONGATION	Penicillin and related beta-lactams comprise one of our oldest and most widely used antibiotic therapies. These drugs have long been known to target enzymes called penicillin-binding proteins (PBPs) that build the bacterial cell wall. Investigating the down-stream consequences of target inhibition and how they contribute to the lethal action of these important drugs, we demonstrate that beta-lactams do more than just inhibit the PBPs as is commonly believed. Rather, they induce a toxic malfunctioning of their target biosynthetic machinery involving a futile cycle of cell wall synthesis and degradation, thereby depleting cellular resources and bolstering their killing activity. Characterization of this mode of action additionally revealed a quality control function for enzymes that cleave bonds in the cell wall matrix. The results thus provide insight into the mechanism of cell wall assembly and suggest how best to interfere with the process for future antibiotic development.	[Cho, Hongbaek; Uehara, Tsuyoshi; Bernhardt, Thomas G.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Bernhardt, TG (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA.	thomas_bernhardt@hms.harvard.edu		Uehara, Tsuyoshi/0000-0001-6994-4286	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01-AI099144, U19-AI109764]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109764, R01AI099144] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank Christina Montero and Alex Godfrey for help with mutant characterization and members of the Bernhardt, Rudner, and Walker laboratories for helpful discussions. We also thank Tom Dougherty, Mary-Jane Tsang, Anastasiya Yakhnina, and David Rudner for comments on the manuscript. Special thanks to Suzanne Walker and her laboratory their help with LC/MS. This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01-AI099144 and U19-AI109764).	Banzhaf M, 2012, MOL MICROBIOL, V85, P179, DOI 10.1111/j.1365-2958.2012.08103.x; BEACHEY EH, 1981, EUR J BIOCHEM, V116, P355, DOI 10.1111/j.1432-1033.1981.tb05342.x; Begg K, 1998, J BACTERIOL, V180, P881, DOI 10.1128/JB.180.4.881-884.1998; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BURMAN LG, 1983, J BACTERIOL, V155, P447, DOI 10.1128/JB.155.2.447-453.1983; Chung HS, 2009, P NATL ACAD SCI USA, V106, P21872, DOI 10.1073/pnas.0911674106; Costa CS, 2006, FEMS MICROBIOL LETT, V256, P311, DOI 10.1111/j.1574-6968.2006.00133.x; CURTIS NAC, 1979, ANTIMICROB AGENTS CH, V16, P533, DOI 10.1128/AAC.16.5.533; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Fisher JF, 2014, BIOORG CHEM, V56, P41, DOI 10.1016/j.bioorg.2014.05.011; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; GLAUNER B, 1990, J BIOL CHEM, V265, P18988; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; KOHLRAUSCH U, 1991, J BACTERIOL, V173, P3425, DOI 10.1128/jb.173.11.3425-3431.1991; Kraft AR, 1999, J BACTERIOL, V181, P7192, DOI 10.1128/JB.181.23.7192-7198.1999; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Lee M, 2013, J AM CHEM SOC, V135, P3311, DOI 10.1021/ja309036q; Lee TK, 2014, P NATL ACAD SCI USA, V111, P4554, DOI 10.1073/pnas.1313826111; MOREILLON P, 1990, ANTIMICROB AGENTS CH, V34, P33, DOI 10.1128/AAC.34.1.33; PARK JT, 1957, SCIENCE, V125, P99, DOI 10.1126/science.125.3238.99; ROMEIS T, 1994, J BIOL CHEM, V269, P21603; SCHWARZ U, 1969, J MOL BIOL, V41, P419, DOI 10.1016/0022-2836(69)90285-X; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; TEMPLIN MF, 1992, J BIOL CHEM, V267, P20039; THUNNISSEN AMWH, 1994, NATURE, V367, P750, DOI 10.1038/367750a0; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; TOMASZ A, 1975, P NATL ACAD SCI USA, V72, P4162, DOI 10.1073/pnas.72.10.4162; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; Uehara T, 2011, CURR OPIN MICROBIOL, V14, P698, DOI 10.1016/j.mib.2011.10.003; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; VINELLA D, 1993, J BACTERIOL, V175, P6704, DOI 10.1128/jb.175.20.6704-6710.1993; VINELLA D, 1992, EMBO J, V11, P1493, DOI 10.1002/j.1460-2075.1992.tb05194.x; vonRechenberg M, 1996, MICROB DRUG RESIST, V2, P155, DOI 10.1089/mdr.1996.2.155; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987	46	333	339	9	172	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1300	1311		10.1016/j.cell.2014.11.017	http://dx.doi.org/10.1016/j.cell.2014.11.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480295	Green Accepted, Bronze			2022-12-28	WOS:000346652900010
J	Galluzzi, L; Pietrocola, F; Levine, B; Kroemer, G				Galluzzi, Lorenzo; Pietrocola, Federico; Levine, Beth; Kroemer, Guido			Metabolic Control of Autophagy	CELL			English	Review							ACTIVATED PROTEIN-KINASE; EXTENDS LIFE-SPAN; STRESS-INDUCED AUTOPHAGY; BECLIN 1 PHOSPHORYLATION; DIET-INDUCED OBESITY; AMINO-ACIDS; MITOCHONDRIAL DISEASE; NICOTINAMIDE RIBOSIDE; GLUCOSE-HOMEOSTASIS; NEONATAL AUTOPHAGY	Macroautophagy (herein referred to as autophagy) is an evolutionarily conserved mechanism of adaptation to adverse microenvironmental conditions, including limited nutrient supplies. Several sensors interacting with the autophagic machinery have evolved to detect fluctuations in key metabolic parameters. The signal transduction cascades operating downstream of these sensors are highly interconnected to control a spatially and chronologically coordinated autophagic response that maintains the health and function of individual cells while preserving organismal homeostasis. Here, we discuss the physiological regulation of autophagy by metabolic circuitries, as well as alterations of such control in disease.	[Galluzzi, Lorenzo; Pietrocola, Federico; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Llabellise Ligue Natl Canc 11, F-75006 Paris, France; [Galluzzi, Lorenzo; Pietrocola, Federico; Kroemer, Guido] INSERM, U1138, F-75006 Paris, France; [Galluzzi, Lorenzo; Pietrocola, Federico; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, F-75005 Paris, France; [Galluzzi, Lorenzo; Pietrocola, Federico; Kroemer, Guido] Univ Paris 06, F-75005 Paris, France; [Pietrocola, Federico] Univ Paris 11, F-94805 Villejuif, France; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75690 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kroemer, Guido] Hop Europe Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France; [Kroemer, Guido] Metabol Platform, F-94805 Villejuif, France; [Kroemer, Guido] Cell Biol Platform, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe Llabellise Ligue Natl Canc 11, F-75006 Paris, France.	kroemer@orange.fr	KROEMER, Guido/B-4263-2013; Galluzzi, Lorenzo/AAG-6294-2019; Kroemer, Guido/AAY-9859-2020; Galluzzi, Lorenzo/AAH-3286-2021; Pietrocola, Federico/AAW-9621-2020; Galluzzi, Lorenzo/AAG-6432-2019	KROEMER, Guido/0000-0002-9334-4405; Pietrocola, Federico/0000-0002-2930-234X; 	Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR); Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Fondation Bettencourt-Schueller; Fondation de France; Fondation pour la Recherche Medicale (FRM); European Commission (ArtForce); European Research Council (ERC); E-Rare-2 project; LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); NIH [RO1 CA109618, U19 AI109725]; Cancer Prevention Research Institute of Texas [RP120718-PI]; NATIONAL CANCER INSTITUTE [R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725] Funding Source: NIH RePORTER	Ligue contre le Cancer (equipe labelisee)(Ligue nationale contre le cancer); Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation Bettencourt-Schueller; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)); E-Rare-2 project; LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are indebted to Erika Vacchelli (Centre de Recherche des Cordeliers) for help with table preparation. G.K. is supported by the Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR); Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Fondation Bettencourt-Schueller; Fondation de France; Fondation pour la Recherche Medicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); the E-Rare-2 project, the LabEx Immuno-Oncology; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI). B.L. is supported by NIH grants RO1 CA109618 and U19 AI109725 and a Cancer Prevention Research Institute of Texas grant RP120718-PI.	Amir M, 2011, EXPERT REV GASTROENT, V5, P159, DOI [10.1586/EGH.11.4, 10.1586/egh.11.4]; ATKINSON DE, 1967, J BIOL CHEM, V242, P3239; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bonfili L, 2013, APOPTOSIS, V18, P1188, DOI 10.1007/s10495-013-0856-0; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Chen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059682; Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Criollo A, 2011, EMBO J, V30, P4908, DOI 10.1038/emboj.2011.413; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Dou ZX, 2013, MOL CELL, V50, P29, DOI 10.1016/j.molcel.2013.01.022; Dupont N, 2014, CURR BIOL, V24, P609, DOI 10.1016/j.cub.2014.02.008; Duran RV, 2013, ONCOGENE, V32, P4549, DOI 10.1038/onc.2012.465; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Galluzzi L., 2015, CELL DEATH DIFFER, V22; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Guo R, 2013, BBA-MOL BASIS DIS, V1832, P1136, DOI 10.1016/j.bbadis.2013.03.013; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Harder LM, 2014, AUTOPHAGY, V10, P339, DOI 10.4161/auto.26863; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Inokuchi-Shimizu S, 2014, J CLIN INVEST, V124, P3566, DOI 10.1172/JCI74068; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363; Khaldoun SA, 2014, MOL BIOL CELL, V25, P118, DOI 10.1091/mbc.E13-06-0324; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Kondomerkos DJ, 2005, HISTOL HISTOPATHOL, V20, P689, DOI 10.14670/HH-20.689; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981; Lapierre LR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3267; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Li N, 2013, J CLIN INVEST, V123, P2231, DOI 10.1172/JCI64498; Lizaso A, 2013, AUTOPHAGY, V9, P1228, DOI 10.4161/auto.24893; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Mackeh R, 2014, J BIOL CHEM, V289, P11816, DOI 10.1074/jbc.M113.507400; Madeo F, 2014, NAT REV DRUG DISCOV, V13, P727, DOI 10.1038/nrd4391; Mader BJ, 2012, ACS CHEM NEUROSCI, V3, P1063, DOI 10.1021/cn300145z; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Riehle C, 2013, J CLIN INVEST, V123, P5319, DOI 10.1172/JCI71171; Roberts DJ, 2014, MOL CELL, V53, P521, DOI 10.1016/j.molcel.2013.12.019; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Seldin MM, 2013, J BIOL CHEM, V288, P36073, DOI 10.1074/jbc.M113.500736; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Sharara-Chami RI, 2012, INT J BIOCHEM CELL B, V44, P905, DOI 10.1016/j.biocel.2012.02.016; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Troncoso R, 2012, CARDIOVASC RES, V93, P320, DOI 10.1093/cvr/cvr321; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang X, 2014, BIOCHEM PHARMACOL, V88, P334, DOI 10.1016/j.bcp.2014.01.040; Wauson EM, 2014, TRENDS ENDOCRIN MET, V25, P274, DOI 10.1016/j.tem.2014.03.006; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Williams-Bey Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097957; Xu L, 2013, BBA-MOL BASIS DIS, V1832, P1605, DOI 10.1016/j.bbadis.2013.05.003; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yuan HX, 2013, AUTOPHAGY, V9, P1983, DOI 10.4161/auto.26058; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	106	589	623	8	150	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1263	1276		10.1016/j.cell.2014.11.006	http://dx.doi.org/10.1016/j.cell.2014.11.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480292	Bronze, Green Accepted			2022-12-28	WOS:000346652900007
J	Bercsenyi, K; Schmieg, N; Bryson, JB; Wallace, M; Caccin, P; Golding, M; Zanotti, G; Greensmith, L; Nischt, R; Schiavo, G				Bercsenyi, Kinga; Schmieg, Nathalie; Bryson, J. Barney; Wallace, Martin; Caccin, Paola; Golding, Matthew; Zanotti, Giuseppe; Greensmith, Linda; Nischt, Roswitha; Schiavo, Giampietro			Nidogens are therapeutic targets for the prevention of tetanus	SCIENCE			English	Article							BOTULINUM NEUROTOXIN-B; PROTEIN-RECEPTOR; BINDING-SITE; MATRIX; AFFINITY; DEFECTS; COMPLEX; LAMININ	T cell responses are initiated by antigen and promoted by a range of costimulatory signals. Understanding how T cells integrate alternative signal combinations and make decisions affecting immune response strength or tolerance poses a considerable theoretical challenge. Here, we report that T cell receptor (TCR) and costimulatory signals imprint an early, cell-intrinsic, division fate, whereby cells effectively count through generations before returning automatically to a quiescent state. This autonomous program can be extended by cytokines. Signals from the TCR, costimulatory receptors, and cytokines add together using a linear division calculus, allowing the strength of a T cell response to be predicted from the sum of the underlying signal components. These data resolve a long-standing costimulation paradox and provide a quantitative paradigm for therapeutically manipulating immune response strength.	[Bercsenyi, Kinga; Schmieg, Nathalie; Wallace, Martin; Golding, Matthew] Canc Res UK London Res Inst, Mol Neuropathobiol Lab, London WC2A 3LY, England; [Bercsenyi, Kinga; Schmieg, Nathalie; Bryson, J. Barney; Wallace, Martin; Greensmith, Linda; Schiavo, Giampietro] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Caccin, Paola; Zanotti, Giuseppe] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Nischt, Roswitha] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany	Cancer Research UK; University of London; University College London; University of Padua; University of Cologne	Schiavo, G (corresponding author), UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England.	giampietro.schiavo@ucl.ac.uk	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Bryson, J. Barney/0000-0001-5486-0258; Bercsenyi, Kinga/0000-0001-5730-9752	Cancer Research UK; Medical Research Council; University of Padua; Deutsche Forschungsgemeinschaft through the Collaborative Research Center at the University of Cologne [SFB 829]; "Koln Fortune Programm"; Brain Research Trust; Medical Research Council [MR/K000608/1] Funding Source: researchfish; MRC [MR/K000608/1] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Padua; Deutsche Forschungsgemeinschaft through the Collaborative Research Center at the University of Cologne; "Koln Fortune Programm"; Brain Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Kjaer (Cancer Research UK London Research Institute) for help with the Octet RED96 system and K<INF>d</INF> determination. N. O'Reilly and members of the Protein and Peptide Chemistry Laboratory (Cancer Research UK London Research Institute) for peptide synthesis, purification, and analysis; F. Giribaldi (Cancer Research UK London Research Institute) for help with footprint analyses; K. Deinhardt (University of Southampton) for mass spec analysis of axonal signaling endosomes; S. Swaminathan (Brookhaven National Laboratory) for experiments aiming at the crystallization of the N1 peptide-H<INF>C</INF>T complex; A. Rummel and T. Binz (Medizinische Hochschule Hannover) and N. Fairweather (Imperial College London) for providing access to published H<INF>C</INF>T mutants; I. Koxholt (University of Cologne) for help with nidogen-1 and -2 KO mice; and J. N. Sleigh (University College London) for help with statistical analyses. We also thank C. Montecucco (University of Padua) and S. Novoselov (University College London) for constructive comments. This work was supported by Cancer Research UK (K. B., N. S., M. G., M. W., and G. S.), by the Medical Research Council (M. W.), by the University of Padua (P. C. and G.Z.), and by the Deutsche Forschungsgemeinschaft (SFB 829) through the Collaborative Research Center at the University of Cologne and the "Koln Fortune Programm" (R. N.). L. G. is the Graham Watts Senior Research Fellow, supported by the Brain Research Trust. The data presented in this manuscript are found in the main paper and the supplementary data and materials and methods. The authors declare that they have no conflict of interest.	Bader BL, 2005, MOL CELL BIOL, V25, P6846, DOI 10.1128/MCB.25.15.6846-6856.2005; Benoit RM, 2014, NATURE, V505, P108, DOI 10.1038/nature12732; Berntsson RPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3058; Berntsson RPA, 2013, STRUCTURE, V21, P1602, DOI 10.1016/j.str.2013.06.026; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen C, 2009, J BIOL CHEM, V284, P26569, DOI 10.1074/jbc.M109.027391; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Dong LJ, 2002, LAB INVEST, V82, P1617, DOI 10.1097/01.LAB.0000042240.52093.0F; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Fox MA, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-24; Ho MSP, 2008, MICROSC RES TECHNIQ, V71, P387, DOI 10.1002/jemt.20567; Jayaraman S, 2005, PROTEINS, V61, P288, DOI 10.1002/prot.20595; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; MANN K, 1989, EMBO J, V8, P65, DOI 10.1002/j.1460-2075.1989.tb03349.x; Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663; MATSUDA M, 1982, BIOCHEM BIOPH RES CO, V104, P799, DOI 10.1016/0006-291X(82)90708-2; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Montecucco C., 1995, CURR TOP MICROBIOL I, V195, P278; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; Peng LS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002008; Restani L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003087; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Stryker E, 2007, J CELL SCI, V120, P3723, DOI 10.1242/jcs.03491; Suwan-apichou O, 2006, INVEST OPHTH VIS SCI, V47, P133, DOI 10.1167/iovs.05-0380; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207	30	50	52	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1118	1123		10.1126/science.1258138	http://dx.doi.org/10.1126/science.1258138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430769	Green Submitted			2022-12-28	WOS:000345763400044
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION Spearman's rank correlation coefficient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LINEAR-REGRESSION		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Hall WD, 2003, BRIT MED J, V326, P1008, DOI 10.1136/bmj.326.7397.1008; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2979; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2686; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2340; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4483; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1753	7	93	94	7	55	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2014	349								g7327	10.1136/bmj.g7327	http://dx.doi.org/10.1136/bmj.g7327			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KH	25432873	Green Published			2022-12-28	WOS:000346115900007
J	Gammon, K				Gammon, Katharine			Joint effort	NATURE			English	Editorial Material							HEMOPHILIA											Ceponis A, 2013, HAEMOPHILIA, V19, P790, DOI 10.1111/hae.12175; Greene WB, 1997, CLIN ORTHOP RELAT R, P19; Hakobyan N, 2014, J THROMB HAEMOST, V12, P1	3	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S170	S171		10.1038/515S170a	http://dx.doi.org/10.1038/515S170a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427210	Bronze			2022-12-28	WOS:000346247600012
J	Fisher, ES; Corrigan, J				Fisher, Elliott S.; Corrigan, Janet			Accountable Health Communities Getting There From Here	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Fisher, Elliott S.; Corrigan, Janet] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Hlth, Lebanon, NH 03766 USA	Dartmouth College	Fisher, ES (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Ctr Hlth, 35 Centerra Pkwy, Lebanon, NH 03766 USA.	elliot.s.fisher@dartmouth.edu						Bradley EH, 2011, BMJ QUAL SAF, V20, P826, DOI 10.1136/bmjqs.2010.048363; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Colla CH, 2014, HEALTH AFFAIR, V33, P964, DOI 10.1377/hlthaff.2013.1463; Community Preventive Serv Task, 2012, AM J PREV MED, V43, P92, DOI [10.1016/j.amepre.2012.04.008, 10.1016/j.amepre.2012.08.013]; Corrigan J, 2014, ACCOUNTABLE HLTH CAR; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; Kania J., 2011, STANFORD SOCIAL INNO, P36, DOI DOI 10.1007/S13398-014-0173-7.2; Magnan Sanne, 2012, Minn Med, V95, P37; Ostrom E, 2010, AM ECON REV, V100, P641, DOI 10.1257/aer.100.3.641	9	16	17	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2093	2094		10.1001/jama.2014.13815	http://dx.doi.org/10.1001/jama.2014.13815			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25423215				2022-12-28	WOS:000345626800008
J	Knoll, GA; Koko, MB; Lick, RM; Beck, A; Buenaventura, CD; Ducharme, R; Barsoum, R; Bernasconi, C; Blydt-Hansen, TD; Ekberg, H; Felipe, CR; Firth, J; Gallon, L; Gelens, M; Glotz, D; Gossmann, J; Guba, M; Morsy, AA; Salgo, R; Scheuermann, EH; Tedesco-Silva, H; Vitko, S; Watson, C; Fergusson, DA				Knoll, Greg A.; Koko, Madzouka B.; Lick, Ranjeeta Ma; Beck, Andrew; Buenaventura, Chieny D.; Ducharme, Robin; Barsoum, Rashad; Bernasconi, Corrado; Blydt-Hansen, Tom D.; Ekberg, Henrik; Felipe, Claudia R.; Firth, John; Gallon, Lorenzo; Gelens, Marielle; Glotz, Denis; Gossmann, Jan; Guba, Markus; Morsy, Ahmed Ali; Salgo, Rebekka; Scheuermann, Earnst H.; Tedesco-Silva, Helio; Vitko, Stefan; Watson, Christopher; Fergusson, Dean A.			Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RENAL-ALLOGRAFT RECIPIENTS; NONMELANOMA SKIN-CANCER; RANDOMIZED CONTROLLED-TRIAL; PHASE-II TRIAL; MYCOPHENOLATE-MOFETIL; RAPAMYCIN INHIBITORS; MAMMALIAN TARGET; MAINTENANCE IMMUNOSUPPRESSION; CALCINEURIN INHIBITORS; COMPARING SIROLIMUS	Objective To examine risk of malignancy and death in patients with kidney transplant who receive the immunosuppressive drug sirolimus. Design Systematic review and meta-analysis of individual patient data. Data sources Medline, Embase, and the Cochrane Central Register of Controlled Trials from inception to March 2013. Eligibility Randomized controlled trials comparing immunosuppressive regimens with and without sirolimus in recipients of kidney or combined pancreatic and renal transplant for which the author was willing to provide individual patient level data. Two reviewers independently screened titles/abstracts and full text reports of potentially eligible trials to identify studies for inclusion. All eligible trials reported data on malignancy or survival. Results The search yielded 2365 unique citations. Patient level data were available from 5876 patients from 21 randomized trials. Sirolimus was associated with a 40% reduction in the risk of malignancy (adjusted hazard ratio 0.60, 95% confidence interval 0.39 to 0.93) and a 56% reduction in the risk of non-melanoma skin cancer (0.44, 0.30 to 0.63) compared with controls. The most pronounced effect was seen in patients who converted to sirolimus from an established immunosuppressive regimen, resulting in a reduction in risk of malignancy (0.34, 0.28 to 0.41), non-melanoma skin cancer (0.32, 0.24 to 0.42), and other cancers (0.52, 0.38 to 0.69). Sirolimus was associated with an increased risk of death (1.43, 1.21 to 1.71) compared with controls. Conclusions Sirolimus was associated with a reduction in the risk of malignancy and non-melanoma skin cancer in transplant recipients. The benefit was most pronounced in patients who converted from an established immunosuppressive regimen to sirolimus. Given the risk of mortality, however, the use of this drug does not seem warranted for most patients with kidney transplant. Further research is needed to determine if different populations, such as those at high risk of cancer, might benefit from sirolimus.	[Knoll, Greg A.; Koko, Madzouka B.; Lick, Ranjeeta Ma; Beck, Andrew; Buenaventura, Chieny D.; Ducharme, Robin; Fergusson, Dean A.] Ottawa Hosp, Res Inst, Ottawa, ON K1H 7W9, Canada; [Knoll, Greg A.; Ducharme, Robin; Fergusson, Dean A.] Univ Ottawa, Ottawa, ON, Canada; [Barsoum, Rashad] Cairo Univ, Cairo Kidney Ctr, Cairo, Egypt; [Bernasconi, Corrado] Limites Med Res, Vacallo, Switzerland; [Blydt-Hansen, Tom D.] Univ Manitoba, Dept Pediat & Childs Hlth, Winnipeg, MB, Canada; [Ekberg, Henrik] Lund Univ, Dept Nephrol & Transplantat, Malmo, Sweden; [Felipe, Claudia R.; Tedesco-Silva, Helio] Univ Fed Sao Paulo, Hosp Rim & Hipertensao, Sao Paulo, Brazil; [Firth, John] Addenbrookes Hosp, Dept Renal Med, Cambridge, England; [Gallon, Lorenzo] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Gelens, Marielle] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Glotz, Denis] St Louis Hosp, Dept Nephrol, Paris, France; [Gossmann, Jan; Scheuermann, Earnst H.] Hosp JW Goethe, Div Nephrol, Frankfurt, Germany; [Guba, Markus] Univ Munich, Dept Surg, Munich, Germany; [Morsy, Ahmed Ali] Cairo Univ, Cairo Kidney Ctr, Cairo, Egypt; [Salgo, Rebekka] Goethe Univ Frankfurt, JW Goethe Clin, Clin Dermatol Venerol & Allergol, Frankfurt, Germany; [Vitko, Stefan] Inst Klin Expt Med, Dept Nephrol, Prague, Czech Republic; [Watson, Christopher] Univ Cambridge, Addenbrookes Hosp, Dept Surg, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Egyptian Knowledge Bank (EKB); Cairo University; General Organization of Teaching Hospitals & Institutes (GOTHI); National Institute of Kidney; University of Manitoba; Lund University; Universidade Federal de Sao Paulo (UNIFESP); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Northwestern University; Feinberg School of Medicine; Maastricht University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Munich; Egyptian Knowledge Bank (EKB); Cairo University; General Organization of Teaching Hospitals & Institutes (GOTHI); National Institute of Kidney; Goethe University Frankfurt; Institute for Clinical & Experimental Medicine (IKEM); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Knoll, GA (corresponding author), Ottawa Hosp, Riverside Campus,1967 Riverside Dr, Ottawa, ON K1H 7W9, Canada.	gknoll@ottawahospital.on.ca	Guba, Markus/M-4309-2019; Beck, Andrew/K-3382-2019	Barsoum, Rashad/0000-0003-1620-764X; Knoll, Greg/0000-0001-5442-9310; Glotz, Denis/0000-0001-5258-4237; Ducharme, Robin/0000-0002-5665-7429; Blydt-Hansen, Tom D./0000-0002-8864-0197; Beck, Andrew/0000-0002-8308-2202; Watson, Christopher/0000-0002-0590-4901; Fergusson, Dean/0000-0002-3389-2485	Pfizer	Pfizer(Pfizer)	This study was funded by an investigator grant from Pfizer (previously Wyeth Pharmaceuticals). Pfizer did not have any role in the study concept, design, data analysis, or writing of the manuscript. Representatives from Pfizer were given a copy of the manuscript to review before submission for publication.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; [Anonymous], 2010, ANZDATA REG REP 2010; Asch WS, 2014, ADV CHRONIC KIDNEY D, V21, P106, DOI 10.1053/j.ackd.2013.07.003; Barsoum RS, 2007, EXP CLIN TRANSPLANT, V5, P649; Blydt-Hansen TD, 2010, PEDIATR TRANSPLANT, V14, P909, DOI 10.1111/j.1399-3046.2010.01374.x; Campbell SB, 2012, AM J TRANSPLANT, V12, P1146, DOI 10.1111/j.1600-6143.2012.04004.x; Campistol JM, 2007, NEPHROL DIAL TRANSPL, V22, pI36, DOI 10.1093/ndt/gfm090; Cortazar F, 2012, AM J TRANSPLANT, V12, P379, DOI 10.1111/j.1600-6143.2011.03826.x; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Euvrard S, 2012, NEW ENGL J MED, V367, P329, DOI 10.1056/NEJMoa1204166; Flechner SM, 2011, AM J TRANSPLANT, V11, P1633, DOI 10.1111/j.1600-6143.2011.03573.x; Flechner SM, 2013, TRANSPLANTATION, V95, P1233, DOI 10.1097/TP.0b013e318291a269; Gallon L, 2006, AM J TRANSPLANT, V6, P1617, DOI 10.1111/j.1600-6143.2006.01340.x; Gelens MACJ, 2006, TRANSPLANTATION, V82, P1221, DOI 10.1097/01.tp.0000232688.76018.19; Glotz D, 2010, TRANSPLANTATION, V89, P1511, DOI 10.1097/TP.0b013e3181db09e4; Groth CG, 1999, TRANSPLANTATION, V67, P1036, DOI 10.1097/00007890-199904150-00017; Guba M, 2010, TRANSPLANTATION, V90, P175, DOI 10.1097/TP.0b013e3181e11798; Halimi JM, 2013, TRANSPLANTATION, V96, P121, DOI 10.1097/TP.0b013e31828719fb; Halleck F, 2012, NAT REV NEPHROL, V8, P687, DOI 10.1038/nrneph.2012.216; Isakova T, 2013, AM J TRANSPLANT, V13, P100, DOI 10.1111/j.1600-6143.2012.04281.x; Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202; Kahan BD, 1999, TRANSPLANTATION, V68, P1526, DOI 10.1097/00007890-199911270-00016; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Kaplan B, 2002, AM J TRANSPLANT, V2, P970, DOI 10.1034/j.1600-6143.2002.21015.x; Kapoor A, 2008, DRUGS, V68, P11, DOI 10.2165/00003495-200868001-00003; Kasiske BL, 2008, AM J TRANSPLANT, V8, P1384, DOI 10.1111/j.1600-6143.2008.02272.x; Kauffman HM, 2005, TRANSPLANTATION, V80, P883, DOI 10.1097/01.TP.0000184006.43152.8D; Khokhar NZ, 2011, CURR OPIN ONCOL, V23, P578, DOI 10.1097/CCO.0b013e32834b892d; Knoll G, 2005, AM J TRANSPLANT, V5, P1719, DOI 10.1111/j.1600-6143.2005.00921.x; Kramer BK, 2012, TRANSPLANTATION, V94, P492, DOI 10.1097/TP.0b013e31825c1d6c; Kreis H, 2000, TRANSPLANTATION, V69, P1252, DOI 10.1097/00007890-200004150-00009; Krynitz B, 2013, INT J CANCER, V132, P1429, DOI 10.1002/ijc.27765; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Letavernier Emmanuel, 2008, Transplant Rev (Orlando), V22, P125, DOI 10.1016/j.trre.2007.12.001; MacDonald AS, 2001, TRANSPLANTATION, V71, P271, DOI 10.1097/00007890-200101270-00019; Machado PG, 2004, CLIN TRANSPLANT, V18, P28, DOI 10.1111/j.1399-0012.2004.00113.x; Mackenzie KA, 2010, NEPHROL DIAL TRANSPL, V25, P300, DOI 10.1093/ndt/gfp482; Pengel LHM, 2011, TRANSPL INT, V24, P1216, DOI 10.1111/j.1432-2277.2011.01357.x; Reeves BC, 2008, COCHRANE HDB SYSTEMA, P391, DOI DOI 10.1002/9780470712184.CH13; Russ GR, 2013, AM J TRANSPLANT, V13, P1746, DOI 10.1111/ajt.12251; Salgo R, 2010, AM J TRANSPLANT, V10, P1385, DOI 10.1111/j.1600-6143.2009.02997.x; Sampaio EL, 2008, CLIN TRANSPLANT, V22, P141, DOI 10.1111/j.1399-0012.2007.00756.x; Schena FP, 2009, TRANSPLANTATION, V87, P233, DOI 10.1097/TP.0b013e3181927a41; Sharif A, 2011, J AM SOC NEPHROL, V22, P2107, DOI 10.1681/ASN.2010111160; Srinivas TR, 2007, AM J TRANSPLANT, V7, P586, DOI 10.1111/j.1600-6143.2006.01658.x; United States Renal Data System, 2012, USRDS 2012 ANN DAT R; US Renal Data System, 2013, USRDS 2013 ANN DAT R; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Vincenti F, 2012, AM J TRANSPLANT, V12, P2446, DOI 10.1111/j.1600-6143.2012.04127.x; Vitko S, 2006, AM J TRANSPLANT, V6, P531, DOI 10.1111/j.1600-6143.2005.01193.x; Watson CJE, 2005, AM J TRANSPLANT, V5, P2496, DOI 10.1111/j.1600-6143.2005.01055.x; Webster AC, 2006, TRANSPLANTATION, V81, P1234, DOI 10.1097/01.tp.0000219703.39149.85; Who-ONT-Collaboration, GLOB OBS DON TRANSPL; Wisgerhof HC, 2010, TRANSPLANTATION, V89, P1231, DOI 10.1097/TP.0b013e3181d84cdc; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Zavos G, 2011, INT J DERMATOL, V50, P1496, DOI 10.1111/j.1365-4632.2011.04939.x	56	122	126	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2014	349								g6679	10.1136/bmj.g6679	http://dx.doi.org/10.1136/bmj.g6679			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KC	25422259	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000346115400003
J	Berridge, V				Berridge, Virginia			The art of medicine Drugs, alcohol, and the First World War	LANCET			English	Editorial Material									London Sch Hyg & Trop Med, Ctr Hist Publ Hlth, Fac Publ Hlth & Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Berridge, V (corresponding author), London Sch Hyg & Trop Med, Ctr Hist Publ Hlth, Fac Publ Hlth & Policy, London WC1H 9SH, England.	Virginia.Berridge@lshtm.ac.uk		berridge, virginia/0000-0001-8011-8348					0	3	3	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1840	1841		10.1016/S0140-6736(14)62234-0	http://dx.doi.org/10.1016/S0140-6736(14)62234-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7LA	25478609				2022-12-28	WOS:000345116800014
J	Watts, G				Watts, Geoff			Dannie Abse Obituary	LANCET			English	Biographical-Item																		ABSE D, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1666	1666		10.1016/S0140-6736(14)62023-7	http://dx.doi.org/10.1016/S0140-6736(14)62023-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KU	25473678	Bronze			2022-12-28	WOS:000345116200017
J	Li, ZY; Liu, J; Zheng, MH; Xu, XZS				Li, Zhaoyu; Liu, Jie; Zheng, Maohua; Xu, X. Z. Shawn			Encoding of Both Analog- and Digital-like Behavioral Outputs by One C. elegans Interneuron	CELL			English	Article							CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; ALLOSTERIC MODULATION; NEURAL CIRCUITS; NEURONS; RECEPTOR; IDENTIFICATION; SENSITIVITY; CONNECTOME; FAMILY	Model organisms usually possess a small nervous system but nevertheless execute a large array of complex behaviors, suggesting that some neurons are likely multifunctional and may encode multiple behavioral outputs. Here, we show that the C. elegans interneuron AIY regulates two distinct behavioral outputs: locomotion speed and direction-switch by recruiting two different circuits. The "speed" circuit is excitatory with a wide dynamic range, which is well suited to encode speed, an analog-like output. The "direction-switch" circuit is inhibitory with a narrow dynamic range, which is ideal for encoding direction-switch, a digital-like output. Both circuits employ the neurotransmitter ACh but utilize distinct postsynaptic ACh receptors, whose distinct biophysical properties contribute to the distinct dynamic ranges of the two circuits. This mechanism enables graded C. elegans synapses to encode both analog- and digital-like outputs. Our studies illustrate how an interneuron in a simple organism encodes multiple behavioral outputs at the circuit, synaptic, and molecular levels.	[Li, Zhaoyu; Liu, Jie; Zheng, Maohua; Xu, X. Z. Shawn] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Li, Zhaoyu; Liu, Jie; Zheng, Maohua; Xu, X. Z. Shawn] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu		liu, jie/0000-0002-1215-5814; Li, Zhaoyu/0000-0002-5222-6832	NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083241] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bing Ye for technical assistance and helpful discussions, and Liz Ronan and Bing Ye for critically reading the manuscript. Some strains were obtained from the Caenorhabditis Genetics Center (CGC) and Knockout Consortiums in the United States and Japan. This work was supported by grants from the NIH (X.Z.S.X.).	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Berkowitz A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00036; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chang YH, 2001, J PHYSIOL-LONDON, V536, P471, DOI 10.1111/j.1469-7793.2001.0471c.xd; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Kocabas A, 2012, NATURE, V490, P273, DOI 10.1038/nature11431; Li W, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1308; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; McLaughlin James T., 2009, BMC Pharmacology, V9, P1, DOI 10.1186/1471-2210-9-1; Mehrotra K., 1996, ELEMENTS ARTIFICIAL, DOI [10.7551/mitpress/2687.001.0001, DOI 10.7551/MITPRESS/2687.001.0001]; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Putrenko I, 2005, J BIOL CHEM, V280, P6392, DOI 10.1074/jbc.M412644200; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Rammes G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006715; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Schiller PH, 1996, BEHAV BRAIN RES, V76, P21, DOI 10.1016/0166-4328(95)00186-7; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Sherlekar AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060597; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	43	69	71	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					751	765		10.1016/j.cell.2014.09.056	http://dx.doi.org/10.1016/j.cell.2014.09.056			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417153	Green Accepted, Bronze			2022-12-28	WOS:000344522000009
J	Eldridge, D; Ledoux, M				Eldridge, David; Ledoux, Matthew			Needs more salt: old hydration habits are hard to break	LANCET			English	Editorial Material							SERIOUSLY ILL CHILDREN; HOSPITALIZED CHILDREN; INTRAVENOUS FLUIDS; METAANALYSIS		[Eldridge, David; Ledoux, Matthew] E Carolina Univ, Brody Sch Med, Dept Pediat, Greenville, NC 27834 USA	University of North Carolina; East Carolina University	Eldridge, D (corresponding author), E Carolina Univ, Brody Sch Med, Dept Pediat, Greenville, NC 27834 USA.	eldridged@ecu.edu						ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; Balasubramanian K, 2012, ACTA PAEDIATR, V101, P236, DOI 10.1111/j.1651-2227.2011.02508.x; Duke T, 2003, LANCET, V362, P1320, DOI 10.1016/S0140-6736(03)14577-1; Foster BA, 2014, J PEDIATR-US, V165, P163, DOI 10.1016/j.jpeds.2014.01.040; Grissinger Matthew, 2013, P T, V38, P575; HOLLIDAY MA, 1957, PEDIATRICS, V19, P823; Holliday MA, 2004, LANCET, V363, P241, DOI 10.1016/S0140-6736(03)15333-0; Kannan L, 2011, INDIAN J PEDIATR, V78, P357, DOI 10.1007/s12098-010-0277-9; Koczmara Christine, 2010, Dynamics, V21, P21; Magder S, 2014, BEST PRAC RES-CL ANA, V28, P235, DOI 10.1016/j.bpa.2014.07.001; McNab S, 2014, LANCET; Wang JJ, 2014, PEDIATRICS, V133, P105, DOI 10.1542/peds.2013-2041	12	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1159	1160		10.1016/S0140-6736(14)61741-4	http://dx.doi.org/10.1016/S0140-6736(14)61741-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25472863				2022-12-28	WOS:000351715100008
J	Roffi, M				Roffi, Marco			The struggle of carotid artery stenting	LANCET			English	Editorial Material									Univ Hosp, Div Cardiol, CH-1211 Geneva 14, Switzerland	University of Geneva	Roffi, M (corresponding author), Univ Hosp, Div Cardiol, CH-1211 Geneva 14, Switzerland.	marco.roffi@hcuge.ch						Bonati LH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000515.pub4; Bonati LH, 2014, LANCET; Calvet D, 2014, STROKE, V45, P527, DOI 10.1161/STROKEAHA.113.003526; Economopoulos KP, 2011, STROKE, V42, P687, DOI 10.1161/STROKEAHA.110.606079; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Moore WS, 1996, J VASC SURG, V23, P323, DOI 10.1016/S0741-5214(96)70277-X; Roffi M, 2010, LANCET NEUROL, V9, P339, DOI 10.1016/S1474-4422(10)70027-2	7	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					490	491		10.1016/S0140-6736(14)61829-8	http://dx.doi.org/10.1016/S0140-6736(14)61829-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AV	25453444				2022-12-28	WOS:000349213600009
J	Ness, DL; Johnson, BH				Ness, Debra L.; Johnson, Beverley H.			Dying in America: A Constructive Step Forward and an Opportunity to Deepen Partnerships With Patients and Families	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ness, Debra L.] Natl Partnership Women & Families, Washington, DC 20009 USA; [Johnson, Beverley H.] Inst Patient & Family Ctr Care, Bethesda, MD 20814 USA		Ness, DL (corresponding author), Natl Partnership Women & Families, 1875 Connecticut Ave NW,Suite 650, Washington, DC 20009 USA.	dness@nationalpartnership.org						[Anonymous], 2014, C REC PARTN PAT FAM; Committee on Approaching Death: Addressing Key End of Life Issues, 2014, DYING AM IMPR QUAL H; Fulmer T, 2014, PARTNERING PATIENTS; Inst. Med, 2013, BEST CAR LOW COST PA; Johnson B. H., 2012, PARTNERING PATIENTS; Weinberger SE, 2014, ANN INTERN MED, V161, P73, DOI 10.7326/M13-2993	6	5	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					226	U136		10.7326/M14-2537	http://dx.doi.org/10.7326/M14-2537			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NP	25486367				2022-12-28	WOS:000350108100009
J	Nice, TJ; Baldridge, MT; McCune, BT; Norman, JM; Lazear, HM; Artyomov, M; Diamond, MS; Virgin, HW				Nice, Timothy J.; Baldridge, Megan T.; McCune, Broc T.; Norman, Jason M.; Lazear, Helen M.; Artyomov, Maxim; Diamond, Michael S.; Virgin, Herbert W.			Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity	SCIENCE			English	Article							NOSOCOMIAL TRANSMISSION; SUFFICIENT; PROTEIN; REPLICATION; PREVALENCE; REPLICON	Norovirus gastroenteritis is a major public health burden worldwide. Although fecal shedding is important for transmission of enteric viruses, little is known about the immune factors that restrict persistent enteric infection. We report here that although the cytokines interferon-alpha (IFN-alpha) and IFN-beta prevented the systemic spread of murine norovirus (MNoV), only IFN-lambda controlled persistent enteric infection. Infection-dependent induction of IFN-lambda was governed by the MNoV capsid protein and correlated with diminished enteric persistence. Treatment of established infection with IFN-lambda cured mice in a manner requiring nonhematopoietic cell expression of the IFN-lambda receptor, Ifnlr1, and independent of adaptive immunity. These results suggest the therapeutic potential of IFN-lambda for curing virus infections in the gastrointestinal tract.	[Nice, Timothy J.; Baldridge, Megan T.; McCune, Broc T.; Norman, Jason M.; Artyomov, Maxim; Diamond, Michael S.; Virgin, Herbert W.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Lazear, Helen M.; Diamond, Michael S.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.	virgin@wustl.edu	Diamond, Michael/AAH-1733-2019; Nice, Timothy/X-9114-2019; Baldridge, Megan/T-7274-2019	Diamond, Michael/0000-0002-8791-3165; Nice, Timothy/0000-0002-4471-7666; Baldridge, Megan/0000-0002-7030-6131; Virgin, Herbert/0000-0001-8580-7628; Lazear, Helen/0000-0002-8649-4579	NIH [R01 AI084887, U19 AI109725, U19 AI083019, U19 AI106772, 5T32A100716334, 5T32CA009547, F31CA177194-01, 5T32AI007163]; Crohn's and Colitis Foundation Genetics Initiative [274415]; Broad Foundation [IBD-0357]; Cancer Research Institute and American Cancer Society; Washington University; NATIONAL CANCER INSTITUTE [T32CA009547, F31CA177194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109725, T32AI007163, U19AI083019, R01AI084887, U19AI106772] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation Genetics Initiative; Broad Foundation; Cancer Research Institute and American Cancer Society; Washington University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Kreamalmeyer for maintaining our mouse colony and S. Doyle and Bristol-Myers Squibb for providing Ifnlr1<SUP>-/-</SUP> mice and recombinant IFN-lambda protein. The mouse norovirus strains used in this paper are available from Washington University under a material transfer agreement (MTA). Ifnlr1<SUP>-/-</SUP> mice were made available from ZymoGenetics (Bristol-Myers Squibb) under a MTA with Washington University School of Medicine. H.W.V. is a co-inventor on a patent filed by Washington University School of Medicine related to the use of murine norovirus. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. H.W.V. was supported by NIH grants R01 AI084887 and U19 AI109725, the Crohn's and Colitis Foundation Genetics Initiative grant 274415, and Broad Foundation grant IBD-0357. M.S.D. and H.M.L. were supported by NIH grants U19 AI083019 and U19 AI106772. T.J.N. was supported by NIH training grant 5T32A100716334 and postdoctoral fellowships from the Cancer Research Institute and American Cancer Society. M.T.B. was supported by NIH training grant 5T32CA009547 and the W. M. Keck Fellowship from Washington University. B.T.M. was supported by NIH award F31CA177194-01. J.M.N. was supported by NIH training grant 5T32AI007163.	Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Ayukekbong J, 2011, J MED VIROL, V83, P2135, DOI 10.1002/jmv.22243; Borin BN, 2014, PROTEINS, V82, P1200, DOI 10.1002/prot.24484; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Cheon DS, 2010, FOODBORNE PATHOG DIS, V7, P1427, DOI 10.1089/fpd.2010.0547; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Liu GL, 2009, J VIROL, V83, P6963, DOI 10.1128/JVI.00284-09; Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Phillips G, 2010, EPIDEMIOL INFECT, V138, P1454, DOI 10.1017/S0950268810000439; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saito M, 2014, CLIN INFECT DIS, V58, P483, DOI 10.1093/cid/cit763; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Sukhrie FHA, 2012, CLIN INFECT DIS, V54, P931, DOI 10.1093/cid/cir971; Sukhrie FHA, 2010, J CLIN MICROBIOL, V48, P4303, DOI 10.1128/JCM.01308-10; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Thackray LB, 2012, J VIROL, V86, P13515, DOI 10.1128/JVI.01824-12; Tomov VT, 2013, J VIROL, V87, P7015, DOI 10.1128/JVI.03389-12; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Zhang BY, 2014, SCIENCE, V346, P861, DOI 10.1126/science.1256999	30	232	249	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2015	347	6219					269	273		10.1126/science.1258100	http://dx.doi.org/10.1126/science.1258100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ0DA	25431489	Green Submitted, Green Accepted			2022-12-28	WOS:000347915300035
J	Gurdasani, D; Carstensen, T; Tekola-Ayele, F; Pagani, L; Tachmazidou, I; Hatzikotoulas, K; Karthikeyan, S; Iles, L; Pollard, MO; Choudhury, A; Ritchie, GS; Xue, YL; Asimit, J; Nsubuga, RN; Young, EH; Pomilla, C; Kivinen, K; Rockett, K; Kamali, A; Doumatey, AP; Asiki, G; Seeley, J; Sisay-Joof, F; Jallow, M; Tollman, S; Mekonnen, E; Ekong, R; Oljira, T; Bradman, N; Bojang, K; Ramsay, M; Adeyemo, A; Bekele, E; Motala, A; Norris, SA; Pirie, F; Kaleebu, P; Kwiatkowski, D; Tyler-Smith, C; Rotimi, C; Zeggini, E; Sandhu, MS				Gurdasani, Deepti; Carstensen, Tommy; Tekola-Ayele, Fasil; Pagani, Luca; Tachmazidou, Ioanna; Hatzikotoulas, Konstantinos; Karthikeyan, Savita; Iles, Louise; Pollard, Martin O.; Choudhury, Ananyo; Ritchie, GrahamR. S.; Xue, Yali; Asimit, Jennifer; Nsubuga, Rebecca N.; Young, Elizabeth H.; Pomilla, Cristina; Kivinen, Katja; Rockett, Kirk; Kamali, Anatoli; Doumatey, Ayo P.; Asiki, Gershim; Seeley, Janet; Sisay-Joof, Fatoumatta; Jallow, Muminatou; Tollman, Stephen; Mekonnen, Ephrem; Ekong, Rosemary; Oljira, Tamiru; Bradman, Neil; Bojang, Kalifa; Ramsay, Michele; Adeyemo, Adebowale; Bekele, Endashaw; Motala, Ayesha; Norris, Shane A.; Pirie, Fraser; Kaleebu, Pontiano; Kwiatkowski, Dominic; Tyler-Smith, Chris; Rotimi, Charles; Zeggini, Eleftheria; Sandhu, Manjinder S.			The African Genome Variation Project shapes medical genetics in Africa	NATURE			English	Article							POPULATION-GENETICS; MALARIA; SELECTION; WIDE; SUSCEPTIBILITY; REVEALS; ASSOCIATION; DIVERSITY; VARIANTS; ANCESTRY	Given the importance of Africa to studies of human origins and disease susceptibility, detailed characterization of African genetic diversity is needed. The African Genome Variation Project provides a resource with which to design, implement and interpret genomic studies in sub-Saharan Africa and worldwide. The African Genome Variation Project represents dense genotypes from 1,481 individuals and whole-genome sequences from 320 individuals across sub-Saharan Africa. Using this resource, we find novel evidence of complex, regionally distinct hunter-gatherer and Eurasian admixture across sub-Saharan Africa. We identify new loci under selection, including loci related to malaria susceptibility and hypertension. We show that modern imputation panels (sets of reference genotypes from which unobserved or missing genotypes in study sets can be inferred) can identify association signals at highly differentiated loci across populations in sub-Saharan Africa. Using whole-genome sequencing, we demonstrate further improvements in imputation accuracy, strengthening the case for large-scale sequencing efforts of diverse African haplotypes. Finally, we present an efficient genotype array design capturing common genetic variation in Africa.	[Gurdasani, Deepti; Carstensen, Tommy; Pagani, Luca; Tachmazidou, Ioanna; Hatzikotoulas, Konstantinos; Karthikeyan, Savita; Iles, Louise; Pollard, Martin O.; Ritchie, GrahamR. S.; Xue, Yali; Asimit, Jennifer; Young, Elizabeth H.; Pomilla, Cristina; Kivinen, Katja; Adeyemo, Adebowale; Kwiatkowski, Dominic; Tyler-Smith, Chris; Zeggini, Eleftheria; Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Gurdasani, Deepti; Carstensen, Tommy; Karthikeyan, Savita; Iles, Louise; Young, Elizabeth H.; Pomilla, Cristina; Sandhu, Manjinder S.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Tekola-Ayele, Fasil; Doumatey, Ayo P.; Adeyemo, Adebowale; Rotimi, Charles] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20891 USA; [Pagani, Luca] Univ Bologna, Dept Biol Geol & Environm Sci, I-40126 Bologna, Italy; [Iles, Louise] Univ York, Dept Archaeol, York YO1 7EP, N Yorkshire, England; [Choudhury, Ananyo; Ramsay, Michele] Univ Witwatersrand, SBIMB, Johannesburg, Gauteng, South Africa; [Ritchie, GrahamR. S.] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Nsubuga, Rebecca N.; Kamali, Anatoli; Asiki, Gershim; Seeley, Janet; Kaleebu, Pontiano] Uganda Virus Res Inst, MRC, Entebbe, Uganda; [Rockett, Kirk; Kwiatkowski, Dominic] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Sisay-Joof, Fatoumatta; Jallow, Muminatou; Bojang, Kalifa] MRC Unit, Banjul, Gambia; [Tollman, Stephen] MRC, Sch Publ Hlth, Wits Rural Publ Hlth & Hlth Transit Unit, Johannesburg, Gauteng, South Africa; [Tollman, Stephen] INDEPTH Network, Accra, Ghana; [Mekonnen, Ephrem] Univ Addis Ababa, Inst Biotechnol, Addis Ababa, Ethiopia; [Ekong, Rosemary] UCL, Dept Genet Evolut & Environm, London, England; [Oljira, Tamiru] Univ Haramaya, Dept Biol, Dire Dawa, Ethiopia; [Bradman, Neil] Henry Stewart Grp, London WC1A 2HN, England; [Ramsay, Michele] Natl Hlth Lab Serv, Div Human Genet, ZA-2000 Johannesburg, South Africa; [Ramsay, Michele] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, ZA-2000 Johannesburg, South Africa; [Bekele, Endashaw] Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Motala, Ayesha; Pirie, Fraser] Univ KwaZulu Natal, Dept Endocrinol & Diabet, ZA-4013 Durban, South Africa; [Norris, Shane A.] Univ Witwatersrand, Dept Paediat, Johannesburg, Gauteng, South Africa	Wellcome Trust Sanger Institute; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Bologna; University of York - UK; University of Witwatersrand; European Molecular Biology Laboratory (EMBL); Uganda Virus Research Institute; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine; INDEPTH Network; Addis Ababa University; University of London; University College London; Haramaya University; National Health Laboratory Service; University of Witwatersrand; Addis Ababa University; University of Kwazulu Natal; University of Witwatersrand	Sandhu, MS (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Cambridge CB10 1SA, England.	dg11@sanger.ac.uk; cts@sanger.ac.uk; rotimic@mail.nih.gov; eleftheria@sanger.ac.uk; ms23@sanger.ac.uk	Asimit, Jennifer/P-7567-2017; Pomilla, Cristina/AAC-4035-2020; Norris, Shane/C-4664-2014; Pagani, Luca/G-8511-2017; Pollard, Martin O./G-7205-2012; Pomilla, Cristina/GYD-9678-2022	Asimit, Jennifer/0000-0002-4857-2249; Pomilla, Cristina/0000-0002-2581-8365; Norris, Shane/0000-0001-7124-3788; Pagani, Luca/0000-0002-6639-524X; Pollard, Martin O./0000-0001-8738-0920; Adeyemo, Adebowale/0000-0002-3105-3231; Tollman, Stephen/0000-0003-0744-7588; Kwiatkowski, Dominic/0000-0002-5023-0176; Tekola-Ayele, Fasil/0000-0003-4194-9370; Motala, Ayesha/0000-0003-0517-1784; Zeggini, Eleftheria/0000-0003-4238-659X; Gurdasani, Deepti/0000-0001-9996-6929; Asiki, Gershim/0000-0002-9966-1153; Bojang, Kalifa/0000-0001-7506-0938; Ramsay, Michele/0000-0002-4156-4801; Hatzikotoulas, Konstantinos/0000-0002-4699-3672; Iles, Louise Elizabeth/0000-0003-4113-5844; Mekonnen, Ephrem/0000-0003-0416-649X; Ekong, Rosemary/0000-0002-5984-7893; Kivinen, Katja/0000-0002-1135-7625; Choudhury, Ananyo/0000-0001-8225-9531; Seeley, Janet/0000-0002-0583-5272	Wellcome Trust [WT077383/Z/05/Z]; Wellcome Trust Sanger Institute [WT098051]; Bill and Melinda Gates Foundation; Foundation for the National Institutes of Health [566]; UK Medical Research Council [G0901213-92157, G0801566, G0600718, MR/K013491/1]; South African Sugar Association; Servier South Africa; Victor Daitz Foundation; National Institute on Minority Health and Health Disparities; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Human Genome Research Institute (NHGRI); Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH) [Z01HG200362]; MRC Centre for Genomics and Global Health; Cambridge Commonwealth Scholarship; MRC [G0801566, MR/K013491/1, G1001333, G0901213, G0600718, MC_UP_A900_1118] Funding Source: UKRI; Medical Research Council [G0901213, MC_UP_A900_1118, MR/K013491/1, G0600718, G1001333, G0801566] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10012] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200362, ZIAHG200362] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Sanger Institute(Wellcome Trust); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African Sugar Association; Servier South Africa; Victor Daitz Foundation; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH); MRC Centre for Genomics and Global Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Commonwealth Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was funded in part by the Wellcome Trust (grant number WT077383/Z/05/Z), The Wellcome Trust Sanger Institute (grant number WT098051), the Bill and Melinda Gates Foundation, the Foundation for the National Institutes of Health (grant number 566), and the UK Medical Research Council (grant numbers G0901213-92157, G0801566, G0600718 and MR/K013491/1). We also acknowledge the National Institute for Health Research Cambridge Biomedical Research Centre and the Wellcome Trust Cambridge Centre for Global Health Research. We are very grateful to J. Pickrell for sharing human origins data and MALDER code, and for useful input on interpretations of these analyses. We also thank E. Garrison for his suggestions on using Genome in a bottle sets (ftp://ftp-trace.ncbi.nih.gov/giab/ftp/data/NA12878/variant_calls/NIST/README.NIST.v2.18.txt) for validation of whole-genome sequencing data. We also thank the African Partnership for Chronic Disease Research (APCDR)for providing a network to support this study as well as a repository for deposition of curated data. Sample collections from South Africa were funded by The South African Sugar Association, Servier South Africa and The Victor Daitz Foundation. The Kenyan samples were collected by D. Ngare of Moi University, Eldoret, Kenya, as part of the Africa America Diabetes Mellitus (AADM) study and the International HapMap project (D. Ngare, who is now deceased, was a great supporter of genomics in Africa,as exemplified by his leadership in engaging the Luhya and Maasai communities for the HapMap project). The Igbo samples were collected by J. Oli of the University of Nigeria, Enugu, Nigeria. The Ga-Adangbe samples were collected by the laboratories of A. Amoah of the University of Ghana, Accra, Ghana, and J. Acheampong of the University of Science and Technology, Kumasi, Ghana. Support for the AADM study is provided by the National Institute on Minority Health and Health Disparities, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Human Genome Research Institute (NHGRI). The Gambian samples were collected by M. Jallow and colleagues at the MRC Unit, The Gambia and form part of the MalariaGEN Consortial Resource. This research was supported in part by the Intramural Research Program of the Center for Research on Genomics and Global Health (CRGGH; grant number Z01HG200362) and by the MRC Centre for Genomics and Global Health. D.G. was funded by the Cambridge Commonwealth Scholarship. We thank the 1000 Genomes Project for sharing genotype data that were analysed as part of this project. We also thank all study participants who contributed to this study.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersen KG, 2012, PHILOS T R SOC B, V367, P868, DOI 10.1098/rstb.2011.0299; Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Botigue LR, 2013, P NATL ACAD SCI USA, V110, P11791, DOI 10.1073/pnas.1306223110; Cox JV, 2012, CELL MICROBIOL, V14, P1497, DOI 10.1111/j.1462-5822.2012.01823.x; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318; Edwards M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000867; Eid NA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-119; Fumagalli M, 2010, MOL BIOL EVOL, V27, P2555, DOI 10.1093/molbev/msq141; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Graffe CC, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-15; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Hong KW, 2010, J HUM HYPERTENS, V24, P367, DOI 10.1038/jhh.2009.86; Jacobs T, 2002, J IMMUNOL, V169, P2323, DOI 10.4049/jimmunol.169.5.2323; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Jarvis JP, 2012, PLOS GENET, V8, P299, DOI 10.1371/journal.pgen.1002641; Ko WY, 2013, AM J HUM GENET, V93, P54, DOI 10.1016/j.ajhg.2013.05.014; Kosoy R, 2011, GENES IMMUN, V12, P582, DOI 10.1038/gene.2011.33; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Kusi KA, 2008, CLIN VACCINE IMMUNOL, V15, P1456, DOI 10.1128/CVI.00506-07; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lopes MF, 1999, EUR J IMMUNOL, V29, P81, DOI 10.1002/(SICI)1521-4141(199901)29:01&lt;81::AID-IMMU81&gt;3.0.CO;2-Y; Machado P, 2010, BRIT J HAEMATOL, V149, P775, DOI 10.1111/j.1365-2141.2010.08165.x; Martins GA, 2001, IMMUNOLOGY, V103, P122, DOI 10.1046/j.1365-2567.2001.01216.x; Natividad A, 2010, INFECT IMMUN, V78, P4895, DOI 10.1128/IAI.00844-10; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015; Panda AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049420; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Patin E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4163; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Ribeiro CMS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013012; Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002995; Shimojima M, 2012, J VIROL, V86, P2067, DOI 10.1128/JVI.06451-11; Tabara Y, 2010, HYPERTENSION, V56, P973, DOI 10.1161/HYPERTENSIONAHA.110.153429; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; The Bradshaw Foundation, 2014, OR PREH ROCK ART ART; Tilman L.-E., 2007, ATLAS CULTURAL ENV C; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Zhang GC, 2012, INFECT IMMUN, V80, P2316, DOI 10.1128/IAI.00261-12	50	326	326	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					327	U397		10.1038/nature13997	http://dx.doi.org/10.1038/nature13997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25470054	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000347810300037
J	Stewart, AK; Rajkumar, SV; Dimopoulos, MA; Masszi, T; Spicka, I; Oriol, A; Hajek, R; Rosinol, L; Siegel, DS; Mihaylov, GG; Goranova-Marinova, V; Rajnics, P; Suvorov, A; Niesvizky, R; Jakubowiak, AJ; San-Miguel, JF; Ludwig, H; Wang, M; Maisnar, V; Minarik, J; Bensinger, WI; Mateos, MV; Ben-Yehuda, D; Kukreti, V; Zojwalla, N; Tonda, ME; Yang, XQ; Xing, B; Moreau, P; Palumbo, A				Stewart, A. Keith; Rajkumar, S. Vincent; Dimopoulos, Meletios A.; Masszi, Tamas; Spicka, Ivan; Oriol, Albert; Hajek, Roman; Rosinol, Laura; Siegel, David S.; Mihaylov, Georgi G.; Goranova-Marinova, Vesselina; Rajnics, Peter; Suvorov, Aleksandr; Niesvizky, Ruben; Jakubowiak, Andrzej J.; San-Miguel, Jesus F.; Ludwig, Heinz; Wang, Michael; Maisnar, Vladimr; Minarik, Jiri; Bensinger, William I.; Mateos, Maria-Victoria; Ben-Yehuda, Dina; Kukreti, Vishal; Zojwalla, Naseem; Tonda, Margaret E.; Yang, Xinqun; Xing, Biao; Moreau, Philippe; Palumbo, Antonio		ASPIRE Investigators	Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SINGLE-AGENT CARFILZOMIB; LOW-DOSE DEXAMETHASONE; RANDOMIZED PHASE-III; STEM-CELL TRANSPLANTATION; PLUS DEXAMETHASONE; BORTEZOMIB; COMBINATION; SURVIVAL; ESCALATION; PX-171-006	Background Lenalidomide plus dexamethasone is a reference treatment for relapsed multiple myeloma. The combination of the proteasome inhibitor carfilzomib with lenalidomide and dexamethasone has shown efficacy in a phase 1 and 2 study in relapsed multiple myeloma. Methods We randomly assigned 792 patients with relapsed multiple myeloma to carfilzomib with lenalidomide and dexamethasone (carfilzomib group) or lenalidomide and dexamethasone alone (control group). The primary end point was progression-free survival. Results Progression-free survival was significantly improved with carfilzomib (median, 26.3 months, vs. 17.6 months in the control group; hazard ratio for progression or death, 0.69; 95% confidence interval [CI], 0.57 to 0.83; P = 0.0001). The median overall survival was not reached in either group at the interim analysis. The Kaplan-Meier 24-month overall survival rates were 73.3% and 65.0% in the carfilzomib and control groups, respectively (hazard ratio for death, 0.79; 95% CI, 0.63 to 0.99; P = 0.04). The rates of overall response (partial response or better) were 87.1% and 66.7% in the carfilzomib and control groups, respectively (P< 0.001; 31.8% and 9.3% of patients in the respective groups had a complete response or better; 14.1% and 4.3% had a stringent complete response). Adverse events of grade 3 or higher were reported in 83.7% and 80.7% of patients in the carfilzomib and control groups, respectively; 15.3% and 17.7% of patients discontinued treatment owing to adverse events. Patients in the carfilzomib group reported superior health-related quality of life. Conclusions In patients with relapsed multiple myeloma, the addition of carfilzomib to lenalidomide and dexamethasone resulted in significantly improved progression-free survival at the interim analysis and had a favorable risk-benefit profile. (Funded by Onyx Pharmaceuticals; ClinicalTrials.gov number, NCT01080391.)	[Stewart, A. Keith] Mayo Clin, Div Hematol Oncol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA; [Rajkumar, S. Vincent] Mayo Clin, Div Hematol, Rochester, MN USA; [Dimopoulos, Meletios A.] Alexandra Hosp, Athens, Greece; [Masszi, Tamas] Semmelweis Univ, St Istvan & St Laszlo Hosp, Dept Hematol & Stem Cell Transplantat, H-1085 Budapest, Hungary; [Spicka, Ivan] Gen Univ Hosp, Dept Internal Med, Prague, Czech Republic; [Hajek, Roman] Univ Hosp Brno, Brno, Czech Republic; [Hajek, Roman] Univ Ostrava, Fac Med, Ostrava, Czech Republic; [Maisnar, Vladimr] Charles Univ Prague, Fac Hosp, Hradec Kralove, Czech Republic; [Minarik, Jiri] Univ Hosp Olomouc, Dept Hematol, Olomouc, Czech Republic; [Oriol, Albert] Hosp Badalona Germans Trias & Pujol, Inst Catal Oncol, Dept Clin Hematol, Inst Josep Carreras, Barcelona, Spain; [Rosinol, Laura] Hosp Clin Barcelona, Barcelona, Spain; [San-Miguel, Jesus F.] Univ Navarra Clin, Ctr Invest Med Aplicada, Pamplona, Spain; [Mateos, Maria-Victoria] Hosp Univ Salamanca, Salamanca, Spain; [Siegel, David S.] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA; [Mihaylov, Georgi G.] Queen Joanna Univ Hosp, Sofia, Bulgaria; [Goranova-Marinova, Vesselina] Univ Multiprofile Hosp Act, Hematol Clin, Plovdiv, Bulgaria; [Rajnics, Peter] Mor Kaposi Teaching Hosp, Kaposvar, Hungary; [Suvorov, Aleksandr] First Republican Clin Hosp Udmurtia, Izhevsk, Russia; [Niesvizky, Ruben] Weill Cornell Med Coll, New York, NY USA; [Jakubowiak, Andrzej J.] Univ Chicago Med, Chicago, IL USA; [Ludwig, Heinz] Wilhelminenspital Stadt Wien, Wilhelminen Canc Res Inst, Vienna, Austria; [Wang, Michael] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Bensinger, William I.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Ben-Yehuda, Dina] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel; [Kukreti, Vishal] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada; [Zojwalla, Naseem; Tonda, Margaret E.; Yang, Xinqun; Xing, Biao] Onyx Pharmaceut, San Francisco, CA USA; [Moreau, Philippe] Univ Nantes, Nantes, France; [Palumbo, Antonio] Univ Turin, Turin, Italy	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Alexandra Hospital; Semmelweis University; General University Hospital Prague; University Hospital Brno; University of Ostrava; Charles University Prague; University Hospital Hradec Kralove; University Hospital Olomouc; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); University of Barcelona; Hospital Clinic de Barcelona; University of Navarra; University of Salamanca; Hackensack University Medical Center; Medical University Sofia; Medical University Plovdiv; Cornell University; Wilhelminenspital; University of Texas System; UTMD Anderson Cancer Center; Fred Hutchinson Cancer Center; Hebrew University of Jerusalem; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Nantes Universite; University of Turin	Stewart, AK (corresponding author), Mayo Clin, Div Hematol Oncol, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	stewart.keith@mayo.edu	Gaidano, Gianluca/AAW-2773-2021; Hajek, Roman/I-6639-2017; Maisnar, Vladimir/Q-8579-2017; Oriol, Albert/K-9923-2017; Rajkumar, S. Vincent/AAV-1834-2021; Dimopoulos, Meletios Athanasios/AAD-4130-2019; Blimark, Cecilie Hveding/AAZ-6423-2021; San-Miguel, Jesús F./V-8977-2018; Symeonidis, Argiris/K-2287-2019; Minarik, Jiri/GWR-0249-2022; FACON, THIERRY/M-9736-2014	Gaidano, Gianluca/0000-0002-4681-0151; Hajek, Roman/0000-0001-6955-6267; Maisnar, Vladimir/0000-0003-1738-4920; Oriol, Albert/0000-0001-6804-2221; Rajkumar, S. Vincent/0000-0002-5862-1833; Blimark, Cecilie Hveding/0000-0003-3297-6019; San-Miguel, Jesús F./0000-0002-9183-4857; Symeonidis, Argiris/0000-0002-3685-3473; Minarik, Jiri/0000-0003-0513-326X; de Fabritiis, Paolo/0000-0002-1835-0581; nahi, hareth/0000-0003-4711-5094; Goranova-Marinova, Veselina/0000-0002-7811-162X; moreau, philippe/0000-0003-1780-8746; FACON, THIERRY/0000-0001-7705-8460; Spicka, Ivan/0000-0002-5451-5283; de la Rubia, Javier/0000-0002-8354-768X; Grasa-Ullrich, Jose-Maria/0000-0002-6023-7590; Masszi, Tamas/0000-0003-2322-9863; Dimopoulos, Meletios/0000-0001-8990-3254	Onyx Pharmaceuticals; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Onyx Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Onyx Pharmaceuticals; ClinicalTrials.gov number, NCT01080391.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Arnulf B, 2012, HAEMATOL-HEMATOL J, V97, P1925, DOI 10.3324/haematol.2012.067793; Attal M, 2012, NEW ENGL J MED, V366, P1782, DOI 10.1056/NEJMoa1114138; Benboubker L, 2014, NEW ENGL J MED, V371, P906, DOI 10.1056/NEJMoa1402551; Berenson JR, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8594; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Cocks K, 2011, J CLIN ONCOL, V29, P89, DOI 10.1200/JCO.2010.28.0107; DeMets D L, 1995, Cancer Treat Res, V75, P1; Dimopoulos M, 2009, NEW ENGL J MED, V361, P544; Dimopoulos MA, 2010, LEUKEMIA, V24, P1769, DOI 10.1038/leu.2010.175; Dimopoulos MA, 2009, LEUKEMIA, V23, P2147, DOI 10.1038/leu.2009.147; Durie BGM, 2007, LEUKEMIA, V21, P1134, DOI 10.1038/sj.leu.2404582; Garderet L, 2014, J CLIN ONCOL, V32, P1285; Garderet L, 2012, J CLIN ONCOL, V30, P3429, DOI 10.1200/JCO.2012.46.1848; Garderet L, 2012, J CLIN ONCOL, V30, P2475, DOI 10.1200/JCO.2011.37.4918; Jagannath S, 2012, CL LYMPH MYELOM LEUK, V12, P310, DOI 10.1016/j.clml.2012.08.003; Jakubowiak A. J., 2013, J CLIN ONCOL S, V31, P8543, DOI 10.1200/jco.2013.31.15_suppl.8543; Jakubowiak AJ, 2012, BLOOD, V120, P1801, DOI 10.1182/blood-2012-04-422683; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lonial S, 2014, LEUKEMIA, V28, P258, DOI 10.1038/leu.2013.220; McCarthy PL, 2012, NEW ENGL J MED, V366, P1770, DOI 10.1056/NEJMoa1114083; Munshi NC, 2011, BLOOD, V117, P4696, DOI 10.1182/blood-2010-10-300970; Niesvizky R, 2013, CLIN CANCER RES, V19, P2248, DOI 10.1158/1078-0432.CCR-12-3352; Orlowski RZ, 2007, J CLIN ONCOL, V25, P3892, DOI 10.1200/JCO.2006.10.5460; Palumbo A, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8515; Palumbo A, 2012, NEW ENGL J MED, V367, P285; Palumbo A, 2012, NEW ENGL J MED, V366, P1759, DOI 10.1056/NEJMoa1112704; Rajkumar SV, 2010, LANCET ONCOL, V11, P14; Richardson PG, 2014, BLOOD, V123, P1461, DOI 10.1182/blood-2013-07-517276; Siegel D, 2013, HAEMATOLOGICA, V98, P1753, DOI 10.3324/haematol.2013.089334; Siegel DS, 2012, BLOOD, V120, P2817, DOI 10.1182/blood-2012-05-425934; Wang M, 2013, BLOOD, V122, P3122, DOI 10.1182/blood-2013-07-511170; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Zingone A, 2013, BLOOD, V122, P538	36	919	952	1	141	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 8	2015	372	2					142	152		10.1056/NEJMoa1411321	http://dx.doi.org/10.1056/NEJMoa1411321			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY2UA	25482145				2022-12-28	WOS:000347443300009
J	Roberts, I; Perner, A				Roberts, Ian; Perner, Anders			Ebola virus disease: clinical care and patient-centred research	LANCET			English	Editorial Material									[Roberts, Ian] London Sch Hyg & Trop Med, Clin Trials Unit, London WC1E 7HT, England; [Perner, Anders] Univ Copenhagen, Rigshosp, Dept Intens Care, DK-1168 Copenhagen, Denmark	University of London; London School of Hygiene & Tropical Medicine; Rigshospitalet; University of Copenhagen	Roberts, I (corresponding author), London Sch Hyg & Trop Med, Clin Trials Unit, London WC1E 7HT, England.	ian.roberts@lshtm.ac.uk		Perner, Anders/0000-0002-4668-0123				Bah EI, 2015, NEW ENGL J MED, V372, P40, DOI 10.1056/NEJMoa1411249; Chertow DS, 2014, NEW ENGL J MED, V371, P2054, DOI 10.1056/NEJMp1413084; Ker K, 2014, COCHRANE DB SYST REV, V11; Kreuels B, 2014, NEW ENGL J MED, V371, P2394, DOI 10.1056/NEJMoa1411677; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Perner A, 2015, INTENSIVE C IN PRESS; Rid A, 2014, LANCET, V384, P1896, DOI 10.1016/S0140-6736(14)61315-5; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Spasovski G, 2014, NEPHROL DIAL TRANSPL, V29, P1, DOI 10.1093/ndt/gfu040; WHO, 2014, EB VIR DIS	10	23	24	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2001	2002		10.1016/S0140-6736(14)62316-3	http://dx.doi.org/10.1016/S0140-6736(14)62316-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW6BD	25483156				2022-12-28	WOS:000346353600005
J	Heller, SB				Heller, Sara B.			Summer jobs reduce violence among disadvantaged youth	SCIENCE			English	Article							LIFE-COURSE; CRIME; WORK; EMPLOYMENT; UNEMPLOYMENT; EDUCATION; IMPACT	Every day, acts of violence injure more than 6000 people in the United States. Despite decades of social science arguing that joblessness among disadvantaged youth is a key cause of violent offending, programs to remedy youth unemployment do not consistently reduce delinquency. This study tests whether summer jobs, which shift focus from remediation to prevention, can reduce crime. In a randomized controlled trial among 1634 disadvantaged high school youth in Chicago, assignment to a summer jobs program decreases violence by 43% over 16 months (3.95 fewer violent-crime arrests per 100 youth). The decline occurs largely after the 8-week intervention ends. The results suggest the promise of using low-cost, well-targeted programs to generate meaningful behavioral change, even with a problem as complex as youth violence.	[Heller, Sara B.] Univ Penn, Dept Criminol, Philadelphia, PA 19104 USA; [Heller, Sara B.] Univ Chicago, Crime Lab, Chicago, IL 60637 USA	University of Pennsylvania; University of Chicago	Heller, SB (corresponding author), Univ Penn, Dept Criminol, Philadelphia, PA 19104 USA.	hellersa@sas.upenn.edu			U.S. Department of Labor [B139634411]; Office of Juvenile Justice and Delinquency Prevention, Office of Justice Programs, U.S. Department of Justice [2012-MU-FX-0002]	U.S. Department of Labor; Office of Juvenile Justice and Delinquency Prevention, Office of Justice Programs, U.S. Department of Justice	This project was supported by award B139634411 from the U.S. Department of Labor and grant 2012-MU-FX-0002 from the Office of Juvenile Justice and Delinquency Prevention, Office of Justice Programs, U.S. Department of Justice. The study received approval from the University of Chicago's IRB (protocol 12-1112) with secondary approval from the University of Pennsylvania's IRB (protocol 818707). I gratefully acknowledge the City of Chicago and Mayor R. Emanuel, the work of the Chicago Department of Family Support Services, especially E. Diaz, J. Axelrod, A. Fernandez, and J. Welch, and the organizations that implemented the program: Phalanx Family Services, Sinai Community Institute, Saint Sabina Employment Resource Center, SGA Youth and Family Services, and Youth Guidance. I thank Chicago Public Schools partners J. Foreman, K. Klein, J. Loudon, and S. Norris; Chief R. Tracy, T. Lavery, and the Chicago Police Department; R. Goerge and Chapin Hall; R. Ander, S. Coussens, J. Davis, G. Cusick, M. Egan, H. Pollack (Chicago PI), R. Harris, N. Hess, A. Metivier, and J. Rountree for project support; and K. Charles, J. Guryan, C. Loeffler, J. Ludwig, J. MacDonald, E. Owens, S. Raudenbush, S. Sotelo, and D. Tannenbaum for helpful comments. Replication data are posted at the University of Michigan's ICPSR data depository (http://doi.org/10.3886/E18627V1); see supplementary materials section 1.5 for details. All content is the responsibility of the author and does not represent the official position or policies of the Chicago Police Department, Chicago Public Schools, Chicago Department of Family and Support Services, U.S. Department of Justice, or U.S. Department of Labor.	AGNEW R, 1992, CRIMINOLOGY, V30, P47, DOI 10.1111/j.1745-9125.1992.tb01093.x; [Anonymous], 2014, OJJDP STAT BRIEF BOO; Barnoski R., 2004, OUTCOME EVALUATION W; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Bloom HS, 1997, J HUM RESOUR, V32, P549, DOI 10.2307/146183; Cave G., 1993, JOBSTART FINAL REPOR; Center for Disease Control and Prevention, 2014, STRYVE PREV YOUTH VI; Cook Philip J., 2011, CONTROLLING CRIME ST, V1; Cutler DM, 2008, J ECON PERSPECT, V22, P3, DOI 10.1257/jep.22.4.3; Deming DJ, 2011, Q J ECON, V126, P2063, DOI 10.1093/qje/qjr036; Dodge KA, 1997, HDB ANTISOCIAL BEHAV, P171; Federal Bureau of Investigation, 2012, CRIM US 2012; Fernandes-Alcantara A., 2011, VULNERABLE YOUTH FED; Gottschalk P, 2005, J POLICY ANAL MANAG, V24, P485, DOI 10.1002/pam.20111; Grogger J, 1998, J LABOR ECON, V16, P756, DOI 10.1086/209905; Grossman JB, 1998, EVALUATION REV, V22, P403, DOI 10.1177/0193841X9802200304; HECKMAN JJ, 2003, INEQUALITY AM WHAT R; Heinrich CJ, 2011, ANN AM ACAD POLIT SS, V635, P163, DOI 10.1177/0002716210391968; Heller SB, 2013, 19014 NBER; Jacob BA, 2003, AM ECON REV, V93, P1560, DOI 10.1257/000282803322655446; Kemple James J., 2008, CAREER ACAD LONG TER; Kling JR, 2005, Q J ECON, V120, P87, DOI 10.1162/qjec.2005.120.1.87; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; LaLonde RJ, 2003, NBER CONF R, P517; Langton L., 2012, VICTIMIZATIONS NOT R; Lochner L, 2004, AM ECON REV, V94, P155, DOI 10.1257/000282804322970751; Ludwig J., 2014, 201402 BROOK I HAM P; Manpower Demonstration Research Corporation, 1980, SUMM FIND NAT SUPP W; McCrary J., 2011, CONTROLLING CRIME ST, P521, DOI [10.7208/chicago/9780226115139.003.0012, DOI 10.7208/CHICAGO/9780226115139.003.0012]; Merton RK, 1938, AM SOCIOL REV, V3, P672, DOI 10.2307/2084686; Millenky M., 2011, STAYING COURSE 3 YEA; Moss P, 1996, WORK OCCUPATION, V23, P252, DOI 10.1177/0730888496023003002; Piehl A. M., 1998, HDB CRIME PUNISHMENT, P302; Raphael S, 2001, J LAW ECON, V44, P259, DOI 10.1086/320275; Roder A, 2011, PROMISING START YEAR; Sampson R.J., 1995, STUDIES CRIME PREVEN; SAMPSON RJ, 1990, AM SOCIOL REV, V55, P609, DOI 10.2307/2095859; Schirm Allen, 2006, QUANTUM OPPORTUNITY; Schwartz A. E., 2014, EXPANDING SUMMER EMP; THORNBERRY TP, 1984, AM SOCIOL REV, V49, P398, DOI 10.2307/2095283; Uggen C, 2000, AM SOCIOL REV, V65, P529, DOI 10.2307/2657381; Wilson WJ, 1996, WORK DISAPPEARS WORL	43	61	61	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1219	1223		10.1126/science.1257809	http://dx.doi.org/10.1126/science.1257809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW3LU	25477459				2022-12-28	WOS:000346189000055
J	Li, G; Xiang, Z; Yu, F; Asaba, T; Lawson, B; Cai, P; Tinsman, C; Berkley, A; Wolgast, S; Eo, YS; Kim, DJ; Kurdak, C; Allen, JW; Sun, K; Chen, XH; Wang, YY; Fisk, Z; Li, L				Li, G.; Xiang, Z.; Yu, F.; Asaba, T.; Lawson, B.; Cai, P.; Tinsman, C.; Berkley, A.; Wolgast, S.; Eo, Y. S.; Kim, Dae-Jeong; Kurdak, C.; Allen, J. W.; Sun, K.; Chen, X. H.; Wang, Y. Y.; Fisk, Z.; Li, Lu			Two-dimensional Fermi surfaces in Kondo insulator SmB6	SCIENCE			English	Article							TOPOLOGICAL INSULATOR; STATES; TRANSPORT; PHASE; GAS	In the Kondo insulator samarium hexaboride (SmB6), strong correlation and band hybridization lead to an insulating gap and a diverging resistance at low temperature. The resistance divergence ends at about 3 kelvin, a behavior that may arise from surface conductance. We used torque magnetometry to resolve the Fermi surface topology in this material. The observed oscillation patterns reveal two Fermi surfaces on the (100) surface plane and one Fermi surface on the (101) surface plane. The measured Fermi surface cross sections scale as the inverse cosine function of the magnetic field tilt angles, which demonstrates the two-dimensional nature of the conducting electronic states of SmB6.	[Li, G.; Xiang, Z.; Yu, F.; Asaba, T.; Lawson, B.; Cai, P.; Tinsman, C.; Berkley, A.; Wolgast, S.; Eo, Y. S.; Kurdak, C.; Allen, J. W.; Sun, K.; Li, Lu] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Xiang, Z.; Chen, X. H.] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Xiang, Z.; Chen, X. H.] Univ Sci & Technol China, Dept Phys, Hefei 230026, Anhui, Peoples R China; [Cai, P.; Wang, Y. Y.] Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China; [Kim, Dae-Jeong; Fisk, Z.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA	University of Michigan System; University of Michigan; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Tsinghua University; University of California System; University of California Irvine	Li, L (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.	luli@umich.edu	Sun, Kai/F-2282-2010; Li, Lu/AAF-9416-2019; Li, Gang/E-3033-2015	Sun, Kai/0000-0001-9595-7646; Li, Lu/0000-0002-8054-7406; Li, Gang/0000-0002-1137-7642; Asaba, Tomoya/0000-0003-4631-9589; Cai, Peng/0000-0001-6832-5758	U. S. Department of Energy (DOE) [DE-SC0008110]; startup fund at the University of Michigan (low-field magnetization characterization); Mcubed project at the University of Michigan (low-field magnetization characterization); NSF [DMR-0801253, DMR-1006500, ECCS-1307744, F031543, DMR-084173]; Univ. of California-Irvine CORCL grant [MIIG-2011-12-8]; China Scholarship Council; National Basic Research Program of China (973 Program) [2012CB922002]; Nakajima Foundation Scholarship; NSF; State of Florida; DOE; Direct For Mathematical & Physical Scien [1006500] Funding Source: National Science Foundation; Div Of Electrical, Commun & Cyber Sys [1307744] Funding Source: National Science Foundation	U. S. Department of Energy (DOE)(United States Department of Energy (DOE)); startup fund at the University of Michigan (low-field magnetization characterization); Mcubed project at the University of Michigan (low-field magnetization characterization); NSF(National Science Foundation (NSF)); Univ. of California-Irvine CORCL grant; China Scholarship Council(China Scholarship Council); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Nakajima Foundation Scholarship; NSF(National Science Foundation (NSF)); State of Florida; DOE(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This study is based on work supported by the U. S. Department of Energy (DOE) under Award no. DE-SC0008110 (high-field torque magnetometry), by the startup fund and the Mcubed project at the University of Michigan (low-field magnetization characterization), and by the NSF DMR-0801253 and Univ. of California-Irvine CORCL grant MIIG-2011-12-8 (Z. F. group, sample growth). Part of the work performed at the University of Michigan was supported by NSF grant DMR-1006500 (C.K. group, device fabrication) and by NSF grant ECCS-1307744 (L.L. group, device transport characterization). Z.X. and X.H.C. thank the China Scholarship Council for support and the National Basic Research Program of China (973 Program, grant no. 2012CB922002). B.L. thanks the NSF graduate research fellowship (F031543) for support. T.A. thanks the Nakajima Foundation Scholarship for support. The Corbino samples were fabricated at the Lurie Nanofabrication Facility (LNF), a member of the National Nanotechnology Infrastructure Network, which is supported by the NSF. The high-field experiments were performed at the National High Magnetic Field Laboratory, which is supported by NSF Cooperative Agreement no. DMR-084173, by the State of Florida, and by the DOE.	Alexandrov V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.226403; Analytis JG, 2010, NAT PHYS, V6, P960, DOI 10.1038/NPHYS1861; Aronson MC, 1999, PHYS REV B, V59, P4720, DOI 10.1103/PhysRevB.59.4720; Behnia K, 2007, SCIENCE, V317, P1729, DOI 10.1126/science.1146509; Checkelsky JG, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.246601; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; Denlinger J. D., 2013, TEMPERATURE DEPENDEN; EISENSTEIN JP, 1985, PHYS REV LETT, V55, P875, DOI 10.1103/PhysRevLett.55.875; Eto K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195309; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Hall D, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.233105; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Jiang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4010; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; LARSON CO, 1967, PHYS REV, V156, P703, DOI 10.1103/PhysRev.156.703; Li L, 2008, SCIENCE, V321, P547, DOI 10.1126/science.1158908; Lu F, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.096401; MENTH A, 1969, PHYS REV LETT, V22, P295, DOI 10.1103/PhysRevLett.22.295; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; NISHITANI R, 1980, SURF SCI, V95, P341, DOI 10.1016/0039-6028(80)90181-8; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Qu DX, 2010, SCIENCE, V329, P821, DOI 10.1126/science.1189792; Sacepe B, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1586; Sebastian SE, 2008, NATURE, V454, P200, DOI 10.1038/nature07095; Shoenberg D., 1984, MAGNETIC OSCILLATION; Wiegers SAJ, 1997, PHYS REV LETT, V79, P3238, DOI 10.1103/PhysRevLett.79.3238; Wolgast S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.180405; Xiong J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045314; Zhang XH, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.011011; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	38	222	225	9	331	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1208	1212		10.1126/science.1250366	http://dx.doi.org/10.1126/science.1250366			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477456	Green Submitted, Green Published			2022-12-28	WOS:000346189000052
J	Gosselin, D; Link, VM; Romanoski, CE; Fonseca, GJ; Eichenfield, DZ; Spann, NJ; Stender, JD; Chun, HB; Garner, H; Geissmann, F; Glass, CK				Gosselin, David; Link, Verena M.; Romanoski, Casey E.; Fonseca, Gregory J.; Eichenfield, Dawn Z.; Spann, Nathanael J.; Stender, Joshua D.; Chun, Hyun B.; Garner, Hannah; Geissmann, Frederic; Glass, Christopher K.			Environment Drives Selection and Function of Enhancers Controlling Tissue-Specific Macrophage Identities	CELL			English	Article							MASTER TRANSCRIPTION FACTORS; HEMATOPOIETIC STEM-CELLS; SUPER-ENHANCERS; FRACTALKINE RECEPTOR; LANGERHANS CELLS; DENDRITIC CELLS; GENE-REGULATION; EXPRESSION; MICROGLIA; LINEAGE	Macrophages reside in essentially all tissues of the body and play key roles in innate and adaptive immune responses. Distinct populations of tissue macrophages also acquire context-specific functions that are important for normal tissue homeostasis. To investigate mechanisms responsible for tissue-specific functions, we analyzed the transcriptomes and enhancer landscapes of brain microglia and resident macrophages of the peritoneal cavity. In addition, we exploited natural genetic variation as a genome-wide "mutagenesis'' strategy to identify DNA recognition motifs for transcription factors that promote common or subset-specific binding of the macrophage lineage-determining factor PU.1. We find that distinct tissue environments drive divergent programs of gene expression by differentially activating a common enhancer repertoire and by inducing the expression of divergent secondary transcription factors that collaborate with PU.1 to establish tissue-specific enhancers. These findings provide insights into molecular mechanisms by which tissue environment influences macrophage phenotypes that are likely to be broadly applicable to other cell types.	[Gosselin, David; Link, Verena M.; Romanoski, Casey E.; Fonseca, Gregory J.; Eichenfield, Dawn Z.; Spann, Nathanael J.; Stender, Joshua D.; Chun, Hyun B.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Link, Verena M.] Univ Munich, Dept 2, Fac Biol, D-82152 Planegg Martinsried, Germany; [Garner, Hannah; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England; [Garner, Hannah; Geissmann, Frederic] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 1UL, England; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Munich; University of London; King's College London; University of London; King's College London; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Gosselin, David/0000-0001-5327-2868; Link, Verena/0000-0002-3207-312X; Romanoski, Casey/0000-0002-0149-225X; geissmann, frederic/0000-0001-5029-2468	NIH grants [DK091183, CA17390, DK063491]; San Diego Center for Systems Biology [GM085764]; Canadian Institutes of Health Research Fellowship; American Heart Association [12POST11760017]; NIH Pathway to Independence Award [1K99HL12348]; American Heart Association predoctoral fellowship [12PRE11610007]; Wellcome Trust Senior Investigator award [WT101853MA]; Biotechnology and Biological Sciences Research Council [1168004] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA052599, P30CA023100, R01CA173903] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL123485, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R01DK091183, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198, P50GM085764] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); San Diego Center for Systems Biology; Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); American Heart Association(American Heart Association); NIH Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship(American Heart Association); Wellcome Trust Senior Investigator award(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Lynn Bautista, Andrea Crotti, and Renee F. Glass for valuable assistance with preparation of the manuscript and Sven Heinz for assistance with the ChIP-seq library preparation protocol. The authors would also like to thank the UCSD Human Embryonic Stem Cell Core Facility for assistance with cell sorting. These studies were primarily supported by NIH grants DK091183, CA17390, and DK063491 and the San Diego Center for Systems Biology (GM085764). D. G. was supported by a Canadian Institutes of Health Research Fellowship. C. E. R. was supported by the American Heart Association (12POST11760017) and the NIH Pathway to Independence Award (1K99HL12348). D.Z.E. was supported by an American Heart Association predoctoral fellowship (12PRE11610007). F.G. was supported by a Wellcome Trust Senior Investigator award (WT101853MA).	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Andrews NC, 1998, INT J BIOCHEM CELL B, V30, P429, DOI 10.1016/S1357-2725(97)00135-0; Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ivanova AV, 2004, J MOL BIOL, V340, P641, DOI 10.1016/J.Jmb.2004.05.025; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Perdiguero E.G., 2014, NATURE; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Threadgill DW, 2012, G3-GENES GENOM GENET, V2, P153, DOI 10.1534/g3.111.001891; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009	48	812	827	5	90	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1327	1340		10.1016/j.cell.2014.11.023	http://dx.doi.org/10.1016/j.cell.2014.11.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480297	Bronze, Green Accepted			2022-12-28	WOS:000346652900012
J	Smith, JM				Smith, Jeanette M.			Winter Landscape John W. Hardrick	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2194	2195		10.1001/jama.2013.279867	http://dx.doi.org/10.1001/jama.2013.279867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25461984				2022-12-28	WOS:000345684800001
J	Brody, H				Brody, Herb			Haemophilia	NATURE			English	Editorial Material																			0	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S157	S157		10.1038/515S157a	http://dx.doi.org/10.1038/515S157a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427203	Bronze			2022-12-28	WOS:000346247600005
J	Schuckit, MA				Schuckit, Marc A.			Recognition and Management of Withdrawal Delirium (Delirium Tremens)	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SEVERE ALCOHOL-WITHDRAWAL; OXCARBAZEPINE; PREDICTORS; INFUSION; PLACEBO; DRUG; CARE	At some time in their lives, 20% of men and 10% of women in most Western societies will have an alcohol-use disorder, which is defined as repetitive alcohol-related problems in at least 2 of 11 areas of life.(1,2) These conditions can decrease the life span by a decade and are associated with severe impairments in social functioning, as well as high rates of medical problems. Although alcohol-related conditions occur in persons from all social strata and affect more than 20% of patients in most medical settings,(2,3) few physicians have been adequately trained in identifying and treating these serious problems. About 50% of persons with alcohol-use disorders have symptoms of alcohol withdrawal when they reduce or discontinue their alcohol consumption; in 3 to 5% of these persons, grand mal convulsions, severe confusion (a delirium), or both develop.(1) It is essential that clinicians know how to prevent, recognize, and treat these severe withdrawal states to minimize costly hospitalizations and avoidable deaths.	Univ Calif San Diego, Dept Psychiat, Sch Med, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Schuckit, MA (corresponding author), Univ Calif San Diego, Dept Psychiat, Sch Med, 8950 Villa La Jolla Dr, La Jolla, CA 92037 USA.	mschuckit@ucsd.edu						Amato L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005063.pub3; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Attard A, 2008, CNS DRUGS, V22, P631, DOI 10.2165/00023210-200822080-00002; Bar KJ, 2007, DRUG ALCOHOL DEPEN, V89, P259, DOI 10.1016/j.drugalcdep.2007.01.010; Barrons R, 2010, J CLIN PHARM THER, V35, P153, DOI 10.1111/j.1365-2710.2009.01098.x; Berggren U, 2009, ALCOHOL ALCOHOLISM, V44, P382, DOI 10.1093/alcalc/agp012; Bonnet U, 2011, ALCOHOL ALCOHOLISM, V46, P68, DOI 10.1093/alcalc/agq081; Cook CCH, 1998, ALCOHOL ALCOHOLISM, V33, P317; DeBellis Ronald, 2005, J Intensive Care Med, V20, P164, DOI 10.1177/0885066605275353; DeCarolis DD, 2007, PHARMACOTHERAPY, V27, P510, DOI 10.1592/phco.27.4.510; Eyer F, 2011, ALCOHOL ALCOHOLISM, V46, P427, DOI 10.1093/alcalc/agr053; Heilig M, 2010, ADDICT BIOL, V15, P169, DOI 10.1111/j.1369-1600.2009.00194.x; Khan A, 2008, ACAD EMERG MED, V15, P788, DOI 10.1111/j.1553-2712.2008.00187.x; Koethe D, 2007, ALCOHOL CLIN EXP RES, V31, P1188, DOI 10.1111/j.1530-0277.2007.00419.x; Kosten TR, 2003, NEW ENGL J MED, V348, P1786, DOI 10.1056/NEJMra020617; Krupitsky EM, 2007, ALCOHOL CLIN EXP RES, V31, P604, DOI 10.1111/j.1530-0277.2007.00344.x; LINEAWEAVER WC, 1988, CRIT CARE MED, V16, P294, DOI 10.1097/00003246-198803000-00018; Lorentzen K, 2014, DAN MED J, V61; Lum E, 2006, ANN PHARMACOTHER, V40, P441, DOI 10.1345/aph.1G243; Mainerova B, 2013, BIOMED PAP, V157, P1; Mayo-Smith MF, 2004, ARCH INTERN MED, V164, P1405, DOI 10.1001/archinte.164.13.1405; Mertens JR, 2005, ALCOHOL CLIN EXP RES, V29, P989, DOI 10.1097/01.ALC.0000167958.68586.3D; Michaelsen IH, 2010, DAN MED BULL, V57; Muzyk AJ, 2011, ANN PHARMACOTHER, V45, P649, DOI 10.1345/aph.1P575; Rayner SG, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-12; Russell M, 2009, ALCOHOL CLIN EXP RES, V33, P324, DOI 10.1111/j.1530-0277.2008.00836.x; Sarai M, 2013, COCHRANE DB SYST REV, V6; SCHUCKIT MA, 1995, ADDICTION, V90, P1335, DOI 10.1046/j.1360-0443.1995.901013355.x; Schuckit MA., 2011, GOODMAN GILMANS PHAR, P629; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Thomson AD, 2002, ALCOHOL ALCOHOLISM, V37, P513, DOI 10.1093/alcalc/37.6.513; Williams D, 2001, ALCOHOL ALCOHOLISM, V36, P104, DOI 10.1093/alcalc/36.2.104; Wright T, 2006, AM J ADDICTION, V15, P213, DOI 10.1080/10550490600625798	33	142	149	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2109	2113		10.1056/NEJMra1407298	http://dx.doi.org/10.1056/NEJMra1407298			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25427113	Green Published			2022-12-28	WOS:000345580000010
J	Laurance, J				Laurance, Jeremy			Efua Dorkenoo Nurse and biosocial scientist who led the campaign against female genital mutilation. Born on Sept 6, 1949, in Cape Coast, Ghana, she died of cancer on Oct 18, 2014, in London, UK, aged 65 years. Obituary	LANCET			English	Biographical-Item																		PUBLICATION LIST	1	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1842	1842		10.1016/S0140-6736(14)62235-2	http://dx.doi.org/10.1016/S0140-6736(14)62235-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7LA	25478610				2022-12-28	WOS:000345116800015
J	Gujral, TS; Chan, M; Peshkin, L; Sorger, PK; Kirschner, MW; MacBeath, G				Gujral, Taranjit S.; Chan, Marina; Peshkin, Leonid; Sorger, Peter K.; Kirschner, Marc W.; MacBeath, Gavin			A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis	CELL			English	Article							SERINE PHOSPHORYLATION; CANCER METASTASIS; GENE-EXPRESSION; CELL-MIGRATION; PROTEIN; STAT3; INHIBITORS; BINDING; BREAST; SENSITIVITY	Wnt signaling plays a critical role in embryonic development, and genetic aberrations in this network have been broadly implicated in colorectal cancer. We find that the Wnt receptor Frizzled2 (Fzd2) and its ligands Wnt5a/b are elevated in metastatic liver, lung, colon, and breast cancer cell lines and in high-grade tumors and that their expression correlates with markers of epithelial-mesenchymal transition (EMT). Pharmacologic and genetic perturbations reveal that Fzd2 drives EMT and cell migration through a previously unrecognized, noncanonical pathway that includes Fyn and Stat3. A gene signature regulated by this pathway predicts metastasis and overall survival in patients. We have developed an antibody to Fzd2 that reduces cell migration and invasion and inhibits tumor growth and metastasis in xenografts. We propose that targeting this pathway could provide benefit for patients with tumors expressing high levels of Fzd2 and Wnt5a/ b.	[Gujral, Taranjit S.; Chan, Marina; Peshkin, Leonid; Sorger, Peter K.; Kirschner, Marc W.; MacBeath, Gavin] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave,Warren Alpert 524, Boston, MA 02115 USA.	marc@hms.harvard.edu; gavin_macbeath@harvard.edu		Peshkin, Leonid/0000-0002-6420-848X; MacBeath, Gavin/0000-0003-2585-6772; Gujral, Taran/0000-0002-4453-3031; Sorger, Peter/0000-0002-3364-1838	National Institutes of Health [R01 GM072872, P50 GM68762, U54 HG006097, R01 HD073104, R01 GM103785]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073104] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, R01GM103785, R01GM072872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by awards from the National Institutes of Health (R01 GM072872, P50 GM68762, U54 HG006097, R01 HD073104, and R01 GM103785). T.S.G. is a Human Frontier Science Program Fellow. We thank the staff of the Nikon Imaging Center and Systems Biology Flow Cytometry Facility at Harvard Medical School for help and support. G.M. is an employee, cofounder, and shareholder of Merrimack Pharmaceuticals and P.K.S. is a cofounder and shareholder of Merrimack Pharmaceuticals.	Balanis N, 2013, J BIOL CHEM, V288, P17954, DOI 10.1074/jbc.M113.475277; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Cottone M, 2012, NEW ENGL J MED, V367, P1960, DOI 10.1056/NEJMc1211073; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Deka J, 2010, CANCER RES, V70, P6619, DOI 10.1158/0008-5472.CAN-10-0148; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Freissmuth M, 1996, MOL PHARMACOL, V49, P602; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Gujral TS, 2014, P NATL ACAD SCI USA, V111, P5048, DOI 10.1073/pnas.1403080111; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; HE L, 1984, IN VITRO CELL DEV B, V20, P493, DOI 10.1007/BF02619623; Jordan NV, 2013, MOL CELL BIOL, V33, P3011, DOI 10.1128/MCB.01443-12; Katada T, 2012, BIOL PHARM BULL, V35, P2103, DOI 10.1248/bpb.b212024; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lenaerts T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-43; Li CG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-11; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; PAYNE G, 1993, P NATL ACAD SCI USA, V90, P4902, DOI 10.1073/pnas.90.11.4902; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tarcic G, 2012, FASEB J, V26, P1582, DOI 10.1096/fj.11-194654; Teng TS, 2009, J CELL SCI, V122, P4150, DOI 10.1242/jcs.057109; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P11312, DOI 10.1073/pnas.1203015109; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	43	221	230	0	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					844	856		10.1016/j.cell.2014.10.032	http://dx.doi.org/10.1016/j.cell.2014.10.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417160	Bronze, Green Accepted			2022-12-28	WOS:000344522000016
J	Yeung, MSY; Zdunek, S; Bergmann, O; Bernard, S; Salehpour, M; Alkass, K; Perl, S; Tisdale, J; Possnert, G; Brundin, L; Druid, H; Frisen, J				Yeung, Maggie S. Y.; Zdunek, Sofia; Bergmann, Olaf; Bernard, Samuel; Salehpour, Mehran; Alkass, Kanar; Perl, Shira; Tisdale, John; Possnert, Goran; Brundin, Lou; Druid, Henrik; Frisen, Jonas			Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain	CELL			English	Article							WHITE-MATTER MICROSTRUCTURE; CENTRAL-NERVOUS-SYSTEM; ELECTRICAL-ACTIVITY; CELLS; NEUROGENESIS; PROTEINS; AGE; DIFFERENTIATION; PROLIFERATION; DEPENDS	The myelination of axons by oligodendrocytes has been suggested to be modulated by experience, which could mediate neural plasticity by optimizing the performance of the circuitry. We have assessed the dynamics of oligodendrocyte generation and myelination in the human brain. The number of oligodendrocytes in the corpus callosum is established in childhood and remains stable after that. Analysis of the integration of nuclear bomb test-derived C-14 revealed that myelin is exchanged at a high rate, whereas the oligodendrocyte population in white matter is remarkably stable in humans, with an annual exchange of 1/300 oligodendrocytes. We conclude that oligodendrocyte turnover contributes minimally to myelin modulation in human white matter and that this instead may be carried out by mature oligodendrocytes, which may facilitate rapid neural plasticity.	[Yeung, Maggie S. Y.; Zdunek, Sofia; Bergmann, Olaf; Alkass, Kanar; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Bernard, Samuel] Univ Lyon, CNRS, UMR 5208, Inst Camille Jordan, F-69622 Villeurbanne, France; [Salehpour, Mehran; Possnert, Goran] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Alkass, Kanar; Druid, Henrik] Karolinska Inst, Dept Forens Med, S-17177 Stockholm, Sweden; [Perl, Shira; Tisdale, John] NHLBI, NIH, Bethesda, MD 20892 USA; [Brundin, Lou] Karolinska Univ Hosp, Karolinska Inst, Dept Neurol & Neurosurg, Dept Clin Neurosci, S-17177 Stockholm, Sweden	Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Uppsala University; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Karolinska Institutet; Karolinska University Hospital	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Bernard, Samuel/A-5623-2009; Bergmann, Olaf/A-5706-2009	Bernard, Samuel/0000-0002-8442-9968; Bergmann, Olaf/0000-0003-1065-4107; alkass, kanar/0000-0002-9154-5393; Brundin, Lou/0000-0003-4408-7817; Yeung Wong, Maggie/0000-0001-5487-780X; Druid, Henrik/0000-0002-9198-023X	Swedish Research Council; Swedish Cancer Society; Karolinska Institute; Tobias Stiftelsen; AFA Forsakringar; Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institute (StratRegen); Swedish Foundation for Strategic Research; ERC; Torsten Soderbergs Stiftelse; Knut och Alice Wallenbergs Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; AFA Forsakringar; Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institute (StratRegen); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); ERC(European Research Council (ERC)European Commission); Torsten Soderbergs Stiftelse; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation)	We thank M. Carlen for discussions, L. Slomianka for advice on stereology, C. Lebel for providing imaging data, M. Toro and S. Giatrellis for help with flow cytometry, K. Hakansson for AMS sample preparation, and the National Institute of Child, Health, and Human Development (NICHD) Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD for providing tissue. This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, AFA Forsakringar, the Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institute (StratRegen), Swedish Foundation for Strategic Research, the ERC, Torsten Soderbergs Stiftelse, and Knut och Alice Wallenbergs Stiftelse.	Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bergmann O, 2013, SCIENCE, V340, P695, DOI 10.1126/science.1237976; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Bhat RV, 1996, GLIA, V17, P169; Blakemore WF, 1999, J NEUROIMMUNOL, V98, P69, DOI 10.1016/S0165-5728(99)00083-1; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Cerghet M, 2006, J NEUROSCI, V26, P1439, DOI 10.1523/JNEUROSCI.2219-05.2006; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Fields R.D., 2012, NEUROGLIA; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2013, NEUROIMAGE, V73, P260, DOI 10.1016/j.neuroimage.2012.08.085; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Lovden M, 2010, NEUROPSYCHOLOGIA, V48, P3878, DOI 10.1016/j.neuropsychologia.2010.08.026; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Snaidero N, 2014, CELL, V156, P277, DOI 10.1016/j.cell.2013.11.044; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	40	279	280	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					766	774		10.1016/j.cell.2014.10.011	http://dx.doi.org/10.1016/j.cell.2014.10.011			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417154	Green Submitted, Bronze			2022-12-28	WOS:000344522000010
J	Misasi, J; Sullivan, NJ				Misasi, John; Sullivan, Nancy J.			Camouflage and Misdirection: The Full-On Assault of Ebola Virus Disease	CELL			English	Review							INTERFERON INHIBITORY DOMAIN; DOUBLE-STRANDED-RNA; VESICULAR STOMATITIS-VIRUS; INNATE IMMUNE-RESPONSE; NIEMANN-PICK C1; VP35 PROTEIN; DC-SIGN; HEMORRHAGIC-FEVER; ZAIRE-EBOLAVIRUS; ENTRY REQUIRES	Ebolaviruses cause a severe hemorrhagic fever syndrome that is rapidly fatal to humans and nonhuman primates. Ebola protein interactions with host cellular proteins disrupt type I and type II interferon responses, RNAi antiviral responses, antigen presentation, T-cell-dependent B cell responses, humoral antibodies, and cell-mediated immunity. This multifaceted approach to evasion and suppression of innate and adaptive immune responses in their target hosts leads to the severe immune dysregulation and "cytokine storm" that is characteristic of fatal ebolavirus infection. Here, we highlight some of the processes by which Ebola interacts with its mammalian hosts to evade antiviral defenses.	[Misasi, John] Boston Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Sullivan, Nancy J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sullivan, NJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	njsull@mail.nih.gov		Misasi, John/0000-0001-7169-2639	US NIH NIAID Vaccine Research Center, NIH [K08-AI079381]; Boston Children's Hospital Faculty Development Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI079381] Funding Source: NIH RePORTER	US NIH NIAID Vaccine Research Center, NIH; Boston Children's Hospital Faculty Development Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank B. Hartman for graphics and A. Tislerics for editing the manuscript. This work was supported by the Intramural Research Program of the US NIH NIAID Vaccine Research Center, NIH grant K08-AI079381, and a Boston Children's Hospital Faculty Development Fellowship.	Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Baribaud F, 2002, J VIROL, V76, P9135, DOI 10.1128/JVI.76.18.9135-9142.2002; Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; Biedenkopf N, 2013, J BIOL CHEM, V288, P11165, DOI 10.1074/jbc.M113.461285; Biermann M, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065007; Brecher M, 2012, J VIROL, V86, P364, DOI 10.1128/JVI.05708-11; Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002; Brunner JE, 2005, J VIROL, V79, P3254, DOI 10.1128/JVI.79.6.3254-3266.2005; Brunner JE, 2010, VIROLOGY, V400, P240, DOI 10.1016/j.virol.2010.01.031; Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Chepurnov AA, 1999, IMMUNOL LETT, V68, P257, DOI 10.1016/S0165-2478(99)00058-9; Chiang JJ, 2014, CYTOKINE GROWTH FACT; Cilloniz C, 2011, J VIROL, V85, P9060, DOI 10.1128/JVI.00659-11; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Ebihara H, 2006, PLOS PATHOG, V2, P705, DOI 10.1371/journal.ppat.0020073; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Feng ZD, 2007, J VIROL, V81, P182, DOI 10.1128/JVI.01006-06; Gnirss K, 2014, VIRUSES-BASEL, V6, P1654, DOI 10.3390/v6041654; Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Halfmann P, 2011, J INFECT DIS, V204, pS953, DOI 10.1093/infdis/jir325; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hartlieb B, 2003, J BIOL CHEM, V278, P41830, DOI 10.1074/jbc.M307036200; Hartlieb B, 2007, P NATL ACAD SCI USA, V104, P624, DOI 10.1073/pnas.0606730104; Hartman AL, 2008, J VIROL, V82, P5348, DOI 10.1128/JVI.00215-08; Hartman AL, 2008, J VIROL, V82, P2699, DOI 10.1128/JVI.02344-07; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Hood CL, 2010, J VIROL, V84, P2972, DOI 10.1128/JVI.02151-09; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480; Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kimberlin CR, 2010, P NATL ACAD SCI USA, V107, P314, DOI 10.1073/pnas.0910547107; Kindzelskii AL, 2000, J IMMUNOL, V164, P953, DOI 10.4049/jimmunol.164.2.953; Kneller ELP, 2009, J VIROL, V83, P770, DOI 10.1128/JVI.01279-08; Koma T, 2013, J MOL BIOL, V425, P4893, DOI 10.1016/j.jmb.2013.09.028; Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; Kuhl A, 2011, J INFECT DIS, V204, pS850, DOI 10.1093/infdis/jir378; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2001, CLIN EXP IMMUNOL, V124, P453, DOI 10.1046/j.1365-2249.2001.01517.x; Leung DW, 2010, J MOL BIOL, V399, P347, DOI 10.1016/j.jmb.2010.04.022; Leung DW, 2010, NAT STRUCT MOL BIOL, V17, P165, DOI 10.1038/nsmb.1765; Leung DW, 2009, P NATL ACAD SCI USA, V106, P411, DOI 10.1073/pnas.0807854106; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Liu Y, 2010, FUTURE VIROL, V5, P481, DOI 10.2217/FVL.10.33; Lopez LA, 2012, J VIROL, V86, P5467, DOI 10.1128/JVI.06280-11; Lopez LA, 2010, J VIROL, V84, P7243, DOI 10.1128/JVI.02636-09; Mahanty S, 2003, J IMMUNOL, V170, P2797, DOI 10.4049/jimmunol.170.6.2797; Martinez MJ, 2011, J INFECT DIS, V204, pS934, DOI 10.1093/infdis/jir320; Martinez O, 2011, J INFECT DIS, V204, pS825, DOI 10.1093/infdis/jir295; Mateo M, 2011, J INFECT DIS, V204, pS1011, DOI 10.1093/infdis/jir338; Mateo M, 2010, J VIROL, V84, P1169, DOI 10.1128/JVI.01372-09; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Misasi J, 2012, J VIROL, V86, P3284, DOI 10.1128/JVI.06346-11; Modrof J, 2003, J VIROL, V77, P3334, DOI 10.1128/JVI.77.5.3334-3338.2003; Mohan GS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003065; Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13; Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13; Muhlberger E, 1999, J VIROL, V73, P2333; Mulherkar N, 2011, VIROLOGY, V419, P72, DOI 10.1016/j.virol.2011.08.009; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Noisakran S, 2008, BIOCHEM BIOPH RES CO, V372, P67, DOI 10.1016/j.bbrc.2008.04.165; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Prins KC, 2010, J VIROL, V84, P3004, DOI 10.1128/JVI.02459-09; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; Quinn K, 2009, J VIROL, V83, P10176, DOI 10.1128/JVI.00422-09; Reid SP, 2007, J VIROL, V81, P13469, DOI 10.1128/JVI.01097-07; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schornberg KL, 2009, P NATL ACAD SCI USA, V106, P8003, DOI 10.1073/pnas.0807578106; Schumann M, 2009, J VIROL, V83, P8993, DOI 10.1128/JVI.00523-09; Shabman RS, 2011, J INFECT DIS, V204, pS904, DOI 10.1093/infdis/jir323; Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Stahelin RV, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00300; Stanley D.A., 2014, NAT MED; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Takada A, 2000, VIROLOGY, V278, P20, DOI 10.1006/viro.2000.0601; VOLCHKOV VE, 1992, FEBS LETT, V305, P181, DOI 10.1016/0014-5793(92)80662-Z; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837; Wen ZY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-331; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Wong G, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004582; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Xu W, 2014, CELL HOST MICROBE, V16, P187, DOI 10.1016/j.chom.2014.07.008; Yaddanapudi K, 2006, FASEB J, V20, P2519, DOI 10.1096/fj.06-6151com; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zhang APP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002550; Zhu YL, 2012, J VIROL, V86, P3038, DOI 10.1128/JVI.05741-11	117	44	48	0	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					477	486		10.1016/j.cell.2014.10.006	http://dx.doi.org/10.1016/j.cell.2014.10.006			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417101	Bronze, Green Accepted			2022-12-28	WOS:000344521700006
J	Kamisawa, T; Zen, Y; Pillai, S; Stone, JH				Kamisawa, Terumi; Zen, Yoh; Pillai, Shiv; Stone, John H.			IgG4-related disease	LANCET			English	Review							IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS; SERUM IGG4 CONCENTRATIONS; AUTOIMMUNE PANCREATITIS; SYSTEMIC-DISEASE; RETROPERITONEAL FIBROSIS; SCLEROSING PANCREATITIS; DIAGNOSTIC-CRITERIA; MIKULICZS-DISEASE; RIEDELS THYROIDITIS; EXOCRINE FUNCTION	IgG4-related disease is a protean condition that mimics many malignant, infectious, and inflammatory disorders. This multi-organ immune-mediated condition links many disorders previously regarded as isolated, single-organ diseases without any known underlying systemic condition. It was recognised as a unified entity only 10 years ago. Histopathology is the key to diagnosis. The three central pathology features of IgG4-related disease are lymphoplasmacytic infiltration, storiform fibrosis, and obliterative phlebitis. The extent of fibrosis is an important determinant of responsiveness to immunosuppressive therapies. IgG4-related disease generally responds to glucocorticoids in its inflammatory stage, but recurrent or refractory cases are common. Important mechanistic insights have been derived from studies of patients treated by B-cell depletion. Greater awareness of this disease is needed to ensure earlier diagnoses, which can prevent severe organ damage, disabling tissue fibrosis, and even death. Identification of specific antigens and T-cell clones that drive the disease will be the first steps to elucidate the pathogenesis of IgG4-related disease.	[Kamisawa, Terumi] Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Tokyo, Japan; [Zen, Yoh] Kobe Univ, Dept Pathol, Kobe, Hyogo 657, Japan; [Pillai, Shiv] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc Res, Boston, MA USA; [Stone, John H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA USA	Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Kobe University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Stone, JH (corresponding author), Massachusetts Gen Hosp, Rheumatol Unit, Yawkey 2,55 Fruit St, Boston, MA 02114 USA.	jhstone@mgh.harvard.edu			Genentech	Genentech(Roche HoldingGenentech)	JHS is the principal investigator in a Genentech-funded trial of rituximab in IgG4-related disease and has consulted for Genentech on this disease. The other authors declare no competing interests.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Alexander MP, 2013, KIDNEY INT, V83, P455, DOI 10.1038/ki.2012.382; Baer AN, 2013, OR SURG OR MED OR PA, V115, pE34, DOI 10.1016/j.oooo.2012.07.485; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Boonstra K, 2014, HEPATOLOGY, V59, P1954, DOI 10.1002/hep.26977; Carruthers MN, 2013, ARTHRITIS RHEUM, V10, P2649; Carruthers MN, 2015, ANN RHEUM DIS, V74, P14, DOI 10.1136/annrheumdis-2013-204907; Cheuk W, 2012, SEMIN DIAGN PATHOL, V29, P226, DOI 10.1053/j.semdp.2012.07.001; Dahlgren M, 2010, ARTHRIT CARE RES, V62, P1312, DOI 10.1002/acr.20215; Della Torre E, 2014, ALLERGY, V69, P269, DOI 10.1111/all.12320; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Deshpande V, 2012, J CLIN PATHOL, V65, P725, DOI 10.1136/jclinpath-2011-200485; Ebbo M, 2014, ARTHRIT CARE RES, V66, P86, DOI 10.1002/acr.22058; Fatemi G, 2013, ARTHRITIS RHEUM-US, V65, P2217, DOI 10.1002/art.37999; Geyer JT, 2010, AM J SURG PATHOL, V34, P202, DOI 10.1097/PAS.0b013e3181c811ad; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Gupta R, 2013, PANCREAS, V42, P506, DOI 10.1097/MPA.0b013e31826bef91; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Hart PA, 2013, GUT, V62, P1607, DOI 10.1136/gutjnl-2012-302886; Hart PA, 2013, INT J UROL, V20, P132, DOI 10.1111/j.1442-2042.2012.03194.x; Hermet M, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/303506; Himi T, 2012, AURIS NASUS LARYNX, V39, P9, DOI 10.1016/j.anl.2011.01.023; Hirano K, 2010, GASTROINTEST ENDOSC, V71, P85, DOI 10.1016/j.gie.2009.08.008; Hu EK, 2013, ANN ALLERG ASTHMA IM, V111, P75, DOI 10.1016/j.anai.2013.05.007; Ikeda T, 2013, EUR J DERMATOL, V23, P241, DOI 10.1684/ejd.2013.1958; Inokuchi G, 2014, FORENSIC SCI MED PAT, V10, P103, DOI 10.1007/s12024-013-9516-5; Inoue D., 2012, INT J RHEUMATOL, V29, P212; Inoue D, 2011, RADIOLOGY, V261, P625, DOI 10.1148/radiol.11102250; Inoue D, 2009, RADIOLOGY, V251, P260, DOI 10.1148/radiol.2511080965; Ito T, 2007, PANCREAS, V34, P254, DOI 10.1097/01.mpa.0000250127.18908.38; Itoi T, 2013, J GASTROENTEROL, V48, P504, DOI 10.1007/s00535-012-0652-6; Kalaitzakis E, 2011, CLIN GASTROENTEROL H, V9, P800, DOI 10.1016/j.cgh.2011.05.019; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Kamisawa T, 2003, AM J GASTROENTEROL, V98, P2811, DOI 10.1111/j.1572-0241.2003.08758.x; Kamisawa T, 2003, PANCREAS, V27, P235, DOI 10.1097/00006676-200310000-00007; Kamisawa T, 2003, GUT, V52, P683, DOI 10.1136/gut.52.5.683; Kamisawa T, 2009, GUT, V58, P1504, DOI 10.1136/gut.2008.172908; Kamisawa T, 2013, GUT, V62, P1373, DOI 10.1136/gutjnl-2012-304224; Kamisawa T, 2010, NAT REV GASTRO HEPAT, V7, P401, DOI 10.1038/nrgastro.2010.81; Kamisawa T, 2010, J GASTROENTEROL, V45, P471, DOI 10.1007/s00535-010-0221-9; Kanno A, 2012, PANCREAS, V41, P835, DOI 10.1097/MPA.0b013e3182480c99; Kasashima S, 2010, J VASC SURG, V52, P1587, DOI 10.1016/j.jvs.2010.06.072; Kawa S, 2013, IGG4 RELATED DIS; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Khosroshahi A, 2014, ARTHRITIS RHEUMATOL, V66, P213, DOI 10.1002/art.38193; Khosroshahi A, 2013, MEDICINE, V92, P82, DOI 10.1097/MD.0b013e318289610f; Khosroshahi A, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/139409; Khosroshahi A, 2012, MEDICINE, V91, P57, DOI 10.1097/MD.0b013e3182431ef6; Khosroshahi A, 2010, ARTHRITIS RHEUM-US, V62, P1755, DOI 10.1002/art.27435; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Ko SBH, 2010, GASTROENTEROLOGY, V138, P1988, DOI 10.1053/j.gastro.2010.01.001; Leporati P, 2011, J CLIN ENDOCR METAB, V96, P1971, DOI 10.1210/jc.2010-2970; Mahajan VS, 2014, ANNU REV PATHOL-MECH, V9, P315, DOI 10.1146/annurev-pathol-012513-104708; Maruyama M, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/272595; Masaki Y, 2014, 2 INT S IGG4 REL DIS; Masaki Y, 2010, J RHEUMATOL, V37, P1380, DOI 10.3899/jrheum.091153; Mattoo H, 2014, ALLERGY, V69, P399, DOI 10.1111/all.12342; Mattoo H, 2014, J ALLERGY CLIN IMMUN, V134, P679, DOI 10.1016/j.jaci.2014.03.034; Mendes FD, 2006, AM J GASTROENTEROL, V101, P2070, DOI 10.1111/j.1572-0241.2006.00772.x; Nakazawa T, 2011, J HEPATO-BIL-PAN SCI, V18, P127, DOI 10.1007/s00534-010-0320-2; Ohara H, 2012, J HEPATO-BIL-PAN SCI, V19, P536, DOI 10.1007/s00534-012-0521-y; Ohno K, 2014, MOD RHEUMATOL, V24, P195, DOI 10.3109/14397595.2013.852842; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Oseini AM, 2011, HEPATOLOGY, V54, P940, DOI 10.1002/hep.24487; Ota M, 2007, IMMUNOGENETICS, V59, P45, DOI 10.1007/s00251-006-0178-2; Ota M, 2011, DIS MARKERS, V31, P223, DOI [10.3233/DMA-2011-0820, 10.1155/2011/264747]; Ozaki Y, 2008, J GASTROENTEROL, V43, P144, DOI 10.1007/s00535-007-2132-y; Peikert T, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/207056; Pezzilli Raffaele, 2011, Case Rep Gastroenterol, V5, P378, DOI 10.1159/000330291; Pusztaszeri M, 2012, THYROID, V22, P964, DOI 10.1089/thy.2011.0404; Sadler R, 2011, EUR J GASTROEN HEPAT, V23, P139, DOI 10.1097/MEG.0b013e3283423486; Saeki T, 2013, KIDNEY INT, V84, P826, DOI 10.1038/ki.2013.191; Saeki T, 2010, KIDNEY INT, V78, P1016, DOI 10.1038/ki.2010.271; Sah RP, 2011, CURR OPIN RHEUMATOL, V23, P108, DOI 10.1097/BOR.0b013e3283413469; Sah RP, 2010, GASTROENTEROLOGY, V139, P140, DOI 10.1053/j.gastro.2010.03.054; Salvarani C, 2011, CLIN EXP RHEUMATOL, V29, pS79; Schiffenbauer AI, 2012, LARYNGOSCOPE, V122, P681, DOI 10.1002/lary.22486; Shimizu Y, 2013, RHEUMATOLOGY, V52, P679, DOI 10.1093/rheumatology/kes358; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Stone JR, 2011, CURR OPIN RHEUMATOL, V23, P88, DOI 10.1097/BOR.0b013e3283412f7c; Stone JH, 2012, NEW ENGL J MED, V367, P2335, DOI 10.1056/NEJMcpc1209330; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Strehl JD, 2011, J CLIN PATHOL, V64, P237, DOI 10.1136/jcp.2010.085613; Sugumar A, 2011, GUT, V60, P666, DOI 10.1136/gut.2010.207951; Tabata T, 2009, CLIN CHIM ACTA, V408, P25, DOI 10.1016/j.cca.2009.06.036; Takahira M, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/635473; Tsuboi H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3924; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Umemura T, 2006, GUT, V55, P1367, DOI 10.1136/gut.2006.095059; Umemura T, 2008, AM J GASTROENTEROL, V103, P588, DOI 10.1111/j.1572-0241.2007.01750.x; Wallace ZS, 2014, SEMIN ARTHRITIS RHEU, V43, P806, DOI 10.1016/j.semarthrit.2013.11.008; Wallace ZS, 2013, MEDICINE, V92, P206, DOI 10.1097/MD.0b013e31829cce35; Wallace ZS, 2012, SURV OPHTHALMOL, V57, P26, DOI 10.1016/j.survophthal.2011.07.004; Wallace ZS, 2014, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2014-205233.rint, DOI 10.1136/ANNRHEUMDIS-2014-205233.RINT]; Watanabe T, 2013, SCAND J RHEUMATOL, V42, P325, DOI 10.3109/03009742.2012.761281; Yao Q, 2013, CLIN EXP RHEUMATOL, V31, P289; Zen Y, 2004, AM J SURG PATHOL, V28, P1193, DOI 10.1097/01.pas.0000136449.37936.6c; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Zen Y, 2012, SEMIN DIAGN PATHOL, V29, P212, DOI 10.1053/j.semdp.2012.07.003; Zen Y, 2010, AM J SURG PATHOL, V34, P1812, DOI 10.1097/PAS.0b013e3181f7266b; Zen Y, 2009, AM J SURG PATHOL, V33, P1886, DOI 10.1097/PAS.0b013e3181bd535b; Zen Y, 2009, AM J SURG PATHOL, V33, P1833, DOI 10.1097/PAS.0b013e3181b72882	106	725	797	7	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2015	385	9976					1460	1471		10.1016/S0140-6736(14)60720-0	http://dx.doi.org/10.1016/S0140-6736(14)60720-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF7EU	25481618				2022-12-28	WOS:000352719800034
J	Cecchini, S; Soares, FV				Cecchini, Simone; Soares, Fabio Veras			Conditional cash transfers and health in Latin America	LANCET			English	Editorial Material							TRANSFER PROGRAMS; CHILD HEALTH		[Cecchini, Simone] Comis Econ Amer Latina & Carib, Santiago 7630412, Chile; [Soares, Fabio Veras] UN Dev Programme, Int Policy Ctr Inclus Growth, Brasilia, DF, Brazil		Cecchini, S (corresponding author), Comis Econ Amer Latina & Carib, Santiago 7630412, Chile.	simone.cecchini@cepal.org	Cecchini, Simone/P-8773-2019	Cecchini, Simone/0000-0002-9757-3141				Attanasio O, 2009, INITIATIVE WORKING P; Atun R., 2014, LANCET; Cecchini S, 2012, LIBROS CEPAL, V111; de Andrade LOM, 2014, LANCET; de Brauw A., 2012, IMPACT BOLSA FAMILIA; DNP, 2006, PROGR FAM ACC IMP PR; Economic Commission for Latin America and the Caribbean, NONC SOC PROT PROGR; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Gaarder MM, 2010, J DEV EFFECT, V2, P6, DOI 10.1080/19439341003646188; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; Gertler Paul J., 2001, EXPT INCENTIVE UNPUB; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Leroy JL, 2009, J DEV EFFECT, V1, P103, DOI 10.1080/19439340902924043; Manley J, 2013, WORLD DEV, V48, P133, DOI 10.1016/j.worlddev.2013.03.010; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1	15	11	11	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					E32	E34		10.1016/S0140-6736(14)61279-4	http://dx.doi.org/10.1016/S0140-6736(14)61279-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF0ZD	25458719				2022-12-28	WOS:000352272400005
J	Etienne, CF				Etienne, Carissa F.			Achieving universal health coverage is a moral imperative	LANCET			English	Editorial Material									Pan Amer Hlth Org, Washington, DC 20037 USA	Pan American Health Organization	Etienne, CF (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.	director@paho.org						*PAHO, 2007, REN PRIM HLTH CAR AM; PAHO, 2007, ALM AT MILL DECL; PAHO, 2014, CD53 5 STRAT UN ACC; PAHO, 2013, 65 SESS WHO REG COMM; Pan American Health Organization (PAHO), 2012, HLTH AM; UN, 2012, UN C JUN 20 22; WHO, 2007, EV BUS STRENGTH HLTH; WHO(World Health Organization), 1946, CONST; World Health Organization (WHO), 1978, INT C PRIM HLTH CAR	9	9	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1271	1273		10.1016/S0140-6736(14)61679-2	http://dx.doi.org/10.1016/S0140-6736(14)61679-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF0ZD	25458723				2022-12-28	WOS:000352272400014
J	Wain, J; Hendriksen, RS; Mikoleit, ML; Keddy, KH; Ochiai, RL				Wain, John; Hendriksen, Rene S.; Mikoleit, Matthew L.; Keddy, Karen H.; Ochiai, R. Leon			Typhoid fever	LANCET			English	Article							ENTERICA SEROVAR TYPHI; RESISTANT SALMONELLA-TYPHI; CONTROLLED FIELD TRIAL; MULTIDRUG-RESISTANT; RISK-FACTORS; ANTIMICROBIAL RESISTANCE; POLYSACCHARIDE VACCINE; BETA-LACTAMASE; SOUTH-AFRICA; PARATYPHI-A	Control of typhoid fever relies on clinical information, diagnosis, and an understanding for the epidemiology of the disease. Despite the breadth of work done so far, much is not known about the biology of this human-adapted bacterial pathogen and the complexity of the disease in endemic areas, especially those in Africa. The main barriers to control are vaccines that are not immunogenic in very young children and the development of multidrug resistance, which threatens efficacy of antimicrobial chemotherapy. Clinicians, microbiologists, and epidemiologists worldwide need to be familiar with shifting trends in enteric fever. This knowledge is crucial, both to control the disease and to manage cases. Additionally, salmonella serovars that cause human infection can change over time and location. In areas of Asia, multidrug-resistant Salmonella enterica serovar Typhi (S Typhi) has been the main cause of enteric fever, but now S Typhi is being displaced by infections with drug-resistant S enterica serovar Paratyphi A. New conjugate vaccines are imminent and new treatments have been promised, but the engagement of local medical and public health institutions in endemic areas is needed to allow surveillance and to implement control measures.	[Wain, John] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Hendriksen, Rene S.] Tech Univ Denmark, Natl Food Inst, WHO Collaborating Ctr Antimicrobial Resistance Fo, Kongens Lyngby, Denmark; [Hendriksen, Rene S.] European Union Reference Lab Antimicrobial Resist, Kongens Lyngby, Denmark; [Mikoleit, Matthew L.] Ctr Dis Control & Prevent, Enter Dis Lab Branch, Natl Enter Reference Lab Team, Atlanta, GA USA; [Keddy, Karen H.] Natl Inst Communicable Dis, Div Natl Hlth Lab Serv NHLS, Ctr Enter Dis, Johannesburg, South Africa; [Keddy, Karen H.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Ochiai, R. Leon] Independent Consultant Vaccines, Tokyo, Japan	University of East Anglia; Technical University of Denmark; Centers for Disease Control & Prevention - USA; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Wain, J (corresponding author), Innovat Ctr, Norwich Res Pk, Norwich NR4 7GJ, Norfolk, England.	j.wain@uea.ac.uk	Keddy, Karen Helena/AAZ-2189-2020; Wain, John Richard/B-3446-2013	Keddy, Karen Helena/0000-0001-8640-2235; Ochiai, Leon/0000-0002-5079-6786; Hendriksen, Rene S./0000-0003-2934-8214; Wain, John Richard/0000-0002-1257-1148	MRC [G0600805] Funding Source: UKRI; Medical Research Council [G0600805] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AbdelGhani SMM, 2010, J INFECT DEV COUNTR, V4, P58, DOI 10.3855/jidc.386; Accou-Demartin M, 2011, EMERG INFECT DIS, V17, P1091, DOI [10.3201/eid1706.101242, 10.3201/eid/1706.101242]; Ahmed D, 2006, ANTIMICROB AGENTS CH, V50, P3516, DOI 10.1128/AAC.00667-06; Akinyemi KO, 2012, J INFECT DEV COUNTR, V6, P387, DOI 10.3855/jidc.2120; Al-Sanouri TM, 2008, J INFECT DEV COUNTR, V2, P295; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P49; Baker S, 2005, J CLIN MICROBIOL, V43, P4418, DOI 10.1128/JCM.43.9.4418-4425.2005; Barquist L, 2013, NUCLEIC ACIDS RES, V41, P4549, DOI 10.1093/nar/gkt148; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Bhutta ZA, 1996, ACTA PAEDIATR, V85, P809, DOI 10.1111/j.1651-2227.1996.tb14156.x; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Brooks WA, 2005, EMERG INFECT DIS, V11, P326, DOI 10.3201/eid1102.040422; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; Butler T, 2011, CLIN MICROBIOL INFEC, V17, P959, DOI 10.1111/j.1469-0691.2011.03552.x; Capoor MR, 2007, J MED MICROBIOL, V56, P1490, DOI 10.1099/jmm.0.47353-0; Capoor MR, 2009, J MED MICROBIOL, V58, P337, DOI 10.1099/jmm.0.47853-0; Cardona-Castro NM, 2007, BIOMEDICA, V27, P236, DOI 10.7705/biomedica.v27i2.219; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Chheng K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060634; Chonzi Prosper, 2012, Morbidity and Mortality Weekly Report, V61, P435; Clemens John D, 2009, Emerg Infect Dis, V15, pe2, DOI 10.3201/eid1507.090416; Commons RJ, 2012, MED J AUSTRALIA, V196, P332, DOI 10.5694/mja12.10082; Cooke FJ, 2007, T ROY SOC TROP MED H, V101, P398, DOI 10.1016/j.trstmh.2006.07.005; COOVADIA YM, 1992, S AFR MED J, V81, P280; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; Crump JA, 2011, CLIN INFECT DIS, V52, P341, DOI 10.1093/cid/ciq103; Deen J, 2012, LANCET INFECT DIS, V12, P480, DOI 10.1016/S1473-3099(12)70028-2; DeRoeck D, 2008, EXPERT REV VACCINES, V7, P547, DOI 10.1586/14760584.7.5.547; Diacon AH, 2012, LANCET, V380, P986, DOI 10.1016/S0140-6736(12)61080-0; Dimitrov T, 2010, J CLIN PATHOL, V63, P83, DOI 10.1136/jcp.2009.070664; Dong BQ, 2010, B WORLD HEALTH ORGAN, V88, P689, DOI [10.2471/BLT.09.069310, 10.1590/S0042-96862010000900013]; Dongol S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047342; Drigalski V., 1904, ZBL BAKT, V35, P776; Dutta S, 2006, DIAGN MICR INFEC DIS, V56, P359, DOI 10.1016/j.diagmicrobio.2006.06.024; Engels EA, 2000, COCHRANE DB SYST REV, V2; Feasey NA, 2010, EMERG INFECT DIS, V16, P1448, DOI 10.3201/eid1609.100125; Frean J, 2012, B WORLD HEALTH ORGAN, V90, P191, DOI 10.2471/BLT.11.091876; Gasem MH, 2001, TROP MED INT HEALTH, V6, P484, DOI 10.1046/j.1365-3156.2001.00734.x; Gordon MA, 2011, CURR OPIN INFECT DIS, V24, P484, DOI 10.1097/QCO.0b013e32834a9980; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; House D, 2001, J CLIN MICROBIOL, V39, P1002, DOI 10.1128/JCM.39.3.1002-1007.2001; Hutton G, 2013, J WATER HEALTH, V11, P1, DOI 10.2166/wh.2012.105; Joshi S, 2007, T ROY SOC TROP MED H, V101, P308, DOI 10.1016/j.trstmh.2006.05.009; Kaljee LM, 2013, VACCINE, V31, P2994, DOI 10.1016/j.vaccine.2013.04.058; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Karkey A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002391; Kasper MR, 2010, DIAGN MICR INFEC DIS, V66, P207, DOI 10.1016/j.diagmicrobio.2009.09.002; Kaur J, 2013, J CLIN DIAGN RES, V7, P576, DOI 10.7860/JCDR/2013/4765.2831; Keddy KH, 2011, EPIDEMIOL INFECT, V139, P1239, DOI 10.1017/S0950268810002207; Keddy KH, 2011, B WORLD HEALTH ORGAN, V89, P640, DOI 10.2471/BLT.11.087627; Keddy KH, 2010, EMERG INFECT DIS, V16, P879, DOI 10.3201/eid1605.091917; Khan K. H., 2012, International Journal of Biosciences (IJB), V2, P110; Khan MI, 2012, EPIDEMIOL INFECT, V140, P665, DOI 10.1017/S0950268811000938; Khanam F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002316; KING CC, 1989, INT J EPIDEMIOL, V18, P254, DOI 10.1093/ije/18.1.254; Klugman KP, 1996, VACCINE, V14, P435, DOI 10.1016/0264-410X(95)00186-5; Kovalenko A N, 2011, Voen Med Zh, V332, P33; Kumar Y, 2011, J INFECT DEV COUNTR, V5, P227, DOI 10.3855/jidc.1310; Kumarasamy K, 2012, J ANTIMICROB CHEMOTH, V67, P775, DOI 10.1093/jac/dkr514; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lee CJ, 2013, J MICROBIOL IMMUNOL, V46, P469, DOI 10.1016/j.jmii.2013.01.002; LEVINE MM, 1990, LANCET, V336, P891; Ley B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-147; Lin FYC, 2000, AM J TROP MED HYG, V62, P644, DOI 10.4269/ajtmh.2000.62.644; Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luby SP, 1998, EPIDEMIOL INFECT, V120, P129, DOI 10.1017/S0950268897008558; Lunguya Octavie, 2012, PLoS Negl Trop Dis, V6, pe1921, DOI 10.1371/journal.pntd.0001921; Lutterloh E, 2012, CLIN INFECT DIS, V54, P1100, DOI 10.1093/cid/cis012; Luxemburger C, 2001, T ROY SOC TROP MED H, V95, P19, DOI 10.1016/S0035-9203(01)90318-9; Lynch MF, 2009, JAMA-J AM MED ASSOC, V302, P859, DOI 10.1001/jama.2009.1229; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Martin LB, 2012, CURR OPIN INFECT DIS, V25, P489, DOI 10.1097/QCO.0b013e328356ffeb; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Mermin JH, 1999, J INFECT DIS, V179, P1416, DOI 10.1086/314766; Mirza S, 2000, J CLIN MICROBIOL, V38, P1449, DOI 10.1128/JCM.38.4.1449-1452.2000; Mohammed A, 2012, J INFECT DEV COUNTR, V6, P478, DOI 10.3855/jidc.1805; Morita M, 2010, EPIDEMIOL INFECT, V138, P318, DOI 10.1017/S0950268809990380; Morita M, 2010, ANTIMICROB AGENTS CH, V54, P3991, DOI 10.1128/AAC.00225-10; Mushtaq M. A., 2006, Pakistan Journal of Medical Sciences, V22, P51; Muyembe-Tamfum JJ, 2009, TRAVEL MED INFECT DI, V7, P40, DOI 10.1016/j.tmaid.2008.12.006; Naheed A, 2010, INT J INFECT DIS, V14, pE93, DOI 10.1016/j.ijid.2009.11.023; Neil KP, 2012, CLIN INFECT DIS, V54, P1091, DOI 10.1093/cid/cis025; Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; Owais A, 2010, PEDIATR INFECT DIS J, V29, P1035, DOI 10.1097/INF.0b013e3181e39f8b; Parry CM, 2011, EXPERT REV ANTI-INFE, V9, P711, DOI [10.1586/eri.11.47, 10.1586/ERI.11.47]; Pfeifer Y, 2009, EMERG INFECT DIS, V15, P1533, DOI 10.3201/eid1509.090567; Phan MD, 2009, ANTIMICROB AGENTS CH, V53, P716, DOI 10.1128/AAC.00645-08; Phetsouvanh R, 2006, AM J TROP MED HYG, V75, P978; Pokharel BM, 2006, INT J INFECT DIS, V10, P434, DOI 10.1016/j.ijid.2006.07.001; ProMED, 2013, PROMED, P129; REED RP, 1994, PEDIATR INFECT DIS J, V13, P774, DOI 10.1097/00006454-199409000-00004; Rotimi VO, 2008, J MED MICROBIOL, V57, P881, DOI 10.1099/jmm.0.47509-0; Sabbagh SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036643; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Saha SK, 2006, J CLIN MICROBIOL, V44, P3811, DOI 10.1128/JCM.01197-06; Saha SK, 1999, PEDIATR INFECT DIS J, V18, P387, DOI 10.1097/00006454-199904000-00018; Sheikh A, 2009, CLIN VACCINE IMMUNOL, V16, P1587, DOI 10.1128/CVI.00311-09; Shetty Anup Kumar, 2012, J Lab Physicians, V4, P74, DOI 10.4103/0974-2727.105585; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Smith AM, 2010, EPIDEMIOL INFECT, V138, P86, DOI 10.1017/S0950268809990331; Smith AM, 2011, J MED MICROBIOL, V60, P1405, DOI 10.1099/jmm.0.030700-0; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Song JM, 2010, CELL HOST MICROBE, V8, P369, DOI 10.1016/j.chom.2010.09.003; Starkl M, 2013, ENVIRON SCI TECHNOL, V47, P6102, DOI 10.1021/es3048416; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; Swaddiwudhipong Witaya, 2001, Journal of the Medical Association of Thailand, V84, P1513; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; TACKET CO, 1986, J INFECT DIS, V154, P342, DOI 10.1093/infdis/154.2.342; Tatavarthy A, 2012, J CLIN MICROBIOL, V50, P2631, DOI 10.1128/JCM.00593-12; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051823; Tohme Aline, 2004, J Med Liban, V52, P71; Tran TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011778; Tran VTN, 2012, T ROY SOC TROP MED H, V106, P26, DOI 10.1016/j.trstmh.2011.10.004; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; van Damme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025398; van den Bergh ETAM, 1999, TROP MED INT HEALTH, V4, P211; Velema JP, 1997, TROP MED INT HEALTH, V2, P1088, DOI 10.1046/j.1365-3156.1997.d01-179.x; Vollaard AM, 2004, JAMA-J AM MED ASSOC, V291, P2607, DOI 10.1001/jama.291.21.2607; Thiem VD, 2011, CLIN VACCINE IMMUNOL, V18, P730, DOI 10.1128/CVI.00532-10; WAHDAN MH, 1975, B WORLD HEALTH ORGAN, V52, P69; WAHDAN MH, 1982, J INFECT DIS, V145, P292, DOI 10.1093/infdis/145.3.292; Wain J, 2004, T ROY SOC TROP MED H, V98, P423, DOI 10.1016/j.trstmh.2003.10.015; Wain J, 2003, ANTIMICROB AGENTS CH, V47, P2732, DOI 10.1128/AAC.47.9.2732-2739.2003; Wain J, 1997, CLIN INFECT DIS, V25, P1404, DOI 10.1086/516128; Wain J, 2008, J INFECT DEV COUNTR, V2, P421, DOI 10.3855/jidc.164; Wang JY, 2000, INFECT IMMUN, V68, P4647, DOI 10.1128/IAI.68.8.4647-4652.2000; Wu WY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-32; Yang HH, 2001, B WORLD HEALTH ORGAN, V79, P625; Yang J, 2008, J INFECT DEV COUNTR, V2, P283; Zaki SA, 2011, J INFECT DEV COUNTR, V5, P324, DOI 10.3855/jidc.1405; Zhou WZ, 2007, PEDIATR INFECT DIS J, V26, P1001, DOI 10.1097/INF.0b013e31812565bc	136	194	206	0	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1136	1145		10.1016/S0140-6736(13)62708-7	http://dx.doi.org/10.1016/S0140-6736(13)62708-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25458731				2022-12-28	WOS:000351270400032
J	Ong, MEH; Anantharaman, V				Ong, Marcus Eng Hock; Anantharaman, Venkataraman			Out-of-hospital cardiac arrest: manual or mechanical CPR?	LANCET			English	Editorial Material							CHEST COMPRESSION DEVICE; CARDIOPULMONARY-RESUSCITATION; QUALITY		[Ong, Marcus Eng Hock; Anantharaman, Venkataraman] Singapore Gen Hosp, Dept Emergency Med, Singapore 169608, Singapore; [Ong, Marcus Eng Hock] Duke NUS Grad Med Sch, Hlth Serv & Syst Res, Singapore 169857, Singapore	Singapore General Hospital; National University of Singapore	Ong, MEH (corresponding author), Singapore Gen Hosp, Dept Emergency Med, Singapore 169608, Singapore.	marcus.ong.e.h@sgh.com.sg						Casner Michael, 2005, Prehosp Emerg Care, V9, P61, DOI 10.1080/10903120590891714; Hallstrom A, 2006, JAMA-J AM MED ASSOC, V295, P2620, DOI 10.1001/jama.295.22.2620; Ong MEH, 2006, JAMA-J AM MED ASSOC, V295, P2629, DOI 10.1001/jama.295.22.2629; Ong MEH, 2013, PREHOSP EMERG CARE, V17, P491, DOI 10.3109/10903127.2013.818176; Ong MEH, 2013, RESUSCITATION, V84, P508, DOI 10.1016/j.resuscitation.2012.07.033; Ong MEH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-39; Ong MEH, 2010, ANN EMERG MED, V56, P233, DOI 10.1016/j.annemergmed.2010.01.004; Perkins GD, 2014, LANCET; Rubertsson S, 2014, JAMA-J AM MED ASSOC, V311, P53, DOI 10.1001/jama.2013.282538; Russi CS, 2011, PREHOSP EMERG CARE, V15, P410, DOI 10.3109/10903127.2011.561414; Wang HC, 2007, RESUSCITATION, V74, P453, DOI 10.1016/j.resuscitation.2007.01.018; Wik L, 2014, RESUSCITATION, V85, P741, DOI 10.1016/j.resuscitation.2014.03.005	13	5	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					920	922		10.1016/S0140-6736(14)61941-3	http://dx.doi.org/10.1016/S0140-6736(14)61941-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD2EK	25467563	hybrid			2022-12-28	WOS:000350886900007
J	Yang, M; Li, S; Wang, Y; Herron, JA; Xu, Y; Allard, LF; Lee, S; Huang, J; Mavrikakis, M; Flytzani-Stephanopoulos, M				Yang, Ming; Li, Sha; Wang, Yuan; Herron, Jeffrey A.; Xu, Ye; Allard, Lawrence F.; Lee, Sungsik; Huang, Jun; Mavrikakis, Manos; Flytzani-Stephanopoulos, Maria			Catalytically active Au-O(OH)(x)-species stabilized by alkali ions on zeolites and mesoporous oxides	SCIENCE			English	Article							GAS SHIFT REACTION; PROMOTED ALUMINA CATALYSTS; GOLD NANOPARTICLES; CO OXIDATION; NO REDUCTION; WATER; AU; DECOMPOSITION; ADSORPTION; REACTIVITY	We report that the addition of alkali ions (sodium or potassium) to gold on KLTL-zeolite and mesoporous MCM-41 silica stabilizes mononuclear gold in Au-O(OH)(x)-(Na or K) ensembles. This single-site gold species is active for the low-temperature (<200 degrees C) water-gas shift (WGS) reaction. Unexpectedly, gold is thus similar to platinum in creating -O linkages with more than eight alkali ions and establishing an active site on various supports. The intrinsic activity of the single-site gold species is the same on irreducible supports as on reducible ceria, iron oxide, and titania supports, apparently all sharing a common, similarly structured gold active site. This finding paves the way for using earth-abundant supports to disperse and stabilize precious metal atoms with alkali additives for the WGS and potentially other fuel-processing reactions.	[Yang, Ming; Wang, Yuan; Flytzani-Stephanopoulos, Maria] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA; [Li, Sha; Herron, Jeffrey A.; Mavrikakis, Manos] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Xu, Ye] Louisiana State Univ, Dept Chem Engn, Baton Rouge, LA 70803 USA; [Allard, Lawrence F.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Lee, Sungsik] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Huang, Jun] Univ Sydney, Sch Chem & Biomol Engn, Sydney, NSW 2006, Australia	Tufts University; University of Wisconsin System; University of Wisconsin Madison; Louisiana State University System; Louisiana State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Sydney	Flytzani-Stephanopoulos, M (corresponding author), Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.	maria.flytzani-stephanopoulos@tufts.edu	Xu, Ye/B-5447-2009; Huang, Jun/D-6959-2013; Mavrikakis, Manos/D-5702-2012	Xu, Ye/0000-0002-6406-7832; Mavrikakis, Manos/0000-0002-5293-5356; Lee, Sungsik/0000-0002-1425-9852; Yang, Ming/0000-0002-6321-8854; Huang, Jun/0000-0001-8704-605X	U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES) [DE-FG02-05ER15730]; Center for Nanophase Materials Sciences (CNMS) - Scientific User Facilities Division, DOE-BES; Center for Nanophase Materials Sciences (CNMS) - U.S. DOE Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Office, Propulsion Materials Program; Advanced Photon Source at ANL [DE-AC02-06CH11357]; DOE-BES, Office of Chemical Sciences; Department of Energy's Office of Biological and Environmental Research located at PNNL; U.S. Department of Energy, Office of Science [DE-AC02-06CH11357, DE-AC02-05CH11231]; USyd Early Career Researcher Scheme	U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES)(United States Department of Energy (DOE)); Center for Nanophase Materials Sciences (CNMS) - Scientific User Facilities Division, DOE-BES; Center for Nanophase Materials Sciences (CNMS) - U.S. DOE Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Office, Propulsion Materials Program(United States Department of Energy (DOE)); Advanced Photon Source at ANL; DOE-BES, Office of Chemical Sciences(United States Department of Energy (DOE)); Department of Energy's Office of Biological and Environmental Research located at PNNL(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science(United States Department of Energy (DOE)); USyd Early Career Researcher Scheme	The financial support by the U.S. Department of Energy, Office of Basic Energy Sciences (DOE-BES) under grant DE-FG02-05ER15730 is gratefully acknowledged. M.Y. thanks H. Luo (Massachusetts Institute of Technology) for some of the surface area and pore structure analysis, C. Wang (Tufts University) for acquiring the XRD data, and B. Reinhart [Argonne National Laboratory (ANL)] for assisting with the in situ XAS experiments. Microscopy research was sponsored in part by a user project supported by the Center for Nanophase Materials Sciences (CNMS), which is sponsored at Oak Ridge National Laboratory (ORNL) by the Scientific User Facilities Division, DOE-BES, and by the U.S. DOE Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Office, Propulsion Materials Program. The XAS research is sponsored by the Advanced Photon Source at ANL under contract DE-AC02-06CH11357. Work at the University of Wisconsin-Madison was supported by DOE-BES, Office of Chemical Sciences. Computational work was performed in part with supercomputing resources from the following institutions: Environmental Molecular Sciences Laboratory (EMSL), a national scientific user facility at Pacific Northwest National Laboratory (PNNL); the Center for Nanoscale Materials (CNM) at ANL; the CNMS at ORNL; and the National Energy Research Scientific Computing Center (NERSC). EMSL is sponsored by the Department of Energy's Office of Biological and Environmental Research located at PNNL. CNM and NERSC are supported by the U.S. Department of Energy, Office of Science, under contracts DE-AC02-06CH11357 and DE-AC02-05CH11231, respectively. Work at Sydney was supported by USyd Early Career Researcher Scheme. The authors declare no conflict of interest.	AMENOMIYA Y, 1982, J CATAL, V76, P345, DOI 10.1016/0021-9517(82)90265-2; Deng WL, 2007, TOP CATAL, V44, P199, DOI 10.1007/S11244-007-0293-9; Fierro-Gonzalez JC, 2004, J PHYS CHEM B, V108, P16999, DOI 10.1021/jp046171y; Flytzani-Stephanopoulos M, 2014, ACCOUNTS CHEM RES, V47, P783, DOI 10.1021/ar4001845; Flytzani-Stephanopoulos M, 2012, ANNU REV CHEM BIOMOL, V3, P545, DOI 10.1146/annurev-chembioeng-062011-080939; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Fu Q, 2005, APPL CATAL B-ENVIRON, V56, P57, DOI 10.1016/j.apcatb.2004.07.015; Gluhoi AC, 2006, TOP CATAL, V39, P101, DOI 10.1007/s11244-006-0043-4; Gokhale AA, 2008, J AM CHEM SOC, V130, P1402, DOI 10.1021/ja0768237; Henkelman G, 2006, COMP MATER SCI, V36, P354, DOI 10.1016/j.commatsci.2005.04.010; Huang HH, 1998, LANGMUIR, V14, P7217, DOI 10.1021/la980616q; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRUPAY BW, 1981, J CATAL, V67, P362, DOI 10.1016/0021-9517(81)90296-7; Lessard JD, 2012, CHEM COMMUN, V48, P4857, DOI 10.1039/c2cc31105d; Lu J, 2012, ANGEW CHEM INT EDIT, V51, P5842, DOI 10.1002/anie.201107391; Merte LR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5193; Miller JT, 2006, J CATAL, V240, P222, DOI 10.1016/j.jcat.2006.04.004; Mohamed MM, 2000, J COLLOID INTERF SCI, V232, P381, DOI 10.1006/jcis.2000.7176; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; QIU S, 1992, J CHEM SOC CHEM COMM, P1425, DOI 10.1039/c39920001425; QIU SL, 1994, J PHYS CHEM-US, V98, P2719, DOI 10.1021/j100062a001; Rim KT, 2012, J AM CHEM SOC, V134, P18979, DOI 10.1021/ja305294x; Rim KT, 2009, J PHYS CHEM C, V113, P10198, DOI 10.1021/jp8112599; Rodriguez JA, 2014, ACCOUNTS CHEM RES, V47, P773, DOI 10.1021/ar400182c; Sawyer R, 2012, J NON-CRYST SOLIDS, V358, P290, DOI 10.1016/j.jnoncrysol.2011.09.027; Shekhar M, 2012, J AM CHEM SOC, V134, P4700, DOI 10.1021/ja210083d; Si R, 2008, ANGEW CHEM INT EDIT, V47, P2884, DOI 10.1002/anie.200705828; STORK WHJ, 1974, J PHYS CHEM-US, V78, P2496, DOI 10.1021/j100617a016; Thomas JM, 2011, TOP CATAL, V54, P588, DOI 10.1007/s11244-011-9677-y; Veith GM, 2010, CHEMCATCHEM, V2, P281, DOI 10.1002/cctc.200900243; Yang M, 2013, J AM CHEM SOC, V135, P3768, DOI 10.1021/ja312646d; Zhai Y., 2011, THESIS TUFTS U; Zhai YP, 2010, SCIENCE, V329, P1633, DOI 10.1126/science.1192449; Zugic B, 2014, J AM CHEM SOC, V136, P3238, DOI 10.1021/ja4123889	34	457	459	26	810	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2014	346	6216					1498	1501		10.1126/science.1260526	http://dx.doi.org/10.1126/science.1260526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8UI	25431492	Green Submitted			2022-12-28	WOS:000346536500060
J	Pizer, W; Adler, M; Aldy, J; Anthoff, D; Cropper, M; Gillingham, K; Greenstone, M; Murray, B; Newell, R; Richels, R; Rowell, A; Waldhoff, S; Wiener, J				Pizer, William; Adler, Matthew; Aldy, Joseph; Anthoff, David; Cropper, Maureen; Gillingham, Kenneth; Greenstone, Michael; Murray, Brian; Newell, Richard; Richels, Richard; Rowell, Arden; Waldhoff, Stephanie; Wiener, Jonathan			Using and improving the social cost of carbon	SCIENCE			English	Editorial Material									[Pizer, William; Adler, Matthew; Murray, Brian; Newell, Richard; Wiener, Jonathan] Duke Univ, Durham, NC 27708 USA; [Pizer, William; Aldy, Joseph; Cropper, Maureen; Newell, Richard; Wiener, Jonathan] Resources Future Inc, Washington, DC 20036 USA; [Aldy, Joseph] Harvard Univ, Cambridge, MA 02138 USA; [Anthoff, David] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Cropper, Maureen] Univ Maryland, College Pk, MD 20742 USA; [Gillingham, Kenneth] Yale Univ, New Haven, CT 06511 USA; [Greenstone, Michael] Univ Chicago, Chicago, IL 60637 USA; [Richels, Richard] Elect Power Res Inst, Washington, DC 20036 USA; [Rowell, Arden] Univ Illinois, Champaign, IL 61801 USA; [Waldhoff, Stephanie] Pacific NW Natl Lab, Richland, WA 99354 USA	Duke University; Resources for the Future; Harvard University; University of California System; University of California Berkeley; University System of Maryland; University of Maryland College Park; Yale University; University of Chicago; Electric Power Research Institute (EPRI); University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Pizer, W (corresponding author), Duke Univ, Durham, NC 27708 USA.	william.pizer@duke.edu	Rowell, Kristen/ABE-3721-2020; Newell, Richard G/I-3838-2015	Rowell, Kristen/0000-0003-3112-755X; Newell, Richard G/0000-0002-3205-5562	Directorate For Geosciences [1240507] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Anthoff D, 2013, CLIMATIC CHANGE, V117, P515, DOI 10.1007/s10584-013-0706-7; Arrow K, 2013, SCIENCE, V341, P349, DOI 10.1126/science.1235665; Blanford G, 2014, CLIMATIC CHANGE, V123, P527, DOI 10.1007/s10584-013-0869-2; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Environmental Protection Agency, 2014, FED REGISTER, V79, P34830; Gayer T., 2014, DETERMINING PROPER S; Hope C, 2013, CLIMATIC CHANGE, V117, P531, DOI 10.1007/s10584-012-0633-z; Interagency Working Group on Social Cost of Carbon, 2013, TECHN SUPP DOC SOC C; National Highway Traffic and Safety Administration, 2008, FED REGISTER, V73, P24352; Newbold SC, 2014, J ENVIRON ECON MANAG, V68, P111, DOI 10.1016/j.jeem.2014.01.002; Nordhaus WD, 2010, P NATL ACAD SCI USA, V107, P11721, DOI 10.1073/pnas.1005985107; US Office of Management and Budget, 2003, A4 US OFF MAN BUDG	12	93	95	6	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1189	1190		10.1126/science.1259774	http://dx.doi.org/10.1126/science.1259774			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW3LU	25477446				2022-12-28	WOS:000346189000046
J	Bhatnagar, S; Gazin, C; Chamberlain, L; Ou, JH; Zhu, XC; Tushir, JS; Virbasius, CM; Lin, L; Zhu, LHJ; Wajapeyee, N; Green, MR				Bhatnagar, Sanchita; Gazin, Claude; Chamberlain, Lynn; Ou, Jianhong; Zhu, Xiaochun; Tushir, Jogender S.; Virbasius, Ching-Man; Lin, Ling; Zhu, Lihua J.; Wajapeyee, Narendra; Green, Michael R.			TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein	NATURE			English	Article							POLYCOMB GROUP PROTEINS; CHIP-CHIP DATA; GENE-EXPRESSION; TRANSCRIPTION ACTIVATION; 17Q23 AMPLICON; COMPLEX; CHROMATIN; UBIQUITYLATION; BIOCONDUCTOR; METHYLATION	The TRIM37 (also known as MUL) gene is located in the 17q23 chromosomal region, which is amplified in up to similar to 40% of breast cancers(1). TRIM37 contains a RING finger domain, a hallmark of E3 ubiquitin ligases(2), but its protein substrate(s) is unknown. Here we report that TRIM37 mono-ubiquitinates histone H2A, a chromatin modification associated with transcriptional repression(3). We find that in human breast cancer cell lines containing amplified 17q23, TRIM37 is upregulated and, reciprocally, the major H2A ubiquitin ligase RNF2 (also known as RING1B)(3,4) is downregulated. Genome-wide chromatin immunoprecipitation (ChIP) -chip experiments in 17q23-amplified breast cancer cells identified many genes, including multiple tumour suppressors, whose promoters were bound by TRIM37 and enriched for ubiquitinated H2A. However, unlike RNF2, which is a subunit of polycomb repressive complex 1 (PRC1)(3-5), we find that TRIM37 associates with polycomb repressive complex 2 (PRC2). TRIM37, PRC2 and PRC I are co-bound to specific target genes, resulting in their transcriptional silencing. RNA-interference-mediated knockdown of TRIM37 results in loss of ubiquitinated H2A, dissociation of PRCI and PRC2 from target promoters, and transcriptional reactivation of silenced genes. Knockdown of TRIM37 in human breast cancer cells containing amplified 17q23 substantially decreases tumour growth in mouse xenografts. Conversely, ectopic expression of TRIM37 renders non-transformed cells tumorigenic. Collectively, our results reveal TRIM37 as an oncogenic H2A ubiquitin ligase that is overexpressed in a subset of breast cancers and promotes transformation by facilitating silencing of tumour suppressors and other genes.	[Bhatnagar, Sanchita; Chamberlain, Lynn; Zhu, Xiaochun; Virbasius, Ching-Man; Lin, Ling; Green, Michael R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Bhatnagar, Sanchita; Chamberlain, Lynn; Ou, Jianhong; Zhu, Xiaochun; Virbasius, Ching-Man; Lin, Ling; Zhu, Lihua J.; Green, Michael R.] Univ Massachusetts, Sch Med, Programs Gene Funct & Express & Mol Med, Worcester, MA 01605 USA; [Gazin, Claude] CEA DSV iRCM LEFG, Genopole G2, F-91057 Evry, France; [Gazin, Claude] Univ Paris Diderot, F-91057 Evry, France; [Tushir, Jogender S.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Zhu, Lihua J.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Wajapeyee, Narendra] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; UDICE-French Research Universities; Universite Paris Cite; Boehringer Ingelheim; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	michael.green@umassmed.edu		Zhu, Lihua/0000-0001-7416-0590; Bhatnagar, Sanchita/0000-0002-3588-7874; ou, jianhong/0000-0002-8652-2488	National Lung Cancer Partnership/Uniting Against Lung Cancer; Melanoma Research Alliance; International Association for the Study of Lung Cancer; CEA-DSV; ATIGE Genopole; Centre National de la Recherche Scientifique (CNRS); National Institutes of Health [R01GM033977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033977] Funding Source: NIH RePORTER	National Lung Cancer Partnership/Uniting Against Lung Cancer; Melanoma Research Alliance; International Association for the Study of Lung Cancer; CEA-DSV(French Atomic Energy Commission); ATIGE Genopole; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Peterson for providing Xenopus nucleosomes; R. Weinberg and M. Cristofanilli for providing cell lines; A. Virbasius and the University of Massachusetts Medical School (UMMS) RNAi Core Facility for providing shRNAs; P. Spatrick at the UMMS Genomics Core Facility; the UMMS Proteomics and Mass Spectroscopy Facility for mass spectrometry analysis; and S. Deibler for providing editorial assistance. N.W. is a Sidney Kimmel Scholar for Cancer Research and is supported by young investigator awards from the National Lung Cancer Partnership/Uniting Against Lung Cancer, Melanoma Research Alliance and International Association for the Study of Lung Cancer. This work was also supported by grants from CEA-DSV, ATIGE Genopole and Centre National de la Recherche Scientifique (CNRS) to C.G., and from the National Institutes of Health (R01GM033977) to M.R.G. M.R.G. is an investigator of the Howard Hughes Medical Institute.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Dawson PJ, 1996, AM J PATHOL, V148, P313; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Deb G, 2013, EPIGENETICS-US, V8, P464, DOI 10.4161/epi.24532; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fernandez SV, 2013, BREAST CANCER RES TR, V140, P23, DOI 10.1007/s10549-013-2600-4; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; Luger K, 1999, METH MOL B, V119, P1; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Maston GA, 2012, ELIFE, V1, DOI 10.7554/eLife.00068; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; Orlando DA, 2012, GENOMICS, V100, P320, DOI 10.1016/j.ygeno.2012.07.006; Richly H, 2010, NATURE, V468, P1124, DOI 10.1038/nature09574; Riising EM, 2014, MOL CELL, V55, P347, DOI 10.1016/j.molcel.2014.06.005; Salicru M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-401; Sinclair CS, 2003, BREAST CANCER RES TR, V78, P313, DOI 10.1023/A:1023081624133; Tanese N, 1997, METHODS, V12, P224, DOI 10.1006/meth.1997.0475; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2000, GENE DEV, V14, P927; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Zacher B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-194; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	42	121	139	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					116	U313		10.1038/nature13955	http://dx.doi.org/10.1038/nature13955			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470042	Green Accepted			2022-12-28	WOS:000346310800051
J	Freund, A; Zhong, FL; Venteicher, AS; Meng, ZJ; Veenstra, TD; Frydman, J; Artandi, SE				Freund, Adam; Zhong, Franklin L.; Venteicher, Andrew S.; Meng, Zhaojing; Veenstra, Timothy D.; Frydman, Judith; Artandi, Steven E.			Proteostatic Control of Telomerase Function through TRiC-Mediated Folding of TCAB1	CELL			English	Article							TERT PROMOTER MUTATIONS; DYSKERATOSIS-CONGENITA; CYTOSOLIC CHAPERONIN; CAJAL BODIES; MOLECULAR CHAPERONES; CELLS; RNA; RECRUITMENT; HOLOENZYME; PROTEINS	Telomere maintenance by telomerase is impaired in the stem cell disease dyskeratosis congenita and during human aging. Telomerase depends upon a complex pathway for enzyme assembly, localization in Cajal bodies, and association with telomeres. Here, we identify the chaperonin CCT/TRiC as a critical regulator of telomerase trafficking using a high-content genome-wide siRNA screen in human cells for factors required for Cajal body localization. We find that TRiC is required for folding the telomerase cofactor TCAB1, which controls trafficking of telomerase and small Cajal body RNAs (scaRNAs). Depletion of TRiC causes loss of TCAB1 protein, mislocalization of telomerase and scaRNAs to nucleoli, and failure of telomere elongation. DC patient-derived mutations in TCAB1 impair folding by TRiC, disrupting telomerase function and leading to severe disease. Our findings establish a critical role for TRiC-mediated protein folding in the telomerase pathway and link proteostasis, telomere maintenance, and human disease.	[Freund, Adam; Venteicher, Andrew S.; Artandi, Steven E.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Zhong, Franklin L.; Artandi, Steven E.] Stanford Univ, Canc Biol Program, Sch Med, Stanford, CA 94305 USA; [Meng, Zhaojing; Veenstra, Timothy D.] Sci Applicat Int Corp Frederick, Natl Canc Inst Frederick, Lab Prote & Analyt Technol, Frederick, MD 21702 USA; [Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Artandi, Steven E.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Stanford University; Stanford University	Artandi, SE (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Venteicher, Andrew/AAN-5666-2021	Venteicher, Andrew/0000-0003-0643-0493; Zhong, Franklin/0000-0002-0516-6021; , judith/0000-0003-2302-6943	NIH NCRR Instrumentation grant [S10RR026338]; Stanford Cancer Biology Training Program [T32 CA09302]; Jane Coffin Childs Memorial Fund for Medical Research; Agency for Science, Technology, and Research (A*STAR), Singapore; NIH [AG033747, CA125453, CA111691, AG036695]; Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE [R01CA125453, T32CA009302, R01CA111691] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695, R56AG033747, R01AG033747] Funding Source: NIH RePORTER	NIH NCRR Instrumentation grant; Stanford Cancer Biology Training Program; Jane Coffin Childs Memorial Fund for Medical Research; Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Artandi and Frydman labs for helpful discussions and advice. We thank David Solow-Cordero in the Stanford High-Throughput Bioscience Center, with support from NIH NCRR Instrumentation grant S10RR026338. We are grateful to Anthony Tomlinson for generously providing purified bovine TRiC and to Sharon Savage for supplying DC patient lymphoblasts. A.F. was supported by Stanford Cancer Biology Training Program (T32 CA09302) and by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research. F.L.Z. was supported by a fellowship from the Agency for Science, Technology, and Research (A*STAR), Singapore. This work was supported by NIH grants AG033747, CA125453, CA111691, and AG036695 and by the Glenn Foundation for Medical Research.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Batista LFZ, 2013, CURR OPIN GENET DEV, V23, P526, DOI 10.1016/j.gde.2013.07.006; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Diolaiti ME, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt689; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kubota H, 1997, FEBS LETT, V402, P53, DOI 10.1016/S0014-5793(96)01501-3; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pfeiffer V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010405; Rashid R, 2006, MOL CELL, V21, P249, DOI 10.1016/j.molcel.2005.11.017; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Stern JL, 2012, MOL CELL BIOL, V32, P2384, DOI 10.1128/MCB.00379-12; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Zaug AJ, 2013, NUCLEIC ACIDS RES, V41, P8969, DOI 10.1093/nar/gkt653; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	49	79	81	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1389	1403		10.1016/j.cell.2014.10.059	http://dx.doi.org/10.1016/j.cell.2014.10.059			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25467444	Green Accepted, Bronze			2022-12-28	WOS:000346652900017
J	Liu, TY; Kim, CJ				Liu, Tingyi Leo; Kim, Chang-Jin CJ			Turning a surface superrepellent even to completely wetting liquids	SCIENCE			English	Article							CONTACT-ANGLE; SUPEROLEOPHOBIC SURFACES; TRANSPARENT; WETTABILITY	Superhydrophobic and superoleophobic surfaces have so far been made by roughening a hydrophobic material. However, no surfaces were able to repel extremely-low-energy liquids such as fluorinated solvents, which completely wet even the most hydrophobic material. We show how roughness alone, if made of a specific doubly reentrant structure that enables very low liquid-solid contact fraction, can render the surface of any material superrepellent. Starting from a completely wettable material (silica), we micro-and nanostructure its surface to make it superomniphobic and bounce off all available liquids, including perfluorohexane. The same superomniphobicity is further confirmed with identical surfaces of a metal and a polymer. Free of any hydrophobic coating, the superomniphobic silica surface also withstands temperatures over 1000 degrees C and resists biofouling.	[Liu, Tingyi Leo; Kim, Chang-Jin CJ] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA; [Kim, Chang-Jin CJ] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kim, CJ (corresponding author), Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA.	cjkim@ucla.edu	Kim, Chang-Jin/F-6730-2011; Liu, Tingyi/AAB-8492-2020; Liu, Tingyi/O-8127-2014	Kim, Chang-Jin/0000-0002-4600-9962; Liu, Tingyi/0000-0002-8928-1560				Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Betz AR, 2013, INT J HEAT MASS TRAN, V57, P733, DOI 10.1016/j.ijheatmasstransfer.2012.10.080; Brutin D, 2009, MICROGRAVITY SCI TEC, V21, P67, DOI 10.1007/s12217-009-9132-x; Carey V.P., 1992, LIQUID VAPOR PHASE C; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; Choi CH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.066001; Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115; Dufour R, 2010, LANGMUIR, V26, P17242, DOI 10.1021/la103462z; Feng L, 2008, LANGMUIR, V24, P4114, DOI 10.1021/la703821h; Grigoryev A, 2012, J AM CHEM SOC, V134, P12916, DOI 10.1021/ja305348n; Hensel R, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2012.66; Hensel R, 2013, LANGMUIR, V29, P1100, DOI 10.1021/la304179b; Janssen D, 2006, THIN SOLID FILMS, V515, P1433, DOI 10.1016/j.tsf.2006.04.006; Kim C.-J., 1985, THESIS IOWA STATE U; Kota AK, 2012, ADV MATER, V24, P5838, DOI 10.1002/adma.201202554; Lee C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.014502; Liu T., 2013, P INT C SOL STAT SEN; Ma Y, 2007, POLYMER, V48, P7455, DOI 10.1016/j.polymer.2007.10.038; MARTO PJ, 1966, J HEAT TRANSF, V88, P196, DOI 10.1115/1.3691514; Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o; Quere D, 2005, REP PROG PHYS, V68, P2495, DOI 10.1088/0034-4885/68/11/R01; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Tuteja A, 2008, P NATL ACAD SCI USA, V105, P18200, DOI 10.1073/pnas.0804872105; Urata C, 2013, LANGMUIR, V29, P12472, DOI 10.1021/la402714s; Webb R.L., 2007, HEAT TRANSF ENG, V2, P46, DOI [10.1080/01457638108962760, DOI 10.1080/01457638108962760]; Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447	26	711	735	69	1181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1096	1100		10.1126/science.1254787	http://dx.doi.org/10.1126/science.1254787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430765	Green Submitted			2022-12-28	WOS:000345763400038
J	Klass, P				Klass, Perri			Illness Not as Metaphor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, New York, NY 10012 USA	New York University	Klass, P (corresponding author), NYU, New York, NY 10012 USA.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2057	2059		10.1056/NEJMp1410399	http://dx.doi.org/10.1056/NEJMp1410399			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25427111				2022-12-28	WOS:000345580000004
J	Savage, N				Savage, Neil			Stretching time	NATURE			English	Editorial Material																		Hacker MR, 2001, HAEMOPHILIA, V7, P392, DOI 10.1046/j.1365-2516.2001.00534.x; Webster R, 2007, DRUG METAB DISPOS, V35, P9, DOI 10.1124/dmd.106.012419	2	2	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S162	S164		10.1038/515S162a	http://dx.doi.org/10.1038/515S162a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427206	Bronze			2022-12-28	WOS:000346247600008
J	Olin, JT; Wechsler, ME				Olin, J. Tod; Wechsler, Michael E.			Asthma: pathogenesis and novel drugs for treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Review							EXHALED NITRIC-OXIDE; AIRWAY SMOOTH-MUSCLE; STEP-UP THERAPY; INHALED CORTICOSTEROIDS; INTERFERON-GAMMA; CHILDHOOD ASTHMA; DNA METHYLATION; MESSENGER-RNA; BONE-MARROW; T-CELLS	Asthma affects almost 20 million people in the United States and more than 300 million people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly available drugs. New drugs are needed because those that are currently available cannot control symptoms and exacerbations in all patients and can cause adverse reactions. In the past 10 years, there have been substantial advances in the understanding of asthma genetics, airway biology, and immune cell signaling. These advances have led to the development of small molecule therapeutics and biologic agents that may improve asthma care in tie future. Several new classes of asthma drugs including ultra long acting beta agonists and modulators of the interleukin 4 (IL-4), IL-5, IL-13, and IL-17 pathways have been evaluated in randomized controlled trials. Other new drug classes including dissociated corticosteroids, CXC chemokine receptor 2 antagonists, toll-like receptor 9 agonists, and tyrosine kinase inhibitors remain in earlier phases of development. Despite some preliminary efficacy data, there is insufficient evidence to make strong recommendations about the use of these newer agents. Future research on the clinical efficacy of these biologic agents, tie effect of newer agents on severe asthma in pediatric patients, and the biology of non-eosinophilic and corticosteroid resistant asthma is needed to reduce the morbidity of asthma worldwide.	[Olin, J. Tod] Natl Jewish Hlth, Dept Pediat, Pediat Exercise Tolerance Ctr, Denver, CO USA; [Wechsler, Michael E.] Natl Jewish Hlth, Dept Med, Asthma Program, Denver, CO 80206 USA	National Jewish Health; National Jewish Health	Wechsler, ME (corresponding author), Natl Jewish Hlth, Dept Med, Asthma Program, Denver, CO 80206 USA.	wechslerm@njhealth.org	Wechsler, Michael/AAC-5506-2019					Adamko DJ, 2012, CHEST, V141, P1295, DOI 10.1378/chest.11-2028; Agache I, 2010, RESP MED, V104, P1131, DOI 10.1016/j.rmed.2010.02.018; Akinbami Lara J, 2012, NCHS Data Brief, P1; [Anonymous], 2014, GLOB STRAT ASTHM MAN; Asher MI, 1998, EUR RESPIR J, V12, P315; Bacharier LB, 1998, INT ARCH ALLERGY IMM, V115, P257, DOI 10.1159/000069456; Barnes Peter J, 2009, Lancet, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barnes PJ, 2012, SEMIN RESP CRIT CARE, V33, P685, DOI 10.1055/s-0032-1326965; Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Beeh KM, 2013, J ALLERGY CLIN IMMUN, V131, P866, DOI 10.1016/j.jaci.2012.12.1561; Bonilla S, 2005, J PEDIATR-US, V147, P802, DOI 10.1016/j.jpeds.2005.06.041; Borish LC, 2001, J ALLERGY CLIN IMMUN, V107, P963, DOI 10.1067/mai.2001.115624; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; BOSLEY CM, 1994, EUR RESPIR J, V7, P504, DOI 10.1183/09031936.94.07030504; Bossley CJ, 2012, J ALLERGY CLIN IMMUN, V129, P974, DOI 10.1016/j.jaci.2012.01.059; Bradding P, 2003, CURR OPIN ALLERGY CL, V3, P45, DOI 10.1097/01.all.0000053267.39029.fd; Brand S, 2012, J ALLERGY CLIN IMMUN, V129, P1602, DOI 10.1016/j.jaci.2011.12.963; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Burch J, 2012, PHARMACOECONOMICS, V30, P991, DOI 10.2165/11597160-000000000-00000; BURD PR, 1995, J EXP MED, V181, P1373, DOI 10.1084/jem.181.4.1373; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P1237, DOI 10.1016/j.jaci.2010.04.005; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Carolan BJ, 2013, J ALLERGY CLIN IMMUN, V131, P627, DOI 10.1016/j.jaci.2013.01.010; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Chang C, 2012, CARBOHYDRATES COMPRE; Chang TS, 2014, J ALLERGY CLIN IMMUN, V133, P363, DOI 10.1016/j.jaci.2013.09.002; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Clark NA, 2010, ENVIRON HEALTH PERSP, V118, P284, DOI 10.1289/ehp.0900916; Cohen P, 2000, AM J PHYSIOL-LUNG C, V278, pL545, DOI 10.1152/ajplung.2000.278.3.L545; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; COX G, 1995, J IMMUNOL, V154, P4719; Cox G, 2007, NEW ENGL J MED, V356, P1327, DOI 10.1056/NEJMoa064707; Cox PG, 2004, EUR RESPIR J, V24, P659, DOI 10.1183/09031936.04.00054604; Custovic A, 2011, J ALLERGY CLIN IMMUN, V127; Doeing DC, 2013, J APPL PHYSIOL, V114, P834, DOI 10.1152/japplphysiol.00950.2012; DUBUCQUOI S, 1994, J EXP MED, V179, P703, DOI 10.1084/jem.179.2.703; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Erjefalt JS, 1997, THORAX, V52, P1010, DOI 10.1136/thx.52.11.1010; Erkkola M, 2012, PEDIAT ALLERG IMM-UK, V23, P186, DOI 10.1111/j.1399-3038.2012.01272.x; Fish SC, 2005, J IMMUNOL, V174, P7716, DOI 10.4049/jimmunol.174.12.7716; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, DOI DOI 10.1016/LJACI.2010.11.015; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Gauvreau GM, 2009, CLIN EXP ALLERGY, V39, P1297, DOI 10.1111/j.1365-2222.2009.03325.x; Gauvreau GM, 2008, AM J RESP CRIT CARE, V177, P952, DOI 10.1164/rccm.200708-1251OC; Gelb AF, 2000, AM J RESP CRIT CARE, V162, P1778, DOI 10.1164/ajrccm.162.5.2001037; Gizycki MJ, 1997, AM J RESP CELL MOL, V16, P664, DOI 10.1165/ajrcmb.16.6.9191468; Goebeler M, 1997, IMMUNOLOGY, V91, P450, DOI 10.1046/j.1365-2567.1997.00263.x; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Guntur VP, 2012, CURR OPIN ALLERGY CL, V12, P68, DOI 10.1097/ACI.0b013e32834ecb4f; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; HAMID Q, 1991, J CLIN INVEST, V87, P1541, DOI 10.1172/JCI115166; Hammad H, 2007, ADV IMMUNOL, V93, P265, DOI 10.1016/S0065-2776(06)93007-7; Hanania NA, 2013, AM J RESP CRIT CARE, V187, P804, DOI 10.1164/rccm.201208-1414OC; HER E, 1991, J CLIN INVEST, V88, P1982, DOI 10.1172/JCI115524; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Hirst SJ, 1996, AM J PHYSIOL-LUNG C, V270, pL415, DOI 10.1152/ajplung.1996.270.3.L415; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Holz O, 2010, EUR RESPIR J, V35, P564, DOI 10.1183/09031936.00048509; HUANG SK, 1995, J IMMUNOL, V155, P2688; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Johansson AK, 2004, EUR J IMMUNOL, V34, P3135, DOI 10.1002/eji.200425043; Joos S, 2008, THORAX, V63, P453, DOI 10.1136/thx.2007.081596; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kallal LE, 2010, EUR J IMMUNOL, V40, P1042, DOI 10.1002/eji.200939778; Kato T, 1995, NAT IMMUN, V14, P198; Kausel L, 2013, SCI WORLD J, DOI 10.1155/2013/937935; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606; Kita H, 2013, INT ARCH ALLERGY IMM, V161, P3, DOI 10.1159/000350662; Kroegel C, 1996, EUR RESPIR J, V9, P899, DOI 10.1183/09031936.96.09050899; LaForce C, 2009, CURR MED RES OPIN, V25, P2353, DOI 10.1185/03007990903143143; Lai CKW, 1996, J ALLERGY CLIN IMMUN, V97, P1320, DOI 10.1016/S0091-6749(96)70201-4; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Laviolette M, 2013, J ALLERGY CLIN IMMUN, V132; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Li HM, 1996, J IMMUNOL, V156, P4833; Li-Weber M, 2003, NAT REV IMMUNOL, V3, P534, DOI 10.1038/nri1128; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; Lloyd CM, 2013, J ALLERGY CLIN IMMUN, V131, P1267, DOI 10.1016/j.jaci.2013.02.016; Maazi H, 2013, ALLERGY, V68, P695, DOI 10.1111/all.12166; Martinez FD, 2011, J ALLERGY CLIN IMMUN, V128, P939, DOI 10.1016/j.jaci.2011.09.020; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; MONTEFORT S, 1993, RESP MED, V87, P9, DOI 10.1016/0954-6111(93)90118-J; Morishima Y, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/609395; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Nicolai T, 2003, EUR RESPIR J, V21, P956, DOI 10.1183/09031936.03.00041103a; Normansell R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003559.pub4; Nutku E, 2003, BLOOD, V101, P5014, DOI 10.1182/blood-2002-10-3058; Nwaru BI, 2013, J ALLERGY CLIN IMMUN, V131, P78, DOI 10.1016/j.jaci.2012.10.028; O'Hehir RE, 2009, AM J RESP CRIT CARE, V180, P936, DOI 10.1164/rccm.200905-0686OC; Ochiai K, 1997, CLIN EXP IMMUNOL, V107, P198, DOI 10.1046/j.1365-2249.1997.d01-884.x; Oh CK, 2010, EUR RESPIR REV, V19, P46, DOI 10.1183/09059180.00007609; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Otero K, 2010, BLOOD, V116, P2942, DOI 10.1182/blood-2009-12-259903; Partridge Martyn R, 2006, BMC Pulm Med, V6, P13, DOI 10.1186/1471-2466-6-13; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Pearlman DS, 2008, ANN ALLERG ASTHMA IM, V101, P90, DOI 10.1016/S1081-1206(10)60840-X; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Perez-de-Llano LA, 2010, EUR RESPIR J, V35, P1221, DOI 10.1183/09031936.00118809; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Philip G, 2009, J ALLERGY CLIN IMMUN, V124, p[699, e8]; Philip G, 2009, J ALLERGY CLIN IMMUN, V124, p[691, e6]; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Pichavant M, 2005, J ALLERGY CLIN IMMUN, V115, P771, DOI 10.1016/j.jaci.2004.11.043; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Rabe KF, 2000, EUR RESPIR J, V16, P802, DOI 10.1183/09031936.00.16580200; Reber L, 2006, EUR J PHARMACOL, V533, P327, DOI 10.1016/j.ejphar.2005.12.067; Reber LL, 2012, J IMMUNOL, V188, P3478, DOI 10.4049/jimmunol.1004227; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Saglani S, 2013, J ALLERGY CLIN IMMUN, V132, P676, DOI 10.1016/j.jaci.2013.04.012; Sakuishi K, 2007, J IMMUNOL, V179, P3452, DOI 10.4049/jimmunol.179.6.3452; Salazar F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00356; Schmid-Grendelmeier P, 2002, J IMMUNOL, V169, P1021, DOI 10.4049/jimmunol.169.2.1021; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sehmi R, 1997, J CLIN INVEST, V100, P2466, DOI 10.1172/JCI119789; Serra-Batlles J, 1998, EUR RESPIR J, V12, P1322, DOI 10.1183/09031936.98.12061322; Shaw DE, 2007, AM J RESP CRIT CARE, V176, P231, DOI 10.1164/rccm.200610-1427OC; Silverstein MD, 2001, J PEDIATR-US, V139, P278, DOI 10.1067/mpd.2001.115573; Sitkauskiene B, 2004, AM J RESP CELL MOL, V30, P367, DOI 10.1165/rcmb.2002-0311OC; Slager RE, 2012, J ALLERGY CLIN IMMUN, V130, P516, DOI 10.1016/j.jaci.2012.03.030; Sonnappa S, 2011, EUR RESPIR J, V38, P1431, DOI 10.1183/09031936.00164910; Strachan DP, 1998, THORAX, V53, P204, DOI 10.1136/thx.53.3.204; Suissa S, 2001, J ALLERGY CLIN IMMUN, V107, P937, DOI 10.1067/mai.2001.115653; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Sullivan PW, 2011, J ALLERGY CLIN IMMUN, V127, P363, DOI 10.1016/j.jaci.2010.10.042; Szabo Shelagh M, 2013, Paediatr Respir Rev, V13 Suppl 2, pS9, DOI 10.1016/S1526-0542(12)70161-6; Tyner JW, 2006, J CLIN INVEST, V116, P309, DOI 10.1172/JCI25167; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Warner SM, 2008, CURR OPIN ALLERGY CL, V8, P44, DOI 10.1097/ACI.0b013e3282f3b5cb; Wechsler ME, 2013, J ALLERGY CLIN IMMUN, V132, P1295, DOI 10.1016/j.jaci.2013.08.009; Wechsler ME, 2009, LANCET, V374, P1754, DOI 10.1016/S0140-6736(09)61492-6; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wenzel SE, 2007, J ALLERGY CLIN IMMUN, V119, P14, DOI 10.1016/j.jaci.2006.10.025; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Woodcock A, 2013, CHEST, V144, P1222, DOI 10.1378/chest.13-0178; World Health Organization, 2007, GLOB SURV PREV CONTR; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; YING S, 1995, AM J RESP CELL MOL, V12, P477, DOI 10.1165/ajrcmb.12.5.7742012; Zahran Hatice S., 2011, Morbidity and Mortality Weekly Report, V60, P547; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133; Zimmermann N, 2008, ALLERGY, V63, P1156, DOI 10.1111/j.1398-9995.2008.01709.x; Zimmermann N, 2003, J ALLERGY CLIN IMMUN, V111, P227, DOI 10.1067/mai.2003.139	172	160	169	1	45	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2014	349								g5517	10.1136/bmj.g5517	http://dx.doi.org/10.1136/bmj.g5517			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KC	25420994				2022-12-28	WOS:000346115400001
J	Inglis, L				Inglis, Lucy			The art of medicine Elsie Inglis, the suff ragette physician	LANCET			English	Editorial Material																		Balfour F., 1919, DR ELSIE INGLIS; Leneman L., 2004, ELSIE MAUD 1864 1917; Leneman Leah, 1998, ELSIE INGLIS FOUNDER; Shaw McLaren E., 1920, ELSIE LNGLIS THE WOM	4	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1664	1665		10.1016/S0140-6736(14)62022-5	http://dx.doi.org/10.1016/S0140-6736(14)62022-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KU	25473677				2022-12-28	WOS:000345116200016
J	Shanks, GD				Shanks, G. Dennis			Legacy of the 1914-18 war 1 How World War 1 changed global attitudes to war and infectious diseases	LANCET			English	Article							PANDEMIC INFLUENZA; PURULENT BRONCHITIS; UNITED-STATES; EPIDEMIC; TETANUS; INOCULATION; MORTALITY; DEATHS; VIRUS; BASE	World War 1 was a key transition point towards scientific medicine. Medical officers incorporated Louis Pasteur's discoveries into their understanding of microorganisms as the cause of infectious diseases, which were therefore susceptible to rational control and treatment measures even in the pre-antibiotic era. Typhoid vaccination led to the successful evasion of the disastrous epidemics of previous wars. The incidence of tetanus was probably decreased by giving millions of doses of horse antitoxin to wounded soldiers. Quinine treated but could not control malaria; its use required mass compulsion. Tuberculosis was not a great military problem during World War 1, although mortality in civilian populations increased substantially. Treatment of sexually transmitted infections remained a matter of aversive conditioning, with invasive antiseptics used in the absence of antibiotics. Pandemic influenza in 1918-19 killed more people than died during the entire war, showing how much remained beyond the capability of the scientists and doctors who fought infectious diseases during World War 1.	[Shanks, G. Dennis] Australian Army Malaria Inst, Enoggera, Qld 4051, Australia; [Shanks, G. Dennis] Univ Queensland, Sch Populat Hlth, Ctr Australian Mil & Vet Hlth, Brisbane, Qld, Australia; [Shanks, G. Dennis] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	QIMR Berghofer Medical Research Institute; University of Queensland; University of Oxford	Shanks, GD (corresponding author), Australian Army Malaria Inst, Enoggera, Qld 4051, Australia.	dennis.shanks@defence.gov.au			Australian Defence Force; Global Emerging Infections Surveillance and Response System (GEIS) at the Armed Forces Health Surveillance Center of the US Department of Defense	Australian Defence Force; Global Emerging Infections Surveillance and Response System (GEIS) at the Armed Forces Health Surveillance Center of the US Department of Defense	The Australian Defence Force and the Global Emerging Infections Surveillance and Response System (GEIS) at the Armed Forces Health Surveillance Center of the US Department of Defense provided support for this project. I thank Peter Dennis at the University of New South Wales for assistance with military history, Ian Howie-Willis for commenting on an early version of the paper, and Odette Hopwood and other medical librarians at Australian Defence Force Library Services, Gallipoli Barracks, for help in locating references. The opinions expressed are my own, and do not necessarily reflect those of the Australian Defence Force or the US Department of Defense.	Abrahams A, 1919, LANCET, V1, P1; Abrahams A, 1917, LANCET, V2, P377; Adami J, 1923, MED SERVICES PATHOLO, P413; Adami J, 1923, MED SERVICES PATHOLO, P467; Angus W, 1919, REPORT MALARIA EGYPT; [Anonymous], 1919, LANCET, V193, P1125; ARKWRIGHT Joseph A., 1918, Transactions of the Royal Society of Tropical Medicine and Hygiene, V11, P127, DOI 10.1016/S0035-9203(18)90002-7; Bahr PM, 1920, LANCET, V1, P79; Bazy L, 1918, LANCET, V2, P523; Biggs H, 1928, MED DEP US ARMY WORL, P171; Blair, 2001, ARDUIS FIDELIS CENTE; Bruce D, 1916, LANCET, V2, P929; Bruce D, 1915, LANCET, V186, P901; Bruce D, 1917, LANCET, V189, P986; Bruce D, 1919, LANCET, V193, P331; Bruce D, 1917, T R SOC TROP MED HYG, V11, P1; Bruce D, 1920, PREVENTION TETANUS G, P1914; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Burke FS, 1939, CAN MED ASSOC J, V41, P457; BUSHNELL G, 1920, STUDY EPIDEMIOLOGY T; Bushnell G E, 1921, Trans Am Climatol Clin Assoc, V37, P147; Butler A, 1943, AUSTR ARMY MED SERVI, P148; Byerly Carol R, 2005, FEVER WAR INFLUENZA; Cole CEC, 1918, BRIT MED J, V1918, P566, DOI 10.1136/bmj.2.3021.566; Crosby AW, 2003, AMERICAS FORGOTTEN P, V2nd; Cummins S, 1918, STUDIES INFLUENZA HO; Cummins S, 1923, MED SERVICES PATHOLO, P164; Dreyer G, 1918, LANCET, V1, P498; DROLET GJ, 1945, AM J PUBLIC HEALTH, V35, P689, DOI 10.2105/AJPH.35.7.689; Eyre JWH, 1919, LANCET, V1, P553; FAIRLEY N. H., 1920, Transactions of the Royal Society of Tropical Medicine and Hygiene, V13, P121, DOI 10.1016/S0035-9203(20)90169-4; Feachem RGA, 2010, LANCET, V376, P1517, DOI 10.1016/S0140-6736(10)61500-0; FINDLAY GM, 1949, ANN TROP MED PARASIT, V43, P140, DOI 10.1080/00034983.1949.11685400; Gibson HG, 1918, BRIT MED J, V1918, P645, DOI 10.1136/bmj.2.3024.645; Golla F, 1917, LANCET, V2, P966; Gorgas William Crawford, 1918, SANITATION PANAMA; Greenwood M, 1917, LANCET, V1, P687; Gullett HS, 1923, AUSTR IMPERIAL FORCE; Hammond JAB, 1917, LANCET, V2, P41; Harries EHR, 1916, LANCET, V2, P939; Harrison L, 1922, MED SERVICES DIS WAR, P118; Hutchinson Woods., 1918, DOCTOR WAR; Ireland M, 1920, REPORT SURG GEN; James R., 1994, HENRY WELLCOME; Leishman W, 1923, MED SERVICES PATHOLO, P211; Leishman W, 1917, LANCET, V189, P131; Leishman WB, 1920, LANCET, V1, P366; Long ER., 1955, TUBERCULOSIS ARMY US; Macdonald L, 1989, ROSES NO MANS LAND; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Martin CJ, 1918, BRIT MED J, V1918, P281; McGrigor H, 1916, T R SOC TROP MED HYG, V9, P161; Medina RA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1026; Mitchell T. J., 1931, MED SERVICES CASUALT; Mitchie H, 1928, MED DEP US ARMY WORL, P263; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Osler W, 1916, LANCET, V2, P220; Osler W, 1917, LANCET, V1, P787; Oxford JS, 2002, LANCET INFECT DIS, V2, P111, DOI 10.1016/S1473-3099(02)00185-8; Poser Charles M., 1999, ILLUSTRATED HIST MAL; Reed W, 1900, ORIGIN SPREAD TYPHOI; Ross R, 1920, LANCET, V1, P60; Ross Ronald, 1919, OBSERVATIONS MALARIA; SEWELL E. P., 1920, Journal of the Royal Army Medical Corps, V34, P204; Shanks GD, 2013, EPIDEMIOL INFECT, V141, P2205, DOI 10.1017/S0950268812003032; Shanks GD, 2012, EMERG INFECT DIS, V18, P201, DOI 10.3201/eid1802.102042; Shanks GD, 2011, LANCET INFECT DIS, V11, P793, DOI 10.1016/S1473-3099(11)70151-7; Shanks GD, 2011, INFLUENZA OTHER RESP, V5, P213, DOI 10.1111/j.1750-2659.2010.00195.x; Shanks GD, 2010, J INFECT DIS, V201, P1880, DOI 10.1086/652868; Siler Joseph F., 1928, MED DEP US ARMY WORL, VIX, P15; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Taubenberger JK, 2007, ANTIVIR THER, V12, P581; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Torrens Andrewes F, 1923, MED SERVICES PATHOLO, P188; Torrens J., 1922, MEDICAL SERVICES DIS, P11; Treadgold C H, 1918, Br Med J, V1, P525; van Panhuis WG, 2013, NEW ENGL J MED, V369, P2152, DOI 10.1056/NEJMms1215400; Vaughan VC, 1919, J LAB CLIN MED, V4, P647; Vaughan VC., 1926, DOCTORS MEMORIES; Wenyon C, 1922, MED SERVICES DIS WAR, P227; Wenyon C, 1923, MED SERVICES HYGIENE, P188; Wenyon C. M., 1921, Journal of the Royal Army Medical Corps, V37, P83; Woodcock H. M., 1920, Journal of the Royal Army Medical Corps London, V34; Wright A E, 1897, Br Med J, V1, P256	85	21	22	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1699	1707		10.1016/S0140-6736(14)61786-4	http://dx.doi.org/10.1016/S0140-6736(14)61786-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KU	25441200				2022-12-28	WOS:000345116200033
J	Agrawal, N; Akbani, R; Aksoy, BA; Ally, A; Arachchi, H; Asa, SL; Auman, JT; Balasundaram, M; Balu, S; Baylin, SB; Behera, M; Bernard, B; Beroukhim, R; Bishop, JA; Black, AD; Bodenheimer, T; Boice, L; Bootwalla, MS; Bowen, J; Bowlby, R; Bristow, CA; Brookens, R; Brooks, D; Bryant, R; Buda, E; Butterfield, YSN; Carling, T; Carlsen, R; Carter, SL; Carty, SE; Chan, TA; Chen, AY; Cherniack, AD; Cheung, D; Chin, L; Cho, J; Chu, A; Chuah, E; Cibulskis, K; Ciriello, G; Clarke, A; Clayman, GL; Cope, L; Copland, JA; Covington, K; Danilova, L; Davidsen, T; Demchok, JA; DiCara, D; Dhalla, N; Dhir, R; Dookran, SS; Dresdner, G; Eldridge, J; Eley, G; El-Naggar, AK; Eng, S; Fagin, JA; Fennell, T; Ferris, RL; Fisher, S; Frazer, S; Frick, J; Gabriel, SB; Ganly, I; Gao, JJ; Garraway, LA; Gastier-Foster, JM; Getz, G; Gehlenborg, N; Ghossein, R; Gibbs, RA; Giordano, TJ; Gomez-Hernandez, K; Grimsby, J; Gross, B; Guin, R; Hadjipanayis, A; Harper, HA; Hayes, DN; Heiman, DI; Herman, JG; Hoadley, KA; Hofree, M; Holt, RA; Hoyle, AP; Huang, FW; Huang, M; Hutter, CM; Ideker, T; Iype, L; Jacobsen, A; Jefferys, SR; Jones, CD; Jones, SJM; Kasaian, K; Kebebew, E; Khuri, FR; Kim, J; Kramer, R; Kreisberg, R; Kucherlapati, R; Kwiatkowski, DJ; Ladanyi, M; Lai, PH; Laird, PW; Lander, E; Lawrence, MS; Lee, D; Lee, E; Lee, S; Lee, W; Leraas, KM; Lichtenberg, TM; Lichtenstein, L; Lin, P; Ling, SY; Liu, JZ; Liu, WB; Liu, YC; LiVolsi, VA; Lu, YL; Ma, Y; Mahadeshwar, HS; Marra, MA; Mayo, M; McFadden, DG; Meng, SW; Meyerson, M; Mieczkowski, PA; Miller, M; Mills, G; Moore, RA; Mose, LE; Mungall, AJ; Murray, BA; Nikiforov, YE; Noble, MS; Ojesina, AI; Owonikoko, TK; Ozenberger, BA; Pantazi, A; Parfenov, M; Park, PJ; Parker, JS; Paull, EO; Pedamallu, CS; Perou, CM; Prins, JF; Protopopov, A; Ramalingam, SS; Ramirez, NC; Ramirez, R; Raphael, BJ; Rathmell, WK; Ren, XJ; Reynolds, SM; Rheinbay, E; Ringel, MD; Rivera, M; Roach, J; Robertson, AG; Rosenberg, MW; Rosenthal, M; Sadeghi, S; Saksena, G; Sander, C; Santoso, N; Schein, JE; Schultz, N; Schumacher, SE; Seethala, RR; Seidman, J; Senbabaoglu, Y; Seth, S; Sharpe, S; Shaw, KRM; Shen, JP; Shen, RL; Sherman, S; Sheth, M; Shi, Y; Shmulevich, I; Sica, GL; Simons, JV; Sinha, R; Sipahimalani, P; Smallridge, RC; Sofia, HJ; Soloway, MG; Song, XZ; Sougnez, C; Stewart, C; Stojanov, P; Stuart, JM; Sumer, SO; Sun, YC; Tabak, B; Tam, A; Tan, DH; Tang, JB; Tarnuzzer, R; Taylor, BS; Thiessen, N; Thorne, L; Thorsson, V; Tuttle, RM; Umbricht, CB; Van Den Berg, DJ; Vandin, F; Veluvolu, U; Verhaak, RGW; Vinco, M; Voet, D; Walter, V; Wang, ZN; Waring, S; Weinberger, PM; Weinhold, N; Weinstein, JN; Weisenberger, DJ; Wheeler, D; Wilkerson, MD; Wilson, J; Williams, M; Winer, DA; Wise, L; Wu, JY; Xi, L; Xu, AW; Yang, LM; Yang, LX; Zack, TI; Zeiger, MA; Zeng, D; Zenklusen, JC; Zhao, N; Zhang, HL; Zhang, JH; Zhang, JS; Zhang, W; Zmuda, E; Zou, LH				Agrawal, Nishant; Akbani, Rehan; Aksoy, B. Arman; Ally, Adrian; Arachchi, Harindra; Asa, Sylvia L.; Auman, J. Todd; Balasundaram, Miruna; Balu, Saianand; Baylin, Stephen B.; Behera, Madhusmita; Bernard, Brady; Beroukhim, Rameen; Bishop, Justin A.; Black, Aaron D.; Bodenheimer, Tom; Boice, Lori; Bootwalla, Moiz S.; Bowen, Jay; Bowlby, Reanne; Bristow, Christopher A.; Brookens, Robin; Brooks, Denise; Bryant, Robert; Buda, Elizabeth; Butterfield, Yaron S. N.; Carling, Tobias; Carlsen, Rebecca; Carter, Scott L.; Carty, Sally E.; Chan, Timothy A.; Chen, Amy Y.; Cherniack, Andrew D.; Cheung, Dorothy; Chin, Lynda; Cho, Juok; Chu, Andy; Chuah, Eric; Cibulskis, Kristian; Ciriello, Giovanni; Clarke, Amanda; Clayman, Gary L.; Cope, Leslie; Copland, John A.; Covington, Kyle; Danilova, Ludmila; Davidsen, Tanja; Demchok, John A.; DiCara, Daniel; Dhalla, Noreen; Dhir, Rajiv; Dookran, Sheliann S.; Dresdner, Gideon; Eldridge, Jonathan; Eley, Greg; El-Naggar, Adel K.; Eng, Stephanie; Fagin, James A.; Fennell, Timothy; Ferris, Robert L.; Fisher, Sheila; Frazer, Scott; Frick, Jessica; Gabriel, Stacey B.; Ganly, Ian; Gao, Jianjiong; Garraway, Levi A.; Gastier-Foster, Julie M.; Getz, Gad; Gehlenborg, Nils; Ghossein, Ronald; Gibbs, Richard A.; Giordano, Thomas J.; Gomez-Hernandez, Karen; Grimsby, Jonna; Gross, Benjamin; Guin, Ranabir; Hadjipanayis, Angela; Harper, Hollie A.; Hayes, D. Neil; Heiman, David I.; Herman, James G.; Hoadley, Katherine A.; Hofree, Matan; Holt, Robert A.; Hoyle, Alan P.; Huang, Franklin W.; Huang, Mei; Hutter, Carolyn M.; Ideker, Trey; Iype, Lisa; Jacobsen, Anders; Jefferys, Stuart R.; Jones, Corbin D.; Jones, Steven J. M.; Kasaian, Katayoon; Kebebew, Electron; Khuri, Fadlo R.; Kim, Jaegil; Kramer, Roger; Kreisberg, Richard; Kucherlapati, Raju; Kwiatkowski, David J.; Ladanyi, Marc; Lai, Phillip H.; Laird, Peter W.; Lander, Eric; Lawrence, Michael S.; Lee, Darlene; Lee, Eunjung; Lee, Semin; Lee, William; Leraas, Kristen M.; Lichtenberg, Tara M.; Lichtenstein, Lee; Lin, Pei; Ling, Shiyun; Liu, Jinze; Liu, Wenbin; Liu, Yingchun; LiVolsi, Virginia A.; Lu, Yiling; Ma, Yussanne; Mahadeshwar, Harshad S.; Marra, Marco A.; Mayo, Michael; McFadden, David G.; Meng, Shaowu; Meyerson, Matthew; Mieczkowski, Piotr A.; Miller, Michael; Mills, Gordon; Moore, Richard A.; Mose, Lisle E.; Mungall, Andrew J.; Murray, Bradley A.; Nikiforov, Yuri E.; Noble, Michael S.; Ojesina, Akinyemi I.; Owonikoko, Taofeek K.; Ozenberger, Bradley A.; Pantazi, Angeliki; Parfenov, Michael; Park, Peter J.; Parker, Joel S.; Paull, Evan O.; Pedamallu, Chandra Sekhar; Perou, Charles M.; Prins, Jan F.; Protopopov, Alexei; Ramalingam, Suresh S.; Ramirez, Nilsa C.; Ramirez, Ricardo; Raphael, Benjamin J.; Rathmell, W. Kimryn; Ren, Xiaojia; Reynolds, Sheila M.; Rheinbay, Esther; Ringel, Matthew D.; Rivera, Michael; Roach, Jeffrey; Robertson, A. Gordon; Rosenberg, Mara W.; Rosenthal, Matthew; Sadeghi, Sara; Saksena, Gordon; Sander, Chris; Santoso, Netty; Schein, Jacqueline E.; Schultz, Nikolaus; Schumacher, Steven E.; Seethala, Raja R.; Seidman, Jonathan; Senbabaoglu, Yasin; Seth, Sahil; Sharpe, Samantha; Shaw, Kenna R. Mills; Shen, John P.; Shen, Ronglai; Sherman, Steven; Sheth, Margi; Shi, Yan; Shmulevich, Ilya; Sica, Gabriel L.; Simons, Janae V.; Sinha, Rileen; Sipahimalani, Payal; Smallridge, Robert C.; Sofia, Heidi J.; Soloway, Matthew G.; Song, Xingzhi; Sougnez, Carrie; Stewart, Chip; Stojanov, Petar; Stuart, Joshua M.; Sumer, S. Onur; Sun, Yichao; Tabak, Barbara; Tam, Angela; Tan, Donghui; Tang, Jiabin; Tarnuzzer, Roy; Taylor, Barry S.; Thiessen, Nina; Thorne, Leigh; Thorsson, Vesteinn; Tuttle, R. Michael; Umbricht, Christopher B.; Van Den Berg, David J.; Vandin, Fabio; Veluvolu, Umadevi; Verhaak, Roel G. W.; Vinco, Michelle; Voet, Doug; Walter, Vonn; Wang, Zhining; Waring, Scot; Weinberger, Paul M.; Weinhold, Nils; Weinstein, John N.; Weisenberger, Daniel J.; Wheeler, David; Wilkerson, Matthew D.; Wilson, Jocelyn; Williams, Michelle; Winer, Daniel A.; Wise, Lisa; Wu, Junyuan; Xi, Liu; Xu, Andrew W.; Yang, Liming; Yang, Lixing; Zack, Travis I.; Zeiger, Martha A.; Zeng, Dong; Zenklusen, Jean Claude; Zhao, Ni; Zhang, Hailei; Zhang, Jianhua; Zhang, Jiashan (Julia); Zhang, Wei; Zmuda, Erik; Zou, Lihua		Canc Genome Atlas Res Network	Integrated Genomic Characterization of Papillary Thyroid Carcinoma	CELL			English	Article							ACTIVATED RAS ONCOGENES; TERT PROMOTER MUTATIONS; BRAF MUTATIONS; HUMAN CANCERS; PATHWAY; FUSION; GENES; CELLS; BRAF(V600E); NODULES	Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Here, we describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic alterations (relative to other carcinomas) and extended the set of known PTC driver alterations to include EIF1AX, PPM1D, and CHEK2 and diverse gene fusions. These discoveries reduced the fraction of PTC cases with unknown oncogenic driver from 25% to 3.5%. Combined analyses of genomic variants, gene expression, and methylation demonstrated that different driver groups lead to different pathologies with distinct signaling and differentiation characteristics. Similarly, we identified distinct molecular subgroups of BRAF-mutant tumors, and multidimensional analyses highlighted a potential involvement of onco-miRs in less-differentiated subgroups. Our results propose a reclassification of thyroid cancers into molecular subtypes that better reflect their underlying signaling and differentiation properties, which has the potential to improve their pathological classification and better inform the management of the disease.	[Giordano, Thomas J.; Canc Genome Atlas Res Network] NCI, Canc Genome Atlas Program Off, NIH, Bethesda, MD 20892 USA	International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG)	Giordano, TJ (corresponding author), NCI, Canc Genome Atlas Program Off, NIH, 31 Ctr Dr,Bldg 31,Suite 3A20, Bethesda, MD 20892 USA.	gadgetz@broadinstitute.org; giordano@umich.edu	Pedamallu, Chandra Sekhar/AAV-6723-2020; liu, ying/GXF-4294-2022; Holt, Robert A/C-3303-2009; Seth, Sahil/I-5809-2019; Walter, Vonn/AAI-3450-2021; Cherniack, Andrew/AAC-5310-2019; Weinberger, Paul/B-7007-2008; LIU, YING/GZL-7252-2022; Marra, Marco A/B-5987-2008; Gao, JianJiong/B-5673-2016; Ladanyi, Marc/AAG-8585-2019; Verhaak, Roel/ABE-7058-2020; Van Den Berg, David J/G-8598-2017; Ling, Shiyun/P-2242-2014; Schein, Jacquie E/G-3674-2015; Lee, Semin/S-2629-2016; Pedamallu, Chandra Sekhar/AAV-6745-2020; Ramalingam, Suresh/AAV-7478-2020; Mungall, Andrew J./U-7067-2018; Cherniack, Andrew D./AAY-8132-2020; Zhao, Ni/P-9086-2014; Weisenberger, Daniel/AAA-8314-2020; Stojanov, Petar/GQI-4462-2022; Kucherlapati, Raju/ABC-8807-2021; Akbani, Rehan/AAG-1490-2019; Laird, Peter W/G-8683-2012; Chan, Timothy A/ABD-5850-2021; Schultz, Nikolaus/ABE-6347-2020; Khuri, Fadlo R./AAU-4942-2020; Jones, Steven J/C-3621-2009; Cibulskis, Kristian/AAC-7380-2019; Lawrence, Michael/AAC-8202-2020; Skanderup, Anders Jacobsen/K-1081-2013; Perou, Charles M/H-9934-2014; Parker, Joel/AAG-1108-2019	Holt, Robert A/0000-0002-7259-1247; Seth, Sahil/0000-0003-4579-3959; Walter, Vonn/0000-0001-6114-6714; Weinberger, Paul/0000-0002-5885-2631; Marra, Marco A/0000-0001-7146-7175; Gao, JianJiong/0000-0002-5739-1781; Van Den Berg, David J/0000-0002-5404-5218; Lee, Semin/0000-0002-9015-6046; Mungall, Andrew J./0000-0002-0905-2742; Cherniack, Andrew D./0000-0003-0470-0111; Zhao, Ni/0000-0002-7762-3949; Weisenberger, Daniel/0000-0001-8303-2603; Stojanov, Petar/0000-0001-7815-776X; Laird, Peter W/0000-0001-9117-3641; Khuri, Fadlo R./0000-0002-8638-7618; Jones, Steven J/0000-0003-3394-2208; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Perou, Charles M/0000-0001-9827-2247; Tarnuzzer, Roy/0000-0002-3725-4173; Bowen, Jay/0000-0001-6861-9043; Giordano, Thomas/0000-0003-0641-8873; Mieczkowski, Piotr/0000-0003-2418-0096; Park, Peter/0000-0001-9378-960X; Stuart, Joshua/0000-0002-2171-565X; Meyerson, Matthew/0000-0002-9133-8108; Hoadley, Katherine/0000-0002-1216-477X; Sinha, Rileen/0000-0001-5497-5055	United States National Institutes of Health [5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273, P30CA16672]; NATIONAL CANCER INSTITUTE [U24CA143883, K08CA160658, P30CA046592, U24CA143858, P30CA177558, P30CA016672, U24CA143799, U24CA143843, R01CA050706, U24CA143866, U24CA143848, U24CA143845, U24CA143867, P30CA008748, U24CA180951, U24CA143840, U24CA144025, U24CA143882, U24CA143835] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007069, U54HG003067, R01HG006272, U54HG003273, U54HG003079] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to all the patients and families who contributed to this study, to Chris Gunter for editing, and Margi Sheth and Jiashan (Julia) Zhang for project management. Thomas Giordano thanks his colleagues who covered his clinical duties. Supported by the following grants from the United States National Institutes of Health: 5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, and U54HG003273, P30CA16672. Yuri Nikiforov is a consultant for Quest Diagnostics. Raju Kucherlapati serves on the Board of Directors of KEW Group, Inc. Daniel J. Weisenberger is a consultant for Zymo Research Corporation.	Adeniran AJ, 2006, AM J SURG PATHOL, V30, P216, DOI 10.1097/01.pas.0000176432.73455.1b; Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; Bischoff LA, 2013, ENDOCR PRACT, V19, P995, DOI 10.4158/EP13029.OR; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chakravarty D, 2011, J CLIN INVEST, V121, P4700, DOI 10.1172/JCI46382; Charles RP, 2011, CANCER RES, V71, P3863, DOI 10.1158/0008-5472.CAN-10-4463; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Chu J., 2014, BIOINFORMATICS; Ciampi R, 2005, J CLIN INVEST, V115, P94, DOI 10.1172/JCI200523237; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Durante C, 2007, J CLIN ENDOCR METAB, V92, P2840, DOI 10.1210/jc.2006-2707; Ellis RJ, 2014, J CLIN ENDOCR METAB, V99, pE329, DOI 10.1210/jc.2013-2749; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franco AT, 2011, P NATL ACAD SCI USA, V108, P1615, DOI 10.1073/pnas.1015557108; Ghossein RA, 2013, J CLIN ENDOCR METAB, V98, pE1414, DOI 10.1210/jc.2013-1408; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Groenewoud MJ, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130185; Guerra A, 2012, J CLIN ENDOCR METAB, V97, P517, DOI 10.1210/jc.2011-0618; HAY ID, 1993, SURGERY, V114, P1050; Hay ID, 2002, WORLD J SURG, V26, P879, DOI 10.1007/s00268-002-6612-1; Ho AL, 2013, NEW ENGL J MED, V368, P623, DOI 10.1056/NEJMoa1209288; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hutchinson KE, 2013, CLIN CANCER RES, V19, P6696, DOI 10.1158/1078-0432.CCR-13-1746; Imam JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052397; Jung CK, 2014, J CLIN ENDOCR METAB, V99, pE276, DOI 10.1210/jc.2013-2503; Kelly LM, 2014, P NATL ACAD SCI USA, V111, P4233, DOI 10.1073/pnas.1321937111; Kimura ET, 2003, CANCER RES, V63, P1454; Kjellman P, 2001, GENE CHROMOSOME CANC, V32, P43, DOI 10.1002/gcc.1165; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039653; LEMOINE NR, 1988, CANCER RES, V48, P4459; Mardente S, 2012, ONCOL REP, V28, P2285, DOI 10.3892/or.2012.2058; Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674; Melo M, 2014, J CLIN ENDOCR METAB, V99, pE754, DOI 10.1210/jc.2013-3734; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Minamiya Y, 2012, CANCER BIOMARK, V11, P139, DOI 10.3233/CBM-2012-00272; Mitsutake N, 2006, ENDOCRINOLOGY, V147, P1014, DOI 10.1210/en.2005-0280; Nikiforov YE, 2013, CLIN CANCER RES, V19, P2283, DOI 10.1158/1078-0432.CCR-12-1253; Nikiforov YE, 2011, J CLIN ENDOCR METAB, V96, P3390, DOI 10.1210/jc.2011-1469; Nucera C, 2011, CANCER RES, V71, P2417, DOI 10.1158/0008-5472.CAN-10-3844; Oliva-Trastoy M, 2007, ONCOGENE, V26, P1449, DOI 10.1038/sj.onc.1209927; Park JY, 2013, ENDOCR PATHOL, V24, P69, DOI 10.1007/s12022-013-9244-0; Paull EO, 2013, BIOINFORMATICS, V29, P2757, DOI 10.1093/bioinformatics/btt471; PIEROTTI MA, 1995, J ENDOCRINOL INVEST, V18, P130, DOI 10.1007/BF03349721; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Qiu YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1331, DOI 10.1159/000354531; Ricarte JC, 2013, J CLIN INVEST, V123, P4935, DOI 10.1172/JCI69766; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Sabra MM, 2013, J CLIN ENDOCR METAB, V98, pE829, DOI 10.1210/jc.2012-3933; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Streit M, 2014, NAT METHODS, V11, P884, DOI 10.1038/nmeth.3088; SUAREZ HG, 1988, ONCOGENE, V2, P403; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Woiwode A, 2008, MOL CELL BIOL, V28, P4204, DOI 10.1128/MCB.01912-07; Wreesmann VB, 2004, CANCER RES, V64, P3780, DOI 10.1158/0008-5472.CAN-03-1460; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Yip L, 2014, ANN SURG, V260, P163, DOI 10.1097/SLA.0000000000000215; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	69	1603	1628	15	143	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					676	690		10.1016/j.cell.2014.09.050	http://dx.doi.org/10.1016/j.cell.2014.09.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417114	hybrid, Green Accepted			2022-12-28	WOS:000344521700021
J	Castel, SE; Ren, J; Bhattacharjee, S; Chang, AY; Sanchez, M; Valbuena, A; Antequera, F; Martienssen, RA				Castel, Stephane E.; Ren, Jie; Bhattacharjee, Sonali; Chang, An-Yun; Sanchez, Mar; Valbuena, Alberto; Antequera, Francisco; Martienssen, Robert A.			Dicer Promotes Transcription Termination at Sites of Replication Stress to Maintain Genome Stability	CELL			English	Article							RNA-POLYMERASE-II; DNA-REPLICATION; FISSION YEAST; HOMOLOGOUS RECOMBINATION; HISTONE MODIFICATION; POL-II; HETEROCHROMATIN; GENE; INTERFERENCE; CHROMATIN	Nuclear RNAi is an important regulator of transcription and epigenetic modification, but the underlying mechanisms remain elusive. Using a genome-wide approach in the fission yeast S. pombe, we have found that Dcr1, but not other components of the canonical RNAi pathway, promotes the release of Pol II from the 30 end of highly transcribed genes, and, surprisingly, from antisense transcription of rRNA and tRNA genes, which are normally transcribed by Pol I and Pol III. These Dcr1-terminated loci correspond to sites of replication stress and DNA damage, likely resulting from transcription-replication collisions. At the rDNA loci, release of Pol II facilitates DNA replication and prevents homologous recombination, which would otherwise lead to loss of rDNA repeats especially during meiosis. Our results reveal a novel role for Dcr1-mediated transcription termination in genome maintenance and may account for widespread regulation of genome stability by nuclear RNAi in higher eukaryotes.	[Castel, Stephane E.; Ren, Jie; Bhattacharjee, Sonali; Chang, An-Yun; Martienssen, Robert A.] Gordon & Betty Moore Fdn, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chang, An-Yun; Martienssen, Robert A.] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA; [Sanchez, Mar; Valbuena, Alberto; Antequera, Francisco] Univ Salamanca, CSIC, Inst Biol Func & Genom, Salamanca 37007, Spain	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Martienssen, RA (corresponding author), Gordon & Betty Moore Fdn, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	SANCHEZ, MAR/L-1898-2017; Antequera, Francisco/B-1115-2017	Antequera, Francisco/0000-0003-2623-4131; Sanchez, Maria del Mar/0000-0003-4438-0722	Natural Sciences and Engineering Research Council of Canada (PGSD); Cashin Scholarship from the Watson School of Biological Sciences; Spanish Ministerio de Economia y Competitividad [BFU2011-28804, CSD2007-00015]; NIH [GM076396]; Howard Hughes Medical Institute-Gordon and Betty Moore Foundation [GMBF3033]; Cancer Center Support Grant [5PP30CA045508]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1025830] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada (PGSD)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cashin Scholarship from the Watson School of Biological Sciences; Spanish Ministerio de Economia y Competitividad(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute-Gordon and Betty Moore Foundation(Howard Hughes Medical Institute); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank M. O'Connell, and B. Arcangioli for strains, advice, and discussion, F. Chedin for advice on DRIP-seq, and M.T.A. Donoghue for discussion and advice relating to statistical analysis. S.E.C. was supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada (PGSD) and a Cashin Scholarship from the Watson School of Biological Sciences. This work was supported by grants BFU2011-28804 and CSD2007-00015 from the Spanish Ministerio de Economia y Competitividad to F.A. and by a grant from the NIH (GM076396) to R.A.M. R.A.M. is also supported by the Howard Hughes Medical Institute-Gordon and Betty Moore Foundation (GMBF3033) and held a Chaire Blaise Pascal (Region Ile-de-France) at Institut Biologie Ecole Normale Superieure, Paris. The authors acknowledge assistance from the Cold Spring Harbor Laboratory Shared Resources, which are funded in part by the Cancer Center Support Grant (5PP30CA045508).	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Bahubeshi A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002493; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Buhler M, 2009, EMBO J, V28, P2149, DOI 10.1038/emboj.2009.185; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Cecere G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-44; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Ellermeier C, 2010, P NATL ACAD SCI USA, V107, P8701, DOI 10.1073/pnas.0914160107; Ganley ARD, 2014, FEMS YEAST RES, V14, P49, DOI 10.1111/1567-1364.12133; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Goto DB, 2012, DEV GROWTH DIFFER, V54, P129, DOI 10.1111/j.1440-169X.2011.01310.x; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Gullerova M, 2011, GENE DEV, V25, P556, DOI 10.1101/gad.618611; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Holmes A, 2012, CELL REP, V2, P1513, DOI 10.1016/j.celrep.2012.10.011; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Lan F, 2007, MOL CELL, V26, P89, DOI 10.1016/j.molcel.2007.02.023; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Liu FQ, 2012, SCIENCE, V335, P1621, DOI 10.1126/science.1214402; Marasovic M, 2013, MOL CELL, V52, P173, DOI 10.1016/j.molcel.2013.08.046; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; Nakama M, 2012, GENES CELLS, V17, P218, DOI 10.1111/j.1365-2443.2012.01583.x; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Padmanabhan K, 2012, SCIENCE, V337, P599, DOI 10.1126/science.1221592; Park NJ, 2004, MOL CELL BIOL, V24, P4092, DOI 10.1128/MCB.24.10.4092-4103.2004; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Rozenzhak S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001032; Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111; Sanchez JA, 1998, EXP CELL RES, V238, P220, DOI 10.1006/excr.1997.3835; Schlackow M, 2013, RNA, V19, P1617, DOI 10.1261/rna.040675.113; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; Tanaka H, 2002, NUCLEIC ACIDS RES, V30, P4728, DOI 10.1093/nar/gkf590; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wahba L, 2013, ELIFE, V2, DOI 10.7554/eLife.00505; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; West S, 2009, MOL CELL, V33, P354, DOI 10.1016/j.molcel.2009.01.008; White E, 2014, NAT STRUCT MOL BIOL, V21, P552, DOI 10.1038/nsmb.2827; Woolcock KJ, 2012, GENE DEV, V26, P683, DOI 10.1101/gad.186866.112; Woolcock KJ, 2011, NAT STRUCT MOL BIOL, V18, P94, DOI 10.1038/nsmb.1935; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716; YANG XJ, 1989, P NATL ACAD SCI USA, V86, P5301, DOI 10.1073/pnas.86.14.5301; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501; Zhang ZY, 2013, GENE DEV, V27, P145, DOI 10.1101/gad.209494.112; Zhou ZX, 2013, GENOME RES, V23, P705, DOI 10.1101/gr.146357.112	68	84	84	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					572	583		10.1016/j.cell.2014.09.031	http://dx.doi.org/10.1016/j.cell.2014.09.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417108	Bronze, Green Accepted			2022-12-28	WOS:000344521700013
J	Junker, JP; Noel, ES; Guryev, V; Peterson, KA; Shah, G; Huisken, J; McMahon, AP; Berezikov, E; Bakkers, J; van Oudenaarden, A				Junker, Jan Philipp; Noel, Emily S.; Guryev, Victor; Peterson, Kevin A.; Shah, Gopi; Huisken, Jan; McMahon, Andrew P.; Berezikov, Eugene; Bakkers, Jeroen; van Oudenaarden, Alexander			Genome-wide RNA Tomography in the Zebrafish Embryo	CELL			English	Article							IN-SITU HYBRIDIZATION; GENE-EXPRESSION; SEQ; IDENTIFICATION; FAMILY	Advancing our understanding of embryonic development is heavily dependent on identification of novel pathways or regulators. Although genome-wide techniques such as RNA sequencing are ideally suited for discovering novel candidate genes, they are unable to yield spatially resolved information in embryos or tissues. Microscopy-based approaches, using in situ hybridization, for example, can provide spatial information about gene expression, but are limited to analyzing one or a few genes at a time. Here, we present a method where we combine traditional histological techniques with low-input RNA sequencing and mathematical image reconstruction to generate a high-resolution genome-wide 3D atlas of gene expression in the zebrafish embryo at three developmental stages. Importantly, our technique enables searching for genes that are expressed in specific spatial patterns without manual image annotation. We envision broad applicability of RNA tomography as an accurate and sensitive approach for spatially resolved transcriptomics in whole embryos and dissected organs.	[Junker, Jan Philipp; Noel, Emily S.; Bakkers, Jeroen; van Oudenaarden, Alexander] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Junker, Jan Philipp; Noel, Emily S.; Bakkers, Jeroen; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, Canc Genom Netherlands, NL-3584 CT Utrecht, Netherlands; [Guryev, Victor; Berezikov, Eugene] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, NL-9713 AV Groningen, Netherlands; [Peterson, Kevin A.; McMahon, Andrew P.] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA 90089 USA; [Shah, Gopi; Huisken, Jan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Berezikov, Eugene; van Oudenaarden, Alexander] Skolkovo Inst Sci & Technol Skoltech, Skolkovo 143025, Moscow Region, Russia	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Groningen; University of Southern California; Max Planck Society; Skolkovo Institute of Science & Technology	van Oudenaarden, A (corresponding author), KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.	a.vanoudenaarden@hubrecht.eu	Bakkers, Jeroen/H-5551-2011; McMahon, Andrew P/ABE-7520-2020; Junker, Jan Philipp/A-9754-2010; Berezikov, Eugene/D-3363-2013; Huisken, Jan/B-2472-2009; huang, dezhi/ABC-6566-2021; van Oudenaarden, Alexander/AAA-1705-2019	Bakkers, Jeroen/0000-0002-9418-0422; Junker, Jan Philipp/0000-0002-2826-8290; Berezikov, Eugene/0000-0002-1145-2884; Huisken, Jan/0000-0001-7250-3756; Guryev, Victor/0000-0002-5810-6022; Noel, Emily/0000-0003-1026-634X	European Research Council Advanced grant [ERC-AdG 294325-GeneNoiseControl]; Nederlandse Organisatie voor We tenschappelijk Onderzoek (NWO) Vidi and Vici awards; NIH [NS033642]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033642, R37NS033642] Funding Source: NIH RePORTER	European Research Council Advanced grant(European Research Council (ERC)); Nederlandse Organisatie voor We tenschappelijk Onderzoek (NWO) Vidi and Vici awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Grun and B. Spanjaard for help with computational analysis. This work was supported by a European Research Council Advanced grant (ERC-AdG 294325-GeneNoiseControl) and by Nederlandse Organisatie voor We tenschappelijk Onderzoek (NWO) Vidi and Vici awards. Work in A. P. M.'s laboratory was supported by a grant from the NIH (NS033642).	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Combs PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071820; Cutty SJ, 2012, INT J DEV BIOL, V56, P285, DOI 10.1387/ijdb.113447sc; FIENBERG SE, 1970, ANN MATH STAT, V41, P907, DOI 10.1214/aoms/1177696968; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Geffers L, 2012, MAMM GENOME, V23, P525, DOI 10.1007/s00335-012-9413-3; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Hashimoto H, 2004, DEVELOPMENT, V131, P1741, DOI 10.1242/dev.01070; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Seo HC, 1998, MECH DEVELOP, V73, P45, DOI 10.1016/S0925-4773(98)00028-8; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tibshirani R., 2006, J R STAT SOC B, V63; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang XH, 2008, DEV DYNAM, V237, P3640, DOI 10.1002/dvdy.21771; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yu J, 2012, DEVELOPMENT, V139, P1863, DOI 10.1242/dev.074005	41	162	166	6	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					662	675		10.1016/j.cell.2014.09.038	http://dx.doi.org/10.1016/j.cell.2014.09.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417113	Bronze, Green Published			2022-12-28	WOS:000344521700020
J	Lengerke, C; Fernandez-Capetillo, O; Tolic-Norrelykke, I; Barna, M; Coleman, T; Zamboni, D				Lengerke, Claudia; Fernandez-Capetillo, Oscar; Tolic-Norrelykke, Iva; Barna, Maria; Coleman, Todd; Zamboni, Dario			When the Going Gets Tough: Scientists' Personal Challenges	CELL			English	Editorial Material								As part of Cell's 40th anniversary celebration, we are spotlighting 40 principal investigators under the age of 40, and we asked each of them to describe their biggest personal challenges while working in science. See the full profiles of all our "40 under 40" scientists and their responses to this and other questions at http://www.cell.com/40/under40.	[Lengerke, Claudia] Univ Basel, CH-4003 Basel, Switzerland; [Fernandez-Capetillo, Oscar] Spanish Natl Canc Res Ctr, HHMI, Madrid, Spain; [Tolic-Norrelykke, Iva] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Barna, Maria] Stanford Univ, Stanford, CA 94305 USA; [Coleman, Todd] UCSD, La Jolla, CA USA; [Zamboni, Dario] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil	University of Basel; Centro Nacional de Investigaciones Oncologicas (CNIO); Max Planck Society; Stanford University; University of California System; University of California San Diego; Universidade de Sao Paulo	Lengerke, C (corresponding author), Univ Basel, CH-4003 Basel, Switzerland.		Lengerke, Claudia/AAV-8745-2021; Fernandez-Capetillo, Oscar/H-3508-2015; Zamboni, Dario S/D-3024-2012; Tolić, Iva/F-1704-2014	Lengerke, Claudia/0000-0001-5442-2805; Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Zamboni, Dario S/0000-0002-7856-7512; Tolić, Iva/0000-0003-1305-7922					0	0	0	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 9	2014	159	2					225	226						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AQ8QU	25436265				2022-12-28	WOS:000343095600001
J	Yamin, AE; Frisancho, A				Yamin, Alicia Ely; Frisancho, Ariel			Human-rights-based approaches to health in Latin America	LANCET			English	Editorial Material									[Yamin, Alicia Ely] Harvard Univ, Sch Publ Hlth, FXB Ctr Hlth & Human Rights, Boston, MA 02115 USA; [Frisancho, Ariel] Community Practitioners Accountabil & Social Act, Int Initiat Maternal Mortal & Human Rights, Lima 33, Peru; [Frisancho, Ariel] Hlth Workforce Advocacy Initiat, Lima 33, Peru	Harvard University; Harvard T.H. Chan School of Public Health	Frisancho, A (corresponding author), Community Practitioners Accountabil & Social Act, Int Initiat Maternal Mortal & Human Rights, Lima 33, Peru.	afrisanchoarroyo@yahoo.es						[Anonymous], 2012, TIEMPO; Atun R., 2014, LANCET; Bustreo F, 2013, WOMENS CHILDRENS HLT; CARE Peru, 2010, GUID ORG SYST NGO AC, V2010, P1; Frisancho A, 2013, MATERNAL MORTALITY H, P13; Frisancho A, 2013, DIARIO REPUBLIC 0628, P20; Grepin KA, 2013, INVESTING WOMENS REP; Hoffmann FF, 2008, COURTING SOCIAL JUSTICE: JUDICIAL ENFORCEMENT OF SOCIAL AND ECONOMIC RIGHTS IN THE DEVELOPING WORLD, P100, DOI 10.1017/CBO9780511511240.005; independent Expert Review Group (iERG), 2012, 1 IERG WHO; Keith-Brown K, 2005, INVESTING LIFE MAKIN, P1; Miranda JJ, 2004, LANCET, V363, P68, DOI 10.1016/S0140-6736(03)15175-6; Norheim Ole Frithjof, 2011, LITIGATING HLTH RIGH, P304; Nunn A, 2012, GLOB PUBLIC HEALTH, V7, P1031, DOI 10.1080/17441692.2012.736681; Parra-Vera O, 2013, SALUD IGUALDADES DER; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH; Yamin AE, 2010, SUR, V7, P95	16	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					E26	E29		10.1016/S0140-6736(14)61280-0	http://dx.doi.org/10.1016/S0140-6736(14)61280-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF0ZD	25458722				2022-12-28	WOS:000352272400002
J	Atun, R; de Andrade, LOM; Almeida, G; Cotlear, D; Dmytraczenko, T; Frenz, P; Garcia, P; Gomez-Dantes, O; Knaul, FM; Muntaner, C; de Paula, JB; Rigoli, F; Serrate, PCF; Wagstaff, A				Atun, Rifat; Monteiro de Andrade, Luiz Odorico; Almeida, Gisele; Cotlear, Daniel; Dmytraczenko, T.; Frenz, Patricia; Garcia, Patricia; Gomez-Dantes, Octavio; Knaul, Felicia M.; Muntaner, Carles; de Paula, Juliana Braga; Rigoli, Felix; Castell-Florit Serrate, Pastor; Wagstaff, Adam			Health-system reform and universal health coverage in Latin America	LANCET			English	Article							SECTOR REFORM; NATIONWIDE ANALYSIS; SOCIAL PROTECTION; INFANT-MORTALITY; CASH TRANSFERS; CHILD HEALTH; PRIMARY-CARE; INSURANCE; IMPACT; MEXICO	Starting in the late 1980s, many Latin American countries began social sector reforms to alleviate poverty, reduce socioeconomic inequalities, improve health outcomes, and provide financial risk protection. In particular, starting in the 1990s, reforms aimed at strengthening health systems to reduce inequalities in health access and outcomes focused on expansion of universal health coverage, especially for poor citizens. In Latin America, health-system reforms have produced a distinct approach to universal health coverage, underpinned by the principles of equity, solidarity, and collective action to overcome social inequalities. In most of the countries studied, government financing enabled the introduction of supply-side interventions to expand insurance coverage for uninsured citizens-with defined and enlarged benefits packages-and to scale up delivery of health services. Countries such as Brazil and Cuba introduced tax-financed universal health systems. These changes were combined with demand-side interventions aimed at alleviating poverty (targeting many social determinants of health) and improving access of the most disadvantaged populations. Hence, the distinguishing features of health-system strengthening for universal health coverage and lessons from the Latin American experience are relevant for countries advancing universal health coverage.	[Atun, Rifat] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Knaul, Felicia M.] Harvard Univ, Harvard Global Equity Initiat, Boston, MA 02115 USA; [Monteiro de Andrade, Luiz Odorico] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Monteiro de Andrade, Luiz Odorico] Univ Fed Ceara, Sch Med, Fortaleza, Ceara, Brazil; [Almeida, Gisele] Pan Amer Hlth Org, Washington, DC USA; [Cotlear, Daniel; Dmytraczenko, T.; Wagstaff, Adam] World Bank, Washington, DC 20433 USA; [Frenz, Patricia] Univ Chile, Sch Publ Hlth, Santiago, Chile; [Garcia, Patricia] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm FASPA, Lima, Peru; [Gomez-Dantes, Octavio] Natl Inst Publ Hlth Mexico, Cuernavaca, Morelos, Mexico; [Muntaner, Carles] Univ Toronto, Inst Global Hlth Equ & Innovat, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [de Paula, Juliana Braga; Rigoli, Felix] Pan Amer Hlth Org, Brasilia, DF, Brazil; [Castell-Florit Serrate, Pastor] Natl Sch Publ Hlth, Havana, Cuba	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Fundacao Oswaldo Cruz; Universidade Federal do Ceara; Pan American Health Organization; The World Bank; Universidad de Chile; Universidad Peruana Cayetano Heredia; Instituto Nacional de Salud Publica; University of Toronto; Pan American Health Organization	Atun, R (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	ratun@hsph.harvard.edu	Monteiro, Odorico/HHC-3812-2022; Atun, Rifat/AAH-5537-2021	Monteiro, Odorico/0000-0002-3335-0619; Wagstaff, Adam/0000-0003-4442-5070; Knaul, Felicia/0000-0002-0512-4788; Atun, Rifat/0000-0002-1531-5983; Almeida, Gisele/0000-0001-7880-6993				Ramirez NA, 2011, CAD SAUDE PUBLICA, V27, P1875, DOI 10.1590/S0102-311X2011001000002; Aitsiselmi A, 2004, PUBLIC HEALTH, V118, P599, DOI 10.1016/j.puhe.2003.12.008; [Anonymous], 2004, LANCET, V364, P1911; Aquino R, 2009, AM J PUBLIC HEALTH, V99, P87, DOI 10.2105/AJPH.2007.127480; Aran D, 2011, SALUD PUBLICA MEXICO, V53, pS265; Arrieta A, 2011, HEALTH POLICY, V99, P124, DOI 10.1016/j.healthpol.2010.07.016; Atun R.A., 2005, HLTH EXPENDITURE NVE; Atun RA, 2005, ADV EC GROWTH INVEST; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; Atun R, 2012, HEALTH POLICY PLANN, V27, P4, DOI 10.1093/heapol/czs088; Barrientos A, 2000, HEALTH POLICY PLANN, V15, P417, DOI 10.1093/heapol/15.4.417; Barrientos A., 2003, SOCIAL POLICY REFORM, P183; Berman P, 1999, HLTH CARE FINANCING; Bitran R, 2013, UNIVERSAL HLTH COVER, V21; Bonilla-Chacin ME, 2013, UNICO STUDIES SERIES, V1; Borraz F., 2009, CUADERNOS EC, V46, P243, DOI DOI 10.4067/S0717-68212009000200006; Bursztyn Ivani, 2010, Rev. salud pública, V12, P77; Cecchini S, 2014, LANCET; Cecchini S, 2011, CONDITIONAL CASH TRA; Clark M.A., 2002, W WILS CTR WORKSH PO; Cohn A, 2008, MED SOCIAL, V3, P87; Comision Economica para America Latina y el Caribe, 2011, PAN SOC AM LAT; Cooper RS, 2006, INT J EPIDEMIOL, V35, P817, DOI 10.1093/ije/dyl175; Corte Constitucional de Colombia, SENT T 760 08; Cortez R, 2013, UNIVERSAL HLTH COVER, V12; Cotlear D, 2014, LANCET; Couttolenc B, 2013, UNICO STUDIES SERIES, V2; D?az Y., 2013, UNICO STUDIES SERIES, V25; Dachs J. Norberto W., 2002, Rev Panam Salud Publica, V11, P335, DOI 10.1590/S1020-49892002000500009; de Andrade LOM, 2014, LANCET; de la Torre A, 2010, WASHINGTON CONSENSUS; De Vos P, 2005, INT J HEALTH SERV, V35, P189, DOI 10.2190/M72R-DBKD-2XWV-HJWB; DELAJARA JJ, 1995, HEALTH POLICY, V32, P155, DOI 10.1016/0168-8510(95)00733-9; Drechsler D, 2007, J HEALTH POLIT POLIC, V32, P497, DOI 10.1215/03616878-2007-012; Dresang LT, 2005, J AM BOARD FAM PRACT, V18, P297, DOI 10.3122/jabfm.18.4.297; Eckstein Susan, 2001, POWER POPULAR PROTES; Encuesta Nacional de Salud Mexico, 2000, VIV POBL UT SERV SAL; Escobar A., 1992, MAKING SOCIAL MOVEME; ESCOBAR ML, 2011, IMPACT HLTH INSURANC; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Filardo Z, 2013, REFORMA SISTEMA SALU; Frencke P, 2013, UNICO STUDIES SERIES, V11; Frencke P, 2006, POLITICA POBREZA PAI; Frenk J, 2003, LANCET, V362, P1667, DOI 10.1016/S0140-6736(03)14803-9; Frenk J, 1988, NEXOS, VXXII, P25; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Frenk J, 2009, B WORLD HEALTH ORGAN, V87, P542, DOI 10.2471/BLT.08.053199; Frenz P, 2013, REV MED CHILE, V141, P1095, DOI 10.4067/S0034-98872013000900001; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; Gertler PJ, 2011, PLAN NACER; Gragnolati M, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9843-2; Gutierrez Susana M. Borroto, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P937; Health Data OECD, 2014, DOES CHIL COMP; Homedes N, 2005, HEALTH POLICY, V71, P83, DOI 10.1016/j.healthpol.2004.01.011; Homedes N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000124; IHR, 2005, INT HLTH REG 2005, V2; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS GLOB R; Iwami M, 2002, J PUBLIC HEALTH MED, V24, P246, DOI 10.1093/pubmed/24.4.246; Jack W, 2002, WORLD BANK RES OBSER, V17, P67, DOI 10.1093/wbro/17.1.67; Jimenez J, 2007, HEALTH AFFAIR, V26, P458, DOI 10.1377/hlthaff.26.2.458; Jones N, 2008, ENVIRON URBAN, V20, P255, DOI 10.1177/0956247808089162; Kim MK, 2013, HEALTH EXPECT, V16, P155, DOI 10.1111/j.1369-7625.2012.00777.x; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Knaul FM, 2012, FINANCING HLTH LATIN; Knaul FM, 2012, HOUSEHOLD SPENDING I, V1; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137; Langer A, 2000, B WORLD HEALTH ORGAN, V78, P667; Latinobarometro, 1995, LAT 1995 2011; Lavinas MH, 2011, MI FAMILIA PROGR MIF; Leeson GW, 2011, DEMOGRAPHICS POPULAT; Leite VR, 2011, INT J HEALTH SERV, V41, P711, DOI 10.2190/HS.41.4.f; Levino A, 2011, REV PANAM SALUD PUBL, V30, P490, DOI 10.1590/S1020-49892011001100013; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Londono JL, 1997, HEALTH POLICY, V41, P1, DOI 10.1016/S0168-8510(97)00010-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madies C V, 2000, Rev Panam Salud Publica, V8, P33, DOI 10.1590/S1020-49892000000700007; Mahmood Q, 2013, GLOB HEALTH PROMOT, V20, P59, DOI 10.1177/1757975913476902; Mahmood Q, 2012, GLOBALIZATIONS, V9, P815, DOI 10.1080/14747731.2012.739341; Manuel A, 2002, SALUD PUBLICA MEXICO, V44, P60, DOI 10.1590/S0036-36342002000100009; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Knaul FM, 2011, SALUD PUBLICA MEXICO, V53, pS85; Matsuura H, 2013, 106 PGDA HARV SCH PU; Mckee M, 2009, LANCET, V373, P349, DOI 10.1016/S0140-6736(09)60098-2; Mendez CA, 2010, REV PANAM SALUD PUBL, V27, P144, DOI 10.1590/S1020-49892010000200009; Ministerio de Salud. Gobierno de Chile, 2013, ACC UN GAR EXPL; Ministerio de Salud (MINSAL) de Chile, 2008, CAM CTR SAL FAM; Ministerio Secretaria General de la, FIJ TEXT REF COORD S; Muntaner C, 2008, SOC MED, V3, P232; Muntaner C, 2006, CAN J PUBLIC HEALTH, V97, pI19, DOI 10.1007/BF03405240; Nelson J, 2003, W WILSON CTR UPDATE; Ortiz-Andrellucchi A, 2006, NUTR HOSP, V21, P533; Pan American Health Organization, 2012, PAN AM HLTH ORG SCI, V636; Pan American Health Organization/WHO, 2002, PUBL HLTH AM CONC RE; Perova E., 2009, WELFARE IMPACTS JUNT; PNDS, 2006, PESQ NAC DEM SAUD CR; Rasella Davide, 2014, BMJ, V349, pg4014, DOI 10.1136/bmj.g4014; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; Rawlings L.B., 2003, 3119 WORLD BANK; Ritter ARM, 2010, LAT AM RES REV, V45, P229; Rodrik D, 2006, J ECON LIT, V44, P973, DOI 10.1257/jel.44.4.973; Romero T, 2009, MEDICC REV, V11, P5, DOI 10.37757/MR2009V11.N3.2; Gomez FR, 2013, REV PANAM SALUD PUBL, V33, P107, DOI 10.1590/S1020-49892013000200005; Sachs JD, 2001, MACR HLTH INV HLTH E; Savedoff W., 2009, MOVING TARGET UNIVER; SCHULTZ TW, 1980, J POLIT ECON, V88, P639, DOI 10.1086/260895; Sojo A, 2006, ESTUDIEOS PERSPECTIV; Sojo A, 2011, CIENC SAUDE COLETIVA, V16, P2673, DOI 10.1590/S1413-81232011000600002; Solidario C, 2004, CHILE SOLIDARIO; Stiglitz, 2017, ANTI GLOBALIZATION E; Stiglitz JE, 2003, CEPAL REV, V80, P7; Stuckler D, 2010, POLITICAL EC UNIVERS; The World Bank, INDICATORS; The World Bank, MEASURE DHS DEM HLTH; Torres FM, 2013, UNIVERSAL HLTH COVER, V14; Transparency International, 2012, CORR PERC IND 2012; Tribunal Electoral del Poder Judicial de la Federacion, 2013, POL CONST UN MEX STA; Unger JP, 2008, PLOS MED, V5, P542, DOI 10.1371/journal.pmed.0050079; UNICEF, DESP MAJ PROGR FULL; United Nations, AM LAT URB POBR DES; Vega-Romero R, 2006, REV GERENC POLIT SAL, V5, P38; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; WHO, 2010, WOR HEALT REP, P1; WHO, TRAD FOR POL DIPL HL; WHO, 2003, WHOMNCOSD0301; WHO, GLOB HLTH DAT REP DI; WHO, 2008, CUB PRIM HLTH CAR RE; WHO, GLOB HLTH EXP DAT; WHO and the World Bank Group, MON PROGR UN COV COU; WHO Europe, 1978, DECL ALM AT; WILLIAMSON J, 1993, WORLD DEV, V21, P1329, DOI 10.1016/0305-750X(93)90046-C; Williamson J., 1990, LATIN AM ADJUSTMENT; Williamson J., 2002, DID WASHINGTON CONSE; World Bank, 2009, PROT PROP HLTH SERV; World Bank, PRIM TIM FOC COND CA; World Bank, DAT CUB; World Health Organization, GLOB HLTH OBS DAT RE	136	294	311	11	143	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1230	1247		10.1016/S0140-6736(14)61646-9	http://dx.doi.org/10.1016/S0140-6736(14)61646-9			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE3GQ	25458725	Green Submitted			2022-12-28	WOS:000351715100037
J	Taylor, AI; Pinheiro, VB; Smola, MJ; Morgunov, AS; Peak-Chew, S; Cozens, C; Weeks, KM; Herdewijn, P; Holliger, P				Taylor, Alexander I.; Pinheiro, Vitor B.; Smola, Matthew J.; Morgunov, Alexey S.; Peak-Chew, Sew; Cozens, Christopher; Weeks, Kevin M.; Herdewijn, Piet; Holliger, Philipp			Catalysts from synthetic genetic polymers	NATURE			English	Article							CLEAVING DNA ENZYME; ARABINONUCLEIC ACIDS; STRUCTURAL BASIS; RNA SECONDARY; NUCLEIC-ACIDS; EVOLUTION; SHAPE; HYBRIDIZATION; SEQUENCES; RIBOZYME	The emergence of catalysis in early genetic polymers such as RNA is considered a key transition in the origin of life(1), pre-dating the appearance of protein enzymes. DNA also demonstrates the capacity to fold into three-dimensional structures and form catalysts in vitro(2). However, to what degree these natural biopolymers comprise functionally privileged chemical scaffolds(3) for folding or the evolution of catalysis is not known. The ability of synthetic genetic polymers (XNAs) with alternative backbone chemistries not found in nature to fold into defined structures and bind ligands(4) raises the possibility that these too might be capable of forming catalysts (XNAzymes). Here we report the discovery of such XNAzymes, elaborated in four different chemistries (arabino nucleic acids, ANA(5); 2'-fluoroarabino nucleic acids, FANA(6); hexitol nucleic acids, HNA; and cyclohexene nucleic acids, CeNA(7)) directly from random XNA oligomer pools, exhibiting in trans RNA endonuclease and ligase activities. We also describe an XNA-XNA ligase metalloenzyme in the FANA framework, establishing catalysis in an entirely synthetic system and enabling the synthesis of FANA oligomers and an active RNA endonuclease FANAzyme from its constituent parts. These results extend catalysis beyond biopolymers and establish technologies for the discovery of catalysts in a wide range of polymer scaffolds not found in nature(8). Evolution of catalysis independent of any natural polymer has implications for the definition of chemical boundary conditions for the emergence of life on Earth and elsewhere in the Universe(9).	[Taylor, Alexander I.; Pinheiro, Vitor B.; Morgunov, Alexey S.; Peak-Chew, Sew; Cozens, Christopher; Holliger, Philipp] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Smola, Matthew J.; Weeks, Kevin M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Herdewijn, Piet] Katholieke Univ Leuven, Rea Inst, B-3000 Louvain, Belgium; [Herdewijn, Piet] Univ Evry, Inst Syst & Synthet Biol, F-91030 Evry, France	MRC Laboratory Molecular Biology; University of North Carolina; University of North Carolina Chapel Hill; KU Leuven; UDICE-French Research Universities; Universite Paris Saclay	Holliger, P (corresponding author), MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	ph1@mrc-lmb.cam.ac.uk	Pinheiro, Vitor/O-5514-2017	Pinheiro, Vitor/0000-0003-2491-0028; Cozens, Christopher/0000-0003-4067-6921; Smola, Matthew/0000-0002-2123-9681; Morgunov, Alexey/0000-0001-9636-3284; Herdewijn, Piet/0000-0003-3589-8503; Taylor, Alexander/0000-0001-7684-1437	Medical Research Council (MRC) [U105178804]; European Science Foundation (ESF); Biotechnology and Biological Sciences Research Council (BBSRC) UK [09-EuroSYNBIO-OP-013]; European Union; European Research Council [ERC-2012 ADG_20120216/320683]; US National Science Foundation [MCB-1121024]; NSF Graduate Research Fellowship [DGE-1144081]; BBSRC [BB/M005623/1] Funding Source: UKRI; MRC [MC_U105185859, MC_U105178804] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/M005623/1] Funding Source: researchfish; Medical Research Council [MC_U105185859, MC_U105178804] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Science Foundation (ESF)(European Science Foundation (ESF)); Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); US National Science Foundation(National Science Foundation (NSF)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (MRC) programme grant U105178804 (P. Holliger, A.I.T., V.B.P., A.S.M., S.P.-C., C.C.) and by grants from the European Science Foundation (ESF) and the Biotechnology and Biological Sciences Research Council (BBSRC) UK (09-EuroSYNBIO-OP-013) (P.H., A.I.T.), the European Union Framework (FP7/2007-2013 (P. Herdewijn), the European Research Council (ERC-2012 ADG_20120216/320683 (P. Herdewijn)), the US National Science Foundation (MCB-1121024 (K.M.W.)) and by an NSF Graduate Research Fellowship (DGE-1144081 (M.J.S.)).	Atkins J. F., 2012, RNA WORLDS; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Benner SA, 2004, CURR OPIN CHEM BIOL, V8, P672, DOI 10.1016/j.cbpa.2004.10.003; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bowler FR, 2013, NAT CHEM, V5, P383, DOI 10.1038/nchem.1626; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; Brody JR, 2004, BIOTECHNIQUES, V36, P214, DOI 10.2144/04362BM02; CHU BCF, 1983, NUCLEIC ACIDS RES, V11, P6513, DOI 10.1093/nar/11.18.6513; CUENOUD B, 1995, NATURE, V375, P611, DOI 10.1038/375611a0; Deleavey GF, 2010, NUCLEIC ACIDS RES, V38, P4547, DOI 10.1093/nar/gkq181; Dowler T, 2006, NUCLEIC ACIDS RES, V34, P1669, DOI 10.1093/nar/gkl033; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Eschenmoser A, 1999, SCIENCE, V284, P2118, DOI 10.1126/science.284.5423.2118; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; Hendrix C, 1997, CHEM-EUR J, V3, P1513, DOI 10.1002/chem.19970030920; Herdewijn P, 2010, CHEM BIODIVERS, V7, P1, DOI 10.1002/cbdv.200900185; Homan PJ, 2014, P NATL ACAD SCI USA, V111, P13858, DOI 10.1073/pnas.1407306111; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Lescrinier E, 2000, CHEM BIOL, V7, P719, DOI 10.1016/S1074-5521(00)00017-X; Lilley DMJ, 2011, PHILOS T R SOC B, V366, P2910, DOI 10.1098/rstb.2011.0132; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Martin-Pintado N, 2012, NUCLEIC ACIDS RES, V40, P9329, DOI 10.1093/nar/gks672; Minasov G, 2000, BIOCHEMISTRY-US, V39, P3525, DOI 10.1021/bi992792j; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Nauwelaerts K, 2007, J AM CHEM SOC, V129, P9340, DOI 10.1021/ja067047q; Noronha AM, 2000, BIOCHEMISTRY-US, V39, P7050, DOI 10.1021/bi000280v; Paul N, 2006, CHEM BIOL, V13, P329, DOI 10.1016/j.chembiol.2006.01.007; Pinheiro VB, 2012, CURR OPIN CHEM BIOL, V16, P245, DOI 10.1016/j.cbpa.2012.05.198; Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622; Rogers J, 2001, RNA, V7, P395, DOI 10.1017/S135583820100228X; Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/nmeth.3029, 10.1038/NMETH.3029]; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Wilds CJ, 2000, NUCLEIC ACIDS RES, V28, P3625, DOI 10.1093/nar/28.18.3625; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Zlatev I., 2001, CURRENT PROTOCOLS NU; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	170	174	2	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					427	430		10.1038/nature13982	http://dx.doi.org/10.1038/nature13982			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470036	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000349547400048
J	Beard, JR; Bloom, DE				Beard, John R.; Bloom, David E.			Towards a comprehensive public health response to population ageing	LANCET			English	Editorial Material							OLDER-ADULTS; CHRONIC DISEASES; MORTALITY; TRIALS; US		[Beard, John R.] WHO, Dept Ageing & Life Course, CH-1211 Geneva, Switzerland; [Bloom, David E.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health	Beard, JR (corresponding author), WHO, Dept Ageing & Life Course, CH-1211 Geneva, Switzerland.	beardj@who.int	Beard, John/AAI-4592-2021; Beard, John R/K-9621-2014	Beard, John/0000-0002-8557-0242; Beard, John R/0000-0002-8557-0242	NATIONAL INSTITUTE ON AGING [P30AG024409] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG024409, P30AG024409] Funding Source: Medline; World Health Organization [001] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); World Health Organization(World Health Organization)		Age Wave, SUNAMERICA RET RES; Beard JR, 2010, PUBLIC HEALTH REV, V32, P427, DOI 10.1007/BF03391610; Bloom DE., 2010, EC CONSEQUENCES DEMO, P61; Brooks-Wilson AR, 2013, HUM GENET, V132, P1323, DOI 10.1007/s00439-013-1342-z; Cordery DV, 2011, SEX HEALTH, V8, P534, DOI 10.1071/SH11026; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; Gonzalez-Gonzalez C, 2014, REV PANAM SALUD PUBL, V35, P89; Gubler T, 2014, PSYCHOL SCI, V25, P1822, DOI 10.1177/0956797614540467; Gurwitz JH, 2011, ARCH INTERN MED, V171, P557, DOI 10.1001/archinternmed.2011.33; Kautz T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2841; Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a; Lee PG, 2009, J AM GERIATR SOC, V57, P511, DOI 10.1111/j.1532-5415.2008.02150.x; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Lloyd-Sherlock P, 2012, LANCET, V379, P1295, DOI 10.1016/S0140-6736(12)60519-4; Lordos EF, 2008, REJUV RES, V11, P829, DOI 10.1089/rej.2008.0721; McElhaney JE, 2012, VACCINE, V30, P2060, DOI 10.1016/j.vaccine.2012.01.015; Stephens C, 2015, PSYCHOL HEALTH, V30, P715, DOI 10.1080/08870446.2014.904862; Steves CJ, 2012, AGE AGEING, V41, P581, DOI 10.1093/ageing/afs097; Tomassini C, LIVING ARRANGEMENTS; WHO, 2007, GLOB AG FRIENDL CIT; World Health Organization, 2004, AG FRIENDL PRIM HLTH	22	265	277	6	57	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					658	661		10.1016/S0140-6736(14)61461-6	http://dx.doi.org/10.1016/S0140-6736(14)61461-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AZ	25468151	Green Accepted			2022-12-28	WOS:000349214000034
J	Kobayashi, E; Setsu, N				Kobayashi, Eisuke; Setsu, Nokitaka			Osteosclerosis induced by denosumab	LANCET			English	Editorial Material									[Kobayashi, Eisuke; Setsu, Nokitaka] Natl Canc Ctr, Div Musculoskeletal Oncol, Chuo Ku, Tokyo 1040045, Japan	National Cancer Center - Japan	Kobayashi, E (corresponding author), Natl Canc Ctr, Div Musculoskeletal Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	ekobayas@ncc.go.jp							0	23	26	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					539	539		10.1016/S0140-6736(14)61338-6	http://dx.doi.org/10.1016/S0140-6736(14)61338-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AV	25465110	Bronze			2022-12-28	WOS:000349213600032
J	Prince, MJ; Wu, F; Guo, YF; Robledo, LMG; O'Donnell, M; Sullivan, R; Yusuf, S				Prince, Martin J.; Wu, Fan; Guo, Yanfei; Gutierrez Robledo, Luis M.; O'Donnell, Martin; Sullivan, Richard; Yusuf, Salim			The burden of disease in older people and implications for health policy and practice	LANCET			English	Article							CORONARY-HEART-DISEASE; SUB-SAHARAN AFRICA; OBSTRUCTIVE PULMONARY-DISEASE; LOW-INCOME COUNTRIES; RISK-FACTORS; COST-EFFECTIVENESS; ELDERLY-PEOPLE; MIDDLE-INCOME; CARDIOVASCULAR-DISEASE; ALZHEIMERS-DISEASE	23% of the total global burden of disease is attributable to disorders in people aged 60 years and older. Although the proportion of the burden arising from older people (>= 60 years) is highest in high-income regions, disability-adjusted life years (DALYs) per head are 40% higher in low-income and middle-income regions, accounted for by the increased burden per head of population arising from cardiovascular diseases, and sensory, respiratory, and infectious disorders. The leading contributors to disease burden in older people are cardiovascular diseases (30.3% of the total burden in people aged 60 years and older), malignant neoplasms (15.1%), chronic respiratory diseases (9.5%), musculoskeletal diseases (7.5%), and neurological and mental disorders (6.6%). A substantial and increased proportion of morbidity and mortality due to chronic disease occurs in older people. Primary prevention in adults aged younger than 60 years will improve health in successive cohorts of older people, but much of the potential to reduce disease burden will come from more effective primary, secondary, and tertiary prevention targeting older people. Obstacles include misplaced global health priorities, ageism, the poor preparedness of health systems to deliver age-appropriate care for chronic diseases, and the complexity of integrating care for complex multimorbidities. Although population ageing is driving the worldwide epidemic of chronic diseases, substantial untapped potential exists to modify the relation between chronological age and health. This objective is especially important for the most age-dependent disorders (ie, dementia, stroke, chronic obstructive pulmonary disease, and vision impairment), for which the burden of disease arises more from disability than from mortality, and for which long-term care costs outweigh health expenditure. The societal cost of these disorders is enormous.	[Prince, Martin J.] Inst Psychiat, London SE5 8AF, England; [Sullivan, Richard] Kings Coll London, Kings Hlth Partners Integrated Canc, Hlth Partners Canc Ctr, London, England; [Sullivan, Richard] Kings Coll London, Kings Hlth Partners Integrated Canc, Inst Canc Policy, London, England; [Sullivan, Richard] Kings Coll London, Ctr Global Hlth, London, England; [Wu, Fan] Shanghai Inst Preventat Med, Shanghai, Peoples R China; [Wu, Fan; Guo, Yanfei] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Gutierrez Robledo, Luis M.] Inst Nacl Geriatr, Mexico City, DF, Mexico; [Gutierrez Robledo, Luis M.] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [O'Donnell, Martin] Natl Univ Ireland Univ Coll Galway, Galway, Ireland; [Yusuf, Salim] McMaster Univ, Hamilton, ON, Canada	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; Shanghai Center for Disease Control & Prevention; Universidad Nacional Autonoma de Mexico; Ollscoil na Gaillimhe-University of Galway; McMaster University	Prince, MJ (corresponding author), Inst Psychiat, P060,De Crespigny Pk, London SE5 8AF, England.	martin.prince@kcl.ac.uk	Prince, Martin J/A-9170-2010; O'Donnell, Martin/ABE-7459-2020	Prince, Martin J/0000-0003-1379-7146; O'Donnell, Martin/0000-0002-7347-7761; Sullivan, Richard/0000-0002-6435-1825; Yusuf, Salim/0000-0003-4776-5601; Gutierrez Robledo, Luis M/0000-0002-9728-6644				Adamson Joy, 2004, J Stroke Cerebrovasc Dis, V13, P171, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.003; Aguilar-Salinas CA, 2003, DIABETES CARE, V26, P2021, DOI 10.2337/diacare.26.7.2021; Ait-Khaled N, 2008, INT J TUBERC LUNG D, V12, P595; Ait-Khaled N, 2001, B WORLD HEALTH ORGAN, V79, P971; Akgun KM, 2012, J GERONTOL A-BIOL, V67, P276, DOI 10.1093/gerona/glr251; Albanese E, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-153; Alzheimer's Disease International, 2013, POL BRIEF G8 HEADS G; Alzheimer's Disease International, 2009, WORLD ALZHEIMER REPO; Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; [Anonymous], GLOB BURD DIS 2004 U; Avezum A, 2005, AM HEART J, V149, P67, DOI 10.1016/j.ahj.2004.06.003; Avila-Funes JA, 2009, J AM GERIATR SOC, V57, P453, DOI 10.1111/j.1532-5415.2008.02136.x; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baltussen R, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e615; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Brown ML, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P569; Brown ML, 2002, MED CARE, V40, P104; Buist AS, 2008, INT J TUBERC LUNG D, V12, P703; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Cancer Research UK, 2012, CANC INC AG UK STAT; Caughey GE, 2010, J EPIDEMIOL COMMUN H, V64, P1036, DOI 10.1136/jech.2009.088260; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Cong RH, 2008, ANN EPIDEMIOL, V18, P647, DOI 10.1016/j.annepidem.2008.04.002; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Dachs J. Norberto W., 2002, Rev Panam Salud Publica, V11, P335, DOI 10.1590/S1020-49892002000500009; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; Das S K, 2008, J Assoc Physicians India, V56, P175; De Lepeleire J, 2009, BRIT J GEN PRACT, V59, P364, DOI 10.3399/bjgp09X420653; de Vugt ME, 2005, INT PSYCHOGERIATR, V17, P577, DOI 10.1017/S101610205002292; Deepa M, 2003, J Assoc Physicians India, V51, P863; Deo R, 2012, ARCH INTERN MED, V172, P741, DOI 10.1001/archinternmed.2012.1294; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Feenstra TL, 2001, AM J RESP CRIT CARE, V164, P590, DOI 10.1164/ajrccm.164.4.2003167; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Ferri CP, 2011, J NEUROL NEUROSUR PS, V82, P1074, DOI 10.1136/jnnp.2010.234153; Fletcher AE, 2010, OPHTHALMIC RES, V44, P191, DOI 10.1159/000316476; Foley KM, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P981; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2003, ETHNIC DIS, V13, P85; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Frick KD, 2009, OPHTHAL EPIDEMIOL, V16, P378, DOI 10.3109/09286580903312277; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Gheorghiade Mihai, 2009, Acute Card Care, V11, P83, DOI 10.1080/17482940902883246; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Grabowski DC, 2001, J AM GERIATR SOC, V49, P968, DOI 10.1046/j.1532-5415.2001.49189.x; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Haveman-Nies A, 2002, AM J EPIDEMIOL, V156, P962, DOI 10.1093/aje/kwf144; He L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-34; House JS, 2005, J GERONTOL B-PSYCHOL, V60, P15; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hrobonova E., 2011, J AGING RES, V2011, DOI DOI 10.4061/2011/651931; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jitapunkul S, 2009, GERIATR GERONTOL INT, V9, P47, DOI 10.1111/j.1447-0594.2008.00501.x; Jotheeswaran AT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-366; Khanam MA, 2011, J HEALTH POPUL NUTR, V29, P406, DOI 10.3329/jhpn.v29i4.8458; Kinsella K., 2005, GLOBAL AGING CHALLEN; Kirchberger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030556; Konrat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033559; KOWAL P, 2010, GLOB HLTH ACTION, V3; Lacas A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-4; Lacey L, 2005, EUR J HEART FAIL, V7, P677, DOI 10.1016/j.ejheart.2004.10.020; Lewallen S, 2009, BRIT J OPHTHALMOL, V93, P295, DOI 10.1136/bjo.2008.140301; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lievesley N, 2009, AGEISM AGE DISCRIMIN; Lloyd-Sherlock P, 2012, LANCET, V379, P1295, DOI 10.1016/S0140-6736(12)60519-4; Luengo-Fernandez R, 2010, DEMENTIA 2010 PREVAL; Luker JA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-161; Ma Xj, 2008, Biomed Imaging Interv J, V4, pe39, DOI 10.2349/biij.4.3.e39; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; Morlion B, 2013, NAT REV NEUROL, V9, P462, DOI 10.1038/nrneurol.2013.130; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Musini VM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000028.pub2; National Institutes of Health. National Heart Lung and Blood Institute, 2009, MORB MORT 2009 CHART; Ng N, 2006, SCAND J PUBLIC HEALT, V34, P199, DOI 10.1080/14034940500204506; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Olaiz G, 2003, ENCUESTA NACL SALUD; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Ostchega Y, 2008, AM J HYPERTENS, V21, P159, DOI 10.1038/ajh.2007.32; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Partnership for Solution, 2004, CHRONIC CONDITIONS M; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Pitner Janet K, 2005, Consult Pharm, V20, P498, DOI 10.4140/TCP.n.2005.498; Preston SD, 2008, J ROY SOC MED, V101, P409, DOI 10.1258/jrsm.2008.080035; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2011, WORLD ALZHEIMER REPO; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince M, 2012, LANCET, V380, P50, DOI 10.1016/S0140-6736(12)60399-7; Prince M, 2012, INT J GERIATR PSYCH, V27, P670, DOI 10.1002/gps.2727; Prince MJ, 2012, J HYPERTENS, V30, P177, DOI 10.1097/HJH.0b013e32834d9eda; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Ramsay SE, 2005, J PUBLIC HEALTH-UK, V27, P338, DOI 10.1093/pubmed/fdi053; Rao GN, 2011, CURR OPIN OPHTHALMOL, V22, P4, DOI 10.1097/ICU.0b013e3283414fc8; Reed DM, 1998, AM J PUBLIC HEALTH, V88, P1463, DOI 10.2105/AJPH.88.10.1463; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Reveille JD, 2013, AM J MED SCI, V345, P431, DOI 10.1097/MAJ.0b013e318294457f; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Roy K, 2008, SOC SCI MED, V66, P1951, DOI 10.1016/j.socscimed.2008.01.015; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sanderson S, 1996, HLTH TRENDS, V28, P71; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Shay CM, 2012, CIRCULATION, V125, P45, DOI 10.1161/CIRCULATIONAHA.111.035733; Sousa RM, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-53; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Sposato LA, 2012, STROKE, V43, P170, DOI 10.1161/STROKEAHA.111.632158; Stanciole AE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e608; Standard & Poor's, 2010, GLOB AG 2010 IRR TRU; Strawbridge WJ, 1998, J GERONTOL B-PSYCHOL, V53, pS9, DOI 10.1093/geronb/53B.1.S9; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Turner NJ, 1999, BRIT MED J, V319, P309, DOI 10.1136/bmj.319.7205.309; UN General Assembly, 2011, POL HIGH LEV M GEN A; United Nations, 2002, 2 WORLD ASS AG MADR; van Durme YMTA, 2009, CHEST, V135, P368, DOI 10.1378/chest.08-0684; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1; Vashist P, 2011, OPHTHALMOLOGY, V118, pe1; Vashist P, 2011, OPHTHALMOLOGY, V118, P272, DOI 10.1016/j.ophtha.2010.05.020; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Wolff JL, 2005, J AM GERIATR SOC, V53, P851, DOI 10.1111/j.1532-5415.2005.53262.x; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; World Health Organization, 2008, GLOBAL BURDEN DIS; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	142	970	1007	20	303	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					549	562		10.1016/S0140-6736(14)61347-7	http://dx.doi.org/10.1016/S0140-6736(14)61347-7			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AV	25468153				2022-12-28	WOS:000349213600034
J	Dao, A; Yaro, AS; Diallo, M; Timbine, S; Huestis, DL; Kassogue, Y; Traore, AI; Sanogo, ZL; Samake, D; Lehmann, T				Dao, A.; Yaro, A. S.; Diallo, M.; Timbine, S.; Huestis, D. L.; Kassogue, Y.; Traore, A. I.; Sanogo, Z. L.; Samake, D.; Lehmann, T.			Signatures of aestivation and migration in Sahelian malaria mosquito populations	NATURE			English	Article							ANOPHELES-GAMBIAE COMPLEX; DRY SEASON; MOLECULAR-FORMS; SUDAN SAVANNA; WEST-AFRICA; MALI; PERSISTENCE; ARABIENSIS; DIFFERENTIATION; TRANSMISSION	During the long Sahelian dry season, mosquito vectors of malaria are expected to perish when no larval sites are available; yet, days after the first rains, mosquitoes reappear in large numbers. How these vectors persist over the 3-6-month long dry season has not been resolved, despite extensive research for over a century(1-3.) Hypotheses for vector persistence include dry-season diapause (aestivation) and long-distance migration (LDM); both are facets of vector biology that have been highly controversial owing to lack of concrete evidence. Here we show that certain species persist by a form of aestivation, while others engage in LDM. Using time-series analyses, the seasonal cycles of Anopheles coluzzii, Anopheles gambiae sensu stricto (s.s.), and Anopheles arabiensis were estimated, and their effects were found to be significant, stable and highly species-specific. Contrary to all expectations, the most complex dynamics occurred during the dry season, when the density of A. coluzzii fluctuated markedly, peaking when migration would seem highly unlikely, whereas A. gambiae s.s. was undetected. The population growth of A. coluzzii followed the first rains closely, consistent with aestivation, whereas the growth phase of both A. gambiae s.s. and A. arabiensis lagged by two months. Such a delay is incompatible with local persistence, but fits LDM. Surviving the long dry season in situ allows A. coluzzii to predominate and form the primary force of malaria transmission. Our results reveal profound ecological divergence between A. coluzzii and A. gambiae s.s., whose standing as distinct species has been challenged, and suggest that climate is one of the selective pressures that led to their speciation. Incorporating vector dormancy and LDM is key to predicting shifts in the range of malaria due to global climate change(4), and to the elimination of malaria from Africa.	[Dao, A.; Yaro, A. S.; Diallo, M.; Timbine, S.; Kassogue, Y.; Traore, A. I.; Sanogo, Z. L.; Samake, D.] Univ Sci Tech & Technol, ICER, Bamako, Mali; [Huestis, D. L.; Lehmann, T.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	University of Science & Technology of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lehmann, T (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	tlehmann@niaid.nih.gov	Kassogue, Y/AAN-9587-2020	Lehmann, Tovi/0000-0002-8142-3915; Kassogue, Yaya/0000-0003-2476-4016	Tamaki Foundation; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001196] Funding Source: NIH RePORTER	Tamaki Foundation; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the residents of Thierola for their hospitality and assistance with mosquito collections; J. Ribeiro, T. Wellems, P. McQueen, R. Faiman and G. Wasserberg for their comments on previous versions of this manuscript; and C. Traore, R. Sakai, R. Gwadz and T. Wellems for logistical support. This study was supported by the Tamaki Foundation and by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Adamou A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-151; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023; DENLINGER DL, 1986, ANNU REV ENTOMOL, V31, P239, DOI 10.1146/annurev.en.31.010186.001323; Donnelly MJ, 2002, TRENDS PARASITOL, V18, P75, DOI 10.1016/S1471-4922(01)02198-5; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Harvey A.C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; Holstein M. H., 1954, RES FRENCH W AFRICA; Huestis D.L., 2014, INFECT GENET EVOL; Huestis DL, 2012, J EXP BIOL, V215, P2013, DOI 10.1242/jeb.069468; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Lehmann T, 2014, J MED ENTOMOL, V51, P27, DOI 10.1603/ME13094; Lehmann T, 2010, AM J TROP MED HYG, V83, P601, DOI 10.4269/ajtmh.2010.09-0779; Lemasson JJ, 1997, J MED ENTOMOL, V34, P396, DOI 10.1093/jmedent/34.4.396; OMER SM, 1968, NATURE, V217, P879, DOI 10.1038/217879b0; OMER SM, 1970, B WORLD HEALTH ORGAN, V42, P319; Simard F, 2000, INSECT MOL BIOL, V9, P467, DOI 10.1046/j.1365-2583.2000.00210.x; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Sogoba N, 2007, AM J TROP MED HYG, V77, P82, DOI 10.4269/ajtmh.2007.77.82; Sogoba N, 2007, ACTA TROP, V101, P232, DOI 10.1016/j.actatropica.2007.02.005; Sogoba N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-205; Tauber M.J., 1986, SEASONAL ADAPTATIONS; TAYLOR CE, 1993, MED VET ENTOMOL, V7, P351, DOI 10.1111/j.1365-2915.1993.tb00704.x; TOURE YT, 1994, GENETICA, V94, P213, DOI 10.1007/BF01443435; Toure YT, 1996, MED VET ENTOMOL, V10, P197, DOI 10.1111/j.1365-2915.1996.tb00731.x; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yaro AS, 2012, J INSECT PHYSIOL, V58, P1050, DOI 10.1016/j.jinsphys.2012.04.002	31	83	84	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2014	516	7531					387	+		10.1038/nature13987	http://dx.doi.org/10.1038/nature13987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW8BE	25470038	Green Accepted			2022-12-28	WOS:000346484800045
J	Meyer, SN; Amoyel, M; Bergantinos, C; de la Cova, C; Schertel, C; Basler, K; Johnston, LA				Meyer, S. N.; Amoyel, M.; Bergantinos, C.; de la Cova, C.; Schertel, C.; Basler, K.; Johnston, L. A.			An ancient defense system eliminates unfit cells from developing tissues during cell competition	SCIENCE			English	Article							NF-KAPPA-B; IMMUNE-RESPONSE; TOLL-LIKE; DROSOPHILA; MYC; GROWTH; DORSAL; GENE; GENOME; RELISH	Developing tissues that contain mutant or compromised cells present risks to animal health. Accordingly, the appearance of a population of suboptimal cells in a tissue elicits cellular interactions that prevent their contribution to the adult. Here we report that this quality control process, cell competition, uses specific components of the evolutionarily ancient and conserved innate immune system to eliminate Drosophila cells perceived as unfit. We find that Toll-related receptors (TRRs) and the cytokine Spatzle (Spz) lead to NF kappa B-dependent apoptosis. Diverse "loser" cells require different TRRs and NF kappa B factors and activate distinct pro-death genes, implying that the particular response is stipulated by the competitive context. Our findings demonstrate a functional repurposing of components of TRRs and NF kappa B signaling modules in the surveillance of cell fitness during development.	[Meyer, S. N.; Schertel, C.; Basler, K.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Amoyel, M.; Bergantinos, C.; de la Cova, C.; Johnston, L. A.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	University of Zurich; Columbia University	Basler, K (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	konrad.basler@imls.uzh.ch; lj180@columbia.edu	Amoyel, Marc/GLR-0962-2022; Johnston, Laura A/ABC-1945-2021	Amoyel, Marc/0000-0002-2691-2097; Basler, Konrad/0000-0003-3534-1529; JOHNSTON, LAURA A/0000-0001-9477-7897; de la Cova, Claire/0000-0001-8719-6883	European Molecular Biology Organization; Leukemia and Lymphoma Society; European Research Council; Swiss National Science Foundation; NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD067918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078464, R01GM084947] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank numerous colleagues for providing fly strains and reagents; L. Alpar, J. D'Arcangelo, S. Park, E. Bates, and F. Mayer for discussions and assistance with some experiments; J.-M. Reichhart, T. Ip, N. Silverman, and P. Meier for helpful discussions early in the project; and D. Littman, S. Reiner, and members of the Johnston and Basler labs for advice. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P40OD018537) and the Harvard TRiP collection (National Institute of General Medical Sciences R01-GM084947) were used in this study. This work was supported by a European Molecular Biology Organization Long-Term Postdoctoral Fellowship (M.A.), the Leukemia and Lymphoma Society (C.B.), the European Research Council (K.B.), the Swiss National Science Foundation (K.B. and S.N.M.), and the NIH (L.A.J.). The S2 cells used in the cell-based competition assays in this study are available under a materials transfer agreement from Columbia University.	Baker NE, 2011, CURR BIOL, V21, pR11, DOI 10.1016/j.cub.2010.11.030; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Buss LW, 1987, EVOLUTION INDIVIDUAL, DOI DOI 10.1515/9781400858712; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; de la Cova C, 2014, CELL METAB, V19, P470, DOI 10.1016/j.cmet.2014.01.012; Dejosez M, 2013, SCIENCE, V341, P1511, DOI 10.1126/science.1241628; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; Gauthier MEA, 2010, EVOL DEV, V12, P519, DOI 10.1111/j.1525-142X.2010.00436.x; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Kanzok SM, 2004, J MOL EVOL, V58, P442, DOI 10.1007/s00239-003-2565-8; Kazemian M, 2011, NUCLEIC ACIDS RES, V39, pW79, DOI 10.1093/nar/gkr291; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Niklas KJ, 2013, EVOL DEV, V15, P41, DOI 10.1111/ede.12013; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Roach JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054156; Rodrigues AB, 2012, DEVELOPMENT, V139, P4051, DOI 10.1242/dev.076760; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; Senoo-Matsuda N, 2007, P NATL ACAD SCI USA, V104, P18543, DOI 10.1073/pnas.0709021104; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Song XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051657; Stein D, 1998, DEVELOPMENT, V125, P2159; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773; Vincent JP, 2011, DEV CELL, V21, P366, DOI 10.1016/j.devcel.2011.06.021; Wu DC, 2010, GENETICS, V184, P199, DOI 10.1534/genetics.109.110379; Ziosi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001140	46	129	136	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1199	+	1258236	10.1126/science.1258236	http://dx.doi.org/10.1126/science.1258236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6XQ	25477468	Green Accepted			2022-12-28	WOS:000349770700002
J	Phadnis, N; Malik, HS				Phadnis, Nitin; Malik, Harmit S.			Speciation via Autoimmunity: A Dangerous Mix	CELL			English	Editorial Material							SINGLE-GENE SPECIATION		[Phadnis, Nitin] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, HHMI, Seattle, WA 98109 USA	Utah System of Higher Education; University of Utah; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Malik, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	nitin.phadnis@utah.edu; hsmalik@fhcrc.org	Malik, Harmit S/I-5591-2019	Malik, Harmit S/0000-0001-6005-0016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074108] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM115914, NIH R01 GM074108, R01 GM074108] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chae E, 2014, CELL, V159, P1341, DOI 10.1016/j.cell.2014.10.049; Coyne J.A., 2004, SPECIATION; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; ORR HA, 1991, EVOLUTION, V45, P764, DOI 10.1111/j.1558-5646.1991.tb04345.x; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Ueshima R, 2003, NATURE, V425, P679, DOI 10.1038/425679a	10	2	2	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1247	1249		10.1016/j.cell.2014.11.028	http://dx.doi.org/10.1016/j.cell.2014.11.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480288	Bronze			2022-12-28	WOS:000346652900003
J	Pemberton, S				Pemberton, Stephen			The fix is in	NATURE			English	Editorial Material							GENE-THERAPY; HEMOPHILIA		New Jersey Inst Technol, Newark, NJ 07102 USA	New Jersey Institute of Technology	Pemberton, S (corresponding author), New Jersey Inst Technol, Newark, NJ 07102 USA.	stephen.pemberton@njit.edu						High KH, 2014, HAEMOPHILIA, V20, P43, DOI 10.1111/hae.12411; High KA, 2011, MOL THER, V19, P1749, DOI 10.1038/mt.2011.203; Mannucci PM, 2011, HAEMOPHILIA, V17, P1, DOI 10.1111/j.1365-2516.2011.02657.x; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Pemberton Stephen Gregory, 2011, BLEEDING DIS HEMOPHI; Wailoo Keith, 2006, TROUBLED DREAM GENET	6	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S165	S165		10.1038/515S165a	http://dx.doi.org/10.1038/515S165a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427207	Bronze			2022-12-28	WOS:000346247600009
J	Gao, P; Postiglione, MP; Krieger, TG; Hernandez, L; Wang, C; Han, Z; Streicher, C; Papusheva, E; Insolera, R; Chugh, K; Kodish, O; Huang, K; Simons, BD; Luo, LQ; Hippenmeyer, S; Shi, SH				Gao, Peng; Postiglione, Maria Pia; Krieger, Teresa G.; Hernandez, Luisirene; Wang, Chao; Han, Zhi; Streicher, Carmen; Papusheva, Ekaterina; Insolera, Ryan; Chugh, Kritika; Kodish, Oren; Huang, Kun; Simons, Benjamin D.; Luo, Liqun; Hippenmeyer, Simon; Shi, Song-Hai			Deterministic Progenitor Behavior and Unitary Production of Neurons in the Neocortex	CELL			English	Article							OUTER SUBVENTRICULAR ZONE; NEURAL PROGENITORS; CEREBRAL-CORTEX; RADIAL GLIA; STEM; CELLS; NEUROGENESIS; DISPERSION; MIGRATION; REGIONS	Radial glial progenitors (RGPs) are responsible for producing nearly all neocortical neurons. To gain insight into the patterns of RGP division and neuron production, we quantitatively analyzed excitatory neuron genesis in the mouse neocortex using Mosaic Analysis with Double Markers, which provides single-cell resolution of progenitor division patterns and potential in vivo. We found that RGPs progress through a coherent program in which their proliferative potential diminishes in a predictable manner. Upon entry into the neurogenic phase, individual RGPs produce similar to 8-9 neurons distributed in both deep and superficial layers, indicating a unitary output in neuronal production. Removal of OTX1, a transcription factor transiently expressed in RGPs, results in both deep-and superficial-layer neuron loss and a reduction in neuronal unit size. Moreover, similar to 1/6 of neurogenic RGPs proceed to produce glia. These results suggest that progenitor behavior and histogenesis in the mammalian neocortex conform to a remarkably orderly and deterministic program.	[Gao, Peng; Hernandez, Luisirene; Insolera, Ryan; Chugh, Kritika; Kodish, Oren; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Gao, Peng; Hernandez, Luisirene; Insolera, Ryan; Shi, Song-Hai] Weill Cornell Med Coll, Grad Program Neurosci, New York, NY 10065 USA; [Postiglione, Maria Pia; Streicher, Carmen; Papusheva, Ekaterina; Hippenmeyer, Simon] IST Austria, A-3400 Klosterneuburg, Austria; [Krieger, Teresa G.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Krieger, Teresa G.; Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Wang, Chao; Huang, Kun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Wang, Chao; Huang, Kun] Ohio State Univ, Dept Elect & Comp Engn, Columbus, OH 43210 USA; [Han, Zhi] Nankai Univ, Coll Software, Tianjin 300071, Peoples R China; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1QR, England; [Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Institute of Science & Technology - Austria; University of Cambridge; University of Cambridge; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nankai University; University of Cambridge; Howard Hughes Medical Institute; Stanford University; Stanford University	Hippenmeyer, S (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	simon.hippenmeyer@ist.ac.at; shis@mskcc.org	Huang, Kun/E-3272-2011; Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Luo, Liqun/0000-0001-5467-9264; Insolera, Ryan/0000-0001-8282-9370; Han, Zhi/0000-0002-5603-8433; Gao, Peng (Kate)/0000-0002-6557-8511; Hippenmeyer, Simon/0000-0003-2279-1061	European Union [FP7-CIG618444]; Simons Foundation [274336]; NIH [R01DA024681, R01MH101382, R01NS050835, T32HD060600]; Wellcome Trust [098357/Z/12/Z]; Human Frontier Science Program [RGP0053]; Engineering and Physical Sciences Research Council [1208869] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060600] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	European Union(European Commission); Simons Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Dr. Nicoletta Tekki-Kessaris, Dr. Ryoichiro Kageyama, and Dr. Antonio Simeone for kindly providing Emx1-CreER<SUP>T2</SUP>, Nestin-CreER<SUP>T2</SUP>, and Otx1<SUP>+/-</SUP> mouse lines, respectively; Dr. Rick Livesey for helpful discussions, Zhizhong Li and Susanne Laukoter for technical support; and Shi and Hippenmeyer lab members for insightful discussions and input. This work was supported by the European Union (FP7-CIG618444 to S.H.), the Simons Foundation (274336 to S.-H.S.), NIH grants (R01DA024681 and R01MH101382 to S.-H.S., R01NS050835 to L.L., and T32HD060600 to L.H.), the Wellcome Trust (098357/Z/12/Z to B.D.S.), and the Human Frontier Science Program (RGP0053 to S.-H.S., S.H., B.D.S., and K.H.). L.L. is an investigator of the Howard Hughes Medical Institute.	Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bayraktar OA, 2013, NATURE, V498, P449, DOI 10.1038/nature12266; Betizeau M, 2013, NEURON, V80, P442, DOI 10.1016/j.neuron.2013.09.032; Brown KN, 2011, SCIENCE, V334, P480, DOI 10.1126/science.1208884; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Costa MR, 2009, CEREB CORTEX, V19, pI135, DOI 10.1093/cercor/bhp046; Desai AR, 2000, DEVELOPMENT, V127, P2863; Diggle P.J., 2003, STAT ANAL SPATIAL PO; Dominguez MH, 2013, CEREB CORTEX, V23, P2632, DOI 10.1093/cercor/bhs252; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Guo C, 2013, NEURON, V80, P1167, DOI 10.1016/j.neuron.2013.09.037; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; He J, 2012, NEURON, V75, P786, DOI 10.1016/j.neuron.2012.06.033; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Li X, 2013, NATURE, V498, P456, DOI 10.1038/nature12319; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Magavi S, 2012, J NEUROSCI, V32, P4762, DOI 10.1523/JNEUROSCI.3560-11.2012; Marin O, 2012, NATURE, V490, P185, DOI 10.1038/490185a; McCarthy M, 2001, J NEUROSCI, V21, P6772, DOI 10.1523/JNEUROSCI.21-17-06772.2001; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Teixeira VH, 2013, ELIFE, V2, DOI 10.7554/eLife.00966; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	53	235	237	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					775	788		10.1016/j.cell.2014.10.027	http://dx.doi.org/10.1016/j.cell.2014.10.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417155	Green Published, hybrid			2022-12-28	WOS:000344522000011
J	Adams, PJ; Ben-Johny, M; Dick, IE; Inoue, T; Yue, DT				Adams, Paul J.; Ben-Johny, Manu; Dick, Ivy E.; Inoue, Takanari; Yue, David T.			Apocalmodulin Itself Promotes Ion Channel Opening and Ca2+ Regulation	CELL			English	Article							PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; DOPAMINE NEURONS; SODIUM-CHANNELS; CALMODULIN; INACTIVATION; MODULATION; ACTIVATION; EXPRESSION; INDUCTION	The Ca2+-free form of calmodulin (apoCaM) often appears inert, modulating target molecules only upon conversion to its Ca2+-bound form. This schema has appeared to govern voltage-gated Ca2+ channels, where apoCaM has been considered a dormant Ca2+ sensor, associated with channels but awaiting the binding of Ca2+ ions before inhibiting channel opening to provide vital feedback inhibition. Using single-molecule measurements of channels and chemical dimerization to elevate apoCaM, we find that apoCaM binding on its own markedly upregulates opening, rivaling the strongest forms of modulation. Upon Ca2+ binding to this CaM, inhibition may simply reverse the initial upregulation. As RNA-edited and - spliced channel variants show different affinities for apoCaM, the apoCaM-dependent control mechanisms may underlie the functional diversity of these variants and explain an elongation of neuronal action potentials by apoCaM. More broadly, voltage-gated Na channels adopt this same modulatory principle. ApoCaM thus imparts potent and pervasive ion-channel regulation.	[Adams, Paul J.; Ben-Johny, Manu; Dick, Ivy E.; Yue, David T.] Johns Hopkins Univ, Ctr Cell Dynam, Sch Med, Calcium Signals Lab,Dept Biomed Engn, Baltimore, MD 21205 USA; [Adams, Paul J.; Ben-Johny, Manu; Dick, Ivy E.; Yue, David T.] Johns Hopkins Univ, Ctr Cell Dynam, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Inoue, Takanari] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Inoue, Takanari] Johns Hopkins Univ, Sch Med, Ctr Cell Dynam, Baltimore, MD 21205 USA; [Inoue, Takanari] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Japan Science & Technology Agency (JST)	Yue, DT (corresponding author), Johns Hopkins Univ, Ctr Cell Dynam, Sch Med, Calcium Signals Lab,Dept Biomed Engn, 720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@jhmi.edu		Dick, Ivy/0000-0002-7253-6846; Ben-Johny, Manu/0000-0002-5645-0815	NINDS; NHLBI; NIMH; Parkinson Society Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL076795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073874, R01NS085074] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Parkinson Society Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Hojjat Bazzazi and Philemon Yang for providing some Ca<INF>V</INF>1.3 variants, Ca<SUP>2+</SUP> Signals Lab members for valuable comments, and Wanjun Yang for technical support. This work was supported by grants from the NINDS (to D.T.Y.), NHLBI (D.T.Y.), NIMH (M.B.-J.), and Parkinson Society Canada (P.J.A.).	Alberts B., 1994, MOL BIOL CELL; Bazzazi H, 2013, CELL REP, V5, P367, DOI 10.1016/j.celrep.2013.09.006; Bean BP, 2007, NATURE, V447, P1059, DOI 10.1038/4471059a; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Bock G, 2011, J BIOL CHEM, V286, P42736, DOI 10.1074/jbc.M111.269951; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bossuyt J, 2013, J MOL MED, V91, P907, DOI 10.1007/s00109-013-1060-y; CARDOZO DL, 1995, J NEUROPHYSIOL, V74, P1137, DOI 10.1152/jn.1995.74.3.1137; CHAFOULEAS JG, 1982, CELL, V28, P41, DOI 10.1016/0092-8674(82)90373-7; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Christel CJ, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2012.239954; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GRACE AA, 1984, J NEUROSCI, V4, P2866; Hahn KM, 2010, NAT METHODS, V7, P595, DOI 10.1038/nmeth0810-595; Herzog RI, 2003, J NEUROSCI, V23, P8261; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; Hille B, 1984, IONIC CHANNELS EXCIT; Huang H, 2012, NEURON, V73, P304, DOI 10.1016/j.neuron.2011.11.022; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kim EY, 2010, EMBO J, V29, P3924, DOI 10.1038/emboj.2010.260; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; Liu XD, 2010, NATURE, V463, P968, DOI 10.1038/nature08766; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Miriyala J, 2008, CIRC RES, V102, pE54, DOI 10.1161/CIRCRESAHA.108.171736; Nedergaard S, 1999, J NEUROPHYSIOL, V82, P2903, DOI 10.1152/jn.1999.82.6.2903; Obeso JA, 2008, ANN NEUROL, V64, pS30, DOI 10.1002/ana.21481; Phua SC, 2012, ACS CHEM BIOL, V7, P1950, DOI 10.1021/cb300280k; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Schroeter A, 2010, J MOL CELL CARDIOL, V49, P16, DOI 10.1016/j.yjmcc.2010.04.004; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tay LH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1777; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; Ueno T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002033; Vocke K, 2013, J GEN PHYSIOL, V142, P381, DOI 10.1085/jgp.201311015; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yacoubian TA, 2008, NEUROBIOL DIS, V29, P515, DOI 10.1016/j.nbd.2007.11.008; Yang TT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3540; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569	59	52	54	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					608	622		10.1016/j.cell.2014.09.047	http://dx.doi.org/10.1016/j.cell.2014.09.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417111	Green Accepted, Bronze			2022-12-28	WOS:000344521700016
J	Gusarova, V; Alexa, CA; Na, EQ; Stevis, PE; Xin, YR; Bonner-Weir, S; Cohen, JC; Hobbs, HH; Murphy, AJ; Yancopoulos, GD; Gromada, J				Gusarova, Viktoria; Alexa, Corey A.; Na, Erqian; Stevis, Panayiotis E.; Xin, Yurong; Bonner-Weir, Susan; Cohen, Jonathan C.; Hobbs, Helen H.; Murphy, Andrew J.; Yancopoulos, George D.; Gromada, Jesper			ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion	CELL			English	Article							GLUCOSE-INFUSION; INSULIN-RESISTANCE; BETATROPHIN; MICE; REGENERATION; INDIVIDUALS; REPLICATION; HYPERPLASIA; METABOLISM; DISEASE	Recently, it was reported that angiopoietin-like protein 8 (ANGPTL8) was the long-sought "betatrophin" that could control pancreatic beta cell proliferation. However, studies of Angptl8(-/-) mice revealed profound reduction of triglyceride levels, but no abnormalities in glucose homeostasis. We now report that Angptl8(-/-) mice undergo entirely normal beta cell expansion in response to insulin resistance resulting from either a high-fat diet or from the administration of the insulin receptor antagonist S961. Furthermore, overexpression of ANGPTL8 in livers of mice doubles plasma triglyceride levels, but does not alter beta cell expansion nor glucose metabolism. These data indicate that ANGPTL8 does not play a role in controlling beta cell growth, nor can it be given to induce such expansion. The findings that plasma triglyceride levels are reduced by Angptl8 deletion and increased following ANGPTL8 overexpression support the possibility that inhibition of ANGPTL8 represents a therapeutic strategy for hypertriglyceridemia.	[Gusarova, Viktoria; Alexa, Corey A.; Na, Erqian; Stevis, Panayiotis E.; Xin, Yurong; Murphy, Andrew J.; Yancopoulos, George D.; Gromada, Jesper] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Bonner-Weir, Susan] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Regeneron; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gusarova, V (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	viktoria.gusarova@regeneron.com		Murphy, Andrew/0000-0003-4152-4081; Bonner-Weir, Susan/0000-0003-4682-0656	NIH [PO1 HL20948]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We wish to thank Lisa Shihanian, Kristen Tramaglini, and Lawrence Miloscio for excellent technical assistance. We would also like to acknowledge support from the NIH (PO1 HL20948). Viktoria Gusarova, Corey A. Alexa, Erqian Na, Panayiotis E. Stevis, Yurong Xin, Andrew J. Murphy, George D. Yancopoulos, and Jesper Gromada are employees and shareholders of Regeneron Pharmaceuticals.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Bernard C, 1998, DIABETES, V47, P1058, DOI 10.2337/diabetes.47.7.1058; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Espes D, 2014, DIABETOLOGIA, V57, P50, DOI 10.1007/s00125-013-3071-1; Fenzl A, 2014, DIABETOLOGIA, V57, P1204, DOI 10.1007/s00125-014-3208-x; Fu ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05013; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Jiao Y, 2014, DIABETES, V63, P1283, DOI 10.2337/db13-1435; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; TURNER RC, 1995, DIABETES, V44, P1249; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735	22	170	189	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					691	696		10.1016/j.cell.2014.09.027	http://dx.doi.org/10.1016/j.cell.2014.09.027			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417115	Green Accepted, Bronze			2022-12-28	WOS:000344521700022
J	Titelman, D; Cetrangolo, O; Acosta, OL				Titelman, Daniel; Cetrangolo, Oscar; Luca Acosta, Olga			Universal health coverage in Latin American countries: how to improve solidarity-based schemes	LANCET			English	Article								In this Health Policy we examine the association between the financing structure of health systems and universal health coverage. Latin American health systems encompass a wide range of financial sources, which translate into different solidarity-based schemes that combine contributory (payroll taxes) and non-contributory (general taxes) sources of financing. To move towards universal health coverage, solidarity-based schemes must heavily rely on countries' capacity to increase public expenditure in health. Improvement of solidarity-based schemes will need the expansion of mandatory universal insurance systems and strengthening of the public sector including increased fiscal expenditure. These actions demand a new model to integrate different sources of health-sector financing, including general tax revenue, social security contributions, and private expenditure. The extent of integration achieved among these sources will be the main determinant of solidarity and universal health coverage. The basic challenges for improvement of universal health coverage are not only to spend more on health, but also to reduce the proportion of out-of-pocket spending, which will need increased fiscal resources.	[Titelman, Daniel] Comis Econ Amer Latina & Carib, Econ Dev Div, Santiago, Chile; [Cetrangolo, Oscar] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Luca Acosta, Olga] ECLAC Bogota, Bogota, Colombia	University of Buenos Aires	Titelman, D (corresponding author), Comis Econ Amer Latina & Carib, Econ Dev Div, Av Dag Hammarskjold 3477, Santiago, Chile.	daniel.titelman@cepal.org			Rockefeller Foundation through a grant to ECLAC	Rockefeller Foundation through a grant to ECLAC	This paper accompanies a Series funded by the Rockefeller Foundation through a grant to ECLAC. We thank the commission and the foundation for convening various author meetings, and their participants for very helpful suggestions.	Bastagli F., 2009, SOCIAL SAFETY NET SO; Bitran R, 2008, GOOD PRACTICES HLTH, P89; Cercone J, 2008, GOOD PRACTICES HLTH, P182; Cetrangolo O, 2012, DECENTRALIZATION AND REFORM IN LATIN AMERICA: IMPROVING INTERGOVERNMENTAL RELATIONS, P38; ECLAC, 2006, SHAP FUT SOC PROT AC; ECLAC, 2013, SUST DEV LAT AM CAR; ECLAC, 2013, INF AN 2012; Economic Commission for Latin America and the Caribbean (ECLAC), 2013, SOC PAN LAT AM 2013; Economic Commission for Latin America and the Caribbean (ECLAC), 2012, SOC PAN LAT AM 2012; Giedion U, 2011, POLITICA FISCAL AFIA, P127; Glassman A. L., 2009, FEW MANY 10 YEARS HL; Gomez J, 2012, SERIE MACROECONOMIA, V124; Gomez J, 2011, POLITICA FISCAL AFIA, P71; Kutzin J, 2013, B WORLD HEALTH ORGAN, V91, P602, DOI 10.2471/BLT.12.113985; Marten R, 2014, LANCET; Medina-Flores A, 2004, SURF COAT TECH, V188, P7, DOI 10.1016/j.surfcoat.2004.07.092; Mesa-Lago Carmelo, 2004, SERIE FINANCIAMIENTO, V144; Musgrave R.A., 1989, PUBLIC FINANCE THEOR, V5; Oates WE, 1972, FISCAL FEDERALISM; PAHO, 2009, PERF SIST SAL REP OR; Pan American Health Organization, STRAT PLAN PAN AM HL; Pan American Health Organization, 2013, 154 SESS EX COMM; Pan American Health Organization (PAHO), 2002, HLTH AM; Romaguera P, 2011, POLIFICA FISCAL AFIA, P159; Sabaini, 2007, SERIE MACROECONOMIA, V60; Savedoff W., 2003, 22003 WHO; Sojo A, 2007, COHESION SOCIAL AM L, P209; Titelman D., 2000, FINANCIAMIENTO DESAR, V104 (LC/L.1425-P/E); Titelman D, 2000, ENSAYOS FINANCIAMIEN; Van Doorslaer E, 1992, EQUITY FINANCE DELIV; Wagstaff A, 2009, 4821 WORLD BANK; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1	33	20	21	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1359	1363		10.1016/S0140-6736(14)61780-3	http://dx.doi.org/10.1016/S0140-6736(14)61780-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF0ZD	25458734				2022-12-28	WOS:000352272400042
J	Vega, J; Frenz, P				Vega, Jeanette; Frenz, Patricia			Latin America: priorities for universal health coverage	LANCET			English	Editorial Material							MEXICO		[Vega, Jeanette] Chiles Natl Hlth Fund, Fondo Nacl Salud, Santiago, Chile; [Frenz, Patricia] Univ Chile, Sch Publ Hlth, Santiago 8380453, Chile	Universidad de Chile	Frenz, P (corresponding author), Univ Chile, Sch Publ Hlth, Santiago 8380453, Chile.	pfrenz@med.uchile.cl						[Anonymous], 2014, HLTH BENEFIT PLANS L; Aran D, 2013, REV SALUD PUBLICA ME, V53, P265; Bitran R, 2010, HEALTH AFFAIR, V29, P2161, DOI 10.1377/hlthaff.2010.0972; Congreso de la Republica, 2009, C REP FRAM LAW UN HL; Dawes A, 2010, IMPORTANCE HOSP SUPP; Frenk J, 2009, B WORLD HEALTH ORGAN, V87, P542, DOI 10.2471/BLT.08.053199; Giedion U, 2009, HEALTH AFFAIR, V28, P853, DOI 10.1377/hlthaff.28.3.853; Glassman A, 2012, PRIORITY SETTING HLT; Johannes L., 2007, OBAPPROACHES, V13, P1; Kapiriri L, 2013, SOC SCI MED, V85, P38, DOI 10.1016/j.socscimed.2013.02.024; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Rodriguez Herrera A., 2006, HLTH REFORM HONDURAS; Sandoval Orellana H., 2004, CUADERNOS MED SOCIAL, V43, P5; Sojo A., 2006, HLTH BENEFITS GUARAN; Vargas V, 2008, HEALTH AFFAIR, V27, P782, DOI 10.1377/hlthaff.27.3.782; Zúñiga Fajuri Alejandra, 2011, Acta bioeth., V17, P73, DOI 10.4067/S1726-569X2011000100009	16	10	10	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					E31	E32		10.1016/S0140-6736(14)61635-4	http://dx.doi.org/10.1016/S0140-6736(14)61635-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF0ZD	25458720				2022-12-28	WOS:000352272400004
J	Duval, X; Hoen, B				Duval, Xavier; Hoen, Bruno			Prophylaxis for infective endocarditis: let's end the debate	LANCET			English	Editorial Material							ANTIBIOTIC-PROPHYLAXIS; PREVENTION; ADULTS; TRENDS; IMPACT		[Duval, Xavier] Hop Univ Bichat, AP HP, INSERM, CIC 1425, F-75018 Paris, France; [Duval, Xavier] Univ Paris Diderot, IAME, UFR Med Bichat, Inserm U1137, Paris, France; [Duval, Xavier; Hoen, Bruno] Assoc Etud & Prevent Endocard Infect, Paris, France; [Hoen, Bruno] Univ Antilles, Fac Med Hyacinthe Bastaraud, Pointe a Pitre, Guadeloupe, France; [Hoen, Bruno] Univ Antilles, INSERM, CIC1424, Pointe a Pitre, Guadeloupe, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite des Antilles; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles	Duval, X (corresponding author), Hop Univ Bichat, AP HP, INSERM, CIC 1425, F-75018 Paris, France.	xavier.duval@bch.aphp.fr						[Anonymous], 1992, LANCET, V339, P525; Dayer MJ, 2015, LANCET, V385, P1219, DOI 10.1016/S0140-6736(14)62007-9; Duval X, 2006, CLIN INFECT DIS, V42, pE102, DOI 10.1086/504385; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hoen B, 2013, NEW ENGL J MED, V368, P1425, DOI 10.1056/NEJMcp1206782; Lacassin F, 1995, EUR HEART J, V16, P1968, DOI 10.1093/oxfordjournals.eurheartj.a060855; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; National Institute for Health and Clinical Excellence, 2008, PROPH INF END; Pasquali SK, 2012, AM HEART J, V163, P894, DOI 10.1016/j.ahj.2012.03.002; Stokes T, 2008, HEART, V94, P930, DOI 10.1136/hrt.2008.147090; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095	13	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1164	+		10.1016/S0140-6736(14)62121-8	http://dx.doi.org/10.1016/S0140-6736(14)62121-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25467570				2022-12-28	WOS:000351715100011
J	LeFevre, ML				LeFevre, Michael L.		US Preventive Serv Task Force	Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							OSTEOPOROSIS; POPULATION; AMERICANS	Description: New USPSTF recommendation on screening for vitamin D deficiency in adults. Methods: The USPSTF reviewed the evidence on screening for and treatment of vitamin D deficiency, including the benefits and harms of screening and early treatment. Population: This recommendation applies to communitydwelling, nonpregnant adults aged 18 years or older who are seen in primary care settings and are not known to have signs or symptoms of vitamin D deficiency or conditions for which vitamin D treatment is recommended. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (I statement)					Phillips, William R./V-1065-2017	Phillips, William R./0000-0003-2802-4349; Kemper, Alex/0000-0001-5491-3997; Davidson, Karina/0000-0002-9162-477X	USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	Aloia JF, 2008, AM J CLIN NUTR, V88, p545S, DOI 10.1093/ajcn/88.2.545S; American Academy of Family Physicians, 2014, REC TYP CLIN PREV SE; American Geriatrics Society British Geriatrics Society, 2010, AGS BGS CLIN PRACT G; Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; Carter GD, 2012, CLIN CHEM, V58, P486, DOI 10.1373/clinchem.2011.180562; Committee on Practice Bulletins-Gynecology The American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P718, DOI 10.1097/AOG.0b013e31826dc446; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Huang KE, 2014, SOUTH MED J, V107, P214, DOI 10.1097/SMJ.0000000000000085; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; LeBlanc E, 2014, AHRQ PUBLICATION, V13-05183-EF-1; LeBlanc ES, 2015, ANN INTERN MED, V162, P109, DOI 10.7326/M14-1659; Looker Anne C, 2011, NCHS Data Brief, P1; National Institutes of Health, 2011, VIT D FACT SHEET HLT; National Institutes of Health Office of Dietary Supplements, 2014, VIT D STAND PROGR; National Osteoporosis Foundation, 2014, CLIN GUID PREV TREAT; Newberry SJ, 2014, AHRQ PUBLICATION, V14-E004-EF; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Rollins G., 2009, CLIN LAB NEWS, V35, P1; ROLLINS G, 2009, CLIN LAB NEWS, V35, P8; ROLLINS G, 2009, CLIN LAB NEWS, V35, P6; Taylor CL, 2013, AM J CLIN NUTR, V97, P72, DOI 10.3945/ajcn.112.046094; Vesper HW, 2014, VITAMIN D STANDARDIZ	24	132	137	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2					133	+		10.7326/M14-2450	http://dx.doi.org/10.7326/M14-2450			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NB	25419853				2022-12-28	WOS:000350106600019
J	Buller, HR; Bethune, C; Bhanot, S; Gailani, D; Monia, BP; Raskob, GE; Segers, A; Verhamme, P; Weitz, JI				Bueller, Harry R.; Bethune, Claudette; Bhanot, Sanjay; Gailani, David; Monia, Brett P.; Raskob, Gary E.; Segers, Annelise; Verhamme, Peter; Weitz, Jeffrey I.		FXI-ASO TKA Investigators	Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COAGULATION-FACTOR XI; BLOOD-COAGULATION; BLEEDING RISK; INHIBITION; THROMBOEMBOLISM; DEFICIENCY	Background Experimental data indicate that reducing factor XI levels attenuates thrombosis without causing bleeding, but the role of factor XI in the prevention of postoperative venous thrombosis in humans is unknown. FXI-ASO (ISIS 416858) is a second-generation antisense oligonucleotide that specifically reduces factor XI levels. We compared the efficacy and safety of FXI-ASO with those of enoxaparin in patients undergoing total knee arthroplasty. Methods In this open-label, parallel-group study, we randomly assigned 300 patients who were undergoing elective primary unilateral total knee arthroplasty to receive one of two doses of FXI-ASO (200 mg or 300 mg) or 40 mg of enoxaparin once daily. The primary efficacy outcome was the incidence of venous thromboembolism (assessed by mandatory bilateral venography or report of symptomatic events). The principal safety outcome was major or clinically relevant nonmajor bleeding. Results Around the time of surgery, the mean (+/- SE) factor XI levels were 0.38 +/- 0.01 units per milliliter in the 200-mg FXI-ASO group, 0.20 +/- 0.01 units per milliliter in the 300-mg FXI-ASO group, and 0.93 +/- 0.02 units per milliliter in the enoxaparin group. The primary efficacy outcome occurred in 36 of 134 patients (27%) who received the 200-mg dose of FXI-ASO and in 3 of 71 patients (4%) who received the 300-mg dose of FXI-ASO, as compared with 21 of 69 patients (30%) who received enoxaparin. The 200-mg regimen was noninferior, and the 300-mg regimen was superior, to enoxaparin (P<0.001). Bleeding occurred in 3%, 3%, and 8% of the patients in the three study groups, respectively. Conclusions This study showed that factor XI contributes to postoperative venous thromboembolism; reducing factor XI levels in patients undergoing elective primary unilateral total knee arthroplasty was an effective method for its prevention and appeared to be safe with respect to the risk of bleeding. Copyright (C) 2014 Massachusetts Medical Society.	[Bueller, Harry R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Segers, Annelise] Int Trial Expertise Advisory & Serv ITREAS, Amsterdam, Netherlands; [Bethune, Claudette; Bhanot, Sanjay; Monia, Brett P.] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Gailani, David] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA; [Verhamme, Peter] Katholieke Univ Leuven, Dept Cardiovasc Sci Vasc Med & Hemostasis, Leuven, Belgium; [Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON, Canada	University of Amsterdam; Academic Medical Center Amsterdam; Isis Pharmaceuticals Inc; Vanderbilt University; University of Oklahoma System; University of Oklahoma Health Sciences Center; KU Leuven; McMaster University; McMaster University	Buller, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, F4-275,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.r.buller@amc.uva.nl	Korzh, Mykola/C-8491-2018; Weitz, Jeffrey/AAD-1929-2019; Sulyma, Vadym/GVT-5704-2022	Korzh, Mykola/0000-0002-0489-3104; Weitz, Jeffrey/0000-0002-1092-7550; Sulyma, Vadym/0000-0001-6618-2546; Petronis, Sarunas/0000-0003-4592-5851	Isis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081326, R01HL058837] Funding Source: NIH RePORTER	Isis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by Isis Pharmaceuticals; FXI-ASO TKA ClinicalTrials.gov number, NCT01713361.	Buller HR, 2007, NEW ENGL J MED, V357, P1094; Cushman M, 2009, BLOOD, V114, P2878, DOI 10.1182/blood-2009-05-219915; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Fuji T, 2010, J THROMB HAEMOST, V8, P2458, DOI 10.1111/j.1538-7836.2010.04021.x; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Salomon O, 2011, THROMB HAEMOSTASIS, V105, P269, DOI 10.1160/TH10-05-0307; Tucker EI, 2009, BLOOD, V113, P936, DOI 10.1182/blood-2008-06-163675; Verhamme P, 2013, THROMB HAEMOSTASIS, V109, P1091, DOI 10.1160/TH13-01-0066; Wang XK, 2006, J THROMB HAEMOST, V4, P1982, DOI 10.1111/j.1538-7836.2006.02093.x; Younis HS, 2012, BLOOD, V119, P2401, DOI 10.1182/blood-2011-10-387134; Zhang H, 2010, BLOOD, V116, P4684, DOI 10.1182/blood-2010-04-277798	16	369	376	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 15	2015	372	3					232	240		10.1056/NEJMoa1405760	http://dx.doi.org/10.1056/NEJMoa1405760			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ3HX	25482425	Green Accepted			2022-12-28	WOS:000348119200007
J	Bar-Peled, L				Bar-Peled, Liron			Size does matter	SCIENCE			English	Editorial Material							AMINO-ACID LEVELS; RAG GTPASES; TUMOR-SUPPRESSOR; MTORC1; MUTATIONS; RAGULATOR; COMPLEX; GAP		Scripps Res Inst, La Jolla, CA 92122 USA	Scripps Research Institute	Bar-Peled, L (corresponding author), Scripps Res Inst, La Jolla, CA 92122 USA.	lironbp@scripps.edu						Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Dibbens LM, 2013, NAT GENET, V45, P546, DOI 10.1038/ng.2599; Ishida S, 2013, NAT GENET, V45, P552, DOI 10.1038/ng.2601; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Shaw RJ, 2013, SCIENCE, V340, P1056, DOI 10.1126/science.1240315; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	14	0	0	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1191	1192		10.1126/science.aaa1808	http://dx.doi.org/10.1126/science.aaa1808			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477447				2022-12-28	WOS:000346189000047
J	Wood, CL				Wood, Chelsea L.			Environmental change and the ecology of infectious disease	SCIENCE			English	Editorial Material							BIODIVERSITY		[Wood, Chelsea L.] Univ Michigan, Dept Ecol & Evolut Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Wood, CL (corresponding author), Univ Michigan, Dept Ecol & Evolut Biol, Ann Arbor, MI 48109 USA.	chelwood@umich.edu		Wood, Chelsea/0000-0003-2738-3139				Lafferty KD, 2013, TRENDS ECOL EVOL, V28, P503, DOI 10.1016/j.tree.2013.06.012; Wood CL, 2015, ECOLOGY, V96, P1383, DOI 10.1890/13-2154.1; Wood CL, 2014, ECOLOGY, V95, P1929, DOI 10.1890/13-1270.1; Wood CL, 2014, ECOLOGY, V95, P817, DOI 10.1890/13-1041.1; Wood CL, 2013, J ANIM ECOL, V82, P1276, DOI 10.1111/1365-2656.12104; Wood CL, 2013, TRENDS ECOL EVOL, V28, P239, DOI 10.1016/j.tree.2012.10.011; Wood CL, 2010, ECOL LETT, V13, P761, DOI 10.1111/j.1461-0248.2010.01467.x; WOOD CL, 2014, PARASITOLOGY, P1	8	6	6	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1192	1192		10.1126/science.aaa1810	http://dx.doi.org/10.1126/science.aaa1810			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477450				2022-12-28	WOS:000346189000064
J	Hayden, EC				Hayden, Erika Check			THE AUTOMATED LAB	NATURE			English	Editorial Material																			0	41	42	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					131	132		10.1038/516131a	http://dx.doi.org/10.1038/516131a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471888	Bronze			2022-12-28	WOS:000346310800054
J	Kumar, RM; Cahan, P; Shalek, AK; Satija, R; DaleyKeyser, A; Li, H; Zhang, J; Pardee, K; Gennert, D; Trombetta, JJ; Ferrante, TC; Regev, A; Daley, GQ; Collins, JJ				Kumar, Roshan M.; Cahan, Patrick; Shalek, Alex K.; Satija, Rahul; DaleyKeyser, Ajay; Li, Hu; Zhang, Jin; Pardee, Keith; Gennert, David; Trombetta, John J.; Ferrante, Thomas C.; Regev, Aviv; Daley, George Q.; Collins, James J.			Deconstructing transcriptional heterogeneity in pluripotent stem cells	NATURE			English	Article							RNA-SEQ; GROUND-STATE; SELF-RENEWAL; MICRORNA; GENERATION; EXPRESSION; NOISE; DIFFERENTIATION; QUANTIFICATION; MAINTENANCE	Pluripotent stem cells (PSCs) are capable of dynamic interconversion between distinct substates; however, the regulatory circuits specifying these states and enabling transitions between them are not well understood. Here we set out to characterize transcriptional heterogeneity in mouse PSCs by single-cell expression profiling under different chemical and genetic perturbations. Signalling factors and developmental regulators show highly variable expression, with expression states for some variable genes heritable through multiple cell divisions. Expression variability and population heterogeneity can be influenced by perturbation of signalling pathways and chromatin regulators. Notably, either removal of mature microRNAs or pharmacological blockage of signalling pathways drives PSCs into a low-noise ground state characterized by a reconfigured pluripotency network, enhanced self-renewal and a distinct chromatin state, an effect mediated by opposing microRNA families acting on the Myc/Lin28/let-7 axis. These data provide insight into the nature of transcriptional heterogeneity in PSCs.	[Kumar, Roshan M.; DaleyKeyser, Ajay; Pardee, Keith; Ferrante, Thomas C.; Collins, James J.] Harvard Univ, Wyss lnst Biologically Inspired Engn, Boston, MA 02115 USA; [Kumar, Roshan M.; Pardee, Keith; Collins, James J.] Boston Univ, Ctr Synthet Biol, Dept Biomed Engn, Howard Hughes Inst, Boston, MA 02215 USA; [Cahan, Patrick; Zhang, Jin; Daley, George Q.] Boston Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Stem Cell Transplantat Program,Div Pediat Hematol, Boston, MA 02115 USA; [Cahan, Patrick; Daley, George Q.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Dana Farber Canc Inst,Dept Biol Chem & Mol Pharma, Boston, MA 02115 USA; [Shalek, Alex K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Shalek, Alex K.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Satija, Rahul; Gennert, David; Trombetta, John J.; Regev, Aviv] Harvard Univ, MIT, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Li, Hu] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Ctr Individualized Med, Rochester, MN 55905 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02140 USA	Harvard University; Boston University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Mayo Clinic; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Daley, GQ (corresponding author), Harvard Univ, Sch Med,Manton Ctr Orphan Dis Res, Harvard Stem Cell Inst,Howard Hughes Med Inst, Stem Cell Transplantat Program,Div Pediat Hematol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; jcollins@bu.edu	Satija, Rahul/AAF-9564-2019; Shalek, Alex/Y-2434-2019	Shalek, Alex/0000-0001-5670-8778; Cahan, Patrick/0000-0003-3652-2540	NIH [R24DK092760, R01GM107536, P50HG005550]; HHMI; Broad Institute; Klarman Cell Observatory at the Broad Institute; NIH CEGS [1P50HG006193-01]; NIH Pioneer Award [DP1OD003958-01]; Wyss Institute; NIDDK [K01DK096013]; NHLBI [T32HL066987, T32HL007623]; Manton Center for Orphan Disease Research; NIH Postdoctoral Fellowship [1F32HD075541-01]; Mayo Clinic Center for Individualized Medicine;  [NIH-P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, F32HD075541] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623, T32HL066987] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092760, K01DK096013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107536] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Broad Institute; Klarman Cell Observatory at the Broad Institute; NIH CEGS; NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wyss Institute; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Manton Center for Orphan Disease Research; NIH Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Individualized Medicine; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Collins and Daley laboratories for discussions. J.J.C. is supported by NIH grant R24DK092760 and the HHMI. G.Q.D. is supported by grants from the NIH (R01GM107536, R24DK092760, P50HG005550) and is an affiliate member of the Broad Institute and an investigator of the Manton Center for Orphan Disease Research and the Howard Hughes Medical Institute. A.R. is supported by the Broad Institute, the Klarman Cell Observatory at the Broad Institute, an NIH CEGS (1P50HG006193-01), an NIH Pioneer Award (DP1OD003958-01) and the HHMI. R.M.K. is supported by the Wyss Institute. P.C. is supported by NIDDK (K01DK096013) and received support from NHLBI (T32HL066987 and T32HL007623) and the Manton Center for Orphan Disease Research. R.S. was supported by an NIH Postdoctoral Fellowship (1F32HD075541-01). H.L. is supported by the Mayo Clinic Center for Individualized Medicine. Sequencing was performed by the Broad Institute Genomics Platform. Flow cytometry was performed in the Hematologic Neoplasia Flow Cytometry Facility at the Dana-Farber Cancer Institute and the BCH IDDRC Stem Cell Core Facility at Boston Children's Hospital supported by NIH-P30-HD18655. Single-cell qPCR experiments were performed at the BCH IDDRC Molecular Genetics Core Facility at Children's Hospital Boston supported by NIH-P30-HD18655. Fludigm C<INF>1</INF> experiments were performed at the Broad Institute and the Biopolymers Facility at Harvard Medical School.	Arias A. M., 2011, CURR OPIN CELL BIOL, V23, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cherry A, 2010, CELL STEM CELL, V7, P641, DOI 10.1016/j.stem.2010.11.020; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Halley JD, 2012, STEM CELL RES, V8, P324, DOI 10.1016/j.scr.2011.11.001; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; HOLM S, 1979, SCAND J STAT, V6, P65; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Karwacki-Neisius V, 2013, CELL STEM CELL, V12, P531, DOI 10.1016/j.stem.2013.04.023; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2011, ANNU REV GENOM HUM G, V12, P165, DOI 10.1146/annurev-genom-082410-101506; MacArthur BD, 2013, CELL, V154, P484, DOI 10.1016/j.cell.2013.07.024; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; SPECTOR DL, 1986, EXP CELL RES, V163, P87, DOI 10.1016/0014-4827(86)90560-4; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	69	241	249	6	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					56	U112		10.1038/nature13920	http://dx.doi.org/10.1038/nature13920			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471879	Green Accepted, Green Submitted			2022-12-28	WOS:000346310800037
J	Saini, SD; van Hees, F; Vijan, S				Saini, Sameer D.; van Hees, Frank; Vijan, Sandeep			Smarter Screening for Cancer Possibilities and Challenges of Personalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLORECTAL-CANCER; OLDER-ADULTS; WOMEN		[Saini, Sameer D.; Vijan, Sandeep] Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Saini, Sameer D.; Vijan, Sandeep] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [van Hees, Frank] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands	University of Michigan System; University of Michigan; Erasmus University Rotterdam; Erasmus MC	Saini, SD (corresponding author), Vet Affairs Med Ctr, 2215 Fuller Rd,Ste 111D, Ann Arbor, MI 48105 USA.	sdsaini@umich.edu	Saini, Sameer/C-7249-2015		NCI NIH HHS [U01-CA152959, U01 CA152959, U01 CA097426] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA152959, U01CA097426] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Freedman AN, 2009, J CLIN ONCOL, V27, P686, DOI 10.1200/JCO.2008.17.4797; Lansdorp-Vogelaar I, 2014, ANN INTERN MED, V161, P104, DOI 10.7326/M13-2867; Leach CR, 2012, CANCER-AM CANCER SOC, V118, P27, DOI 10.1002/cncr.26233; Saini SD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1247; Torke AM, 2013, JAMA INTERN MED, V173, P526, DOI 10.1001/jamainternmed.2013.2903; van Hees F, 2014, ANN INTERN MED, V160, P750, DOI 10.7326/M13-2263; Win AK, 2012, CANCER EPIDEM BIOMAR, V21, P398, DOI 10.1158/1055-9965.EPI-11-0771; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	8	25	25	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2211	2212		10.1001/jama.2014.13933	http://dx.doi.org/10.1001/jama.2014.13933			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25461993	Green Accepted			2022-12-28	WOS:000345684800011
J	Williams, R; Aspinall, R; Bellis, M; Camps-Walsh, G; Cramp, M; Dhawan, A; Ferguson, J; Forton, D; Foster, G; Gilmore, S; Hickman, M; Hudson, M; Kelly, D; Langford, A; Lombard, M; Longworth, L; Martin, N; Moriarty, K; Newsome, P; O'Grady, J; Pryke, R; Rutter, H; Ryder, S; Sheron, N; Smith, T				Williams, Roger; Aspinall, Richard; Bellis, Mark; Camps-Walsh, Ginette; Cramp, Matthew; Dhawan, Anil; Ferguson, James; Forton, Dan; Foster, Graham; Gilmore, Ian; Hickman, Matthew; Hudson, Mark; Kelly, Deirdre; Langford, Andrew; Lombard, Martin; Longworth, Louise; Martin, Natasha; Moriarty, Kieran; Newsome, Philip; O'Grady, John; Pryke, Rachel; Rutter, Harry; Ryder, Stephen; Sheron, Nick; Smith, Tom			Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis	LANCET			English	Review							ADVERSE CHILDHOOD EXPERIENCES; OPIATE SUBSTITUTION THERAPY; C VIRUS-INFECTION; B SURFACE-ANTIGEN; 15-YEAR FOLLOW-UP; COST-EFFECTIVENESS; ADVANCED FIBROSIS; SYRINGE PROGRAMS; BILIARY ATRESIA; NATURAL-HISTORY		[Williams, Roger] Fdn Liver Res, London WC1E 6HX, England; [Aspinall, Richard] Queen Alexandra Hosp, Portsmouth, Hants, England; [Bellis, Mark] Bangor Univ, Coll Hlth & Behav Sci, Bangor, Gwynedd, Wales; [Camps-Walsh, Ginette] Med Mkt Consultants, Oxford, England; [Cramp, Matthew] Plymouth Hosp NHS Trust, Plymouth, Devon, England; [Cramp, Matthew] Plymouth Univ Peninsula, Sch Med, Plymouth, Devon, England; [Cramp, Matthew] Plymouth Univ Peninsula, Sch Dent, Plymouth, Devon, England; [Dhawan, Anil; O'Grady, John] Kings Coll Hosp London, London, England; [Ferguson, James] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; [Forton, Dan] St George Hosp, London, England; [Foster, Graham] Queen Marys Univ, London, England; [Gilmore, Ian] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Hickman, Matthew; Martin, Natasha] Univ Bristol, Bristol, Avon, England; [Hudson, Mark] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Kelly, Deirdre] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Langford, Andrew] British Liver Trust, Ringwood, England; [Lombard, Martin] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England; [Longworth, Louise] Brunel Univ, Uxbridge UB8 3PH, Middx, England; [Moriarty, Kieran] Royal Bolton Hosp, Bolton, England; [Newsome, Philip] Univ Birmingham, Natl Inst Hlth Res NIHR Ctr Liver Res, Birmingham, W Midlands, England; [Newsome, Philip] Univ Birmingham, Biomed Res Unit, Birmingham, W Midlands, England; [Pryke, Rachel] Winyates Hlth Ctr, Redditch, Worcs, England; [Rutter, Harry] London Sch Hyg & Trop Med, London WC1, England; [Ryder, Stephen] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Sheron, Nick] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Smith, Tom] British Soc Gastroenterol, London, England	University of London; University College London; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; Bangor University; University of Plymouth; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Birmingham; St Georges University London; University of London; Queen Mary University London; University of Liverpool; University of Bristol; Newcastle Freeman Hospital; Newcastle University - UK; University of Birmingham; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; Brunel University; Royal Bolton Hospital; University of Birmingham; University of Birmingham; University of London; London School of Hygiene & Tropical Medicine; Nottingham University Hospital NHS Trust; University of Southampton	Williams, R (corresponding author), Fdn Liver Res, London WC1E 6HX, England.	r.williams@researchinliver.org.uk	Hickman, Matthew/Y-2400-2019; Rutter, Harry/HCI-8765-2022; Forton, Daniel/AAN-6669-2020; Bellis, Mark A./HGA-2019-2022; Newsome, Philip N/D-4495-2018	Hickman, Matthew/0000-0001-9864-459X; Newsome, Philip N/0000-0001-6085-3652; Forton, Daniel/0000-0002-0903-9169; Sheron, Nick/0000-0002-6156-8367; Foster, Graham/0000-0002-3704-386X; Aspinall, Richard/0000-0002-5208-8185; Sheron, Nick/0000-0001-5232-8292; Ryder, Stephen David/0000-0001-9649-4444; Dhawan, Anil/0000-0002-4942-0845; Martin, Natasha/0000-0001-8344-1810; Rutter, Harry/0000-0002-9322-0656	MRC [MR/K023233/1] Funding Source: UKRI; Medical Research Council [MR/K023195/1, MR/K023195/1B, MR/J006742/1, MR/K023233/1] Funding Source: researchfish; National Institute for Health Research [PDF-2011-04-049, RP-DG-0610-10055] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Abdel-Hady M, 2011, J VIRAL HEPATITIS, V18, pE535, DOI 10.1111/j.1365-2893.2011.01456.x; Academy of Medical Royal Colleges, 2013, MEAS MED PROF PRESCR; Academy of Medical Sciences, 2004, CALL TIM NAT DRINK M; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; All- Party Parliamentary Hepatology Group (APPHG), 2014, INQ IMPR OUTC LIV DI; Anderson P., 2006, ALCOHOL EUROPE PUBLI; Annunziato RA, 2007, PEDIATR TRANSPLANT, V11, P608, DOI 10.1111/j.1399-3046.2007.00689.x; [Anonymous], 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16040; [Anonymous], 2012, AC UPP GASTR BLEED M; Armstrong MJ, 2014, QJM-INT J MED, V107, P33, DOI 10.1093/qjmed/hct198; Armstrong MJ, 2012, J HEPATOL, V56, P234, DOI 10.1016/j.jhep.2011.03.020; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Babor TF, 2003, ALCOHOL NO ORDINARY; Balogun MA, 2013, EPIDEMIOL INFECT, V141, P916, DOI 10.1017/S0950268812001513; Barrett B, 2006, DRUG ALCOHOL DEPEN, V81, P47, DOI 10.1016/j.drugalcdep.2005.05.015; Barshop NJ, 2008, ALIMENT PHARM THER, V28, P13, DOI 10.1111/j.1365-2036.2008.03703.x; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Bellis MA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-72; Bellis MA, 2014, J PUBLIC HEALTH-UK, V36, P81, DOI 10.1093/pubmed/fdt038; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Boxall EH, 2004, ARCH DIS CHILD-FETAL, V89, pF456, DOI 10.1136/adc.2002.009837; British Society of Paediatric Gastreonterology Hepatology and Nutrition, 2012, INV NEON CONJ HYP; Bruce CK, 2010, HUM MUTAT, V31, P858, DOI 10.1002/humu.21261; Cartledge P, 2012, ARCH DIS CHILD, V97, P166, DOI 10.1136/adc.2009.179812; Castelnuovo E, 2006, HEALTH TECHNOL ASSES, V10, P1; Centre for Workforce Intelligence, 2011, REC MED SPEC TRAIN G; Chen SM, 2006, PEDIATRICS, V117, P1147, DOI 10.1542/peds.2005-1267; Chief Medical Officer Department of Health, 2014, GETT AH CURV STRAT C; Chief Medical Officer for England, 2008, ANN REPORT; Chien YC, 2006, EPIDEMIOL REV, V28, P126, DOI 10.1093/epirev/mxj010; Coates T, 2001, CLIN THER, V23, P392, DOI 10.1016/S0149-2918(01)80044-8; Crawford M, 2004, LANCET, V364, P1334, DOI 10.1016/S0140-6736(04)17190-0; Crossan C, HLTH TECHNO IN PRESS; Davenport M, 2011, J PEDIATR SURG, V46, P1689, DOI 10.1016/j.jpedsurg.2011.04.013; Day CP, 2000, J ROY COLL PHYS LOND, V34, P557; De Angelis D, 2009, STAT METHODS MED RES, V18, P361, DOI 10.1177/0962280208094691; de Franchis R, 2005, J HEPATOL, V43, P167, DOI 10.1016/j.jhep.2005.05.009; Department of Health, 2007, PROGR BUDG GUID MAN; Department of Health, PUBL HLTH RESP DEAL; Department of Health, 2013, LIV WELL LONG CALL A; Department of Health, 2008, TRANS MOV WELL GOOD; Department of Health, 2011, CONS STRAT IMPR LIV; Department of Health (UK), 2008, SAF SENS SOC GOV ALC; Dong M, 2003, ARCH INTERN MED, V163, P1949, DOI 10.1001/archinte.163.16.1949; Donnan PT, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13250; Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006; Dwyer MJ, 1996, EPIDEMIOL INFECT, V117, P121, DOI 10.1017/S0950268800001217; Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; General Medical Council, 2010, SPEC TRAIN CURR GAST; Giraudon I, 2009, VACCINE, V27, P2016, DOI 10.1016/j.vaccine.2008.12.016; Godbole G, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-222; Goldberger JJ, 2013, JAMA-J AM MED ASSOC, V309, P2559, DOI 10.1001/jama.2013.6629; Gordon SC, 2012, HEPATOLOGY, V56, P1651, DOI 10.1002/hep.25842; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3190; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7646; Government Office for Science, 2014, TRACKL OB FUT CHOIC; Gregorio GV, 2002, AUTOIMMUNITY, V35, P515, DOI 10.1080/0891693021000056721; Hahne S, 2004, J CLIN VIROL, V29, P211, DOI 10.1016/j.jcv.2003.09.016; Harman DJ, 2013, HEPATOLOGY, V58, p328A; Harris RJ, 2014, J HEPATOL, V61, P530, DOI 10.1016/j.jhep.2014.05.008; Hastings G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1227; Hastings G, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1767; Hatton J, 2009, ADDICTION, V104, P587, DOI 10.1111/j.1360-0443.2008.02493.x; HCV Action, 2011, CENS MED WORKF INFR; Health and Social Care Information Centre (HSCIC) Public Health England, 2013, PUBL HLTH ENGL NAT C; HM Government, 2012, GOV ALC STRAT; Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4; HRUBEC Z, 1981, ALCOHOL CLIN EXP RES, V5, P207, DOI 10.1111/j.1530-0277.1981.tb04890.x; HSCIC, HOSP EP STAT; HSCIC, 2014, STAT OB PHYS ACT DIE; Hughes NR, 2013, FRONTLINE GASTROENTE, V4, P130, DOI 10.1136/flgastro-2012-100260; Hutchinson SJ, 2006, SCOT MED J, V51, P8; Jackson R., 2009, SCREENING BRIEF INTE; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jairath V, 2014, DIGEST LIVER DIS, V46, P419, DOI 10.1016/j.dld.2013.12.010; Jewell J, 2010, CLIN MED, V10, P259, DOI 10.7861/clinmedicine.10-3-259; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Kwon JA, 2012, AIDS, V26, P2201, DOI 10.1097/QAD.0b013e3283578b5d; Lawitz EJ, 2014, J GASTROEN HEPATOL, V29, P1574, DOI 10.1111/jgh.12632; Lawson A, 2010, J VIRAL HEPATITIS, V17, P51, DOI 10.1111/j.1365-2893.2009.01148.x; Lee CF, 2006, BMJ-BRIT MED J, V332, P328, DOI 10.1136/bmj.38719.435833.7C; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Liang WB, 2011, DRUG ALCOHOL REV, V30, P524, DOI 10.1111/j.1465-3362.2010.00281.x; Lilford RJ, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17280; Lister G, 2007, P NATL SOCIAL MARKET; Marcos A, 2000, TRANSPLANTATION, V69, P2410, DOI 10.1097/00007890-200006150-00034; Martin NK, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003153; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Martin NK, 2014, J VIRAL HEPATITUS, DOI [10.1111/jvh.1233, DOI 10.1111/JVH.1233]; Martinez SM, 2011, HEPATOLOGY, V53, P325, DOI 10.1002/hep.24013; McDonagh JE, 2003, PEDIATR CLIN N AM, V50, P1561, DOI 10.1016/S0031-3955(03)00131-7; McKiernan PJ, 2000, LANCET, V355, P25, DOI 10.1016/S0140-6736(99)03492-3; McLernon DJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004837; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; McVernon J, 2003, LANCET, V361, P1521, DOI 10.1016/S0140-6736(03)13171-6; Mieli-Vergani G, 2008, DIS LIVER BILIARY SY, P191; Miller WR, 2002, ADDICTION, V97, P265, DOI 10.1046/j.1360-0443.2002.00019.x; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Morando F, 2013, J HEPATOL, V59, P257, DOI 10.1016/j.jhep.2013.03.010; Moriarty JK, 2014, ALCOHOL RELATED DIS; Moriarty K, 2014, QUALITY PRODUCTIVITY; Moriarty KJ, 2007, CLIN MED, V7, P125, DOI 10.7861/clinmedicine.7-2-125; Moriarty KJ, 2011, FRONTLINE GASTROENTE, V2, P77, DOI 10.1136/fg.2010.002105; Morling JR, 2014, LIVER INT, V34, P1267, DOI 10.1111/liv.12385; Morling JR, 2014, J HEPATOL, V60, P384, DOI 10.1016/j.jhep.2013.10.017; Mushtaq I, 1999, BRIT MED J, V319, P471, DOI 10.1136/bmj.319.7208.471; Nakamura R, 2014, ADDICTION, V109, P558, DOI 10.1111/add.12419; NatCen Social Research University College London Department of Epidemiology and Public Health, 2014, HLTH SURV ENGL; National Confidential Enquiry into Patient Outcome and Death (NCEPOD), 2013, ALC REL LIV DIS MEAS; National Health Service Blood and Transplant, 2014, TAK ORG TRANSPL 2020; National Health Service Right Care, 2013, LIV DIS NHS ATL VAR; National Institute for Health and Care Excellence, ALC DEP NALM; National Institute for Health and Clinical Excellence, 2010, ALC US DIS PREV DEV; National Offender Management Service, 2013, NAT PARTN AGR; NHS Commissioning Board, 2013, CLIN COMM POL COMPL; NHS Information Centre, 2014, IND QUAL IMPR; NHS National Institute of Health Research, 2014, LOCATE STUD; NICE, 2010, NEON JAUND; NICE, 2012, HEP B C WAYS PROM OF; Nobili V, 2010, GUT, V59, P561, DOI 10.1136/gut.2009.187039; O'Brien AJ, 2012, INTENS CARE MED, V38, P991, DOI 10.1007/s00134-012-2523-2; O'Grady JG, 2013, FRONTLINE GASTROENTE, V4, P187, DOI 10.1136/flgastro-2012-100267; Office for National Statistics, 2013, MORT STAT DEATHS REG; Office for National Statistics, 2010, MORT STAT DEATHS REG; Office for National Statistics, 2014, CANC SURV RAT; Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238; Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637; Pagadala MR, 2012, AM J GASTROENTEROL, V107, P1859, DOI 10.1038/ajg.2012.320; Patanwala I, 2012, FRONTLINE GASTROENTE, V3, P52, DOI 10.1136/flgastro-2011-100028; PETERSON B, 1983, DRUG ALCOHOL DEPEN, V11, P279, DOI 10.1016/0376-8716(83)90019-4; PETERSSON B, 1985, CIBA F SYMP, V110, P143; Petta S, 2015, LIVER INT, V35, P1566, DOI 10.1111/liv.12584; Powell JE, 2003, J MED SCREEN, V10, P112, DOI 10.1258/096914103769010996; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Poynard Thierry, 2011, Gastroenterol Hepatol (N Y), V7, P445; Poynard T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-40; Prime Minister's Strategy Unit, 2003, STRAT UN ALC HARM RE; Public Health England, LOC ALC PROF ENGL LA; Public Health England, 2012, DEATHS LIV DIS IMPL; Public Health England, HLTH PROF ENGL IND D; Public Health England National Liver Disease Information Service, 2014, LOC AUTH LIV DIS PRO; Puoti C, 2012, J VIRAL HEPATITIS, V19, P229, DOI 10.1111/j.1365-2893.2011.01485.x; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Rand Europe, 2012, ASS YOUNG PEOPL EXP; Ratib S, 2014, J HEPATOL, V60, P282, DOI 10.1016/j.jhep.2013.09.027; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Roulot D, 2011, GUT, V60, P977, DOI 10.1136/gut.2010.221382; Royal College of Nursing Competences, 2013, CAR PEOPL LIV DIS CO; Royal College of Psychiatrists, 2014, ALC BRAIN DAM AD REF; Ryder SD, 2010, CLIN MED, V10, P435, DOI 10.7861/clinmedicine.10-5-435; Sarri G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3893; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Science Group of the European Alcohol Health Forum, 2009, DOES MARK COMM IMP V; Sheen D, 2013, STAT HDB 2013; Sheron N, 2013, BRIT J GEN PRACT, V63, pE698, DOI 10.3399/bjgp13X673711; Sheron N, 2011, BMJ-BRIT MED J, V341, P1105; Sheron N, 2014, CLIN MED, V14, P396, DOI 10.7861/clinmedicine.14-4-396; Sheron N, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X654588; Shield KD, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-53; Siddiqui MR, 2011, VACCINE, V29, P466, DOI 10.1016/j.vaccine.2010.10.075; Siegler Veronique, 2011, Health Stat Q, P4, DOI 10.1057/hsq.2011.7; Simon TG, 2015, J HEPATOL, V62, P18, DOI 10.1016/j.jhep.2014.08.013; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Stockwell T, 2011, ADDICTION, V106, P768, DOI 10.1111/j.1360-0443.2010.03331.x; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; University of Stirling, 2013, HLTH 1 EV BAS ALC ST; Vergniol J, 2014, HEPATOLOGY, V60, P65, DOI 10.1002/hep.27069; Verma S, 2013, LIVER INT, V33, P1398, DOI 10.1111/liv.12226; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Verrill C, 2009, ADDICTION, V104, P768, DOI 10.1111/j.1360-0443.2009.02521.x; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; Volk ML, 2010, GASTROENTEROLOGY, V139, P14, DOI 10.1053/j.gastro.2010.05.017; Wallis DE, 1999, BRIT MED J, V318, P1112, DOI 10.1136/bmj.318.7191.1112; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P60, DOI 10.1111/jvh.12249; [WHO W. H. Organization], 2014, GUID SCREEN CAR TREA; WHO Regional Office for Europe, 2013, EUR REP PREV CHILD M; Williams R, 2013, LANCET, V381, P2164, DOI 10.1016/S0140-6736(13)61438-5; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; World Health Organization regional office for Europe, 2014, EUR HLTH ALL DAT HFA; Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1; Yeomans J, 2014, GROCER          0319; Zhao JH, 2013, ADDICTION, V108, P1059, DOI 10.1111/add.12139	197	352	353	2	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1953	1997		10.1016/S0140-6736(14)61838-9	http://dx.doi.org/10.1016/S0140-6736(14)61838-9			45	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25433429	Green Submitted			2022-12-28	WOS:000345450100032
J	Lee, JH; Loya, PE; Lou, J; Thomas, EL				Lee, Jae-Hwang; Loya, Phillip E.; Lou, Jun; Thomas, Edwin L.			Dynamic mechanical behavior of multilayer graphene via supersonic projectile penetration	SCIENCE			English	Article							INTRINSIC STRENGTH; GRAIN-BOUNDARIES; BALLISTIC IMPACT; RATE DEFORMATION; FIBER	Multilayer graphene is an exceptional anisotropic material due to its layered structure composed of two-dimensional carbon lattices. Although the intrinsic mechanical properties of graphene have been investigated at quasi-static conditions, its behavior under extreme dynamic conditions has not yet been studied. We report the high-strain-rate behavior of multilayer graphene over a range of thicknesses from 10 to 100 nanometers by using miniaturized ballistic tests. Tensile stretching of the membrane into a cone shape is followed by initiation of radial cracks that approximately follow crystallographic directions and extend outward well beyond the impact area. The specific penetration energy for multilayer graphene is similar to 10 times more than literature values for macroscopic steel sheets at 600 meters per second.	[Lee, Jae-Hwang; Loya, Phillip E.; Lou, Jun; Thomas, Edwin L.] Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA; [Lee, Jae-Hwang] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA	Rice University; University of Massachusetts System; University of Massachusetts Amherst	Lee, JH (corresponding author), Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA.	leejh@umass.edu; elt@rice.edu		Lou, Jun/0000-0002-4351-9561; Thomas, Edwin/0000-0001-5911-6524	Defense Threat Reduction Agency [1-12-10008]; Welch Foundation [C-1716]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Welch Foundation(The Welch Foundation)	This work was funded by the Defense Threat Reduction Agency under contract 1-12-10008 and the Welch Foundation grant C-1716.	Abbud L., 2010, INT J MECH MATER ENG, V5, P123; Anthony J. W., 1990, HDB MINERALOGY; Cheng M, 2005, J ENG MATER-T ASME, V127, P197, DOI 10.1115/1.1857937; Dean J, 2009, INT J IMPACT ENG, V36, P1250, DOI 10.1016/j.ijimpeng.2009.05.002; DRESSELHAUS MS, 1991, J MATER RES, V6, P1114, DOI 10.1557/JMR.1991.1114; Field JE, 2004, INT J IMPACT ENG, V30, P725, DOI 10.1016/j.ijimpeng.2004.03.005; Gama B.A., 2004, APPL MECH REV, V57, P223, DOI DOI 10.1115/1.1704626; Garcia-Castillo SK, 2012, J STRAIN ANAL ENG, V47, P444, DOI 10.1177/0309324712454996; Goldsmith W., 1971, INT J MECH SCI, V13, P843; Gotsmann B, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2977867; Grantab R, 2010, SCIENCE, V330, P946, DOI 10.1126/science.1196893; Gupta NK, 2006, INT J IMPACT ENG, V32, P1921, DOI 10.1016/j.ijimpeng.2005.06.007; Iqbal MA, 2008, LAT AM J SOLIDS STRU, V5, P259; Kim K, 2012, NANO LETT, V12, P293, DOI 10.1021/nl203547z; Lee BL, 2001, J COMPOS MATER, V35, P1605, DOI 10.1106/YRBH-JGT9-U6PT-L555; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Lee GH, 2013, SCIENCE, V340, P1073, DOI 10.1126/science.1235126; Lee JH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2166; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Palik E, 1998, HDB OPTICAL CONSTANT, VII; Phoenix SL, 2003, INT J SOLIDS STRUCT, V40, P6723, DOI 10.1016/S0020-7683(03)00329-9; Rabb RJ, 2010, INT J NUMER METH ENG, V83, P537, DOI 10.1002/nme.2841; Rasool HI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3811; TOMLIN SG, 1968, J PHYS D APPL PHYS, V1, P1667, DOI 10.1088/0022-3727/1/12/312; WRIGHT SC, 1993, INT J IMPACT ENG, V13, P1, DOI 10.1016/0734-743X(93)90105-G; Xu MS, 2013, CHEM REV, V113, P3766, DOI 10.1021/cr300263a; Yungwirth CJ, 2011, J AM CERAM SOC, V94, pS62, DOI 10.1111/j.1551-2916.2011.04501.x; Zhang JF, 2012, ACS NANO, V6, P2704, DOI 10.1021/nn3001356; Zukas J.A., 1990, CHEM ENG SCI, V59, P525	29	245	257	18	336	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1092	1096		10.1126/science.1258544	http://dx.doi.org/10.1126/science.1258544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430764				2022-12-28	WOS:000345763400037
J	Bardgett, RD; van der Putten, WH				Bardgett, Richard D.; van der Putten, Wim H.			Belowground biodiversity and ecosystem functioning	NATURE			English	Review							ARBUSCULAR MYCORRHIZAL FUNGI; COMMUNITY COMPOSITION; SOIL BIODIVERSITY; GLOBAL PATTERNS; LITTER DECOMPOSITION; SPATIAL-PATTERNS; LEAF-LITTER; FOOD WEBS; PLANT; DIVERSITY	Evidence is mounting that the immense diversity of microorganisms and animals that live belowground contributes significantly to shaping aboveground biodiversity and the functioning of terrestrial ecosystems. Our understanding of how this belowground biodiversity is distributed, and how it regulates the structure and functioning of terrestrial ecosystems, is rapidly growing. Evidence also points to soil biodiversity as having a key role in determining the ecological and evolutionary responses of terrestrial ecosystems to current and future environmental change. Here we review recent progress and propose avenues for further research in this field.	[Bardgett, Richard D.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [van der Putten, Wim H.] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, NL-6700 AB Wageningen, Netherlands; [van der Putten, Wim H.] Wageningen Univ, Nematol Lab, NL-6700 ES Wageningen, Netherlands	University of Manchester; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Bardgett, RD (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	richard.bardgett@manchester.ac.uk	van der Putten, Wim H/C-3707-2011; KNAW, NIOO-KNAW/A-4320-2012	van der Putten, Wim H/0000-0002-9341-4442; KNAW, NIOO-KNAW/0000-0002-3835-159X	European Commission through the project Ecological Function and Biodiversity Indicators in European Soils (EcoFINDERS) [264465]; ERC-ADV grant	European Commission through the project Ecological Function and Biodiversity Indicators in European Soils (EcoFINDERS); ERC-ADV grant	This work was conceived as part of a symposium on Soil Biodiversity and Ecosystem Functioning at INTECOL, London 2013, which was supported by the British Ecological Society. The work was supported by the European Commission through the project Ecological Function and Biodiversity Indicators in European Soils (EcoFINDERS) (FP7-264465) and an ERC-ADV grant to W.H.v.d.P. We are grateful to P. Brinkman for logistical support, and A. Jones from the Joint Research Centre, Ispra, for providing photographs, and A. Bardgett for compiling Fig. 1.	Alphei J, 1996, OECOLOGIA, V106, P111, DOI 10.1007/BF00334413; ANDERSON JM, 1983, SOIL BIOL BIOCHEM, V15, P463, DOI 10.1016/0038-0717(83)90012-3; Ayres E, 2007, FUNCT ECOL, V21, P256, DOI 10.1111/j.1365-2435.2006.01227.x; Ayres E, 2009, SOIL BIOL BIOCHEM, V41, P606, DOI 10.1016/j.soilbio.2008.12.022; Babikova Z, 2013, ECOL LETT, V16, P835, DOI 10.1111/ele.12115; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Biere A, 2013, FUNCT ECOL, V27, P567, DOI 10.1111/1365-2435.12100; Bradford MA, 2002, SCIENCE, V298, P615, DOI 10.1126/science.1075805; Briones MJI, 2007, GLOBAL CHANGE BIOL, V13, P2252, DOI 10.1111/j.1365-2486.2007.01434.x; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Cameron TC, 2013, ECOL LETT, V16, P754, DOI 10.1111/ele.12107; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; CLARHOLM M, 1985, SOIL BIOL BIOCHEM, V17, P181, DOI 10.1016/0038-0717(85)90113-0; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Courtright EM, 2001, ANTARCT SCI, V13, P9, DOI 10.1017/S0954102001000037; Crowther TW, 2013, ECOL LETT, V16, P469, DOI 10.1111/ele.12069; de Vries FT, 2013, P NATL ACAD SCI USA, V110, P14296, DOI 10.1073/pnas.1305198110; de Vries FT, 2012, NAT CLIM CHANGE, V2, P276, DOI [10.1038/NCLIMATE1368, 10.1038/nclimate1368]; Decaens T, 2010, GLOBAL ECOL BIOGEOGR, V19, P287, DOI 10.1111/j.1466-8238.2009.00517.x; Delgado-Baquerizo M, 2013, J ARID ENVIRON, V91, P147, DOI 10.1016/j.jaridenv.2013.01.005; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Diez JM, 2010, ECOL LETT, V13, P803, DOI 10.1111/j.1461-0248.2010.01474.x; Dostal P, 2013, ECOL LETT, V16, P1277, DOI 10.1111/ele.12166; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; Eggleton P., 1995, P473; Eisenhauer N, 2008, OIKOS, V117, P1026, DOI 10.1111/j.0030-1299.2008.16812.x; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2011, AM J BOT, V98, P439, DOI 10.3732/ajb.1000498; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Gange AC, 2007, SCIENCE, V316, P71, DOI 10.1126/science.1137489; GANGE AC, 1993, FUNCT ECOL, V7, P616, DOI 10.2307/2390139; Garbeva P, 2011, SOIL BIOL BIOCHEM, V43, P469, DOI 10.1016/j.soilbio.2010.11.020; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Guitian R, 2000, PLANT SOIL, V220, P271, DOI 10.1023/A:1004787710886; Gundale MJ, 2014, NEW PHYTOL, V202, P415, DOI 10.1111/nph.12699; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Handa IT, 2014, NATURE, V509, P218, DOI 10.1038/nature13247; Hedlund K, 2000, OIKOS, V88, P585, DOI 10.1034/j.1600-0706.2000.880315.x; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Henry S, 2008, ENVIRON MICROBIOL, V10, P3082, DOI 10.1111/j.1462-2920.2008.01599.x; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Hunt HW, 2002, GLOBAL CHANGE BIOL, V8, P33, DOI 10.1046/j.1365-2486.2002.00425.x; INGHAM RE, 1985, ECOL MONOGR, V55, P119, DOI 10.2307/1942528; Kardol P, 2006, ECOL LETT, V9, P1080, DOI 10.1111/j.1461-0248.2006.00953.x; Kauserud H, 2008, P NATL ACAD SCI USA, V105, P3811, DOI 10.1073/pnas.0709037105; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kostenko O, 2012, ECOL LETT, V15, P813, DOI 10.1111/j.1461-0248.2012.01801.x; Laakso J, 1999, OIKOS, V87, P57, DOI 10.2307/3546996; Lankau RA, 2011, NEW PHYTOL, V189, P536, DOI 10.1111/j.1469-8137.2010.03481.x; Lankau RA, 2009, P NATL ACAD SCI USA, V106, P15362, DOI 10.1073/pnas.0905446106; Lau JA, 2012, P NATL ACAD SCI USA, V109, P14058, DOI 10.1073/pnas.1202319109; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lavelle P, 2003, PEDOBIOLOGIA, V47, P419; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Mikola J, 2009, ECOL MONOGR, V79, P221, DOI 10.1890/08-1846.1; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Neher DA, 2005, APPL SOIL ECOL, V30, P47, DOI 10.1016/j.apsoil.2005.01.002; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Nielsen UN, 2011, EUR J SOIL SCI, V62, P105, DOI 10.1111/j.1365-2389.2010.01314.x; Nielsen UN, 2014, GLOBAL ECOL BIOGEOGR, V23, P968, DOI 10.1111/geb.12177; Noordijk J., 2010, NEDERLANDSE BIODIVER, V10; Norton R. A., 2009, MANUAL ACAROLOGY, V3, P430, DOI DOI 10.1653/024.092.0323; Opik M, 2013, MYCORRHIZA, V23, P411, DOI 10.1007/s00572-013-0482-2; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Placella SA, 2013, APPL ENVIRON MICROB, V79, P3294, DOI 10.1128/AEM.00404-13; Placella SA, 2012, P NATL ACAD SCI USA, V109, P10931, DOI 10.1073/pnas.1204306109; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Reinhart KO, 2010, NEW PHYTOL, V186, P484, DOI 10.1111/j.1469-8137.2009.03159.x; Richard B, 2012, EUR J SOIL BIOL, V53, P62, DOI 10.1016/j.ejsobi.2012.08.005; ROBERTSON GP, 1995, ECOLOGY, V76, P1425, DOI 10.2307/1938145; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Saetre P, 2000, SOIL BIOL BIOCHEM, V32, P909, DOI 10.1016/S0038-0717(99)00215-1; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Setala Heikki, 2005, P236, DOI 10.1017/CBO9780511541926.014; Soler R, 2012, J CHEM ECOL, V38, P755, DOI 10.1007/s10886-012-0104-z; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Veen G. F., 2014, OIKOS; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wall DH, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P1; Wardle D., 2002, COMMUNITIES ECOSYSTE; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wu TH, 2011, P NATL ACAD SCI USA, V108, P17720, DOI 10.1073/pnas.1103824108; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X; Yeates GW, 2000, BIOL FERT SOILS, V31, P391, DOI 10.1007/s003749900186; Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11	109	1471	1606	260	2684	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					505	511		10.1038/nature13855	http://dx.doi.org/10.1038/nature13855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428498				2022-12-28	WOS:000346247600043
J	Frakt, A				Frakt, Austin			High-tech Care Can Save Lives-But It Also May Create Incentives That Result in Lives Lost	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Frakt, Austin] Boston Univ, Sch Med, Boston, MA 02215 USA; [Frakt, Austin] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA	Boston University; Boston University	Frakt, A (corresponding author), Boston Univ, Sch Med, Boston, MA 02215 USA.	frakt@bu.edu		Frakt, Austin/0000-0002-0795-5462					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2081	2081		10.1001/jama.2014.14531	http://dx.doi.org/10.1001/jama.2014.14531			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25423204	Bronze			2022-12-28	WOS:000345626800003
J	Powers, BW; Cassel, CK; Jain, SH				Powers, Brian W.; Cassel, Christine K.; Jain, Sachin H.			Ending the Cycle of Blame in US Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							KNIGHTS; KNAVES; PAWNS		[Powers, Brian W.; Jain, Sachin H.] Harvard Univ, Sch Med, Boston, MA 02110 USA; [Cassel, Christine K.] Natl Qual Forum, Washington, DC USA; [Jain, Sachin H.] Boston VA Med Ctr, Boston, MA USA; [Jain, Sachin H.] Merck & Co Inc, Boston, MA USA	Harvard University; Harvard Medical School; Merck & Company	Jain, SH (corresponding author), Harvard Univ, Sch Med, 65 E India Row,33B, Boston, MA 02110 USA.	shjain@post.harvard.edu						Antos JR, 2012, NEW ENGL J MED, V367, P954, DOI 10.1056/NEJMsb1207996; Institute of Medicine, 2012, BEST CAR LOW COST PA; Jain SH, 2011, JAMA-J AM MED ASSOC, V305, P2112, DOI 10.1001/jama.2011.694; Jain SH, 2010, JAMA-J AM MED ASSOC, V304, P1009, DOI 10.1001/jama.2010.1250; Stone DA., 1988, POLICY PARADOX POLIT; Treasure CL, 2014, JAMA-J AM MED ASSOC, V311, P907, DOI 10.1001/jama.2014.404; Woolhandler S, 2003, JAMA-J AM MED ASSOC, V290, P798	7	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2091	2092		10.1001/jama.2014.13630	http://dx.doi.org/10.1001/jama.2014.13630			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25423214				2022-12-28	WOS:000345626800007
J	Mayer, KH				Mayer, Kenneth H.			Advancing HIV prevention science: the roads from Cape Town	LANCET			English	Editorial Material							ANTIRETROVIRAL PROPHYLAXIS; PREEXPOSURE PROPHYLAXIS; INFECTION; THAILAND; TRIAL; WOMEN; MEN		Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Fenway Hlth, Boston, MA 02215 USA	Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Mayer, KH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Fenway Hlth, Boston, MA 02215 USA.	khmayer@gmail.com			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI060354] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2013, UNAIDS REP GLOB AIDS; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Bolland MJ, 2013, NEW ENGL J MED, V368, P82, DOI 10.1056/NEJMc1210464; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Graham BS, 2014, HIV RES PREV 2014 OC; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Marrazzo JM, 2013, 20 C RETR OPP INF CR; Mensch BS, 2014, AIDS RES HUM RETROV, V30, pA252; PROUD study, 2014, PROUD STUD INT AN FI; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Tanser F, 2014, HIV RES PREV 2014 OC; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Young B, 2014, CLIN INFECT DIS, V59, pS1, DOI 10.1093/cid/ciu298	18	0	0	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1725	1727		10.1016/S0140-6736(14)62036-5	http://dx.doi.org/10.1016/S0140-6736(14)62036-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KX	25455236	Green Accepted			2022-12-28	WOS:000345116400006
J	Green, AA; Silver, PA; Collins, JJ; Yin, P				Green, Alexander A.; Silver, Pamela A.; Collins, James J.; Yin, Peng			Toehold Switches: De-Novo-Designed Regulators of Gene Expression	CELL			English	Article							SYNTHETIC BIOLOGY APPLICATIONS; STRAND DISPLACEMENT CASCADES; ESCHERICHIA-COLI; LIVING CELLS; TRANSCRIPTIONAL REGULATORS; MESSENGER-RNAS; RIBOREGULATORS; COMPUTATION; LOGIC; DNA	Efforts to construct synthetic networks in living cells have been hindered by the limited number of regulatory components that provide wide dynamic range and low crosstalk. Here, we report a class of de-novo-designed prokaryotic riboregulators called toehold switches that activate gene expression in response to cognate RNAs with arbitrary sequences. Toehold switches provide a high level of orthogonality and can be forward engineered to provide average dynamic range above 400. We show that switches can be integrated into the genome to regulate endogenous genes and use them as sensors that respond to endogenous RNAs. We exploit the orthogonality of toehold switches to regulate 12 genes independently and to construct a genetic circuit that evaluates 4-input AND logic. Toehold switches, with their wide dynamic range, orthogonality, and programmability, represent a versatile and powerful platform for regulation of translation, offering diverse applications in molecular biology, synthetic biology, and biotechnology.	[Green, Alexander A.; Silver, Pamela A.; Collins, James J.; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Silver, Pamela A.; Yin, Peng] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Collins, James J.] Boston Univ, Dept Biomed Engn, Howard Hughes Med Inst, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA	Harvard University; Harvard University; Harvard Medical School; Boston University; Howard Hughes Medical Institute; Boston University	Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	py@hms.harvard.edu	Green, Alexander A./X-7025-2019	Green, Alexander A./0000-0003-2058-1204	DARPA Living Foundries [HR001112C0061]; NIH Director's New Innovator Award [1DP2OD007292]; NIH Transformative Research Award [1R01EB018659]; Office of Naval Research (ONR) Young Investigator Program Award [N000141110914]; ONR [N000141010827, N000141310593, N000141410610]; National Science Foundation (NSF) Faculty Early Career Development Award [CCF1054898]; NSF Expedition in Computing Award [CCF1317291]; NSF [CCF1162459]; Wyss Institute funds; Defense Threat Reduction Agency [HDTRA1-14-1-0006]; ONR MURI [N000141110725]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER	DARPA Living Foundries; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Transformative Research Award; Office of Naval Research (ONR) Young Investigator Program Award; ONR(Office of Naval Research); National Science Foundation (NSF) Faculty Early Career Development Award(National Science Foundation (NSF)); NSF Expedition in Computing Award; NSF(National Science Foundation (NSF)); Wyss Institute funds; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); ONR MURI(MURIOffice of Naval Research); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge J. Kim, C. Myhrvold, K. Pardee, and X. Chen for critical reading of the manuscript and helpful discussions and J.M.L. Ho for preliminary experiments, plasmid preparation, and helpful discussions. This work was supported by a DARPA Living Foundries grant (HR001112C0061) to P.A.S., P.Y., and J.J.C.; an NIH Director's New Innovator Award (1DP2OD007292); an NIH Transformative Research Award (1R01EB018659); an Office of Naval Research (ONR) Young Investigator Program Award (N000141110914); ONR grants (N000141010827, N000141310593, and N000141410610); a National Science Foundation (NSF) Faculty Early Career Development Award (CCF1054898); an NSF Expedition in Computing Award (CCF1317291); NSF grant (CCF1162459) and Wyss Institute funds to P.Y.; Defense Threat Reduction Agency grant HDTRA1-14-1-0006 to J.J.C.; ONR MURI grant N000141110725 to J.J.C. and P.A.S.; and the Howard Hughes Medical Institute (J.J.C.). A provisional patent based on this work has been filed.	Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; Brantl S, 2000, MOL MICROBIOL, V35, P1469, DOI 10.1046/j.1365-2958.2000.01813.x; Callura JM, 2012, P NATL ACAD SCI USA, V109, P5850, DOI 10.1073/pnas.1203808109; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Daniel R, 2013, NATURE, V497, P619, DOI 10.1038/nature12148; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gultyaev AP, 1997, J MOL BIOL, V273, P26, DOI 10.1006/jmbi.1997.1295; Gutell RR, 2000, J MOL BIOL, V300, P791, DOI 10.1006/jmbi.2000.3900; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Liu CC, 2012, NAT METHODS, V9, P1088, DOI [10.1038/NMETH.2184, 10.1038/nmeth.2184]; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Qi L, 2012, NUCLEIC ACIDS RES, V40, P5775, DOI 10.1093/nar/gks168; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rhodius VA, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.58; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Takahashi MK, 2013, NUCLEIC ACIDS RES, V41, P7577, DOI 10.1093/nar/gkt452; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	40	403	422	22	257	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					925	939		10.1016/j.cell.2014.10.002	http://dx.doi.org/10.1016/j.cell.2014.10.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417166	Green Accepted, Bronze			2022-12-28	WOS:000344522000022
J	Wong, TN; Ramsingh, G; Young, AL; Miller, CA; Touma, W; Welch, JS; Lamprecht, TL; Shen, D; Hundal, J; Fulton, RS; Heath, S; Baty, JD; Klco, JM; Ding, L; Mardis, ER; Westervelt, P; DiPersio, JF; Walter, MJ; Graubert, TA; Ley, TJ; Druley, TE; Link, DC; Wilson, RK				Wong, Terrence N.; Ramsingh, Giridharan; Young, Andrew L.; Miller, Christopher A.; Touma, Waseem; Welch, John S.; Lamprecht, Tamara L.; Shen, Dong; Hundal, Jasreet; Fulton, Robert S.; Heath, Sharon; Baty, Jack D.; Klco, Jeffery M.; Ding, Li; Mardis, Elaine R.; Westervelt, Peter; DiPersio, John F.; Walter, Matthew J.; Graubert, Timothy A.; Ley, Timothy J.; Druley, Todd E.; Link, Daniel C.; Wilson, Richard K.			Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia	NATURE			English	Article							CLONAL EVOLUTION; P53; DYNAMICS	Therapy-related acute myeloid leukaemia (t-AML) and therapy-related myelodysplastic syndrome (t-MDS) are well-recognized complications of cytotoxic chemotherapy and/or radiotherapy(1). There are several features that distinguish t-AML from de novo AMI, induding a higher incidence of TP53 mutations(3,3) abnormalities of chromosomes 5 or 7, complex cytogenetics and a reduced response to chemotherapy'. However, it is not clear how prior exposure to cytotoxic therapy influences leukaemogenesis. In particular, the mechanism by which TP53 mutations are selectively enriched in t-ANIL/t-MDS is unknown. Here, by sequencing the genomes of 22 patients with t-AML, we show that the total number of somatic single-nucleotide variants and the percentage of chemotherapy-related transversions are similar in t-AML and de novo AML, indicating that previous chemotherapy does not induce genome-wide DNA damage. We identified four cases of t-ANIL/ t-MDS in which the exact TP53 mutation found at diagnosis was also present at low frequencies (0.003-0.7%) in mobilized blood leukocytes or bone marrow 1-6 years before the development of t-AML/tMDS, including two cases in which the relevant TP53 mutation was detected before any chemotherapy. Moreover, functional TP53 mutations were identified in small populations of peripheral blood cells of healthy chemotherapy-naive elderly individuals. Finally, in mouse bone marrow chimaeras containing both wild-type and Tp53(+/-) haematopoietic stein/progenitor cells (HSPCs), the Tp53(+/-) HSPCs preferentially expanded after exposure to chemotherapy. These data suggest that cytotoxic therapy does not directly induce TP53 mutations. Rather, they support a model in which rare HSPCs carrying age-related TP53 mutations are resistant to chemotherapy and expand preferentially after treatment. The early acquisition of TP53 mutations in the founding HSPC clone probably contributes to the frequent cytogenetic abnormalities and poor responses to chemotherapy that are typical of patients with t-AML/t-MDS.	[Wong, Terrence N.; Touma, Waseem; Welch, John S.; Lamprecht, Tamara L.; Heath, Sharon; Ding, Li; Westervelt, Peter; DiPersio, John F.; Walter, Matthew J.; Graubert, Timothy A.; Ley, Timothy J.; Link, Daniel C.] Washington Univ, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Ramsingh, Giridharan] Univ So Calif, Dept Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90089 USA; [Young, Andrew L.; Druley, Todd E.] Washington Univ, Dept Pediat, Div Hematol Oncol, St Louis, MO 63110 USA; [Miller, Christopher A.; Hundal, Jasreet; Fulton, Robert S.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63110 USA; [Welch, John S.; Ding, Li; Mardis, Elaine R.; Westervelt, Peter; DiPersio, John F.; Walter, Matthew J.; Graubert, Timothy A.; Ley, Timothy J.; Link, Daniel C.; Wilson, Richard K.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Shen, Dong] AstraZeneca, Gaithersburg, MD 20878 USA; [Baty, Jack D.] Washington Univ, Div Biostat, St Louis, MO 63110 USA; [Klco, Jeffery M.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); University of Southern California; Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); AstraZeneca; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Link, DC (corresponding author), Washington Univ, Dept Med, Div Oncol, St Louis, MO 63110 USA.	dlink@dom.wustl.edu	Walter, Matthew J/S-7758-2018; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Klco, Jeffery/M-9717-2018	Wilson, Richard K./0000-0002-1992-1358; Klco, Jeffery/0000-0003-2961-6960; Young, Andrew/0000-0001-7698-3267; Ramsingh, Giridharan/0000-0003-0706-3584; Touma, Waseem/0000-0002-3273-432X; Druley, Todd/0000-0002-3245-7561; Westover, Tamara/0000-0002-1000-6698; Graubert, Timothy/0000-0002-7710-1171	National Institutes of Health [PO1 CA101937, U54 HG003079]; Leukemia & Lymphoma Society; NATIONAL CANCER INSTITUTE [P50CA171963, P01CA101937, R01CA180006] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL116605, T32HL007088] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank A. Schmidt, B. McKethan and R. Miller for technical assistance, and K. Odell and J. Tucker-Davis for animal care. We thank P. Goodfellow and J. Ivanovich for providing peripheral blood leukocyte genomic DNA from cancer-free individuals. This work was supported by National Institutes of Health grants PO1 CA101937 (D.C.L) and U54 HG003079 (R.K.W.) and by a grant from the Leukemia & Lymphoma Society (D.C.L.).	Birch JM, 2001, ONCOGENE, V20, P4621, DOI 10.1038/sj.onc.1204621; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Casas-Selves Matias, 2011, Evolution (N Y), V4, P624; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Christiansen DH, 2001, J CLIN ONCOL, V19, P1405, DOI 10.1200/JCO.2001.19.5.1405; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Godley LA, 2008, SEMIN ONCOL, V35, P418, DOI 10.1053/j.seminoncol.2008.04.012; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kayser S, 2011, BLOOD, V117, P2137, DOI 10.1182/blood-2010-08-301713; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Link DC, 2011, JAMA-J AM MED ASSOC, V305, P1568, DOI 10.1001/jama.2011.473; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Shih AH, 2013, HAEMATOLOGICA, V98, P908, DOI 10.3324/haematol.2012.076729; Walter MJ, 2013, LEUKEMIA, V27, P1275, DOI 10.1038/leu.2013.58; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106	24	475	483	5	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					552	555		10.1038/nature13968	http://dx.doi.org/10.1038/nature13968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25487151	Green Accepted			2022-12-28	WOS:000350097300050
J	Carey, BW; Finley, LWS; Cross, JR; Allis, CD; Thompson, CB				Carey, Bryce W.; Finley, Lydia W. S.; Cross, Justin R.; Allis, C. David; Thompson, Craig B.			Intracellular alpha-ketoglutarate maintains the pluripotency of embryonic stem cells	NATURE			English	Article							GROUND-STATE PLURIPOTENCY; SELF-RENEWAL; DNA DEMETHYLATION; MOUSE; DIFFERENTIATION; METHYLATION; EXPRESSION; PHASE; ESCS	The role of cellular metabolism in regulating cell proliferation and differentiation remains poorly understood(1). For example, most mammalian cells cannot proliferate without exogenous glutamine supplementation even though glutamine is a non-essential amino acid(1,2). Here we show that mouse embryonic stem (ES) cells grown under conditions that maintain naive pluripotency(3) are capable of proliferation in the absence of exogenous glutamine. Despite this, ES cells consume high levels of exogenous glutamine when the metabolite is available. In comparison to more differentiated cells, naive ES cells utilize both glucose and glutamine catabolism to maintain a high level of intracellular alpha-ketoglutarate (alpha KG). Consequently, naive ES cells exhibit an elevated alpha KG to succinate ratio that promotes histone/DNA demethylation and maintains pluripotency. Direct manipulation of the intracellular alpha KG/succinate ratio is sufficient to regulate multiple chromatin modifications, including H3K27me3 and ten-eleven translocation (Tet)-dependent DNA demethylation, which contribute to the regulation of pluripotency-associated gene expression. In vitro, supplementation with cell-permeable alpha KG directly supports ES-cell self-renewal while cell-permeable succinate promotes differentiation. This work reveals that intracellular alpha KG/succinate levels can contribute to the maintenance of cellular identity and have a mechanistic role in the transcriptional and epigenetic state of stem cells.	[Carey, Bryce W.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Finley, Lydia W. S.; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Thompson, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	alliscd@mail.rockefeller.edu; thompsonc@mskcc.org		Cross, Justin/0000-0002-6356-057X	National Institutes of Health/National Institute of General Medical Sciences; National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA105463, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	B.W.C. is a Howard Hughes Medical Institute fellow of the Jane Coffin Childs Memorial Research Fund. L.W.S.F. is the Jack Sorrell Fellow of the Damon Runyon Cancer Research Foundation (DRG-2144-13). This work was funded by grants from the National Institutes of Health/National Institute of General Medical Sciences (C.D.A.) and from the National Cancer Institute (C.B.T.). We thank C. Li for assistance with FACS analysis and M. Dawlaty, D. Faddah and R. Jaenisch for sharing cell lines used in this study.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; EAGLE H, 1956, J BIOL CHEM, V218, P607; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hackett JA, 2013, STEM CELL REP, V1, P518, DOI 10.1016/j.stemcr.2013.11.010; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Markoulaki S, 2008, METHODS, V45, P101, DOI 10.1016/j.ymeth.2008.04.002; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shipony Z, 2014, NATURE, V513, P115, DOI 10.1038/nature13458; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005	30	565	584	10	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					413	416		10.1038/nature13981	http://dx.doi.org/10.1038/nature13981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25487152	Green Accepted			2022-12-28	WOS:000349547400045
J	Dominissini, D				Dominissini, Dan			Genomics and Proteomics Roadmap to the epitranscriptome	SCIENCE			English	Editorial Material							MESSENGER-RNA; STRUCTURAL BASIS; NUCLEAR-RNA; YTH DOMAIN; M(6)A RNA; N-6-METHYLADENOSINE; TRANSCRIPTOME; METHYLATION; BINDING; IME4		Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Dominissini, D (corresponding author), Univ Chicago, Dept Chem, Chicago, IL 60637 USA.	dandominissini@gmail.com		Dominissini, Dan/0000-0003-1121-5130				Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; CECH TR, 2012, COLD SPRING HARB, V4; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; GROSJEAN H, 2005, TOPICS CURRENT GENE, V12; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	19	14	14	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1192	1192		10.1126/science.aaa1807	http://dx.doi.org/10.1126/science.aaa1807			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477448				2022-12-28	WOS:000346189000063
J	McGlynn, EA; Schneider, EC; Kerr, EA				McGlynn, Elizabeth A.; Schneider, Eric C.; Kerr, Eve A.			Reimagining Quality Measurement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE		[McGlynn, Elizabeth A.] Kaiser Permanente Ctr Effectiveness & Safety Res, Pasadena, CA USA; [Schneider, Eric C.] Harvard Univ, Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02115 USA; [Schneider, Eric C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Kerr, Eve A.] Veteran Affairs Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Kerr, Eve A.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Kerr, Eve A.] Inst Healthcare Policy & Innovat, Ann Arbor, MI USA	Kaiser Permanente; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	McGlynn, EA (corresponding author), Kaiser Permanente Ctr Effectiveness & Safety Res, Pasadena, CA USA.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Schneider, Eric/0000-0002-1132-5084				Kerr EA, 2013, JAMA-J AM MED ASSOC, V310, P137, DOI 10.1001/jama.2013.6828; Lugtenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025987; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265	3	54	54	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2150	2153		10.1056/NEJMp1407883	http://dx.doi.org/10.1056/NEJMp1407883			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW0IY	25470693				2022-12-28	WOS:000345976700003
J	Ribeiro, ED; Pinotsis, N; Ghisleni, A; Salmazo, A; Konarev, PV; Kostan, J; Sjoblom, B; Schreiner, C; Polyansky, AA; Gkougkoulia, EA; Holt, MR; Aachmann, FL; Zagrovic, B; Bordignon, E; Pirker, KF; Svergun, DI; Gautel, M; Djinovic-Carugo, K				Ribeiro, Euripedes de Almeida, Jr.; Pinotsis, Nikos; Ghisleni, Andrea; Salmazo, Anita; Konarev, Petr V.; Kostan, Julius; Sjoeblom, Bjoern; Schreiner, Claudia; Polyansky, Anton A.; Gkougkoulia, Eirini A.; Holt, Mark R.; Aachmann, Finn L.; Zagrovic, Bojan; Bordignon, Enrica; Pirker, Katharina F.; Svergun, Dmitri I.; Gautel, Mathias; Djinovic-Carugo, Kristina			The Structure and Regulation of Human Muscle alpha-Actinin	CELL			English	Article							SARCOMERIC Z-DISK; Z-BAND; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; HYPERTROPHIC CARDIOMYOPATHY; TARGET RECOGNITION; CRYSTAL-STRUCTURE; LIM PROTEIN; F-ACTIN; Z-LINE; BINDING	The spectrin superfamily of proteins plays key roles in assembling the actin cytoskeleton in various cell types, crosslinks actin filaments, and acts as scaffolds for the assembly of large protein complexes involved in structural integrity and mechanosensation, as well as cell signaling. alpha-actinins in particular are the major actin crosslinkers in muscle Z-disks, focal adhesions, and actin stress fibers. We report a complete high-resolution structure of the 200 kDa alpha-actinin-2 dimer from striated muscle and explore its functional implications on the biochemical and cellular level. The structure provides insight into the phosphoinositide-based mechanism controlling its interaction with sarcomeric proteins such as titin, lays a foundation for studying the impact of pathogenic mutations at molecular resolution, and is likely to be broadly relevant for the regulation of spectrin-like proteins.	[Ribeiro, Euripedes de Almeida, Jr.; Pinotsis, Nikos; Salmazo, Anita; Kostan, Julius; Sjoeblom, Bjoern; Schreiner, Claudia; Polyansky, Anton A.; Gkougkoulia, Eirini A.; Zagrovic, Bojan; Djinovic-Carugo, Kristina] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Ghisleni, Andrea; Holt, Mark R.; Gautel, Mathias] Kings Coll London, Randall Div Cell & Mol Biophys, British Heart Fdn Ctr Res Excellence, London SE1 1UL, England; [Konarev, Petr V.; Svergun, Dmitri I.] European Mol Biol Lab, Deutsch Elektronen Synchrotron, D-22603 Hamburg, Germany; [Aachmann, Finn L.] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway; [Bordignon, Enrica] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Pirker, Katharina F.] Univ Nat Resources & Life Sci, Div Biochem, Dept Chem, A-1190 Vienna, Austria; [Djinovic-Carugo, Kristina] Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, Ljubljana 1000, Slovenia; [Polyansky, Anton A.] Russian Acad Sci, MM Shemyakin & Yu Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Bordignon, Enrica] Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of London; King's College London; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Norwegian University of Science & Technology (NTNU); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Natural Resources & Life Sciences, Vienna; University of Ljubljana; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Free University of Berlin	Gautel, M (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, British Heart Fdn Ctr Res Excellence, London SE1 1UL, England.	mathias.gautel@kcl.ac.uk; kristina.djinovic@univie.ac.at	Pinotsis, Nikos/AAD-4013-2019; Konarev, Petr V/W-1380-2017; Gautel, Mathias/AAB-9860-2019; Aachmann, Finn/G-4136-2015; Polyansky, Anton A/J-2145-2018; Gkougkoulia, Eirini/AAY-9789-2020; Djinovic-Carugo, Kristina/AAW-1167-2021	Pinotsis, Nikos/0000-0002-5096-257X; Aachmann, Finn/0000-0003-1613-4663; Polyansky, Anton A/0000-0002-1011-2706; Gkougkoulia, Eirini/0000-0003-0112-5449; Djinovic-Carugo, Kristina/0000-0003-0252-2972; Gautel, Mathias/0000-0003-4027-9803; Svergun, Dmitri/0000-0003-0830-5696; Bordignon, Enrica/0000-0003-2450-5161; Ghisleni, Andrea/0000-0001-8456-5903; Kostan, Julius/0000-0002-8347-111X; Holt, Mark/0000-0001-7775-8539; Konarev, Petr/0000-0002-5606-1596; Zagrovic, Bojan/0000-0003-3814-3675	Austrian Science Fund (FWF) [I525, I1593, P22276, P19060]; Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise'' the Center of Optimized Structural Studies [253275]; Marie Curie Initial Training Network: MUZIC [238423]; University of Vienna; European Community [283570]; BioTek2021 Project [217708/O10]; Research Council of Norway; European Research Council [279408]; Russian Scientific Foundation [14-24-00118]; Leducq Foundation Transatlantic Network of Excellence: Proteotoxicity [11 CVD 04]; Medical Research Council of Great Britain [MR/J010456/1]; Human Frontier Science Program [RGP0017/2012]; MRC [MR/J010456/1, G0600251, MR/K015664/1] Funding Source: UKRI; Russian Science Foundation [14-24-00118] Funding Source: Russian Science Foundation; Austrian Science Fund (FWF) [I 525, I 1593] Funding Source: researchfish; Medical Research Council [G0600251, G0200496, MR/K015664/1, MR/J010456/1] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise'' the Center of Optimized Structural Studies; Marie Curie Initial Training Network: MUZIC; University of Vienna; European Community(European Commission); BioTek2021 Project; Research Council of Norway(Research Council of Norway); European Research Council(European Research Council (ERC)European Commission); Russian Scientific Foundation(Russian Science Foundation (RSF)); Leducq Foundation Transatlantic Network of Excellence: Proteotoxicity(Leducq Foundation); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Russian Science Foundation(Russian Science Foundation (RSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are greatly indebted to Ay Lin Kho for NRC preparations. Thanks also to Dusan Turk (Institute Jozef Stefan, Ljubljana) for initial help with refinement and Oliviero Carugo (University of Vienna and University of Pavia) and Bettina Hartlieb (Baxter Innovations GmbH) for critical reading of the manuscript. We thank the staff of the MX beamlines at the ESRF in Grenoble, SAXS beamline X33 (Deutsches Elektronen-Synchrotron, Hamburg), and SWING beamline (Soleil, Saint-Aubin) for their excellent support. We thank the staff of Campus Science Support Facilities GmbH (Campus Vienna Biocenter) for technical assistance. The K. D.-C. group was supported by Austrian Science Fund (FWF) Projects I525, I1593, P22276, and P19060, by the Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise'' funding the Center of Optimized Structural Studies (253275), by the Marie Curie Initial Training Network: MUZIC (238423), and by the University of Vienna. This research was also funded by the European Community Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (283570). F. L. A. thanks BioTek2021 Project 217708/O10 and the Research Council of Norway for financial support. B.Z. and A. A. P. were supported by the European Research Council (279408). A. A. P. was supported by the Russian Scientific Foundation (14-24-00118). M. G. and A. G. were supported by the Leducq Foundation Transatlantic Network of Excellence: Proteotoxicity (11 CVD 04) and the Medical Research Council of Great Britain (MR/J010456/1). A. G. and E.d.A.R. were also supported by the Marie Curie Initial Training Network: MUZIC (238423). M. G. holds the British Heart Foundation Chair of Molecular Cardiology (CH/08/001). D. I. S. acknowledges support from the Human Frontier Science Program (RGP0017/2012).	Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; Beck MR, 2011, J MOL BIOL, V413, P712, DOI 10.1016/j.jmb.2011.08.059; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Carugo O., 2014, WOLUMES ALGORITHM CO; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Faulkner G, 1999, J CELL BIOL, V146, P465, DOI 10.1083/jcb.146.2.465; Foley KS, 2014, BIOCHEM J, V459, P1, DOI 10.1042/BJ20131511; Fraley TS, 2003, J BIOL CHEM, V278, P24039, DOI 10.1074/jbc.M213288200; Franzot G, 2005, J MOL BIOL, V348, P151, DOI 10.1016/j.jmb.2005.01.002; Fukami K, 1996, J BIOL CHEM, V271, P2646, DOI 10.1074/jbc.271.5.2646; FUKAMI K, 1992, NATURE, V359, P150, DOI 10.1038/359150a0; Full SJ, 2007, PROTEIN SCI, V16, P2597, DOI 10.1110/ps.073146807; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P614, DOI 10.1038/nsmb.1789; Gautel M, 1996, J CELL SCI, V109, P2747; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; GOLDSTEIN MA, 1988, J GEN PHYSIOL, V92, P113, DOI 10.1085/jgp.92.1.113; GOLDSTEIN MA, 1979, J CELL BIOL, V83, P187, DOI 10.1083/jcb.83.1.187; Gueguen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074728; Hampton CM, 2007, J MOL BIOL, V368, P92, DOI 10.1016/j.jmb.2007.01.071; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200; Korsgren C, 2010, BLOOD, V116, P2600, DOI 10.1182/blood-2009-12-260612; Korsgren C, 2010, J BIOL CHEM, V285, P4757, DOI 10.1074/jbc.M109.056200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kunishima S, 2013, AM J HUM GENET, V92, P431, DOI 10.1016/j.ajhg.2013.01.015; Li JL, 2013, AM J PHYSIOL-HEART C, V305, pH1614, DOI 10.1152/ajpheart.00477.2013; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; MASAKI T, 1967, J BIOCHEM-TOKYO, V62, P630, DOI 10.1093/oxfordjournals.jbchem.a128717; MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Papa I, 1999, J MUSCLE RES CELL M, V20, P187, DOI 10.1023/A:1005489319058; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Sanger JM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.132pe37; SCHACHT J, 1976, J NEUROCHEM, V27, P1119, DOI 10.1111/j.1471-4159.1976.tb00318.x; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Swindells MB, 1996, NAT STRUCT BIOL, V3, P501, DOI 10.1038/nsb0696-501; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tang JH, 2001, J MOL BIOL, V310, P845, DOI 10.1006/jmbi.2001.4789; TAYLOR KA, 1993, J MOL BIOL, V230, P196, DOI 10.1006/jmbi.1993.1136; Theis JL, 2006, BIOCHEM BIOPH RES CO, V351, P896, DOI 10.1016/j.bbrc.2006.10.119; Tskhovrebova L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/612482; Winkler J, 1997, EUR J BIOCHEM, V248, P193, DOI 10.1111/j.1432-1033.1997.00193.x; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614; Young P, 2000, EMBO J, V19, P6331, DOI 10.1093/emboj/19.23.6331; Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343	52	110	110	2	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1447	1460		10.1016/j.cell.2014.10.056	http://dx.doi.org/10.1016/j.cell.2014.10.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25433700	Green Published, hybrid			2022-12-28	WOS:000346652900021
J	Michalski, MH; Ross, JS				Michalski, Mark H.; Ross, Joseph S.			The Shape of Things to Come 3D Printing in Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Michalski, Mark H.] Yale Univ, Sch Med, Dept Diagnost Radiol, Invest Med Program, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, Sect Gen Internal Med,Dept Internal Med, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Yale University	Michalski, MH (corresponding author), Yale Univ, Sch Med, Dept Diagnost Radiol, POB 208042, New Haven, CT 06520 USA.	mark.michalski@yale.edu		Ross, Joseph/0000-0002-9218-3320				Flugge TV, 2013, J ORAL MAXIL SURG, V71, P1340, DOI 10.1016/j.joms.2013.04.010; Gaffney A., 2014, FDA PLANS M EXPL REG; Henn S, 2013, 3 D PRINTER BRINGS D; Liu QB, 2006, INT J ADV MANUF TECH, V29, P317, DOI 10.1007/s00170-005-2523-2; Spottiswoode BS, 2013, STEREOT FUNCT NEUROS, V91, P162, DOI 10.1159/000345264; Zein NN, 2013, LIVER TRANSPLANT, V19, P1304, DOI 10.1002/lt.23729; Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319	7	147	169	2	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2213	2214		10.1001/jama.2014.9542	http://dx.doi.org/10.1001/jama.2014.9542			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25461994				2022-12-28	WOS:000345684800012
J	Sharp, T				Sharp, Thomas			Bridgmanite-named at last	SCIENCE			English	Editorial Material							TENHAM METEORITE; DEEP EARTH; PEROVSKITE		Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85004 USA	Arizona State University; Arizona State University-Tempe	Sharp, T (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85004 USA.	tom.sharp@asu.edu						Bass JD, 2008, ELEMENTS, V4, P157, DOI 10.2113/GSELEMENTS.4.3.157; BINNS RA, 1969, NATURE, V221, P943, DOI 10.1038/221943a0; Hazen RM., 1999, THE DIAMOND MAKERS; Mcmillan PF, 2005, NAT MATER, V4, P715, DOI 10.1038/nmat1488; Miyahara M, 2011, P NATL ACAD SCI USA, V108, P5999, DOI 10.1073/pnas.1016921108; Pearson DG, 2014, NATURE, V507, P221, DOI 10.1038/nature13080; Sharp T.G., 2006, METEORITES EARLY SOL, P653; Stoffler D, 1997, SCIENCE, V278, P1576, DOI 10.1126/science.278.5343.1576; Tomioka N, 1997, SCIENCE, V277, P1084, DOI 10.1126/science.277.5329.1084; Tschauner O, 2014, SCIENCE, V346, P1100, DOI 10.1126/science.1259369	10	2	3	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1057	1058		10.1126/science.1261887	http://dx.doi.org/10.1126/science.1261887			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430755				2022-12-28	WOS:000345763400021
J	Dolgin, E				Dolgin, Elie			Oral solutions	NATURE			English	Editorial Material							HEMOPHILIA-A MICE; GENE-THERAPY; INHIBITOR FORMATION; IMMUNE TOLERANCE; FACTOR-VIII; FACTOR-IX; B-CELLS; INDUCTION; DELIVERY; FVIII											Bowman K, 2008, J CONTROL RELEASE, V132, P252, DOI 10.1016/j.jconrel.2008.06.019; Dhadwar SS, 2010, J THROMB HAEMOST, V8, P2743, DOI 10.1111/j.1538-7836.2010.04116.x; High KA, 2012, BLOOD, V120, P4482, DOI 10.1182/blood-2012-05-423210; Lei TC, 2005, BLOOD, V105, P4865, DOI 10.1182/blood-2004-11-4274; Quade-Lyssy P, 2014, J THROMB HAEMOST, V12, P932, DOI 10.1111/jth.12572; Rawle FE, 2006, J THROMB HAEMOST, V4, P2172, DOI 10.1111/j.1538-7836.2006.02118.x; Ruhlman T, 2007, PLANT BIOTECHNOL J, V5, P495, DOI 10.1111/j.1467-7652.2007.00259.x; Sherman A, 2014, BLOOD, V124, P1659, DOI 10.1182/blood-2013-10-528737; Verma D, 2010, P NATL ACAD SCI USA, V107, P7101, DOI 10.1073/pnas.0912181107; Wang XM, 2014, MOL THER, V22, P1139, DOI 10.1038/mt.2014.43; Zhang AHA, 2013, BLOOD, V122	11	5	6	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S166	S167		10.1038/515S166a	http://dx.doi.org/10.1038/515S166a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427208	Bronze			2022-12-28	WOS:000346247600010
J	Reynolds, AJ; Richardson, BA; Hayakawa, M; Lease, EM; Warner-Richter, M; Englund, MM; Ou, SR; Sullivan, M				Reynolds, Arthur J.; Richardson, Brandt A.; Hayakawa, Momoko; Lease, Erin M.; Warner-Richter, Mallory; Englund, Michelle M.; Ou, Suh-Ruu; Sullivan, Molly			Association of a Full-Day vs Part-Day Preschool Intervention With School Readiness, Attendance, and Parent Involvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EARLY-CHILDHOOD INTERVENTION; LOW-BIRTH-WEIGHT; EDUCATIONAL-ATTAINMENT; FOLLOW-UP; HEALTH; INCOME; PARTICIPATION; PREDICTORS; CHILDREN	IMPORTANCE Early childhood interventions have demonstrated positive effects on well-being. Whether full-day vs part-day attendance improves outcomes is unknown. OBJECTIVE To evaluate the association between a full-vs part-day early childhood program and school readiness, attendance, and parent involvement. DESIGN, SETTING, AND PARTICIPANTS End-of-preschool follow-up of a nonrandomized, matched-group cohort of predominantly low-income, ethnic minority children enrolled in the Child-Parent Centers (CPC) for the full day (7 hours; n = 409) or part day (3 hours on average; n = 573) in the 2012-2013 school year in 11 schools in Chicago, Illinois. INTERVENTION The Midwest CPC Education Program provides comprehensive instruction, family-support, and health services from preschool to third grade. MAIN OUTCOMES AND MEASURES School readiness skills at the end of preschool, attendance and chronic absences, and parental involvement. The readiness domains in the Teaching Strategies GOLD Assessment System include a total of 49 items with a score range of 105-418. The specific domains are socioemotional with 9 items (score range, 20-81), language with 6 items (score range, 15-54), literacy with 12 items (score range, 9-104), math with 7 items (score, 8-60), physical health with 5 items (score range, 14-45), and cognitive development with 10 items (score range, 18-90). RESULTS Full-day preschool participants had higher scores than part-day peers on socioemotional development (58.6 vs 54.5; difference, 4.1; 95% CI, 0.5-7.6; P = .03), language (39.9 vs 37.3; difference, 2.6; 95% CI, 0.6-4.6; P = .01), math (40.0 vs 36.4; difference, 3.6; 95% CI, 0.5-6.7; P = .02), physical health (35.5 vs 33.6; difference, 1.9; 95% CI, 0.5-3.2; P = .006), and the total score (298.1 vs 278.2; difference, 19.9; 95% CI, 1.2-38.4; P = .04). Literacy (64.5 vs 58.6; difference, 5.9; 95% CI, -0.07 to 12.4; P = .08) and cognitive development (59.7 vs 57.7; difference, 2.0; 95% CI, -2.4 to 6.3; P = .38) were not significant. Full-day preschool graduates also had higher rates of attendance (85.9% vs 80.4%; difference, 5.5; 95% CI, 2.6-8.4; P = .001) and lower rates of chronic absences (>= 10% days missed; 53.0% vs 71.6%; difference, -18.6; 95% CI, -28.5 to -8.7; P = .001; >= 20% days missed; 21.2% vs 38.8%; difference -17.6%; 95% CI, -25.6 to -9.7; P <.001) but no differences in parental involvement. CONCLUSIONS AND RELEVANCE In an expansion of the CPCs in Chicago, a full-day preschool intervention was associated with increased school readiness skills in 4 of 6 domains, attendance, and reduced chronic absences compared with a part-day program. These findings should be replicated in other programs and contexts.	[Reynolds, Arthur J.; Hayakawa, Momoko; Lease, Erin M.; Warner-Richter, Mallory; Englund, Michelle M.; Ou, Suh-Ruu] Univ Minnesota, Inst Child Dev, Minneapolis, MN 55455 USA; [Reynolds, Arthur J.; Richardson, Brandt A.; Hayakawa, Momoko; Lease, Erin M.; Warner-Richter, Mallory; Englund, Michelle M.; Ou, Suh-Ruu; Sullivan, Molly] Univ Minnesota, Human Capital Res Collaborat, Minneapolis, MN 55455 USA; [Richardson, Brandt A.] Univ Minnesota, Dept Appl Econ, Minneapolis, MN 55455 USA; [Reynolds, Arthur J.; Hayakawa, Momoko; Sullivan, Molly] Univ Minnesota, Humphrey Sch Publ Affairs, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Reynolds, AJ (corresponding author), Univ Minnesota, Inst Child Dev, 51 E River Rd, Minneapolis, MN 55455 USA.	ajr@umn.edu		Ou, Suh-Ruu/0000-0003-4735-3113; Englund, Michelle/0000-0002-3800-3157	US Department of Education's Investing in Innovation Fund [U411B110098]; J. B. and M. K. Pritzker Family Foundation; McCormick Foundation; Boeing Corp; Evanston Community Foundation; Finnegan Family Foundation; Lewis-Sebring Family Foundation; Foundation65; Northwestern University; Elizabeth Beidler Tisdahl Foundation; Target Corp; W. K. Kellogg Foundation; Doris Duke Charitable Trust; Foundation for Child Development; McKnight Foundation; Greater Twin Cities United Way; St Paul Foundation; Minneapolis Foundation; Joyce Foundation; National Institute of Child Health and Human Development [R01HD034294]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034294] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD034294] Funding Source: NIH RePORTER	US Department of Education's Investing in Innovation Fund; J. B. and M. K. Pritzker Family Foundation; McCormick Foundation; Boeing Corp; Evanston Community Foundation; Finnegan Family Foundation; Lewis-Sebring Family Foundation; Foundation65; Northwestern University; Elizabeth Beidler Tisdahl Foundation; Target Corp; W. K. Kellogg Foundation; Doris Duke Charitable Trust(Doris Duke Charitable Foundation (DDCF)); Foundation for Child Development; McKnight Foundation; Greater Twin Cities United Way; St Paul Foundation; Minneapolis Foundation; Joyce Foundation; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Preparation of this report was supported by grant U411B110098 from the US Department of Education's Investing in Innovation Fund and the following contributors: J. B. and M. K. Pritzker Family Foundation, McCormick Foundation, Boeing Corp, Evanston Community Foundation, Finnegan Family Foundation, Lewis-Sebring Family Foundation, Foundation65, Northwestern University, Elizabeth Beidler Tisdahl Foundation, Target Corp, W. K. Kellogg Foundation, Doris Duke Charitable Trust, Foundation for Child Development, McKnight Foundation, Greater Twin Cities United Way, St Paul Foundation, Minneapolis Foundation, and the Joyce Foundation. Support also was provided by grant R01HD034294 from the National Institute of Child Health and Human Development.	Arteaga I, 2014, ECON EDUC REV, V40, P221, DOI 10.1016/j.econedurev.2013.07.009; Balfanz R., 2012, CHRONIC ABSENTEEISM; Barnett W. S., 2012, THE STATE OF PRESCHO; Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206; CAMPBELL FA, 2002, APPL DEVELOPMENTAL S, V0006; Diggle P. J., 2002, ANALYSIS OF LONGITUD; Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898; Hill JL, 2003, DEV PSYCHOL, V39, P730, DOI 10.1037/0012-1649.39.4.730; Hoffman JP, 2003, GENERALIZED LINEAR M; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Human Capital Research Collaborative, 2014, IMPLEMENTATION FIDEL; Human Capital Research Collaborative, 2012, PROGRAM REQUIREMENT; Karoly LA., 2005, EARLY CHILDHOOD INTE; Koh HK, 2014, JAMA-J AM MED ASSOC, V311, P2475, DOI 10.1001/jama.2014.6446; Lambert R, 2013, EVIDENCE FOR THE ASS; Lambert R, 2013, TECHNICAL MANUAL FOR; Lambert RG, 2014, J PSYCHOEDUC ASSESS, V32, P27, DOI 10.1177/0734282913485214; Lipsey M.W., 2001, PRACTICAL META ANAL, V49; Little R. J. A., 1987, STATISTICAL ANALYSIS; Loeb S, 2007, ECON EDUC REV, V26, P52, DOI 10.1016/j.econedurev.2005.11.005; Manning M, 2010, CHILD YOUTH SERV REV, V32, P506, DOI 10.1016/j.childyouth.2009.11.003; Ou SR, 2008, SCHOOL PSYCHOL QUART, V23, P199, DOI 10.1037/1045-3830.23.2.199; Ou SR, 2007, SOC SERV REV, V81, P85, DOI 10.1086/510783; RAMEY CT, 1992, PEDIATRICS, V89, P454; Reynolds AJ, 2001, JAMA-J AM MED ASSOC, V285, P2339, DOI 10.1001/jama.285.18.2339; REYNOLDS AJ, 1995, EARLY CHILD RES Q, V10, P1, DOI 10.1016/0885-2006(95)90024-1; Reynolds AJ, 2011, ASSESSING THE VALIDI; Reynolds AJ, 2000, SUCCESS IN EARLY INT; Reynolds AJ, 2007, ARCH PEDIAT ADOL MED, V161, P730, DOI 10.1001/archpedi.161.8.730; Reynolds AJ, 2011, SCIENCE, V333, P360, DOI 10.1126/science.1203618; Reynolds AJ, 2011, CHILD DEV, V82, P555, DOI 10.1111/j.1467-8624.2010.01562.x; Reynolds AJ, 2011, CHILD DEV, V82, P379, DOI 10.1111/j.1467-8624.2010.01563.x; Robin KB, 2006, IS MORE BETTER THE E; Schweinhart Lawrence J., 2005, LIFETIME EFFECTS THE; Soderberg JS, 2014, INTER RATER RELIABIL; SPSSInc, 2013, ADVANCED STATISTICS; Teaching Strategies Inc, 2011, TEACHING STRATEGIES; US Department of Education National Center for Education Statistics, 2013, CONDITIONS OF EDUCAT; Valenti JE, 2009, EDUC URBAN SOC, V41, P695, DOI 10.1177/0013124509336060; Yves H, 2007, EARLY CHILD RES PRAC, V9, P1	40	38	38	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2126	2134		10.1001/jama.2014.15376	http://dx.doi.org/10.1001/jama.2014.15376			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU5DG	25423219	Green Accepted, Bronze			2022-12-28	WOS:000345626800016
J	Chellamuthu, VR; Ermilova, E; Lapina, T; Luddecke, J; Minaeva, E; Herrmann, C; Hartmann, MD; Forchhammer, K				Chellamuthu, Vasuki-Ranjani; Ermilova, Elena; Lapina, Tatjana; Lueddecke, Jan; Minaeva, Ekaterina; Herrmann, Christina; Hartmann, Marcus D.; Forchhammer, Karl			A Widespread Glutamine-Sensing Mechanism in the Plant Kingdom	CELL			English	Article							SIGNAL-TRANSDUCTION PROTEINS; N-ACETYLGLUTAMATE-KINASE; PII-LIKE PROTEIN; P-II PROTEIN; CHLAMYDOMONAS-REINHARDTII; METABOLITE CONCENTRATIONS; SUBCELLULAR VOLUMES; REGULATORY PROTEIN; CRYSTAL-STRUCTURE; COMPLEX-FORMATION	Glutamine is the primary metabolite of nitrogen assimilation from inorganic nitrogen sources in microorganisms and plants. The ability to monitor cellular nitrogen status is pivotal for maintaining metabolic homeostasis and sustaining growth. The present study identifies a glutamine-sensing mechanism common in the entire plant kingdom except Brassicaceae. The plastid-localized PII signaling protein controls, in a glutamine-dependent manner, the key enzyme of the ornithine synthesis pathway, N-acetyl-L-glutamate kinase (NAGK), that leads to arginine and polyamine formation. Crystal structures reveal that the plant-specific C-terminal extension of PII, which we term the Q loop, forms a low-affinity glutamine-binding site. Glutamine binding alters PII conformation, promoting interaction and activation of NAGK. The binding motif is highly conserved in plants except Brassicaceae. A functional Q loop restores glutamine sensing in a recombinant Arabidopsis thaliana PII protein, demonstrating the modular concept of the glutamine-sensing mechanism adopted by PII proteins during the evolution of plant chloroplasts.	[Chellamuthu, Vasuki-Ranjani; Lueddecke, Jan; Herrmann, Christina; Forchhammer, Karl] Univ Tubingen, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Ermilova, Elena; Lapina, Tatjana; Minaeva, Ekaterina] St Petersburg State Univ, Lab Adaptat Microorganisms, Fac Biol, St Petersburg 199034, Russia; [Chellamuthu, Vasuki-Ranjani; Hartmann, Marcus D.] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Saint Petersburg State University; Max Planck Society	Forchhammer, K (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Morgenstelle 28, D-72076 Tubingen, Germany.	karl.forchhammer@uni-tuebingen.de	Minaeva, Ekaterina/O-4647-2014; Lapina, Tatyana V/J-4802-2013; Hartmann, Marcus/L-8759-2019; /H-1738-2013	Minaeva, Ekaterina/0000-0002-3174-6134; Lapina, Tatyana V/0000-0002-5663-1990; Hartmann, Marcus/0000-0001-6937-5677; /0000-0003-0800-5933	Deutsche Forschungsgemeinschaft [Fo195/9-1, Fo195/10/11]; Russian Foundation for Basic Research [N 13-04-00087]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was funded by the Deutsche Forschungsgemeinschaft (grants Fo195/9-1 and Fo195/10/11 to K.F.) and by a grant of the Russian Foundation for Basic Research (N 13-04-00087 to E.E.). V.-R.C. and M.D.H. are grateful to Andrei Lupas for continuous support. We thank Karen Brune for careful linguistic editing of the paper and Oleksandra Fokina for helpful experimental advice, acknowledge the skillful assistance of Reinhard Albrecht and Kerstin Bar in crystallographic sample preparation, and are grateful for the excellent support by the staff of Swiss Light Source beamline X10SA.	ADLER SP, 1975, J BIOL CHEM, V250, P6264; Beez S, 2009, J MOL BIOL, V389, P748, DOI 10.1016/j.jmb.2009.04.053; Bolling C, 2005, PLANT PHYSIOL, V139, P1995, DOI 10.1104/pp.105.071589; Chellamuthu VR, 2013, PLANTA, V237, P451, DOI 10.1007/s00425-012-1801-0; Ermilova E, 2013, PROTIST, V164, P49, DOI 10.1016/j.protis.2012.04.002; Ferrario-Mery S, 2006, FEBS LETT, V580, P2015, DOI 10.1016/j.febslet.2006.02.075; Ferrario-Mery S, 2005, PLANTA, V223, P28, DOI 10.1007/s00425-005-0063-5; Ferrario-Mery S, 2008, FEBS LETT, V582, P1061, DOI 10.1016/j.febslet.2008.02.056; Fokina O, 2010, P NATL ACAD SCI USA, V107, P19760, DOI 10.1073/pnas.1007653107; FORCHHAMMER K, 1994, J BACTERIOL, V176, P84, DOI 10.1128/JB.176.1.84-91.1994; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Forchhammer K, 2007, FRONT BIOSCI-LANDMRK, V12, P358, DOI 10.2741/2069; Foyer CH, 2003, J EXP BOT, V54, P585, DOI 10.1093/jxb/erg053; Fritz C, 2006, PLANT CELL ENVIRON, V29, P2055, DOI 10.1111/j.1365-3040.2006.01580.x; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Heinrich A, 2006, J BIOL CHEM, V281, P34909, DOI 10.1074/jbc.M607582200; Hesketh A, 2002, MOL MICROBIOL, V46, P319, DOI 10.1046/j.1365-2958.2002.03149.x; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Jiang P, 1997, J BACTERIOL, V179, P4342, DOI 10.1128/jb.179.13.4342-4353.1997; Jiang P, 2011, BIOCHEMISTRY-US, V50, P10929, DOI 10.1021/bi201410x; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11522, DOI 10.1021/bi9011594; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11514, DOI 10.1021/bi901158h; Keys AJ, 2006, PHOTOSYNTH RES, V87, P165, DOI 10.1007/s11120-005-9024-x; Lea P.J., 2010, ANN PLANT REV, V42, P1, DOI [10.1002/9781444328608.ch1, DOI 10.1002/9781444328608.CH1]; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Llacer JL, 2008, CURR OPIN STRUC BIOL, V18, P673, DOI 10.1016/j.sbi.2008.11.002; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; Maier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026327; Mizuno Y, 2007, J BIOL CHEM, V282, P35733, DOI 10.1074/jbc.M707127200; Mizuno Y, 2007, BIOCHEMISTRY-US, V46, P1477, DOI 10.1021/bi062149e; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Radchenko M, 2011, BIOCHEM SOC T, V39, P189, DOI 10.1042/BST0390189; Radchenko MV, 2013, P NATL ACAD SCI USA, V110, P12948, DOI 10.1073/pnas.1304386110; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; Sant'Anna F, 2009, J MOL EVOL, V68, P322, DOI 10.1007/s00239-009-9209-6; Smith CS, 2004, BBA-PROTEINS PROTEOM, V1699, P145, DOI 10.1016/j.bbapap.2004.02.009; Smith CS, 2003, PLANT J, V33, P353, DOI 10.1046/j.1365-313X.2003.01634.x; Sugiyama K, 2004, PLANT CELL PHYSIOL, V45, P1768, DOI 10.1093/pcp/pch199; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; Uhrig RG, 2009, TRENDS PLANT SCI, V14, P505, DOI 10.1016/j.tplants.2009.07.003; WINTER H, 1993, PLANTA, V191, P180, DOI 10.1007/BF00199748; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558; Zeth K, 2014, J BIOL CHEM, V289, P8960, DOI 10.1074/jbc.M113.536557; Zheng ZL, 2009, PLANT SIGNAL BEHAV, V4, P584, DOI 10.4161/psb.4.7.8540	49	86	87	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1188	1199		10.1016/j.cell.2014.10.015	http://dx.doi.org/10.1016/j.cell.2014.10.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416954	Bronze			2022-12-28	WOS:000345506300027
J	Matoba, S; Liu, YT; Lu, FL; Iwabuchi, KA; Shen, L; Inoue, A; Zhang, Y				Matoba, Shogo; Liu, Yuting; Lu, Falong; Iwabuchi, Kumiko A.; Shen, Li; Inoue, Azusa; Zhang, Yi			Embryonic Development following Somatic Cell Nuclear Transfer Impeded by Persisting Histone Methylation	CELL			English	Article							PLURIPOTENT STEM-CELLS; CLONED BOVINE EMBRYOS; PREIMPLANTATION EMBRYOS; SIGNIFICANT IMPROVEMENT; DEACETYLASE INHIBITOR; LYSINE 9; HETEROCHROMATIN; GENOME; OOCYTES; CLONING	Mammalian oocytes can reprogram somatic cells into a totipotent state enabling animal cloning through somatic cell nuclear transfer (SCNT). However, the majority of SCNT embryos fail to develop to term due to undefined reprogramming defects. Here, we identify histone H3 lysine 9 trimethylation (H3K9me3) of donor cell genome as a major barrier for efficient reprogramming by SCNT. Comparative transcriptome analysis identified reprogramming resistant regions (RRRs) that are expressed normally at 2-cell mouse embryos generated by in vitro fertilization (IVF) but not SCNT. RRRs are enriched for H3K9me3 in donor somatic cells and its removal by ectopically expressed H3K9me3 demethylase Kdm4d not only reactivates the majority of RRRs, but also greatly improves SCNT efficiency. Furthermore, use of donor somatic nuclei depleted of H3K9 methyltransferases markedly improves SCNT efficiency. Our study thus identifies H3K9me3 as a critical epigenetic barrier in SCNT-mediated reprogramming and provides a promising approach for improving mammalian cloning efficiency.	[Matoba, Shogo; Liu, Yuting; Lu, Falong; Iwabuchi, Kumiko A.; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Matoba, Shogo; Liu, Yuting; Lu, Falong; Iwabuchi, Kumiko A.; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Matoba, Shogo; Liu, Yuting; Lu, Falong; Iwabuchi, Kumiko A.; Shen, Li; Inoue, Azusa; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, Y (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, WAB 149G,200 Longwood Ave, Boston, MA 02115 USA.	yzhang@genetics.med.harvard.edu	Lu, Falong/Q-3013-2016; MATOBA, Shogo/D-9995-2016	MATOBA, Shogo/0000-0003-0474-232X; Lu, Falong/0000-0002-8321-4818	NIH [U01DK089565]; Japan Society for the Promotion of Science (JSPS); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs.Shinpei Yamaguchi, Luis M.Tuesta, and Hao Wu for critical reading of the manuscript.This project is supported by NIH U01DK089565 (to Y.Z.).S.M.and K.A.I.are supported by postdoctoral fellowship from the Japan Society for the Promotion of Science (JSPS).Y.Z.is an investigator of the Howard Hughes Medical Institute.	Akagi S, 2011, J REPROD DEVELOP, V57, P120, DOI 10.1262/jrd.10-058A; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Canzio D, 2013, NATURE, V496, P377, DOI 10.1038/nature12032; Chang G, 2014, CELL RES, V24, P293, DOI 10.1038/cr.2013.173; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chung YG, 2014, CELL STEM CELL, V14, P777, DOI 10.1016/j.stem.2014.03.015; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evsikov AV, 2004, CYTOGENET GENOME RES, V105, P240, DOI 10.1159/000078195; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Krishnan S, 2013, STRUCTURE, V21, P98, DOI 10.1016/j.str.2012.10.018; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li SG, 2006, REPRODUCTION, V131, P1085, DOI 10.1530/rep.1.01065; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Ono Y, 2001, BIOL REPROD, V64, P44, DOI 10.1095/biolreprod64.1.44; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pichugin A, 2010, REPRODUCTION, V139, P129, DOI 10.1530/REP-08-0435; Poleshko A, 2014, NUCLEUS-PHILA, V5, P32, DOI 10.4161/nucl.28167; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Suzuki T, 2006, CLONING STEM CELLS, V8, P295, DOI 10.1089/clo.2006.8.295; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Terndrup M, 2014, MOL CELL BIOL, V34, P1031, DOI 10.1128/MCB.00864-13; Van Thuan N, 2009, REPRODUCTION, V138, P309, DOI 10.1530/REP-08-0299; Vassena R, 2007, DEV BIOL, V304, P75, DOI 10.1016/j.ydbio.2006.12.015; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu GM, 2013, NAT CELL BIOL, V15, P1089, DOI 10.1038/ncb2816; Yamada M, 2014, NATURE, V510, P533, DOI 10.1038/nature13287; Yang CX, 2013, REPRODUCTION, V145, P149, DOI 10.1530/REP-11-0421; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	43	289	324	3	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					884	895		10.1016/j.cell.2014.09.055	http://dx.doi.org/10.1016/j.cell.2014.09.055			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417163	Bronze, Green Accepted			2022-12-28	WOS:000344522000019
J	Pardee, K; Green, AA; Ferrante, T; Cameron, DE; DaleyKeyser, A; Yin, P; Collins, JJ				Pardee, Keith; Green, Alexander A.; Ferrante, Tom; Cameron, D. Ewen; DaleyKeyser, Ajay; Yin, Peng; Collins, James J.			Paper-Based Synthetic Gene Networks	CELL			English	Article							ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATORS; ENVIRONMENTAL SIGNAL; DNA; RNA; RIBOREGULATORS; TRANSLATION; EXPRESSION; PATHWAY; CELLS	Synthetic gene networks have wide-ranging uses in reprogramming and rewiring organisms. To date, there has not been a way to harness the vast potential of these networks beyond the constraints of a laboratory or in vivo environment. Here, we present an in vitro paper-based platform that provides an alternate, versatile venue for synthetic biologists to operate and a much-needed medium for the safe deployment of engineered gene circuits beyond the lab. Commercially available cell-free systems are freeze dried onto paper, enabling the inexpensive, sterile, and abiotic distribution of synthetic-biology-based technologies for the clinic, global health, industry, research, and education. For field use, we create circuits with colorimetric outputs for detection by eye and fabricate a low-cost, electronic optical interface. We demonstrate this technology with small-molecule and RNA actuation of genetic switches, rapid proto-typing of complex gene circuits, and programmable in vitro diagnostics, including glucose sensors and strain-specific Ebola virus sensors.	[Pardee, Keith; Green, Alexander A.; Ferrante, Tom; DaleyKeyser, Ajay; Yin, Peng; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Pardee, Keith; Green, Alexander A.; Cameron, D. Ewen; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Pardee, Keith; Green, Alexander A.; Cameron, D. Ewen; Collins, James J.] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA; [Cameron, D. Ewen; Collins, James J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston University; Boston University; Howard Hughes Medical Institute	Collins, JJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	jcollins@bu.edu	Green, Alexander A./X-7025-2019	Green, Alexander A./0000-0003-2058-1204	Canadian Institutes of Health Research; Wyss Institute; NIH Director's New Innovator Award [1DP2OD007292]; ONR Young Investigator Program Award [N000141110914]; NSF Expedition in Computing Award [CCF1317291]; Howard Hughes Medical Institute; Office of Naval Research MURI program; Defense Threat Reduction Agency [HDTRA1-14-1-0006]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wyss Institute; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR Young Investigator Program Award; NSF Expedition in Computing Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Naval Research MURI program(MURI); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	K.P. is a Canadian Institutes of Health Research-funded postdoctoral fellow at the Wyss Institute at Harvard University. This work was supported by the Wyss Institute; and NIH Director's New Innovator Award (1DP2OD007292), an ONR Young Investigator Program Award (N000141110914), and an NSF Expedition in Computing Award (CCF1317291) through P.Y. and the Howard Hughes Medical Institute, the Office of Naval Research MURI program, and the Defense Threat Reduction Agency grant HDTRA1-14-1-0006 through J.J.C.	Anbarasi MS., 2011, INT J COMPUT SCI INF, V2, P512; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; BUDD J, 1989, COLLOID SURFACE, V36, P273, DOI 10.1016/0166-6622(89)80243-4; Byrd KB, 2014, REMOTE SENS ENVIRON, V149, P166, DOI 10.1016/j.rse.2014.04.003; Callura JM, 2012, P NATL ACAD SCI USA, V109, P5850, DOI 10.1073/pnas.1203808109; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p; Cooper RM, 2014, LAB CHIP, V14, P182, DOI 10.1039/c3lc50935d; Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002; Hong SH, 2014, ACS SYNTH BIOL, V3, P398, DOI 10.1021/sb400140t; Hughes TR, 2011, SUBCELL BIOCHEM, V52, P11, DOI 10.1007/978-90-481-9069-0; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Kang JH, 2014, NAT MED, V20, P1211, DOI 10.1038/nm.3640; Karzbrun E, 2014, SCIENCE, V345, P829, DOI 10.1126/science.1255550; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kobori S, 2013, MOL BIOSYST, V9, P1282, DOI 10.1039/c3mb70032a; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Kuruma Y, 2009, BBA-BIOMEMBRANES, V1788, P567, DOI 10.1016/j.bbamem.2008.10.017; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Pardee K, 2011, SUBCELL BIOCHEM, V52, P123, DOI 10.1007/978-90-481-9069-0_6; Schmidt JA., 2010, LIGNIN LIGNANS ADV C, P49, DOI 10.1201/EBK1574444865-c3; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shimizu Y, 2010, METHODS MOL BIOL, V607, P11, DOI 10.1007/978-1-60327-331-2_2; Sun ZZ, 2014, ACS SYNTH BIOL, V3, P387, DOI 10.1021/sb400131a; Takahashi MK, 2014, ACS SYNTH BIOL; Takanaga H, 2010, FASEB J, V24, P2849, DOI 10.1096/fj.09-146472; Torella JP, 2013, P NATL ACAD SCI USA, V110, P11290, DOI 10.1073/pnas.1307129110; Yan L, 2014, MOL BIOSYST, V10, P970, DOI 10.1039/c3mb70304e; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	39	399	416	18	250	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					940	954		10.1016/j.cell.2014.10.004	http://dx.doi.org/10.1016/j.cell.2014.10.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417167	Green Accepted, Bronze			2022-12-28	WOS:000344522000023
J	Jewkes, R; Flood, M; Lang, J				Jewkes, Rachel; Flood, Michael; Lang, James			From work with men and boys to changes of social norms and reduction of inequities in gender relations: a conceptual shift in prevention of violence against women and girls	LANCET			English	Article							INTIMATE-PARTNER VIOLENCE; RURAL SOUTH-AFRICA; RANDOMIZED CONTROLLED-TRIAL; CHILD SEXUAL-ABUSE; COLLEGE MEN; HIV RISK; INTERVENTION; PERPETRATION; MASCULINITY; PREVALENCE	Violence perpetrated by and against men and boys is a major public health problem. Although individual men's use of violence differs, engagement of all men and boys in action to prevent violence against women and girls is essential. We discuss why this engagement approach is theoretically important and how prevention interventions have developed from treating men simply as perpetrators of violence against women and girls or as allies of women in its prevention, to approaches that seek to transform the relations, social norms, and systems that sustain gender inequality and violence. We review evidence of intervention effectiveness in the reduction of violence or its risk factors, features commonly seen in more effective interventions, and how strong evidence-based interventions can be developed with more robust use of theory. Future interventions should emphasise work with both men and boys and women and girls to change social norms on gender relations, and need to appropriately accommodate the differences between men and women in the design of programmes.	[Jewkes, Rachel] MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa; [Flood, Michael] Univ Wollongong, Dept Sociol, Wollongong, NSW, Australia; [Lang, James] Asia Pacific Reg Ctr, UN Dev Programme, Bangkok, Thailand	University of Wollongong	Jewkes, R (corresponding author), MRC, Private Bag X385, ZA-0001 Pretoria, South Africa.	rjewkes@mrc.ac.za	Flood, Michael/V-4941-2018	Jewkes, Rachel/0000-0002-4330-6267	Medical Research Council of South Africa; Department for International Development (DFID); United Nations Development Plan; University of Wollongong; UK Aid from the UK DFID	Medical Research Council of South Africa(South African Medical Research Council); Department for International Development (DFID); United Nations Development Plan; University of Wollongong; UK Aid from the UK DFID	RJ was supported by the Medical Research Council of South Africa and received funding from the Department for International Development (DFID). JL was supported by the United Nations Development Plan. MF was supported by the University of Wollongong for the work of writing the manuscript. This document is an output from What Works to prevent Violence: a Global Programme which is funded by the UK Aid from the UK DFID for the benefit of developing countries. However, the views expressed and information contained in it are not necessarily those of or endorsed by DFID, which can accept no responsibility for such views or information or for any reliance placed on them. RJ is grateful to the South Africa/Sweden research links programme Hegemonic Masculinities study group for inspiration in the development some of the ideas presented here.	Abrahams N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028620; Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; Achyut P., 2011, BUILDING SUPPORT GEN; [Anonymous], 2003, ANN NY ACAD SCI; [Anonymous], 1994, GOING GOLD; Bajos N, 1998, SEXUAL BEHAV HIV AID; Banyard VL, 2007, J COMMUNITY PSYCHOL, V35, P463, DOI 10.1002/jcop.20159; Barker G., 2011, EVOLVING MEN INITIAL; Black M.C., 2011, NATL INTIMATE PARTNE; Bourgois P, 1996, BRIT J CRIMINOL, V36, P412; Breckenridge K, 1998, J S AFR STUD, V24, P669, DOI 10.1080/03057079808708596; Connell R., 2005, MASCULINITIES; Connell R., 2013, GENDER POWER SOC PER; Das A, 2012, CULT HEALTH SEX, V14, P659, DOI 10.1080/13691058.2012.677477; de Leeuw RNH, 2008, ADDICTION, V103, P1713, DOI 10.1111/j.1360-0443.2008.02293.x; Diop N., 2004, TOSTAN PROGRAM EVALU, DOI 10.31899/rh2.1002; Dobash E, 2000, CHANGING VIOLENT MEN; Donovan RJ, 2005, COMMUNICATION; Dworkin SL, 2013, AIDS BEHAV, V17, P2845, DOI 10.1007/s10461-013-0565-2; Ellsberg M, 2014, LANCET; Feder L., 2008, CAMPBELL SYSTEMATIC, V12, P1, DOI [DOI 10.4073/CSR.2008.12, 10.4073/csr.2008.12., DOI 10.4073/csr.2008.12]; Flood M, 2011, MEN MASC, V14, P358, DOI 10.1177/1097184X10363995; Fonagy P., 2003, PSYCHOANALYTIC THEOR; Foshee VA, 1998, AM J PUBLIC HEALTH, V88, P45, DOI 10.2105/AJPH.88.1.45; Fulu E., 2013, WHY DO SOME MEN USE; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Gavey Nicola, 2005, JUST SEX CULTURAL SC; Gidycz CA, 2011, VIOLENCE AGAINST WOM, V17, P720, DOI 10.1177/1077801211409727; Grieg A, 2000, MEN MASCULINITIES DE; Hawkins SR, EVALUATION FINDINGS; Hearn J., 2004, FEM THEOR, V5, P49, DOI DOI 10.1177/1464700104040813; Hearn J, 2012, MEN MASC, V15, P31, DOI 10.1177/1097184X11432113; Heise L., 2014, WHAT WORKS PREVENT V; Hornik RC, 2003, USING THEORY DESIGN; Hossain M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-339; Institute for Health Metrics and Evaluation, GLOB BURD DIS HEAT M; Jewkes R, 2012, SOC SCI MED, V74, P1729, DOI 10.1016/j.socscimed.2011.05.020; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2013, LANCET GLOB HEALTH, V1, pE208, DOI 10.1016/S2214-109X(13)70069-X; Jewkes R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029590; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Kaner EFS, 2009, DRUG ALCOHOL REV, V28, P301, DOI 10.1111/j.1465-3362.2009.00071.x; Katz J., 2006, MACHO PARADOX WHY SO; Kimball E, 2010, GLOBAL EFFORTS ENGAG; Kimmel M., 2004, MEN MASCULINITIES SO, P503; Knight RA, 2003, ANN NY ACAD SCI, V989, P72, DOI 10.1111/j.1749-6632.2003.tb07294.x; Levinson D., 1989, FAMILY VIOLENCE CROS; Livingston M, 2008, ADDICTION, V103, P619, DOI 10.1111/j.1360-0443.2008.02136.x; Mathews S, 2011, BRIT J CRIMINOL, V51, P960, DOI 10.1093/bjc/azr051; Miller E, 2014, J INTERPERS VIOLENCE, V29, P758, DOI 10.1177/0886260513505205; Miller E, 2013, AM J PREV MED, V45, P108, DOI 10.1016/j.amepre.2013.03.007; Morrell R, 1998, J S AFR STUD, V24, P605, DOI 10.1080/03057079808708593; Morrell R, 2001, CHANGING MEN SO AFRI; Morrell R., 2009, GENDER EQUALITY S AF; Morrell R., 2001, BOYS GENTLEMEN SETTL; Morrell R, 2012, MEN MASC, V15, P11, DOI 10.1177/1097184X12438001; Morrell R, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-17; Murphy M, 2009, J MENS STUDIES, V18, P103; Nascimento, 2007, ENGAGING MEN BOYS TR; Pease B., 2008, ENGAGING MEN MENS VI; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Pulerwitz J, 2006, PROMOTING EQUITABLE; Ricardo C, 2012, ENGAGING BOYS YOUNG; Rice K, 2014, J S AFR STUD, V40, P381, DOI 10.1080/03057070.2014.896720; Room R, 2002, ALCOHOL DEV SOC PUBL; Smedslund G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006048; Stephens KA, 2009, J INTERPERS VIOLENCE, V24, P996, DOI 10.1177/0886260508319366; Stockl H, 2013, LANCET, V382, P859, DOI 10.1016/S0140-6736(13)61030-2; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; Sweetman C., 2013, GENDER DEV, V21, P1, DOI [DOI 10.1080/13552074.2013.779445, https://doi.org/10.1080/13552074.13552013.13779445]; Talbot K, 2010, MEN MASC, V13; Taylor A, 2013, PROGRAMMES MEN WHO H; United Nations Division for the Advancement of Women, 2003, ROL MEN BOYS ACH GEN; Unterhalter E, 2005, GEND EQ S AFR ED 199; Wagenaar AC, 2010, AM J PUBLIC HEALTH, V100, P2270, DOI 10.2105/AJPH.2009.186007; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589; Whitaker DJ, 2008, CHILD ABUSE NEGLECT, V32, P529, DOI 10.1016/j.chiabu.2007.08.005; White JW, 2004, CRIM JUSTICE BEHAV, V31, P182, DOI 10.1177/0093854803261342; Wolfe DA, 2009, ARCH PEDIAT ADOL MED, V163, P692, DOI 10.1001/archpediatrics.2009.69; Wood K., 2001, CHANGING MEN SO AFRI, P317; World Health Organization, 2007, ENG MEN BOYS CHANG G	82	352	357	10	108	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1580	1589		10.1016/S0140-6736(14)61683-4	http://dx.doi.org/10.1016/S0140-6736(14)61683-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG3ZT	25467578	Green Submitted			2022-12-28	WOS:000353220000039
J	Elmariah, S; Mauri, L; Doros, G; Galper, BZ; O'Neill, KE; Steg, PG; Kereiakes, DJ; Yeh, RW				Elmariah, Sammy; Mauri, Laura; Doros, Gheorghe; Galper, Benjamin Z.; O'Neill, Kelly E.; Steg, Philippe Gabriel; Kereiakes, Dean J.; Yeh, Robert W.			Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ELUTING STENT IMPLANTATION; CLOPIDOGREL; ASPIRIN; DEATH; DISCONTINUATION; EFFICACY	Background Treatment with aspirin and a P2Y12 inhibitor is commonly used in patients with cardiovascular disorders. The overall effect of such treatment on all-cause mortality is unknown. In the Dual Antiplatelet Therapy (DAPT) Study, continuation of dual antiplatelet therapy beyond 12 months after coronary stenting was associated with an unexpected increase in non-cardiovascular death. In view of the potential public health importance of these findings, we aimed to assess the effect of extended duration dual antiplatelet therapy on mortality by doing a meta-analysis of all randomised, controlled trials of treatment duration in various cardiovascular disorders. Methods We searched Medline, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) to identify randomised controlled trials assessing the effect of extended duration versus no or short duration dual antiplatelet therapy, published before Oct 1, 2014. We did a meta-analysis to pool results with a hierarchical Bayesian random-effects model. The primary outcomes were hazard ratios comparing rates of all-cause, cardiovascular, and non-cardiovascular death. Findings Including the DAPT Study, we identified 14 eligible trials that randomly assigned 69 644 participants to different durations of dual antiplatelet therapy. Compared with aspirin alone or short duration dual antiplatelet therapy (<= 6 months), continued treatment was not associated with a difference in all-cause mortality (hazard ratio [HR] 1.05, 95% credible interval [CrI] 0.96-1.19; p=0.33). Similarly, cardiovascular (1.01, 0.93-1.12; p=0.81) and non-cardiovascular mortality (1.04, 0.90-1.26; p=0.66) were no different with extended duration versus short duration dual antiplatelet therapy or aspirin alone. Interpretation Extended duration dual antiplatelet therapy was not associated with a difference in the risk of all-cause, cardiovascular, or non-cardiovascular death compared with aspirin alone or short duration dual antiplatelet therapy.	[Elmariah, Sammy; Yeh, Robert W.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiol Div,Dept Med, Boston, MA 02114 USA; [Mauri, Laura; Galper, Benjamin Z.; O'Neill, Kelly E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med,Dept Med, Boston, MA 02114 USA; [Elmariah, Sammy; Mauri, Laura; Doros, Gheorghe; Yeh, Robert W.] Harvard Clin Res Inst, Boston, MA USA; [Doros, Gheorghe] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Steg, Philippe Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Steg, Philippe Gabriel] Dept Hosp Univ FIRE Fibrosis Inflammat & Remodeli, INSERM, U1148, Paris, France; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Steg, Philippe Gabriel] Univ London Imperial Coll Sci Technol & Med, Natl Heart Lung Inst, Royal Brompton Hosp, London, England; [Kereiakes, Dean J.] Christ Hosp Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital; Christ Hospital - Ohio	Yeh, RW (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiol Div,Dept Med, Boston, MA 02114 USA.	ryeh@mgh.harvard.edu	Elmariah, Sammy/AAG-8752-2021; Galper, Benjamin/AAT-5236-2020; Yeh, Robert/AAJ-3463-2020; STEG, Philippe Gabriel/Z-1567-2019; mauri, laura/GPS-4868-2022	Elmariah, Sammy/0000-0002-8013-8733; STEG, Philippe Gabriel/0000-0001-6896-2941; , Gheorghe/0000-0001-5524-4721	American Heart Association; Siemens Medical Solutions; Abbott; Boston Scientific; Cordis; Medtronic; Eli Lilly/Daiichi Sankyo; Sanofi-Aventis/Bristol-Myers Squibb; Recor; St Jude Medical (St Paul, MN, USA); Biotronik; Amarin; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi-Sankyo; GlaxoSmithKline; Eli Lilly; Merck-Sharpe-Dohme; Novartis; Otsuka; Pfizer; Sanofi-Aventis; Servier; Vivus; Janssen; Medicines Company; Orexigen; Abbott Vascular; Gilead Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL118138] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Siemens Medical Solutions(Siemens AG); Abbott(Abbott Laboratories); Boston Scientific(Boston Scientific); Cordis; Medtronic(Medtronic); Eli Lilly/Daiichi Sankyo(Daiichi Sankyo Company LimitedEli Lilly); Sanofi-Aventis/Bristol-Myers Squibb(Sanofi-AventisBristol-Myers Squibb); Recor; St Jude Medical (St Paul, MN, USA)(St. Jude Medical); Biotronik; Amarin; AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi-Sankyo(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); Eli Lilly(Eli Lilly); Merck-Sharpe-Dohme(Merck & Company); Novartis(Novartis); Otsuka(Otsuka Pharmaceutical); Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Servier(Servier); Vivus; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medicines Company; Orexigen; Abbott Vascular(Abbott Laboratories); Gilead Sciences(Gilead Sciences); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SE reports institutional research grants from the American Heart Association and Siemens Medical Solutions. LM reports institutional research grants from Abbott, Boston Scientific, Cordis, Medtronic, Eli Lilly/Daiichi Sankyo, and Sanofi-Aventis/Bristol-Myers Squibb; and personal fees from Medtronic, Recor, St Jude Medical (St Paul, MN, USA), and Biotronik. PGS reports personal fees from Amarin, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Eli Lilly, Merck-Sharpe-Dohme, Novartis, Otsuka, Pfizer, Roche, Medtronic, Sanofi-Aventis, Servier, Vivus, Janssen, The Medicines Company, and Orexigen; and grants from Sanofi-Aventis and Servier. RWY reports personal fees from Abbott Vascular and Gilead Sciences.	Belch JJF, 2010, J VASC SURG, V52, P825, DOI 10.1016/j.jvs.2010.04.027; Benavente OR, 2012, NEW ENGL J MED, V367, P817, DOI 10.1056/NEJMoa1204133; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ho PM, 2008, JAMA-J AM MED ASSOC, V299, P532, DOI 10.1001/jama.299.5.532; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Mauri L, N ENGL J ME IN PRESS; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Spiegelhalter D J, 2000, Health Technol Assess, V4, P1; Spoon DB, 2014, CIRCULATION, V129, P1286, DOI 10.1161/CIRCULATIONAHA.113.006518; Steg PG, 2014, CIRCULATION, V129, P1267, DOI 10.1161/CIRCULATIONAHA.114.008492; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; TSIATIS AA, 1981, BIOMETRIKA, V68, P311, DOI 10.1093/biomet/68.1.311; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Yusuf S, 2001, NEW ENGL J MED, V345, P494	25	136	143	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					792	798		10.1016/S0140-6736(14)62052-3	http://dx.doi.org/10.1016/S0140-6736(14)62052-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC0UD	25467565	Green Accepted			2022-12-28	WOS:000350051700033
J	Bath, PMW; Woodhouse, L; Scutt, P; Krishnan, K; Wardlaw, JM; Bereczki, D; Sprigg, N; Berge, E; Beridze, M; Caso, V; Chen, C; Christensen, H; Collins, R; El Etribi, A; Laska, AC; Lees, KR; Ozturk, S; Phillips, S; Pocock, S; de Silva, HA; Szatmari, S; Utton, S				Bath, Philip M. W.; Woodhouse, Lisa; Scutt, Polly; Krishnan, Kailash; Wardlaw, Joanna M.; Bereczki, Daniel; Sprigg, Nikola; Berge, Eivind; Beridze, Maia; Caso, Valeria; Chen, Christopher; Christensen, Hanne; Collins, Ronan; El Etribi, Anwar; Laska, Ann Charlotte; Lees, Kennedy R.; Ozturk, Serefnur; Phillips, Steve; Pocock, Stuart; de Silva, H. Asita; Szatmari, Szabolcs; Utton, Sally		ENOS Trial Investigators	Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial	LANCET			English	Article							ACUTE ISCHEMIC-STROKE; TRANSDERMAL GLYCERYL TRINITRATE; STATISTICAL-ANALYSIS; REDUCTION; RELIABILITY; OUTCOMES; TAIST; SCALE	Background High blood pressure is associated with poor outcome after stroke. Whether blood pressure should be lowered early after stroke, and whether to continue or temporarily withdraw existing antihypertensive drugs, is not known. We assessed outcomes after stroke in patients given drugs to lower their blood pressure. Methods In our multicentre, partial-factorial trial, we randomly assigned patients admitted to hospital with an acute ischaemic or haemorrhagic stroke and raised systolic blood pressure (systolic 140-220 mm Hg) to 7 days of transdermal glyceryl trinitrate (5 mg per day), started within 48 h of stroke onset, or to no glyceryl trinitrate (control group). A subset of patients who were taking antihypertensive drugs before their stroke were also randomly assigned to continue or stop taking these drugs. The primary outcome was function, assessed with the modified Rankin Scale at 90 days by observers masked to treatment assignment. This study is registered, number ISRCTN99414122. Findings Between July 20, 2001, and Oct 14, 2013, we enrolled 4011 patients. Mean blood pressure was 167 (SD 19) mm Hg/90 (13) mm Hg at baseline (median 26 h [16-37] after stroke onset), and was significantly reduced on day 1 in 2000 patients allocated to glyceryl trinitrate compared with 2011 controls (difference -7.0 [95% CI -8.5 to -5.6] mm Hg/-3.5 [-4.4 to -2.6] mm Hg; both p<0.0001), and on day 7 in 1053 patients allocated to continue antihypertensive drugs compared with 1044 patients randomised to stop them (difference -9.5 [95% CI -11.8 to -7.2] mm Hg/-5.0 [-6.4 to -3.7] mm Hg; both p<0.0001). Functional outcome at day 90 did not differ in either treatment comparison-the adjusted common odds ratio (OR) for worse outcome with glyceryl trinitrate versus no glyceryl trinitrate was 1.01 (95% CI 0.91-1.13; p=0.83), and with continue versus stop antihypertensive drugs OR was 1.05 (0.90-1.22; p=0.55). Interpretation In patients with acute stroke and high blood pressure, transdermal glyceryl trinitrate lowered blood pressure and had acceptable safety but did not improve functional outcome. We show no evidence to support continuing prestroke antihypertensive drugs in patients in the first few days after acute stroke.	[Bath, Philip M. W.] Univ Nottingham, Div Clin Neurosci, Stroke Trials Unit, Nottingham NG5 1PB, England	University of Nottingham	Bath, PMW (corresponding author), Univ Nottingham, Div Clin Neurosci, Stroke Trials Unit, Nottingham NG5 1PB, England.	philip.bath@nottingham.ac.uk	Szatmari, Szabolcs/C-3070-2011; Sacco, Simona/I-5253-2012; Szatmari, Szabolcs/AAG-7508-2020; Hernandez, María/GYU-3543-2022; Fuentes, Blanca/I-2114-2019; Sriwastva, Mukesh/S-7681-2019; Batur Caglayan, Hale/C-9857-2013; Wardlaw, Joanna M/Y-3456-2019; Strain, William/Y-9858-2019; OZTURK, SEREFNUR/AAG-4973-2019; Mettananda, Kukulege Chamila Dinushi/Y-3222-2019; ince, birsen/AAI-1704-2019; CASO, VALERIA/AAC-5156-2022; Chen, Christopher/E-7023-2013; Bereczki, Daniel/AAL-9886-2020; Bath, Philip/F-9020-2011	Szatmari, Szabolcs/0000-0001-8197-3231; Sacco, Simona/0000-0003-0651-1939; Szatmari, Szabolcs/0000-0001-8197-3231; Fuentes, Blanca/0000-0002-0363-862X; Sriwastva, Mukesh/0000-0003-4370-4625; Batur Caglayan, Hale/0000-0002-3279-1842; Wardlaw, Joanna M/0000-0002-9812-6642; Strain, William/0000-0002-6826-418X; OZTURK, SEREFNUR/0000-0001-8986-155X; Mettananda, Kukulege Chamila Dinushi/0000-0002-3328-1553; CASO, VALERIA/0000-0002-2020-8891; Chen, Christopher/0000-0002-1047-9225; Krishnan, Kailash/0000-0002-6486-3783; Nazliel, Bijen/0000-0002-6148-3814; Kwan, Joseph/0000-0003-4635-3322; Dineen, Robert/0000-0002-9523-2546; Piechowski-Jozwiak, Bartlomiej/0000-0001-7814-0028; Christensen, Hanne/0000-0002-7472-3194; Gommans, John/0000-0003-3750-765X; Whiteley, William/0000-0002-4816-8991; Laska, Ann Charlotte/0000-0002-7330-940X; Leonardi-Bee, Jo/0000-0003-0893-6068; PIECHOWSKI-JOZWIAK, BARTLOMIEJ/0000-0002-1886-9949; Bath, Philip/0000-0003-2734-5132; collins, Ronan/0000-0003-0404-8266; Woodhouse, Lisa/0000-0002-4472-1999	UK Medical Research Council; Agency for Science, Technology, and Research (Singapore); BUPA Foundation (UK); Hypertension Trust (UK); Queen Elizabeth II Health Sciences Centre Research Fund (Canada); Reichstadt family (UK); The Stroke Association (UK, Division of Stroke, University of Nottingham, Nottingham, UK); UK National Institute for Health Research, through the Stroke Research Network; collaboration between the Scottish Funding Council (SFC); Scottish Imagine Network: a Platform for Scientific Excellence; MRC [G0501797] Funding Source: UKRI; Medical Research Council [G0501797] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10003] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Agency for Science, Technology, and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); BUPA Foundation (UK); Hypertension Trust (UK); Queen Elizabeth II Health Sciences Centre Research Fund (Canada); Reichstadt family (UK); The Stroke Association (UK, Division of Stroke, University of Nottingham, Nottingham, UK); UK National Institute for Health Research, through the Stroke Research Network; collaboration between the Scottish Funding Council (SFC); Scottish Imagine Network: a Platform for Scientific Excellence; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This trial was primarily funded by the UK Medical Research Council. Other funders who supported the trial were the Agency for Science, Technology, and Research (Singapore), BUPA Foundation (UK), Hypertension Trust (UK), Queen Elizabeth II Health Sciences Centre Research Fund (Canada), Reichstadt family (UK), and The Stroke Association (UK, through its funding of the Division of Stroke, University of Nottingham, Nottingham, UK). We thank the co-investigators and research staff at the participating sites for their support. ENOS acknowledges the support of the UK National Institute for Health Research, through the Stroke Research Network; the large recruitment in the UK would not have been possible without network support. PMWB is Stroke Association Professor of Stroke Medicine. JMW was supported by a collaboration between the Scottish Funding Council (SFC) and the Scottish Imagine Network: a Platform for Scientific Excellence.; Funding UK Medical Research Council.	Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Ankolekar S, 2014, J STROKE CEREBROVASC, V23, P1821, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.022; Ankolekar S, 2013, STROKE, V44, P3120, DOI 10.1161/STROKEAHA.113.001301; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BARER DH, 1988, BRIT MED J, V296, P737, DOI 10.1136/bmj.296.6624.737; Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; Bath PMW, 2014, INT J STROKE, V9, P372, DOI 10.1111/ijs.12235; Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Bath PMW, 2001, CEREBROVASC DIS, V11, P265, DOI 10.1159/000047649; Bath PMW, 2000, AGE AGEING, V29, P554, DOI 10.1093/ageing/29.6.554; Bath PMW, 2001, LANCET, V358, P702, DOI 10.1016/S0140-6736(01)05837-8; Butterworth RJ, 1998, CEREBROVASC DIS, V8, P158, DOI 10.1159/000015842; Dachtler J, 2012, J NEUROSCI, V32, P14994, DOI 10.1523/JNEUROSCI.3189-12.2012; DESMOND DW, 1994, INT J GERIATR PSYCH, V9, P803, DOI 10.1002/gps.930091006; Fischberg GM, 2000, J EMERG MED, V19, P339, DOI 10.1016/S0736-4679(00)00267-5; Geeganage C, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000039.PUB2; Geeganage C, 2011, STROKE, V42, P491, DOI 10.1161/STROKEAHA.110.596163; Geeganage CM, 2009, HYPERTENSION, V54, P775, DOI 10.1161/HYPERTENSIONAHA.109.133538; Gray LJ, 2009, J STROKE CEREBROVASC, V18, P466, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.003; He J, 2014, JAMA-J AM MED ASSOC, V311, P479, DOI 10.1001/jama.2013.282543; Jusufovic M, 2014, STROKE; Lees KR, 2012, STROKE, V43, P1163, DOI 10.1161/STROKEAHA.111.641423; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; Lees KR, 1996, J HYPERTENS, V14, pS35; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; LINDENSTROM E, 1991, CEREBROVASC DIS, V1, P103, DOI 10.1159/000108825; Metitieri T, 2001, INT J GERIATR PSYCH, V16, P166, DOI 10.1002/1099-1166(200102)16:2<166::AID-GPS290>3.3.CO;2-D; Neal B, 2000, LANCET, V356, P1955; Rashid P, 2003, STROKE, V34, P2741, DOI 10.1161/01.STR.0000092488.40085.15; Rashid Parveen, 2003, J Stroke Cerebrovasc Dis, V12, P143, DOI 10.1016/S1052-3057(03)00037-5; Robinson TG, 2010, LANCET NEUROL, V9, P767, DOI 10.1016/S1474-4422(10)70163-0; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Schellinger PD, 2012, INT J STROKE, V7, P227, DOI 10.1111/j.1747-4949.2012.00773.x; Sprigg N, 2006, J HYPERTENS, V24, P1413, DOI 10.1097/01.hjh.0000234123.55895.12; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Thomas D, 2006, INT J STROKE, V1, P245, DOI 10.1111/j.1747-4949.2006.00059.x; WAHLGREN NG, 1994, CEREBROVASC DIS, V4, P204, DOI 10.1159/000108483; Weir CJ, 2003, STAT MED, V22, P705, DOI 10.1002/sim.1366; Whynes DK, 2013, MED DECIS MAKING, V33, P252, DOI 10.1177/0272989X12465016; Willmot M, 2005, NITRIC OXIDE-BIOL CH, V12, P141, DOI 10.1016/j.niox.2005.01.003; Willmot M, 2004, HYPERTENSION, V43, P18, DOI 10.1161/01.HYP.0000105052.65787.35; Willmot M, 2006, HYPERTENSION, V47, P1209, DOI 10.1161/01.HYP.0000223024.02939.1e; Willmot MR, 2003, EXPERT OPIN INV DRUG, V12, P455, DOI 10.1517/eoid.12.3.455.21476; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	44	194	196	0	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					617	628		10.1016/S0140-6736(14)61121-1	http://dx.doi.org/10.1016/S0140-6736(14)61121-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AZ	25465108	Green Published, Green Accepted			2022-12-28	WOS:000349214000030
J	Calo, E; Flynn, RA; Martin, L; Spitale, RC; Chang, HY; Wysocka, J				Calo, Eliezer; Flynn, Ryan A.; Martin, Lance; Spitale, Robert C.; Chang, Howard Y.; Wysocka, Joanna			RNA helicase DDX21 coordinates transcription and ribosomal RNA processing	NATURE			English	Article							BOX C/D SNORNA; P-TEFB; 7SK; POLYMERASE; PROTEIN; REPLICATION; II/GU; ELONGATION; NUCLEOTIDE; DEPLETION	DEAD-box RNA helicases are vital for the regulation of variousaspects of the RNA life cycle(1), but the molecular underpinnings of their involvement, particularly in mammalian cells, remain poorly understood. Here we show that the DEAD-box RNA helicase DDX21 can sense the transcriptional status of both RNA polymerase (Pol) I and II to control multiple steps of ribosome biogenesis in human cells. We demonstrate that DDX21 widely associates with Pol I-and Pol II-transcribed genes and with diverse species of RNA, most prominently with non-coding RNAs involved in the formation of ribonucleoprotein complexes, including ribosomal RNA, small nucleolar RNAs (snoRNAs) and 7SK RNA. Although broad, these molecular interactions, both at the chromatin and RNA level, exhibit remarkable specificity for the regulation of ribosomal genes. In the nucleolus, DDX21 occupies the transcribed rDNA locus, directly contacts both rRNA and snoRNAs, and promotes rRNA transcription, processing and modification. In the nucleoplasm, DDX21 binds 7SK RNA and, as a component of the 7SK small nuclear ribonucleoprotein (snRNP) complex, is recruited to the promoters of Pol II-transcribed genes encoding ribosomal proteins and snoRNAs. Promoter-bound DDX21 facilitates the release of the positive transcription elongation factor b (P-TEFb) from the 7SK snRNP in a manner that is dependent on its helicase activity, thereby promoting transcription of its target genes. Our results uncover the multifaceted role of DDX21 in multiple steps of ribosome biogenesis, and provide evidence implicating a mammalian RNA helicase in RNA modification and Pol II elongation control.	[Calo, Eliezer; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Flynn, Ryan A.; Martin, Lance; Spitale, Robert C.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Flynn, Ryan A.; Martin, Lance; Spitale, Robert C.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	howchang@stanford.edu; wysocka@stanford.edu		Flynn, Ryan/0000-0001-5013-0442	Stanford Medical Scientist Training Program; AP Giannini Foundation; National Institutes of Health [R01-HG004361, R01-ES023168, P50-HG007735, R01-GM095555]; W. M. Keck Foundation; Helen Hay Whitney Foundation;  [T32CA09302]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361, P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095555] Funding Source: NIH RePORTER	Stanford Medical Scientist Training Program; AP Giannini Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Helen Hay Whitney Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. H. Price for the LARP7 antibody, K. Lane from M. Covert's laboratory formetabolic inhibitors, K. Cimprich and members of the Chang and Wysocka laboratories for discussions, and B. Zarnegar and P. Khavari for discussions regarding iCLIP. This work was supported by the Stanford Medical Scientist Training Program and T32CA09302 (R.A.F.), AP Giannini Foundation (R.C.S.), National Institutes of Health grants R01-HG004361, R01-ES023168, P50-HG007735 (H.Y.C.) and R01-GM095555 (J.W.), W. M. Keck Foundation (J.W.), and Helen Hay Whitney Foundation (E.C.). H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5330; Castelo-Branco G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r98; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Cong R, 2012, NUCLEIC ACIDS RES, V40, P9441, DOI 10.1093/nar/gks720; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Fatica A, 2000, RNA, V6, P88, DOI 10.1017/S1355838200991623; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Lui LR, 2013, ESSAYS BIOCHEM, V54, P53, DOI [10.1042/BSE0540053, 10.1042/bse0540053]; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McNamara RP, 2013, CELL REP, V5, P1256, DOI 10.1016/j.celrep.2013.11.003; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Perlaky L, 1997, EXP CELL RES, V235, P413, DOI 10.1006/excr.1997.3686; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; Putnam AA, 2013, BBA-GENE REGUL MECH, V1829, P884, DOI 10.1016/j.bbagrm.2013.02.002; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Russell R, 2013, RNA BIOL, V10, P44, DOI 10.4161/rna.22210; Sharma A, 2007, J BIOL CHEM, V282, P12048, DOI 10.1074/jbc.M608104200; Valdez BC, 1997, EUR J BIOCHEM, V250, P800, DOI 10.1111/j.1432-1033.1997.00800.x; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Westermarck J, 2002, EMBO J, V21, P451, DOI 10.1093/emboj/21.3.451; Yang HS, 2003, J BIOL CHEM, V278, P38847, DOI 10.1074/jbc.M302258200; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yu YT, 1997, RNA, V3, P324; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326	37	174	179	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					249	U269		10.1038/nature13923	http://dx.doi.org/10.1038/nature13923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8SD	25470060	Green Accepted			2022-12-28	WOS:000349190300042
J	Dumanski, JP; Rasi, C; Lonn, M; Davies, H; Ingelsson, M; Giedraitis, V; Lannfelt, L; Magnusson, PKE; Lindgren, CM; Morris, AP; Cesarini, D; Johannesson, M; Janson, ET; Lind, L; Pedersen, NL; Ingelsson, E; Forsberg, LA				Dumanski, Jan P.; Rasi, Chiara; Lonn, Mikael; Davies, Hanna; Ingelsson, Martin; Giedraitis, Vilmantas; Lannfelt, Lars; Magnusson, Patrik K. E.; Lindgren, Cecilia M.; Morris, Andrew P.; Cesarini, David; Johannesson, Magnus; Janson, Eva Tiensuu; Lind, Lars; Pedersen, Nancy L.; Ingelsson, Erik; Forsberg, Lars A.			Smoking is associated with mosaic loss of chromosome Y	SCIENCE			English	Article							SWEDISH TWIN REGISTRY; SEX DISPARITIES; CANCER; MORTALITY; BLOOD	Tobacco smoking is a risk factor for numerous disorders, including cancers affecting organs outside the respiratory tract. Epidemiological data suggest that smoking is a greater risk factor for these cancers in males compared with females. This observation, together with the fact that males have a higher incidence of and mortality from most non-sex-specific cancers, remains unexplained. Loss of chromosome Y (LOY) in blood cells is associated with increased risk of nonhematological tumors. We demonstrate here that smoking is associated with LOY in blood cells in three independent cohorts [TwinGene: odds ratio (OR) = 4.3, 95% confidence interval (CI) = 2.8 to 6.7; Uppsala Longitudinal Study of Adult Men: OR = 2.4, 95% CI = 1.6 to 3.6; and Prospective Investigation of the Vasculature in Uppsala Seniors: OR = 3.5, 95% CI = 1.4 to 8.4] encompassing a total of 6014 men. The data also suggest that smoking has a transient and dose-dependent mutagenic effect on LOY status. The finding that smoking induces LOY thus links a preventable risk factor with the most common acquired human mutation.	[Dumanski, Jan P.; Rasi, Chiara; Davies, Hanna; Forsberg, Lars A.] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Dumanski, Jan P.; Rasi, Chiara; Davies, Hanna; Ingelsson, Erik; Forsberg, Lars A.] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Lonn, Mikael] Sodertorn Univ, Sch Life Sci, Huddinge, Sweden; [Ingelsson, Martin; Giedraitis, Vilmantas; Lannfelt, Lars] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lindgren, Cecilia M.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lindgren, Cecilia M.] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA USA; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Cesarini, David] NYU, Ctr Expt Social Sci, New York, NY 10012 USA; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [Janson, Eva Tiensuu; Lind, Lars; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Sodertorn University; Uppsala University; Karolinska Institutet; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Liverpool; New York University; Stockholm School of Economics; Uppsala University	Dumanski, JP (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	jan.dumanski@igp.uu.se; lars.forsberg@igp.uu.se	Magnusson, Patrik KE/C-4458-2017; Johannesson, Magnus/E-9680-2011	Magnusson, Patrik KE/0000-0002-7315-7899; Johannesson, Magnus/0000-0001-8759-6393; Lindgren, Cecilia/0000-0002-4903-9374; Davies, Hanna/0000-0002-6289-3815; Forsberg, Lars/0000-0002-1701-755X; Dumanski, Jan Piotr/0000-0002-1489-1452; Cesarini, David/0000-0002-0043-009X	Swedish Cancer Society; Swedish Research Council [M-2005-1112]; Swedish Heart-Lung Foundation and Science for Life Laboratory Uppsala; Olle Enqvist Byggmastare Foundation; Wellcome Trust [WT098017, WT064890, WT090532]; Uppsala University; Uppsala University Hospital; Swedish Heart-Lung Foundation; GenomEUtwin [EU/QLRT-2001-01254, QLG2-CT-2002-01254]; NIH DK [U01-066134]; Swedish Foundation for Strategic Research (SSF); Heart and Lung foundation [20070481]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066134] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation and Science for Life Laboratory Uppsala(Swedish Heart-Lung Foundation); Olle Enqvist Byggmastare Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Uppsala University; Uppsala University Hospital; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); GenomEUtwin; NIH DK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Heart and Lung foundation(Swedish Heart-Lung Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Lindblad-Toh, R. M. Myers, C.-H. Heldin, D. H. Ledbetter, G. J. B. van Ommen, and U. Landegren for critical evaluation of the manuscript. This study was sponsored by the Swedish Cancer Society, the Swedish Research Council, the Swedish Heart-Lung Foundation and Science for Life Laboratory Uppsala to J.P.D. and the Olle Enqvist Byggmastare Foundation to L.A.F. Genotyping and next-generation sequencing were performed by the SNP&SEQ Technology Platform in Uppsala, Sweden, and supported by Wellcome Trust Grants WT098017, WT064890, and WT090532, Uppsala University, Uppsala University Hospital, the Swedish Research Council, and the Swedish Heart-Lung Foundation. The SNP&SEQ Technology Platform is part of Science for Life Laboratory at Uppsala University and supported as a national infrastructure by the Swedish Research Council. C.M.L. is a Wellcome Trust Research Career Development Fellow (086596/Z/08/Z). A.P.M. is a Wellcome Trust Senior Research Fellow in Basic Biomedical Science. A.P.M. acknowledges funding from the Wellcome Trust under awards WT064890, WT090532, and WT098017. TwinGene was supported by the Swedish Research Council (M-2005-1112), GenomEUtwin (EU/QLRT-2001-01254 and QLG2-CT-2002-01254), NIH DK U01-066134, the Swedish Foundation for Strategic Research (SSF), and the Heart and Lung foundation no. 20070481. J.P.D. and L.A.F. are cofounders and shareholders in Cray Innovation AB, as well as co-inventors on Patent Application No. PCT/EP2014/071448, protecting the commercial applications of LOY for the assessment of cancer risk. Genetic variants detected in this study are available at the Database of Genomic Structural Variation (dbVar) under accession code nstd92 for ULSAM and PIVUS cohorts and accession code nstd104 for the TwinGene cohort.	Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Bianchi NO, 2009, MUTAT RES-REV MUTAT, V682, P21, DOI 10.1016/j.mrrev.2009.02.001; Clark AG, 2014, NATURE, V508, P463, DOI 10.1038/508463a; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Duijf PHG, 2013, INT J CANCER, V132, P2316, DOI 10.1002/ijc.27924; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Edgren G, 2012, EUR J EPIDEMIOL, V27, P187, DOI 10.1007/s10654-011-9647-5; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Forsberg LA, 2013, J MED GENET, V50, P1, DOI 10.1136/jmedgenet-2012-101322; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; Lemos B, 2010, P NATL ACAD SCI USA, V107, P15826, DOI 10.1073/pnas.1010383107; Lichtenstein P, 2006, TWIN RES HUM GENET, V9, P875, DOI 10.1375/twin.9.6.875; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Magnusson PKE, 2013, TWIN RES HUM GENET, V16, P317, DOI 10.1017/thg.2012.104; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; Veiga LCS, 2012, BRAZ J MED BIOL RES, V45, P172, DOI 10.1590/S0100-879X2012007500004; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Zhang LJ, 2007, CHINESE MED J-PEKING, V120, P2002, DOI 10.1097/00029330-200711020-00012	24	113	114	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217					81	83		10.1126/science.1262092	http://dx.doi.org/10.1126/science.1262092			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25477213	Green Accepted			2022-12-28	WOS:000347102300053
J	Johnson, SC				Johnson, Simon C.			A target for pharmacological intervention in an untreatable human disease	SCIENCE			English	Article							MTOR		Albert Einstein Coll Med, Bronx, NY 10462 USA	Yeshiva University; Albert Einstein College of Medicine	Johnson, SC (corresponding author), Albert Einstein Coll Med, 1301 Morris Pk Ave,Room 469, Bronx, NY 10462 USA.	simon.johnson@einstein.yu.edu		Johnson, Simon/0000-0002-1942-3674				Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Johnson SC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007316; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Schleit J, 2013, AGING CELL, V12, P1050, DOI 10.1111/acel.12130	4	6	6	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214								10.1126/science.aaa1811	http://dx.doi.org/10.1126/science.aaa1811			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB7UV	25477449				2022-12-28	WOS:000349834700001
J	Morata, G; Ballesteros-Arias, L				Morata, Gines; Ballesteros-Arias, Luna			Death to the losers	SCIENCE			English	Editorial Material							CELL COMPETITION; DROSOPHILA; APOPTOSIS; MECHANISM; ELIMINATE		[Morata, Gines; Ballesteros-Arias, Luna] Univ Autonoma Madrid, CSIC, Ctr Biol Mol, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Morata, G (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol, E-28049 Madrid, Spain.	gmorata@cbm.csic.es		Morata, Gines/0000-0003-3274-5173; Ballesteros-Arias, Luna/0000-0002-5701-699X				Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Amoyel M, 2014, DEVELOPMENT, V141, P988, DOI 10.1242/dev.079129; Ballesteros-Arias L, 2014, ONCOGENE, V33, P4377, DOI 10.1038/onc.2013.407; Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Claveria C, 2013, NATURE, V500, P39, DOI 10.1038/nature12389; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; Martins VC, 2014, NATURE, V509, P465, DOI 10.1038/nature13317; Meyer SN, 2014, SCIENCE, V346, P1199, DOI 10.1126/science.1258236; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Sancho M, 2013, DEV CELL, V26, P19, DOI 10.1016/j.devcel.2013.06.012; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7	14	5	5	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1181	1182		10.1126/science.aaa2345	http://dx.doi.org/10.1126/science.aaa2345			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477441				2022-12-28	WOS:000346189000041
J	Tenboer, J; Basu, S; Zatsepin, N; Pande, K; Milathianaki, D; Frank, M; Hunter, M; Boutet, S; Williams, GJ; Koglin, JE; Oberthuer, D; Heymann, M; Kupitz, C; Conrad, C; Coe, J; Roy-Chowdhury, S; Weierstall, U; James, D; Wang, DJ; Grant, T; Barty, A; Yefanov, O; Scales, J; Gati, C; Seuring, C; Srajer, V; Henning, R; Schwander, P; Fromme, R; Ourmazd, A; Moffat, K; Van Thor, JJ; Spence, JCH; Fromme, P; Chapman, HN; Schmidt, M				Tenboer, Jason; Basu, Shibom; Zatsepin, Nadia; Pande, Kanupriya; Milathianaki, Despina; Frank, Matthias; Hunter, Mark; Boutet, Sebastien; Williams, Garth J.; Koglin, Jason E.; Oberthuer, Dominik; Heymann, Michael; Kupitz, Christopher; Conrad, Chelsie; Coe, Jesse; Roy-Chowdhury, Shatabdi; Weierstall, Uwe; James, Daniel; Wang, Dingjie; Grant, Thomas; Barty, Anton; Yefanov, Oleksandr; Scales, Jennifer; Gati, Cornelius; Seuring, Carolin; Srajer, Vukica; Henning, Robert; Schwander, Peter; Fromme, Raimund; Ourmazd, Abbas; Moffat, Keith; Van Thor, Jasper J.; Spence, John C. H.; Fromme, Petra; Chapman, Henry N.; Schmidt, Marius			Time-resolved serial crystallography captures high-resolution intermediates of photoactive yellow protein	SCIENCE			English	Article							X-RAY CRYSTALLOGRAPHY; FREE-ELECTRON LASER; MACROMOLECULAR CRYSTALLOGRAPHY; LAUE CRYSTALLOGRAPHY; STRUCTURAL DYNAMICS; ROOM-TEMPERATURE; SPECTROSCOPY; DIFFRACTION; NANOCRYSTALLOGRAPHY; PHOTOCYCLE	Serial femtosecond crystallography using ultrashort pulses from x-ray free electron lasers (XFELs) enables studies of the light-triggered dynamics of biomolecules. We used microcrystals of photoactive yellow protein (a bacterial blue light photoreceptor) as a model system and obtained high-resolution, time-resolved difference electron density maps of excellent quality with strong features; these allowed the determination of structures of reaction intermediates to a resolution of 1.6 angstroms. Our results open the way to the study of reversible and nonreversible biological reactions on time scales as short as femtoseconds under conditions that maximize the extent of reaction initiation throughout the crystal.	[Tenboer, Jason; Pande, Kanupriya; Scales, Jennifer; Schwander, Peter; Ourmazd, Abbas; Schmidt, Marius] Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA; [Basu, Shibom; Kupitz, Christopher; Conrad, Chelsie; Coe, Jesse; Roy-Chowdhury, Shatabdi; Fromme, Raimund; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Zatsepin, Nadia; Weierstall, Uwe; James, Daniel; Wang, Dingjie; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Milathianaki, Despina; Boutet, Sebastien; Williams, Garth J.; Koglin, Jason E.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Frank, Matthias; Hunter, Mark] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Oberthuer, Dominik; Gati, Cornelius; Seuring, Carolin; Chapman, Henry N.] Univ Hamburg, Ctr Ultrafast Imaging, D-22761 Hamburg, Germany; [Heymann, Michael; Barty, Anton; Yefanov, Oleksandr; Gati, Cornelius; Chapman, Henry N.] Deutsch Elektronen Synchrotron DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Grant, Thomas] SUNY Buffalo, Hauptman Woodward Inst, Buffalo, NY 14260 USA; [Srajer, Vukica; Henning, Robert; Moffat, Keith] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA; [Moffat, Keith] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Moffat, Keith] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Van Thor, Jasper J.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, London SW7 2AZ, England	University of Wisconsin System; University of Wisconsin Milwaukee; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Chicago; University of Chicago; University of Chicago; Imperial College London	Schmidt, M (corresponding author), Univ Wisconsin, Dept Phys, Milwaukee, WI 53211 USA.	m-schmidt@uwm.edu	Milathianaki, Despina/AAG-5381-2021; Oberthuer, Dominik/AAG-5059-2021; Seuring, Carolin/K-6364-2016; FRS, Henry N Chapman/G-2153-2010; Zatsepin, Nadia/AAF-2451-2019; Grant, Thomas/GXH-9990-2022; Heymann, Michael/J-6134-2015; Fromme, Raimund/AAG-6578-2019; Schmidt, Marius/A-1537-2014; Fromme, Raimund/C-8885-2012; Fromme, Raimund/W-5838-2019; Grant, Thomas/T-2921-2019; Basu, Shibom/GLU-3308-2022; Barty, Anton/K-5137-2014	Oberthuer, Dominik/0000-0002-0894-9590; Seuring, Carolin/0000-0003-1000-0859; FRS, Henry N Chapman/0000-0002-4655-1743; Grant, Thomas/0000-0002-8583-3700; Heymann, Michael/0000-0002-9278-8207; Schmidt, Marius/0000-0002-0962-9468; Fromme, Raimund/0000-0003-4835-1080; Fromme, Raimund/0000-0003-4835-1080; Grant, Thomas/0000-0002-8583-3700; Basu, Shibom/0000-0001-6484-8236; Barty, Anton/0000-0003-4751-2727; Frank, Matthias/0000-0002-5244-0791; Pande, Kanupriya/0000-0003-4272-9273; Zatsepin, Nadia/0000-0003-1757-0205; Yefanov, Oleksandr/0000-0001-8676-0091; James, Daniel/0000-0002-8348-6661	NSF [0952643]; NIH [R01GM095583, R24GM111072]; NSF Science and Technology Centers [NSF-1231306]; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; LLNL Lab-Directed Research and Development Project [012-ERD-031]; NATIONAL EYE INSTITUTE [R01EY024363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103543, R24GM111072, R01GM095583] Funding Source: NIH RePORTER; EPSRC [EP/I003304/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I003304/1] Funding Source: researchfish	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Science and Technology Centers; U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); LLNL Lab-Directed Research and Development Project; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Supported by NSF career grant 0952643 (M.S.), NIH grant R01GM095583 (P.F.), NIH grant R24GM111072 (V.S., R.H., and K.M.), and NSF Science and Technology Centers grant NSF-1231306 ("Biology with X-ray Lasers"). The work of M.F. and his team was performed in part under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344 and supported by LLNL Lab-Directed Research and Development Project 012-ERD-031. We thank T. White for making the newest version of CrystFEL available to us, R. G. Sierra and H. DeMirci for help setting up crystal preparation in their labs, S. Lisova for making injector nozzles, and D. Deponte for help with the injector setup. M.S. thanks R. Hovey and S. Tripathi for help on early attempts to produce microcrystals. The TR-SFX measurements were carried out at the Linac Coherent Light Source (LCLS) at SLAC National Accelerator Laboratory. LCLS is an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. J.S. is an inventor on a patent applied for by Arizona State University that covers the gas dynamic virtual nozzle. Coordinates and (difference) structure factors are deposited in the Protein Data Bank under accession numbers 4WL9 and 4WLA.	Aquila A, 2012, OPT EXPRESS, V20, P2706, DOI 10.1364/OE.20.002706; Arnlund D, 2014, NAT METHODS, V11, P923, DOI [10.1038/nmeth.3067, 10.1038/NMETH.3067]; Barends TRM, 2014, NATURE, V505, P244, DOI 10.1038/nature12773; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bourgeois D, 2006, P NATL ACAD SCI USA, V103, P4924, DOI 10.1073/pnas.0508880103; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Groenhof G, 2004, J AM CHEM SOC, V126, P4228, DOI 10.1021/ja039557f; Ihee H, 2005, P NATL ACAD SCI USA, V102, P7145, DOI 10.1073/pnas.0409035102; Jung YO, 2013, NAT CHEM, V5, P212, DOI [10.1038/NCHEM.1565, 10.1038/nchem.1565]; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kim TW, 2012, J AM CHEM SOC, V134, P3145, DOI 10.1021/ja210435n; Kirian RA, 2011, ACTA CRYSTALLOGR A, V67, P131, DOI 10.1107/S0108767310050981; Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; Lincoln CN, 2012, PHYS CHEM CHEM PHYS, V14, P15752, DOI 10.1039/c2cp41718a; Lomb L, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.214111; MOFFAT K, 1989, ANNU REV BIOPHYS BIO, V18, P309, DOI 10.1146/annurev.biophys.18.1.309; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Neutze R, 2012, CURR OPIN STRUC BIOL, V22, P651, DOI 10.1016/j.sbi.2012.08.006; Purwar N, 2013, INT J MOL SCI, V14, P18881, DOI 10.3390/ijms140918881; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Schmidt M, 2012, J SYNCHROTRON RADIAT, V19, P264, DOI 10.1107/S090904951105549X; Schmidt M, 2003, BIOPHYS J, V84, P2112, DOI 10.1016/S0006-3495(03)75018-8; Schmidt M., 2008, P201, DOI 10.1007/978-3-540-73566-3_9; Schmidt M, 2013, ACTA CRYSTALLOGR D, V69, P2534, DOI 10.1107/S0907444913025997; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Schotte F, 2012, P NATL ACAD SCI USA, V109, P19256, DOI 10.1073/pnas.1210938109; Spence JCH, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102601; Spence JCH, 2011, OPT EXPRESS, V19, P2866, DOI 10.1364/OE.19.002866; Ujj L, 1998, BIOPHYS J, V75, P406, DOI 10.1016/S0006-3495(98)77525-3; van Thor JJ, 2014, FARADAY DISCUSS, V171, P439, DOI 10.1039/c4fd00011k; van Wilderen LJGW, 2006, P NATL ACAD SCI USA, V103, P15050, DOI 10.1073/pnas.0603476103; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040	34	328	331	3	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1242	1246		10.1126/science.1259357	http://dx.doi.org/10.1126/science.1259357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477465	Green Accepted, Green Submitted			2022-12-28	WOS:000346189000061
J	Matusek, T; Wendler, F; Poles, S; Pizette, S; D'Angelo, G; Furthauer, M; Therond, PP				Matusek, Tamas; Wendler, Franz; Poles, Sophie; Pizette, Sandrine; D'Angelo, Gisela; Fuerthauer, Maximilian; Therond, Pascal P.			The ESCRT machinery regulates the secretion and long-range activity of Hedgehog	NATURE			English	Article							CHOLESTEROL MODIFICATION; EXTRACELLULAR VESICLES; DROSOPHILA EPITHELIA; SONIC HEDGEHOG; PROTEIN; TRAFFICKING; MEMBRANE; RELEASE; VPS25; MICROVESICLES	The conserved family of Hedgehog (Hh) proteins acts as short- and long-range secreted morphogens, controlling tissue patterning and differentiation during embryonic development(1). Mature Hh carries hydrophobic palmitic acid and cholesterol modifications essential for its extracellular spreading(2). Various extracellular transportation mechanisms for Hh have been suggested, but the pathways actually used for Hh secretion and transport in vivo remain unclear. Here we show that Hh secretion in Drosophila wing imaginal discs is dependent on the endosomal sorting complex required for transport (ESCRT)(3). In vivo the reduction of ESCRT activity in cells producing Hh leads to a retention of Hh at the external cell surface. Furthermore, we show that ESCRT activity in Hh-producing cells is required for long-range signalling. We also provide evidence that pools of Hh and ESCRT proteins are secreted together into the extracellular space in vivo and can subsequently be detected together at the surface of receiving cells. These findings uncover a new function for ESCRT proteins in controlling morphogen activity and reveal a new mechanism for the transport of secreted Hh across the tissue by extracellular vesicles, which is necessary for long-range target induction.	[Matusek, Tamas; Wendler, Franz; Poles, Sophie; Pizette, Sandrine; D'Angelo, Gisela; Fuerthauer, Maximilian; Therond, Pascal P.] Univ Nice Sophia Antipolis, IBV, UMR 7277, F-06100 Nice, France; [Matusek, Tamas; Wendler, Franz; Poles, Sophie; Pizette, Sandrine; D'Angelo, Gisela; Fuerthauer, Maximilian; Therond, Pascal P.] CNRS, IBV, UMR 7277, F-06100 Nice, France; [Matusek, Tamas; Wendler, Franz; Poles, Sophie; Pizette, Sandrine; D'Angelo, Gisela; Fuerthauer, Maximilian; Therond, Pascal P.] INSERM, IBV, U1091, F-06100 Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Therond, PP (corresponding author), Univ Nice Sophia Antipolis, IBV, UMR 7277, F-06100 Nice, France.	therond@unice.fr	Therond, pascal/AAE-4811-2019; FÃrthauer, Maximilian/AAY-4516-2020	FÃrthauer, Maximilian/0000-0001-6344-6585; D'ANGELO, Gisela/0000-0003-3150-2241; THEROND, PASCAL/0000-0003-0434-2334	French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE [ANR-11-LABX-0028-01]; Fondation pour la Recherche Medicale [DEQ20110421324]; Fondation Association pour la Recherche Contre le Cancer (ARC); Ligue Nationale Contre le Cancer; ATIP/Avenir; ARC; Human Frontier Science Program	French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation Association pour la Recherche Contre le Cancer (ARC); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); ATIP/Avenir; ARC(Australian Research Council); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by the French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE (program reference number ANR-11-LABX-0028-01) and by the Fondation pour la Recherche Medicale (reference number DEQ20110421324). T.M. and F.W. were supported by the Fondation Association pour la Recherche Contre le Cancer (ARC) and Ligue Nationale Contre le Cancer, respectively. M.F. was supported by ATIP/Avenir, ARC and the Human Frontier Science Program. The authors acknowledge S. Pagnotta for technical support. We thank K. Haglund for sharing the anti-AliX antibody before publication. We thank L. Staccini-Lavenant and M.-A. Derieppe for technical help.	ADLER PN, 1987, DEV GENET, V8, P99, DOI 10.1002/dvg.1020080206; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bischoff M, 2013, NAT CELL BIOL, V15, P1269, DOI 10.1038/ncb2856; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Gallet A, 2006, DEVELOPMENT, V133, P407, DOI 10.1242/dev.02212; Gallet A, 2003, DEV CELL, V4, P191, DOI 10.1016/S1534-5807(03)00031-5; GomezSkarmeta JL, 1996, GENE DEV, V10, P2935, DOI 10.1101/gad.10.22.2935; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Johnson RL, 2000, MOL CELL, V6, P467, DOI 10.1016/S1097-2765(00)00045-9; Letizia A, 2007, DEVELOPMENT, V134, P1337, DOI 10.1242/dev.02823; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Palm W, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001505; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Torroja C, 2005, J NEUROBIOL, V64, P334, DOI 10.1002/neu.20168; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	33	97	98	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					99	U240		10.1038/nature13847	http://dx.doi.org/10.1038/nature13847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471885	Green Published			2022-12-28	WOS:000346310800047
J	Ranade, SS; Woo, SH; Dubin, AE; Moshourab, RA; Wetzel, C; Petrus, M; Mathur, J; Begay, V; Coste, B; Mainquist, J; Wilson, AJ; Francisco, AG; Reddy, K; Qiu, ZZ; Wood, JN; Lewin, GR; Patapoutian, A				Ranade, Sanjeev S.; Woo, Seung-Hyun; Dubin, Adrienne E.; Moshourab, Rabih A.; Wetzel, Christiane; Petrus, Matt; Mathur, Jayanti; Begay, Valerie; Coste, Bertrand; Mainquist, James; Wilson, A. J.; Francisco, Allain G.; Reddy, Kritika; Qiu, Zhaozhu; Wood, John N.; Lewin, Gary R.; Patapoutian, Ardem			Piezo2 is the major transducer of mechanical forces for touch sensation in mice	NATURE			English	Article							REGULATED ANION CHANNEL; MERKEL CELLS; SENSORY NEURONS; MECHANOSENSITIVE CURRENTS; ESSENTIAL COMPONENT; ION CHANNELS; MOUSE; NOCICEPTION; PROTEIN; CONTRIBUTES	The sense of touch provides critical information about our physical environment by transforming mechanical energy into electrical signals(1). It is postulated that mechanically activated cation channels initiate touch sensation, but the identity of these molecules in mammals has been elusive(2). Piezo2 is a rapidly adapting, mechanically activated ion channel expressed in a subset of sensory neurons of the dorsal root ganglion and in cutaneous mechanoreceptors known as Merkel-cell-neurite complexes(3,4). It has been demonstrated that Merkel cells have a role in vertebrate mechanosensation using Piezo2, particularly in shaping the type of current sent by the innervating sensory neuron(4-6); however, major aspects of touch sensation remain intact without Merkel cell activity(4,7). Here we show that mice lacking Piezo2 in both adult sensory neurons and Merkel cells exhibit a profound loss of touch sensation. We precisely localize Piezo2 to the peripheral endings of a broad range of low-threshold mechanoreceptors that innervate both hairy and glabrous skin. Most rapidly adapting, mechanically activated currents in dorsal root ganglion neuronal cultures are absent in Piezo2 conditional knockout mice, and ex vivo skin nerve preparation studies show that the mechanosensitivity of low-threshold mechanoreceptors strongly depends on Piezo2. This cellular phenotype correlates with an unprecedented behavioural phenotype: an almost complete deficit in light-touch sensation in multiple behavioural assays, without affecting other somatosensory functions. Our results highlight that a single ion channel that displays rapidly adapting, mechanically activated currents in vitro is responsible for the mechanosensitivity of most low-threshold mechanoreceptor subtypes involved in innocuous touch sensation. Notably, we find that touch and pain sensation are separable, suggesting that as-yet-unknown mechanically activated ion channel(s) must account for noxious (painful) mechanosensation.	[Ranade, Sanjeev S.; Woo, Seung-Hyun; Dubin, Adrienne E.; Coste, Bertrand; Francisco, Allain G.; Reddy, Kritika; Qiu, Zhaozhu; Patapoutian, Ardem] Scripps Res Inst, Dorris Neurosci Ctr, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Moshourab, Rabih A.; Wetzel, Christiane; Begay, Valerie; Lewin, Gary R.] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13092 Berlin, Germany; [Moshourab, Rabih A.] Univ Med Berlin, Klin Anasthesiol Schwerpunkt Operat Intens Med, Virchow Klinikum Charite, D-13353 Berlin, Germany; [Petrus, Matt; Mathur, Jayanti; Mainquist, James; Wilson, A. J.; Qiu, Zhaozhu] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Wood, John N.] UCL, Mol Nocicept Grp, Wolfson Inst Biomed Res, London WC1E 6BT, England	Howard Hughes Medical Institute; Scripps Research Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Novartis; University of London; University College London	Patapoutian, A (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ardem@scripps.edu	Lewin, Gary R/B-8028-2011	Ranade, Sanjeev/0000-0001-8601-3563; Coste, Bertrand/0000-0002-0163-2494; moshourab, rabih/0000-0002-9180-8472; Lewin, Gary/0000-0002-2890-6352; Wetzel, Christiane/0000-0003-0587-8018	California Institute of Regenerative Medicine; Max Delbruck Center (MDC); European Research Council [294678]; Deutsche Forschungsgemeinshaft [SFB958]; NIH [R01 DE022358]; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G0901905] Funding Source: researchfish; Versus Arthritis [20200] Funding Source: researchfish; Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022358] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Max Delbruck Center (MDC); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinshaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We acknowledge T. Goode for help in behavioural analysis. We also thank R. Moran and T. Johnson for assistance with histology, K. Spencer for imaging analysis and M. Braunschweig for technical assistance. S.S.R. was funded by a pre-doctoral fellowship from the California Institute of Regenerative Medicine. R.A.M. was supported by Clinical Research Fellowship from the Max Delbruck Center (MDC). G.R.L.'s laboratory was supported by senior European Research Council grant (project 294678) and a grant from the Deutsche Forschungsgemeinshaft (SFB958 project A9). A.P. is a Howard Hughes Medical Institute Investigator. This study was partly funded by NIH grant R01 DE022358 to A.P.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673; Faucherre A, 2013, J NEUROSCI, V 33, P17089, DOI 10.1523/JNEUROSCI.0522-13.2013; Garrison SR, 2012, J NEUROPHYSIOL, V107, P913, DOI 10.1152/jn.00658.2011; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Ikeda R, 2014, CELL, V157, P664, DOI 10.1016/j.cell.2014.02.026; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lariviere WR, 2002, PAIN, V97, P75, DOI 10.1016/S0304-3959(01)00492-4; Lau J, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-100; Lechner SG, 2013, PHYSIOLOGY, V28, P142, DOI 10.1152/physiol.00059.2012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Maksimovic S, 2013, ANN NY ACAD SCI, V1279, P13, DOI 10.1111/nyas.12057; Maricich SM, 2012, J NEUROSCI, V32, P3296, DOI 10.1523/JNEUROSCI.5307-11.2012; Maricich SM, 2009, SCIENCE, V324, P1580, DOI 10.1126/science.1172890; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; Moshourab RA, 2013, J PHYSIOL-LONDON, V591, P5555, DOI 10.1113/jphysiol.2013.261180; Petrus M, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-40; Poole K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4520; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Rugiero F, 2010, J PHYSIOL-LONDON, V588, P301, DOI 10.1113/jphysiol.2009.182360; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wellnitz SA, 2010, J NEUROPHYSIOL, V103, P3378, DOI 10.1152/jn.00810.2009; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251	35	436	449	18	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					121	U330		10.1038/nature13980	http://dx.doi.org/10.1038/nature13980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471886	Green Accepted			2022-12-28	WOS:000346310800052
J	Rhee, HS; Bataille, AR; Zhang, LY; Pugh, BF				Rhee, Ho Sung; Bataille, Alain R.; Zhang, Liye; Pugh, B. Franklin			Subnucleosomal Structures and Nucleosome Asymmetry across a Genome	CELL			English	Article							BASE-PAIR RESOLUTION; BUDDING YEAST; HISTONE H2A; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC GENOME; GENE-REGULATION; RNA-POLYMERASE; DNA; CHROMATIN; ORGANIZATION	Genes are packaged into nucleosomal arrays, each nucleosome typically having two copies of histones H2A, H2B, H3, and H4. Histones have distinct post-translational modifications, variant isoforms, and dynamics. Whether each histone copy within a nucleosome has distinct properties, particularly in relation to the direction of transcription, is unknown. Here we use chromatin immunoprecipitation-exonuclease (ChIP-exo) to resolve the organization of individual histones on a genomic scale. We detect widespread subnucleosomal structures in dynamic chromatin, including what appear to be half-nucleosomes consisting of one copy of each histone. We also detect interactions of H3 tails with linker DNA between nucleosomes, which may be negatively regulated by methylation of H3K36. Histone variant H2A. Z is enriched on the promoter-distal half of the +1 nucleosome, whereas H2BK123 ubiquitylation and H3K9 acetylation are enriched on the promoter-proximal half in a transcription-linked manner. Subnucleosome asymmetries might serve as molecular beacons that guide transcription.	[Rhee, Ho Sung; Bataille, Alain R.; Zhang, Liye; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	bfp2@psu.edu			National Institutes of Health [HG004160]; Peconic, LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peconic, LLC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Yunfei Li, Rohit Reja, and William Lai for bioinformatic support, Matthew Rossi for sharing unpublished ChIP input DNA data, and members of the Pugh laboratory, the Penn State Center for Eukaryotic Gene Regulation, and Philipp Korber for valuable discussions. We are grateful to Bongsoo Park for computational assistance. National Institutes of Health grant HG004160 supported this work. B.F.P. has a financial interest in Peconic, LLC, which utilizes the ChIP-exo technology implemented in this study and could potentially benefit from the outcomes of this research.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P10719, DOI 10.1093/nar/gks865; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; CHEN TA, 1991, J BIOL CHEM, V266, P6489; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Furuyama T, 2013, NUCLEIC ACIDS RES, V41, P5769, DOI 10.1093/nar/gkt314; Henikoff JG, 2011, P NATL ACAD SCI USA, V108, P18318, DOI 10.1073/pnas.1110731108; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krassovsky K, 2012, P NATL ACAD SCI USA, V109, P243, DOI 10.1073/pnas.1118898109; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; MORGAN BA, 1991, MOL CELL BIOL, V11, P4111, DOI 10.1128/MCB.11.8.4111; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Rando OJ, 2007, CURR OPIN CELL BIOL, V19, P250, DOI 10.1016/j.ceb.2007.04.006; Ranjan A, 2013, CELL, V154, P1232, DOI 10.1016/j.cell.2013.08.005; Rhee Ho Sung, 2012, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2124s100; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Shukla MS, 2011, NUCLEIC ACIDS RES, V39, P2559, DOI 10.1093/nar/gkq1174; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; USACHENKO SI, 1994, P NATL ACAD SCI USA, V91, P6845, DOI 10.1073/pnas.91.15.6845; Weber CM, 2014, MOL CELL, V53, P819, DOI 10.1016/j.molcel.2014.02.014; WEINTRAUB H, 1976, CELL, V9, P409, DOI 10.1016/0092-8674(76)90085-4; WEINTRAUB H, 1975, CELL, V6, P85, DOI 10.1016/0092-8674(75)90077-X; Yen KY, 2013, CELL, V154, P1246, DOI 10.1016/j.cell.2013.08.043; Zhang JJ, 2011, P NATL ACAD SCI USA, V108, P11872, DOI 10.1073/pnas.1103467108; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Zheng CY, 2005, J BIOL CHEM, V280, P33552, DOI 10.1074/jbc.M507241200; Zlatanova J, 2009, STRUCTURE, V17, P160, DOI 10.1016/j.str.2008.12.016	45	137	139	0	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1377	1388		10.1016/j.cell.2014.10.054	http://dx.doi.org/10.1016/j.cell.2014.10.054			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480300	Green Accepted, Bronze			2022-12-28	WOS:000346652900016
J	Rubin, DC				Rubin, David C.			How quickly we forget	SCIENCE			English	Editorial Material							MEMORY; SCHOOL		[Rubin, David C.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Rubin, David C.] Aarhus Univ, Ctr Autobiog Memory Res, DK-8000 Aarhus C, Denmark	Duke University; Aarhus University	Rubin, DC (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA.	david.rubin@duke.edu						ANDERSON JR, 1991, PSYCHOL SCI, V2, P396, DOI 10.1111/j.1467-9280.1991.tb00174.x; BAHRICK HP, 1984, J EXP PSYCHOL GEN, V113, P1, DOI 10.1037/0096-3445.113.1.1; BAHRICK HP, 1991, J EXP PSYCHOL GEN, V120, P20, DOI 10.1037/0096-3445.120.1.20; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Ebbinghaus H., 1964, MEMORY CONTRIBUTION; Galton F., 1983, INQUIRY HUMAN FACULT; Hirst W, 2008, MEMORY, V16, P183, DOI 10.1080/09658210701811912; Roediger HL, 2014, SCIENCE, V346, P1106, DOI 10.1126/science.1259627; Rubin DC, 2006, PERSPECT PSYCHOL SCI, V1, P277, DOI 10.1111/j.1745-6916.2006.00017.x; Rubin DC, 2015, PSYCHOL REV, V122, P1, DOI 10.1037/a0037907; Rubin David C., 1995, MEMORY ORAL TRADITIO; Rubin DC, 1998, PSYCHON B REV, V5, P397, DOI 10.3758/BF03208816	12	9	9	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1058	1059		10.1126/science.aaa2341	http://dx.doi.org/10.1126/science.aaa2341			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU7EK	25430756				2022-12-28	WOS:000345763400022
J	Suppes, GJ				Suppes, Galen J.			Simulation as a tool for biopolymers design	SCIENCE			English	Editorial Material							POLYOLS		Univ Missouri, Dept Chem Engn, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Suppes, GJ (corresponding author), Univ Missouri, Dept Chem Engn, Columbia, MO 65211 USA.	suppesg@missouri.edu						Abraham TW, 2012, ACS SYM SER, V1105, P165; Alipour A, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.41332; Du X. X., 2012, 2 GENERATION HONEY B; Gower W. C., 2011, NEW VERSATILE HIGH R; Nodelman N., 2012, POLYURETHANE RIGID F; Vaughan BR, 2011, J APPL POLYM SCI, V119, P2683, DOI 10.1002/app.32865; Zhao YS, 2013, J APPL POLYM SCI, V130, P1131, DOI 10.1002/app.39287	7	3	3	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1055	1056		10.1126/science.1259181	http://dx.doi.org/10.1126/science.1259181			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430754				2022-12-28	WOS:000345763400020
J	Jones, I; Chandra, PS; Dazzan, P; Howard, LM				Jones, Ian; Chandra, Prabha S.; Dazzan, Paola; Howard, Louise M.			Perinatal mental health 2 Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period	LANCET			English	Article							ALPHA ER-ALPHA; PUERPERAL PSYCHOSIS; WOMEN; RISK; PREDICTORS; LITHIUM; MOTHER; ILLNESS; PREVENTION; FERTILITY	The perinatal period is associated with an increased risk of severe mental disorders. We summarise the evidence regarding the epidemiology, risk factors, and treatment of severe mental illness in relation to childbirth, focusing on bipolar disorder, affective psychosis, and schizophrenia. We discuss women with ongoing chronic conditions and those with the onset of new episodes of post-partum psychosis. Despite the importance of perinatal episodes, with suicide a leading cause of maternal death, few studies are available to guide the management of women with severe mental disorders in pregnancy and the post-partum period. However, general principles of management are discussed, including the need for an individual risk-benefit analysis for each woman.	[Jones, Ian] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Natl Ctr Mental Hlth, Cardiff CF24 4HQ, S Glam, Wales; [Chandra, Prabha S.] Natl Inst Mental Hlth & Neurosci NIMHNS, Bangalore, Karnataka, India; [Dazzan, Paola] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Howard, Louise M.] Kings Coll London, Inst Psychiat, Hlth Serv, London WC2R 2LS, England; [Howard, Louise M.] Kings Coll London, Inst Psychiat, Populat Res Dept, London WC2R 2LS, England	Cardiff University; National Institute of Mental Health & Neurosciences - India; University of London; King's College London; University of London; King's College London; University of London; King's College London	Jones, I (corresponding author), Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Natl Ctr Mental Hlth, Hadyn Ellis Bldg,Maindy Rd, Cardiff CF24 4HQ, S Glam, Wales.	jonesir1@cf.ac.uk	Jones, Ian R/B-4925-2009; Howard, Louise/E-3495-2010	Jones, Ian R/0000-0001-5821-5889; Howard, Louise/0000-0001-9942-744X; Dazzan, Paola/0000-0002-8427-3617	Chief Investigator of a National Institute for Health Research (NIHR) Programme [RP-RP-DG-1108-10012]; NIHR; Tommy's baby; NIHR Mental Health Biomedical Research Centre at the South London; Maudsley NHS Foundation Trust and King's College London; Wellcome Trust; British Occupational Health Research Foundation; National Institute of Social Care Research and Health Research; Big Lottery; Medical Research Council (MRC); Women's Mental Health Trust; National Alliance for Research on Schizophrenia and Depression (NARSAD); Medical Research Foundation for research in post-partum psychosis; Indian Council of Medical Research; Ranbaxy India; Medical Research Council [MR/L010305/1] Funding Source: researchfish; Medical Research Foundation [C0439] Funding Source: researchfish	Chief Investigator of a National Institute for Health Research (NIHR) Programme(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); Tommy's baby; NIHR Mental Health Biomedical Research Centre at the South London; Maudsley NHS Foundation Trust and King's College London; Wellcome Trust(Wellcome TrustEuropean Commission); British Occupational Health Research Foundation; National Institute of Social Care Research and Health Research; Big Lottery; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Women's Mental Health Trust; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Medical Research Foundation for research in post-partum psychosis; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Ranbaxy India; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LH is Chair of the National Institute for Health and Care Excellence (NICE) (update) guideline on Antenatal and Postnatal Mental Health. She is Chief Investigator of a National Institute for Health Research (NIHR) Programme Grant for Applied Research on the effectiveness of perinatal mental health services (RP-RP-DG-1108-10012) and has funding from an NIHR Research Professorship on maternal mental health, and a grant from Tommy's baby charity (with the support of a corporate social responsibility grant from Johnson and Johnson) on antipsychotics in pregnancy. Her work is also supported by the NIHR Mental Health Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author and not necessarily those of the NHS, the NIHR or the Department of Health. IJ is a member of the Guideline Development Group of the NICE (update) guideline on Antenatal and Postnatal Mental Health. He has received funding for research in bipolar disorder and perinatal mental health from the Wellcome Trust, British Occupational Health Research Foundation, National Institute of Social Care Research and Health Research, NIHR, The Big Lottery, The Medical Research Council (MRC), and The Women's Mental Health Trust. He is Director of the National Centre for Mental Health (NISCHR-funded Biomedical Research Centre). He is Director of the Bipolar Psychoeducation Programme Cymru (BEP-C). Although he has not received honoraria in the last three years he has previously received honoraria from Lilly, GlaxoSmithKline, Lundbeck, Jansen and AstraZeneca to give talks on Psychoeducation and his research on perinatal mood disorders. PD receives funding from National Alliance for Research on Schizophrenia and Depression (NARSAD) and the Medical Research Foundation for research in post-partum psychosis. PC reports grants from the Indian Council of Medical Research and support for educational posters on preconception counselling from Ranbaxy India, however, with no mention of the company name on the posters.	Anderson EL, 2009, PSYCHOSOM MED, V71, P235, DOI 10.1097/PSY.0b013e318190d7ca; Austin MP, 2007, MED J AUSTRALIA, V186, P364, DOI 10.5694/j.1326-5377.2007.tb00940.x; AUSTIN MPV, 1992, BRIT J PSYCHIAT, V161, P692, DOI 10.1192/bjp.161.5.692; Babu GN, 2013, ARCH WOMEN MENT HLTH, V16, P247, DOI 10.1007/s00737-013-0342-2; Bergink V, 2013, BIOL PSYCHIAT, V73, P1000, DOI 10.1016/j.biopsych.2012.11.006; Bergink V, 2012, AM J PSYCHIAT, V169, P609, DOI 10.1176/appi.ajp.2012.11071047; Bergink V, 2011, J CLIN PSYCHIAT, V72, P1531, DOI 10.4088/JCP.10m06648; Beyond Blue Clinical Practice Guidelines, 2011, DEPRESSION RELATED D; Bilszta JLC, 2010, BIPOLAR DISORD, V12, P568, DOI 10.1111/j.1399-5618.2010.00845.x; Blackmore ER, 2013, BIPOLAR DISORD, V15, P394, DOI 10.1111/bdi.12071; Blackmore ER, 2006, BRIT J PSYCHIAT, V188, P32, DOI 10.1192/bjp.188.1.32; Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924; Bloch M, 2003, COMPR PSYCHIAT, V44, P234, DOI 10.1016/S0010-440X(03)00034-8; Boden R, 2012, BMJ-BRIT MED J, V345, P7085; BROCKINGTON IF, 1990, BRIT J PSYCHIAT, V157, P331, DOI 10.1192/bjp.157.3.331; Buist A, 2004, Arch Womens Ment Health, V7, P81, DOI 10.1007/s00737-003-0040-6; Bundy H, 2011, ACTA PSYCHIAT SCAND, V123, P98, DOI 10.1111/j.1600-0447.2010.01623.x; Campbell E, 2014, J NEUROL NEUROSUR PS, V85, P1029, DOI 10.1136/jnnp-2013-306318; Coyle N, 2000, LANCET, V356, P1490, DOI 10.1016/S0140-6736(00)02877-4; Di Florio A, 2014, J AFFECT DISORDERS, V152, P334, DOI 10.1016/j.jad.2013.09.034; Di Florio A, 2013, JAMA PSYCHIAT, V70, P168, DOI 10.1001/jamapsychiatry.2013.279; Dolman C, 2013, ARCH WOMEN MENT HLTH, V16, P173, DOI 10.1007/s00737-013-0336-0; Doucet S, 2011, ARCH WOMEN MENT HLTH, V14, P89, DOI 10.1007/s00737-010-0199-6; DOWLATSHAHI D, 1990, PSYCHOL MED, V20, P655, DOI 10.1017/S0033291700017177; Fahim C, 2007, BIPOLAR DISORD, V9, P541, DOI 10.1111/j.1399-5618.2007.00404.x; Feng JN, 2001, AM J MED GENET, V105, P369, DOI 10.1002/ajmg.1364; Ganjekar S, 2013, BIPOLAR DISORD, V15, P713, DOI 10.1111/bdi.12076; Gentile S, 2010, SCHIZOPHRENIA BULL, V36, P518, DOI 10.1093/schbul/sbn107; Glangeaud-Freudenthal NMC, 2011, EUR PSYCHIAT, V26, P215, DOI 10.1016/j.eurpsy.2010.03.006; Glangeaud-Freudenthal NMC, 2013, SOC PSYCH PSYCH EPID, V48, P553, DOI 10.1007/s00127-012-0527-4; Habermann F, 2013, J CLIN PSYCHOPHARM, V33, P453, DOI 10.1097/JCP.0b013e318295fe12; Heron J, 2008, BJOG-INT J OBSTET GY, V115, P348, DOI 10.1111/j.1471-0528.2007.01563.x; Hipwell AE, 1996, BRIT J PSYCHIAT, V169, P655, DOI 10.1192/bjp.169.5.655; Howard L, 2003, SOC PSYCH PSYCH EPID, V38, P450, DOI 10.1007/s00127-003-0663-y; Howard LM, 2013, BJOG-INT J OBSTET GY, V120, P362, DOI 10.1111/1471-0528.12059; Howard LM, 2005, EUR J OBSTET GYN R B, V119, P3, DOI 10.1016/j.ejogrb.2004.06.026; Howard LM, 2004, SCHIZOPHR RES, V71, P49, DOI 10.1016/j.schres.2004.01.003; Howard LM, 2004, ACTA PSYCHIAT SCAND, V110, P347, DOI 10.1111/j.1600-0447.2004.00375.x; Howard LM, 2002, AM J PSYCHIAT, V159, P991, DOI 10.1176/appi.ajp.159.6.991; Howard LM, 2001, BRIT J PSYCHIAT, V178, P427, DOI 10.1192/bjp.178.5.427; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Jahanfar S, 2011, COCHRANE DB SYST REV, V2; Jeffery D, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-120; Jenkins A, 2011, J ROY SOC MED, V104, P286, DOI 10.1258/jrsm.2011.100376; Johnson FN, 1980, HDB LITHIUM THERAPY, P421; Jones I, 2005, BRIT J PSYCHIAT, V186, P453, DOI 10.1192/bjp.186.6.453; Jones I, 2002, PSYCHIATR GENET, V12, P177, DOI 10.1097/00041444-200209000-00011; Jones I, 2001, AM J PSYCHIAT, V158, P913, DOI 10.1176/appi.ajp.158.6.913; Jones I, 2009, ADV PSYCHIAT TREAT, V15, P411, DOI [10.1192/apt.bp.107.004333, DOI 10.1192/apt.bp.107.004333]; Jones I, OXFORD TXB WOMENS ME, V20, P179; Jones I, 2007, AM J PSYCHIAT, V164, P1099, DOI 10.1176/appi.ajp.164.7.1099; Jones I, 2007, PSYCHOPHARMACOL BULL, V40, P115; KENDELL RE, 1987, BRIT J PSYCHIAT, V150, P662, DOI 10.1192/bjp.150.5.662; Lanczik M., 1998, ARCH WOMEN MENT HLTH, V1, P45, DOI [10.1007/s007370050005, DOI 10.1007/S007370050005, DOI 10.1007/S0073]; Laursen TM, 2010, SCHIZOPHR RES, V121, P234, DOI 10.1016/j.schres.2010.05.018; MARKS MN, 1992, J AFFECT DISORDERS, V24, P253, DOI 10.1016/0165-0327(92)90110-R; McColl H, 2013, ARCH WOMEN MENT HLTH, V16, P39, DOI 10.1007/s00737-012-0315-x; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; MCNEIL TF, 1988, ACTA PSYCHIAT SCAND, V77, P645, DOI 10.1111/j.1600-0447.1988.tb05183.x; MCNEIL TF, 1984, ACTA PSYCHIAT SCAND, V70, P127, DOI 10.1111/j.1600-0447.1984.tb01190.x; Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Middle F, 2003, AM J MED GENET B, V118B, P72, DOI 10.1002/ajmg.b.10021; Middle F, 2000, PSYCHIATR GENET, V10, P195, DOI 10.1097/00041444-200010040-00008; Miller LJ, 1996, PSYCHIATR SERV, V47, P502; Mourao-Miranda J, 2012, PSYCHOL MED, V42, P1037, DOI 10.1017/S0033291711002005; Munk-Olsen T, 2007, J CLIN PSYCHIAT, V68, P1947, DOI 10.4088/JCP.v68n1217; Munk-Olsen T, 2006, JAMA-J AM MED ASSOC, V296, P2582, DOI 10.1001/jama.296.21.2582; Munk-Olsen T, 2014, BIPOLAR DISORD, V16, P300, DOI 10.1111/bdi.12145; Munk-Olsen T, 2009, ARCH GEN PSYCHIAT, V66, P189, DOI 10.1001/archgenpsychiatry.2008.528; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; Nishizawa O, 2007, PSYCHIAT CLIN NEUROS, V61, P665, DOI 10.1111/j.1440-1819.2007.01721.x; NORA JJ, 1974, LANCET, V2, P594; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Poston L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-148; Robertson E, 2005, BRIT J PSYCHIAT, V186, P258, DOI 10.1192/bjp.186.3.258; Robertson E, 2003, ACTA PSYCHIAT SCAND, V108, P387, DOI 10.1034/j.1600-0447.2003.00167.x; Robinson D, 1999, ARCH GEN PSYCHIAT, V56, P241, DOI 10.1001/archpsyc.56.3.241; Rowe M, 2012, THER ADV PSYCHOPHARM, V2, P265, DOI 10.1177/2045125312460395; Scottish Intercollegiate Guidelines Network (SIGN), 2012, MAN PER MOOD DIS; Sharma V, 2006, BIPOLAR DISORD, V8, P400, DOI 10.1111/j.1399-5618.2006.00335.x; Sharma V, 2012, J CLIN PSYCHIAT, V73, P1447, DOI 10.4088/JCP.11r07499; Sharma VP, 2004, TRA HERB, V4, P83; Smith D., 2010, ADV PSYCHIAT TREAT, V16, P147, DOI [DOI 10.1192/APT.BP.108.006403, 10.1192/apt.bp.108.006403]; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Spielvogel AM, 2010, CURR WOMENS HEALTH R, V6, P44, DOI 10.2174/157340410790979716; Spinelli MG, 2004, AM J PSYCHIAT, V161, P1548, DOI 10.1176/appi.ajp.161.9.1548; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; STEWART DE, 1991, BRIT J PSYCHIAT, V158, P393, DOI 10.1192/bjp.158.3.393; Terp IM, 1998, BRIT J PSYCHIAT, V172, P521, DOI 10.1192/bjp.172.6.521; Toh S, 2013, ARCH WOMEN MENT HLTH, V16, P149, DOI 10.1007/s00737-013-0330-6; Trixler M, 1995, Acta Psychiatr Belg, V95, P159; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Vigod SN, 2012, SCHIZOPHR RES, V139, P169, DOI 10.1016/j.schres.2012.05.010; Viguera AC, 2000, AM J PSYCHIAT, V157, P179, DOI 10.1176/appi.ajp.157.2.179; Viguera AC, 2007, AM J PSYCHIAT, V164, P1817, DOI 10.1176/appi.ajp.2007.06101639; Viguera AC, 2011, AM J PSYCHIAT, V168, P1179, DOI 10.1176/appi.ajp.2011.11010148; Webb RT, 2004, COCHRANE DB SYST REV, V2; Weigelt K, 2013, BRAIN BEHAV IMMUN, V29, P147, DOI 10.1016/j.bbi.2012.12.018; Whitmore J, 2011, INT J SOC PSYCHIATR, V57, P455, DOI 10.1177/0020764010365412; Wisner KL, 1996, INT J PSYCHIAT MED, V26, P479, DOI 10.2190/NFJK-A4V7-CXUU-AM89; Yacobi S, 2008, ISR J PSYCHIATR REL, V45, P95	102	264	266	6	81	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1789	1799		10.1016/S0140-6736(14)61278-2	http://dx.doi.org/10.1016/S0140-6736(14)61278-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KX	25455249				2022-12-28	WOS:000345116400030
J	Spiegel, P; Golub, G				Spiegel, Paul; Golub, Ginger			Refugees and health: lessons from World War 1	LANCET			English	Editorial Material							WAR		[Spiegel, Paul] United Nations High Commissioner Refugees, CH-1211 Geneva, Switzerland; [Golub, Ginger] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Columbia University	Spiegel, P (corresponding author), United Nations High Commissioner Refugees, CH-1211 Geneva, Switzerland.	spiegel@unhcr.org	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				Ahmed JA, 2013, EMERG INFECT DIS, V19, P1010, DOI 10.3201/eid1906.130275; Arms Control Association, TIM SYR CHEM WEAP AC; Aylward RB, 2014, LANCET, V383, P489, DOI 10.1016/S0140-6736(14)60132-X; Councell CE, 1941, PUBLIC HEALTH REP, V56, P547, DOI 10.2307/4583663; Cox Michael, 2001, WORLD WAR 1 DATABOOK; de Jastrzebski TTS, 1916, J R STAT SOC, V79, P133, DOI 10.2307/2340812; Fitzgerald GJ, 2008, AM J PUBLIC HEALTH, V98, P611, DOI 10.2105/AJPH.2007.11930; Gatrell P, 2008, IMMIGR MINOR, V26, P82, DOI 10.1080/02619280802442613; Gray Randal, 1990, CHRONICLE 1 WORLD WA; Hagopian A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001533; Science Insider, 2010, SCI INSIDER MANY HAV; Sellstrom A., UN MISSION INVESTIGA; Stibbe Matthew, 2013, CAPTIVITY FORCED LAB; United Nations High Commissioner for Refugees, 2013, UNHCR GLOB TRENDS; United Nations High Commissioner for Refugees, 1951 REF CONV	15	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1644	1646		10.1016/S0140-6736(14)61896-1	http://dx.doi.org/10.1016/S0140-6736(14)61896-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KU	25441183				2022-12-28	WOS:000345116200006
J	Holmes, D				Holmes, David			David Napier: cultivating the role of culture in health Profile	LANCET			English	Biographical-Item																			0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1568	1568		10.1016/S0140-6736(14)61937-1	http://dx.doi.org/10.1016/S0140-6736(14)61937-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9NK	25443480	Bronze			2022-12-28	WOS:000343901700013
J	Baeza-Trinidad, R; de La Cuesta-Lopez, MR				Baeza-Trinidad, Ramon; Ruiz de La Cuesta-Lopez, Mirian			Chocolate-coloured serum in methaemoglobinaemia	LANCET			English	Editorial Material									[Baeza-Trinidad, Ramon] Hosp San Pedro, Dept Internal Med, La Rioja, Spain; [Ruiz de La Cuesta-Lopez, Mirian] Hosp San Pedro, Intens Care Unit, La Rioja, Spain		Baeza-Trinidad, R (corresponding author), Piqueras St 98, Logrono 26007, La Rioja, Spain.	rbaezat@riojasalud.es		Baeza-Trinidad, Ramon/0000-0002-7854-3115					0	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 15	2015	386	9994					E6	E6		10.1016/S0140-6736(14)62011-0	http://dx.doi.org/10.1016/S0140-6736(14)62011-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP4KA	25468159				2022-12-28	WOS:000359849200003
J	Ansell, SM; Lesokhin, AM; Borrello, I; Halwani, A; Scott, EC; Gutierrez, M; Schuster, SJ; Millenson, MM; Cattry, D; Freeman, GJ; Rodig, SJ; Chapuy, B; Ligon, AH; Zhu, LL; Grosso, JF; Kim, SY; Timmerman, JM; Shipp, MA; Armand, P				Ansell, Stephen M.; Lesokhin, Alexander M.; Borrello, Ivan; Halwani, Ahmad; Scott, Emma C.; Gutierrez, Martin; Schuster, Stephen J.; Millenson, Michael M.; Cattry, Deepika; Freeman, Gordon J.; Rodig, Scott J.; Chapuy, Bjoern; Ligon, Azra H.; Zhu, Lili; Grosso, Joseph F.; Kim, Su Young; Timmerman, John M.; Shipp, Margaret A.; Armand, Philippe			PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; T-CELLS; LYMPHOPROLIFERATIVE DISORDERS; ANTI-PD-1 ANTIBODY; RESPONSE CRITERIA; PHASE-II; CANCER; SAFETY; THERAPEUTICS; PIDILIZUMAB	BACKGROUND Preclinical studies suggest that Reed-Sternberg cells exploit the programmed death 1 (PD-1) pathway to evade immune detection. In classic Hodgkin's lymphoma, alterations in chromosome 9p24.1 increase the abundance of the PD-1 ligands, PD-L1 and PD-L2, and promote their induction through Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling. We hypothesized that nivolumab, a PD-1-blocking antibody, could inhibit tumor immune evasion in patients with relapsed or refractory Hodgkin's lymphoma. METHODS In this ongoing study, 23 patients with relapsed or refractory Hodgkin's lymphoma that had already been heavily treated received nivolumab (at a dose of 3 mg per kilogram of body weight) every 2 weeks until they had a complete response, tumor progression, or excessive toxic effects. Study objectives were measurement of safety and efficacy and assessment of the PDL1 and PDL2 (also called CD274 and PDCD1LG2, respectively) loci and PD-L1 and PD-L2 protein expression. RESULTS Of the 23 study patients, 78% were enrolled in the study after a relapse following autologous stem-cell transplantation and 78% after a relapse following the receipt of brentuximab vedotin. Drug-related adverse events of any grade and of grade 3 occurred in 78% and 22% of patients, respectively. An objective response was reported in 20 patients (87%), including 17% with a complete response and 70% with a partial response; the remaining 3 patients (13%) had stable disease. The rate of progression-free survival at 24 weeks was 86%; 11 patients were continuing to participate in the study. Reasons for discontinuation included stem-cell transplantation (in 6 patients), disease progression (in 4 patients), and drug toxicity (in 2 patients). Analyses of pretreatment tumor specimens from 10 patients revealed copy-number gains in PDL1 and PDL2 and increased expression of these ligands. Reed-Sternberg cells showed nuclear positivity of phosphorylated STAT3, indicative of active JAK-STAT signaling. CONCLUSIONS Nivolumab had substantial therapeutic activity and an acceptable safety profile in patients with previously heavily treated relapsed or refractory Hodgkin's lymphoma.	[Ansell, Stephen M.] Mayo Clin, Rochester, MN 55905 USA; [Lesokhin, Alexander M.; Cattry, Deepika] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Lesokhin, Alexander M.] Weill Cornell Med Coll, New York, NY 10021 USA; [Borrello, Ivan] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Borrello, Ivan] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Halwani, Ahmad] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Scott, Emma C.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Scott, Emma C.] Knight Canc Inst, Portland, OR USA; [Gutierrez, Martin] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA; [Zhu, Lili; Grosso, Joseph F.; Kim, Su Young] Bristol Myers Squibb Co, Lawrenceville, NJ USA; [Schuster, Stephen J.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Millenson, Michael M.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Freeman, Gordon J.; Chapuy, Bjoern; Shipp, Margaret A.; Armand, Philippe] Dana Farber Canc Inst, Boston, MA 02215 USA; [Rodig, Scott J.; Ligon, Azra H.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Freeman, Gordon J.; Rodig, Scott J.; Chapuy, Bjoern; Ligon, Azra H.; Shipp, Margaret A.; Armand, Philippe] Harvard Univ, Sch Med, Boston, MA USA; [Timmerman, John M.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	Mayo Clinic; Memorial Sloan Kettering Cancer Center; Cornell University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Oregon Health & Science University; Hackensack University Medical Center; Bristol-Myers Squibb; University of Pennsylvania; Pennsylvania Medicine; Fox Chase Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Ansell, SM (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	ansell.stephen@mayo.edu; philippe_armand@dfci.harvard.edu	Freeman, Gordon/AAC-5380-2019; Zhu, Li/GXH-9801-2022; Rodig, Scott/Y-3889-2019	Freeman, Gordon/0000-0002-7210-5616; Halwani, Ahmad/0000-0001-6183-6491	Bristol-Myers Squibb; National Institutes of Health [U54CA163125, P01AI056299, R01CA161026]; Miller Fund; Seattle Genetics; Celldex Therapeutics; Millennium; Idera; Regeneron; Kyowa Hakko Kirin; AbbVie; Genentech; Ventana/Roche; Bayer; Gilead; Merck; Pharmacyclics; Janssen; Sanofi Aventis; NATIONAL CANCER INSTITUTE [R01CA161026, U54CA163125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056299] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miller Fund; Seattle Genetics; Celldex Therapeutics; Millennium(Takeda Pharmaceutical Company Ltd); Idera; Regeneron(Regeneron); Kyowa Hakko Kirin(Kyowa Kirin Ltd); AbbVie(AbbVie); Genentech(Roche HoldingGenentech); Ventana/Roche; Bayer(Bayer AG); Gilead(Gilead Sciences); Merck(Merck & Company); Pharmacyclics; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Sanofi Aventis(Sanofi-Aventis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by Bristol-Myers Squibb, by grants from the National Institutes of Health (U54CA163125 and P01AI056299, to Dr. Freeman; and R01CA161026, to Dr. Shipp), and by a grant from the Miller Fund (to Dr. Shipp).; Dr. Ansell reports receiving grant support from Seattle Genetics, Celldex Therapeutics, Millennium, Idera, and Regeneron; Dr. Lesokhin, receiving consulting fees and grant support from Bristol-Myers Squibb; Dr. Halwani, receiving grant support from Seattle Genetics, Millennium, Kyowa Hakko Kirin, AbbVie, Genentech, and Bristol-Myers Squibb; Dr. Freeman, receiving royalties from patents related to PD-1, PD-L1, and PD-L2 pathways (US 6808710, US 6936704, US 7038013, US7101550, US 7432059, US 7635757, US 7638492, US 7700301, US 7709214, US 8552154, and US 8652465), which are licensed to Bristol-Myers Squibb, Roche, Merck, EMD Serono, Boehringer Ingelheim, Amplimmune, and Novartis; Dr. Rodig, receiving grant support from Bristol-Myers Squibb and Ventana/Roche and having a pending patent application related to anti-PD-L1 monoclonal antibodies and fragments (US 61/895,543); Ms. Zhu, Dr. Grosso, and Dr. Kim, being employees of Bristol-Myers Squibb; Dr. Timmerman, receiving grant support from Bristol-Myers Squibb; Dr. Shipp, receiving fees for serving on advisory boards from Bristol-Myers Squibb, Bayer, Gilead, Merck, Pharmacyclics, and Janssen and receiving grant support from Bristol-Myers Squibb, Sanofi Aventis, and Bayer; and Dr. Armand, receiving consulting fees from Merck. No other potential conflict of interest relevant to this article was reported.	Andorsky DJ, 2011, CLIN CANCER RES, V17, P4232, DOI 10.1158/1078-0432.CCR-10-2660; Arai S, 2013, LEUKEMIA LYMPHOMA, V54, P2531, DOI 10.3109/10428194.2013.798868; Armand P, 2013, J CLIN ONCOL, V31, P4199, DOI 10.1200/JCO.2012.48.3685; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; CARBONE A, 1993, VIRCHOWS ARCH A, V422, P39, DOI 10.1007/BF01605131; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Connors JM, 2005, J CLIN ONCOL, V23, P6400, DOI 10.1200/JCO.2005.05.016; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Juszczynski P, 2007, P NATL ACAD SCI USA, V104, P13134, DOI 10.1073/pnas.0706017104; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Majhail NS, 2006, BIOL BLOOD MARROW TR, V12, P1065, DOI 10.1016/j.bbmt.2006.06.006; National Cancer Institute, 2009, NIH PUBLICATION; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Steidl C, 2011, NATURE, V471, P377, DOI 10.1038/nature09754; Steidl C, 2010, BLOOD, V116, P418, DOI 10.1182/blood-2009-12-257345; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Weber J, 2010, SEMIN ONCOL, V37, P430, DOI 10.1053/j.seminoncol.2010.09.005; Westin JR, 2014, LANCET ONCOL, V15, P69, DOI 10.1016/S1470-2045(13)70551-5; Wilcox RA, 2009, BLOOD, V114, P2149, DOI 10.1182/blood-2009-04-216671; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Younes A, 2012, J CLIN ONCOL, V30, P2183, DOI 10.1200/JCO.2011.38.0410	26	2481	2614	9	465	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 22	2015	372	4					311	319		10.1056/NEJMoa1411087	http://dx.doi.org/10.1056/NEJMoa1411087			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AZ4PJ	25482239	Green Accepted, Bronze			2022-12-28	WOS:000348204500006
J	Grallert, A; Boke, E; Hagting, A; Hodgson, B; Connolly, Y; Griffiths, JR; Smith, DL; Pines, J; Hagan, IM				Grallert, Agnes; Boke, Elvan; Hagting, Anja; Hodgson, Ben; Connolly, Yvonne; Griffiths, John R.; Smith, Duncan L.; Pines, Jonathon; Hagan, Iain M.			A PP1-PP2A phosphatase relay controls mitotic progression	NATURE			English	Article							XENOPUS EGG EXTRACTS; CELL-DIVISION CYCLE; PROTEIN PHOSPHATASE; SCHIZOSACCHAROMYCES-POMBE; M-PHASE; 2A; PHOSPHORYLATION; KINASE; HOLOENZYME; GENE	The widespread reorganization of cellular architecture in mitosis is achieved through extensive protein phosphorylation, driven by the coordinated activation of a mitotic kinase network and repression of counteracting phosphatases. Phosphatase activity must subsequently be restored to promote mitotic exit. Although Cdc14 phosphatase drives this reversal in budding yeast, protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) activities have each been independently linked to mitotic exit control in other eukaryotes(1-6). Here we describe a mitotic phosphatase relay in which PP1 reactivation is required for the reactivation of both PP2A-B55 and PP2A-B56 to coordinate mitotic progression and exit in fission yeast. The staged recruitment of PP1 (the Dis2 isoform) to the regulatory sub-units of the PP2A-B55 and PP2A-B56 (B55 also known as Pab1; B56 also known as Par1) holoenzymes sequentially activates each phosphatase. The pathway is blocked in early mitosis because the Cdk1-cyclin B kinase (Cdk1 also known as Cdc2) inhibits PP1 activity, but declining cyclin B levels later in mitosis permit PP1 to auto-reactivate(1,7-10). PP1 first reactivates PP2A-B55; this enables PP2A-B55 in turn to promote the reactivation of PP2A-B56 by dephosphorylating a PP1-docking site in PP2A-B56, thereby promoting the recruitment of PP1. PP1 recruitment to human, mitotic PP2A-B56 holoenzymes and the sequences of these conserved PP1-docking motifs(11,12) suggest that PP1 regulates PP2A-B55 and PP2A-B56 activities in a variety of signalling contexts throughout eukaryotes.	[Grallert, Agnes; Boke, Elvan; Hodgson, Ben; Hagan, Iain M.] Univ Manchester, CRUK Manchester Inst, Cell Div Grp, Manchester M20 4BX, Lancs, England; [Hagting, Anja; Pines, Jonathon] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Connolly, Yvonne; Griffiths, John R.; Smith, Duncan L.] Univ Manchester, CRUK Manchester Inst, Manchester M20 4BX, Lancs, England	University of Manchester; University of Cambridge; University of Manchester	Hagan, IM (corresponding author), Univ Manchester, CRUK Manchester Inst, Cell Div Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	Iain.Hagan@cruk.manchester.ac.uk	Boke, Elvan/O-6725-2017	Hagan, Iain/0000-0002-5858-9415; Grallert, Agnes/0000-0002-0127-3495; Pines, Jonathon/0000-0002-5227-6004	Cancer Research UK (CRUK) [C147/A16406, C29/A13678]; Cancer Research UK [16406, 13678] Funding Source: researchfish	Cancer Research UK (CRUK)(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (CRUK) grant numbers C147/A16406 and C29/A13678. We thank I. Alvarez-Tabares, K. Labib, K. Gull, M. Yanagida, V. Simanis, J. Ba " hler and K. Gould for reagents.	Alvarez-Tabares I, 2007, J CELL SCI, V120, P3589, DOI 10.1242/jcs.007567; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; CREANOR J, 1979, J GEN MICROBIOL, V112, P385, DOI 10.1099/00221287-112-2-385; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Fennessy D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097683; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Gould KL, 2004, METHODS, V33, P239, DOI 10.1016/j.ymeth.2003.11.019; Grallert A, 2013, CURR BIOL, V23, P213, DOI 10.1016/j.cub.2012.12.039; Hachet O, 2011, CELL, V145, P1116, DOI 10.1016/j.cell.2011.05.014; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; HUDSON JD, 1990, GENETICS, V126, P309; Ishiguro T, 2010, NAT CELL BIOL, V12, P500, DOI 10.1038/ncb2052; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jiang W, 2000, GENETICS, V154, P1025; Johnson LN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002234; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; KING SM, 1982, CAN J MICROBIOL, V28, P261, DOI 10.1139/m82-036; Kinoshita K, 1996, GENES CELLS, V1, P29, DOI 10.1046/j.1365-2443.1996.02002.x; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; MORENO S, 1991, METHOD ENZYMOL, V194, P795; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; OHKURA H, 1989, CELL, V57, P997, DOI 10.1016/0092-8674(89)90338-3; Petersen J, 2001, J CELL SCI, V114, P4371; Pines J, 2011, PHILOS T R SOC B, V366, P3625, DOI 10.1098/rstb.2011.0080; Porter IM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3677; Qian JB, 2013, CURR OPIN CELL BIOL, V25, P697, DOI 10.1016/j.ceb.2013.06.005; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; STONE EM, 1993, CURR BIOL, V3, P13, DOI 10.1016/0960-9822(93)90140-J; Suijkerbuijk SJE, 2012, DEV CELL, V23, P745, DOI 10.1016/j.devcel.2012.09.005; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; YAMANO H, 1994, EMBO J, V13, P5310, DOI 10.1002/j.1460-2075.1994.tb06865.x	47	127	127	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					94	U248		10.1038/nature14019	http://dx.doi.org/10.1038/nature14019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25487150	Green Accepted			2022-12-28	WOS:000347178400042
J	Hu, S; Lozada-Hidalgo, M; Wang, FC; Mishchenko, A; Schedin, F; Nair, RR; Hill, EW; Boukhvalov, DW; Katsnelson, MI; Dryfe, RAW; Grigorieva, IV; Wu, HA; Geim, AK				Hu, S.; Lozada-Hidalgo, M.; Wang, F. C.; Mishchenko, A.; Schedin, F.; Nair, R. R.; Hill, E. W.; Boukhvalov, D. W.; Katsnelson, M. I.; Dryfe, R. A. W.; Grigorieva, I. V.; Wu, H. A.; Geim, A. K.			Proton transport through one-atom-thick crystals	NATURE			English	Article							GRAPHENE OXIDE MEMBRANES; NANOPOROUS GRAPHENE; POROUS GRAPHENE; SINGLE-LAYER; WATER DESALINATION; NAFION; CONDUCTIVITY; TEMPERATURE; PERMEATION; MECHANISMS	Graphene is increasingly explored as a possible platform for developing novel separation technologies(1-19). This interest has arisen because it is a maximally thin membrane that, once perforated with atomic accuracy, may allow ultrafast and highly selective sieving of gases, liquids, dissolved ions and other species of interest(2,9-19). However, a perfect graphene monolayer is impermeable to all atoms and molecules under ambient conditions(1-7): even hydrogen, the smallest of atoms, is expected to take billions of years to penetrate graphene's dense electronic cloud(3-6). Only accelerated atoms possess the kinetic energy required to do this(20,21). The same behaviour might reasonably be expected in the case of other atomically thin crystals(22,23). Here we report transport and mass spectroscopy measurements which establish that monolayers of graphene and hexagonal boron nitride (hBN) are highly permeable to thermal protons under ambient conditions, whereas no proton transport is detected for thicker crystals such as monolayer molybdenum disulphide, bilayer graphene or multilayer hBN. Protons present an intermediate case between electrons (which can tunnel easily through atomically thin barriers(24)) and atoms, yet our measured transport rates are unexpectedly high(4,5) and raise fundamental questions about the details of the transport process. We see the highest room-temperature proton conductivity with monolayer hBN, for which we measure a resistivity to proton flow of about 10 Omega cm(2) and a low activation energy of about 0.3 electronvolts. At higher temperatures, hBN is outperformed by graphene, the resistivity of which is estimated to fall below 10(-3) Omega cm(2) above 250 degrees Celsius. Proton transport can be further enhanced by decorating the graphene and hBN membranes with catalytic metal nanoparticles. The high, selective proton conductivity and stability make one-atom-thick crystals promising candidates for use in many hydrogen-based technologies.	[Hu, S.; Lozada-Hidalgo, M.; Mishchenko, A.; Nair, R. R.; Grigorieva, I. V.; Geim, A. K.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Hu, S.; Schedin, F.; Hill, E. W.; Geim, A. K.] Univ Manchester, Manchester Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England; [Wang, F. C.; Wu, H. A.] Univ Sci & Technol China, Dept Modern Mech, Key Lab Mech Behav & Design Mat, Chinese Acad Sci, Hefei 230027, Anhui, Peoples R China; [Boukhvalov, D. W.; Katsnelson, M. I.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Dryfe, R. A. W.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Radboud University Nijmegen; University of Manchester	Lozada-Hidalgo, M (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.	marcelo.lozadahidalgo@manchester.ac.uk; wuha@ustc.edu.cn	Lozada-Hidalgo, Marcelo/U-1642-2017; Katsnelson, Mikhail I./D-4359-2012; Boukhvalov, Danil/F-7517-2017; Wu, Hengan/A-3646-2009; Raveendran Nair, Rahul/G-5839-2010; Geim, Andre K/J-7888-2012; Mishchenko, Artem/C-7561-2011; Wang, Fengchao/G-1708-2012; Nair, Rahul Raveendran/Z-1566-2019; Hill, Ernie/K-6942-2015	Lozada-Hidalgo, Marcelo/0000-0003-3216-7537; Wu, Hengan/0000-0003-0288-1617; Geim, Andre K/0000-0003-2861-8331; Mishchenko, Artem/0000-0002-0427-5664; Wang, Fengchao/0000-0002-5954-3881; Hill, Ernie/0000-0001-9412-6795	European Research Council; Royal Society; Office of Naval Research; Air Force Office of Scientific Research; National Science Foundation of China; Consejo Nacional de Ciencia y Tecnologia (Mexico); EPSRC [EP/K005014/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Research Council, the Royal Society, the Office of Naval Research, the Air Force Office of Scientific Research and the National Science Foundation of China. M.L.-H. acknowledges a PhD studentship provided by the Consejo Nacional de Ciencia y Tecnologia (Mexico).	Agrait N, 2003, PHYS REP, V377, P81, DOI 10.1016/S0370-1573(02)00633-6; Alberti G, 2001, J MEMBRANE SCI, V185, P73, DOI 10.1016/S0376-7388(00)00635-9; Berry V, 2013, CARBON, V62, P1, DOI 10.1016/j.carbon.2013.05.052; Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; Bunch JS, 2008, NANO LETT, V8, P2458, DOI 10.1021/nl801457b; Celebi K, 2014, SCIENCE, V344, P289, DOI 10.1126/science.1249097; Cohen-Tanugi D, 2012, NANO LETT, V12, P3602, DOI 10.1021/nl3012853; DeLuca NW, 2006, J MEMBRANE SCI, V282, P217, DOI 10.1016/j.memsci.2006.05.025; Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Goedecker S, 1996, PHYS REV B, V54, P1703, DOI 10.1103/PhysRevB.54.1703; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Jiang DE, 2009, NANO LETT, V9, P4019, DOI 10.1021/nl9021946; Kim HW, 2013, SCIENCE, V342, P91, DOI 10.1126/science.1236098; Koenig SP, 2012, NAT NANOTECHNOL, V7, P728, DOI [10.1038/NNANO.2012.162, 10.1038/nnano.2012.162]; Konatham D, 2013, LANGMUIR, V29, P11884, DOI 10.1021/la4018695; Kretinin AV, 2014, NANO LETT, V14, P3270, DOI 10.1021/nl5006542; Leenaerts O, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3021413; Li H, 2013, SCIENCE, V342, P95, DOI 10.1126/science.1236686; Liu L, 2008, NANO LETT, V8, P1965, DOI 10.1021/nl0808684; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Miao M, 2013, PHYS CHEM CHEM PHYS, V15, P16132, DOI 10.1039/c3cp52318g; MORGAN H, 1986, J PHYS E SCI INSTRUM, V19, P80, DOI 10.1088/0022-3735/19/1/016; MURPHY DW, 1993, CHEM MATER, V5, P767, DOI 10.1021/cm00030a009; Nair RR, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3492845; Ni ZH, 2010, NANO LETT, V10, P3868, DOI 10.1021/nl101399r; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; O'Hern SC, 2014, NANO LETT, V14, P1234, DOI 10.1021/nl404118f; O'Hern SC, 2012, ACS NANO, V6, P10130, DOI 10.1021/nn303869m; Qiu H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3642; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; SCHULDINER S, 1958, J CHEM PHYS, V28, P16, DOI 10.1063/1.1744059; Silva RF, 2004, ELECTROCHIM ACTA, V49, P3211, DOI 10.1016/j.electacta.2004.02.035; Sint K, 2008, J AM CHEM SOC, V130, P16448, DOI 10.1021/ja804409f; Sone Y, 1996, J ELECTROCHEM SOC, V143, P1254, DOI 10.1149/1.1836625; Spry DB, 2009, J PHYS CHEM B, V113, P10210, DOI 10.1021/jp9036777; Stolyarova E, 2009, NANO LETT, V9, P332, DOI 10.1021/nl803087x; Sun CZ, 2014, LANGMUIR, V30, P675, DOI 10.1021/la403969g; Tsetseris L, 2014, CARBON, V67, P58, DOI 10.1016/j.carbon.2013.09.055; VandeVondele J, 2005, COMPUT PHYS COMMUN, V167, P103, DOI 10.1016/j.cpc.2004.12.014; VandeVondele J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770708; Wang WL, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125012; Xu T, 2018, WOODH PUB SER ELECT, P137, DOI 10.1016/B978-0-08-102053-1.00005-3; Yuan WJ, 2014, MATER TODAY, V17, P77, DOI 10.1016/j.mattod.2014.01.021; Zhong C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1489	45	474	492	43	1177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					227	+		10.1038/nature14015	http://dx.doi.org/10.1038/nature14015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25470058	Green Submitted, Green Published			2022-12-28	WOS:000346383500040
J	Scalfani, VF				Scalfani, Vincent F.			Finally free	SCIENCE			English	Editorial Material									Univ Alabama, Tuscaloosa, AL 35487 USA	University of Alabama System; University of Alabama Tuscaloosa	Scalfani, VF (corresponding author), Univ Alabama, Tuscaloosa, AL 35487 USA.		Scalfani, Vincent/O-8031-2016	Scalfani, Vincent/0000-0002-7363-531X					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1258	1258		10.1126/science.346.6214.1258	http://dx.doi.org/10.1126/science.346.6214.1258			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477466				2022-12-28	WOS:000346189000062
J	Weiss, BP; Tikoo, SM				Weiss, Benjamin P.; Tikoo, Sonia M.			The lunar dynamo	SCIENCE			English	Review							MAGNETIC-FIELDS; SCALING LAWS; CORE DYNAMO; MOON; DRIVEN; CONSTRAINTS; SAMPLES; ORIGIN; MANTLE; MOMENT	The inductive generation of magnetic fields in fluid planetary interiors is known as the dynamo process. Although the Moon today has no global magnetic field, it has been known since the Apollo era that the lunar rocks and crust are magnetized. Until recently, it was unclear whether this magnetization was the product of a core dynamo or fields generated externally to the Moon. New laboratory and spacecraft measurements strongly indicate that much of this magnetization is the product of an ancient core dynamo. The dynamo field persisted from at least 4.25 to 3.56 billion years ago (Ga), with an intensity reaching that of the present Earth. The field then declined by at least an order of magnitude by similar to 3.3 Ga. The mechanisms for sustaining such an intense and long-lived dynamo are uncertain but may include mechanical stirring by the mantle and core crystallization.	[Weiss, Benjamin P.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Tikoo, Sonia M.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Tikoo, Sonia M.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; Berkeley Geochronolgy Center	Weiss, BP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bpweiss@mit.edu			NASA Lunar Advanced Science and Exploration Program; NASA Solar System Exploration Research Virtual Institute; Massachusetts Institute of Technology International Science and Technology Initiatives Global Seed Fund; Miller Institute for Basic Research in Science	NASA Lunar Advanced Science and Exploration Program; NASA Solar System Exploration Research Virtual Institute; Massachusetts Institute of Technology International Science and Technology Initiatives Global Seed Fund; Miller Institute for Basic Research in Science	We thank the NASA Lunar Advanced Science and Exploration Program, the NASA Solar System Exploration Research Virtual Institute, the Massachusetts Institute of Technology International Science and Technology Initiatives Global Seed Fund, and the Miller Institute for Basic Research in Science for support. We thank M. Fuller, M. Laneuville, M. Wieczorek, I. Garrick-Bethell, A. Scheinberg, J. Buz, S. Stanley, and B. Tian for sharing their unpublished manuscripts and thoughts with us. We also thank L. Hood, R. Harrison, and an anonymous referee for thoughtful reviews; J. Gattacceca, C. Suavet, B. Buffett, and M. Purucker for helpful discussions; and B. Carbone for administrative help.	Anderson BJ, 2010, SPACE SCI REV, V152, P307, DOI 10.1007/s11214-009-9544-3; Buz J., 2011, THESIS MIT CAMBRIDGE; Cahill J. T. S., 2014, LUN PLAN SCI C 45; Cebron D, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/1/L25; Christensen UR, 2010, SPACE SCI REV, V152, P565, DOI 10.1007/s11214-009-9553-2; Cournede C, 2012, EARTH PLANET SC LETT, V331, P31, DOI 10.1016/j.epsl.2012.03.004; Crawford DA, 1999, INT J IMPACT ENG, V23, P169, DOI 10.1016/S0734-743X(99)00070-6; Dolginov S. S., 1961, GEOMAGN AERON, V1, P18; Dwyer CA, 2011, NATURE, V479, P212, DOI 10.1038/nature10564; Evans AJ, 2014, J GEOPHYS RES-PLANET, V119, P1061, DOI 10.1002/2013JE004494; Fagan AL, 2014, EARTH MOON PLANETS, V112, P59, DOI 10.1007/s11038-014-9437-7; Fuller M., 1987, GEOMAGN AERON, V2, P307; Fuller M, 1998, PHYS CHEM EARTH, V23, P725, DOI DOI 10.1016/S0079-1946(98)00083-4; GAPCYNSKI JP, 1975, GEOPHYS RES LETT, V2, P353, DOI 10.1029/GL002i008p00353; Garcia RF, 2011, PHYS EARTH PLANET IN, V188, P96, DOI 10.1016/j.pepi.2011.06.015; Garrick-Bethell I., 2013, LUN SCI FOR; Garrick-Bethell I, 2009, ICARUS, V204, P399, DOI 10.1016/j.icarus.2009.05.032; Garrick-Bethell I, 2009, SCIENCE, V323, P356, DOI 10.1126/science.1166804; Gastine T, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219799; Gattacceca J, 2010, EARTH PLANET SC LETT, V299, P42, DOI 10.1016/j.epsl.2010.08.011; Glatzmaier GA, 1999, NATURE, V401, P885, DOI 10.1038/44776; Halekas JS, 2003, METEORIT PLANET SCI, V38, P565, DOI 10.1111/j.1945-5100.2003.tb00027.x; Hauri EH, 2011, SCIENCE, V333, P213, DOI 10.1126/science.1204626; Hemingway D, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004165; Hood L. L., 2014, LUN PLAN SCI C 45; HOOD LL, 1987, J GEOPHYS RES-SOLID, V92, pE396, DOI 10.1029/JB092iB04p0E396; Hood LL, 1999, GEOPHYS RES LETT, V26, P2327, DOI 10.1029/1999GL900487; HOOD LL, 1979, PHYS EARTH PLANET IN, V20, P291, DOI 10.1016/0031-9201(79)90052-9; Hood LL, 2008, ICARUS, V193, P485, DOI 10.1016/j.icarus.2007.08.023; Hood LL, 2013, J GEOPHYS RES-PLANET, V118, P1265, DOI 10.1002/jgre.20078; Hood LL, 2011, ICARUS, V211, P1109, DOI 10.1016/j.icarus.2010.08.012; HOYLE F, 1946, MON NOT R ASTRON SOC, V106, P406, DOI 10.1093/mnras/106.5.406; Jing ZC, 2014, EARTH PLANET SC LETT, V396, P78, DOI 10.1016/j.epsl.2014.04.015; King EM, 2013, EARTH PLANET SC LETT, V371, P156, DOI 10.1016/j.epsl.2013.04.001; Konopliv AS, 1998, SCIENCE, V281, P1476, DOI 10.1126/science.281.5382.1476; Konrad W, 1997, ADV SPACE RES-SERIES, V19, P1511, DOI 10.1016/S0273-1177(97)00364-5; KUIPER GP, 1954, P NATL ACAD SCI USA, V40, P1096, DOI 10.1073/pnas.40.12.1096; Laneuville M, 2014, EARTH PLANET SC LETT, V401, P251, DOI 10.1016/j.epsl.2014.05.057; Laneuville M, 2013, J GEOPHYS RES-PLANET, V118, P1435, DOI 10.1002/jgre.20103; Lawrence K, 2008, PHYS EARTH PLANET IN, V168, P71, DOI 10.1016/j.pepi.2008.05.007; Le Bars M, 2011, NATURE, V479, P215, DOI 10.1038/nature10565; LIN RP, 1988, ICARUS, V74, P529, DOI 10.1016/0019-1035(88)90119-4; Meyer J, 2011, ICARUS, V211, P921, DOI 10.1016/j.icarus.2010.09.016; Mitchell DL, 2008, ICARUS, V194, P401, DOI 10.1016/j.icarus.2007.10.027; MUELLER S, 1988, J GEOPHYS RES-SOLID, V93, P6338, DOI 10.1029/JB093iB06p06338; Nimmo F., 2007, TREATISE GEOPHYS, V9, P217, DOI [10.1016/B978-044452748-6.00147-4, DOI 10.1016/B978-044452748-6.00147-4]; Oruba L, 2014, GEOPHYS J INT, V198, P828, DOI 10.1093/gji/ggu159; Pearce G. W., 1973, P LUNAR PLANET SCI C, V4, P3045; Pritchard M.E., 2000, ORIGIN EARTH MOON, P179, DOI [10.2307/j.ctv1v7zdrp.16, DOI 10.2307/J.CTV1V7ZDRP.16]; Purucker ME, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003922; Purucker ME, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003650; Rai N, 2014, EARTH PLANET SC LETT, V388, P343, DOI 10.1016/j.epsl.2013.12.001; Richmond NC, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002933; Runcorn SK, 1996, GEOCHIM COSMOCHIM AC, V60, P1205, DOI 10.1016/0016-7037(96)00024-5; RUNCORN SK, 1978, SCIENCE, V199, P771, DOI 10.1126/science.199.4330.771; Shea EK, 2012, SCIENCE, V335, P453, DOI 10.1126/science.1215359; Shimizu H, 2013, ICARUS, V222, P32, DOI 10.1016/j.icarus.2012.10.029; Simitev RD, 2012, PHYS SCRIPTA, V86, DOI 10.1088/0031-8949/86/01/018409; Smith DE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043751; Smoluchowski R., 1973, Moon, V7, P127, DOI 10.1007/BF00578811; Stegman DR, 2003, NATURE, V421, P143, DOI 10.1038/nature01267; Stevenson DJ, 2010, SPACE SCI REV, V152, P651, DOI 10.1007/s11214-009-9572-z; Suavet C, 2013, P NATL ACAD SCI USA, V110, P8453, DOI 10.1073/pnas.1300341110; Sugiura N., 1980, P LUN PLAN SCI C 11, P1801; Takahashi F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041221; Tian B. Y., 2014, AGU FALL MEETING; Tikoo S. M., 2014, LUN PLAN SCI C 45; Tikoo SM, 2014, EARTH PLANET SC LETT, V404, P89, DOI 10.1016/j.epsl.2014.07.010; Tikoo SM, 2012, EARTH PLANET SC LETT, V337, P93, DOI 10.1016/j.epsl.2012.05.024; TURKEVICH AL, 1967, SCIENCE, V158, P635, DOI 10.1126/science.158.3801.635; Urey H. C., 1956, VISTAS ASTRON, V2, P1667, DOI 10.1016/0083-6656(56)90091-5; Weber RC, 2011, SCIENCE, V331, P309, DOI 10.1126/science.1199375; Wieczorek MA, 2006, REV MINERAL GEOCHEM, V60, P221, DOI 10.2138/rmg.2006.60.3; Wieczorek MA, 2012, SCIENCE, V335, P1212, DOI 10.1126/science.1214773; Williams JG, 2001, J GEOPHYS RES-PLANET, V106, P27933, DOI 10.1029/2000JE001396; Williams Q, 2009, EARTH PLANET SC LETT, V284, P564, DOI 10.1016/j.epsl.2009.05.019; Wood J.A., 1970, P AP 11 LUN SCI C, P965; Zhang N, 2013, J GEOPHYS RES-PLANET, V118, P1789, DOI 10.1002/jgre.20121; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839	79	100	100	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1198	+	1246753	10.1126/science.1246753	http://dx.doi.org/10.1126/science.1246753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB6XQ	25477467				2022-12-28	WOS:000349770700001
J	[Anonymous]				[Anonymous]			The Good Bed-Side Manner (Reprinted from JAMA, vol 18, pg 203-204, 1892)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1892, JAMA-J AM MED ASSOC, V18, P203	1	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2293	2293		10.1001/jama.2013.279874	http://dx.doi.org/10.1001/jama.2013.279874			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25462008				2022-12-28	WOS:000345684800032
J	Johnson, KE; Tachibana, C; Coronado, GD; Dember, LM; Glasgow, RE; Huang, SS; Martin, PJ; Richards, J; Rosenthal, G; Septimus, E; Simon, GE; Solberg, L; Suls, J; Thompson, E; Larson, EB				Johnson, Karin E.; Tachibana, Chris; Coronado, Gloria D.; Dember, Laura M.; Glasgow, Russell E.; Huang, Susan S.; Martin, Paul J.; Richards, Julie; Rosenthal, Gary; Septimus, Ed; Simon, Gregory E.; Solberg, Leif; Suls, Jerry; Thompson, Ella; Larson, Eric B.			A guide to research partnerships for pragmatic clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POLICY		[Johnson, Karin E.; Tachibana, Chris; Richards, Julie; Simon, Gregory E.; Thompson, Ella; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA 98101 USA; [Coronado, Gloria D.] Kaiser Permanente Ctr Hlth Res, Portland, OR 97227 USA; [Dember, Laura M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Glasgow, Russell E.] Univ Colorado, Colorado Hlth Outcomes Program, Sch Med, Aurora, CO 80045 USA; [Huang, Susan S.] Univ Calif Irvine, Sch Med, Irvine, CA 92697 USA; [Martin, Paul J.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Rosenthal, Gary] Univ Iowa, Iowa City, IA 52242 USA; [Septimus, Ed] Hosp Corp Amer, Clin Serv Grp, Nashville, TN 37402 USA; [Solberg, Leif] HealthPartners Inst Educ & Res, Bloomington, MN 55425 USA; [Suls, Jerry] NCI, Bethesda, MD 20892 USA	Kaiser Permanente; University of Pennsylvania; Pennsylvania Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; Fred Hutchinson Cancer Center; University of Iowa; Hospital Corporation of America; HealthPartners Institute for Education & Research; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Johnson, KE (corresponding author), Grp Hlth Res Inst, Seattle, WA 98101 USA.	johnson.ke@ghc.org		Richards, Julie/0000-0002-7037-4177; Solberg, Leif/0000-0001-5509-1139	NIH Common Fund for the NIH Health Care Systems Research Collaboratory [U54 AT007748]; NATIONAL CANCER INSTITUTE [UH3CA188640] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [U54AT007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH3DK102384] Funding Source: NIH RePORTER	NIH Common Fund for the NIH Health Care Systems Research Collaboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: this work was supported by a cooperative agreement (U54 AT007748) from the NIH Common Fund for the NIH Health Care Systems Research Collaboratory; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; SSH received non-financial support from Sage Products and Molnlycke.	Califf RM, 2012, JAMA-J AM MED ASSOC, V308, P1747, DOI 10.1001/jama.2012.28745; Campbell M K, 2007, Health Technol Assess, V11, pix; Chalkidou K, 2012, CLIN TRIALS, V9, P436, DOI 10.1177/1740774512450097; Clinical and Translational Science Awards Consortium Community Engagement Key Function Committee Task Force on the Principles of Community Engagement, 2011, PRINCIPLES OF COMMUN; Feldstein AC, 2008, JT COMM J QUAL PATIE, V34, P228, DOI 10.1016/S1553-7250(08)34030-6; Francis D, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-37; Gawlinski A, 2008, AM J CRIT CARE, V17, P315; Glasgow RE, 2013, AM J PREV MED, V45, P237, DOI 10.1016/j.amepre.2013.03.010; Glasgow RE, 2013, HEALTH EDUC BEHAV, V40, P257, DOI 10.1177/1090198113486805; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Maclure M, 2009, CAN MED ASSOC J, V180, P1001, DOI 10.1503/cmaj.090076; MacPherson H, 2004, COMPLEMENT THER MED, V12, P136, DOI 10.1016/j.ctim.2004.07.043; Matthews S, 2012, NAT MED, V18, P1598, DOI 10.1038/nm1112-1598a; Patsopoulos Nikolaos A, 2011, Dialogues Clin Neurosci, V13, P217; Rahman S, 2011, ADV MED EDUC PRACT, V2, P85, DOI 10.2147/AMEP.S14103; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624	20	36	37	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2014	349								g6826	10.1136/bmj.g6826	http://dx.doi.org/10.1136/bmj.g6826			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KJ	25446054	Green Published, Bronze			2022-12-28	WOS:000346116200002
J	Gorna, R				Gorna, Robin			AIDS: transforming global health	LANCET			English	Editorial Material							HIV		AIDS Strategy Advocacy & Policy ASAP, Brighton BN1 2PG, E Sussex, England		Gorna, R (corresponding author), AIDS Strategy Advocacy & Policy ASAP, Brighton BN1 2PG, E Sussex, England.	robin@asapltd.com						Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Gorna R, 1988, AIDS TREATMENT UPDAT; Gorna R, 2013, HUFFINGTON POST; Gorna R, 1994, POSITIVE PRACTICE GU; Gorna R, 1996, VIRGINS VICTIMS CAN; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Loutfy MR, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18509; Monforte AD, 2010, AIDS, V24, P1091, DOI 10.1097/QAD.0b013e3283390db3; Remme M, 2012, LANCET, V379, P2150, DOI 10.1016/S0140-6736(12)60944-1	9	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					E58	E59		10.1016/S0140-6736(14)62260-1	http://dx.doi.org/10.1016/S0140-6736(14)62260-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU2LP	25435454				2022-12-28	WOS:000345450100001
J	Kirby, T				Kirby, Tony			Anatoli Kamali: spearheading HIV prevention in Africa	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1920	1920		10.1016/S0140-6736(14)62269-8	http://dx.doi.org/10.1016/S0140-6736(14)62269-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25435442	Bronze			2022-12-28	WOS:000345450100016
J	Herbst, RS; Soria, JC; Kowanetz, M; Fine, GD; Hamid, O; Gordon, MS; Sosman, JA; McDermott, DF; Powderly, JD; Gettinger, SN; Kohrt, HEK; Horn, L; Lawrence, DP; Rost, S; Leabman, M; Xiao, YY; Mokatrin, A; Koeppen, H; Hegde, PS; Mellman, I; Chen, DS; Hodi, FS				Herbst, Roy S.; Soria, Jean-Charles; Kowanetz, Marcin; Fine, Gregg D.; Hamid, Omid; Gordon, Michael S.; Sosman, Jeffery A.; McDermott, David F.; Powderly, John D.; Gettinger, Scott N.; Kohrt, Holbrook E. K.; Horn, Leora; Lawrence, Donald P.; Rost, Sandra; Leabman, Maya; Xiao, Yuanyuan; Mokatrin, Ahmad; Koeppen, Hartmut; Hegde, Priti S.; Mellman, Ira; Chen, Daniel S.; Hodi, F. Stephen			Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients	NATURE			English	Article							T-CELLS; IN-VIVO; SAFETY; TUMORS; PD-1; MELANOMA; CRITERIA; PATHWAY; DISEASE; B7-H1	The development of human cancer is a multistep process characterized by the accumulation of genetic and epigenetic alterations that drive or reflect tumour progression. These changes distinguish cancer cells from their normal counterparts, allowing tumours to be recognized as foreign by the immune system(1-4). However, tumours are rarely rejected spontaneously, reflecting their ability to maintain an immunosuppressive microenvironmen(5). Programmed death-ligand 1 (PD-Li; also called B7-H1 or CD274), which is expressed on many cancer and immune cells, plays an important part in blocking the 'cancer immunity cycle' by binding programmed death-1 (PD-1) and B7.1 (CD80), both of which are negative regulators of T-lymphocyte activation. Binding of PD-L1 to its receptors suppresses T-cell migration, proliferation and secretion of cytotoxic mediators, and restricts tumour cell killing(6-10). The PD -LI-PD -1 axis protects the host from overactive T-effector cells not only in cancer but also during microbial infections(11). Blocking PD-L1 should therefore enhance anticancer immunity, but little is known about predictive factors of efficacy. This study was designed to evaluate the safety, activity and biomarkers of PD-L1 inhibition using the engineered humanized antibody MPDL3280A. Here we show that across multiple cancer types, responses (as evaluated by Response Evaluation Criteria in Solid Tumours, version 1.1) were observed in patients with tumours expressing high levels of PD-L1, especially when PD-L1 was expressed by tumour-infiltrating immune cells. Furthermore, responses were associated with T-helper type 1 (T(H)1) gene expression, CTLA4 expression and the absence of fractalkine (CX3CL1) in baseline tumour specimens. Together, these data suggest that MPDL3280A is most effective in patients in which pre-existing immunity is suppressed by PD-L1, and is re-invigorated on antibody treatment.	[Herbst, Roy S.; Gettinger, Scott N.] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT 06520 USA; [Soria, Jean-Charles] Gustave Roussy South Paris Univ, F-94805 Villejuif, France; [Kowanetz, Marcin; Fine, Gregg D.; Rost, Sandra; Leabman, Maya; Xiao, Yuanyuan; Mokatrin, Ahmad; Koeppen, Hartmut; Hegde, Priti S.; Mellman, Ira; Chen, Daniel S.] Genentech Inc, San Francisco, CA 94080 USA; [Hamid, Omid] Angeles Clin & Res Inst, Los Angeles, CA 90025 USA; [Gordon, Michael S.] Pinnacle Oncol Hematol, Scottsdale, AZ 85258 USA; [Sosman, Jeffery A.; Horn, Leora] Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [McDermott, David F.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Powderly, John D.] Carolina BioOncol Inst, Huntersville, NC 28078 USA; [Kohrt, Holbrook E. K.] Stanford Univ, Stanford, CA 94305 USA; [Lawrence, Donald P.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hodi, F. Stephen] Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02215 USA	Yale University; Roche Holding; Genentech; Angeles Clinic & Research Institute; Vanderbilt University; Harvard University; Beth Israel Deaconess Medical Center; Stanford University; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute	Herbst, RS (corresponding author), Yale Univ, Sch Med, Yale Comprehens Canc Ctr, 333 Cedar St,WWW221, New Haven, CT 06520 USA.	roy.herbst@yale.edu	Chen, Daniel Shin-Yu/AGD-8923-2022; Mellman, Ira/ABG-5896-2020; Soria, Jean-Charles/F-3619-2014	Chen, Daniel Shin-Yu/0000-0001-5085-3579; 	NCI [1R01CA155196, P30 CA 016359]; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA155196] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the patients and their families. We also thank all of the investigators and their staff, including A. Balmanoukian and P. Boasberg from The Angeles Clinic and Research Institute; T. Powles from Barts Cancer Institute, QMUL, Barts Health NHS Trust; D. Cho from NYU Langone Medical Center; P. Cassier from Centre Leon-Berard; F. Braiteh from USON Research Network, Comprehensive Cancer Centers of Nevada; N. Vogelzang from USON Research Network, Comprehensive Cancer Centers of Nevada and University of Nevada; T. Choueiri, L. Gandhi, N. Ibrahim and P. Ott from Dana-Farber Cancer Institute; J.-P. Delord and C. Gomez-Rocca from Institut Claudius Regaud; A. Hollebecque and R. Bahleda from Gustave Roussy; L. Emens from Johns Hopkins Medicine, The Sidney Kimmel Comprehensive Cancer Center; K. Flaherty and R. Sullivan from Massachusetts General Hospital; S. Antonia from Moffitt Cancer Center; H. Burris, J. Infante and D. Spigel from Sarah Cannon Research Institute; G. Fisher from Stanford Medicine, Cancer Institute; P. Conkling and L. Garbo from US Oncology Research, Inc.; C. Cruz and J. Tabenero from Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital; W. Pao and I. Puzanov from Vanderbilt-Ingram Cancer Center; P. Eder, H. Kluger and M. Sznol from Yale Cancer Center. From Genentech, we thank M. Anderson, M. Boe, Z. Boyd, C. Chappey, M. Denker, R. Desai, L. Fu, B. Irving, D. Jin, W. Kadel, R. Nakamura, I. Rhee, X. Shen, M. Stroh, T. Sumiyoshi, J. Wu,Y. Xin and J. Yi. Support for third-party writing assistance for this manuscript was provided by F. Hoffmann-La Roche Ltd. NCI grants 1R01CA155196 (Battle-2) and P30 CA 016359 (CCSG) to R.S.H. helped support the infrastructure for this trial and program.	Akbari O, 2010, MUCOSAL IMMUNOL, V3, P81, DOI 10.1038/mi.2009.112; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chen DK, 2012, ATMOS OCEAN, V50, P1, DOI 10.1080/07055900.2012.741787; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Isaacs JD, 1996, CLIN EXP IMMUNOL, V106, P427, DOI 10.1046/j.1365-2249.1996.d01-876.x; Matsumoto K, 2008, BIOCHEM BIOPH RES CO, V365, P170, DOI 10.1016/j.bbrc.2007.10.156; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Park HJ, 2012, CELL IMMUNOL, V278, P76, DOI 10.1016/j.cellimm.2012.07.001; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Powles T., 2014, NATURE; Schleifman EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088401; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Warncke M, 2012, J IMMUNOL, V188, P4405, DOI 10.4049/jimmunol.1200090; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Yang J, 2011, J IMMUNOL, V187, P1113, DOI 10.4049/jimmunol.1100056	31	3512	3706	23	546	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					563	+		10.1038/nature14011	http://dx.doi.org/10.1038/nature14011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428504	Green Accepted			2022-12-28	WOS:000346247600053
J	Raman, AP; Abou Anoma, M; Zhu, LX; Rephaeli, E; Fan, SH				Raman, Aaswath P.; Abou Anoma, Marc; Zhu, Linxiao; Rephaeli, Eden; Fan, Shanhui			Passive radiative cooling below ambient air temperature under direct sunlight	NATURE			English	Article								Cooling is a significant end-use of energy globally and a major driver of peak electricity demand. Air conditioning, for example, accounts for nearly fifteen per cent of the primary energy used by buildings in the United States(1). A passive cooling strategy that cools without any electricity input could therefore have a significant impact on global energy consumption. To achieve cooling one needs to be able to reach and maintain a temperature below that of the ambient air. At night, passive cooling below ambient air temperature has been demonstrated using a technique known as radiative cooling, in which a device exposed to the sky is used to radiate heat to outer space through a transparency window in the atmosphere between 8 and 13 micrometres(2-11). Peak cooling demand, however, occurs during the daytime. Daytime radiative cooling to a temperature below ambient of a surface under direct sunlight has not been achieved(3,4,12,13) because sky access during the day results in heating of the radiative cooler by the Sun. Here, we experimentally demonstrate radiative cooling to nearly 5 degrees Celsius below the ambient air temperature under direct sunlight. Using a thermal photonic approach(14-25), we introduce an integrated photonic solar reflector and thermal emitter consisting of seven layers of HfO2 and SiO2 that reflects 97 per cent of incident sunlight while emitting strongly and selectively in the atmospheric transparency window. When exposed to direct sunlight exceeding 850 watts per square metre on a rooftop, the photonic radiative cooler cools to 4.9 degrees Celsius below ambient air temperature, and has a cooling power of 40.1 watts per square metre at ambient air temperature. These results demonstrate that a tailored, photonic approach can fundamentally enable new technological possibilities for energy efficiency. Further, the cold darkness of the Universe can be used as a renewable thermodynamic resource, even during the hottest hours of the day.	[Raman, Aaswath P.; Rephaeli, Eden; Fan, Shanhui] Stanford Univ, Dept Elect Engn, Ginzton Lab, Stanford, CA 94305 USA; [Abou Anoma, Marc] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Zhu, Linxiao] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA		Raman, AP; Fan, SH (corresponding author), Stanford Univ, Dept Elect Engn, Ginzton Lab, Stanford, CA 94305 USA.	aaswath@stanford.edu; shanhui@stanford.edu	Fan, Shanhui/B-4659-2012; Raman, Aaswath/AAE-8507-2019	Raman, Aaswath/0000-0003-0106-8341; Zhu, Linxiao/0000-0001-9465-597X	Advanced Research Projects Agency-Energy (ARPA-E), Department of Energy [DE-AR0000316]; National Science Foundation through the NNIN [ECS-9731293]; Stanford Nano Center (SNC)/Stanford Nanocharacterization Laboratory (SNL)	Advanced Research Projects Agency-Energy (ARPA-E), Department of Energy(United States Department of Energy (DOE)); National Science Foundation through the NNIN(National Science Foundation (NSF)); Stanford Nano Center (SNC)/Stanford Nanocharacterization Laboratory (SNL)	This work is supported by the Advanced Research Projects Agency-Energy (ARPA-E), Department of Energy (contract number DE-AR0000316). We acknowledge discussions with J. Eaton and K. Goodson. Part of this work was performed at the Stanford Nanofabrication Facility, which is supported by the National Science Foundation through the NNIN under grant number ECS-9731293, and the Stanford Nano Center (SNC)/Stanford Nanocharacterization Laboratory (SNL), part of the Stanford Nano Shared Facilities.	BARTOLI B, 1977, APPL ENERG, V3, P267, DOI 10.1016/0306-2619(77)90015-0; Bazilian M, 2013, RENEW ENERG, V53, P329, DOI 10.1016/j.renene.2012.11.029; BERDAHL P, 1984, APPL OPTICS, V23, P370, DOI 10.1364/AO.23.000370; BERDAHL P, 1983, INT J HEAT MASS TRAN, V26, P871, DOI 10.1016/S0017-9310(83)80111-2; Berk A, 2006, PROC SPIE, V6233, DOI 10.1117/12.665077; Bright TJ, 2012, THIN SOLID FILMS, V520, P6793, DOI 10.1016/j.tsf.2012.07.037; Campbell Matthew, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy, P4409; CATALANOTTI S, 1975, SOL ENERGY, V17, P83, DOI 10.1016/0038-092X(75)90062-6; Crawley DB, 2000, ASHRAE J, V42, P49; De Zoysa M, 2012, NAT PHOTONICS, V6, P535, DOI 10.1038/nphoton.2012.146; Deru M, 2011, NRELTP550046861, DOI [NREL/TP-5500-46861, DOI 10.2172/1009264]; Drevillon J, 2007, J APPL PHYS, V102, DOI 10.1063/1.2816244; Gentle AR, 2011, SOL ENERG MAT SOL C, V95, P3207, DOI 10.1016/j.solmat.2011.07.018; Gentle AR, 2010, NANO LETT, V10, P373, DOI 10.1021/nl903271d; GRANQVIST CG, 1981, J APPL PHYS, V52, P4205, DOI 10.1063/1.329270; GRANQVIST CG, 1980, APPL PHYS LETT, V36, P139, DOI 10.1063/1.91406; Greffet JJ, 2002, NATURE, V416, P61, DOI 10.1038/416061a; Isaac M, 2009, ENERG POLICY, V37, P507, DOI 10.1016/j.enpol.2008.09.051; Jacob Z, 2010, APPL PHYS B-LASERS O, V100, P215, DOI 10.1007/s00340-010-4096-5; Kelso J. K., 2011, BUILD EN DAT BOOK; Keshner M. S., 2004, NRELSR52036846; Lee BJ, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2010613; Lenert A, 2014, NAT NANOTECHNOL, V9, P126, DOI [10.1038/nnano.2013.286, 10.1038/NNANO.2013.286]; Lin SY, 2000, PHYS REV B, V62, pR2243, DOI 10.1103/PhysRevB.62.R2243; Luo CY, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.213905; Marion W., 1995, USERS MANUAL TMY2S; MARTIN M, 1984, SOL ENERGY, V33, P321, DOI 10.1016/0038-092X(84)90162-2; Narayanaswamy A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.125101; NILSSON TMJ, 1995, SOL ENERG MAT SOL C, V37, P93, DOI 10.1016/0927-0248(94)00200-2; NILSSON TMJ, 1992, SOL ENERG MAT SOL C, V28, P175, DOI 10.1016/0927-0248(92)90010-M; OREL B, 1993, SOL ENERGY, V50, P477, DOI 10.1016/0038-092X(93)90108-Z; Palik E. D., 1985, HDB OPTICAL CONSTANT, DOI 10.1016/C2009-0-20920-2; Rephaeli E, 2013, NANO LETT, V13, P1457, DOI 10.1021/nl4004283; Rephaeli E, 2009, OPT EXPRESS, V17, P15145, DOI 10.1364/OE.17.015145; Schuller JA, 2009, NAT PHOTONICS, V3, P658, DOI 10.1038/NPHOTON.2009.188; Tikhonravov AV, 1996, APPL OPTICS, V35, P5493, DOI 10.1364/AO.35.005493; TROMBE F, 1967, REV GEN THERM, V6, P1285; Wu CH, 2012, J OPTICS-UK, V14, DOI 10.1088/2040-8978/14/2/024005	38	1283	1311	130	919	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					540	+		10.1038/nature13883	http://dx.doi.org/10.1038/nature13883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VL6BY	25428501				2022-12-28	WOS:000892096100001
J	Anderson, KA; Green, MF; Huynh, FK; Wagner, GR; Hirschey, MD				Anderson, Kristin A.; Green, Michelle F.; Huynh, Frank K.; Wagner, Gregory R.; Hirschey, Matthew D.			SnapShot: Mammalian Sirtuins	CELL			English	Editorial Material							PROTEIN; SIRT6		[Anderson, Kristin A.; Green, Michelle F.; Huynh, Frank K.; Wagner, Gregory R.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Anderson, Kristin A.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Anderson, KA (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA.		Huynh, Frank/AAK-9575-2020	Huynh, Frank/0000-0002-4764-9558; Green, Michelle/0000-0002-6055-4342; Hirschey, Matthew/0000-0003-4541-5376	NCI NIH HHS [T32 CA059365] Funding Source: Medline; NIAAA NIH HHS [R01 AA022146, R01AA022146] Funding Source: Medline; NIA NIH HHS [P30 AG028716, R01 AG045351, R01AG04535, P30AG028716-01] Funding Source: Medline; NIDDK NIH HHS [T32 DK007012] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045351, P30AG028716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022146] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gertler AA, 2013, BIOGERONTOLOGY, V14, P629, DOI 10.1007/s10522-013-9478-8; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Ryu D., 2014, CELL METAB; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Zhu YM, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-15	10	56	56	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4								10.1016/j.cell.2014.10.045	http://dx.doi.org/10.1016/j.cell.2014.10.045			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417168	Green Accepted, Bronze			2022-12-28	WOS:000344522000025
J	Bachtrog, D				Bachtrog, Doris			Signs of Genomic Battles in Mouse Sex Chromosomes	CELL			English	Editorial Material								Y chromosomes are challenged by a lack of recombination and are transmitted to the next generation only via males. Sequencing of the mouse Y reveals how these properties drive opposing evolutionary processes: massive decay of ancestral genes and convergent acquisition and amplification of spermatid-expressed gene families on the X and Y chromosome. The convergent acquisition and amplification of X-linked paralogs on the Y maintains a surprisingly gene-rich, euchromatic mammalian male chromosome.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bachtrog, D (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	dbachtrog@berkeley.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093182, R01GM076007] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM093182, R01 GM076007] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bellott DW, 2009, COLD SH Q B, V74, P345, DOI 10.1101/sqb.2009.74.048; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Cocquet J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002900; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; Ellis PJI, 2011, HUM MOL GENET, V20, P3010, DOI 10.1093/hmg/ddr204; Good JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001148; Meiklejohn CD, 2010, TRENDS ECOL EVOL, V25, P215, DOI 10.1016/j.tree.2009.10.005; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Soh YQS, 2014, CELL, V159, P800, DOI 10.1016/j.cell.2014.09.052	10	8	8	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					715	717		10.1016/j.cell.2014.10.036	http://dx.doi.org/10.1016/j.cell.2014.10.036			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417148	Bronze, Green Accepted			2022-12-28	WOS:000344522000004
J	Klepfish, A; Vaknine, H; Schattner, A				Klepfish, Abraham; Vaknine, Hananya; Schattner, Ami			Never say never: unexpected herpes lymphadenitis	LANCET			English	Editorial Material							INFECTIONS; RITUXIMAB		[Klepfish, Abraham] Wolfson Med Ctr, Blood Bank, Holon, Israel; [Klepfish, Abraham] Wolfson Med Ctr, Inst Hematol, Holon, Israel; [Vaknine, Hananya] Wolfson Med Ctr, Dept Pathol, Holon, Israel; Tel Aviv Univ, Sackler Fac Med, Holon, Israel; [Schattner, Ami] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem	Klepfish, A (corresponding author), Wolfson Med Ctr, Blood Bank, Holon, Israel.	klepfish@zahav.net.il	Schattner, Ami/ABI-1894-2020	Schattner, Ami/0000-0002-1413-8858				Aksoy S, 2007, LEUKEMIA LYMPHOMA, V48, P1307, DOI 10.1080/10428190701411441; AUDOUIN J, 1985, VIRCHOWS ARCH A, V408, P313, DOI 10.1007/BF00707994; Bowen DA, 2014, LEUKEMIA LYMPHOMA, V25, P1; Higgins JPT, 1999, CANCER-AM CANCER SOC, V86, P1210; Lanini S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-317	5	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1640	1640		10.1016/S0140-6736(14)61466-5	http://dx.doi.org/10.1016/S0140-6736(14)61466-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9NK	25443491				2022-12-28	WOS:000343901700031
J	Aplin, LM; Farine, DR; Morand-Ferron, J; Cockburn, A; Thornton, A; Sheldon, BC				Aplin, Lucy M.; Farine, Damien R.; Morand-Ferron, Julie; Cockburn, Andrew; Thornton, Alex; Sheldon, Ben C.			Experimentally induced innovations lead to persistent culture via conformity in wild birds	NATURE			English	Article							TRANSMISSION; CHIMPANZEES; DYNAMICS	In human societies, cultural norms arise when behaviours are transmitted through social networks via high-fidelity social learning'. However, a paucity of experimental studies has meant that there is no comparable understanding of the process by which socially transmitted behaviours might spread and persist in animal populations'''. Here we show experimental evidence of the establishment of foraging traditions in a wild bird population. We introduced alternative novel foraging techniques into replicated wild sub-populations of great tits (Parus major) and used automated tracking to map the diffusion, establishment and long-term persistence of the seeded innovations. Furthermore, we used social network analysis to examine the social factors that influenced diffusion dynamics. From only two trained birds in each sub-population, the information spread rapidly through social network ties, to reach an average of 75% of individuals, with a total of 414 knowledgeable individuals performing 57,909 solutions over all replicates. The sub-populations were heavily biased towards using the technique that was originally introduced, resulting in established local traditions that were stable over two generations, despite a high population turnover. Finally, we demonstrate a strong effect of social conformity, with individuals disproportionately adopting the most frequent local variant when first acquiring an innovation, and continuing to favour social information over personal information. Cultural conformity is thought to be a key factor in the evolution of complex culture in humans''. In providing the first experimental demonstration of conformity in a wild non-primate, and of cultural norms in foraging techniques in any wild animal, our results suggest a much broader taxonomic occurrence of such an apparently complex cultural behaviour.	[Aplin, Lucy M.; Farine, Damien R.; Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Aplin, Lucy M.; Cockburn, Andrew] Australian Natl Univ, Res Sch Biol, Dept Evolut Ecol & Genet, Canberra, ACT 2600, Australia; [Farine, Damien R.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Farine, Damien R.] Smithsonian Trop Res Inst, Ancon 9100, Panama; [Morand-Ferron, Julie] Univ Ottawa, Dept Biol, Ottawa, ON K1N 9B2, Canada; [Thornton, Alex] Univ Exeter, Ctr Ecol & Conservat, Dept Biosci, Penryn TR10 9EZ, England; [Sheldon, Ben C.] Uppsala Univ, Dept Ecol & Genet, S-75236 Uppsala, Sweden	University of Oxford; Australian National University; University of California System; University of California Davis; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Ottawa; University of Exeter; Uppsala University	Aplin, LM (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England.	lucy.aplin@zoo.ox.ac.uk	Sheldon, Ben C/A-8056-2010; Cockburn, Andrew/A-4864-2008; Morand-Ferron, Julie/AAW-7022-2021; Farine, Damien R./Y-2454-2019	Sheldon, Ben C/0000-0002-5240-7828; Morand-Ferron, Julie/0000-0001-5186-7710; Farine, Damien R./0000-0003-2208-7613; Thornton, Alex/0000-0002-1607-2047	BBSRC [BB/L006081/1, BB/H021817/1]; ERC [AdG 250164]; Australian Postgraduate Award; BBSRC [BB/H021817/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H021817/2, BB/L006081/1, BB/H021817/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Australian Postgraduate Award(Australian Government); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was supported by grants from the BBSRC (BB/L006081/1) and the ERC (AdG 250164) to B.C.S., who was also supported by a visiting professorship at Uppsala University. L.M.A. was also supported by an Australian Postgraduate Award; and AT., by a BBSRC David Phillips Fellowship (BB/H021817/1). The EGI social networks group, S. Lang and K. McMahon provided assistance in the field, and M. Whitaker produced electronic components for the puzzle boxes.	Allen J, 2013, SCIENCE, V340, P485, DOI 10.1126/science.1231976; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; Aplin LM, 2013, ANIM BEHAV, V85, P1225, DOI 10.1016/j.anbehav.2013.03.009; Bouwhuis S, 2012, AM NAT, V179, pE15, DOI 10.1086/663194; Cantor M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0340; Claidiere N, 2013, CURR BIOL, V23, P1251, DOI 10.1016/j.cub.2013.05.036; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; de Waal FBM, 2013, SCIENCE, V340, P437, DOI 10.1126/science.1237521; Dean LG, 2012, SCIENCE, V335, P1114, DOI 10.1126/science.1213969; FISHER J., 1949, BRITISH BIRDS, V42, P347; Galef B. G., 2012, OXFORD HDB COMP COGN, P803; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Haun DBM, 2012, CURR BIOL, V22, P727, DOI 10.1016/j.cub.2012.03.006; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 2004, LEARN BEHAV, V32, P4; Morand-Ferron J, 2011, BEHAV ECOL, V22, P1241, DOI 10.1093/beheco/arr120; Morgan TJH, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00087; Psorakis I, 2012, J R SOC INTERFACE, V9, P3055, DOI 10.1098/rsif.2012.0223; Rendell L, 2011, TRENDS COGN SCI, V15, P68, DOI 10.1016/j.tics.2010.12.002; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; SHERRY DF, 1984, ANIM BEHAV, V32, P937, DOI 10.1016/S0003-3472(84)80185-2; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Thornton A, 2009, P ROY SOC B-BIOL SCI, V276, P1269, DOI 10.1098/rspb.2008.1794; van de Waal E, 2013, SCIENCE, V340, P483, DOI 10.1126/science.1232769; van Leeuwen EJC, 2013, EVOL HUM BEHAV, V34, P1, DOI 10.1016/j.evolhumbehav.2012.07.005; van Schaik CP, 2012, CURR BIOL, V22, pR402, DOI 10.1016/j.cub.2012.04.001; WARNER RR, 1988, NATURE, V335, P719, DOI 10.1038/335719a0; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Whiten A, 2011, PHILOS T R SOC B, V366, P938, DOI 10.1098/rstb.2010.0372	30	394	402	7	348	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 26	2015	518	7540					538	541		10.1038/nature13998	http://dx.doi.org/10.1038/nature13998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC1JP	25470065	Green Accepted, Green Submitted			2022-12-28	WOS:000350097300047
J	Oppegaard, KS; Qvigstad, E; Fiala, C; Heikinheimo, O; Benson, L; Gemzell-Danielsson, K				Oppegaard, Kevin Sunde; Qvigstad, Erik; Fiala, Christian; Heikinheimo, Oskari; Benson, Lina; Gemzell-Danielsson, Kristina			Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial	LANCET			English	Article							CHORIONIC-GONADOTROPIN; SURGICAL INTERVENTION; PREGNANCY TEST; MIFEPRISTONE; ACCEPTABILITY; ALTERNATIVES; ULTRASOUND; GESTATION; HCG	Background Medical abortion with mifepristone and prostaglandins is well established. We compared clinical assessment with self-assessment of abortion outcome. Methods This randomised, controlled, non-inferiority trial was done in four clinics in Austria, Finland, Norway, and Sweden, between Aug 16, 2011, and Jan 31, 2013. Women aged 18 years and older who had requested medical termination of a pregnancy up to 63 days of gestation were eligible. Computer-generated block randomisation (block size ten) assigned women in a 1: 1 ratio to attend routine clinical follow-up or to self-assess outcome at home with a semiquantitative urine human chorionic gonadotropin (hCG) test 1-3 weeks after abortion. The primary outcome was the percentage of women with complete abortion not requiring further medical or surgical intervention within 3 months. Analysis was per protocol and by intention to treat. The non-inferiority margin was five percentage points. This trial is registered with ClinicalTrials.gov, number NCT01487213. Findings 924 women were assigned routine follow-up (n=466) or self-assessment (n=458) and included in the intention-to-treat analysis. 901 were included in the per-protocol analysis (n=446 and n=455, respectively). Complete abortion was reported in 432 (95%) of 455 in the routine follow-up group and 419 (94%) of 446 women in the self-assessment group (crude difference -1.0, 95% CI -4.0 to 2.0). 20 (4%) women in the routine follow-up group and 17 (4%) in the self-assessment group required surgery. No women in the routine follow-up group versus three in the self-assessment group had undetected continuing pregnancies. Eight (1.8%) and one (0.2%) women, respectively, had infections (p=0.038). Interpretation Self-assessment was non-inferior to routine follow-up and could save resources.	[Oppegaard, Kevin Sunde] Klin Hammerfest, Dept Gynaecol, N-9613 Hammerfest, Norway; [Qvigstad, Erik] Univ Oslo, Fac Med, Oslo, Norway; [Qvigstad, Erik] Ullevaal Univ Hosp, Dept Gynaecol, Women & Childrens Div, Oslo, Norway; [Fiala, Christian] GynMed Clin, Vienna, Austria; [Heikinheimo, Oskari] Univ Helsinki, Dept Obstet & Gynaecol, Helsinki, Finland; [Heikinheimo, Oskari] Univ Cent Hosp, Katiloopisto Hosp Helsinki, Helsinki, Finland; [Benson, Lina] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Fiala, Christian; Gemzell-Danielsson, Kristina] Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynaecol, Stockholm, Sweden; Karolinska Univ Hosp, Stockholm, Sweden	University of Oslo; University of Oslo; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Oppegaard, KS (corresponding author), Klin Hammerfest, Dept Gynaecol, Sykehusveien 35, N-9613 Hammerfest, Norway.	kevinsunde@hotmail.com	Heikinheimo, Oskari/ABC-7792-2020	Fiala, Christian/0000-0001-6451-7349; Heikinheimo, Oskari/0000-0002-8671-130X; Benson, Lina/0000-0002-5393-0055	Nordic Federation of Obstetrics and Gynaecology; European Society of Contraception; Helsinki University Central Hospital; Helse Finnmark; Swedish Research Council; Stockholm County Council; Karolinska University Hospital	Nordic Federation of Obstetrics and Gynaecology; European Society of Contraception; Helsinki University Central Hospital; Helse Finnmark; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Karolinska University Hospital(Karolinska Institutet)	Nordic Federation of Obstetrics and Gynaecology, European Society of Contraception, Helsinki University Central Hospital, Helse Finnmark, Swedish Research Council, and Stockholm County Council and Karolinska University Hospital.	Blum J, 2012, CONTRACEPTION, V86, P757, DOI 10.1016/j.contraception.2012.06.005; Cameron ST, 2012, CONTRACEPTION, V86, P67, DOI 10.1016/j.contraception.2011.11.010; Clark W, 2010, OBSTET GYNECOL, V115, P264, DOI 10.1097/AOG.0b013e3181c996f3; Clark WH, 2007, CONTRACEPTION, V75, P245, DOI 10.1016/j.contraception.2006.11.011; Fiala C, 2003, EUR J OBSTET GYN R B, V109, P190, DOI 10.1016/S0301-2115(03)00012-5; Fiala C, 2006, CONTRACEPTION, V74, P66, DOI 10.1016/j.contraception.2006.03.018; Gomperts R, 2012, ACTA OBSTET GYN SCAN, V91, P226, DOI 10.1111/j.1600-0412.2011.01285.x; Grossman D, 2004, OBSTET GYNECOL, V103, P738, DOI 10.1097/01.AOG.0000115511.14004.19; Grossman D, 2011, CONTRACEPTION, V83, P504, DOI 10.1016/j.contraception.2010.08.023; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Kallner HK, 2010, HUM REPROD, V25, P1153, DOI 10.1093/humrep/deq037; KAUNITZ AM, 1985, OBSTET GYNECOL, V66, P533; Lokeland M, 2010, OBSTET GYNECOL, V115, P962, DOI 10.1097/AOG.0b013e3181da0c3e; Lynd K, 2013, INT J GYNECOL OBSTET, V121, P144, DOI 10.1016/j.ijgo.2012.11.022; Michie L, 2014, CONTRACEPTION, V89, P440, DOI 10.1016/j.contraception.2014.01.010; Ngoc NTN, 2014, OBSTET GYNECOL, V123, P88, DOI 10.1097/AOG.0000000000000050; Papaioannou GI, 2010, FETAL DIAGN THER, V28, P207, DOI 10.1159/000319589; Perriera LK, 2010, CONTRACEPTION, V81, P143, DOI 10.1016/j.contraception.2009.08.008; Reeves MF, 2009, ULTRASOUND OBST GYN, V34, P104, DOI 10.1002/uog.6404; Royal College of Obstetricians and Gynaecologists, CAR WOM REQ IND AB E; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; VANDERLUGT B, 1985, ACTA OBSTET GYN SCAN, V64, P547, DOI 10.3109/00016348509156360; von Hertzen H, 2010, BJOG-INT J OBSTET GY, V117, P1186, DOI 10.1111/j.1471-0528.2010.02636.x; Walker K, 2001, CONTRACEPTION, V64, P271, DOI 10.1016/S0010-7824(01)00266-9; WINIKOFF B, 1995, FAM PLANN PERSPECT, V27, P142, DOI 10.2307/2136257; World Health Organization, SAF AB TECHN POL GUI	26	43	45	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					698	704		10.1016/S0140-6736(14)61054-0	http://dx.doi.org/10.1016/S0140-6736(14)61054-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7ED	25468164				2022-12-28	WOS:000349788300026
J	Thomas, AJ; Ogilvy, CS				Thomas, Ajith J.; Ogilvy, Christopher S.			ISAT: equipoise in treatment of ruptured cerebral aneurysms?	LANCET			English	Editorial Material							INTRACRANIAL ANEURYSMS; ENDOVASCULAR COILING; TRIAL ISAT; METAANALYSIS; MANAGEMENT; OCCLUSION		[Thomas, Ajith J.; Ogilvy, Christopher S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Neurosurg Serv, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ogilvy, CS (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Neurosurg Serv, Boston, MA 02215 USA.	cogilvy@bidmc.harvard.edu	Thomas, Ajith/AAX-9054-2020	Thomas, Ajith/0000-0003-4412-3152				Alshafai N, 2013, WORLD NEUROSURG, V80, P717, DOI 10.1016/j.wneu.2013.01.092; Broderick J, 2009, LANCET NEUROL, V8, P414, DOI 10.1016/S1474-4422(09)70086-9; Ferns SP, 2009, STROKE, V40, pE523, DOI 10.1161/STROKEAHA.109.553099; Huang MC, 2011, STROKE, V42, P1730, DOI 10.1161/STROKEAHA.110.603803; Lanzino G, 2013, AM J NEURORADIOL, V34, P1764, DOI 10.3174/ajnr.A3515; Li H, 2013, STROKE, V44, P29, DOI 10.1161/STROKEAHA.112.663559; Lin N, 2012, J NEUROINTERV SURG, V4, P182, DOI 10.1136/jnis.2011.004978; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Molyneux AJ, 2014, LANCET; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Scott RB, 2010, STROKE, V41, P1743, DOI 10.1161/STROKEAHA.110.585240; Tait MJ, 2007, BRIT J NEUROSURG, V21, P3, DOI 10.1080/02688690601170726	13	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 21	2015	385	9969					666	668		10.1016/S0140-6736(14)61736-0	http://dx.doi.org/10.1016/S0140-6736(14)61736-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CB7ED	25465112				2022-12-28	WOS:000349788300005
J	Campos, M; Surovtsev, IV; Kato, S; Paintdakhi, A; Beltran, B; Ebmeier, SE; Jacobs-Wagner, C				Campos, Manuel; Surovtsev, Ivan V.; Kato, Setsu; Paintdakhi, Ahmad; Beltran, Bruno; Ebmeier, Sarah E.; Jacobs-Wagner, Christine			A Constant Size Extension Drives Bacterial Cell Size Homeostasis	CELL			English	Article							ESCHERICHIA-COLI K-12; CAULOBACTER-CRESCENTUS; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; CHROMOSOME-REPLICATION; DIVISION CYCLE; GROWTH; YEAST; DYNAMICS; VARIABILITY	Cell size control is an intrinsic feature of the cell cycle. In bacteria, cell growth and division are thought to be coupled through a cell size threshold. Here, we provide direct experimental evidence disproving the critical size paradigm. Instead, we show through single-cell microscopy and modeling that the evolutionarily distant bacteria Escherichia coli and Caulobacter crescentus achieve cell size homeostasis by growing, on average, the same amount between divisions, irrespective of cell length at birth. This simple mechanism provides a remarkably robust cell size control without the need of being precise, abating size deviations exponentially within a few generations. This size homeostasis mechanism is broadly applicable for symmetric and asymmetric divisions, as well as for different growth rates. Furthermore, our data suggest that constant size extension is implemented at or close to division. Altogether, our findings provide fundamentally distinct governing principles for cell size and cell-cycle control in bacteria.	[Campos, Manuel; Surovtsev, Ivan V.; Paintdakhi, Ahmad; Beltran, Bruno; Ebmeier, Sarah E.; Jacobs-Wagner, Christine] Yale Univ, Microbial Sci Inst, West Haven, CT 06516 USA; [Campos, Manuel; Surovtsev, Ivan V.; Paintdakhi, Ahmad; Beltran, Bruno; Jacobs-Wagner, Christine] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Kato, Setsu; Beltran, Bruno; Ebmeier, Sarah E.; Jacobs-Wagner, Christine] Yale Univ, Sch Med, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Jacobs-Wagner, Christine] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Jacobs-Wagner, C (corresponding author), Louisiana State Univ, Dept Math, Baton Rouge, LA 70803 USA.	christine.jacobs-wagner@yale.edu	Campos, Manuel/AAC-6129-2020; Kato, Setsu/AAC-1418-2019	Campos, Manuel/0000-0001-9751-4531; Jacobs-Wagner, Christine/0000-0003-0980-5334; Beltran, Bruno/0000-0003-2931-5412	National Institute of Health [R01 GM065835, 5 T32 GM 7223-39]; Astellas Foundation for Research on Metabolic Disorders; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, R01GM065835] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Astellas Foundation for Research on Metabolic Disorders; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Dr. Johan Elf for sharing the design of his microfluidic device, Matts Walden and Jason Hocking for help setting up the microfluidic system in our laboratory, and the Yale E. coli genetic stock center for the E. coli BW25113 derived strains. This work was, in part, supported by the National Institute of Health (R01 GM065835 to C.J.-W.). S.K. and S.E.E. were, in part, supported by the Astellas Foundation for Research on Metabolic Disorders and a predoctoral training grant of the National Institute of Health (5 T32 GM 7223-39), respectively. We are also grateful to the staffs of the Yale University Faculty of Arts and Sciences High Performance Computing Center for support and to the members of the Jacobs-Wagner laboratory for fruitful discussions and for critical reading of this manuscript. C.J.-W. is an investigator of the Howard Hughes Medical Institute.	ADLER HI, 1967, P NATL ACAD SCI USA, V57, P321, DOI 10.1073/pnas.57.2.321; Amir A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.208102; Boye E, 2003, EMBO REP, V4, P757, DOI 10.1038/sj.embor.embor895; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Cooper S., 1991, BACTERIAL GROWTH DIV, V1; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; EVINGER M, 1979, P NATL ACAD SCI USA, V76, P175, DOI 10.1073/pnas.76.1.175; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; FANTES PA, 1977, J CELL SCI, V24, P51; Fantes PA, 1981, CELL CYCLE, P11; Harris L.K., 2014, MOL MICROBIOL; Hosoda K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031118; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; JAFFE A, 1988, J BACTERIOL, V170, P3094, DOI 10.1128/jb.170.7.3094-3101.1988; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; KOCH AL, 1962, J GEN MICROBIOL, V29, P435, DOI 10.1099/00221287-29-3-435; KOPPES LJH, 1980, J BACTERIOL, V143, P1241, DOI 10.1128/JB.143.3.1241-1252.1980; LORD PG, 1981, J CELL SCI, V50, P361; McAdams HH, 2009, FEBS LETT, V583, P3984, DOI 10.1016/j.febslet.2009.09.030; Osella M, 2014, P NATL ACAD SCI USA, V111, P3431, DOI 10.1073/pnas.1313715111; Robert L, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-17; Santi I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3470; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; SCHAECHTER M, 1962, J GEN MICROBIOL, V29, P421, DOI 10.1099/00221287-29-3-421; Siegal-Gaskins D, 2008, BIOPHYS J, V95, P2063, DOI 10.1529/biophysj.108.128785; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Sveiczer A, 1996, J CELL SCI, V109, P2947; TERRANA B, 1975, DEV BIOL, V44, P380, DOI 10.1016/0012-1606(75)90409-1; Tsukanov R, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066003; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Ullman G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0025; Voorn WJ, 1998, ARCH MICROBIOL, V169, P43; Wakamoto Y, 2005, ANALYST, V130, P311, DOI 10.1039/b409860a; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; WOLD S, 1994, EMBO J, V13, P2097, DOI 10.1002/j.1460-2075.1994.tb06485.x; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671	38	244	246	1	97	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1433	1446		10.1016/j.cell.2014.11.022	http://dx.doi.org/10.1016/j.cell.2014.11.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480302	Green Accepted, Bronze			2022-12-28	WOS:000346652900020
J	Cassel, CK; Conway, PH; Delbanco, SF; Jha, AK; Saunders, RS; Lee, TH				Cassel, Christine K.; Conway, Patrick H.; Delbanco, Suzanne F.; Jha, Ashish K.; Saunders, Robert S.; Lee, Thomas H.			Getting More Performance from Performance Measurement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Conway, Patrick H.] Ctr Medicare Serv, Baltimore, MD USA; [Conway, Patrick H.] Ctr Medicaid Serv, Baltimore, MD USA; [Delbanco, Suzanne F.] Catalyst Payment Reform, San Francisco, CA USA; [Jha, Ashish K.; Saunders, Robert S.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Lee, Thomas H.] Press Ganey, Boston, MA USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Harvard University; Harvard T.H. Chan School of Public Health			Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				Bazinsky K., 2013, SIGNIFICANT LACK ALI; Department of Health and Human Services, 2014, NEW HHS DAT SHOWS MA; Higgins A, 2013, HEALTH AFFAIR, V32, P1453, DOI 10.1377/hlthaff.2013.0007; Leapfrog Group, HOSP RAT EARL SCHED; Meyer GS, 2012, BMJ QUAL SAF, V21, P964, DOI 10.1136/bmjqs-2012-001081	5	70	71	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2145	2147		10.1056/NEJMp1408345	http://dx.doi.org/10.1056/NEJMp1408345			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW0IY	25470691				2022-12-28	WOS:000345976700001
J	Freeman, KH				Freeman, Katherine H.			EARTH SCIENCE Controls on isotopic gradients in rain	NATURE			English	Editorial Material							HYDROGEN ISOTOPES; OXYGEN; WATER; PRECIPITATION; TEMPERATURE; HIMALAYA		Penn State Univ, Dept Geosci, University Pk, PA 16803 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Freeman, KH (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16803 USA.	khf4@psu.edu	Freeman, Katherine H/H-5140-2011	Freeman, Katherine H/0000-0002-3350-7671				DANSGAARD W, 1964, TELLUS, V16, P436; ERIKSSON E, 1965, TELLUS, V18, P498; Fricke HC, 2004, AM J SCI, V304, P612, DOI 10.2475/ajs.304.7.612; Garzione CN, 2000, EARTH PLANET SC LETT, V183, P215, DOI 10.1016/S0012-821X(00)00252-1; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; GAT JR, 1991, J GEOPHYS RES-ATMOS, V96, P13179, DOI 10.1029/91JD00054; HORITA J, 1994, GEOCHIM COSMOCHIM AC, V58, P3425, DOI 10.1016/0016-7037(94)90096-5; INGRAHAM NL, 1991, WATER RESOUR RES, V27, P77, DOI 10.1029/90WR01708; Polissar PJ, 2009, EARTH PLANET SC LETT, V287, P64, DOI 10.1016/j.epsl.2009.07.037; Rowley DB, 2001, EARTH PLANET SC LETT, V188, P253, DOI 10.1016/S0012-821X(01)00324-7; Rozanski K., 1993, GEOPHYS MONOGR SER, V78, P1, DOI DOI 10.1029/GM078P0001; Winnick MJ, 2014, EARTH PLANET SC LETT, V406, P123, DOI 10.1016/j.epsl.2014.09.005	12	0	0	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					41	42		10.1038/516041a	http://dx.doi.org/10.1038/516041a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471876				2022-12-28	WOS:000346310800029
J	Schwartz, M				Schwartz, Myron			PERSPECTIVE: Incision revision	NATURE			English	Editorial Material									Mt Sinai Med Ctr, Miller Transplantat Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Schwartz, M (corresponding author), Mt Sinai Med Ctr, Miller Transplantat Inst, New York, NY 10029 USA.								0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S17	S17		10.1038/516S17a	http://dx.doi.org/10.1038/516S17a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470196	hybrid			2022-12-28	WOS:000346310800006
J	Stelzer, EHK				Stelzer, Ernst H. K.			Better Imaging through Chemistry	CELL			English	Editorial Material							STRUCTURED-ILLUMINATION MICROSCOPY; RESOLUTION LIMIT; SINGLE MOLECULES; EXCITATION; RECONSTRUCTION; IMPROVEMENT		[Stelzer, Ernst H. K.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, D-60438 Frankfurt, Germany; [Stelzer, Ernst H. K.] Goethe Univ Frankfurt, Cluster Excellence CEF MC, D-60438 Frankfurt, Germany; [Stelzer, Ernst H. K.] Goethe Univ Frankfurt, Fachbereich 15, Inst Zellbiol & Neurowissensch, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Stelzer, EHK (corresponding author), Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci BMLS, D-60438 Frankfurt, Germany.	ernst.stelzer@physikalischebiologie.de	Stelzer, Ernst H K/A-7648-2011	Stelzer, Ernst H K/0000-0003-1545-0736				Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/bf02956173, DOI 10.1007/BF02956173, 10.1007/ BF02956173]; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; Betzig E, 2005, OPT EXPRESS, V13, P3021, DOI 10.1364/OPEX.13.003021; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BINNIG G, 1982, APPL PHYS LETT, V40, P178, DOI 10.1063/1.92999; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Ehmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5650; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Heintzmann R, 2002, J OPT SOC AM A, V19, P1599, DOI 10.1364/JOSAA.19.001599; HELL S, 1992, OPT COMMUN, V93, P277, DOI 10.1016/0030-4018(92)90185-T; HELL SW, 1994, APPL PHYS LETT, V64, P1335, DOI 10.1063/1.111926; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HIRSCHFELD T, 1976, APPL OPTICS, V15, P2965, DOI 10.1364/AO.15.002965; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; MOERNER WE, 1989, PHYS REV LETT, V62, P2535, DOI 10.1103/PhysRevLett.62.2535; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; STELZER EHK, 1994, OPT COMMUN, V111, P536, DOI 10.1016/0030-4018(94)90533-9; Vainrub A, 2006, OPT LETT, V31, P2855, DOI 10.1364/OL.31.002855; Zanacchi FC, 2011, NAT METHODS, V8, P1047, DOI [10.1038/NMETH.1744, 10.1038/nmeth.1744]	25	6	6	0	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1243	1246		10.1016/j.cell.2014.11.032	http://dx.doi.org/10.1016/j.cell.2014.11.032			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480287	Bronze			2022-12-28	WOS:000346652900002
J	Yilmaz, B; Portugal, S; Tran, TM; Gozzelino, R; Ramos, S; Gomes, J; Regalado, A; Cowan, PJ; d'Apice, AJF; Chong, AS; Doumbo, OK; Traore, B; Crompton, PD; Silveira, H; Soares, MP				Yilmaz, Bahtiyar; Portugal, Silvia; Tran, Tuan M.; Gozzelino, Raffaella; Ramos, Susana; Gomes, Joana; Regalado, Ana; Cowan, Peter J.; d'Apice, Anthony J. F.; Chong, Anita S.; Doumbo, Ogobara K.; Traore, Boubacar; Crompton, Peter D.; Silveira, Henrique; Soares, Miguel P.			Gut Microbiota Elicits a Protective Immune Response against Malaria Transmission	CELL			English	Article							ALPHA-GALACTOSYL IGG; ANTI-GAL ANTIBODIES; HYPERACUTE REJECTION; HUMAN SERUM; CELLS; CARBOHYDRATE; ALPHA-1,3-GALACTOSYLTRANSFERASE; PATHOGENESIS; INACTIVATION; TRYPANOSOMA	Glycosylation processes are under high natural selection pressure, presumably because these can modulate resistance to infection. Here, we asked whether inactivation of the UDP-galactose: beta-galac-toside- alpha-1-3-galactosyltransferase (alpha 1,3GT) gene, which ablated the expression of the Gal alpha 1-3Gal beta 1-4GlcNAc- R(alpha-gal) glycan and allowed for the production of anti-alpha-gal antibodies (Abs) in humans, confers protection against Plasmodium spp. infection, the causative agent of malaria and a major driving force in human evolution. We demonstrate that both Plasmodium spp. and the human gut pathobiont E. coli O86: B7 express alpha-gal and that anti-alpha-gal Abs are associated with protection against malaria transmission in humans as well as in alpha 1,3GT-deficient mice, which produce protective anti-alpha-gal Abs when colonized by E. coli O86:B7. Anti-alpha-gal Abs target Plasmodium sporozoites for complement-mediated cytotoxicity in the skin, immediately after inoculation by Anopheles mosquitoes. Vaccination against a-gal confers sterile protection against malaria in mice, suggesting that a similar approach may reduce malaria transmission in humans.	[Yilmaz, Bahtiyar; Gozzelino, Raffaella; Ramos, Susana; Gomes, Joana; Regalado, Ana; Soares, Miguel P.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Portugal, Silvia; Tran, Tuan M.; Crompton, Peter D.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Gomes, Joana; Silveira, Henrique] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Trop, Inst Higiene & Med Trop, P-1349008 Lisbon, Portugal; [Cowan, Peter J.; d'Apice, Anthony J. F.] St Vincents Hosp, Immunol Res Ctr, Melbourne, Vic 3065, Australia; [Cowan, Peter J.; d'Apice, Anthony J. F.] Univ Melbourne, Dept Med, Parkville, Vic 2900, Australia; [Chong, Anita S.] Univ Chicago, Sect Transplantat, Dept Surg, Chicago, IL 60637 USA; [Doumbo, Ogobara K.; Traore, Boubacar] Univ Sci Tech & Technol Bamako, Mali Int Ctr Excellence Res, Bamako 1805, Mali	Instituto Gulbenkian de Ciencia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; St Vincent's Hospital Melbourne; University of Melbourne; University of Chicago; University of Science & Technology of Bamako	Soares, MP (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	mpsoares@igc.gulbenkian.pt	Tran, Tuan M./H-9439-2019; Yilmaz, Bahtiyar/U-6646-2019; Silveira, Henrique/AAB-4948-2022; Gozzelino, Raffaella/AAS-8598-2021; Cowan, Peter/AAH-7218-2020; Silveira, Henrique/G-2229-2011; Ramos, Susana/M-2064-2014; Gozzelino, Raffaella/E-8147-2017; Crompton, Peter/N-1130-2016; Regalado, Ana/K-7809-2014	Tran, Tuan M./0000-0002-1928-861X; Silveira, Henrique/0000-0002-7939-772X; Silveira, Henrique/0000-0002-7939-772X; Ramos, Susana/0000-0001-6356-1065; Gozzelino, Raffaella/0000-0002-1195-8527; Portugal, Silvia/0000-0003-4567-9101; Regalado, Ana/0000-0002-6378-7125; Soares, Miguel/0000-0002-9314-4833; Yilmaz, Bahtiyar/0000-0003-1888-9226	Bill and Melinda Gates Foundation [OPP1024563]; Fundacao para a Ciencia e Tecnologia [RECI-IMI-IMU-0038-2012]; European Research Council [ERC-2011-AdG 294709-DAMAGECONTROL]; Fundacao para a Ciencia e a Tecnologia within the PhDProgram of Integrative Biomedical Science of the Instituto Gulbenkian de Ciencia [SFRH/BD/51176/2010]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; NIH; EMMA; EU; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001155] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Fundacao para a Ciencia e a Tecnologia within the PhDProgram of Integrative Biomedical Science of the Instituto Gulbenkian de Ciencia; Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMMA; EU(European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Inflammation Group (IGC) for insightful discussions and review of the manuscript, Sofia Rebelo and Silvia Cardoso for mouse breeding and genotyping, Pedro Almada and Nuno Pimpao Martins (IGC Imaging Facility) for technical support, Karen Berman de Ruiz and Joana Bom (IGC Animal Facility) for germ-free breeding, Joana Tavares, Rogerio Amino, and Robert Menard (Institute Pasteur) for technical support, Alekos Athanasiadis and Jocelyne Demengeot for insightful discussions, Pascal Gagneaux (University of California San Diego), and Daniel Mucida (Rockefeller University) for critical review of the initial version of the manuscript. Financial support from the Bill and Melinda Gates Foundation (OPP1024563), Fundacao para a Ciencia e Tecnologia (RECI-IMI-IMU-0038-2012), and European Research Council (ERC-2011-AdG 294709-DAMAGECONTROL) (to M.P.S.) and Fundacao para a Ciencia e a Tecnologia (SFRH/BD/51176/2010) within the PhDProgram of Integrative Biomedical Science of the Instituto Gulbenkian de Ciencia (to B.Y.) is gratefully acknowledged. The Division of Intramural Research, National Institute of Allergy and Infectious Diseases, and NIH supported the Mali cohort study. Mouse axenization was supported by the EMMA, EU FP7 Capacities Specific Program.	AVILA JL, 1989, J IMMUNOL, V142, P2828; AVILA JL, 1992, AM J TROP MED HYG, V47, P413, DOI 10.4269/ajtmh.1992.47.413; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Benatuil L, 2005, EUR J IMMUNOL, V35, P2638, DOI 10.1002/eji.200526146; Bishop JR, 2007, GLYCOBIOLOGY, V17, p23R, DOI 10.1093/glycob/cwm005; Chen L, 2000, CLIN EXP IMMUNOL, V120, P125, DOI 10.1046/j.1365-2249.2000.01196.x; Chiang TR, 2000, TRANSPLANTATION, V69, P2593, DOI 10.1097/00007890-200006270-00020; Cretin N, 2002, J IMMUNOL, V168, P1479, DOI 10.4049/jimmunol.168.3.1479; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; Ding JW, 2008, J IMMUNOL, V180, P261, DOI 10.4049/jimmunol.180.1.261; Doenz U, 2000, J HEART LUNG TRANSPL, V19, P1108, DOI 10.1016/S1053-2498(00)00196-0; DOLOWY WC, 1964, P SOC EXP BIOL MED, V116, P365, DOI 10.3181/00379727-116-29249; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Galili U, 1998, TRANSPLANTATION, V65, P1129, DOI 10.1097/00007890-199804270-00020; GALILI U, 1991, P NATL ACAD SCI USA, V88, P7401, DOI 10.1073/pnas.88.16.7401; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; GALILI U, 1985, J EXP MED, V162, P573, DOI 10.1084/jem.162.2.573; GALILI U, 1988, INFECT IMMUN, V56, P1730, DOI 10.1128/IAI.56.7.1730-1737.1988; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Hegge S, 2010, FASEB J, V24, P5003, DOI 10.1096/fj.10-164814; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Huflejt ME, 2009, MOL IMMUNOL, V46, P3037, DOI 10.1016/j.molimm.2009.06.010; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Kimmel J, 2003, BIOCHIMIE, V85, P473, DOI 10.1016/S0300-9084(03)00019-1; LACROIXDESMAZES S, 1995, EUR J IMMUNOL, V25, P2598, DOI 10.1002/eji.1830250929; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Manez R, 2001, XENOTRANSPLANTATION, V8, P15, DOI 10.1034/j.1399-3089.2001.00082.x; Menard R, 2013, NAT REV MICROBIOL, V11, P701, DOI 10.1038/nrmicro3111; Miyatake T, 1998, J IMMUNOL, V160, P4114; Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MORAN P, 1994, J CELL BIOL, V125, P333, DOI 10.1083/jcb.125.2.333; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagele EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060726; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Oyelaran O, 2009, J PROTEOME RES, V8, P4301, DOI 10.1021/pr900515y; PAL SC, 1969, B WORLD HEALTH ORGAN, V41, P851; Parker W, 1999, GLYCOBIOLOGY, V9, P865, DOI 10.1093/glycob/9.9.865; Porcherie A, 2011, J EXP MED, V208, P2225, DOI 10.1084/jem.20110845; Posekany KJ, 2002, INFECT IMMUN, V70, P6215, DOI 10.1128/IAI.70.11.6215-6222.2002; RICKMAN LS, 1990, AM J TROP MED HYG, V43, P441, DOI 10.4269/ajtmh.1990.43.441; Ringel-Kulka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064315; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; SPRINGER GF, 1969, J CLIN INVEST, V48, P1280, DOI 10.1172/JCI106094; SPRINGER GF, 1959, J EXP MED, V110, P221, DOI 10.1084/jem.110.2.221; Takeuchi Y, 1996, NATURE, V379, P85, DOI 10.1038/379085a0; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004; Tran TM, 2014, J INFECT DIS, V209, P789, DOI 10.1093/infdis/jit553; Verhage DF, 2005, NETH J MED, V63, P52; Warburg A, 2007, MICROBES INFECT, V9, P192, DOI 10.1016/j.micinf.2006.11.006; WEISS WR, 1989, J IMMUNOL, V143, P4263; Yang YG, 1998, J EXP MED, V187, P1335, DOI 10.1084/jem.187.8.1335; Yin DP, 2004, J IMMUNOL, V172, P7235, DOI 10.4049/jimmunol.172.12.7235	61	214	224	0	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1277	1289		10.1016/j.cell.2014.10.053	http://dx.doi.org/10.1016/j.cell.2014.10.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480293	hybrid, Green Published			2022-12-28	WOS:000346652900008
J	Rawlings, AM; Sharrett, AR; Schneider, ALC; Coresh, J; Albert, M; Couper, D; Griswold, M; Gottesman, RF; Wagenknecht, LE; Windham, BG; Selvin, E				Rawlings, Andreea M.; Sharrett, A. Richey; Schneider, Andrea L. C.; Coresh, Josef; Albert, Marilyn; Couper, David; Griswold, Michael; Gottesman, Rebecca F.; Wagenknecht, Lynne E.; Windham, B. Gwen; Selvin, Elizabeth			Diabetes in Midlife and Cognitive Change Over 20 Years A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							VASCULAR RISK-FACTORS; BLOOD-PRESSURE; APOE GENOTYPE; UNITED-STATES; DEMENTIA; DECLINE; GLUCOSE; ATTRITION; MELLITUS; DISEASE	Background: Type 2 diabetes is associated with dementia risk, but evidence is limited for possible associations of diabetes and prediabetes with cognitive decline. Objective: To determine whether diabetes in midlife is associated with 20-year cognitive decline and to characterize long-term cognitive decline across clinical categories of hemoglobin A(1c) (HbA(1c)) levels. Design: Prospective cohort study. Setting: The community-based ARIC (Atherosclerosis Risk in Communities) study. Participants: 13 351 black and white adults aged 48 to 67 years at baseline (1990 to 1992). Measurements: Diabetes was defined by self-reported physician diagnosis or medication use or HbA1c level of 6.5% or greater. Undiagnosed diabetes, prediabetes, and glucose control in persons with diagnosed diabetes were defined by clinical categories of HbA1c level. Delayed word recall, digit symbol substitution, and word fluency tests were used to assess cognitive performance and were summarized with a global Z score. Results: Diabetes in midlife was associated with a 19% greater cognitive decline over 20 years ( adjusted global Z-score difference, -0.15 [95% CI, -0.22 to -0.08]) compared with no diabetes. Cognitive decline was significantly greater among persons with prediabetes (HbA1c level of 5.7% to 6.4%) than among those with an HbA1c level less than 5.7%. Participants with poorly controlled diabetes (HbA1c level >= 7.0%) had greater decline than those whose diabetes was controlled (adjusted global Z-score difference, -0.16; P = 0.071). Longer-duration diabetes was also associated with greater late-life cognitive decline (P for trend < 0.001). Rates of decline did not differ significantly between white and black persons (P for interaction = 0.44). Limitation: Single HbA(1c) measurement at baseline, 1 test per cognitive domain, and potential geographic confounding of race comparisons. Conclusion: Diabetes prevention and glucose control in midlife may protect against late-life cognitive decline.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Univ N Carolina, Chapel Hill, NC USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Wake Forest Univ, Winston Salem, NC 27109 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of Mississippi; University of Mississippi Medical Center; Wake Forest University	Selvin, E (corresponding author), Welch Ctr Prevent Epidemiol & Clin Res, 2024 East Monument St,Suite 2-600, Baltimore, MD 21287 USA.	lselvin@jhsph.edu	Gottesman, Rebecca/ABA-8468-2020	Couper, David/0000-0002-4313-9235; Christman Schneider, Andrea Lauren/0000-0003-0026-5052; Rawlings, Andreea/0000-0002-4903-7360	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NHLBI [U01HL096812, HL096814, HL096899, HL096902, HL096917, R01HL70825, T32HL007024]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK089174]; National Institute on Aging [R01AG040282]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096812, U01HL096917, U01HL096899, U01HL096814, R01HL070825, U01HL096902, T32HL007024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040282] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	ARIC is a collaborative study supported by contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C from the National Heart, Lung, and Blood Institute (NHLBI). Neurocognitive (ARIC-NCS) data are collected with support from NHLBI grants U01HL096812, HL096814, HL096899, HL096902, and HL096917, and previous magnetic resonance imaging examinations of the brain were funded by NHLBI grant R01HL70825. Ms. Rawlings and Dr. Schneider were supported by training grant T32HL007024 from NHLBI. Dr. Selvin was supported by grant R01DK089174 from the National Institute of Diabetes and Digestive and Kidney Diseases. Dr. Gottesman was supported by grant R01AG040282 from the National Institute on Aging.	Alonso A, 2009, J NEUROL NEUROSUR PS, V80, P1194, DOI 10.1136/jnnp.2009.176818; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bangen KJ, 2013, J STROKE CEREBROVASC, V22, P1361, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.013; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Benton AL., 1983, MULTILINGUAL APHASIA; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Christman AL, 2011, DIABETOLOGIA, V54, P1645, DOI 10.1007/s00125-011-2095-7; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Elias PK, 1997, DIABETES CARE, V20, P1388, DOI 10.2337/diacare.20.9.1388; Gerstein HC, 2013, NEW ENGL J MED, V369, P189, DOI 10.1056/NEJMe1306987; Gottesman RF, 2014, AM J EPIDEMIOL, V179, P956, DOI 10.1093/aje/kwu020; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Herzog RI, 2012, NAT REV NEUROL, V8, P124, DOI 10.1038/nrneurol.2012.10; Jokinen H, 2006, J NEUROL NEUROSUR PS, V77, P28, DOI 10.1136/jnnp.2005.069120; Kaffashian S, 2013, NEUROLOGY, V80, P1300, DOI 10.1212/WNL.0b013e31828ab370; Knopman DS, 2009, ALZHEIMERS DEMENT, V5, P207, DOI 10.1016/j.jalz.2009.01.027; KNOPMAN DS, 1989, ARCH NEUROL-CHICAGO, V46, P141, DOI 10.1001/archneur.1989.00520380041011; Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0; O'Brien JT, 2002, ANN NY ACAD SCI, V977, P436, DOI 10.1111/j.1749-6632.2002.tb04849.x; Power MC, 2013, EPIDEMIOLOGY, V24, P886, DOI 10.1097/EDE.0b013e3182a7121c; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Sanz CM, 2013, DIABETES CARE, V36, P1512, DOI 10.2337/dc12-1017; Sarwar N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000278; Schneider AL, 2014, ALZHEIMER DIS ASS DI; Selnes OA, 2006, NAT CLIN PRACT NEURO, V2, P538, DOI 10.1038/ncpneuro0294; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Selvin E, 2011, DIABETES, V60, P298, DOI 10.2337/db10-1198; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Spauwen PJJ, 2013, DIABETES CARE, V36, P1554, DOI 10.2337/dc12-0746; Tuligenga RH, 2014, LANCET DIABETES ENDO, V2, P228, DOI 10.1016/S2213-8587(13)70192-X; Wechsler D., 2010, WAIS R MANUAL, VUK 4th Edn; Weuve J, 2012, EPIDEMIOLOGY, V23, P119, DOI 10.1097/EDE.0b013e318230e861; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson RS, 2012, NEUROLOGY, V78, P1116, DOI 10.1212/WNL.0b013e31824f7ff2; Yaffe K, 2012, ARCH NEUROL-CHICAGO, V69, P1170, DOI 10.1001/archneurol.2012.1117	39	228	236	7	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					785	U68		10.7326/M14-0737	http://dx.doi.org/10.7326/M14-0737			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UJ	25437406	Green Accepted			2022-12-28	WOS:000347247200007
J	Ortqvist, AK; Lundholm, C; Kieler, H; Ludvigsson, JF; Fall, T; Ye, WM; Almqvist, C				Ortqvist, Anne K.; Lundholm, Cecilia; Kieler, Helle; Ludvigsson, Jonas F.; Fall, Tove; Ye, Weimin; Almqvist, Catarina			Antibiotics in fetal and early life and subsequent childhood asthma: nationwide population based study with sibling analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIRTH COHORT; ALLERGIC DISEASE; INCREASED RISK; INFECTIONS; EXPOSURE; CHILDREN; ECZEMA; ASSOCIATION; CONSUMPTION; PREGNANCY	Objective To investigate the association between exposure to antibiotics in fetal and early life and asthma in childhood, with adjustment for confounding factors. Design Nationwide prospective population based cohort study, including sibling control design. Setting Swedish population identified from national demographic and health registers. Participants 493 785 children born 2006-10; 180 894 of these were eligible for sibling analyses. Main outcome measure Asthma defined as having both an asthma diagnosis and dispensed asthma drugs. The association between antibiotic exposure and asthma was investigated in the whole cohort with Cox proportional hazard regression. A stratified proportional hazards model conditional on sibling group was used to adjust for shared factors within families. Confounding by respiratory infections was assessed by investigating whether specific groups of antibiotics were associated with asthma. Results Antibiotic exposure in fetal life was associated with an increased risk of asthma in cohort analyses (hazard ratio 1.28, 95% confidence interval 1.25 to 1.32), but not in sibling analyses (0.99, 0.92 to 1.07). In cohort analyses, antibiotics used to treat respiratory infections in childhood were associated with a more pronounced increased risk of asthma (4.12, 3.78 to 4.50) than antibiotics used for urinary tract and skin infections (1.54, 1.24 to 1.92). In sibling analyses, the excess risks after exposure to antibiotics for respiratory infections decreased (2.36, 1.78 to 3.13) and disappeared for antibiotics for urinary tract and skin (0.85, 0.47 to 1.55). Conclusions Previous positive associations between exposure to antibiotics in fetal and early life and subsequent childhood asthma could have been caused by confounding by shared familial factors, in addition to confounding by respiratory infections.	[Ortqvist, Anne K.; Lundholm, Cecilia; Ludvigsson, Jonas F.; Ye, Weimin; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Kieler, Helle] Karolinska Univ Hosp, Dept Med, Ctr Pharmacoepidemiol T2, S-17176 Stockholm, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Paediat, S-70185 Orebro, Sweden; [Fall, Tove] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Lung & Allergy Unit, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Orebro University; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Ortqvist, AK (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, S-17177 Stockholm, Sweden.	Anne.ortqvist@ki.se	Fall, Tove/O-7226-2014; Örtqvist, Anne Kristina/P-6618-2019; Ludvigsson, Jonas F/A-8560-2012	Ludvigsson, Jonas F/0000-0003-1024-5602; Lundholm, Cecilia/0000-0002-6546-3650; Kieler, Helle/0000-0001-9338-7133	Swedish Research Council through Swedish Initiative for Research on Microdata in the Social and Medical Sciences (SIMSAM) [2011-3060, 80748301, 340-2013-5867]; Stockholm County Council (ALF project); Karolinska Institutet; Swedish Heart Lung Foundation	Swedish Research Council through Swedish Initiative for Research on Microdata in the Social and Medical Sciences (SIMSAM); Stockholm County Council (ALF project)(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation)	This study was funded by the Swedish Research Council (grant No 2011-3060) through the Swedish Initiative for Research on Microdata in the Social and Medical Sciences (SIMSAM) framework grants No 80748301 and 340-2013-5867, grants provided by the Stockholm County Council (ALF project), the strategic research programme in epidemiology at Karolinska Institutet, and the Swedish Heart Lung Foundation. The funding sources had no role in the study design; the collection, analysis and interpretation of data; and the writing of the article and the decision to submit it for publication.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Almqvist C, 2012, CLIN EXP ALLERGY, V42, P104, DOI 10.1111/j.1365-2222.2011.03850.x; Almqvist C, ACTA PAEDIA IN PRESS; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Celedon JC, 2004, CLIN EXP ALLERGY, V34, P1011, DOI 10.1111/j.1365-2222.2004.01994.x; D'Onofrio BM, 2013, AM J PUBLIC HEALTH, V103, P46, DOI 10.2105/AJPH.2013.301252; Dom S, 2010, CLIN EXP ALLERGY, V40, P1378, DOI 10.1111/j.1365-2222.2010.03538.x; Goksor E, 2013, PEDIAT ALLERG IMM-UK, V24, P339, DOI 10.1111/pai.12078; Heintze K, 2013, EUR J CLIN PHARMACOL, V69, P1197, DOI 10.1007/s00228-012-1463-7; Hellman J, 2012, SWEDRES SWARM 2012 U; Ic-Jusufagic AS, 2014, LANCET RESP MED, V2, P621, DOI 10.1016/S2213-2600(14)70096-7; Kardas P, 2002, J ANTIMICROB CHEMOTH, V49, P897, DOI 10.1093/jac/dkf046; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Little P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1606; Marra F, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-32; Marra F, 2009, PEDIATRICS, V123, P1003, DOI 10.1542/peds.2008-1146; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; McKeever TM, 2002, J ALLERGY CLIN IMMUN, V109, P43, DOI 10.1067/mai.2002.121016; McKeever TM, 2002, AM J RESP CRIT CARE, V166, P827, DOI 10.1164/rccm.200202-158OC; Metsala J, 2015, CLIN EXP ALLERGY, V45, P137, DOI 10.1111/cea.12356; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Murk W, 2011, PEDIATRICS, V127, P1125, DOI 10.1542/peds.2010-2092; Noverr MC, 2005, CLIN EXP ALLERGY, V35, P1511, DOI 10.1111/j.1365-2222.2005.02379.x; Ong MS, 2014, ANN ALLERG ASTHMA IM, V112, P441, DOI 10.1016/j.anai.2014.01.022; Ortqvist AK, 2013, PHARMACOEPIDEM DR S, V22, P850, DOI 10.1002/pds.3465; Rusconi F, 2007, AM J RESP CRIT CARE, V175, P16, DOI 10.1164/rccm.200512-1978OC; Rusconi F, 2011, INT J EPIDEMIOL, V40, P662, DOI 10.1093/ije/dyq263; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Su Y, 2010, CLIN EXP ALLERGY, V40, P1222, DOI 10.1111/j.1365-2222.2010.03539.x; Wang JY, 2013, INT J EPIDEMIOL, V42, P1087, DOI 10.1093/ije/dyt121; Wickens K, 2008, CLIN EXP ALLERGY, V38, P1318, DOI 10.1111/j.1365-2222.2008.03024.x	33	84	88	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2014	349								g6979	10.1136/bmj.g6979	http://dx.doi.org/10.1136/bmj.g6979			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KH	25432937	Green Published, hybrid			2022-12-28	WOS:000346115900001
J	Wielawski, IM				Wielawski, Irene M.			Engaging to No Avail	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												imw@cloud9.net							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2097	2098		10.1001/jama.2014.12935	http://dx.doi.org/10.1001/jama.2014.12935			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25423216				2022-12-28	WOS:000345626800010
J	Soh, YQS; Alfoldi, J; Pyntikova, T; Brown, LG; Graves, T; Minx, PJ; Fulton, RS; Kremitzki, C; Koutseva, N; Mueller, JL; Rozen, S; Hughes, JF; Owens, E; Womack, JE; Murphy, WJ; Cao, Q; de Jong, P; Warren, WC; Wilson, RK; Skaletsky, H; Page, DC				Soh, Y. Q. Shirleen; Alfoeldi, Jessica; Pyntikova, Tatyana; Brown, Laura G.; Graves, Tina; Minx, Patrick J.; Fulton, Robert S.; Kremitzki, Colin; Koutseva, Natalia; Mueller, Jacob L.; Rozen, Steve; Hughes, Jennifer F.; Owens, Elaine; Womack, James E.; Murphy, William J.; Cao, Qing; de Jong, Pieter; Warren, Wesley C.; Wilson, Richard K.; Skaletsky, Helen; Page, David C.			Sequencing the Mouse Y Chromosome Reveals Convergent Gene Acquisition and Amplification on Both Sex Chromosomes	CELL			English	Article							HYBRID MALE-STERILITY; HUMAN X-CHROMOSOME; LONG ARM; HUMAN GENOME; SEGREGATION DISTORTION; SPERMIOGENESIS GENE; REPETITIVE SEQUENCE; SPERM DEVELOPMENT; MEIOTIC DRIVE; HOUSE MICE	We sequenced the MSY (male-specific region of the Y chromosome) of the C57BL/6J strain of the laboratory mouse Mus musculus. In contrast to theories that Y chromosomes are heterochromatic and gene poor, the mouse MSY is 99.9% euchromatic and contains about 700 protein-coding genes. Only 2% of the MSY derives from the ancestral autosomes that gave rise to the mammalian sex chromosomes. Instead, all but 45 of the MSY's genes belong to three acquired, massively amplified gene families that have no homologs on primate MSYs but do have acquired, amplified homologs on the mouse X chromosome. The complete mouse MSY sequence brings to light dramatic forces in sex chromosome evolution: line-age-specific convergent acquisition and amplification of X-Y gene families, possibly fueled by antagonism between acquired X-Y homologs. The mouse MSY sequence presents opportunities for experimental studies of a sex-specific chromosome in its entirety, in a genetically tractable model organism.	[Soh, Y. Q. Shirleen; Alfoeldi, Jessica; Pyntikova, Tatyana; Brown, Laura G.; Koutseva, Natalia; Mueller, Jacob L.; Rozen, Steve; Hughes, Jennifer F.; Skaletsky, Helen; Page, David C.] Whitehead Inst, Cambridge, MA 02142 USA; [Soh, Y. Q. Shirleen; Alfoeldi, Jessica; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Brown, Laura G.; Skaletsky, Helen; Page, David C.] Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Graves, Tina; Minx, Patrick J.; Fulton, Robert S.; Kremitzki, Colin; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Owens, Elaine; Womack, James E.; Murphy, William J.] 4458 Texas A&M Univ, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Cao, Qing; de Jong, Pieter] Childrens Hosp Oakland, BACPAC Resources, Oakland, CA 94609 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Washington University (WUSTL); Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Page, DC (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu	Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	Wilson, Richard K./0000-0002-1992-1358; Soh, Shirleen/0000-0002-7422-7414; Mueller, Jacob L./0000-0003-1232-0303; Kremitzki, Colin/0000-0001-9175-3136; Rozen, Steven G./0000-0002-4288-0056	NIH; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD064753] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Goodheart for assistance with mice; D.W. Bellott, B.J. Lesch, K. Romer, and L. Teitz for comments on the manuscript and T. DiCesare for graphical assistance. This work is supported by NIH and Howard Hughes Medical Institute.	Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Bergstrom DE, 1998, GENOMICS, V48, P304, DOI 10.1006/geno.1997.5176; BISHOP CE, 1987, NUCLEIC ACIDS RES, V15, P2959, DOI 10.1093/nar/15.7.2959; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Burgoyne PS, 1998, SEMIN CELL DEV BIOL, V9, P423, DOI 10.1006/scdb.1998.0228; BURGOYNE PS, 1992, CELL, V71, P391, DOI 10.1016/0092-8674(92)90509-B; Campbell P, 2012, GENETICS, V191, P1271, DOI 10.1534/genetics.112.141804; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cocquet J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002900; Cocquet J, 2010, MOL BIOL CELL, V21, P3497, DOI 10.1091/mbc.E10-07-0601; Cocquet J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000244; CONWAY SJ, 1994, MAMM GENOME, V5, P203, DOI 10.1007/BF00360546; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EICHER EM, 1989, GENETICS, V122, P181; Elliott RW, 2004, MAMM GENOME, V15, P704, DOI 10.1007/s00335-004-2388-y; Elliott RW, 2001, MAMM GENOME, V12, P45, DOI 10.1007/s003350010234; Ellis PJI, 2011, HUM MOL GENET, V20, P3010, DOI 10.1093/hmg/ddr204; Ellis PJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-171; Ellis PJI, 2005, HUM MOL GENET, V14, P2705, DOI 10.1093/hmg/ddi304; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferguson L, 2009, MAMM GENOME, V20, P193, DOI 10.1007/s00335-009-9175-8; FORD C. E., 1966, TRANSPLANTATION, V4, P333, DOI 10.1097/00007890-196605000-00012; FRANK SA, 1991, EVOLUTION, V45, P262, DOI 10.1111/j.1558-5646.1991.tb04401.x; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Good JM, 2008, GENETICS, V179, P2213, DOI 10.1534/genetics.107.085340; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; HURST LD, 1991, GENETICS, V128, P841; HURST LD, 1992, GENETICS, V130, P229; Jaenike J, 2001, ANNU REV ECOL SYST, V32, P25, DOI 10.1146/annurev.ecolsys.32.081501.113958; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lahn BT, 2000, HUM MOL GENET, V9, P311, DOI 10.1093/hmg/9.2.311; Lange J, 2009, CELL, V138, P855, DOI 10.1016/j.cell.2009.07.042; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li G, 2013, GENOME RES, V23, P1486, DOI 10.1101/gr.154286.112; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; Mazeyrat S, 1998, HUM MOL GENET, V7, P1713, DOI 10.1093/hmg/7.11.1713; MCLAREN A, 1988, P NATL ACAD SCI USA, V85, P6442, DOI 10.1073/pnas.85.17.6442; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; MOENS PB, 1995, CHROMOSOMA, V104, P175, DOI 10.1007/BF00352182; Moriwaki K, 1988, MOUSE NEWS LETT, V82, P138; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Murphy WJ, 2006, PLOS GENET, V2, P353, DOI 10.1371/journal.pgen.0020043; NISHIOKA Y, 1986, GENETICS, V113, P417; Oh B, 1997, DEVELOPMENT, V124, P493; OHNO S, 1967, MONOGRAPHS ENDOCRINO, V1; PALUMBO G, 1994, GENETICS, V138, P1181; Paria N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021374; Partridge L, 1998, SCIENCE, V281, P2003, DOI 10.1126/science.281.5385.2003; Pertile MD, 2009, GENOME RES, V19, P2202, DOI 10.1101/gr.092080.109; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; PHILLIPS SJ, 1982, NATURE, V297, P241, DOI 10.1038/297241a0; PRADO VF, 1992, CYTOGENET CELL GENET, V61, P87, DOI 10.1159/000133375; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Reynard LN, 2007, BIOL REPROD, V77, P329, DOI 10.1095/biolreprod.107.061101; Reynard LN, 2009, BIOL REPROD, V81, P250, DOI 10.1095/biolreprod.108.075382; RICE WR, 1987, GENETICS, V116, P161; ROBERTS C, 1988, P NATL ACAD SCI USA, V85, P6446, DOI 10.1073/pnas.85.17.6446; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Silver L.M., 1995, MOUSE GENETICS CONCE; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Slonim D, 1997, J COMPUT BIOL, V4, P487, DOI 10.1089/cmb.1997.4.487; Smit A, 1996, REPEATMASKER OPEN 30; STYRNA J, 1991, J REPROD FERTIL, V92, P187, DOI 10.1530/jrf.0.0920187; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; Toure A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r102; Toure A, 2004, GENETICS, V166, P901, DOI 10.1534/genetics.166.2.901; Toure A, 2004, GENOMICS, V83, P140, DOI 10.1016/S0888-7543(03)00216-7; Vernet N, 2012, REPRODUCTION, V144, P433, DOI 10.1530/REP-12-0158; Vernet N, 2011, CURR BIOL, V21, P787, DOI 10.1016/j.cub.2011.03.057; Wang HY, 2013, NAT BIOTECHNOL, V31, P530, DOI 10.1038/nbt.2595; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Yamauchi Y, 2014, SCIENCE, V343, P69, DOI 10.1126/science.1242544	88	194	197	2	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					800	813		10.1016/j.cell.2014.09.052	http://dx.doi.org/10.1016/j.cell.2014.09.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417157	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000344522000013
J	Korostelev, AA				Korostelev, Andrei A.			A Deeper Look into Translation Initiation	CELL			English	Editorial Material							COMPLEX; MECHANISM	Eukaryotic translation initiation requires coordinated assembly of a remarkable array of initiation factors onto the small ribosomal subunit to select an appropriate mRNA start codon. Studies from Erzberger et al. and Hussain et al. bring new insights into this mechanism by looking at early and late initiation intermediates.	Univ Massachusetts, Sch Med, RNA Therapeut Inst, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Korostelev, AA (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Dept Biochem & Mol Pharmacol, 368 Plantat St, Worcester, MA 01605 USA.	andrei.korostelev@umassmed.edu		Korostelev, Andrei/0000-0003-1588-717X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106105] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM106105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hinnebusch AG, 2012, COLD SPRING HARB PER, V4; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hussain T, 2014, CELL, V159, P597, DOI 10.1016/j.cell.2014.10.001; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lomakin IB, 2013, NATURE, V500, P307, DOI 10.1038/nature12355; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Svidritskiy E, 2014, STRUCTURE, V22, P1210, DOI 10.1016/j.str.2014.06.003	10	3	3	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					475	476		10.1016/j.cell.2014.10.005	http://dx.doi.org/10.1016/j.cell.2014.10.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417100	Bronze			2022-12-28	WOS:000344521700005
J	Mogk, A; Bukau, B				Mogk, Axel; Bukau, Bernd			Mitochondria Tether Protein Trash to Rejuvenate Cellular Environments	CELL			English	Editorial Material							ASYMMETRIC INHERITANCE; DAMAGED PROTEINS; BUDDING YEAST; SEGREGATION	Protein damage segregates asymmetrically in dividing yeast cells, rejuvenating daughters at the expense of mother cells. Zhou et al. now show that newly synthesized proteins are particularly prone to aggregation and describe a mechanism that tethers aggregated proteins to mitochondria. This association constrains aggregate mobility, effectively retaining and sorting toxic aggregates away from younger cells.	[Mogk, Axel; Bukau, Bernd] Univ Heidelberg ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Mogk, Axel; Bukau, Bernd] Deutsch Krebsforschungszentrum DKFZ, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Bukau, B (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	bukau@zmbh.uni-heidelberg.de		Bukau, Bernd/0000-0003-0521-7199				Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Song J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004539; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002	8	6	6	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					471	472		10.1016/j.cell.2014.10.007	http://dx.doi.org/10.1016/j.cell.2014.10.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417098	Bronze			2022-12-28	WOS:000344521700003
J	Thaiss, CA; Zeevi, D; Levy, M; Zilberman-Schapira, G; Suez, J; Tengeler, AC; Abramson, L; Katz, MN; Korem, T; Zmora, N; Kuperman, Y; Biton, I; Gilad, S; Harmelin, A; Shapiro, H; Halpern, Z; Segal, E; Elinav, E				Thaiss, Christoph A.; Zeevi, David; Levy, Maayan; Zilberman-Schapira, Gili; Suez, Jotham; Tengeler, Anouk C.; Abramson, Lior; Katz, Meirav N.; Korem, Tal; Zmora, Niv; Kuperman, Yael; Biton, Inbal; Gilad, Shlomit; Harmelin, Alon; Shapiro, Hagit; Halpern, Zamir; Segal, Eran; Elinav, Eran			Transkingdom Control of Microbiota Diurnal Oscillations Promotes Metabolic Homeostasis	CELL			English	Article							CIRCADIAN CLOCK; GUT MICROBIOTA; PHOSPHORYLATION; ENTRAINMENT; RECEPTORS; SLEEP; TIME	All domains of life feature diverse molecular clock machineries that synchronize physiological processes to diurnal environmental fluctuations. However, no mechanisms are known to cross-regulate prokaryotic and eukaryotic circadian rhythms in multikingdom ecosystems. Here, we show that the intestinal microbiota, in both mice and humans, exhibits diurnal oscillations that are influenced by feeding rhythms, leading to time-specific compositional and functional profiles over the course of a day. Ablation of host molecular clock components or induction of jet lag leads to aberrant microbiota diurnal fluctuations and dysbiosis, driven by impaired feeding rhythmicity. Consequently, jet-lag-induced dysbiosis in both mice and humans promotes glucose intolerance and obesity that are transferrable to germ-free mice upon fecal transplantation. Together, these findings provide evidence of coordinated metaorganism diurnal rhythmicity and offer a microbiome-dependent mechanism for common metabolic disturbances in humans with aberrant circadian rhythms, such as those documented in shift workers and frequent flyers.	[Thaiss, Christoph A.; Levy, Maayan; Zilberman-Schapira, Gili; Suez, Jotham; Tengeler, Anouk C.; Abramson, Lior; Katz, Meirav N.; Shapiro, Hagit; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Zeevi, David; Korem, Tal; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Katz, Meirav N.; Zmora, Niv; Halpern, Zamir] Tel Aviv Univ, Res Ctr Digest Tract & Liver Dis, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Zmora, Niv] Tel Aviv Sourasky Med Ctr, Dept Internal Med, IL-64239 Tel Aviv, Israel; [Zmora, Niv; Halpern, Zamir] Tel Aviv Sourasky Med Ctr, Digest Ctr, IL-64239 Tel Aviv, Israel; [Kuperman, Yael; Biton, Inbal; Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Gilad, Shlomit] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science; Weizmann Institute of Science	Elinav, E (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	eran.elinav@weizmann.ac.il	Suez, Jotham/AAZ-5433-2020; Korem, Tal/D-4155-2018; Segal, Eran/AAF-4855-2019; Shapiro, Hagit/F-8648-2015; Tengeler, Anouk/H-3214-2015; Elinav, Eran/ABE-8881-2020	Suez, Jotham/0000-0003-3836-972X; Korem, Tal/0000-0002-0609-0858; Tengeler, Anouk/0000-0001-8346-8132; Elinav, Eran/0000-0002-5775-2110; Zeevi, David/0000-0002-6492-6078; Segal, Eran/0000-0002-6859-1164	Weizmann Institute management; Nancy and Stephen Grand Israel Center for Personalized Medicine; Boehringer Ingelheim Fonds PhD Fellowship; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; CNRS (Centre National de la Recherche Scientifique); estate of Samuel and Alwyn J. Weber; European Research Council; Kenneth Rainin Foundation; German-Israel Binational foundation; Israel Science Foundation; Minerva Foundation; Rising Tide foundation; Alon Foundation scholar award	Weizmann Institute management; Nancy and Stephen Grand Israel Center for Personalized Medicine; Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); estate of Samuel and Alwyn J. Weber; European Research Council(European Research Council (ERC)European Commission); Kenneth Rainin Foundation; German-Israel Binational foundation; Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Rising Tide foundation; Alon Foundation scholar award	We thank the members of the Elinav lab for fruitful discussions. We thank Gad Asher and Liat Rousso-Noori (Department of Biological Chemistry, Weizmann Institute of Science) for helpful advice, meaningful insights, and for providing Per1/2<SUP>-/-</SUP> mice. ASC<SUP>-/-</SUP> mice were kindly provided by Richard Flavell (Yale University). We acknowledge Carmit Bar-Nathan for dedicated germ-free mouse care taking. We thank the Weizmann Institute management and The Nancy and Stephen Grand Israel Center for Personalized Medicine for providing financial and infrastructure support. C.A.T. is the recipient of a Boehringer Ingelheim Fonds PhD Fellowship and thanks Shalev Itzkovitz and Yair Reisner for helpful discussions. E.E. is supported by Yael and Rami Ungar, Israel; Abisch Frenkel Foundation for the Promotion of Life Sciences; the Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; estate of Jack Gitlitz; estate of Lydia Hershkovich; the Benoziyo Endowment Fund for the Advancement of Science; Adelis Foundation; John L. and Vera Schwartz, Pacific Palisades; Alan Markovitz, Canada; Cynthia Adelson, Canada; CNRS (Centre National de la Recherche Scientifique); estate of Samuel and Alwyn J. Weber; Mr. and Mrs. Donald L. Schwarz, Sherman Oaks; grants funded by the European Research Council; the Kenneth Rainin Foundation; the German-Israel Binational foundation; the Israel Science Foundation; the Minerva Foundation; the Rising Tide foundation; and the Alon Foundation scholar award. E.E. is the incumbent of the Rina Gudinski Career Development Chair.	Adamovich Y, 2014, CELL METAB, V19, P319, DOI 10.1016/j.cmet.2013.12.016; Archer SN, 2014, P NATL ACAD SCI USA, V111, pE682, DOI 10.1073/pnas.1316335111; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686; Hogenesch JB, 2011, NAT REV GENET, V12, P407, DOI 10.1038/nrg2972; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Johnson CH, 2008, SCIENCE, V322, P697, DOI 10.1126/science.1150451; Johnson CH, 2011, ANNU REV BIOPHYS, V40, P143, DOI 10.1146/annurev-biophys-042910-155317; Kaasik K, 2013, CELL METAB, V17, P291, DOI 10.1016/j.cmet.2012.12.017; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Lenz P, 2011, NAT REV MICROBIOL, V9, P565, DOI 10.1038/nrmicro2612; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Yamaguchi Y, 2013, SCIENCE, V342, P85, DOI 10.1126/science.1238599; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884	45	671	708	12	190	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					514	529		10.1016/j.cell.2014.09.048	http://dx.doi.org/10.1016/j.cell.2014.09.048			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417104	Bronze			2022-12-28	WOS:000344521700009
J	Ledgerwood, JE; DeZure, AD; Stanley, DA; Coates, EE; Novik, L; Enama, ME; Berkowitz, NM; Hu, ZH; Joshi, G; Ploquin, A; Sitar, S; Gordon, IJ; Plummer, SA; Holman, LA; Hendel, CS; Yamshchikov, G; Roman, F; Nicosia, A; Colloca, S; Cortese, R; Bailer, RT; Schwartz, RM; Roederer, M; Mascola, JR; Koup, RA; Sullivan, NJ; Graham, BS				Ledgerwood, Julie E.; DeZure, Adam D.; Stanley, Daphne A.; Coates, Emily E.; Novik, Laura; Enama, Mary E.; Berkowitz, Nina M.; Hu, Zonghui; Joshi, Gyan; Ploquin, Aurelie; Sitar, Sandra; Gordon, Ingelise J.; Plummer, Sarah A.; Holman, LaSonji A.; Hendel, Cynthia S.; Yamshchikov, Galina; Roman, Francois; Nicosia, Alfredo; Colloca, Stefano; Cortese, Riccardo; Bailer, Robert T.; Schwartz, Richard M.; Roederer, Mario; Mascola, John R.; Koup, Richard A.; Sullivan, Nancy J.; Graham, Barney S.		VRC 207 Study Team	Chimpanzee Adenovirus Vector Ebola Vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTECTIVE IMMUNITY; VIRUS INFECTION; IMMUNOGENICITY; SAFETY	BACKGROUND The unprecedented 2014 epidemic of Ebola virus disease (EVD) prompted an international response to accelerate the availability of a preventive vaccine. A replication-defective recombinant chimpanzee adenovirus type 3-vectored ebolavirus vaccine (cAd3-EBO), encoding the glycoprotein from Zaire and Sudan species, that offers protection in the nonhuman primate model, was rapidly advanced into phase 1 clinical evaluation. METHODS We conducted a phase 1, dose-escalation, open-label trial of cAd3-EBO. Twenty healthy adults, in sequentially enrolled groups of 10 each, received vaccination intramuscularly in doses of 2x10(10) particle units or 2x10(11) particle units. Primary and secondary end points related to safety and immunogenicity were assessed throughout the first 8 weeks after vaccination; in addition, longer-term vaccine durability was assessed at 48 weeks after vaccination. RESULTS In this small study, no safety concerns were identified; however, transient fever developed within 1 day after vaccination in two participants who had received the 2x10(11) particle-unit dose. Glycoprotein-specific antibodies were induced in all 20 participants; the titers were of greater magnitude in the group that received the 2x10(11) particle-unit dose than in the group that received the 2x10(10) particle-unit dose (geometric mean titer against the Zaire antigen at week 4, 2037 vs. 331; P = 0.001). Glycoprotein-specific T-cell responses were more frequent among those who received the 2x10(11) particle-unit dose than among those who received the 2x10(10) particle-unit dose, with a CD4 response in 10 of 10 participants versus 3 of 10 participants (P = 0.004) and a CD8 response in 7 of 10 participants versus 2 of 10 participants (P = 0.07) at week 4. Assessment of the durability of the antibody response showed that titers remained high at week 48, with the highest titers in those who received the 2x10(11) particle-unit dose. CONCLUSIONS Reactogenicity and immune responses to cAd3-EBO vaccine were dose-dependent. At the 2x10(11) particle-unit dose, glycoprotein Zaire-specific antibody responses were in the range reported to be associated with vaccine-induced protective immunity in challenge studies involving nonhuman primates, and responses were sustained to week 48. Phase 2 studies and efficacy trials assessing cAd3-EBO are in progress. (Funded by the Intramural Research Program of the National Institutes of Health; VRC 207 ClinicalTrials.gov number, NCT02231866.)	[Ledgerwood, Julie E.; DeZure, Adam D.; Stanley, Daphne A.; Coates, Emily E.; Novik, Laura; Enama, Mary E.; Berkowitz, Nina M.; Ploquin, Aurelie; Sitar, Sandra; Gordon, Ingelise J.; Plummer, Sarah A.; Holman, LaSonji A.; Hendel, Cynthia S.; Yamshchikov, Galina; Bailer, Robert T.; Schwartz, Richard M.; Roederer, Mario; Mascola, John R.; Koup, Richard A.; Sullivan, Nancy J.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hu, Zonghui; Joshi, Gyan] NIAID, Biostat Res Branch, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Roman, Francois] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Nicosia, Alfredo; Colloca, Stefano] ReiThera, Rome, Italy; [Nicosia, Alfredo] Univ Naples Federico II, CEINGE, Naples, Italy; [Nicosia, Alfredo] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Cortese, Riccardo] Keires, Basel, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); GlaxoSmithKline; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II	Ledgerwood, JE (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ledgerwood@mail.nih.gov	Roederer, Mario/G-1887-2011; Graham, Barney S./AAC-5898-2019; Mascola, John/AAI-7193-2021	Graham, Barney S./0000-0001-8112-0853; Romano, Sarah/0000-0002-9965-6848	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005073, ZIAAI005047, ZIAAI005021, ZICAI005123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Intramural Research Program of the National Institutes of Health; VRC 207 ClinicalTrials.gov number, NCT02231866.	Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Center for Disease Control, 2014, 2014 EB OUTBR W AFR; Centers for Disease Control and Prevention, 2014, OUTBR CHRON EB VIR D; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; ClinicalTrials.gov, 2014, SAF TOL IMM EB CHIMP; De Santis O, 2016, LANCET INFECT DIS, V16, P311, DOI 10.1016/S1473-3099(15)00486-7; Enama ME, 2011, 14 ANN C VACC RES BA; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Food and Drug Administration (FDA), 2007, GUID IND TOX GRAD SC; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Paris R, 2014, CLIN VACCINE IMMUNOL, V21, P783, DOI 10.1128/CVI.00011-14; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Porobic JM, 2005, CLIN EXP IMMUNOL, V142, P377, DOI 10.1111/j.1365-2249.2005.02923.x; Quinn KM, 2013, J IMMUNOL, V190, P2720, DOI 10.4049/jimmunol.1202861; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sarwar UN, 2015, J INFECT DIS, V211, P549, DOI 10.1093/infdis/jiu511; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Sullivan N, 2003, J VIROL, V77, P9733, DOI 10.1128/JVI.77.18.9733-9737.2003; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Tapia MD, 2016, LANCET INFECT DIS, V16, P16; World Health Organization, 2016, SIT REP; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519	31	176	181	0	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 9	2017	376	10					928	938		10.1056/NEJMoa1410863	http://dx.doi.org/10.1056/NEJMoa1410863			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9JA	25426834	Bronze			2022-12-28	WOS:000395626500009
J	Michau, L; Horn, J; Bank, A; Dutt, M; Zimmerman, C				Michau, Lori; Horn, Jessica; Bank, Amy; Dutt, Mallika; Zimmerman, Cathy			Prevention of violence against women and girls: lessons from practice	LANCET			English	Article							INTIMATE-PARTNER VIOLENCE; RANDOMIZED CONTROLLED-TRIAL; GENDER-BASED VIOLENCE; RAPE CRISIS CENTERS; RURAL SOUTH-AFRICA; SOCIAL-CHANGE; ENTERTAINMENT-EDUCATION; IMPACT; HIV; SUPPORT	This Series paper describes programming to prevent violence against women and girls, and emphasises the importance of systematic, sustained programming across the social ecology (ie, the delicate equilibrium of interacting social, institutional, cultural, and political contexts of people's lives) to transform gender-power inequalities. Effective prevention policy and programming is founded on five core principles: first, analysis and actions to prevent violence across the social ecology (individual, interpersonal, community, and societal); second, intervention designs based on an intersectional gender-power analysis; third, theory-informed models developed on the basis of evidence; fourth, sustained investment in multisector interventions; and finally, aspirational programming that promotes personal and collective thought, and enables activism on women's and girls' rights to violence-free lives. Prevention programming of the future will depend on all of us having a vision of, and a commitment to, gender equality to make violence-free lives for women and girls a reality.	[Michau, Lori] Raising Voices, Kampala, Uganda; [Horn, Jessica] Akiiki Consulting, London, England; [Bank, Amy] Puntos de Encuentro, Managua, Nicaragua; [Dutt, Mallika] Breakthrough, New York, NY USA; [Zimmerman, Cathy] London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Michau, L (corresponding author), Raising Voices, Kampala, Uganda.			Horn, Jessica/0000-0002-7833-8349				Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; [Anonymous], 2011, WORKING PAPER; [Anonymous], 2011, CHANG MAK WE AD NEW; [Anonymous], WORLD REPORT VIOLENC; Antai D, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-12; Arutyuonva A, 2013, WATERING LEAVES STAR; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bicchieri C, STANFORD ENCY PHILOS; Borja SE, 2006, J TRAUMA STRESS, V19, P905, DOI 10.1002/jts.20169; Bott S., 2005, PREVENTING RESPONDIN; Brenner A, 2013, HARVARD J LAW GENDER, V36, P503; Buel, 2013, 50 OBSTACLES LEAVING; Burgess G, 2011, GLOBALIZATIONS, V8, P163, DOI 10.1080/14747731.2010.493016; Campbell R, 1998, AM J COMMUN PSYCHOL, V26, P457, DOI 10.1023/A:1022115322289; Casey EA, 2013, MEN MASC, V16, P228, DOI 10.1177/1097184X12472336; Coker AL, 2002, J WOMEN HEALTH GEN-B, V11, P465, DOI 10.1089/15246090260137644; Council of Australian Governments, 2010, 4 ACT PLAN NAT PLAN; Diop N., 2004, TOSTAN PROGRAM EVALU, DOI 10.31899/rh2.1002; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Dutta D, 2012, COUNT ME VIOLENCE DI; Dutta-Bergman MJ, 2005, HEALTH COMMUN, V18, P103, DOI 10.1207/s15327027hc1802_1; Dworkin SL, 2013, MEN MASC, V16, P181, DOI 10.1177/1097184X12469878; Dyson S, 2012, PREVENTING VIOLENCE; Ellsberg M, 2006, INT J GYNECOL OBSTET, V94, P325, DOI 10.1016/j.ijgo.2006.04.021; Ellsberg M, 2014, LANCET; Esplen E, 2006, ENGAGING MEN GENDER; Fabiano PM, 2003, J AM COLL HEALTH, V52, P105, DOI 10.1080/07448480309595732; Fergus L., 2012, PREVENTION VIOLENCE; Figueroa ME, 2002, COMMUNICATION SOCIAL; Fraser C., 1998, COMMUNICATING DEV HU; Freire P., 2005, PEDAGOGY OPPRESSED; Fried ST., 2003, HLTH HUMAN RIGHTS J, V6, P88, DOI 10.2307/4065431; Fulu E., 2013, WHY DO SOME MEN USE; Garcia-Moreno C, 2014, LANCET; Gokal S, 2013, RELIG CULTURE TRADIT; Greene M.E., 2010, SYNCHRONIZING GENDER; Grey-Felder D, 1999, COMMUNICATION SOCIAL; Guedes A., 2004, ADDRESSING GENDER BA; Gumucio-Dagron A, 2006, COMMUNICATION SOCIAL; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; HEISE LL, 1994, SOC SCI MED, V39, P1165, DOI 10.1016/0277-9536(94)90349-2; Horn J., 2005, HUMAN RIGHTS BEGIN H, P35; Horn J., 2013, GENDER SOCIAL MOVEME; Htun M, 2012, AM POLIT SCI REV, V106, P548, DOI 10.1017/S0003055412000226; Hunnicutt G, 2009, VIOLENCE AGAINST WOM, V15, P553, DOI 10.1177/1077801208331246; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R, 2014, LANCET; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Kahn JS, 2011, J CONSTR PSYCHOL, V24, P30, DOI 10.1080/10720537.2011.530486; Katz J., 2006, MACHO PARADOX WHY SO; Kelmendi K., 2014, J INTERPERS VIOLENCE; Lacayo V., 2013, THESIS OHIO U ATHENS; Laisser RM, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-13; Maier SL, 2011, VIOLENCE AGAINST WOM, V17, P1383, DOI 10.1177/1077801211428599; Michau L, 2008, SASA ACTIVIST KIT PR; Michau L., 2002, RESPONDING CAIRO CAS, DOI 10.1002/cbdv.200490137/abstract; Michau L, 2007, GENDER DEV, V15, P95, DOI DOI 10.1080/13552070601179144; Miller V., 2006, CONCEPTS REVISIONING, DOI [10.1177/0021886312469254, DOI 10.1177/0021886312469254]; Mir-Hosseini Z., 2010, CONTROL SEXUALITY RE, P19; Montalvo-Liendo N, 2009, J ADV NURS, V65, P20, DOI 10.1111/j.1365-2648.2008.04850.x; Morrison A, 2007, WORLD BANK RES OBSER, V22, P25, DOI 10.1093/wbro/lkm003; OECD Development Assistance Committee (DAC) Network on Gender Equality, 2014, FIN UNF BUS GEND EQ; Office of Women's Policy Department of Planning and Community Development, 2009, VICT PLAN PREV VIOL; Papa MJ, 2000, J COMMUN, V50, P31, DOI 10.1093/joc/50.4.31; Peacock D., 2004, International Journal of Men's Health, V3, P173, DOI 10.3149/jmh.0303.173; Prochaska J. O., 2018, SYSTEMS PSYCHOTHERAP, V9th; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Pulerwitz J, 2010, PROMOTING GENDER QUA; Rogers EM., 2005, INNOVATION J PUBLIC, V10, P1, DOI DOI 10.1002/9781118785317.WE0M120209]; Sabri B, 2014, WOMEN HEALTH, V54, P281, DOI 10.1080/03630242.2014.896445; Schechtman R, 2008, SCALING ZERO TOLERAN; Singhal A, 2002, COMMUN THEOR, V12, P117, DOI 10.1111/j.1468-2885.2002.tb00262.x; SINGHAL A, 1999, ENTERTAINMENT ED COM; Solorzano I., 2008, CATALYZING PERSONAL; Storey D., 2012, HDB GLOBAL HLTH COMM, V1st edn; Towers J., 2012, MEASURING IMPACT CUT; Trewartha C, 2011, THESIS U AUCKLAND; U.S. Department of State and U.S. Agency for International Development, 2012, US STRAT PREV RESP G; UN, 2011, HUM RIGHTS COUNC 17; UN Women, 2011, PROGR WORLDS WOM PUR; UNFPA, 2009, PROGR ADDR VIOL WOM; United Nations General Assembly, 2006, IND STUD ALL FORMS V; Upadhyay UD, 2012, INT PERSPECT SEX R H, V38, P78, DOI 10.1363/3807812; Usdin S, 2005, SOC SCI MED, V61, P2434, DOI 10.1016/j.socscimed.2005.04.035; Usdin S, 2000, REPROD HEALTH MATTER, V8, P55, DOI 10.1016/S0968-8080(00)90187-3; Uthman OA, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-14; Venis S, 2002, LANCET, V359, P1172, DOI 10.1016/S0140-6736(02)08251-X; Vicoria Health Promotion Foundation, 2007, PREV VIOL OCC FRAM B; Wagman J, LANCET GLOB IN PRESS; Waisbord S, 2001, FAMILY FREE THEORIES; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Weldon S.L., 2013, GEND DEV, V21, P231; WLUML, 2011, STRAT RES CHALL CULT; World Bank, 2014, VOIC AG EMP WOM GIRL; World Health Organization, 2005, WHO MULT STUD WOM HL; World Health Organization, 2010, VIOLENCE PREVENTION; World Health Organization, 2021, VIOL WOM PREV EST 20; World Health Organization Joint United Nations Programme on HIV/AIDS, 2010, ADDR VIOL WOM HIV AI; World Health Organization/London School of Hygiene and Tropical Medicine, 2010, PREV INT PARTN SEX V	100	130	135	2	64	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					1672	1684		10.1016/S0140-6736(14)61797-9	http://dx.doi.org/10.1016/S0140-6736(14)61797-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG6NG	25467577				2022-12-28	WOS:000353418000040
J	Lemesle, G				Lemesle, Gilles			Dual antiplatelet therapy and non-cardiovascular mortality	LANCET			English	Editorial Material							ELUTING STENT IMPLANTATION; DISCONTINUATION; DURATION; TRIAL; MULTICENTER; THROMBOSIS; EFFICACY		[Lemesle, Gilles] Ctr Hosp Reg & Univ Lille, Hop Cardiol, F-59000 Lille, France; [Lemesle, Gilles] Fac Med Lille, F-59045 Lille, France; [Lemesle, Gilles] Inst Pasteur, INSERM, UMR744, F-59019 Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Lemesle, G (corresponding author), Ctr Hosp Reg & Univ Lille, Hop Cardiol, F-59000 Lille, France.	gilles_lemesle@yahoo.fr		Lemesle, Gilles/0000-0002-2917-9273				Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Bauters C, 2014, AM J CARDIOL, V113, P1142, DOI 10.1016/j.amjcard.2013.12.019; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Elmariah S, 2014, LANCET; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303; Mauri L, N ENGL J ME IN PRESS; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275; Spoon DB, 2014, CIRCULATION, V129, P1286, DOI 10.1161/CIRCULATIONAHA.113.006518; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589	13	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					756	+		10.1016/S0140-6736(14)62125-5	http://dx.doi.org/10.1016/S0140-6736(14)62125-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC0UD	25467568				2022-12-28	WOS:000350051700012
J	Schmidt, H; Zalyte, R; Urnavicius, L; Carter, AP				Schmidt, Helgo; Zalyte, Ruta; Urnavicius, Linas; Carter, Andrew P.			Structure of human cytoplasmic dynein-2 primed for its power stroke	NATURE			English	Article							MICROTUBULE-BINDING DOMAIN; CRYSTAL-STRUCTURE; MOTOR DOMAIN; COILED-COIL; HEAVY-CHAIN; STALK; IMAGE; MECHANISM; PROTEINS; SEQUENCE	Members of the dynein family, consisting of cytoplasmic and axonemal isoforms, are motors that move towards the minus ends of microtubules. Cytoplasmic dynein-1 (dynein-1) plays roles in mitosis and cellular cargo transport(1), and is implicated in viral infections(2) and neurodegenerative diseases(3). Cytoplasmic dynein-2 (dynein-2) performs intraflagellar transport(4) and is associated with human skeletal ciliopathies(5). Dyneins share a conserved motor domain that couples cycles of ATP hydrolysis with conformational changes to produce movement(6-9). Here we present the crystal structure of the human cytoplasmic dynein-2 motor bound to the ATP-hydrolysis transition state analogue ADP. vanadate(10). The structure reveals a closure of the motor's ring of six AAA+ domains (ATPases associated with various cellular activites: AAA1-AAA6). This induces a steric clash with the linker, the key element for the generation of movement, driving it into a conformation that is primed to produce force. Ring closure also changes the interface between the stalk and buttress coiled-coil extensions of the motor domain. This drives helix sliding in the stalk which causes the microtubule binding domain at its tip to release from the microtubule. Our structure answers the key questions of how ATP hydrolysis leads to linker remodelling and microtubule affinity regulation.	[Schmidt, Helgo; Zalyte, Ruta; Urnavicius, Linas; Carter, Andrew P.] MRC, Mol Biol Lab, Div Struct Studies, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Carter, AP (corresponding author), MRC, Mol Biol Lab, Div Struct Studies, Francis Crick Ave, Cambridge CB2 0QH, England.	cartera@mrc-lmb.cam.ac.uk		Carter, Andrew/0000-0001-7292-5430	Medical Research Council, UK [MC_UP_A025_1011]; Wellcome Trust New Investigator Award [WT100387]; EMBO Young Investigator Award; MRC [MC_UP_A025_1011] Funding Source: UKRI; Medical Research Council [1274168, MC_UP_A025_1011, 1352465] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust New Investigator Award(Wellcome Trust); EMBO Young Investigator Award(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council, UK (MC_UP_A025_1011), a Wellcome Trust New Investigator Award (WT100387) and an EMBO Young Investigator Award. We thank M. Yu for in-house support with X-ray data collection and Diamond Light Source for access to beamline I02 (MX8547-70). We thank G. Dornan and M. Barczyk for assistance with insect cell culture. We also thank S. Bullock and D. Barford for their advice and comments on the manuscript.	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2013, J CELL SCI, V126, P705, DOI 10.1242/jcs.120725; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Davies DR, 2004, FEBS LETT, V577, P315, DOI 10.1016/j.febslet.2004.10.022; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; Gleave ES, 2014, J STRUCT BIOL, V186, P367, DOI 10.1016/j.jsb.2014.03.019; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Lin JF, 2014, NAT CELL BIOL, V16, P479, DOI 10.1038/ncb2939; Liu Y, 2013, GENE DEV, V27, P1233, DOI 10.1101/gad.212381.112; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishikawa Y, 2014, J MOL BIOL, V426, P3232, DOI 10.1016/j.jmb.2014.06.023; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Roberts AJ, 2012, STRUCTURE, V20, P1670, DOI 10.1016/j.str.2012.07.003; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schiavo G, 2013, TRENDS NEUROSCI, V36, P641, DOI 10.1016/j.tins.2013.08.001; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Schmidts M, 2013, J MED GENET, V50, P309, DOI 10.1136/jmedgenet-2012-101284; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014	43	97	97	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					435	438		10.1038/nature14023	http://dx.doi.org/10.1038/nature14023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470043	Green Accepted			2022-12-28	WOS:000349547400050
J	Ramesar, R				Ramesar, Raj			African dawn	NATURE			English	Editorial Material									Univ Cape Town, MRC Human Genet Res Unit, Div Human Genet, Inst Infect Dis & Mol Med,Fac Hlth Sci, ZA-7925 Observatory, South Africa	University of Cape Town	Ramesar, R (corresponding author), Univ Cape Town, MRC Human Genet Res Unit, Div Human Genet, Inst Infect Dis & Mol Med,Fac Hlth Sci, ZA-7925 Observatory, South Africa.	raj.ramesar@uct.ac.za	Ramesar, Rajkumar/I-6941-2015	Ramesar, Rajkumar/0000-0001-5688-1634				Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; The H3Africa Consortium, 2014, SCIENCE, V344, P1346	4	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					276	277		10.1038/nature14077	http://dx.doi.org/10.1038/nature14077			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25470066				2022-12-28	WOS:000347810300026
J	Finkelstein, A; Derdikman, D; Rubin, A; Foerster, JN; Las, L; Ulanovsky, N				Finkelstein, Arseny; Derdikman, Dori; Rubin, Alon; Foerster, Jakob N.; Las, Liora; Ulanovsky, Nachum			Three-dimensional head-direction coding in the bat brain	NATURE			English	Article							MEDIAL ENTORHINAL CORTEX; HIPPOCAMPAL PLACE CELLS; FREELY MOVING RATS; GRID CELLS; SPATIAL REPRESENTATION; ECHOLOCATING BATS; PATH-INTEGRATION; VERTICAL PLANE; COGNITIVE MAP; DYNAMICS	Navigation requires a sense of direction ('compass'), which in mammals is thought to be provided by head-direction cells, neurons that discharge when the animal's head points to a specific azimuth. However, it remains unclear whether a three-dimensional (3D) compass exists in the brain. Here we conducted neural recordings in bats, mammals well-adapted to 3D spatial behaviours, and found head-direction cells tuned to azimuth, pitch or roll, or to conjunctive combinations of 3D angles, in both crawling and flying bats. Head-direction cells were organized along a functional-anatomical gradient in the presubiculum, transitioning from 2D to 3D representations. In inverted bats, the azimuth-tuning of neurons shifted by 180 degrees, suggesting that 3D head direction is represented in azimuth x pitch toroidal coordinates. Consistent with our toroidal model, pitch-cell tuning was unimodal, circular, and continuous within the available 360 degrees of pitch. Taken together, these results demonstrate a 3D head-direction mechanism in mammals, which could support navigation in 3D space.	[Finkelstein, Arseny; Derdikman, Dori; Rubin, Alon; Foerster, Jakob N.; Las, Liora; Ulanovsky, Nachum] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Derdikman, Dori] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Derdikman, Dori] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Ulanovsky, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	nachum.ulanovsky@weizmann.ac.il	LAS, LIORA/AGF-2249-2022; Finkelstein, Arseny/AAH-9250-2021	Finkelstein, Arseny/0000-0003-1480-5670; Ulanovsky, Nachum/0000-0001-8598-4667	European Research Council (ERC-NEUROBAT); Human Frontiers Science Program [HFSP RGP0062/2009-C]; Israel Science Foundation [ISF 1017/08, ISF 1319/13]; Minerva Foundation; Clore predoctoral excellence fellowship; MIT-Israel (MISTI) student exchange internship	European Research Council (ERC-NEUROBAT); Human Frontiers Science Program(Human Frontier Science Program); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Clore predoctoral excellence fellowship; MIT-Israel (MISTI) student exchange internship	We thank A. Treves, J.-M. Fellous, M. Okun, A. Wallach, M. Geva-Sagiv and M. M. Yartsev for comments on the manuscript; B. Pasmantirer and G. Ankaoua for mechanical designs; S. Kaufman for bat training, assistance in neural recordings, and illustrations; T. Eliav and T. Tamir for help in experiments; A. Tuval and M. Weinberg for veterinary oversight; G. Brodsky for graphics; R. Eilam and C. Ra'anan for histology; and M. P. Witter for advice on reconstruction of tetrode-track locations and anatomical delineations. This study was supported by research grants to N.U. from the European Research Council (ERC-NEUROBAT), the Human Frontiers Science Program (HFSP RGP0062/2009-C), the Israel Science Foundation (ISF 1017/08 and ISF 1319/13), and the Minerva Foundation; by a Clore predoctoral excellence fellowship to A.F.; and by an MIT-Israel (MISTI) student exchange internship to J.N.F. D.D. is the incumbent of the David and Inez Myers Career Advancement Chair in Life Sciences.	Altringham JD, 1996, BATS BIOL BEHAV; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Bassett JP, 2001, J NEUROSCI, V21, P5740, DOI 10.1523/JNEUROSCI.21-15-05740.2001; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Brandon MP, 2013, NAT NEUROSCI, V16, P739, DOI 10.1038/nn.3383; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; Calton JL, 2005, J NEUROSCI, V25, P2420, DOI 10.1523/JNEUROSCI.3511-04.2005; Calton JL, 2003, J NEUROSCI, V23, P9719; Canto CB, 2012, J NEUROSCI, V32, P17620, DOI 10.1523/JNEUROSCI.3526-12.2012; Gallistel C. R., 1990, ORG LEARNING; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hayman R, 2011, NAT NEUROSCI, V14, P1182, DOI 10.1038/nn.2892; Honda Y, 2004, J COMP NEUROL, V473, P463, DOI 10.1002/cne.20093; Iriarte-Diaz J, 2008, J EXP BIOL, V211, P3478, DOI 10.1242/jeb.017590; Jacobs J, 2013, NAT NEUROSCI, V16, P1188, DOI 10.1038/nn.3466; Jeffery KJ, 2013, BEHAV BRAIN SCI, V36, P523, DOI 10.1017/S0140525X12002476; Knierim JJ, 2000, NAT NEUROSCI, V3, P209, DOI 10.1038/72910; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Miller JF, 2013, SCIENCE, V342, P1111, DOI 10.1126/science.1244056; Neuweiler G., 2000, BIOL BATS; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Rubin A, 2014, J NEUROSCI, V34, P1067, DOI 10.1523/JNEUROSCI.5393-12.2014; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Sharp PE, 1996, CEREB CORTEX, V6, P238, DOI 10.1093/cercor/6.2.238; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Stackman RW, 2000, J NEUROPHYSIOL, V83, P393, DOI 10.1152/jn.2000.83.1.393; Stackman RW, 1998, J NEUROSCI, V18, P9020; Taube JS, 2007, ANNU REV NEUROSCI, V30, P181, DOI 10.1146/annurev.neuro.29.051605.112854; Taube JS, 2013, J NEUROPHYSIOL, V109, P873, DOI 10.1152/jn.00239.2012; Taube JS, 2004, J NEUROPHYSIOL, V92, P2887, DOI 10.1152/jn.00887.2003; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1990, J NEUROSCI, V10, P436; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Ulanoysky N, 2011, HIPPOCAMPUS, V21, P150, DOI 10.1002/hipo.20731; Valerio S, 2012, NAT NEUROSCI, V15, P1445, DOI 10.1038/nn.3215; Wallace DJ, 2013, NATURE, V498, P65, DOI 10.1038/nature12153; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wu LQ, 2012, SCIENCE, V336, P1054, DOI 10.1126/science.1216567; Yartsev MM, 2013, SCIENCE, V340, P367, DOI 10.1126/science.1235338; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Yovel Y, 2011, J COMP PHYSIOL A, V197, P515, DOI 10.1007/s00359-011-0639-4; Yovel Y, 2010, SCIENCE, V327, P701, DOI 10.1126/science.1183310; Zar, 2011, BIOSTAT ANAL; Zhang K, 1996, J NEUROSCI, V16, P2112; Zugaro MB, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-14-j0001.2001	59	134	136	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					159	U65		10.1038/nature14031	http://dx.doi.org/10.1038/nature14031			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25470055				2022-12-28	WOS:000347477600027
J	Therizols, P; Illingworth, RS; Courilleau, C; Boyle, S; Wood, AJ; Bickmore, WA				Therizols, Pierre; Illingworth, Robert S.; Courilleau, Celine; Boyle, Shelagh; Wood, Andrew J.; Bickmore, Wendy A.			Chromatin decondensation is sufficient to alter nuclear organization in embryonic stem cells	SCIENCE			English	Article							LAMINA INTERACTIONS; EARLY G1; REORGANIZATION; TRANSCRIPTION; DYNAMICS; MODELS; MAPS	During differentiation, thousands of genes are repositioned toward or away from the nuclear envelope. These movements correlate with changes in transcription and replication timing. Using synthetic (TALE) transcription factors, we found that transcriptional activation of endogenous genes by a viral trans-activator is sufficient to induce gene repositioning toward the nuclear interior in embryonic stem cells. However, gene relocation was also induced by recruitment of an acidic peptide that decondenses chromatin without affecting transcription, indicating that nuclear reorganization is driven by chromatin remodeling rather than transcription. We identified an epigenetic inheritance of chromatin decondensation that maintained central nuclear positioning through mitosis even after the TALE transcription factor was lost. Our results also demonstrate that transcriptional activation, but not chromatin decondensation, is sufficient to change replication timing.	[Therizols, Pierre; Illingworth, Robert S.; Courilleau, Celine; Boyle, Shelagh; Wood, Andrew J.; Bickmore, Wendy A.] Univ Edinburgh, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Bickmore, WA (corresponding author), Univ Edinburgh, MRC Human Genet Unit, Inst Genet & Mol Med, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	wendy.bickmore@igmm.ed.ac.uk	Therizols, Pierre/AAA-5515-2021	Illingworth, Rob/0000-0001-9275-1933; Therizols, Pierre/0000-0002-5916-0987; Wood, Andrew/0000-0002-0653-2070	Marie Curie Intra European Fellowship; Wellcome Trust; UK Medical Research Council; European Research Council [249956]; MRC [MC_PC_U127527202] Funding Source: UKRI; Medical Research Council [MC_PC_U127527202] Funding Source: researchfish	Marie Curie Intra European Fellowship(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank E. Freyer for FACS analysis, A. Tsakiridis and A. Lavigni for cell culture assistance, P. Perry for help with image analysis, and P. Madapura-Marulasiddappa and N. Gilbert for their insightful comments. Supported by a Marie Curie Intra European Fellowship (P.T.), Sir Henry Wellcome and Sir Henry Dale Fellowships from the Wellcome Trust (A.J.W.), the UK Medical Research Council, and European Research Council advanced grant 249956. The Gene Expression Omnibus accession number for microarray expression data is GSE62379.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Carpenter AE, 2005, MOL CELL BIOL, V25, P958, DOI 10.1128/MCB.25.3.958-968.2005; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Meister P, 2013, CURR OPIN GENET DEV, V23, P96, DOI 10.1016/j.gde.2012.12.001; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	17	187	190	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1238	1242		10.1126/science.1259587	http://dx.doi.org/10.1126/science.1259587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477464	Green Accepted			2022-12-28	WOS:000346189000060
J	Gaudet, D; Brisson, D; Tremblay, K; Alexander, VJ; Singleton, W; Hughes, SG; Geary, RS; Baker, BF; Graham, MJ; Crooke, RM; Witztum, JL				Gaudet, Daniel; Brisson, Diane; Tremblay, Karine; Alexander, Veronica J.; Singleton, Walter; Hughes, Steven G.; Geary, Richard S.; Baker, Brenda F.; Graham, Mark J.; Crooke, Rosanne M.; Witztum, Joseph L.			Targeting APOC3 in the Familial Chylomicronemia Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-C-III; DENSITY-LIPOPROTEIN CHOLESTEROL; OF-FUNCTION MUTATIONS; CARDIOVASCULAR-DISEASE; SEVERE HYPERTRIGLYCERIDEMIA; PLASMA TRIGLYCERIDES; TRANSGENIC MICE; RISK; LIPASE; GENE	The familial chylomicronemia syndrome is a genetic disorder characterized by severe hypertriglyceridemia and recurrent pancreatitis due to a deficiency in lipoprotein lipase (LPL). Currently, there are no effective therapies except for extreme restriction in the consumption of dietary fat. Apolipoprotein C-III (APOC3) is known to inhibit LPL, although there is also evidence that APOC3 increases the level of plasma triglycerides through an LPL-independent mechanism. We administered an inhibitor of APOC3 messenger RNA (mRNA), called ISIS 304801, to treat three patients with the familial chylomicronemia syndrome and triglyceride levels ranging from 1406 to 2083 mg per deciliter (15.9 to 23.5 mmol per liter). After 13 weeks of study-drug administration, plasma APOC3 levels were reduced by 71 to 90% and triglyceride levels by 56 to 86%. During the study, all patients had a triglyceride level of less than 500 mg per deciliter (5.7 mmol per liter) with treatment. These data support the role of APOC3 as a key regulator of LPL-independent pathways of triglyceride metabolism.	[Gaudet, Daniel; Brisson, Diane; Tremblay, Karine] Chicoutimi Hosp, ECOGENE Clin Res Ctr 21, Chicoutimi, PQ, Canada; [Gaudet, Daniel; Brisson, Diane; Tremblay, Karine] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Alexander, Veronica J.; Singleton, Walter; Hughes, Steven G.; Geary, Richard S.; Baker, Brenda F.; Graham, Mark J.; Crooke, Rosanne M.] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Witztum, Joseph L.] Univ Calif San Diego, Dept Med, Sch Med, Div Endocrinol Metab, La Jolla, CA 92093 USA	Universite de Montreal; Isis Pharmaceuticals Inc; University of California System; University of California San Diego	Witztum, JL (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	daniel.gaudet@umontreal.ca; jwitztum@ucsd.edu	Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899; Tremblay, Karine/0000-0002-2774-9738; Baker, Brenda/0000-0001-8586-768X	Isis Pharmaceuticals	Isis Pharmaceuticals	Supported by Isis Pharmaceuticals.	AALTOSETALA K, 1992, J CLIN INVEST, V90, P1889, DOI 10.1172/JCI116066; Alexander V, 2014, J AM COLL CARDIOL S, V12, P63; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Brown WV, 2012, J CLIN LIPIDOL, V6, P397, DOI 10.1016/j.jacl.2012.08.002; BROWN WV, 1972, BIOCHEM BIOPH RES CO, V46, P375; Brunzell JD, 2000, METABOLIC MOL BASIS, P2789; CHAIT A, 1992, ADV INTERNAL MED, V37, P249; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Christian JB, 2011, J CARDIOVASC MED, V12, P714, DOI 10.2459/JCM.0b013e328349c4e5; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Fredenrich A, 1997, J LIPID RES, V38, P1421; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Johansen CT, 2011, J LIPID RES, V52, P189, DOI 10.1194/jlr.R009720; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; KINNUNEN PKJ, 1976, FEBS LETT, V65, P354, DOI 10.1016/0014-5793(76)80145-7; LAROSA JC, 1970, BIOCHEM BIOPH RES CO, V41, P57, DOI 10.1016/0006-291X(70)90468-7; Lee R G, 2013, DIABETES S1A, V62, pLB14; Lee RG, 2013, J CARDIOVASC TRANSL, V6, P969, DOI 10.1007/s12265-013-9495-7; MAEDA N, 1994, J BIOL CHEM, V269, P23610; Mendivil CO, 2011, CIRCULATION, V124, P2065, DOI 10.1161/CIRCULATIONAHA.111.056986; Ooi EMM, 2008, CLIN SCI, V114, P611, DOI 10.1042/CS20070308; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; SCHONFELD G, 1979, METABOLISM, V28, P1001, DOI 10.1016/0026-0495(79)90004-0; Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x; Tremblay K, 2011, J CLIN LIPIDOL, V5, P37, DOI 10.1016/j.jacl.2010.11.004; Yao ZM, 2012, CURR OPIN LIPIDOL, V23, P206, DOI 10.1097/MOL.0b013e328352dc70; Zheng CY, 2014, CURR OPIN LIPIDOL, V25, P35, DOI 10.1097/MOL.0000000000000040	31	303	318	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2200	2206		10.1056/NEJMoa1400284	http://dx.doi.org/10.1056/NEJMoa1400284			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW0IY	25470695				2022-12-28	WOS:000345976700008
J	Lavin, Y; Winter, D; Blecher-Gonen, R; David, E; Keren-Shaul, H; Merad, M; Jung, S; Amit, I				Lavin, Yonit; Winter, Deborah; Blecher-Gonen, Ronnie; David, Eyal; Keren-Shaul, Hadas; Merad, Miriam; Jung, Steffen; Amit, Ido			Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment	CELL			English	Article							THROUGHPUT CHROMATIN IMMUNOPRECIPITATION; GENE-EXPRESSION; MONOCYTE DIFFERENTIATION; CIRCULATING MONOCYTES; ALVEOLAR MACROPHAGES; STATE DYNAMICS; PPAR-GAMMA; CELL-TYPES; RNA-SEQ; SPI-C	Macrophages are critical for innate immune defense and also control organ homeostasis in a tissue-specific manner. They provide a fitting model to study the impact of ontogeny and microenvironment on chromatin state and whether chromatin modifications contribute to macrophage identity. Here, we profile the dynamics of four histone modifications across seven tissue-resident macrophage populations. We identify 12,743 macrophage-specific enhancers and establish that tissue-resident macrophages have distinct enhancer landscapes beyond what can be explained by developmental origin. Combining our enhancer catalog with gene expression profiles and open chromatin regions, we show that a combination of tissue- and lineage-specific transcription factors form the regulatory networks controlling chromatin specification in tissue- resident macrophages. The environment is capable of shaping the chromatin landscape of transplanted bone marrow precursors, and even differentiated macrophages can be reprogramed when transferred into a new microenvironment. These results provide a comprehensive view of macrophage regulatory landscape and highlight the importance of the microenvironment, along with pioneer factors in orchestrating identity and plasticity.	[Lavin, Yonit; Merad, Miriam] Icahn Sch Med Mt Sinai, Inst Immunol, Dept Oncol Sci, New York, NY 10029 USA; [Lavin, Yonit; Merad, Miriam] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Winter, Deborah; Blecher-Gonen, Ronnie; David, Eyal; Keren-Shaul, Hadas; Jung, Steffen; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Weizmann Institute of Science	Merad, M (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, Dept Oncol Sci, New York, NY 10029 USA.	miriam.merad@mssm.edu; s.jung@weizmann.ac.il; ido.amit@weizmann.ac.il	Winter, Deborah R./AAQ-9253-2020; Jung, Steffen/K-1409-2012	Winter, Deborah R./0000-0003-1806-673X; Jung, Steffen/0000-0003-4290-5716; Blecher, Ronnie/0000-0003-2847-1149; Lavin, Yonit/0000-0003-0593-3910	European Research Council [309788, 340345]; Israeli Science Foundation [1782/11, 887/11]; Human Frontiers Science Program; Career Development Award; Center for Excellence in Genome Science from the NHGRI [1P50HG006193]; Deutsche Forschungsgemeinschaft [FOR1336]; NIH [R01CA154947A, NIHR01CA173861, NIHU01AI095611, NIH-R01AI104848]; Azrieli Foundation; EMBO; MSTP; NATIONAL CANCER INSTITUTE [R01CA173861, R01CA154947] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104848, U01AI095611] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Israeli Science Foundation(Israel Science Foundation); Human Frontiers Science Program(Human Frontier Science Program); Career Development Award; Center for Excellence in Genome Science from the NHGRI; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Azrieli Foundation; EMBO(European Molecular Biology Organization (EMBO)); MSTP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the I. A., S.J., and M. M. labs for discussions. We thank Tali Wiesel and Genia Brodsky for artwork. Research in the I. A. lab is supported by the European Research Council (309788) and the Israeli Science Foundation (1782/11), The Human Frontiers Science Program, Career Development Award, and the Center for Excellence in Genome Science from the NHGRI 1P50HG006193. Research in the S.J. lab is supported by the Israeli Science Foundation (887/11), the European Research Council (340345), and the Deutsche Forschungsgemeinschaft (FOR1336). M. M. is supported by NIH R01CA154947A, NIHR01CA173861, NIHU01AI095611, and NIH-R01AI104848. D. W. is grateful to the Azrieli Foundation for the Azrieli Fellowship award and EMBO for the Long-Term Fellowship. Y.L. is grateful for the MSTP training grant support.	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; Abutbul S, 2012, GLIA, V60, P1160, DOI 10.1002/glia.22343; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Happle C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009750; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lavin Y, 2013, CANCER IMMUNOL RES, V1, P201, DOI 10.1158/2326-6066.CIR-13-0117; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Speliotes EK, 1996, NEUROSCIENCE, V70, P67, DOI 10.1016/0306-4522(95)00301-X; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Suzuki T, 2014, NATURE, V514, P450, DOI 10.1038/nature13807; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; VIROLAINEN M, 1968, J EXP MED, V127, P943, DOI 10.1084/jem.127.5.943; Winter DR, 2014, IMMUNOL REV, V261, P9, DOI 10.1111/imr.12200; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Yang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065070; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	60	1269	1291	9	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1312	1326		10.1016/j.cell.2014.11.018	http://dx.doi.org/10.1016/j.cell.2014.11.018			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480296	Green Accepted, Bronze			2022-12-28	WOS:000346652900011
J	Lim, J; Ha, M; Chang, H; Kwon, SC; Simanshu, DK; Patel, DJ; Kim, VN				Lim, Jaechul; Ha, Minju; Chang, Hyeshik; Kwon, S. Chul; Simanshu, Dhirendra K.; Patel, Dinshaw J.; Kim, V. Narry			Uridylation by TUT4 and TUT7 Marks mRNA for Degradation	CELL			English	Article							TRANSLATIONAL REPRESSION; LIN28-LET-7 PATHWAY; CYTOPLASMIC RNA; QUALITY-CONTROL; POLY(A) TAIL; STEM-LOOP; 3' END; DECAY; MICRORNA; PROTEINS	Uridylation occurs pervasively on mRNAs, yet its mechanism and significance remain unknown. By applying TAIL-seq, we identify TUT4 and TUT7 (TUT4/7), also known as ZCCHC11 and ZCCHC6, respectively, as mRNA uridylation enzymes. Uridylation readily occurs on deadenylated mRNAs in cells. Consistently, purified TUT4/7 selectively recognize and uridylate RNAs with short A-tails (less than similar to 25 nt) in vitro. PABPC1 antagonizes uridylation of polyadenylated mRNAs, contributing to the specificity for short A-tails. In cells depleted of TUT4/7, the vast majority of mRNAs lose the oligo-U-tails, and their half-lives are extended. Suppression of mRNA decay factors leads to the accumulation of oligo-uridylated mRNAs. In line with this, microRNA induces uridylation of its targets, and TUT4/7 are required for enhanced decay of microRNA targets. Our study explains the mechanism underlying selective uridylation of deadenylated mRNAs and demonstrates a fundamental role of oligo-U-tail as a molecular mark for global mRNA decay.	[Lim, Jaechul; Ha, Minju; Chang, Hyeshik; Kwon, S. Chul; Kim, V. Narry] Inst for Basic Sci Korea, Ctr RNA Res, Seoul 151742, South Korea; [Lim, Jaechul; Ha, Minju; Chang, Hyeshik; Kwon, S. Chul; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Simanshu, Dhirendra K.; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Memorial Sloan Kettering Cancer Center	Kim, VN (corresponding author), Inst for Basic Sci Korea, Ctr RNA Res, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Kwon, S. Chul/K-2515-2017; Kwon, S. Chul/ABG-9415-2020; Ha, Minju/G-3559-2017	Kwon, S. Chul/0000-0002-9519-5132; Chang, Hyeshik/0000-0002-9812-8015; Simanshu, Dhirendra/0000-0002-9717-4618; Ha, Minju/0000-0003-2328-415X	Institute for Basic Science from the Ministry of Science, ICT and Future Planning of Korea [IBS-R008-D1]; BK21 Research Fellowships from the Ministry of Education of Korea; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Institute for Basic Science from the Ministry of Science, ICT and Future Planning of Korea; BK21 Research Fellowships from the Ministry of Education of Korea(Ministry of Education (MOE), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to members of our laboratory for discussion and technical help, especially Eunji Kim for help with plasmid cloning. We thank Dr. E. Izaurralde for insightful suggestions and the gifts of DCP1/2 mutant plasmids and Dr. G. Dreyfuss for the gift of anti-PABPC1 antibody. This work was supported by IBS-R008-D1 of Institute for Basic Science from the Ministry of Science, ICT and Future Planning of Korea (J.L., M. H., H. C., S. C. K., and V.N.K.) and the BK21 Research Fellowships from the Ministry of Education of Korea (J.L.).	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; Barckmann B, 2013, BBA-GENE REGUL MECH, V1829, P714, DOI 10.1016/j.bbagrm.2012.12.011; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Chang CT, 2014, NUCLEIC ACIDS RES, V42, P5217, DOI 10.1093/nar/gku129; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; Chowdhury A, 2007, RNA, V13, P998, DOI 10.1261/rna.502507; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dreyfus M, 2002, CELL, V111, P611, DOI 10.1016/S0092-8674(02)01137-6; Eliseeva IA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1377, DOI 10.1134/S0006297913130014; Faehnle CR, 2014, NATURE, V514, P252, DOI 10.1038/nature13553; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Hoefig KP, 2013, NAT STRUCT MOL BIOL, V20, P73, DOI 10.1038/nsmb.2450; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Khanam Tasneem, 2006, RNA Biol, V3, P170; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; Lapointe CP, 2013, J BIOL CHEM, V288, P20723, DOI 10.1074/jbc.M113.455451; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Liu XH, 2014, MOL CELL, V55, P868, DOI 10.1016/j.molcel.2014.07.017; Lubas M, 2013, EMBO J, V32, P1855, DOI 10.1038/emboj.2013.135; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Marnef A, 2010, BIOCHEM SOC T, V38, P1602, DOI 10.1042/BST0381602; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Morozov IY, 2012, MOL CELL BIOL, V32, P2585, DOI 10.1128/MCB.00316-12; Morozov IY, 2010, MOL CELL BIOL, V30, P460, DOI 10.1128/MCB.00997-09; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Norbury CJ, 2013, NAT REV MOL CELL BIO, V14, P643, DOI 10.1038/nrm3645; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; Schmidt MJ, 2011, RNA, V17, P39, DOI 10.1261/rna.2252511; Sement FM, 2013, NUCLEIC ACIDS RES, V41, P7115, DOI 10.1093/nar/gkt465; Sharif H, 2013, CELL REP, V5, P283, DOI 10.1016/j.celrep.2013.10.004; Slevin MK, 2014, MOL CELL, V53, P1020, DOI 10.1016/j.molcel.2014.02.027; Song MG, 2007, RNA, V13, P2356, DOI 10.1261/rna.765807; Su W, 2013, RNA, V19, P1, DOI 10.1261/rna.034470.112; Subtelny AO, 2014, NATURE, V508, P66, DOI 10.1038/nature13007; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Ustianenko D, 2013, RNA, V19, P1632, DOI 10.1261/rna.040055.113; Wilusz CJ, 2013, RNA BIOL, V10, P592, DOI 10.4161/rna.23695; Zhou LJ, 2014, CELL RES, V24, P497, DOI 10.1038/cr.2014.18	50	168	175	4	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1365	1376		10.1016/j.cell.2014.10.055	http://dx.doi.org/10.1016/j.cell.2014.10.055			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480299	Green Accepted, Bronze			2022-12-28	WOS:000346652900015
J	Servais, L; Aubert, G				Servais, Laurent; Aubert, Genevieve			Muscular Dystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Servais, Laurent] Hop La Pitie Salpetriere, Paris, France; [Aubert, Genevieve] Clin Univ St Luc, B-1200 Brussels, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Servais, L (corresponding author), Hop La Pitie Salpetriere, Paris, France.	genevieve.aubert@uclouvain.be	Servais, Laurent/AAL-7384-2020; Gholse, Yogesh/AAT-3373-2021	Gholse, Yogesh/0000-0003-2232-1262; Servais, Laurent/0000-0001-9270-4061					0	1	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					E35	E35		10.1056/NEJMicm1007790	http://dx.doi.org/10.1056/NEJMicm1007790			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW0IY	25470715				2022-12-28	WOS:000345976700011
J	Keyhani, S; Myers, LJ; Cheng, E; Hebert, P; Williams, LS; Bravata, DM				Keyhani, Salomeh; Myers, Laura J.; Cheng, Eric; Hebert, Paul; Williams, Linda S.; Bravata, Dawn M.			Effect of Clinical and Social Risk Factors on Hospital Profiling for Stroke Readmission A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							30-DAY READMISSION; HEART-FAILURE; PREDICTION; MORTALITY; IDENTIFY; MODELS; CARE	Background: The Centers for Medicare & Medicaid Services (CMS) and Veterans Health Administration (VA) will report 30-day stroke readmission rates as a measure of hospital quality. A national debate on whether social risk factors should be included in models developed for hospital profiling is ongoing. Objective: To compare a CMS-based model of 30-day readmission with a more comprehensive model that includes measures of social risk (such as homelessness) or clinical factors (such as stroke severity and functional status). Design: Data from a retrospective cohort study were used to develop a CMS-based 30-day readmission model that included age and comorbid conditions based on codes from the International Classification of Diseases, Ninth Revision, Clinical Modification (model 1). This model was then compared with one that included administrative social risk factors (model 2). Finally, the CMS model (model 1) was compared with a model that included social risk and clinical factors from chart review (model 3). These 3 models were used to rank hospitals by 30-day risk-standardized readmission rates and examine facility rankings among the models. Setting: Hospitals in the VA. Participants: Patients hospitalized with stroke in 2007. Measurements: 30-day readmission rates. Results: The 30-day readmission rate was 12.8%. The c-statistics for the 3 models were 0.636, 0.646, and 0.661, respectively. All hospitals were classified as performing "as expected" using all 3 models (that is, performance did not differ from the VA national average); therefore, the addition of detailed clinical information or social risk factors did not alter assessment of facility performance. Limitation: A predominantly male veteran cohort limits the generalizability of these findings. Conclusion: In the VA, more comprehensive models that included social risk and clinical factors did not affect hospital comparisons based on 30-day readmission rates.	[Keyhani, Salomeh] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Indiana Univ Sch Med, Vet Hlth Adm Hlth Serv Res & Dev, Stroke Qual Enhancement Res Initiat Program, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Ctr Excellence Implementing Evidence Based Practi, Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; Regenstrief Inst Hlth Care, Indianapolis, IN USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Washington, Seattle, WA 98195 USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Keyhani, S (corresponding author), San Francisco VA Med Ctr, 4150 Clement,111A1, San Francisco, CA 94121 USA.	salomeh.keyhani@va.gov			Veterans Health Administration Office of Quality and Performance; Health Services Research and Development Service Quality Enhancement Research Initiative of the Department of Veterans Affairs [RRP 12-192]; National Heart, Lung, and Blood Institute, U. S. Department of Health and Human Services [1R01HL116522-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116522] Funding Source: NIH RePORTER	Veterans Health Administration Office of Quality and Performance; Health Services Research and Development Service Quality Enhancement Research Initiative of the Department of Veterans Affairs; National Heart, Lung, and Blood Institute, U. S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the Veterans Health Administration Office of Quality and Performance and Health Services Research and Development Service Quality Enhancement Research Initiative of the Department of Veterans Affairs (RRP 12-192) and the National Heart, Lung, and Blood Institute, U.S. Department of Health and Human Services (1R01HL116522-01A1).	Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; [Anonymous], 2011, FED REGISTER, V76, P51476; Arbaje AI, 2008, GERONTOLOGIST, V48, P495, DOI 10.1093/geront/48.4.495; Arling G, 2012, CIRC-CARDIOVASC QUAL, V5, P44, DOI 10.1161/CIRCOUTCOMES.111.961474; Austin PC, 2003, MED DECIS MAKING, V23, P526, DOI 10.1177/0272989X03258443; Austin PC, 2002, MED DECIS MAKING, V22, P163, DOI 10.1177/02729890222063044; Bernheim S, 2010, HOSP 30 DAY READMISS; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Keyhani S, 2012, MED CARE, V50, P66, DOI 10.1097/MLR.0b013e3182294092; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Krumholz HM, 2011, RISK ADJUSTMENT MODE; Lichtman JH, 2010, STROKE, V41, P2525, DOI 10.1161/STROKEAHA.110.599159; Morse JM, 2002, AM J INFECT CONTROL, V30, P376, DOI 10.1067/mic.2002.125808; MORSE JM, 1989, SOC SCI MED, V28, P81, DOI 10.1016/0277-9536(89)90309-2; National Quality Forum, 2014, RISK ADJ SOC STAT OT; O'Connell B, 2002, J CLIN NURS, V11, P134, DOI 10.1046/j.1365-2702.2002.00578.x; Reker DM, 2005, J REHABIL RES DEV, V42, P77, DOI 10.1682/JRRD.2003.11.0164; U.S. Department of Health and Human Services, 2011, HOSP COMP; United States Census Bureau, 2014, AM COMM SURV; Williams LS, 2000, STROKE, V31, P858, DOI 10.1161/01.STR.31.4.858; Yale New Haven Health Services Corporation/Center for Outcomes Research and Evaluation, 2012, TEST HOSP LEV AC ISC; Yale New Haven Health Services Corporation/Center for Outcomes Research and Evaluation, 2012, RESP HOSP 30 DAY ISC	27	23	23	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					775	U51		10.7326/M14-0361	http://dx.doi.org/10.7326/M14-0361			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX9UJ	25437405				2022-12-28	WOS:000347247200006
J	Blom, JD; Sommer, IEC; Koops, S; Sacks, OW				Blom, Jan Dirk; Sommer, Iris E. C.; Koops, Sanne; Sacks, Oliver W.			Prosopometamorphopsia and facial hallucinations	LANCET			English	Editorial Material									[Blom, Jan Dirk] Parnassia Psychiat Inst, NL-2552 DH The Hague, Netherlands; [Blom, Jan Dirk] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Sommer, Iris E. C.; Koops, Sanne] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [Sommer, Iris E. C.; Koops, Sanne] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands; [Sacks, Oliver W.] NYU, Sch Med, New York, NY USA	Parnassia Psychiatric Institute; University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; New York University	Blom, JD (corresponding author), Parnassia Psychiat Inst, NL-2552 DH The Hague, Netherlands.	jd.blom@parnassia.nl	; sommer, iris/D-1190-2014	, CCT ServiceDesk/0000-0001-6397-1320; Sommer, Iris/0000-0001-5597-3262; sommer, iris/0000-0002-2682-5313				Bala A, 2014, NEUROCASE; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; ffytche DH, 1999, BRAIN, V122, P1247, DOI 10.1093/brain/122.7.1247; Ffytche DH, 2010, J NEUROL NEUROSUR PS, V81, P1280, DOI 10.1136/jnnp.2008.171348; Pearce JMS, 1998, LANCET, V332, P270	5	12	12	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1998	1998		10.1016/S0140-6736(14)61690-1	http://dx.doi.org/10.1016/S0140-6736(14)61690-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25435453				2022-12-28	WOS:000345450100033
J	Bhabha, G; Cheng, HC; Zhang, N; Moeller, A; Liao, MF; Speir, JA; Cheng, YF; Vale, RD				Bhabha, Gira; Cheng, Hui-Chun; Zhang, Nan; Moeller, Arne; Liao, Maofu; Speir, Jeffrey A.; Cheng, Yifan; Vale, Ronald D.			Allosteric Communication in the Dynein Motor Domain	CELL			English	Article							EM STRUCTURE DETERMINATION; MICROTUBULE-BINDING; CYTOPLASMIC DYNEIN; CRYSTAL-STRUCTURE; FORCE GENERATION; ATP HYDROLYSIS; POWER STROKE; UCSF CHIMERA; COILED-COIL; AAA	Dyneins power microtubule motility using ring-shaped, AAA-containing motor domains. Here, we report X-ray and electron microscopy (EM) structures of yeast dynein bound to different ATP analogs, which collectively provide insight into the roles of dynein's two major ATPase sites, AAA1 and AAA3, in the conformational change mechanism. ATP binding to AAA1 triggers a cascade of conformational changes that propagate to all six AAA domains and cause a large movement of the ``linker,'' dynein's mechanical element. In contrast to the role of AAA1 in driving motility, nucleotide transitions in AAA3 gate the transmission of conformational changes between AAA1 and the linker, suggesting that AAA3 acts as a regulatory switch. Further structural and mutational studies also uncover a role for the linker in regulating the catalytic cycle of AAA1. Together, these results reveal how dynein's two major ATP-binding sites initiate and modulate conformational changes in the motor domain during motility.	[Bhabha, Gira; Cheng, Hui-Chun; Zhang, Nan; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Bhabha, Gira; Cheng, Hui-Chun; Zhang, Nan; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Moeller, Arne; Speir, Jeffrey A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Liao, Maofu; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Scripps Research Institute; University of California System; University of California San Francisco	Cheng, HC (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan.	hccheng@life.nthu.edu.tw; ron.vale@ucsf.edu	Liao, Maofu/AAD-7333-2021	Liao, Maofu/0000-0002-3481-450X; Moeller, Arne/0000-0003-1101-5366; Cheng, Yifan/0000-0001-9535-0369	NIH [R01GM09731, S10RR026814, 9 P41 GM103310]; UCSF (Breakthrough Biomedical Research Award); American Heart Association [11POST7110022]; Merck fellowship of the Damon Runyon Cancer Research Foundation [DRG-2136-12]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, R01GM097312] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF (Breakthrough Biomedical Research Award); American Heart Association(American Heart Association); Merck fellowship of the Damon Runyon Cancer Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge Bridget Carragher, Clint Potter, and their team (NRAMM, Scripps) and staff at ALS beamline 8.3.1 at the Lawrence Berkeley Laboratory for assistance with data collection.We thank Carol Cho (Stanford), Luke Rice (UT Southwestern Medical Center), and all members in the Vale and Cheng labs for helpful discussions. Funding was provided by NIH (R01GM09731, R.D.V.), NIH (S10RR026814; Y.C.), UCSF (Breakthrough Biomedical Research Award, Y.C.), the American Heart Association (11POST7110022, H.-C.C.), the Merck fellowship of the Damon Runyon Cancer Research Foundation (DRG-2136-12, G.B.), and NIH (9 P41 GM103310, to the National Resource for Automated Molecular Microscopy).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Burgess SA, 2004, CURR OPIN STRUC BIOL, V14, P138, DOI 10.1016/j.sbi.2004.03.013; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2013, J CELL SCI, V126, P705, DOI 10.1242/jcs.120725; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Cho C, 2012, BBA-MOL CELL RES, V1823, P182, DOI 10.1016/j.bbamcr.2011.10.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; GIBBONS BH, 1987, J BIOL CHEM, V262, P8354; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2011, NAT STRUCT MOL BIOL, V18, P638, DOI 10.1038/nsmb.2074; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kull FJ, 2013, J CELL SCI, V126, P9, DOI 10.1242/jcs.103911; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lin JF, 2014, NAT CELL BIOL, V16, P479, DOI 10.1038/ncb2939; Nyquist K, 2014, TRENDS BIOCHEM SCI, V39, P53, DOI 10.1016/j.tibs.2013.11.003; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Rayment I, 1996, ANNU REV PHYSIOL, V58, P671; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Roberts AJ, 2012, STRUCTURE, V20, P1670, DOI 10.1016/j.str.2012.07.003; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Zhao CG, 2013, P NATL ACAD SCI USA, V110, pE1545, DOI 10.1073/pnas.1300676110	46	62	62	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					857	868		10.1016/j.cell.2014.10.018	http://dx.doi.org/10.1016/j.cell.2014.10.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417161	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000344522000017
J	Goodrich, JK; Waters, JL; Poole, AC; Sutter, JL; Koren, O; Blekhman, R; Beaumont, M; Van Treuren, W; Knight, R; Bell, JT; Spector, TD; Clark, AG; Ley, RE				Goodrich, Julia K.; Waters, Jillian L.; Poole, Angela C.; Sutter, Jessica L.; Koren, Omry; Blekhman, Ran; Beaumont, Michelle; Van Treuren, William; Knight, Rob; Bell, Jordana T.; Spector, Timothy D.; Clark, Andrew G.; Ley, Ruth E.			Human Genetics Shape the Gut Microbiome	CELL			English	Article							BODY-MASS INDEX; METHANOBREVIBACTER-SMITHII; BIFIDOBACTERIUM-ANIMALIS; LACTOBACILLUS-REUTERI; MONOZYGOTIC TWINS; DIETARY PATTERNS; HOST GENETICS; OBESITY; GENOTYPE; ADULT	Host genetics and the gut microbiome can both influence metabolic phenotypes. However, whether host genetic variation shapes the gut microbiome and interacts with it to affect host phenotype is unclear. Here, we compared microbiotas across >1,000 fecal samples obtained from the TwinsUK population, including 416 twin pairs. We identified many microbial taxa whose abundances were influenced by host genetics. The most heritable taxon, the family Christensenellaceae, formed a co-occurrence network with other heritable Bacteria and with methanogenic Archaea. Furthermore, Christensenellaceae and its partners were enriched in individuals with low body mass index (BMI). An obese-associated microbiome was amended with Christensenella minuta, a cultured member of the Christensenellaceae, and transplanted to germ-free mice. C. minuta amendment reduced weight gain and altered the microbiome of recipient mice. Our findings indicate that host genetics influence the composition of the human gut microbiome and can do so in ways that impact host metabolism.	[Goodrich, Julia K.; Waters, Jillian L.; Poole, Angela C.; Sutter, Jessica L.; Koren, Omry; Blekhman, Ran; Clark, Andrew G.; Ley, Ruth E.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Goodrich, Julia K.; Waters, Jillian L.; Poole, Angela C.; Sutter, Jessica L.; Koren, Omry; Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Beaumont, Michelle; Bell, Jordana T.; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Van Treuren, William; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Cornell University; Cornell University; University of London; King's College London; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Ley, RE (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	rel222@cornell.edu	Bell, Jordana/AAH-7312-2019; Ley, Ruth E/M-8542-2014; Waters, Jillian L./Q-5368-2019; Goodrich, Julia/ABD-8368-2021; Koren, Omry/A-5222-2016; wang, edwin/G-5372-2010; Knight, Rob/D-1299-2010	Ley, Ruth E/0000-0002-9087-1672; Waters, Jillian L./0000-0002-4460-1591; Koren, Omry/0000-0002-7738-1337; Blekhman, Ran/0000-0003-3218-613X; Beaumont, Michelle/0000-0002-3227-380X; Knight, Rob/0000-0002-0975-9019; Clark, Andrew/0000-0001-7159-8511; Bell, Jordana/0000-0002-3858-5986; Poole, Angela/0000-0003-0278-7655	NIH [RO1 DK093595, DP2 OD007444]; Cornell Center for Comparative Population Genomics; Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR) BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) BioResource Clinical Research Facility and Biomedical Research Centre at King's College London; ERC Advanced Researcher Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007617] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007444] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell Center for Comparative Population Genomics; Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR) BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research (NIHR) BioResource Clinical Research Facility and Biomedical Research Centre at King's College London; ERC Advanced Researcher Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Wei Zhang, Sara Di Rienzi, Lauren Harroff, Largus Angenent, Hannah de Jong, Gabe Fox, Nick Scalfone, Ayme Spor, and Beth Bell for their help. We also thank three anonymous reviewers for their helpful comments and Mary-Claire King for her advice and encouragement. This work was funded by NIH RO1 DK093595, DP2 OD007444, The Cornell Center for Comparative Population Genomics, the Wellcome Trust, and the European Community's Seventh Framework Programme (FP7/2007-2013). The study also received support from the National Institute for Health Research (NIHR) BioResource Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London. R.E.L. is a Fellow of the David and Lucile Packard Foundation and of the Arnold and Mabel Beckman Foundation. J.K.G. is a National Academy of Sciences predoctoral Fellow. T.D.S. is holder of an ERC Advanced Researcher Award. R.K. is a Howard Hughes Medical Institute Early Career Scientist.	Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bevins CL, 2011, CELL MOL LIFE SCI, V68, P3675, DOI 10.1007/s00018-011-0830-3; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee S, 2011, APPL ENVIRON MICROB, V77, P7433, DOI 10.1128/AEM.05490-11; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Menni C, 2013, METABOLOMICS, V9, P506, DOI 10.1007/s11306-012-0469-6; Million M, 2013, INT J OBESITY, V37, P1460, DOI 10.1038/ijo.2013.20; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Morotomi M, 2012, INT J SYST EVOL MICR, V62, P144, DOI 10.1099/ijs.0.026989-0; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Simoes CD, 2013, J NUTR, V143, P417, DOI 10.3945/jn.112.166322; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Teucher B, 2007, TWIN RES HUM GENET, V10, P734, DOI 10.1375/twin.10.5.734; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Tims S, 2011, METAGENOMICS OF THE HUMAN BODY, P15, DOI 10.1007/978-1-4419-7089-3_2; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	60	1719	1788	27	607	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					789	799		10.1016/j.cell.2014.09.053	http://dx.doi.org/10.1016/j.cell.2014.09.053			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417156	Green Accepted, Bronze			2022-12-28	WOS:000344522000012
J	Renier, N; Wu, ZH; Simon, DJ; Yang, J; Ariel, P; Tessier-Lavigne, M				Renier, Nicolas; Wu, Zhuhao; Simon, David J.; Yang, Jing; Ariel, Pablo; Tessier-Lavigne, Marc			iDISCO: A Simple, RapidMethod to Immunolabel Large Tissue Samples for Volume Imaging	CELL			English	Article							NEURONAL DEATH; FOXP2; EXPRESSION; BAX; VISUALIZATION; PROTEIN; SCALE	The visualization of molecularly labeled structures within large intact tissues in three dimensions is an area of intense focus. We describe a simple, rapid, and inexpensive method, iDISCO, that permits whole-mount immunolabeling with volume imaging of large cleared samples ranging from perinatal mouse embryos to adult organs, such as brains or kidneys. iDISCO is modeled on classical histology techniques, facilitating translation of section staining assays to intact tissues, as evidenced by compatibility with 28 antibodies to both endogenous antigens and transgenic reporters like GFP. When applied to degenerating neurons, iDISCO revealed unexpected variability in number of apoptotic neurons within individual sensory ganglia despite tight control of total number in all ganglia. It also permitted imaging of single degenerating axons in adult brain and the first visualization of cleaved Caspase-3 in degenerating embryonic sensory axons in vivo, even single axons. iDISCO enables facile volume imaging of immunolabeled structures in complex tissues.	[Renier, Nicolas; Wu, Zhuhao; Simon, David J.; Yang, Jing; Tessier-Lavigne, Marc] Rockefeller Univ, Lab Brain Dev & Repair, New York, NY 10065 USA; [Ariel, Pablo] Rockefeller Univ, Bioimaging Resource Ctr, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Tessier-Lavigne, M (corresponding author), Rockefeller Univ, Lab Brain Dev & Repair, 1230 York Ave, New York, NY 10065 USA.	marctl@rockefeller.edu	Wu, Zhuhao/I-5852-2018; Yang, Jing/M-2831-2017; Renier, Nicolas/E-1855-2018	Yang, Jing/0000-0002-2048-735X; Renier, Nicolas/0000-0003-2642-4402; Wu, Zhuhao/0000-0002-2471-0555; Ariel, Pablo/0000-0002-8494-0379; Simon, David/0000-0002-2683-5757	The Rockefeller University; EMBO; Empire State Stem Cell Fund through New York State Department of Health (NYSDOH) [C023046]	The Rockefeller University; EMBO(European Molecular Biology Organization (EMBO)); Empire State Stem Cell Fund through New York State Department of Health (NYSDOH)	We thank Frank Bradke and Alain Chedotal for sharing insights on 3DISCO, Olav Olsen for valuable input, Ricardo Azevedo for technical support, and other members of the M.T.-L. laboratory for helpful discussions. Our gratitude goes to other team members of the Rockefeller University Bio-Imaging Resource Center, and in particular Kaye Thomas, Tao Tong, and Alison North. Supported by The Rockefeller University. N. R. is supported by an EMBO longterm fellowship. The imaging center is supported by the Empire State Stem Cell Fund through New York State Department of Health (NYSDOH) contract C023046. Opinions expressed here are solely those of the author and do not necessarily reflect those of the Empire State Stem Cell Fund, the NYSDOH, or the state of NY.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Campbell DS, 2013, J CELL BIOL, V203, P657, DOI 10.1083/jcb.201303072; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Erturk A, 2014, JOVE-J VIS EXP, DOI 10.3791/51382; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; FREDERIC F, 1992, EUR J NEUROSCI, V4, P127, DOI 10.1111/j.1460-9568.1992.tb00859.x; Fujita H, 2012, J COMP NEUROL, V520, P656, DOI 10.1002/cne.22760; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Horng S, 2009, J NEUROSCI, V29, P13672, DOI 10.1523/JNEUROSCI.2127-09.2009; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Oh WJ, 2013, NEURON, V80, P458, DOI 10.1016/j.neuron.2013.09.005; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Scott GD, 2014, AM J RESP CELL MOL, V51, P43, DOI 10.1165/rcmb.2013-0284OC; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Spalteholz W., 1914, DURCHSICHTIAMACHEN M; Sun W, 2003, J NEUROSCI, V23, P7298, DOI 10.1523/jneurosci.23-19-07298.2003; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	36	785	807	13	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					896	910		10.1016/j.cell.2014.10.010	http://dx.doi.org/10.1016/j.cell.2014.10.010			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417164	Bronze			2022-12-28	WOS:000344522000020
J	Amrith, SS				Amrith, Sunil S.			The art of medicine Migration and health in southeast Asian history	LANCET			English	Editorial Material									Univ London Birkbeck Coll, Dept Hist, London WC1E 7HX, England	University of London; Birkbeck University London	Amrith, SS (corresponding author), Univ London Birkbeck Coll, Dept Hist, London WC1E 7HX, England.	s.amrith@bbk.ac.uk						Amrith S.S., 2013, CROSSING BAY BENGAL; Cochran Sherman, 2006, CHINESE MED MEN CONS; Harper Tim, 2014, HIST HLTH SE ASIA PE; International Federation of Red Cross and Red Crescent Societies (IFRC), 2012, WORLD DIS REP 2012 F; Kaur A., 2006, MOBILITY LABOUR MIGR	5	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1569	1570		10.1016/S0140-6736(14)61976-0	http://dx.doi.org/10.1016/S0140-6736(14)61976-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AR9NK	25473672				2022-12-28	WOS:000343901700014
J	Napier, AD; Ancarno, C; Butler, B; Calabrese, J; Chater, A; Chatterjee, H; Guesnet, F; Horne, R; Jacyna, S; Jadhav, S; Macdonald, A; Neuendorf, U; Parkhurst, A; Reynolds, R; Scambler, G; Shamdasani, S; Smith, SZ; Stougaard-Nielsen, J; Thomson, L; Tyler, N; Volkmann, AM; Walker, T; Watson, J; Williams, ACD; Willott, C; Wilson, J; Woolf, K				Napier, A. David; Ancarno, Clyde; Butler, Beverley; Calabrese, Joseph; Chater, Angel; Chatterjee, Helen; Guesnet, Francois; Horne, Robert; Jacyna, Stephen; Jadhav, Sushrut; Macdonald, Alison; Neuendorf, Ulrike; Parkhurst, Aaron; Reynolds, Rodney; Scambler, Graham; Shamdasani, Sonu; Smith, Sonia Zafer; Stougaard-Nielsen, Jakob; Thomson, Linda; Tyler, Nick; Volkmann, Anna-Maria; Walker, Trinley; Watson, Jessica; Williams, Amanda C. de C.; Willott, Chris; Wilson, James; Woolf, Katherine			Culture and health	LANCET			English	Review							MENTAL-HEALTH; COMPETENCE; FORMULATION; MODEL; CARE; POPULATION; EDUCATION; MULTICULTURALISM; PROFESSIONALS; PRESCRIPTION		[Napier, A. David; Butler, Beverley; Calabrese, Joseph; Chatterjee, Helen; Guesnet, Francois; Macdonald, Alison; Neuendorf, Ulrike; Parkhurst, Aaron; Scambler, Graham; Smith, Sonia Zafer; Stougaard-Nielsen, Jakob; Thomson, Linda; Tyler, Nick; Volkmann, Anna-Maria; Williams, Amanda C. de C.; Wilson, James] UCL, London WC1E 6BT, England; [Horne, Robert] UCL, Sch Pharm, London WC1E 6BT, England; [Reynolds, Rodney; Willott, Chris] UCL, Inst Global Hlth, London WC1E 6BT, England; [Jacyna, Stephen] UCL, Ctr Hist Med, London WC1E 6BT, England; [Jadhav, Sushrut] UCL, Div Psychiat, London WC1E 6BT, England; [Shamdasani, Sonu] UCL, Sch European Languages Culture & Soc, London WC1E 6BT, England; [Woolf, Katherine] UCL, Sch Med, London WC1E 6BT, England; [Ancarno, Clyde] Kings Coll London, Dept Educ, London, England; [Chater, Angel] Univ Bedfordshire, Dept Psychol, Luton, Beds, England; [Walker, Trinley; Watson, Jessica] Int Longev Ctr, London, England	University of London; University College London; University of London; University College London; University of London School of Pharmacy; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University of London; King's College London; University of Bedfordshire	Napier, AD (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	d.napier@ucl.ac.uk	Calabrese, Joseph/AFU-2467-2022; Li, Shuangyu/R-8334-2019; Woolf, Katherine/AAD-8043-2021	Calabrese, Joseph/0000-0002-7966-3493; Li, Shuangyu/0000-0002-8651-1148; Woolf, Katherine/0000-0003-4915-0715; Chatterjee, Helen/0000-0001-7943-1580; Tyler, Nick/0000-0001-7079-1301; Willott, Chris/0000-0003-0940-4215; Chater, Angel Marie/0000-0002-9043-2565; Butler, Beverley/0000-0002-6512-2362; Wilson, James/0000-0002-0911-8510; Williams, Amanda/0000-0003-3761-8704; Ancarno, Clyde/0000-0002-8611-2868	Merlin UK; Novo Nordisk; University College London Business spin out company; European Social Research Council; Boston Scientific; Pfizer; Astellas; AHRC [AH/J008524/1] Funding Source: UKRI; EPSRC [EP/J017698/1, EP/G013071/1, EP/K020323/1, EP/F004117/1, EP/I031723/1, EP/F019254/1] Funding Source: UKRI; MRC [G0700729] Funding Source: UKRI; Arts and Humanities Research Council [AH/J008524/1] Funding Source: researchfish; Economic and Social Research Council [1046444] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J017698/1, EP/K020323/1, EP/C533429/1, EP/F019254/1, GR/S44631/01, EP/C525841/1, EP/I031723/1, EP/F004117/1, EP/G013071/1] Funding Source: researchfish; Medical Research Council [G0700729] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10197] Funding Source: researchfish	Merlin UK; Novo Nordisk(Novo Nordisk); University College London Business spin out company; European Social Research Council; Boston Scientific(Boston Scientific); Pfizer(Pfizer); Astellas(Astellas Pharmaceuticals); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	ADN has received grants from the UN, Merlin UK, and Novo Nordisk to develop vulnerability assessments for vulnerable populations. RH has undertaken speaker engagements with honoraria with Abbvie, Amgen, Biogen Idec, Gilead Sciences, GlaxoSmithKline, Janssen, Pfizer, Roche, and Shire Pharmaceuticals, and is a funder and shareholder of a University College London Business spin out company providing consultancy on medication-related behaviours to health-care policy makers, providers, and industry. SZS has received grants from the European Social Research Council. ACdCW has received grants from Boston Scientific, Pfizer, and Astellas. All other authors declare no competing interests.	Adshead G, 2005, ADV PSYCHIAT TREAT, V11, P330, DOI DOI 10.1192/APT.11.5.330; Aggarwal NK, 2011, ACAD PSYCHIATR, V35, P331, DOI 10.1176/appi.ap.35.5.331; Allan CA, 2011, RESPONSE AM PSYCHIAT; Alston P, 2000, HUMAN DEV REPORT 200, P81; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2009, SELF CAR CONT PRIM H; [Anonymous], 1984, ILLNESS CULTURE CONT; [Anonymous], 2010, BBC NEWS; [Anonymous], 2013, TIMES AUSTR NZ  0619; [Anonymous], 2011, BBC NEWS POLITI 0205; Baarnhielm S, 2009, TRANSCULT PSYCHIATRY, V46, P406, DOI 10.1177/1363461509342946; Baraka MA, 2011, J PERINAT MED, V39, P685, DOI [10.1515/JPM.2011.085, 10.1515/jpm.2011.085]; Barth, 1969, ETHNIC GROUPS BOUNDA; Bauman Z, 2007, LIQUID TIMES LIVING; Bauman Zygmunt, 2006, LIQUID MODERNITY; Beach MC, 2005, MED CARE, V43, P356, DOI 10.1097/01.mlr.0000156861.58905.96; Beck U., 1994, RISK SOC NEW MODERNI; Beckett SL, 1997, CONTR ST WO, pR9; Beneduce R, 2008, SOC SCI INFORM, V47, P505, DOI 10.1177/0539018408096444; Betancourt JR, 2006, ACAD MED, V81, P499, DOI 10.1097/01.ACM.0000225211.77088.cb; Betancourt JR, 2004, NEW ENGL J MED, V351, P953, DOI 10.1056/NEJMp048033; Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293; Betancourt JR., 2002, CULTURAL COMPETENCE; Bharadwaj A, 2005, CROSSING BORDERS CUL, P325; Borofsky R, 2005, YANOMAMI FIERCE CONT; Bourdieu P., 1977, OUTLINE THEORY PRACT, DOI DOI 10.1017/CBO9780511812507; Bourgois P, 2004, CURR ANTHROPOL, V45, P317; Bourgois P, 2011, CITY SOC, V23, P2, DOI 10.1111/j.1548-744X.2011.01045.x; Brown B., 2006, EVIDENCE BASED HLTH; Brundtland Commission, 1987, OUR COMMON FUTURE, DOI DOI 10.1080/07488008808408783; Calabrese J, 2013, DIFFERENT MED POSTCO; Castro A., 2004, UNHEALTHY HLTH POLIC; Cetina Karin Knorr, 1999, EPISTEMIC CULTURES S; Chan M, WHO RETURN ALMA ATA; Chatterjee H, 2013, MUSEUMS, HEALTH AND WELL-BEING, P1; Clift C., 2014, WHATS WHO; Cohen Lawrence, 1998, NO AGING INDIA ALZHE; CONRAD P, 1988, J HEALTH SOC BEHAV, V29, P323, DOI 10.2307/2136866; Conrad P, 2005, J HEALTH SOC BEHAV, V46, P3, DOI 10.1177/002214650504600102; Crisp Nigel., 2010, TURNING WORLD UPSIDE; Csordas T, 1997, SACRED SELF CULTURAL; Cuypers K, 2012, J EPIDEMIOL COMMUN H, V66, P698, DOI 10.1136/jech.2010.113571; Danforth Loring M., 1989, FIREWALKING RELIG HE; Das J, HLTH AFF MILLWOOD, V31, P2774; Das V, 2007, LIFE AND WORDS: VIOLENCE AND THE DESCENT INTO THE ORDINARY, P1; Das Veena, 2000, VIOLENCE SUBJECTIVIT; Das Veena, 2001, REMAKING WORLD VIOLE; Dein S, 2008, TRANSCULT PSYCHIATRY, V45, P31, DOI 10.1177/1363461507087997; DelVecchio Good MJ, 2002, 199 RUSS SAG FDN, P595; DiGiacomo S, 1987, CASE STUDIES MED ANT, P315; Dinh NMH, 2012, ANTHROPOL MED, V19, P261, DOI 10.1080/13648470.2011.646944; Dogra Nisha, 2007, BMC Med Educ, V7, P8, DOI 10.1186/1472-6920-7-8; Donnan PT, 2002, DIABETIC MED, V19, P279, DOI 10.1046/j.1464-5491.2002.00689.x; Dormandy E, 2005, INT J EPIDEMIOL, V34, P346, DOI 10.1093/ije/dyi021; Durkheim E., 1982, RULES SOCIOLOGICAL M; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Ebeigbe P N, 2010, Ghana Med J, V44, P47; Edmonds A, 2007, J ROY ANTHROPOL INST, V13, P363, DOI 10.1111/j.1467-9655.2007.00427.x; Educational UN, 1996, OUR CREAT DIV; Emanuel EJ, 2011, NY TIMES; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Engels F., 1973, CONDITION WORKING CL; Eriksen TH, 2001, CULTURE RIGHTS ANTHR; Fabbri K., 2007, THESIS SCH ORIENTAL; Fadiman A., 1997, SPIRIT CATCHES YOU Y; Farmer J, 2003, SOC SCI MED, V57, P673, DOI 10.1016/S0277-9536(02)00410-0; Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250; Farmer P., 2003, Pathologies of power: health, human rights and the new war on the poor; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Fassin D, 2012, HUMANITARIAN REASON: A MORAL HISTORY OF THE PRESENT, P1; Fassin Didier, 2009, EMPIRE TRAUMA INQUIR; Finkielkraut A., 1987, DEFAITE PENSEE; Fleck Ludwik, 1979, GENESIS DEV SCI FACT; Foucault M., 1995, DISCIPLINE PUNISH BI, P201; Fox RC, 2005, NEW ENGL J MED, V353, P1316, DOI 10.1056/NEJMp058066; Freeman J, 2009, TYRANNY E MAIL 4000; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Galanti G-A., 2013, CULTURAL SENSITIVITY; Galanti GA, 2008, CARING PATIENTS DIFF; Garcia Angela., 2010, PASTORAL CLIN ADDICT; Garroutte EM, 2003, REAL INDIANS: IDENTITY AND THE SURVIVAL OF NORTH AMERICA, P1; Godkin MA, 2001, FAM MED, V33, P178; Good B, 1994, MED RATIONALITY EXPE; GOOD MJD, 1990, CULT MED PSYCHIAT, V14, P59; Good MJD, 2011, SHATTERING CULTURE: AMERICAN MEDICINE RESPONDS TO CULTURAL DIVERSITY, P1; Gray JA, 2011, BUILD HEALTHCARE SYS; Gray JAM, 2011, GET BETTER VALUE HEA; Greenhalgh T, 1999, BMJ-BRIT MED J, V318, P323, DOI 10.1136/bmj.318.7179.323; Gregg J, 2006, ACAD MED, V81, P542, DOI 10.1097/01.ACM.0000225218.15207.30; Grinker R. R., 2008, UNSTRANGE MINDS REMA; Groce N., 1985, EVERYONE HERE SPOKE; Habermas J, 1987, THEORY COMMUNICATIVE, V2; Haines A, 2011, LANCET, V377, P363, DOI 10.1016/S0140-6736(11)60108-6; Hamdy S, 2012, OUR BODIES BELONG TO GOD: ORGAN TRANSPLANTS, ISLAM, AND THE STRUGGLE FOR HUMAN DIGNITY IN EGYPT, P1; HAMPTON JR, 1975, BRIT MED J, V2, P486, DOI 10.1136/bmj.2.5969.486; Hansen HB, 2013, HEALTH AFFAIR, V32, P984, DOI 10.1377/hlthaff.2011.0596; HARDON AP, 1987, SOC SCI MED, V25, P277, DOI 10.1016/0277-9536(87)90231-0; Health Jeeves A., 2000, S AFR HIST J, V43, P244; HELMAN C G, 1978, Culture Medicine and Psychiatry, V2, P107, DOI 10.1007/BF00054580; Helman C.G., 2007, CULTURE HLTH ILLNESS; Henry, 2012, PRICE OFFSHORE REVIS; Holden J, 2012, GUARDIAN; Holmes Seth, 2013, FRESH FRUIT BROKEN B; Horgan J., 2011, SCI AM; Hunt LM, 2001, MED ANTHROPOL Q, V15, P347, DOI 10.1525/maq.2001.15.3.347; JADHAV S, 1995, LANCET, V345, P808, DOI 10.1016/S0140-6736(95)92959-2; Jadhav S, 2001, BIBL PSYCHIAT, P141; Jadhav S, 2009, THEORY ACTION ESSAYS, P92; Jenks AC, 2011, CULT MED PSYCHIAT, V35, P209, DOI 10.1007/s11013-011-9212-4; JOSHI BR, 1980, PAC AFF, V53, P193, DOI 10.2307/2757470; Joshi BR, INDIAS UNTOUCHABLES; Kaplan FE, 1996, MUSEUMS MAKING OURSE; Keynes JM, 1937, Q J ECON, V51, P209, DOI 10.2307/1882087; Khanna P, 2011, RUN WORLD CHARTING C; Kiernan Ben., 2008, POL POT REGIME RACE, V3rd; Kim JY, 2005, SOC SCI MED, V61, P847, DOI 10.1016/j.socscimed.2004.08.046; Kirmayer Laurence J, 2003, Anthropol Med, V10, P167, DOI 10.1080/1364847032000122843; Kirmayer LJ, 2012, SOC SCI MED, V75, P249, DOI 10.1016/j.socscimed.2012.03.018; Kleinman A., 1994, PAIN HUMAN EXPERIENC; Kleinman A., 1989, ILLNESS NARRATIVES S; Kleinman A, 2006, PLOS MED, V3, P1673, DOI 10.1371/journal.pmed.0030294; Konner M., 1993, MED CROSSROADS CRISI; Kripalani S, 2006, J GEN INTERN MED, V21, P1116, DOI 10.1111/j.1525-1497.2006.00557.x; Krishnan N, 2010, TRANSPLANTATION, V89, P1456, DOI 10.1097/TP.0b013e3181da6019; Lakoff A, 2010, HUMANITY, V1, P59, DOI 10.1353/hum.2010.0001; LaMotagne C, 2014, NERDWALLET HLTH FIND; Landecker H, 2013, ANNU REV SOCIOL, V39, P333, DOI 10.1146/annurev-soc-071312-145707; Last M., 2007, KNOWING NOT KNOWING; Laurance J., 2013, INDEPENDENT LON 0625, P11; Leach E., 1964, NEW DIRECTIONS STUDY, P23; Lee SA., 2006, ANTHR NEWS, V47, P9, DOI [DOI 10.1525/an.2006.47.3.9, 10.1525/an.2006.47.3.9, DOI 10.1525/AN.2006.47.3.9]; Levi-Strauss C, 1961, RACE HIST; Levis-Strauss C., 1975, VOIE MASQUES; Lewis-Fernandez R, 2002, PSYCHIAT QUART, V73, P271, DOI 10.1023/A:1020412000183; Lewis-Fernandez R, 2014, PSYCHIATRY, V77, P130, DOI 10.1521/psyc.2014.77.2.130; Lewis-Fernandez R, 2013, J NERV MENT DIS, V201, P860, DOI 10.1097/NMD.0b013e3182a5c184; Lipsky M, 1980, STREET LEVEL BUREAUC; Littlewood R, 1982, ALIENS ALIENISTS ETH; Livingston J., 2012, IMPROVISING MED AFRI; Lock M, 2005, CURR ANTHROPOL, V46, pS47, DOI 10.1086/432452; Lock M, 2010, ANTHR BIOMEDICINE; Lock M, 1988, BIOMEDICINE EXAMINED; Lock M, 2013, MED ANTHROPOL, V32, P291, DOI 10.1080/01459740.2012.746973; Lock Margaret, 1995, CULT MED PSYCHIAT, DOI DOI 10.1007/BF01379401; Loizos Peter, 2008, IRON SOUL DISPLACEME; Lu FG, 2008, CULTURAL FORMULATION; Luhrman T, 2012, GOD TALKS BACK UNDER; Lukes, 2011, MORAL RELATIVISM; Mackintosh M, 2006, J INT DEV, V18, P757; Mahler H, 1981, WORLD HEALTH FORUM, V2, P5; Manderson L, 2004, INT FEM J POLIT, V6, P285, DOI DOI 10.1080/1461674042000211272; Manderson L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000332; Martinez-Hernaez A, 2000, WHATS SYMPTOM PSYCHI; Mattingly Cheryl, 2000, NARRATIVE T HE CULTU; Mazzanti M, 2002, J SOCIO-ECON, V31, P529, DOI DOI 10.1016/S1053-5357(02)00133-6; McCrae M, 2003, NATL HLTH SERVICE SC; Mensah K, 2005, SKILLS DRAIN HLTH PR; Mestrovic SG, 1992, DURKHEIM POSTMODERN, P56; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mohanty SP, 1989, NEW FORMATIONS, V8, P55; Mol A, 2008, LOGIC CARE HLTH PROB; Mol A., 2002, BODY MULTIPLE ONTOLO, DOI [10.1215/9780822384151, DOI 10.1215/9780822384151]; Moncrieff J., 2009, MYTH CHEM CURE CRITI; Napier AD, 2013, CAMB J ANTHROPOL, V31, P20, DOI 10.3167/ca.2013.310202; Napier AD, 2012, CULT ANTHROPOL, V27, P122, DOI 10.1111/j.1548-1360.2012.01130.x; Napier AD, 2004, CONTEMP ETHNOGR, P1; Napier AD, 1992, FOREIGN BODIES PERFO; Napier AD, 1993, VERMONT STATE ME SEP, P7; Napier AD, 2013, MAKING THINGS BETTER; Napier AD, 2003, AGE IMMUNOLOGY CONCE, P128; Needham Rodney, 1972, BELIEF LANGUAGE EXPE; Nunez-de la Mora A, 2009, HLTH RISK ADVERSITY; Nussbaum M, 2004, GLOBAL TENSIONS CHAL, P246; Nussbaum M.C., 2000, WOMEN HUMAN DEV CAPA; Obeyesekere Gannath, 1985, CULTURE DEPRESSION S, P134; Office for National Statistics, PAR COUNTR BIRTH ENG; Ohnuki-Tierney E., 1994, RICE SELF JAPANESE I; Ong A., 2006, NEOLIBERALISM EXCEPT, DOI 10.1515/9780822387879; Orr Jackie, 2006, PANIC DIARIES GENEAL; Pandolfo S, 2008, POSTCOLONIAL DISORDERS, P329; Papoz L, 1996, AM J EPIDEMIOL, V143, P1018; Payer L., 1988, MED CULTURE VARIETIE; Petryna A., 2009, EXPT TRAVEL CLIN TRI; Pfeiffer J, 2003, SOC SCI MED, V56, P725, DOI 10.1016/S0277-9536(02)00068-0; Piller Ingrid, 2011, INTERCULTURAL COMMUN; Pollock AM, 2004, NHS PLC PRIVATISATIO; Popenoe B, 2003, FEEDING DESIRE FATNE; Redfield R., 1941, FOLK CULTURE YUCATAN, P132; Richards P., 2005, NO PEACE NO WAR ANTH; Rivers WH, 2001, MAGIC MED RELIG, P1; Roberts C, 2005, MED EDUC, V39, P465, DOI 10.1111/j.1365-2929.2005.02121.x; Roberts Elizabeth F. S., 2012, GODS LAB ASSISTED RE, DOI DOI 10.1525/9780520952256; Rose Nikolas, 2007, POLITICS LIFE ITSELF; Royal New Zealand College of General Practitioners, 2007, CULT COMP ADV GPS CR; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Sainsbury Centre for Mental Health, 2006, 6 SAINSB CTR MENT HL; Santiago-Irizarry V, 2001, MED ETHNICITY CONSTR; Scambler G, 2012, SOCIOL HEALTH ILL, V34, P130, DOI 10.1111/j.1467-9566.2011.01387.x; Scambler G, 2009, SOCIOL HEALTH ILL, V31, P441, DOI 10.1111/j.1467-9566.2009.01161.x; Scheper-Hughes N, 2007, AM J TRANSPLANT, V7, P507, DOI 10.1111/j.1600-6143.2006.01679.x; Scheper-Hughes N, 2007, ETHNOG STUD SUBJ, V7, P179; Scheper-Hughes Nancy, 2004, VIOLENCE WAR PEACE A, P1; Scheper-Hughes Nancy., 1992, DEATH WEEPING VIOLEN; Scheper--Hughes Nancy, 2002, COMMODIFYING BODIES; SCHEPERHUGHES N, 1990, SOC SCI MED, V30, P189, DOI 10.1016/0277-9536(90)90079-8; Scott J. C., 1985, WEAPONS WEAK EVERYDA; Sen A., 1999, COMMODITIES CAPABILI; Sen A., 1999, DEV FREEDOM; Sen A., 2005, J HUMAN DEV, V6, P151, DOI DOI 10.1080/14649880500120491; Sen A. K., 1993, QUALITY LIFE; Shamdasani S, 2005, HIST HUM SCI, V18, P1, DOI 10.1177/0952695105051123; Shimazono Y, 2007, B WORLD HEALTH ORGAN, V85, P955, DOI 10.2471/BLT.06.039370; Shucksmith M, 1996, RURAL SCOTLAND TODAY; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; SINGER M, 1995, MED ANTHROPOL Q, V9, P80, DOI 10.1525/maq.1995.9.1.02a00060; Singer M, 1995, MED ANTHROPOL Q, V9, P107; Singh I, 2012, BIOSOCIETIES, V7, P308, DOI 10.1057/biosoc.2012.20; Sonneck G, 1996, OMEGA, V33, P253; Staricoff RL, 2004, RES REPROD, V36, P1; Staricoff RL, 2006, J R SOC PROMO HEALTH, V126, P116, DOI 10.1177/1466424006064300; Stern, 2012, END GRAUZ GER VERB R; Stoller P., 2005, STRANGER VILLAGE SIC; Strathern M., 2000, AUDIT CULTURES ANTHR; Strathern M., 1992, REPROD FUTURE ESSAYS; Talbot M, 2004, MED EDUC, V38, P587, DOI 10.1046/j.1365-2923.2004.01794.x; Taylor JS, 2003, ACAD MED, V78, P555, DOI 10.1097/00001888-200306000-00003; Taylor R., 2013, GUARDIAN LONDON 0309; Towle A, 2010, MED EDUC, V44, P64, DOI 10.1111/j.1365-2923.2009.03530.x; Trostle JamesA., 2005, EPIDEMIOLOGY CULTURE; Tylor EdwardB., 1920, PRIMITIVE CULTURE, V6th; Virchow R., 1958, DIS LIFE MAN; Walzer M., 1994, THICK THIN MORAL ARG; Wang FH, 2005, HEALTH PLACE, V11, P131, DOI 10.1016/j.healthplace.2004.02.003; Wear D, 2003, ACAD MED, V78, P549, DOI 10.1097/00001888-200306000-00002; Weiss, 1997, TRANSCULT PSYCHIATRY, V34, P235, DOI [DOI 10.1177/136346159703400204, 10.1177/136346159703400204]; WHO, 2001, WHO GLOB STRAT CONT; WHO Regional Office for Europe, 2013, EUR HLTH REP 2012 CH; WHO Western Pacific Region, 2012, WHO MULT COOP STRAT; Whyte SR, 1991, CHANGING UGANDA DILE, P130; Widder Joachim, 2004, Med Health Care Philos, V7, P99, DOI 10.1023/B:MHEP.0000021679.52642.25; Wideman D., 2010, CHRONIC CONDITIONS F; Wijesinghe Pushpa R, 2012, WHO South East Asia J Public Health, V1, P28, DOI 10.4103/2224-3151.206911; Wilkinson R., 2003, Social determinants of health: the solid facts; Wilkinson Richard, 2009, SPIRIT LEVEL WHY EQU; World Conference on Social Determinants of Health, 2011, RIO POL DECL SOC DET; World Health Organization. Regional Office for Europe, 2013, HLTH 2020 EUR POL FR; World Health Organization (WHO), WHO DEF HLTH; Zafar A, 2010, PRIM CARE DIABETES, V4, P203, DOI 10.1016/j.pcd.2010.07.003	249	336	338	17	111	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1607	1639		10.1016/S0140-6736(14)61603-2	http://dx.doi.org/10.1016/S0140-6736(14)61603-2			33	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9NK	25443490				2022-12-28	WOS:000343901700030
J	Jia, J; Arif, A; Terenzi, F; Willard, B; Plow, EF; Hazen, SL; Fox, PL				Jia, Jie; Arif, Abul; Terenzi, Fulvia; Willard, Belinda; Plow, Edward F.; Hazen, Stanley L.; Fox, Paul L.			Target-Selective Protein S-Nitrosylation by Sequence Motif Recognition	CELL			English	Article							NITRIC-OXIDE SYNTHASE; TRANSFER-RNA SYNTHETASE; NONCANONICAL FUNCTION; GENOME-WIDE; CELL-DEATH; BINDING; COMPLEX; GAPDH; IDENTIFICATION; EXPRESSION	S-nitrosylation is a ubiquitous protein modification emerging as a principal mechanism of nitric oxide (NO)-mediated signal transduction and cell function. S-nitrosylases can use NO synthase (NOS)-derived NO to modify selected cysteines in target proteins. Despite proteomic identification of over a thousand S-nitrosylated proteins, few S-nitrosylases have been identified. Moreover, mechanisms underlying site-selective S-nitrosylation and the potential role of specific sequence motifs remain largely unknown. Here, we describe a stimulus-inducible, heterotrimeric S-nitrosylase complex consisting of inducible NOS (iNOS), S100A8, and S100A9. S100A9 exhibits transnitrosylase activity, shuttling NO from iNOS to the target protein, whereas S100A8 and S100A9 coordinately direct site selection. A family of proteins S-nitrosylated by iNOS-S100A8/A9 were revealed by proteomic analysis. A conserved I/L-X-C-X-2-D/E motif was necessary and sufficient for iNOS-S100A8/A9-mediated S-nitrosylation. These results reveal an elusive parallel between protein S-nitrosylation and phosphorylation, namely, stimulus-dependent posttranslational modification of selected targets by primary sequence motif recognition.	[Jia, Jie; Arif, Abul; Terenzi, Fulvia; Hazen, Stanley L.; Fox, Paul L.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Willard, Belinda] Cleveland Clin, Lerner Res Inst, Mass Spectrometry Lab Prot Sequencing, Cleveland, OH 44195 USA; [Plow, Edward F.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.	foxp@ccf.org	Hazen, Stanley L/ABD-5845-2021	Jia, Jie/0000-0002-9583-1055	NIH [P01 HL029582, P01 HL076491, R01 GM086430, S10 RR031537]; AHA, National Affiliate; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL017964, P01HL076491, P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086430] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA, National Affiliate; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants P01 HL029582, P01 HL076491, and R01 GM086430 (to P.L.F.). A.A. was supported by a Scientist Development Grant from the AHA, National Affiliate. Shared Instrument Grant, S10 RR031537 from the NIH (to B.W.) was used to purchase the Orbitrap mass spectrometer. A patent has been filed for the SunTag technology.	Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Buzko O, 2002, BIOINFORMATICS, V18, P1274, DOI 10.1093/bioinformatics/18.9.1274; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chen YJ, 2010, J PROTEOME RES, V9, P6417, DOI 10.1021/pr100680a; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Edwards SD, 2001, BIOCHEMISTRY-US, V40, P7061, DOI 10.1021/bi010419h; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gould N, 2013, J BIOL CHEM, V288, P26473, DOI 10.1074/jbc.R113.460261; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Ha TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008840; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUBER R, 1992, J MOL BIOL, V223, P683, DOI 10.1016/0022-2836(92)90984-R; Ionita MG, 2009, ARTERIOSCL THROM VAS, V29, P1220, DOI 10.1161/ATVBAHA.109.190314; Ismail SA, 2005, ACTA CRYSTALLOGR D, V61, P1508, DOI 10.1107/S0907444905026740; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jia J, 2012, MOL CELL, V47, P656, DOI 10.1016/j.molcel.2012.06.006; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lee S, 2014, CELL METAB, V19, P484, DOI 10.1016/j.cmet.2014.01.013; Lee TY, 2012, BIOINFORMATICS, V28, P2293, DOI 10.1093/bioinformatics/bts436; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Lim SY, 2008, J IMMUNOL, V181, P5627, DOI 10.4049/jimmunol.181.8.5627; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Ma LP, 2012, INT J CARDIOL, V155, P26, DOI 10.1016/j.ijcard.2011.01.082; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; Marozkina NV, 2012, BBA-GEN SUBJECTS, V1820, P722, DOI 10.1016/j.bbagen.2011.06.017; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nakamura T, 2013, ANTIOXID REDOX SIGN, V18, P239, DOI 10.1089/ars.2012.4703; Nathan C, 2005, J EXP MED, V202, P1163, DOI 10.1084/jem.20051529; Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012; PADGETT CM, 1995, AM J PHYSIOL-CELL PH, V269, pC739, DOI 10.1152/ajpcell.1995.269.3.C739; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Riva M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061832; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; van Tits LJH, 2000, FREE RADICAL BIO MED, V29, P747, DOI 10.1016/S0891-5849(00)00372-5; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vyas K, 2009, MOL CELL BIOL, V29, P458, DOI 10.1128/MCB.00824-08; Wu CG, 2011, J PROTEOMICS, V74, P2498, DOI 10.1016/j.jprot.2011.06.001; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Zahid S, 2014, NEUROSCIENCE, V256, P126, DOI 10.1016/j.neuroscience.2013.10.026; Zareba-Koziol M, 2014, MOL CELL PROTEOMICS, V13, P2288, DOI 10.1074/mcp.M113.036079	61	112	123	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					623	634		10.1016/j.cell.2014.09.032	http://dx.doi.org/10.1016/j.cell.2014.09.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417112	Bronze, Green Accepted			2022-12-28	WOS:000344521700017
J	Li, YY; Wen, H; Xi, YX; Tanaka, K; Wang, HB; Peng, DN; Ren, YF; Jin, QH; Dent, SYR; Li, W; Li, HT; Shi, XB				Li, Yuanyuan; Wen, Hong; Xi, Yuanxin; Tanaka, Kaori; Wang, Haibo; Peng, Danni; Ren, Yongfeng; Jin, Qihuang; Dent, Sharon Y. R.; Li, Wei; Li, Haitao; Shi, Xiaobing			AF9 YEATS Domain Links Histone Acetylation to DOT1L-Mediated H3K79 Methylation	CELL			English	Article							ELONGATION COMPLEX SEC; TANDEM PHD FINGER; TRANSCRIPTION ELONGATION; HIV-1 TAT; CHROMATIN; MLL; ACETYLTRANSFERASE; BINDING; YAF9; RECOGNITION	The recognition of modified histones by "reader'' proteins constitutes a key mechanism regulating gene expression in the chromatin context. Compared with the great variety of readers for histone methylation, few protein modules that recognize histone acetylation are known. Here, we show that the AF9 YEATS domain binds strongly to histone H3K9 acetylation and, to a lesser extent, H3K27 and H3K18 acetylation. Crystal structural studies revealed that AF9 YEATS adopts an eight-stranded immunoglobin fold and utilizes a serine-lined aromatic "sandwiching'' cage for acetyllysine readout, representing a novel recognition mechanism that is distinct from that of known acetyllysine readers. ChIP-seq experiments revealed a strong colocalization of AF9 and H3K9 acetylation genome-wide, which is important for the chromatin recruitment of the H3K79 methyltransferase DOT1L. Together, our studies identified the evolutionarily conserved YEATS domain as a novel acetyllysine-binding module and established a direct link between histone acetylation and DOT1L-mediated H3K79 methylation in transcription control.	[Li, Yuanyuan; Wang, Haibo; Ren, Yongfeng; Li, Haitao] Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, MOE Key Lab Prot Sci, Ctr Struct Biol,Sch Life Sci, Beijing 100084, Peoples R China; [Li, Yuanyuan; Wang, Haibo; Ren, Yongfeng; Li, Haitao] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Li, Yuanyuan; Wang, Haibo; Ren, Yongfeng; Li, Haitao] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Li, Yuanyuan] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Wen, Hong; Peng, Danni; Jin, Qihuang; Dent, Sharon Y. R.; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Houston, TX 77030 USA; [Wen, Hong; Tanaka, Kaori; Dent, Sharon Y. R.; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Dent, Sharon Y. R.; Shi, Xiaobing] Univ Texas Houston, Grad Sch Biomed Sci, Genes & Dev & Program, Houston, TX 77030 USA; [Dent, Sharon Y. R.; Shi, Xiaobing] Univ Texas Houston, Mol Carcinogenesis Grad Program, Grad Sch Biomed Sci, Houston, TX 77030 USA	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Li, HT (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, MOE Key Lab Prot Sci, Ctr Struct Biol,Sch Life Sci, Beijing 100084, Peoples R China.	lht@tsinghua.edu.cn; xbshi@mdanderson.org	Li, Haitao/B-2668-2012; Dent, Sharon YR/F-1746-2011	Li, Haitao/0000-0001-6741-293X; Dent, Sharon YR/0000-0002-4824-3269; Shi, Xiaobing/0000-0001-5242-8189; Li, Wei/0000-0001-9931-5990; Wang, Haibo/0000-0003-2416-9153; Wen, Hong/0000-0001-8739-4572	Welch [G1719]; American Cancer Society [RSG-13-290-01-TBE]; Major State Basic Research Development Program in China [2011CB965300]; Program for New Century Excellent Talents in University; NIH [R01HG007538, R01GM067718]; CPRIT [RP110471]; MDACC Institutional Research Grant; Center for Cancer Epigenetics pilot grant; China Postdoctoral Science Foundation [2014T70069]; Duncan Scholar Award; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067718] Funding Source: NIH RePORTER	Welch(The Welch Foundation); American Cancer Society(American Cancer Society); Major State Basic Research Development Program in China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; MDACC Institutional Research Grant; Center for Cancer Epigenetics pilot grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Duncan Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Bedford, J. Bradner, O. Gozani, J. Tyler, and B. Li for comments and reagents. We thank the staffs at beamline BL17U of the Shanghai Synchrotron Radiation Facility and Dr. S. Fan at Tsinghua Center for Structural Biology for their assistance in data collection and the China National Center for Protein Sciences Beijing for providing facility support. We thank the MD Anderson Sequencing and Microarray Facility and the Science Park Next-Generation Sequencing Facility for Solexa sequencing. We thank Joseph Munch for editing the manuscript. This work was supported in part by funds from Welch (G1719) and American Cancer Society (RSG-13-290-01-TBE) to X.S, the Major State Basic Research Development Program in China (2011CB965300) and Program for New Century Excellent Talents in University to H.L., NIH (R01HG007538 to W.L and R01GM067718 to S.Y.R.D), CPRIT (RP110471 to X.S., W.L., and S.Y.R.D), MDACC Institutional Research Grant and Center for Cancer Epigenetics pilot grant to H. Wen, and China Postdoctoral Science Foundation (2014T70069 to Y.L.). Y.L. is a Tsinghua-Peking Center for Life Sciences postdoctoral fellow. W.L. is a recipient of a Duncan Scholar Award. X.S. is a Kimmel Scholar and a R. Lee Clark Fellow.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Le Masson I, 2003, MOL CELL BIOL, V23, P6086, DOI 10.1128/MCB.23.17.6086-6102.2003; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lin CQ, 2013, CELL, V152, P144, DOI 10.1016/j.cell.2012.12.015; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Nishio M, 1998, METH STEREO, P1; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiu Y, 2012, GENE DEV, V26, P1376, DOI 10.1101/gad.188359.112; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P384, DOI 10.1038/87531; Schulze JM, 2010, EPIGENETICS-US, V5, P573, DOI 10.4161/epi.5.7.12856; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang AY, 2009, P NATL ACAD SCI USA, V106, P21573, DOI 10.1073/pnas.0906539106; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	46	222	228	6	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					558	571		10.1016/j.cell.2014.09.049	http://dx.doi.org/10.1016/j.cell.2014.09.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417107	Green Accepted, Bronze			2022-12-28	WOS:000344521700012
J	Garcia-Moreno, C; Hegarty, K; d'Oliveira, AFL; Koziol-McLain, J; Colombini, M; Feder, G				Garcia-Moreno, Claudia; Hegarty, Kelsey; d'Oliveira, Ana Flavia Lucas; Koziol-McLain, Jane; Colombini, Manuela; Feder, Gene			The health-systems response to violence against women	LANCET			English	Article							INTIMATE PARTNER VIOLENCE; DOMESTIC VIOLENCE; PRIMARY-CARE; INTERVENTION; ABUSE; MODEL; PROFESSIONALS; SURVIVORS; EMERGENCY; SAFETY	Health systems have a crucial role in a multisector response to violence against women. Some countries have guidelines or protocols articulating this role and health-care workers are trained in some settings, but generally system development and implementation have been slow to progress. Substantial system and behavioural barriers exist, especially in low-income and middle-income countries. Violence against women was identified as a health priority in 2013 guidelines published by WHO and the 67th World Health Assembly resolution on strengthening the role of the health system in addressing violence, particularly against women and girls. In this Series paper, we review the evidence for clinical interventions and discuss components of a comprehensive health-system approach that helps health-care providers to identify and support women subjected to intimate partner or sexual violence. Five country case studies show the diversity of contexts and pathways for development of a health system response to violence against women. Although additional research is needed, strengthening of health systems can enable providers to address violence against women, including protocols, capacity building, effective coordination between agencies, and referral networks.	[Garcia-Moreno, Claudia] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland; [Hegarty, Kelsey] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic, Australia; [d'Oliveira, Ana Flavia Lucas] Univ Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil; [Koziol-McLain, Jane] Auckland Univ Technol, Ctr Interdisciplinary Trauma Res, Auckland, New Zealand; [Colombini, Manuela] London Sch Hyg & Trop Med, London WC1, England; [Feder, Gene] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	World Health Organization; University of Melbourne; Universidade de Sao Paulo; Auckland University of Technology; University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Garcia-Moreno, C (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland.	garciamorenoc@who.int	d'Oliveira, Ana Flavia Pires Lucas/K-6813-2016	Feder, Gene/0000-0002-7890-3926; Hegarty, Kelsey/0000-0002-7532-5147; Koziol-McLain, Jane/0000-0003-3453-023X	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2009, HLTH TECHNOL ASSESS; Ansara DL, 2010, SOC SCI MED, V70, P1011, DOI 10.1016/j.socscimed.2009.12.009; Bacchus L, 2012, HLTH SECTOR RESPONSE, P202; Bair-Merritt MH, 2014, AM J PREV MED, V46, P188, DOI 10.1016/j.amepre.2013.10.001; Bartels SA, 2012, DISASTER MED PUBLIC, V6, P393, DOI 10.1001/dmp.2012.66; Black CM, 2001, AM J LIFESTYLE MED, V5, P428; Bonomi AE, 2009, HEALTH SERV RES, V44, P1052, DOI 10.1111/j.1475-6773.2009.00955.x; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Campbell JC, 2001, ACAD EMERG MED, V8, P131, DOI 10.1111/j.1553-2712.2001.tb01277.x; Center for Disease Control, 2003, COSTS INTIMATE PARTN; Chang JC, 2010, J WOMENS HEALTH, V19, P251, DOI 10.1089/jwh.2009.1568; Coben JH, 2002, J EMERG MED, V22, P313, DOI 10.1016/S0736-4679(01)00498-X; Cohn F., 2002, CONFRONTING CHRONIC; Colombini M, 2008, B WORLD HEALTH ORGAN, V86, P635, DOI 10.2471/BLT.07.045906; Colombini M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-548; Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI DOI 10.2307/1229039; d'Oliveira AFPL, 2002, LANCET, V359, P1681, DOI 10.1016/S0140-6736(02)08592-6; Decker MR, 2012, J WOMENS HEALTH, V21, P1222, DOI 10.1089/jwh.2012.4058; Easton CJ, 2000, J SUBST ABUSE TREAT, V18, P23, DOI 10.1016/S0740-5472(99)00019-7; Ellsberg M., 2003, VIOLENCE WOMEN HLTH; Fanslow JL, 1999, AUST NZ J PUBL HEAL, V23, P418, DOI 10.1111/j.1467-842X.1999.tb01286.x; Feder G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13160; Feder G, 2011, LANCET, V378, P1788, DOI 10.1016/S0140-6736(11)61179-3; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Government of Spain, 2007, NAT PLAN HEIGHT AW P; Government of Spain Ministry of Health Social Services and Equality, 2010, CONT ED BAS MAT DID; Government of Spain Ministry of Health Social Services and Equality, 2012, COMM PROT HEALTHC RE; Government of Spain Ministry of Health Social Services and Equality, 2007, COMM INF IND QUAL CR; Graham-Bermann SA, 2007, J CONSULT CLIN PSYCH, V75, P199, DOI 10.1037/0022-006X.75.2.199; Hassan A, 1994, MED SERVICES MANAGEM, P88; Hegarty K, 2013, LANCET, V382, P249, DOI 10.1016/S0140-6736(13)60052-5; Hegarty KL, 2008, J FAM STUD, V14, P376, DOI 10.5172/jfs.327.14.2-3.376; Heyman RE, 2002, J MARRIAGE FAM, V64, P864, DOI 10.1111/j.1741-3737.2002.00864.x; Humphreys C, 2005, BRIT J SOC WORK, V35, P1303, DOI 10.1093/bjsw/bch212; Jina R, 2010, INT J GYNECOL OBSTET, V109, P85, DOI 10.1016/j.ijgo.2010.02.001; Jouriles EN, 2009, J CONSULT CLIN PSYCH, V77, P705, DOI 10.1037/a0015994; Joyner K, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-399; Kenya Ministry of Public health and sanitation Ministry of Medical Services, 2009, NAT GUID MAN SEX VIO; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Kim J, 2002, SOC SCI MED, V54, P1243, DOI 10.1016/S0277-9536(01)00093-4; Kim JC, 2003, REPROD HEALTH MATTER, V11, P101, DOI 10.1016/S0968-8080(03)02285-7; Kim JC, 2009, REFENTSE MODEL POSTR; Kim ME, 2010, RESTORATIVE JUSTICE, P193; Kiss LB, 2011, CIENC SAUDE COLETIVA, V16, P1943, DOI 10.1590/S1413-81232011000300028; Kitzmann KM, 2003, J CONSULT CLIN PSYCH, V71, P339, DOI 10.1037/0022-006X.71.2.339; Koon AD, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-30; KOSS MP, 1991, ARCH INTERN MED, V151, P342, DOI 10.1001/archinte.151.2.342; Lipsky S, 2011, J EMERG MED, V40, P696, DOI 10.1016/j.jemermed.2008.04.043; MacMillan HL, 2009, LANCET, V373, P250, DOI 10.1016/S0140-6736(08)61708-0; Macy RJ, 2012, TRAUMA VIOLENCE ABUS, V13, P234, DOI 10.1177/1524838012455874; McCaw B, 2001, AM J PREV MED, V21, P170, DOI 10.1016/S0749-3797(01)00347-6; McFarlane J, 2002, NURS RES, V51, P347, DOI 10.1097/00006199-200211000-00002; Meneghel SN, 2011, CAD SAUDE PUBLICA, V27, P743, DOI 10.1590/S0102-311X2011000400013; Michau L, 2015, LANCET, V385, P1672, DOI 10.1016/S0140-6736(14)61797-9; Ministry of Health, 2012, GUID PROV COMPR SERV; National Institute for Health and Care Excellence (NICE), 2013, REV INT ID PREV RED; O'Campo P, 2011, SOC SCI MED, V72, P855, DOI 10.1016/j.socscimed.2010.12.019; Powell A., 2011, REV BYSTANDER APPROA; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Reisenhofer S, 2013, PATIENT EDUC COUNS, V93, P536, DOI 10.1016/j.pec.2013.08.004; Rivas C, 2005, INTERVENTIONS REDUCE; Rosenberg L, 2011, J BEHAV HEALTH SER R, V38, P428, DOI 10.1007/s11414-011-9256-9; Rybarczyk Megan, 2011, Med Confl Surviv, V27, P91, DOI 10.1080/13623699.2011.607733; Saftlas AF, 2014, ANN EPIDEMIOL, V24, P144, DOI 10.1016/j.annepidem.2013.10.006; Salisbury C, 2012, LANCET, V380, P7, DOI 10.1016/S0140-6736(12)60482-6; Schraiber LB, 1999, INTERFACE BOTUCATU, V3, P11; Sharps PW, 2001, PREV MED, V33, P373, DOI 10.1006/pmed.2001.0902; Sheikh K, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-19; South Africa Department of Health, 2003, NAT MAN GUID SEX ASS; Sprague S, 2012, WOMEN HEALTH, V52, P587, DOI 10.1080/03630242.2012.690840; SUGG NK, 1992, JAMA-J AM MED ASSOC, V267, P3157, DOI 10.1001/jama.267.23.3157; Sugg NK, 1999, ARCH FAM MED, V8, P301, DOI 10.1001/archfami.8.4.301; Taft Angela, 2013, Cochrane Database Syst Rev, pCD007007, DOI 10.1002/14651858.CD007007.pub2; Tirado-Munoz J, 2014, ANN MED; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; Tiwari A, POSITIVE FATHERING P; Tiwari A, 2010, JAMA-J AM MED ASSOC, V304, P536, DOI 10.1001/jama.2010.1052; United Nations Population Fund Asia Pacific Regional Office, 2010, HLTH SECT RESP GEND; Upston B, 2012, EVERYONES BUSINESS G; Walby S., 2004, COST DOMESTIC VIOLEN; Wallace F., 2005, IMPLEMENTATION RES S; Walters JLH, 2012, VIOLENCE VICTIMS, V27, P135, DOI 10.1891/0886-6708.27.2.135; Warshaw C, 1997, ACAD MED, V72, pS26; Watts C, 2004, INT FAM PLAN PERSPEC, V30, P207, DOI 10.1363/3020704; WHO, 2003, GUID MED LEG CAR SEX; WHO, 2011, PSYCH 1 AID GUID FIE, P64; WHO, 2012, WHORHRHRP1218; WHO, 2013, MHGAP MOD ASS MAN CO, P18; WHO, 2010, EXP M HLTH SECT RESP, P30; WHO, 2010, PREV INT PARTN VIOL, P102; WHO, 2010, MONITORING BUILDING; WHO and UNFPA, 2013, M REP REG AD DISS WO; Wong SLF, 2006, BRIT J GEN PRACT, V56, P249; World Health Assembly, 2014, STRENGTH ROL HLTH SY; World Health Organisation, 2013, RESPONDING INTIMATE; World Health Organization, 2005, ADDR VIOL WOM ACH MI; World Health Organization, 2011, INT CLASS FUNCT DIS, P1; World Health Organization, 2021, VIOL WOM PREV EST 20; Zaher E, 2014, CAN FAM PHYSICIAN, V60, P618	99	316	332	1	64	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1567	1579		10.1016/S0140-6736(14)61837-7	http://dx.doi.org/10.1016/S0140-6736(14)61837-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG3ZT	25467583				2022-12-28	WOS:000353220000038
J	Meng, LY; Ward, AJ; Chun, S; Bennett, CF; Beaudet, AL; Rigo, F				Meng, Linyan; Ward, Amanda J.; Chun, Seung; Bennett, C. Frank; Beaudet, Arthur L.; Rigo, Frank			Towards a therapy for Angelman syndrome by targeting a long non-coding RNA	NATURE			English	Article							ANTISENSE OLIGONUCLEOTIDE; UBIQUITIN LIGASE; UBE3A; MODEL; PHARMACOLOGY; TRANSCRIPT; EXPRESSION; MUTATIONS; REPRESSES; DEFICITS	Angelman syndromeis a single-gene disorder characterized by intellectual disability, developmental delay, behavioural uniqueness, speech impairment, seizures and ataxia(1,2). It is caused by maternal deficiency of the imprinted gene UBE3A, encoding an E3 ubiquitin ligase(3-5). All patients carry at least one copy of paternal UBE3A, which is intact but silenced by a nuclear-localized long non-coding RNA, UBE3A antisense transcript (UBE3A-ATS)(6-8). Murine Ube3a-ATS reduction by either transcription termination or topoisomerase I inhibition has been shown to increase paternal Ube3a expression(9,10). Despite a clear understanding of the disease-causing event in Angelman syndrome and the potential to harness the intact paternal allele to correct the disease, no gene-specific treatment exists for patients. Here we developed a potential therapeutic intervention for Angelman syndrome by reducing Ube3a-ATS with antisense oligonucleotides (ASOs). ASO treatment achieved specific reduction of Ube3a-ATS and sustained unsilencing of paternal Ube3a in neurons in vitro and in vivo. Partial restoration of UBE3A protein in an Angelman syndrome mouse model ameliorated some cognitive deficits associated with the disease. Although additional studies of phenotypic correction are needed, we have developed a sequence-specific and clinically feasible method to activate expression of the paternal Ube3a allele.	[Meng, Linyan; Beaudet, Arthur L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Meng, Linyan; Beaudet, Arthur L.] Texas Childrens Hosp, Houston, TX 77030 USA; [Ward, Amanda J.; Chun, Seung; Bennett, C. Frank; Rigo, Frank] ISIS Pharmaceut, Dept Core Antisense Res, Carlsbad, CA 92010 USA	Baylor College of Medicine; Baylor College of Medicine; Isis Pharmaceuticals Inc	Beaudet, AL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	abeaudet@bcm.edu; frigo@isisph.com		Whipple, Amanda/0000-0002-7000-2453	National Institutes of Health [R01 HD037283]; Angelman Syndrome Foundation; Baylor College of Medicine Intellectual and Developmental Disability Research Center [P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, U54HD083092, R01HD037283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Angelman Syndrome Foundation; Baylor College of Medicine Intellectual and Developmental Disability Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank T. Cooper for suggesting the collaboration between L.M., A.L.B. and Isis Pharmaceuticals. L.M. thanks D. Liu, X. Jun, H. Zheng, J. Rosen, C. Spencer and X. Zhai for technical support and reagent sharing, and M. Costa-Mattioli, J. Jankowsky and Y. Elgersma for discussions. This research was supported by funding from National Institutes of Health grant R01 HD037283 (A.L.B.), the Angelman Syndrome Foundation (A.L.B. and L.M.), and Baylor College of Medicine Intellectual and Developmental Disability Research Center grant P30HD024064.	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Allensworth M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-7; Butler M, 1997, LAB INVEST, V77, P379; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Cattanach BM, 1997, MAMM GENOME, V8, P472, DOI 10.1007/s003359900479; Chamberlain SJ, 2001, GENOMICS, V73, P316, DOI 10.1006/geno.2001.6543; Chiriboga C., 2013, 65 AM AC NEUR ANN M; Dagli A, 2011, MOL SYNDROMOL, V2, P100, DOI 10.1159/000328837; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Huang HS, 2013, BEHAV BRAIN RES, V243, P79, DOI 10.1016/j.bbr.2012.12.052; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Meng LY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004039; Meng LY, 2012, HUM MOL GENET, V21, P3001, DOI 10.1093/hmg/dds130; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Rigo F, 2014, J PHARMACOL EXP THER, V350, P46, DOI 10.1124/jpet.113.212407; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Swayze EE, 2007, NUCLEIC ACIDS RES, V35, P687, DOI 10.1093/nar/gkl1071; Williams CA, 2010, GENET MED, V12, P385, DOI 10.1097/GIM.0b013e3181def138; Wu HJ, 2004, J BIOL CHEM, V279, P17181, DOI 10.1074/jbc.M311683200	26	314	333	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					409	412		10.1038/nature13975	http://dx.doi.org/10.1038/nature13975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470045	Green Accepted			2022-12-28	WOS:000349547400044
J	Aboderin, IAG; Beard, JR				Aboderin, Isabella A. G.; Beard, John R.			Older people's health in sub- Saharan Africa	LANCET			English	Editorial Material							CHALLENGES; IBADAN; HIV		[Aboderin, Isabella A. G.] African Populat & Hlth Res Ctr, Nairobi 00100, Kenya; [Aboderin, Isabella A. G.] Univ Southampton, Ctr Res Ageing, Southampton, Hants, England; [Beard, John R.] WHO, Dept Ageing & Life Course, CH-1211 Geneva, Switzerland	African Population & Health Research Centre; University of Southampton; World Health Organization	Aboderin, IAG (corresponding author), African Populat & Hlth Res Ctr, POB 10787, Nairobi 00100, Kenya.	iaboderin@aphrc.org	Beard, John R/K-9621-2014; Beard, John/AAI-4592-2021	Beard, John R/0000-0002-8557-0242; Beard, John/0000-0002-8557-0242	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Aboderin I., 2010, DIMENSIONS DETERMINA; Aboderin I, 2013, 20 INT ASS GER GER W; Bekibele CO, 2008, OPHTHAL EPIDEMIOL, V15, P250, DOI 10.1080/09286580802336583; Bloom D.E., 2012, GLOBAL POPULATION AG, P35; Clausen T, 2005, J NUTR HEALTH AGING, V9, P455; Gureje O, 2007, LANCET, V370, P957, DOI 10.1016/S0140-6736(07)61446-9; Gureje O, 2014, J AM GERIATR SOC, V62, P836, DOI 10.1111/jgs.12802; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Lowsky DJ, 2014, J GERONTOL A-BIOL, V69, P640, DOI 10.1093/gerona/glt162; Mathenge M.K., 2011, MARKET PARTICIPATION; McIntyre D., 2004, LIVING LONGER AGEING, P160; Mills EJ, 2012, NEW ENGL J MED, V366, P1270, DOI 10.1056/NEJMp1113643; Olukoya P., 2014, GHANA COUNTRY ASSESS; Payne CF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001435; Skovdal M, 2011, AIDS CARE, V23, P957, DOI 10.1080/09540121.2010.542298; United Nations Children's Fund (UNICEF), 2007, STAT WORLDS CHILDR D; United Nations Economic Commission for Africa, 2013, AFR REG CONS M SUST; United Nations Population Division, 2012, POP AG DEV 2012; United Nations Population Division, WORLD POP PROSP 2012; World Health Organization, 2012, GOOD HLTH ADDS LIF Y	20	92	94	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					E9	E11		10.1016/S0140-6736(14)61602-0	http://dx.doi.org/10.1016/S0140-6736(14)61602-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AZ	25468150				2022-12-28	WOS:000349214000002
J	Murray, CJL				Murray, Christopher J. L.			Maximizing Antiretroviral Therapy in Developing Countries The Dual Challenge of Efficiency and Quality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV		Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Institute for Health Metrics & Evaluation	Murray, CJL (corresponding author), Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Ste 600, Seattle, WA 98121 USA.	cjlm@uw.edu						De Cock KM, 2014, CLIN INFECT DIS, V58, P1012, DOI 10.1093/cid/ciu026; IHME, 2014, HLTH SERVICE PROVISI; Institute for Health Metrics and Evaluation, 2014, FIN GLOB HLTH 2013 T; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; UNAIDS, 2014, GAP REP; World Health Organization, CONS GUID US ANT DRU	6	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2015	313	4					359	360		10.1001/jama.2014.16376	http://dx.doi.org/10.1001/jama.2014.16376			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7BS	25436833				2022-12-28	WOS:000349072600014
J	Humphries, C				Humphries, Courtney			SEX DIFFERENCES: Luck of the chromosomes	NATURE			English	Editorial Material							GENDER DISPARITY											Hartwell HJ, 2014, P NATL ACAD SCI USA, V111, P11455, DOI 10.1073/pnas.1404267111; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Liu WC, 2014, WORLD J GASTROENTERO, V20, P6252, DOI 10.3748/wjg.v20.i20.6252; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143	5	9	10	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S10	S11		10.1038/516S10a	http://dx.doi.org/10.1038/516S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470193	Bronze			2022-12-28	WOS:000346310800004
J	Kandel, E				Kandel, Eric			A Place and a Grid in the Sun	CELL			English	Editorial Material							FREELY-MOVING RAT; ENTORHINAL CORTEX; SPATIAL REPRESENTATION; UNIT-ACTIVITY; HIPPOCAMPUS; CELLS; MAP		[Kandel, Eric] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Kandel, Eric] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Kandel, Eric] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Kandel, Eric] Columbia Univ, Dept Psychiat, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University; Columbia University	Kandel, E (corresponding author), Columbia Univ, Kavli Inst Brain Sci, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626	17	4	5	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1239	1242		10.1016/j.cell.2014.11.033	http://dx.doi.org/10.1016/j.cell.2014.11.033			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480286	Bronze			2022-12-28	WOS:000346652900001
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Industry's interest in diagnosing more dementia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Alzheimer's Society, 2012, THE PATIENT JOURNEY; Alzheimer's Society, 2014, DEMENTIA UK UPDATE; Alzheimer's Society, 2013, WORRIED ABOUT YOUR M; [Anonymous], 2014, MEMBERS LILLY UK; Brunet M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6666; Burns A, 2013, TIMELY DIAGNOSIS OF; Hughes J, 2014, RAPID RESPONSE; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Ramesh R., 2013, GUARDIAN	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2014	349								g7480	10.1136/bmj.g7480	http://dx.doi.org/10.1136/bmj.g7480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KN	25471323	Green Published, hybrid			2022-12-28	WOS:000346116600013
J	Johansson, S; Villamor, E; Altman, M; Bonamy, AKE; Granath, F; Cnattingius, S				Johansson, Stefan; Villamor, Eduardo; Altman, Maria; Bonamy, Anna-Karin Edstedt; Granath, Fredrik; Cnattingius, Sven			Maternal overweight and obesity in early pregnancy and risk of infant mortality: a population based cohort study in Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; WEIGHT; OUTCOMES; DEATH; STILLBIRTH; SMOKING; WOMEN; FAT	Objective To investigate associations between maternal overweight and obesity and infant mortality outcomes, including cause-specific mortality. Design Population based cohort study. Setting and participants 1 857 822 live single births in Sweden 1992-2010. Main outcome measures Associations between maternal body mass index (BMI) in early pregnancy and risks of infant, neonatal, and postneonatal mortality, overall and stratified by gestational length and by causes of infant death. Odds ratios were adjusted for maternal age, parity, smoking, education, height, country of birth, and year of delivery. Results Infant mortality rates increased from 2.4/1000 among normal weight women (BMI 18.5-24.9) to 5.8/1000 among women with obesity grade 3 (BMI >= 40.0). Compared with normal weight, overweight (BMI 25.0-29.9) and obesity grade 1 (BMI 30.0-34.9) were associated with modestly increased risks of infant mortality (adjusted odds ratios 1.25 (95% confidence interval 1.16 to 1.35) and 1.37 (1.22 to 1.53), respectively), and obesity grade 2 (BMI 35.0-39.9) and grade 3 were associated with more than doubled risks (adjusted odds ratios 2.11 (1.79 to 2.49) and 2.44 (1.88 to 3.17)). In analyses stratified by preterm and term births, maternal BMI was related to risks of infant mortality primarily in term births (>= 37 weeks), where risks of deaths due to birth asphyxia and other neonatal morbidities increased with maternal overweight and obesity. Obesity grade 2-3 was also associated with increased infant mortality due to congenital anomalies and sudden infant death syndrome. Conclusions Maternal overweight and obesity are associated with increased risks of infant mortality due to increased mortality risk in term births and an increased prevalence of preterm births. Maternal overweight and obesity may be an important preventable risk factor for infant mortality in many countries.	[Johansson, Stefan; Altman, Maria; Bonamy, Anna-Karin Edstedt; Granath, Fredrik; Cnattingius, Sven] Dept Med, Clin Epidemiol Unit, Solna, Sweden; [Johansson, Stefan; Altman, Maria; Bonamy, Anna-Karin Edstedt; Granath, Fredrik; Cnattingius, Sven] Karolinska Univ Hosp, Karolinska Inst, SE-17176 Stockholm, Sweden; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Karolinska Institutet; Karolinska University Hospital; University of Michigan System; University of Michigan	Johansson, S (corresponding author), Dept Med, Clin Epidemiol Unit, Solna, Sweden.	stefan.johansson@ki.se	Bonamy, Anna-Karin E/B-7106-2012	Bonamy, Anna-Karin E/0000-0003-4552-9912; Johansson, Stefan/0000-0001-8832-6918	Karolinska Institutet; Swedish Research Council for Health, Working Life and Welfare [2014-0073]	Karolinska Institutet(Karolinska Institutet); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	An unrestricted grant from Karolinska Institutet (Distinguished Professor Award to SC) and from the Swedish Research Council for Health, Working Life and Welfare (project No 2014-0073).	Altman M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001152; Ambalavanan N, 2012, PEDIATRICS, V130, pE115, DOI 10.1542/peds.2011-3693; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Bahadue FL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001456.pub2; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Carpenter R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002299; Cawley J, 2004, J HEALTH ECON, V23, P293, DOI 10.1016/j.jhealeco.2003.12.003; Chapman DJ, 2013, PEDIATRICS, V131, pE162, DOI 10.1542/peds.2012-0688; Chen A, 2009, EPIDEMIOLOGY, V20, P74, DOI 10.1097/EDE.0b013e3181878645; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Eriksson Ulf J, 2012, Methods Mol Biol, V889, P425, DOI 10.1007/978-1-61779-867-2_26; George L, 2006, ACTA OBSTET GYN SCAN, V85, P1331, DOI 10.1080/00016340600935433; Guelinckx I, 2008, OBES REV, V9, P140, DOI 10.1111/j.1467-789X.2007.00464.x; Hakansson S, 2008, ACTA PAEDIATR, V97, P1386, DOI 10.1111/j.1651-2227.2008.00940.x; Hernandez-Diaz S, 2007, PEDIATRICS, V120, pE272, DOI 10.1542/peds.2006-3037; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Hutcheon JA, 2012, PAEDIATR PERINAT EP, V26, P109, DOI 10.1111/j.1365-3016.2011.01254.x; Jolly MC, 2003, EUR J OBSTET GYN R B, V111, P9, DOI 10.1016/S0301-2115(03)00154-4; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Lindsay CA, 1997, OBSTET GYNECOL, V89, P377, DOI 10.1016/S0029-7844(96)00517-0; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; MacDorman MF, 2010, INT J HEALTH SERV, V40, P577, DOI 10.2190/HS.40.4.a; Meehan S, 2014, PEDIATRICS, V133, P863, DOI 10.1542/peds.2013-1480; National Board of Health and Welfare Centre for Epidemiology, 2003, SWED MED BIRTH REG S; National Board of Health and Welfare Sweden, NAT BOARD HLTH WELF, V2020-12-7089; Persson M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001648; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Robinson H, 2003, OBSTET GYNECOL, V101, P24, DOI 10.1016/S0029-7844(02)02448-1; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Salihu HM, 2008, OBSTET GYNECOL, V111, P1410, DOI 10.1097/AOG.0b013e318173ecd4; Sewell MF, 2007, J REPROD MED, V52, P907; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Statistics Sweden, 2010, TABL POP SWED 2009; Statistics Sweden, 2006, EV SWED REG ED; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Thompson DR, 2008, PUBLIC HEALTH REP, V123, P487, DOI 10.1177/003335490812300410; Villalbi JR, 2007, PAEDIATR PERINAT EP, V21, P441, DOI 10.1111/j.1365-3016.2007.00845.x; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23; World Health Organization, GLOB DAT BOD MASS IN; Zhang J, 2008, AM J OBSTET GYNECOL, V199, pS51, DOI 10.1016/j.ajog.2008.09.161	43	101	102	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2014	349								g6572	10.1136/bmj.g6572	http://dx.doi.org/10.1136/bmj.g6572			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW2KK	25467170	Green Published, hybrid			2022-12-28	WOS:000346116300001
J	Doudna, JA; Charpentier, E				Doudna, Jennifer A.; Charpentier, Emmanuelle			The new frontier of genome engineering with CRISPR-Cas9	SCIENCE			English	Review							RNA-GUIDED CAS9; CRISPR/CAS9-MEDIATED TARGETED MUTAGENESIS; SITE-SPECIFIC CLEAVAGE; DOUBLE-STRAND BREAKS; ONE-STEP GENERATION; HOMOLOGOUS RECOMBINATION; DNA RECOGNITION; HUMAN-CELLS; INTERFERENCE COMPLEX; CRYSTAL-STRUCTURE	The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.	[Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Charpentier, Emmanuelle] Helmholtz Ctr Infect Res, Dept Regulat Infect Biol, D-38124 Braunschweig, Germany; [Charpentier, Emmanuelle] Umea Univ, Lab Mol Infect Med Sweden, Umea Ctr Microbial Res, Dept Mol Biol, S-90187 Umea, Sweden; [Charpentier, Emmanuelle] Hannover Med Sch, D-30625 Hannover, Germany	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Helmholtz Association; Helmholtz-Center for Infection Research; Umea University; Hannover Medical School	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu; emmanuelle.charpentier@helmholtz-hzi.de			Alexander von Humboldt Foundation; German Federal Ministry for Education and Research; Helmholtz Association; German Research Foundation; Goran Gustafsson Foundation; Swedish Research Council; Kempe Foundation; Umea University; Howard Hughes Medical Institute; NSF; Gates Foundation; Li Ka Shing Foundation; NIH	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); German Research Foundation(German Research Foundation (DFG)); Goran Gustafsson Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation; Umea University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); Gates Foundation(Bill & Melinda Gates Foundation); Li Ka Shing Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.A.D. is a co-founder of Caribou Biosciences Inc. and Editas Medicine and is on the scientific advisory board of Caribou Biosciences Inc. E. C. is a cofounder of CRISPR Therapeutics and is on the scientific advisory board of CRISPR Therapeutics and Horizon Discovery. E. C. is supported by the Alexander von Humboldt Foundation, the German Federal Ministry for Education and Research, the Helmholtz Association, the German Research Foundation, the Goran Gustafsson Foundation, the Swedish Research Council, the Kempe Foundation, and Umea University. J.A.D. acknowledges financial support from the Howard Hughes Medical Institute, NSF, the Gates Foundation, the Li Ka Shing Foundation, and NIH; J.A.D. is a Howard Hughes Medical Institute Investigator and a member of the Center for RNA Systems Biology at UC Berkeley (J. Cate, P.I.).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; CHO JY, 1995, P NATL ACAD SCI USA, V92, P10389, DOI 10.1073/pnas.92.22.10389; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Faruqi AF, 1996, MOL CELL BIOL, V16, P6820; Faruqi AF, 1998, P NATL ACAD SCI USA, V95, P1398, DOI 10.1073/pnas.95.4.1398; FELSENFELD G, 1957, J AM CHEM SOC, V79, P2023, DOI 10.1021/ja01565a074; Flowers GP, 2014, DEVELOPMENT, V141, P2165, DOI 10.1242/dev.105072; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Guell M, 2014, BIOINFORMATICS, V30, P2968, DOI 10.1093/bioinformatics/btu427; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Guy CP, 2004, NUCLEIC ACIDS RES, V32, P6176, DOI 10.1093/nar/gkh960; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hou ZG, 2013, P NATL ACAD SCI USA, V110, P15644, DOI 10.1073/pnas.1313587110; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Hu XL, 2013, CELL RES, V23, P1322, DOI 10.1038/cr.2013.141; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Ma YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089413; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; O'Brien A, 2014, BIOINFORMATICS, V30, P2673, DOI 10.1093/bioinformatics/btu354; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PLESSIS A, 1992, GENETICS, V130, P451; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rong ZL, 2014, PROTEIN CELL, V5, P258, DOI 10.1007/s13238-014-0032-5; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; RUDIN N, 1989, GENETICS, V122, P519; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; SANDOR Z, 1995, FEBS LETT, V374, P287, DOI 10.1016/0014-5793(95)01133-Y; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shah SA, 2013, RNA BIOL, V10, P891, DOI 10.4161/rna.23764; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; STROBEL SA, 1991, NATURE, V350, P172, DOI 10.1038/350172a0; STROBEL SA, 1991, SCIENCE, V254, P1639, DOI 10.1126/science.1836279; STROBEL SA, 1990, SCIENCE, V249, P73, DOI 10.1126/science.2195655; Sugano SS, 2014, PLANT CELL PHYSIOL, V55, P475, DOI 10.1093/pcp/pcu014; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; Sun CL, 2013, ENVIRON MICROBIOL, V15, P463, DOI 10.1111/j.1462-2920.2012.02879.x; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; THOMAS KR, 1986, CELL, V44, P419, DOI 10.1016/0092-8674(86)90463-0; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Varshavsky A, 2006, CELL, V127, P1295, DOI 10.1016/j.cell.2006.12.008; WANG G, 1995, MOL CELL BIOL, V15, P1759; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Whitworth KM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121723; Wu JC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093806, 10.1371/journal.pone.0090528]; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xiao A, 2014, BIOINFORMATICS, V30, P1180, DOI 10.1093/bioinformatics/btt764; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xie SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100448; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang J, 1996, NATURE, V381, P332, DOI 10.1038/381332a0; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhao YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03943; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166; ZIMMERLY S, 1995, CELL, V83, P529, DOI 10.1016/0092-8674(95)90092-6	153	3390	3705	314	4329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1077	+	1258096	10.1126/science.1258096	http://dx.doi.org/10.1126/science.1258096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430774				2022-12-28	WOS:000345763400031
J	Ruths, D; Pfeffer, J				Ruths, Derek; Pfeffer, Juergen			Social media for large studies of behavior	SCIENCE			English	Editorial Material									[Ruths, Derek] McGill Univ, Dept Comp Sci, Montreal, PQ H3A 0G4, Canada; [Pfeffer, Juergen] Carnegie Mellon Univ, Inst Software Res, Pittsburgh, PA 15213 USA	McGill University; Carnegie Mellon University	Ruths, D (corresponding author), McGill Univ, Dept Comp Sci, Montreal, PQ H3A 0G4, Canada.	derek.ruths@mcgill.ca	Pfeffer, Juergen/H-7926-2013	Pfeffer, Juergen/0000-0002-1677-150X				[Anonymous], [No title captured]; [Anonymous], 2013, BIG DATA REVOLUTION; Cohen R., 2013, P 7 INT AAAI C WEBL, P91; Directorate for European Integration, 2018, PUBL OP POLLS; Duggan M, 2013, DEMOGRAPHICS SOCIAL; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mislove A, 2011, P 5 INT C WEBL SOC M, P554; Morstatter F., 2014, P 23 INT C WORLD WID, P555, DOI DOI 10.1145/2567948.2576952; Mosteller Frederick, 1949, BULLETIN, V60; Russell S.J., 2016, ARTIF INTELL; Schoen H, 2013, INTERNET RES, V23, P528, DOI 10.1108/IntR-06-2013-0115; Tufekci Zeynep, 2014, P 8 INT AAAI C WEBL, P505	15	338	341	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1063	+		10.1126/science.346.6213.1063	http://dx.doi.org/10.1126/science.346.6213.1063			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU7EK	25430759				2022-12-28	WOS:000345763400025
J	Edwards, DS; Mayhew, ER; Rice, ASC				Edwards, Dafydd S.; Mayhew, Emily R.; Rice, Andrew S. C.			Legacy of the 1914-18 war 3 "Doomed to go in company with miserable pain": surgical recognition and treatment of amputation-related pain on the Western Front during World War 1	LANCET			English	Article							PHANTOM	The principal feature of injuries from World War 1 was musculoskeletal trauma and injury to peripheral nerves as a result of damage to the upper and lower limbs caused by gunshot wounds and fragments of artillery munitions. Amputation was used as a treatment in field hospitals to save lives; limb conservation was a secondary consideration. A century later, the principal feature of injuries to soldiers in today's wars in Iraq and Afghanistan is also musculoskeletal trauma and injury to the peripheral nerves caused by improvised explosive devices. Common to both types of injury is postamputation pain. We searched The Lancet's archives in this Series paper to show the efforts of surgeons in World War 1 to understand and treat postamputation pain in its own right both during and immediately after the war. Despite unprecedented patient numbers and levels of civilian medical expertise, little progress was made in providing relief from this type of pain, a grave concern to the surgeons treating these soldiers. Today postamputation pain is understood beyond a surgical context but remains a complex and poorly understood condition with few effective treatments.	[Edwards, Dafydd S.] New Queen Elizabeth Hosp, Royal Ctr Def Med, Birmingham, W Midlands, England; [Edwards, Dafydd S.] Univ London Imperial Coll Sci Technol & Med, Ctr Blast Injury Studies, London SW7 2AZ, England; [Mayhew, Emily R.] Univ London Imperial Coll Sci Technol & Med, Dept Cocurricular Studies, London SW7 2AZ, England; [Rice, Andrew S. C.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England; [Rice, Andrew S. C.] Chelsea & Westminster Hosp NHS Fdn Trust, Dept Pain Med, London, England	Royal Centre for Defence Medicine; University of Birmingham; Imperial College London; Imperial College London; Imperial College London; Imperial College London	Mayhew, ER (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Cocurricular Studies, London SW7 2AZ, England.	e.mayhew@imperial.ac.uk						Alviar MJM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006380.pub2; [Anonymous], 1916, LANCET, V2, P867; Brown KV, 2013, J ROY ARMY MED CORPS, V159, P300, DOI 10.1136/jramc-2013-000103; Clasper J, 2007, J R Army Med Corps, V153, P172; Cooter Roger, 1993, SURG SOC PEACE WAR O; Corner EM, 1922, BRIT OFFICIAL MED HI, P486; Elster E, 2013, LAB WAR MILITARY TRA; Gardner DJ, 2005, SURG SCI SOLDIER LIF; Guthrie HC, 2011, J ROY ARMY MED CORPS, V157, P170, DOI 10.1136/jramc-157-02-09; Hsu E, 2013, J PAIN RES, V6, P121, DOI 10.2147/JPR.S32299; Huggins GM, 1917, LANCET, V1, P646; JENSEN TS, 1985, PAIN, V21, P267, DOI 10.1016/0304-3959(85)90090-9; Kinch KJ, 2011, J ROY ARMY MED CORPS, V157, P374, DOI 10.1136/jramc-157-04-05; Le Feuvre P, 2014, J ROY ARMY MED CORPS, V160, P16, DOI 10.1136/jramc-2013-000141; Liston Robert, 1837, PRACTICAL SURG; Makins GH, 2009, SURG EXPERIENCES S A; Mayhew E, 2013, WOUNDED BATTLEFIELD; Medical Society of London, 1920, LANCET, V195, P768; Mitchell SW., 1864, GUNSHOT WOUNDS OTHER; Mulvey MR, 2010, COCHRANE DB SYST REV, V5; Pocock Tom, 2013, HORATIO NELSON, P204; Scarry Elaine, 1985, BODY PAIN MAKING UNM; Sedillot C, 1839, TRAITE MED OPERATOIR, P253; Sheild AM, 1916, LANCET, V2, P342; Sheild AM, 1916, LANCET, V188, P1003; SHERMAN RA, 1984, PAIN, V18, P83, DOI 10.1016/0304-3959(84)90128-3; Skirving RS, 1922, BRIT OFFICIAL MED HI, P656; Terraine J., 1982, WHITE HEAT NEW WARFA; The Lancet, 1918, LANCET, V191, P59; The Lancet, 1918, LANCET, V192, P401; Velpeau A, 1832, NOVEAUX ELEMENTS MED, V1, P345; Whitehead Ian, 1999, DOCTORS GREAT WAR	32	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1715	1719		10.1016/S0140-6736(14)61643-3	http://dx.doi.org/10.1016/S0140-6736(14)61643-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KU	25441202				2022-12-28	WOS:000345116200035
J	Doll, JA; Roe, MT				Doll, Jacob A.; Roe, Matthew T.			Time to treatment as a quality metric for acute STEMI care	LANCET			English	Editorial Material							ELEVATION MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME		[Doll, Jacob A.; Roe, Matthew T.] Duke Univ, Med Ctr, Duke Clin Res Inst, Div Cardiol, Durham, NC 27705 USA	Duke University	Roe, MT (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Div Cardiol, Durham, NC 27705 USA.	matthew.roe@duke.edu						Bagai A, 2013, CIRCULATION, V128, P352, DOI 10.1161/CIRCULATIONAHA.113.002339; Bates ER, 2013, NEW ENGL J MED, V369, P889, DOI 10.1056/NEJMp1308772; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Gupta N, 2014, AM J CARDIOL, V113, P1087, DOI 10.1016/j.amjcard.2013.12.014; Jollis JG, 2012, CIRCULATION, V126, P189, DOI 10.1161/CIRCULATIONAHA.111.068049; Levine GN, 2011, CIRCULATION, V124, P2574, DOI 10.1161/CIR.0b013e31823a5596; Masoudi FA, 2013, J AM COLL CARDIOL, V62, P1931, DOI 10.1016/j.jacc.2013.05.099; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; Nallamothu BK, 2014, LANCET; Nallamothu BK, 2007, NEW ENGL J MED, V357, P1631, DOI 10.1056/NEJMra065985; Nicholson BD, CIRC CARDIO IN PRESS; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Schiele F, 2010, EUR HEART J, V31, P2614, DOI 10.1093/eurheartj/ehq305	13	7	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1056	1057		10.1016/S0140-6736(14)62051-1	http://dx.doi.org/10.1016/S0140-6736(14)62051-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD7KX	25467572				2022-12-28	WOS:000351270400010
J	Schwartz, SD; Regillo, CD; Lam, BL; Eliott, D; Rosenfeld, PJ; Gregori, NZ; Hubschman, JP; Davis, JL; Heilwell, G; Spirn, M; Maguire, J; Gay, R; Bateman, J; Ostrick, RM; Morris, D; Vincent, M; Anglade, E; Del Priore, LV; Lanza, R				Schwartz, Steven D.; Regillo, Carl D.; Lam, Byron L.; Eliott, Dean; Rosenfeld, Philip J.; Gregori, Ninel Z.; Hubschman, Jean-Pierre; Davis, Janet L.; Heilwell, Gad; Spirn, Marc; Maguire, Joseph; Gay, Roger; Bateman, Jane; Ostrick, Rosaleen M.; Morris, Debra; Vincent, Matthew; Anglade, Eddy; Del Priore, Lucian V.; Lanza, Robert			Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies	LANCET			English	Article							VISUAL FUNCTION QUESTIONNAIRE; RCS RATS; TRANSPLANTATION; TRANSLOCATION; VITRECTOMY; SURGERY; NEOVASCULARIZATION; RESCUE; SAFETY	Background Since they were first derived more than three decades ago, embryonic stem cells have been proposed as a source of replacement cells in regenerative medicine, but their plasticity and unlimited capacity for self-renewal raises concerns about their safety, including tumour formation ability, potential immune rejection, and the risk of differentiating into unwanted cell types. We report the medium-term to long-term safety of cells derived from human embryonic stem cells (hESC) transplanted into patients. Methods In the USA, two prospective phase 1/2 studies were done to assess the primary endpoints safety and tolerability of subretinal transplantation of hESC-derived retinal pigment epithelium in nine patients with Stargardt's macular dystrophy (age > 18 years) and nine with atrophic age-related macular degeneration (age > 55 years). Three dose cohorts (50 000, 100 000, and 150 000 cells) were treated for each eye disorder. Transplanted patients were followed up for a median of 22 months by use of serial systemic, ophthalmic, and imaging examinations. The studies are registered with ClinicalTrials.gov, numbers NCT01345006 (Stargardt's macular dystrophy) and NCT01344993 (age-related macular degeneration). Findings There was no evidence of adverse proliferation, rejection, or serious ocular or systemic safety issues related to the transplanted tissue. Adverse events were associated with vitreoretinal surgery and immunosuppression. 13 (72%) of 18 patients had patches of increasing subretinal pigmentation consistent with transplanted retinal pigment epithelium. Best-corrected visual acuity, monitored as part of the safety protocol, improved in ten eyes, improved or remained the same in seven eyes, and decreased by more than ten letters in one eye, whereas the untreated fellow eyes did not show similar improvements in visual acuity. Vision-related quality-of-life measures increased for general and peripheral vision, and near and distance activities, improving by 16-25 points 3-12 months after transplantation in patients with atrophic age-related macular degeneration and 8-20 points in patients with Stargardt's macular dystrophy. Interpretation The results of this study provide the first evidence of the medium-term to long-term safety, graft survival, and possible biological activity of pluripotent stem cell progeny in individuals with any disease. Our results suggest that hESC-derived cells could provide a potentially safe new source of cells for the treatment of various unmet medical disorders requiring tissue repair or replacement.	[Schwartz, Steven D.; Hubschman, Jean-Pierre; Heilwell, Gad; Ostrick, Rosaleen M.] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA; [Schwartz, Steven D.; Hubschman, Jean-Pierre; Heilwell, Gad; Ostrick, Rosaleen M.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Regillo, Carl D.; Spirn, Marc; Maguire, Joseph] Thomas Jefferson Univ, Wills Eye Hosp, Philadelphia, PA 19107 USA; [Lam, Byron L.; Gregori, Ninel Z.; Davis, Janet L.] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA; [Eliott, Dean] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Eliott, Dean] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gay, Roger; Bateman, Jane; Morris, Debra; Vincent, Matthew; Anglade, Eddy; Lanza, Robert] Adv Cell Technol, Marlborough, MA 01752 USA; [Del Priore, Lucian V.] Med Univ S Carolina, Storm Eye Inst, Charleston, SC 29425 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Jefferson University; Bascom Palmer Eye Institute; University of Miami; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Medical University of South Carolina	Lanza, R (corresponding author), Adv Cell Technol, Marlborough, MA 01752 USA.	schwartz@jsei.ucla.edu; rlanza@advancedcell.com	Davis, Janet L/GPC-8037-2022	Davis, Janet L/0000-0001-6395-5881; Hubschman, Jean-Pierre/0000-0002-8631-3467; Lanza, Robert/0000-0002-3047-3074	Advanced Cell Technology	Advanced Cell Technology	Advanced Cell Technology funded the study. We thank Maureen McMahon and Jennifer Grossman for patient evaluation and follow-up; Donald Kohn, Aisha Khan, Omaima Hanif, and Darlene Miller for good manufacturing practice therapeutic material preparation; Tong Li, Deborah Peak, and Judson Ratliff for their help in preparation and technical transfer of the retinal pigment epithelium cells; and Robert Almanzor, Jennifer Verriotto, Cristy Lage-Rodriguez, Nina Zelcer, and Logan Hitchcock for clinical coordination and data monitoring.	Aisenbrey S, 2006, ARCH OPHTHALMOL-CHIC, V124, P183, DOI 10.1001/archopht.124.2.183; ALGVERE PV, 1994, GRAEF ARCH CLIN EXP, V232, P707, DOI 10.1007/BF00184273; Berger AS, 2003, OPHTHALMOLOGY, V110, P383, DOI 10.1016/S0161-6420(02)01738-4; Binder S, 2004, INVEST OPHTH VIS SCI, V45, P4151, DOI 10.1167/iovs.04-0118; Binder S, 2002, AM J OPHTHALMOL, V133, P215, DOI 10.1016/S0002-9394(01)01373-3; Bull ND, 2011, STEM CELLS, V29, P1170, DOI 10.1002/stem.676; Chakravarthy U, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c981; Del Priore LV, 2005, ARCH OPHTHALMOL-CHIC, V123, P1156, DOI 10.1001/archopht.123.8.1156-a; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Finger RP, 2008, QUAL LIFE RES, V17, P559, DOI 10.1007/s11136-008-9327-4; Grisanti S, 2002, JPN J OPHTHALMOL, V46, P36, DOI 10.1016/S0021-5155(01)00464-6; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Kaplan H J, 1999, Chem Immunol, V73, P207; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Lanza R, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, pXV, DOI 10.1016/B978-0-12-374729-7.00073-1; Lappas A, 2000, GRAEF ARCH CLIN EXP, V238, P631, DOI 10.1007/s004170000149; Lindblad AS, 2005, ARCH OPHTHALMOL-CHIC, V123, P1207; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; MacLaren RE, 2005, OPHTHALMOLOGY, V112, P2081, DOI 10.1016/j.ophtha.2005.06.029; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire JI, 2008, EYE, V22, P1290, DOI 10.1038/eye.2008.51; Mahmoud TH, 2003, GRAEF ARCH CLIN EXP, V241, P298, DOI 10.1007/s00417-003-0637-5; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Pan CK, 2013, EXPERT OPIN BIOL TH, V13, P1125, DOI 10.1517/14712598.2013.793304; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; SILVERMAN MS, 1990, CURR EYE RES, V9, P183, DOI 10.3109/02713689008995205; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Stein JD, 2009, ARCH OPHTHALMOL-CHIC, V127, P1656, DOI 10.1001/archophthalmol.2009.300; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tezel TH, 1998, EXP EYE RES, V66, P807, DOI 10.1006/exer.1998.0492; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thumann G, 2000, ARCH OPHTHALMOL-CHIC, V118, P1350	34	782	831	9	69	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					509	516		10.1016/S0140-6736(14)61376-3	http://dx.doi.org/10.1016/S0140-6736(14)61376-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AV	25458728				2022-12-28	WOS:000349213600029
J	Cowling, BJ; Yu, HJ				Cowling, Benjamin J.; Yu, Hongjie			Ebola: worldwide dissemination risk and response priorities	LANCET			English	Editorial Material									[Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Div Infect Dis, Beijing 102206, Peoples R China	University of Hong Kong; Chinese Center for Disease Control & Prevention	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Div Infect Dis, Beijing 102206, Peoples R China.	yuhj@chinacdc.cn	Cowling, Benjamin John/C-4263-2009; Yu, Hongjie/GZK-5351-2022	Cowling, Benjamin John/0000-0002-6297-7154; 				[Anonymous], 2014, LANCET, V384, P637, DOI 10.1016/S0140-6736(14)61377-5; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baxter AG, 2000, LANCET, V355, P2178, DOI 10.1016/S0140-6736(00)02394-1; Bogoch I, 2014, LANCET; Booth R, 2014, UK INTRO EBOLA SCREE; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Fowler RA, 2014, AM J RESP CRIT CARE, V190, P733, DOI 10.1164/rccm.201408-1514CP; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166; MacIntyre CR, 2014, INT J NURS STUD, V51, P1421, DOI 10.1016/j.ijnurstu.2014.09.002; Piot P, 2014, LANCET INFECT DIS	11	13	13	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					7	9		10.1016/S0140-6736(14)61895-X	http://dx.doi.org/10.1016/S0140-6736(14)61895-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX8IW	25458730	Green Submitted			2022-12-28	WOS:000347154200008
J	Harry, EJ				Harry, Elizabeth J.			MICROBIOLOGY A beacon for bacterial tubulin	NATURE			English	Editorial Material							DIVISION		Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia	University of Technology Sydney	Harry, EJ (corresponding author), Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia.	liz.harry@uts.edu.au	Harry, Elizabeth/G-8123-2017; Harry, Liz/AAT-9396-2020	Harry, Elizabeth/0000-0003-0858-9473				Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Bailey MW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004504; Beilharz K, 2012, P NATL ACAD SCI USA, V109, pE905, DOI 10.1073/pnas.1119172109; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Fleurie A, 2014, NATURE, V516, P259, DOI 10.1038/nature13966; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Monahan LG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00019; Pinho MG, 2013, NAT REV MICROBIOL, V11, P601, DOI 10.1038/nrmicro3088; Rodrigues CDA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002561; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513	10	0	0	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2014	516	7530					175	176		10.1038/nature14071	http://dx.doi.org/10.1038/nature14071			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6ML	25470050	Green Submitted			2022-12-28	WOS:000346383500029
J	Bollyky, TJ; Emanuel, EJ; Goosby, EP; Satcher, D; Shalala, DE; Thompson, TG				Bollyky, Thomas J.; Emanuel, Ezekiel J.; Goosby, Eric P.; Satcher, David; Shalala, Donna E.; Thompson, Tommy G.			NCDs and an outcome-based approach to global health	LANCET			English	Editorial Material									[Bollyky, Thomas J.] Council Foreign Relat, Washington, DC 20006 USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Goosby, Eric P.] Univ Calif San Francisco, Sch Med, Inst Global Hlth Delivery & Diplomacy, San Francisco, CA USA; [Satcher, David] Morehouse Sch Med, Satcher Hlth Leadership Inst, Atlanta, GA 30310 USA; [Satcher, David] Morehouse Sch Med, Ctr Excellence Hlth Dispar, Atlanta, GA 30310 USA; [Shalala, Donna E.] Univ Miami, Off President, Coral Gables, FL 33124 USA; [Thompson, Tommy G.] Thompson Family Holdings, Washington, DC USA	University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; Morehouse School of Medicine; Morehouse School of Medicine; University of Miami	Bollyky, TJ (corresponding author), Council Foreign Relat, Washington, DC 20006 USA.	tbollyky@cfr.org			National Institute on Minority Health and Health Disparities [U54MD008173] Funding Source: NIH RePORTER; NIMHD NIH HHS [U54 MD008173] Funding Source: Medline	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Independent Task Force on Noncommunicable Diseases, 2014, EM GLOB HLTH CRIS NO; Institute for Health Metrics and Evaluation, 2014, FIN GLOB HLTH 2013 T, P61; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; United Nations, 2011, REPORT SPECIAL RAPPO; World Health Organization, 2013, GLOB ACT PLAN PREV C	5	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2003	2004		10.1016/S0140-6736(14)62291-1	http://dx.doi.org/10.1016/S0140-6736(14)62291-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW6BD	25483157				2022-12-28	WOS:000346353600006
J	Kim, J; Hong, XP; Jin, CH; Shi, SF; Chang, CYS; Chiu, MH; Li, LJ; Wang, F				Kim, Jonghwan; Hong, Xiaoping; Jin, Chenhao; Shi, Su-Fei; Chang, Chih-Yuan S.; Chiu, Ming-Hui; Li, Lain-Jong; Wang, Feng			Ultrafast generation of pseudo-magnetic field for valley excitons in WSe2 monolayers	SCIENCE			English	Article							SINGLE-ELECTRON SPIN; MONO LAYER; MOS2; MANIPULATION; POLARIZATION; DYNAMICS	The valley pseudospin is a degree of freedom that emerges in atomically thin two-dimensional transition metal dichalcogenides (MX2). The capability to manipulate it, in analogy to the control of spin in spintronics, can open up exciting opportunities. Here, we demonstrate that an ultrafast and ultrahigh valley pseudo-magnetic field can be generated by using circularly polarized femtosecond pulses to selectively control the valley degree of freedom in monolayer MX2. Using ultrafast pump-probe spectroscopy, we observed a pure and valley-selective optical Stark effect in WSe2 monolayers from the nonresonant pump, resulting in an energy splitting of more than 10 milli-electron volts between the K and K' valley exciton transitions. Our study opens up the possibility to coherently manipulate the valley polarization for quantum information applications.	[Kim, Jonghwan; Hong, Xiaoping; Jin, Chenhao; Shi, Su-Fei; Wang, Feng] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Shi, Su-Fei; Wang, Feng] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Chang, Chih-Yuan S.; Li, Lain-Jong] Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan; [Chiu, Ming-Hui; Li, Lain-Jong] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia; [Wang, Feng] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Wang, Feng] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Academia Sinica - Taiwan; King Abdullah University of Science & Technology; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wang, F (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	fengwang76@berkeley.edu	Hong, Xiaoping/G-8673-2013; Chiu, Ming-Hui/J-3830-2018; wang, Feng/I-5727-2015; JIN, CHENHAO/GYV-5734-2022; Chang, Chih-Yuan S./O-9942-2019; Li, Lain-Jong/D-5244-2011; Chang, Chih-Yuan/D-2610-2018	Hong, Xiaoping/0000-0002-5864-4533; Chiu, Ming-Hui/0000-0003-3753-8149; wang, Feng/0000-0001-8369-6194; Chang, Chih-Yuan S./0000-0001-9325-6408; Li, Lain-Jong/0000-0002-4059-7783; Chang, Chih-Yuan/0000-0001-9325-6408; shi, sufei/0000-0001-5158-805X	Office of Basic Energy Science, U.S. Department of Energy [DE-SC0003949, DE-AC02-05CH11231]; Academia Sinica; National Science Council Taiwan [NSC-102-2119-M-001-005-MY3]; David and Lucile Packard fellowship	Office of Basic Energy Science, U.S. Department of Energy(United States Department of Energy (DOE)); Academia Sinica(Academia Sinica - Taiwan); National Science Council Taiwan(Ministry of Science and Technology, Taiwan); David and Lucile Packard fellowship(The David & Lucile Packard Foundation)	This work was supported by Office of Basic Energy Science, U.S. Department of Energy under contract DE-SC0003949 (Early Career Award) and DE-AC02-05CH11231 (Materials Science Division). L.J.L. thanks the support from Academia Sinica and National Science Council Taiwan (NSC-102-2119-M-001-005-MY3). F.W. also acknowledges the support from a David and Lucile Packard fellowship. All data described in the paper are presented in this report and supplementary materials.	Berezovsky J, 2008, SCIENCE, V320, P349, DOI 10.1126/science.1154798; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Cohen-Tannoudji C, 1998, PHYS SCRIPTA, VT76, P33, DOI 10.1238/Physica.Topical.076a00033; COHENTANNOUDJI C, 1977, J PHYS B-AT MOL OPT, V10, P345, DOI 10.1088/0022-3700/10/3/005; Gupta JA, 2001, SCIENCE, V292, P2458, DOI 10.1126/science.1061169; Huang JK, 2014, ACS NANO, V8, P923, DOI 10.1021/nn405719x; Jessen PS, 1996, ADV ATOM MOL OPT PHY, V37, P95; Jones AM, 2013, NAT NANOTECHNOL, V8, P634, DOI [10.1038/NNANO.2013.151, 10.1038/nnano.2013.151]; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Mai C, 2014, NANO LETT, V14, P202, DOI 10.1021/nl403742j; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; Mak KF, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.196405; Poole C., 1983, ELECT SPIN RESONANCE, V2nd; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Shen Y. R., 1984, PRINCIPLES NONLINEAR; Shi HY, 2013, ACS NANO, V7, P1072, DOI 10.1021/nn303973r; Sie E. J., 2013, BIEXCITON FORMATION; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; VONLEHMEN A, 1986, OPT LETT, V11, P609, DOI 10.1364/OL.11.000609; Wang F, 2008, SCIENCE, V320, P206, DOI 10.1126/science.1152793; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Wang QS, 2013, ACS NANO, V7, P11087, DOI 10.1021/nn405419h; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Xu XD, 2014, NAT PHYS, V10, P343, DOI [10.1038/NPHYS2942, 10.1038/nphys2942]; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329	29	204	207	16	443	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1205	1208		10.1126/science.1258122	http://dx.doi.org/10.1126/science.1258122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477455	Green Submitted			2022-12-28	WOS:000346189000051
J	Brohawn, SG; Campbell, EB; MacKinnon, R				Brohawn, Stephen G.; Campbell, Ernest B.; MacKinnon, Roderick			Physical mechanism for gating and mechano sensitivity of the human TRAAK K+ channel	NATURE			English	Article							MECHANOSENSITIVE CHANNELS; CRYSTAL-STRUCTURE; LIPID-BILAYER; TREK-1; PORE; MEMBRANE; PROTEIN; MODEL; MSCL	Activation of mechanosensitive ion channels by physical force underlies many physiological processes including the sensation of touch, hearing and pain(1-5). TRAAK (also known as KCNK4) ion channels are neuronally expressed members of the two-pore domain K+ (K2P) channel family and are mechano sensitive'. They are involved in controlling mechanical and temperature nociception in mice'. Mechanosensitivity of TRAAK is mediated directly through the lipid bilayer it is a membrane-tension-gated channel'. However, the molecular mechanism of TRAAK channel gating and mechanosensitivity is unknown. Here we present crystal structures of TRAAK in conductive and non-conductive conformations defined by the presence of permeant ions along the conduction pathway. In the non-conductive state, a lipid acyl chain accesses the channel cavity through a 5 Awide lateral opening in the membrane inner leaflet and physically blocks ion passage. In the conductive state, rotation of a transmembrane helix (TM4) about a central hinge seals the intramembrane opening, preventing lipid block of the cavity and permitting ion entry. Additional rotation of a membrane interacting TM2-TM 3 segment, unique to mechanosensitive K2Ps, against TM4 may further stabilize the conductive conformation. Comparison of the structures reveals a biophysical explanation for TRAAK mechanosensitivity an expansion in cross-sectional area up to 2.7 nm(2) in the conductive state is expected to create a membrane-tension-dependent energy difference between conformations that promotes force activation. Our results show how tension of the lipid bilayer can be harnessed to control gating and mechanosensitivity of a eukaryotic ion channel.	[Brohawn, Stephen G.; Campbell, Ernest B.; MacKinnon, Roderick] Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA; [Brohawn, Stephen G.; Campbell, Ernest B.; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu		Brohawn, Stephen/0000-0001-6768-3406	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; Bagriantsev SN, 2012, EMBO J, V31, P3297, DOI 10.1038/emboj.2012.171; Bautista DM, 2011, J GEN PHYSIOL, V138, P291, DOI 10.1085/jgp.201110637; Brohawn SG, 2014, P NATL ACAD SCI USA, V111, P3614, DOI 10.1073/pnas.1320768111; Brohawn SG, 2013, P NATL ACAD SCI USA, V110, P2129, DOI 10.1073/pnas.1218950110; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; Delmas P, 2013, CELL, V155, P278, DOI 10.1016/j.cell.2013.09.026; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Harinath S, 2004, NEUROPHARMACOLOGY, V46, P750, DOI 10.1016/j.neuropharm.2003.11.023; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; Honore E, 2006, P NATL ACAD SCI USA, V103, P6859, DOI 10.1073/pnas.0600463103; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Maksaev G, 2011, CHANNELS, V5, P34, DOI 10.4161/chan.5.1.13906; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murbartian J, 2005, J BIOL CHEM, V280, P30175, DOI 10.1074/jbc.M503862200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nilius B, 2012, TRENDS NEUROSCI, V35, P477, DOI 10.1016/j.tins.2012.04.002; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; OPSAHL LR, 1994, BIOPHYS J, V66, P75, DOI 10.1016/S0006-3495(94)80752-0; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; Ursell Tristan, 2008, V1, P37, DOI 10.1007/978-1-4020-6426-5_2	40	181	184	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					126	U345		10.1038/nature14013	http://dx.doi.org/10.1038/nature14013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471887	Green Accepted, Green Submitted			2022-12-28	WOS:000346310800053
J	Ghidiu, M; Lukatskaya, MR; Zhao, MQ; Gogotsi, Y; Barsoum, MW				Ghidiu, Michael; Lukatskaya, Maria R.; Zhao, Meng-Qiang; Gogotsi, Yury; Barsoum, Michel W.			Conductive two-dimensional titanium carbide 'clay' with high volumetric capacitance	NATURE			English	Article							ELECTROCHEMICAL ENERGY-STORAGE; INTERCALATION; OXIDE; DENSE	Safe and powerful energy storage devices are becoming increasingly important. Charging times of seconds to minutes, with power densities exceeding those of batteries, can in principle be provided by electrochemical capacitors in particular, pseudocapacitors(1,2). Recent research has focused mainly on improving the gravimetric performance of the electrodes of such systems, but for portable electronics and vehicles volume is at a premium(3). The best volumetric capacitances of carbon-based electrodes are around 300 farads per cubic centimetre(4,5); hydrated ruthenium oxide can reach capacitances of 1,000 to 1,500 farads per cubic centimetre with great cydability, but only in thin films(6) Recently, electrodes made of two-dimensional titanium carbide (Ti3C2, a member of the 'MXene' family), produced by etching aluminium from titanium aluminium carbide (Ti3AlC2, a 'MAX' phase) in concentrated hydrofluoric acid, have been shown to have volumetric capacitances of over 300 farads per cubic centimetre(7,8). Here we report a method of producing this material using a solution of lithium fluoride and hydrochloric acid. The resulting hydrophilic material swells in volume when hydrated, and can be shaped like clay and dried into a highly conductive solid or rolled into films tens of micrometres thick. Additive-free films of this titanium carbide 'clay' have volumetric capacitances of up to 900 farads per cubic centimetre, with excellent cyclability and rate performances. This capacitance is almost twice that of our previous report(8), and our synthetic method also offers a much faster route to film production as well as the avoidance of handling hazardous concentrated hydrofluoric acid.	[Ghidiu, Michael; Lukatskaya, Maria R.; Zhao, Meng-Qiang; Gogotsi, Yury; Barsoum, Michel W.] Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Ghidiu, Michael; Lukatskaya, Maria R.; Zhao, Meng-Qiang; Gogotsi, Yury; Barsoum, Michel W.] Drexel Univ, AJ Drexel Nanomat Inst, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Gogotsi, Y (corresponding author), Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.	gogotsi@drexel.edu; barsoumw@drexel.edu	Gogotsi, Yury/B-2167-2008; Lukatskaya, Maria R./A-8118-2012; Zhao, Meng-Qiang/L-7663-2017	Gogotsi, Yury/0000-0001-9423-4032; Lukatskaya, Maria R./0000-0002-2794-4322; Zhao, Meng-Qiang/0000-0002-0547-3144; Ghidiu, Michael/0000-0002-0599-9824	US National Science Foundation [DMR-1310245]; Fluid Interface Reactions, Structures and Transport (FIRST) Center, an Energy Frontier Research Center - US Department of Energy, Office of Science, and Office of Basic Energy Sciences; Direct For Mathematical & Physical Scien [1310245] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Fluid Interface Reactions, Structures and Transport (FIRST) Center, an Energy Frontier Research Center - US Department of Energy, Office of Science, and Office of Basic Energy Sciences(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank O. Mashtalir and Z. Ling for help with material characterization. This work was supported by the US National Science Foundation under grant number DMR-1310245. Electrochemical research was supported by the Fluid Interface Reactions, Structures and Transport (FIRST) Center, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, and Office of Basic Energy Sciences. XRD, X-ray photoelectron spectroscopy, SEM and TEM investigations were performed at the Centralized Research Facilities at Drexel University.	Augustyn V, 2013, NAT MATER, V12, P518, DOI [10.1038/nmat3601, 10.1038/NMAT3601]; Barsoum MW, 2013, MAX PHASES: PROPERTIES OF MACHINABLE TERNARY CARBIDES AND NITRIDES, P1, DOI 10.1002/9783527654581; Chang FY, 2013, MATER LETT, V109, P295, DOI 10.1016/j.matlet.2013.07.102; Conway BE, 2013, ELECTROCHEMICAL SUPE; Dmowski W, 2002, J PHYS CHEM B, V106, P12677, DOI 10.1021/jp026228l; Enyashin AN, 2013, J SOLID STATE CHEM, V207, P42, DOI 10.1016/j.jssc.2013.09.010; Ghaffari M, 2013, ADV MATER, V25, P4879, DOI 10.1002/adma.201301243; Gogotsi Y, 2011, SCIENCE, V334, P917, DOI 10.1126/science.1213003; Halim J, 2014, CHEM MATER, V26, P2374, DOI 10.1021/cm500641a; Hensen EJM, 2002, J PHYS CHEM B, V106, P12664, DOI 10.1021/jp0264883; Jung I, 2008, NANO LETT, V8, P4283, DOI 10.1021/nl8019938; Levi M. D., 2014, ADV ENERGY MAT; Lis D, 2014, SCIENCE, V344, P1138, DOI 10.1126/science.1253793; Lukatskaya MR, 2013, SCIENCE, V341, P1502, DOI 10.1126/science.1241488; Madsen F. T., 1989, Applied Clay Science, V4, P143, DOI 10.1016/0169-1317(89)90005-7; Mashtalir O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2664; Mashtalir O, 2013, MATER CHEM PHYS, V139, P147, DOI 10.1016/j.matchemphys.2013.01.008; Murali S, 2013, NANO ENERGY, V2, P764, DOI 10.1016/j.nanoen.2013.01.007; Naguib M, 2014, ADV MATER, V26, P992, DOI 10.1002/adma.201304138; Naguib M, 2011, ADV MATER, V23, P4248, DOI 10.1002/adma.201102306; Nicolosi V, 2013, SCIENCE, V340, P1420, DOI 10.1126/science.1226419; Peng QM, 2014, J AM CHEM SOC, V136, P4113, DOI 10.1021/ja500506k; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Simon P, 2014, SCIENCE, V343, P1210, DOI 10.1126/science.1249625; Tang Q, 2012, J AM CHEM SOC, V134, P16909, DOI 10.1021/ja308463r; Tao Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02975; Wang J, 2007, J PHYS CHEM C, V111, P14925, DOI 10.1021/jp074464w; Xie XH, 2014, NANOSCALE, V6, P11035, DOI 10.1039/c4nr02080d; Yang XW, 2013, SCIENCE, V341, P534, DOI 10.1126/science.1239089; ZHENG JP, 1995, J ELECTROCHEM SOC, V142, P2699, DOI 10.1149/1.2050077	30	2991	3095	331	4603	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					78	U171		10.1038/nature13970	http://dx.doi.org/10.1038/nature13970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470044	Green Submitted			2022-12-28	WOS:000346310800042
J	Steuber, J; Vohl, G; Casutt, MS; Vorburger, T; Diederichs, K; Fritz, G				Steuber, Julia; Vohl, Georg; Casutt, Marco S.; Vorburger, Thomas; Diederichs, Kay; Fritz, Guenter			Structure of the V. cholerae Na+-pumping NADH:quinone oxidoreductase	NATURE			English	Article							NADH-QUINONE OXIDOREDUCTASE; TRANSLOCATING NADH; UBIQUINONE OXIDOREDUCTASE; CRYSTAL-STRUCTURE; VIBRIO-CHOLERAE; NQRC SUBUNITS; PROTEIN; CRYSTALLIZATION; MECHANISM; ELECTRON	NADH oxidation in the respiratory chain is coupled to ion translocation across the membrane to build up an electrochemical gradient. The sodium -translocattng NADH:quinone oxidoreductase (Na+-NQR), amembrane protein complex widespread among pathogenic bacteria' consists of six subunits, NqrA, B, C, D, E and F. our knowledge, no structural information on the Na+-NQR complex has been available until now. Here we present the crystal structure of the Na+-NQR complex at 3.5 angstrom resolution. The arrangement of cofactors both at the cytoplasmic and the periplastnic side of the complex, together with a hitherto unknown iron centre in the midst of the membrane-embedded part, reveals an electron transfer pathway from the NADH- oxidizing cytoplasmic NqrF subunit across the membrane to the petiplasmic NqrC, and back to the qui none reduction site on NqrA located in the cytoplasm. A soditun channel was localized in subunit Nqr13, which represents the largest membrane subunit of the Na+-NQR and is structurally related to urea and ammonia transporters. On the basis of the structure we propose a mechanism of redox-driven Na+ translocation where the change in redox state of the flavin mononucleotide cofactor in NqrB triggers the transport of Na+ through the observed channel.	[Steuber, Julia; Vorburger, Thomas] Univ Hohenheim, Dept Microbiol, D-70599 Stuttgart, Germany; [Vohl, Georg; Casutt, Marco S.; Fritz, Guenter] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Vohl, Georg] Univ Freiburg, Hermann Staudinger Grad Sch, D-79104 Freiburg, Germany; [Diederichs, Kay] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University Hohenheim; University of Freiburg; University of Freiburg; University of Konstanz	Fritz, G (corresponding author), Univ Freiburg, Inst Neuropathol, Breisacher Str 64, D-79106 Freiburg, Germany.	guenter.fritz@uniklinik-freiburg.de	Fritz, Guenter/E-2933-2013	Fritz, Guenter/0000-0002-4571-8812	'Methoden in den Lebenswissenschaften' of the Baden-Wurttemberg Stiftung P-LS-Meth/4; Deutsche Forschungsgemeinschaft [FR 1321/3-1, FR 1488/3-2]	'Methoden in den Lebenswissenschaften' of the Baden-Wurttemberg Stiftung P-LS-Meth/4; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the staff at beamlines X06SA and X06DA at Swiss Light Source for excellent support. This work was supported by contract research 'Methoden in den Lebenswissenschaften' of the Baden-Wurttemberg Stiftung P-LS-Meth/4 (to J.S. and G.F.), and by the Deutsche Forschungsgemeinschaft grant FR 1321/3-1 (to J.S.) and grant FR 1488/3-2 (to G.F.). We thank Y. Obermaier for expression and preparation of Na<SUP>+</SUP>-NQR.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Bertsova YV, 2013, J BIOL CHEM, V288, P14276, DOI 10.1074/jbc.M113.455402; Bogachev AV, 2007, BIOCHEMISTRY-US, V46, P10186, DOI 10.1021/bi700440w; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, J BIOL CHEM, V284, P5533, DOI 10.1074/jbc.M808984200; Bogachev AV, 2002, BBA-BIOENERGETICS, V1556, P113, DOI 10.1016/S0005-2728(02)00342-0; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Bogachev AV, 1997, FEBS LETT, V409, P475, DOI 10.1016/S0014-5793(97)00536-X; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Casutt MS, 2012, BBA-BIOENERGETICS, V1817, P1817, DOI 10.1016/j.bbabio.2012.02.012; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; Casutt MS, 2010, ACTA CRYSTALLOGR F, V66, P1677, DOI [10.1107/S1744309110043125, 10.1107/S17443091100431]; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Leung KKK, 2013, J BIOL CHEM, V288, P11242, DOI 10.1074/jbc.M113.457002; Levin EJ, 2012, P NATL ACAD SCI USA, V109, P11194, DOI 10.1073/pnas.1207362109; LLC, 2010, PYMOL MOL GRAPH SYST; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Muller V, 2008, ANN NY ACAD SCI, V1125, P137, DOI 10.1196/annals.1419.011; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nedielkov R, 2013, J BIOL CHEM, V288, P30597, DOI 10.1074/jbc.M112.435750; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Saaf A, 1999, P NATL ACAD SCI USA, V96, P8540, DOI 10.1073/pnas.96.15.8540; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steuber J, 2014, BIOL CHEM, V395, P1389, DOI 10.1515/hsz-2014-0204; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; Tao ML, 2006, ACTA CRYSTALLOGR F, V62, P110, DOI 10.1107/S174430910504306X; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verkhovsky MI, 2012, BIOCHEMISTRY-US, V51, P5414, DOI 10.1021/bi300322n; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; Vohl G, 2014, ACTA CRYSTALLOGR F, V70, P987, DOI 10.1107/S2053230X14009881; Wacker T, 2014, P NATL ACAD SCI USA, V111, P9995, DOI 10.1073/pnas.1406409111; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu WD, 2003, BIOCHEMISTRY-US, V42, P5469, DOI 10.1021/bi0272196	56	89	90	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					62	U379		10.1038/nature14003	http://dx.doi.org/10.1038/nature14003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471880	Green Submitted			2022-12-28	WOS:000346310800038
J	Munro, J				Munro, James			What I know I owe to patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Patient Opin, Sheffield S3 8EN, S Yorkshire, England		Munro, J (corresponding author), Patient Opin, Sheffield S3 8EN, S Yorkshire, England.	James.Munro@patientopinion.org.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2014	349								g6734	10.1136/bmj.g6734	http://dx.doi.org/10.1136/bmj.g6734			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KJ	25452623				2022-12-28	WOS:000346116200001
J	Khoury, MJ; Ioannidis, JPA				Khoury, Muin J.; Ioannidis, John P. A.			Big data meets public health	SCIENCE			English	Editorial Material									[Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA; [Khoury, Muin J.] NCI, Epidemiol & Genom Res Program, Bethesda, MD 20850 USA; [Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Palo Alto, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford, Palo Alto, CA 94305 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University; Stanford University	Khoury, MJ (corresponding author), Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA.	muk1@cdc.gov; jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011		Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], 2014, SPURIOUS CORRELATION; Butler D., 2013, NATURE NEWS; Clyne M, 2014, GENET MED, V16, P535, DOI 10.1038/gim.2013.184; Eysenbach G, 2011, AM J PREV MED, V40, pS154, DOI 10.1016/j.amepre.2011.02.006; High R., 2014, SCI AM; Ioannidis JPA, 2013, GENOME MED, V5, DOI 10.1186/gm436; Ioannidis JPA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000247; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Khoury MJ, 2012, GENET MED, V14, P643, DOI 10.1038/gim.2012.43; Khoury MJ, 2011, GENET EPIDEMIOL, V35, P845, DOI 10.1002/gepi.20634; Schully S. D., 2014, APPL TRANSL GENOMICS; Standen A., 2014, KQED SCI	12	218	240	11	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1054	1055		10.1126/science.aaa2709	http://dx.doi.org/10.1126/science.aaa2709			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU7EK	25430753	Green Accepted			2022-12-28	WOS:000345763400019
J	Gascoigne, NRJ				Gascoigne, Nicholas R. J.			IMMUNOLOGY Tolerance lies in the timing	NATURE			English	Editorial Material							T-CELL TOLERANCE; THRESHOLD; KINASE; CD8; LCK		Natl Univ Singapore, Dept Microbiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore	National University of Singapore	Gascoigne, NRJ (corresponding author), Natl Univ Singapore, Dept Microbiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore.	micnrjg@nus.edu.sg						Bachmann MF, 1999, J EXP MED, V189, P1521, DOI 10.1084/jem.189.10.1521; Casas J., 2014, NATURE COMMUN; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220	10	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					502	503		10.1038/515502a	http://dx.doi.org/10.1038/515502a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25428497				2022-12-28	WOS:000346247600042
J	Wolchok, JD; Chan, TA				Wolchok, Jedd D.; Chan, Timothy A.			CANCER Antitumour immunity gets a boost	NATURE			English	Editorial Material							ADVANCED MELANOMA; SAFETY; IMMUNOGENICITY; IPILIMUMAB; ANTI-PD-1; SURVIVAL; ANTIBODY; REVEALS		[Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Wolchok, JD (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.	wolchokj@mskcc.org	Chan, Timothy A/ABD-5850-2021		NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Coley W. B., 1910, P ROY SOC MED, V3, P1, DOI DOI 10.1177/003591571000301601; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Snyder A, 2014, N ENGL J MED; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wolchok JD, 2013, ANN ONCOL, V24, P2174, DOI 10.1093/annonc/mdt161; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001	21	81	89	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					496	498		10.1038/515496a	http://dx.doi.org/10.1038/515496a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25428495	Green Accepted			2022-12-28	WOS:000346247600038
J	Yadav, M; Jhunjhunwala, S; Phung, QT; Lupardus, P; Tanguay, J; Bumbaca, S; Franci, C; Cheung, TK; Fritsche, J; Weinschenk, T; Modrusan, Z; Mellman, I; Lill, JR; Delamarre, L				Yadav, Mahesh; Jhunjhunwala, Suchit; Phung, Qui T.; Lupardus, Patrick; Tanguay, Joshua; Bumbaca, Stephanie; Franci, Christian; Cheung, Tommy K.; Fritsche, Jens; Weinschenk, Toni; Modrusan, Zora; Mellman, Ira; Lill, Jennie R.; Delamarre, Lelia			Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing	NATURE			English	Article							T-CELL EXHAUSTION; ANALYSIS REVEALS; PROSTATE-CANCER; UP-REGULATION; PEPTIDES; PD-1; ANTIGENS; PATIENT; MICROENVIRONMENT; SURVEILLANCE	Human tumours typically harbour a remarkable number of somatic mutations(1). If presented on major histocompatibility complex class I molecules (MHCI), peptides containing these mutations could potentially be immunogenic as they should be recognized as 'non-self neo-antigens by the adaptive immune system. Recent work has confirmed that mutant peptides can serve as T-cell epitopes'. However, few mutant epitopes have been described because their discovery required the laborious screening of patient tumour-infiltrating lymphocytes for their ability to recognize antigen libraries constructed following tumour exome sequencing. We sought to simplify the discovery of immunogenic mutant peptides by characterizing their general properties. We developed an approach that combines whole-exome and transcriptome sequencing analysis with mass spectrometry to identify neo-epitopes in two widely used murine tumour models. Of the >1,300 amino acid changes identified, 13% were predicted to bind MH CI, a small fraction of which were confirmed by mass spectrometry. The peptides were then structurally modelled bound to MHCI. Mutations that were solvent-exposed and therefore accessible to T-cell antigen receptors were predicted to be immunogenic. Vaccination of mice confirmed the approach, with each predicted immunogenic peptide yielding therapeutically active T-cell responses. The predictions also enabled the generation of peptide-MHCI dextramers that could be used to monitor the kinetics and distribution of the anti-tumour T-cell response before and after vaccination. These findings indicate that a suitable prediction algorithm may provide an approach for the pharmacodynamic monitoring of T-cell responses as well as for the development of personalized vaccines in cancer patients.	[Yadav, Mahesh; Jhunjhunwala, Suchit; Phung, Qui T.; Lupardus, Patrick; Tanguay, Joshua; Bumbaca, Stephanie; Franci, Christian; Cheung, Tommy K.; Modrusan, Zora; Mellman, Ira; Lill, Jennie R.; Delamarre, Lelia] Genentech Inc, San Francisco, CA 94080 USA; [Fritsche, Jens; Weinschenk, Toni] Immat Biotechnol GmbH, D-72076 Tubingen, Germany	Roche Holding; Genentech; Immatics Biotechnologies GmbH	Delamarre, L (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	lill.jennie@gene.com; delamarre.lelia@gene.com	Mellman, Ira/ABG-5896-2020; Jhunjhunwala, Suchit/GNH-2256-2022	Jhunjhunwala, Suchit/0000-0003-3484-0588; Fritsche, J./0000-0002-5557-8577				Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bertsch E, 2014, MODERN PATHOL, V27, P1144, DOI 10.1038/modpathol.2013.243; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Butler NS, 2008, J IMMUNOL, V180, P3926, DOI 10.4049/jimmunol.180.6.3926; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Crespo J, 2013, CURR OPIN IMMUNOL, V25, P214, DOI 10.1016/j.coi.2012.12.003; Denton AE, 2011, J IMMUNOL, V187, P5733, DOI 10.4049/jimmunol.1003937; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fortier MH, 2008, J EXP MED, V205, P595, DOI 10.1084/jem.20071985; Fourcade J, 2012, CANCER RES, V72, P887, DOI 10.1158/0008-5472.CAN-11-2637; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Granados DP, 2012, BLOOD, V119, pE181, DOI 10.1182/blood-2012-02-412593; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gujar SA, 2011, MOL THER, V19, P797, DOI 10.1038/mt.2010.297; Jin HT, 2011, CURR TOP MICROBIOL, V350, P17, DOI 10.1007/82_2010_116; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Ostrov DA, 2002, J IMMUNOL, V168, P283, DOI 10.4049/jimmunol.168.1.283; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SETTE A, 1994, J IMMUNOL, V153, P5586; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wang B, 2002, J IMMUNOL, V169, P3137, DOI 10.4049/jimmunol.169.6.3137; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wick DA, 2014, CLIN CANCER RES, V20, P1125, DOI 10.1158/1078-0432.CCR-13-2147; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; Zhao R, 1999, J EXP MED, V189, P359, DOI 10.1084/jem.189.2.359	38	760	826	3	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					572	+		10.1038/nature14001	http://dx.doi.org/10.1038/nature14001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428506				2022-12-28	WOS:000346247600055
J	Rolland, T; Tasan, M; Charloteaux, B; Pevzner, SJ; Zhong, Q; Sahni, N; Yi, S; Lemmens, I; Fontanillo, C; Mosca, R; Kamburov, A; Ghiassian, SD; Yang, XP; Ghamsari, L; Balcha, D; Begg, BE; Braun, P; Brehme, M; Broly, MP; Carvunis, AR; Convery-Zupan, D; Corominas, R; Coulombe-Huntington, J; Dann, E; Dreze, M; Dricot, A; Fan, CY; Franzosa, E; Gebreab, F; Gutierrez, BJ; Hardy, MF; Jin, M; Kang, SL; Kiros, R; Lin, GN; Luck, K; MacWilliams, A; Menche, JR; Murray, RR; Palagi, A; Poulin, MM; Rambout, X; Rasla, J; Reichert, P; Romero, V; Ruyssinck, E; Sahalie, JM; Scholz, A; Shah, AA; Sharma, A; Shen, Y; Spirohn, K; Tam, S; Tejeda, AO; Trigg, SA; Twizere, JC; Vega, K; Walsh, J; Cusick, ME; Xia, Y; Barabasi, AL; Iakoucheva, LM; Aloy, P; De Las Rivas, J; Tavernier, J; Calderwood, MA; Hill, DE; Hao, T; Roth, FP; Vidal, M				Rolland, Thomas; Tasan, Murat; Charloteaux, Benoit; Pevzner, Samuel J.; Zhong, Quan; Sahni, Nidhi; Yi, Song; Lemmens, Irma; Fontanillo, Celia; Mosca, Roberto; Kamburov, Atanas; Ghiassian, Susan D.; Yang, Xinping; Ghamsari, Lila; Balcha, Dawit; Begg, Bridget E.; Braun, Pascal; Brehme, Marc; Broly, Martin P.; Carvunis, Anne-Ruxandra; Convery-Zupan, Dan; Corominas, Roser; Coulombe-Huntington, Jasmin; Dann, Elizabeth; Dreze, Matija; Dricot, Amelie; Fan, Changyu; Franzosa, Eric; Gebreab, Fana; Gutierrez, Bryan J.; Hardy, Madeleine F.; Jin, Mike; Kang, Shuli; Kiros, Ruth; Lin, Guan Ning; Luck, Katja; MacWilliams, Andrew; Menche, Joerg; Murray, Ryan R.; Palagi, Alexandre; Poulin, Matthew M.; Rambout, Xavier; Rasla, John; Reichert, Patrick; Romero, Viviana; Ruyssinck, Elien; Sahalie, Julie M.; Scholz, Annemarie; Shah, Akash A.; Sharma, Amitabh; Shen, Yun; Spirohn, Kerstin; Tam, Stanley; Tejeda, Alexander O.; Trigg, Shelly A.; Twizere, Jean-Claude; Vega, Kerwin; Walsh, Jennifer; Cusick, Michael E.; Xia, Yu; Barabasi, Albert-Laszlo; Iakoucheva, Lilia M.; Aloy, Patrick; De Las Rivas, Javier; Tavernier, Jan; Calderwood, Michael A.; Hill, David E.; Hao, Tong; Roth, Frederick P.; Vidal, Marc			A Proteome-Scale Map of the Human Interactome Network	CELL			English	Article							MOLECULAR INTERACTION DATABASE; GENOME-WIDE ASSOCIATION; POSTTRANSLATIONAL MODIFICATIONS; COMPREHENSIVE RESOURCE; HUMAN-DISEASE; CANCER GENES; UPDATE; EXPRESSION; PROTEINS; DISORDERS	Just as reference genome sequences revolutionized human genetics, reference maps of interactome networks will be critical to fully understand geno-type- phenotype relationships. Here, we describe a systematic map of similar to 14,000 high-quality human binary protein-protein interactions. At equal quality, this map is similar to 30% larger than what is available from small-scale studies published in the literature in the last few decades. While currently available information is highly biased and only covers a relatively small portion of the proteome, our systematic map appears strikingly more homogeneous, revealing a "broader'' human interactome network than currently appreciated. The map also uncovers significant inter-connectivity between known and candidate cancer gene products, providing unbiased evidence for an expanded functional cancer landscape, while demonstrating how high-quality interactome models will help "connect the dots'' of the genomic revolution.	[Rolland, Thomas; Tasan, Murat; Charloteaux, Benoit; Pevzner, Samuel J.; Zhong, Quan; Sahni, Nidhi; Yi, Song; Kamburov, Atanas; Ghiassian, Susan D.; Yang, Xinping; Ghamsari, Lila; Balcha, Dawit; Begg, Bridget E.; Braun, Pascal; Brehme, Marc; Broly, Martin P.; Carvunis, Anne-Ruxandra; Convery-Zupan, Dan; Coulombe-Huntington, Jasmin; Dann, Elizabeth; Dreze, Matija; Dricot, Amelie; Fan, Changyu; Franzosa, Eric; Gebreab, Fana; Gutierrez, Bryan J.; Hardy, Madeleine F.; Jin, Mike; Kiros, Ruth; Luck, Katja; MacWilliams, Andrew; Menche, Joerg; Murray, Ryan R.; Palagi, Alexandre; Poulin, Matthew M.; Rambout, Xavier; Rasla, John; Reichert, Patrick; Romero, Viviana; Sahalie, Julie M.; Scholz, Annemarie; Shah, Akash A.; Sharma, Amitabh; Shen, Yun; Spirohn, Kerstin; Tam, Stanley; Tejeda, Alexander O.; Trigg, Shelly A.; Twizere, Jean-Claude; Vega, Kerwin; Walsh, Jennifer; Cusick, Michael E.; Xia, Yu; Barabasi, Albert-Laszlo; Calderwood, Michael A.; Hill, David E.; Hao, Tong; Roth, Frederick P.; Vidal, Marc] Dana Farber Canc Inst, CCSB, Boston, MA 02215 USA; [Rolland, Thomas; Tasan, Murat; Charloteaux, Benoit; Pevzner, Samuel J.; Zhong, Quan; Sahni, Nidhi; Yi, Song; Kamburov, Atanas; Ghiassian, Susan D.; Yang, Xinping; Ghamsari, Lila; Balcha, Dawit; Begg, Bridget E.; Braun, Pascal; Brehme, Marc; Broly, Martin P.; Carvunis, Anne-Ruxandra; Convery-Zupan, Dan; Coulombe-Huntington, Jasmin; Dann, Elizabeth; Dreze, Matija; Dricot, Amelie; Fan, Changyu; Franzosa, Eric; Gebreab, Fana; Gutierrez, Bryan J.; Hardy, Madeleine F.; Jin, Mike; Kiros, Ruth; Luck, Katja; MacWilliams, Andrew; Menche, Joerg; Murray, Ryan R.; Palagi, Alexandre; Poulin, Matthew M.; Rambout, Xavier; Rasla, John; Reichert, Patrick; Romero, Viviana; Sahalie, Julie M.; Scholz, Annemarie; Shah, Akash A.; Sharma, Amitabh; Shen, Yun; Spirohn, Kerstin; Tam, Stanley; Tejeda, Alexander O.; Trigg, Shelly A.; Twizere, Jean-Claude; Vega, Kerwin; Walsh, Jennifer; Cusick, Michael E.; Xia, Yu; Barabasi, Albert-Laszlo; Calderwood, Michael A.; Hill, David E.; Hao, Tong; Roth, Frederick P.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Rolland, Thomas; Charloteaux, Benoit; Pevzner, Samuel J.; Zhong, Quan; Sahni, Nidhi; Yi, Song; Kamburov, Atanas; Yang, Xinping; Ghamsari, Lila; Balcha, Dawit; Begg, Bridget E.; Braun, Pascal; Brehme, Marc; Broly, Martin P.; Carvunis, Anne-Ruxandra; Convery-Zupan, Dan; Dann, Elizabeth; Dreze, Matija; Dricot, Amelie; Fan, Changyu; Gebreab, Fana; Gutierrez, Bryan J.; Hardy, Madeleine F.; Jin, Mike; Kiros, Ruth; Lin, Guan Ning; Luck, Katja; MacWilliams, Andrew; Murray, Ryan R.; Palagi, Alexandre; Poulin, Matthew M.; Rambout, Xavier; Rasla, John; Reichert, Patrick; Romero, Viviana; Sahalie, Julie M.; Scholz, Annemarie; Shah, Akash A.; Shen, Yun; Spirohn, Kerstin; Tam, Stanley; Tejeda, Alexander O.; Trigg, Shelly A.; Twizere, Jean-Claude; Vega, Kerwin; Walsh, Jennifer; Cusick, Michael E.; Calderwood, Michael A.; Hill, David E.; Hao, Tong; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Tasan, Murat; Roth, Frederick P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Tasan, Murat; Roth, Frederick P.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3E1, Canada; [Tasan, Murat; Roth, Frederick P.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Tasan, Murat; Roth, Frederick P.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Pevzner, Samuel J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Pevzner, Samuel J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Zhong, Quan] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Lemmens, Irma; Ruyssinck, Elien; Tavernier, Jan] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Fontanillo, Celia; De Las Rivas, Javier] Univ Salamanca, Canc Res Ctr, E-37008 Salamanca, Spain; [Fontanillo, Celia; De Las Rivas, Javier] CSIC, Salamanca 37008, Spain; [Mosca, Roberto; Aloy, Patrick] Inst Res Biomed IRB Barcelona, Joint IRB BSC Program Computat Biol, Barcelona 08028, Spain; [Menche, Joerg; Sharma, Amitabh; Barabasi, Albert-Laszlo] Northeastern Univ, CCNR, Boston, MA 02115 USA; [Menche, Joerg; Sharma, Amitabh; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Corominas, Roser; Kang, Shuli; Lin, Guan Ning; Iakoucheva, Lilia M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Coulombe-Huntington, Jasmin; Franzosa, Eric; Xia, Yu] McGill Univ, Dept Bioengn, Montreal, PQ H3A 0C3, Canada; [Rambout, Xavier; Twizere, Jean-Claude] Univ Liege, GIGA R, Prot Signaling & Interact Lab, B-4000 Liege, Belgium; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Aloy, Patrick] ICREA, Barcelona 08010, Spain; [Roth, Frederick P.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Boston University; Boston University; University System of Ohio; Wright State University Dayton; Flanders Institute for Biotechnology (VIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Northeastern University; Northeastern University; University of California System; University of California San Diego; McGill University; University of Liege; Harvard University; Brigham & Women's Hospital; Harvard Medical School; ICREA; Canadian Institute for Advanced Research (CIFAR)	Roth, FP (corresponding author), Dana Farber Canc Inst, CCSB, Boston, MA 02215 USA.	fritz.roth@utoronto.ca; marc_vidal@dfci.harvard.edu	Brehme, Marc/G-8697-2015; De Las Rivas, Javier/G-5936-2014; zhong, quan/AAE-8893-2021; Yi, Song/ABG-6526-2020; Yang, Xinping/HGA-6104-2022; Braun, Pascal/B-9669-2013; Barabasi, Albert-Laszlo/S-6474-2017; Corominas, Roser/H-4163-2016; Menche, Jörg/G-3994-2015; Twizere, Jean-Claude/AAG-3706-2019; Calderwood, Mike/B-2475-2014; Tavernier, Jan/AAG-3636-2019; Menche, Jörg/AAB-7008-2021; Roth, Frederick P/H-6308-2011; Dreze, Matija/AAZ-3293-2020; Xia, Yu/W-6150-2019; Aloy, Patrick/AAB-3538-2019	Brehme, Marc/0000-0003-0694-331X; De Las Rivas, Javier/0000-0002-0984-9946; Yi, Song/0000-0003-0047-8103; Braun, Pascal/0000-0003-2012-6746; Corominas, Roser/0000-0001-8888-5402; Menche, Jörg/0000-0002-1583-6404; Calderwood, Mike/0000-0001-6475-1418; Menche, Jörg/0000-0002-1583-6404; Xia, Yu/0000-0002-5596-5518; TWIZERE, Jean-Claude/0000-0002-8683-705X; Rolland, Thomas/0000-0001-6468-8391; Jin, Mike/0000-0001-7237-6697; Trigg, Shelly/0000-0001-6904-4149; Fontanillo, Celia/0000-0002-3631-7881; Kamburov, Atanas/0000-0002-0580-0619; Rambout, Xavier/0000-0002-5147-2863; Aloy, Patrick/0000-0002-3557-0236; Zhong, Quan/0000-0003-2910-5597; Carvunis, Anne-Ruxandra/0000-0002-6474-6413; Barabasi, Albert/0000-0002-4028-3522; Roth, Frederick/0000-0002-6628-649X; Mosca, Roberto/0000-0002-3244-1885; Sahni, Nidhi/0000-0002-9155-5882; Yang, Xinping/0000-0003-4086-4180; Iakoucheva, Lilia/0000-0002-4542-5219; /0000-0001-7002-8488	NHGRI [R01/U01HG001715, P50HG004233]; NHLBI [U01HL098166, U01HL108630]; NCI [U54CA112962, R33CA132073]; NIH [RC4HG006066]; NICHD [R01HD065288, R21MH104766, R01MH105524]; NIMH [R01MH091350]; NSF [CCF-1219007]; NSERC [RGPIN-2014-03892]; Canada Excellence Research Chair; Krembil Foundation; Ontario Research Fund-Research Excellence Award; Avon Foundation; Junta de Castilla y Leon (Valladolid, Spain) [CSI07A09]; Ministerio de Economia y Competitividad (AES, ISCiii, Madrid, Spain) [PI12/00624]; Consejo Superior de Investigaciones Cientificas (CSIC, Madrid, Spain) [i-Link0398]; Spanish Ministerio de Ciencia e Innovacion [BIO2010-22073]; European Commission [306240]; Group-ID Multidisciplinary Research Partnerships of Ghent University; Fund for Scientific Research-Flanders [FWO-V G.0864.10]; ERC [340941]; EMBO long-term fellowship; Institute Sponsored Research funds from the Dana-Farber Cancer Institute Strategic Initiative; ICREA Funding Source: Custom; Division of Computing and Communication Foundations [1219007] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065288] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R33CA132073, U54CA112962] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098166, U01HL108630] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC4HG006066, R01HG001715, U01HG001715, P50HG004233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH104766, R01MH091350, R01MH105524] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Excellence Research Chair; Krembil Foundation; Ontario Research Fund-Research Excellence Award; Avon Foundation; Junta de Castilla y Leon (Valladolid, Spain)(Junta de Castilla y Leon); Ministerio de Economia y Competitividad (AES, ISCiii, Madrid, Spain); Consejo Superior de Investigaciones Cientificas (CSIC, Madrid, Spain); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Group-ID Multidisciplinary Research Partnerships of Ghent University; Fund for Scientific Research-Flanders(FWO); ERC(European Research Council (ERC)European Commission); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Institute Sponsored Research funds from the Dana-Farber Cancer Institute Strategic Initiative; ICREA(ICREA); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors wish to acknowledge past and present members of the Center for Cancer Systems Biology (CCSB) and particularly H. Yu for helpful discussions. This work was supported primarily by NHGRI grant R01/U01HG001715 awarded to M.V., D.E.H., F.P.R., and J.T. and in part by the following grants and agencies: NHGRI P50HG004233 to M.V., F.P.R., and A.-L.B.; NHLBI U01HL098166 subaward to M.V.; NHLBI U01HL108630 subaward to A.-L. B.; NCI U54CA112962 subaward to M.V.; NCI R33CA132073 to M.V.; NIH RC4HG006066 to M.V., D.E.H., and T.H.; NICHD ARRA R01HD065288, R21MH104766, and R01MH105524 to L.M.I.; NIMH R01MH091350 to L.M.I. and T.H.; NSF CCF-1219007 and NSERC RGPIN-2014-03892 to Y.X.; Canada Excellence Research Chair, Krembil Foundation, Ontario Research Fund-Research Excellence Award, Avon Foundation, grant CSI07A09 from Junta de Castilla y Leon (Valladolid, Spain), grant PI12/00624 from Ministerio de Economia y Competitividad (AES 2012, ISCiii, Madrid, Spain), and grant i-Link0398 from Consejo Superior de Investigaciones Cientificas (CSIC, Madrid, Spain) to J.D.L.R.; Spanish Ministerio de Ciencia e Innovacion (BIO2010-22073) and the European Commission through the FP7 project SyStemAge grant agreement n:306240 to P.A.; Group-ID Multidisciplinary Research Partnerships of Ghent University, grant FWO-V G.0864.10 from the Fund for Scientific Research-Flanders and ERC Advanced Grant No 340941 to J.T.; EMBO long-term fellowship to A.K.; Institute Sponsored Research funds from the Dana-Farber Cancer Institute Strategic Initiative to M.V. I.L. is a postdoctoral fellow with the FWO-V. M.V. is a "Chercheur Qualifie Honoraire'' from the Fonds de la Recherche Scientifique (FRS-FNRS, Wallonia-Brussels Federation, Belgium). Since performing the work described, C. Fontanillo has become an employee of Celgene Research SL, part of the Celgene Corporation.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Caufield JH, 2012, METHODS, V58, P317, DOI 10.1016/j.ymeth.2012.12.001; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kornblau SM, 2011, BLOOD, V118, P5604, DOI 10.1182/blood-2011-04-348052; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Loveys DA, 1996, NUCLEIC ACIDS RES, V24, P2813, DOI 10.1093/nar/24.14.2813; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Payne Kimberly J., 2011, Critical Reviews in Oncogenesis, V16, P3; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramachandran N, 2008, NAT METHODS, V5, P535, DOI 10.1038/NMETH.1210; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Woodsmith J, 2014, CURR OPIN STRUC BIOL, V24, P34, DOI 10.1016/j.sbi.2013.11.009; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	56	833	849	10	243	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1212	1226		10.1016/j.cell.2014.10.050	http://dx.doi.org/10.1016/j.cell.2014.10.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416956	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000345506300029
J	Heredia, N; Laurell, AC; Feo, O; Noronha, J; Gonzalez-Guzman, R; Torres-Tovar, M				Heredia, Nila; Laurell, Asa Cristina; Feo, Oscar; Noronha, Jose; Gonzalez-Guzman, Rafael; Torres-Tovar, Mauricio			The right to health: what model for Latin America?	LANCET			English	Editorial Material									[Heredia, Nila] ALAMES, La Paz, Bolivia; [Laurell, Asa Cristina] ALAMES, Mexico City, DF, Mexico; [Feo, Oscar] ALAMES, Maracay, Aragua, Venezuela; [Noronha, Jose] ALAMES, Ctr Brasileiro Estudos Saude CEBES, Rio De Janeiro, Brazil; [Gonzalez-Guzman, Rafael] Univ Nacl Autonoma Mexico, ALAMES, Dept Salud Publ, Fac Med, Mexico City 04510, DF, Mexico; [Torres-Tovar, Mauricio] Univ Nacl Colombia, ALAMES, Bogota, Colombia; [Torres-Tovar, Mauricio] IAHP, Bogota, Colombia	Universidad Nacional Autonoma de Mexico; Universidad Nacional de Colombia	Heredia, N (corresponding author), ALAMES, Casilla Postal 7021, La Paz, Bolivia.	nherediam@gmail.com						Annada F, 2009, INT J HEALTH SERV, V39, P161, DOI 10.2190/HS.39.1.h; [Anonymous], 2007, FOND NAC SAL PROT SO; Asamblea Constituyente de Bolivia, 2008, CONST POL EST PLUR B; CEBES, 2012, REN POL PRES INT PUB; Consejo Nacional de Evaluacion, 2012, EV ESTR PROT SOC MEX; Corte Constitucional, 2012, SAL ESP SEG SENT T 7; D?az Y., 2013, IMPACT UNIVERSAL COV; De Groote T, 2005, INT J HEALTH SERV, V35, P125, DOI 10.2190/LH52-5FCB-4XDE-76CW; Feo O, 2004, SALUD PROCESO CONSTI; Gianella-Malca C, 2009, DEMOCRATIC DELIBERAT; ISAGS, 2012, SIST SAL SUR DES UN; Lakin JM, 2010, J HEALTH POLIT POLIC, V35, P313, DOI 10.1215/03616878-2010-002; Laurell AC, 2013, SISTEMAS U SALUD RET; Laurell Asa Cristina, 2013, IMPACTO SEGURO POPUL; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Ministerio de Salud y Deportes, 2014, PLAN ESTR SECT SAL 2; Missoni E., 2010, 4 WHO; Morelli S, 2012, EC COLOMBIANA, V336; Muntaner C, 2006, INT J HEALTH SERV, V36, P803, DOI 10.2190/C4EW-X8RP-GUM4-P5AD; Ocke-Reiss O, 2012, SUS DESAFIO SER UNIC; OPS. Salud en Sudamerica, 2012, SAL SUD PAN SIT SAL; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Alvarez LS, 2011, INT J HEALTH SERV, V41, P355, DOI 10.2190/HS.41.2.i; Torres-Tovar M, 2008, SAUDE DEBATE, V32, P207; Torres-Tovar Mauricio, 2010, SOC MED, V5, P177; Yepes Lujan FJ, 2010, LUCES SOMBRAS REFORM	26	27	29	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					E34	E37		10.1016/S0140-6736(14)61493-8	http://dx.doi.org/10.1016/S0140-6736(14)61493-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF0ZD	25458721				2022-12-28	WOS:000352272400006
J	Horton, R; Das, P				Horton, Richard; Das, Pamela			Universal health coverage: not why, what, or when-but how?	LANCET			English	Editorial Material									[Horton, Richard; Das, Pamela] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Atun R., 2014, LANCET; Cotlear D, 2014, LANCET; de Andrade LOM, 2014, LANCET; Frenk J, 2014, LANCET; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Sustainable Development Platform, OUTC DOC OP WORK GRO; Titelman D, 2014, LANCET; WHO, 2010, WORLD MALARIA REPORT 2010, P1	8	25	25	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1156	1157		10.1016/S0140-6736(14)61742-6	http://dx.doi.org/10.1016/S0140-6736(14)61742-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE3GQ	25458724				2022-12-28	WOS:000351715100006
J	Ratziu, V				Ratziu, Vlad			Starting the battle to control non-alcoholic steatohepatitis	LANCET			English	Editorial Material							LIVER-TRANSPLANTATION		Univ Paris 06, Hop La Pitie Salpetriere, AP HP, INSERM,Inst Cardiometab & Nutr,UMR S 893, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Ratziu, V (corresponding author), Univ Paris 06, Hop La Pitie Salpetriere, AP HP, INSERM,Inst Cardiometab & Nutr,UMR S 893, F-75013 Paris, France.	vlad.ratziu@upmc.fr		Ratziu, Vlad/0000-0002-6865-3791				Albanis E., 2005, HEPATOLOGY, V42, p1040A; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ekstedt M, 2012, SCAND J GASTROENTERO, V47, P108, DOI 10.3109/00365521.2011.634024; Fickert P, 2009, AM J PATHOL, V175, P2392, DOI 10.2353/ajpath.2009.090114; Hartman HB, 2009, J LIPID RES, V50, P1090, DOI 10.1194/jlr.M800619-JLR200; Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; Neuschwander-Tetri BA, 2014, LANCET; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	13	11	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					922	924		10.1016/S0140-6736(14)62010-9	http://dx.doi.org/10.1016/S0140-6736(14)62010-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD2EK	25468161				2022-12-28	WOS:000350886900008
J	Steptoe, A; Deaton, A; Stone, AA				Steptoe, Andrew; Deaton, Angus; Stone, Arthur A.			Subjective wellbeing, health, and ageing	LANCET			English	Article							SOCIOEMOTIONAL SELECTIVITY THEORY; POSITIVE AFFECT; LIFE EXPERIENCE; OLDER MEN; ASSOCIATION; DEPRESSION; MORTALITY; DISEASE; QUALITY; NEUROENDOCRINE	Subjective wellbeing and health are closely linked to age. Three aspects of subjective wellbeing can be distinguished-evaluative wellbeing (or life satisfaction), hedonic wellbeing (feelings of happiness, sadness, anger, stress, and pain), and eudemonic wellbeing (sense of purpose and meaning in life). We review recent advances in the specialty of psychological wellbeing, and present new analyses about the pattern of wellbeing across ages and the association between wellbeing and survival at older ages. The Gallup World Poll, a continuing survey in more than 160 countries, shows a U-shaped relation between evaluative wellbeing and age in high-income, English speaking countries, with the lowest levels of wellbeing in ages 45-54 years. But this pattern is not universal. For example, respondents from the former Soviet Union and eastern Europe show a large progressive reduction in wellbeing with age, respondents from Latin America also shows decreased wellbeing with age, whereas wellbeing in sub-Saharan Africa shows little change with age. The relation between physical health and subjective wellbeing is bidirectional. Older people with illnesses such as coronary heart disease, arthritis, and chronic lung disease show both increased levels of depressed mood and impaired hedonic and eudemonic wellbeing. Wellbeing might also have a protective role in health maintenance. In an analysis of the English Longitudinal Study of Ageing, we identify that eudemonic wellbeing is associated with increased survival; 29.3% of people in the lowest wellbeing quartile died during the average follow-up period of 8.5 years compared with 9.3% of those in the highest quartile. Associations were independent of age, sex, demographic factors, and baseline mental and physical health. We conclude that the wellbeing of elderly people is an important objective for both economic and health policy. Present psychological and economic theories do not adequately account for the variations in patterns of wellbeing with age across different parts of the world. The apparent association between wellbeing and survival is consistent with a protective role of high wellbeing, but alternative explanations cannot be ruled out at this stage.	[Steptoe, Andrew] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Deaton, Angus] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA; [Deaton, Angus] Princeton Univ, Dept Econ, Princeton, NJ 08544 USA; [Stone, Arthur A.] SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY USA; [Stone, Arthur A.] Univ So Calif, Los Angeles, CA USA	University of London; University College London; Princeton University; Princeton University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Southern California	Steptoe, A (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	a.steptoe@uclac.uk	Beard, John R/K-9621-2014; Steptoe, Andrew/Y-2440-2019; Stone, Arthur A./AAC-3610-2019	Beard, John R/0000-0002-8557-0242; 	British Heart Foundation; US National Institute on Ageing [2RO1AG7644-01A1, 2RO1AG017644]; consortium of UK Government departments; US National Institute on Aging through the National Bureau of Economic Research [5R01AG040629-02, P01 AG05842-14]; Gallup Organization; ESRC [ES/H021221/1, ES/F03511X/1] Funding Source: UKRI; Economic and Social Research Council [ES/F03511X/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG005842, P30AG024928, R01AG017644, R01AG040629] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); US National Institute on Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); consortium of UK Government departments; US National Institute on Aging through the National Bureau of Economic Research; Gallup Organization; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	AS is supported by the British Heart Foundation. The English Longitudinal Study of Ageing was developed by a team of researchers based at University College London, the Institute of Fiscal Studies, and the National Centre for Social Research. The funding is provided by the US National Institute on Ageing (grants 2RO1AG7644-01A1 and 2RO1AG017644) and a consortium of UK Government departments coordinated by the Office for National Statistics. AD and AAS are supported by the US National Institute on Aging through the National Bureau of Economic Research (grants 5R01AG040629-02 and P01 AG05842-14), and by the Gallup Organization.	Arias E, 2008, US LIFE TABLES; Blanchflower DG, 2008, SOC SCI MED, V66, P1733, DOI 10.1016/j.socscimed.2008.01.030; Boehm JK, 2012, PSYCHOL BULL, V138, P655, DOI 10.1037/a0027448; Cantril H., 1965, PATTERN HUMAN CONCER; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Chochinov HM, 2011, LANCET ONCOL, V12, P753, DOI 10.1016/S1470-2045(11)70153-X; Davidson KW, 2010, EUR HEART J, V31, P1065, DOI 10.1093/eurheartj/ehp603; Deaton A, 2008, J ECON PERSPECT, V22, P53, DOI 10.1257/jep.22.2.53; Diener E., 2003, WELL BEING FDN HEDON; Dockray S, 2010, SOC INDIC RES, V99, P269, DOI 10.1007/s11205-010-9578-7; Dolan P, 2007, PERSPECT PSYCHOL SCI, V2, P71, DOI 10.1111/j.1745-6916.2007.00030.x; Frijters P, 2012, J ECON BEHAV ORGAN, V82, P525, DOI 10.1016/j.jebo.2012.03.008; Hales S, 2008, ARCH INTERN MED, V168, P912, DOI 10.1001/archinte.168.9.912; Harter JK, 2008, APS OBS, V21, P23; Hedayati SS, 2010, JAMA-J AM MED ASSOC, V303, P1946, DOI 10.1001/jama.2010.619; Huskamp HA, 2012, MED CARE RES REV, V69, P3, DOI 10.1177/1077558711418518; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kahneman Daniel, 2010, P NATL ACAD SCI US; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Layard R, 2011, HAPPINESS LESSONS NE; Lockenhoff CE, 2004, J PERS, V72, P1395, DOI 10.1111/j.1467-6494.2004.00301.x; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ryff CD, 2004, PHILOS T R SOC B, V359, P1383, DOI 10.1098/rstb.2004.1521; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Seaford C, 2011, NATURE, V477, P532, DOI 10.1038/477532a; Sen A., 2010, IDEA JUSTICE, DOI DOI 10.2307/J.CTVJNRV7N; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Sloan RP, 2011, LANCET, V377, P896, DOI 10.1016/S0140-6736(11)60339-5; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; STEPTOE A, 2006, DEPRESSION PHYS ILLN; Steptoe A, NEUROENDOCRINE CARDI; Steptoe A, 2008, AM J EPIDEMIOL, V167, P96, DOI 10.1093/aje/kwm252; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Steptoe A, 2012, PSYCHOSOM MED, V74, P501, DOI 10.1097/PSY.0b013e31824f82c8; Steptoe A, 2012, ARCH INTERN MED, V172, P273, DOI 10.1001/archinternmed.2011.1028; Steptoe A, 2011, P NATL ACAD SCI USA, V108, P18244, DOI 10.1073/pnas.1110892108; Stiglitz J, 2013, REPORT COMMISSION ME; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; Ulloa B. F. L., 2013, 7328 IZA; Weiss A, 2012, P NATL ACAD SCI USA, V109, P19949, DOI 10.1073/pnas.1212592109; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952; Windle G, 2010, AGING MENT HEALTH, V14, P652, DOI 10.1080/13607861003713232	49	962	989	51	578	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					640	648		10.1016/S0140-6736(13)61489-0	http://dx.doi.org/10.1016/S0140-6736(13)61489-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AZ	25468152	Green Accepted, Green Published			2022-12-28	WOS:000349214000032
J	Bonati, LH; Dobson, J; Featherstone, RL; Ederle, J; van der Worp, HB; de Borst, GJ; Mali, WPTM; Beard, JD; Cleveland, T; Engelter, ST; Lyrer, PA; Ford, GA; Dorman, PJ; Brown, MM				Bonati, Leo H.; Dobson, Joanna; Featherstone, Roland L.; Ederle, Joerg; van der Worp, H. Bart; de Borst, Gert J.; Mali, Willem P. Th M.; Beard, Jonathan D.; Cleveland, Trevor; Engelter, Stefan T.; Lyrer, Philippe A.; Ford, Gary A.; Dorman, Paul J.; Brown, Martin M.		Int Carotid Stenting Study Investi	Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial	LANCET			English	Article							STROKE; ANGIOPLASTY; PROTOCOL	Background Stenting is an alternative to endarterectomy for treatment of carotid artery stenosis, but long-term efficacy is uncertain. We report long-term data from the randomised International Carotid Stenting Study comparison of these treatments. Methods Patients with symptomatic carotid stenosis were randomly assigned 1:1 to open treatment with stenting or endarterectomy at 50 centres worldwide. Randomisation was computer generated centrally and allocated by telephone call or fax. Major outcomes were assessed by an independent endpoint committee unaware of treatment assignment. The primary endpoint was fatal or disabling stroke in any territory after randomisation to the end of follow-up. Analysis was by intention to treat ([ITT] all patients) and per protocol from 31 days after treatment (all patients in whom assigned treatment was completed). Functional ability was rated with the modified Rankin scale. This study is registered, number ISRCTN25337470. Findings 1713 patients were assigned to stenting (n=855) or endarterectomy (n=858) and followed up for a median of 4.2 years (IQR 3.0-5.2, maximum 10.0). Three patients withdrew immediately and, therefore, the ITT population comprised 1710 patients. The number of fatal or disabling strokes (52 vs 49) and cumulative 5-year risk did not differ significantly between the stenting and endarterectomy groups (6.4% vs 6.5%; hazard ratio [HR] 1.06, 95% CI 0.72-1.57, p=0.77). Any stroke was more frequent in the stenting group than in the endarterectomy group (119 vs 72 events; ITT population, 5-year cumulative risk 15.2% vs 9.4%, HR 1.71, 95% CI 1.28-2.30, p<0.001; per-protocol population, 5-year cumulative risk 8.9% vs 5.8%, 1.53, 1.02-2.31, p=0.04), but were mainly non-disabling strokes. The distribution of modified Rankin scale scores at 1 year, 5 years, or final follow-up did not differ significantly between treatment groups. Interpretation Long-term functional outcome and risk of fatal or disabling stroke are similar for stenting and endarterectomy for symptomatic carotid stenosis. Copyright (C) Bonati et al. Open Access article distributed under the terms of CC BY.	[Bonati, Leo H.; Featherstone, Roland L.; Ederle, Joerg; Brown, Martin M.] UCL, Inst Neurol, Dept Brain Repair & Rehabil, London WC1N 3BG, England; [Bonati, Leo H.; Engelter, Stefan T.; Lyrer, Philippe A.] Univ Basel, Univ Basel Hosp, Dept Neurol, Basel, Switzerland; [Bonati, Leo H.; Engelter, Stefan T.; Lyrer, Philippe A.] Univ Basel, Univ Basel Hosp, Stroke Unit, Basel, Switzerland; [Dobson, Joanna] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [van der Worp, H. Bart] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [de Borst, Gert J.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Mali, Willem P. Th M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Beard, Jonathan D.; Cleveland, Trevor] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield Vasc Inst, Sheffield, S Yorkshire, England; [Ford, Gary A.] Newcastle Univ, Stroke Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Dorman, Paul J.] Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of London; University College London; University of Basel; University of Basel; University of London; London School of Hygiene & Tropical Medicine; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Sheffield; Newcastle University - UK; Newcastle University - UK	Brown, MM (corresponding author), UCL, Natl Hosp Neurol & Neurosurg, Inst Neurol, Box 6,Queen Sq, London WC1N 3BG, England.	martin.brown@ucl.ac.uk	Bonati, Leo/G-4058-2012; Beiles, C Barry/I-2322-2019; de Leeuw, Frank-Erik/E-4795-2012; Ford, Gary/AAY-6405-2020; Ijäs, Petra/F-8280-2015; Blankensteijn, Jan D/Q-9291-2016; Curtze, Sami/AAK-8595-2020; Hirt, Lorenz/G-3553-2010; Vanhooren, Geert/H-4433-2011	Bonati, Leo/0000-0003-1163-8133; Beiles, C Barry/0000-0001-5026-1661; Ford, Gary/0000-0001-8719-4968; Ijäs, Petra/0000-0002-7292-1971; Blankensteijn, Jan D/0000-0002-2062-8749; Curtze, Sami/0000-0003-1545-8500; Hirt, Lorenz/0000-0002-2921-5000; Bonvin, Christophe/0000-0002-9058-8105; Stansby, Gerard/0000-0001-5539-3049; Malmstedt, Jonas/0000-0002-2758-9623; Vanhooren, Geert/0000-0001-6818-9346; Zeilstra, Dick/0000-0001-7770-9913; Brown, Martin M/0000-0002-3273-1356; Wahlgren, Carl Magnus/0000-0002-9619-3577; Doig, David/0000-0002-7492-6610; Engelter, Stefan/0000-0003-3855-6234; McGahan, Tim/0000-0003-2935-3072; Hendriks, Jeroen/0000-0001-9145-3643; Sidhu, Paul/0000-0003-1928-4077; Macho Fernandez, Juan Miguel/0000-0002-8417-7094; Chamorro, Angel/0000-0003-0493-5340; Tibballs, Jonathan/0000-0001-6562-3434; lovblad, karl-olof/0000-0003-2768-9779	Medical Research Council; Stroke Association; Sanofi-Synthelabo; European Union; MRC [G0300411] Funding Source: UKRI; Medical Research Council [G0300411] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10339] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; Sanofi-Synthelabo; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Medical Research Council, Stroke Association, Sanofi-Synthelabo, European Union.	Arquizan C, 2011, STROKE, V42, P1015, DOI 10.1161/STROKEAHA.110.589309; Bonati LH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000515.pub4; Bonati LH, 2010, LANCET, V376, P1062, DOI 10.1016/S0140-6736(10)61009-4; Bonati LH, 2009, LANCET NEUROL, V8, P908, DOI 10.1016/S1474-4422(09)70227-3; Bost RBC, 2014, J STROKE CEREBROVASC, V23, P699, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.020; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Calvet D, 2014, CEREBROVASC DIS, V37, P192; Calvet D, 2014, STROKE, V45, P527, DOI 10.1161/STROKEAHA.113.003526; Collet D, 2003, MODELLING SURVIVAL D, P286; de Castro-Afonso LH, 2013, CIRC-CARDIOVASC INTE, V6, P552, DOI 10.1161/CIRCINTERVENTIONS.113.000479; Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0; Ederle J, 2013, LANCET NEUROL, V12, P866, DOI 10.1016/S1474-4422(13)70135-2; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Ederle J, 2009, LANCET NEUROL, V8, P898, DOI 10.1016/S1474-4422(09)70228-5; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Featherstone RL, 2004, CEREBROVASC DIS, V18, P69, DOI 10.1159/000078753; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Howard G, 2012, STROKE, V43, P664, DOI 10.1161/STROKEAHA.111.632935; Kennedy F, 2013, CEREBROVASC DIS, V35, P463; Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Nederkoorn PJ, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-36; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Silver FL, 2011, STROKE, V42, P675, DOI 10.1161/STROKEAHA.110.610212; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604	27	326	355	0	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					529	538		10.1016/S0140-6736(14)61184-3	http://dx.doi.org/10.1016/S0140-6736(14)61184-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AV	25453443	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000349213600031
J	Sreeramkumar, V; Adrover, JM; Ballesteros, I; Cuartero, MI; Rossaint, J; Bilbao, I; Nacher, M; Pitaval, C; Radovanovic, I; Fukui, Y; McEver, RP; Filippi, MD; Lizasoain, I; Ruiz-Cabello, J; Zarbock, A; Moro, MA; Hidalgo, A				Sreeramkumar, Vinatha; Adrover, Jose M.; Ballesteros, Ivan; Isabel Cuartero, Maria; Rossaint, Jan; Bilbao, Izaskun; Nacher, Maria; Pitaval, Christophe; Radovanovic, Irena; Fukui, Yoshinori; McEver, Rodger P.; Filippi, Marie-Dominique; Lizasoain, Ignacio; Ruiz-Cabello, Jesus; Zarbock, Alexander; Moro, Maria A.; Hidalgo, Andres			Neutrophils scan for activated platelets to initiate inflammation	SCIENCE			English	Article							EXTRACELLULAR TRAPS; LEUKOCYTE; MICRODOMAINS; CHEMOTAXIS; MOTILITY; ADHESION; POLARITY; CASCADE; SIGNALS; INJURY	Immune and inflammatory responses require leukocytes to migrate within and through the vasculature, a process that is facilitated by their capacity to switch to a polarized morphology with an asymmetric distribution of receptors. We report that neutrophil polarization within activated venules served to organize a protruding domain that engaged activated platelets present in the bloodstream. The selectin ligand PSGL-1 transduced signals emanating from these interactions, resulting in the redistribution of receptors that drive neutrophil migration. Consequently, neutrophils unable to polarize or to transduce signals through PSGL-1 displayed aberrant crawling, and blockade of this domain protected mice against thromboinflammatory injury. These results reveal that recruited neutrophils scan for activated platelets, and they suggest that the neutrophils' bipolarity allows the integration of signals present at both the endothelium and the circulation before inflammation proceeds.	[Sreeramkumar, Vinatha; Adrover, Jose M.; Bilbao, Izaskun; Nacher, Maria; Pitaval, Christophe; Radovanovic, Irena; Ruiz-Cabello, Jesus; Hidalgo, Andres] CNIC, Dept Atherothrombosis Imaging & Epidemiol, Madrid, Spain; [Ballesteros, Ivan; Isabel Cuartero, Maria; Lizasoain, Ignacio; Moro, Maria A.] Univ Complutense Madrid, Fac Med, Dept Pharmacol, Unidad Invest Neurovasc, E-28040 Madrid, Spain; [Ballesteros, Ivan; Isabel Cuartero, Maria; Lizasoain, Ignacio; Moro, Maria A.] Hosp 12 Octubre I 12, Inst Invest, Madrid, Spain; [Rossaint, Jan; Zarbock, Alexander] Univ Munster, Dept Anesthesiol & Crit Care Med, D-48149 Munster, Germany; [Rossaint, Jan; Zarbock, Alexander] Max Planck Inst Munster, Munster, Germany; [Bilbao, Izaskun; Ruiz-Cabello, Jesus] Ciber Enfermedades Resp CIBERES, Madrid, Spain; [Nacher, Maria] Univ Wollongong, Fac Sci Med & Hlth, Wollongong, NSW 2522, Australia; [Fukui, Yoshinori] Kyushu Univ, Dept Immunobiol & Neurosci, Div Immunogenet, Fukuoka 812, Japan; [McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Filippi, Marie-Dominique] Univ Cincinnati, Coll Med, Cincinnati Childrens Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Hidalgo, Andres] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Complutense University of Madrid; Hospital Universitario 12 de Octubre; University of Munster; Max Planck Society; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Wollongong; Kyushu University; Oklahoma Medical Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Munich	Hidalgo, A (corresponding author), CNIC, Dept Atherothrombosis Imaging & Epidemiol, Madrid, Spain.	ahidalgo@cnic.es	Ballesteros, Iván/AAA-6745-2020; Ruiz-Cabello, Jesus/A-9570-2012; Hidalgo, Andrés/L-5643-2014; Martin, Ivan Ballesteros/G-6623-2017; Cuartero, Maria Isabel/E-8103-2012; Moro, María Ángeles/K-6396-2014; Adrover, Jose M/G-9741-2017	Ruiz-Cabello, Jesus/0000-0001-8681-5056; Hidalgo, Andrés/0000-0001-5513-555X; Cuartero, Maria Isabel/0000-0003-4728-068X; Moro, María Ángeles/0000-0003-1010-8237; Adrover, Jose M/0000-0002-1395-5477; Radovanovic, Irena/0000-0002-3823-3729	NIH [HL03463, HL085607, HL090676]; German Research Foundation [ZA428/8-1, ZA428/6-1, SFB 1009-TP A05]; FP7 Marie Curie from Comunidad de Madrid [ITN-264864, S2010/BMD-2326]; Japan Society for the Promotion of Science; Ministerio de Economia y Competitividad (MINECO) [SAF2012-33216]; Comunidad de Madrid [S2010/BMD-2336, S2010/BMD-2314]; Ramon y Cajal Fellowship from MINECO [RYC-2007-00697, SAF2009-11037, 2012-31142]; FP7-People-IRG Program [246655]; MINECO; Pro-CNIC Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085607, R01HL034363, K08HL003463, R01HL090676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); FP7 Marie Curie from Comunidad de Madrid; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Ramon y Cajal Fellowship from MINECO; FP7-People-IRG Program; MINECO(Spanish Government); Pro-CNIC Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank G. Crainiciuc, J. A. Quintana, I. Ortega, and A. Santos for technical support and D. Sancho and S. Gonzalez for insightful comments. The data presented in this manuscript can be found in the main paper and supplementary materials. This study was supported by NIH grants HL03463, HL085607 (R.P.M.), and HL090676 (M.-D.F.); German Research Foundation grants ZA428/8-1, ZA428/6-1, and SFB 1009-TP A05 (A.Z.); FP7 Marie Curie (ITN-264864; pi-net) and S2010/BMD-2326 from Comunidad de Madrid (J. R-C.); Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Y.F.); CSD2010-00045 and SAF2012-33216 from Ministerio de Economia y Competitividad (MINECO) and S2010/BMD-2336 from Comunidad de Madrid (M.A.M.); and a Ramon y Cajal Fellowship (RYC-2007-00697), SAF2009-11037 and 2012-31142 from MINECO, S2010/BMD-2314 from Comunidad de Madrid, and 246655 from FP7-People-IRG Program (A.H.). The CNIC is supported by the MINECO and the Pro-CNIC Foundation. R.P.M. is cofounder of Selexys Pharmaceuticals, which is developing monoclonal antibodies to PSGL-1 and P-selectin to treat inflammatory and thrombotic diseases. A patent application for the blockade of PSGL-1 in thromboinflammation has been filed by V.S. and A.H. (EP14382425.8). The authors declare no other conflicts of interest.	Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Chiang EY, 2007, NAT METHODS, V4, P219, DOI 10.1038/nmeth1018; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Hidalgo A, 2009, NAT MED, V15, P384, DOI 10.1038/nm.1939; Cuartero MI, 2013, STROKE, V44, P3498, DOI 10.1161/STROKEAHA.113.002470; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Looney MR, 2010, CURR OPIN HEMATOL, V17, P418, DOI 10.1097/MOH.0b013e32833c07d3; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Szczur K, 2009, BLOOD, V114, P4527, DOI 10.1182/blood-2008-12-195164; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566	22	398	409	7	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1234	1238		10.1126/science.1256478	http://dx.doi.org/10.1126/science.1256478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477463	Green Accepted			2022-12-28	WOS:000346189000059
J	Rudin, RS; Motala, A; Goldzweig, CL; Shekelle, PG				Rudin, Robert S.; Motala, Aneesa; Goldzweig, Caroline L.; Shekelle, Paul G.			Usage and Effect of Health Information Exchange A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							EMERGENCY-DEPARTMENT; AMBULATORY-CARE; RECORD ADOPTION; TECHNOLOGY; PHYSICIANS; QUALITY; ORGANIZATIONS; PERCEPTIONS; CLINICIAN; ATTITUDES	Background: Health information exchange (HIE) is increasing in the United States, and it is incentivized by government policies. Purpose: To systematically review and evaluate evidence of the use and effect of HIE on clinical care. Data Sources: Selected databases from 1 January 2003 to 31 May 2014. Study Selection: English-language hypothesis-testing or quantitative studies of several types of data exchange among unaffiliated organizations for use in clinical care that addressed health outcomes, efficiency, utilization, costs, satisfaction, HIE usage, sustainability, and attitudes or barriers. Data Extraction: Data extraction was done in duplicate. Data Synthesis: Low-quality evidence from 12 hypothesis-testing studies supports an effect of HIE use on reduced use or costs in the emergency department. Direct evidence that HIEs were used by providers was reported in 21 studies involving 13 distinct HIE organizations, 6 of which were located in New York, and generally showed usage in less than 10% of patient encounters. Findings from 17 studies of sustainability suggest that approximately one quarter of existing HIE organizations consider themselves financially stable. Findings from 38 studies about attitudes and barriers showed that providers, patients, and other stakeholders consider HIE to be valuable, but barriers include technical and workflow issues, costs, and privacy concerns. Limitation: Publication bias, possible selective reporting of outcomes, and a dearth of reporting on context and implementation processes. Conclusion: Health information exchange use probably reduces emergency department usage and costs in some cases. Effects on other outcomes are unknown. All stakeholders claim to value HIE, but many barriers to acceptance and sustainability exist. A small portion of operational HIEs have been evaluated, and more research is needed to identify and understand success factors.	RAND Corp, Boston, MA USA; RAND Corp, Santa Monica, CA USA; Southern Calif Evidence Based Practice Ctr, Santa Monica, CA USA; West Los Angeles Vet Affairs Med Ctr, Los Angeles, CA USA	RAND Corporation; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center	Rudin, RS (corresponding author), RAND Hlth, 20 Pk Plaza,9th Floor,Suite 920, Boston, MA 02116 USA.	rrudin@rand.org			U.S. Department of Veterans Affairs [691-D58178]	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs (contract 691-D58178). No statement in this article should be construed as an official position of the U.S. Department of Veterans Affairs.	Abramson EL, 2014, HEALTH SERV RES, V49, P361, DOI 10.1111/1475-6773.12137; Abramson EL, 2012, J EVAL CLIN PRACT, V18, P1156, DOI 10.1111/j.1365-2753.2011.01755.x; Adjerid Idris, 2011, AMIA Annu Symp Proc, V2011, P48; Adler-Milstein J, 2008, HEALTH AFFAIR, V27, pW60, DOI 10.1377/hlthaff.27.1.w60; Adler-Milstein J, 2013, HEALTH AFFAIR, V32, P1486, DOI 10.1377/hlthaff.2013.0124; Adler-Milstein J, 2011, AM J MANAG CARE, V17, P761; Adler-Milstein J, 2011, ANN INTERN MED, V154, P666, DOI 10.7326/0003-4819-154-10-201105170-00006; Adler-Milstein J, 2010, J AM MED INFORM ASSN, V17, P61, DOI 10.1197/jamia.M3284; Adler-Milstein J, 2009, HEALTH AFFAIR, V28, P483, DOI 10.1377/hlthaff.28.2.483; Altman Richard, 2012, Inform Prim Care, V20, P249; Anand Vibha, 2012, Online J Public Health Inform, V4, DOI 10.5210/ojphi.v4i3.4303; Ancker JS, 2014, J AM MED INFORM ASSN, V21, P664, DOI 10.1136/amiajnl-2013-002073; Ancker JS, 2013, J AM MED INFORM ASSN, V20, P152, DOI 10.1136/amiajnl-2012-001062; Ancker JS, 2012, AM J PREV MED, V43, P76, DOI 10.1016/j.amepre.2012.02.027; Bailey JE, 2013, ANN EMERG MED, V62, P16, DOI 10.1016/j.annemergmed.2013.01.006; Bailey JE, 2013, J GEN INTERN MED, V28, P176, DOI 10.1007/s11606-012-2092-7; Beckjord EB, 2011, J ONCOL PRACT, V7, P237, DOI 10.1200/JOP.2011.000324; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Campion TR, 2013, INT J MED INFORM, V82, P810, DOI 10.1016/j.ijmedinf.2013.05.001; Campion Thomas R Jr, 2013, AMIA Annu Symp Proc, V2013, P175; Campion Thomas R Jr, 2012, AMIA Annu Symp Proc, V2012, P77; Chang KC, 2010, J AM MED INFORM ASSN, V17, P99, DOI 10.1197/jamia.M3391; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dhopeshwarkar RV, 2012, ANN FAM MED, V10, P428, DOI 10.1370/afm.1396; Dimitropoulos Linda, 2011, Am J Manag Care, V17, pSP111; Dixon B, 2013, J HEALTHC INF MANAG, V27, P55; Dixon BE, 2010, J AM MED INFORM ASSN, V17, P295, DOI 10.1136/jamia.2009.000570; Dullabh P, 2013, STUD HEALTH TECHNOL, V192, P613, DOI 10.3233/978-1-61499-289-9-613; eHealth Initiative, 2013, RES SURV HLTH DAT EX; Finnell John T, 2010, AMIA Annu Symp Proc, V2010, P222; Foldy Seth, 2007, WMJ, V106, P120; Fontaine P, 2010, ARCH INTERN MED, V170, P622, DOI 10.1001/archinternmed.2010.54; Frisse ME, 2012, J AM MED INFORM ASSN, V19, P328, DOI [10.1136/amiajnl-2011-000394, 10.1136/amiajnl-2011000394]; Furukawa MF, 2013, HEALTH AFFAIR, V32, P1346, DOI 10.1377/hlthaff.2013.0010; Gadd CS, 2011, J AM MED INFORM ASSN, V18, P711, DOI 10.1136/amiajnl-2011-000281; Genes N, 2011, APPL CLIN INFORM, V2, P263, DOI 10.4338/ACI-2011-02-CR-0010; Goldzweig CL, 2009, HEALTH AFFAIR, V28, pW282, DOI 10.1377/hlthaff.28.2.w282; Grossman Joy M, 2008, Res Brief, P1; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hincapie AL, 2011, J AM MED INFORM ASSN, V18, P60, DOI 10.1136/jamia.2010.006502; Hripcsak G, 2007, J BIOMED INFORM, V40, pS3, DOI 10.1016/j.jbi.2007.08.002; JC McCullough, 2013, THESIS U CALIFORNIA; Johnson KB, 2011, J AM MED INFORM ASSN, V18, P690, DOI 10.1136/amiajnl-2011-000308; Johnson Kevin B, 2008, AMIA Annu Symp Proc, P333; Jones SS, 2014, ANN INTERN MED, V160, P48, DOI 10.7326/M13-1531; Jones Spencer S, 2011, AMIA Annu Symp Proc, V2011, P644; Kaelber DC, 2013, AM J MANAG CARE, V19, pSP337; Kern LM, 2012, APPL CLIN INFORM, V3, P197, DOI 10.4338/ACI-2012-02-RA-0005; Kern LM, 2009, HEALTH AFFAIR, V28, P493, DOI 10.1377/hlthaff.28.2.493; Kho AN, 2013, CLIN INFECT DIS, V57, P254, DOI 10.1093/cid/cit229; Lammers EJ, 2014, MED CARE, V52, P227, DOI 10.1097/MLR.0000000000000067; Lobach David F, 2007, AMIA Annu Symp Proc, P473; Miller AR, 2014, J HEALTH ECON, V33, P28, DOI 10.1016/j.jhealeco.2013.10.004; Miller RH, 2007, HEALTH AFFAIR, V26, pW568, DOI 10.1377/hlthaff.26.5.w568; Miller RH, 2012, HEALTH AFFAIR, V31, P537, DOI 10.1377/hlthaff.2011.0531; Moore Thomas, 2012, AMIA Annu Symp Proc, V2012, P635; Nagykaldi ZJ, 2014, J AMBUL CARE MANAG, V37, P20, DOI 10.1097/JAC.0000000000000002; Nocella Kiki C, 2008, J Healthc Inf Manag, V22, P34; O'Donnell HC, 2011, J GEN INTERN MED, V26, P1019, DOI 10.1007/s11606-011-1733-6; Office of the National Coordinator for Health Information Technology, 2014, HLTH INF EXCH HIE WH; Overhage JM, 2007, HEALTH AFFAIR, V26, pW595, DOI 10.1377/hlthaff.26.5.w595; Overhage JM, 2005, J AM MED INFORM ASSN, V12, P107, DOI 10.1197/jamia.M1680; Overhage JM, 2002, ANN EMERG MED, V39, P14, DOI 10.1067/mem.2002.120794; Ozkaynak M, 2013, J EVAL CLIN PRACT, V19, P370, DOI 10.1111/j.1365-2753.2012.01837.x; Patel V, 2011, INT J MED INFORM, V80, P171, DOI 10.1016/j.ijmedinf.2010.11.008; Patel VN, 2012, J MED SYST, V36, P1043, DOI 10.1007/s10916-010-9566-0; Patel VN, 2011, INFORM HEALTH SOC CA, V36, P233, DOI 10.3109/17538157.2011.554930; Pevnick JM, 2012, J MED SYST, V36, P601, DOI 10.1007/s10916-010-9524-x; Potthoff Sandra, 2007, AMIA Annu Symp Proc, P1082; Ross SE, 2013, J AM MED INFORM ASSN, V20, P1137, DOI 10.1136/amiajnl-2012-001608; Ross SE, 2010, INT J MED INFORM, V79, P123, DOI 10.1016/j.ijmedinf.2009.12.001; Rudin R, 2011, APPL CLIN INFORM, V2, P250, DOI 10.4338/ACI-2011-03-RA-0021; Rudin RS, 2014, J AM MED INFORM ASSN, V21, P13, DOI 10.1136/amiajnl-2013-001737; Rudin RS, 2012, HEALTH AFFAIR, V31, P548, DOI 10.1377/hlthaff.2011.0799; Rudin RS, 2011, J AM MED INFORM ASSN, V18, P853, DOI 10.1136/amiajnl-2010-000072; Rudin RS, 2011, J AM MED INFORM ASSN, V18, P529, DOI 10.1136/amiajnl-2011-000288; Rudin RS, 2009, AM J PUBLIC HEALTH, V99, P950, DOI 10.2105/AJPH.2008.144873; Salzberg CA, 2012, INT J MED INFORM, V81, P713, DOI 10.1016/j.ijmedinf.2012.07.007; Shank N, 2012, J AM MED INFORM ASSN, V19, P562, DOI 10.1136/amiajnl-2011-000374; Shapiro JS, 2007, J AM MED INFORM ASSN, V14, P700, DOI 10.1197/jamia.M2507; Shekelle PG, 2011, ANN INTERN MED, V154, P693, DOI 10.7326/0003-4819-154-10-201105170-00011; Simon SR, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1164; Stiell A, 2003, CAN MED ASSOC J, V169, P1023; Tham E, 2010, APPL CLIN INFORM, V1, P1, DOI 10.4338/ACI-2009-10-RA-0007; Thorn SA, 2014, ANN EMERG MED, V63, P329, DOI 10.1016/j.annemergmed.2013.09.024; Thornewill J, 2011, AM J PREV MED, V40, pS123, DOI 10.1016/j.amepre.2011.01.010; Tzeel A, 2011, AM HEALTH DRUG BENEF, V4, P207; Vaidya SR, 2012, CIN-COMPUT INFORM NU, V30, P503, DOI 10.1097/NXN.0b013e3182573a91; Vest JR, 2014, APPL CLIN INFORM, V5, P219, DOI 10.4338/ACI-2013-10-RA-0083; Vest JR, 2011, APPL CLIN INFORM, V2, P447, DOI 10.4338/ACI-2011-06-RA-0040; Vest Joshua R, 2013, AMIA Annu Symp Proc, V2013, P1402; Vest JR, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9987-7; Vest JR, 2012, J MED SYST, V36, P3195, DOI 10.1007/s10916-011-9810-2; Vest JR, 2012, J MED SYST, V36, P2455, DOI 10.1007/s10916-011-9712-3; Vest JR, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-78; Vest JR, 2010, INT J MED INFORM, V79, P797, DOI 10.1016/j.ijmedinf.2010.09.003; Vest JR, 2010, J AM MED INFORM ASSN, V17, P302, DOI 10.1136/jamia.2009.000471; Vest JR, 2009, J MED SYST, V33, P223, DOI 10.1007/s10916-008-9183-3; Walker Jan, 2005, Health Aff (Millwood), VSuppl Web Exclusives, pW5; Wen KY, 2010, J MED INTERNET RES, V12, P122, DOI 10.2196/jmir.1668; Williams C, 2012, HEALTH AFFAIR, V31, P527, DOI 10.1377/hlthaff.2011.1314; Wright A, 2010, J AM MED INFORM ASSN, V17, P66, DOI 10.1197/jamia.M3241; Yasnoff WA, 2014, METHOD INFORM MED, V53, P66, DOI 10.3414/ME13-02-0030	104	121	120	0	58	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					803	U97		10.7326/M14-0877	http://dx.doi.org/10.7326/M14-0877			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX9UJ	25437408				2022-12-28	WOS:000347247200009
J	Iacobucci, G				Iacobucci, Gareth			Anatomy of a Care Quality Commission inspection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Iacobucci, G (corresponding author), BMJ, London, England.	giacobucci@bmj.com							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 1	2014	349								g7353	10.1136/bmj.g7353	http://dx.doi.org/10.1136/bmj.g7353			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KJ	25452616				2022-12-28	WOS:000346116200006
J	Tedersoo, L; Bahram, M; Polme, S; Koljalg, U; Yorou, NS; Wijesundera, R; Ruiz, LV; Vasco-Palacios, AM; Thu, PQ; Suija, A; Smith, ME; Sharp, C; Saluveer, E; Saitta, A; Rosas, M; Riit, T; Ratkowsky, D; Pritsch, K; Poldmaa, K; Piepenbring, M; Phosri, C; Peterson, M; Parts, K; Partel, K; Otsing, E; Nouhra, E; Njouonkou, AL; Nilsson, RH; Morgado, LN; Mayor, J; May, TW; Majuakim, L; Lodge, DJ; Lee, SS; Larsson, KH; Kohout, P; Hosaka, K; Hiiesalu, I; Henkel, TW; Harend, H; Guo, LD; Greslebin, A; Grelet, G; Geml, J; Gates, G; Dunstan, W; Dunk, C; Drenkhan, R; Dearnaley, J; De Kesel, A; Dang, T; Chen, X; Buegger, F; Brearley, FQ; Bonito, G; Anslan, S; Abell, S; Abarenkov, K				Tedersoo, Leho; Bahram, Mohammad; Polme, Sergei; Koljalg, Urmas; Yorou, Nourou S.; Wijesundera, Ravi; Villarreal Ruiz, Luis; Vasco-Palacios, Aida M.; Pham Quang Thu; Suija, Ave; Smith, Matthew E.; Sharp, Cathy; Saluveer, Erki; Saitta, Alessandro; Rosas, Miguel; Riit, Taavi; Ratkowsky, David; Pritsch, Karin; Poldmaa, Kadri; Piepenbring, Meike; Phosri, Cherdchai; Peterson, Marko; Parts, Kaarin; Paertel, Kadri; Otsing, Eveli; Nouhra, Eduardo; Njouonkou, Andre L.; Nilsson, R. Henrik; Morgado, Luis N.; Mayor, Jordan; May, Tom W.; Majuakim, Luiza; Lodge, D. Jean; Lee, Su See; Larsson, Karl-Henrik; Kohout, Petr; Hosaka, Kentaro; Hiiesalu, Indrek; Henkel, Terry W.; Harend, Helery; Guo, Liang-dong; Greslebin, Alina; Grelet, Gwen; Geml, Jozsef; Gates, Genevieve; Dunstan, William; Dunk, Chris; Drenkhan, Rein; Dearnaley, John; De Kesel, Andre; Tan Dang; Chen, Xin; Buegger, Franz; Brearley, Francis Q.; Bonito, Gregory; Anslan, Sten; Abell, Sandra; Abarenkov, Kessy			Global diversity and geography of soil fungi	SCIENCE			English	Article							ECTOMYCORRHIZAL FUNGI; COMMUNITY STRUCTURE; CLIMATE-CHANGE; PATTERNS; PLANT; BIOGEOGRAPHY; GRADIENT; ECOSYSTEMS; DISPERSAL; ABUNDANCE	Fungi play major roles in ecosystem processes, but the determinants of fungal diversity and biogeographic patterns remain poorly understood. Using DNA metabarcoding data from hundreds of globally distributed soil samples, we demonstrate that fungal richness is decoupled from plant diversity. The plant-to-fungus richness ratio declines exponentially toward the poles. Climatic factors, followed by edaphic and spatial variables, constitute the best predictors of fungal richness and community composition at the global scale. Fungi show similar latitudinal diversity gradients to other organisms, with several notable exceptions. These findings advance our understanding of global fungal diversity patterns and permit integration of fungi into a general macroecological framework.	[Tedersoo, Leho; Polme, Sergei; Abarenkov, Kessy] Univ Tartu, Nat Hist Museum, EE-50090 Tartu, Estonia; [Bahram, Mohammad; Koljalg, Urmas; Suija, Ave; Saluveer, Erki; Riit, Taavi; Poldmaa, Kadri; Peterson, Marko; Parts, Kaarin; Paertel, Kadri; Otsing, Eveli; Kohout, Petr; Hiiesalu, Indrek; Harend, Helery; Anslan, Sten] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Yorou, Nourou S.] Univ Parakou, Fac Agron, Parakou, Benin; [Wijesundera, Ravi] Univ Colombo, Dept Plant Sci, Colombo 3, Sri Lanka; [Villarreal Ruiz, Luis] Colegio Postgrad Lineas Prioritarias Invest 6, LARGEMBIO, Mexico City, DF, Mexico; [Vasco-Palacios, Aida M.] Royal Netherlands Acad Arts & Sci, Cent Bur Schimmelcultures, Fungal Biodivers Ctr, Utrecht, Netherlands; [Pham Quang Thu; Tan Dang] Vietnamese Acad Forest Sci, Hanoi, Vietnam; [Smith, Matthew E.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Sharp, Cathy] Nat Hist Museum, Bulawayo, Zimbabwe; [Saitta, Alessandro] Univ Palermo, Dept Agr & Forest Sci, Palermo, Italy; [Rosas, Miguel; Piepenbring, Meike] Goethe Univ Frankfurt, Dept Mycol, D-60054 Frankfurt, Germany; [Ratkowsky, David; Gates, Genevieve] Tasmanian Inst Agr, Hobart, Tas, Australia; [Pritsch, Karin; Buegger, Franz] Helmholtz Zentrum Munchen, Inst Soil Ecol, Neuherberg, Germany; [Phosri, Cherdchai] Nakhon Phanom Univ, Dept Biol, Nakhon Phanom, Thailand; [Nouhra, Eduardo] Inst Multidisciplinario Biol Vegetal, Cordoba, Argentina; [Njouonkou, Andre L.] Univ Bamenda, Dept Biol Sci, Bambili, Cameroon; [Nilsson, R. Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Morgado, Luis N.; Geml, Jozsef] Naturalis Biodivers Ctr, Leiden, Netherlands; [Mayor, Jordan; Dunk, Chris] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden; [May, Tom W.; Bonito, Gregory] Royal Bot Gardens, Melbourne, Vic, Australia; [Majuakim, Luiza] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Sabah, Malaysia; [Lodge, D. Jean] US Forest Serv, Ctr Forest Mycol Res, USDA, Luquillo, PR USA; [Lee, Su See] Forest Res Inst Malaysia, Kepong, Selangor, Malaysia; [Larsson, Karl-Henrik] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Hosaka, Kentaro] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan; [Henkel, Terry W.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Guo, Liang-dong] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Greslebin, Alina] Univ Nacl Patagonia SJB, Fac Cs Nat, CONICET, Esquel, Chubut, Argentina; [Grelet, Gwen] Landcare Res, Ecosyst & Global Change Team, Lincoln, New Zealand; [Dunstan, William] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Drenkhan, Rein] Estonian Univ Life Sci, Inst Forestry & Rural Engn, Tartu, Estonia; [Dearnaley, John] Univ So Queensland, Fac Hlth Engn & Sci, Toowoomba, Qld 4350, Australia; [De Kesel, Andre] Bot Garden Meise, Meise, Belgium; [Chen, Xin] Zhejiag Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Brearley, Francis Q.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester M15 6BH, Lancs, England; [Abell, Sandra] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia	University of Tartu; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Colombo; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); State University System of Florida; University of Florida; University of Palermo; Goethe University Frankfurt; University of Tasmania; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Nakhon Phanom University; University of Gothenburg; Naturalis Biodiversity Center; Swedish University of Agricultural Sciences; Universiti Malaysia Sabah; United States Department of Agriculture (USDA); United States Forest Service; Institute Penyelidikan Perhutanan Malaysia; University of Oslo; National Museum of Nature and Science; California State University System; California State Polytechnic University, Humboldt; Chinese Academy of Sciences; Institute of Microbiology, CAS; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Landcare Research - New Zealand; Murdoch University; Estonian University of Life Sciences; University of Southern Queensland; Manchester Metropolitan University; James Cook University	Tedersoo, L (corresponding author), Univ Tartu, Nat Hist Museum, Ulikooli 18, EE-50090 Tartu, Estonia.	leho.tedersoo@ut.ee	Kõljalg, Urmas/H-6925-2015; Geml, Jozsef/C-2223-2018; Tedersoo, Leho/ABE-7452-2020; Geml, Jozsef/AAW-9993-2020; Kõljalg, Urmas/AAM-7828-2020; Smith, Matthew E/A-8115-2012; Abell-Davis, Sandra E/G-9637-2011; Smith, Matthew E./ABC-3015-2020; Bahram, Mohammad/A-9766-2010; Põldmaa, Kadri/AAB-8631-2019; Vasco-Palacios, Aida/AAU-9075-2020; YOROU, Nourou S./AAE-2754-2022; Kohout, Petr/B-4975-2011; Abarenkov, Kessy/H-9611-2015; GUO, Liang-dong/C-1407-2015; Põldmaa, Kadri/AAV-6439-2020; May, Tom/C-2460-2014; Nilsson, R. Henrik/A-6062-2009	Geml, Jozsef/0000-0001-8745-0423; Kõljalg, Urmas/0000-0002-5171-1668; Smith, Matthew E/0000-0002-0878-0932; Abell-Davis, Sandra E/0000-0001-8296-9867; Smith, Matthew E./0000-0002-0878-0932; Bahram, Mohammad/0000-0002-9539-3307; Vasco-Palacios, Aida/0000-0003-0539-9711; YOROU, Nourou S./0000-0001-6997-811X; Kohout, Petr/0000-0002-3985-2310; Abarenkov, Kessy/0000-0001-5526-4845; Põldmaa, Kadri/0000-0002-7936-2455; Nilsson, R. Henrik/0000-0002-8052-0107; May, Tom/0000-0003-2214-4972; Villarreal Ruiz, Luis/0000-0001-8472-4898; Dearnaley, John/0000-0001-9842-727X; Anslan, Sten/0000-0002-2299-454X; Saluveer, Erki/0000-0002-9759-1905; SAITTA, Alessandro/0000-0002-5670-7780; Dang, Tan/0000-0002-2765-0084; De Kesel, Andre/0000-0002-5287-4637; Phosri, Cherdchai/0000-0003-3963-752X; Otsing, Eveli/0000-0001-7416-257X	Estonian Science Foundation [9286, 171PUT, IUT20-30, EMP265]; Frontiers in Biodiversity Research; European Research Council; Direct For Biological Sciences [1239764] Funding Source: National Science Foundation	Estonian Science Foundation; Frontiers in Biodiversity Research; European Research Council(European Research Council (ERC)European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The sequence data and metadata are deposited in the Short Read Archive (accession SRP043706) and UNITE databases. Data used for analyses are available as supplementary materials, data files S1 and S2. We thank A. Corrales, H. Mann, D. Sveshnikov, F. O. P. Stefani, A. Voitk, and Y. Wu for supplying single soil samples; R. Puusepp, M. Haugas, and M. Noukas for sample preparation; H. Kreft for providing interpolated plant diversity data; S. Juris for designing the printed figure; M. I. Bidartondo, K. G. Peay, and three anonymous reviewers for constructive comments on the manuscript; and relevant institutions of multiple countries for issuing permissions for sampling and delivery. The bulk of this project was funded from Estonian Science Foundation grants 9286, 171PUT, and IUT20-30; EMP265; Frontiers in Biodiversity Research; European Research Council; and in part by numerous funding sources that facilitated co-author efforts in collecting and preprocessing samples.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Bahram M, 2014, FUNGAL ECOL, V7, P70, DOI 10.1016/j.funeco.2013.10.003; Bahram M, 2013, J ECOL, V101, P1335, DOI 10.1111/1365-2745.12120; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Geml J, 2012, J BIOGEOGR, V39, P74, DOI 10.1111/j.1365-2699.2011.02588.x; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Hiiesalu I, 2014, NEW PHYTOL, V203, P233, DOI 10.1111/nph.12765; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Liu XB, 2012, ECOL LETT, V15, P111, DOI 10.1111/j.1461-0248.2011.01715.x; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Peay KG, 2010, NEW PHYTOL, V185, P878, DOI 10.1111/j.1469-8137.2009.03158.x; Polme S, 2013, NEW PHYTOL, V198, P1239, DOI 10.1111/nph.12170; Qian H, 2013, GLOBAL ECOL BIOGEOGR, V22, P659, DOI 10.1111/geb.12020; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Reich PB, 2005, ECOL LETT, V8, P811, DOI 10.1111/j.1461-0248.2005.00779.x; Robeson MS, 2011, P NATL ACAD SCI USA, V108, P4406, DOI 10.1073/pnas.1012678108; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Sato H, 2012, MOL ECOL, V21, P5599, DOI 10.1111/mec.12053; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Serna-Chavez HM, 2013, GLOBAL ECOL BIOGEOGR, V22, P1162, DOI 10.1111/geb.12070; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Sul WJ, 2013, P NATL ACAD SCI USA, V110, P2342, DOI 10.1073/pnas.1212424110; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Tedersoo L, 2013, FUNGAL BIOL REV, V27, P83, DOI 10.1016/j.fbr.2013.09.001; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Tedersoo L, 2012, NEW PHYTOL, V195, P832, DOI 10.1111/j.1469-8137.2012.04217.x; Timling I, 2014, MOL ECOL, V23, P3258, DOI 10.1111/mec.12743; Treseder KK, 2014, ECOL LETT, V17, P1086, DOI 10.1111/ele.12311; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Xu XF, 2013, GLOBAL ECOL BIOGEOGR, V22, P737, DOI 10.1111/geb.12029	53	1813	1928	192	2037	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1078	+	1256688	10.1126/science.1256688	http://dx.doi.org/10.1126/science.1256688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430773	Green Accepted, Green Submitted			2022-12-28	WOS:000345763400032
J	Gigerenzer, G				Gigerenzer, Gerd			THE ART OF RISK COMMUNICATION Should patients listen to how doctors frame messages?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHOICE		[Gigerenzer, Gerd] Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany; [Gigerenzer, Gerd] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany	Max Planck Society; Max Planck Society	Gigerenzer, G (corresponding author), Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany.	gigerenzer@mpib-berlin.mpg.de	Gigerenzer, Gerd/A-6250-2012; Gigerenzer, Gerd/M-5595-2013	Gigerenzer, Gerd/0000-0002-6163-5419; 				House of Lords, 2011, SCI TECHN SEL COMM; Keren G, 2011, PERSPECTIVES FRAMING; Kuhberger A, 2010, J BEHAV DECIS MAKING, V23, P314, DOI 10.1002/bdm.656; KUHBERGER A, 1995, ORGAN BEHAV HUM DEC, V62, P230, DOI 10.1006/obhd.1995.1046; Mandel DR, 2001, ORGAN BEHAV HUM DEC, V85, P56, DOI 10.1006/obhd.2000.2932; McKenzie CRM, 2003, PSYCHON B REV, V10, P596, DOI 10.3758/BF03196520; Moxey A, 2003, J GEN INTERN MED, V18, P948, DOI 10.1046/j.1525-1497.2003.20928.x; Sher S, 2006, COGNITION, V101, P467, DOI 10.1016/j.cognition.2005.11.001; Thaler RH., 2021, NUDGE FINAL EDITION; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365	10	5	5	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2014	349								g7091	10.1136/bmj.g7091	http://dx.doi.org/10.1136/bmj.g7091			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW2KG	25430638	Green Published			2022-12-28	WOS:000346115800004
J	Jack, A				Jack, Andrew			INFLUENZA TREATMENT Will Tamiflu recommendations change this winter?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				[Anonymous], 2010, WHO GUID PHARM MAN P; [Anonymous], 2013, WHO MOD LIST ESS MED; [Anonymous], 2021, HUM INF AV INFL AH5N; Cohen D, 2014, BMJ-BRIT MED J, V340, pc2912; European Centre for Disease Prevention and Control, 2014, NEW UPD EV NEUR INH; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Multiparty Group for Advice on Science, MULT EXP TEAM M; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; WHO, ESS MED SEL OS; World Health Organization (WHO), 2014, AV INFL A H7N9 VIR P	11	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2014	349								g6742	10.1136/bmj.g6742	http://dx.doi.org/10.1136/bmj.g6742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KG	25430733				2022-12-28	WOS:000346115800002
J	Neumark-Sztainer, D; Eisenberg, ME				Neumark-Sztainer, Dianne; Eisenberg, Marla E.			Body Image Concerns, Muscle-Enhancing Behaviors, and Eating Disorders in Males	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADOLESCENT; SATISFACTION; ASSOCIATIONS	IMPORTANCE Relatively little is known about the prevalence of concerns with physique and eating disorders among males and their relation to subsequent adverse outcomes. A broader range of eating disorders needs to be defined to diagnose these illnesses appropriately in males. OBJECTIVE To investigate whether males with psychiatric symptoms related to disordered eating and concern about physique are more likely to become obese, to start using drugs, to consume alcohol frequently (binge drinking), or to develop high levels of depressive symptoms. DESIGN, SETTING, AND PARTICIPANTS The data come from questionnaires sent every 12 to 36 months from 1999 through 2010 to youth in a prospective cohort study, the Growing Up Today Study. The analysis included 5527 males aged 12 to 18 years in 1999 from across the United States who responded to the Growing Up Today Study questionnaires. MAIN OUTCOMES AND MEASURES Development of obesity and high levels of depressive symptoms and initiation of drug use and binge drinking at least monthly. RESULTS From 1999 through 2011 in at least 1 study year, 9.2% of respondents reported high concerns with muscularity but no bulimic behaviors; 2.4%, high concerns with muscularity and use of supplements, growth hormone derivatives, or anabolic steroids to achieve their desired physique; 2.5%, high concerns with thinness but no bulimic behaviors; and 6.3%, high concerns with thinness and muscularity. For eating disorders, 0.8% had partial-or full-criteria bulimia nervosa or purging disorder and 2.9% had partial-or full-criteria binge eating disorder but no association with the outcomes of interest. Infrequent binge eating or purging or overeating without a loss of controlwere reported by 31.0%. However, independent of age and body mass index, males with high concerns about thinness but not muscularitywere more likely to develop high depressive symptoms (odds ratio, 2.72; 95% CI, 1.36-5.44). Males with high concerns about muscularity and thinnesswere more likely than their peers to use drugs (odds ratio, 2.13; 95% CI, 1.31-3.46), and males with high concerns about muscularity who used supplements and other products to enhance physiquewere more likely to start binge drinking frequently (2.06; 1.58-2.69) and using drugs (2.16; 1.49-3.11). CONCLUSIONS AND RELEVANCE High concerns with muscularity are relatively common among adolescent boys and young men. Males with these concerns who use potentially unhealthy products to improve their physique are at increased risk of adverse outcomes but may not be recognized by their health care providers as having a weight-related disorder because of the sex-specific presentation.	[Neumark-Sztainer, Dianne] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Eisenberg, Marla E.] Univ Minnesota, Div Gen Pediat & Adolescent Hlth, Dept Pediat, Minneapolis, MN 55454 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Neumark-Sztainer, D (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, 1300 S Second St, Minneapolis, MN 55454 USA.	neumark@epi.umn.edu		Neumark-Sztainer, Dianne/0000-0001-9435-1669				Cafri G, 2005, CLIN PSYCHOL REV, V25, P215, DOI 10.1016/j.cpr.2004.09.003; Eisenberg ME, 2012, PEDIATRICS, V130, P1019, DOI 10.1542/peds.2012-0095; Field AE, 2014, JAMA PEDIATR, V168, P34, DOI 10.1001/jamapediatrics.2013.2915; Irving LM, 2002, J ADOLESCENT HEALTH, V30, P243, DOI 10.1016/S1054-139X(01)00414-1; Neumark-Sztainer D, 2006, J ADOLESCENT HEALTH, V39, P244, DOI 10.1016/j.jadohealth.2005.12.001; Sonneville KR, 2012, INT J OBESITY, V36, P944, DOI 10.1038/ijo.2012.68	6	20	20	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2156	2157		10.1001/jama.2014.5138	http://dx.doi.org/10.1001/jama.2014.5138			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU5DG	25423220				2022-12-28	WOS:000345626800019
J	Rajkumar, SV; Kyle, RA				Rajkumar, S. Vincent; Kyle, Robert A.			Protein Electrophoresis and Immunofixation for the Diagnosis of Monoclonal Gammopathies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNDETERMINED SIGNIFICANCE; RISK; PROGRESSION; PREVALENCE		[Rajkumar, S. Vincent; Kyle, Robert A.] Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic	Kyle, RA (corresponding author), Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA.	kyle.robert@mayo.edu	Rajkumar, S. Vincent/AAV-1834-2021	Rajkumar, S. Vincent/0000-0002-5862-1833				Blade J, 2006, NEW ENGL J MED, V355, P2765, DOI 10.1056/NEJMcp052790; Dispenzieri A, 2009, LEUKEMIA, V23, P215, DOI 10.1038/leu.2008.307; Katzmann JA, 2006, MAYO CLIN PROC, V81, P1575, DOI 10.4065/81.12.1575; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Landgren O, 2014, LEUKEMIA, V28, P1537, DOI [10.1038/leu.2014.34, 10.1038/1eu.2014.34]; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Turesson I, 2014, BLOOD, V123, P338, DOI 10.1182/blood-2013-05-505487	10	2	2	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2160	2161		10.1001/jama.2014.8237	http://dx.doi.org/10.1001/jama.2014.8237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25423222				2022-12-28	WOS:000345626800021
J	Gagne, JJ; Thompson, L; O'Keefe, K; Kesselheim, AS				Gagne, Joshua J.; Thompson, Lauren; O'Keefe, Kelly; Kesselheim, Aaron S.			Innovative research methods for studying treatments for rare diseases: methodological review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PROSPECTIVE INCEPTION COHORT; RANDOMIZED CLINICAL-TRIALS; PROPENSITY SCORE; UVEAL MELANOMA; DESIGN; ORPHAN; RISK; CHALLENGES; OUTCOMES; REGISTRY	Objective To examine methods for generating evidence on health outcomes in patients with rare diseases. Design Methodological review of existing literature. Setting PubMed, Embase, and Academic Search Premier searched for articles describing innovative approaches to randomized trial design and analysis methods and methods for conducting observational research in patients with rare diseases. Main outcome measures We assessed information related to the proposed methods, the specific rare disease being studied, and outcomes from the application of the methods. We summarize methods with respect to their advantages in studying health outcomes in rare diseases and provide examples of their application. Results We identified 46 articles that proposed or described methods for studying patient health outcomes in rare diseases. Articles covered a wide range of rare diseases and most (72%) were published in 2008 or later. We identified 16 research strategies for studying rare disease. Innovative clinical trial methods minimize sample size requirements (n=4) and maximize the proportion of patients who receive active treatment (n=2), strategies crucial to studying small populations of patients with limited treatment choices. No studies describing unique methods for conducting observational studies in patients with rare diseases were identified. Conclusions Though numerous studies apply unique clinical trial designs and considerations to assess patient health outcomes in rare diseases, less attention has been paid to innovative methods for studying rare diseases using observational data.	[Gagne, Joshua J.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gagne, JJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	jgagne1@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Agency for Healthcare Research and Quality, US Department of Health and Human Services [290 2010 00006l]	Agency for Healthcare Research and Quality, US Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded under Contract No 290 2010 00006l TO #4 from the Agency for Healthcare Research and Quality, US Department of Health and Human Services as part of the Developing Evidence to Inform decisions about Effectiveness (DEcIDE) program. The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by the Agency for Healthcare Research and Quality or the US Department of Health and Human Services.	Armstrong-Wells J, 2011, SEMIN FETAL NEONAT M, V16, P355, DOI 10.1016/j.siny.2011.07.004; Barash JA, 2012, MIL MED, V177, P1343, DOI 10.7205/MILMED-D-12-00198; Berlin JA, 2010, J CLIN EPIDEMIOL, V63, P1283, DOI 10.1016/j.jclinepi.2010.05.006; Bernard TJ, 2013, SEMIN THROMB HEMOST, V39, P10, DOI 10.1055/s-0032-1329551; Buckley BM, 2008, LANCET, V371, P2051, DOI 10.1016/S0140-6736(08)60876-4; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; Chow SC, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-11; Cole JA, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-61; Cornu C, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-48; Dimichele DM, 2012, HAEMOPHILIA, V18, P18, DOI 10.1111/j.1365-2516.2012.02824.x; European Organisation for Rare Diseases, 2005, RAR DIS UND THIS PUB; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; Fasnacht MS, 2007, SWISS MED WKLY, V137, P510; Gallin JI, 2003, NEW ENGL J MED, V348, P2416, DOI 10.1056/NEJMoa021931; Goss CH, 2002, ADV DRUG DELIVER REV, V54, P1505, DOI 10.1016/S0169-409X(02)00163-1; Grabowski GA, 2009, GENET MED, V11, P92, DOI 10.1097/GIM.0b013e31818e2c19; Griggs RC, 2009, MOL GENET METAB, V96, P20, DOI 10.1016/j.ymgme.2008.10.003; Gupta S, 2011, J CLIN EPIDEMIOL, V64, P1085, DOI 10.1016/j.jclinepi.2010.12.019; Halpern SD, 2002, JAMA-J AM MED ASSOC, V288, P358, DOI 10.1001/jama.288.3.358; Hyman Leslie, 2005, Retina, V25, pS69, DOI 10.1097/00006982-200512001-00033; Kesselheim AS, 2014, CLIN PHARMACOL THER, V95, P265, DOI 10.1038/clpt.2013.218; Kesselheim AS, 2011, JAMA-J AM MED ASSOC, V305, P2320, DOI 10.1001/jama.2011.769; Kinder B, 2010, LYMPHAT RES BIOL, V8, P71, DOI 10.1089/lrb.2009.0027; Lagakos SW, 2003, NEW ENGL J MED, V348, P2455, DOI 10.1056/NEJMe030024; Lilford RJ, 1995, BMJ-BRIT MED J, V311, P1621, DOI 10.1136/bmj.311.7020.1621; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; McCann LJ, 2006, RHEUMATOLOGY, V45, P1255, DOI 10.1093/rheumatology/kel099; Nakamura C, 2012, J MED INTERNET RES, V14, P246, DOI 10.2196/jmir.2127; National Center for Advancing Translational Sciences. Office of Rare Disease Research, 2013, FREQ ASK QUEST; Ozsahin M, 2010, INT J RADIAT ONCOL, V78, P992, DOI 10.1016/j.ijrobp.2009.09.019; de la Paz MP, 2010, ADV EXP MED BIOL, V686, P17, DOI 10.1007/978-90-481-9485-8_2; Pugnet G, 2010, BASIC CLIN PHARMACOL, V10, P533; Puopolo M, 2011, ANN I SUPER SANITA, V47, P55, DOI 10.4415/ANN_11_01_12; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schick U, 2012, INT J RADIAT ONCOL, V82, pE757, DOI 10.1016/j.ijrobp.2011.11.005; Schmidt-Pokrzywniak Andrea, 2004, BMC Ophthalmol, V4, P11, DOI 10.1186/1471-2415-4-11; Schmidt-Pokrzywniak A, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-26; Schmidt-Pokrzywniak A, 2009, OPHTHALMOLOGY, V116, P340, DOI 10.1016/j.ophtha.2008.09.040; Shurin S, 2012, BIOL BLOOD MARROW TR, V18, pS8, DOI 10.1016/j.bbmt.2011.10.030; Stang A, 2009, J NATL CANCER I, V101, P120, DOI 10.1093/jnci/djn441; Stone Edwin M, 2005, Retina, V25, pS72, DOI 10.1097/00006982-200512001-00034; Sun P, 2012, CURR MED RES OPIN, V28, P665, DOI 10.1185/03007995.2012.673480; Sun P, 2012, CURR MED RES OPIN, V28, P657, DOI 10.1185/03007995.2012.658907; Sun P, 2012, CURR MED RES OPIN, V28, P651, DOI 10.1185/03007995.2012.658908; Tan SB, 2003, BRIT MED J, V327, P47, DOI 10.1136/bmj.327.7405.47; van der Lee JH, 2008, J CLIN EPIDEMIOL, V61, P324, DOI 10.1016/j.jclinepi.2007.07.008; Weinreich SS, 2012, ORPHANET J RARE D S2, V7, pA29; Whitehead J, 2012, INVEST OPHTH VIS SCI, V53, P4986, DOI 10.1167/iovs.12-9858; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837	50	111	112	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2014	349								g6802	10.1136/bmj.g6802	http://dx.doi.org/10.1136/bmj.g6802			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KC	25422272	Green Published, hybrid			2022-12-28	WOS:000346115400004
J	Tainaka, K; Kubota, SI; Suyama, TQ; Susaki, EA; Perrin, D; Ukai-Tadenuma, M; Ukai, H; Ueda, HR				Tainaka, Kazuki; Kubota, Shimpei I.; Suyama, Takeru Q.; Susaki, Etsuo A.; Perrin, Dimitri; Ukai-Tadenuma, Maki; Ukai, Hideki; Ueda, Hiroki R.			Whole-Body Imaging with Single-Cell Resolution by Tissue Decolorization	CELL			English	Article							LIGHT SHEET MICROSCOPY; MOUSE-BRAIN; FLUORESCENCE; SYSTEM; RECONSTRUCTION; HISTOLOGY; ORGANS; ACID; MICE; GFP	The development of whole-body imaging at single-cell resolution enables system-level approaches to studying cellular circuits in organisms. Previous clearing methods focused on homogenizing mismatched refractive indices of individual tissues, enabling reductions in opacity but falling short of achieving transparency. Here, we show that an aminoalcohol decolorizes blood by efficiently eluting the heme chromophore from hemoglobin. Direct transcardial perfusion of an aminoalcohol-containing cocktail that we previously termed CUBIC coupled with a 10 day to 2 week clearing protocol decolorized and rendered nearly transparent almost all organs of adult mice as well as the entire body of infant and adult mice. This CUBIC-perfusion protocol enables rapid whole-body and whole-organ imaging at single-cell resolution by using light-sheet fluorescent microscopy. The CUBIC protocol is also applicable to 3D pathology, anatomy, and immunohistochemistry of various organs. These results suggest that whole-body imaging of colorless tissues at high resolution will contribute to organism-level systems biology.	[Tainaka, Kazuki; Kubota, Shimpei I.; Suyama, Takeru Q.; Susaki, Etsuo A.; Ueda, Hiroki R.] Univ Tokyo, Grad Sch Med, Dept Syst Pharmacol, Bunkyo Ku, Tokyo 1130033, Japan; [Tainaka, Kazuki; Susaki, Etsuo A.; Perrin, Dimitri; Ukai-Tadenuma, Maki; Ukai, Hideki; Ueda, Hiroki R.] RIKEN, Quantitat Biol Ctr, Lab Synthet Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Tainaka, Kazuki; Susaki, Etsuo A.; Ueda, Hiroki R.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Ueda, HR (corresponding author), Univ Tokyo, Grad Sch Med, Dept Syst Pharmacol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	uedah-tky@umin.ac.jp	Ueda, Hiroki R/C-5037-2014; Perrin, Dimitri/H-8630-2013	Ueda, Hiroki R/0000-0001-8342-9176; Perrin, Dimitri/0000-0002-4007-5256; Tainaka, Kazuki/0000-0002-5943-8723; Susaki, Etsuo/0000-0001-5621-7311	Program for Innovative Cell Biology, Innovative Technology; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT/Japan Society for the Promotion of Science (JSPS) [25221004, 23115006, 26-1180]; strategic programs for R&D (President's discretionary fund) of RIKEN; RIKEN Center for Developmental Biology; RIKEN Quantitative Biology Center; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency (JST); Japan Foundation for Applied Enzymology; Shimabara Science Promotion Foundation; RIKEN Foreign Postdoctoral Researcher Program	Program for Innovative Cell Biology, Innovative Technology; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); strategic programs for R&D (President's discretionary fund) of RIKEN; RIKEN Center for Developmental Biology; RIKEN Quantitative Biology Center; Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Foundation for Applied Enzymology; Shimabara Science Promotion Foundation; RIKEN Foreign Postdoctoral Researcher Program	We thank the lab members at RIKEN CDB, QBiC, and The University of Tokyo, in particular, H. Yukinaga, J. Hara, J. Yoshida, C. Imai, and Y. Niwa for their kind help in preparing the materials; A. Millius for reviewing and editing the manuscript; K. Matsumoto for helpful suggestions in developing the CB-Perfusion protocol; Y. Abe, T. Sengoku, and S. Kondo for their kind help in developing the CB-Perfusion protocol and transmittance evaluation; and S. Shoi for his kind help in statistical analysis. We also thank T. Abe and H. Kiyonari for providing materials for targeting vectors and R26-H2B EGFP mice; LARGE, RIKEN CDB for housing the mice; D. Asanuma and K. Hirose for their kind help in measuring visible spectra; H. Sekiya, K. Kanemaru, D. Ino, J. Suzuki, K. Miyazono, S. Ehata, K. Takahashi, H. Takayanagi, S. Sawa, G. Matteo, Y. Mori, and Y. Yoshioka for their kind comments and suggestions; and Media Cybernetics for supporting the usage of AutoQuant X3. This work was supported by the Program for Innovative Cell Biology by Innovative Technology and the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, a Grant-in-Aid for Scientific Research (S) (grant no. 25221004), a Grant-in-Aid for Scientific Research on Innovative Areas (grant no. 23115006), and a Grant-in-Aid JSPS Fellows (grant no. 26-1180) from MEXT/Japan Society for the Promotion of Science (JSPS), the strategic programs for R&D (President's discretionary fund) of RIKEN, an intramural Grant-in-Aid from the RIKEN Center for Developmental Biology and RIKEN Quantitative Biology Center, a grant from Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST), a Grant-in-Aid from Japan Foundation for Applied Enzymology, a Grant-in-Aid from the Shimabara Science Promotion Foundation, and by the RIKEN Foreign Postdoctoral Researcher Program.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Alnuami AA, 2008, INT J BIOL MACROMOL, V43, P182, DOI 10.1016/j.ijbiomac.2008.05.002; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Faber DJ, 2003, OPT LETT, V28, P1436, DOI 10.1364/OL.28.001436; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Keller PJ, 2012, CURR OPIN NEUROBIOL, V22, P138, DOI 10.1016/j.conb.2011.08.003; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Kristinsson HG, 2004, J AGR FOOD CHEM, V52, P3633, DOI 10.1021/jf034563g; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Mack SA, 2014, METHODS MOL BIOL, V1130, P165, DOI 10.1007/978-1-62703-989-5_12; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; Steinke H, 2001, ANN ANAT, V183, P91, DOI 10.1016/S0940-9602(01)80020-0; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tomer R, 2011, CURR OPIN GENET DEV, V21, P558, DOI 10.1016/j.gde.2011.07.003; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	30	314	334	2	82	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					911	924		10.1016/j.cell.2014.10.034	http://dx.doi.org/10.1016/j.cell.2014.10.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417165	Bronze, Green Submitted			2022-12-28	WOS:000344522000021
J	Sood, HS; Maruthappu, M; Keogh, B				Sood, Harpreet S.; Maruthappu, Mahiben; Keogh, Bruce			A future vision for the NHS: the case for change	LANCET			English	Editorial Material									[Sood, Harpreet S.; Maruthappu, Mahiben] NHS England, Chief Execut Off, London SE1 6LH, England; [Keogh, Bruce] NHS England, Off Natl Med Director, London SE1 6LH, England		Sood, HS (corresponding author), NHS England, Chief Execut Off, London SE1 6LH, England.	hsood@nhs.net						Davies K, 2014, MIRROR MIRROR WALL P; NHS England Care Quality Commission Public Health England Health Education England Monitor Trust Development Authority, 2014, NHS 5 YEAR FORW VIEW; The National Advisory Group on the Safety of Patients in England, 2013, PROMISE LEARN COMMIT	3	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1551	1552		10.1016/S0140-6736(14)61948-6	http://dx.doi.org/10.1016/S0140-6736(14)61948-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9NK	25443477				2022-12-28	WOS:000343901700004
J	Cotlear, D; Gomez-Dantes, O; Knaul, F; Atun, R; Barreto, ICHC; Cetrangolo, O; Cueto, M; Francke, P; Frenz, P; Guerrero, R; Lozano, R; Marten, R; Saenz, R				Cotlear, Daniel; Gomez-Dantes, Octavio; Knaul, Felicia; Atun, Rifat; Barreto, Ivana C. H. C.; Cetrangolo, Oscar; Cueto, Marcos; Francke, Pedro; Frenz, Patricia; Guerrero, Ramiro; Lozano, Rafael; Marten, Robert; Saenz, Rocio			Overcoming social segregation in health care in Latin America	LANCET			English	Article							MEDICAL-CARE; SYSTEM REFORM; INSURANCE; LESSONS; PROGRAMS; COVERAGE; MEXICO	Latin America continues to segregate different social groups into separate health-system segments, including two separate public sector blocks: a well resourced social security for salaried workers and their families and a Ministry of Health serving poor and vulnerable people with low standards of quality and needing a frequently impoverishing payment at point of service. This segregation shows Latin America's longstanding economic and social inequality, cemented by an economic framework that predicted that economic growth would lead to rapid formalisation of the economy. Today, the institutional setup that organises the social segregation in health care is perceived, despite improved life expectancy and other advances, as a barrier to fulfilling the right to health, embodied in the legislation of many Latin American countries. This Series paper outlines four phases in the history of Latin American countries that explain the roots of segmentation in health care and describe three paths taken by countries seeking to overcome it: unification of the funds used to finance both social security and Ministry of Health services (one public payer); free choice of provider or insurer; and expansion of services to poor people and the non-salaried population by making explicit the health-care benefits to which all citizens are entitled.	[Cotlear, Daniel] World Bank, Hlth Nutr & Populat Global Practice, Washington, DC 20433 USA; [Gomez-Dantes, Octavio] Natl Inst Publ Hlth Mexico, Cuernavaca, Morelos, Mexico; [Knaul, Felicia] Harvard Univ, Havard Global Equity Initiat, Boston, MA 02115 USA; [Atun, Rifat] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Barreto, Ivana C. H. C.] Univ Fed Ceara, Fortaleza, Ceara, Brazil; [Barreto, Ivana C. H. C.] Ceara Sch Publ Hlth, Fortaleza, Ceara, Brazil; [Cetrangolo, Oscar] Univ Buenos Aires, Buenos Aires, DF, Argentina; [Cueto, Marcos] Fiocruz MS, BR-21045900 Rio De Janeiro, Brazil; [Francke, Pedro] Pontificia Univ Catolica Peru, Lima, Peru; [Frenz, Patricia] Univ Chile, Sch Publ Hlth, Santiago, Chile; [Marten, Robert] Rockefeller Fdn, New York, NY USA; [Guerrero, Ramiro] Univ Icesi, Ctr Estudios Protecc Social & Econ Salud PROESA, Cali, Colombia; [Lozano, Rafael] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Lozano, Rafael] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Saenz, Rocio] Univ Costa Rica, Escuela Salud Publ, San Pedro, Costa Rica	The World Bank; Instituto Nacional de Salud Publica; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Universidade Federal do Ceara; University of Buenos Aires; Fundacao Oswaldo Cruz; Pontificia Universidad Catolica del Peru; Universidad de Chile; Universidad ICESI; Instituto Nacional de Salud Publica; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Universidad Costa Rica	Cotlear, D (corresponding author), World Bank, HDNHE, 1818 H St NW, Washington, DC 20433 USA.	dcotlear@worldbank.org	Lozano, Rafael/T-5352-2018; Barreto, Ivana/GZL-8122-2022; Atun, Rifat/AAH-5537-2021	Lozano, Rafael/0000-0002-7356-8823; Atun, Rifat/0000-0002-1531-5983; Knaul, Felicia/0000-0002-0512-4788; Cristina de Holanda Cunha Barreto, Ivana/0000-0001-8447-3654	Rockefeller Foundation	Rockefeller Foundation	OC was undersecretary of Finance for intergovernmental Relations in Argentina, 1999-2001. PFra was President of the Social Investment Fund of Peru. RG was Vice-Minister of Social Protection in Colombia, 2004-07. RS was Minister of Health in Costa Rica 2002-06. This Review is part of a series funded by the Rockefeller Foundation through a grant to the Economic Commission for Latin America and the Caribbean (ECLAC). DC, OGD, FK, RA, ICHCB, MC, PFre, RL, and RM declare no competing interests.	Adams O., 2002, PROVISION PERSONAL N; [Anonymous], 1993, WORLD DEV REP 1993; [Anonymous], 1978, INT C PRIM HLTH CAR; Aran D, 2013, SALUD PUBLICA MEX S2, V53, pS265; Armada F, 2001, INT J HEALTH SERV, V31, P729, DOI 10.2190/70BE-TJ0Q-P7WJ-2ELU; Atun R., 2014, LANCET; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Bitran Ricardo, 2013, EXPLICIT HLTH GUARAN; Bossert T, 2000, Rev Panam Salud Publica, V8, P84, DOI 10.1590/S1020-49892000000700011; Bossert TJ, 2003, B WORLD HEALTH ORGAN, V81, P95; BROWN ER, 1976, AM J PUBLIC HEALTH, V66, P897, DOI 10.2105/AJPH.66.9.897; Camposeco VM, 2011, LETRAS LIBRES, V13, P14; CEPAL, TRANS DEM AM LAT; Cueto Marcos, 2004, VALOR SALUD HIST ORG; de Andrade LOM, 2014, LANCET; DE FERRANTI David, 1985, PAYING HLTH SERVICES; de Ferranti David, 2004, INEQUALITY LATIN AM; Deaton A., 2013, GREAT ESCAPE HLTH WE; DELAJARA JJ, 1995, HEALTH POLICY, V32, P155, DOI 10.1016/0168-8510(95)00733-9; Farag E, CUBAN HLTH CARE ANAL; Feinsilver Julie, 1993, HEALING MASSES CUBAN; Fleury S, 2009, CIENC SAUDE COLETIVA, V14, P743, DOI 10.1590/S1413-81232009000300010; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Frenk J, 1988, NEXOS, VXXII, P25; Frenk J, 2004, GLOBAL FORUM UPDATE, P48; Gambone L, MOVIMIENTO LIBERTARI; Garrison M, 1997, NEW YORK TIMES BK R, P20; Gonzalez-Block M., 1989, Health Policy and Planning, V4, P301, DOI 10.1093/heapol/4.4.301; Guerrero CR, 2008, WELL BEING SOCIAL PO, V4, P75; Guerrero R, 2011, SALUD PUBLICA MEXICO, V53, pS144; Heredia N, LANCET IN PRESS; Homedes N, 2005, HEALTH POLICY, V71, P83, DOI 10.1016/j.healthpol.2004.01.011; Howard-Jones N., 1981, PAN AM HLTH ORG ORIG; Howard-Jones N, 1975, SCI BACKGR INT SAN C; Hunt S, 2009, DESARROLLO EC BIENES, P23; Huntington S.P., 1991, J DEMOCRACY, V2, P12; Institute for Health Metrics and Evaluation Human Development Network The World Bank, 2013, GLOB BURD DIS GEN EV, VRegional; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Knaul FM, FINANCING HLTH LATIN; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lakin JM, 2010, J HEALTH POLIT POLIC, V35, P313, DOI 10.1215/03616878-2010-002; Laurell AC, 2007, INT J HEALTH SERV, V37, P515, DOI 10.2190/0133-572V-564N-4831; Levy, 2010, GOOD INTENTIONS BAD; Londono JL, 1997, HEALTH POLICY, V41, P1, DOI 10.1016/S0168-8510(97)00010-9; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Mainwaring S, CONSOLIDATION DEMOCR; Manuel A, 2002, SALUD PUBLICA MEXICO, V44, P60, DOI 10.1590/S0036-36342002000100009; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Marquez P V, 1986, J Public Health Policy, V7, P378, DOI 10.2307/3342464; Martinez J, 2006, SEGURIDAD SOCIAL COS; Mesa-Lago C, 2008, REASSEMBLING SOCIAL; Ministerio de Salud de Colombia, 1994, REF SEG SOC SAL ANT; Molina-Bustos C, 2004, POLIS, V9, P1; Montenegro-Torres F., 2013, COLOMBIA CASE STUDY; Montenegro-Torres F, 2013, COSTA RICA CASE STUD; Muriel Josefina., 1990, HOSPITALES NUEVA ESP; OXFAM, UN HLTH COV WHY HLTH; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Palmer N, 2004, LANCET, V364, P1365, DOI 10.1016/S0140-6736(04)17195-X; Rodriguez-Herrera A, 2005, REFORMA SALUD COSTA; ROEMER MI, 1963, MED CARE, V1, P182, DOI 10.1097/00005650-196307000-00012; ROEMER MI, 1964, MILBANK FUND Q, V42, P54, DOI 10.2307/3348627; Roemer MI, 1980, PERSPECTIVA MUNDIAL, P135; Saenz MR, 2010, UNIVERSAL HLTH COVER; Salvany Joan Tomas, 1883, NACL DIARIO UNIVERSA, P2; Sandoval-Orellana H, 2004, CUAD MED SOC, V43, P5; Save the Children, 2005, UNN EV US FEES HLTH; Savedoff WD, 2011, ACHIEVING UNIVERSAL; Terris M, 1985, J Public Health Policy, V6, P15, DOI 10.2307/3342015; TERRIS M, 1978, AM J PUBLIC HEALTH, V68, P1125, DOI 10.2105/AJPH.68.11.1125; UN Documents, GLOB STRAT HLTH ALL; Unger JP, 2008, AM J PUBLIC HEALTH, V98, P636, DOI 10.2105/AJPH.2006.099598; UNICEF, 1950S ER MASS DIS CA; World Bank, DAT GDP GROWTH ANN; *WORLD BANK, 1987, FIN HLTH SERV DEV CO; World Health Organization, 2019, GLOBAL HLTH EXPENDIT	78	89	90	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1248	1259		10.1016/S0140-6736(14)61647-0	http://dx.doi.org/10.1016/S0140-6736(14)61647-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE3GQ	25458715				2022-12-28	WOS:000351715100038
J	Oehlers, SH; Cronan, MR; Scott, NR; Thomas, MI; Okuda, KS; Walton, EM; Beerman, RW; Crosier, PS; Tobin, DM				Oehlers, Stefan H.; Cronan, Mark R.; Scott, Ninecia R.; Thomas, Monica I.; Okuda, Kazuhide S.; Walton, Eric M.; Beerman, Rebecca W.; Crosier, Philip S.; Tobin, David M.			Interception of host angiogenic signalling limits mycobacterial growth	NATURE			English	Article							ZEBRAFISH; GRANULOMA; METRONIDAZOLE; TUBERCULOSIS; INFECTION; TUMOR; VEGF; MACROPHAGE; INHIBITOR; TISSUE	Pathogenic mycobacteria induce the formation of complex cellular aggregates called granulomas that are the hallmark of tuberculosis(1,2). Here we examine the development and consequences of vascularization of the tuberculous granuloma in the zebrafish-Mycobacterium marinum infection model, which is characterized by organized granulomas with necrotic cores that bear striking resemblance to those of human tuberculosis(2). Using intravital microscopy in the transparent larval zebrafish, we show that granuloma formation is intimately associated with angiogenesis. The initiation of angiogenesis in turn coincides with the generation of local hypoxia and transcriptional induction of the canonical pro-angiogenic molecule Vegfaa. Pharmacological inhibition of the Vegf pathway suppresses granuloma-associated angiogenesis, reduces infection burden and limits dissemination. Moreover, anti-angiogenic therapies synergize with the first-line anti-tubercular antibiotic rifampicin, as well as with the antibiotic metronidazole, which targets hypoxic bacterial populations(3). Our data indicate that mycobacteria induce granuloma-associated angiogenesis, which promotes mycobacterial growth and increases spread of infection to new tissue sites. We propose the use of anti-angiogenic agents, now being used in cancer regimens, as a host-targeting tuberculosis therapy, particularly in extensively drug-resistant disease for which current antibiotic regimens are largely ineffective.	[Oehlers, Stefan H.; Cronan, Mark R.; Scott, Ninecia R.; Thomas, Monica I.; Walton, Eric M.; Beerman, Rebecca W.; Tobin, David M.] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Ctr Microbial Pathogenesis, Durham, NC 27710 USA; [Okuda, Kazuhide S.; Crosier, Philip S.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1023, New Zealand	Duke University; University of Auckland	Tobin, DM (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Ctr Microbial Pathogenesis, Durham, NC 27710 USA.	david.tobin@duke.edu	Oehlers, Stefan/L-5341-2019; Okuda, Kazuhide Shaun/N-2576-2017	Oehlers, Stefan/0000-0003-0260-672X; Okuda, Kazuhide Shaun/0000-0002-8060-0377; Tobin, David/0000-0003-3465-5518; Beerman, Rebecca/0000-0002-2057-4170; Scott, Ninecia/0000-0002-7847-0673; Cronan, Mark/0000-0002-3760-1649	Australian National Health and Medical Research Council CJ Martin Early Career Fellowship; American Cancer Society Postdoctoral Fellowship [PF-13-223-01-MPC]; Duke Summer Research Opportunities Program; Malaysian Ministry of Science and Technology and Innovation scholarship; New Zealand Ministry of Science and Innovation [UOAX0813]; Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH) [5P30 AI064518]; Mallinckrodt Scholar Award; Searle Scholar Award; Vallee Foundation Young Investigator Award; NIH Director's New Innovator Award [1DP2-OD008614]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008614] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council CJ Martin Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); American Cancer Society Postdoctoral Fellowship(American Cancer Society); Duke Summer Research Opportunities Program; Malaysian Ministry of Science and Technology and Innovation scholarship; New Zealand Ministry of Science and Innovation; Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mallinckrodt Scholar Award; Searle Scholar Award; Vallee Foundation Young Investigator Award; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Sisk and J. Saelens for technical assistance, L. Ramakrishnan, P. Edelstein and C. Kontos for helpful discussions, L. Ramakrishnan, W. Britton and J. Coers for critical review of the manuscript, and J. Fuller, C. Gallione, E. Linney, H. Mao, S. Lee, D. Marchuk, H. Matsunami, A. Nixon, J. Perfect, J. Rawls, D. Silver, K. Smith, K. Takaki, J. Tenor and B. Uy for reagents and equipment This work was funded by an Australian National Health and Medical Research Council CJ Martin Early Career Fellowship (S.H.O.); an American Cancer Society Postdoctoral Fellowship PF-13-223-01-MPC (M.R.C.); the Duke Summer Research Opportunities Program (N.R.S.); a Malaysian Ministry of Science and Technology and Innovation scholarship (K.S.O.); a New Zealand Ministry of Science and Innovation grant UOAX0813 (P.S.C.); the Duke University Center for AIDS Research (CFAR), a National Institutes of Health (NIH)-funded program (5P30 AI064518), and by a Mallinckrodt Scholar Award, a Searle Scholar Award, a Vallee Foundation Young Investigator Award and an NIH Director's New Innovator Award 1DP2-OD008614 (D.M.T.).	Aly S, 2007, J PATHOL, V212, P295, DOI 10.1002/path.2185; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Carroll MW, 2013, ANTIMICROB AGENTS CH, V57, P3903, DOI 10.1128/AAC.00753-13; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Elks PM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003789; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Fong TAT, 1999, CANCER RES, V59, P99; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Freeman CD, 1997, DRUGS, V54, P679, DOI 10.2165/00003495-199754050-00003; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Liang D, 1998, BBA-GENE STRUCT EXPR, V1397, P14, DOI 10.1016/S0167-4781(97)00233-9; Lin PL, 2012, P NATL ACAD SCI USA, V109, P14188, DOI 10.1073/pnas.1121497109; Matsuyama W, 2000, AM J RESP CRIT CARE, V162, P1120, DOI 10.1164/ajrccm.162.3.9911010; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; Podar K, 2006, P NATL ACAD SCI USA, V103, P19478, DOI 10.1073/pnas.0609329103; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rittershaus ESC, 2013, CELL HOST MICROBE, V13, P643, DOI 10.1016/j.chom.2013.05.012; Saita N, 2000, INFECT IMMUN, V68, P5991, DOI 10.1128/IAI.68.10.5991-5997.2000; Santhakumar K, 2012, CANCER RES, V72, P4017, DOI 10.1158/0008-5472.CAN-11-3148; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367	38	158	164	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 29	2015	517	7536					612	U178		10.1038/nature13967	http://dx.doi.org/10.1038/nature13967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2ZL	25470057	Green Submitted, Green Accepted			2022-12-28	WOS:000348775000043
J	Santhakumar, S; Adashi, EY				Santhakumar, Sachin; Adashi, Eli Y.			The Physician Payment Sunshine Act Testing the Value of Transparency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISCLOSURE LAWS; STATE		[Santhakumar, Sachin; Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA	Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	Eli_Adashi@brown.edu						Centers for Medicare & Medicaid Services (CMS), 2013, FED REGISTER, V78, P9457; Chimonas S, 2010, HEALTH SERV RES, V45, P98, DOI 10.1111/j.1475-6773.2009.01048.x; Hanauer DA, 2014, JAMA-J AM MED ASSOC, V311, P734, DOI 10.1001/jama.2013.283194; Hwong AR, 2014, J LAW MED ETHICS, V42, P208, DOI 10.1111/jlme.12136; Pham-Kanter G, 2012, ARCH INTERN MED, V172, P819, DOI 10.1001/archinternmed.2012.1210; Schmidt C, 2014, NAT BIOTECHNOL, V32, P859, DOI 10.1038/nbt.3008; Steinbrook R, 2014, JAMA-J AM MED ASSOC, V311, P1285, DOI 10.1001/jama.2014.1033	7	78	79	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2015	313	1					23	24		10.1001/jama.2014.15472	http://dx.doi.org/10.1001/jama.2014.15472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AY3IQ	25473969				2022-12-28	WOS:000347478000006
J	Mankowsky, R; Subedi, A; Forst, M; Mariager, SO; Chollet, M; Lemke, HT; Robinson, JS; Glownia, JM; Minitti, MP; Frano, A; Fechner, M; Spaldin, NA; Loew, T; Keimer, B; Georges, A; Cavalleri, A				Mankowsky, R.; Subedi, A.; Foerst, M.; Mariager, S. O.; Chollet, M.; Lemke, H. T.; Robinson, J. S.; Glownia, J. M.; Minitti, M. P.; Frano, A.; Fechner, M.; Spaldin, N. A.; Loew, T.; Keimer, B.; Georges, A.; Cavalleri, A.			Nonlinear lattice dynamics as a basis for enhanced superconductivity in YBa2Cu3O6.5	NATURE			English	Article							WAVE; PHONONICS; ORDER; MODE	Terahertz-frequency optical pulses can resonantly drive selected vibrational modes in solids and deform their crystal structures(1-3). In complex oxides, this method has been used to melt electronic order(4-6), drive insulator-to-metal transitions(7) and induce superconductivity(8). Strikingly, coherent interlayer transport strongly reminiscent of superconductivity can be transiently induced up to room temperature (300 kelvin) in IrBa2Cu3O6+x (refs 9, 10). Here we report the crystal structure of this exotic non-equilibrium state, determined by femtosecond X-ray diffraction and ab initio density functional theory calculations. We find that nonlinear lattice excitation in normal-state IrBa2Cu3O6-x at above the transition temperature of 52 kelvin causes a simultaneous increase and decrease in the Cu-O-2 intra-bilayer and, respectively, inter-bilayer distances, accompanied by anisotropic changes in the in-plane O-Cu-O bond buckling. Density functional theory calculations indicate that these motions cause drastic changes in the electronic structure. Among these, the enhancement in the d(x2-y2) character of the in-plane electronic structure is likely to favour superconductivity.	[Mankowsky, R.; Foerst, M.; Cavalleri, A.] Max Planck Inst Struct & Dynam Matter, D-22761 Hamburg, Germany; [Mankowsky, R.; Cavalleri, A.] Univ Hamburg, D-22761 Hamburg, Germany; [Mankowsky, R.; Foerst, M.; Cavalleri, A.] Ctr Free Elect Laser Sci CFEL, D-22761 Hamburg, Germany; [Subedi, A.; Georges, A.] Ecole Polytech, CNRS, Ctr Phys Theor, F-91128 Palaiseau, France; [Mariager, S. O.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Chollet, M.; Lemke, H. T.; Robinson, J. S.; Glownia, J. M.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Frano, A.; Loew, T.; Keimer, B.] Max Planck Inst Solid State Res, D-70599 Stuttgart, Germany; [Fechner, M.; Spaldin, N. A.] ETH, CH-8093 Zurich, Switzerland; [Georges, A.] Coll France, F-75005 Paris, France; [Georges, A.] Univ Geneva, Dept Phys Mat Condensee MaNEP, CH-1211 Geneva, Switzerland; [Cavalleri, A.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	Max Planck Society; University of Hamburg; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; UDICE-French Research Universities; PSL Research University Paris; College de France; University of Geneva; University of Oxford	Mankowsky, R (corresponding author), Max Planck Inst Struct & Dynam Matter, D-22761 Hamburg, Germany.	roman.mankowsky@mpsd.mpg.de; andrea.cavalleri@mpsd.mpg.de	Mankowsky, Roman/AAK-8181-2020; Först, Michael/D-8924-2012; Georges, Antoine/H-4855-2012; Lemke, Henrik Till T/N-7419-2016; Fechner, Michael/J-7198-2018; Spaldin, Nicola A/A-1017-2010	Mankowsky, Roman/0000-0001-6784-0344; Georges, Antoine/0000-0001-9479-9682; Lemke, Henrik Till T/0000-0003-1577-8643; Spaldin, Nicola A/0000-0003-0709-9499; Keimer, Bernhard/0000-0001-5220-9023; Fechner, Michael/0000-0003-2774-7684; Subedi, Alaska/0000-0001-7537-8196	European Research Council under the European Union [319286]; German Science Foundation [SFB925]; Swiss National Supercomputing Centre [s404]; Swiss National Science Foundation through its National Centre of Competences in Research MUST	European Research Council under the European Union(European Research Council (ERC)); German Science Foundation(German Research Foundation (DFG)); Swiss National Supercomputing Centre; Swiss National Science Foundation through its National Centre of Competences in Research MUST	The research leading to these results received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement no.319286 (QMAC). Funding from the priority program SFB925 of the German Science Foundation is acknowledged. Portions of this research were carried out at the Linac Coherent Light Source (LCLS) at the SLAC National Accelerator Laboratory. The LCLS is an Office of Science User Facility operated for the US Department of Energy Office of Science by Stanford University. This work was supported by the Swiss National Supercomputing Centre under project ID s404. This work was supported by the Swiss National Science Foundation through its National Centre of Competences in Research MUST.	Blanco-Canosa S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.054513; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Carrington A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.140508; Chaloupka J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184513; Elfimov IS, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.060504; Fausti D, 2011, SCIENCE, V331, P189, DOI 10.1126/science.1197294; Forst M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.157002; Forst M, 2013, SOLID STATE COMMUN, V169, P24, DOI 10.1016/j.ssc.2013.06.024; Forst M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.241104; Ghiringhelli G, 2012, SCIENCE, V337, P821, DOI 10.1126/science.1223532; HOMES CC, 1995, PHYSICA C, V254, P265, DOI 10.1016/0921-4534(95)00579-X; Hu W, 2014, NAT MATER, V13, P705, DOI [10.1038/nmat3963, 10.1038/NMAT3963]; Kaiser S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.184516; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Parlinski K, 1997, PHYS REV LETT, V78, P4063, DOI 10.1103/PhysRevLett.78.4063; Pavarini E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047003; Rini M, 2007, NATURE, V449, P72, DOI 10.1038/nature06119; Shah N, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.024506; Subedi A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.220301; Tobey RI, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197404; Togo A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134106; Yu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.177004	25	322	324	13	293	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					71	73		10.1038/nature13875	http://dx.doi.org/10.1038/nature13875			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471882	Green Submitted, Green Published			2022-12-28	WOS:000346310800040
J	Grisham, JR; Williams, AD				Grisham, Jessica R.; Williams, Alishia D.			Long-term Outcomes of Young People Who Attempted Suicide	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK-FACTORS		[Grisham, Jessica R.] Univ New S Wales, Sch Psychol, Mathews Bldg, Sydney, NSW 2052, Australia; [Williams, Alishia D.] Univ New S Wales, Sch Psychiat, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Grisham, JR (corresponding author), Univ New S Wales, Sch Psychol, Mathews Bldg, Sydney, NSW 2052, Australia.	jessicag@unsw.edu.au		Grisham, Jessica/0000-0002-5035-1744				Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; Fergusson DM, 2000, PSYCHOL MED, V30, P23, DOI 10.1017/S003329179900135X; Goldman-Mellor SJ, 2014, JAMA PSYCHIAT, V71, P119, DOI 10.1001/jamapsychiatry.2013.2803; Zlotnick C, 1997, J AM ACAD CHILD PSY, V36, P793, DOI 10.1097/00004583-199706000-00016	7	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2277	+		10.1001/jama.2014.9032	http://dx.doi.org/10.1001/jama.2014.9032			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU6AP	25461997	Green Published			2022-12-28	WOS:000345684800022
J	Willyard, C				Willyard, Cassandra			Balancing act	NATURE			English	Editorial Material																		NORDFANG O, 1991, THROMB HAEMOSTASIS, V66, P464	1	9	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S168	S169		10.1038/515S168a	http://dx.doi.org/10.1038/515S168a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427209				2022-12-28	WOS:000346247600011
J	Mather, AE; Baker, KS; McGregor, H; Coupland, P; Mather, PL; Deheer-Graham, A; Parkhill, J; Bracegirdle, P; Russell, JE; Thomson, NR				Mather, Alison E.; Baker, Kate S.; McGregor, Hannah; Coupland, Paul; Mather, Pamela L.; Deheer-Graham, Ana; Parkhill, Julian; Bracegirdle, Philippa; Russell, Julie E.; Thomson, Nicholas R.			Bacillary dysentery from World War 1 and NCTC1, the first bacterial isolate in the National Collection	LANCET			English	Editorial Material									[Mather, Alison E.; Baker, Kate S.; Coupland, Paul; Parkhill, Julian; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [McGregor, Hannah; Deheer-Graham, Ana; Bracegirdle, Philippa; Russell, Julie E.] Publ Hlth England, Natl Collect Type Cultures, Porton Down, England; [Thomson, Nicholas R.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	Wellcome Trust Sanger Institute; Public Health England; University of London; London School of Hygiene & Tropical Medicine	Thomson, NR (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	nrt@sanger.ac.uk	Thomson, Nicholas R/P-5988-2014; Baker, Kate/P-2087-2016; Parkhill, Julian/G-4703-2011	Thomson, Nicholas R/0000-0002-4432-8505; Baker, Kate/0000-0001-5850-1949; Parkhill, Julian/0000-0002-7069-5958; Coupland, Paul/0000-0002-2871-3374				Andrewes FW, 1919, SPECIAL REPORT NO 42; [Anonymous], Patent No. [WO 95/4105, 954105]; [Anonymous], Patent No. [WO 95/3988, 953988]; [Anonymous], Patent No. [WO 339/10792, 33910792]; Atenstaedt RL, 2011, THE MEDICAL RESPONSE; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Linton DS, 2010, B HIST MED, V84, P607, DOI 10.1353/bhm.2010.0036	7	10	12	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1720	1720		10.1016/S0140-6736(14)61790-6	http://dx.doi.org/10.1016/S0140-6736(14)61790-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KU	25441203				2022-12-28	WOS:000345116200036
J	McCabe, PJ; DeVon, HA				McCabe, Pamela J.; DeVon, Holli A.			Home-based management of patients with atrial fibrillation	LANCET			English	Editorial Material									[McCabe, Pamela J.] Mayo Coll Med, Rochester, MN 55905 USA; [DeVon, Holli A.] Univ Illinois, Coll Nursing, Chicago, IL USA	Mayo Clinic; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	McCabe, PJ (corresponding author), Mayo Coll Med, Rochester, MN 55905 USA.	mccabe.pamela2@mayo.edu		DeVon, Holli/0000-0002-4526-9631				Brandt CL, 2013, REHABIL NURS, V38, P11, DOI 10.1002/rnj.56; Carrington MJ, 2013, EUR J CARDIOVASC NUR, V12, P337, DOI 10.1177/1474515112451702; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Horne R, 2000, HEART, V83, P388, DOI 10.1136/heart.83.4.388; Inglis Sally, 2004, J Cardiovasc Nurs, V19, P118; Lam C, 2013, J CARDIOVASC NURS, V28, P348, DOI 10.1097/JCN.0b013e3182531cf7; McCabe PJ, J CLIN NURS IN PRESS; Stewart S, 2014, LANCET; Takeda A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002752.pub3	9	2	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					752	753		10.1016/S0140-6736(14)62013-4	http://dx.doi.org/10.1016/S0140-6736(14)62013-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC0UD	25467561				2022-12-28	WOS:000350051700010
J	Halpern, SD; Emanuel, EJ				Halpern, Scott D.; Emanuel, Ezekiel J.			Can the United States Buy Better Advance Care Planning?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OF-LIFE CARE; PALLIATIVE CARE; END; TRANSITIONS; IMPACT		Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, 719 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	shalpern@exchange.upenn.edu						American Hospital Association, 2014, AM HOSP ASS ANN HOSP; Back AL, 2007, ARCH INTERN MED, V167, P453, DOI 10.1001/archinte.167.5.453; Halpern SD, 2013, HEALTH AFFAIR, V32, P408, DOI 10.1377/hlthaff.2012.0895; Kwok AC, 2011, LANCET, V378, P1408, DOI 10.1016/S0140-6736(11)61268-3; May P, 2014, J PALLIAT MED, V17, P1054, DOI 10.1089/jpm.2013.0594; Quest T, 2010, J PAIN SYMPTOM MANAG, V39, P334, DOI 10.1016/j.jpainsymman.2009.11.247; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624	8	14	14	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					224	U133		10.7326/M14-2476	http://dx.doi.org/10.7326/M14-2476			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NP	25486099				2022-12-28	WOS:000350108100008
J	Kurtova, AV; Xiao, J; Mo, QX; Pazhanisamy, S; Krasnow, R; Lerner, SP; Chen, FJ; Roh, TT; Lay, E; Ho, PL; Chan, KS				Kurtova, Antonina V.; Xiao, Jing; Mo, Qianxing; Pazhanisamy, Senthil; Krasnow, Ross; Lerner, Seth P.; Chen, Fengju; Roh, Terrence T.; Lay, Erica; Ho, Philip Levy; Chan, Keith Syson			Blocking PGE(2)-induced tumour repopulation abrogates bladder cancer chemoresistance	NATURE			English	Article							STEM-CELLS; CHEMOTHERAPY; NEOADJUVANT; HOMEOSTASIS; PROGRESSION; RENEWAL; GROWTH; REPAIR	Cytotoxic chemotherapy is effective in debulking tumour masses initially; however, in some patients tumours become progressively unresponsive after multiple treatment cycles. Previous studies have demonstrated that cancer stem cells (CSCs) are selectively enriched after chemotherapy through enhanced survival(1-3). Here we reveal a new mechanism by which bladder CSCs actively contribute to therapeutic resistance via an unexpected proliferative response to repopulate residual tumours between chemotherapy cycles, using human bladder cancer xenografts. Further analyses demonstrate the recruitment of a quiescent label-retaining pool of CSCs into cell division in response to chemotherapy-induced damages, similar to mobilization of normal stem cells during wound repair(4-7). While chemotherapy effectively induces apoptosis, associated prostaglandin E-2 (PGE(2)) release paradoxically promotes neighbouring CSC repopulation. This repopulation can be abrogated by a PGE(2)-neutralizing antibody and celecoxib drug-mediated blockade of PGE(2) signalling. In vivo administration of the cyclooxygenase-2 (COX2) inhibitor celecoxib effectively abolishes a PGE(2)- and COX2-mediated wound response gene signature, and attenuates progressive manifestation of chemoresistance in xenograft tumours, including primary xenografts derived from a patient who was resistant to chemotherapy. Collectively, these findings uncover a new underlying mechanism that models the progressive development of clinical chemoresistance, and implicate an adjunctive therapy to enhance chemotherapeutic response of bladder urothelial carcinomas by abrogating early tumour repopulation.	[Kurtova, Antonina V.; Xiao, Jing; Roh, Terrence T.; Chan, Keith Syson] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Kurtova, Antonina V.; Chan, Keith Syson] Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Mo, Qianxing; Chen, Fengju; Chan, Keith Syson] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Mo, Qianxing; Chen, Fengju; Chan, Keith Syson] Baylor Coll Med, Ctr Cell Gene & Therapy, Houston, TX 77030 USA; [Pazhanisamy, Senthil; Krasnow, Ross; Lerner, Seth P.; Lay, Erica; Ho, Philip Levy; Chan, Keith Syson] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Roh, Terrence T.] Baylor Coll Med, Summer Med & Res Training SMART Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Chan, KS (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.	kc1@bcm.edu	Kurtova, Antonina/H-6546-2015	Krasnow, Ross/0000-0001-9773-9431; Lay, Erica/0000-0001-7568-2737; Roh, Terrence/0000-0001-6831-1153	National Cancer Institute [CA129640, CA175397]; V Scholar Award; Dan L Duncan Career Award; Bladder Cancer Partnership; CPRIT pre-doctoral fellowship [RP101499]; AUA Research Scholar Award; CPRIT training grant [RP140102]; NATIONAL CANCER INSTITUTE [P30CA125123, R00CA129640, R01CA175397] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Scholar Award; Dan L Duncan Career Award; Bladder Cancer Partnership; CPRIT pre-doctoral fellowship; AUA Research Scholar Award; CPRIT training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank S. Tsai, J. Rosen, L. Donehower, M. Brenner and B. Deneen for their editorial suggestions, and grant funding from the National Cancer Institute CA129640, CA175397, V Scholar Award, Dan L Duncan Career Award, and Bladder Cancer Partnership (K.S.C.), CPRIT pre-doctoral fellowship RP101499 (A.V.K.), AUA Research Scholar Award (P.L.H.) and CPRIT training grant RP140102 for SMART program (T.T.R.). This work is supported by the Genomic & RNA Profiling Core (L. White), Cytometry & Cell Sorting Core (NIAID AI036211, NCI CA125123 and RR024574; J. Sederstorm), and Human Tissue Acquisition & Pathology Core (NCI CA125123; M. Ittmann) at Baylor College of Medicine, the Texas Advanced Computing Center at UT Austin and Rice University for providing High Performance Computing resources. We dedicate this work to the memory of J. Pride (a patient with bladder cancer and friend of I. Weissman), who funded the original work of K.S.C., which served as an important foundation leading to the current study.	Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Flaig TW, 2012, NAT REV UROL, V9, P65, DOI 10.1038/nrurol.2011.220; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Green DR, 2011, IMMUNITY, V35, P441, DOI 10.1016/j.immuni.2011.10.003; Ho PL, 2012, NAT REV UROL, V9, P583, DOI 10.1038/nrurol.2012.142; Ho PL, 2012, CANCER RES, V72, P3135, DOI 10.1158/0008-5472.CAN-11-3195; Hoggatt J, 2013, NATURE, V495, P365, DOI 10.1038/nature11929; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Knowles M. A., NATURE REV IN PRESS; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Meeks JJ, 2012, EUR UROL, V62, P523, DOI 10.1016/j.eururo.2012.05.048; Niegisch G, 2013, EUR UROL, V64, P355, DOI 10.1016/j.eururo.2013.06.002; Shin K, 2014, NAT CELL BIOL, V16, P469, DOI 10.1038/ncb2956; Sternberg CN, 2013, EUR UROL, V63, P58, DOI 10.1016/j.eururo.2012.08.010; Van Batavia J, 2014, NAT CELL BIOL, V16, P982, DOI 10.1038/ncb3038; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697	30	389	403	8	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2015	517	7533					209	U224		10.1038/nature14034	http://dx.doi.org/10.1038/nature14034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY3IM	25470039	Green Accepted			2022-12-28	WOS:000347477600038
J	Cheung, GYC; Otto, M				Cheung, Gordon Y. C.; Otto, Michael			MICROBIOLOGY Diverted on the way to memory	NATURE			English	Editorial Material							STAPHYLOCOCCUS-AUREUS; PROTEIN-A; IMMUNE EVASION; SUPERANTIGEN		[Cheung, Gordon Y. C.; Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cheung, GYC (corresponding author), NIAID, Lab Human Bacterial Pathogenesis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	motto@niaid.nih.gov		Otto, Michael/0000-0002-2222-4115	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		DeLeo FR, 2008, J EXP MED, V205, P271, DOI 10.1084/jem.20080167; Falugi F, 2013, MBIO, V4, DOI 10.1128/mBio.00575-13; FORSGREN A, 1974, ANN NY ACAD SCI, V236, P252, DOI 10.1111/j.1749-6632.1974.tb41496.x; Goodyear CS, 2003, J EXP MED, V197, P1125, DOI 10.1084/jem.20020552; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Kim HK, 2012, INFECT IMMUN, V80, P3460, DOI 10.1128/IAI.00230-12; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Pauli NT, 2014, J EXP MED, V211, P2331, DOI 10.1084/jem.20141404; Pier GB, 2013, HUM VACC IMMUNOTHER, V9, P1865, DOI 10.4161/hv.25182; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002	10	1	1	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					28	29		10.1038/nature14083	http://dx.doi.org/10.1038/nature14083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25487148	Bronze			2022-12-28	WOS:000347178400026
J	Cox, E; Borio, L; Temple, R				Cox, Edward; Borio, Luciana; Temple, Robert			Evaluating Ebola Therapies - The Case for RCTs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EPIDEMIC		[Cox, Edward; Temple, Robert] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Borio, Luciana] US FDA, Off Commissioner, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Cox, E (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Joffe S, 2014, JAMA-J AM MED ASSOC, V312, P1299, DOI 10.1001/jama.2014.12867; Lamontagne F, 2014, NEW ENGL J MED, V371, P1565, DOI 10.1056/NEJMp1411310	4	61	62	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2014	371	25					2350	2351		10.1056/NEJMp1414145	http://dx.doi.org/10.1056/NEJMp1414145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW7DX	25470568				2022-12-28	WOS:000346425800003
J	Duan, B; Cheng, LZ; Bourane, S; Britz, O; Padilla, C; Garcia-Campmany, L; Krashes, M; Knowlton, W; Velasquez, T; Ren, XY; Ross, SE; Lowell, BB; Wang, Y; Goulding, M; Ma, QF				Duan, Bo; Cheng, Longzhen; Bourane, Steeve; Britz, Olivier; Padilla, Christopher; Garcia-Campmany, Lidia; Krashes, Michael; Knowlton, Wendy; Velasquez, Tomoko; Ren, Xiangyu; Ross, Sarah E.; Lowell, Bradford B.; Wang, Yun; Goulding, Martyn; Ma, Qiufu			Identification of Spinal Circuits Transmitting and Gating Mechanical Pain	CELL			English	Article							SUBSTANTIA-GELATINOSA NEURONS; SUPERFICIAL DORSAL-HORN; MARGINAL ZONE; GABAERGIC NEURONS; THERMAL STIMULI; SENSORY NEURONS; CELLULAR BASIS; CORD; HYPERALGESIA; GATE	Pain information processing in the spinal cord has been postulated to rely on nociceptive transmission (T) neurons receiving inputs from nociceptors and A beta mechanoreceptors, with A beta inputs gated through feed-forward activation of spinal inhibitory neurons (INs). Here, we used intersectional genetic manipulations to identify these critical components of pain transduction. Marking and ablating six populations of spinal excitatory and inhibitory neurons, coupled with behavioral and electrophysiological analysis, showed that excitatory neurons expressing somatostatin (SOM) include T-type cells, whose ablation causes loss of mechanical pain. Inhibitory neurons marked by the expression of dynorphin (Dyn) represent INs, which are necessary to gate A beta fibers from activating SOM+ neurons to evoke pain. Therefore, peripheral mechanical nociceptors and A beta mechanoreceptors, together with spinal SOM+ excitatory and Dyn(+) inhibitory neurons, form a microcircuit that transmits and gates mechanical pain.	[Duan, Bo; Cheng, Longzhen; Knowlton, Wendy; Ma, Qiufu] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Duan, Bo; Cheng, Longzhen; Knowlton, Wendy; Ma, Qiufu] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bourane, Steeve; Britz, Olivier; Padilla, Christopher; Garcia-Campmany, Lidia; Velasquez, Tomoko; Goulding, Martyn] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Garcia-Campmany, Lidia; Krashes, Michael; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; [Garcia-Campmany, Lidia; Krashes, Michael; Lowell, Bradford B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Ross, Sarah E.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Ross, Sarah E.] Univ Pittsburgh, Pain Ctr, Pittsburgh, PA 15213 USA; [Cheng, Longzhen; Wang, Yun] Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Cheng, Longzhen; Wang, Yun] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Salk Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University; Fudan University	Goulding, M (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	goulding@salk.edu; Qiufu_Ma@dfci.harvard.edu	Krashes, Michael/P-7677-2019; Ren, Xiangyu/AAR-3691-2020; Cheng, Longzhen/ABF-7581-2021; Bourane, Steeve/AAI-6143-2020	Bourane, Steeve/0000-0002-9805-2196; Ren, Xiangyu/0000-0001-5497-5194	NIH [R01NS086372, NS047710, P01 NS072040, R01 NS 080586, P01 NS072031, R01 AR063772, R21 AR064445, R01 DK075632, R37 DK053477, R01 DK071051, R01 DK089044, R01 DK096010, P30 DK057521, P30 DK046200, F32 DK089710]; National Natural Science Foundation of China [81171224, 81100815]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063772, R21AR064445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R01DK089044, R01DK071051, F32DK089710, R01DK096010, R37DK053477, P30DK057521, R01DK075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572, P01NS072040, R01NS047710, P30NS072031, R01NS086372, R01NS080586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Z. Josh Huang and the Jackson laboratory for the SOM-IRES-Cre and Calb2-IRES-Cre mice, GENSAT and MMRRC at University of California, Davis, for the NPY-Cre mice, the Allen Brain Institute, and the Jackson Laboratory for the Rosa26<SUP>LSL-tdTomato</SUP> mice, and Dr. Susan Dymecki for the ROSA26<SUP>CAG-FRT-STOP-FRT-GFP</SUP> mice. We thank Drs. Yan Lu, Clifford Woolf, and Fu-Chia Yang for critical comments on the manuscript; Dr Yan Lu for his advice on spinal cord slice recording; and Dr. Enrique Jose Cobos for providing the scoring system in measuring dynamic allodynia. The Ma lab was supported by NIH grants (R01NS086372, NS047710, and P01 NS072040), the Goulding lab is supported by NIH grants (R01NS086372, R01 NS 080586, and P01 NS072031), the Ross lab is supported by NIH grants (R01 AR063772 and R21 AR064445), and the Lowell lab was supported by NIH grants (R01 DK075632, R37 DK053477, R01 DK071051, R01 DK089044, R01 DK096010, P30 DK057521, and P30 DK046200). M.K. was supported by F32 DK089710. L.C. and Y.W. were supported by grants from the National Natural Science Foundation of China (81171224 and 81100815).	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Baba H, 2003, MOL CELL NEUROSCI, V24, P818, DOI 10.1016/S1044-7431(03)00236-7; BENNETT GJ, 1980, J COMP NEUROL, V194, P809, DOI 10.1002/cne.901940407; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; BINI G, 1984, PAIN, V18, P239, DOI 10.1016/0304-3959(84)90819-4; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; Bruno RM, 2011, CURR OPIN NEUROBIOL, V21, P701, DOI 10.1016/j.conb.2011.06.003; BURGESS PR, 1967, J PHYSIOL-LONDON, V190, P541, DOI 10.1113/jphysiol.1967.sp008227; Bushnell M.C., 2008, SENSES COMPREHENSIVE, P279, DOI 10.1016/b978-012370880-9.00163-8; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; Carstens EE, 2010, NEUROREPORT, V21, P303, DOI 10.1097/WNR.0b013e328337310a; CERVERO F, 1979, Q J EXP PHYSIOL CMS, V64, P297, DOI 10.1113/expphysiol.1979.sp002484; CERVERO F, 1976, PAIN, V2, P5, DOI 10.1016/0304-3959(76)90042-7; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHRISTENSEN BN, 1970, J NEUROPHYSIOL, V33, P293, DOI 10.1152/jn.1970.33.2.293; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Furue H, 1999, J PHYSIOL-LONDON, V521, P529, DOI 10.1111/j.1469-7793.1999.00529.x; GOBEL S, 1978, J COMP NEUROL, V180, P395, DOI 10.1002/cne.901800213; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Head H, 1905, BRAIN, V28, P100; Kato G, 2009, J NEUROSCI, V29, P5088, DOI 10.1523/JNEUROSCI.6175-08.2009; Knowlton WM, 2013, J NEUROSCI, V33, P2837, DOI 10.1523/JNEUROSCI.1943-12.2013; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; Kosugi M, 2013, J PHYSIOL-LONDON, V591, P1935, DOI 10.1113/jphysiol.2012.244210; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; KUMAZAWA T, 1978, J COMP NEUROL, V177, P417, DOI 10.1002/cne.901770305; Lai J, 2006, NAT NEUROSCI, V9, P1534, DOI 10.1038/nn1804; LIGHT AR, 1979, J COMP NEUROL, V186, P151, DOI 10.1002/cne.901860204; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Lu Y, 2013, J CLIN INVEST, V123, P4050, DOI 10.1172/JCI70026; Ma QF, 2012, NEUROSCI BULL, V28, P91, DOI 10.1007/s12264-012-1201-2; Ma QF, 2010, J CLIN INVEST, V120, P3773, DOI 10.1172/JCI43426; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Mar L, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-3; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Mendell LM, 2014, PAIN, V155, P210, DOI 10.1016/j.pain.2013.12.010; Miraucourt LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001116; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; MOLONY V, 1981, Q J EXP PHYSIOL CMS, V66, P211, DOI 10.1113/expphysiol.1981.sp002551; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; NOORDENBOS W, 1987, PAIN, V29, P141, DOI 10.1016/0304-3959(87)91031-1; Prescott SA, 2014, NAT NEUROSCI, V17, P183, DOI 10.1038/nn.3629; PRICE DD, 1979, J NEUROPHYSIOL, V42, P1590, DOI 10.1152/jn.1979.42.6.1590; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; SALTER MW, 1990, PAIN, V40, P311, DOI 10.1016/0304-3959(90)91128-6; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Sardella TCP, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-76; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; Wall P., 2008, CHALLENGE PAIN; WALL PD, 1978, BRAIN, V101, P1, DOI 10.1093/brain/101.1.1; WALL PD, 1967, SCIENCE, V155, P108, DOI 10.1126/science.155.3758.108; Wang XD, 2013, NEURON, V78, P312, DOI 10.1016/j.neuron.2013.03.001; Willis WD, 2001, PAIN, V92, P267, DOI 10.1016/S0304-3959(01)00268-8; Woolf Clifford J., 1994, Current Opinion in Neurobiology, V4, P525, DOI 10.1016/0959-4388(94)90053-1; Xu Y, 2013, J NEUROSCI, V33, P14738, DOI 10.1523/JNEUROSCI.5512-12.2013; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; YOSHIMURA M, 1995, J PHYSIOL-LONDON, V482, P29, DOI 10.1113/jphysiol.1995.sp020497; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010	69	307	316	7	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1417	1432		10.1016/j.cell.2014.11.003	http://dx.doi.org/10.1016/j.cell.2014.11.003			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25467445	Bronze, Green Accepted			2022-12-28	WOS:000346652900019
J	Hopkins, PF				Hopkins, Philip F.			ASTROPHYSICS Stars fight back	NATURE			English	Editorial Material							ORIGIN; FEEDBACK; GALAXIES		CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Hopkins, PF (corresponding author), CALTECH, Pasadena, CA 91125 USA.	phopkins@caltech.edu		Hopkins, Philip/0000-0003-3729-1684	Direct For Mathematical & Physical Scien [1411920, 1455342] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; Geach JE, 2014, NATURE, V516, P68, DOI 10.1038/nature14012; HECKMAN TM, 1990, ASTROPHYS J SUPPL S, V74, P833, DOI 10.1086/191522; Hopkins PF, 2005, ASTROPHYS J, V625, pL71, DOI 10.1086/431146; Murray N, 2005, ASTROPHYS J, V618, P569, DOI 10.1086/426067	6	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					44	45		10.1038/516044a	http://dx.doi.org/10.1038/516044a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471877				2022-12-28	WOS:000346310800031
J	Appleby, J				Appleby, John			DATA BRIEFING Is general practice in trouble?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Health and Social Care Information Centre, 2014, NHS HOSPITAL AND COM; Health and Social Care Information Centre, 2009, TRENDS IN CONSULTATI; Health and Social Care Information Centre, 2014, INVESTMENT IN GENERA; Health and Social Care Information Centre, 2014, GP EARNINGS AND EXPE; Health and Social Care Information Centre, 2010, INVESTMENT IN GENERA; Health and Social Care Information Centre, 2013, INVESTMENT IN GENERA; King's Fund, 2014, SATISFACTION WITH TH; Nuffield Trust, 2014, IS GENERAL PRACTICE; Royal College of General Practitioners, 2014, PUT PATIENTS FIRST B	9	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2014	349								g6814	10.1136/bmj.g6814	http://dx.doi.org/10.1136/bmj.g6814			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KG	25430850				2022-12-28	WOS:000346115800003
J	Beach, SR; Kroshinsky, D; Kontos, N				Beach, Scott R.; Kroshinsky, Daniela; Kontos, Nicholas			Case 37-2014: A 35-Year-Old Woman with Suspected Mite Infestation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DELUSIONAL PARASITOSIS; ANTIPSYCHOTICS; PSYCHOSIS; THERAPY		[Beach, Scott R.; Kontos, Nicholas] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Kroshinsky, Daniela] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Beach, Scott R.; Kontos, Nicholas] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Kroshinsky, Daniela] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Beach, SR (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.		Kroshinsky, Daniela/AAM-4608-2020	Kroshinsky, Daniela/0000-0002-4781-9676				Akiyama K, 2006, ANN NY ACAD SCI, V1074, P125, DOI 10.1196/annals.1369.012; Bostwick JM, 2011, GEN HOSP PSYCHIAT, V33, P533, DOI 10.1016/j.genhosppsych.2011.07.002; Cather C, 2005, CAN J PSYCHIAT, V50, P258, DOI 10.1177/070674370505000504; Elston DM, 2004, CUTIS, V74, P23; Floris G, 2008, NEUROCASE, V14, P385, DOI 10.1080/13554790802385418; Foster AA, 2012, J AM ACAD DERMATOL, V67, DOI 10.1016/j.jaad.2011.12.012; Freudenmann RW, 2008, J CLIN PSYCHOPHARM, V28, P500, DOI 10.1097/JCP.0b013e318185e774; Freudenmann RW, 2009, CLIN MICROBIOL REV, V22, P690, DOI 10.1128/CMR.00018-09; Freudenreich O, 2010, PSYCHOSOMATICS, V51, P453, DOI 10.1176/appi.psy.51.6.453; Hicks MI, 2009, DERMATOL THER, V22, P279, DOI 10.1111/j.1529-8019.2009.01243.x; Huber M, 2011, GEN HOSP PSYCHIAT, V33, P604, DOI 10.1016/j.genhosppsych.2011.05.013; Huber M, 2008, PROG NEURO-PSYCHOPH, V32, P1967, DOI 10.1016/j.pnpbp.2008.09.014; Ko CJ, 2004, J AM ACAD DERMATOL, V50, P1, DOI 10.1016/S0190-9622(03)02729-4; Legesse B, 2011, PSYCHOSOMATICS, V52, P468, DOI 10.1016/j.psym.2011.01.030; Lepping P, 2007, BRIT J PSYCHIAT, V191, P198, DOI 10.1192/bjp.bp.106.029660; Middelveen MJ, 2013, CLIN COSMET INV DERM, V6, P1, DOI 10.2147/CCID.S39017; Middelveen MJ, 2011, CLIN COSMET INVESTI, V4, P167, DOI 10.2147/CCID.S26183; Middelveen MJ, 2013, F1000RES, V2, P25, DOI DOI 10.12688/F1000RESEARCH.2-25.V1; Pearson ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029908; SMITH GR, 1986, NEW ENGL J MED, V314, P1407, DOI 10.1056/NEJM198605293142203; Turkington D, 2006, AM J PSYCHIAT, V163, P365, DOI 10.1176/appi.ajp.163.3.365; Ujike H, 2004, ANN NY ACAD SCI, V1025, P279, DOI 10.1196/annals.1316.035; Weibel Sebastien, 2012, J Clin Psychiatry, V73, pe756, DOI 10.4088/JCP.11cr07608; Wong S, 2011, BRIT J DERMATOL, V165, P893, DOI 10.1111/j.1365-2133.2011.10426.x	25	9	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2115	2123		10.1056/NEJMcpc1305989	http://dx.doi.org/10.1056/NEJMcpc1305989			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25427115				2022-12-28	WOS:000345580000013
J	Cole, TB				Cole, Thomas B.			Mound of Butter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2014	312	20					2076	2077		10.1001/jama.2013.279839	http://dx.doi.org/10.1001/jama.2013.279839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU5DG	25423202				2022-12-28	WOS:000345626800001
J	Bachelet, M				Bachelet, Michelle			Towards universal health coverage: applying a gender lens	LANCET			English	Editorial Material									La Moneda Palace, Santiago 8320216, Chile		Bachelet, M (corresponding author), La Moneda Palace, Santiago 8320216, Chile.	auriarte@presidencia.cl						Ambrosio V, 2009, EC INITIATIVES GENDE; Economic Commission for Latin America and the Caribbean, 2009, REV IMPL BEIJ DECL P; Economic Commission for Latin America and the Caribbean, 2005, SOC PAN LAT AM, P231; Economic Commission for Latin America and the Caribbean United Nations Children's Fund, 2011, CHALL NEWSL PROGR MI; Solar X, 2000, GENDER PUBLIC POLICI; United Nations Children's Fund, 2007, TEEN MOTH LAT AM CAR; United Nations Educational Scientific and Cultural Organization (UNESCO), 2011, ED COUNTS MILL DEV G	7	4	4	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					E25	E26		10.1016/S0140-6736(14)61781-5	http://dx.doi.org/10.1016/S0140-6736(14)61781-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF0ZD	25458733				2022-12-28	WOS:000352272400001
J	Simpson, C; Grove, E; Houston, BA				Simpson, Catherine; Grove, Evan; Houston, Brian A.			Pseudopseudohypoparathyroidism	LANCET			English	Editorial Material									[Simpson, Catherine; Grove, Evan; Houston, Brian A.] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Houston, BA (corresponding author), Johns Hopkins Univ Hosp, 1800 Orleans St,Zayed 7125, Baltimore, MD 21287 USA.	bhousto2@jhmi.edu							0	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1123	1123		10.1016/S0140-6736(14)61640-8	http://dx.doi.org/10.1016/S0140-6736(14)61640-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25484027				2022-12-28	WOS:000351270400030
J	Chatterji, S; Byles, J; Cutler, D; Seeman, T; Verdes, E				Chatterji, Somnath; Byles, Julie; Cutler, David; Seeman, Teresa; Verdes, Emese			Health, functioning, and disability in older adults-present status and future implications	LANCET			English	Article							FREE LIFE EXPECTANCY; ELDERLY POPULATION; UNITED-STATES; DYNAMIC EQUILIBRIUM; RECENT TRENDS; AGE 65; MORBIDITY; COMPRESSION; MORTALITY; AMERICANS	Ageing is a dynamic process, and trends in the health status of older adults aged at least 60 years vary over time because of several factors. We examined reported trends in morbidity and mortality in older adults during the past two decades to identify patterns of ageing across the world. We showed some evidence for compression of morbidity (ie, a reduced amount of time spent in worse health), in four types of studies: 1) of good quality based on assessment criteria scores; 2) those in which a disability-related or impairment-related measure of morbidity was used; 3) longitudinal studies; or 4) studies undertaken in the USA and other high-income countries. Many studies, however, reported contrasting evidence (ie, for an expansion of morbidity), but with different methods, these measures are not directly comparable. Expansion of morbidity was more common when trends in chronic disease prevalence were studied. Our secondary analysis of data from longitudinal ageing surveys presents similar results. However, patterns of limitations in functioning vary substantially between countries and within countries over time, with no discernible explanation. Data from low-income countries are very sparse, and efforts to obtain information about the health of older adults in less-developed regions of the world are urgently needed. We especially need studies that focus on refining measurements of health, functioning, and disability in older people, with a core set of domains of functioning, that investigate the effects of these evolving patterns on the health-care system and their economic implications.	[Chatterji, Somnath; Verdes, Emese] WHO, Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland; [Byles, Julie] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Callaghan, NSW 2308, Australia; [Cutler, David] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Cutler, David] Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA; [Seeman, Teresa] Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA	World Health Organization; University of Newcastle; Harvard University; Harvard University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chatterji, S (corresponding author), WHO, Measurement & Hlth Informat Syst, CH-1211 Geneva, Switzerland.	chatterjis@who.int	CHATTERJI, Somnath/ABE-6832-2020; Byles, julie/C-5062-2008	Cutler, David/0000-0002-4949-8917; Byles, julie/0000-0002-3984-6877	Division of Behavioural and Social Research at the US National Institute on Aging through Interagency Agreements [OGHA 04034785, YA1323-08-CN-0020, Y1-AG- 1005-01];  [R01-AG034479];  [R21-AG034263]; NATIONAL INSTITUTE ON AGING [R21AG034263, R01AG034479, P01AG005842] Funding Source: NIH RePORTER	Division of Behavioural and Social Research at the US National Institute on Aging through Interagency Agreements; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Division of Behavioural and Social Research at the US National Institute on Aging through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG- 1005-01), and research grants (R01-AG034479 and R21-AG034263). The views expressed by SC and EV are theirs alone and not necessarily those of WHO.	[Anonymous], 2006, Health Stat Q, P59; [Anonymous], 2000, DEMOGR RES, DOI DOI 10.4054/DEMRES.2000.3.9; [Anonymous], 2013, WORLD POP AG 2013; Baker A, 2000, HLTH STAT Q, V7, P32; Banerjee S., 2014, LANCET; BARENDREGT JJ, 1994, J EPIDEMIOL COMMUN H, V48, P482, DOI 10.1136/jech.48.5.482; Beard J.R., 2014, LANCET; Bloom DE, 2014, LANCET; Breakwell Claudia, 2006, Health Stat Q, P18; Bronnum-Hansen H, 1998, DAN MED BULL, V45, P217; Bronnum-Hansen H, 2005, EUR J PUBLIC HEALTH, V15, P20, DOI 10.1093/eurpub/cki106; Cai LM, 2007, DEMOGRAPHY, V44, P479, DOI 10.1353/dem.2007.0022; Cambois E, 2008, EUR J AGEING, V5, P287, DOI 10.1007/s10433-008-0097-1; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Crimmins EM, 2009, DEMOGRAPHY, V46, P627, DOI 10.1353/dem.0.0070; Crimmins EM, 1999, J GERONTOL B-PSYCHOL, V54, pS31, DOI 10.1093/geronb/54B.1.S31; Crimmins EM, 2004, ANNU REV PUBL HEALTH, V25, P79, DOI 10.1146/annurev.publhealth.25.102802.124401; Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; Diczfalusy E, 1996, CONTRACEPTION, V53, P1, DOI 10.1016/0010-7824(95)00258-8; Fang XH, 2009, DISABIL REHABIL, V31, P701, DOI 10.1080/09638280802305945; Freedman VA, 2000, AM J PUBLIC HEALTH, V90, P1755, DOI 10.2105/AJPH.90.11.1755; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Freedman VA, 2007, DEMOGRAPHY, V44, P459, DOI 10.1353/dem.2007.0026; Fries JF, 2003, ANN INTERN MED, V139, P455, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00015; Graham P, 2004, J EPIDEMIOL COMMUN H, V58, P659, DOI 10.1136/jech.2003.014910; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Gu D, 2009, SOC SCI MED, V68, P2170, DOI 10.1016/j.socscimed.2009.03.031; Hashimoto S, 2010, J EPIDEMIOL, V20, P308, DOI 10.2188/jea.JE20090190; Hosseinpoor AR, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-52; Hubert HB, 2002, J GERONTOL A-BIOL, V57, pM347, DOI 10.1093/gerona/57.6.M347; Jacobzone S, 2000, HEALTH AFFAIR, V19, P213, DOI 10.1377/hlthaff.19.3.213; Jang SN, 2010, J AM GERIATR SOC, V58, P592, DOI 10.1111/j.1532-5415.2010.02744.x; Jeune B, 2008, EUR J AGEING, V5, P279, DOI 10.1007/s10433-008-0100-x; Kramer A., 2009, POPUL HLTH METRICS, V7, P4, DOI [10.1186/1478-7954-7-4, DOI 10.1186/1478-7954-7-4]; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Liu JF, 2009, J AGING HEALTH, V21, P266, DOI 10.1177/0898264308328978; Lynch C, 2007, AUST HEALTH REV, V31, P571, DOI 10.1071/AH070571; Manton KG, 2008, J GERONTOL B-PSYCHOL, V63, pS269, DOI 10.1093/geronb/63.5.S269; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Manton KG, 1999, J GERONTOL A-BIOL, V54, pB247, DOI 10.1093/gerona/54.6.B247; Martin LG, 2011, POP STUD-J DEMOG, V65, P289, DOI 10.1080/00324728.2011.604730; Mathers CD, 1997, J EPIDEMIOL COMMUN H, V51, P80, DOI 10.1136/jech.51.1.80; Moe JO, 2011, EUR J AGEING, V8, P49, DOI 10.1007/s10433-011-0179-3; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Murray CJ, 2003, HLTH SYSTEMS PERFORM, P1; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; Parker M, 2008, EUR J AGEING, V5, P299, DOI 10.1007/s10433-008-0096-2; Payne G, 2007, MILBANK Q, V85, P213, DOI 10.1111/j.1468-0009.2007.00485.x; Perenboom RJM, 2005, PUBLIC HEALTH REP, V120, P46, DOI 10.1177/003335490512000109; Perenboom RJM, 2004, DISABIL REHABIL, V26, P377, DOI 10.1080/0963828032000174098; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince MJ, 2014, LANCET; Reither EN, 2011, HEALTH AFFAIR, V30, P1562, DOI 10.1377/hlthaff.2011.0092; Rodriguez-Mallas L., 2014, LANCET; Sagardui-Villamor J, 2005, J GERONTOL A-BIOL, V60, P1028, DOI 10.1093/gerona/60.8.1028; Salomon JA, 2003, HLTH SYSTEM PERFORMA; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Schoeni RF, 2006, POP STUD-J DEMOG, V60, P39, DOI 10.1080/00324720500462280; Schoeni RF, 2001, J GERONTOL B-PSYCHOL, V56, pS206, DOI 10.1093/geronb/56.4.S206; Steptoe A, 2014, LANCET; UN Economic Commission for Europe, 2012, SURV MOD MEAS HLTH S; Van Oyen H, 2008, EUR J AGEING, V5, P137, DOI 10.1007/s10433-008-0082-8; Verdecchia A, 2001, EUR J CANCER, V37, P1149, DOI 10.1016/S0959-8049(01)00094-6; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506; WHO, 2014, WHO STRAT PEOPL CTR; *WHO, 2006, INT CLASS FUNCT DIS; Wilson Mark, 2006, Health Educ Res, V21 Suppl 1, pi4, DOI 10.1093/her/cyl108	69	463	486	7	122	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					563	575		10.1016/S0140-6736(14)61462-8	http://dx.doi.org/10.1016/S0140-6736(14)61462-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AV	25468158	Green Accepted			2022-12-28	WOS:000349213600035
J	Meng, FL; Du, Z; Federation, A; Hu, JZ; Wang, Q; Kieffer-Kwon, KR; Meyers, RM; Amor, C; Wasserman, CR; Neuberg, D; Casellas, R; Nussenzweig, MC; Bradner, JE; Liu, XS; Alt, FW				Meng, Fei-Long; Du, Zhou; Federation, Alexander; Hu, Jiazhi; Wang, Qiao; Kieffer-Kwon, Kyong-Rim; Meyers, Robin M.; Amor, Corina; Wasserman, Caitlyn R.; Neuberg, Donna; Casellas, Rafael; Nussenzweig, Michel C.; Bradner, James E.; Liu, X. Shirley; Alt, Frederick W.			Convergent Transcription at Intragenic Super-Enhancers Targets AID-Initiated Genomic Instability	CELL			English	Article							RNA-POLYMERASE-II; INDUCED CYTIDINE DEAMINASE; CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; SEQUENCING REVEALS; NONCODING TRANSCRIPTION; B-CELLS; GENE; ACTIVATION; MECHANISMS	Activation-induced cytidine deaminase (AID) initiates both somatic hypermutation (SHM) for antibody affinity maturation and DNA breakage for antibody class switch recombination (CSR) via transcription-dependent cytidine deamination of single-stranded DNA targets. Though largely specific for immunoglobulin genes, AID also acts on a limited set of off-targets, generating oncogenic translocations and mutations that contribute to B cell lymphoma. How AID is recruited to off-targets has been a long-standing mystery. Based on deep GRO-seq studies of mouse and human B lineage cells activated for CSR or SHM, we report that most robust AID off-target translocations occur within highly focal regions of target genes in which sense and antisense transcription converge. Moreover, we found that such AID-targeting "convergent'' transcription arises from antisense transcription that emanates from super-enhancers within sense transcribed gene bodies. Our findings provide an explanation for AID off-targeting to a small subset of mostly lineage-specific genes in activated B cells.	[Meng, Fei-Long; Du, Zhou; Hu, Jiazhi; Meyers, Robin M.; Amor, Corina; Wasserman, Caitlyn R.; Alt, Frederick W.] Harvard Univ, Boston Childrens Hosp, Howard Hughes Med Inst, Program Cellular & Mol Med,Med Sch, Boston, MA 02115 USA; [Meng, Fei-Long; Du, Zhou; Hu, Jiazhi; Meyers, Robin M.; Amor, Corina; Wasserman, Caitlyn R.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Du, Zhou] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Federation, Alexander; Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Federation, Alexander; Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Wang, Qiao; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10065 USA; [Kieffer-Kwon, Kyong-Rim; Casellas, Rafael] NCI, NIAMS, NIH, Bethesda, MD 20892 USA; [Kieffer-Kwon, Kyong-Rim; Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Neuberg, Donna; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Neuberg, Donna; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Tongji University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Bradner, JE (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	james_bradner@dfci.harvard.edu; alt@enders.tch.harvard.edu	Nussenzweig, Michel/AAE-7292-2019; Amor, Corina/AAZ-1904-2020	Amor, Corina/0000-0002-7654-6216; Wang, Qiao/0000-0001-6416-1733; Meng, Feilong/0000-0003-0333-6872; Meyers, Robin/0000-0002-1802-7231; Federation, Alexander/0000-0002-7771-1148; Hu, Jiazhi/0000-0002-6345-0039	NIH grants [R01AI077595, P01CA109901]; Leukemia and Lymphoma Society (LLS) SCOR grant; NIH grant [1R01GM099409]; Leukemia and Lymphoma Society SCOR; National Science Foundation; NIH [1R01 CA176745-01, P01 CA109901, AI072529, AI037526]; intramural research program of NIAMS, NIH; Robertson Foundation/Cancer Research Institute Irvington Fellowship; National Science Foundation of China [NSFC 31329003]; NATIONAL CANCER INSTITUTE [P01CA109901, R01CA176745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037526, R37AI077595, R01AI072529, R01AI077595, R01AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099409] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society (LLS) SCOR grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); intramural research program of NIAMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Robertson Foundation/Cancer Research Institute Irvington Fellowship; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	F.W.A was supported by NIH grants R01AI077595 and P01CA109901, and a Leukemia and Lymphoma Society (LLS) SCOR grant, and he is an investigator of the Howard Hughes Medical Institute. X.S.L was supported by NIH grant 1R01GM099409. A.F. and J.E.B. were supported by a Leukemia and Lymphoma Society SCOR, the National Science Foundation, and NIH grants 1R01 CA176745-01 and P01 CA109901. M.C.N. was supported by NIH grants AI072529 and AI037526 and is an investigator of the Howard Hughes Medical Institute. K.K. and R.C. were supported by the intramural research program of NIAMS, NIH. F.L.M. is a Lymphoma Research Foundation postdoctoral fellow and was a Cancer Research Institute postdoctoral fellow. J.Z. is supported by a Robertson Foundation/Cancer Research Institute Irvington Fellowship. Z.D. was supported by the National Science Foundation of China grant NSFC 31329003. The authors thank Drs. Yi Zhang and Li Shen for assistance with DNA sequencing and Dr. David Schatz (Yale University) for providing primers for GC SHM targets. Dr. Bradner is a scientific founder of Syros Pharmaceuticals, which is developing drugs targeting super-enhancers.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; Cato MH, 2011, NAT PROTOC, V6, P953, DOI 10.1038/nprot.2011.344; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Duke JL, 2013, J IMMUNOL, V190, P3878, DOI 10.4049/jimmunol.1202547; Frock R. L., 2014, NAT BIOTECHNOL; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Gullerova M, 2012, NAT STRUCT MOL BIOL, V19, P1193, DOI 10.1038/nsmb.2392; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; LIU YJ, 1991, EUR J IMMUNOL, V21, P1905, DOI 10.1002/eji.1830210819; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Marusawa H, 2011, ADV IMMUNOL, V111, P109, DOI 10.1016/B978-0-12-385991-4.00003-9; Matthews AJ, 2014, ADV IMMUNOL, V122, P1, DOI 10.1016/B978-0-12-800267-4.00001-8; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Qian J, 2014, CELL, V159, P1524, DOI 10.1016/j.cell.2014.11.013; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Richter K, 2009, J BIOL CHEM, V284, P30652, DOI 10.1074/jbc.M109.014506; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Storb U, 2014, ADV IMMUNOL, V122, P253, DOI 10.1016/B978-0-12-800267-4.00007-9; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; WARD DF, 1979, J MOL BIOL, V133, P249, DOI 10.1016/0022-2836(79)90533-3; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	53	166	168	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1538	1548		10.1016/j.cell.2014.11.014	http://dx.doi.org/10.1016/j.cell.2014.11.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25483776	Bronze, Green Accepted			2022-12-28	WOS:000347922500009
J	Kapoor, R; Saint, S; Kapoor, JR; Johnson, RA; Dhaliwal, G				Kapoor, Roger; Saint, Sanjay; Kapoor, John R.; Johnson, Richard A.; Dhaliwal, Gurpreet			D Is for Delay	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PELLAGRA; SKIN		[Kapoor, Roger] Beloit Hlth Syst, Dept Med, Beloit, WI 53511 USA; [Kapoor, Roger] Univ Illinois, Coll Med, Rockford, IL 61107 USA; [Kapoor, John R.] Chicago Med Sch, Dept Med, Chicago, IL USA; [Saint, Sanjay] Ann Arbor Vet Affairs VA Med Ctr, Ann Arbor, MI USA; [Saint, Sanjay] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Johnson, Richard A.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Dhaliwal, Gurpreet] San Francisco VA Med Ctr, Dept Med, San Francisco, CA USA; [Dhaliwal, Gurpreet] Univ Calif San Francisco, Sch Med, San Francisco, CA USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Chicago Medical School; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Kapoor, R (corresponding author), Beloit Hlth Syst, Dept Med, 1969 W Hart Rd, Beloit, WI 53511 USA.	rogerkapoor@gmail.com	Saint, Sanjay/AAF-5126-2019		Doximity; Jvion	Doximity; Jvion	Dr. Saint reports receiving fees for board membership from Doximity and Jvion. No other potential conflict of interest relevant to this article was reported.	Ashourian N, 2006, NEW ENGL J MED, V354, P1614, DOI 10.1056/NEJMicm050641; Crutchfield ED, 1928, ARCH DERMATOL SYPH, V17, P650, DOI 10.1001/archderm.1928.02380110068006; French D, 2002, ACAD EMERG MED, V9, P1205, DOI 10.1111/j.1553-2712.2002.tb01575.x; HENDRICKS WM, 1991, SEMIN DERMATOL, V10, P282; Hilliard AA, 2004, NEW ENGL J MED, V350, P599, DOI 10.1056/NEJMcps031794; Karthikeyan K, 2002, INT J DERMATOL, V41, P476, DOI 10.1046/j.1365-4362.2002.01551.x; Katz K, 2007, FITZPATRICKS DERMATO, P1201; Newacheck PW, 2003, HEALTH SERV RES, V38, P1235, DOI 10.1111/1475-6773.00174; Prousky Jonathan E, 2003, Altern Med Rev, V8, P180; Rivlin RS, 1998, CECIL TXB MED, P1231; SPIVAK JL, 1977, JOHNS HOPKINS MED J, V140, P295; Wan P, 2011, BRIT J DERMATOL, V164, P1188, DOI 10.1111/j.1365-2133.2010.10163.x; ZIEVE L, 1963, AM J CLIN NUTR, V13, P312, DOI 10.1093/ajcn/13.5.312	13	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2218	2223		10.1056/NEJMcps1212211	http://dx.doi.org/10.1056/NEJMcps1212211			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW0IY	25470698				2022-12-28	WOS:000345976700012
J	Zhuravleva, A; Radford, SE				Zhuravleva, Anastasia; Radford, Sheena E.			How TriC Folds Tricky Proteins	CELL			English	Editorial Material							CHAPERONIN TRIC/CCT		[Zhuravleva, Anastasia; Radford, Sheena E.] Univ Leeds, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Zhuravleva, A (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	a.zhuravleva@leeds.ac.uk; s.e.radford@leeds.ac.uk		Radford, Sheena/0000-0002-3079-8039; Zhuravleva, Anastasia/0000-0001-6165-8509				Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; Freund A, 2014, CELL, V159, P1389, DOI 10.1016/j.cell.2014.10.059; Joachimiak LA, 2014, CELL, V159, P1042, DOI 10.1016/j.cell.2014.10.042; Kalisman N, 2013, STRUCTURE, V21, P540, DOI 10.1016/j.str.2013.01.017; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Reissmann S, 2012, CELL REP, V2, P866, DOI 10.1016/j.celrep.2012.08.036; Shahmoradian SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00710; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Venteicher AS, 2009, CELL CYCLE, V8, P1329, DOI 10.4161/cc.8.9.8288; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515	10	4	4	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1251	1252		10.1016/j.cell.2014.11.029	http://dx.doi.org/10.1016/j.cell.2014.11.029			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480290	Bronze			2022-12-28	WOS:000346652900005
J	Weir, MR				Weir, Matthew R.			Hypertension	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AMERICAN-HEART-ASSOCIATION; WHITE-COAT HYPERTENSION; BLOOD-PRESSURE; HIGH-RISK; CARDIOVASCULAR PROGNOSIS; SCIENTIFIC STATEMENT; MASKED HYPERTENSION; TRIAL; SODIUM; REDUCTION						Lalonde, Christine/AAR-4784-2020; Weir, Matthew R/ABC-3654-2021	Lalonde, Christine/0000-0002-7467-5575; Weir, Matthew R/0000-0001-8820-5702				Alexander CN, 1996, HYPERTENSION, V28, P228, DOI 10.1161/01.HYP.28.2.228; Allen NB, 2014, JAMA-J AM MED ASSOC, V311, P490, DOI 10.1001/jama.2013.285122; Angeli F, 2005, BLOOD PRESS MONIT, V10, P301, DOI 10.1097/00126097-200512000-00003; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Batey DM, 2000, ANN EPIDEMIOL, V10, P45, DOI 10.1016/S1047-2797(99)00041-1; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bobrie G, 2004, JAMA-J AM MED ASSOC, V291, P1342, DOI 10.1001/jama.291.11.1342; Bray GA, 2004, AM J CARDIOL, V94, P222, DOI 10.1016/j.amjcard.2004.03.070; Calhoun DA, 2008, CIRCULATION, V117, pE510, DOI 10.1161/CIRCULATIONAHA.108.189141; Calonge N, 2007, ANN INTERN MED, V147, P783, DOI 10.7326/0003-4819-147-11-200712040-00009; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cicconetti P, 2003, ANGIOLOGY, V54, P661, DOI 10.1177/000331970305400605; Commission UNR, 2013, STAT WIR WIR SUBSCR, P1; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Eguchi K, 2008, BLOOD PRESS MONIT, V13, P15, DOI 10.1097/MBP.0b013e3282f13f4a; Fagrell B, 1999, J INTERN MED, V246, P331, DOI 10.1046/j.1365-2796.1999.00576.x; FierroCarrion GA, 1997, AM J CARDIOL, V80, P775, DOI 10.1016/S0002-9149(97)00514-6; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT S, V2, P414; Mallion JM, 2006, J HYPERTENS, V24, P2365, DOI 10.1097/01.hjh.0000251895.55249.82; MATTES RD, 1991, J AM COLL NUTR, V10, P383; McGuire Heather L, 2004, J Clin Hypertens (Greenwich), V6, P383, DOI 10.1111/j.1524-6175.2004.03147.x; MESSERLI FH, 1986, AM J MED, V80, P906, DOI 10.1016/0002-9343(86)90636-4; Moser M, 2006, NEW ENGL J MED, V355, P385, DOI 10.1056/NEJMcp041698; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Pickering T, 1996, AM J HYPERTENS, V9, P1, DOI 10.1016/0895-7061(95)00341-X; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Pickering TG, 2008, HYPERTENSION, V52, P10, DOI 10.1161/HYPERTENSIONAHA.107.189010; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; Taubert D, 2007, ARCH INTERN MED, V167, P626, DOI 10.1001/archinte.167.7.626; Townsend R, 2000, INTENSIVE CARE UNIT, P602; Weir MR, 2001, AM J HYPERTENS, V14, P963, DOI 10.1016/S0895-7061(01)02167-7; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Wilson, 1997, Blood Press Monit, V2, P201; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	49	19	19	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					ITC1	ITC17		10.7326/0003-4819-161-11-201412020-01006	http://dx.doi.org/10.7326/0003-4819-161-11-201412020-01006			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UJ	25437425				2022-12-28	WOS:000347247200001
J	Chan, M				Chan, Margaret			Food safety must accompany food and nutrition security	LANCET			English	Editorial Material									WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	chanm@who.int						WHO, 2014, WHO DRAFT GLOB ACT P; WHO, 2014, 5 KEYS SAF FOOD PROG; WHO, 2014, INFOSAN ACT AM; WHO, BURD FOODB DIS; WHO and FAO, 2013, 50 ANN COD AL; World Health Organization, 2014, FAO WHO 2 INT C NUTR	6	29	30	7	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1910	1911		10.1016/S0140-6736(14)62037-7	http://dx.doi.org/10.1016/S0140-6736(14)62037-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25467592				2022-12-28	WOS:000345450100010
J	Honig, SF; Watson, D; Kishimoto, M; Hjorth, J				Honig, Sebastian F.; Watson, Darach; Kishimoto, Makoto; Hjorth, Jens			A dust-parallax distance of 19 megaparsecs to the supermassive black hole in NGC 4151	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; BROAD-LINE REGION; INNER RADIUS; NARROW-LINE; REVERBERATION; KINEMATICS; SCALE; MASS; CIRCUMNUCLEAR; EMISSION	The active galaxy NGC 4151 has a crucial role as one of only two active galactic nuclei for which black hole mass measurements based on emission line reverberation mapping can be calibrated against other dynamical techniques(1-3). Unfortunately, effective calibration requires accurate knowledge of the distance to NGC 4151, which is not at present available(4). Recently reported distances range from 4 to 29 megaparsecs(5-7). Strong peculiar motions make a redshift-based distance very uncertain, and the geometry of the galaxy and its nucleus prohibit accurate measurements using other techniques. Here we report a dust-parallax distance to NGC 4151 of 19.0+(+2.4)(-2.6) megaparsecs. The measurement is based on an adaptation of a geometric method that uses the emission line regions of active galaxies(8). Because these regions are too small to be imaged with present technology, we use instead the ratio of the physical and angular sizes of the more extended hot-dust emission(9) as determined from time delays(10) and infrared interferometry(11-14). This distance leads to an approximately 1.4-fold increase in the dynamical black hole mass, implying a corresponding correction to emission line reverberation masses of black holes if they are calibrated against the two objects with additional dynamical masses.	[Honig, Sebastian F.; Watson, Darach; Hjorth, Jens] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen O, Denmark; [Honig, Sebastian F.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Kishimoto, Makoto] Kyoto Sangyo Univ, Fac Sci, Dept Phys, Kita Ku, Kyoto 6038555, Japan	University of Copenhagen; Niels Bohr Institute; University of Southampton; Kyoto Sangyo University	Honig, SF (corresponding author), Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, Juliane Maries Vej 30, DK-2100 Copenhagen O, Denmark.	s.hoenig@soton.ac.uk	Kishimoto, Makoto/AAK-1587-2021; Watson, Darach/E-4521-2015	Watson, Darach/0000-0002-4465-8264; Hoenig, Sebastian/0000-0002-6353-1111	Marie Curie International Incoming Fellowship within the Seventh European Community Framework Programme [PIIF-GA-2013-623804]; Danish National Research Foundation; NASA	Marie Curie International Incoming Fellowship within the Seventh European Community Framework Programme(European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); NASA(National Aeronautics & Space Administration (NASA))	We thank R. Wojtak for discussions on peculiar velocities near the Virgo cluster. S.F.H. acknowledges support from the Marie Curie International Incoming Fellowship within the Seventh European Community Framework Programme (PIIF-GA-2013-623804). The Dark Cosmology Centre is funded by the Danish National Research Foundation. This research has made use of the NASA/IPAC Extragalactic Database (NED) which is operated by JPL, Caltech, under contract with NASA.	[Anonymous], 2014, NASA IPAC EXTR DAT; Bentz MC, 2006, ASTROPHYS J, V651, P775, DOI 10.1086/507417; Das V, 2005, ASTRON J, V130, P945, DOI 10.1086/432255; Elvis M, 2002, ASTROPHYS J, V581, pL67, DOI 10.1086/346015; Grier CJ, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/90; Hicks EKS, 2008, ASTROPHYS J SUPPL S, V174, P31, DOI 10.1086/521650; Honig SF, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/87; Honig SF, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117750; Honig SF, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/1/L4; Kawaguchi T, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/105; Kishimoto M, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117367; Kishimoto M, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201016054; Kishimoto M, 2009, ASTRON ASTROPHYS, V507, pL57, DOI 10.1051/0004-6361/200913512; Kishimoto M, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/2/L36; Koshida S, 2009, ASTROPHYS J LETT, V700, pL109, DOI 10.1088/0004-637X/700/2/L109; Landt H, 2011, MON NOT R ASTRON SOC, V414, P218, DOI 10.1111/j.1365-2966.2011.18383.x; Martel AR, 1998, ASTROPHYS J, V508, P657, DOI 10.1086/306453; Mould JR, 2000, ASTROPHYS J, V529, P786, DOI 10.1086/308304; Muller-Sanchez F, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/69; Mundell CG, 2003, ASTROPHYS J, V583, P192, DOI 10.1086/345356; Onken CA, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/37; Pancoast A, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/49; Peterson BM, 2014, SPACE SCI REV, V183, P253, DOI 10.1007/s11214-013-9987-4; Pott JU, 2010, ASTROPHYS J, V715, P736, DOI 10.1088/0004-637X/715/2/736; Schnulle K, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321802; Suganuma M, 2006, ASTROPHYS J, V639, P46, DOI 10.1086/499326; Swain M, 2003, ASTROPHYS J, V596, pL163, DOI 10.1086/379235; Theureau G, 2007, ASTRON ASTROPHYS, V465, P71, DOI 10.1051/0004-6361:20066187; Woo JH, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/49; Yoshii Y, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/1/L11	30	54	54	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					528	+		10.1038/nature13914	http://dx.doi.org/10.1038/nature13914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428499	Green Submitted			2022-12-28	WOS:000346247600047
J	Callard, F				Callard, Felicity			Hubbub: troubling rest through experimental entanglements	LANCET			English	Editorial Material									[Callard, Felicity] Wellcome Collect, Hubbub, London, England; [Callard, Felicity] Univ Durham, Durham DH1 3HP, England	Durham University	Callard, F (corresponding author), Wellcome Collect, Hubbub, London, England.	felicity.callard@durham.ac.uk	Callard, Felicity/AEP-9676-2022; Callard, Felicity J/C-8959-2009	Callard, Felicity/0000-0002-5350-1963; Callard, Felicity J/0000-0002-5350-1963	Wellcome Trust [086049, 103817] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1839	1839		10.1016/S0140-6736(14)62233-9	http://dx.doi.org/10.1016/S0140-6736(14)62233-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7LA	25457909				2022-12-28	WOS:000345116800013
J	Brown, JCS; Nelson, J; VanderSluis, B; Deshpande, R; Butts, A; Kagan, S; Polacheck, I; Krysan, DJ; Myers, CL; Madhani, HD				Brown, Jessica C. S.; Nelson, Justin; VanderSluis, Benjamin; Deshpande, Raamesh; Butts, Arielle; Kagan, Sarah; Polacheck, Itzhack; Krysan, Damian J.; Myers, Chad L.; Madhani, Hiten D.			Unraveling the Biology of a Fungal Meningitis Pathogen Using Chemical Genetics	CELL			English	Article							BIOACTIVE COMPOUNDS; DRUG-COMBINATIONS; ANTIFUNGAL AGENTS; CAPSULE; MECHANISMS; RESISTANCE; VIRULENCE; YEAST; POLYSACCHARIDE; INHIBITOR	The fungal meningitis pathogen Cryptococcus neoformans is a central driver of mortality in HIV/AIDS. We report a genome-scale chemical genetic data map for this pathogen that quantifies the impact of 439 small-molecule challenges on 1,448 gene knockouts. We identified chemical phenotypes for 83% of mutants screened and at least one genetic response for each compound. C. neoformans chemical-genetic responses are largely distinct from orthologous published profiles of Saccharomyces cerevisiae, demonstrating the importance of pathogen-centered studies. We used the chemical-genetic matrix to predict novel pathogenicity genes, infer compound mode of action, and to develop an algorithm, O2M, that predicts antifungal synergies. These predictions were experimentally validated, thereby identifying virulence genes, a molecule that triggers G2/M arrest and inhibits the Cdc25 phosphatase, and many compounds that synergize with the antifungal drug fluconazole. Our work establishes a chemical-genetic foundation for approaching an infection responsible for greater than one-third of AIDS-related deaths.	[Brown, Jessica C. S.; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Nelson, Justin; VanderSluis, Benjamin; Deshpande, Raamesh; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Butts, Arielle; Krysan, Damian J.] Univ Rochester, Med Ctr, Dept Chem, Rochester, NY 14643 USA; [Kagan, Sarah; Polacheck, Itzhack] Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, IL-91120 Jerusalem, Israel; [Krysan, Damian J.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14643 USA; [Krysan, Damian J.] Univ Rochester, Sch Med & Dent, Dept Microbiol Immunol, Rochester, NY 14643 USA	University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of Rochester; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Rochester; University of Rochester	Myers, CL (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.	cmyers@cs.umn.edu; hitenmadhani@gmail.com		Krysan, Damian/0000-0001-6330-3365; Brown, Jessica/0000-0002-3255-1486; Madhani, Hiten/0000-0001-7400-6657	NIH [5R01AI099206, 1R01AI091422, 1R01HG005084, 1R01GM04975]; CIFAR Genetic Networks Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100272, R01AI096869, R01AI091422, T32AI060537, R01AI099206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104975] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIFAR Genetic Networks Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants 5R01AI099206 to H.D.M., 1R01AI091422 to D.J.K., 1R01HG005084 and 1R01GM04975 to C.L.M, and a grant from the CIFAR Genetic Networks Program to C.L.M.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; Armstrong-James D, 2014, TRENDS MICROBIOL, V22, P120, DOI 10.1016/j.tim.2014.01.001; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; BROEK D, 1991, NATURE, V349, P388, DOI 10.1038/349388a0; Butts A, 2014, MBIO, V5, DOI 10.1128/mBio.00765-13; Butts A, 2013, EUKARYOT CELL, V12, P278, DOI 10.1128/EC.00314-12; Butts A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002870; Cantas L, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00096; Chang YC, 1998, INFECT IMMUN, V66, P2230, DOI 10.1128/IAI.66.5.2230-2236.1998; Chun CD, 2011, CELL HOST MICROBE, V9, P243, DOI 10.1016/j.chom.2011.02.003; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; Del Poeta M, 2004, EUKARYOT CELL, V3, P1067, DOI 10.1128/EC.3.5.1067-1075.2004; Dittmar JC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-353; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Feldman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093225; Fernandez L, 2012, CLIN MICROBIOL REV, V25, P661, DOI 10.1128/CMR.00043-12; Florio AR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-97; Francis LK, 2006, CLIN CANCER RES, V12, P6826, DOI 10.1158/1078-0432.CCR-06-1331; Geyer JA, 2005, BBA-PROTEINS PROTEOM, V1754, P160, DOI 10.1016/j.bbapap.2005.07.031; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Haynes BC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002411; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; HILL HD, 1968, ANAL BIOCHEM, V24, P9, DOI 10.1016/0003-2697(68)90054-7; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; HSIEH MH, 1993, DIAGN MICR INFEC DIS, V16, P343, DOI 10.1016/0732-8893(93)90087-N; Jansen G, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.95; Jiang B, 2008, CHEM BIOL, V15, P363, DOI 10.1016/j.chembiol.2008.02.016; Kagan SH, 2014, GERIATR NURS, V35, P69, DOI 10.1016/j.gerinurse.2013.11.006; Kalan L, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001766; Kathiravan MK, 2012, BIOORGAN MED CHEM, V20, P5678, DOI 10.1016/j.bmc.2012.04.045; Kozel TR, 2003, INFECT IMMUN, V71, P2868, DOI 10.1128/IAI.71.5.2868-2875.2003; KOZEL TR, 1984, INFECT IMMUN, V43, P879, DOI 10.1128/IAI.43.3.879-886.1984; Kumar P, 2014, EUKARYOT CELL, V13, P560, DOI 10.1128/EC.00290-13; Kumar P, 2011, CURR OPIN STRUC BIOL, V21, P597, DOI 10.1016/j.sbi.2011.08.006; Kumar R, 2005, MOL BIOCHEM PARASIT, V141, P29, DOI 10.1016/j.molbiopara.2005.01.012; Kuo D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r77; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Liu OW, 2007, EUKARYOT CELL, V6, P630, DOI 10.1128/EC.00398-06; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mandell GL, 2010, MANDELL DOUGLAS BENN; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; O'Meara TR, 2012, CLIN MICROBIOL REV, V25, P387, DOI 10.1128/CMR.00001-12; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Pu LX, 2002, J BIOL CHEM, V277, P46877, DOI 10.1074/jbc.M207902200; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Vecchiarelli A, 2013, FUTURE MICROBIOL, V8, P1107, DOI 10.2217/fmb.13.84; WHELAN WL, 1986, J BACTERIOL, V166, P924, DOI 10.1128/jb.166.3.924-929.1986; World Health Organization, 2011, RAP ADV DIAGN PREV M; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Xu DM, 2009, J BIOL CHEM, V284, P19754, DOI 10.1074/jbc.M109.019877; Zhai B, 2012, ANTIMICROB AGENTS CH, V56, P3758, DOI 10.1128/AAC.00212-12	63	52	53	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1168	1187		10.1016/j.cell.2014.10.044	http://dx.doi.org/10.1016/j.cell.2014.10.044			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416953	Green Accepted, Bronze			2022-12-28	WOS:000345506300026
J	Wright, DJM; Drasar, BS				Wright, David J. M.; Drasar, Bohumil S.			Dysentery in World War 1: Shigella a century on	LANCET			English	Editorial Material							ESCHERICHIA-COLI; GENOME SEQUENCE; FLEXNERI; 2A		[Wright, David J. M.] Univ London Imperial Coll Sci Technol & Med, London W6 8RF, England; [Drasar, Bohumil S.] Univ London London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Wright, DJM (corresponding author), Univ London Imperial Coll Sci Technol & Med, London W6 8RF, England.	d.j.wright@ic.ac.uk						Baker KS, 2014, LANCET, V384, P1691, DOI 10.1016/S0140-6736(14)61789-X; Bando SY, 2010, MEM I OSWALDO CRUZ, V105, P786, DOI 10.1590/S0074-02762010000600009; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Deng JK, 2014, J THORAC DIS, V6, P539, DOI 10.3978/j.issn.2072-1439.2014.02.20; EWING WH, 1949, J BACTERIOL, V57, P633, DOI 10.1128/JB.57.6.633-638.1949; Fernandez IM, 2001, J INFECT DIS, V184, P743, DOI 10.1086/323035; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Knirel YA, 2013, GLYCOBIOLOGY, V23, P475, DOI 10.1093/glycob/cws222; MARTINI E, 1902, Z HYG INFEKTIONSKR, V41, P540; Mather AE, 2014, LANCET, V384, P1720, DOI 10.1016/S0140-6736(14)61790-6; NORIEGA FR, 1995, J INFECT DIS, V172, P1408, DOI 10.1093/infdis/172.5.1408; Octavia S, 2015, MOL MED MICROBIOLOGY, V2, P1181; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Qui S, 2011, J CLIN MICROBIOL, V49, P1148; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003	15	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1651	1653		10.1016/S0140-6736(14)61940-1	http://dx.doi.org/10.1016/S0140-6736(14)61940-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KU	25441185	hybrid			2022-12-28	WOS:000345116200010
J	Cornberg, M; Manns, MP				Cornberg, Markus; Manns, Michael P.			New kids on the block-step by step to an ideal HCV therapy	LANCET			English	Editorial Material							GENOTYPE 1 INFECTION; CHRONIC HEPATITIS-C; SOFOSBUVIR; ABT-450/R-OMBITASVIR; RIBAVIRIN; DASABUVIR; LEDIPASVIR; CIRRHOSIS		[Cornberg, Markus; Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany	Hannover Medical School	Cornberg, M (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.	cornberg.markus@mh-hannover.de	Cornberg, Markus/AAN-6939-2021	Cornberg, Markus/0000-0002-9141-8001				Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, LANCET; Maasoumy B, 2014, EUR J GASTROEN HEPAT, V26, P836, DOI 10.1097/MEG.0000000000000121; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; Manns MP, 2013, LANCET INFECT DIS, V13, P378, DOI 10.1016/S1473-3099(13)70074-4; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Sulkowski M., 2014, LANCET; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	16	9	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2015	385	9973					1050	1052		10.1016/S0140-6736(14)62008-0	http://dx.doi.org/10.1016/S0140-6736(14)62008-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD7KX	25468162				2022-12-28	WOS:000351270400007
J	Harlan, LC; Warren, JL				Harlan, Linda C.; Warren, Joan L.			Global survival patterns: potential for cancer control	LANCET			English	Editorial Material									[Harlan, Linda C.; Warren, Joan L.] NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Harlan, LC (corresponding author), NCI, Bethesda, MD 20892 USA.	harlanl@mail.nih.gov						Allemani C, 2014, LANCET, DOI S0140-6736(14)62038-9; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Casali PG, 2014, ANN ONCOL, V25, P1458, DOI 10.1093/annonc/mdu218; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Nieburg HE, 2005, CANCER DETECT PREV, V29, P403, DOI 10.1016/j.cdp.2005.09.001; Thomas B, 2013, J LAW MED ETHICS, V41, P16, DOI 10.1111/jlme.12002; Valsecchi MG, 2008, LANCET ONCOL, V9, P159, DOI 10.1016/S1470-2045(08)70028-7; Vineis P, 2014, LANCET, V383, P549, DOI 10.1016/S0140-6736(13)62224-2	8	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					926	928		10.1016/S0140-6736(14)62251-0	http://dx.doi.org/10.1016/S0140-6736(14)62251-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CD2EK	25467589				2022-12-28	WOS:000350886900010
J	Rodriguez-Manas, L; Fried, LP				Rodriguez-Manas, Leocadio; Fried, Linda P.			Frailty in the clinical scenario	LANCET			English	Editorial Material							WOMENS HEALTH; OLDER-ADULTS; DISABILITY		[Rodriguez-Manas, Leocadio] Univ Europea Madrid, Hosp Univ Getafe, Dept Geriatr, Getafe 28905, Spain; [Rodriguez-Manas, Leocadio] Univ Europea Madrid, Sch Hlth Sci, Getafe 28905, Spain; [Fried, Linda P.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Fried, Linda P.] Columbia Univ, Med Ctr, New York, NY USA	European University of Madrid; Hospital Universitario de Getafe; European University of Madrid; Columbia University; Columbia University	Rodriguez-Manas, L (corresponding author), Univ Europea Madrid, Hosp Univ Getafe, Dept Geriatr, Getafe 28905, Spain.	leocadio.rodriguez@salud.madrid.org		Rodriguez-Manas, Leocadio/0000-0002-6551-1333				Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; European Commission, 2012, EUR EC, V2; Ferrucci L, 1996, J CLIN EPIDEMIOL, V49, P1089, DOI 10.1016/0895-4356(96)00231-4; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; FRAILOMIC project, EU FP7 HLTH 2012 INN; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2009, HAZZARDS GEIATRIC ME; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Garcia-Garcia FJ, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2014.01.004; Laosa O, 2014, CURR PHARM DESIGN, V20, P3068, DOI 10.2174/13816128113196660705; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rodriguez-Artalejo F, 2014, J EPIDEMIOL COMMUN H, V68, P703, DOI 10.1136/jech-2014-203863; Rodriguez-Manas L, 2013, J GERONTOL A-BIOL, V68, P62, DOI 10.1093/gerona/gls119; Sourial N, 2013, J GERONTOL A-BIOL, V68, P1505, DOI 10.1093/gerona/glt053; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x; Xue QL, 2011, ARCH INTERN MED, V171, P1119, DOI 10.1001/archinternmed.2011.252	18	159	164	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					E7	E9		10.1016/S0140-6736(14)61595-6	http://dx.doi.org/10.1016/S0140-6736(14)61595-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AZ	25468154				2022-12-28	WOS:000349214000001
J	Sequist, TD; Taveras, EM				Sequist, Thomas D.; Taveras, Elsie M.			Clinic-Community Linkages for High-Value Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sequist, Thomas D.] Harvard Univ, Brigham & Womens Hosp, Partners HealthCare Syst, Dept Hlth Care Policy,Med Sch,Div Gen Med, Boston, MA 02115 USA; [Taveras, Elsie M.] Massachusetts Gen Hosp, Div Gen Pediat, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System; Harvard University; Massachusetts General Hospital	Sequist, TD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Partners HealthCare Syst, Dept Hlth Care Policy,Med Sch,Div Gen Med, Boston, MA 02115 USA.							Beck AF, 2013, J PEDIATR-US, V163, P574, DOI 10.1016/j.jpeds.2013.01.064; Duncan DT, 2014, ENV HLTH PERSPECT; Healthe RX, YOUR CONN HLTH CAR S; Herrin J, 2014, HLTH SERV RES	4	22	22	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2148	2150		10.1056/NEJMp1408457	http://dx.doi.org/10.1056/NEJMp1408457			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW0IY	25470692				2022-12-28	WOS:000345976700002
J	Wu, F				Wu, Felicia			PERSPECTIVE: Time to face the fungal threat	NATURE			English	Editorial Material							AFLATOXIN; EXPOSURE; INTERVENTIONS; EFFICACY; RISK		Michigan State Univ, E Lansing, MI 48824 USA	Michigan State University	Wu, F (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.							Chen JG, 2013, CANCER PREV RES, V6, P1038, DOI 10.1158/1940-6207.CAPR-13-0168; Cleveland TE, 2003, PEST MANAG SCI, V59, P629, DOI 10.1002/ps.724; Egner PA, 2003, MUTAT RES-FUND MOL M, V523, P209, DOI 10.1016/S0027-5107(02)00337-8; Groopman JD, 2008, ANNU REV PUBL HEALTH, V29, P187, DOI 10.1146/annurev.publhealth.29.020907.090859; Khlangwiset P, 2010, FOOD ADDIT CONTAM A, V27, P998, DOI 10.1080/19440041003677475; Liu Y, 2012, EUR J CANCER, V48, P2125, DOI 10.1016/j.ejca.2012.02.009; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Mitchell NJ, 2014, AM J TROP MED HYG, V91, P777, DOI 10.4269/ajtmh.14-0093; Turner PC, 2005, LANCET, V365, P1950, DOI 10.1016/S0140-6736(05)66661-5; Wu F, 2014, TOXICOL SCI, V141, P329, DOI 10.1093/toxsci/kfu137	10	32	35	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					S7	S7		10.1038/516S7a	http://dx.doi.org/10.1038/516S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25470199	Bronze			2022-12-28	WOS:000346310800002
J	Brunet, M				Brunet, Martin			PERSONAL VIEW Target diagnosis rates in primary care are misleading and unethical	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Binscombe Med Ctr, Godalming GU7 3PR, Surrey, England		Brunet, M (corresponding author), Binscombe Med Ctr, Godalming GU7 3PR, Surrey, England.	martin@binscombe.net						Alzheimer's Society, 2014, DEM UK 2 ED OV; Association of Public Health Observatories, 2014, APHO DIAB PREV MOD E; Brunet M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2224; Donnelly L, 2014, TELEGRAPH; NHS England, 2014, GEN PRACT OUTC STAND; NHS England, 2014, PRIM CAR WEB TOOL; UK National Screening Committee, 2014, ATR FIBR	7	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2014	349								g7235	10.1136/bmj.g7235	http://dx.doi.org/10.1136/bmj.g7235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KK	25467381				2022-12-28	WOS:000346116300009
J	Sohn, E				Sohn, Emily			Dogged pursuit	NATURE			English	Editorial Material							CANINE HEMOPHILIA; FACTOR-VIII; EXPRESSION; THERAPY											BRINKHOUS KM, 1956, ARCH PATHOL, V61, P6; GILES AR, 1988, BLOOD, V72, P335; KAY MA, 1993, SCIENCE, V262, P117, DOI 10.1126/science.8211118; Margaritis P, 2009, BLOOD, V113, P3682, DOI 10.1182/blood-2008-07-168377; White Gilbert C, 2010, Trans Am Clin Climatol Assoc, V121, P61; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	7	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					S172	S173		10.1038/515S172a	http://dx.doi.org/10.1038/515S172a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW4JP	25427211	Bronze			2022-12-28	WOS:000346247600013
J	Steinberg, BE; Tracey, KJ; Slutsky, AS				Steinberg, Benjamin E.; Tracey, Kevin J.; Slutsky, Arthur S.			Bacteria and the Neural Code	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SENSORY NEURONS		[Steinberg, Benjamin E.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Slutsky, Arthur S.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Tracey, Kevin J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY USA	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Northwell Health	Steinberg, BE (corresponding author), Univ Toronto, Dept Anesthesia, Toronto, ON, Canada.		Slutsky, Arthur/M-3325-2019	Tracey, Kevin J/0000-0003-1884-6314	NIGMS NIH HHS [R01 GM057226] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; WATKINS LR, 1995, NEUROSCI LETT, V183, P27, DOI 10.1016/0304-3940(94)11105-R	5	9	11	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2131	2133		10.1056/NEJMcibr1412003	http://dx.doi.org/10.1056/NEJMcibr1412003			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU4KP	25427116				2022-12-28	WOS:000345580000017
J	Tumeh, PC; Harview, CL; Yearley, JH; Shintaku, IP; Taylor, EJM; Robert, L; Chmielowski, B; Spasic, M; Henry, G; Ciobanu, V; West, AN; Carmona, M; Kivork, C; Seja, E; Cherry, G; Gutierrez, AJ; Grogan, TR; Mateus, C; Tomasic, G; Glaspy, JA; Emerson, RO; Robins, H; Pierce, RH; Elashoff, DA; Robert, C; Ribas, A				Tumeh, Paul C.; Harview, Christina L.; Yearley, Jennifer H.; Shintaku, I. Peter; Taylor, Emma J. M.; Robert, Lidia; Chmielowski, Bartosz; Spasic, Marko; Henry, Gina; Ciobanu, Voicu; West, Alisha N.; Carmona, Manuel; Kivork, Christine; Seja, Elizabeth; Cherry, Grace; Gutierrez, Antonio J.; Grogan, Tristan R.; Mateus, Christine; Tomasic, Gorana; Glaspy, John A.; Emerson, Ryan O.; Robins, Harlan; Pierce, Robert H.; Elashoff, David A.; Robert, Caroline; Ribas, Antoni			PD-1 blockade induces responses by inhibiting adaptive immune resistance	NATURE			English	Article							ADVANCED MELANOMA; T-CELLS; SAFETY; SURVIVAL; IPILIMUMAB; EXPRESSION; ANTI-PD-1; ANTIBODY	Therapies that target the programmed death-1 (PD-1) receptor have shown unprecedented rates of durable clinical responses in patients with various cancer types(1-5). One mechanism by which cancer tissues limit the host immune response is via upregulation of PD-1 ligand (PD-L1) and its ligation to PD-1 on antigen-specific CD8(+) T cells (termed adaptive immune resistance)7. Here we show that pre-existing CD8(+) T cells distinctly located at the invasive tumour margin are associated with expression of the PD-1/PD-Li immune inhibitory axis and may predict response to therapy. We analysed samples from 46 patients with metastatic melanoma obtained before and during anti-PD-1 therapy (pembrolizumab) using quantitative immunohistochemistry, quantitative multiplex immunofluorescence, and nextgeneration sequencing for T-cell antigen receptors (TCRs). In serially sampled tumours, patients responding to treatment showed proliferation of intratumoral CD8(+) T cells that directly correlated with radiographic reduction in tumour size. Pre-treatment samples obtained from responding patients showed higher numbers of CD8-, PD-1- and PD-L1-expressing cells at the invasive tumour margin and inside tumours, with close proximity between PD-1 and PD-L1, and a more clonal TCR repertoire. Using multivariate analysis, we established a predictive model based on CD8(+) expression at the invasive margin and validated the model in an independent cohort of 15 patients. Our findings indicate that tumour regression after therapeutic PD-1 blockade requires pre-existing CD8 T cells that are negatively regulated by PD-1 /PD-Li-mediated adaptive immune resistance.	[Tumeh, Paul C.; Harview, Christina L.; Shintaku, I. Peter; Taylor, Emma J. M.; Robert, Lidia; Chmielowski, Bartosz; Spasic, Marko; Henry, Gina; Ciobanu, Voicu; West, Alisha N.; Carmona, Manuel; Kivork, Christine; Seja, Elizabeth; Cherry, Grace; Gutierrez, Antonio J.; Grogan, Tristan R.; Glaspy, John A.; Elashoff, David A.; Ribas, Antoni] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Tumeh, Paul C.; Chmielowski, Bartosz; Glaspy, John A.; Elashoff, David A.; Ribas, Antoni] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Yearley, Jennifer H.; Pierce, Robert H.] Merck & Co Inc, Palo Alto, CA 94304 USA; [Mateus, Christine; Tomasic, Gorana; Robert, Caroline] Univ Paris Sud, Gustave Roussy, Villejuif, France; [Mateus, Christine; Tomasic, Gorana; Robert, Caroline] INSERM, U981, Villejuif, Paris Sud, France; [Emerson, Ryan O.; Robins, Harlan] Adapt Biotechnol, Seattle, WA 98102 USA; [Robins, Harlan] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Merck & Company; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Fred Hutchinson Cancer Center	Tumeh, PC (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	ptumeh@mednet.ucla.edu; aribas@mednet.ucla.edu	Robert, Caroline/G-6157-2018	Robert, Caroline/0000-0002-9493-0238; Pierce, MD, Robert Hamilton/0000-0002-2677-144X; Ciobanu, Voicu/0000-0002-5750-2402; Glaspy, John/0000-0002-1800-9076; Harview, Christina/0000-0002-5003-8539; Chmielowski, Bartosz/0000-0002-2374-3320	National Institutes of Health [K08 AI091663]; Kure It Research Grant [UL1TR000124, P01 CA168585, U54 CA119347, R01 CA170689]; Ressler Family Fund; Dr Robert Vigen Memorial Fund; Wesley Coyle Memorial Fund; Garcia-Corsini Family Fund; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Research Grant [SU2C-AACR-DT1012]; Merck Sharp and Dome; Adaptive Biotechnologies; V Foundation-Gil Nickel Family Endowed Fellowship in Melanoma Research; Spanish Society of Medical Oncology for Translational Research in Reference Centers;  [P30 CA16042]; NATIONAL CANCER INSTITUTE [R01CA170689, P01CA168585, P30CA016042, U54CA119347] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI091663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kure It Research Grant; Ressler Family Fund; Dr Robert Vigen Memorial Fund; Wesley Coyle Memorial Fund; Garcia-Corsini Family Fund; Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Research Grant; Merck Sharp and Dome; Adaptive Biotechnologies; V Foundation-Gil Nickel Family Endowed Fellowship in Melanoma Research; Spanish Society of Medical Oncology for Translational Research in Reference Centers; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by National Institutes of Health grants K08 AI091663, Kure It Research Grant, UL1TR000124 (to P.C.T.), P01 CA168585, U54 CA119347, R01 CA170689, the Ressler Family Fund, the Dr Robert Vigen Memorial Fund, the Wesley Coyle Memorial Fund, and the Garcia-Corsini Family Fund (to A.R.), P30 CA16042 to D.A.E. A.R. was supported by a Stand Up To Cancer-Cancer Research Institute Cancer Immunology Dream Team Translational Research Grant (SU2C-AACR-DT1012). Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research. M.S. was supported as a Howard Hughes Medical Institute Medical Research Fellow. Some of the studies were funded by Merck Sharp and Dome and by Adaptive Biotechnologies. L.R. was supported by the V Foundation-Gil Nickel Family Endowed Fellowship in Melanoma Research and a grant from the Spanish Society of Medical Oncology for Translational Research in Reference Centers. We acknowledge the Translational Pathology Core Laboratory for tissue sectioning and slide scanning, S. Roy, N. Kamsu-Kom, R. Guo, J. Pang, W. Li, A. Villanueva and K. Crawford for biopsy processing and clinical data, S. Hashaghan for assisting with quantitative imaging approaches, E. Penaflor for assisting in IHC assay optimization, execution and digital image generation, and B. Dogdas and S. Mehta who assisted with the proximity assay. We would like to thank S. Ebbinghaus, E. Rubin, S. P. Kang, R. L. Modlin, C. R. Taylor and C. Denny for critically reviewing the manuscript.	Atefi M, 2014, CLIN CANCER RES, V20, P3446, DOI 10.1158/1078-0432.CCR-13-2797; Bald T, 2014, CANCER DISCOV, V4, P674, DOI 10.1158/2159-8290.CD-13-0458; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Duraiswamy J, 2014, CANCER RES, V74, P633, DOI 10.1158/0008-5472.CAN-13-2752; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Ribas AF, 2014, J CLIN ONCOL S, V32, p5s; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	20	4160	4365	53	845	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					568	+		10.1038/nature13954	http://dx.doi.org/10.1038/nature13954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428505	Green Submitted, Green Accepted			2022-12-28	WOS:000346247600054
J	Altman, DG; Bland, JM				Altman, Douglas G.; Bland, J. Martin			STATISTICS NOTES Uncertainty beyond sampling error	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CANCER; BIAS		[Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Oxford; University of York - UK	Altman, DG (corresponding author), Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.	doug.altman@csm.ox.ac.uk			Cancer Research UK [16895] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Altman DG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7064; Greenland S, 2004, INT J EPIDEMIOL, V33, P1389, DOI 10.1093/ije/dyh276; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JP, 2011, LANCET, V343, pd5928; Kaplan RM, 2014, CTS-CLIN TRANSL SCI, V7, P342, DOI 10.1111/cts.12178; Lange T, 2014, INT J EPIDEMIOL, V43, P971, DOI 10.1093/ije/dyu100; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177	7	5	5	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2014	349								g7065	10.1136/bmj.g7065	http://dx.doi.org/10.1136/bmj.g7065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KE	25424583	Green Published, Bronze			2022-12-28	WOS:000346115600011
J	Klein, PMC; Zaal, IJ; Spitoni, C; Ong, DSY; van der Kooi, AW; Bonten, MJM; Slooter, AJC; Cremer, OL				Klein, Peter M. C.; Zaal, Irene J.; Spitoni, Cristian; Ong, David S. Y.; van der Kooi, Arendina W.; Bonten, Marc J. M.; Slooter, Arjen J. C.; Cremer, Olaf L.			The attributable mortality of delirium in critically ill patients: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; RANDOMIZED CONTROLLED-TRIAL; MARGINAL STRUCTURAL MODELS; RISK-FACTORS; OLDER PATIENTS; ICU PATIENTS; OBSERVATIONAL COHORT; HOSPITAL MORTALITY; TERM MORTALITY	Objective To determine the attributable mortality caused by delirium in critically ill patients. Design Prospective cohort study. Setting 32 mixed bed intensive care unit in the Netherlands, January 2011 to July 2013. Participants 1112 consecutive adults admitted to an intensive care unit for a minimum of 24 hours. Exposures Trained observers evaluated delirium daily using a validated protocol. Logistic regression and competing risks survival analyses were used to adjust for baseline variables and a marginal structural model analysis to adjust for confounding by evolution of disease severity before the onset of delirium. Main outcome measure Mortality during admission to an intensive care unit. Results Among 1112 evaluated patients, 558 (50.2%) developed at least one episode of delirium, with a median duration of 3 days (interquartile range 2-7 days). Crude mortality was 94/558 (17%) in patients with delirium compared with 40/554 (7%) in patients without delirium (P<0.001). Delirium was significantly associated with mortality in the multivariable logistic regression analysis (odds ratio 1.77, 95% confidence interval 1.15 to 2.72) and survival analysis (subdistribution hazard ratio 2.08, 95% confidence interval 1.40 to 3.09). However, the association disappeared after adjustment for time varying confounders in the marginal structural model (subdistribution hazard ratio 1.19, 95% confidence interval 0.75 to 1.89). Using this approach, only 7.2% (95% confidence interval -7.5% to 19.5%) of deaths in the intensive care unit were attributable to delirium, with an absolute mortality excess in patients with delirium of 0.9% (95% confidence interval -0.9% to 2.3%) by day 30. In post hoc analyses, however, delirium that persisted for two days or more remained associated with a 2.0% (95% confidence interval 1.2% to 2.8%) absolute mortality increase. Furthermore, competing risk analysis showed that delirium of any duration was associated with a significantly reduced rate of discharge from the intensive care unit (cause specific hazard ratio 0.65, 95% confidence interval 0.55 to 0.76). Conclusions Overall, delirium prolongs admission in the intensive care unit but does not cause death in critically ill patients. Future studies should focus on episodes of persistent delirium and its long term sequelae rather than on acute mortality.	[Klein, Peter M. C.; Zaal, Irene J.; Ong, David S. Y.; van der Kooi, Arendina W.; Slooter, Arjen J. C.; Cremer, Olaf L.] Univ Med Ctr Utrecht, Dept Intens Care Med, NL-3508 GA Utrecht, Netherlands; [Spitoni, Cristian] Univ Utrecht, Dept Math, Utrecht, Netherlands; [Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center	Klein, PMC (corresponding author), Univ Med Ctr Utrecht, Dept Intens Care Med, NL-3508 GA Utrecht, Netherlands.	p.m.c.kleinklouwenberg@umcutrecht.nl	Cremer, Olaf L/G-3855-2016	Cremer, Olaf L/0000-0003-4264-1108; Ong, David/0000-0001-5688-6443; van Diem-Zaal, Irene/0000-0002-8946-7920	Centre for Translational Molecular Medicine [04I-201]; Netherlands Organization of Scientific Research (NWO) [Vici 918.76.611]	Centre for Translational Molecular Medicine; Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Centre for Translational Molecular Medicine (http://www.ctmm.nl), project MARS (grant 04I-201). MB has received research funding from the Netherlands Organization of Scientific Research (NWO Vici 918.76.611). The study sponsors did not have a role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Agarwal V, 2010, J BURN CARE RES, V31, P706, DOI 10.1097/BCR.0b013e3181eebee9; Al-Qadheeb NS, 2014, CRIT CARE MED, V42, P1442, DOI 10.1097/CCM.0000000000000224; Aldemir M, 2001, CRIT CARE, V5, P265, DOI 10.1186/cc1044; Axell AIRG, 2002, ACTA ANAESTH SCAND, V46, P726, DOI 10.1034/j.1399-6576.2002.460616.x; Balas MC, 2007, J NURS SCHOLARSHIP, V39, P147, DOI 10.1111/j.1547-5069.2007.00160.x; Bekaert M, 2011, AM J RESP CRIT CARE, V184, P1133, DOI 10.1164/rccm.201105-0867OC; Bekaert M, 2010, LIFETIME DATA ANAL, V16, P45, DOI 10.1007/s10985-009-9130-8; Breitbart W, 2002, PSYCHOSOMATICS, V43, P183, DOI 10.1176/appi.psy.43.3.183; Chang YL, 2008, AM J CRIT CARE, V17, P567; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Ely EW, 2013, MODIFYING IMPACT ICU; Engels JM, 2003, J CLIN EPIDEMIOL, V56, P968, DOI 10.1016/S0895-4356(03)00170-7; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Gofton TE, 2012, NAT REV NEUROL, V8, P557, DOI 10.1038/nrneurol.2012.183; Greenland S, 2003, EPIDEMIOLOGY, V14, P300, DOI 10.1097/00001648-200305000-00009; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hshieh TT, 2008, J GERONTOL A-BIOL, V63, P764, DOI 10.1093/gerona/63.7.764; Hughes CG, 2011, ANESTH ANALG, V112, P1212, DOI 10.1213/ANE.0b013e318215366d; Jaber S, 2005, CHEST, V128, P2749, DOI 10.1378/chest.128.4.2749; KISHI Y, 1995, GEN HOSP PSYCHIAT, V17, P371, DOI 10.1016/0163-8343(95)00056-W; Klouwenberg PMCK, 2013, CRIT CARE MED, V41, P2373, DOI 10.1097/CCM.0b013e3182923712; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Lin SM, 2008, J CRIT CARE, V23, P372, DOI 10.1016/j.jcrc.2006.09.001; Lin SM, 2004, CRIT CARE MED, V32, P2254, DOI 10.1097/01.CCM.0000145587.16421.BB; MacLullich AMJ, 2008, J PSYCHOSOM RES, V65, P229, DOI 10.1016/j.jpsychores.2008.05.019; Martin BJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9273; McNicoll L, 2003, J AM GERIATR SOC, V51, P591, DOI 10.1034/j.1600-0579.2003.00201.x; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Patel SB, 2014, AM J RESP CRIT CARE, V189, P658, DOI 10.1164/rccm.201310-1815OC; Pisani MA, 2007, ARCH INTERN MED, V167, P1629, DOI 10.1001/archinte.167.15.1629; Pisani MA, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2010.02.009; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Pisani MA, 2009, CRIT CARE MED, V37, P177, DOI 10.1097/CCM.0b013e318192fcf9; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Salluh JI, 2010, CRIT CARE, V14, DOI 10.1186/cc9333; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Seaman JS, 2006, PSYCHOSOMATICS, V47, P56, DOI 10.1176/appi.psy.47.1.56; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shehabi Y, 2013, INTENS CARE MED, V39, P910, DOI 10.1007/s00134-013-2830-2; Shi CM, 2010, CHINESE MED J-PEKING, V123, P993, DOI 10.3760/cma.j.issn.0366-6999.2010.08.004; Shintani AK, 2009, CRIT CARE MED, V37, P2939, DOI 10.1097/CCM.0b013e3181b7fbbb; Steiner LA, 2011, EUR J ANAESTH, V28, P628, DOI 10.1097/EJA.0b013e328349b7f5; Strijbos MJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-78; Svenningsen H, 2013, ACTA ANAESTH SCAND, V57, P288, DOI 10.1111/aas.12048; Thomason JWW, 2005, CRIT CARE, V9, pR375, DOI 10.1186/cc3729; Tomasi CD, 2012, J CRIT CARE, V27, P212, DOI 10.1016/j.jcrc.2011.05.015; Trzepacz P T, 2000, Semin Clin Neuropsychiatry, V5, P132; Trzepacz PT, 1999, DEMENT GERIATR COGN, V10, P330, DOI 10.1159/000017164; van den Boogaard M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e420; van den Boogaard M, 2012, INT J NURS STUD, V49, P775, DOI 10.1016/j.ijnurstu.2011.11.016; van den Boogaard M, 2010, CRIT CARE, V14, DOI 10.1186/cc9214; van der Wal WM, 2011, J STAT SOFTW, V43, P1; van Eijk M M J, 2008, Ned Tijdschr Geneeskd, V152, P2768; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; van Rompaey B, 2009, CRIT CARE, V13, DOI 10.1186/cc7892; Wolkewitz M, 2008, CRIT CARE, V12, DOI 10.1186/cc6852; Wolkewitz M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5060; Woods JC, 2004, INTENS CARE MED, V30, P1066, DOI 10.1007/s00134-004-2193-9; Zaal IJ, 2015, J CRIT CARE, V30, P375, DOI 10.1016/j.jcrc.2014.10.031; Zaal IJ, 2013, INTENS CARE MED, V39, P481, DOI 10.1007/s00134-012-2726-6; Zaal IJ, 2012, DRUGS, V72, P1457, DOI 10.2165/11635520-000000000-00000; Zhang ZG, 2013, GEN HOSP PSYCHIAT, V35, P105, DOI 10.1016/j.genhosppsych.2012.11.003; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	71	115	120	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2014	349								g6652	10.1136/bmj.g6652	http://dx.doi.org/10.1136/bmj.g6652			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW2KC	25422275	Green Published, hybrid			2022-12-28	WOS:000346115400002
J	Tuitama, LT; Young-soo, S; Clark, H; Tukuitonga, C; Beaglehole, R				Tuitama, Leao Talalelei; Young-soo, Shin; Clark, Helen; Tukuitonga, Colin; Beaglehole, Robert			Acting on the Pacific crisis in non-communicable diseases	LANCET			English	Editorial Material									[Tuitama, Leao Talalelei] Govt Samoa, Minist Hlth, Apia, Samoa; [Young-soo, Shin] WHO Reg Off Western Pacific, Manila, Philippines; [Clark, Helen] United Nations Dev Programme, New York, NY USA; [Tukuitonga, Colin] Secretariat Pacific Community, Noumea, New Caledonia; [Beaglehole, Robert] Univ Auckland, Auckland 1010, New Zealand	WHO Western Pacific Regional Office; World Health Organization; University of Auckland	Beaglehole, R (corresponding author), Univ Auckland, Auckland 1010, New Zealand.	r.beaglehole@auckland.ac.nz			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Anderson I., 2013, EC COSTS NONCOMMUNIC; MANA Pacific, 2014, PAC HLTH MIN M HON J; Pacific Islands Forum Secretariat, 2014, HLTH MIN WANT TOB FR; Secretariat of the Pacifi c Community, 2011, PAC NCD CRIS; Taylor R, 2013, AUST NZ J PUBL HEAL, V37, P509, DOI 10.1111/1753-6405.12116; UNDP, 2013, TRAD TRAD AGR NONC D; World Bank, 2014, NONC DIS NCD ROADM R; World Health Organization, 2010, GLOBAL STATUS REPORT	8	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1823	+		10.1016/S0140-6736(14)61824-9	http://dx.doi.org/10.1016/S0140-6736(14)61824-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7LA	25457906				2022-12-28	WOS:000345116800004
J	Honigsbaum, M				Honigsbaum, Mark			The art of medicine Ebola: epidemic echoes and the chronicle of a tragedy foretold	LANCET			English	Editorial Material									Queen Mary Univ London, London, England	University of London; Queen Mary University London	Honigsbaum, M (corresponding author), Queen Mary Univ London, London, England.	mark.honigsbaum@qmul.ac.uk		honigsbaum, mark/0000-0002-1891-8763	Wellcome Trust [103159] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	3	3	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1740	1741		10.1016/S0140-6736(14)62063-8	http://dx.doi.org/10.1016/S0140-6736(14)62063-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KX	25473684	Bronze, Green Published			2022-12-28	WOS:000345116400014
J	Watts, G				Watts, Geoff			Joyce Baird Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1742	1742		10.1016/S0140-6736(14)62064-X	http://dx.doi.org/10.1016/S0140-6736(14)62064-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KX	25473685	Bronze			2022-12-28	WOS:000345116400015
J	Jones, E; Wessely, S				Jones, Edgar; Wessely, Simon			Legacy of the 1914-18 war 2 Battle for the mind: World War 1 and the birth of military psychiatry	LANCET			English	Article							TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; SHELL-SHOCK; HIGH EXPLOSIVES; IRAQ; AFGHANISTAN; COMBAT; 20TH-CENTURY; NEUROTRAUMA; PSYCHOLOGY	The 100th anniversary of the outbreak of World War 1 could be viewed as a tempting opportunity to acknowledge the origins of military psychiatry and the start of a journey from psychological ignorance to enlightenment. However, the psychiatric legacy of the war is ambiguous. During World War 1, a new disorder (shellshock) and a new treatment (forward psychiatry) were introduced, but the former should not be thought of as the first recognition of what is now called post-traumatic stress disorder and the latter did not off er the solution to the management of psychiatric casualties, as was subsequently claimed. For this Series paper, we researched contemporary publications, classified military reports, and casualty returns to reassess the conventional narrative about the effect of shellshock on psychiatric practice. We conclude that the expression of distress by soldiers was culturally mediated and that patients with postcombat syndromes presented with symptom clusters and causal interpretations that engaged the attention of doctors but also resonated with popular health concerns. Likewise, claims for the efficacy of forward psychiatry were inflated. The vigorous debates that arose in response to controversy about the nature of psychiatric disorders and the discussions about how these disorders should be managed remain relevant to the trauma experienced by military personnel who have served in Iraq and Afghanistan. The psychiatric history of World War 1 should be thought of as an opportunity for commemoration and in terms of its contemporary relevance-not as an opportunity for self-congratulation.	[Jones, Edgar; Wessely, Simon] Kings Coll London, Inst Psychiat, Kings Ctr Mil Hlth Res, London SE5 9RJ, England	University of London; King's College London	Jones, E (corresponding author), Kings Coll London, Inst Psychiat, Kings Ctr Mil Hlth Res, 10 Cutcombe Rd, London SE5 9RJ, England.	edgar.jones@kcl.ac.uk	Wessely, Simon C/A-8713-2008	Wessely, Simon Charles/0000-0002-6743-9929; Jones, Edgar/0000-0002-4610-9584	UK charity	UK charity	EJ is employed by the Institute of Psychiatry and is the programme leader for an MSc in war and psychiatry. SW is an honorary civilian consultant adviser in psychiatry to the British Army and a trustee of Combat Stress, a UK charity that provides service and support for veterans with mental health problems. We declare that we have no competing interests.	[Anonymous], 1939, BRIT MED J, V2, P1199; [Anonymous], 1917, ADM DISCH BOOK 4 STA; ARTISS KL, 1963, MIL MED, V128, P1011, DOI 10.1093/milmed/128.10.1011; Barker P, 1991, REGENERATION; Beebe GW, 1952, BATTLE CASUALTIES IN; Beebe GW, 1958, VARIATION PSYCHOL TO, P88; Brown W, 1918, LANCET, V2, P197; Cooper EL, 1942, MED J AUSTRALIA, V2, P73; GLASS A J, 1947, Bull U S Army Med Dep, V7, P1034; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Holmes G, 1939, PIN15240215B, P12; JAMES GWB, 1945, LANCET, V249, P801; James GWB, 1955, TYPESCRIPT, V2, P98; Jones DWC, 1919, BRAIN, V42, P171, DOI 10.1093/brain/42.3.171; Jones E, 2006, J MILITARY HIST, V70, P439, DOI 10.1353/jmh.2006.0103; Jones E, 2003, J TRAUMA STRESS, V16, P411, DOI 10.1023/A:1024426321072; Jones E, 2003, BRIT J PSYCHIAT, V182, P158, DOI 10.1192/bjp.182.2.158; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Jones E, 2001, BRIT J PSYCHIAT, V178, P242, DOI 10.1192/bjp.178.3.242; Jones E, 2007, PSYCHOL MED, V37, P215, DOI 10.1017/S0033291706009329; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Jones E, 2007, MED HIST, V51, P357, DOI 10.1017/S0025727300001484; Jones E, 2007, J ANXIETY DISORD, V21, P164, DOI 10.1016/j.janxdis.2006.09.009; Jones E, 2014, WAR HIST, V21, P355, DOI 10.1177/0968344513510248; Jones E, 2010, J HIST MED ALL SCI, V65, P368, DOI 10.1093/jhmas/jrq006; Leri A., 1919, SHELL SHOCK COMMOTIO; LEVAV I, 1979, AM J PSYCHIAT, V136, P637; LUDWIG A O, 1947, Mil Surg, V100, P51; Ministry of Pensions, 1953, 28 MIN PENS; Mott F W, 1917, Br Med J, V2, P612; Mott FW, 1917, J MENT SCI, V63, P467, DOI 10.1192/bjp.63.263.467; Mott Frederick Walker, 1919, WAR NEUROSES SHELL S; Mott FW, 1916, LANCET, V1, P441; Mott FW, 1916, LANCET, V1, P331; Mott FW, 1917, BRIT MED J, V1917, P39, DOI 10.1136/bmj.2.2950.39; Mott FW, 1918, LANCET, V1, P169; Myers Charles S., 1940, SHELL SHOCK FRANCE 1; Myers CS, 1915, LANCET, V1, P316; Newman Bonnie J., 1992, Archives of Physical Medicine and Rehabilitation, V73, P955; Prost A, 2014, CAMBRIDGE HISTORY OF THE FIRST WORLD WAR, VOL III: CIVIL SOCIETY, P561; Raynor MW, 1918, STATE HOSP Q, V4, P301; Rhein John H. W., 1919, J ABNORM PSYCHOL, V14, P9; Rivers WHR, 1918, LANCET, V1, P173; Rivers WHR, 1917, LANCET, V2, P237; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Ross TA, 1941, LECT WAR NEROSES; Russell C., 1973, THE ORIGINS OF THE E, p[1, 2]; Salmon T, 1929, MED DEP US ARMY, VX; Sheffield Gary, 2001, FORGOTTEN VICTORY 1; Shephard B, 1999, HIST PSYCHIATR, V10, P491, DOI 10.1177/0957154X9901004005; Shephard B, 2000, WAR NERVES SOLDIER P; Smith G. Elliot, 1917, SHELL SHOCK ITS LESS; Southborough L., 1922, REPORT WAR OFFICE CO; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Wessely S, 2006, J ROY SOC MED, V99, P440, DOI 10.1258/jrsm.99.9.440; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Winter J, 2014, CAMBRIDGE HISTORY OF THE FIRST WORLD WAR, VOL III: CIVIL SOCIETY, P310; Wolfsohn JM, 1918, LANCET, V1, P177; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003	61	16	17	1	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1708	1714		10.1016/S0140-6736(14)61260-5	http://dx.doi.org/10.1016/S0140-6736(14)61260-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KU	25441201				2022-12-28	WOS:000345116200034
J	Kennedy, BK; Berger, SL; Brunet, A; Campisi, J; Cuervo, AM; Epel, ES; Franceschi, C; Lithgow, GJ; Morimoto, RI; Pessin, JE; Rando, TA; Richardson, A; Schadt, EE; Wyss-Coray, T; Sierra, F				Kennedy, Brian K.; Berger, Shelley L.; Brunet, Anne; Campisi, Judith; Cuervo, Ana Maria; Epel, Elissa S.; Franceschi, Claudio; Lithgow, Gordon J.; Morimoto, Richard I.; Pessin, Jeffrey E.; Rando, Thomas A.; Richardson, Arlan; Schadt, Eric E.; Wyss-Coray, Tony; Sierra, Felipe			Geroscience: Linking Aging to Chronic Disease	CELL			English	Editorial Material							LIFE-SPAN; LONGEVITY; CELLS	Mammalian aging can be delayed with genetic, dietary, and pharmacologic approaches. Given that the elderly population is dramatically increasing and that aging is the greatest risk factor for a majority of chronic diseases driving both morbidity and mortality, it is critical to expand geroscience research directed at extending human healthspan.	[Kennedy, Brian K.; Campisi, Judith; Lithgow, Gordon J.] Buck Inst Res Aging, Novato, CA USA; [Berger, Shelley L.] Univ Penn, Perelman Sch Med, Penn Epigenet Program, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Biol, Philadelphia, PA 19104 USA; [Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Brunet, Anne; Rando, Thomas A.] Stanford Univ, Glenn Ctr Biol Aging, Stanford, CA 94305 USA; [Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA; [Epel, Elissa S.] Univ Calif San Francisco, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; [Franceschi, Claudio] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy; [Franceschi, Claudio] Univ Bologna, CIG, Interdept Ctr L Galvani Integrated Studies Bioinf, Bologna 3, Italy; [Franceschi, Claudio] Univ Bologna, Dept Expt Diagnost & Specialty Med, DIMES, Bologna 3, Italy; [Morimoto, Richard I.] Northwestern Univ, Rice Inst Biomed Res, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10461 USA; [Rando, Thomas A.; Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rando, Thomas A.; Wyss-Coray, Tony] Vet Adm Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA 94304 USA; [Richardson, Arlan] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Richardson, Arlan] Oklahoma City VA Med Ctr, Oklahoma City, OK 73104 USA; [Schadt, Eric E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Schadt, Eric E.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Sierra, Felipe] NIA, Div Aging Biol, Bethesda, MD 20892 USA	Buck Institute for Research on Aging; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna; Northwestern University; Yeshiva University; Albert Einstein College of Medicine; Stanford University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kennedy, BK (corresponding author), Buck Inst Res Aging, Novato, CA USA.	bkennedy@buckinstitute.org	Wyss-Coray, Tony/AAF-3380-2019; Franceschi, Claudio/L-4484-2017	Wyss-Coray, Tony/0000-0001-5893-0831; Franceschi, Claudio/0000-0001-9841-6386; Rando, Thomas/0000-0001-5843-8564; Kennedy, Brian/0000-0002-5754-1874; Cuervo, Ana Maria/0000-0002-0771-700X; Berger, Shelley/0000-0001-5398-4400	NATIONAL INSTITUTE ON AGING [R01AG043080, R01AG033373, P01AG031782, P01AG036695, R01AG024287] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Deelen J, 2013, BIOESSAYS, V35, P386, DOI 10.1002/bies.201200148; Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170; Heintz C, 2014, CELL, V156, P408, DOI 10.1016/j.cell.2014.01.025; Kennedy BK, 2014, TRANSL RES, V163, P456, DOI 10.1016/j.trsl.2013.11.007; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mahmoudi S, 2012, CURR OPIN CELL BIOL, V24, P744, DOI 10.1016/j.ceb.2012.10.004; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168; Pawelec G, 2012, CURR OPIN IMMUNOL, V24, P507, DOI 10.1016/j.coi.2012.04.002; Rando TA, 2014, J GERONTOL A-BIOL, V69, pS39, DOI 10.1093/gerona/glu043; Robison LL, 2014, NAT REV CANCER, V14, P61, DOI 10.1038/nrc3634; Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675	14	1041	1058	4	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					708	712		10.1016/j.cell.2014.10.039	http://dx.doi.org/10.1016/j.cell.2014.10.039			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417146	Bronze, Green Accepted			2022-12-28	WOS:000344522000002
J	Okabe, K; Kobayashi, S; Yamada, T; Kurihara, T; Tai-Nagara, I; Miyamoto, T; Mukouyama, YS; Sato, TN; Suda, T; Ema, M; Kubota, Y				Okabe, Keisuke; Kobayashi, Sakiko; Yamada, Toru; Kurihara, Toshihide; Tai-Nagara, Ikue; Miyamoto, Takeshi; Mukouyama, Yoh-suke; Sato, Thomas N.; Suda, Toshio; Ema, Masatsugu; Kubota, Yoshiaki			Neurons Limit Angiogenesis by Titrating VEGF in Retina	CELL			English	Article							BAC TG MICE; PROGENITOR CELLS; VASCULAR DEVELOPMENT; ENDOTHELIAL-CELLS; GROWTH; MOUSE; MORPHOGENESIS; RECEPTOR; EXPRESSION; SURVIVAL	Vascular and nervous systems, two major networks in mammalian bodies, show a high degree of anatomical parallelism and functional crosstalk. During development, neurons guide and attract blood vessels, and consequently this parallelism is established. Here, we identified a noncanonical neurovascular interaction in eye development and disease. VEGFR2, a critical endothelial receptor for VEGF, was more abundantly expressed in retinal neurons than in endothelial cells, including endothelial tip cells. Genetic deletion of VEGFR2 in neurons caused misdirected angiogenesis toward neurons, resulting in abnormally increased vascular density around neurons. Further genetic experiments revealed that this misdirected angiogenesis was attributable to an excessive amount of VEGF protein around neurons caused by insufficient engulfment of VEGF by VEGFR2-deficient neurons. Moreover, absence of neuronal VEGFR2 caused misdirected regenerative angiogenesis in ischemic retinopathy. Thus, this study revealed neurovascular crosstalk and unprecedented cellular regulation of VEGF: retinal neurons titrate VEGF to limit neuronal vascularization.	[Okabe, Keisuke; Kobayashi, Sakiko; Yamada, Toru; Tai-Nagara, Ikue; Kubota, Yoshiaki] Keio Univ, Sch Med, Lab Vasc Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Okabe, Keisuke] Keio Univ, Sch Med, Dept Plast Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Yamada, Toru] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Kurihara, Toshihide] Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo 1608582, Japan; [Kurihara, Toshihide] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab,Shinjuku Ku, Tokyo 1608582, Japan; [Mukouyama, Yoh-suke] NHLBI, Lab Stem Cell & Neurovasc Biol, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Sato, Thomas N.] Japan Sci & Technol Agcy, ERATO Sato Live Bioforecasting Project, Kyoto 6190288, Japan; [Sato, Thomas N.] Adv Telecommun Res Inst Int, Kyoto 6190288, Japan; [Sato, Thomas N.] Dept Biomed Engn, Ithaca, NY 14850 USA; [Sato, Thomas N.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Sato, Thomas N.] Centenary Inst, Sydney, NSW 2050, Australia; [Ema, Masatsugu] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Otsu, Shiga 5202192, Japan	Keio University; Keio University; Keio University; Keio University; Keio University; Keio University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Japan Science & Technology Agency (JST); Advanced Telecommunications Research Institute International; Nara Institute of Science & Technology; University of Sydney; Centenary Institute; Shiga University of Medical Science	Kubota, Y (corresponding author), Keio Univ, Sch Med, Lab Vasc Biol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	ykubo33@a3.keio.jp	Kurihara, Toshihide/ABA-7058-2020; Suda, Toshio/H-6761-2013	Kurihara, Toshihide/0000-0002-5457-2720; Suda, Toshio/0000-0001-7540-1771; Mukouyama, Yoh-suke/0000-0002-9084-4922; Ema, Masatsugu/0000-0003-0645-6183	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Kanae Foundation; Mochida Memorial Foundation; SENSHIN Medical Research Foundation; Daiichi Sankyo Foundation of Life Science; Naito Foundation; Grants-in-Aid for Scientific Research [26221309] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006115] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanae Foundation; Mochida Memorial Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Daiichi Sankyo Foundation of Life Science; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Toshihiro Nagai and Naoko Numata (Keio University) for their technical supports, and Institute of Immunology (Utsunomiya, Japan) for helping us generate some of the mutant mice. This work was supported by Grants-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by a research grant from Takeda Science Foundation, The Kanae Foundation, The Mochida Memorial Foundation, SENSHIN Medical Research Foundation, Daiichi Sankyo Foundation of Life Science, and The Naito Foundation.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Bellon A, 2010, NEURON, V66, P205, DOI 10.1016/j.neuron.2010.04.006; Binet F, 2013, CELL METAB, V17, P353, DOI 10.1016/j.cmet.2013.02.003; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Ema M, 2006, BLOOD, V108, P4018, DOI 10.1182/blood-2006-03-012872; Erskine L, 2011, NEURON, V70, P951, DOI 10.1016/j.neuron.2011.02.052; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Ishitobi H, 2011, DEVELOPMENT, V138, P5357, DOI 10.1242/dev.065565; Ishitobi H, 2010, EXP ANIM TOKYO, V59, P615, DOI 10.1538/expanim.59.615; Kubo F, 2005, DEVELOPMENT, V132, P2759, DOI 10.1242/dev.01856; Kubota Y, 2011, J EXP MED, V208, P949, DOI 10.1084/jem.20102187; Kurihara T, 2010, DEVELOPMENT, V137, P1563, DOI 10.1242/dev.049015; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lang RA, 1997, CELL DEATH DIFFER, V4, P12, DOI 10.1038/sj.cdd.4400211; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; LILLIEN L, 1992, DEVELOPMENT, V115, P253; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Luo L, 2013, ELIFE, V2, DOI 10.7554/eLife.00324; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Matsumoto K, 2012, GENESIS, V50, P561, DOI 10.1002/dvg.22031; Milde F, 2013, INTEGR BIOL-UK, V5, P1426, DOI 10.1039/c3ib40085a; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Nakamura-Ishizu A, 2012, DEV BIOL, V363, P106, DOI 10.1016/j.ydbio.2011.12.027; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Ryan HE, 2000, CANCER RES, V60, P4010; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Yang XJ, 1996, J NEUROSCI, V16, P6089; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	50	173	175	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					584	596		10.1016/j.cell.2014.09.025	http://dx.doi.org/10.1016/j.cell.2014.09.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417109	Bronze			2022-12-28	WOS:000344521700014
J	Rutherford, MJ				Rutherford, Mark J.			Care needed in interpretation of cancer survival measures	LANCET			English	Editorial Material							MORTALITY		Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England	University of Leicester	Rutherford, MJ (corresponding author), Univ Leicester, Dept Hlth Sci, Univ Rd, Leicester LE1 7RH, Leics, England.	mark.rutherford@le.ac.uk		Rutherford, Mark/0000-0003-1557-6697	Cancer Research UK [13275] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Borland S, 2014, HALF CANC PATIENTS A; Boseley S, 2014, CANC SURVIVAL RATES; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Cronin KA, 2000, STAT MED, V19, P1729, DOI 10.1002/1097-0258(20000715)19:13<1729::AID-SIM484>3.0.CO;2-9; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Dickman PW, 2006, J INTERN MED, V260, P103, DOI 10.1111/j.1365-2796.2006.01677.x; Ellis L, 2014, INT J CANCER, V135, P1774, DOI 10.1002/ijc.28990; Eloranta S, 2013, CANCER CAUSE CONTROL, V24, P505, DOI 10.1007/s10552-012-0141-5; Lambert PC, 2010, STAT MED, V29, P885, DOI 10.1002/sim.3762; Lambert PC, 2011, CANCER EPIDEMIOL, V35, P526, DOI 10.1016/j.canep.2011.04.003; Perme MP, 2012, BIOMETRICS, V68, P113, DOI 10.1111/j.1541-0420.2011.01640.x; Quaresma M, 2014, LANCET	12	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1162	1163		10.1016/S0140-6736(14)62292-3	http://dx.doi.org/10.1016/S0140-6736(14)62292-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CE3GQ	25479695	Green Submitted			2022-12-28	WOS:000351715100010
J	Hashimshony, T; Feder, M; Levin, M; Hall, BK; Yanai, I				Hashimshony, Tamar; Feder, Martin; Levin, Michal; Hall, Brian K.; Yanai, Itai			Spatiotemporal transcriptomics reveals the evolutionary history of the endoderm germ layer	NATURE			English	Article							C-ELEGANS EMBRYOS; GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; INDUCTION; ORIGIN; MUSCLE; GUT; DIFFERENTIATION; INTESTINE; MESODERM	The concept of germ layers has been one of the foremost organizing principles in developmental biology, classification, systematics and evolution for 150 years (refs 1-3). Of the three germ layers, the mesoderm is found in bilaterian animals but is absent in species in the phyla Cnidaria and Ctenophora, which has been taken as evidence that the mesoderm was the final germ layer to evolve(1,4,5). The origin of the ectoderm and endoderm germ layers, however, remains unclear, with models supporting the antecedence of each as well as a simultaneous origin(4,6-9). Here we determine the temporal and spatial components of gene expression spanning embryonic development for all Caenorhabditis elegans genes and use it to determine the evolutionary ages of the germ layers. The gene expression program of the mesoderm is induced after those of the ectoderm and endoderm, thus making it the last germ layer both to evolve and to develop. Strikingly, the C. elegans endoderm and ectoderm expression programs do not co-induce; rather the endoderm activates earlier, and this is also observed in the expression of endoderm orthologues during the embryology of the frog Xenopus tropicalis, the sea anemone Nema-tostella vectensis and the sponge Amphimedon queenslandica. Querying the phylogenetic ages of specifically expressed genes reveals that the endoderm comprises older genes. Taken together, we propose that the endoderm program dates back to the origin of multicellularity, whereas the ectoderm originated as a secondary germ layer freed from ancestral feeding functions.	[Hashimshony, Tamar; Feder, Martin; Levin, Michal; Yanai, Itai] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Hall, Brian K.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada	Technion Israel Institute of Technology; Dalhousie University	Yanai, I (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	yanai@technion.ac.il		Levin, Michal/0000-0003-3484-890X; Yanai, Itai/0000-0002-8438-2741	European Research Council grant (EvoDevoPaths); EMBO Young Investigator Program	European Research Council grant (EvoDevoPaths); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO))	We acknowledge the contribution of computational analyses by D. H. Silver, L. Anavy and F. Wagner in an early stage of this project. We also acknowledge advice from B. Degnan, A. Cole, M. Adamska and A. Polsky. We thank the Technion Genome Center for technical assistance. This work was supported by a European Research Council grant (EvoDevoPaths) and the EMBO Young Investigator Program.	Anavy L, 2014, DEVELOPMENT, V141, P1161, DOI 10.1242/dev.105288; [Anonymous], 2011, PRINCIPLES DEV; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Burtschli O., 1884, MORPH JB, V18, P415; Buss LW, 1987, EVOLUTION INDIVIDUAL, DOI DOI 10.1515/9781400858712; COWAN AE, 1985, CELL, V41, P923, DOI 10.1016/S0092-8674(85)80073-8; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; Edgar LG, 2012, METHOD CELL BIOL, V107, P153, DOI 10.1016/B978-0-12-394620-1.00005-9; Fischer Steve, 2011, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0612s35; Fox RM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r188; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; GOLDSTEIN B, 1993, DEVELOPMENT, V118, P1267; GOLDSTEIN B, 1995, DEVELOPMENT, V121, P1227; GOLDSTEIN B, 1992, NATURE, V357, P255, DOI 10.1038/357255a0; Good K, 2004, DEVELOPMENT, V131, P1967, DOI 10.1242/dev.01088; Gould S. J., 1977, ONTOGENY PHYLOGENY; Guberman Jonathan M, 2011, Database (Oxford), V2011, pbar041, DOI 10.1093/database/bar041; Haeckel E., 1874, JENAISCHE Z NATURWIS, P1; Hall B.K., 1998, EVOLUTIONARY DEV BIO; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Helm RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-266; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; LAUFER JS, 1980, CELL, V19, P569, DOI 10.1016/S0092-8674(80)80033-X; Leininger S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4905; Levin M, 2012, DEV CELL, V22, P1101, DOI 10.1016/j.devcel.2012.04.004; Leys SP, 2012, J EXP ZOOL PART B, V318B, P438, DOI 10.1002/jez.b.21442; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Nakanishi N, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-26; Neves A, 2005, DEV CELL, V8, P867, DOI 10.1016/j.devcel.2005.03.012; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Pryszcz LP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq953; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Schwarz EM, 2006, NUCLEIC ACIDS RES, V34, pD475, DOI 10.1093/nar/gkj061; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Technau U, 2003, INT J DEV BIOL, V47, P531; VALENTINE JW, 2004, ORIGIN PHYLA; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015	46	97	98	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 12	2015	519	7542					219	+		10.1038/nature13996	http://dx.doi.org/10.1038/nature13996			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD0NH	25487147	Green Accepted			2022-12-28	WOS:000350770500036
J	Braunwald, E				Braunwald, Eugene			The war against heart failure: the Lancet lecture	LANCET			English	Review							VENTRICULAR ASSIST DEVICE; MECHANICAL CIRCULATORY SUPPORT; MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; CALCIUM UP-REGULATION; CARDIOSPHERE-DERIVED CELLS; BONE-MARROW-CELLS; GENE-THERAPY; SARCOPLASMIC-RETICULUM; ISCHEMIC CARDIOMYOPATHY	Heart failure is a global problem with an estimated prevalence of 38 million patients worldwide, a number that is increasing with the ageing of the population. It is the most common diagnosis in patients aged 65 years or older admitted to hospital and in high-income nations. Despite some progress, the prognosis of heart failure is worse than that of most cancers. Because of the seriousness of the condition, a declaration of war on five fronts has been proposed for heart failure. Efforts are underway to treat heart failure by enhancing myofilament sensitivity to Ca2+; transfer of the gene for SERCA2a, the protein that pumps calcium into the sarcoplasmic reticulum of the cardiomyocyte, seems promising in a phase 2 trial. Several other abnormal calcium-handling proteins in the failing heart are candidates for gene therapy; many short, non-coding RNAs-ie, microRNAs (miRNAs)-block gene expression and protein translation. These molecules are crucial to calcium cycling and ventricular hypertrophy. The actions of miRNAs can be blocked by a new class of drugs, antagomirs, some of which have been shown to improve cardiac function in animal models of heart failure; cell therapy, with autologous bone marrow derived mononuclear cells, or autogenous mesenchymal cells, which can be administered as cryopreserved off the shelf products, seem to be promising in both preclinical and early clinical heart failure trials; and long-term ventricular assistance devices are now used increasingly as a destination therapy in patients with advanced heart failure. In selected patients, left ventricular assistance can lead to myocardial recovery and explantation of the device. The approaches to the treatment of heart failure described, when used alone or in combination, could become important weapons in the war against heart failure.	[Braunwald, Eugene] Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Boston, MA 02115 USA; [Braunwald, Eugene] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Braunwald, E (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	ebraunwald@partners.org						Acimovic I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/512831; Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; [Anonymous], 2012, COCHRANE DB SYST REV; Ascheim DD, 2014, CIRCULATION, V129, P2287, DOI 10.1161/CIRCULATIONAHA.113.007412; Assmus B, 2014, EUR HEART J, V35, P1275, DOI 10.1093/eurheartj/ehu062; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; Beeri R, 2010, CIRC-HEART FAIL, V3, P627, DOI 10.1161/CIRCHEARTFAILURE.109.891184; Belevych AE, 2011, CARDIOVASC RES, V90, P493, DOI 10.1093/cvr/cvr025; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bennett MK, 2014, CIRC-HEART FAIL, V7, P612, DOI 10.1161/CIRCHEARTFAILURE.113.000849; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bers DM, 2013, J MOL CELL CARDIOL, V58, P59, DOI 10.1016/j.yjmcc.2013.01.002; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; Birks EJ, 2013, CIRC RES, V113, P777, DOI 10.1161/CIRCRESAHA.113.301413; Birks EJ, 2012, J THORAC CARDIOV SUR, V144, P190, DOI 10.1016/j.jtcvs.2012.03.021; Birks EJ, 2011, CIRCULATION, V123, P381, DOI 10.1161/CIRCULATIONAHA.109.933960; Bretzner F, 2011, CELL STEM CELL, V8, P468, DOI 10.1016/j.stem.2011.04.012; Brinks H, 2011, J AM COLL CARDIOL, V58, P966, DOI 10.1016/j.jacc.2011.03.054; Brinks H, 2010, J CARDIOVASC TRANSL, V3, P499, DOI 10.1007/s12265-010-9206-6; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; BURCH GE, 1965, CIRCULATION, V32, P852, DOI 10.1161/01.CIR.32.5.852; Byrne MJ, 2008, GENE THER, V15, P1550, DOI 10.1038/gt.2008.120; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castaldi A, 2014, CIRC RES, V115, P273, DOI 10.1161/CIRCRESAHA.115.303252; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; Cleland JGF, 2011, HEART, V97, P876, DOI 10.1136/hrt.2010.209171; Condorelli G, 2014, J AM COLL CARDIOL, V63, P2177, DOI 10.1016/j.jacc.2014.01.050; Dandel M, 2012, CIRCULATION, V126, pS9, DOI 10.1161/CIRCULATIONAHA.111.084640; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; Dipla K, 1998, CIRCULATION, V97, P2316, DOI 10.1161/01.CIR.97.23.2316; EGHBALI M, 1991, P NATL ACAD SCI USA, V88, P795, DOI 10.1073/pnas.88.3.795; Emmert MY, 2014, ADV DRUG DELIVER REV, V69, P254, DOI 10.1016/j.addr.2013.12.004; Engelhardt S, 2004, CIRCULATION, V109, P1154, DOI 10.1161/01.CIR.0000117254.68497.39; Feldman D, 2013, J HEART LUNG TRANSPL, V32, P157, DOI 10.1016/j.healun.2012.09.013; Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847; Frazier OH, 1996, ANN THORAC SURG, V62, P675, DOI 10.1016/S0003-4975(96)00437-7; Frazier OH, 1999, ANN THORAC SURG, V68, P734, DOI 10.1016/S0003-4975(99)00801-2; Ganesh SK, 2013, CIRCULATION, V128, P2813, DOI 10.1161/01.cir.0000437913.98912.1d; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Greenberg B, 2014, JACC-HEART FAIL, V2, P84, DOI 10.1016/j.jchf.2013.09.008; Guha K, 2013, CURR CARDIOL REV, V9, P123, DOI 10.2174/1573403X11309020005; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Hata JA, 2004, J MOL CELL CARDIOL, V37, P11, DOI 10.1016/j.yjmcc.2004.03.014; Heldman AW, 2014, JAMA-J AM MED ASSOC, V311, P62, DOI 10.1001/jama.2013.282909; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; HILL JD, 1989, ANN THORAC SURG, V47, P167, DOI 10.1016/0003-4975(89)90259-2; Huffman MD, 2010, NATL MED J INDIA, V23, P283; JACOBSON LO, 1950, J LAB CLIN MED, V35, P746; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jaski BE, 2009, J CARD FAIL, V15, P171, DOI 10.1016/j.cardfail.2009.01.013; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Jeune VL, 2013, HUM GENE THER METHOD, V24, P59, DOI 10.1089/hgtb.2012.243; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Kaye DM, 2007, J AM COLL CARDIOL, V50, P253, DOI 10.1016/j.jacc.2007.03.047; Khazanie P, 2014, J AM COLL CARDIOL, V63, P1395, DOI 10.1016/j.jacc.2013.12.020; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Kirklin JK, 2012, J THORAC CARDIOV SUR, V144, P584, DOI 10.1016/j.jtcvs.2012.05.044; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226; Kumarswamy R, 2012, EUR HEART J, V33, P1067, DOI 10.1093/eurheartj/ehs043; Lai NC, 2004, CIRCULATION, V110, P330, DOI 10.1161/01.CIR.0000136033.21777.4D; Lala A, 2014, CIRC J, V78, P288, DOI 10.1253/circj.CJ-13-1498; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lenneman Andrew J, 2014, Curr Treat Options Cardiovasc Med, V16, P287, DOI 10.1007/s11936-013-0287-9; LEVIN HR, 1995, CIRCULATION, V91, P2717, DOI 10.1161/01.CIR.91.11.2717; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Li RK, 1996, ANN THORAC SURG, V62, P654; Liem DA, 2014, CIRC-HEART FAIL, V7, P359, DOI 10.1161/CIRCHEARTFAILURE.113.000250; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Mann DL, 2012, J AM COLL CARDIOL, V60, P2465, DOI 10.1016/j.jacc.2012.06.062; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Marx SO, 2013, J MOL CELL CARDIOL, V58, P225, DOI 10.1016/j.yjmcc.2013.03.005; Matkovich SJ, 2012, CIRC RES, V111, P521, DOI 10.1161/CIRCRESAHA.112.265736; Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209; Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Melman YF, 2014, CIRC-HEART FAIL, V7, P203, DOI 10.1161/CIRCHEARTFAILURE.113.000266; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Miller N, 2012, NAT REV DRUG DISCOV, V11, DOI 10.1038/nrd3572-c1; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Mohsin S, 2013, CIRC RES, V113, P1169, DOI 10.1161/CIRCRESAHA.113.302302; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Muller J, 1997, CIRCULATION, V96, P542; Nichols M, 2013, EUR HEART J, V34, P3017, DOI 10.1093/eurheartj/eht159; Opie LH, 2015, BRAUNWALDS HEART DIS, P429; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ott Harald C, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS27, DOI 10.1038/ncpcardio0771; Perin EC, 2014, AM HEART J, V168, P88, DOI 10.1016/j.ahj.2014.03.022; Pfister O, 2014, TRANSL RES, V163, P307, DOI 10.1016/j.trsl.2013.12.005; Phillips MI, 2014, CELL CYCLE, V13, P1519, DOI 10.4161/cc.28894; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Pleger ST, 2007, CIRCULATION, V115, P2506, DOI 10.1161/CIRCULATIONAHA.106.671701; Pleger ST, 2014, CIRC RES, V114, P12, DOI 10.1161/CIRCRESAHA.113.302748; Pleger ST, 2013, CIRC RES, V113, P792, DOI 10.1161/CIRCRESAHA.113.300269; Pokorny M, 2014, PHYSIOL RES, V63, P147, DOI 10.33549/physiolres.932617; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; Raake PWJ, 2013, EUR HEART J, V34, P1437, DOI 10.1093/eurheartj/ehr447; Respress JL, 2012, CIRC RES, V110, P1474, DOI 10.1161/CIRCRESAHA.112.268094; Ritterhoff J, 2012, GENE THER, V19, P613, DOI 10.1038/gt.2012.8; Rodrigue-Way A, 2005, J HEART LUNG TRANSPL, V24, P73, DOI 10.1016/j.healun.2003.10.016; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Sedej S, 2014, J AM COLL CARDIOL, V63, P1569, DOI 10.1016/j.jacc.2013.11.010; Shah AS, 2000, CIRCULATION, V101, P408, DOI 10.1161/01.CIR.101.4.408; Slaughter MS, 2013, J HEART LUNG TRANSPL, V32, P675, DOI 10.1016/j.healun.2013.04.004; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Smolina K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8059; Starling RC, 2014, NEW ENGL J MED, V370, P33, DOI 10.1056/NEJMoa1313385; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang T, 2012, GENE THER, V19, P606, DOI 10.1038/gt.2012.36; Telukuntla KS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000338; Thum T, 2011, J CLIN INVEST, V121, P461, DOI 10.1172/JCI45938; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Torre-Amione G, 1999, CIRCULATION, V100, P1189, DOI 10.1161/01.CIR.100.11.1189; van Rijsingen IAW, 2014, CIRC-CARDIOVASC GENE, V7, P455, DOI 10.1161/CIRCGENETICS.113.000374; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; VanMeter CH, 1996, ANN THORAC SURG, V62, P660; Vigen Rebecca, 2012, Curr Heart Fail Rep, V9, P369, DOI 10.1007/s11897-012-0114-8; Vogel B, 2013, EUR HEART J, V34, P2812, DOI 10.1093/eurheartj/eht256; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang HX, 2014, CELL REP, V6, P951, DOI 10.1016/j.celrep.2014.01.038; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xiong Q, 2013, CIRCULATION, V127, P997, DOI 10.1161/CIRCULATIONAHA.112.000641; Yacoub MH, 2001, EUR HEART J, V22, P534, DOI 10.1053/euhj.2001.2613; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Zhang L, 2014, CELL CYCLE, V13, P762, DOI 10.4161/cc.27677; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zsebo K, 2014, CIRC RES, V114, P101, DOI 10.1161/CIRCRESAHA.113.302421	159	520	556	3	171	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 28	2015	385	9970					812	824		10.1016/S0140-6736(14)61889-4	http://dx.doi.org/10.1016/S0140-6736(14)61889-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC0UD	25467564				2022-12-28	WOS:000350051700036
J	Joordens, JCA; d'Errico, F; Wesselingh, FP; Munro, S; de Vos, J; Wallinga, J; Ankjaergaard, C; Reimann, T; Wijbrans, JR; Kuiper, KF; Mucher, HJ; Coqueugniot, H; Prie, V; Joosten, I; van Os, B; Schulp, AS; Panuel, M; van der Haas, V; Lustenhouwer, W; Reijmer, JJG; Roebroeks, W				Joordens, Josephine C. A.; d'Errico, Francesco; Wesselingh, Frank P.; Munro, Stephen; de Vos, John; Wallinga, Jakob; Ankjaergaard, Christina; Reimann, Tony; Wijbrans, Jan R.; Kuiper, Klaudia F.; Muecher, Herman J.; Coqueugniot, Helene; Prie, Vincent; Joosten, Ineke; van Os, Bertil; Schulp, Anne S.; Panuel, Michel; van der Haas, Victoria; Lustenhouwer, Wim; Reijmer, John J. G.; Roebroeks, Wil			Homo erectus at Trinil on Java used shells for tool production and engraving	NATURE			English	Article							LUMINESCENCE SIGNALS; QUARTZ; AGE; SEDIMENTS; SANGIRAN; RECORD; RATES	The manufacture of geometric engravings is generally interpreted as indicative of modern cognition and behaviour(1). Key questions in the debate on the origin of such behaviour are whether this innovation is restricted to Homo sapiens, and whether it has a uniquely African origin(1). Here we report on a fossil freshwater shell assemblage from the Hauptknochenschicht ('main bone layer') of Trinil (Java, Indonesia), the type locality of Homo erectus discovered by Eugene Dubois in 1891 (refs 2 and 3). In the Dubois collection(in the Naturalis museum, Leiden, The Netherlands) we found evidence for freshwater shellfish consumption by hominins, one unambiguous shell tool, and a shell with a geometric engraving. We dated sediment contained in the shells with Ar-40/Ar-39 and luminescence dating methods, obtaining a maximum age of 0.54 +/- 0.10 million years and a minimum age of 0.43 +/- 0.05 million years. This implies that the Trinil Hauptkno-chenschicht is younger than previously estimated. Together, our data indicate that the engraving was made by Homo erectus, and that it is considerably older than the oldest geometric engravings described so far(4,5). Although it is at present not possible to assess the function or meaning of the engraved shell, this discovery suggests that engraving abstract patterns was in the realm of Asian Homo erectus cognition and neuromotor control.	[Joordens, Josephine C. A.; Muecher, Herman J.; van der Haas, Victoria; Roebroeks, Wil] Leiden Univ, Fac Archaeol, NL-2300 RA Leiden, Netherlands; [Joordens, Josephine C. A.; Wijbrans, Jan R.; Kuiper, Klaudia F.; Schulp, Anne S.; Lustenhouwer, Wim; Reijmer, John J. G.] Vrije Univ Amsterdam, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands; [d'Errico, Francesco; Coqueugniot, Helene] Univ Bordeaux, CNRS, UMR 5199, F-33615 Pessac, France; [d'Errico, Francesco] Univ Bergen, Inst Archaeol Hist Cultural Studies & Relig, Bergen, Norway; [Wesselingh, Frank P.; de Vos, John; Schulp, Anne S.] Naturalis Biodivers Ctr, NL-2300 RA Leiden, Netherlands; [Munro, Stephen] Australian Natl Univ, Sch Archaeol & Anthropol, Canberra, ACT 0200, Australia; [Munro, Stephen] Natl Museum Australia, Canberra, ACT 2601, Australia; [Wallinga, Jakob; Ankjaergaard, Christina; Reimann, Tony] Wageningen Univ, Soil Geog & Landscape Grp, NL-6700 AA Wageningen, Netherlands; [Wallinga, Jakob; Ankjaergaard, Christina; Reimann, Tony] Wageningen Univ, Netherlands Ctr Luminescence Dating, NL-6700 AA Wageningen, Netherlands; [Wallinga, Jakob; Ankjaergaard, Christina; Reimann, Tony] Delft Univ Technol, Fac Sci Appl, NL-2629 JB Delft, Netherlands; [Prie, Vincent] Museum Natl Hist Nat, Inst Systemat, UMR 7205, CP51, F-75005 Paris, France; [Prie, Vincent] Biotope Rech & Dev, F-34140 Meze, France; [Joosten, Ineke; van Os, Bertil] Cultural Heritage Agcy Netherlands, NL-3800 BP Amersfoort, Netherlands; [Schulp, Anne S.] Nat Hist Museum Maastricht, NL-6211 KJ Maastricht, Netherlands; [Panuel, Michel] Univ Aix Marseille, CNRS, Fac Med, EFS,UMR 7268, F-13344 Marseille, France; [Panuel, Michel] Hop Nord Marseille, Assistance Publ Hop Marseille, Dept Med Imaging, F-13915 Marseille, France	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Bergen; Naturalis Biodiversity Center; Australian National University; Wageningen University & Research; Wageningen University & Research; Delft University of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Joordens, JCA (corresponding author), Leiden Univ, Fac Archaeol, POB 9515, NL-2300 RA Leiden, Netherlands.	j.c.a.joordens@arch.leidenuniv.nl	Prié, Vincent/AAH-1189-2019; Schulp, Anne/AAM-9015-2020; Wijbrans, J.R./M-6067-2019; Wesselingh, Frank/C-1367-2018; Reijmer, John/B-5000-2009; Reijmer, John J.G./M-9759-2019; Wijbrans, Jan/Q-1914-2016; Wallinga, Jakob/J-4046-2017	Prié, Vincent/0000-0002-6261-3270; Schulp, Anne/0000-0001-9389-1540; Wesselingh, Frank/0000-0003-3655-0701; Reijmer, John/0000-0001-5807-1256; Reijmer, John J.G./0000-0001-5807-1256; Wijbrans, Jan/0000-0002-8091-1239; Wallinga, Jakob/0000-0003-4061-3066; van Os, Bertil/0000-0003-1739-1696; Roebroeks, Wil/0000-0002-5075-6899; Ankjaergaard, Christina/0000-0001-5620-6663; Reimann, Tony/0000-0001-7948-5159; Joordens, Josephine/0000-0002-5757-1168	Netherlands Organization for Scientific Research NWO [28-548, 825.11.03]; European Research Council [TRACSYMBOLS 249587]; STW Technology Foundation [STW.10502]	Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); STW Technology Foundation	We thank colleagues O. F. Huffman, P. Albers, R. Dennell, M. Martinon-Torres, G. Cadee, O. Dutour, K. M. Cohen, P. deBoer, A. van Gijn, C. Hofman, Y. Lammers-Keijsers, A. C. Sorensen, W. Renema, R. Moolenbeek, R. van Zelst, C. A. Johns, A. J. Versendaal, E. Voskuilen, T. G. van Meerten, R. van Elsas, H. Vonhof, S. Kars, W. Koot, P. Bouchet, V. Heros, J. W. Dogger, L. Dekkers, B. Dutailly, G. Devilder and J. Porck. J.C.A.J., W. R. and T. R. acknowledge financial support from the Netherlands Organization for Scientific Research NWO (Open Programme Grant to J.C.A.J., Spinoza Grant 28-548 to W. R. and Rubicon Grant 825.11.03 to T. R.). F.d'E. acknowledges financial support from the European Research Council (FP7/2007/2013, TRACSYMBOLS 249587), and C. A. acknowledges financial support from the STW Technology Foundation (STW.10502).	Aitken MJ, 1985, THERMOLUMINESCENCE D; Alexanderson H, 2012, QUAT GEOCHRONOL, V10, P250, DOI 10.1016/j.quageo.2012.01.001; Ankjaergaard C, 2013, QUAT GEOCHRONOL, V18, P99, DOI 10.1016/j.quageo.2013.06.001; Antczak A, 2005, CARIBBEAN MARINE BIO, P213; Bello SM, 2008, J ARCHAEOL SCI, V35, P1542, DOI 10.1016/j.jas.2007.10.018; Benyarku C. A., 2005, GUIDELINES FOR PREPA, V33; Buylaert JP, 2012, BOREAS, V41, P435, DOI 10.1111/j.1502-3885.2012.00248.x; Carlton JT, 2003, MAR ECOL PROG SER, V256, P271, DOI 10.3354/meps256271; Choi K, 2007, J ARCHAEOL SCI, V34, P48, DOI 10.1016/j.jas.2006.03.013; Claassen C., 1998, SHELLS; Cristiani E., 2005, FROM HOOVES TO HORNS, V15, P319; Solana DC, 2010, TRABAJOS PREHIST, V67, P211, DOI 10.3989/tp.2010.10037; Cunningham AC, 2011, GEOLOGY, V39, P1063, DOI 10.1130/G32244.1; d'Errico F., 1993, TRACES FONCTION GEST, V50, P243; d'Errico F., 1995, LART GRAVE AZILIEN D; d'Errico F, 2012, J ARCHAEOL SCI, V39, P942, DOI 10.1016/j.jas.2011.10.032; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; Dennell R., 2009, THE PALAEOLITHIC SET; Douka K, 2012, J WORLD PREHIST, V25, P45, DOI 10.1007/s10963-012-9056-z; Dubois E., 1894, PITHECANTHROPUS EREC; Dubois E., 1908, TIJDSCHR KON NED A 2, V25, P1235; Duller GAT, 2012, QUAT GEOCHRONOL, V7, P6, DOI 10.1016/j.quageo.2011.09.003; Dutailly B, 2009, IEEE IMAGE PROC, P2505, DOI 10.1109/ICIP.2009.5413911; Fritz C., 1999, LA GRAVURE DANS LART, V75; Guerin G., 2011, ANCIENT TL, V29, P5; Gumert MD, 2012, AM J PHYS ANTHROPOL, V149, P447, DOI 10.1002/ajpa.22143; Henshilwood C. S., 2011, HOMOSYMBOLICUS DAWN, P75; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Huffman O. F., 2012, QUAT INT SPEC ISSUE, p[279, 210]; Huffman OF, 2006, J HUM EVOL, V50, P431, DOI 10.1016/j.jhevol.2005.11.002; Huntley D.J., 2001, ANCIENT TL, V19, P43; Huntley D.J., 1997, ANCIENT TL, V15, P11; Hyodo M, 2011, P NATL ACAD SCI USA, V108, P19563, DOI 10.1073/pnas.1113106108; Indriati E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021562; Jain M, 2009, RADIAT MEAS, V44, P445, DOI 10.1016/j.radmeas.2009.03.011; Jongerius A., 1963, THE PREPARATION OF M; Joordens JCA, 2009, J HUM EVOL, V57, P656, DOI 10.1016/j.jhevol.2009.06.003; Joordens JCA, 2013, J HUM EVOL, V65, P731, DOI 10.1016/j.jhevol.2013.09.002; Jutting T. van B., 1937, Zoologische Mededeelingen Leiden, V20, P83; Kars RH, 2012, QUAT GEOCHRONOL, V12, P74, DOI 10.1016/j.quageo.2012.05.001; Koppers AAP, 2002, COMPUT GEOSCI-UK, V28, P605, DOI 10.1016/S0098-3004(01)00095-4; Kotzian Carla Bender, 2006, REVISTA BRASILEIRA DE PALEONTOLOGIA, V9, P243; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; Lee JY, 2006, GEOCHIM COSMOCHIM AC, V70, P4507, DOI 10.1016/j.gca.2006.06.1563; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Murray A, 2008, RADIAT MEAS, V43, P776, DOI 10.1016/j.radmeas.2008.01.014; Murray AS, 2003, RADIAT MEAS, V37, P377, DOI 10.1016/S1350-4487(03)00053-2; NIELSEN AE, 1991, AM ANTIQUITY, V56, P483, DOI 10.2307/280897; Pascal L., 1873, CATALOGUE DES MOLLUS; Peng F, 2012, CHINESE SCI BULL, V57, P4594, DOI 10.1007/s11434-012-5317-6; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Preusser F., 2008, QUATERNARY SCI J, V57, P95, DOI [DOI 10.3285/EG.57.1-2.5, 10.3285/eg.57.1-2.5]; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Stone Richard, 2006, Science, V312, P361, DOI 10.1126/science.312.5772.361; Stoops G., 2003, GUIDELINES FOR ANALY; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Thomsen KJ, 2008, RADIAT MEAS, V43, P1474, DOI 10.1016/j.radmeas.2008.06.002; TOTH N, 1989, J FIELD ARCHAEOL, V16, P250, DOI 10.1179/jfa.1989.16.2.250; Tumung L., 2012, IOP CONF SER MATERIA, V37, P1; Wallinga J, 2007, QUAT GEOCHRONOL, V2, P216, DOI 10.1016/j.quageo.2006.05.014	62	186	190	3	91	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 12	2015	518	7538					228	U182		10.1038/nature13962	http://dx.doi.org/10.1038/nature13962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CA8SD	25470048				2022-12-28	WOS:000349190300037
J	Becattini, S; Latorre, D; Mele, F; Foglierini, M; De Gregorio, C; Cassotta, A; Fernandez, B; Kelderman, S; Schumacher, TN; Corti, D; Lanzavecchia, A; Sallusto, F				Becattini, Simone; Latorre, Daniela; Mele, Federico; Foglierini, Mathilde; De Gregorio, Corinne; Cassotta, Antonino; Fernandez, Blanca; Kelderman, Sander; Schumacher, Ton N.; Corti, Davide; Lanzavecchia, Antonio; Sallusto, Federica			Functional heterogeneity of human memory CD4(+) T cell clones primed by pathogens or vaccines	SCIENCE			English	Article							HYPER-IGE SYNDROME; ENVIRONMENTAL CUES; DENDRITIC CELLS; IMMUNE-RESPONSE; TH17 CELLS; NAIVE; DIFFERENTIATION; EFFECTOR; RECOGNITION; FATE	Distinct types of CD4(+) T cells protect the host against different classes of pathogens. However, it is unclear whether a given pathogen induces a single type of polarized T cell. By combining antigenic stimulation and T cell receptor deep sequencing, we found that human pathogen-and vaccine-specific T helper 1 (T(H)1), T(H)2, and T(H)17 memory cells have different frequencies but comparable diversity and comprise not only clones polarized toward a single fate, but also clones whose progeny have acquired multiple fates. Single naive T cells primed by a pathogen in vitro could also give rise to multiple fates. Our results unravel an unexpected degree of interclonal and intraclonal functional heterogeneity of the human T cell response and suggest that polarized responses result from preferential expansion rather than priming.	[Becattini, Simone; Latorre, Daniela; Mele, Federico; Foglierini, Mathilde; De Gregorio, Corinne; Cassotta, Antonino; Fernandez, Blanca; Corti, Davide; Lanzavecchia, Antonio; Sallusto, Federica] Univ Svizzera Italiana, Inst Res Biomed, Lugano, Switzerland; [Becattini, Simone; Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Kelderman, Sander; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; Netherlands Cancer Institute	Sallusto, F (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Lugano, Switzerland.	federica.sallusto@irb.usi.ch	Cassotta, Antonino/AAW-2529-2021; Latorre, Daniela/HHZ-9540-2022; Schumacher, Ton/Y-2432-2019	Cassotta, Antonino/0000-0001-8674-4294; Latorre, Daniela/0000-0003-1031-1534; Schumacher, Ton/0000-0003-0517-8804; Becattini, Simone/0000-0001-5985-0403; Foglierini, Mathilde/0000-0001-7538-4262	European Research Council [323183]; Swiss National Science Foundation [149475, 147662]; European Commission [FP7-HEALTH-2011-280873, FP7-HEALTH-2013-601958]; Helmut Horten Foundation	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Helmut Horten Foundation	We thank D. Jarrossay for cell sorting; O. Petrini, C. Fragoso, and A. Sette for providing valuable reagents; the Adaptive Biotechnologies team for technical support; and S. Monticelli for critical reading of the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. All TCR sequences are available in the supplementary materials as. txt files. FASTA format files are available at downloads. adaptivebiotech.com (username: SallustoSciDec2014data; password: di2PhaiT). The sequences have been deposited in the Gene Expression Omnibus (accession numbers xxxxxx). Supported by European Research Council grant 323183 PREDICT (F.S.), Swiss National Science Foundation grants 149475 (F.S.) and 147662 (A.L.), and European Commission grants FP7-HEALTH-2011-280873, ADITEC (A.L. and F.S.) and FP7-HEALTH-2013-601958, SUPERSIST (T.N.S.). The Institute for Research in Biomedicine is supported by the Helmut Horten Foundation.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Bacher P, 2013, J IMMUNOL, V190, P3967, DOI 10.4049/jimmunol.1202221; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Pulendran B, 2005, J IMMUNOL, V174, P2457, DOI 10.4049/jimmunol.174.5.2457; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	31	220	224	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2015	347	6220					400	406		10.1126/science.1260668	http://dx.doi.org/10.1126/science.1260668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4XZ	25477212				2022-12-28	WOS:000348225800038
J	LeBlanc, ES; Zakher, B; Daeges, M; Pappas, M; Chou, R				LeBlanc, Erin S.; Zakher, Bernadette; Daeges, Monica; Pappas, Miranda; Chou, Roger			Screening for Vitamin D Deficiency: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED-CONTROLLED-TRIAL; SERUM 25-HYDROXYVITAMIN D; AFRICAN-AMERICAN WOMEN; PLACEBO-CONTROLLED TRIAL; BONE-MINERAL DENSITY; HIP FRACTURE RISK; AGED 65-71 YEARS; D SUPPLEMENTATION; DOUBLE-BLIND; CALCIUM SUPPLEMENTATION	Background: Vitamin D deficiency has been associated with adverse health outcomes. Purpose: To systematically review benefits and harms of vitamin D screening in asymptomatic adults. Data Sources: Ovid MEDLINE (through the third week of August 2014), Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews. Study Selection: Randomized trials of screening for and treatment of vitamin D deficiency and case-control studies nested within the Women's Health Initiative. Data Extraction: One investigator abstracted data, a second reviewed data for accuracy, and 2 investigators independently assessed study quality using predefined criteria. Data Synthesis: No study examined the effects of vitamin D screening versus no screening on clinical outcomes. Vitamin D treatment was associated with decreased mortality versus placebo or no treatment (11 studies; risk ratio [RR], 0.83 [95% CI, 0.70 to 0.99]), although benefits were no longer seen after trials of institutionalized persons were excluded (8 studies; RR, 0.93 [CI, 0.73 to 1.18]). Vitamin D treatment was associated with possible decreased risk for having at least 1 fall (5 studies; RR, 0.84 [CI, 0.69 to 1.02]) and falls per person (5 studies; incidence rate ratio, 0.66 [CI, 0.50 to 0.88]) but not fractures (5 studies; RR, 0.98 [CI, 0.82 to 1.16]). Vitamin D treatment was not associated with a statistically significant increased risk for serious adverse events (RR, 1.17 [CI, 0.74 to 1.84]). Limitation: Variability across studies in 25-hydroxyvitamin D assays and baseline levels, treatment doses, use of calcium, and duration of follow-up. Conclusion: Treatment of vitamin D deficiency in asymptomatic persons might reduce mortality risk in institutionalized elderly persons and risk for falls but not fractures.	[LeBlanc, Erin S.] Kaiser Permanente, Ctr Hlth Res, Portland, OR 97227 USA; [Zakher, Bernadette; Daeges, Monica; Pappas, Miranda; Chou, Roger] Oregon Hlth & Sci Univ, Portland, OR 97239 USA	Kaiser Permanente; Oregon Health & Science University	LeBlanc, ES (corresponding author), Kaiser Permanente, Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA.	erin.s.leblanc@kpchr.org		Chou, Roger/0000-0001-9889-8610	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Aloia JF, 2005, ARCH INTERN MED, V165, P1618, DOI 10.1001/archinte.165.14.1618; [Anonymous], 2010, CLIN GUID PREV TREAT; [Anonymous], 2011, 2011 DIET REF INT CA; Arvold DS, 2009, ENDOCR PRACT, V15, P203, DOI 10.4158/EP.15.3.203; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Bedner M, 2013, CLIN CHIM ACTA, V426, P6, DOI 10.1016/j.cca.2013.08.012; BERLIN T, 1986, SCAND J CLIN LAB INV, V46, P723, DOI 10.3109/00365518609084043; Binkley N, 2010, CLIN CHIM ACTA, V411, P1976, DOI 10.1016/j.cca.2010.08.018; Bischoff HA, 2003, J BONE MINER RES, V18, P343, DOI 10.1359/jbmr.2003.18.2.343; Bischoff-Ferrari HA, 2010, ARCH INTERN MED, V170, P813, DOI 10.1001/archinternmed.2010.67; Brazier M, 2005, CLIN THER, V27, P1885, DOI 10.1016/j.clinthera.2005.12.010; Brondum-Jacobsen P, 2012, ARTERIOSCL THROM VAS, V32, P2794, DOI 10.1161/ATVBAHA.112.248039; Carter GD, 2011, CURR DRUG TARGETS, V12, P19; Cashman KD, 2013, AM J CLIN NUTR, V97, P1235, DOI 10.3945/ajcn.112.057182; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; Cauley JA, 2011, J BONE MINER RES, V26, P2378, DOI 10.1002/jbmr.449; Cauley JA, 2010, J BONE MINER RES, V25, P545, DOI 10.1359/jbmr.090826; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; Chlebowski RT, 2008, JNCI-J NATL CANCER I, V100, P1581, DOI 10.1093/jnci/djn360; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Chung M., 2009, AHRQ PUBLICATION; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; Corless D, 1985, DIABETES CARE, V14, P76, DOI DOI 10.2337/DC12-1204; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Dawson-Hughes B, 2014, IOF STATEMENT NEW IO; de Boer IH, 2008, DIABETES CARE, V31, P701, DOI 10.2337/dc07-1829; Forouhi NG, 2012, DIABETOLOGIA, V55, P2173, DOI 10.1007/s00125-012-2544-y; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729; Fraser WD, 2013, CALCIFIED TISSUE INT, V92, P118, DOI 10.1007/s00223-012-9693-3; Gallagher JC, 2014, J BONE MINER RES, V29, P173, DOI 10.1002/jbmr.2010; Gallagher JC, 2013, J CLIN ENDOCR METAB, V98, P1137, DOI 10.1210/jc.2012-3106; Gallagher JC, 2012, ANN INTERN MED, V156, P425, DOI 10.7326/0003-4819-156-6-201203200-00005; Gandini S, 2011, INT J CANCER, V128, P1414, DOI 10.1002/ijc.25439; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; GLOTH FM, 1995, J AM GERIATR SOC, V43, P1269, DOI 10.1111/j.1532-5415.1995.tb07404.x; Gonzalez-Molero I, 2012, CLIN NUTR, V31, P571, DOI 10.1016/j.clnu.2011.12.001; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Grant WB, 2010, J PHOTOCH PHOTOBIO B, V101, P130, DOI 10.1016/j.jphotobiol.2010.04.008; Grimnes G, 2011, DIABETES, V60, P2748, DOI 10.2337/db11-0650; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Harris SS, 1999, J AM COLL NUTR, V18, P470, DOI 10.1080/07315724.1999.10718885; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holmes EW, 2013, AM J CLIN PATHOL, V140, P550, DOI 10.1309/AJCPU2SKW1TFKSWY; Holvik K, 2013, J CLIN ENDOCR METAB, V98, P3341, DOI 10.1210/jc.2013-1468; HONKANEN R, 1990, J AM GERIATR SOC, V38, P862, DOI 10.1111/j.1532-5415.1990.tb05700.x; Husemoen LLN, 2012, EUR J CLIN NUTR, V66, P1309, DOI 10.1038/ejcn.2012.134; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jackson RD, 2003, ANN EPIDEMIOL, V13, pS98, DOI 10.1016/S1047-2797(03)00046-2; Jacques PF, 1997, AM J CLIN NUTR, V66, P929, DOI 10.1093/ajcn/66.4.929; Janssen HCJP, 2010, AGING CLIN EXP RES, V22, P78, DOI 10.1007/BF03324819; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Karkkainen M, 2010, OSTEOPOROSIS INT, V21, P2047, DOI 10.1007/s00198-009-1167-8; Karkkainen MK, 2010, MATURITAS, V65, P359, DOI 10.1016/j.maturitas.2009.12.018; Kjaergaard M, 2012, BRIT J PSYCHIAT, V201, P360, DOI 10.1192/bjp.bp.111.104349; Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad; Knutsen KV, 2014, J CLIN ENDOCR METAB, V99, P194, DOI 10.1210/jc.2013-2647; Krieg MA, 1999, OSTEOPOROSIS INT, V9, P483, DOI 10.1007/s001980050174; LaCroix AZ, 2009, J GERONTOL A-BIOL, V64, P559, DOI 10.1093/gerona/glp006; Lai JKC, 2012, INTERN MED J, V42, P43, DOI 10.1111/j.1445-5994.2011.02471.x; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; LeBlanc E, 2014, SCREENING VITAMIN D; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Lehmann U, 2013, J CLIN ENDOCR METAB, V98, P4339, DOI 10.1210/jc.2012-4287; Linos E, 2012, CANCER CAUSE CONTROL, V23, P133, DOI 10.1007/s10552-011-9862-0; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Lips P, 2010, AM J CLIN NUTR, V91, P985, DOI 10.3945/ajcn.2009.28113; Looker A. C., 2011, NCHS Data Briefs; Looker AC, 2008, J BONE MINER RES, V23, P143, DOI 10.1359/JBMR.071003; Maddock J, 2013, CLIN NUTR, V32, P758, DOI 10.1016/j.clnu.2013.01.006; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Mastaglia SR, 2006, EUR J CLIN NUTR, V60, P681, DOI 10.1038/sj.ejcn.1602369; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; McCullough ML, 2010, AM J EPIDEMIOL, V172, P21, DOI 10.1093/aje/kwq113; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Milaneschi Y, 2010, J CLIN ENDOCR METAB, V95, P3225, DOI 10.1210/jc.2010-0347; Millen AE, 2010, AM J CLIN NUTR, V91, P1324, DOI 10.3945/ajcn.2009.28908; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Moon HW, 2012, CLIN BIOCHEM, V45, P326, DOI 10.1016/j.clinbiochem.2011.12.025; Moyer VA, 2012, ANN INTERN MED, V157, P197, DOI 10.7326/0003-4819-157-3-201208070-00462; OOMS ME, 1995, J CLIN ENDOCR METAB, V80, P1052, DOI 10.1210/jc.80.4.1052; Orwoll E, 2009, J CLIN ENDOCR METAB, V94, P1214, DOI 10.1210/jc.2008-1784; ORWOLL ES, 1989, J BONE MINER RES, V4, P81; OTT SM, 1989, ANN INTERN MED, V110, P267, DOI 10.7326/0003-4819-110-4-267; Pfeifer M, 2009, OSTEOPOROSIS INT, V20, P315, DOI 10.1007/s00198-008-0662-7; Pfeifer M, 2000, J BONE MINER RES, V15, P1113, DOI 10.1359/jbmr.2000.15.6.1113; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Samuel L, 2013, ANN EPIDEMIOL, V23, P409, DOI 10.1016/j.annepidem.2013.05.011; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Schottker B, 2013, EUR J EPIDEMIOL, V28, P267, DOI 10.1007/s10654-013-9769-z; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; Sun Q, 2012, STROKE, V43, P1470, DOI 10.1161/STROKEAHA.111.636910; Talwar SA, 2007, AM J CLIN NUTR, V86, P1657; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; Tsur A, 2013, DIABETES CARE, V36, P1361, DOI 10.2337/dc12-1050; U.S. Preventive Services Task Force, 2014, VIT D CALC SUPPL PRE; U.S. Preventive Services Task Force, 2014, FIN REC STAT VIT SUP; U.S. Preventive Services Task Force, 2014, FIN REC STAT VIT D C; US Preventive Services Task Force, 2013, AHRQ PUBLICATION; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Vieth R, 2006, PROG BIOPHYS MOL BIO, V92, P26, DOI 10.1016/j.pbiomolbio.2006.02.003; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wagner D, 2009, CLIN BIOCHEM, V42, P1549, DOI 10.1016/j.clinbiochem.2009.07.013; Wamberg L, 2013, EUR J INTERN MED, V24, P644, DOI 10.1016/j.ejim.2013.03.005; Wamberg L, 2013, CALCIFIED TISSUE INT, V93, P69, DOI 10.1007/s00223-013-9729-3; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604; Williams DA, 2011, ARTHRIT CARE RES, V63, pS86, DOI 10.1002/acr.20531; Witham MD, 2010, CIRC-HEART FAIL, V3, P195, DOI 10.1161/CIRCHEARTFAILURE.109.907899; Wood AD, 2012, J CLIN ENDOCR METAB, V97, P3557, DOI 10.1210/jc.2012-2126; World Health Organization; International Agency for Research on Cancer, 2008, IARC WORK GROUP REPO, V5; Yin L, 2009, CANCER EPIDEMIOL, V33, P435, DOI 10.1016/j.canep.2009.10.014; Zhu K, 2008, J BONE MINER RES, V23, P1343, DOI 10.1359/JBMR.080327	123	91	93	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 20	2015	162	2					109	+		10.7326/M14-1659	http://dx.doi.org/10.7326/M14-1659			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CC1NB	25419719				2022-12-28	WOS:000350106600017
J	Bogoch, II; Creatore, MI; Cetron, MS; Brownstein, JS; Pesik, N; Miniota, J; Tam, T; Hu, W; Nicolucci, A; Ahmed, S; Yoon, JW; Berry, I; Hay, SI; Anema, A; Tatem, AJ; MacFadden, D; German, M; Khan, K				Bogoch, Isaac I.; Creatore, Maria I.; Cetron, Martin S.; Brownstein, John S.; Pesik, Nicki; Miniota, Jennifer; Tam, Theresa; Hu, Wei; Nicolucci, Adriano; Ahmed, Saad; Yoon, James W.; Berry, Isha; Hay, Simon I.; Anema, Aranka; Tatem, Andrew J.; MacFadden, Derek; German, Matthew; Khan, Kamran			Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak	LANCET			English	Article							HEALTH REGULATIONS	Background The WHO declared the 2014 west African Ebola epidemic a public health emergency of international concern in view of its potential for further international spread. Decision makers worldwide are in need of empirical data to inform and implement emergency response measures. Our aim was to assess the potential for Ebola virus to spread across international borders via commercial air travel and assess the relative efficiency of exit versus entry screening of travellers at commercial airports. Methods We analysed International Air Transport Association data for worldwide flight schedules between Sept 1, 2014, and Dec 31, 2014, and historic traveller flight itinerary data from 2013 to describe expected global population movements via commercial air travel out of Guinea, Liberia, and Sierra Leone. Coupled with Ebola virus surveillance data, we modelled the expected number of internationally exported Ebola virus infections, the potential effect of air travel restrictions, and the efficiency of airport-based traveller screening at international ports of entry and exit. We deemed individuals initiating travel from any domestic or international airport within these three countries to have possible exposure to Ebola virus. We deemed all other travellers to have no significant risk of exposure to Ebola virus. Findings Based on epidemic conditions and international flight restrictions to and from Guinea, Liberia, and Sierra Leone as of Sept 1, 2014 (reductions in passenger seats by 51% for Liberia, 66% for Guinea, and 85% for Sierra Leone), our model projects 2.8 travellers infected with Ebola virus departing the above three countries via commercial flights, on average, every month. 91 547 (64%) of all air travellers departing Guinea, Liberia, and Sierra Leone had expected destinations in low-income and lower-middle-income countries. Screening international travellers departing three airports would enable health assessments of all travellers at highest risk of exposure to Ebola virus infection.	[Bogoch, Isaac I.; MacFadden, Derek; Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada; [Bogoch, Isaac I.] Univ Hlth Network, Div Internal Med, Toronto, ON, Canada; [Bogoch, Isaac I.] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada; [Creatore, Maria I.; Miniota, Jennifer; Hu, Wei; Nicolucci, Adriano; Yoon, James W.; Berry, Isha; German, Matthew; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Cetron, Martin S.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; [Brownstein, John S.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Brownstein, John S.; Anema, Aranka] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Pesik, Nicki] Ctr Dis Control & Prevent, Quarantine & Border Hlth Serv Branch, Div Global Migrat & Quarantine, Atlanta, GA USA; [Tam, Theresa] Publ Hlth Agcy Canada, Hlth Secur Infrastruct Branch, Ottawa, ON, Canada; [Ahmed, Saad] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Hay, Simon I.; Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Anema, Aranka] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada; [Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, Southampton, Hants, England; [Tatem, Andrew J.] Flowminder Fdn, Stockholm, Sweden	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Centers for Disease Control & Prevention - USA; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Centers for Disease Control & Prevention - USA; Public Health Agency of Canada; Western University (University of Western Ontario); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Oxford; University of British Columbia; University of Southampton	Khan, K (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	khank@smh.ca	Hay, Simon Iain/F-8967-2015; Bogoch, Isaac/AAS-9631-2020	Hay, Simon Iain/0000-0002-0611-7272; Tatem, Andrew/0000-0002-7270-941X; Ahmed, Syed/0000-0001-7633-6617	Canadian Institutes of Health Research; NATIONAL LIBRARY OF MEDICINE [R01LM010812] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Canadian Institutes of Health Research.	Anema A, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-1; [Anonymous], 2014, LANCET INFECT DIS, V14, P779, DOI 10.1016/S1473-3099(14)70785-6; [Anonymous], 2014, LANCET, V384, P637, DOI 10.1016/S0140-6736(14)61377-5; [Anonymous], 2014, ECONOMIST; [Anonymous], 2014, EB CRIS LIB POL FIR; [Anonymous], 2014, EB TRAV S AFR BANS I; [Anonymous], INT GUID MON MOV PER; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859; Chretien JP, 2010, BIOSECUR BIOTERROR, V8, P277, DOI 10.1089/bsp.2009.0058; Davies M, 2014, REEBOLA HEMORRHAGIC; Khan K, 2013, B WORLD HEALTH ORGAN, V91, P368, DOI 10.2471/BLT.12.114777; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; Mai-Duc C, 2014, LOS ANGELES TIMES, P1; WHO, 2014, 1 WHO; World Bank, 2013, WORLD DEV IND POP DY; York Geoffrey, 2014, GLOBE MAIL	18	135	138	0	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 3	2015	385	9962					29	35		10.1016/S0140-6736(14)61828-6	http://dx.doi.org/10.1016/S0140-6736(14)61828-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX8IW	25458732	Green Published			2022-12-28	WOS:000347154200025
J	Catania, K				Catania, Kenneth			The shocking predatory strike of the electric eel	SCIENCE			English	Article							MOTOR UNITS; BEHAVIOR; DOUBLET; MUSCLE	Electric eels can incapacitate prey with an electric discharge, but the mechanism of the eel's attack is unknown. Through a series of experiments, I show that eel high-voltage discharges can activate prey motor neurons, and hence muscles, allowing eels to remotely control their target. Eels prevent escape in free-swimming prey using high-frequency volleys to induce immobilizing whole-body muscle contraction (tetanus). Further, when prey are hidden, eels can emit periodic volleys of two or three discharges that cause massive involuntary twitch, revealing the prey's location and eliciting the full, tetanus-inducing volley. The temporal patterns of eel electrical discharges resemble motor neuron activity that induces fast muscle contraction, suggesting that eel high-voltage volleys have been selected to most efficiently induce involuntary muscle contraction in nearby animals.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Catania, K (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B,Box 35-1634, Nashville, TN 37235 USA.	ken.catania@vanderbilt.edu			Pradel Award from the National Academy of Sciences; Guggenheim Fellowship; NSF [0844743]; Division Of Integrative Organismal Systems [0844743] Funding Source: National Science Foundation	Pradel Award from the National Academy of Sciences; Guggenheim Fellowship; NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	I thank E. Catania for suggesting experimental designs and manuscript comments. This work was supported by a Pradel Award from the National Academy of Sciences, a Guggenheim Fellowship, and NSF grant 0844743. Raw data are available in the supplementary materials.	BAUER R, 1979, BEHAV ECOL SOCIOBIOL, V4, P311, DOI 10.1007/BF00303239; BULLOCK TH, 1969, BRAIN BEHAV EVOLUT, V2, P85, DOI 10.1159/000125815; Celichowski J, 1998, ACTA NEUROBIOL EXP, V58, P47; Cheng AJ, 2013, J PHYSIOL-LONDON, V591, P3739, DOI 10.1113/jphysiol.2013.257188; COATES C. W., 1940, ZOOLOGICA [NEW YORK], V25, P249; Gallant JR, 2014, SCIENCE, V344, P1522, DOI 10.1126/science.1254432; Grundfest H., 1956, PROG BIOPHYS BIOP CH, V1957, P1; HAGIWARA S, 1965, J NEUROPHYSIOL, V28, P775, DOI 10.1152/jn.1965.28.5.775; HENNIG R, 1985, NATURE, V314, P164, DOI 10.1038/314164a0; KALMIJN AJ, 1971, J EXP BIOL, V55, P371; Keesey John, 2005, J Hist Neurosci, V14, P149, DOI 10.1080/096470490512599; Pedersen KK, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.26; Piccolino M, 2011, SHOCKING HIST ELECT, P5; WESTBY GWM, 1988, BEHAV ECOL SOCIOBIOL, V22, P341; ZAJAC FE, 1980, J NEUROPHYSIOL, V43, P1206, DOI 10.1152/jn.1980.43.5.1206; ZAJAC FE, 1980, J NEUROPHYSIOL, V43, P1221, DOI 10.1152/jn.1980.43.5.1221	16	58	60	10	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1231	1234		10.1126/science.1260807	http://dx.doi.org/10.1126/science.1260807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477462				2022-12-28	WOS:000346189000058
J	Zhu, HH; Huang, XJ				Zhu, Hong-Hu; Huang, Xiao-Jun			Oral Arsenic and Retinoic Acid for Non-High-Risk Acute Promyelocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							TRIOXIDE		[Zhu, Hong-Hu; Huang, Xiao-Jun] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China	Peking University	Zhu, HH (corresponding author), Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China.	xjhrm@medmail.com.cn	Huang, Xiao-Jun/HIK-3759-2022	Huang, Xiao-Jun/0000-0002-2145-6643				Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; O'Donnell MR, 2013, J NATL COMPR CANC NE, V11, P1047, DOI 10.6004/jnccn.2013.0127; Zhu HH, 2014, NEW ENGL J MED, V370, P1864, DOI 10.1056/NEJMc1316382; Zhu HH, 2013, J CLIN ONCOL, V31, P4215, DOI 10.1200/JCO.2013.48.8312	4	65	79	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2239	2241		10.1056/NEJMc1412035	http://dx.doi.org/10.1056/NEJMc1412035			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW0IY	25470713				2022-12-28	WOS:000345976700029
J	Chalmers, I; Nylenna, M				Chalmers, Iain; Nylenna, Magne			A new network to promote evidence-based research	LANCET			English	Editorial Material							SYSTEMATIC REVIEWS; TRIALS		[Chalmers, Iain] James Lind Initiat, Oxford OX2 7LG, England; [Nylenna, Magne] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway	Norwegian Knowledge Centre for Health Services	Chalmers, I (corresponding author), James Lind Initiat, Oxford OX2 7LG, England.	ichalmers@jameslind.net						ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Clark S, 2010, LANCET, V376, P10, DOI 10.1016/S0140-6736(10)61001-X; Clarke M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102670; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Gilbert R, 2005, INT J EPIDEMIOL, V34, P874, DOI 10.1093/ije/dyi088; Goudie AC, 2010, J CLIN EPIDEMIOL, V63, P983, DOI 10.1016/j.jclinepi.2010.01.022; Health Research Authority, 2014, GUID SPEC QUEST NEED; Horn J, 2001, STROKE, V32, P2433, DOI 10.1161/hs1001.096009; Jamtvedt Gro, 2014, Tidsskr Nor Laegeforen, V134, P10, DOI 10.4045/tidsskr.13.1324; Jones AP, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-50; Liberati A, 2011, LANCET, V378, P1777, DOI 10.1016/S0140-6736(11)61772-8; Manduca P, 2014, LANCET, V384, P746, DOI 10.1016/S0140-6736(14)61316-7; National Institute for Health Research, 2013, GUID NOT APPL ENS AL; Robinson KA, 2009, USE PRIOR RES JUSTIF; Robinson KA, 2011, ANN INTERN MED, V154, P50, DOI 10.7326/0003-4819-154-1-201101040-00007	15	18	18	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1903	1904		10.1016/S0140-6736(14)62252-2	http://dx.doi.org/10.1016/S0140-6736(14)62252-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU2LP	25435440				2022-12-28	WOS:000345450100006
J	Bagcchi, S				Bagcchi, Sanjeet			BLOOD DONATION More blood for India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drsanjitbagchi@gmail.com						Aggarwal S, 2012, ANN TROP MED PUBLIC, V5, P50; [Anonymous], 2014, DNA; Bhaumik S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5623; Indian Red Cross Society, 2013, NAT VOL BLOOD DON DA; Sharman G., 2012, WEEK            0901; World Health Organization, BLOOD SAF AV	6	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2014	349								g7166	10.1136/bmj.g7166	http://dx.doi.org/10.1136/bmj.g7166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KH	25432665				2022-12-28	WOS:000346115900002
J	Rybak-Wolf, A; Jens, M; Murakawa, Y; Herzog, M; Landthaler, M; Rajewsky, N				Rybak-Wolf, Agnieszka; Jens, Marvin; Murakawa, Yasuhiro; Herzog, Margareta; Landthaler, Markus; Rajewsky, Nikolaus			A Variety of Dicer Substrates in Human and C-elegans	CELL			English	Article							RNA-BINDING PROTEIN; TRANSCRIPTOME-WIDE IDENTIFICATION; MESSENGER-RNA; GERM-CELLS; P-GRANULES; PRE-MIRNA; DROSHA; RECOGNITION; CLEAVAGE; EXPRESSION	The endoribonuclease Dicer is known for its central role in the biogenesis of eukaryotic small RNAs/microRNAs. Despite its importance, Dicer target transcripts have not been directly mapped. Here, we apply biochemical methods to human cells and C. elegans and identify thousands of Dicer-binding sites. We find known and hundreds of additional miRNAs with high sensitivity and specificity. We also report structural RNAs, promoter RNAs, and mitochondrial transcripts as Dicer targets. Interestingly, most Dicer-binding sites reside on mRNAs/lncRNAs and are not significantly processed into small RNAs. These passive sites typically harbor small, Dicer-bound hairpins within intact transcripts and generally stabilize target expression. We show that passive sites can sequester Dicer and reduce microRNA expression. mRNAs with passive sites were in human and worm significantly associated with processing-body/granule function. Together, we provide the first transcriptome-wide map of Dicer targets and suggest conserved binding modes and functions outside of the miRNA pathway.	[Rybak-Wolf, Agnieszka; Jens, Marvin; Herzog, Margareta; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Syst Biol Gene Regulatory Elements, D-13125 Berlin, Germany; [Murakawa, Yasuhiro; Landthaler, Markus] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab RNA Biol & Posttranscript Regulat, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Landthaler, M (corresponding author), Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Syst Biol Gene Regulatory Elements, Robert Rossle Str 10, D-13125 Berlin, Germany.	markus.landthaler@mdc-berlin.de; rajewsky@mdc-berlin.de	Landthaler, Markus/A-1427-2010	Landthaler, Markus/0000-0002-1075-8734; Rajewsky, Nikolaus/0000-0002-4785-4332; Jens, Marvin/0000-0002-6660-8743; Rybak-Wolf, Agnieszka/0000-0002-1192-5290	DFG [GRK1772]; BMBF; Senate of Berlin; DAAD fellowship	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Senate of Berlin; DAAD fellowship(Deutscher Akademischer Austausch Dienst (DAAD))	The authors would like to thank all members of the Rajewsky lab for discussion and support. We thank T. Duchaine and W. Filipowicz for discussion and advice on the manuscript. We would like to thank H. Tabara for the anti DCR-1 antibodies. M. J. received a fellowship of the DFG-funded GRK1772. The group of M. L. was supported by the BMBF and Senate of Berlin. Y. M. was funded by DAAD fellowship.	Ando Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023385; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bennasser Y, 2011, NAT STRUCT MOL BIOL, V18, P323, DOI 10.1038/nsmb.1987; Beshore EL, 2011, DEV BIOL, V350, P370, DOI 10.1016/j.ydbio.2010.12.005; Castellano L, 2013, NUCLEIC ACIDS RES, V41, P3339, DOI 10.1093/nar/gks1474; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Doyle M, 2013, RNA, V19, P1238, DOI 10.1261/rna.039255.113; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Feng Y, 2012, RNA, V18, P2083, DOI 10.1261/rna.033688.112; Friedlander MR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r57; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fukunaga R, 2014, EMBO J, V33, P371, DOI 10.1002/embj.201387176; Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Goodarzi H, 2014, NATURE, V513, P256, DOI 10.1038/nature13466; Gromak N, 2013, CELL REP, V5, P1499, DOI 10.1016/j.celrep.2013.11.032; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Hellwig S, 2008, P NATL ACAD SCI USA, V105, P12897, DOI 10.1073/pnas.0805118105; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jungkamp AC, 2011, MOL CELL, V44, P828, DOI 10.1016/j.molcel.2011.11.009; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; Nejepinska J, 2012, NUCLEIC ACIDS RES, V40, P399, DOI 10.1093/nar/gkr702; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Ricci EP, 2014, NAT STRUCT MOL BIOL, V21, P26, DOI 10.1038/nsmb.2739; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Sarkies P, 2013, BIOCHEM SOC T, V41, P876, DOI 10.1042/BST20130021; Schisa JA, 2001, DEVELOPMENT, V128, P1287; Shi Z, 2013, GENOME RES, V23, P497, DOI 10.1101/gr.149112.112; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Taylor DW, 2013, NAT STRUCT MOL BIOL, V20, P662, DOI 10.1038/nsmb.2564; Tian Y, 2014, MOL CELL, V53, P606, DOI 10.1016/j.molcel.2014.01.003; Updike DL, 2011, J CELL BIOL, V192, P939, DOI 10.1083/jcb.201010104; Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	52	73	77	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1153	1167		10.1016/j.cell.2014.10.040	http://dx.doi.org/10.1016/j.cell.2014.10.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416952	Bronze			2022-12-28	WOS:000345506300025
J	Stein, A; Pearson, RM; Goodman, SH; Rapa, E; Rahman, A; McCallum, M; Howard, LM; Pariante, CM				Stein, Alan; Pearson, Rebecca M.; Goodman, Sherryl H.; Rapa, Elizabeth; Rahman, Atif; McCallum, Meaghan; Howard, Louise M.; Pariante, Carmine M.			Effects of perinatal mental disorders on the fetus and child	LANCET			English	Article							MATERNAL DEPRESSIVE SYMPTOMS; MOTHER-INFANT INTERACTION; TODDLER-PARENT PSYCHOTHERAPY; LOW-INCOME COUNTRIES; POSTNATAL DEPRESSION; POSTPARTUM DEPRESSION; ANTENATAL DEPRESSION; COGNITIVE-DEVELOPMENT; LANGUAGE-DEVELOPMENT; CONTROLLED-TRIAL	Perinatal mental disorders are associated with increased risk of psychological and developmental disturbances in children. However, these disturbances are not inevitable. In this Series paper, we summarise evidence for associations between parental disorders and off spring outcomes from fetal development to adolescence in high-income, middle-income, and low-income countries. We assess evidence for mechanisms underlying transmission of disturbance, the role of mediating variables (underlying links between parent psychopathology and off spring outcomes) and possible moderators (which change the strength of any association), and focus on factors that are potentially modifiable, including parenting quality, social (including partner) and material support, and duration of the parental disorder. We review research of interventions, which are mostly about maternal depression, and emphasise the need to both treat the parent's disorder and help with associated caregiving difficulties. We conclude with policy implications and underline the need for early identification of those parents at high risk and for more early interventions and prevention research, especially in socioeconomically disadvantaged populations and low-income countries.	[Stein, Alan; Pearson, Rebecca M.; Rapa, Elizabeth] Univ Oxford, Dept Psychiat, Sect Child & Adolescent Psychiat, Oxford OX3 7JX, England; [Stein, Alan] Univ Witwatersrand, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Pearson, Rebecca M.] Univ Bristol, Sch Social & Community Med, Elizabeth Blackwell Inst Hlth Res, Bristol, Avon, England; [Goodman, Sherryl H.; McCallum, Meaghan] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Rahman, Atif] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Howard, Louise M.] Kings Coll London, Inst Psychiat, Hlth Serv, London WC2R 2LS, England; [Howard, Louise M.] Kings Coll London, Inst Psychiat, Populat Res Dept, London WC2R 2LS, England; [Pariante, Carmine M.] Kings Coll London, Inst Psychiat, Dept Psychol Med, London WC2R 2LS, England	University of Oxford; University of Witwatersrand; University of Bristol; Emory University; University of Liverpool; University of London; King's College London; University of London; King's College London; University of London; King's College London	Stein, A (corresponding author), Univ Oxford, Dept Psychiat, Sect Child & Adolescent Psychiat, Oxford OX3 7JX, England.	alan.stein@psych.ox.ac.uk	Pariante, Carmine Maria/B-1297-2011; Howard, Louise/E-3495-2010	Pariante, Carmine Maria/0000-0002-9132-5091; Howard, Louise/0000-0001-9942-744X; Stein, Alan/0000-0001-8207-2822; Pearson, Rebecca/0000-0001-8527-3400; Rapa, Elizabeth/0000-0001-8818-8148	Wellcome Trust [090139]; Medical Research Council UK; Barclay Foundation; Grand Challenges (Canada); Department for Education (UK); Wellcome Trust Institutional Strategic Award; National Institute of Health Research (NIHR) Programme Grant [RP-RP-DG-1108-10012]; NIHR Research Professorship on maternal mental health [NIHR-RP-R3-12-011]; Tommy's baby charity (Johnson and Johnson); NIHR Mental Health Biomedical Research Centre at the south London; Maudsley NHS Foundation Trust; King's College London; Eli Lilly; Servier; Janssen; Medical Research Council; European Commission; NIHR; NIHR Biomedical Research Centre for Mental Health at the south London; NARSAD; Psychiatry Research Trust; MRC [G108/603] Funding Source: UKRI; Medical Research Council [G108/603] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Barclay Foundation; Grand Challenges (Canada)(CGIAR); Department for Education (UK); Wellcome Trust Institutional Strategic Award(Wellcome Trust); National Institute of Health Research (NIHR) Programme Grant(National Institute for Health Research (NIHR)); NIHR Research Professorship on maternal mental health; Tommy's baby charity (Johnson and Johnson); NIHR Mental Health Biomedical Research Centre at the south London; Maudsley NHS Foundation Trust; King's College London(General Electric); Eli Lilly(Eli Lilly); Servier(Servier); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); NIHR(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre for Mental Health at the south London(National Institute for Health Research (NIHR)); NARSAD(NARSAD); Psychiatry Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AS has received several grants in relation to parental perinatal health and child development from the Wellcome Trust (090139), Medical Research Council UK, Barclay Foundation, Grand Challenges (Canada), and The Department for Education (UK). RMP is supported by an early career fellowship funded by a Wellcome Trust Institutional Strategic Award. RMP has been supported by grants from the Wellcome Trust. ER was previously employed on a grant funded by the Wellcome Trust. LMH is chair of the NICE (update) guideline on Antenatal and Postnatal Mental Health. LMH is chief investigator of an National Institute of Health Research (NIHR) Programme Grant for Applied Research on the eff ectiveness of perinatal mental health services (grant number RP-RP-DG-1108-10012) which also supports CMP, and has received funding from an NIHR Research Professorship (NIHR-RP-R3-12-011) on maternal mental health, and a grant from Tommy's baby charity (with the support of a corporate social responsibility grant from Johnson and Johnson) on antipsychotics in pregnancy. LMH is also supported by the NIHR Mental Health Biomedical Research Centre at the south London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. CMP has received research funding and consultancy fees from Eli Lilly, Servier, and Janssen, which are pharmaceutical companies involved in the development of antidepressants in the past 5 years. CMP is supported by the Medical Research Council and the European Commission; the NIHR and the NIHR Biomedical Research Centre for Mental Health at the south London and Maudsley NHS Foundation Trust and King's College London; the Wellcome Trust, the NARSAD, and the Psychiatry Research Trust; and Eli Lilly, and Janssen. We declare no other competing interests.	Abbott R, 2004, ACTA PSYCHIAT SCAND, V110, P365, DOI 10.1111/j.1600-0447.2004.00406.x; Abel KM, 2005, J CLIN PSYCHIAT, V66, P781, DOI 10.4088/JCP.v66n0618; Atkinson L, 2000, CLIN PSYCHOL REV, V20, P1019, DOI 10.1016/S0272-7358(99)00023-9; Avan B, 2010, ARCH DIS CHILD, V95, P690, DOI 10.1136/adc.2009.164848; Baker-Henningham H, 2005, ARCH DIS CHILD, V90, P1230, DOI 10.1136/adc.2005.073015; Bakermans-Kranenburg MJ, 2003, PSYCHOL BULL, V129, P195, DOI 10.1037/0033-2909.129.2.195; Barker ED, 2011, DEPRESS ANXIETY, V28, P696, DOI 10.1002/da.20856; Blair MM, 2011, STRESS, V14, P644, DOI 10.3109/10253890.2011.594121; Bornstein MH, 2014, ANNU REV PSYCHOL, V65, P121, DOI 10.1146/annurev-psych-120710-100359; Buss C, 2011, STRESS, V14, P665, DOI 10.3109/10253890.2011.623250; Campbell SB, 2004, DEV PSYCHOPATHOL, V16, P231, DOI 10.1017/S0954579404044499; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Cicchetti D, 2000, J ABNORM CHILD PSYCH, V28, P135, DOI 10.1023/A:1005118713814; Clark R, 2003, AM J ORTHOPSYCHIAT, V73, P441, DOI 10.1037/0002-9432.73.4.441; Connell AM, 2002, PSYCHOL BULL, V128, P746, DOI 10.1037//0033-2909.128.5.746; Conroy S, 2012, J AM ACAD CHILD PSY, V51, P51, DOI 10.1016/j.jaac.2011.10.007; Cooper PJ, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b974; Davis EP, 2012, PSYCHONEUROENDOCRINO, V37, P1224, DOI 10.1016/j.psyneuen.2011.12.016; C-L D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006116.pub2; Dennis CL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3064; Ding XX, 2014, J AFFECT DISORDERS, V159, P103, DOI 10.1016/j.jad.2014.02.027; DiPietro JA, 2012, J ADOLESCENT HEALTH, V51, pS3, DOI 10.1016/j.jadohealth.2012.04.008; Edward KL, 2015, AM J MENS HEALTH, V9, P26, DOI 10.1177/1557988314526614; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Enlow MB, 2011, INFANT BEHAV DEV, V34, P487, DOI 10.1016/j.infbeh.2011.07.007; Ertel KA, 2012, J CLIN EPIDEMIOL, V65, P1300, DOI 10.1016/j.jclinepi.2012.05.013; Evans J, 2012, J CHILD PSYCHOL PSYC, V53, P632, DOI 10.1111/j.1469-7610.2011.02513.x; Feldman R, 2009, J AM ACAD CHILD PSY, V48, P919, DOI 10.1097/CHI.0b013e3181b21651; Fernandes M, 2014, J DEV ORIG HLTH DIS, V5, P178, DOI 10.1017/S2040174414000129; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; Fihrer I, 2009, J AFFECT DISORDERS, V119, P116, DOI 10.1016/j.jad.2009.03.001; Flach C, 2011, BJOG-INT J OBSTET GY, V118, P1383, DOI 10.1111/j.1471-0528.2011.03040.x; Fletcher RJ, 2011, MED J AUSTRALIA, V195, P685, DOI 10.5694/mja11.10192; Forman DR, 2007, DEV PSYCHOPATHOL, V19, P585, DOI 10.1017/S0954579407070289; Galera C, 2011, ARCH GEN PSYCHIAT, V68, P1267, DOI 10.1001/archgenpsychiatry.2011.138; Galler JR, 2004, J CHILD PSYCHOL PSYC, V45, P1064, DOI 10.1111/j.1469-7610.2004.t01-1-00299.x; Galler JR, 2000, J CHILD PSYCHOL PSYC, V41, P747, DOI 10.1017/S0021963099005910; Gerardin P, 2011, J CLIN PSYCHIAT, V72, P378, DOI 10.4088/JCP.09m05724blu; Glasheen C, 2010, ARCH WOMEN MENT HLTH, V13, P61, DOI 10.1007/s00737-009-0109-y; Glover V, 2010, NEUROSCI BIOBEHAV R, V35, P17, DOI 10.1016/j.neubiorev.2009.11.008; Goodman SH, 2008, INFANT MENT HEALTH J, V29, P492, DOI 10.1002/imhj.20188; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Grace S L, 2003, Arch Womens Ment Health, V6, P263, DOI 10.1007/s00737-003-0024-6; Grigoriadis S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f6932; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Hadley C, 2008, ANN HUM BIOL, V35, P259, DOI 10.1080/03014460802043624; Hamadani JD, 2012, J HEALTH POPUL NUTR, V30, P193, DOI 10.3329/jhpn.v30i2.11313; Hanington L, 2012, CHILD CARE HLTH DEV, V38, P520, DOI 10.1111/j.1365-2214.2011.01270.x; Hartley C, 2010, PSYCHOL HEALTH MED, V15, P278, DOI 10.1080/13548501003615258; Hay DF, 2010, CHILD DEV, V81, P149, DOI 10.1111/j.1467-8624.2009.01386.x; Hayden T, 2012, J CLIN PSYCHOL MED S, V19, P285, DOI 10.1007/s10880-011-9294-8; Hayes LJ, 2013, ATTACH HUM DEV, V15, P133, DOI 10.1080/14616734.2013.743256; Herba CM, 2013, JAMA PSYCHIAT, V70, P830, DOI 10.1001/jamapsychiatry.2013.1361; Hipwell AE, 2000, DEV PSYCHOPATHOL, V12, P157, DOI 10.1017/S0954579400002030; Horowitz JA, 2013, JOGNN-J OBST GYN NEO, V42, P287, DOI 10.1111/1552-6909.12038; Howard LM, 2005, EUR J OBSTET GYN R B, V119, P3, DOI 10.1016/j.ejogrb.2004.06.026; Howard LM, 2004, ACTA PSYCHIAT SCAND, V110, P347, DOI 10.1111/j.1600-0447.2004.00375.x; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Howard LM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001452; Husain N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000523; Jacobi C, 2001, J AM ACAD CHILD PSY, V40, P364, DOI 10.1097/00004583-200103000-00017; Jonas W, 2013, GENES BRAIN BEHAV, V12, P681, DOI 10.1111/gbb.12069; Jones I, 2014, LANCET, V384, P1789, DOI 10.1016/S0140-6736(14)61278-2; Kaplan PS, 2011, INFANT BEHAV DEV, V34, P35, DOI 10.1016/j.infbeh.2010.07.014; Kendler KS, 2001, PSYCHOL MED, V31, P411, DOI 10.1017/S0033291701003622; Kenny M, 2013, J PSYCHIATR RES, V47, P1192, DOI 10.1016/j.jpsychires.2013.05.012; Kersten-Alvarez LE, 2012, CHILD PSYCHIAT HUM D, V43, P201, DOI 10.1007/s10578-011-0257-y; Kersten-Alvarez LE, 2011, INFANT MENT HEALTH J, V32, P362, DOI 10.1002/imhj.20301; King-Hele S, 2009, ARCH DIS CHILD-FETAL, V94, pF105, DOI 10.1136/adc.2007.135459; Korhonen M, 2012, J AFFECT DISORDERS, V136, P680, DOI 10.1016/j.jad.2011.10.007; Koutra K, 2012, SOC PSYCHIAT EPIDEMI, V48, P1335, DOI DOI 10.1007/S00127-012-0636-0; Kvalevaag AL, 2013, PEDIATRICS, V131, pE463, DOI 10.1542/peds.2012-0804; Lampard AM, 2014, PREV MED, V59, P60, DOI 10.1016/j.ypmed.2013.11.020; Leis JA, 2014, J ABNORM CHILD PSYCH, V42, P161, DOI 10.1007/s10802-013-9766-4; Letourneau NL, 2013, J PEDIATR NURS, V28, P223, DOI 10.1016/j.pedn.2012.07.014; Littleton HL, 2007, AM J OBSTET GYNECOL, V196, P424, DOI 10.1016/j.ajog.2007.03.042; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Martins C, 2000, J CHILD PSYCHOL PSYC, V41, P737, DOI 10.1111/1469-7610.00661; McManus BM, 2012, INFANT BEHAV DEV, V35, P489, DOI 10.1016/j.infbeh.2012.04.005; Meins E, 2001, J CHILD PSYCHOL PSYC, V42, P637, DOI 10.1111/1469-7610.00759; Micali N, 2009, EUR EAT DISORD REV, V17, P448, DOI 10.1002/erv.963; Miranda JJ, 2005, PLOS MED, V2, P962, DOI 10.1371/journal.pmed.0020291; Murray L, 1996, DEV MED CHILD NEUROL, V38, P109; Murray L, 2003, BRIT J PSYCHIAT, V182, P420, DOI 10.1192/bjp.182.5.420; MURRAY L, 2010, HDB INFANT DEV; Murray L, 2007, J CHILD PSYCHOL PSYC, V48, P45, DOI 10.1111/j.1469-7610.2006.01657.x; Murray L, 2011, J AM ACAD CHILD PSY, V50, P460, DOI 10.1016/j.jaac.2011.02.001; Murray L, 2010, J CHILD PSYCHOL PSYC, V51, P1150, DOI 10.1111/j.1469-7610.2010.02259.x; Naicker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033422; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; O'Donnell KJ, 2014, DEV PSYCHOPATHOL, V26, P393, DOI 10.1017/S0954579414000029; O'Hara MW, 2000, ARCH GEN PSYCHIAT, V57, P1039, DOI 10.1001/archpsyc.57.11.1039; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Paris R, 2011, INFANT MENT HEALTH J, V32, P319, DOI 10.1002/imhj.20299; Parsons CE, 2012, BRIT MED BULL, V101, P57, DOI 10.1093/bmb/ldr047; Patel P, 2002, CLIN CHILD FAM PSYCH, V5, P1, DOI 10.1023/A:1014524207660; Patel V, 2004, BMJ-BRIT MED J, V328, P820, DOI 10.1136/bmj.328.7443.820; Patel V, 2003, ARCH DIS CHILD, V88, P34, DOI 10.1136/adc.88.1.34; Paulson JF, 2009, J CHILD PSYCHOL PSYC, V50, P254, DOI 10.1111/j.1469-7610.2008.01973.x; Pawlby S, 2009, J AFFECT DISORDERS, V113, P236, DOI 10.1016/j.jad.2008.05.018; Pawlby S, 2011, BRIT J PSYCHIAT, V199, P106, DOI 10.1192/bjp.bp.110.087734; Pearson RM, 2012, INFANT BEHAV DEV, V35, P613, DOI 10.1016/j.infbeh.2012.07.020; Pearson RM, 2013, AM J PSYCHIAT, V170, P434, DOI 10.1176/appi.ajp.2012.12050673; Pearson R, 2013, NY TIMES BK REV, P18; Pemberton CK, 2010, DEV PSYCHOPATHOL, V22, P803, DOI 10.1017/S0954579410000477; Poobalan AS, 2007, BRIT J PSYCHIAT, V191, P378, DOI 10.1192/bjp.bp.106.032789; Quevedo LA, 2012, CHILD CARE HLTH DEV, V38, P420, DOI 10.1111/j.1365-2214.2011.01251.x; Rahman A, 2007, ARCH DIS CHILD, V92, P24, DOI 10.1136/adc.2005.086579; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Ramchandani P, 2009, LANCET, V374, P646, DOI 10.1016/S0140-6736(09)60238-5; Ramchandani PG, 2008, J AM ACAD CHILD PSY, V47, P390, DOI 10.1097/CHI.0b013e31816429c2; Reck C, 2013, J ANXIETY DISORD, V27, P404, DOI 10.1016/j.janxdis.2013.03.009; Rice F, 2010, PSYCHOL MED, V40, P335, DOI 10.1017/S0033291709005911; Santos IS, 2010, J PEDIATR-US, V157, P401, DOI 10.1016/j.jpeds.2010.03.008; Schetter CD, 2012, CURR OPIN PSYCHIATR, V25, P141, DOI 10.1097/YCO.0b013e3283503680; Stanley C, 2004, DEV PSYCHOPATHOL, V16, P1, DOI 10.1017/S0954579404044384; Stein A, 2008, CHILD CARE HLTH DEV, V34, P603, DOI 10.1111/j.1365-2214.2008.00837.x; Stein A, 2006, AM J PSYCHIAT, V163, P899, DOI 10.1176/appi.ajp.163.5.899; Stein A, RUTTERS CHI IN PRESS; Stein A, 2006, BRIT J PSYCHIAT, V189, P324, DOI 10.1192/bjp.bp.105.014316; Stein A, 2012, J ABNORM PSYCHOL, V121, P795, DOI 10.1037/a0026847; Stewart RC, 2007, MATERN CHILD NUTR, V3, P94, DOI 10.1111/j.1740-8709.2007.00088.x; Stice E, 1999, INT J EAT DISORDER, V25, P375, DOI 10.1002/(SICI)1098-108X(199905)25:4&lt;375::AID-EAT2&gt;3.0.CO;2-K; Surkan PJ, 2012, PEDIATRICS, V130, pE847, DOI 10.1542/peds.2011-2118; Sutter-Dallay AL, 2011, EUR PSYCHIAT, V26, P484, DOI 10.1016/j.eurpsy.2010.05.004; Szyf M, 2013, J GENET GENOMICS, V40, P331, DOI 10.1016/j.jgg.2013.06.004; Tharner A, 2012, ATTACH HUM DEV, V14, P63, DOI 10.1080/14616734.2012.636659; Tomlinson M, 2005, CHILD DEV, V76, P1044, DOI 10.1111/j.1467-8624.2005.00896.x; Toth SL, 2006, J CONSULT CLIN PSYCH, V74, P1006, DOI 10.1037/0022-006X.74.6.1006; Tronick E, 2009, HARVARD REV PSYCHIAT, V17, P147, DOI 10.1080/10673220902899714; Tse AC, 2010, PAEDIATR PERINAT EP, V24, P232, DOI 10.1111/j.1365-3016.2010.01113.x; Van Batenburg-Eddes T, 2013, J CHILD PSYCHOL PSYC, V54, P591, DOI 10.1111/jcpp.12023; van Doesum KTM, 2008, CHILD DEV, V79, P547, DOI 10.1111/j.1467-8624.2008.01142.x; Velders FP, 2011, EUR CHILD ADOLES PSY, V20, P341, DOI 10.1007/s00787-011-0178-0; Verbeek T, 2012, J AFFECT DISORDERS, V136, P948, DOI 10.1016/j.jad.2011.08.035; Wan MW, 2008, ARCH WOMEN MENT HLTH, V11, P171, DOI 10.1007/s00737-008-0010-0; Waters E, 2000, CHILD DEV, V71, P164, DOI 10.1111/1467-8624.00130; Webb R, 2005, AM J PSYCHIAT, V162, P1045, DOI 10.1176/appi.ajp.162.6.1045; Webb RT, 2010, ARCH GEN PSYCHIAT, V67, P69, DOI 10.1001/archgenpsychiatry.2009.172; Weikum WM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00180; Wojcicki JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016737	143	1063	1079	21	255	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1800	1819		10.1016/S0140-6736(14)61277-0	http://dx.doi.org/10.1016/S0140-6736(14)61277-0			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KX	25455250				2022-12-28	WOS:000345116400031
J	Mckee, M; Stuckler, D				McKee, Martin; Stuckler, David			The changing role of the British state and its citizens	LANCET			English	Editorial Material									[McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England; [Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Mckee, M (corresponding author), London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Stuckler, David/0000-0002-1288-8401	Wellcome Trust [100709] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1975, FORMATION NATL STATE; Cameron D., 2011, TELEGRAPH; Downing B. M., 1993, MILITARY REVOLUTION; Halliday 2Stephen, 2001, GREAT STINK LONDON J; Illman J, 2014, HLTH SERVICE J; Lewis, 1980, POLITICS MOTHERHOOD; Partington A., 1992, OXFORD DICT QUOTATIO; Reynolds L, 2012, CLIN MED, V12, P128, DOI 10.7861/clinmedicine.12-2-128; Rivett G, 1986, DEV LONDON HOSP SYST; Taylor A.J.P., 1965, ENGLISH HIST 1914 19; Vorspan Rachel, 2005, VANDERBILT J TRANS L, V38, P261; Zweiniger-Bargielowska Ina, 2000, AUSTERITY BRITAIN RA	12	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1643	1644		10.1016/S0140-6736(14)61928-0	http://dx.doi.org/10.1016/S0140-6736(14)61928-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KU	25441182				2022-12-28	WOS:000345116200005
J	Ellsberg, M; Arango, DJ; Morton, M; Gennari, F; Kiplesund, S; Contreras, M; Watts, C				Ellsberg, Mary; Arango, Diana J.; Morton, Matthew; Gennari, Floriza; Kiplesund, Sveinung; Contreras, Manuel; Watts, Charlotte			Prevention of violence against women and girls: what does the evidence say?	LANCET			English	Article							INTIMATE PARTNER VIOLENCE; RANDOMIZED-CONTROLLED-TRIAL; DOMESTIC VIOLENCE; GLOBAL PREVALENCE; SEXUAL VIOLENCE; CHILD MARRIAGE; INTERVENTION; HEALTH; EMPOWERMENT; PROGRAM	In this Series paper, we review evidence for interventions to reduce the prevalence and incidence of violence against women and girls. Our reviewed studies cover a broad range of intervention models, and many forms of violence-ie, intimate partner violence, non-partner sexual assault, female genital mutilation, and child marriage. Evidence is highly skewed towards that from studies from high-income countries, with these evaluations mainly focusing on responses to violence. This evidence suggests that women-centred, advocacy, and home-visitation programmes can reduce a woman's risk of further victimisation, with less conclusive evidence for the preventive effect of programmes for perpetrators. In low-income and middle-income countries, there is a greater research focus on violence prevention, with promising evidence on the effect of group training for women and men, community mobilisation interventions, and combined livelihood and training interventions for women. Despite shortcomings in the evidence base, several studies show large effects in programmatic timeframes. Across different forms of violence, effective programmes are commonly participatory, engage multiple stakeholders, support critical discussion about gender relationships and the acceptability of violence, and support greater communication and shared decision making among family members, as well as non-violent behaviour. Further investment in intervention design and assessment is needed to address evidence gaps.	[Ellsberg, Mary; Arango, Diana J.; Contreras, Manuel] George Washington Univ, Global Womens Inst, Washington, DC 20052 USA; [Ellsberg, Mary] George Washington Univ, Milken Inst, Sch Publ Hlth, Dept Global Hlth, Washington, DC 20052 USA; [Gennari, Floriza] George Washington Univ, Milken Inst, Sch Publ Hlth, Dept Prevent & Community Hlth, Washington, DC 20052 USA; [Morton, Matthew; Kiplesund, Sveinung] World Bank Grp, Washington, DC USA; [Watts, Charlotte] London Sch Hyg & Trop Med, Gender Violence & Hlth Ctr, London WC1, England	George Washington University; George Washington University; George Washington University; The World Bank; University of London; London School of Hygiene & Tropical Medicine	Ellsberg, M (corresponding author), George Washington Univ, Global Womens Inst, Washington, DC 20052 USA.	mellsberg@gwu.edu		Gennari, Floriza/0000-0002-2480-3743	World Bank Group; Australian Government (DFAT); UKAID What Works Consortium; UK AID Strive Research Programme Consortium; Department for International Development (DFID) [201447] Funding Source: researchfish	World Bank Group; Australian Government (DFAT)(Australian Government); UKAID What Works Consortium; UK AID Strive Research Programme Consortium; Department for International Development (DFID)	We received funding from the World Bank Group and the Australian Government (DFAT). We thank Karen DeVries, Gene Feder, Nancy Glass, and an anonymous reviewer for helpful comments on earlier drafts of the manuscript. We also thank Chelsea Ullman and Amber Hill for their support in the preparation of the manuscript. CW is part funded by the UKAID What Works Consortium and the UK AID Strive Research Programme Consortium.	Abrahams N, 2014, LANCET, V383, P1648, DOI 10.1016/S0140-6736(13)62243-6; Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Adam T, 2010, B WORLD HEALTH ORGAN, V88, P281, DOI 10.2471/BLT.09.064808; Anderson LA, 2005, PSYCHOL WOMEN QUART, V29, P374, DOI 10.1111/j.1471-6402.2005.00237.x; [Anonymous], 2011, WORKING PAPER; Arango D, AGENCY PART IN PRESS; Askew I., 2012, REV EVALUATION MULTI; Babcock JC, 2004, CLIN PSYCHOL REV, V23, P1023, DOI 10.1016/j.cpr.2002.07.001; Bair-Merritt MH, 2010, ARCH PEDIAT ADOL MED, V164, P16, DOI 10.1001/archpediatrics.2009.237; Baird S, 2011, Q J ECON, V126, P1709, DOI 10.1093/qje/qjr032; Bandiera O., 2012, EMPOWERING ADOLESCEN; Barker G., 2006, PROMOTING GENDER EQU; Bell ME, 2001, VIOLENCE AGAINST WOM, V7, P1377, DOI 10.1177/10778010122183919; Boba R, 2009, VIOLENCE AGAINST WOM, V15, P168, DOI 10.1177/1077801208329146; Bott S., 2005, PREVENTING RESPONDIN; Colombini M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-548; Das M, 2014, ENGAGING COACHES ATH; Das S.S., 2008, PROMOTING GENDER EQU; Davis R., 2000, DOES BATTERER TREATM; Davis R.C, 2008, CAMPBELL SYST REV, V4, P1, DOI [10.4073/csr.2008.15., DOI 10.4073/CSR.2008.15]; DeGue S, 2014, AGGRESS VIOLENT BEH, V19, P346, DOI 10.1016/j.avb.2014.05.004; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Diop N., 2004, TOSTAN PROGRAM EVALU, DOI 10.31899/rh2.1002; Duflo E., 2006, 4024 WORLD BANK; Duggan AK, 1999, FUTURE CHILD, V9, P66, DOI 10.2307/1602722; Ellsberg M, 2008, VIOLENCE WOMEN MELAN; Ellsberg M., 1997, REPRODUCTIVE HLTH MA, V5, P82, DOI [DOI 10.1016/S0968-8080(97)90088-4, https://doi.org/10.1016/S0968-8080(97)90088-4]; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Erulkar AS, 2009, INT PERSPECT SEX R H, V35, P6, DOI 10.1363/ifpp.35.006.09; Fals-Stewart W, 2002, J SUBST ABUSE TREAT, V22, P87, DOI 10.1016/S0740-5472(01)00218-5; Feder L., 2008, CAMPBELL SYSTEMATIC, V12, P1, DOI [DOI 10.4073/CSR.2008.12, 10.4073/csr.2008.12., DOI 10.4073/csr.2008.12]; Feldman-Jacobs C., 2014, FEMALE GENITAL MUTIL; Foshee VA, 2004, AM J PUBLIC HEALTH, V94, P619, DOI 10.2105/AJPH.94.4.619; Garcia-Moreno C, 2014, LANCET; Grabe S, 2010, ANAL SOC ISS PUB POL, V10, P146, DOI 10.1111/j.1530-2415.2010.01221.x; Gupta J, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-46; HANSON KA, 1993, J CONSULT CLIN PSYCH, V61, P1046, DOI 10.1037/0022-006X.61.6.1046; Haushofer J., 2013, HOUSEHOLD RESPONSE I; Hegarty KL, 2008, J FAM STUD, V14, P376, DOI 10.5172/jfs.327.14.2-3.376; Heise LL, 2012, DETERMINANTS PARTNER; Hidrobo M, 2013, EFFECT CASH VOUCHERS; Hossain M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-339; International Center for Research on Women, 2008, WOM PROP RIGHTS HIV; Jahanfar S., 2013, COCHRANE DB SYST REV, V2; Jewkes R, 2014, LANCET; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jubb Nadine., 2008, ACCESS JUSTICE WOMEN; Kataoka Y., 2004, JPN J NURS SCI, V1, P77, DOI [10.1111/j.1742-7924.2004.00017.x, DOI 10.1111/J.1742-7924.2004.00017.X]; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Kim JC, 2007, AM J PUBLIC HEALTH, V97, P1794, DOI 10.2105/AJPH.2006.095521; Koenig MA, 2003, DEMOGRAPHY, V40, P269, DOI 10.1353/dem.2003.0014; Lee-Rife S, 2012, STUD FAMILY PLANN, V43, P287, DOI 10.1111/j.1728-4465.2012.00327.x; Loaiza E, 2012, MARRYING TOO YOUNG E; Marx BP, 2001, J CONSULT CLIN PSYCH, V69, P25, DOI 10.1037//0022-006X.69.1.25; Michau L, 2014, LANCET; Miller E, 2011, CONTRACEPTION, V83, P274, DOI 10.1016/j.contraception.2010.07.013; Modi MN, 2014, J WOMENS HEALTH, V23, P253, DOI 10.1089/jwh.2013.4387; Morrison A, 2007, WORLD BANK RES OBSER, V22, P25, DOI 10.1093/wbro/lkm003; Morrison S., 2004, EVIDENCE BASED REV S; Namy S, 2014, BE MAN CHANGE RULES; Nanda P, 2014, IMPACCT IMPACT MARRI; Pande R, 2006, IMPROVING REPROD HLT; Population Reference Bureau, 2013, END FEM GEN MUT CUTT; Pulerwitz J., 2010, PROMOTING GENDER EQU; Ramsay J, 2005, INTERVENTIONS REDUCE; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Ricardo C., 2011, ENGAGING BOYS YOUNG; Sarnquist C, 2014, PEDIATRICS, V133, pE1226, DOI 10.1542/peds.2013-3414; Smedslund G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006048; Solorzano I., 2008, CATALYZING PERSONAL; Solotaroff JL., 2014, VIOLENCE WOMEN GIRLS; Stockl H, 2013, LANCET, V382, P859, DOI 10.1016/S0140-6736(13)61030-2; Sullivan CM, 1999, J CONSULT CLIN PSYCH, V67, P43, DOI 10.1037/0022-006X.67.1.43; Taft A, 2013, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD007007.PUB2; Taft AJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-178; Taft AJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-159; Taylor BG, 2013, PREV SCI, V14, P64, DOI 10.1007/s11121-012-0293-2; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; United Nations General Assembly, 1993, 85 PLEN M DEC 20 GEN; Usdin S, 2005, SOC SCI MED, V61, P2434, DOI 10.1016/j.socscimed.2005.04.035; Wagman JA, 2014, LANCET GLOB IN PRESS; Waldo M., 1988, J MENTAL HLTH COUNSE, V10, P37; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589; Whitaker DJ, 2006, AGGRESS VIOLENT BEH, V11, P151, DOI 10.1016/j.avb.2005.07.007; Wolfe DA, 2003, J CONSULT CLIN PSYCH, V71, P279, DOI 10.1037/0022-006X.71.2.279; Wolfe DA, 2009, ARCH PEDIAT ADOL MED, V163, P692, DOI 10.1001/archpediatrics.2009.69; World Bank Group, 2014, VOIC AG EMP WOM GIRL, P195; World Health Organization, 2010, VIOLENCE PREVENTION	90	386	393	13	210	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1555	1566		10.1016/S0140-6736(14)61703-7	http://dx.doi.org/10.1016/S0140-6736(14)61703-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG3ZT	25467575	Bronze			2022-12-28	WOS:000353220000037
J	Quaresma, M; Coleman, MP; Rachet, B				Quaresma, Manuela; Coleman, Michel P.; Rachet, Bernard			40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971-2011: a population-based study	LANCET			English	Article							FLEXIBLE PARAMETRIC MODELS; BREAST-CANCER; SOCIOECONOMIC INEQUALITIES; RELATIVE SURVIVAL; DISEASE; TIME; COMPLETENESS; AUSTRALIA; DIAGNOSIS; WOMEN	Background Assessment of progress in cancer control at the population level is increasingly important. Population-based survival trends provide a key insight into the overall effectiveness of the health system, alongside trends in incidence and mortality. For this purpose, we aimed to provide a unique measure of cancer survival. Methods In this observational study, we analysed trends in survival with population-based data for 7.2 million adults diagnosed with a first, primary, invasive malignancy in England and Wales during 1971-2011 and followed up to the end of 2012. We constructed a survival index for all cancers combined using data from the National Cancer Registry and the Welsh Cancer Intelligence and Surveillance Unit. The index is designed to be independent of changes in the age distribution of patients with cancer and of changes in the proportion of lethal cancers in each sex. We analysed trends in the cancer survival index at 1, 5, and 10 years after diagnosis for the selected periods 1971-72, 1980-81, 1990-91, 2000-01, 2005-06, and 2010-11. We also estimated trends in age-sex-adjusted survival for each cancer. We define the difference in net survival between the oldest (75-99 years) and youngest (15-44 years) patients as the age gap in survival. We evaluated the absolute change (%) in the age gap since 1971. Findings The overall index of net survival increased substantially during the 40-year period 1971-2011, both in England and in Wales. For patients diagnosed in 1971-72, the index of net survival was 50% at 1 year after diagnosis. 40 years later, the same value of 50% was predicted at 10 years after diagnosis. The average 10% survival advantage for women persisted throughout this period. Predicted 10-year net survival adjusted for age and sex for patients diagnosed between 2010 and 2011 ranged from 1.1% for pancreatic cancer to 98.2% for testicular cancer. Net survival for the oldest patients (75-99 years) was persistently lower than for the youngest (15-44 years), even after adjustment for the much higher mortality from causes other than cancer in elderly people. Interpretation These findings support substantial increases in both short-term and long-term net survival from all cancers combined in both England and Wales. The net survival index provides a convenient, single number that summarises the overall patterns of cancer survival in any one population, in each calendar period, for young and old men and women and for a wide range of cancers with very disparate survival. The persistent sex difference is partly due to a more favourable cancer distribution in women than men. The very wide differences in survival for different cancers, and the persistent age gap in survival, suggest the need for renewed efforts to improve cancer outcomes. Future monitoring of the cancer survival index will not be possible unless the current crisis of public concern about sharing of individual data for public health research can be resolved. Copyright (C) Quaresma et al. Open Access article distributed under the terms of CC BY.	[Quaresma, Manuela; Coleman, Michel P.; Rachet, Bernard] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine	Quaresma, M (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	manuela.quaresma@lshtm.ac.uk	Coleman, Michel/AAA-9543-2020	Coleman, Michel/0000-0001-8940-3807; Quaresma, Manuela/0000-0002-5290-279X; Rachet, Bernard/0000-0001-5837-7773	Cancer Research UK; Cancer Research UK [18348, 18525, 11700] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	Cancer Research UK.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Borland S., 2014, HALF CANC PATIENTS L; *CANC SERV COORD G, 2006, DES TACKL CANC WAL W; Cancer Research UK Cancer Survival Group, 2009, LIF TABL ENGL WAL SE; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Coleman MP, 2014, LANCET, V383, P564, DOI 10.1016/S0140-6736(13)62225-4; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; Coleman MP, 1999, STUDIES MED POPULATI, V61; *DEP HLTH, 1999, CHALL CANC; Department of Health, 2012, IMPR OUTC STRAT CANC; Department of Health, 2000, NHS CANC PLAN PLAN I; Department of Health, 2007, CANC REF STRAT; Expert Advisory Group on Cancer, 1995, POL GRAM COMM CANC S; Klint A, 2010, ACTA ONCOL, V49, P632, DOI 10.3109/02841861003691945; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; Lawrence G, 2009, BREAST CANCER RES TR, V116, P179, DOI 10.1007/s10549-008-0100-8; Moller H, 2011, BRIT J CANCER, V105, P170, DOI 10.1038/bjc.2011.168; National Institute for Health and Care Excellence, 2011, LUNG CANC DIAGN TREA; Nelson CP, 2007, STAT MED, V26, P5486, DOI 10.1002/sim.3064; Office for National Statistics, 2013, SERIES MB1, V42; Perme MP, 2012, BIOMETRICS, V68, P113, DOI 10.1111/j.1541-0420.2011.01640.x; Pollock A, 2014, OPTING OUT CARE DATA; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Richards MA, 2009, BRIT J CANCER, V101, pS125, DOI 10.1038/sj.bjc.6605402; Richards MA, 2009, BRIT J CANCER, V101, pS1, DOI 10.1038/sj.bjc.6605382; Rowan S, 2008, BRIT J CANCER, V99, pS75, DOI 10.1038/sj.bjc.6604595; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Sheldon TA, 2004, BRIT MED J, V329, P999, DOI 10.1136/bmj.329.7473.999; Solomon T., 2013, CANC SURVIVAL ENGLAN; StataCorp, 2013, STATA STAT SOFTW TEX; SWERDLOW AJ, 1993, BRIT J CANCER, V67, P326, DOI 10.1038/bjc.1993.60; The National Awareness and Early Diagnosis Initiative (NAEDI), 2009, NAEDI NEWSL; Woods LM, 2007, BRIT J CANCER, V96, P1135, DOI 10.1038/sj.bjc.6603668; Woods LM, 2010, AUST NZ J PUBL HEAL, V34, P206, DOI 10.1111/j.1753-6405.2010.00508.x	36	272	286	0	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2015	385	9974					1206	1218		10.1016/S0140-6736(14)61396-9	http://dx.doi.org/10.1016/S0140-6736(14)61396-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CE3GQ	25479696	Green Accepted, hybrid			2022-12-28	WOS:000351715100034
J	Eirew, P; Steif, A; Khattra, J; Ha, G; Yap, D; Farahani, H; Gelmon, K; Chia, S; Mar, C; Wan, A; Laks, E; Biele, J; Shumansky, K; Rosner, J; McPherson, A; Nielsen, C; Roth, AJL; Lefebvre, C; Bashashati, A; de Souza, C; Siu, C; Aniba, R; Brimhall, J; Oloumi, A; Osako, T; Bruna, A; Sandoval, JL; Algara, T; Greenwood, W; Leung, K; Cheng, HW; Xue, H; Wang, YZ; Lin, D; Mungall, AJ; Moore, R; Zhao, YJ; Lorette, J; Nguyen, L; Huntsman, D; Eaves, CJ; Hansen, C; Marra, MA; Caldas, C; Shah, SP; Aparicio, S				Eirew, Peter; Steif, Adi; Khattra, Jaswinder; Ha, Gavin; Yap, Damian; Farahani, Hossein; Gelmon, Karen; Chia, Stephen; Mar, Colin; Wan, Adrian; Laks, Emma; Biele, Justina; Shumansky, Karey; Rosner, Jamie; McPherson, Andrew; Nielsen, Cydney; Roth, Andrew J. L.; Lefebvre, Calvin; Bashashati, Ali; de Souza, Camila; Siu, Celia; Aniba, Radhouane; Brimhall, Jazmine; Oloumi, Arusha; Osako, Tomo; Bruna, Alejandra; Sandoval, Jose L.; Algara, Teresa; Greenwood, Wendy; Leung, Kaston; Cheng, Hongwei; Xue, Hui; Wang, Yuzhuo; Lin, Dong; Mungall, Andrew J.; Moore, Richard; Zhao, Yongjun; Lorette, Julie; Long Nguyen; Huntsman, David; Eaves, Connie J.; Hansen, Carl; Marra, Marco A.; Caldas, Carlos; Shah, Sohrab P.; Aparicio, Samuel			Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution	NATURE			English	Article							EVOLUTION; METASTASIS; INFERENCE; REVEALS; TUMORS; MODEL	Human cancers, including breast cancers, comprise clones differing in mutation content. Clones evolve dynamically in space and time following principles of Darwinian evolution(1,2), underpinning important emergent features such as drug resistance and metastasis(3-7). Human breast cancer xenoengraftment is used as a means of capturing and studying tumour biology, and breast tumour xenografts are generally assumed to be reasonable models of the originating tumours(8-10). However, the consequences and reproducibility of engraftment and propagation on the genomic clonal architecture of tumours have not been systematically examined at single-cell resolution. Here we show, using deep-genome and single-cell sequencing methods, the clonal dynamics of initial engraftment and subsequent serial propagation of primary and metastatic human breast cancers in immunodeficient mice. In all 15 cases examined, clonal selection on engraftment was observed in both primary and metastatic breast tumours, varying in degree from extreme selective engraftment of minor (<5% of starting population) clones to moderate, polyclonal engraftment. Furthermore, ongoing clonal dynamics during serial passaging is a feature of tumours experiencing modest initial selection. Through single-cell sequencing, we show that major mutation clusters estimated from tumour population sequencing relate predictably to the most abundant clonal genotypes, even in clonally complex and rapidly evolving cases. Finally, we show that similar clonal expansion patterns can emerge in independent grafts of the same starting tumour population, indicating that genomic aberrations can be reproducible determinants of evolutionary trajectories. Our results show that measurement of genomically defined clonal population dynamics will be highly informative for functional studies using patient-derived breast cancer xenoengraftment.	[Eirew, Peter; Steif, Adi; Khattra, Jaswinder; Ha, Gavin; Yap, Damian; Farahani, Hossein; Wan, Adrian; Laks, Emma; Biele, Justina; Shumansky, Karey; Rosner, Jamie; McPherson, Andrew; Nielsen, Cydney; Roth, Andrew J. L.; Lefebvre, Calvin; Bashashati, Ali; de Souza, Camila; Siu, Celia; Aniba, Radhouane; Brimhall, Jazmine; Oloumi, Arusha; Osako, Tomo; Algara, Teresa; Shah, Sohrab P.; Aparicio, Samuel] British Columbia Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Eirew, Peter; Steif, Adi; Khattra, Jaswinder; Ha, Gavin; Yap, Damian; Farahani, Hossein; Laks, Emma; Biele, Justina; McPherson, Andrew; Nielsen, Cydney; Roth, Andrew J. L.; Lefebvre, Calvin; Bashashati, Ali; Aniba, Radhouane; Oloumi, Arusha; Osako, Tomo; Algara, Teresa; Huntsman, David; Shah, Sohrab P.; Aparicio, Samuel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Gelmon, Karen; Chia, Stephen; Mar, Colin] British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada; [Bruna, Alejandra; Sandoval, Jose L.; Greenwood, Wendy; Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge CB2 2XZ, England; [Bruna, Alejandra; Sandoval, Jose L.; Greenwood, Wendy; Caldas, Carlos] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Leung, Kaston; Hansen, Carl] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Leung, Kaston; Hansen, Carl] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Cheng, Hongwei; Xue, Hui; Wang, Yuzhuo; Lin, Dong] British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 1L3, Canada; [Cheng, Hongwei; Xue, Hui; Wang, Yuzhuo; Lin, Dong] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Cheng, Hongwei; Xue, Hui; Wang, Yuzhuo; Lin, Dong] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Mungall, Andrew J.; Moore, Richard; Zhao, Yongjun; Marra, Marco A.; Shah, Sohrab P.; Aparicio, Samuel] Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Lorette, Julie; Huntsman, David; Aparicio, Samuel] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Long Nguyen; Eaves, Connie J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Long Nguyen; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency	Aparicio, S (corresponding author), British Columbia Canc Agcy, Dept Mol Oncol, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	sshah@bccrc.ca; saparicio@bccrc.ca	Steif, Adi/CAA-0180-2022; McPherson, Andrew W/J-6552-2015; Sandoval, José Luis/ABE-5022-2020; Ha, Gavin/N-1984-2019; Mungall, Andrew J./U-7067-2018; Huntsman, David/ABE-6082-2020; Caldas, Carlos/U-7250-2019; Marra, Marco A/B-5987-2008	McPherson, Andrew W/0000-0002-5654-5101; Sandoval, José Luis/0000-0002-6256-7083; Ha, Gavin/0000-0001-7578-7272; Mungall, Andrew J./0000-0002-0905-2742; Caldas, Carlos/0000-0003-3547-1489; Marra, Marco A/0000-0001-7146-7175; Eaves, Connie/0000-0002-3452-1926; Yap, Damian/0000-0002-5370-4592; Greenwood, Wendy F/0000-0002-2509-8695; Nguyen, Long/0000-0002-3347-438X; Wang, Yuzhuo/0000-0002-9749-8591; Bruna, Alejandra/0000-0003-1214-9665; Rosner, Jamie/0000-0001-8901-7228; Farahani, Hossein/0000-0002-9503-1875; Aparicio, Samuel/0000-0002-0487-9599	Canada Research Chairs; Michael Smith Foundation for Health Research (MSFHR) Fellowship; NSERC CREATE scholarship through the graduate program in Genome Science and Technology at UBC; BC Cancer Foundation; Canadian Breast Cancer Foundation; Canadian Cancer Society Research Institute; Terry Fox Research Institute; Genome Canada; Canadian Institutes for Health Research (CIHR); Cancer Research UK [16942] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	Canada Research Chairs(Canada Research ChairsCGIAR); Michael Smith Foundation for Health Research (MSFHR) Fellowship; NSERC CREATE scholarship through the graduate program in Genome Science and Technology at UBC; BC Cancer Foundation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Research Institute; Genome Canada(Genome Canada); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We are grateful to the staff of the CTAG Molecular Pathology facility, members of the Library Technical Development, Library Construction, Sequencing and Bioinformatics teams at the Michael Smith Genome Sciences Centre for technical assistance with data generation, and S. Kalloger for assistance with sample collection. S.A. and S.P.S. are supported by Canada Research Chairs. P.E. is supported by a Michael Smith Foundation for Health Research (MSFHR) Fellowship. A.S. is supported by an NSERC CREATE scholarship through the graduate program in Genome Science and Technology at UBC. S.P.S. is a MSFHR scholar. We acknowledge long-term funding support provided by the BC Cancer Foundation. The S.A., S.P.S. and C.H. groups receive operating funds from the Canadian Breast Cancer Foundation, Canadian Cancer Society Research Institute, Terry Fox Research Institute, Genome Canada and Canadian Institutes for Health Research (CIHR). We thank S. Mullaly for critical reading of the manuscript.	Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nolan-Stevaux O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067316; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081	24	443	455	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					422	426		10.1038/nature13952	http://dx.doi.org/10.1038/nature13952			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470049	Green Accepted			2022-12-28	WOS:000349547400047
J	Atala, A				Atala, Anthony			Human stem cell-derived retinal cells for macular diseases	LANCET			English	Editorial Material							PIGMENT EPITHELIUM; DEGENERATION		Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27103 USA	Wake Forest University; Wake Forest Baptist Medical Center	Atala, A (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, 300 S Hawthorne Rd, Winston Salem, NC 27103 USA.	aatala@wakehealth.edu						ALGVERE PV, 1994, GRAEF ARCH CLIN EXP, V232, P707, DOI 10.1007/BF00184273; Atala A, 2012, LANCET, V379, P689, DOI 10.1016/S0140-6736(12)60118-4; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Radtke ND, 2008, AM J OPHTHALMOL, V146, P172, DOI 10.1016/j.ajo.2008.04.009; Reardon S, 2014, NATURE, V513, P287, DOI 10.1038/513287a; Schwartz SD, 2014, LANCET; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Zamiri Parisa, 2007, Chem Immunol Allergy, V92, P86, DOI 10.1159/000099259	10	6	6	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					487	488		10.1016/S0140-6736(14)61820-1	http://dx.doi.org/10.1016/S0140-6736(14)61820-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA9AV	25458727				2022-12-28	WOS:000349213600007
J	Combes, SA				Combes, Stacey A. .			Dragonflies predict and plan their hunts	NATURE			English	Editorial Material							MODELS; PREY		Harvard Univ, Dept Organism & Evolutionary Biol, Concord Field Stn, Bedford, MA 01730 USA	Harvard University	Combes, SA (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Concord Field Stn, Bedford, MA 01730 USA.	scombes@oeb.harvard.edu						Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; Gonzalez-Bellido PT, 2013, P NATL ACAD SCI USA, V110, P696, DOI 10.1073/pnas.1210489109; Mehta B, 2002, J NEUROPHYSIOL, V88, P942, DOI 10.1152/jn.2002.88.2.942; Mischiati M, 2015, NATURE, V517, P333, DOI 10.1038/nature14045; Olberg RM, 2007, J COMP PHYSIOL A, V193, P685, DOI 10.1007/s00359-007-0223-0; Webb B, 2004, TRENDS NEUROSCI, V27, P278, DOI 10.1016/j.tins.2004.03.004; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	7	2	2	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 15	2015	517	7534					279	+		10.1038/nature14078	http://dx.doi.org/10.1038/nature14078			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY8NK	25487145				2022-12-28	WOS:000347810300028
J	Giosan, L; Syvitski, J; Constantinescu, S; Day, J				Giosan, Liviu; Syvitski, James; Constantinescu, Stefan; Day, John			Protect the world's deltas	NATURE			English	Editorial Material							MISSISSIPPI DELTA; RESTORATION; MANAGEMENT		[Giosan, Liviu] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Syvitski, James] Univ Colorado, Boulder, CO 80309 USA; [Syvitski, James] Int Geosphere Biosphere Programme, Bucharest, Romania; [Constantinescu, Stefan] Univ Bucharest, Bucharest, Romania; [Day, John] Louisiana State Univ, Baton Rouge, LA 70803 USA	Woods Hole Oceanographic Institution; University of Colorado System; University of Colorado Boulder; University of Bucharest; Louisiana State University System; Louisiana State University	Giosan, L (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	lgiosan@whoi.edu	Constantinescu, Stefan/D-9405-2011; Constantinescu, Stefan/N-1069-2019; Giosan, Liviu/F-1809-2010	Constantinescu, Stefan/0000-0002-0137-9054; Constantinescu, Stefan/0000-0002-0137-9054; Giosan, Liviu/0000-0001-6769-5204; Syvitski, Jaia/0000-0003-3116-6997; Constantinescu, Stefan/0000-0002-1699-1131				Blum MD, 2009, NAT GEOSCI, V2, P488, DOI 10.1038/ngeo553; Day J., 2014, PERSPECTIVES RESTORA; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; Giosan L, 2013, ANTHROPOCENE, V1, P35, DOI 10.1016/j.ancene.2013.09.001; Ibanez C, 2014, ECOL ENG, V65, P122, DOI 10.1016/j.ecoleng.2013.08.002; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kondolf GM, 2014, EARTHS FUTURE, V2, P256, DOI 10.1002/2013EF000184; Paola C, 2011, ANNU REV MAR SCI, V3, P67, DOI 10.1146/annurev-marine-120709-142856; Syvitski JPM, 2007, GLOBAL PLANET CHANGE, V57, P261, DOI 10.1016/j.gloplacha.2006.12.001; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629	10	339	347	8	119	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					31	33		10.1038/516031a	http://dx.doi.org/10.1038/516031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW5JD	25471866	Bronze			2022-12-28	WOS:000346310800019
J	Eccles, S; Pincus, C; Higgins, B; Woodhead, M				Eccles, Sinan; Pincus, Celia; Higgins, Bernard; Woodhead, Mark		Guideline Dev Grp	GUIDELINES Diagnosis and management of community and hospital acquired pneumonia in adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; ETIOLOGY; SOCIETY; UK		[Eccles, Sinan] Royal Gwent Hosp, Newport NP20 2UB, Gwent, Wales; [Pincus, Celia; Higgins, Bernard] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Higgins, Bernard] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Woodhead, Mark] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Dept Resp Med, Manchester, Lancs, England; [Woodhead, Mark] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England	Royal Gwent Hospital; Royal College of Physicians; Newcastle Freeman Hospital; Newcastle University - UK; University of Manchester; University of Manchester	Pincus, C (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	celia.pincus@rcplondon.ac.uk						Guest JF, 1997, EUR RESPIR J, V10, P1530, DOI 10.1183/09031936.97.10071530; LEU HS, 1989, AM J EPIDEMIOL, V129, P1258, DOI 10.1093/oxfordjournals.aje.a115245; Lim WS, 2011, THORAX, V66, P548, DOI 10.1136/thoraxjnl-2011-200081; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; MACFARLANE JT, 1993, LANCET, V341, P511, DOI 10.1016/0140-6736(93)90275-L; Masterton RG, 2008, J ANTIMICROB CHEMOTH, V62, P5, DOI 10.1093/jac/dkn162; McCabe C, 2009, ARCH INTERN MED, V169, P1525, DOI 10.1001/archinternmed.2009.259; Meehan TP, 2001, AM J MED, V111, P203, DOI 10.1016/S0002-9343(01)00803-8; National Institute for Health and Care Excellence, 2014, PNEUM INCL COMM ACQ; WOODHEAD MA, 1987, LANCET, V1, P671; [No title captured]	11	68	74	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 3	2014	349								g6722	10.1136/bmj.g6722	http://dx.doi.org/10.1136/bmj.g6722			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KN	25471702				2022-12-28	WOS:000346116600001
J	Marchingo, JM; Kan, A; Sutherland, RM; Duffy, KR; Wellard, CJ; Belz, GT; Lew, AM; Dowling, MR; Heinzel, S; Hodgkin, PD				Marchingo, Julia M.; Kan, Andrey; Sutherland, Robyn M.; Duffy, Ken R.; Wellard, Cameron J.; Belz, Gabrielle T.; Lew, Andrew M.; Dowling, Mark R.; Heinzel, Susanne; Hodgkin, Philip D.			Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansion	SCIENCE			English	Article							NAIVE; ACTIVATION; MODEL; DIFFERENTIATION; STIMULATION; INDUCTION; RESPONSES; DIVISION; SIGNAL	T cell responses are initiated by antigen and promoted by a range of costimulatory signals. Understanding how T cells integrate alternative signal combinations and make decisions affecting immune response strength or tolerance poses a considerable theoretical challenge. Here, we report that T cell receptor (TCR) and costimulatory signals imprint an early, cell-intrinsic, division fate, whereby cells effectively count through generations before returning automatically to a quiescent state. This autonomous program can be extended by cytokines. Signals from the TCR, costimulatory receptors, and cytokines add together using a linear division calculus, allowing the strength of a T cell response to be predicted from the sum of the underlying signal components. These data resolve a long-standing costimulation paradox and provide a quantitative paradigm for therapeutically manipulating immune response strength.	[Marchingo, Julia M.; Kan, Andrey; Sutherland, Robyn M.; Wellard, Cameron J.; Belz, Gabrielle T.; Lew, Andrew M.; Dowling, Mark R.; Heinzel, Susanne; Hodgkin, Philip D.] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia; [Marchingo, Julia M.; Kan, Andrey; Sutherland, Robyn M.; Wellard, Cameron J.; Belz, Gabrielle T.; Lew, Andrew M.; Dowling, Mark R.; Heinzel, Susanne; Hodgkin, Philip D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Duffy, Ken R.] Natl Univ Ireland, Hamilton Inst, Maynooth, Kildare, Ireland; [Dowling, Mark R.] Royal Melbourne Hosp, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute; University of Melbourne; Maynooth University; Royal Melbourne Hospital	Hodgkin, PD (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia.	hodgkin@wehi.edu.au	Duffy, Ken/D-7955-2011; Belz, Gabrielle T/C-9350-2013; Marchingo, Julia/AAQ-6970-2021; Lew, Andrew/C-7248-2013	Duffy, Ken/0000-0001-5587-9356; Belz, Gabrielle T/0000-0002-9660-9587; Heinzel, Susanne/0000-0001-9524-2835; Lew, Andrew/0000-0002-2198-8164; Dowling, Mark/0000-0002-8056-5348; Hodgkin, Philip/0000-0002-8604-1940; Marchingo, Julia/0000-0001-8823-9718; Wellard, Cameron/0000-0002-6115-5394	National Health and Medical Research Council (NHMRC) [1010654, 1043414, 1054925, 1037321]; Human Frontier Science Program [RGP0060/2012]; Australian Research Council Future Fellowship; Science Foundation Ireland [12IP1263]; Australian Postgraduate Award; Walter and Eliza Hall Institute Edith Moffat Scholarship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program(Human Frontier Science Program); Australian Research Council Future Fellowship(Australian Research Council); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Australian Postgraduate Award(Australian Government); Walter and Eliza Hall Institute Edith Moffat Scholarship	We thank S. Turner for providing the recombinant influenza virus and discussion and comments on the manuscript; L. Corcoran and V. Bryant for discussion and comments on the manuscript; A. Giang for discussion of experiments; M. Camilleri, L. Mackiewicz, M. Dayton, and D. Pavlyshyn for technical assistance; and P. Bouillet for Bcl2l11<SUP>-/-</SUP> mice. Fucci Red and Fucci Green mice were provided by the Riken BioResource Centre through the National BioResource Project of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We also thank K. Lafferty and his two-signal theory for inspiring this work. The data are tabulated in the main paper and in the supplementary materials. Experimental data and the code for fitting the Cyton model will be made available upon request. This work was supported by the National Health and Medical Research Council (NHMRC) through project grants 1010654 and 1043414, program grants 1054925 and 1037321, and fellowships to M. R. D., A. M. L., and P. D. H., K. R. D. and P. D. H. were supported by Human Frontier Science Program grant RGP0060/2012, G. T. B. was supported by an Australian Research Council Future Fellowship, and K. R. D. was supported by Science Foundation Ireland grant 12IP1263. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme. J.M.M. was the recipient of an Australian Postgraduate Award and a Walter and Eliza Hall Institute Edith Moffat Scholarship.	Baxter AG, 2002, NAT REV IMMUNOL, V2, P439, DOI 10.1038/nri823; Bertram EM, 2004, SEMIN IMMUNOL, V16, P185, DOI 10.1016/j.smim.2004.02.006; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Deenick EK, 2003, J IMMUNOL, V170, P4963, DOI 10.4049/jimmunol.170.10.4963; Denton AE, 2011, J IMMUNOL, V187, P5733, DOI 10.4049/jimmunol.1003937; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Dowling MR, 2014, P NATL ACAD SCI USA, V111, P6377, DOI 10.1073/pnas.1322420111; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; GRAVESTEIN LA, 1995, INT IMMUNOL, V7, P551, DOI 10.1093/intimm/7.4.551; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hawkins ED, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3406; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hommel M, 2007, J IMMUNOL, V179, P2250, DOI 10.4049/jimmunol.179.4.2250; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kinnear G, 2013, TRANSPLANTATION, V95, P527, DOI 10.1097/TP.0b013e31826d4672; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; Oxenius A, 1999, J IMMUNOL, V162, P965; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Tomura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073801; Turner ML, 2008, J IMMUNOL, V181, P374, DOI 10.4049/jimmunol.181.1.374; van Gisbergen KPJM, 2011, IMMUNITY, V35, P97, DOI 10.1016/j.immuni.2011.04.020; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	27	134	136	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1123	1127		10.1126/science.1260044	http://dx.doi.org/10.1126/science.1260044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430770	Green Published			2022-12-28	WOS:000345763400045
J	Schulz, C; Rehling, P				Schulz, Christian; Rehling, Peter			Powering the cell cycle	SCIENCE			English	Editorial Material							CONTACT SITES; MITOCHONDRIA; FUSION; VACUOLES; YEAST		[Schulz, Christian; Rehling, Peter] Univ Med Ctr Gottingen, Dept Cellular Biochem, D-37073 Gottingen, Germany; [Rehling, Peter] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	University of Gottingen; Max Planck Society	Schulz, C (corresponding author), Univ Med Ctr Gottingen, Dept Cellular Biochem, D-37073 Gottingen, Germany.	peter.rehling@medizin.uni-goettingen.de	Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797				Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Harbauer AB, 2014, SCIENCE, V346, P1109, DOI 10.1126/science.1261253; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Klecker T, 2014, TRENDS CELL BIOL, V24, P537, DOI 10.1016/j.tcb.2014.04.004; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Rohn JL, 2014, CURR BIOL, V24, P2598, DOI 10.1016/j.cub.2014.09.045; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; Sing A., 2014, SCIENCE, P1293; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012	15	2	2	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1059	1060		10.1126/science.aaa2313	http://dx.doi.org/10.1126/science.aaa2313			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430757				2022-12-28	WOS:000345763400023
J	Altman, DG; Bland, JM				Altman, Douglas G.; Bland, J. Martin			STATISTICS NOTES Uncertainty and sampling error	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Oxford; University of York - UK	Altman, DG (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England.	doug.altman@csm.ox.ac.uk			Cancer Research UK [16895] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Altman DG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7065; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Richards DA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4913; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226	5	11	8	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2014	349								g7064	10.1136/bmj.g7064	http://dx.doi.org/10.1136/bmj.g7064			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KE	25424395	Bronze, Green Published			2022-12-28	WOS:000346115600010
J	Howard, LM; Piot, P; Stein, A				Howard, Louise M.; Piot, Peter; Stein, Alan			No health without perinatal mental health	LANCET			English	Editorial Material									[Howard, Louise M.] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, London WC2R 2LS, England; [Piot, Peter] London Sch Hyg & Trop Med, Off Director, London WC1, England; [Stein, Alan] Univ Oxford, Dept Psychiat, Sect Child & Adolescent Psychiat, Oxford OX3 7JX, England; [Stein, Alan] Univ Witwatersrand, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa	University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Witwatersrand	Stein, A (corresponding author), Univ Oxford, Dept Psychiat, Sect Child & Adolescent Psychiat, Oxford OX3 7JX, England.	alan.stein@psych.ox.ac.uk	Howard, Louise/E-3495-2010	Howard, Louise/0000-0001-9942-744X; Stein, Alan/0000-0001-8207-2822				4World Health Organization and Calouste Gulbenkian Foundation, 2014, SOC DET MENT HLTH; Bauer A, 2014, COSTS PERINATAL MENT; Carneiro P., 2003, 9495 NBER; Farrelly S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-157; Fuhr DC, 2014, LANCET PSYCHIAT, V1, P213, DOI 10.1016/S2215-0366(14)70282-2; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Howard LM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001452; Jones I, 2014, LANCET, V384, P1789, DOI 10.1016/S0140-6736(14)61278-2; Latin American and Caribbean Demographic Centre CELADE, 2012, WORLD POP LAT AM CAR; National Institute for Health and Care Excellence, 2014, ANT POSTN MENT HLTH; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Pearson R, 2013, NY TIMES BK REV, P18; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Thornicroft G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5189	15	87	89	1	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1723	1724		10.1016/S0140-6736(14)62040-7	http://dx.doi.org/10.1016/S0140-6736(14)62040-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KX	25455235				2022-12-28	WOS:000345116400005
J	Howard, LM; Molyneaux, E; Dennis, CL; Rochat, T; Stein, A; Milgrom, J				Howard, Louise M.; Molyneaux, Emma; Dennis, Cindy-Lee; Rochat, Tamsen; Stein, Alan; Milgrom, Jeannette			Perinatal mental health 1 Non-psychotic mental disorders in the perinatal period	LANCET			English	Article							SEROTONIN REUPTAKE INHIBITORS; MIDDLE-INCOME COUNTRIES; POSTTRAUMATIC-STRESS-DISORDER; POSTNATAL DEPRESSION SCALE; PRENATAL ANTIDEPRESSANT EXPOSURE; CORTICOTROPIN-RELEASING HORMONE; OBSESSIVE-COMPULSIVE DISORDER; COGNITIVE-BEHAVIORAL THERAPY; POSTPARTUM DEPRESSION; EATING-DISORDERS	Mental disorders are among the most common morbidities of pregnancy and the postnatal period, and can have adverse effects on the mother, her child, and family. This Series paper summarises the evidence about epidemiology, risk factors, identification, and interventions for non-psychotic mental disorders. Although the phenomenology and risk factors for perinatal mental disorders are largely similar to those for the disorders at other times, treatment considerations differ during pregnancy and breastfeeding. Most randomised controlled trials have examined psychosocial and psychological interventions for postnatal depression, with evidence for effectiveness in treating and preventing the disorder. Few high-quality studies exist on the effectiveness or safety of pharmacological treatments in the perinatal period, despite quite high prescription rates. General principles of prescribing of drugs in the perinatal period are provided, but individual risk-benefit analyses are needed for decisions about treatment.	[Howard, Louise M.; Molyneaux, Emma] Kings Coll London, Hlth Serv, London SE5 8AF, England; [Howard, Louise M.; Molyneaux, Emma] Kings Coll London, Populat Res Dept, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England; [Dennis, Cindy-Lee] Univ Toronto, Toronto, ON, Canada; [Dennis, Cindy-Lee] Womens Coll, Res Inst, Toronto, ON, Canada; [Rochat, Tamsen] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Stein, Alan] Univ Oxford, Dept Psychiat, Oxford, England; [Stein, Alan] Univ Witwatersrand, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Milgrom, Jeannette] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, VA, Australia	University of London; King's College London; University of London; King's College London; University of Toronto; University of Toronto; Women's College Research Institute; University of Kwazulu Natal; University of Oxford; University of Witwatersrand; University of Melbourne	Howard, LM (corresponding author), Kings Coll London, Hlth Serv, London SE5 8AF, England.	louise.howard@kcl.ac.uk	Howard, Louise/E-3495-2010; Dennis, Cindy-Lee/ABA-2860-2020; Rochat, Tamsen/AAU-5756-2021	Howard, Louise/0000-0001-9942-744X; Dennis, Cindy-Lee/0000-0002-0135-7242; Rochat, Tamsen/0000-0002-5223-770X; Stein, Alan/0000-0001-8207-2822; Molyneaux, Emma/0000-0002-0696-5511	ad; Chair of the National Institute for Health and Care Excellence; Chief Investigator of an National Institute of Health Research (NIHR) Programme [RP-RP-DG-1108-10012]; NIHR [NIHR-RP-R3-12-011]; Tommy's baby charity; NIHR Mental Health Biomedical Research Centre at the South London; Maudsley UK National Health Service (NHS) Foundation Trust and King's College London; Medical Research Council; Grand Challenges Canada [0063-03]; Wellcome Trust [097410/Z/11/Z, 090139]; National Institute of Health [1R01HD074267-01]; Barclay Foundation; Department of Education (UK)	ad; Chair of the National Institute for Health and Care Excellence; Chief Investigator of an National Institute of Health Research (NIHR) Programme; NIHR(National Institute for Health Research (NIHR)); Tommy's baby charity; NIHR Mental Health Biomedical Research Centre at the South London; Maudsley UK National Health Service (NHS) Foundation Trust and King's College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grand Challenges Canada(CGIAR); Wellcome Trust(Wellcome Trust); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barclay Foundation; Department of Education (UK)	LMH is Chair of the National Institute for Health and Care Excellence (update) guideline on Antenatal and Postnatal Mental Health, and Chief Investigator of an National Institute of Health Research (NIHR) Programme Grant for Applied Research on the effectiveness of perinatal mental health services (RP-RP-DG-1108-10012) which also supports JM. LMH receives funding from an NIHR Research Professorship on maternal mental health (NIHR-RP-R3-12-011), and a grant from Tommy's baby charity (with the support of a corporate social responsibility grant from Johnson and Johnson) on antipsychotics in pregnancy. LMH is also supported by the NIHR Mental Health Biomedical Research Centre at the South London and Maudsley UK National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the author and not necessarily those of the NHS, the NIHR, or the Department of Health. EM is supported by a Medical Research Council PhD Studentship and Tommy's baby charity. TR receives salary support from Grand Challenges Canada (Grant Number 0063-03), the Wellcome Trust (Grant Number 097410/Z/11/Z) and National Institute of Health (1R01HD074267-01). AS has received many grants in relation to parental perinatal health and child development including from the Wellcome Trust (090139), Medical Research Council UK, Barclay Foundation, Grand Challenges (Canada), and The Department of Education (UK). We declare no other competing interests.	Adewuya AO, 2006, BJOG-INT J OBSTET GY, V113, P284, DOI 10.1111/j.1471-0528.2006.00861.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Andersen LB, 2012, ACTA OBSTET GYN SCAN, V91, P1261, DOI 10.1111/j.1600-0412.2012.01476.x; Appleby L, 1997, BRIT MED J, V314, P932, DOI 10.1136/bmj.314.7085.932; Austin MP, 2008, J AFFECT DISORDERS, V105, P35, DOI 10.1016/j.jad.2007.04.001; Austin MP, 2003, ACTA PSYCHIAT SCAND, V107, P10, DOI 10.1034/j.1600-0447.2003.02024.x; Ayers S, 2004, CLIN OBSTET GYNECOL, V47, P552, DOI 10.1097/01.grf.0000129919.00756.9c; Ban L, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656801; Berle JO, 2011, CURR WOMENS HEALTH R, V7, P28, DOI 10.2174/157340411794474784; Beyondblue: the national depression initiative, 2011, CLIN PRACT GUID DEPR; Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924; Borjesson K, 2005, ARCH WOMEN MENT HLTH, V8, P232, DOI 10.1007/s00737-005-0086-8; Brealey SD, 2010, J REPROD INFANT PSYC, V28, P328, DOI 10.1080/02646838.2010.513045; Buist A, 2011, J AFFECT DISORDERS, V131, P277, DOI 10.1016/j.jad.2011.01.003; Bulik CM, 2007, PSYCHOL MED, V37, P1109, DOI 10.1017/S0033291707000724; Burns A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-33; Buttner MM, 2013, ARCH WOMEN MENT HLTH, V16, P219, DOI 10.1007/s00737-012-0323-x; Challacombe FL, 2011, BEHAV RES THER, V49, P422, DOI 10.1016/j.brat.2011.03.006; Clarke K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001541; Clatworthy J, 2012, J AFFECT DISORDERS, V137, P25, DOI 10.1016/j.jad.2011.02.029; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Collins CH, 2011, ARCH WOMEN MENT HLTH, V14, P3, DOI 10.1007/s00737-010-0198-7; COOPER PJ, 1995, BRIT J PSYCHIAT, V166, P191, DOI 10.1192/bjp.166.2.191; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Craig MC, 2013, BRIT J PSYCHIAT, V202, P9, DOI 10.1192/bjp.bp.111.102855; Croen LA, 2011, ARCH GEN PSYCHIAT, V68, P1104, DOI 10.1001/archgenpsychiatry.2011.73; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dennis Cindy-Lee, 2013, Cochrane Database Syst Rev, pCD001134, DOI 10.1002/14651858.CD001134.pub3; Dennis CL, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001690.pub2; Dennis CL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006795.pub3; Dukhovny D, 2013, AM J PERINAT, V30, P631, DOI 10.1055/s-0032-1331029; Easter A, 2011, BJOG-INT J OBSTET GY, V118, P1491, DOI 10.1111/j.1471-0528.2011.03077.x; Engineer N, 2013, J PSYCHIATR RES, V47, P1166, DOI 10.1016/j.jpsychires.2013.05.003; Epperson N, 2001, AM J PSYCHIAT, V158, P1631, DOI 10.1176/appi.ajp.158.10.1631; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Forty L, 2006, AM J PSYCHIAT, V163, P1549, DOI 10.1176/appi.ajp.163.9.1549; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Furuta M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-125; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Goodman JH, 2004, JOGNN-J OBST GYN NEO, V33, P410, DOI 10.1177/0884217504266915; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Government of South Australia, 2010, S AUSTR PER PRACT GU; Gregoire AJP, 1996, LANCET, V347, P930, DOI 10.1016/S0140-6736(96)91414-2; Grigoriadis S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f6932; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE293, DOI 10.4088/JCP.12r07966; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE309, DOI 10.4088/JCP.12r07967; Grote NK, 2009, PSYCHIAT SERV, V60, P313, DOI 10.1176/appi.ps.60.3.313; Hanley GE, 2013, EARLY HUM DEV, V89, P519, DOI 10.1016/j.earlhumdev.2012.12.012; Hanley GE, 2012, BIRTH DEFECTS RES A, V94, P651, DOI 10.1002/bdra.23032; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Hanlon C, 2010, BRIT J PSYCHIAT, V197, P468, DOI 10.1192/bjp.bp.109.076497; Hayes RM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.028; Henshaw C., 2003, ARCH WOMEN MENT HLTH, V6, pS33, DOI [10.1007/s00737-003-0004-x, DOI 10.1007/S00737-003-0004-X]; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Hewitt CE, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13360; Howard LM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001452; Hunter SK, 2012, AM J PSYCHIAT, V169, P616, DOI 10.1176/appi.ajp.2012.11091365; Hviid A, 2013, NEW ENGL J MED, V369, P2406, DOI 10.1056/NEJMoa1301449; Jimenez-Solem E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001148; Jimenez-Solem E, 2013, AM J PSYCHIAT, V170, P299, DOI 10.1176/appi.ajp.2012.11081251; Jones I, 2014, LANCET, V384, P1789, DOI 10.1016/S0140-6736(14)61278-2; Kieviet N, 2013, NEUROPSYCH DIS TREAT, V9, P1257, DOI 10.2147/NDT.S36394; Klinger G, 2011, J PERINATOL, V31, P615, DOI 10.1038/jp.2010.211; Knoph C, 2013, INT J EAT DISORDER, V46, P355, DOI 10.1002/eat.22088; Ko JY, 2012, J WOMENS HEALTH, V21, P830, DOI 10.1089/jwh.2011.3466; Koren G, 2005, CAN MED ASSOC J, V172, P1457, DOI 10.1503/cmaj.1041100; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Leung SSL, 2011, J PUBLIC HEALTH-UK, V33, P292, DOI 10.1093/pubmed/fdq075; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Lydsdottir LB, 2014, J CLIN PSYCHIAT, V75, P393, DOI 10.4088/JCP.13m08646; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; Marc I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007559.pub2; Micali N, 2007, J PSYCHOSOM RES, V63, P297, DOI 10.1016/j.jpsychores.2007.05.003; Micali N, 2011, J AFFECT DISORDERS, V131, P150, DOI 10.1016/j.jad.2010.09.034; Midmer D, 1995, Fam Med, V27, P200; Milgrom J, 2005, AUST NZ J PSYCHIAT, V39, P833, DOI 10.1111/j.1440-1614.2005.01660.x; Milgrom J, 2011, J AFFECT DISORDERS, V130, P385, DOI 10.1016/j.jad.2010.10.045; Miller BJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009104.pub2; Misri S, 2006, AM J PSYCHIAT, V163, P1026, DOI 10.1176/appi.ajp.163.6.1026; Misri S, 2004, J CLIN PSYCHIAT, V65, P1236, DOI 10.4088/JCP.v65n0913; Molyneaux E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002018.pub2; Morrell CJ, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI [10.3310/hta13300, 10.3310/htal3300]; Munk-Olsen T, 2006, JAMA-J AM MED ASSOC, V296, P2582, DOI 10.1001/jama.296.21.2582; Myers E.R., 2013, EFFICACY SAFETY SCRE; Myles N, 2013, AUST NZ J PSYCHIAT, V47, P1002, DOI 10.1177/0004867413492219; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; National Institute for Health and Clinical Excellence, 2011, GEN ANX DIS AD MAN P; National Institute for Health and Clinical Excellence, 2005, POSTTR STRESS DIS MA; Nulman I, 2012, AM J PSYCHIAT, V169, P1165, DOI 10.1176/appi.ajp.2012.11111721; Nylen KJ, 2013, ARCH WOMEN MENT HLTH, V16, P203, DOI 10.1007/s00737-013-0334-2; O'Hara MW, 2012, J WOMENS HEALTH, V21, P1237, DOI 10.1089/jwh.2012.3612; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Parsons CE, 2012, BRIT MED BULL, V101, P57, DOI 10.1093/bmb/ldr047; Paulden M, 2010, BMJ-BRIT MED J, V340, pb5203; Pedersen LH, 2013, ACTA PSYCHIAT SCAND, V127, P126, DOI 10.1111/acps.12032; Pedersen LH, 2010, PEDIATRICS, V125, pE600, DOI 10.1542/peds.2008-3655; Petersen I, 2011, J CLIN PSYCHIAT, V72, P979, DOI 10.4088/JCP.10m06090blu; Rahman A, 2013, B WORLD HEALTH ORGAN, V91, P593, DOI 10.2471/BLT.12.109819; Rai D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2059; Richter J, 2012, J PSYCHOSOM OBST GYN, V33, P162, DOI 10.3109/0167482X.2012.729111; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Rochat TJ, 2013, ARCH WOMEN MENT HLTH, V16, P401, DOI 10.1007/s00737-013-0353-z; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Ross LE, 2011, HUM REPROD UPDATE, V17, P96, DOI 10.1093/humupd/dmq025; Ross LE, 2009, J WOMENS HEALTH, V18, P475, DOI 10.1089/jwh.2008.0953; Rowan C, 2007, WORLDV EVID-BASED NU, V4, P97, DOI 10.1111/j.1741-6787.2007.00088.x; Russell EJ, 2013, J CLIN PSYCHIAT, V74, P377, DOI 10.4088/JCP.12r07917; Sawyer A, 2010, J AFFECT DISORDERS, V123, P17, DOI 10.1016/j.jad.2009.06.027; Scottish Intercollegiate Guidelines Network (SIGN), 2012, MAN PER MOOD DIS; Seng JS, 2010, J PSYCHOSOM OBST GYN, V31, P176, DOI 10.3109/0167482X.2010.486453; Senturk V, 2012, J AFFECT DISORDERS, V136, P340, DOI 10.1016/j.jad.2011.11.028; Shidhaye R, 2013, INT REV PSYCHIATR, V25, P65, DOI 10.3109/09540261.2012.748651; Skalkidou A, 2009, PSYCHONEUROENDOCRINO, V34, P1329, DOI 10.1016/j.psyneuen.2009.04.003; Soares RM, 2009, INT J EAT DISORDER, V42, P387, DOI 10.1002/eat.20643; Stein A, 1996, PSYCHOSOM MED, V58, P321, DOI 10.1097/00006842-199607000-00004; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Stephansson O, 2013, JAMA-J AM MED ASSOC, V309, P48, DOI 10.1001/jama.2012.153812; Taylor D.M., 2018, MAUDSLEY PRESCRIBING, V13th ed.); Timpano KR, 2011, J PSYCHIATR RES, V45, P1511, DOI 10.1016/j.jpsychires.2011.06.015; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Tsai AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082521; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Vigod SN, 2010, BJOG-INT J OBSTET GY, V117, P540, DOI 10.1111/j.1471-0528.2009.02493.x; Villegas L, 2011, J RURAL HEALTH, V27, P278, DOI 10.1111/j.1748-0361.2010.00339.x; Weikum WM, 2013, INFANT BEHAV DEV, V36, P485, DOI 10.1016/j.infbeh.2013.04.001; Weissman AM, 2004, AM J PSYCHIAT, V161, P1066, DOI 10.1176/appi.ajp.161.6.1066; Wisner KL, 2013, JAMA PSYCHIAT, V70, P490, DOI 10.1001/jamapsychiatry.2013.87; Wisner KL, 2004, J AFFECT DISORDERS, V78, P249, DOI 10.1016/S0165-0327(02)00305-1; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.; Yawn BP, 2012, ANN FAM MED, V10, P320, DOI 10.1370/afm.1418; Yim IS, 2009, ARCH GEN PSYCHIAT, V66, P162, DOI 10.1001/archgenpsychiatry.2008.533; Yonkers KA, 2011, EPIDEMIOLOGY, V22, P848, DOI 10.1097/EDE.0b013e3182306847	133	563	575	9	136	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1775	1788		10.1016/S0140-6736(14)61276-9	http://dx.doi.org/10.1016/S0140-6736(14)61276-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KX	25455248				2022-12-28	WOS:000345116400029
J	Baker, KS; Mather, AE; McGregor, H; Coupland, P; Langridge, GC; Day, M; Deheer-Graham, A; Parkhill, J; Russell, JE; Thomson, NR				Baker, Kate S.; Mather, Alison E.; McGregor, Hannah; Coupland, Paul; Langridge, Gemma C.; Day, Martin; Deheer-Graham, Ana; Parkhill, Julian; Russell, Julie E.; Thomson, Nicholas R.			The extant World War 1 dysentery bacillus NCTC1: a genomic analysis	LANCET			English	Article							GLOBAL ENTERIC MULTICENTER; SHIGELLA-SONNEI; DIARRHEAL DISEASE; ESCHERICHIA-COLI; RESISTANCE; SUSCEPTIBILITY; PATHOGENICITY; EVOLUTION; PLASMIDS; SEQUENCE	Background Shigellosis (previously bacillary dysentery) was the primary diarrhoeal disease of World War 1, but outbreaks still occur in military operations, and shigellosis causes hundreds of thousands of deaths per year in developing nations. We aimed to generate a high-quality reference genome of the historical Shigella flexneri isolate NCTC1 and to examine the isolate for resistance to antimicrobials. Methods In this genomic analysis, we sequenced the oldest extant Shigella flexneri serotype 2a isolate using single-molecule real-time (SMRT) sequencing technology. Isolated from a soldier with dysentery from the British forces fighting on the Western Front in World War 1, this bacterium, NCTC1, was the first isolate accessioned into the National Collection of Type Cultures. We created a reference sequence for NCTC1, investigated the isolate for antimicrobial resistance, and undertook comparative genetics with S flexneri reference strains isolated during the 100 years since World War 1. Findings We discovered that NCTC1 belonged to a 2a lineage of S flexneri, with which it shares common characteristics and a large core genome. NCTC1 was resistant to penicillin and erythromycin, and contained a complement of chromosomal antimicrobial resistance genes similar to that of more recent isolates. Genomic islands gained in the S flexneri 2a lineage over time were predominately associated with additional antimicrobial resistances, virulence, and serotype conversion. Interpretation This S flexneri 2a lineage is a well adapted pathogen that has continued to respond to selective pressures. We have created a valuable historical benchmark for shigellae in the form of a high-quality reference sequence for a publicly available isolate. Copyright (C) Baker et al.	[Baker, Kate S.; Mather, Alison E.; Coupland, Paul; Langridge, Gemma C.; Parkhill, Julian; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [McGregor, Hannah; Deheer-Graham, Ana; Russell, Julie E.] Publ Hlth England, Natl Collect Type Cultures, Salisbury, Wilts, England; [Day, Martin] Publ Hlth England, Gastrointestinal Bacteria Reference Unit, London, England; [Thomson, Nicholas R.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	Wellcome Trust Sanger Institute; Public Health England; Public Health England; University of London; London School of Hygiene & Tropical Medicine	Thomson, NR (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	nrt@sanger.ac.uk	Parkhill, Julian/G-4703-2011; Thomson, Nicholas R/P-5988-2014; Baker, Kate/P-2087-2016	Parkhill, Julian/0000-0002-7069-5958; Thomson, Nicholas R/0000-0002-4432-8505; Baker, Kate/0000-0001-5850-1949; Langridge, Gemma/0000-0001-8037-2741; Coupland, Paul/0000-0002-2871-3374	Wellcome Trust; Wellcome Trust [098051]	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Claire Jenkins from the Gastrointestinal Bacteria Reference Unit, Public Health England, Colindale, for antimicrobial resistance testing and other staff at the Wellcome Trust Sanger Institute (WTSI), including David Harris, members of the sequencing teams, and other support staff. Authors from the WTSI (KSB, AEM, PC, GCL, JP, and NRT) were supported by the Wellcome Trust (grant number 098051).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDREWES F. W., 1919, Special Reports Series; Ashton PM, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-7; Barlow M, 2002, J MOL EVOL, V55, P314, DOI 10.1007/s00239-002-2328-y; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; COHEN D, 1991, J CLIN MICROBIOL, V29, P386, DOI 10.1128/JCM.29.2.386-389.1991; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; DATTA N, 1983, NATURE, V306, P616, DOI 10.1038/306616a0; Devault AM, 2014, NEW ENGL J MED, V370, P334, DOI 10.1056/NEJMoa1308663; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Flexner S., 1900, PHILA MED J, V6, P414; HALE TL, 1991, MICROBIOL REV, V55, P206, DOI 10.1128/MMBR.55.2.206-224.1991; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; HYAMS KC, 1991, NEW ENGL J MED, V325, P1423, DOI 10.1056/NEJM199111143252006; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Kothary MH, 2001, J FOOD SAFETY, V21, P49, DOI 10.1111/j.1745-4565.2001.tb00307.x; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LINDBERG F, 1986, REV INFECT DIS, V8, pS292; Linton DS, 2010, B HIST MED, V84, P607, DOI 10.1353/bhm.2010.0036; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468; Mather AE, 2014, LANCET, V384, P1720, DOI 10.1016/S0140-6736(14)61790-6; Mavris M, 1997, MOL MICROBIOL, V26, P939, DOI 10.1046/j.1365-2958.1997.6301997.x; OLSSON O, 1983, P NATL ACAD SCI-BIOL, V80, P7556, DOI 10.1073/pnas.80.24.7556; Quail MA, 2012, NAT METHODS, V9, P10, DOI 10.1038/nmeth.1814; Rahman M, 2007, J HEALTH POPUL NUTR, V25, P158; Rajakumar K, 1997, INFECT IMMUN, V65, P4606, DOI 10.1128/IAI.65.11.4606-4614.1997; SANSONETTI P, 1980, CR ACAD SCI D NAT, V290, P879; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Scheibye-Alsing K, 2009, COMPUT BIOL CHEM, V33, P121, DOI 10.1016/j.compbiolchem.2008.11.003; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shiga K, 1898, ZENTRALBL BAKTERIOL, V23, P599; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thornton SA, 2005, CLIN INFECT DIS, V40, P519, DOI 10.1086/427501; Vrints M, 2009, J CLIN MICROBIOL, V47, P1379, DOI 10.1128/JCM.02460-08; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Welcome Trust Sangar Institute, SMALT; Yang J, 2007, J MOL EVOL, V64, P71, DOI 10.1007/s00239-006-0052-8; Ye CY, 2010, J CLIN MICROBIOL, V48, P419, DOI 10.1128/JCM.00614-09; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang N, 2014, J CLIN MICROBIOL, V52, P1119, DOI 10.1128/JCM.02669-13	45	22	22	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1691	1697		10.1016/S0140-6736(14)61789-X	http://dx.doi.org/10.1016/S0140-6736(14)61789-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KU	25441199	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000345116200031
J	Boelens, MC; Wu, TJ; Nabet, BY; Xu, B; Qiu, Y; Yoon, T; Azzam, DJ; Victor, CTS; Wiemann, BZ; Ishwaran, H; ter Brugge, PJ; Jonkers, J; Slingerland, J; Minn, AJ				Boelens, Mirjam C.; Wu, Tony J.; Nabet, Barzin Y.; Xu, Bihui; Qiu, Yu; Yoon, Taewon; Azzam, Diana J.; Victor, Christina Twyman-Saint; Wiemann, Brianne Z.; Ishwaran, Hemant; ter Brugge, Petra J.; Jonkers, Jos; Slingerland, Joyce; Minn, Andy J.			Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways	CELL			English	Article							GENE-EXPRESSION; STEM-CELLS; TUMORS; MICROVESICLES; NOTCH; RNAS; RECEPTORS; MICRORNAS; SIGNATURE; MECHANISM	Stromal communication with cancer cells can influence treatment response. We show that stromal and breast cancer (BrCa) cells utilize paracrine and juxtacrine signaling to drive chemotherapy and radiation resistance. Upon heterotypic interaction, exosomes are transferred from stromal to BrCa cells. RNA within exosomes, which are largely noncoding transcripts and transposable elements, stimulates the pattern recognition receptor RIG-I to activate STAT1-dependent antiviral signaling. In parallel, stromal cells also activate NOTCH3 on BrCa cells. The paracrine antiviral and juxtacrine NOTCH3 pathways converge as STAT1 facilitates transcriptional responses to NOTCH3 and expands therapy-resistant tumor-initiating cells. Primary human and/or mouse BrCa analysis support the role of antiviral/NOTCH3 pathways in NOTCH signaling and stroma-mediated resistance, which is abrogated by combination therapy with gamma secretase inhibitors. Thus, stromal cells orchestrate an intricate crosstalk with BrCa cells by utilizing exosomes to instigate antiviral signaling. This expands BrCa subpopulations adept at resisting therapy and reinitiating tumor growth.	[Boelens, Mirjam C.; Wu, Tony J.; Nabet, Barzin Y.; Xu, Bihui; Qiu, Yu; Yoon, Taewon; Wiemann, Brianne Z.; Minn, Andy J.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Victor, Christina Twyman-Saint] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Boelens, Mirjam C.; Wu, Tony J.; Nabet, Barzin Y.; Xu, Bihui; Qiu, Yu; Yoon, Taewon; Victor, Christina Twyman-Saint; Minn, Andy J.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Ishwaran, Hemant] Univ Miami, Miller Sch Med, Div Biostat, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Azzam, Diana J.; Slingerland, Joyce] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Braman Family Breast Canc Inst Sylvester,Sylveste, Miami, FL 33136 USA; [Slingerland, Joyce] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol, NL-1066 CX Amsterdam, Netherlands	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Miami; University of Miami; University of Miami; Netherlands Cancer Institute	Minn, AJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA.	andyminn@exchange.upenn.edu	Azzam, Diana/ABB-8342-2021; Jonkers, Jos/AAG-3246-2019	Azzam, Diana/0000-0002-2605-8855; Jonkers, Jos/0000-0002-9264-9792; Minn, Andy/0000-0003-1418-0906; Twyman-Saint Victor, Christina/0000-0001-7253-6179; Ishwaran, Hemant/0000-0003-2758-9647; Nabet, Barzin/0000-0002-4824-3533; Wu, Tony James/0000-0002-5049-6986	Dutch Cancer Society; Basser Center for BRCA Research; Department of Defense [W81XWH-12-1-0180, W81XWH-09-1-0339]; NIH/NCI [5R01CA172651]; NIH [5R01CA163739, DK007066, TR000139]; NATIONAL CANCER INSTITUTE [R01CA163739, R01CA172651, F31CA189707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007066] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); Basser Center for BRCA Research; Department of Defense(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.C.B. was supported by a fellowship from the Dutch Cancer Society. A.J.M. is a Department of Defense Era of Hope Scholar (W81XWH-09-1-0339). Support for this work and for B.X. was also provided by the Basser Center for BRCA Research. B.Y.N. and T.J.W. were supported by grants from the Department of Defense (W81XWH-12-1-0180 and W81XWH-09-1-0339). A.J.M., T.Y., and Y.Q. were supported by a grant from the NIH/NCI (5R01CA172651). Additional support was provided to H.I. and A.J.M. from the NIH (5R01CA163739) and to C.T. from an NIH training grant and career development award (DK007066 and TR000139). We would like to thank Danielle Loughlin for insightful discussions.	Aster JC, 2012, J CLIN ONCOL, V30, P2418, DOI 10.1200/JCO.2012.42.0992; Azzam DJ, 2013, EMBO MOL MED, V5, P1502, DOI 10.1002/emmm.201302558; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P296, DOI 10.1016/j.bbagrm.2012.09.010; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Goodier JL, 2010, HUM MOL GENET, V19, P1712, DOI 10.1093/hmg/ddq048; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kux K, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00049; Li CCY, 2013, RNA BIOL, V10, P1333, DOI 10.4161/rna.25281; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105	35	557	598	7	194	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					499	513		10.1016/j.cell.2014.09.051	http://dx.doi.org/10.1016/j.cell.2014.09.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417103	Green Accepted, Bronze			2022-12-28	WOS:000344521700008
J	Jangi, M; Sharp, PA				Jangi, Mohini; Sharp, Phillip A.			Building Robust Transcriptomes with Master Splicing Factors	CELL			English	Review							NONSENSE-MEDIATED DECAY; MESSENGER-RNA DECAY; DOSAGE COMPENSATION GENE; BINDING-PROTEIN; SEX-DETERMINATION; CELL-DIFFERENTIATION; REGULATORY NETWORK; MAMMALIAN-TISSUES; POSITIVE FEEDBACK; SUPER-ENHANCERS	Coherent splicing networks arise from many discrete splicing decisions regulated in unison. Here, we examine the properties of robust, context-specific splicing networks. We propose that a subset of key splicing regulators, or "master splicing factors," respond to environmental cues to establish and maintain tissue transcriptomes during development.	[Jangi, Mohini; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu		, Mohini/0000-0003-3138-4484	United States Public Health Service [RO1-GM34277, R01-CA133404, U54-CA112967]; National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [P30CA014051, U54CA112967, R01CA133404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Sharp lab-in particular, Paul Boutz, Sara Dubbury, and Hiroshi Suzuki-for helpful discussion and critical comments on the manuscript. We also thank Jeff Gore and Nicole Vega for insightful discussion. This work was supported by United States Public Health Service grants RO1-GM34277, R01-CA133404, U54-CA112967 to P.A.S. and partially by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute.	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Giudice J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4603; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Hao SL, 2013, P NATL ACAD SCI USA, V110, P11934, DOI 10.1073/pnas.1309990110; Heinicke LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078031; Hertel KJ, 1996, RNA, V2, P969; Heyd F, 2011, TRENDS BIOCHEM SCI, V36, P397, DOI 10.1016/j.tibs.2011.04.003; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Holmes N, 2008, SCIENCE, V321, P646, DOI 10.1126/science.1162294; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Jangi M, 2014, GENE DEV, V28, P637, DOI 10.1101/gad.235770.113; Jayasena CS, 2012, J CELL BIOL, V199, P453, DOI 10.1083/jcb.201204138; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Jin DH, 2010, GENES CELLS, V15, P1158, DOI 10.1111/j.1365-2443.2010.01446.x; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li HY, 2010, MECH DEVELOP, V127, P281, DOI 10.1016/j.mod.2010.03.002; Licatalosi DD, 2012, GENE DEV, V26, P1626, DOI 10.1101/gad.191338.112; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lim KH, 2011, P NATL ACAD SCI USA, V108, P11093, DOI 10.1073/pnas.1101135108; Linke WA, 2012, NAT MED, V18, P660, DOI 10.1038/nm.2762; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lu Y, 2014, CELL STEM CELL, V15, P92, DOI 10.1016/j.stem.2014.04.002; Lynch KW, 1996, GENE DEV, V10, P2089, DOI 10.1101/gad.10.16.2089; Maeda YT, 2006, J MOL BIOL, V359, P1107, DOI 10.1016/j.jmb.2006.03.064; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; MERMOUD JE, 1994, EMBO J, V13, P5679, DOI 10.1002/j.1460-2075.1994.tb06906.x; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Nakaya T, 2013, RNA, V19, P498, DOI 10.1261/rna.037804.112; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Ninomiya K, 2011, J CELL BIOL, V195, P27, DOI 10.1083/jcb.201107093; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Raj B, 2011, MOL CELL, V43, P843, DOI 10.1016/j.molcel.2011.08.014; ROSCIGNO RF, 1995, RNA, V1, P692; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Rossbach O, 2009, MOL CELL BIOL, V29, P1442, DOI 10.1128/MCB.01689-08; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Saltzman AL, 2011, GENE DEV, V25, P373, DOI 10.1101/gad.2004811; Salz HK, 2011, CURR OPIN GENET DEV, V21, P395, DOI 10.1016/j.gde.2011.03.001; Schutt C, 2000, DEVELOPMENT, V127, P667; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Siera SG, 2008, GENETICS, V180, P1963, DOI 10.1534/genetics.108.093898; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; TIAN M, 1993, CELL, V74, P105, DOI 10.1016/0092-8674(93)90298-5; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Venables JP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3480; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Waddington C., 1957, STRATEGY GENES; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Weischenfeldt J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r35; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Young DJ, 2014, HAEMATOLOGICA, V99, P1032, DOI 10.3324/haematol.2013.098657; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x	100	98	101	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					487	498		10.1016/j.cell.2014.09.054	http://dx.doi.org/10.1016/j.cell.2014.09.054			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417102	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000344521700007
J	Ross, AGP; Olveda, RM; Li, YS				Ross, Allen G. P.; Olveda, Remigio M.; Li, Yuesheng			An audacious goal: the elimination of schistosomiasis in our lifetime through mass drug administration	LANCET			English	Editorial Material							DISEASES		[Ross, Allen G. P.] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4222, Australia; [Olveda, Remigio M.] Res Inst Trop Med, Dept Hlth, Manila, Philippines; [Li, Yuesheng] WHO Collaborating Ctr Res & Control Schistosomias, Hunan Inst Parasit Dis, Yueyang, Hunan, Peoples R China; [Li, Yuesheng] Berghofer Med Res Inst, Brisbane, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; QIMR Berghofer Medical Research Institute	Ross, AGP (corresponding author), Griffith Univ, Griffith Hlth Inst, Gold Coast Campus, Southport, Qld 4222, Australia.	a.ross@griffith.edu.au	LI, Yue/GRS-8071-2022	Ross, Allen/0000-0002-2329-0907				Bieri FA, 2013, NEW ENGL J MED, V368, P1603, DOI 10.1056/NEJMoa1204885; Bockarie MJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0144; Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007; Engels D, 2006, TRENDS PARASITOL, V22, P363, DOI 10.1016/j.pt.2006.06.004; Fenwick A, 2006, T ROY SOC TROP MED H, V100, P200, DOI 10.1016/j.trstmh.2005.03.014; Fenwick A, 2005, LANCET, V365, P1029, DOI 10.1016/s0140-6736(05)71134-x; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Hotez P.J., 2008, EMERG INFECT DIS; Hotez P, 2011, VACCINE, V29, pD104, DOI 10.1016/j.vaccine.2011.06.024; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Kabatereine NB, 2007, B WORLD HEALTH ORGAN, V85, P91, DOI 10.2471/BLT.06.030353; Liu R, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-201; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Molyneux DH, 2004, LANCET, V364, P380, DOI 10.1016/S0140-6736(04)16728-7; Muhumuza S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063438; Olliaro PL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001165; Parker M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-3; Rollinson D, 2013, ACTA TROP, V128, P423, DOI 10.1016/j.actatropica.2012.04.013; Ross AG, 2014, J INF DIS; Ross AGP, 2013, MICROBES INFECT, V15, P858, DOI 10.1016/j.micinf.2013.07.010; WHO, 2006, COORD US ANTH DRUGS	21	28	31	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2220	2221		10.1016/S0140-6736(14)61417-3	http://dx.doi.org/10.1016/S0140-6736(14)61417-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ6DG	25467574				2022-12-28	WOS:000355583000032
J	Temmerman, M				Temmerman, Marleen			Research priorities to address violence against women and girls	LANCET			English	Editorial Material									WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland	World Health Organization	Temmerman, M (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland.	temmermanm@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Abramsky T, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0122-5; Barker G., 2011, EVOLVING MEN INITIAL; Diop N., 2004, TOSTAN PROGRAM EVALU, DOI 10.31899/rh2.1002; Ellsberg M, 2014, LANCET; Fulu E, 2013, LANCET GLOB HEALTH, V1, pE187, DOI 10.1016/S2214-109X(13)70074-3; Garcia-Moreno C, 2014, LANCET; Heise L, LANCET GLOB IN PRESS; Jewkes R, 2014, LANCET; Michau L, 2014, LANCET; Spangaro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062600; World Health Organisation, 2013, RESPONDING INTIMATE; World Health Organization, 2021, VIOL WOM PREV EST 20	12	24	24	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2015	385	9978					E38	E40		10.1016/S0140-6736(14)61840-7	http://dx.doi.org/10.1016/S0140-6736(14)61840-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG6NG	25467581				2022-12-28	WOS:000353418000001
J	Neuschwander-Tetri, BA; Loomba, R; Sanyal, AJ; Lavine, JE; Van Natta, ML; Abdelmalek, MF; Chalasani, N; Dasarathy, S; Diehl, AM; Hameed, B; Kowdley, KV; McCullough, A; Terrault, N; Clark, JM; Tonascia, J; Brunt, EM; Kleiner, DE; Doo, E				Neuschwander-Tetri, Brent A.; Loomba, Rohit; Sanyal, Arun J.; Lavine, Joel E.; Van Natta, Mark L.; Abdelmalek, Manal F.; Chalasani, Naga; Dasarathy, Srinivasan; Diehl, Anna Mae; Hameed, Bilal; Kowdley, Kris V.; McCullough, Arthur; Terrault, Norah; Clark, Jeanne M.; Tonascia, James; Brunt, Elizabeth M.; Kleiner, David E.; Doo, Edward		Nash Clin Res Network	Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial	LANCET			English	Article							FATTY LIVER-DISEASE; BILE-ACIDS; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; FXR; AGONIST; THERAPY; NAFLD; NASH; RATS	Background The bile acid derivative 6-ethylchenodeoxycholic acid (obeticholic acid) is a potent activator of the farnesoid X nuclear receptor that reduces liver fat and fibrosis in animal models of fatty liver disease. We assessed the efficacy of obeticholic acid in adult patients with non-alcoholic steatohepatitis. Methods We did a multicentre, double-blind, placebo-controlled, parallel group, randomised clinical trial at medical centres in the USA in patients with non-cirrhotic, non-alcoholic steatohepatitis to assess treatment with obeticholic acid given orally (25 mg daily) or placebo for 72 weeks. Patients were randomly assigned 1: 1 using a computer-generated, centrally administered procedure, stratified by clinical centre and diabetes status. The primary outcome measure was improvement in centrally scored liver histology defined as a decrease in non-alcoholic fatty liver disease activity score by at least 2 points without worsening of fibrosis from baseline to the end of treatment. A planned interim analysis of change in alanine aminotransferase at 24 weeks undertaken before end-of-treatment (72 weeks) biopsies supported the decision to continue the trial (relative change in alanine aminotransferase -24%, 95% CI -45 to -3). A planned interim analysis of the primary outcome showed improved efficacy of obeticholic acid (p=0 . 0024) and supported a decision not to do end-of- treatment biopsies and end treatment early in 64 patients, but to continue the trial to obtain the 24-week post-treatment measures. Analyses were done by intention-to-treat. This trial was registered with ClinicalTrials.gov, number NCT01265498. Findings Between March 16, 2011, and Dec 3, 2012, 141 patients were randomly assigned to receive obeticholic acid and 142 to placebo. 50 (45%) of 110 patients in the obeticholic acid group who were meant to have biopsies at baseline and 72 weeks had improved liver histology compared with 23 (21%) of 109 such patients in the placebo group (relative risk 1 . 9, 95% CI 1 . 3 to 2 . 8; p=0 . 0002). 33 (23%) of 141 patients in the obeticholic acid developed pruritus compared with nine (6%) of 142 in the placebo group. Interpretation Obeticholic acid improved the histological features of non-alcoholic steatohepatitis, but its long-term benefits and safety need further clarifi cation.	[Neuschwander-Tetri, Brent A.] St Louis Univ, St Louis, MO 63110 USA; [Loomba, Rohit] Univ Calif San Diego, La Jolla, CA 92093 USA; [Sanyal, Arun J.] Virginia Commonwealth Univ, Richmond, VA USA; [Lavine, Joel E.] Columbia Univ, New York, NY USA; [Van Natta, Mark L.; Clark, Jeanne M.; Tonascia, James] Johns Hopkins Univ, Baltimore, MD USA; [Abdelmalek, Manal F.; Diehl, Anna Mae] Duke Univ, Durham, NC USA; [Chalasani, Naga] Indiana Univ, Indianapolis, IN 46204 USA; [McCullough, Arthur] Cleveland Clin, Cleveland, OH 44106 USA; [Hameed, Bilal; Terrault, Norah] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kowdley, Kris V.] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [Dasarathy, Srinivasan] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Brunt, Elizabeth M.] Washington Univ, St Louis, MO USA; [Kleiner, David E.] NCI, Bethesda, MD 20892 USA; [Doo, Edward] NIDDK, Bethesda, MD 20892 USA	Saint Louis University; University of California System; University of California San Diego; Virginia Commonwealth University; Columbia University; Johns Hopkins University; Duke University; Indiana University System; Indiana University-Purdue University Indianapolis; Cleveland Clinic Foundation; University of California System; University of California San Francisco; Virginia Mason Medical Center; Case Western Reserve University; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Neuschwander-Tetri, BA (corresponding author), St Louis Univ, Div Gastroenterol & Hepatol, St Louis, MO 63110 USA.	tetriba@slu.edu	Kowdley, Kris/AAF-5202-2019; Kleiner, David E/N-2770-2013; Loomba, Rohit/AAE-7831-2019; Vaughn, Ivana/B-6138-2016; Abdelmalek, Manal F/AAW-2203-2020; Bashir, Mustafa R/P-3428-2015; Clark, Jeanne/AGG-8199-2022	Kleiner, David E/0000-0003-3442-4453; Loomba, Rohit/0000-0002-4845-9991; Vaughn, Ivana/0000-0002-7201-0289; Clark, Jeanne/0000-0003-1194-0092; Abdelmalek, Manal/0000-0002-5001-8618	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, U01DK061713]; National Center for Advancing Translational Sciences (NCATS) for NASH CRN Studies [UL1TR000439, UL1TR000436, UL1TR000006, UL1TR000448, UL1TR000100, UL1TR000004, UL1TR000423, UL1TR000058]; Laboratory of Pathology, Intramural Division of the National Cancer Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004, UL1TR002529, UL1TR000439, UL1TR000100, UL1TR000058, UL1TR000006, UL1TR000423, UL1TR001425, UL1TR000448, UL1TR001108, UL1TR000436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061728, P30DK026743, U01DK061738, U01DK061737, U01DK061713, U01DK061732, U01DK061734, U01DK061731, U01DK061718, U01DK061730] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences (NCATS) for NASH CRN Studies; Laboratory of Pathology, Intramural Division of the National Cancer Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (grants U01DK061718, U01DK061728, U01DK061731, U01DK061732, U01DK061734, U01DK061737, U01DK061738, U01DK061730, U01DK061713). Several clinical centres had support from the National Center for Advancing Translational Sciences (NCATS) for NASH CRN Studies (grants UL1TR000439, UL1TR000436, UL1TR000006, UL1TR000448, UL1TR000100, UL1TR000004, UL1TR000423, and UL1TR000058). Additional support was provided by the Laboratory of Pathology, Intramural Division of the National Cancer Institute. The NASH CRN expresses its gratitude to the patients enrolled in this study, Patricia Robuck for her guidance in trial design, Jay Hoofnagle for his guidance in trial design and data analysis, and Averell Sherker for his assistance in coordinating communications among the NIDDK, the industry sponsor, and the NASH CRN steering committee.	Agopian VG, 2012, ANN SURG, V256, P624, DOI 10.1097/SLA.0b013e31826b4b7e; Bellentani S, 2008, HEPATOLOGY, V47, P746, DOI 10.1002/hep.22009; Bjelakovic G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074558; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Cariou B, 2008, DIABETES METAB, V34, P685, DOI 10.1016/S1262-3636(08)74605-6; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Fickert P, 2009, AM J PATHOL, V175, P2392, DOI 10.2353/ajpath.2009.090114; Hageman J, 2010, ARTERIOSCL THROM VAS, V30, P1519, DOI 10.1161/ATVBAHA.109.197897; Karpen SJ, 2013, GASTROENTEROLOGY, V145, P508, DOI 10.1053/j.gastro.2013.07.017; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kowdley KV, 2011, J HEPATOL, V54, pS13, DOI 10.1016/S0168-8278(11)60030-5; Lindor KD, 2004, HEPATOLOGY, V39, P770, DOI 10.1002/hep.20092; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939; Modica Salvatore, 2010, Nucl Recept Signal, V8, pe005, DOI 10.1621/nrs.08005; Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042; Musso G, 2010, HEPATOLOGY, V52, P79, DOI 10.1002/hep.23623; Page JM, 2009, CLIN LIVER DIS, V13, P631, DOI 10.1016/j.cld.2009.07.007; Porez G, 2012, J LIPID RES, V53, P1723, DOI 10.1194/jlr.R024794; Ratziu V, 2013, NAT REV GASTRO HEPAT, V10, P676, DOI 10.1038/nrgastro.2013.193; Reboussin DM, 2000, CONTROL CLIN TRIALS, V21, P190, DOI 10.1016/S0197-2456(00)00057-X; Sanyal A, 2010, CURR MED RES OPIN, V26, P2183, DOI 10.1185/03007995.2010.506375; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Trauner M, 2010, DIGEST DIS, V28, P220, DOI 10.1159/000282091; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Verbeke L, 2014, HEPATOLOGY, V59, P2286, DOI 10.1002/hep.26939; Yau H, 2013, CURR DIABETES REP, V13, P329, DOI 10.1007/s11892-013-0378-8	30	1380	1472	15	236	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2015	385	9972					956	965		10.1016/S0140-6736(14)61933-4	http://dx.doi.org/10.1016/S0140-6736(14)61933-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD2EK	25468160	Green Accepted			2022-12-28	WOS:000350886900030
J	Bloom, DE; Chatterji, S; Kowal, P; Lloyd-Sherlock, P; Mckee, M; Rechel, B; Rosenberg, L; Smith, JP				Bloom, David E.; Chatterji, Somnath; Kowal, Paul; Lloyd-Sherlock, Peter; Mckee, Martin; Rechel, Bernd; Rosenberg, Larry; Smith, James P.			Macroeconomic implications of population ageing and selected policy responses	LANCET			English	Article							LONG-TERM-CARE; CARDIOVASCULAR-DISEASE; HEALTH-CARE; RISK-FACTORS; LAST YEAR; PREVALENCE; PREVENTION; POLYPILL; INCOME; MIDDLE	Between now and 2030, every country will experience population ageing-a trend that is both pronounced and historically unprecedented. Over the past six decades, countries of the world had experienced only a slight increase in the share of people aged 60 years and older, from 8% to 10%. But in the next four decades, this group is expected to rise to 22% of the total population-a jump from 800 million to 2 billion people. Evidence suggests that cohorts entering older age now are healthier than previous ones. However, progress has been very uneven, as indicated by the wide gaps in population health (measured by life expectancy) between the worst (Sierra Leone) and best (Japan) performing countries, now standing at a difference of 36 years for life expectancy at birth and 15 years for life expectancy at age 60 years. Population ageing poses challenges for countries' economies, and the health of older populations is of concern. Older people have greater health and long-term care needs than younger people, leading to increased expenditure. They are also less likely to work if they are unhealthy, and could impose an economic burden on families and society. Like everyone else, older people need both physical and economic security, but the burden of providing these securities will be falling on a smaller portion of the population. Pension systems will be stressed and will need reassessment along with retirement policies. Health systems, which have not in the past been oriented toward the myriad health problems and long-term care needs of older people and have not sufficiently emphasised disease prevention, can respond in different ways to the new demographic reality and the associated changes in population health. Along with behavioural adaptations by individuals and businesses, the nature of such policy responses will establish whether population ageing will lead to major macroeconomic difficulties.	[Bloom, David E.; Rosenberg, Larry] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Chatterji, Somnath; Kowal, Paul] WHO, CH-1211 Geneva, Switzerland; [Lloyd-Sherlock, Peter] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Mckee, Martin; Rechel, Bernd] London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London WC1, England; [Smith, James P.] RAND Corp, Santa Monica, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; University of East Anglia; European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; RAND Corporation	Bloom, DE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	dbloom@hsph.harvard.edu	CHATTERJI, Somnath/ABE-6832-2020; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Kowal, Paul/0000-0002-6314-8753; Lloyd-Sherlock, Peter/0000-0002-1367-0703; Rechel, Bernd/0000-0001-8020-3956	US National Institute on Aging [2P30AG024409-10]; Harvard University's Center for the Global Demography of Aging; US National Institute on Aging through Interagency Agreements [OGHA04034785, YA1323-08-CN-0020, Y1-AG-1005-0, R01-AG034479, R21-AG034263]; NIA [R37AG025529]; NATIONAL INSTITUTE ON AGING [R21AG034263, R37AG025529, R01AG034479, P30AG024409] Funding Source: NIH RePORTER	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Harvard University's Center for the Global Demography of Aging; US National Institute on Aging through Interagency Agreements; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	DEB and LR were funded by a grant from the US National Institute on Aging (# 2P30AG024409-10) supporting Harvard University's Center for the Global Demography of Aging. SC and PK were supported by the US National Institute on Aging through Interagency Agreements (OGHA04034785; YA1323-08-CN-0020; Y1-AG-1005-0) and through research grants R01-AG034479 and R21-AG034263. JPS was supported by NIA grant R37AG025529. All other authors declare no competing interests.	[Anonymous], 2010, LANCET, V376, P1799, DOI 10.1016/S0140-6736(10)62148-4; [Anonymous], 2011, FIN DEV; [Anonymous], 2009, ECONOMIST, P20; [Anonymous], 2011, NAT INS RET PENS; [Anonymous], 2009, HLTH SYST POLICY ANA; Barr N, 2009, INT SOC SECUR REV, V62, P5, DOI 10.1111/j.1468-246X.2009.01327.x; Basu S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6048; Beaulieu N, 2009, BREAKAWAY GLOBAL BUR; Bloom DE, 2007, J MONETARY ECON, V54, P92, DOI 10.1016/j.jmoneco.2006.12.004; Bloom DE, 2011, SCIENCE, V333, P562, DOI 10.1126/science.1209290; Bloom DE, 2010, OXFORD REV ECON POL, V26, P583, DOI 10.1093/oxrep/grq038; Bloom DE, 2009, J ECON GROWTH, V14, P79, DOI 10.1007/s10887-009-9039-9; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Bloom DE., 2010, EC CONSEQUENCES DEMO, P61; Bloom DE, 2014, INT HDB AGEING PUBLI, P108; Bloom DE, 2011, BURDEN BEST BUYS RED; Bloom DE, 2011, GLOBAL EC BURDEN NON; Burtless G, 2013, CLOSING THE DEFICIT: HOW MUCH CAN LATER RETIREMENT HELP?, P1; Caughey GE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-221; Chakravarty EF, 2012, AM J MED, V125, P190, DOI 10.1016/j.amjmed.2011.08.006; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Coyte PC, 2008, CAN SETTINGS USED PR; Daviglus ML, 2005, ARCH INTERN MED, V165, P1028, DOI 10.1001/archinte.165.9.1028; Do R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001106; Doyle Y., 2009, BMJ-BRIT MED J, V339, P892; Dubois C-A, 2006, HUMAN RESOURCES HLTH, P15; Economist Intelligence Unit, ADDR LACK EXP HLTH C; Egger G, 2009, AM J PREV MED, V37, P78, DOI 10.1016/j.amepre.2009.03.004; Ellis G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub2; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gandjour A, 2005, J HEALTH ECON, V24, P715, DOI 10.1016/j.jhealeco.2004.11.009; Gandjour A, 2009, HEALTH ECON, V18, P355, DOI 10.1002/hec.1370; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Hakkinen U, 2008, HEALTH ECON POLICY L, V3, P165, DOI 10.1017/S174413310800443X; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; Hillman K, 1999, MED J AUSTRALIA, V170, P325, DOI 10.5694/j.1326-5377.1999.tb127789.x; Hopkins S., 2010, OPEN HLTH SERV POL J, V3, P111, DOI [10.2174/1874924001003010111, DOI 10.2174/1874924001003010111]; Marin GH, 2009, GAC SANIT, V23, P272, DOI 10.1016/j.gaceta.2009.02.010; International Labour Organization, 2012, ILO DAT LAB STAT; Kendrick S, 2006, EUR J POPUL, V22, P281, DOI 10.1007/s10680-006-9002-9; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Lee R, 2011, POPULATION AGING AND THE GENERATIONAL ECONOMY: A GLOBAL PERSPECTIVE, P1; Lee R, 2010, DEMOGRAPHY, V47, pS151; Lee R, 2010, EUR J POPUL, V26, P159, DOI 10.1007/s10680-009-9186-x; Liu XY, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-10; Lloyd-Sherlock P, 2009, J POPUL AGEING, V2, P41, DOI 10.1007/s12062-010-9017-1; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Loch CH, 2010, HARVARD BUS REV, P1; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; McGrail K, 2000, AGE AGEING, V29, P249, DOI 10.1093/ageing/29.3.249; Mckee M, 2009, LANCET, V373, P349, DOI 10.1016/S0140-6736(09)60098-2; Milner C., 2012, GLOBAL POPULATION AG, P25; Nagai M, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000240; National Research Council, 2012, AG MACR LONG TERM IM, P106, DOI [10.17226/13465, DOI 10.17226/13465]; Nolte E, 2008, CARING PEOPLE CHRONI; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P183, DOI 10.1093/heapro/15.3.183; O'Neill D, 2011, BMJ-BRIT MED J, V342, pd3815; OECD, 2011, PENS GLANC 2011 RET; Organization WH, 2016, GLOBAL STATUS REPORT; Oxley H., 2009, OECD HLTH WORKING PA, V42, DOI [10.1787/226757488706, DOI 10.1787/226757488706]; Prettner K, 2013, LABOUR ECON, V22, P70, DOI 10.1016/j.labeco.2012.07.001; Pritchett L, 2007, BILATERAL GUEST WORK; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Ryan D, 2012, GLOBAL POPULATION AG, P74; Saltman RB, 1997, EUROPEAN HLTH CARE R; Shi Z, 2008, INT J OBESITY, V32, P975, DOI 10.1038/ijo.2008.21; Soliman EZ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-3; Stanciole A., 2006, ESTIMATION EC IMPACT; Strauss J, 2012, AGING ASIA FINDINGS, P342; Stuck AE, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6799; Suhrcke M, 2006, PUBLIC HEALTH, V120, P994, DOI 10.1016/j.puhe.2006.08.011; Tallis R, 2006, ASIAN J GERONTOL GER, V1, P157; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; The Economist, 2012, ECONOMIST; Turner A, 2006, FINANC DEV, V43, P36; UN, 2008, MADR INT PLAN ACT AG; WHO, 2012, STUD GLOB AGEING AD; WHO(World Health Organization), 2002, GLOB SURV GER MED CU; World Bank, 2013, WORLD DEV IND 2013; World Health Organization, GLOB STAT REP NONC D; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Zamarro G, 2007, HLTH AGEING RETIREME; ZLOTNIK H, 2012, GLOBAL POPULATION AG, V89, P97	86	303	312	39	274	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 14	2015	385	9968					649	657		10.1016/S0140-6736(14)61464-1	http://dx.doi.org/10.1016/S0140-6736(14)61464-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AZ	25468167	Green Accepted			2022-12-28	WOS:000349214000033
J	Schlichting, I				Schlichting, Ilme			STRUCTURAL BIOLOGY Photosynthetic complex in close-up	NATURE			English	Editorial Material							X-RAY-DIFFRACTION; PHOTOSYSTEM-II; CRYSTAL-STRUCTURE; ROOM-TEMPERATURE; SPECTROSCOPY; RESOLUTION; DAMAGE		Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Max Planck Society	Schlichting, I (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.	ilme.schlichting@mpimf-heidelberg.mpg.de	Schlichting, Ilme/I-1339-2013					Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/NMETH.2962, 10.1038/nmeth.2962]; Kern J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5371; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kern J, 2012, P NATL ACAD SCI USA, V109, P9721, DOI 10.1073/pnas.1204598109; Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102	10	6	6	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2015	517	7532					26	27		10.1038/nature14072	http://dx.doi.org/10.1038/nature14072			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8SI	25470040				2022-12-28	WOS:000347178400025
J	Chambers, SA				Chambers, Scott A.			Stability at the surface	SCIENCE			English	Editorial Material									Pacific NW Natl Lab, Div Phys Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Chambers, SA (corresponding author), Pacific NW Natl Lab, Div Phys Sci, Richland, WA 99352 USA.	sa.chambers@pnnl.gov						Bliem R, 2014, SCIENCE, V346, P1215, DOI 10.1126/science.1260556; Breckenfeld E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.196804; Capan C, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3680608; Chambers SA, 2010, SURF SCI REP, V65, P317, DOI 10.1016/j.surfrep.2010.09.001; Chambers SA, 2013, ADV MATER, V25, P4001, DOI 10.1002/adma.201301030; Kalabukhov AS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.146101; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Segal Y, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.241107; Slooten E, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.085128; Takizawa M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245124; Warusawithana MP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3351; Willmott PR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.155502	12	4	4	0	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1186	1187		10.1126/science.aaa1543	http://dx.doi.org/10.1126/science.aaa1543			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477444				2022-12-28	WOS:000346189000044
J	Durand, E; Meheust, R; Soucaze, M; Goubet, PM; Gallina, S; Poux, C; Fobis-Loisy, I; Guillon, E; Gaude, T; Sarazin, A; Figeac, M; Prat, E; Marande, W; Berges, H; Vekemans, X; Billiard, S; Castric, V				Durand, Eleonore; Meheust, Raphael; Soucaze, Marion; Goubet, Pauline M.; Gallina, Sophie; Poux, Celine; Fobis-Loisy, Isabelle; Guillon, Eline; Gaude, Thierry; Sarazin, Alexis; Figeac, Martin; Prat, Elisa; Marande, William; Berges, Helene; Vekemans, Xavier; Billiard, Sylvain; Castric, Vincent			Dominance hierarchy arising from the evolution of a complex small RNA regulatory network	SCIENCE			English	Article							SELF-INCOMPATIBILITY LOCUS; ARABIDOPSIS-THALIANA; S-LOCUS; BRASSICA-CAMPESTRIS; PLANT MICRORNAS; ALLELES; LYRATA; IDENTIFICATION; EXPRESSION; POLLEN	The prevention of fertilization through self-pollination (or pollination by a close relative) in the Brassicaceae plant family is determined by the genotype of the plant at the self-incompatibility locus (S locus). The many alleles at this locus exhibit a dominance hierarchy that determines which of the two allelic specificities of a heterozygous genotype is expressed at the phenotypic level. Here, we uncover the evolution of how at least 17 small RNA (sRNA)-producing loci and their multiple target sites collectively control the dominance hierarchy among alleles within the gene controlling the pollen S-locus phenotype in a self-incompatible Arabidopsis species. Selection has created a dynamic repertoire of sRNA-target interactions by jointly acting on sRNA genes and their target sites, which has resulted in a complex system of regulation among alleles.	[Durand, Eleonore; Meheust, Raphael; Soucaze, Marion; Goubet, Pauline M.; Gallina, Sophie; Poux, Celine; Vekemans, Xavier; Billiard, Sylvain; Castric, Vincent] Univ Lille 1, CNRS UMR 8198, Lab Genet & Evolut Populat Vegetales, F-59655 Villeneuve Dascq, France; [Fobis-Loisy, Isabelle; Guillon, Eline; Gaude, Thierry] Univ Lyon 1, Ecole Normale Super Lyon, CNRS,Reprod & Dev Plantes, Inst Federatif Rech 128,Inst Natl Rech Agron, F-69364 Lyon 07, France; [Sarazin, Alexis] Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland; [Figeac, Martin] UDSL Univ Lille 2 Droit & Sante, F-59000 Lille, France; [Figeac, Martin] Plate Forme Genom Fonct & Struct IFR 114, F-59000 Lille, France; [Prat, Elisa; Marande, William; Berges, Helene] INRA UPR 1258, Ctr Natl Ressources Genom Vegetales, Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Swiss Federal Institutes of Technology Domain; ETH Zurich; INRAE	Castric, V (corresponding author), Univ Lille 1, CNRS UMR 8198, Lab Genet & Evolut Populat Vegetales, F-59655 Villeneuve Dascq, France.	vincent.castric@univ-lille1.fr	billiard, sylvain/A-2108-2009; Vekemans, xavier/A-1721-2009; Castric, Vincent/A-2514-2009	billiard, sylvain/0000-0003-2135-3246; Vekemans, xavier/0000-0002-4836-4394; Sarazin, Alexis/0000-0002-1869-5192; Poux, Celine/0000-0002-9379-2769; Meheust, Raphael/0000-0002-4847-426X; Gallina, Sophie/0000-0002-6194-3649; Figeac, Martin/0000-0001-8523-3708; Durand, Eleonore/0000-0002-0912-9252; BERGES, Helene/0000-0002-5492-1062; Castric, Vincent/0000-0002-4461-4915; GAUDE, Thierry/0000-0002-0804-9445	Agence Nationale de la Recherche Jeunes Chercheurs BRASSIDOM [ANR 11 JSV7-008-01]; Bonus Qualite Recherche Universite Lille 1; Region Nord Pas de Calais (program "projets emergents") [MICRO2]; CNRS	Agence Nationale de la Recherche Jeunes Chercheurs BRASSIDOM(French National Research Agency (ANR)); Bonus Qualite Recherche Universite Lille 1; Region Nord Pas de Calais (program "projets emergents")(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS))	We thank D. Charlesworth, T. Tsuchimatsu, M. Boccara, D. J. Schoen, and M. Mirouze for advice and comments on the manuscript and J. Kitt, A. C. Holl, E. Schmitt, B. Huss, G. Neutelings, A. Achard, G. Laroche, and D. Achour for technical assistance. We acknowledge financial support from Agence Nationale de la Recherche Jeunes Chercheurs BRASSIDOM (ANR 11 JSV7-008-01), Bonus Qualite Recherche Universite Lille 1 and Region Nord Pas de Calais (program "projets emergents" MICRO2). R.M. was supported by an apprentice grant from CNRS. R.M. and E.D. contributed equally to this work. E.D. contributed to the crossing design and the phenotypic analysis. R.M., E.D., M.S., P.M.G., and S.G. contributed to the bioinformatics analysis. E.D., I.F.-L., E.G., and T.G. performed the functional validation experiment. C.P. performed the phylogenetic analysis. M.F. performed the sRNA-seq experiments. E.P., W.M., and H.B. constructed the BAC libraries and performed the screening and BAC sequencing. V.C., S.B., X.V., I.F.-L., and T.G. designed the experiments. All authors discussed the results. E.D., R.M., I.F.-L., X.V., S.B., and V.C. wrote the paper. V.C. and S.B. coordinated the project. S-locus sequences have been deposited on the European Molecular Biology Organization public database, sRNA sequences on the GEO public database (see table S2 for accession numbers), and data matrices and phylogenetic trees on the TreeBASE database (http://purl.org/phylo/treebase/phylows/study/TB2:S16394). BAC clones produced in this project will be distributed through http://cnrgv.toulouse.inra.fr/Library/Arabidopsis upon signature of a material transfer agreement for in-house academic research.	Bagheri HC, 2006, J EXP ZOOL PART B, V306B, P329, DOI 10.1002/jez.b.21069; BATEMAN A. J., 1955, HEREDITY, V9, P53, DOI 10.1038/hdy.1955.2; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Billiard S, 2011, TRENDS GENET, V27, P441, DOI 10.1016/j.tig.2011.06.005; Boggs NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000426; Castric V, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000168; Finnegan EJ, 2011, TRENDS PLANT SCI, V16, P238, DOI 10.1016/j.tplants.2011.01.002; Goubet PM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002495; Guo YL, 2011, PLANT PHYSIOL, V157, P937, DOI 10.1104/pp.111.174912; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Llaurens V, 2009, EVOLUTION, V63, P2427, DOI 10.1111/j.1558-5646.2009.00709.x; Llaurens V, 2008, EVOLUTION, V62, P2545, DOI 10.1111/j.1558-5646.2008.00469.x; Mable BK, 2003, HEREDITY, V90, P422, DOI 10.1038/sj.hdy.6800261; Meng YJ, 2013, RICE, V6, DOI 10.1186/1939-8433-6-8; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nasrallah ME, 2002, SCIENCE, V297, P247, DOI 10.1126/science.1072205; Nasrallah ME, 2004, P NATL ACAD SCI USA, V101, P16070, DOI 10.1073/pnas.0406970101; Nettancourt, 2001, INCOMPATIBILITY INCO; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Otto SP, 1999, AM NAT, V153, P561, DOI 10.1086/303204; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Prigoda NL, 2005, MOL BIOL EVOL, V22, P1609, DOI 10.1093/molbev/msi153; Schoen DJ, 2009, EVOLUTION, V63, P2099, DOI 10.1111/j.1558-5646.2009.00686.x; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2006, NAT GENET, V38, P297, DOI 10.1038/ng1734; Shiba H, 2002, PLANT CELL, V14, P491, DOI 10.1105/tpc.010378; Shiba H, 2012, DEV GROWTH DIFFER, V54, P120, DOI 10.1111/j.1440-169X.2011.01317.x; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Suzuki G, 1999, GENETICS, V153, P391; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Tarutani Y, 2010, NATURE, V466, P983, DOI 10.1038/nature09308; Vekemans X, 2014, J EVOLUTION BIOL, V27, P1372, DOI 10.1111/jeb.12372; Zeller G, 2008, GENOME RES, V18, P918, DOI 10.1101/gr.070169.107; Zhang WL, 2012, PLANT CELL, V24, P2719, DOI 10.1105/tpc.112.098061	37	39	39	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1200	1205		10.1126/science.1259442	http://dx.doi.org/10.1126/science.1259442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477454				2022-12-28	WOS:000346189000050
J	Geach, JE; Hickox, RC; Diamond-Stanic, AM; Krips, M; Rudnick, GH; Tremonti, CA; Sell, PH; Coils, AL; Moustakas, J				Geach, J. E.; Hickox, R. C.; Diamond-Stanic, A. M.; Krips, M.; Rudnick, G. H.; Tremonti, C. A.; Sell, P. H.; Coils, A. L.; Moustakas, J.			Stellar feedback as the origin of an extended molecular outflow in a starburst galaxy	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; HIGH-VELOCITY OUTFLOWS; STAR-FORMATION; RADIATION PRESSURE; AGN FEEDBACK; BLACK-HOLES; EMISSION; CONSTRAINTS; EVOLUTION; MECHANISM	Recent observations have revealed that starburst galaxies can drive molecular gas outflows through stellar radiation pressure(1,2). Molecular gas is the phase of the interstellar medium from which stars form, so these outflows curtail stellar mass growth in galaxies. Previously known outflows, however, involve small fractions of the total molecular gas content and have typical scales of less than a kilopar-sec(1,2). In at least some cases, input from active galactic nuclei is dynamically important(2,3), so pure stellar feedback (the momentum return into the interstellar medium) has been considered incapable of rapidly terminating star formation on galactic scales. Molecular gas has been detected outside the galactic plane of the archetypal starburst galaxy M82 (refs 4 and 5), but so far there has been no evidence that starbursts can propel substantial quantities of cold molecular gas to the same galactocentric radius (about 10 kiloparsecs) as the warmer gas that has been traced by metal ion absorbers in the circumgalactic medium(6,7). Here we report observations of molecular gas in a compact (effective radius 100 parsecs) massive starburst galaxy at redshift 0.7, which is known to drive a fast outflow of ionized gas(8). We find that 35 per cent of the total molecular gas extends approximately 10 kiloparsecs, and one-third of this extended gas has a velocity of up to 1,000 kilometres per second. The kinetic energy associated with this high-velocity component is consistent with the momentum flux available from stellar radiation pressure(9-12). This demonstrates that nuclear bursts of star formation are capable of ejecting large amounts of cold gas from the central regions of galaxies, thereby strongly affecting their evolution by truncating star formation and redistributing matter(13,14).	[Geach, J. E.] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Hickox, R. C.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [Diamond-Stanic, A. M.; Tremonti, C. A.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Krips, M.] Inst Radio Astron Millimetr, F-38406 St Martin Dheres, France; [Rudnick, G. H.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; [Rudnick, G. H.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Sell, P. H.] Texas Tech Univ, Dept Phys, Lubbock, TX 79409 USA; [Coils, A. L.] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; [Moustakas, J.] Siena Coll, Dept Phys & Astron, New York, NY 12211 USA	University of Hertfordshire; Dartmouth College; University of Wisconsin System; University of Wisconsin Madison; University of Kansas; Max Planck Society; Texas Tech University System; Texas Tech University; University of California System; University of California San Diego	Geach, JE (corresponding author), Univ Hertfordshire, Ctr Astrophys Res, Coll Lane, Hatfield AL10 9AB, Herts, England.	j.geach@herts.ac.uk	Sell, Paul/B-1283-2017; Hickox, Ryan/ABC-8882-2020	Sell, Paul/0000-0003-1771-5531; Hickox, Ryan/0000-0003-1468-9526; Moustakas, John/0000-0002-2733-4559	Royal Society; Grainger Foundation; Alexander von Humboldt Foundation; NSF CAREER grant [AST-1055081]; INSU/CNRS (France); MPG (Germany); IGN (Spain); W. M. Keck Foundation; Direct For Mathematical & Physical Scien [1055081] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1211358] Funding Source: National Science Foundation	Royal Society(Royal Society of London); Grainger Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NSF CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); INSU/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); MPG (Germany)(Max Planck Society); IGN (Spain); W. M. Keck Foundation(W.M. Keck Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	J.E.G. acknowledges support from the Royal Society through a University Research Fellowship. A.M.D.-S. acknowledges support from the Grainger Foundation. G.H.R. acknowledges the support of the Alexander von Humboldt Foundation and the hospitality of the Max Planck Institute for Astronomy. A.L.C. acknowledges funding from NSF CAREER grant AST-1055081. We thank E. Brinks, N. Murray, D. Narayanan, R. Neri and F. Walter for advice and discussions. This work is based on observations carried out with the IRAM Plateau de Bure Interferometer. IRAM is supported by INSU/CNRS (France), MPG (Germany) and IGN (Spain). Some of the data presented herein were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and the National Aeronautics and Space Administration. The Observatory was made possible by the generous financial support of the W. M. Keck Foundation.	Andrews BH, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/97; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Bower RG, 2006, MON NOT R ASTRON SOC, V370, P645, DOI 10.1111/j.1365-2966.2006.10519.x; Chary R, 2001, ASTROPHYS J, V556, P562, DOI 10.1086/321609; Condon JJ, 1997, PUBL ASTRON SOC PAC, V109, P166, DOI 10.1086/133871; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; Diamond-Stanic AM, 2012, ASTROPHYS J LETT, V755, DOI 10.1088/2041-8205/755/2/L26; Donley JL, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/142; Geach JE, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/1/L17; Granato GL, 2004, ASTROPHYS J, V600, P580, DOI 10.1086/379875; Guilloteau S., 2000, ASP C P, V217; Hopkins PF, 2012, MON NOT R ASTRON SOC, V421, P3522, DOI 10.1111/j.1365-2966.2012.20593.x; Hopkins PF, 2010, MON NOT R ASTRON SOC, V401, pL19, DOI 10.1111/j.1745-3933.2009.00777.x; Ivison RJ, 2007, MON NOT R ASTRON SOC, V380, P199, DOI 10.1111/j.1365-2966.2007.12044.x; Kauffmann G, 2009, MON NOT R ASTRON SOC, V397, P135, DOI 10.1111/j.1365-2966.2009.14960.x; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Kewley LJ, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/100; Maiolino R, 2012, MON NOT R ASTRON SOC, V425, pL66, DOI 10.1111/j.1745-3933.2012.01303.x; Martin CL, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/41; Moustakas J, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/50; Murray N, 2005, ASTROPHYS J, V618, P569, DOI 10.1086/426067; Murray N, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/66; Narayanan D, 2008, ASTROPHYS J SUPPL S, V176, P331, DOI 10.1086/533500; Peng CY, 2002, ASTRON J, V124, P266, DOI 10.1086/340952; Pontzen A, 2012, MON NOT R ASTRON SOC, V421, P3464, DOI 10.1111/j.1365-2966.2012.20571.x; Salak D, 2013, PUBL ASTRON SOC JPN, V65, DOI 10.1093/pasj/65.3.66; Sell PH, 2014, MON NOT R ASTRON SOC, V441, P3417, DOI 10.1093/mnras/stu636; Shetty R, 2011, MON NOT R ASTRON SOC, V412, P1686, DOI 10.1111/j.1365-2966.2010.18005.x; Solomon PM, 1997, ASTROPHYS J, V478, P144, DOI 10.1086/303765; Stern D, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/30; Tadhunter C, 2014, NATURE, V511, P440, DOI 10.1038/nature13520; Thompson T. A., 2014, PREPRINT; Tremonti CA, 2007, ASTROPHYS J, V663, pL77, DOI 10.1086/520083; Veilleux S, 2005, ANNU REV ASTRON ASTR, V43, P769, DOI 10.1146/annurev.astro.43.072103.150610	40	54	54	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					68	U384		10.1038/nature14012	http://dx.doi.org/10.1038/nature14012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471881	Green Submitted			2022-12-28	WOS:000346310800039
J	Jin, FF; Boucharel, J; Lin, II				Jin, F. -F.; Boucharel, J.; Lin, I. -I.			Eastern Pacific tropical cyclones intensified by El Nino delivery of subsurface ocean heat	NATURE			English	Article							PART I; CLIMATE; MODEL; VARIABILITY; GENESIS; ENSO	The El Nino Southern Oscillation (ENSO) creates strong variations in sea surface temperature in the eastern equatorial Pacific, leading to major climatic and societal impacts(1,2). In particular, ENSO influences the yearly variations of tropical cyclone (TC) activities in both the Pacific and Atlantic basins through atmospheric dynamical factors such as vertical wind shear and stability(3-6). Until recently, however, the direct ocean thermal control of ENSO on TCs has not been taken into consideration because of an apparent mismatch in both timing and location: ENSO peaks in winter and its surface warming occurs mostly along the Equator, a region without TC activity. Here we show that El Nino the warm phase of an ENSO cycle effectively discharges heat into the eastern North Pacific basin two to three seasons after its wintertime peak, leading to intensified TCs. This basin is characterized by abundant TC activity and is the second most active TC region in the world(5-7). As a result of the time involved in ocean transport, El Ninio's equatorial subsurface 'heat reservoir', built up in boreal winter, appears in the eastern North Pacific several months later during peak TC season (boreal summer and autumn). By means of this delayed ocean transport mechanism, ENSO provides an additional heat supply favourable for the formation of strong hurricanes. This thermal control on intense TC variability has significant implications for seasonal predictions and long-term projections of TC activity over the eastern North Pacific.	[Jin, F. -F.; Boucharel, J.] Univ Hawaii Manoa, SOEST, Dept Atmospher Sci, Honolulu, HI 96822 USA; [Lin, I. -I.] Natl Taiwan Univ, Dept Atmospher Sci, Taipei 10617, Taiwan; [Jin, F. -F.] Chinese Meteorol Agcy, Beijing Climate Ctr, Lab Climate Studies, Beijing 100081, Peoples R China	University of Hawaii System; University of Hawaii Manoa; National Taiwan University	Jin, FF (corresponding author), Univ Hawaii Manoa, SOEST, Dept Atmospher Sci, Honolulu, HI 96822 USA.	jff@hawaii.edu; bouch@hawaii.edu	Lin, I-I/J-4695-2013	Lin, I-I/0000-0002-8364-8106; Boucharel, Julien/0000-0003-4598-3349	US National Science Foundation [ATM 1034798, ATM 1406601]; US Department of Energy [DESC005110]; US NOM [NA100AR4310200]; China Meteorological Special Project [GYHY201206033]; 973 Program of China [2010CB950404, 2013CB430203]; Taiwan's Ministry of Science and Technology [NSC 101-2111-M-002-002-MY2, NSC 101-2628-M-002-001-MY4, 102R7803]; Directorate For Geosciences [1034798, 1406601] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); US NOM; China Meteorological Special Project; 973 Program of China(National Basic Research Program of China); Taiwan's Ministry of Science and Technology; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank P. Kim for providing the CMIP5 model's outputs; M. Zhao for making his Atmospheric General Circulation Model outputs available; K. Emanuel for providing the potential intensity calculation program via his website; and C. Huang for help in data processing. This study was supported by US National Science Foundation grants ATM 1034798 and ATM 1406601, US Department of Energy grant DESC005110, US NOM grant NA100AR4310200, the China Meteorological Special Project (GYHY201206033) and the 973 Program of China (2010CB950404 and 2013CB430203). I.I.L.'s work is supported by Taiwan's Ministry of Science and Technology under grants NSC 101-2111-M-002-002-MY2, NSC 101-2628-M-002-001-MY4 and 102R7803.	Balaguru K, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044009; Balmaseda MA, 2008, MON WEATHER REV, V136, P3018, DOI 10.1175/2008MWR2433.1; Bengtsson L, 2007, TELLUS A, V59, P396, DOI [10.1111/j.1600-0870.2007.00236.x, 10.1111/J.1600-0870.2007.00236.x]; Bengtsson L, 2007, TELLUS A, V59, P539, DOI 10.1111/j.1600-0870.2007.00251.x; Bister M, 1998, METEOROL ATMOS PHYS, V65, P233, DOI 10.1007/BF01030791; Camargo SJ, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001861; Chu PS, 1997, J CLIMATE, V10, P2683, DOI 10.1175/1520-0442(1997)010<2683:TCOITV>2.0.CO;2; Clement AC, 1996, J CLIMATE, V9, P2190, DOI 10.1175/1520-0442(1996)009<2190:AODT>2.0.CO;2; Collins J. M., 2007, PAPERS APPL GEOGR C, V30, P324; Collins JM, 2000, GEOPHYS RES LETT, V27, P3881, DOI 10.1029/2000GL011614; Court A., 1980, NWS WR 159; DeMaria M, 1996, J ATMOS SCI, V53, P2076, DOI 10.1175/1520-0469(1996)053<2076:TEOVSO>2.0.CO;2; Dong K., 1994, ACTA MET SIN, V8, P19; EMANUEL KA, 1988, J ATMOS SCI, V45, P1143, DOI 10.1175/1520-0469(1988)045<1143:TMIOH>2.0.CO;2; EMANUEL KA, 1995, J ATMOS SCI, V52, P3969, DOI 10.1175/1520-0469(1995)052<3969:SOTCTS>2.0.CO;2; Glantz M. H., 2001, CURRENT OF CHANGE IM; Goni G, 2009, OCEANOGRAPHY, V22, P190, DOI 10.5670/oceanog.2009.78; Gray WM., 1979, METEOROLOGY TROPICAL, P155, DOI DOI 10.1175/1520-0450; Jin FF, 1996, SCIENCE, V274, P76, DOI 10.1126/science.274.5284.76; Jin FF, 1997, J ATMOS SCI, V54, P811, DOI 10.1175/1520-0469(1997)054<0811:AEORPF>2.0.CO;2; Larow TE, 2008, J CLIMATE, V21, P3191, DOI 10.1175/2007JCLI2036.1; Latif M. D., 2012, J GEOPHYS RES-OCEANS, V103, P14375; Leipper D. F., 1972, Journal of Physical Oceanography, V2, P218, DOI 10.1175/1520-0485(1972)002<0218:HHPOTG>2.0.CO;2; Lin II, 2008, MON WEATHER REV, V136, P3288, DOI 10.1175/2008MWR2277.1; Lin II, 2013, GEOPHYS RES LETT, V40, P1878, DOI 10.1002/grl.50091; Lorenz E. N., 1956, MASSACHUSETTS INSTIT; Maue RN, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047711; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Meinen CS, 2000, J CLIMATE, V13, P3551, DOI 10.1175/1520-0442(2000)013<3551:OOWWVC>2.0.CO;2; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Murakami H, 2013, NAT CLIM CHANGE, V3, P749, DOI [10.1038/nclimate1890, 10.1038/NCLIMATE1890]; Myhre G., 2013, CONTRIBUTION WORKING; Oouchi K, 2006, J METEOROL SOC JPN, V84, P259, DOI 10.2151/jmsj.84.259; Peduzzi P, 2012, NAT CLIM CHANGE, V2, P289, DOI 10.1038/NCLIMATE1410; Price JF, 2009, OCEAN SCI, V5, P351, DOI 10.5194/os-5-351-2009; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Shay LK, 2000, MON WEATHER REV, V128, P1366, DOI 10.1175/1520-0493(2000)128<1366:EOAWOF>2.0.CO;2; Shay LK, 2010, MON WEATHER REV, V138, P2110, DOI 10.1175/2010MWR3189.1; Toma VE, 2010, CLIM DYNAM, V34, P587, DOI 10.1007/s00382-009-0584-x; Wang CZ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041469; WYRTKI K, 1985, J GEOPHYS RES-OCEANS, V90, P7129, DOI 10.1029/JC090iC04p07129; Zhao M, 2009, J CLIMATE, V22, P6653, DOI 10.1175/2009JCLI3049.1	43	89	91	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					82	U178		10.1038/nature13958	http://dx.doi.org/10.1038/nature13958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471884				2022-12-28	WOS:000346310800043
J	Ker, J				Ker, James			A new phenotypic marker of hypertrophic cardiomyopathy	LANCET			English	Editorial Material									Univ Pretoria, Dept Internal Med, ZA-0001 Pretoria, South Africa	University of Pretoria	Ker, J (corresponding author), Univ Pretoria, Dept Internal Med, ZA-0001 Pretoria, South Africa.	jker@wol.co.za	Ker, James/AAF-7021-2019					Ashrafian H, 2011, CIRC RES, V109, P86, DOI 10.1161/CIRCRESAHA.111.242974; Gruner C, 2014, EUR HEART J, V35, P2706, DOI 10.1093/eurheartj/ehu154; Ho CY, 2012, CIRCULATION, V125, P1432, DOI 10.1161/CIRCULATIONAHA.110.017277; Jacoby DL, 2013, CAN MED ASSOC J, V185, P127, DOI 10.1503/cmaj.120138; O'Mahony C, 2013, CIRC-ARRHYTHMIA ELEC, V6, P443, DOI 10.1161/CIRCEP.111.962043; Olivotto I, 2012, CIRC-HEART FAIL, V5, P535, DOI 10.1161/CIRCHEARTFAILURE.112.967026	6	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1731	1731		10.1016/S0140-6736(14)61888-2	http://dx.doi.org/10.1016/S0140-6736(14)61888-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KX	25455237	Green Submitted			2022-12-28	WOS:000345116400009
J	Chen, HY; Zheng, XB; Zheng, YX				Chen, Haiyang; Zheng, Xiaobin; Zheng, Yixian			Age-Associated Loss of Lamin-B Leads to Systemic Inflammation and Gut Hyperplasia	CELL			English	Article							NF-KAPPA-B; NUCLEAR LAMINA; IMMUNE-RESPONSE; GENE-EXPRESSION; INTESTINAL MICROBIOTA; OXIDATIVE STRESS; IMD PATHWAYS; DROSOPHILA; GENOME; MIDGUT	Aging of immune organs, termed as immunosenescence, is suspected to promote systemic inflammation and age-associated disease. The cause of immunosenescence and how it promotes disease, however, has remained unclear. We report that the Drosophila fat body, a major immune organ, undergoes immunosenescence andmounts strong systemic inflammation that leads to deregulation of immune deficiency (IMD) signaling in the midgut of old animals. Inflamed old fat bodies secrete circulating peptidoglycan recognition proteins that repress IMD activity in the midgut, thereby promoting gut hyperplasia. Further, fat body immunosenecence is caused by age-associated lamin-B reduction specifically in fat body cells, which then contributes to heterochromatin loss and derepression of genes involved in immune responses. As lamin-associated heterochromatin domains are enriched for genes involved in immune response in both Drosophila and mammalian cells, our findings may provide insights into the cause and consequence of immunosenescence during mammalian aging.	[Chen, Haiyang; Zheng, Xiaobin; Zheng, Yixian] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA	Carnegie Institution for Science	Zheng, YX (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA.	zheng@ciwemb.edu	Zheng, Xiaobin/AAD-7564-2019		Ellison Medical Foundation [GM056312, GM106023]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312, R01GM106023] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Allan Spradling and his lab for valuable help, Allison Pinder for RNA-seq, Drs. Allan Spradling, Mitchell Dushay, Bruno Lemaitre, Lori Wallrath, Georg Krohne, and Erin Zeituni for fly strains and antibodies, Matthew Sieber, Alexis Marianes, and the Zheng lab for helpful discussions. Supported by a Senior Scholar Award to YZ from the Ellison Medical Foundation, GM056312 and GM106023 (YZ).	Ahmad Aamir, 2009, Curr Aging Sci, V2, P174; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Bank EM, 2011, BIOCHEM SOC T, V39, P1705, DOI 10.1042/BST20110603; Barascu A, 2012, EMBO J, V31, P1080, DOI 10.1038/emboj.2011.492; Biagi E, 2013, PHARMACOL RES, V69, P11, DOI 10.1016/j.phrs.2012.10.005; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; Chen HY, 2013, CELL STEM CELL, V13, P73, DOI 10.1016/j.stem.2013.05.003; Cheng J, 2013, CURR TOP MICROBIOL, V358, P323, DOI 10.1007/82_2011_189; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Day MJ, 2010, J COMP PATHOL, V141, pS60, DOI [10.1016/j.jepa.2009.10.011, 10.1016/j.jcpa.2009.10.011]; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Fulop T, 2011, DISCOV MED, V11, P537, DOI 10.1016/j.coi.2004.01.009; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Guo YX, 2014, MOL BIOL CELL, V25, P1287, DOI 10.1091/mbc.E13-11-0644; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Khatami M, 2009, CELL BIOCHEM BIOPHYS, V55, P55, DOI 10.1007/s12013-009-9059-2; Kim Y, 2013, CELL RES, V23, P1420, DOI 10.1038/cr.2013.118; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Larson K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002473; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; Markovic MP, 2009, MOL IMMUNOL, V46, P3245, DOI 10.1016/j.molimm.2009.08.003; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Osouda S, 2005, DEV BIOL, V284, P219, DOI 10.1016/j.ydbio.2005.05.022; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Ramsden S, 2008, AGING CELL, V7, P225, DOI 10.1111/j.1474-9726.2008.00370.x; Ray K, 2012, NAT REV GASTRO HEPAT, V9, P555, DOI [10.1038/nrgastro.2012.172, 10.1038/nrgastro.2012.165]; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Seroude L, 2002, AGING CELL, V1, P47, DOI 10.1046/j.1474-9728.2002.00007.x; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Wang ZP, 2013, MBIO, V4, DOI 10.1128/mBio.00337-13; Wood JG, 2010, AGING CELL, V9, P971, DOI 10.1111/j.1474-9726.2010.00624.x; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zerofsky M, 2005, AGING CELL, V4, P103, DOI 10.1111/j.1474-9728.2005.00147.x	63	106	108	13	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					829	843		10.1016/j.cell.2014.10.028	http://dx.doi.org/10.1016/j.cell.2014.10.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417159	Bronze, Green Accepted			2022-12-28	WOS:000344522000015
J	Domigan, CK; Iruela-Arispe, ML				Domigan, Courtney K.; Iruela-Arispe, M. Luisa			Stealing VEGF from Thy Neighbor	CELL			English	Editorial Material							ENDOTHELIAL-CELLS; ANGIOGENESIS	The distribution and patterning of blood vessels is controlled by vascular endothelial growth factor (VEGF), which is precisely regulated throughout its life cycle. Okabe et al. show that VEGF is titrated away from the endothelium by adjacent neurons via endocytosis, regulating density and trajectory of blood vessels.	[Domigan, Courtney K.; Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Iruela-Arispe, ML (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, 615 Charles E Young Dr South, Los Angeles, CA 90095 USA.	arispe@mcdb.ucla.edu	Iruela-Arispe, M. Luisa/AAJ-1297-2020	Iruela-Arispe, M. Luisa/0000-0002-3050-4168	NHLBI NIH HHS [T32 HL069766] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069766] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Carmeliet P, 2013, CELL MOL LIFE SCI, V70, P1763, DOI 10.1007/s00018-013-1283-7; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002; Gabhann FM, 2008, MICROCIRCULATION, V15, P715, DOI 10.1080/10739680802095964; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Okabe K, 2014, CELL, V159, P584, DOI 10.1016/j.cell.2014.09.025	10	7	7	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					473	474		10.1016/j.cell.2014.10.008	http://dx.doi.org/10.1016/j.cell.2014.10.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417099	Bronze			2022-12-28	WOS:000344521700004
J	Liang, X; Bushman, FD; FitzGerald, GA				Liang, Xue; Bushman, Frederic D.; FitzGerald, Garret A.			Time in Motion: The Molecular Clock Meets the Microbiome	CELL			English	Editorial Material							CIRCADIAN CLOCK	Thaiss et al. report that the intestinal microbiota undergoes diurnal oscillation, which is controlled by host feeding time. Disruption of the host circadian clock induces dysbiosis, which is associated with host metabolic disorders.	[Liang, Xue; FitzGerald, Garret A.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Bushman, Frederic D.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	FitzGerald, GA (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.	garret@upenn.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NHLBI NIH HHS [U54 HL117798] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; GORDON NP, 1986, AM J PUBLIC HEALTH, V76, P1225, DOI 10.2105/AJPH.76.10.1225; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Rudic RD, 2005, CIRCULATION, V112, P2716, DOI 10.1161/CIRCULATIONAHA.105.568626; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Yang GR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007225; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884	8	19	24	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 23	2014	159	3					469	470		10.1016/j.cell.2014.10.020	http://dx.doi.org/10.1016/j.cell.2014.10.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TU	25417097	Bronze			2022-12-28	WOS:000344521700002
J	Samarasekera, U; Horton, R				Samarasekera, Udani; Horton, Richard			Prevention of violence against women and girls: a new chapter	LANCET			English	Editorial Material									[Samarasekera, Udani; Horton, Richard] The Lancet, London NW1 7BY, England		Samarasekera, U (corresponding author), The Lancet, London NW1 7BY, England.							Atwood Margaret, 1985, THE HANDMAIDS TALE; Ellsberg M, 2014, LANCET; Garcia-Moreno C, 2014, LANCET; Jewkes R, 2014, LANCET; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Michau L, 2014, LANCET; Temmerman M, 2014, LANCET; World Health Organization, 2021, VIOL WOM PREV EST 20	8	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2015	385	9977					1480	1482		10.1016/S0140-6736(14)61775-X	http://dx.doi.org/10.1016/S0140-6736(14)61775-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG3ZT	25467576				2022-12-28	WOS:000353220000005
J	Lang, BT; Cregg, JM; DePaul, MA; Tran, AP; Xu, K; Dyck, SM; Madalena, KM; Brown, BP; Weng, YL; Li, SX; Karimi-Abdolrezaee, S; Busch, SA; Shen, YJ; Silver, J				Lang, Bradley T.; Cregg, Jared M.; DePaul, Marc A.; Tran, Amanda P.; Xu, Kui; Dyck, Scott M.; Madalena, Kathryn M.; Brown, Benjamin P.; Weng, Yi-Lan; Li, Shuxin; Karimi-Abdolrezaee, Soheila; Busch, Sarah A.; Shen, Yingjie; Silver, Jerry			Modulation of the proteoglycan receptor PTP sigma promotes recovery after spinal cord injury	NATURE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CHONDROITIN SULFATE PROTEOGLYCAN; FUNCTIONAL RECOVERY; BLADDER FUNCTION; GROWTH CONE; REGENERATION; PLASTICITY; BARRIER; DOMAIN; MODEL	Contusive spinal cord injury leads to a variety of disabilities owing to limited neuronal regeneration and functional plasticity. It is well established that an upregulation of glial-derived chondroitin sulphate proteoglycans (CSPGs) within the glial scar and perineuronal net creates a barrier to axonal regrowth and sprouting(1-5). Protein tyrosine phosphatase sigma (PTP sigma), along with its sister phosphatase leukocyte common antigen-related (LAR) and the nogo receptors 1 and 3 (NgR), have recently been identified as receptors for the inhibitory glycosylated side chains of CSPGs(6-8). Here we find in rats that PTP sigma has a critical role in converting growth cones into a dystrophic state by tightly stabilizing them within CSPG-rich substrates. We generated a membrane-permeable peptide mimetic of the PTP sigma wedge domain that binds to PTP sigma and relieves CSPG-mediated inhibition. Systemic delivery of this peptide over weeks restored substantial serotonergic innervation to the spinal cord below the level of injury and facilitated functional recovery of both locomotor and urinary systems. Our results add a new layer of understanding to the critical role of PTP sigma in mediating the growth-inhibited state of neurons due to CSPGs within the injured adult spinal cord.	[Lang, Bradley T.; Cregg, Jared M.; DePaul, Marc A.; Tran, Amanda P.; Madalena, Kathryn M.; Busch, Sarah A.; Silver, Jerry] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Xu, Kui; Shen, Yingjie] Ohio State Univ, Ctr Brain & Spinal Cord Repair, Dept Neurosci, Wexner Med Ctr, Columbus, OH 43210 USA; [Dyck, Scott M.; Karimi-Abdolrezaee, Soheila] Univ Manitoba, Regenerat Med Program, Winnipeg, MB R3E 0J9, Canada; [Dyck, Scott M.; Karimi-Abdolrezaee, Soheila] Univ Manitoba, Dept Physiol, Winnipeg, MB R3E 0J9, Canada; [Brown, Benjamin P.] Baldwin Wallace Univ, Berea, OH 44017 USA; [Weng, Yi-Lan] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Li, Shuxin] Temple Univ, Sch Med, Ctr Neural Repair & Rehabil, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19140 USA	Case Western Reserve University; University System of Ohio; Ohio State University; University of Manitoba; University of Manitoba; Baldwin Wallace University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Silver, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	JXS10@case.edu	DePaul, Marc/H-9010-2017; Cregg, Jared/CAG-8414-2022	DePaul, Marc/0000-0002-3249-9550; Cregg, Jared/0000-0002-0027-9748; Tran, Amanda/0000-0002-8393-6124; Brown, Benjamin/0000-0001-5296-087X; Karimi-Abdolrezaee, Soheila/0000-0002-0683-2663	National Institute of Neurological Disorders and Stroke [NS025713]; Case Western Reserve University Council; Unite to Fight Paralysis; Brumagin Memorial Fund; Spinal Cord Injury Sucks; United Paralysis Foundation; Kaneko Family Fund; NATIONAL EYE INSTITUTE [R01EY024575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS025713, R01NS025713, R01NS079432] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Case Western Reserve University Council; Unite to Fight Paralysis; Brumagin Memorial Fund; Spinal Cord Injury Sucks; United Paralysis Foundation; Kaneko Family Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke grant NS025713 (J.S.); the Case Western Reserve University Council to Advance Human Health; P. Jing, R. Senior and S. Poon; Unite to Fight Paralysis; The Brumagin Memorial Fund; Spinal Cord Injury Sucks; United Paralysis Foundation; and The Kaneko Family Fund. The authors thank J. Flanagan, M. Blackmore, A. Filous, S. Brady-Kalnay, R. Gardner and B. Habecker for their valuable discussion and input into the project.	Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; Banks WA, 2005, EXP NEUROL, V193, P218, DOI 10.1016/j.expneurol.2004.11.019; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Cajal S., 1928, DEGENERATION REGENER; Cheng CL, 2004, EXP NEUROL, V187, P445, DOI 10.1016/j.expneurol.2004.02.014; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; DEGROAT WC, 1990, J AUTONOM NERV SYST, V30, pS71, DOI 10.1016/0165-1838(90)90105-R; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Jakeman L. B., 2012, ANIMAL MODELS ACUTE, P417; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Jones LL, 2001, MICROSC RES TECHNIQ, V54, P317, DOI 10.1002/jemt.1144; Lee YS, 2013, J NEUROSCI, V33, P10591, DOI 10.1523/JNEUROSCI.1116-12.2013; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Pikov V, 2001, J NEUROSCI, V21, P559, DOI 10.1523/JNEUROSCI.21-02-00559.2001; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Polleux F, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001925; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Wallace MJ, 1998, MOL CELL BIOL, V18, P2608, DOI 10.1128/MCB.18.5.2608; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Xie YM, 2006, J BIOL CHEM, V281, P16482, DOI 10.1074/jbc.M603131200; Xu B, 2015, NEUROBIOL DIS, V73, P36, DOI 10.1016/j.nbd.2014.08.030	35	291	301	6	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 19	2015	518	7539					404	408		10.1038/nature13974	http://dx.doi.org/10.1038/nature13974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB3SA	25470046	Green Accepted			2022-12-28	WOS:000349547400043
J	Sprague, BL; Stout, NK; Schechter, C; van Ravesteyn, NT; Cevik, M; Alagoz, O; Lee, CI; van den Broek, JJ; Miglioretti, DL; Mandelblatt, JS; de Koning, HJ; Kerlikowske, K; Lehman, CD; Tosteson, ANA				Sprague, Brian L.; Stout, Natasha K.; Schechter, Clyde; van Ravesteyn, Nicolien T.; Cevik, Mucahit; Alagoz, Oguzhan; Lee, Christoph I.; van den Broek, Jeroen J.; Miglioretti, Diana L.; Mandelblatt, Jeanne S.; de Koning, Harry J.; Kerlikowske, Karla; Lehman, Constance D.; Tosteson, Anna N. A.			Benefits, Harms, and Cost-Effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER DETECTION; UNITED-STATES; MAMMOGRAPHY; ULTRASOUND; LEGISLATION; RISK; AGE; US; PERFORMANCE; THERAPY	Background: Many states have laws requiring mammography facilities to tell women with dense breasts and negative results on screening mammography to discuss supplemental screening tests with their providers. The most readily available supplemental screening method is ultrasonography, but little is known about its effectiveness. Objective: To evaluate the benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Design: Comparative modeling with 3 validated simulation models. Data Sources: Surveillance, Epidemiology, and End Results Program; Breast Cancer Surveillance Consortium; and medical literature. Target Population: Contemporary cohort of women eligible for routine screening. Time Horizon: Lifetime. Perspective: Payer. Intervention: Supplemental ultrasonography screening for women with dense breasts after a negative screening mammography result. Outcome Measures: Breast cancer deaths averted, qualityadjusted life-years (QALYs) gained, biopsies recommended after a false-positive ultrasonography result, and costs. Results of Base-Case Analysis: Supplemental ultrasonography screening after a negative mammography result for women aged 50 to 74 years with heterogeneously or extremely dense breasts averted 0.36 additional breast cancer deaths (range across models, 0.14 to 0.75), gained 1.7 QALYs (range, 0.9 to 4.7), and resulted in 354 biopsy recommendations after a falsepositive ultrasonography result (range, 345 to 421) per 1000 women with dense breasts compared with biennial screening by mammography alone. The cost-effectiveness ratio was $325 000 per QALY gained (range, $112 000 to $766 000). Supplemental ultrasonography screening for only women with extremely dense breasts cost $246 000 per QALY gained (range, $74 000 to $535 000). Results of Sensitivity Analysis: The conclusions were not sensitive to ultrasonography performance characteristics, screening frequency, or starting age. Limitation: Provider costs for coordinating supplemental ultrasonography were not considered. Conclusion: Supplemental ultrasonography screening for women with dense breasts would substantially increase costs while producing relatively small benefits.	Univ Vermont, Burlington, VT 05401 USA; Harvard Univ, Sch Med, Boston, MA USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA; Albert Einstein Coll Med, Bronx, NY USA; Erasmus MC, Rotterdam, Netherlands; [Cevik, Mucahit; Alagoz, Oguzhan] Univ Wisconsin, Madison, WI 53706 USA; Univ Washington, Sch Med, Seattle, WA USA; Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; Univ Calif Davis, Sch Med, Davis, CA 95616 USA; Georgetown Univ, Washington, DC USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA	University of Vermont; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Yeshiva University; Albert Einstein College of Medicine; Erasmus University Rotterdam; Erasmus MC; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle; Group Health Cooperative; University of California System; University of California Davis; Georgetown University; University of California System; University of California San Francisco; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Sprague, BL (corresponding author), Univ Vermont, Off Hlth Promot Res, 1 South Prospect St,Univ Hlth Campus Room 4425, Burlington, VT 05401 USA.	Brian.Sprague@uvm.edu	de+Koning, Harry/AAF-9062-2019	de+Koning, Harry/0000-0003-4682-3646; Alagoz, Oguzhan/0000-0002-5133-1382; Lee, Christoph/0000-0002-8185-7721	National Cancer Institute - BCSC [P01 CA154292, HHSN261201100031C]; National Cancer Institute [U01 CA152958, U54 CA163303, U54 CA163307]; NATIONAL CANCER INSTITUTE [U01CA152958, P01CA154292, P30CA023108, U54CA163303, U54CA163307, P30CA093373] Funding Source: NIH RePORTER	National Cancer Institute - BCSC; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute-funded BCSC (P01 CA154292, HHSN261201100031C) and the National Cancer Institute (U01 CA152958, U54 CA163303, and U54 CA163307). The collection of BCSC cancer and vital status data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of these sources, visit http://breastscreening.cancer.gov/work/acknowledgement.html.	American College of Radiology, 2013, ACR BI RADS MAMM; American College of Radiology, 2012, ACT STAT REP BREAST; [Anonymous], JAMA INTERN MED; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Brower V, 2013, JNCI-J NATL CANCER I, V105, P510, DOI 10.1093/jnci/djt086; Brown M, 2014, JAMA INTERN MED, V174, P954; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Clarke Lauren D, 2006, J Natl Cancer Inst Monogr, P96, DOI 10.1093/jncimonographs/lgj013; D'Orsi CJ, 2012, RADIOLOGY, V265, P9, DOI 10.1148/radiol.12121515; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Dehkordy SF, 2013, J AM COLL RADIOL, V10, P899, DOI 10.1016/j.jacr.2013.09.007; Feuer Eric J, 2006, J Natl Cancer Inst Monogr, P2, DOI 10.1093/jncimonographs/lgj002; Fryback Dennis G, 2006, J Natl Cancer Inst Monogr, P37, DOI 10.1093/jncimonographs/lgj007; Gartlehner G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009632.pub2; Giuliano V, 2013, CLIN IMAG, V37, P480, DOI 10.1016/j.clinimag.2012.09.018; Gold MR, 1996, COST EFFECTIVENESS H; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Hooley RJ, 2012, RADIOLOGY, V265, P59, DOI 10.1148/radiol.12120621; Kelly KM, 2010, EUR RADIOL, V20, P734, DOI 10.1007/s00330-009-1588-y; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Lee CI, 2012, RADIOLOGY, V264, P632, DOI 10.1148/radiol.12120184; Mandelblatt Jeanne, 2006, J Natl Cancer Inst Monogr, P47, DOI 10.1093/jncimonographs/lgj008; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Nothacker M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-335; Parris T, 2013, BREAST J, V19, P64, DOI 10.1111/tbj.12053; Pisano ED, 2005, RADIOLOGY, V234, P353, DOI 10.1148/radiol.2342030897; Smith ML, 2013, J AM COLL RADIOL, V10, P909, DOI 10.1016/j.jacr.2013.09.012; Sprague BL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju255; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Stout NK, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju092; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; van Ravesteyn NT, 2012, ANN INTERN MED, V156, P609, DOI 10.7326/0003-4819-156-9-201205010-00002; Weigert J, 2012, BREAST J, V18, P517, DOI 10.1111/tbj.12003; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103	42	148	150	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					157	U33		10.7326/M14-0692	http://dx.doi.org/10.7326/M14-0692			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NP	25486550	Green Accepted			2022-12-28	WOS:000350108100001
J	Fontaine, MC; Pease, JB; Steele, A; Waterhouse, RM; Neafsey, DE; Sharakhov, IV; Jiang, XF; Hall, AB; Catteruccia, F; Kakani, E; Mitchell, SN; Wu, YC; Smith, HA; Love, RR; Lawniczak, MK; Slotman, MA; Emrich, SJ; Hahn, MW; Besansky, NJ				Fontaine, Michael C.; Pease, James B.; Steele, Aaron; Waterhouse, Robert M.; Neafsey, Daniel E.; Sharakhov, Igor V.; Jiang, Xiaofang; Hall, Andrew B.; Catteruccia, Flaminia; Kakani, Evdoxia; Mitchell, Sara N.; Wu, Yi-Chieh; Smith, Hilary A.; Love, R. Rebecca; Lawniczak, Mara K.; Slotman, Michel A.; Emrich, Scott J.; Hahn, Matthew W.; Besansky, Nora J.			Extensive introgression in a malaria vector species complex revealed by phylogenomics	SCIENCE			English	Article							ANOPHELES-GAMBIAE COMPLEX; GENOME SEQUENCE; SPECIATION; HUMANS; POPULATIONS; RESISTANCE; DROSOPHILA; EVOLUTION; HYBRIDS	Introgressive hybridization is now recognized as a widespread phenomenon, but its role in evolution remains contested. Here, we use newly available reference genome assemblies to investigate phylogenetic relationships and introgression in a medically important group of Afrotropical mosquito sibling species. We have identified the correct species branching order to resolve a contentious phylogeny and show that lineages leading to the principal vectors of human malaria were among the first to split. Pervasive autosomal introgression between these malaria vectors means that only a small fraction of the genome, mainly on the X chromosome, has not crossed species boundaries. Our results suggest that traits enhancing vectorial capacity may be gained through interspecific gene flow, including between nonsister species.	[Fontaine, Michael C.; Smith, Hilary A.; Love, R. Rebecca; Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Fontaine, Michael C.; Smith, Hilary A.; Love, R. Rebecca; Emrich, Scott J.; Besansky, Nora J.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Pease, James B.; Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Steele, Aaron; Emrich, Scott J.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Waterhouse, Robert M.; Wu, Yi-Chieh] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Waterhouse, Robert M.; Neafsey, Daniel E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Waterhouse, Robert M.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Waterhouse, Robert M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Sharakhov, Igor V.] Virginia Polytech Inst & State Univ, Dept Entomol, Blacksburg, VA 24061 USA; [Sharakhov, Igor V.; Jiang, Xiaofang; Hall, Andrew B.] Virginia Polytech Inst & State Univ, Interdisciplinary PhD Program Genet Bioinformat &, Blacksburg, VA 24061 USA; [Catteruccia, Flaminia; Kakani, Evdoxia; Mitchell, Sara N.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Catteruccia, Flaminia; Kakani, Evdoxia] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, I-06100 Perugia, Italy; [Lawniczak, Mara K.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Slotman, Michel A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Hahn, Matthew W.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA	University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University Bloomington; University of Notre Dame; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Geneva; Swiss Institute of Bioinformatics; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Harvard University; Harvard T.H. Chan School of Public Health; University of Perugia; Imperial College London; Texas A&M University System; Texas A&M University College Station; Indiana University System; Indiana University Bloomington	Hahn, MW (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	mwh@indiana.edu; nbesansk@nd.edu	Mitchell, Sara/AAB-5536-2020; Sharakhov, Igor/B-1972-2008; Waterhouse, Robert M/A-1858-2010; Pease, James B./G-8358-2012; Fontaine, Michael/G-5350-2011; Mitchell, Sara/I-3104-2014	Sharakhov, Igor/0000-0003-0752-3747; Waterhouse, Robert M/0000-0003-4199-9052; Pease, James B./0000-0003-0125-9156; Jiang, Xiaofang/0000-0002-0955-8284; Lawniczak, Mara/0000-0002-3006-2080; Hahn, Matthew/0000-0002-5731-8808; Fontaine, Michael/0000-0003-1156-4154; Catteruccia, Flaminia/0000-0003-3295-6683; Mitchell, Sara/0000-0002-7926-1881	National Center for Biotechnology Information, NIH [PRJNA6751, PRJNA254046]; Broad Institute by National Human Genome Research Institute; NIH [R01AI076584, R21AI101459, R21AI094289, R21AI099528, R01AI104956, R01AI085079, HHSN272200900039C, T32GM007757]; Foundation for the National Institutes of Health through the Vector-based Control of Transmission Discovery Research program of the Grand Challenges in Global Health Initiative; Marie Curie International Outgoing Fellowship; Department of Education Graduate Assistance in Areas of National Need fellowship; Richard and Peggy Notebaert Premier Fellowship; Jack Kent Cooke Foundation Graduate Scholarship; Fralin Life Science Institute of Virginia Tech; U.K. Medical Research Council Career Development Award; European Research Council FP7 [260897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104956, R21AI101459, R21AI099528, R01AI076584, R21AI094289, R01AI063508, R01AI085079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007757] Funding Source: NIH RePORTER; Medical Research Council [G1100339] Funding Source: researchfish; MRC [G1100339] Funding Source: UKRI	National Center for Biotechnology Information, NIH; Broad Institute by National Human Genome Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health through the Vector-based Control of Transmission Discovery Research program of the Grand Challenges in Global Health Initiative; Marie Curie International Outgoing Fellowship(European Commission); Department of Education Graduate Assistance in Areas of National Need fellowship(US Department of Education); Richard and Peggy Notebaert Premier Fellowship; Jack Kent Cooke Foundation Graduate Scholarship; Fralin Life Science Institute of Virginia Tech; U.K. Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council FP7; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Kern and B. J. White for early assistance with this project. Genome assemblies and sequence reads generated by the Broad and the BGI have been submitted to National Center for Biotechnology Information, NIH, under two umbrella BioProject IDs: PRJNA6751 and PRJNA254046. The mitochondrial genome alignments, VCF files of field individual samples, the Multiple Alignment Format Threaded Blockset Aligner (MAF TBA) genome alignment of reference assemblies, and the MAF genome alignment from high depth field samples are available on Dryad: doi: 10.5061/dryad.f4114. Sequencing was funded at the Broad Institute by a grant from the National Human Genome Research Institute. Individual laboratories were funded by the NIH [R01AI076584 (N. J. B., M.W.H.), R21AI101459 (N. J. B., H.A.S.), R21AI094289 and R21AI099528 (I.V.S.), R01AI104956 (F.C.), R01AI085079 (M.A.S.), HHSN272200900039C (S.J.E.), T32GM007757 (J.B.P.)], Foundation for the National Institutes of Health through the Vector-based Control of Transmission Discovery Research program of the Grand Challenges in Global Health Initiative (N. J. B., M.C.F.), Marie Curie International Outgoing Fellowship (R.M.W.), Department of Education Graduate Assistance in Areas of National Need fellowship (A.S.), Richard and Peggy Notebaert Premier Fellowship and Jack Kent Cooke Foundation Graduate Scholarship (R.R.L.), Fralin Life Science Institute of Virginia Tech (I.V.S.), U.K. Medical Research Council Career Development Award (M.K.L.), European Research Council FP7 (Starting Grant 260897 to F.C.). Author contributions: conceived project: N. J. B.; coordinated project: N. J. B., M.C.F.; supervised project at the Broad Institute: D.E.N.; genome alignments: R.M.W.; genomic data processing, read mapping, development of pipelines for variant calling and scripts for coordinate conversion, mtDNA genome reconstruction: A.S., M.C.F., S.J.E.; provided access to An. gambiae genomic sequences from Mali: R.R.L.; window-based phylogeny reconstruction, development and implementation of chromoplots, development and implementation of divergence-based method to infer species branching order; estimation of sequence-based divergence times: J.B.P., M.W.H.; introgression testing: J.B.P., M.C.F., M.W.H.; polymorphism and divergence analyses, phylogenomic analyses of nuclear and mtDNA genomes: M.C.F.; orthology predictions and gene-based phylogenetic reconstruction: R.M.W., Y.-C.W.; identification of inversion breakpoints, chromosomal inversion phylogeny, estimation of divergence time based on rates of rearrangement: I.V.S., A.B.H., X.J.; genomic library construction, H.A.S., M.C.F.; functional enrichment analyses: H.A.S., M.C.F., J.B.P.; ecdysteroid quantification: F.C., E.K., S.N.M.; molecular evolution: D.E.N., M.K.L., M. A.S.; wrote paper: N. J. B., M.C.F., M.W.H. with input from other authors.	Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Baldini F, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001695; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BESANSKY NJ, 1994, P NATL ACAD SCI USA, V91, P6885, DOI 10.1073/pnas.91.15.6885; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; BRYAN JH, 1979, T ROY SOC TROP MED H, V73, P463, DOI 10.1016/0035-9203(79)90179-2; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Cooke BA, 1999, MOL CELL ENDOCRINOL, V151, P25, DOI 10.1016/S0303-7207(98)00255-X; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Coyne J.A., 2004, SPECIATION; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DAVIDSON G, 1962, NATURE, V196, P907, DOI 10.1038/196907a0; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; dellaTorre A, 1997, GENETICS, V146, P239; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; EERNISSE DJ, 1993, MOL BIOL EVOL, V10, P1170; Fouet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034841; Gabrieli P, 2014, P NATL ACAD SCI USA, V111, P16353, DOI 10.1073/pnas.1410488111; Garcia BA, 1996, GENETICS, V143, P1313; Garrigan D, 2012, GENOME RES, V22, P1499, DOI 10.1101/gr.130922.111; Giles G. M., 1902, HDB GNATS MOSQUITOES; Gray EM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-215; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Harbach RE, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P3, DOI 10.5772/54695; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Maniere G, 2003, J ENDOCRINOL, V177, P35, DOI 10.1677/joe.0.1770035; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; Mawejje HD, 2013, MED VET ENTOMOL, V27, P276, DOI 10.1111/j.1365-2915.2012.01055.x; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; O'Loughlin SM, 2014, MOL BIOL EVOL, V31, P889, DOI 10.1093/molbev/msu040; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pease J. B., 2014, BIORXIV, DOI [10.1101/004689, DOI 10.1101/004689]; Pondeville E, 2008, P NATL ACAD SCI USA, V105, P19631, DOI 10.1073/pnas.0809264105; Powell JR, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P101; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Shaw WR, 2014, P NATL ACAD SCI USA, V111, P5854, DOI 10.1073/pnas.1401715111; Slotman M, 2004, GENETICS, V167, P275, DOI 10.1534/genetics.167.1.275; Temu EA, 1997, ANN TROP MED PARASIT, V91, P963, DOI 10.1080/00034989760383; White BJ, 2011, ANNU REV ECOL EVOL S, V42, P111, DOI 10.1146/annurev-ecolsys-102710-145028; White BJ, 2009, GENETICS, V183, P275, DOI 10.1534/genetics.109.105817; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2; White MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000729	50	333	339	7	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2015	347	6217							1258524	10.1126/science.1258524	http://dx.doi.org/10.1126/science.1258524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7NK	25431491	Green Accepted, Green Published			2022-12-28	WOS:000347102300041
J	Vaduganathan, M; Prasad, V				Vaduganathan, Muthiah; Prasad, Vinay			Modern Drug Development Which Patients Should Come First?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METASTATIC BREAST-CANCER; HEART-FAILURE; TRASTUZUMAB; PERTUZUMAB; ENALAPRIL; TRIAL		[Vaduganathan, Muthiah] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA USA; [Prasad, Vinay] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Prasad, V (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, 615 N Wolfe St,Room W1015, Baltimore, MD 21205 USA.	vprasad4@jhu.edu		Prasad, Vinayak/0000-0002-6110-8221				Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Infectious Diseases Society of America (IDSA), WHEN AND IN WHOM TO; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Packer M, 2002, CIRCULATION, V106, P920, DOI 10.1161/01.CIR.0000029801.86489.50; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; US Food and Drug Administration (FDA). U.S. Department of Health and Human Services, INITIATIVE ON MULTIP; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124	7	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 24	2014	312	24					2619	2620		10.1001/jama.2014.15221	http://dx.doi.org/10.1001/jama.2014.15221			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX5KW	25420013				2022-12-28	WOS:000346966100010
J	Margalida, A; Bogliani, G; Bowden, CGR; Donazar, JA; Genero, F; Gilbert, M; Karesh, WB; Kock, R; Lubroth, J; Manteca, X; Naidoo, V; Neimanis, A; Sanchez-Zapata, JA; Taggart, MA; Vaarten, J; Yon, L; Kuiken, T; Green, RE				Margalida, A.; Bogliani, G.; Bowden, C. G. R.; Donazar, J. A.; Genero, F.; Gilbert, M.; Karesh, W. B.; Kock, R.; Lubroth, J.; Manteca, X.; Naidoo, V.; Neimanis, A.; Sanchez-Zapata, J. A.; Taggart, M. A.; Vaarten, J.; Yon, L.; Kuiken, T.; Green, R. E.			One Health approach to use of veterinary pharmaceuticals	SCIENCE			English	Editorial Material							PROMOTING HUMAN HEALTH; TO-CRADLE STEWARDSHIP; ENVIRONMENTAL DISPOSITION; SOUTH-ASIA; DICLOFENAC; MEDICINES; DRUGS; DISPOSAL; VULTURES					t.kuiken@erasmusmc.nl	Sanchez-Zapata, Jose Antonio/H-1413-2015; Margalida, Antoni/AAG-5337-2020; Yon, Lisa K/G-4453-2011; Naidoo, Vinny/A-1508-2008; Karesh, William/AAU-9084-2020; Margalida, Antoni/A-2723-2011; Neimanis, Aleksija/E-4168-2016; Margalida, Antoni/A-2723-2011	Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953; Yon, Lisa K/0000-0002-9765-3192; Naidoo, Vinny/0000-0003-2740-5983; Karesh, William/0000-0001-6042-2860; Margalida, Antoni/0000-0002-0576-3993; Neimanis, Aleksija/0000-0001-7747-2290; Donazar, Jose Antonio/0000-0002-9433-9755; Taggart, Mark/0000-0002-0649-8490; Margalida, Antoni/0000-0002-3904-6212; Margalida, Antoni/0000-0002-7383-671X; Bogliani, Giuseppe/0000-0001-9066-6540; Gilbert, Martin/0000-0002-9930-4383; Kuiken, Thijs/0000-0001-5501-9049; Kock, Richard/0000-0002-6561-3209				Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Agerstrand M, 2009, ENVIRON INT, V35, P778, DOI 10.1016/j.envint.2008.12.001; Alexandratos N., 2012, WORLD AGR 2030 2050, DOI DOI 10.22004/AG.ECON.288998; Baron M, 2012, WASTE BIOMASS VALORI, V3, P395, DOI 10.1007/s12649-012-9146-2; Beynon SA, 2012, VET PARASITOL, V189, P125, DOI 10.1016/j.vetpar.2012.03.041; Boxall ABA, 2010, HANDB EXP PHARMACOL, V199, P291, DOI 10.1007/978-3-642-10324-7_12; Chaudhry MJI, 2012, BIRD CONSERV INT, V22, P389, DOI 10.1017/S0959270912000445; Committee for Medicinal Products for Veterinary Use, 2008, EMEACVMP4182822005RE; Daughton CG, 2003, ENVIRON HEALTH PERSP, V111, P757, DOI 10.1289/ehp.5947; Daughton CG, 2003, ENVIRON HEALTH PERSP, V111, P775, DOI 10.1289/ehp.5948; Del Hoyo J, 1994, HDB BIRDS WORLD, V2; Friton GM, 2005, VET REC, V156, P809, DOI 10.1136/vr.156.25.809; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Kools SAE, 2008, REGUL TOXICOL PHARM, V50, P59, DOI 10.1016/j.yrtph.2007.06.003; Kools Stefan A. E., 2008, Integrated Environmental Assessment and Management, V4, P399, DOI 10.1897/IEAM_2008-002.1; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818; National Office of Animal Health, FACTS FIG UK AN MED; Pain DJ, 2008, BIRD CONSERV INT, V18, pS30, DOI 10.1017/S0959270908000324; Prakash V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049118; Sanchez-Zapata JA, 2010, BIRD STUDY, V57, P352, DOI 10.1080/00063651003674946; Sharma AK, 2014, BIRD CONSERV INT, V24, P282, DOI 10.1017/S0959270913000609; Tong AYC, 2011, ENVIRON INT, V37, P292, DOI 10.1016/j.envint.2010.10.002; Zorrilla I., 2014, CONSERV BIOL, DOI 10.1111/cobi.12417	24	59	60	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2014	346	6215					1296	1298		10.1126/science.1260260	http://dx.doi.org/10.1126/science.1260260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3MA	25477214	Green Submitted			2022-12-28	WOS:000346189600025
J	Gille, S				Gille, Sarah			How ice shelves melt	SCIENCE			English	Editorial Material							WEST ANTARCTICA; PINE ISLAND; WIDESPREAD; THWAITES; DRIVEN		Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Gille, S (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	sgille@ucsd.edu	Gille, Sarah T./B-3171-2012	Gille, Sarah/0000-0001-9144-4368				Depoorter MA, 2013, NATURE, V502, P89, DOI 10.1038/nature12567; Griggs JA, 2011, J GLACIOL, V57, P485, DOI 10.3189/002214311796905659; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Lee S, 2013, SCIENCE, V339, P563, DOI 10.1126/science.1225154; PARK YH, 1998, J MARINE SYST, V17, P233; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Schmidtko S, 2014, SCIENCE, V346, P1227, DOI 10.1126/science.1256117; Wahlin AK, 2013, J PHYS OCEANOGR, V43, P2054, DOI 10.1175/JPO-D-12-0157.1; Wong APS, 1998, ANTARCT RES SER, V75, P173	12	5	5	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1180	1181		10.1126/science.aaa0886	http://dx.doi.org/10.1126/science.aaa0886			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477440				2022-12-28	WOS:000346189000040
J	Ost, A; Lempradl, A; Casas, E; Weigert, M; Tiko, T; Deniz, M; Pantano, L; Boenisch, U; Itskov, PM; Stoeckius, M; Ruf, M; Rajewsky, N; Reuter, G; Iovino, N; Ribeiro, C; Alenius, M; Heyne, S; Vavouri, T; Pospisilik, JA				Ost, Anita; Lempradl, Adelheid; Casas, Eduard; Weigert, Melanie; Tiko, Theodor; Deniz, Merdin; Pantano, Lorena; Boenisch, Ulrike; Itskov, Pavel M.; Stoeckius, Marlon; Ruf, Marius; Rajewsky, Nikolaus; Reuter, Gunter; Iovino, Nicola; Ribeiro, Carlos; Alenius, Mattias; Heyne, Steffen; Vavouri, Tanya; Pospisilik, J. Andrew			Paternal Diet Defines Offspring Chromatin State and Intergenerational Obesity	CELL			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; HIGH-FAT DIET; GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; C. ELEGANS; MICE; GENOME; TRANSMISSION; ADIPOCYTES; GERMLINE	The global rise in obesity has revitalized a search for genetic and epigenetic factors underlying the disease. We present a Drosophila model of paternal-diet-induced intergenerational metabolic reprogramming (IGMR) and identify genes required for its encoding in offspring. Intriguingly, we find that as little as 2 days of dietary intervention in fathers elicits obesity in offspring. Paternal sugar acts as a physiological suppressor of variegation, desilencing chromatin-state-defined domains in both mature sperm and in offspring embryos. We identify requirements for H3K9/K27me3-dependent reprogramming of metabolic genes in two distinct germline and zygotic windows. Critically, we find evidence that a similar system may regulate obesity susceptibility and phenotype variation in mice and humans. The findings provide insight into the mechanisms underlying intergenerational metabolic reprogramming and carry profound implications for our understanding of phenotypic variation and evolution.	[Ost, Anita; Lempradl, Adelheid; Weigert, Melanie; Tiko, Theodor; Deniz, Merdin; Boenisch, Ulrike; Ruf, Marius; Iovino, Nicola; Heyne, Steffen; Pospisilik, J. Andrew] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Casas, Eduard; Pantano, Lorena; Vavouri, Tanya] Inst Med Predict & Personalitzada Canc, Barcelona 08916, Spain; [Casas, Eduard; Vavouri, Tanya] ICO Hosp GermansTrias & Pujol, Josep Carreras Leukaemia Res Inst IJC, Barcelona 08916, Spain; [Stoeckius, Marlon; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Reuter, Gunter] Univ Halle Wittenberg, Inst Biol, D-06120 Halle, Germany; [Ost, Anita; Alenius, Mattias] Linkoping Univ, Dept Clin & Expt Med, S-58183 Linkoping, Sweden; [Itskov, Pavel M.; Ribeiro, Carlos] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal	Max Planck Society; Catalan Institute of Oncology; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Martin Luther University Halle Wittenberg; Linkoping University; Fundacao Champalimaud	Ost, A (corresponding author), Max Planck Inst Immunobiol & Epigenet, Stuebeweg 51, D-79108 Freiburg, Germany.	anita.ost@liu.se; pospisilik@ie-freiburg.mpg.de	Vavouri, Tanya/I-6124-2019; Lempradl, Adelheid/AAJ-2529-2021	Vavouri, Tanya/0000-0003-2352-9049; Ribeiro, Carlos/0000-0002-9542-7335; Rajewsky, Nikolaus/0000-0002-4785-4332; Weigert, Melanie/0000-0002-8732-1186; Heyne, Steffen/0000-0002-9497-7538; Stoeckius, Marlon/0000-0002-5658-029X; Itskov, Pavel/0000-0002-2191-7083	Max-Planck Society; EU (NoE Epigenesys); ERC [281641]; Swedish VR [K2011-78PK-21893-01-2]; SSMF grants; Spanish Ministry grant [BFU2011-30246, RYC-2010-07114]; Marie Curie European Reintegration Grant "Evo-Chromo''; IMPPC; Champalimaud Foundation; Human Frontiers Program Project Grant [RGP0022/2012]; Portuguese Foundation for Science and Technology (FCT) grant [PTDC/BIA-BCM/118684/2010]; Foundation for Science and Technology [SFRH/BPD/79325/2011]	Max-Planck Society(Max Planck SocietyFoundation CELLEX); EU (NoE Epigenesys); ERC(European Research Council (ERC)European Commission); Swedish VR; SSMF grants; Spanish Ministry grant(Spanish Government); Marie Curie European Reintegration Grant "Evo-Chromo''; IMPPC; Champalimaud Foundation; Human Frontiers Program Project Grant; Portuguese Foundation for Science and Technology (FCT) grant; Foundation for Science and Technology	This research was supported by the Max-Planck Society, EU (NoE Epigenesys), and the ERC 281641. A. O. was supported by Swedish VR K2011-78PK-21893-01-2 and SSMF grants. T. V., L. P., and E. C. were supported by Spanish Ministry grant BFU2011-30246, RYC-2010-07114, Marie Curie European Reintegration Grant "Evo-Chromo,'' and the IMPPC. C. R. and P. M. I. were supported by the Champalimaud Foundation, the Human Frontiers Program Project Grant RGP0022/2012, and the Portuguese Foundation for Science and Technology (FCT) grant PTDC/BIA-BCM/118684/2010. P. M. I. is supported by the postdoctoral fellowship SFRH/BPD/79325/2011 from the Foundation for Science and Technology. The authors are grateful to P. Georgiev, S. Raja, T. Manke, J. Longinotto, and T. Lu for important technical and theoretical help; to D. Corona, R. Bodmer, H. Esterbauer, and T. Jenuwein for critical discussions; and to H. J. and J. C. P. for everything.	Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Blondeau B, 2002, DIABETOLOGIA, V45, P394, DOI 10.1007/s00125-001-0767-4; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Buescher JL, 2013, DIS MODEL MECH, V6, P1123, DOI 10.1242/dmm.011924; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Dorus S, 2006, NAT GENET, V38, P1440, DOI 10.1038/ng1915; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gniuli D, 2008, J LIPID RES, V49, P1936, DOI 10.1194/jlr.M800033-JLR200; Goodliffe JM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-40; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kiani J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003498; Klimcakova E, 2011, J CLIN ENDOCR METAB, V96, pE73, DOI 10.1210/jc.2010-1575; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kucherenko MM, 2011, DEV BIOL, V352, P228, DOI 10.1016/j.ydbio.2011.01.013; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee YH, 2005, DIABETOLOGIA, V48, P1776, DOI 10.1007/s00125-005-1867-3; Lundberg LE, 2013, NUCLEIC ACIDS RES, V41, P4481, DOI 10.1093/nar/gkt158; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ozanne SE, 1999, J ENDOCRINOL, V162, P313, DOI 10.1677/joe.0.1620313; Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376; Patti ME, 2013, CELL MOL LIFE SCI, V70, P1597, DOI 10.1007/s00018-013-1298-0; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; RITOSSA FM, 1966, GENETICS, V54, P819; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Voigt A, 2013, MOL NUTR FOOD RES, V57, P1423, DOI 10.1002/mnfr.201200671; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Whitelaw NC, 2010, DEV CELL, V19, P649, DOI 10.1016/j.devcel.2010.11.001; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Xing YL, 2007, PLOS GENET, V3, P1598, DOI 10.1371/journal.pgen.0030151	51	242	248	0	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1352	1364		10.1016/j.cell.2014.11.005	http://dx.doi.org/10.1016/j.cell.2014.11.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25480298	Green Published, Bronze			2022-12-28	WOS:000346652900014
J	Steiner, L; Ploegh, H				Steiner, Lisa; Ploegh, Hidde			Herman Eisen (1918-2014)	NATURE			English	Biographical-Item									[Steiner, Lisa; Ploegh, Hidde] MIT, Cambridge, MA 02139 USA; [Ploegh, Hidde] MIT Ctr Canc Res, New York, NY USA	Massachusetts Institute of Technology (MIT)	Steiner, L (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lsteiner@mit.edu; ploegh@wi.mit.edu							0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					38	38		10.1038/516038a	http://dx.doi.org/10.1038/516038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471875	Bronze			2022-12-28	WOS:000346310800027
J	Gulamhusein, H; Yun, LS; Cheung, AM; Sutradhar, R; Paszat, L; Warde, P; Alibhai, SH				Gulamhusein, Husayn; Yun, Lingsong; Cheung, Angela M.; Sutradhar, Rinku; Paszat, Lawrence; Warde, Padraig; Alibhai, ShabbirM. H.			Bisphosphonate Prescriptions in Men With Androgen Deprivation Therapy Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							OSTEOPOROSIS		[Gulamhusein, Husayn; Cheung, Angela M.; Alibhai, ShabbirM. H.] Univ Hlth Network, Dept Med, Toronto, ON M5G 2C4, Canada; [Yun, Lingsong; Sutradhar, Rinku; Paszat, Lawrence] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Warde, Padraig] Univ Hlth Network, Radiat Med Program, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Alibhai, SH (corresponding author), Univ Hlth Network, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	shabbir.alibhai@uhn.ca		Alibhai, Shabbir/0000-0001-7815-6046; Cheung, Angela M./0000-0001-8332-0744; Warde, Padraig/0000-0002-4236-0026	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Alibhai SMH, 2012, JAMA-J AM MED ASSOC, V307, P255, DOI 10.1001/jama.2011.2022; Alibhai SMH, 2009, J CLIN ONCOL, V27, P3452, DOI 10.1200/JCO.2008.20.0923; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Cadarette SM, 2011, OSTEOPOROSIS INT, V22, P1335, DOI 10.1007/s00198-010-1329-8; Duncan Graeme G, 2006, Can J Urol, V13, P2962; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67	6	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2285	2286		10.1001/jama.2014.14038	http://dx.doi.org/10.1001/jama.2014.14038			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25462000	Bronze			2022-12-28	WOS:000345684800025
J	Habbema, JDF; Wilt, TJ; Etzioni, R; Nelson, HD; Schechter, CB; Lawrence, WF; Melnikow, J; Kuntz, KM; Owens, DK; Feuer, EJ				Habbema, J. Dik F.; Wilt, Timothy J.; Etzioni, Ruth; Nelson, Heidi D.; Schechter, Clyde B.; Lawrence, William F.; Melnikow, Joy; Kuntz, Karen M.; Owens, Douglas K.; Feuer, Eric J.			Models in the Development of Clinical Practice Guidelines	ANNALS OF INTERNAL MEDICINE			English	Article							TASK-FORCE; COLORECTAL-CANCER; UNITED-STATES; MORTALITY	Clinical practice guidelines should be based on the best scientific evidence derived from systematic reviews of primary research. However, these studies often do not provide evidence needed by guideline development groups to evaluate the tradeoffs between benefits and harms. In this article, the authors identify 4 areas where models can bridge the gaps between published evidence and the information needed for guideline development applying new or updated information on disease risk, diagnostic test properties, and treatment efficacy; exploring a more complete array of alternative intervention strategies; assessing benefits and harms over a lifetime horizon; and projecting outcomes for the conditions for which the guideline is intended. The use of modeling as an approach to bridge these gaps (provided that the models are high-quality and adequately validated) is considered. Colorectal and breast cancer screening are used as examples to show the utility of models for these purposes. The authors propose that a modeling study is most useful when strong primary evidence is available to inform the model but critical gaps remain between the evidence and the questions that the guideline group must address. In these cases, model results have a place alongside the findings of systematic reviews to inform health care practice and policy.	Erasmus MC Univ Med Ctr, NL-3015 CN Rotterdam, Netherlands; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Albert Einstein Coll Med, New York, NY USA; Agcy Healthcare Res & Qual, Rockville, MD USA; UC Davis Med Ctr, Sacramento, CA USA; Stanford Univ, Stanford, CA 94305 USA; NCI, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; University of Minnesota System; University of Minnesota Twin Cities; Fred Hutchinson Cancer Center; Oregon Health & Science University; Yeshiva University; Agency for Healthcare Research & Quality; University of California System; University of California Davis; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Habbema, JDF (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.	j.d.f.habbema@erasmusmc.nl			U.S. Department of Veterans Affairs; Agency for Healthcare Research and Quality; American College of Physicians; National Kidney Foundation; Kidney Diseases International; National Institutes of Health; National Cancer Institute; California Health Benefits Review Program	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American College of Physicians; National Kidney Foundation; Kidney Diseases International; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Health Benefits Review Program	Dr. Wilt is supported by grants from the U.S. Department of Veterans Affairs and the Agency for Healthcare Research and Quality and contracts to conduct evidence synthesis from the American College of Physicians, the National Kidney Foundation, and Kidney Diseases International. Dr. Nelson is supported by the Agency for Healthcare Research and Quality and the National Institutes of Health. Dr. Schechter is supported by grants from the National Cancer Institute to develop and apply models of breast cancer epidemiology. Dr. Melnikow receives extramural support from the California Health Benefits Review Program and the National Institutes of Health. Dr. Owens is supported by the U.S. Department of Veterans Affairs.	Anderson JL, 2014, CIRCULATION, V129, P2329, DOI 10.1161/CIR.0000000000000042; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Buxton MJ, 1997, HEALTH ECON, V6, P217, DOI 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.0.CO;2-W; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Caro JJ, 2012, MED DECIS MAKING, V32, P667, DOI 10.1177/0272989X12454577; de Koning HJ, 2013, AHRQ PUBLICATION; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Gold MR, 1996, COST EFFECTIVENESS H; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Habbema D, 2012, MILBANK Q, V90, P5, DOI 10.1111/j.1468-0009.2011.00652.x; Habbema J Dik F, 2006, J Natl Cancer Inst Monogr, P122, DOI 10.1093/jncimonographs/lgj017; Health Council of the Netherlands, 2009, HLTH COUNC NETH PUBL, V13E; Health Council of the Netherlands, 2011, HLTH COUNC NETH PUBL, V07E; Karnon J, 2012, MED DECIS MAKING, V32, P701, DOI 10.1177/0272989X12455462; Lansdorp-Vogelaar I, 2009, CANCER-AM CANCER SOC, V115, P2410, DOI 10.1002/cncr.24256; Lansdorp-Vogelaar I, 2009, GASTROINTEST ENDOSC, V70, P96, DOI 10.1016/j.gie.2008.08.040; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Miller AB, 2012, NEW ENGL J MED, V366, P1047, DOI 10.1056/NEJMe1200185; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; National Institute for Health and Care Excellence, 2009, GUID MAN APP G METH; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Pitman R, 2012, MED DECIS MAKING, V32, P712, DOI 10.1177/0272989X12454578; Roberts M, 2012, MED DECIS MAKING, V32, P678, DOI [10.1177/0272989X12454941, 10.1016/j.jval.2012.06.016]; Schwartz JAT, 2013, JAMA INTERN MED, V173, P1091, DOI 10.1001/jamainternmed.2013.817; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Shibata A, 1998, J NATL CANCER I, V90, P1230, DOI 10.1093/jnci/90.16.1230; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Stout NK, 2013, USING MATH MODELS IN, P315; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wilschut JA, 2011, CANCER-AM CANCER SOC, V117, P4166, DOI 10.1002/cncr.26009; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	36	30	32	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					812	U105		10.7326/M14-0845	http://dx.doi.org/10.7326/M14-0845			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9UJ	25437409				2022-12-28	WOS:000347247200010
J	Wang, R; Persky, NS; Yoo, B; Ouerfelli, O; Smogorzewska, A; Elledge, SJ; Pavletich, NP				Wang, Renjing; Persky, Nicole S.; Yoo, Barney; Ouerfelli, Ouathek; Smogorzewska, Agata; Elledge, Stephen J.; Pavletich, Nikola P.			Mechanism of DNA interstrand cross-link processing by repair nuclease FAN1	SCIENCE			English	Article							KIAA1018/FAN1; CELLS; IDENTIFICATION; DAMAGE	DNA interstrand cross-links (ICLs) are highly toxic lesions associated with cancer and degenerative diseases. ICLs can be repaired by the Fanconi anemia (FA) pathway and through FA-independent processes involving the FAN1 nuclease. In this work, FAN1-DNA crystal structures and biochemical data reveal that human FAN1 cleaves DNA successively at every third nucleotide. In vitro, this exonuclease mechanism allows FAN1 to excise an ICL from one strand through flanking incisions. DNA access requires a 5 '-terminal phosphate anchor at a nick or a 1- or 2-nucleotide flap and is augmented by a 3 ' flap, suggesting that FAN1 action is coupled to DNA synthesis or recombination. FAN1 ' s mechanism of ICL excision is well suited for processing other localized DNA adducts as well.	[Wang, Renjing; Persky, Nicole S.; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Wang, Renjing; Persky, Nicole S.; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Yoo, Barney; Ouerfelli, Ouathek] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA; [Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Elledge, Stephen J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rockefeller University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pavletin@mskcc.org		Ouerfelli, Ouathek/0000-0002-7038-0219; Smogorzewska, Agata/0000-0001-6285-1562	Howard Hughes Medical Institute; NIH [R01HL120922]; Burroughs Wellcome Career Award; Doris Duke Clinical Scientist Development Award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044664] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (N.P.P. and S.J.E.) and NIH grant R01HL120922 (A. S.). A. S. is a Rita Allen Foundation Scholar and the recipient of a Burroughs Wellcome Career Award and a Doris Duke Clinical Scientist Development Award. The Protein Data Bank accession codes are 4RI8 (5'pG<INF>1</INF>/3'T<INF>4</INF>), 4RI9 (5'pT<INF>1</INF>/3'T<INF>8</INF>), 4RIA (5'pNi), 4RIB (5'pT<INF>1</INF>), 4RIC (5'T<INF>2</INF>), and 4RID (apo-FAN1).	Clauson C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012732; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Fontebasso Y, 2013, DNA REPAIR, V12, P1011, DOI 10.1016/j.dnarep.2013.10.003; Hadden JM, 2007, NATURE, V449, P621, DOI 10.1038/nature06158; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Presolski SI, 2010, J AM CHEM SOC, V132, P14570, DOI 10.1021/ja105743g; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Trujillo JP, 2012, BLOOD, V120, P86, DOI 10.1182/blood-2012-04-420604; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Williams HL, 2013, TRENDS BIOCHEM SCI, V38, P386, DOI 10.1016/j.tibs.2013.05.004; Yoshikiyo K, 2010, P NATL ACAD SCI USA, V107, P21553, DOI 10.1073/pnas.1011081107; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347	20	43	44	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1127	1130		10.1126/science.1258973	http://dx.doi.org/10.1126/science.1258973			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430771	Green Accepted			2022-12-28	WOS:000345763400046
J	Gubin, MM; Zhang, XL; Schuster, H; Caron, E; Ward, JP; Noguchi, T; Ivanova, Y; Hundal, J; Arthur, CD; Krebber, WJ; Mulder, GE; Toebes, M; Vesely, MD; Lam, SSK; Korman, AJ; Allison, JP; Freeman, GJ; Sharpe, AH; Pearce, EL; Schumacher, TN; Aebersold, R; Rammensee, HG; Melief, CJM; Mardis, ER; Gillanders, WE; Artyomov, MN; Schreiber, RD				Gubin, Matthew M.; Zhang, Xiuli; Schuster, Heiko; Caron, Etienne; Ward, Jeffrey P.; Noguchi, Takuro; Ivanova, Yulia; Hundal, Jasreet; Arthur, Cora D.; Krebber, Willem-Jan; Mulder, Gwenn E.; Toebes, Mireille; Vesely, Matthew D.; Lam, Samuel S. K.; Korman, Alan J.; Allison, James P.; Freeman, Gordon J.; Sharpe, Arlene H.; Pearce, Erika L.; Schumacher, Ton N.; Aebersold, Ruedi; Rammensee, Hans-Georg; Melief, Cornelis J. M.; Mardis, Elaine R.; Gillanders, William E.; Artyomov, Maxim N.; Schreiber, Robert D.			Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens	NATURE			English	Article							EXOME ANALYSIS REVEALS; QUANTITATIVE PROTEOMICS; T-CELLS; PD-1; INFLAMMATION; RESPONSES; EQUILIBRIUM; PREDICTIONS; IPILIMUMAB; TOLERANCE	The immune system influences the fate of developing cancers by not only functioning as a tumour promoter that facilitates cellular transformation, promotes tumour growth and sculpts tumour cell immunogenicity(1-6), but also as an extrinsic tumour suppressor that either destroys developing tumours or restrains their expansion(1,2,7). Yet, clinically apparent cancers still arise in immunocompetent individuals in part as a consequence of cancer-induced immunosuppression. In many individuals, immunosuppression is mediated by cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and programmed death-1 (PD -1), two immunomodulatory receptors expressed on T cells(8,9). Monoclonal-antibody-based therapies targeting CTLA-4 and/or PD-1 (checkpoint blockade) have yielded significant clinical benefits including durable responses to patients with different malignancies(10-13). However, little is known about the identity of the tumour antigens that function as the targets of T cells activated by checkpoint blockade immunotherapy and whether these antigens can be used to generate vaccines that are highly tumour-specific. Here we use genomics and bioinformatics approaches to identify tumour-specific mutant proteins as a major class of T-cell rejection antigens following anti-PD-1 and/or anti-CTLA-4 therapy of mice bearing progressively growing sarcomas, and we show that therapeutic synthetic long-peptide vaccines incorporating these mutant epitopes induce tumour rejection comparably to checkpoint blockade immunotherapy. Although mutant tumour-antigen-specific T cells are present in progressively growing tumours, they are reactivated following treatment with anti-PD-1 and/or anti-CTLA-4 and display some overlapping but mostly treatment-specific transcriptional profiles, rendering them capable of mediating tumour rejection. These results reveal that tumour-specific mutant antigens are not only important targets of checkpoint blockade therapy, but they can also be used to develop personalized cancer-specific vaccines and to probe the mechanistic	[Gubin, Matthew M.; Ward, Jeffrey P.; Noguchi, Takuro; Ivanova, Yulia; Arthur, Cora D.; Vesely, Matthew D.; Lam, Samuel S. K.; Pearce, Erika L.; Artyomov, Maxim N.; Schreiber, Robert D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Zhang, Xiuli; Gillanders, William E.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Schuster, Heiko; Rammensee, Hans-Georg] German Canc Res Ctr, Dept Immunol, Inst Cell Biol, D-72076 Tubingen, Germany; [Schuster, Heiko; Rammensee, Hans-Georg] German Canc Res Ctr, German Canc Consortium DKTK, D-72076 Tubingen, Germany; [Caron, Etienne; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Ward, Jeffrey P.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Hundal, Jasreet; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Krebber, Willem-Jan; Mulder, Gwenn E.; Melief, Cornelis J. M.] ISA Therapeut BV, NL-2333 CH Leiden, Netherlands; [Toebes, Mireille; Schumacher, Ton N.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Korman, Alan J.] Bristol Myers Squibb Co, Redwood City, CA 94063 USA; [Allison, James P.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8093 Zurich, Switzerland; [Melief, Cornelis J. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [Mardis, Elaine R.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Swiss Federal Institutes of Technology Domain; ETH Zurich; Washington University (WUSTL); Washington University (WUSTL); Netherlands Cancer Institute; Bristol-Myers Squibb; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Zurich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Washington University (WUSTL)	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA.	schreiber@immunology.wustl.edu	Vesely, Matthew/AAM-6813-2020; Mardis, Elaine/W-2202-2019; Vesely, Matthew/AFM-2324-2022; Freeman, Gordon/AAC-5380-2019; Schumacher, Ton/Y-2432-2019; Schreiber, Robert/Q-7550-2019; Noguchi, Takuro/AAW-9101-2020	Vesely, Matthew/0000-0001-9363-945X; Freeman, Gordon/0000-0002-7210-5616; Schumacher, Ton/0000-0003-0517-8804; Gubin, Matthew/0000-0001-7443-2752; Ward, Jeffrey/0000-0002-9707-895X; Allison, James/0000-0001-8980-5697; Lam, Siu Kit/0000-0003-1671-3999; Schreiber, Robert/0000-0003-1590-2341	National Cancer Institute [R01 CA043059, U01 CA141541, T32 CA00954729]; Cancer Research Institute; WWWW Foundation; Siteman Cancer Center/Barnes-Jewish Hospital (Cancer Frontier Fund); Susan G. Komen for the Cure (Promise grant); National Human Genome Research Institute; National Institute of Health [P50 CA101942, P01 A1054456]; Dutch Cancer Society (Queen Wilhelmina Research Award); Marie Curie Intra-European Fellowship within the Seventh Framework Programme of the European Community for Research; postdoctoral training grant(Irvington Postdoctoral Fellowship)from the Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA190700, T32CA009547, P30CA091842, R37CA043059, P30CA016672, U01CA141541, R01CA043059, P50CA101942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054456, R01AI091965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Institute; WWWW Foundation; Siteman Cancer Center/Barnes-Jewish Hospital (Cancer Frontier Fund); Susan G. Komen for the Cure (Promise grant); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society (Queen Wilhelmina Research Award); Marie Curie Intra-European Fellowship within the Seventh Framework Programme of the European Community for Research; postdoctoral training grant(Irvington Postdoctoral Fellowship)from the Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to K. Murphy for the Batf3<SUP>-/-</SUP> mice, T. Hansen for providing MHC class I antibodies and the H-2K<SUP>b</SUP> construct, D. Fremont for the human beta 2m construct, and the National Institutes of Health (NIH) Tetramer Core Facility for producing MHC class I tetramers. We also thank R. Ahmed and M. Hashimoto for the multiplex staining strategy used to define functional and dysfunctional T cells. We thank A. Bensimon, O. Schubert and P. Kouvonen for instrument maintenance and for technical support with the mass spectrometry measurements and R. Vanganipuram, M. Selby and J. Valle for generating and supplying anti-PD-1 and anti-CTLA-4 in endotoxin-free sterile form. We also thank K. Sheehan, P. Allen, G. Dunn and R. Chan for constructive criticisms and comments, all members of the Schreiber laboratory for discussions, and the many members of The Genome Institute at Washington University School of Medicine. We would also like to thank W. Song for his assistance with the bioinformatics approaches, P. Kvistborg for assistance with tetramer combinatorial coding, and Christopher Nelson for advice with peptide-MHC monomer purification. This work was supported by grants to R.D.S. from the National Cancer Institute (R01 CA043059, U01 CA141541), the Cancer Research Institute and the WWWW Foundation; to R.D.S. and W.E.G. from The Siteman Cancer Center/Barnes-Jewish Hospital (Cancer Frontier Fund); to W.E.G. from Susan G. Komen for the Cure (Promise grant); to E.R.M. from the National Human Genome Research Institute; to G.J.F. from the National Institute of Health (P50 CA101942, P01 A1054456, P50 CA101942); to A.H.S. from the National Institute of Health (P50 CA101942); and to T.N.S. from the Dutch Cancer Society (Queen Wilhelmina Research Award). E.C. is supported by a Marie Curie Intra-European Fellowship within the Seventh Framework Programme of the European Community for Research. M.M.G. was supported by a postdoctoral training grant (T32 CA00954729) from the National Cancer Institute and is currently supported by a postdoctoral training grant(Irvington Postdoctoral Fellowship)from the Cancer Research Institute. Aspects of studies at Washington University were performed with assistance by the Immunomonitoring Laboratory of the Center for Human Immunology and Immunotherapy Programs and the Siteman Comprehensive Cancer Center.	Andersen RS, 2012, NAT PROTOC, V7, P891, DOI 10.1038/nprot.2012.037; Brunner MC, 1999, J IMMUNOL, V162, P5813; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Escher C, 2012, PROTEOMICS, V12, P1111, DOI 10.1002/pmic.201100463; ESQUIVEL F, 1992, J EXP MED, V175, P163, DOI 10.1084/jem.175.1.163; Fritsch EF, 2014, CANCER IMMUNOL RES, V2, P522, DOI 10.1158/2326-6066.CIR-13-0227; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kowalewski Daniel J, 2013, Methods Mol Biol, V960, P145, DOI 10.1007/978-1-62703-218-6_12; Kvistborg P, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.18851; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thommen DS, 2012, J IMMUNOL, V188, P5283, DOI 10.4049/jimmunol.1101506; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268	46	1353	1434	11	567	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2014	515	7528					577	+		10.1038/nature13988	http://dx.doi.org/10.1038/nature13988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4JP	25428507	Green Accepted, Green Submitted			2022-12-28	WOS:000346247600056
J							Drug Therapeutics Bulletin	Republished: Nicotine and health (Reprinted from Drug and Therapeutics Bulletin, vol 52, pg 78, 2014)	BMJ-BRITISH MEDICAL JOURNAL			English	Reprint								Nicotine, an alkaloid derived from the leaves of tobacco plants (Nicotiana tabacum and Nicotiana rustica) is the primary addictive agent in tobacco products. 1,2 There are different ways of administering the various products including smoking cigarettes, chewing tobacco, holding moist snuff in the mouth, inhaling dry snuff through the nose, inhaling smoke from a waterpipe and inhaling vapour from an electronic cigarette.(3-)6 It can be difficult differentiating the effects of nicotine from the many other toxic substances these products also contain. Here we review the pharmacological effects of nicotine but we will not review the well-known harmful effects of cigarettes, where it is primarily the toxins and carcinogens in tobacco smoke rather than the nicotine that cause illness and death. 7 A future article will consider the use of electronic cigarettes.	Drug & Therapeut Bulletin Editorial Off, London WC1H 9JR, England; [Drug Therapeutics Bulletin] Drug & Therapeut Bulletin Editorial Off, London WC1H 9JR, England									[Anonymous], 2014, Drug Ther Bull, V52, P78, DOI 10.1136/dtb.2014.7.0264; [Anonymous], 2014, NEW CDC STUD FINDS D; [Anonymous], 2013, NIC QUICKMIST 1MG SP; [Anonymous], 2014, NIQUITIN STRIPS MINT; Benowitz NL, 2009, ANNU REV PHARMACOL, V49, P57, DOI 10.1146/annurev.pharmtox.48.113006.094742; Benowitz NL, 1999, PRIMARY CARE, V26, P611, DOI 10.1016/S0095-4543(05)70120-2; Cancer Research UK, 2009, SMOK TOB CANC; Coleman T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010078; David SP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003086.pub3; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P1382, DOI 10.1093/ntr/nts007; Greenland S, 1998, DRUG SAFETY, V18, P297, DOI 10.2165/00002018-199818040-00005; Hartmann-Boyce J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007072.pub2; Mayer B, 2014, ARCH TOXICOL, V88, P5, DOI 10.1007/s00204-013-1127-0; National Institute for Health and Care Excellence, 2013, TOB HARM RED APPR SM; Pepper JK, 2014, TOB CONTROL, V23, P375, DOI 10.1136/tobaccocontrol-2013-051122; Punnoose S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004838.pub2; Sanz, 2001, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001749; Scientific Committee on Tobacco and Health; Department of Health, 1998, REP SCI COMM TOB HLT; Seidelin Jakob Benedict, 2006, Ugeskr Laeger, V168, P674; Stead LF, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005231.pub2; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub4; Thiriez Claire, 2011, Expert Rev Clin Pharmacol, V4, P429, DOI 10.1586/ecp.11.27; Tobacco Advisory Group of the Royal College of Physicians, 2007, HARM RED NIC ADD HEL; Toxbase, 2014, EL CIG; WHO, 2005, ADV NOT WAT TOB SMOK	25	7	7	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2014	349								0264rep	10.1136/bmj.2014.7.0264rep	http://dx.doi.org/10.1136/bmj.2014.7.0264rep			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KF	25428425				2022-12-28	WOS:000346115700001
J	Gouldthorpe, C; Heseltine, D				Gouldthorpe, Craig; Heseltine, David			PICTURE QUIZ Occult manifestations of bacteraemia in an 82 year old woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STAPHYLOCOCCUS-AUREUS BACTEREMIA; MANAGEMENT; EXPERIENCE		[Gouldthorpe, Craig] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Heseltine, David] York Dist Gen Hosp, York, N Yorkshire, England	University of Hull; University of York - UK	Gouldthorpe, C (corresponding author), Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England.	hycg@hyms.ac.uk		Gouldthorpe, Craig/0000-0001-6131-2997				Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Cosgrove SE, 2008, CLIN INFECT DIS, V46, pS386, DOI 10.1086/533595; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Fowler VG, 1997, J AM COLL CARDIOL, V30, P1072, DOI 10.1016/S0735-1097(97)00250-7; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Meyer C, 2013, BMJ QUAL IMPROV REPO, V2, pw908; Naber CK, 2009, CLIN INFECT DIS, V48, pS231, DOI 10.1086/598189; Pearson A, 2008, PRESUMPTIVE SOURCES; Public Health England, 2014, ANN EP COMM MAND MRS; Rasmussen RV, 2011, FUTURE MICROBIOL, V6, P43, DOI 10.2217/FMB.10.155; Scottish Antimicrobial Prescribing Group and Scottish Microbiology and Virology Network, 2013, GUID MAN PROV SUSP S; Thwaites G, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-241; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Vos FJ, 2012, MEDICINE, V91, P86, DOI 10.1097/MD.0b013e31824d7ed2	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 24	2014	349								g6807	10.1136/bmj.g6807	http://dx.doi.org/10.1136/bmj.g6807			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KC	25420600				2022-12-28	WOS:000346115400005
J	Chipumuro, E; Marco, E; Christensen, CL; Kwiatkowski, N; Zhang, TH; Hatheway, CM; Abraham, BJ; Sharma, B; Yeung, C; Altabef, A; Perez-Atayde, A; Wong, KK; Yuan, GC; Gray, NS; Young, RA; George, RE				Chipumuro, Edmond; Marco, Eugenio; Christensen, Camilla L.; Kwiatkowski, Nicholas; Zhang, Tinghu; Hatheway, Clark M.; Abraham, Brian J.; Sharma, Bandana; Yeung, Caleb; Altabef, Abigail; Perez-Atayde, Antonio; Wong, Kwok-Kin; Yuan, Guo-Cheng; Gray, Nathanael S.; Young, Richard A.; George, Rani E.			CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer	CELL			English	Article							BET BROMODOMAIN INHIBITION; RNA-POLYMERASE-II; N-MYC; C-MYC; ACTIVATING KINASE; THERAPEUTIC TARGETS; CELLULAR GROWTH; GENE-EXPRESSION; LYMPHOMA-CELLS; NEUROBLASTOMA	The MYC oncoproteins are thought to stimulate tumor cell growth and proliferation through amplification of gene transcription, a mechanism that has thwarted most efforts to inhibit MYC function as potential cancer therapy. Using a covalent inhibitor of cyclin-dependent kinase 7 (CDK7) to disrupt the transcription of amplified MYCN in neuroblastoma cells, we demonstrate downregulation of the oncoprotein with consequent massive suppression of MYCN-driven global transcriptional amplification. This response translated to significant tumor regression in a mouse model of high-risk neuroblastoma, without the introduction of systemic toxicity. The striking treatment selectivity of MYCN-overexpressing cells correlated with preferential downregulation of super-enhancer-associated genes, including MYCN and other known oncogenic drivers in neuroblastoma. These results indicate that CDK7 inhibition, by selectively targeting the mechanisms that promote global transcriptional amplification in tumor cells, may be useful therapy for cancers that are driven by MYC family oncoproteins.	[Chipumuro, Edmond; Hatheway, Clark M.; Sharma, Bandana; Yeung, Caleb; George, Rani E.] Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02215 USA; [Chipumuro, Edmond; Hatheway, Clark M.; Sharma, Bandana; Yeung, Caleb; George, Rani E.] Boston Childrens Hosp, Boston, MA 02215 USA; [Chipumuro, Edmond; Yeung, Caleb; George, Rani E.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Marco, Eugenio; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Marco, Eugenio; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Christensen, Camilla L.; Altabef, Abigail; Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Kwiatkowski, Nicholas; Abraham, Brian J.; Young, Richard A.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Kwiatkowski, Nicholas; Abraham, Brian J.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Zhang, Tinghu; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Zhang, Tinghu; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Perez-Atayde, Antonio] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	George, RE (corresponding author), Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02215 USA.	rani_george@dfci.harvard.edu	George, Rani/AAG-7635-2019; Young, Richard A/F-6495-2012; Abraham, Brian/C-2230-2019; Marco, Eugenio/F-4583-2011	Young, Richard A/0000-0001-8855-8647; Abraham, Brian/0000-0001-8085-3027; Marco, Eugenio/0000-0002-3675-263X; wong, kwok kin/0000-0001-6323-235X	NIH [R01CA148688, R01CA148688S1, R01CA179483-01, CA109901, HG002668, R21HG006778]; American Cancer Society [RSG-12-247-TBG]; Department of Defense [PR120741A]; Friends for Life Neuroblastoma Foundation; NATIONAL CANCER INSTITUTE [R01CA148688, P30CA014051, R01CA179483, P01CA109901] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006778, R01HG002668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense); Friends for Life Neuroblastoma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank K. Ligon, D. Sabatini., W. Weiss, A. Kung, and the Children's Oncology Group for cell lines and plasmids and P. Baran for the dCA compound. We thank J.R. Gilbert and Takaomi Sanda for insightful discussions. This study was supported by NIH R01CA148688 (R. E. G.), R01CA148688S1 (E. C.), R01CA179483-01 (N.S.G. and T.H.Z.), CA109901, HG002668 (R. A. Y., N.K., B.A.), and R21HG006778 (G. C. Y.); American Cancer Society (RSG-12-247-TBG to R. E. G.); Department of Defense (PR120741A to R. E. G.); and Friends for Life Neuroblastoma Foundation (N.S.G. and R.E.G.). THZ1 has been licensed to Syros Pharmaceuticals for clinical development. N.S.G. and R.A.Y. are scientific founders of Syros Pharmaceuticals.	Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; COHN SL, 1990, ONCOGENE, V5, P1821; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Garriga J, 2004, GENE, V337, P15, DOI 10.1016/j.gene.2004.05.007; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Howard MJ, 2000, DEVELOPMENT, V127, P4073; KOHL NE, 1986, NATURE, V319, P73, DOI 10.1038/319073a0; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Labisso WL, 2012, CELL CYCLE, V11, P1593, DOI 10.4161/cc.20008; Lam LT, 2001, GENOME BIOL, V2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Malynn BA, 2000, GENE DEV, V14, P1390; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; NISHIKURA K, 1985, P NATL ACAD SCI USA, V82, P2900, DOI 10.1073/pnas.82.9.2900; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Schuhmacher M, 2013, TRANSCR-AUSTIN, V4, P192, DOI 10.4161/trns.25907; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Stanke M, 1999, DEVELOPMENT, V126, P4087; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Tsarovina K, 2004, DEVELOPMENT, V131, P4775, DOI 10.1242/dev.01370; VERONESE ML, 1995, BLOOD, V85, P2132, DOI 10.1182/blood.V85.8.2132.bloodjournal8582132; Wasylishen Amanda R, 2010, Genes Cancer, V1, P532, DOI 10.1177/1947601910378024; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wyce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072967; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	381	395	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 20	2014	159	5					1126	1139		10.1016/j.cell.2014.10.024	http://dx.doi.org/10.1016/j.cell.2014.10.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AU3IP	25416950	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000345506300023
J	Louis, T; Tomchik, SM				Louis, Thierry; Tomchik, Seth M.			Neurons and Behavior: Ex Uno, Plures	CELL			English	Editorial Material							CAENORHABDITIS-ELEGANS	Li et al. demonstrate that a single interneuron can regulate analog- and digital-like behaviors guided by two different postsynaptic neurons. Releasing a single neurotransmitter onto downstream neurons that express receptors with distinct biophysical properties enables a small set of neurons to direct a range of functional responses.	[Louis, Thierry; Tomchik, Seth M.] Scripps Florida, Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida	Tomchik, SM (corresponding author), Scripps Florida, Scripps Res Inst, Dept Neurosci, 130 Scripps Way 3C1, Jupiter, FL 33458 USA.	stomchik@scripps.edu		Louis, Thierry/0000-0002-4149-1796; Tomchik, Seth/0000-0001-5686-0833				Boto T, 2014, CURR BIOL, V24, P822, DOI 10.1016/j.cub.2014.03.021; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Holden-Dye L, 2013, PARASITOL INT, V62, P606, DOI 10.1016/j.parint.2013.03.004; Lee YS, 2000, J NEUROCHEM, V75, P1800, DOI 10.1046/j.1471-4159.2000.0751800.x; Li ZY, 2014, CELL, V159, P751, DOI 10.1016/j.cell.2014.09.056; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Putrenko I, 2005, J BIOL CHEM, V280, P6392, DOI 10.1074/jbc.M412644200; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017	10	0	0	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 6	2014	159	4					713	714		10.1016/j.cell.2014.10.030	http://dx.doi.org/10.1016/j.cell.2014.10.030			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AS8TY	25417147	Bronze			2022-12-28	WOS:000344522000003
J	Dacre, J				Dacre, Jane			The RCP's five-point plan for the next UK Government	LANCET			English	Editorial Material									Royal Coll Physicians, London NW1 4LE, England	Royal College of Physicians	Dacre, J (corresponding author), Royal Coll Physicians, London NW1 4LE, England.	president@rcplondon.ac.uk						[Anonymous], 2014, ROYAL COLL PHYS 5 PO; NHS England Care Quality Commission Public Health England Monitor NHS Trust Development Authority Health Education England, 2014, NHS 5 YEAR FORW VIEW; Royal College of Physicians Future Hospital Commission. Future hospital: caring for medical patients, 2013, FUT HOSP CAR MED PAT; Triggle N, 2014, BBC NEWS	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1552	1553		10.1016/S0140-6736(14)61821-3	http://dx.doi.org/10.1016/S0140-6736(14)61821-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9NK	25443478				2022-12-28	WOS:000343901700005
J	Pizzo, PA				Pizzo, Philip A.			The Doctor: For Life and at the End of Life	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PALLIATIVE CARE; CANCER		Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Pizzo, PA (corresponding author), Stanford Univ, Sch Med, Lorry Lokey Res Bldg,265 Campus Dr G1078, Stanford, CA 94305 USA.	ppizzo@stanford.edu						Committee on Approaching Death: Addressing Key End of Life Issues, 2014, DYING AM IMPR QUAL H; Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population Board on Health Care Services Institute of Medicine, 2013, DEL HIGH QUAL CANC C; Smith TJ, 2012, J CLIN ONCOL, V30, P880, DOI 10.1200/JCO.2011.38.5161; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410	5	5	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 3	2015	162	3					228	U139		10.7326/M14-2399	http://dx.doi.org/10.7326/M14-2399			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC1NP	25486216				2022-12-28	WOS:000350108100010
J	Qian, J; Wang, Q; Dose, M; Pruett, N; Kieffer-Kwon, KR; Resch, W; Liang, GQ; Tang, ZH; Mathe, E; Benner, C; Dubois, W; Nelson, S; Vian, L; Oliveira, TY; Jankovic, M; Hakim, O; Gazumyan, A; Pavri, R; Awasthi, P; Song, B; Liu, G; Chen, LY; Zhu, SD; Feigenbaum, L; Staudt, L; Murre, C; Ruan, YJ; Robbiani, DF; Pan-Hammarstrom, Q; Nussenzweig, MC; Casellas, R				Qian, Jason; Wang, Qiao; Dose, Marei; Pruett, Nathanael; Kieffer-Kwon, Kyong-Rim; Resch, Wolfgang; Liang, Genqing; Tang, Zhonghui; Mathe, Ewy; Benner, Christopher; Dubois, Wendy; Nelson, Steevenson; Vian, Laura; Oliveira, Thiago Y.; Jankovic, Mila; Hakim, Ofir; Gazumyan, Anna; Pavri, Rushad; Awasthi, Parirokh; Song, Bin; Liu, Geng; Chen, Longyun; Zhu, Shida; Feigenbaum, Lionel; Staudt, Louis; Murre, Cornelis; Ruan, Yijun; Robbiani, Davide F.; Pan-Hammarstrom, Qiang; Nussenzweig, Michel C.; Casellas, Rafael			B Cell Super-Enhancers and Regulatory Clusters Recruit AID Tumorigenic Activity	CELL			English	Article							INDUCED CYTIDINE DEAMINASE; RNA-POLYMERASE-II; SOMATIC HYPERMUTATION; CHROMOSOMAL TRANSLOCATIONS; MUTATIONAL PROCESSES; GENOMIC INSTABILITY; SEQUENCING REVEALS; DNA; BREAKS; GENE	The antibody gene mutator activation-induced cytidine deaminase (AID) promiscuously damages oncogenes, leading to chromosomal translocations and tumorigenesis. Why nonimmunoglobulin loci are susceptible to AID activity is unknown. Here, we study AID-mediated lesions in the context of nuclear architecture and the B cell regulome. We show that AID targets are not randomly distributed across the genome but are predominantly grouped within super-enhancers and regulatory clusters. Unexpectedly, in these domains, AID deaminates active promoters and eRNA(+) enhancers interconnected in some instances over megabases of linear chromatin. Using genome editing, we demonstrate that 3D-linked targets cooperate to recruit AID-mediated breaks. Furthermore, a comparison of hypermutation in mouse B cells, AID-induced kataegis in human lymphomas, and translocations in MEFs reveals that AID damages different genes in different cell types. Yet, in all cases, the targets are predominantly associated with topological complex, highly transcribed super-enhancers, demonstrating that these compartments are key mediators of AID recruitment.	[Qian, Jason; Dose, Marei; Pruett, Nathanael; Kieffer-Kwon, Kyong-Rim; Resch, Wolfgang; Liang, Genqing; Mathe, Ewy; Nelson, Steevenson; Vian, Laura; Casellas, Rafael] NIAMS, NIH, Bethesda, MD 20892 USA; [Wang, Qiao; Oliveira, Thiago Y.; Jankovic, Mila; Gazumyan, Anna; Robbiani, Davide F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Tang, Zhonghui; Ruan, Yijun] Univ Connecticut, Jackson Lab Genom Med, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Murre, Cornelis] Univ Calif San Diego, Div Biol Sci, Dept Mol Biol, La Jolla, CA 92093 USA; [Dubois, Wendy; Casellas, Rafael] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hakim, Ofir] Bar Ilan Univ, IL-5290002 Ramat Gan, Israel; [Pavri, Rushad] Vienna BioCtr, IMP, A-1030 Vienna, Austria; [Awasthi, Parirokh; Feigenbaum, Lionel] Sci Applicat Int Corp Frederick, NCI Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; [Song, Bin; Liu, Geng; Chen, Longyun; Zhu, Shida] Beijing Genom Inst, Shenzhen 518083, Peoples R China; [Staudt, Louis] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA; [Pan-Hammarstrom, Qiang] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, S-14186 Stockholm, Sweden; [Nussenzweig, Michel C.] Rockefeller Univ, HHMI, New York, NY 10065 USA; [Benner, Christopher] Salk Inst Biol Studies, Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Rockefeller University; Jackson Laboratory; University of Connecticut; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Bar Ilan University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Beijing Genomics Institute (BGI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Karolinska University Hospital; Howard Hughes Medical Institute; Rockefeller University; Salk Institute	Dose, M (corresponding author), NIAMS, NIH, Bethesda, MD 20892 USA.	marei.dose@nih.gov; rafael.casellas@nih.gov	Oliveira, Thiago Y/ABF-5186-2020; Robbiani, Davide F./AAF-7662-2019; Nussenzweig, Michel/AAE-7292-2019; 冯, 雅仪/AAS-7511-2021; Oliveira, Thiago Y/HGA-3848-2022; Mathe, Ewy/L-1616-2019; hammarstrom, qiang pan/ABA-4589-2021; Staudt, Louis/AAC-5324-2019	Oliveira, Thiago Y/0000-0002-2654-0879; Robbiani, Davide F./0000-0001-7379-3484; Oliveira, Thiago Y/0000-0002-2654-0879; Wang, Qiao/0000-0001-6416-1733; Song, Bin/0000-0002-9528-3837; pan-hammarstrom, qiang/0000-0003-1990-8804; Resch, Wolfgang/0000-0001-7594-5963; Mathe, Ewy/0000-0003-4491-8107; Dose, Marei/0000-0001-5394-9779; Hakim, Ofir/0000-0003-0063-2721; Tang, Zhonghui/0000-0003-2907-3986; Qian, Jason/0000-0002-1144-2547; Benner, Christopher/0000-0002-4618-0719; Pavri, Rushad/0000-0002-6191-6333	Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Cancer Institute (NCI); Jackson Laboratory fund [JAX19020120]; European Research Council (ERC) [242551-ImmunoSwitch]; NIH grant [AI037526]; NATIONAL CANCER INSTITUTE [P30CA034196, ZICBC011047, R01CA186714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526, R37AI037526] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Jackson Laboratory fund; European Research Council (ERC)(European Research Council (ERC)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Daniel Hodson for isolating GC B cells, Ethan Tyler for designing Figure S7B, Gustavo Gutierrez for technical assistance with deep-sequencing, David Bosque and Tom Eisenreich for managing the mouse colonies, and Jim Simone, Klara Velinzon, and Yelena Shatalina for FACS sorting. This work was supported by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Cancer Institute (NCI), the Jackson Laboratory fund (JAX19020120), the European Research Council (ERC) (242551-ImmunoSwitch), and NIH grant AI037526 to M.C.N. M.C.N. is a Howard Hughes Medical Institute (HHMI) Investigator. Animal experiments were performed according to NIH and Rockefeller approved protocols. This study used the high-performance computational capabilities of NIH Helix Systems (http://helix.nih.gov).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; BETZ AG, 1994, CELL, V77, P239, DOI 10.1016/0092-8674(94)90316-6; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Buerstedde JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001831; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Hasham MG, 2010, NAT IMMUNOL, V11, P820, DOI 10.1038/ni.1909; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huppi K, 2011, TOXICOL MECH METHOD, V21, P325, DOI 10.3109/15376516.2011.562759; Kato L, 2012, P NATL ACAD SCI USA, V109, P2479, DOI 10.1073/pnas.1120791109; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Kovalchuk AL, 2012, P NATL ACAD SCI USA, V109, P10972, DOI 10.1073/pnas.1200106109; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Lada AG, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-47; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Lossos IS, 2004, LEUKEMIA, V18, P1775, DOI 10.1038/sj.leu.2403488; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pefanis E, 2014, NATURE, V514, P389, DOI 10.1038/nature13580; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Seifert Marc, 2013, Methods Mol Biol, V971, P1, DOI 10.1007/978-1-62703-269-8_1; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239; van de Werken HJG, 2012, NAT METHODS, V9, P969, DOI [10.1038/NMETH.2173, 10.1038/nmeth.2173]; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	57	180	185	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 18	2014	159	7					1524	1537		10.1016/j.cell.2014.11.013	http://dx.doi.org/10.1016/j.cell.2014.11.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AZ0FW	25483777	Green Accepted, Bronze			2022-12-28	WOS:000347922500008
J	Jasper, AW; Pelzer, KM; Miller, JA; Kamarchik, E; Harding, LB; Klippenstein, SJ				Jasper, Ahren W.; Pelzer, Kenley M.; Miller, James A.; Kamarchik, Eugene; Harding, Lawrence B.; Klippenstein, Stephen J.			Predictive a priori pressure-dependent kinetics	SCIENCE			English	Article							2-DIMENSIONAL MASTER EQUATION; COLLISIONAL ENERGY-TRANSFER; THERMAL UNIMOLECULAR REACTIONS; 1ST-PRINCIPLES THEORY; CHEMICAL-REACTION; FALLOFF CURVES; GAS-PHASE; DISSOCIATION; LIMIT; RECOMBINATION	The ability to predict the pressure dependence of chemical reaction rates would be a great boon to kinetic modeling of processes such as combustion and atmospheric chemistry. This pressure dependence is intimately related to the rate of collision-induced transitions in energy E and angular momentum J. We present a scheme for predicting this pressure dependence based on coupling trajectory-based determinations of moments of the E, J-resolved collisional transfer rates with the two-dimensional master equation. This completely a priori procedure provides a means for proceeding beyond the empiricism of prior work. The requisite microcanonical dissociation rates are obtained from ab initio transition state theory. Predictions for the CH4 = CH3 + H and C2H3 = C2H2 + H reaction systems are in excellent agreement with experiment.	[Jasper, Ahren W.; Kamarchik, Eugene] Sandia Natl Labs, Combust Res Facil, Livermore, CA 94551 USA; [Pelzer, Kenley M.; Miller, James A.; Harding, Lawrence B.; Klippenstein, Stephen J.] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Argonne National Laboratory	Klippenstein, SJ (corresponding author), Argonne Natl Lab, Chem Sci & Engn Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	sjk@anl.gov	Klippenstein, Stephen/AAF-1741-2021; /A-5292-2011; Jasper, Ahren/AAV-1683-2021	Jasper, Ahren/0000-0003-0216-9347; Klippenstein, Stephen/0000-0001-6297-9187	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy (DOE-BES); Argonne as part of the Argonne-Sandia Consortium on High-Pressure Combustion Chemistry (FWP) [DE-AC02-06CH11357, 59044]; U.S. DOE [DE-AC04-94-AL85000]; AITSTME project as part of the Predictive Theory and Modeling component of the Materials Genome Initiative of DOE-BES; DOE Computational Science Graduate Fellowship [DE-FG02-97ER25308]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy (DOE-BES); Argonne as part of the Argonne-Sandia Consortium on High-Pressure Combustion Chemistry (FWP); U.S. DOE(United States Department of Energy (DOE)); AITSTME project as part of the Predictive Theory and Modeling component of the Materials Genome Initiative of DOE-BES; DOE Computational Science Graduate Fellowship(United States Department of Energy (DOE))	This work is supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy (DOE-BES). The work at Argonne was supported under Contract no. DE-AC02-06CH11357 as part of the Argonne-Sandia Consortium on High-Pressure Combustion Chemistry (FWP no. 59044). Sandia is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the U.S. DOE under Contract no. DE-AC04-94-AL85000. Software development was supported by the AITSTME project as part of the Predictive Theory and Modeling component of the Materials Genome Initiative of DOE-BES. K. Pelzer acknowledges the support of the DOE Computational Science Graduate Fellowship under grant no. DE-FG02-97ER25308.	Barker JR, 2010, J PHYS CHEM A, V114, P10619, DOI 10.1021/jp106443d; BERNSHTEIN V, 1993, J PHYS CHEM-US, V97, P12811, DOI 10.1021/j100151a030; BROUARD M, 1989, J PHYS CHEM-US, V93, P4047, DOI 10.1021/j100347a037; BROWN NJ, 1984, J CHEM PHYS, V80, P5568, DOI 10.1063/1.446621; Gilbert RG., 1990, THEORY UNIMOLECULAR; Goldsmith CF, 2013, P COMBUST INST, V34, P177, DOI 10.1016/j.proci.2012.05.091; Holbrook K.A., 1996, UNIMOLECULAR REACTIO; Jasper AW, 2013, J PHYS CHEM A, V117, P12243, DOI 10.1021/jp409086w; Jasper AW, 2011, J PHYS CHEM A, V115, P6438, DOI 10.1021/jp200048n; Jeffrey SJ, 1996, J PHYS CHEM-US, V100, P7090, DOI 10.1021/jp953430y; Keck J, 1965, J CHEM PHYS, V43, P2284, DOI 10.1063/1.1697125; KEIL DG, 1976, INT J CHEM KINET, V8, P825, DOI 10.1002/kin.550080605; Klippenstein SJ, 2006, PHYS CHEM CHEM PHYS, V8, P1133, DOI 10.1039/b515914h; Klippenstein SJ, 2002, P COMBUST INST, V29, P1229, DOI 10.1016/S1540-7489(02)80152-3; Knyazev VD, 1996, J PHYS CHEM-US, V100, P16899, DOI 10.1021/jp953218u; KNYAZEV VD, 1995, J PHYS CHEM-US, V99, P14738, DOI 10.1021/j100040a023; Mielke SL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.063201; Miller JA, 2004, PHYS CHEM CHEM PHYS, V6, P1192, DOI 10.1039/b313645k; Miller JA, 2002, J PHYS CHEM A, V106, P4904, DOI 10.1021/jp0144698; Miller JA, 2006, J PHYS CHEM A, V110, P10528, DOI 10.1021/jp062693x; PAYNE WA, 1976, J CHEM PHYS, V64, P1150, DOI 10.1063/1.432304; Polino D, 2013, J PHYS CHEM A, V117, P12677, DOI 10.1021/jp406246y; Robertson SH, 1997, J COMPUT CHEM, V18, P1004, DOI 10.1002/(SICI)1096-987X(199706)18:8<1004::AID-JCC4>3.0.CO;2-X; Sabbah H, 2007, SCIENCE, V317, P102, DOI 10.1126/science.1142373; Schatz GC, 1997, J CHEM PHYS, V106, P3548, DOI 10.1063/1.473451; Sivaramakrishnan R, 2011, J PHYS CHEM A, V115, P3366, DOI 10.1021/jp2006205; SMITH SC, 1988, INT J CHEM KINET, V20, P307, DOI 10.1002/kin.550200405; TROE J, 1977, J CHEM PHYS, V66, P4745, DOI 10.1063/1.433837; Venkatesh PK, 1999, J CHEM PHYS, V111, P8313, DOI 10.1063/1.480221; WIDOM B, 1965, SCIENCE, V148, P1555, DOI 10.1126/science.148.3677.1555; Wu T, 2004, SCIENCE, V306, P2227, DOI 10.1126/science.1104085; Zhang DH, 2000, SCIENCE, V290, P961, DOI 10.1126/science.290.5493.961	33	123	124	1	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2014	346	6214					1212	1215		10.1126/science.1260856	http://dx.doi.org/10.1126/science.1260856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW3LU	25477457				2022-12-28	WOS:000346189000053
J	Chae, E; Bomblies, K; Kim, ST; Karelina, D; Zaidem, M; Ossowski, S; Martin-Pizarro, C; Laitinen, RAE; Rowan, BA; Tenenboim, H; Lechner, S; Demar, M; Habring-Muller, A; Lanz, C; Ratsch, G; Weigel, D				Chae, Eunyoung; Bomblies, Kirsten; Kim, Sang-Tae; Karelina, Darya; Zaidem, Maricris; Ossowski, Stephan; Martin-Pizarro, Carmen; Laitinen, Roosa A. E.; Rowan, Beth A.; Tenenboim, Hezi; Lechner, Sarah; Demar, Monika; Habring-Mueller, Anette; Lanz, Christa; Raetsch, Gunnar; Weigel, Detlef			Species-wide Genetic Incompatibility Analysis Identifies Immune Genes as Hot Spots of Deleterious Epistasis	CELL			English	Article							ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; MILDEW RESISTANCE; NATURAL VARIATION; INNATE IMMUNITY; MAJOR CLUSTER; EVOLUTION; HYBRID; RECEPTOR; ASSOCIATION	Intraspecific genetic incompatibilities prevent the assembly of specific alleles into single genotypes and influence genome-and species-wide patterns of sequence variation. A common incompatibility in plants is hybrid necrosis, characterized by autoimmune responses due to epistatic interactions between natural genetic variants. By systematically testing thousands of F-1 hybrids of Arabidopsis thaliana strains, we identified a small number of incompatibility hot spots in the genome, often in regions densely populated by nucleotide-binding domain and leucine-rich repeat (NLR) immune receptor genes. In several cases, these immune receptor loci interact with each other, suggestive of conflict within the immune system. A particularly dangerous locus is a highly variable cluster of NLR genes, DM2, which causes multiple independent incompatibilities with genes that encode a range of biochemical functions, including NLRs. Our findings suggest that deleterious interactions of immune receptors limit the combinations of favorable disease resistance alleles accessible to plant genomes.	[Chae, Eunyoung; Bomblies, Kirsten; Kim, Sang-Tae; Karelina, Darya; Zaidem, Maricris; Ossowski, Stephan; Martin-Pizarro, Carmen; Laitinen, Roosa A. E.; Rowan, Beth A.; Tenenboim, Hezi; Lechner, Sarah; Demar, Monika; Habring-Mueller, Anette; Lanz, Christa; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Karelina, Darya; Raetsch, Gunnar] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Bomblies, Kirsten] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Kim, Sang-Tae] Inst for Basic Sci Korea, Ctr Genome Engn, Daejeon 305811, South Korea; [Ossowski, Stephan] Ctr Genom Regulat, Genom & Epigenom Variat Dis Grp, Barcelona 08003, Spain; [Ossowski, Stephan] Univ Pompeu Fabra, Barcelona 08003, Spain; [Laitinen, Roosa A. E.; Tenenboim, Hezi] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Lechner, Sarah] CeGAT GmbH, D-72076 Tubingen, Germany; [Raetsch, Gunnar] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA	Max Planck Society; Eberhard Karls University of Tubingen; Max Planck Society; Harvard University; Institute for Basic Science - Korea (IBS); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Max Planck Society; CeGaT; Memorial Sloan Kettering Cancer Center	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Ossowski, Stephan/E-2139-2011; Pizarro, Carmen Martín/AAR-3369-2021; Weigel, Detlef/GSJ-0799-2022; Kim, Sang-Tae/X-8917-2019; Kim, Sang-Tae/U-9457-2018; Chae, Eunyoung/AAA-6997-2021; Weigel, Detlef/AAR-3312-2021; Rätsch, Gunnar/O-5914-2017; Weigel, Detlef/C-1418-2008	Ossowski, Stephan/0000-0002-7416-9568; Pizarro, Carmen Martín/0000-0001-9305-3096; Weigel, Detlef/0000-0002-2114-7963; Kim, Sang-Tae/0000-0003-1645-6021; Kim, Sang-Tae/0000-0003-1645-6021; Chae, Eunyoung/0000-0002-0889-9837; Rätsch, Gunnar/0000-0001-5486-8532; Weigel, Detlef/0000-0002-2114-7963; Bomblies, Kirsten/0000-0002-2434-3863; Tenenboim, Hezi/0000-0002-3783-9446; Zaidem, Maricris/0000-0002-1913-6771; Rowan, Beth/0000-0001-7240-4889	NIH Ruth Kirschstein National Research Service Award; Human Frontier Science Program Long-Term Fellowship; Alexander von Humboldt Foundation Fellowship; Human Frontier Science Program Organization Grant [RGP 57/2007]; Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075741] Funding Source: NIH RePORTER	NIH Ruth Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); Alexander von Humboldt Foundation Fellowship(Alexander von Humboldt Foundation); Human Frontier Science Program Organization Grant(Human Frontier Science Program); Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ruben Alcazar, Jane Parker, and Maarten Koornneef for information regarding RPP1, Jesse Poland for GBS advice, Frank Wellmer for AP3 amiRNA, Eui-Hwan Chung and Jeffery Dangl for pointers on cell-death assays, William Ho, Paula Sancha-Vilchez, and Josip Perkovic for technical support, and Jeffery Dangl, Ya-Long Guo, Daniel Koenig, George Wang, and Jun Cao for discussions. We especially thank the anonymous reviewers, who greatly helped us with the evolutionary framing of our work. This work was supported by an NIH Ruth Kirschstein National Research Service Award (K. B.), Human Frontier Science Program Long-Term Fellowship (R. A. E. L.), Alexander von Humboldt Foundation Fellowship (B. A. R.), Human Frontier Science Program Organization Grant (RGP 57/2007), and a Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft and the Max Planck Society (D. W.).	Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Alcazar R, 2010, NAT GENET, V42, P1135, DOI 10.1038/ng.704; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bateson W., 1909, DOI 10.1017/CBO9780511693953.007; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4357; Chin DB, 2001, GENETICS, V157, P831; Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Corbett-Detig RB, 2013, NATURE, V504, P135, DOI 10.1038/nature12678; Crespi B, 2013, TRENDS ECOL EVOL, V28, P48, DOI 10.1016/j.tree.2012.08.015; Cutter AD, 2012, TRENDS ECOL EVOL, V27, P209, DOI 10.1016/j.tree.2011.11.004; de Felippes FF, 2012, PLANT J, V70, P541, DOI 10.1111/j.1365-313X.2011.04896.x; Dobzhansky T., 1937; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Segretin ME, 2014, MOL PLANT MICROBE IN, V27, P624, DOI 10.1094/MPMI-02-14-0040-R; Harris CJ, 2013, P NATL ACAD SCI USA, V110, P21189, DOI 10.1073/pnas.1311134110; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Holub EB, 1997, ADV BOT RES, V24, P227; Hou J, 2014, CURR BIOL, V24, P1153, DOI 10.1016/j.cub.2014.03.063; Jacob F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00297; Jeuken MJW, 2009, PLANT CELL, V21, P3368, DOI 10.1105/tpc.109.070334; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Lachance J, 2010, EVOLUTION, V64, P3035, DOI 10.1111/j.1558-5646.2010.01028.x; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Muller HJ, 1942, BIOL S, V6, P71; Nemri A, 2010, P NATL ACAD SCI USA, V107, P10302, DOI 10.1073/pnas.0913160107; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Phillips PC, 1998, GENETICS, V150, P449; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 2013, NAT REV IMMUNOL, V13, P280, DOI 10.1038/nri3421; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; Steinbrenner A D, 2012, Cold Spring Harb Symp Quant Biol, V77, P249, DOI 10.1101/sqb.2012.77.014860; Tahir J, 2013, PLANT J, V73, P118, DOI 10.1111/tpj.12021; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Todesco M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004459; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Weinreich DM, 2005, EVOLUTION, V59, P1165; Wuest SE, 2012, P NATL ACAD SCI USA, V109, P13452, DOI 10.1073/pnas.1207075109; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Yamamoto E, 2010, MOL GENET GENOMICS, V283, P305, DOI 10.1007/s00438-010-0514-y; Yang SH, 2013, P NATL ACAD SCI USA, V110, P18572, DOI 10.1073/pnas.1318211110	61	167	168	3	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 4	2014	159	6					1341	1351		10.1016/j.cell.2014.10.049	http://dx.doi.org/10.1016/j.cell.2014.10.049			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AX0PA	25467443	Bronze, Green Accepted			2022-12-28	WOS:000346652900013
J	Tschauner, O; Ma, C; Beckett, JR; Prescher, C; Prakapenka, VB; Rossman, GR				Tschauner, Oliver; Ma, Chi; Beckett, John R.; Prescher, Clemens; Prakapenka, Vitali B.; Rossman, George R.			Discovery of bridgmanite, the most abundant mineral in Earth, in a shocked meteorite	SCIENCE			English	Article							LOWER MANTLE; SILICATE PEROVSKITE; MELT VEIN; CHONDRITE; MAGNESIOWUSTITE; (MG,FE)SIO3; AKIMOTOITE; INCLUSIONS; CHEMISTRY; PRESSURE	Meteorites exposed to high pressures and temperatures during impact-induced shock often contain minerals whose occurrence and stability normally confine them to the deeper portions of Earth's mantle. One exception has been MgSiO3 in the perovskite structure, which is the most abundant solid phase in Earth. Here we report the discovery of this important phase as a mineral in the Tenham L6 chondrite and approved by the International Mineralogical Association (specimen IMA 2014-017). MgSiO3-perovskite is now called bridgmanite. The associated phase assemblage constrains peak shock conditions to similar to 24 gigapascals and 2300 kelvin. The discovery concludes a half century of efforts to find, identify, and characterize a natural specimen of this important mineral.	[Tschauner, Oliver] Univ Nevada, Dept Geosci, Las Vegas, NV 89134 USA; [Tschauner, Oliver] Univ Nevada, High Pressure Sci & Engn Ctr, Las Vegas, NV 89134 USA; [Ma, Chi; Beckett, John R.; Rossman, George R.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Prescher, Clemens; Prakapenka, Vitali B.] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60632 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; California Institute of Technology; University of Chicago	Tschauner, O (corresponding author), Univ Nevada, Dept Geosci, Las Vegas, NV 89134 USA.	olivert@physics.unlv.edu	Prescher, Clemens/I-7387-2016; Rossman, George R/D-8894-2013; Prescher, Clemens/AAA-9425-2021	Rossman, George/0000-0002-4571-6884	U.S. Department of Energy (DOE) [DESC0005278]; NASA [NNX12AH63G]; NSF [EAR-1128799, DE-FG02-94ER14466, EAR-0318518, DMR-0080065]; Advanced Photon Source, a DOE Office of Science User Facility [DE-AC02-06CH11357];  [NSF-EAR-1128799]; Directorate For Geosciences [1322082] Funding Source: National Science Foundation	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Advanced Photon Source, a DOE Office of Science User Facility; ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The crystallographic information about bridgmanite is available at the Inorganic Crystal Structure Database and American Mineralogist databases and in the supplementary materials. This work was supported by U.S. Department of Energy (DOE) award DESC0005278, NASA grant NNX12AH63G, and NSF grants EAR-1128799, DE-FG02-94ER14466, EAR-0318518, and DMR-0080065. Part of this work was performed at GeoSoilEnviroCARS (Sector 13), Advanced Photon Source, Argonne National Laboratory. GeoSoilEnviroCARS is supported by NSF-EAR-1128799 and DE-FG02-94ER14466). The Advanced Photon Source, a DOE Office of Science User Facility, is operated by Argonne National Laboratory under contract no. DE-AC02-06CH11357. We thank reviewers N. Ross and T. Sharp for their helpful comments.	Bertka CM, 1997, J GEOPHYS RES-SOL EA, V102, P5251, DOI 10.1029/96JB03270; BINNS RA, 1969, NATURE, V221, P943, DOI 10.1038/221943a0; Brenker FE, 2002, EARTH PLANET SC LETT, V198, P1, DOI 10.1016/S0012-821X(02)00514-9; DURBEN DJ, 1992, AM MINERAL, V77, P890; Grocholski B, 2012, P NATL ACAD SCI USA, V109, P2275, DOI 10.1073/pnas.1109204109; HEMLEY RJ, 1992, ANNU REV EARTH PL SC, V20, P553; Hummer DR, 2012, AM MINERAL, V97, P1915, DOI 10.2138/am.2012.4144; ITO E, 1984, EARTH PLANET SC LETT, V67, P238, DOI 10.1016/0012-821X(84)90119-5; KESSON SE, 1992, EARTH PLANET SC LETT, V111, P229, DOI 10.1016/0012-821X(92)90181-T; Liu LG, 1974, GEOPHYS RES LETT, V1, P277, DOI 10.1029/GL001i006p00277; Luo SN, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002860; MCSWEEN HY, 1993, GEOCHIM COSMOCHIM AC, V57, P1105, DOI 10.1016/0016-7037(93)90044-W; Miyahara M, 2011, P NATL ACAD SCI USA, V108, P5999, DOI 10.1073/pnas.1016921108; Miyajima N, 2007, AM MINERAL, V92, P1545, DOI 10.2138/am.2007.2546; Mori H., 1994, J MINERAL SOC JPN, V23, P171; Murakami M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021956; Nickel EH, 1998, CAN MINERAL, V36, P913; PRICE GD, 1983, CAN MINERAL, V21, P29; RINGWOOD AE, 1991, GEOCHIM COSMOCHIM AC, V55, P2083, DOI 10.1016/0016-7037(91)90090-R; Sanchez-Valle C, 2010, EARTH PLANET SC LETT, V295, P523, DOI 10.1016/j.epsl.2010.04.034; Sharp TG, 1997, SCIENCE, V277, P352, DOI 10.1126/science.277.5324.352; SMITH JV, 1970, SCIENCE, V168, P832, DOI 10.1126/science.168.3933.832; Stixrude L, 2012, ANNU REV EARTH PL SC, V40, P569, DOI 10.1146/annurev.earth.36.031207.124244; Stixrude L, 2011, GEOPHYS J INT, V184, P1180, DOI 10.1111/j.1365-246X.2010.04890.x; Tomioka N, 1999, AM MINERAL, V84, P267; Xie ZD, 2006, GEOCHIM COSMOCHIM AC, V70, P504, DOI 10.1016/j.gca.2005.09.003	26	179	193	6	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2014	346	6213					1100	1102		10.1126/science.1259369	http://dx.doi.org/10.1126/science.1259369			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7EK	25430766				2022-12-28	WOS:000345763400039
J	Edwards, ST; Landon, BE				Edwards, Samuel T.; Landon, Bruce E.			Medicare's Chronic Care Management Payment - Payment Reform for Primary Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							QUALITY		[Edwards, Samuel T.] Vet Affairs Boston Healthcare Syst, Sect Gen Internal Med, Boston, MA 02130 USA; [Edwards, Samuel T.] Harvard Univ, Sch Med, Boston, MA USA; [Landon, Bruce E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Edwards, ST (corresponding author), Vet Affairs Boston Healthcare Syst, Sect Gen Internal Med, Boston, MA 02130 USA.							Centers for Medicaid and Medicare Services, MED PROGR REV PAYM B; Edwards ST, 2014, J GEN INTERN MED, V29, P947, DOI 10.1007/s11606-014-2808-y; Edwards ST, 2014, HLTH AFF MILLWOOD, V33, P1823; Friedberg MW, 2014, JAMA-J AM MED ASSOC, V311, P815, DOI 10.1001/jama.2014.353; Press MJ, 2014, NEW ENGL J MED, V371, P489, DOI 10.1056/NEJMp1406033	5	40	40	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2014	371	22					2049	2051		10.1056/NEJMp1410790	http://dx.doi.org/10.1056/NEJMp1410790			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AU4KP	25427110				2022-12-28	WOS:000345580000001
J	Stegenga, H; Haines, A; Jones, K; Wilding, J				Stegenga, Heather; Haines, Alexander; Jones, Katie; Wilding, John		Guideline Dev Grp	GUIDELINES Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Stegenga, Heather] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London SW1X 8PG, England; [Haines, Alexander; Jones, Katie] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Wilding, John] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Wilding, John] Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England	University of London; University College London; Royal College of Physicians; University of Liverpool; Aintree University Hospitals NHS Foundation Trust	Haines, A (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	Alexander.Haines@rcplondon.ac.uk	Wilding, John/ABB-6443-2020; Wilding, John PH/A-7106-2008	Wilding, John/0000-0003-2839-8404; Wilding, John PH/0000-0003-2839-8404; Haines, Alexander/0000-0001-5598-8907; Batterham, Rachel/0000-0002-5477-8585				[Anonymous], BOD MASS IND WAIST C; Government Office for Science, 2007, FOR TACKL OB FUT CHO; Health and Social Care Information Centre, 2012, HLTH SURV ENGL TREND; National Institute for Health and Care Excellence, 2014, ID ASS MAN OV OB CHI, V189; National Institute for Health and Care Excellence, 2013, PHYS ACT BRIEF ADV A; National Institute for Health and Care Excellence, 2014, BEH CHANG IND APPR; National Institute for Health and Care Excellence, 2014, MAN OV OB AD LIF WEI; National Institute for Health and Care Excellence, 2015, MAINT HLTH WEIGHT PR; National Institute for Health and Care Excellence (NICE), 2013, MAN OV OB CHILDR YOU; National Institute for Health and Clinical Excellence, 2012, OB WORK LOC COMM; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB MAN TYP 2; National Institute for Health and Clinical Excellence, 2010, WEIGHT MAN PREGN; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; National Obesity Observatory, 2011, OB MENT HLTH; NHS England, 2014, JOIN CLIN PATHW OB R; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; Royal College of Paediatrics and Child Health, UK WHO GROWTH CHARTS; Welbourn R, 2011, DENDRITE CLIN SYSTEM	18	109	114	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2014	349								g6608	10.1136/bmj.g6608	http://dx.doi.org/10.1136/bmj.g6608			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2KG	25430558				2022-12-28	WOS:000346115800001
J	de Andrade, LOM; Pellegrini, A; Solar, O; Rigoli, F; de Salazar, LM; Serrate, PCF; Ribeiro, KG; Koller, TS; Cruz, FNB; Atun, R				Monteiro de Andrade, Luiz Odorico; Pellegrini Filho, Alberto; Solar, Orielle; Rigoli, Felix; de Salazar, Ligia Malagon; Serrate, Pastor Castell-Florit; Ribeiro, Kelen Gomes; Koller, Theadora Swift; Bravo Cruz, Fernanda Natasha; Atun, Rifat			Social determinants of health, universal health coverage, and sustainable development: case studies from Latin American countries	LANCET			English	Article							INFANT-MORTALITY; TRANSFER PROGRAM; BRAZIL	Many intrinsically related determinants of health and disease exist, including social and economic status, education, employment, housing, and physical and environmental exposures. These factors interact to cumulatively affect health and disease burden of individuals and populations, and to establish health inequities and disparities across and within countries. Biomedical models of health care decrease adverse consequences of disease, but are not enough to effectively improve individual and population health and advance health equity. Social determinants of health are especially important in Latin American countries, which are characterised by adverse colonial legacies, tremendous social injustice, huge socioeconomic disparities, and wide health inequities. Poverty and inequality worsened substantially in the 1980s, 1990s, and early 2000s in these countries. Many Latin American countries have introduced public policies that integrate health, social, and economic actions, and have sought to develop health systems that incorporate multisectoral interventions when introducing universal health coverage to improve health and its upstream determinants. We present case studies from four Latin American countries to show the design and implementation of health programmes underpinned by intersectoral action and social participation that have reached national scale to effectively address social determinants of health, improve health outcomes, and reduce health inequities. Investment in managerial and political capacity, strong political and managerial commitment, and state programmes, not just time-limited government actions, have been crucial in underpinning the success of these policies.	[Monteiro de Andrade, Luiz Odorico] Fundacao Oswaldo Cruz, Fortaleza, Ceara, Brazil; [Monteiro de Andrade, Luiz Odorico] Sch Med, Fortaleza, Ceara, Brazil; [Ribeiro, Kelen Gomes] Univ Fed Ceara, Fortaleza, Ceara, Brazil; [Pellegrini Filho, Alberto] Fundacao Oswaldo Cruz, Sergio Arouca Natl Sch Publ Hlth, Ctr Studies Policies & Informat Social Determinan, Rio De Janeiro, Brazil; [Solar, Orielle] Latin Amer Fac Social Sci FLACSO, Santiago, Chile; [Rigoli, Felix] Pan Amer Hlth Org, Hlth Syst Div, Brasilia, DF, Brazil; [de Salazar, Ligia Malagon] Fdn Dev Publ Hlth FUNDESALUD, Cali, Colombia; [Serrate, Pastor Castell-Florit] Natl Sch Publ Hlth, Havana, Cuba; [Koller, Theadora Swift] WHO, Gender Equ & Human Rights Team, CH-1211 Geneva, Switzerland; [Bravo Cruz, Fernanda Natasha] Univ Brasilia, Ctr Adv Multidisciplinary Studies, BR-70910900 Brasilia, DF, Brazil; [Atun, Rifat] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA	Fundacao Oswaldo Cruz; Universidade Federal do Ceara; Fundacao Oswaldo Cruz; Pan American Health Organization; World Health Organization; Universidade de Brasilia; Harvard University; Harvard T.H. Chan School of Public Health	Atun, R (corresponding author), Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA.	ratun@hsph.harvard.edu	Monteiro, Odorico/HHC-3812-2022; Atun, Rifat/AAH-5537-2021	Monteiro, Odorico/0000-0002-3335-0619; Atun, Rifat/0000-0002-1531-5983; Koller, Theadora Swift/0000-0001-5655-7690	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Andrade L. B., 2004, THESIS; Attanasio OP, 2004, NUTR CHILD CARE CHOI; Atun R., 2014, LANCET; Bertola L, 2011, I EC DEV LATIN AM; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; Brazil Ministry of Health, DEP HLTH SURV INF SY; Castell-Florit P, 2007, INTERSECTORAL SOCIAL; Castell-Florit P., 2009, SUSTAINABILITY INTER; Cecchini S, 2014, LANCET; Cotlear D, 2014, LANCET; Diaz C, 2009, CAD SAUDE PUBLICA, V25, pS59, DOI 10.1590/S0102-311X2009001300006; EKOS consultants, 2013, EV US ID CRIT NOD IM; Frenz P, 2010, GLOB S HLTH SYST RES; Gasparini L, ECINEQ WORKING PAPER, V2011-13; Gasparini Leonardo, 2009, RECENT TRENDS INCOME; Government of Chile. Chile Grows with Executive Secretariat Department of Health Promotion and Citizenship MINSAL Division of Healthy Public Policy and Health Promotion, 2010, 2010 GUID PROM CHILD; Government of Colombia, NAT STRAT INT ATT EA; Guanais FC, 2013, AM J PUBLIC HEALTH, V103, P2000, DOI 10.2105/AJPH.2013.301452; Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P20; Horton R, 2013, LANCET, V382, P192, DOI 10.1016/S0140-6736(13)61573-1; Kliksberg B., STRATEGIES METHODOLO; Lustig N., 2012, DECLINING INEQUALITY; Noriega V, 2009, REV CUB SALUD PUBLIC, V35, P1; Pellegrini A, 2011, SOCIAL PARTICIPATION; Pellegrinni A, 2012, DECREASE INCOME INEQ; Ramos G., 2004, REV CUBANA SALUD PUB; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; Salles R, 2012, CUESTIONES POLITICAS, V28, P141; Sanchez L, 2005, TROP MED INT HEALTH, V10, P82, DOI 10.1111/j.1365-3156.2004.01347.x; Shei A, 2013, HEALTH AFFAIR, V32, P1274, DOI 10.1377/hlthaff.2012.0827; Solar O, 2009, 7 GLOB C HLTH PROM P; Sorj Bernardo, 2010, USOS ABUSOS DESAFIOS; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; United Nations, LAT AM URB POV HUM D; WHO, 2011, P WORLD C SOC DET HL; WHO Commission on Social Determinants of Health (CSDH), 2007, CHALL IN HLTH SYST; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; WHO Europe, 1978, DECL ALM AT; World Health Organization, 2010, EQUI HLTH	39	121	133	1	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2015	385	9975					1343	1351		10.1016/S0140-6736(14)61494-X	http://dx.doi.org/10.1016/S0140-6736(14)61494-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CF0ZD	25458716				2022-12-28	WOS:000352272400040
J	Suzman, R; Beard, JR; Boerma, T; Chatterji, S				Suzman, Richard; Beard, John R.; Boerma, Ties; Chatterji, Somnath			Health in an ageing world-what do we know?	LANCET			English	Editorial Material									[Suzman, Richard] NIA, Div Behav & Social Res, NIH, Bethesda, MD 20892 USA; [Beard, John R.] WHO, Dept Ageing & Life Course, CH-1211 Geneva, Switzerland; [Boerma, Ties; Chatterji, Somnath] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); World Health Organization; World Health Organization	Chatterji, S (corresponding author), WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland.	chatterjis@who.int	Beard, John/AAI-4592-2021; Beard, John/AAP-5388-2021; CHATTERJI, Somnath/ABE-6832-2020	Beard, John/0000-0002-8557-0242; 	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Beard J.R., 2014, LANCET; Bloom DE, 2014, LANCET; Chatterji S, 2014, LANCET; Mathers C. D., 2014, LANCET; Miret M, BULL WHO IN PRESS; National Institute on Aging, 2013, PSYCH SCI BEH EC SER; National Research Council, 2013, SUBJECTIVE WELL BEIN; National Research Council, 2010, ACC HLTH HLTH CARE A; Prince MJ, 2014, LANCET; Steptoe A, 2014, LANCET; UN Department of Economic and Social Affairs Population Division., WORLD POP PROSP MED; WHO, 2014, WHO STUD GLOB AGEING; World Health Organization World Economic Forum, 2011, BURD BEST BUYS RED E	13	168	172	3	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2015	385	9967					484	+		10.1016/S0140-6736(14)61597-X	http://dx.doi.org/10.1016/S0140-6736(14)61597-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA9AV	25468156				2022-12-28	WOS:000349213600006
J	Gao, L; Liang, JY; Li, CY; Wang, LHV				Gao, Liang; Liang, Jinyang; Li, Chiye; Wang, Lihong V.			Single-shot compressed ultrafast photography at one hundred billion frames per second	NATURE			English	Article								The capture of transient scenes at high imaging speed has been long sought by photographers(1-4), with early examples being the well known recording in 1878 of a horse in motion' and the 1887 photograph of a supersonic bullet(6). However, not until the late twentieth century were breakthroughs achieved in demonstrating ultrahigh-speed imaging (more than 10(5) frames per second)(7). In particular, the introduction of electronic imaging sensors based on the charge-coupled device (CCD) or complementary metal-oxide-semiconductor (CMOS) technology revolutionized high-speed photography, enabling acquisition rates of up to 10(7) frames per second(8). Despite these sensors' widespread impact, further increasing frame rates using CCD or CMOS technology is fundamentally limited by their on-chip storage and electronic readout speed(9). Here we demonstrate a two-dimensional dynamic imaging technique, compressed ultrafast photography (CUP), which can capture non-repetitive time-evolving events at up to 10(11) frames per second. Compared with existing ultrafast imaging techniques, CUP has the prominent advantage of measuring an x-y- t (x, y, spatial coordinates; t, time) scene with a single camera snapshot, thereby allowing observation of transient events with temporal resolution as tens of picoseconds. Furthermore, akin to traditional photography, CUP is receive-only, and so does not need the specialized active illumination required by other single-shot ultrafast imagers(2,3). As a result, CUP can image a variety of luminescent such as fluorescent or bioluminescent objects. Using CUP, we visualize four fundamental physical phenomena with single laser shots only: laser pulse reflection and refraction, photon racing in two media, and fasterthan-light propagation of non-information (that is, motion that appears faster than the speed of light but cannot convey information). Given CUP's capability, we expect it to find widespread applications in both fundamental and applied sciences, including biomedical research.	[Gao, Liang; Liang, Jinyang; Li, Chiye; Wang, Lihong V.] Washington Univ, Dept Biomed Engn, Opt Imaging Lab, St Louis, MO 63130 USA	Washington University (WUSTL)	Wang, LHV (corresponding author), Washington Univ, Dept Biomed Engn, Opt Imaging Lab, Campus Box 1097,One Brookings Dr, St Louis, MO 63130 USA.	lhwang@wustl.edu	Liang, Jinyang/C-7673-2015; Wang, Lihong V./A-7147-2009	Wang, Lihong V./0000-0001-9783-4383; Li, Chiye/0000-0003-3669-4297; Liang, Jinyang/0000-0001-5983-0488	National Institutes of Health [DP1 EB016986, R01 CA186567]; NATIONAL CANCER INSTITUTE [R01CA186567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP1EB016986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank N. Hagen for discussions and J. Ballard for a close reading of the manuscript. We also acknowledge Texas Instruments for providing the DLP device. This work was supported in part by National Institutes of Health grants DP1 EB016986 (NIH Director's Pioneer Award) and R01 CA186567 (NIH Director's Transformative Research Award).	Afonso MV, 2011, IEEE T IMAGE PROCESS, V20, P681, DOI 10.1109/TIP.2010.2076294; Afonso MV, 2010, IEEE T IMAGE PROCESS, V19, P2345, DOI 10.1109/TIP.2010.2047910; Agrawal S., 2011, IEEE Information Theory Workshop (ITW 2011), P563, DOI 10.1109/ITW.2011.6089519; [Anonymous], 2002, GUIDE STREAK CAMERAS; Bioucas-Dias JM, 2007, IEEE T IMAGE PROCESS, V16, P2992, DOI 10.1109/TIP.2007.909319; Borst JW, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/10/102002; Davis D. L, 1999, US patent, Patent No. [5,907 619, 5907619]; El-Desouki M, 2009, SENSORS-BASEL, V9, P430, DOI 10.3390/s90100430; Eldar YC., 2012, COMPRESSED SENSING T; Figueiredo MAT, 2007, IEEE J-STSP, V1, P586, DOI 10.1109/JSTSP.2007.910281; Fuller PWW, 2009, IMAGING SCI J, V57, P293, DOI 10.1179/136821909X12490326247524; Heshmat B., 2014, CLEO SCI INNOV; Kondo Yasushi, 2012, Shimadzu Review, V69, P285; Lawson R.W, 1952, RELATIVITY SPECIAL G; Li ZY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4085; Mach E., 1887, ANN PHYS CHEM, V268, P277, DOI DOI 10.1002/ANDP.18872681008; MUNN OD, 1878, SCI AM, V39, P241, DOI DOI 10.1038/SCIENTIFICAMERICAN10191878-241B; Nakagawa K, 2014, NAT PHOTONICS, V8, P695, DOI [10.1038/nphoton.2014.163, 10.1038/NPHOTON.2014.163]; Nebeker S, 1983, HIGH SPEED PHOTOGR P, V3, P31; Orsdemir A, 2008, IEEE MILIT COMMUN C, P1040; RENTZEPIS PM, 1970, PHYS REV LETT, V25, P1742, DOI 10.1103/PhysRevLett.25.1742; SELANGER KA, 1977, J PHYS CHEM-US, V81, P1960, DOI 10.1021/j100535a016; Solli DR, 2007, NATURE, V450, P1054, DOI 10.1038/nature06402; Velten A., 2011, P SIGGRAPH 44, P44; Velten A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1747; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892	26	308	332	21	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2014	516	7529					74	U159		10.1038/nature14005	http://dx.doi.org/10.1038/nature14005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW5JD	25471883	Green Accepted			2022-12-28	WOS:000346310800041
J	Nabhan, C; Rosen, ST				Nabhan, Chadi; Rosen, Steven T.			Chronic Lymphocytic Leukemia A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FLUDARABINE PLUS CYCLOPHOSPHAMIDE; PREVIOUSLY UNTREATED PATIENTS; STEM-CELL TRANSPLANTATION; PROGRESSION-FREE SURVIVAL; MINIMAL RESIDUAL DISEASE; AUTOIMMUNE HEMOLYTIC-ANEMIA; MONOCLONAL-ANTIBODY THERAPY; PHASE-III TRIAL; 1ST-LINE THERAPY; INITIAL THERAPY	IMPORTANCE The most common leukemia is chronic lymphocytic leukemia (CLL). Every year, there are 15 000 new diagnoses and 5000 CLL deaths in the United States. Although therapeutic choices were once limited, treatment of this disease has vastly improved in the last decade. OBJECTIVE Evidence-based review of the diagnosis, staging, and treatment of CLL. EVIDENCE REVIEW PubMed, Cochrane Library, Scopus, and Google Scholar databases were searched through August 28, 2014. English-language peer-reviewed articles published between 2000-2014 were found using the keywords chronic lymphocytic leukemia, upfront therapy, upfront therapies, upfront therapeutic, upfront therapeutics, upfront treatment, front-line treatment, first-line treatment, front-line treatments, first-line treatments, front-line therapy, front-line therapies, randomized, randomized studies, randomized study, clinical trial, clinical trials, phase 3, and phase 3 clinical trial. Abstracts and presentations at scientific meetings were excluded. A total of 277 articles were retrieved, of which 24 met our predefined selection criteria; treatment recommendations were based on subsequent analysis of these 24 articles. FINDINGS The Rai and Binet systems for staging CLL were established in 1975 and 1977, respectively. However, they do not account for new disease categories such as monoclonal B-cell lymphocytosis (peripheral blood clonal lymphocytosis that does not meet other criteria for CLL). Two subsets of CLL are now recognized based on risk stratification involving molecular and cytogenetic analyses. Outcomes are improved by the addition of immunotherapy to combination chemotherapy for initial treatment in all subsets of treated patients. Overall response rates between 75% and 90% and complete responses between 22% and 45% are expected in the current era, with more than 80% of treated patients alive at 3 years. Overall, 5-year survival has increased to 66% from 60%(P < .001) in the past 10 years. CONCLUSIONS AND RELEVANCE Chemoimmunotherapy is the standard first-line option approach for CLL, the most common leukemia observed in adults. Treatment is initiated when the disease becomes symptomatic, and survival is high following treatment.	[Nabhan, Chadi] Univ Chicago Med, Sect Hematol & Oncol, Dept Med, Chicago, IL 60637 USA; [Rosen, Steven T.] City Hope Comprehens Canc Ctr, Duarte, CA USA	City of Hope	Nabhan, C (corresponding author), Univ Chicago Med, Outpatient Canc Ctr, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave,MC2115, Chicago, IL 60637 USA.	cnabhan@medicine.bsd.uchicago.edu		Rosen, Steven/0000-0002-8818-7724	Genentech; Celgene; GlaxoSmithKline; Bayer	Genentech(Roche HoldingGenentech); Celgene(Bristol-Myers SquibbCelgene Corporation); GlaxoSmithKline(GlaxoSmithKline); Bayer(Bayer AG)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Nabhan reported receiving research support from Genentech and Celgene and serving on advisory boards for Genentech, Janssen, and Pharmacyclics. Dr Rosen reported receiving research support from GlaxoSmithKline, Bayer, and Genentech and serving on advisory boards for Teva, Celgene, Millennium, and Seattle Genetics.	BINET JL, 1977, CANCER-AM CANCER SOC, V40, P855, DOI 10.1002/1097-0142(197708)40:2<855::AID-CNCR2820400239>3.0.CO;2-1; Byrd JC, 2003, BLOOD, V101, P6, DOI 10.1182/blood-2002-04-1258; Byrd JC, 2005, BLOOD, V105, P49, DOI 10.1182/blood-2004-03-0796; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Catovsky D, 2004, BLOOD, V104; Cramer P, 2011, NAT REV CLIN ONCOL, V8, P38, DOI 10.1038/nrclinonc.2010.167; Dearden C, 2008, BLOOD, V111, P1820, DOI 10.1182/blood-2007-07-101303; Del Poeta G, 2008, CANCER-AM CANCER SOC, V112, P119, DOI 10.1002/cncr.23144; Delgado J, 2009, BLOOD, V114, P2581, DOI 10.1182/blood-2009-05-206821; Dreger P, 2005, LEUKEMIA, V19, P1135, DOI 10.1038/sj.leu.2403800; Eichhorst B, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.526.526; Eichhorst BF, 2009, BLOOD, V114, P3382, DOI 10.1182/blood-2009-02-206185; Eichhorst BF, 2006, BLOOD, V107, P885, DOI 10.1182/blood-2005-06-2395; Esteve J, 2002, BLOOD, V99, P1873, DOI 10.1182/blood.V99.5.1873; Faderl S, 2005, LEUKEMIA, V19, P2147, DOI 10.1038/sj.leu.2403984; Fischer K, 2012, J CLIN ONCOL, V30, P3209, DOI 10.1200/JCO.2011.39.2688; Flinn IW, 2007, J CLIN ONCOL, V25, P793, DOI 10.1200/JCO.2006.08.0762; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Geisler CH, 2014, BLOOD, V123, P3255, DOI 10.1182/blood-2014-01-547737; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Gribben JG, 2005, BLOOD, V106, P4389, DOI 10.1182/blood-2005-05-1778; Gribben JG, 2010, BLOOD, V115, P187, DOI 10.1182/blood-2009-08-207126; GRIFFITHS H, 1989, BLOOD, V73, P366; Gupta N, 2002, LEUKEMIA, V16, P2092, DOI 10.1038/sj.leu.2402676; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2013, BLOOD, V122, P3723, DOI 10.1182/blood-2013-05-498287; Hillmen P, 2007, J CLIN ONCOL, V25, P5616, DOI 10.1200/JCO.2007.12.9098; Hillmen P, 2014, J CLIN ONCOL, V32, P1236, DOI 10.1200/JCO.2013.49.6547; Keating MJ, 2005, BLOOD, V106, p599A, DOI 10.1182/blood.V106.11.2118.2118; Keating MJ, 2005, J CLIN ONCOL, V23, P4079, DOI 10.1200/JCO.2005.12.051; Knauf WU, 2012, BRIT J HAEMATOL, V159, P67, DOI 10.1111/bjh.12000; Knauf WU, 2009, J CLIN ONCOL, V27, P4378, DOI 10.1200/JCO.2008.20.8389; Lamanna N, 2012, CURR HEMATOL MALIG R, V7, P21, DOI 10.1007/s11899-011-0111-0; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Leporrier M, 2001, BLOOD, V98, P2319, DOI 10.1182/blood.V98.8.2319; Lepretre S, 2012, BLOOD, V119, P5104, DOI 10.1182/blood-2011-07-365437; Mabed M, 2004, LEUKEMIA LYMPHOMA, V45, P2029, DOI 10.1080/10428190410001714061; Maloney DG, 1997, BLOOD, V90, P2188; Mauro FR, 2000, BLOOD, V95, P2786, DOI 10.1182/blood.V95.9.2786.009k30_2786_2792; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Molica S, 1996, HAEMATOLOGICA, V81, P121; Montillo M, 2006, J CLIN ONCOL, V24, P2337, DOI 10.1200/JCO.2005.04.6037; Moreno C, 2005, J CLIN ONCOL, V23, P3433, DOI 10.1200/JCO.2005.04.531; Moreton P, 2005, J CLIN ONCOL, V23, P2971, DOI 10.1200/JCO.2005.04.021; Morrison VA, 2001, J CLIN ONCOL, V19, P3611, DOI 10.1200/JCO.2001.19.16.3611; Mulligan SP, 2014, LEUKEMIA LYMPHOMA, V55, P2769, DOI 10.3109/10428194.2014.893306; Muntanola A, 2007, J CLIN ONCOL, V25, P1576, DOI 10.1200/JCO.2006.08.4194; Nabhan C, 2014, LEUKEMIA LYMPHOMA, V55, P2778, DOI 10.3109/10428194.2014.898758; Nabhan C, 2011, CLIN MED INSIGHTS-ON, V5, P45, DOI 10.4137/CMO.S4087; Parikh SA, 2014, BLOOD, V123, P1647, DOI 10.1182/blood-2013-11-516229; Parikh SA, 2013, BRIT J HAEMATOL, V162, P774, DOI 10.1111/bjh.12458; Rai K, 2009, BLOOD, V114, pA536; Rai Kanti R, 2011, Clin Lymphoma Myeloma Leuk, V11 Suppl 1, pS7, DOI 10.1016/j.clml.2011.04.007; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Rawstron AC, 2001, BLOOD, V98, P29, DOI 10.1182/blood.V98.1.29; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Robak T, 2000, BLOOD, V96, P2723; Robak T, 2006, BLOOD, V108, P473, DOI 10.1182/blood-2005-12-4828; Robak T, 2010, J CLIN ONCOL, V28, P1863, DOI 10.1200/JCO.2009.25.9630; Robak T, 2010, J CLIN ONCOL, V28, P1756, DOI 10.1200/JCO.2009.26.4556; Rossi D, 2013, ADV EXP MED BIOL, V792, P173, DOI 10.1007/978-1-4614-8051-8_8; Rossi D, 2013, LEUKEMIA LYMPHOMA, V54, P213, DOI 10.3109/10428194.2012.718345; Rossi D, 2011, BLOOD, V117, P3391, DOI 10.1182/blood-2010-09-302174; SACKETT DL, 1989, CHEST, V95, pS2, DOI 10.1378/chest.95.2.2S; Shanafelt T, 2013, HEMATOL-AM SOC HEMAT, P158, DOI 10.1182/asheducation-2013.1.158; Shanafelt TD, 2007, CANCER-AM CANCER SOC, V109, P2291, DOI 10.1002/cncr.22662; Shanafelt TD, 2006, ANN INTERN MED, V145, P435, DOI 10.7326/0003-4819-145-6-200609190-00007; Shanafelt TD, 2004, BLOOD, V103, P1202, DOI 10.1182/blood-2003-07-2281; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sorror ML, 2005, J CLIN ONCOL, V23, P3819, DOI 10.1200/JCO.2005.04.569; Strati P, 2013, BLOOD, V122, P734, DOI 10.1182/blood-2013-04-495341; Tam CS, 2008, BLOOD, V112, P975, DOI 10.1182/blood-2008-02-140582; Tsimberidou AM, 2005, CANCER-AM CANCER SOC, V103, P216, DOI 10.1002/cncr.20773; Wendtner CM, 2004, LEUKEMIA, V18, P1093, DOI 10.1038/sj.leu.2403354; Wiestner A, 2013, J CLIN ONCOL, V31, P128, DOI 10.1200/JCO.2012.44.4281; Zelenetz AD, 2010, J NATL COMPR CANC NE, V8, P288, DOI 10.6004/jnccn.2010.0021; Zhu Q, 2004, LEUKEMIA LYMPHOMA, V45, P2239, DOI 10.1080/10428190412331283260	79	92	98	1	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2265	2276		10.1001/jama.2014.14553	http://dx.doi.org/10.1001/jama.2014.14553			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25461996				2022-12-28	WOS:000345684800021
J	Vohra, S				Vohra, Sameer			Learning Not to Move Forward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PEDIATRIC RESIDENTS		Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago	Vohra, S (corresponding author), Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.	sameer.vohra@uchospitals.edu						Bateman ST, 2012, J PALLIAT MED, V15, P1329, DOI 10.1089/jpm.2012.0253; McCabe ME, 2008, PEDIATRICS, V121, pE731, DOI 10.1542/peds.2007-1657	2	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2014	312	21					2215	2216		10.1001/jama.2014.12931	http://dx.doi.org/10.1001/jama.2014.12931			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU6AP	25461995				2022-12-28	WOS:000345684800013
J	McWilliams, JM; Dalton, JB; Landrum, MB; Frakt, AB; Pizer, SD; Keating, NL				McWilliams, J. Michael; Dalton, Jesse B.; Landrum, Mary Beth; Frakt, Austin B.; Pizer, Steven D.; Keating, Nancy L.			Geographic Variation in Cancer-Related Imaging: Veterans Affairs Health Care System Versus Medicare	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; ACUTE MYOCARDIAL-INFARCTION; FACILITY-LEVEL VARIATION; STAGE IV CANCER; FEE-FOR-SERVICE; REGIONAL-VARIATIONS; ELDERLY-PATIENTS; PRIVATE-SECTOR; OLDER VETERANS; OUTCOMES	Background: Geographic variations in use of medical services have been interpreted as indirect evidence of wasteful care. Less overuse of services, however, may not be reliably associated with less geographic variation. Objective: To compare average use and geographic variation in use of cancer-related imaging between fee-for-service Medicare and the Department of Veterans Affairs (VA) health care system. Design: Observational analysis of cancer-related imaging from 2003 to 2005 using Medicare and VA utilization data linked to cancer registry data. Multilevel models, adjusted for sociodemographic and tumor characteristics, were used to estimate mean differences in annual imaging use between cohorts of Medicare and VA patients within geographic areas and variation in use across areas for each cohort. Setting: 40 hospital referral regions. Patients: Older men with lung, colorectal, or prostate cancer, including 34 475 traditional Medicare beneficiaries (Medicare cohort) and 6835 VA patients (VA cohort). Measurements: Per-patient count of imaging studies for which lung, colorectal, or prostate cancer was the primary diagnosis (each study weighted by a standardized price), and a direct measure of overuse-advanced imaging for prostate cancer at low risk for metastasis. Results: Adjusted annual use of cancer-related imaging was lower in the VA cohort than in the Medicare cohort (price-weighted count, $197 vs. $379 per patient; P < 0.001), as was annual use of advanced imaging for prostate cancer at low risk for metastasis ($41 vs. $117 per patient; P < 0.001). Geographic variation in cancer-related imaging use was similar in magnitude in the VA and Medicare cohorts. Limitation: Observational study design. Conclusion: Use of cancer-related imaging was lower in the VA health care system than in fee-for-service Medicare, but lower use was not associated with less geographic variation. Geographic variation in service use may not be a reliable indicator of the extent of overuse.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Northeastern Univ, Boston, MA 02115 USA; Vet Affairs Boston Healthcare Syst, Jamaica Plain, NY USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Northeastern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	McWilliams, JM (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mcwilliams@hcp.med.harvard.edu	Keating, Nancy L/I-9968-2019	Keating, Nancy L/0000-0002-8274-4681; Pizer, Steven/0000-0003-4908-5976; Frakt, Austin/0000-0002-0795-5462	Doris Duke Charitable Foundation [2010053]; Beeson Career Development Award Program (National Institute on Aging) [K08 AG038354]; Beeson Career Development Award Program (American Federation for Aging Research); VA Health Services Research and Development [IAD 06-112]; Pizer; VA Office of Policy and Planning; California Department of Public Health [103885]; NCI SEER program [N01-PC-35136, N01-PC-35139, N02-PC-15105]; Centers for Disease Control and Prevention's National Program of Cancer Registries [U55/CCR921930-02]; NATIONAL INSTITUTE ON AGING [K08AG038354] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Beeson Career Development Award Program (National Institute on Aging); Beeson Career Development Award Program (American Federation for Aging Research); VA Health Services Research and Development(US Department of Veterans Affairs); Pizer; VA Office of Policy and Planning; California Department of Public Health; NCI SEER program; Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the Doris Duke Charitable Foundation (Clinical Scientist Development Award 2010053; Dr. McWilliams), Beeson Career Development Award Program (National Institute on Aging K08 AG038354 and the American Federation for Aging Research; Dr. McWilliams), VA Health Services Research and Development (IAD 06-112; Drs. Frakt and Pizer), and the VA Office of Policy and Planning (as part of a larger evaluation of the quality of cancer care in the VA; Drs. Landrum and Keating). The collection of the cancer incidence data from California used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the NCI SEER program under contract N01-PC-35136 awarded to the Northern California Cancer Center, contract N01-PC-35139 awarded to the University of Southern California, and contract N02-PC-15105 awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries under agreement U55/CCR921930-02 awarded to the Public Health Institute.	American Society of Clinical Oncology, CHOOS WIS 10 THINGS; [Anonymous], TABL SHOW REIMB VAR; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Ashton CM, 1999, NEW ENGL J MED, V340, P32, DOI 10.1056/NEJM199901073400106; Aspinall SL, 2005, CLIN THER, V27, P258, DOI 10.1016/j.clinthera.2005.02.002; Baker LC, 2010, HEALTH AFFAIR, V29, P2068, DOI 10.1377/hlthaff.2009.0810; Borowsky S, 1999, J GEN INTERN MED, V14, P274, DOI 10.1046/j.1525-1497.1999.00335.x; Center for Medicare & Medicaid Innovation, INN MOD; Centers for Medicare and Medicaid Services, HOSP VAL BAS PURCH P; Centers for Medicare & Medicaid Services, BER EGG TYP SERV BET; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P67802; Chandra A, EC MEETS GEOGRAPHY M; Chandra A, 2007, J POLIT ECON, V115, P103, DOI 10.1086/512249; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Congressional Budget Office, 2008, GEOGR VAR HLTH CAR S; Cutler D, 2013, PHYS BELIEFS PATIENT; Dinan MA, 2010, JAMA-J AM MED ASSOC, V303, P1625, DOI 10.1001/jama.2010.460; Doyle JJ, 2010, J HEALTH ECON, V29, P866, DOI 10.1016/j.jhealeco.2010.08.004; Elshaug AG, 2013, JAMA-J AM MED ASSOC, V309, P775, DOI 10.1001/jama.2013.828; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Gellad W, 2012, ARCH INTERN MED, V172, P1608, DOI 10.1001/archinternmed.2012.4482; Gellad WF, 2013, ANN INTERN MED, V159, P105, DOI 10.7326/0003-4819-159-2-201307160-00664; Gellad WF, 2012, J AM GERIATR SOC, V60, P1222, DOI 10.1111/j.1532-5415.2012.04042.x; Gellad WF, 2010, AM J MANAG CARE, V16, P741; Hu YY, 2012, JNCI-J NATL CANCER I, V104, P1164, DOI 10.1093/jnci/djs286; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; Institute of Medicine, 2013, INTERIM REPORT COMMI; Institute of Medicine Committee on Geographic Variation in Health Care Spending and Promotion of High-Value Care, 2013, VAR HLTH CAR SPEND T; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Keating NL, 2012, MED CARE, V50, P366, DOI 10.1097/MLR.0b013e31824d74c0; Keating NL, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00004; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P3732, DOI 10.1002/cncr.25077; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; Kizer KW, 2009, ANNU REV PUBL HEALTH, V30, P313, DOI 10.1146/annurev.publhealth.29.020907.090940; KIZER KW, 2000, MED CARE S1, V38, P7; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kouri EM, 2012, HEALTH SERV RES, V47, P783, DOI 10.1111/j.1475-6773.2011.01327.x; Landrum MB, 2008, HEALTH AFFAIR, V27, P159, DOI 10.1377/hlthaff.27.1.159; Landrum MB, 2012, J CLIN ONCOL, V30, P1072, DOI 10.1200/JCO.2011.35.6758; Matlock DD, 2013, JAMA-J AM MED ASSOC, V310, P155, DOI 10.1001/jama.2013.7837; MCPHERSON K, 1982, NEW ENGL J MED, V307, P1310, DOI 10.1056/NEJM198211183072104; Nambudiri VE, 2012, UROLOGY, V79, P537, DOI 10.1016/j.urology.2011.11.013; National Cancer Institute, OV SEER PROGR; Petersen LA, 2000, NEW ENGL J MED, V343, P1934, DOI 10.1056/NEJM200012283432606; POTOSKY AL, 1993, MED CARE, V31, P732; Schwartz AL, 2014, JAMA INTERN MED, V174, P1067, DOI 10.1001/jamainternmed.2014.1541; Selim AJ, 2010, HEALTH SERV RES, V45, P376, DOI 10.1111/j.1475-6773.2009.01068.x; Skinner JS, 2006, HEALTH AFFAIR, V25, pW34, DOI 10.1377/hlthaff.25.w34; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Subramanian U, 2002, J GEN INTERN MED, V17, P604, DOI 10.1046/j.1525-1497.2002.11048.x; The Center for Medicare and Medicaid Innovation, 2011, PION ACC CAR ORG ACO; U.S. General Accounting Office, 2002, VA HLTH CAR ALL CHAN; Veterans Affairs Information Resource Center, 2004, VIREC RES US GUID VH; Veterans Affairs Information Resource Center, 2009, VIREC RES US GUID VH; Yabroff KR, 2012, J NATL CANCER I, V104, P1113, DOI 10.1093/jnci/djs316; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	57	27	27	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 2	2014	161	11					794	U87		10.7326/M14-0650	http://dx.doi.org/10.7326/M14-0650			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AX9UJ	25437407	Green Accepted			2022-12-28	WOS:000347247200008
J	Persa, OD; Jazmati, N; Robinson, N; Wolke, M; Kremer, K; Schweer, K; Plum, G; Schlaak, M				Persa, Oana-Diana; Jazmati, Nathalie; Robinson, Nirmal; Wolke, Martina; Kremer, Kim; Schweer, Katharina; Plum, Georg; Schlaak, Max			A pregnant woman with chronic meningococcaemia from Neisseria meningitidis with lpxL1-mutations	LANCET			English	Editorial Material									[Persa, Oana-Diana; Kremer, Kim; Schlaak, Max] Univ Cologne, Dept Dermatol & Venereol, D-50937 Cologne, Germany; [Jazmati, Nathalie; Robinson, Nirmal; Wolke, Martina; Plum, Georg] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50937 Cologne, Germany; [Schweer, Katharina] Univ Cologne, Dept Internal Med 1, Div Infect Dis, D-50937 Cologne, Germany; [Robinson, Nirmal] CECAD Res Ctr, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne	Persa, OD (corresponding author), Univ Cologne, Dept Dermatol & Venereol, D-50937 Cologne, Germany.	oana-diana.persa@uk-koeln.de	Robinson, Nirmal/AAJ-1996-2020	Robinson, Nirmal/0000-0002-7361-9491				Fransen F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000396; Harwood CA, 2005, BRIT J DERMATOL, V153, P669, DOI 10.1111/j.1365-2133.2005.06771.x; Roux M, 2010, REV MED INTERNE, V31, P445, DOI 10.1016/j.revmed.2009.11.010; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Wenzel M, 2014, JAMA DERMATOL, V150, P752, DOI 10.1001/jamadermatol.2013.9350	5	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1900	1900		10.1016/S0140-6736(14)61645-7	http://dx.doi.org/10.1016/S0140-6736(14)61645-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7LA	25457917				2022-12-28	WOS:000345116800031
J	Solomon, BJ; Mok, T; Kim, DW; Wu, YL; Nakagawa, K; Mekhail, T; Felip, E; Cappuzzo, F; Paolini, J; Usari, T; Iyer, S; Reisman, A; Wilner, KD; Tursi, J; Blackhall, F; Boyer, M; Ganju, V; Hughes, B; Pavlakis, N; Solomon, B; Varma, S; Berghmans, T; Canon, JL; Demedts, I; Janssens, A; Louis, R; Pieters, T; Schallier, D; Surmont, V; da Silva, CM; Ferreira, CGM; Hirsh, V; Joy, A; Laberge, F; Morzycki, W; Wierzbicki, R; Han, B; Liu, X; Qin, S; Shi, Y; Wang, Y; Wu, G; Wu, YL; Zhou, C; Ahvonen, J; Barlesi, F; Cadranel, J; Dansin, E; Fayette, J; Morere, JF; Moro-Sibilot, D; Pujol, JL; Quoix, E; Zalcman, G; Frickhofen, N; Schneider, CP; Wehler, T; Mok, T; So, P; Cuffe, S; Bearz, A; Boni, C; Cappuzzo, F; Cognetti, F; De Braud, F; De Pas, T; Galetta, D; Migliorino, M; Rocco, D; Scagliotti, G; Tagliaferri, P; Tiseo, M; Aoe, K; Hida, T; Kato, T; Kozuki, T; Nakagawa, K; Niho, S; Nishio, M; Nokihara, H; Satouchi, M; Seto, T; Takahashi, T; Ahn, JS; Kim, DW; Kim, SW; Berchem, G; Rodriguez, OA; Biesma, B; Dingemans, AM; Smit, E; Helland, A; Barata, F; Gorbunova, V; Manikhas, G; Orlov, S; Leong, S; Lim, HL; Soo, R; Tan, EH; Nosworthy, A; Villena, MC; Felip, E; Lopez, PG; Casado, DI; Banaclocha, NM; Aix, SP; Aransay, NR; Abreu, DR; Perez, JT; Gautschi, O; Pless, M; Zippelius, A; Chang, GC; Tsai, YH; Shparyk, Y; Blackhall, F; Steele, N; Armenio, V; Dragnev, K; Dugan, M; Gadgeel, S; Gerber, D; Graziano, S; Gurubhagavatula, S; Horn, L; Jalal, S; Lauer, R; Mehra, R; Mekhail, T; Mirshahidi, H; Pakkala, S; Polikoff, J; Raftopoulos, H; Saleh, M; Salgia, R; Waqar, S				Solomon, Benjamin J.; Mok, Tony; Kim, Dong-Wan; Wu, Yi-Long; Nakagawa, Kazuhiko; Mekhail, Tarek; Felip, Enriqueta; Cappuzzo, Federico; Paolini, Jolanda; Usari, Tiziana; Iyer, Shrividya; Reisman, Arlene; Wilner, Keith D.; Tursi, Jennifer; Blackhall, Fiona; Boyer, M.; Ganju, V.; Hughes, B.; Pavlakis, N.; Solomon, B.; Varma, S.; Berghmans, T.; Canon, J-L; Demedts, I.; Janssens, A.; Louis, R.; Pieters, T.; Schallier, D.; Surmont, V.; da Silva, C. Maciel; Ferreira, C-G Moreira; Hirsh, V.; Joy, A.; Laberge, F.; Morzycki, W.; Wierzbicki, R.; Han, B.; Liu, X.; Qin, S.; Shi, Y.; Wang, Y.; Wu, G.; Wu, Y-L; Zhou, C.; Ahvonen, J.; Barlesi, F.; Cadranel, J.; Dansin, E.; Fayette, J.; Morere, J-F; Moro-Sibilot, D.; Pujol, J-L; Quoix, E.; Zalcman, G.; Frickhofen, N.; Schneider, C-P; Wehler, T.; Mok, T.; So, P.; Cuffe, S.; Bearz, A.; Boni, C.; Cappuzzo, F.; Cognetti, F.; De Braud, F.; De Pas, T.; Galetta, D.; Migliorino, M.; Rocco, D.; Scagliotti, G.; Tagliaferri, P.; Tiseo, M.; Aoe, K.; Hida, T.; Kato, T.; Kozuki, T.; Nakagawa, K.; Niho, S.; Nishio, M.; Nokihara, H.; Satouchi, M.; Seto, T.; Takahashi, T.; Ahn, J-S; Kim, D-W; Kim, S-W; Berchem, G.; Rodriguez, O. Arrieta; Biesma, B.; Dingemans, A-M; Smit, E.; Helland, A.; Barata, F.; Gorbunova, V.; Manikhas, G.; Orlov, S.; Leong, S.; Lim, H-L; Soo, R.; Tan, E-H; Nosworthy, A.; Villena, M. Codes; Felip, E.; Lopez, P. Garrido; Casado, D. Isla; Banaclocha, N. Martinez; Aix, S. Ponce; Aransay, N. Reguart; Abreu, D. Rodriguez; Perez, J. Trigo; Gautschi, O.; Pless, M.; Zippelius, A.; Chang, G-C; Tsai, Y-H; Shparyk, Y.; Blackhall, F.; Steele, N.; Armenio, V.; Dragnev, K.; Dugan, M.; Gadgeel, S.; Gerber, D.; Graziano, S.; Gurubhagavatula, S.; Horn, L.; Jalal, S.; Lauer, R.; Mehra, R.; Mekhail, T.; Mirshahidi, H.; Pakkala, S.; Polikoff, J.; Raftopoulos, H.; Saleh, M.; Salgia, R.; Waqar, S.		PROFILE 1014 Investigators	First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANAPLASTIC LYMPHOMA; PHASE-III; CISPLATIN; PLUS; ADENOCARCINOMA; GEFITINIB; CRITERIA; THERAPY; QLQ-C30; KINASE	BACKGROUND The efficacy of the ALK inhibitor crizotinib as compared with standard chemotherapy as first-line treatment for advanced ALK-positive non-small-cell lung cancer (NSCLC) is unknown. METHODS We conducted an open-label, phase 3 trial comparing crizotinib with chemotherapy in 343 patients with advanced ALK-positive nonsquamous NSCLC who had received no previous systemic treatment for advanced disease. Patients were randomly assigned to receive oral crizotinib at a dose of 250 mg twice daily or to receive intravenous chemotherapy (pemetrexed, 500 mg per square meter of body-surface area, plus either cisplatin, 75 mg per square meter, or carboplatin, target area under the curve of 5 to 6 mg per milliliter per minute) every 3 weeks for up to six cycles. Crossover to crizotinib treatment after disease progression was permitted for patients receiving chemotherapy. The primary end point was progression-free survival as assessed by independent radiologic review. RESULTS Progression-free survival was significantly longer with crizotinib than with chemotherapy (median, 10.9 months vs. 7.0 months; hazard ratio for progression or death with crizotinib, 0.45; 95% confidence interval [CI], 0.35 to 0.60; P<0.001). Objective response rates were 74% and 45%, respectively (P<0.001). Median overall survival was not reached in either group (hazard ratio for death with crizotinib, 0.82; 95% CI, 0.54 to 1.26; P = 0.36); the probability of 1-year survival was 84% with crizotinib and 79% with chemotherapy. The most common adverse events with crizotinib were vision disorders, diarrhea, nausea, and edema, and the most common events with chemotherapy were nausea, fatigue, vomiting, and decreased appetite. As compared with chemotherapy, crizotinib was associated with greater reduction in lung cancer symptoms and greater improvement in quality of life. CONCLUSIONS Crizotinib was superior to standard first-line pemetrexed-plus-platinum chemotherapy in patients with previously untreated advanced ALK-positive NSCLC.	[Solomon, Benjamin J.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Mok, Tony] Chinese Univ Hong Kong, State Key Lab South China, Hong Kong Canc Inst, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China; [Wu, Yi-Long] Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; [Kim, Dong-Wan] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Nakagawa, Kazuhiko] Kinki Univ, Osaka, Japan; [Mekhail, Tarek] Florida Hosp, Inst Canc, Orlando, FL USA; [Felip, Enriqueta] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain; [Cappuzzo, Federico] Ist Toscano Tumori, Livorno, Italy; [Paolini, Jolanda; Usari, Tiziana; Tursi, Jennifer] Pfizer Oncol, Milan, Italy; [Iyer, Shrividya] Pfizer Oncol, New York, NY USA; [Reisman, Arlene] Pfizer Global Innovat Pharma Business, New York, NY USA; [Wilner, Keith D.] Pfizer Oncol, La Jolla, CA USA; [Blackhall, Fiona] Univ Manchester, Christie Hosp, Manchester, Lancs, England; [Blackhall, Fiona] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England	Peter Maccallum Cancer Center; Chinese University of Hong Kong; Seoul National University (SNU); Seoul National University Hospital; Kindai University (Kinki University); Adventist Health Services; AdventHealth; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Pfizer; Pfizer; Pfizer; Pfizer; Christie NHS Foundation Trust; Christie Hospital; University of Manchester; University of Manchester	Solomon, BJ (corresponding author), Peter MacCallum Canc Ctr, Dept Med Oncol, St Andrews Pl, East Melbourne, Vic 3002, Australia.	ben.solomon@petermac.org	Orlov, Sergey/AAC-8379-2022; Tiseo, Marcello/K-6119-2016; Helland, Åslaug/H-3910-2015; Galetta, Domenico/J-4082-2018; Wu, Yi-Long/GRJ-9238-2022; GARRIDO, PILAR/D-5187-2017; ZALCMAN, Gerard/M-8113-2019; Wu, Yi-Long/AAW-9832-2020; Wu, Yi-Long/AAB-9137-2022; Hughes, Brett/A-4546-2015; Mok, Tony Shu Kam/B-2310-2019; Tagliaferri, Pierosandro/K-9546-2016; Berchem, Guy/C-9364-2014; Wu, Yi-Long/C-3396-2008; Boyer, Michael/GZG-2105-2022; De Pas, tommaso/K-4879-2018; Blackhall, Fiona H/N-2186-2015; FELIP, ENRIQUETA/AAG-6316-2019; Cappuzzo, federico/R-2827-2016; Cognetti, Francesco/AAC-2637-2019; Wehler, Thomas Christian/AAY-6362-2020; Kim, Dong-Wan/J-5391-2012	Tiseo, Marcello/0000-0002-9553-8465; Helland, Åslaug/0000-0002-5520-0275; Galetta, Domenico/0000-0002-4878-5906; Wu, Yi-Long/0000-0002-3611-0258; GARRIDO, PILAR/0000-0002-5899-6125; Hughes, Brett/0000-0002-1811-0537; Mok, Tony Shu Kam/0000-0002-8251-0551; Berchem, Guy/0000-0003-0157-2257; Wu, Yi-Long/0000-0002-3611-0258; Boyer, Michael/0000-0002-0452-2987; Blackhall, Fiona H/0000-0001-8716-3395; Cappuzzo, federico/0000-0002-6295-6767; Smit, Egbert/0000-0002-7329-6995; MORO-SIBILOT, Denis/0000-0001-6776-8610; Rodriguez-Abreu, Delvys/0000-0003-0506-1366; Iyer, shrividya/0000-0002-1770-2311; Balmana, Judith/0000-0002-0762-6415; Solomon, Benjamin/0000-0003-3059-5730; FELIP, ENRIQUETA/0000-0002-7620-0098	Pfizer	Pfizer(Pfizer)	Supported by Pfizer.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; *ABB MOL, 2011, VYS ALK BREAK AP FIS; BERGMAN B, 1994, EUR J CANCER, V30A, P635, DOI 10.1016/0959-8049(94)90535-5; Blackhall FH, 2014, J CLIN ONCOL, V32, P2780, DOI 10.1200/JCO.2013.54.5921; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Camidge DR, 2011, J THORAC ONCOL, V6, P774, DOI 10.1097/JTO.0b013e31820cf053; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Cortes JE, 2012, J CLIN ONCOL, V30; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fayers P, 2002, EUR J CANCER, V38, pS125; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok T, 2013, J CLIN ONCOL, V31, P1081, DOI 10.1200/JCO.2012.43.0652; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; ROBINS JM, 1991, COMMUN STAT THEORY, V20, P2609, DOI 10.1080/03610929108830654; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P319, DOI 10.1097/00001648-199207000-00007; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shaw AT, 2013, ANN ONCOL, V24, P59, DOI 10.1093/annonc/mds242; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; SHAW AT, 2013, 15 WORLD C LUNG CANC; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Temple R, 2006, PHARMACOEPIDEM DR S, V15, P241, DOI 10.1002/pds.1211; White IR, 1999, STAT MED, V18, P2617, DOI 10.1002/(SICI)1097-0258(19991015)18:19<2617::AID-SIM187>3.0.CO;2-E; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	33	2193	2310	8	186	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2014	371	23					2167	2177		10.1056/NEJMoa1408440	http://dx.doi.org/10.1056/NEJMoa1408440			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW0IY	26466011	Bronze, Green Published			2022-12-28	WOS:000345976700005
